PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Barloscio, D; Cerri, E; Domenici, L; Longhi, R; Dallanoce, C; Moretti, M; Vilella, A; Zoli, M; Gotti, C; Origlia, N				Barloscio, Davide; Cerri, Elisa; Domenici, Luciano; Longhi, Renato; Dallanoce, Clelia; Moretti, Milena; Vilella, Antonietta; Zoli, Michele; Gotti, Cecilia; Origlia, Nicola			In vivo study of the role of alpha 6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin	FASEB JOURNAL			English	Article						retina; ganglion cell layer; flash electroretinogram; visual-evoked potential; pattern electroretinogram	LATERAL GENICULATE-NUCLEUS; STARBURST AMACRINE CELLS; ALPHA-CONOTOXIN; GANGLION-CELLS; MICE LACKING; DIRECTIONAL SELECTIVITY; BETA-2 SUBUNIT; OPTIC-NERVE; CHOLINERGIC-RECEPTORS; DOPAMINE RELEASE	Although alpha 6-contaning (alpha 6*) nicotinic acetylcholine receptors (nAChRs) are densely expressed in the visual system, their role is not well known. We have characterized a family of toxins that are antagonists for alpha 6 beta 2* receptors and used one of these [RDP-MII(E11R)] to localize alpha 6* nAChRs and investigate their impact on retinal function in adult Long-Evans rats. The alpha 6* nAChRs in retinal tissue were localized using either a fluorescently tagged [RDP-MII(E11R)] or anti-alpha 6-specific antibodies and found to be predominantly at the level of the ganglion cell layer. After intraocular injection of RDP-MII(E11R) in one eye and vehicle or inactive MII in contralateral eyes as controls, we recorded flash electroretinograms (F-ERGs), pattern ERGs (P-ERGs), and cortical visual-evoked potential (VEPs). There was no significant difference in F-ERG between the RDP-MII(E11R)-treated and control eyes. In contrast, P-ERG response amplitude was significantly reduced in the RDP-MII(E11R)-injected eye. Blocking alpha 6* nAChRs at retinal level also decreased the VEP amplitude recorded in the visual cortex contralateral to the injected eye. Because both the cortical and inner retina output were affected by RDP-MII(E11R), whereas photoreceptor output was preserved, we conclude that the reduced visual response was due to an alteration in the function of alpha 6* nAChRs present in the ganglion cell layer.-Barloscio, D., Cerri, E., Domenici, L., Longhi, R., Dallanoce, C., Moretti, M., Vilella, A., Zoli, M., Gotti, C., and Origlia, N. In vivo study of the roleof alpha 6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin.	[Barloscio, Davide; Cerri, Elisa; Domenici, Luciano; Origlia, Nicola] Natl Res Council CNR, Neurosci Inst Pisa, Pisa, Italy; [Longhi, Renato] CNR Inst Chem Mol Recognit, Milan, Italy; [Dallanoce, Clelia] Univ Milan, Sect Med Chem Pietro Pratesi, Dept Pharmaceut Sci, Milan, Italy; [Moretti, Milena; Gotti, Cecilia] Biometra Univ Milan, CNR Neurosci Inst Milano, Milan, Italy; [Vilella, Antonietta; Zoli, Michele] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Ctr Neurosci & Neurotechnol, Modena, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Milan; Universita di Modena e Reggio Emilia	Gotti, C (corresponding author), CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.; Origlia, N (corresponding author), CNR, Inst Neurosci, Via Giuseppe Moruzzi 1, I-56100 Pisa, Italy.	c.gotti@in.cnr.it; origlia@in.cnr.it	VILELLA, ANTONIETTA/AAU-3373-2021; Vilella, Antonietta/AAF-2084-2019	Vilella, Antonietta/0000-0003-3820-0115; Domenici, Luciano/0000-0003-2923-9421	European Union [HEALTH-F2-2008-202088]; CNR Research Project on Aging; Fondazione Vollaro; Fondazione Monzino	European Union(European Commission); CNR Research Project on Aging(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Vollaro(Fondazione CarifeFondazione Caritro); Fondazione Monzino	This work was supported by the European Union Seventh Framework Programme (Grant HEALTH-F2-2008-202088 "NeuroCypres" project), by the CNR Research Project on Aging, and by the Fondazione Vollaro and Fondazione Monzino. The authors thank Dr. Enrica Strettoi for helpful discussion, Mr. Renzo Di Renzo for technical assistance, and Dr. Francesca Biondi for the excellent animal care, all from the CNR Neuroscience Institute-Pisa.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bansal A, 2000, J NEUROSCI, V20, P7672; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Cerri E, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.6.1; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Criscuolo C, 2015, NEUROSCIENCE, V294, P166, DOI 10.1016/j.neuroscience.2015.03.022; DOMENICI L, 1991, EXP BRAIN RES, V86, P579; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gotti C, 2005, MOL PHARMACOL, V68, P1162, DOI 10.1124/mol.105.015925; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Grzywacz NM, 1998, VISUAL NEUROSCI, V15, P1119, DOI 10.1017/S0952523898156109; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Kim HJ, 2014, EXP EYE RES, V122, P54, DOI 10.1016/j.exer.2014.02.021; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Lee BB, 2010, PROG RETIN EYE RES, V29, P622, DOI 10.1016/j.preteyeres.2010.08.004; Lena C, 1999, P NATL ACAD SCI USA, V96, P12126, DOI 10.1073/pnas.96.21.12126; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; MAFFEI L, 1984, DOC OPHTHALMOL, V58, P97, DOI 10.1007/BF00140905; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASUDA K, 1995, INVEST OPHTH VIS SCI, V36, P2142; McClure-Begley TD, 2012, J NEUROCHEM, V122, P48, DOI 10.1111/j.1471-4159.2012.07759.x; McReynolds J S, 1986, Neurosci Res Suppl, V4, pS153; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Origlia N, 2012, INVEST OPHTH VIS SCI, V53, P1211, DOI 10.1167/iovs.11-8007; Pistillo F, 2015, PROG NEUROBIOL, V124, P1, DOI 10.1016/j.pneurobio.2014.10.002; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Porciatti V, 2012, J NEURO-OPHTHALMOL, V32, P354, DOI 10.1097/WNO.0b013e3182745600; Pucci L, 2011, FASEB J, V25, P3775, DOI 10.1096/fj.10-179853; Reed BT, 2004, VISUAL NEUROSCI, V21, P861, DOI 10.1017/S0952523804216066; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Strang CE, 2015, J NEUROPHYSIOL, V113, P203, DOI 10.1152/jn.00405.2014; Sugawara T, 2000, EXP EYE RES, V70, P693, DOI 10.1006/exer.2000.0842; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zoli M, 1997, STROKE, V28, P1049, DOI 10.1161/01.STR.28.5.1049; Zoli M, 2002, J NEUROSCI, V22, P8785; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	60	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					192	202		10.1096/fj.201600855R	http://dx.doi.org/10.1096/fj.201600855R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27682206				2022-12-26	WOS:000392177600020
J	Harris, DT; Wang, NY; Riley, TP; Anderson, SD; Singh, NK; Procko, E; Baker, BM; Kranz, DM				Harris, Daniel T.; Wang, Ningyan; Riley, Timothy P.; Anderson, Scott D.; Singh, Nishant K.; Procko, Erik; Baker, Brian M.; Kranz, David M.			Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE-DISPLAY; DIRECTED EVOLUTION; IN-VITRO; COMPUTATIONAL DESIGN; THERMAL-STABILITY; PROTEIN FUNCTION; SPECIFICITY; EXPRESSION; INTERFACE; BINDING	Proteins are often engineered to have higher affinity for their ligands to achieve therapeutic benefit. For example, many studies have used phage or yeast display libraries of mutants within complementarity-determining regions to affinity mature antibodies and T cell receptors (TCRs). However, these approaches do not allow rapid assessment or evolution across the entire interface. By combining directed evolution with deep sequencing, it is now possible to generate sequence fitness landscapes that survey the impact of every amino acid substitution across the entire protein-protein interface. Here we used the results of deep mutational scans of a TCR-peptide-MHC interaction to guide mutational strategies. The approach yielded stable TCRs with affinity increases of >200-fold. The substitutions with the greatest enrichments based on the deep sequencing were validated to have higher affinity and could be combined to yield additional improvements. We also conducted in silico binding analyses for every substitution to compare them with the fitness landscape. Computational modeling did not effectively predict the impacts of mutations distal to the interface and did not account for yeast display results that depended on combinations of affinity and protein stability. However, computation accurately predicted affinity changes for mutations within or near the interface, highlighting the complementary strengths of computational modeling and yeast surface display coupled with deep mutational scanning for engineering high affinity TCRs.	[Harris, Daniel T.; Wang, Ningyan; Anderson, Scott D.; Procko, Erik; Kranz, David M.] Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA; [Riley, Timothy P.; Singh, Nishant K.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, South Bend, IN 46557 USA; [Riley, Timothy P.; Singh, Nishant K.; Baker, Brian M.] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN 46557 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame; University of Notre Dame	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, 600 S Matthews Ave, Urbana, IL 61801 USA.	d-kranz@illinois.edu	Singh, Nishant/ABB-3749-2020	Procko, Erik/0000-0002-0028-490X	National Institutes of Health [CA178844, CA187592, GM118166, CA180723]; Indiana CTSI - National Institutes of Health [UL1TR001108]; NATIONAL CANCER INSTITUTE [R01CA178844, R21CA187592, F30CA180723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana CTSI - National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA178844 and CA187592 (to D. M. K.), GM118166 (to B. M. B.), and CA180723 (to D. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the Indiana CTSI, funded in part by National Institutes of Health Grant UL1TR001108.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Harris DT, 2016, STRUCTURE, V24, P1142, DOI 10.1016/j.str.2016.04.011; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Honegger A, 2009, PROTEIN ENG DES SEL, V22, P121, DOI 10.1093/protein/gzn077; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kieke MC, 2001, J MOL BIOL, V307, P1305, DOI 10.1006/jmbi.2001.4560; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Nielsen JE, 2011, PROTEINS, V79, P3249, DOI 10.1002/prot.23194; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Park S, 2006, PROTEIN ENG DES SEL, V19, P211, DOI 10.1093/protein/gzl003; Pierce BG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003478; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; REYNOLDS JA, 1974, P NATL ACAD SCI USA, V71, P2925, DOI 10.1073/pnas.71.8.2925; Riley TP, 2016, PROTEIN ENG DES SEL, V29, P595, DOI 10.1093/protein/gzw050; Riley TP, 2016, METHODS MOL BIOL, V1414, P319, DOI 10.1007/978-1-4939-3569-7_19; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Schmitt TM, 2013, BLOOD, V122, P348, DOI 10.1182/blood-2013-01-478164; Schreiber G, 2013, CURR OPIN STRUC BIOL, V23, P903, DOI 10.1016/j.sbi.2013.08.003; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Smith SN, 2015, METHODS MOL BIOL, V1319, P95, DOI 10.1007/978-1-4939-2748-7_6; Smith SN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6223; Smith SN, 2013, J MOL BIOL, V425, P4496, DOI 10.1016/j.jmb.2013.08.007; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Stranges PB, 2013, PROTEIN SCI, V22, P74, DOI 10.1002/pro.2187; Thiltgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046084; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; Traxlmayr MW, 2012, ARCH BIOCHEM BIOPHYS, V526, P174, DOI 10.1016/j.abb.2012.04.022; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214	62	30	31	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24566	24578		10.1074/jbc.M116.748681	http://dx.doi.org/10.1074/jbc.M116.748681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681597	Green Published, hybrid			2022-12-26	WOS:000388875500019
J	Liu, SS; Long, JY; Yuan, B; Zheng, MJ; Xiao, M; Xu, JM; Lin, X; Feng, XH				Liu, Sisi; Long, Jianyin; Yuan, Bo; Zheng, Mingjie; Xiao, Mu; Xu, Jianming; Lin, Xia; Feng, Xin-Hua			SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-beta Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION; BONE METASTASIS; SIGNAL-TRANSDUCTION; CELL-CYCLE; CANCER; SNIP1; SUMOYLATION; GROWTH; DOMAIN; LUNG	SNIP1 (Smad nuclear interacting protein 1) is a transcription repressor for the TGE-beta and NE-kappa B signaling pathways through disrupting the recruitment of co-activator p300. However, it is unclear how the functions of SNIP1 in the TGE-beta signaling pathway are controlled. Our present studies show that SNIP1 is covalently modified by small ubiquitin-like modifier (SUMO) in vitro and in vivo at three lysine sites: Lys(5), Lys(30), and Lys(108), with Lys(30) being the major SUMO modification site. SUMOylation of SNIP! is enhanced by SUMO E3 ligase PIAS proteins and inhibited by SUMO proteases SENP1/2. Furthermore, we find that SUMOylation of SNIP1 attenuates its inhibitory effect in TGE-beta signaling because the SUMO-conjugated form of SNIP1 exhibits impaired ability to disrupt the formation of Smad complex and the interaction between p300 and Smads. Subsequently, SUMOylation of SNIP1 leads to the loss of SNIP1-mediated inhibition on expression of the TGF-beta target genes PAI-1 and MMP2 and eventually enhances TGE-beta-regulated cell migration and invasion.	[Liu, Sisi; Yuan, Bo; Zheng, Mingjie; Xiao, Mu; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Sisi; Long, Jianyin; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Liu, Sisi; Xu, Jianming; Feng, Xin-Hua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Long, Jianyin] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Dept Emergency Med, Houston, TX 77030 USA	Zhejiang University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Feng, XH (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	fenglab@zju.edu.cn		Zheng, Mingjie/0000-0003-0735-3995; Xiao, Mu/0000-0003-3058-2905	Key Program of the Ministry of Sciences and Technology [2012CB966600]; National Natural Science Foundation of China [91540205, 31571447]; Major Program of the National Natural Science Foundation of China [31090360]; Fundamental Research Funds for the Central Universities; Department of Defense [DAMD W81XWH-15-1-0650]; National Institutes of Health [R21CA209007, R01GM63773, R01AR053591, R01CA108454, R01DK073932]; NATIONAL CANCER INSTITUTE [R21CA209007, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	Key Program of the Ministry of Sciences and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Key Program of the Ministry of Sciences and Technology Grant 2012CB966600, National Natural Science Foundation of China Grants 91540205 and 31571447, Major Program of the National Natural Science Foundation of China Grant 31090360, the Fundamental Research Funds for the Central Universities, Department of Defense Grant DAMD W81XWH-15-1-0650, and National Institutes of Health Grants R21CA209007, R01GM63773, R01AR053591, R01CA108454, and R01DK073932. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonacci T, 2014, J PROTEOME RES, V13, P2478, DOI 10.1021/pr401258d; Chan HM, 2001, J CELL SCI, V114, P2363; Choi SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10384; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Fang YZ, 2013, JNCI-J NATL CANCER I, V105, P47, DOI 10.1093/jnci/djs485; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng YL, 2014, J BIOL CHEM, V289, P2072, DOI 10.1074/jbc.M113.526905; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Li JS, 2015, ONCOTARGET, V6, P6749, DOI 10.18632/oncotarget.3155; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li Z, 2012, CURR MOL MED, V12, P967, DOI 10.2174/156652412802480871; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Lin Y, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-15; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Roche KC, 2007, ONCOGENE, V26, P4523, DOI 10.1038/sj.onc.1210233; Roche KC, 2004, ONCOGENE, V23, P8185, DOI 10.1038/sj.onc.1208025; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zheng C, 2014, J MED CHEM, V57, P600, DOI 10.1021/jm401117t	38	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24418	24430		10.1074/jbc.M116.755850	http://dx.doi.org/10.1074/jbc.M116.755850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703003	hybrid, Green Published			2022-12-26	WOS:000388875500008
J	Ratha, BN; Ghosh, A; Brender, JR; Gayen, N; Ilyas, H; Neeraja, C; Das, KP; Mandal, AK; Bhunia, A				Ratha, Bhisma N.; Ghosh, Anirban; Brender, Jeffrey R.; Gayen, Nilanjan; Ilyas, Humaira; Neeraja, Chilukoti; Das, Kali P.; Mandal, Atin K.; Bhunia, Anirban			Inhibition of Insulin Amyloid Fibrillation by a Novel Amphipathic Heptapeptide: MECHANISTIC DETAILS STUDIED BY SPECTROSCOPY IN COMBINATION WITH MICROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); fluorescence anisotropy; inhibitor; insulin	TRANSFER DIFFERENCE NMR; AGGREGATION PATHWAYS; BETA FIBRILS; PROTEINS; BINDING; LIGAND; FIBRILLIZATION; STABILIZATION; ASSIGNMENT; DYNAMICS	The aggregation of insulin into amyloid fibers has been a limiting factor in the development of fast acting insulin analogues, creating a demand for excipients that limit aggregation. Despite the potential demand, inhibitors specifically targeting insulin have been few in number. Here we report a non-toxic and serum stable-designed heptapeptide, KR7 (KPWWPRR-NH2), that differs significantly from the primarily hydrophobic sequences that have been previously used to interfere with insulin amyloid fibrillation. Thioflavin T fluorescence assays, circular dichroism spectroscopy, and one-dimensional proton NMR experiments suggest KR7 primarily targets the fiber elongation step with little effect on the early oligomerization steps in the lag time period. From confocal fluorescence and atomic force microscopy experiments, the net result appears to be the arrest of aggregation in an early, non-fibrillar aggregation stage. This mechanism is noticeably different from previous peptide-based inhibitors, which have primarily shifted the lag time with little effect on later stages of aggregation. As insulin is an important model system for understanding protein aggregation, the new peptide may be an important tool for understanding peptide-based inhibition of amyloid formation.	[Ratha, Bhisma N.; Ghosh, Anirban; Ilyas, Humaira; Bhunia, Anirban] Bose Inst, Dept Biophys, P 1-12 CIT Scheme 7 M, Kolkata 700054, India; [Gayen, Nilanjan; Mandal, Atin K.] Bose Inst, Dept Mol Med, P 1-12 CIT Scheme 7 M, Kolkata 700054, India; [Brender, Jeffrey R.] NIH, Radiat Biol Branch, Bethesda, MD 20814 USA; [Neeraja, Chilukoti] TIFR Ctr Interdisciplinary Sci TCIS, Hyderabad 500075, Andhra Pradesh, India; [Das, Kali P.] Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; National Institutes of Health (NIH) - USA; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Department of Science & Technology (India); Bose Institute	Bhunia, A (corresponding author), Bose Inst, Dept Biophys, P 1-12 CIT Scheme 7 M, Kolkata 700054, India.	anirbanbhunia@gmail.com	Ghosh, Anirban/S-9315-2017; RATHA, BHISMA NARAYAN/ABF-1767-2020	Ghosh, Anirban/0000-0001-9837-3339; RATHA, BHISMA NARAYAN/0000-0002-0829-1637; Ilyas, Humaira/0000-0002-5784-9086; Bhunia, Anirban/0000-0002-8752-2842; brender, jeffrey/0000-0001-7487-6169; Das, Kali/0000-0001-7686-9077	DBT, Government of India [BT/PR3106/INF/22/138/2011]	DBT, Government of India(Department of Biotechnology (DBT) India)	A. B. acknowledges DBT, Government of India, for infrastructure development Fund BT/PR3106/INF/22/138/2011 to the Bose Institute for procuring a 700-MHz NMR spectrometer with cryoprobe. Central Instrument Facility (CIF) of Bose Institute is greatly acknowledged.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Brender JR, 2013, CHEM COMMUN, V49, P3339, DOI 10.1039/c3cc40383a; Choudhary S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17599; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Crespo R, 2016, J BIOL CHEM, V291, P2018, DOI 10.1074/jbc.M115.699348; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Erlkamp M, 2014, J PHYS CHEM B, V118, P3310, DOI 10.1021/jp500530h; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135976; Gibson TJ, 2006, PROTEIN SCI, V15, P1133, DOI 10.1110/ps.051879606; Goddard T. D., 2014, SPARKY LINUX 2 6 18, V3, P115; Gong H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05648; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Guilhem I, 2006, DIABETES METAB, V32, P279, DOI 10.1016/S1262-3636(07)70281-1; Gupta Yashdeep, 2015, Indian J Endocrinol Metab, V19, P174, DOI 10.4103/2230-8210.146879; Hackl EV, 2015, EUR BIOPHYS J BIOPHY, V44, P249, DOI 10.1007/s00249-015-1019-8; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1990, BIOCHEMISTRY-US, V29, P10545, DOI 10.1021/bi00498a018; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Jakhria T, 2014, J BIOL CHEM, V289, P35781, DOI 10.1074/jbc.M114.586222; Javid N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.028101; Jenssen H., 2008, SERUM STABILITY PEPT, V494, P171; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kar RK, 2016, BIOMACROMOLECULES, V17, P1998, DOI 10.1021/acs.biomac.6b00165; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kurouski D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036989; Lee CC, 2007, BIOPHYS J, V92, P3448, DOI 10.1529/biophysj.106.098608; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020244; Lorenzen K, 2012, J CHEM THEORY COMPUT, V8, P3628, DOI 10.1021/ct300080n; Viet MH, 2015, J PHYS CHEM B, V119, P5145, DOI 10.1021/acs.jpcb.5b00006; Marti-Aluja I, 2013, CHEMOMETR INTELL LAB, V127, P49, DOI 10.1016/j.chemolab.2013.05.015; Matthes D, 2014, J MOL BIOL, V426, P362, DOI 10.1016/j.jmb.2013.10.020; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Mishra NK, 2015, J PHYS CHEM B, V119, P15395, DOI 10.1021/acs.jpcb.5b08215; Murray B, 2015, LANGMUIR, V31, P4246, DOI 10.1021/acs.langmuir.5b00254; Nagase T, 2014, AM J MED, V127, P450, DOI 10.1016/j.amjmed.2013.10.029; Olsen HB, 1998, J MOL BIOL, V284, P477, DOI 10.1006/jmbi.1998.2175; Patel HR, 2014, J PHYS CHEM LETT, V5, P1864, DOI 10.1021/jz5001775; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; Selivanova OM, 2014, J PHYS CHEM B, V118, P1198, DOI 10.1021/jp4083568; Smirnovas V, 2008, BIOPHYS J, V94, P3241, DOI 10.1529/biophysj.107.123133; Smirnovas V, 2006, CHEMPHYSCHEM, V7, P1046, DOI 10.1002/cphc.200500717; Smith RAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132309; Tu LH, 2015, BIOCHEMISTRY-US, V54, P666, DOI 10.1021/bi501016r; Valipour M, 2015, INT J BIOL MACROMOL, V80, P610, DOI 10.1016/j.ijbiomac.2015.07.030; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Wang SH, 2012, BIOCHEM ENG J, V63, P38, DOI 10.1016/j.bej.2012.02.002; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Woods R Jeremy, 2012, J Diabetes Sci Technol, V6, P265; Xue WF, 2010, PRION, V4, P20, DOI 10.4161/pri.4.1.11378; Yesuvadian R, 2014, BIOCHEM BIOPH RES CO, V447, P590, DOI 10.1016/j.bbrc.2014.04.041	66	46	46	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23545	23556		10.1074/jbc.M116.742460	http://dx.doi.org/10.1074/jbc.M116.742460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27679488	hybrid, Green Published			2022-12-26	WOS:000387884400016
J	Zeituni, EM; Wilson, MH; Zheng, XB; Iglesias, PA; Sepanski, MA; Siddiqi, MA; Anderson, JL; Zheng, YX; Farber, SA				Zeituni, Erin M.; Wilson, Meredith H.; Zheng, Xiaobin; Iglesias, Pablo A.; Sepanski, Michael A.; Siddiqi, Mahmud A.; Anderson, Jennifer L.; Zheng, Yixian; Farber, Steven A.			Endoplasmic Reticulum Lipid Flux Influences Enterocyte Nuclear Morphology and Lipid-dependent Transcriptional Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intestine; lipid droplet; lipoprotein; mitochondria; nucleus; apoA-IV; creb3l3; enterocyte; plin2	ELEMENT-BINDING PROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; SMALL INTESTINAL ENTEROCYTES; FATTY-ACID-COMPOSITION; GENE-EXPRESSION DATA; A-IV EXPRESSION; EGG-YOLK; CHOLESTEROL ABSORPTION; MORPHOMETRIC ANALYSIS; APOA-IV	Responding to a high-fat meal requires an interplay between multiple digestive tissues, sympathetic response pathways, and the gut microbiome. The epithelial enterocytes of the intestine are responsible for absorbing dietary nutrients and preparing them for circulation to distal tissues, which requires significant changes in cellular activity, including both morphological and transcriptional responses. Following a high-fat meal, we observe morphological changes in the enterocytes of larval zebrafish, including elongation of mitochondria, formation and expansion of lipid droplets, and the rapid and transient ruffling of the nuclear periphery. Dietary and pharmacological manipulation of zebrafish larvae demonstrated that these subcellular changes are specific to triglyceride absorption. The transcriptional changes that occur simultaneously with these morphological changes were determined using RNA sequencing, revealing a cohort of up-regulated genes associated with lipid droplet formation and lipid transport via lipoprotein particles. Using a microsomal triglyceride transfer protein (MTP) inhibitor to block -lipoprotein particle formation, we demonstrate that the transcriptional response to a high-fat meal is associated with the transfer of ER triglyceride to nascent -lipoproteins, possibly through the activation of Creb3l3/cyclic AMP-responsive element-binding protein. These data suggest that a transient increase in ER lipids is the likely mediator of the initial physiological response of intestinal enterocytes to dietary lipid.	[Zeituni, Erin M.; Wilson, Meredith H.; Zheng, Xiaobin; Sepanski, Michael A.; Siddiqi, Mahmud A.; Anderson, Jennifer L.; Zheng, Yixian; Farber, Steven A.] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Carnegie Institution for Science; Johns Hopkins University	Farber, SA (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	farber@ciwemb.edu	Iglesias, Pablo A/A-5202-2008; Farber, Steven A/G-5851-2012; Zheng, Xiaobin/AAD-7564-2019	Iglesias, Pablo A/0000-0002-0840-155X; Farber, Steven A/0000-0002-8037-7312; Wilson, Meredith/0000-0002-6152-7127	NIDDK, National Institutes of Health [F32DK109592, RO1DK093399]; NIGMS, National Institutes of Health [RO1GM63904]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK109592, R01DK093399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIDDK, National Institutes of Health, Grants F32DK109592 (to M. H. W.) and RO1DK093399 (to S. A. F.) and NIGMS, National Institutes of Health, Grant RO1GM63904 to the Zebrafish Functional Genomics Consortium (to S. Ekker and S. A. F.). This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation (to the laboratory of S. A. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981; Baek JS, 2012, CHOLESTEROL, DOI 10.1155/2012/564705; Barbosa S, 2013, TRAFFIC, V14, P382, DOI 10.1111/tra.12038; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; BOUMA ME, 1990, J LIPID RES, V31, P1; Brown R., 2007, FITCIRCLE M MATLAB C; BUSCHMANN RJ, 1981, J ULTRA MOL STRUCT R, V76, P15, DOI 10.1016/S0022-5320(81)80047-0; BUSCHMANN RJ, 1981, J ULTRA MOL STRUCT R, V76, P1, DOI 10.1016/S0022-5320(81)80046-9; CARDELL RR, 1967, J CELL BIOL, V34, P123, DOI 10.1083/jcb.34.1.123; Carten JD, 2011, DEV BIOL, V360, P276, DOI 10.1016/j.ydbio.2011.09.010; Chakraborty RD, 2007, J AGR FOOD CHEM, V55, P4043, DOI 10.1021/jf063654l; Cheng DM, 2016, J BIOL CHEM, V291, P23793, DOI 10.1074/jbc.M116.749283; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Creamer B, 1974, Biomembranes, V4A, P1; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; GANDER W, 1994, BIT, V34, P558, DOI 10.1007/BF01934268; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Hama K, 2009, AM J PHYSIOL-GASTR L, V296, pG445, DOI 10.1152/ajpgi.90513.2008; Hamilton RL, 1998, J LIPID RES, V39, P1543; HOGAN S, 1987, INT J OBESITY, V11, P35; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; HUSBANDS DR, 1970, BIOCHEM J, V120, P365, DOI 10.1042/bj1200365; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; JASPER DK, 1968, J CELL BIOL, V38, P277, DOI 10.1083/jcb.38.2.277; JERSILD RA, 1966, AM J ANAT, V118, P135, DOI 10.1002/aja.1001180108; JONES D, 1969, NATURE, V221, P780, DOI 10.1038/221780a0; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Otis JP, 2015, DIS MODEL MECH, V8, P295, DOI 10.1242/dmm.018754; PALAY SL, 1959, J BIOPHYS BIOCHEM CY, V5, P373, DOI 10.1083/jcb.5.3.373; Queisser G, 2011, NUCLEUS-PHILA, V2, P98, DOI 10.4161/nucl.2.2.15116; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; SKELLON JH, 1962, J SCI FOOD AGR, V13, P300, DOI 10.1002/jsfa.2740130506; STOECKENIUS W, 1965, LAB INVEST, V14, P1196; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Thisse B, 2004, ZFIN DIRECT DATA SUB; van Heek M, 2001, DIABETES, V50, P1330, DOI 10.2337/diabetes.50.6.1330; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	60	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23804	23816		10.1074/jbc.M116.749358	http://dx.doi.org/10.1074/jbc.M116.749358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655916	Green Published, hybrid			2022-12-26	WOS:000387884400039
J	Kumar, D; Broor, S; Rajala, MS				Kumar, Deepshikha; Broor, Shobha; Rajala, Maitreyi S.			Interaction of Host Nucleolin with Influenza A Virus Nucleoprotein in the Early Phase of Infection Limits the Late Viral Gene Expression	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; REPLICATION; POLYMERASE; NS1; LOCALIZATION; HELICASE; NUCLEUS; COMPLEX; PLAYS	Influenza A virus nucleoprotein, is a multifunctional RNA-binding protein, encoded by segment-5 of the negative sense RNA genome. It serves as a key connector between the virus and the host during virus replication. It continuously shuttles between the cytoplasm and the nucleus interacting with various host cellular factors. In the current study, host proteins interacting with nucleoprotein of Influenza A virus of H1N1 2009 pandemic strain were identified by co-immunoprecipitation studies followed by MALDI-TOF/MS analysis. Here we report the host nucleolin, a major RNA-binding protein of the nucleolus as a novel interacting partner to influenza A virus nucleoprotein. We thus, explored the implications of this interaction in virus life cycle and our studies have shown that these two proteins interact early during infection in the cytoplasm of infected cells. Depletion of nucleolin in A549 cells by siRNA targeting endogenous nucleolin followed by influenza A virus infection, disrupted its interaction with viral nucleoprotein, resulting in increased expression of gene transcripts encoding late viral proteins; matrix (M1) and hemagglutinin (HA) in infected cells. On the contrary, over expression of nucleolin in cells transiently transfected with pEGFP-NCL construct followed by virus infection significantly reduced the late viral gene transcripts, and consequently the viral titer. Altered expression of late viral genes and titers following manipulation of host cellular nucleolin, proposes the functional importance of its interaction with nucleoprotein during influenza A virus infection.	[Kumar, Deepshikha; Rajala, Maitreyi S.] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Broor, Shobha] Shree Guru Gobind Singh Tricentenary Univ, Dept Microbiol, Fac Med & Hlth Sci, Gurgaon, Haryana, India	Jawaharlal Nehru University, New Delhi	Rajala, MS (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India.	msrajala@mail.jnu.ac.in	Broor, Shobha/AAX-4163-2021	Broor, Shobha/0000-0001-9679-4180	Indian Council of Medical Research [VIR/15/2011-ECD-I]; Indian Council of Medical Research, New Delhi, India [VIR/15/2011-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research (www.icmr.nic.in), No. VIR/15/2011-ECD-I to MSR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Indian Council of Medical Research (No. No. VIR/15/2011-ECD-I), New Delhi, India. We acknowledge the facilities (Mass spectrometry and Laser Confocal Microscope) and the technical staff of Advanced Instrumentation Research Facility at JNU, New Delhi.	Abdoli A, 2013, CELL J, V15, P130; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; BOURBON H, 1983, FEBS LETT, V155, P218, DOI 10.1016/0014-5793(82)80606-6; Chan CM, 2016, VIROLOGY, V494, P78, DOI 10.1016/j.virol.2016.04.008; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; COMPANS RW, 1969, VIROLOGY, V39, P499, DOI 10.1016/0042-6822(69)90098-1; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; de Araujo Mariana Eca Guimaraes, 2007, Methods Mol Biol, V357, P73; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Generous A, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0228-6; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Hamamoto I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.00589892, DOI 10.1371/JOURNAL.PONE.00589892]; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hovanessian AG, 2000, CELL SURFACE EXPRESS, V328, P312; Huang WH, 2001, J BIOL CHEM, V276, P25166, DOI 10.1074/jbc.M010087200; Hutchinson EC, 2012, VACCINE, V30, P7353, DOI 10.1016/j.vaccine.2012.04.085; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losfeld ME, 2011, FEBS J, V278, P2552, DOI 10.1111/j.1742-4658.2011.08180.x; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Melen K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-167; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Murayama R, 2007, BIOCHEM BIOPH RES CO, V362, P880, DOI 10.1016/j.bbrc.2007.08.091; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Oksayan S, 2015, J VIROL, V89, P1939, DOI 10.1128/JVI.03320-14; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; ProkudinaKantorovich EN, 1996, VIROLOGY, V223, P51, DOI 10.1006/viro.1996.0454; RAO SVV, 1982, J BIOL CHEM, V257, P5035; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Sharma S, 2014, FEBS J, V281, P2899, DOI 10.1111/febs.12828; Shih SR, 1998, VIRUS GENES, V17, P179, DOI 10.1023/A:1008024909222; Shimakami T, 2006, J VIROL, V80, P3332, DOI 10.1128/JVI.80.7.3332-3340.2006; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; SKORKO R, 1991, VIROLOGY, V180, P668, DOI 10.1016/0042-6822(91)90080-U; STOYKOVA AS, 1985, J NEUROCHEM, V45, P1667, DOI 10.1111/j.1471-4159.1985.tb10521.x; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10	54	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164146	10.1371/journal.pone.0164146	http://dx.doi.org/10.1371/journal.pone.0164146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711134	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600087
J	Pereira, JL; Mendes, A; Crispim, SP; Marchioni, DM; Fisberg, RM				Pereira, Jaqueline Lopes; Mendes, Aline; Crispim, Sandra Patricia; Marchioni, Dirce Maria; Fisberg, Regina Mara			Association of Overweight with Food Portion Size among Adults of Sao Paulo - Brazil	PLOS ONE			English	Article							ENERGY-INTAKE; OBESITY EPIDEMIC; WEIGHT; WOMEN; QUESTIONNAIRE; CONSUMPTION; DENSITY; RISK; DIET; MEN	Background Although studies show that portion size affects energy intake, few have demonstrated a link between portion size and weight status, especially in free-living populations. The objective of the present study was to assess the relationship between food portion sizes and overweight in a representative population of adults of Sao Paulo, Brazil. Methods Cross-sectional population-based study with 1005 adults from Sao Paulo, Brazil. Dietary data were obtained from two 24-hour recalls. Reported foods were classified into groups and energy contribution, prevalence of consumers and portion sizes were calculated. Individuals were classified according to BMI in with and without overweight. Logistic regression models were used to evaluate the association between food portion sizes and being overweight. Results The most consumed food groups were: beans, breads/rolls, coffee/tea, milk, rice, and sugar. Rice, red meat, breads/rolls, and white meat were the groups with the highest percentage of contribution to total energy intake. Butter/margarine, toasts/biscuits, sugar, and cakes were the groups with the highest energy density. After adjustment for confounding variables, overweight was associated with larger portions of pizza (OR = 1.052; p = 0.048), red meat (OR = 1.025; p = 0.043), rice (OR = 1.033; p<0.001), salted snacks (OR = 1.078; p = 0.022), and soft drinks (OR = 1.016; p = 0.007). Conclusions Larger portions of few food groups with different energy densities were associated with being overweight, suggesting that overweight may be related to the consumption of larger portion sizes of a series of food groups, not a food group alone. Additionally, we highlight the importance of considering underreporting as a confounding factor in these associations.	[Mendes, Aline; Marchioni, Dirce Maria; Fisberg, Regina Mara] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Crispim, Sandra Patricia] Univ Fed Parana, Dept Nutr, Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade Federal do Parana	Fisberg, RM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	rfisberg@usp.br	Marchioni, Dirce M/C-6053-2012; Crispim, Sandra P./G-9983-2011; Fisberg, Regina M/C-4069-2012; Pereira, Jaqueline/P-7261-2019; Fisberg, Regina Mara/Q-6494-2019; Marchioni, Dirce/ABH-7023-2020	Marchioni, Dirce M/0000-0002-6810-5779; Crispim, Sandra P./0000-0002-2257-9899; Fisberg, Regina M/0000-0002-4490-9035; Pereira, Jaqueline/0000-0002-0009-1040; Fisberg, Regina Mara/0000-0002-4490-9035; Marchioni, Dirce/0000-0002-6810-5779	Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP) [2009/15831-0, 2012/08431-8]; National Council for Scientific and Technological Development (CNPq) [503128/2010-4]	Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed by the Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP process #2009/15831-0, process #2012/08431-8 (JLP)); and National Council for Scientific and Technological Development (CNPq process #503128/2010-4).	Albar SA, 2014, BRIT J NUTR, V112, P841, DOI 10.1017/S0007114514001548; Azagba S, 2012, J PRIM CARE COMMUNIT, V3, P210, DOI 10.1177/2150131911434206; BAENINGER Rosana, 2012, FASES FACES MIGRACAO; Blake CE, 2015, APPETITE, V88, P17, DOI 10.1016/j.appet.2014.11.005; Bliss RM, 2004, AGR RES, V52, P10; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Carvalho Aline Martins de, 2014, Rev. bras. epidemiol., V17, P735, DOI 10.1590/1809-4503201400030013; Castro Michelle Alessandra de, 2009, Rev. Saúde Pública, V43, P991, DOI 10.1590/S0034-89102009005000084; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Fisberg R.M., 2002, MANUAL RECEITAS MEDI; Fisberg RM, 2002, NUTR CLIN ADULTO, P47; Fisher JO, 2015, APPETITE, V88, P1, DOI 10.1016/j.appet.2014.11.025; Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, IND IBGE PESQ ORC FA; Kelly MT, 2009, BRIT J NUTR, V101, P1413, DOI 10.1017/S0007114508060777; Kral TV, 2004, PHYSIOL BEHAV, V82, P131, DOI 10.1016/j.physbeh.2004.04.063; Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lioret S, 2009, EUR J CLIN NUTR, V63, P382, DOI 10.1038/sj.ejcn.1602958; Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Matthiessen J, 2003, PUBLIC HEALTH NUTR, V6, P65, DOI 10.1079/PHN2002361; Maurer J, 2006, NUTR REV, V64, P53, DOI 10.1111/j.1753-4887.2006.tb00188.x; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pinheiro A.B.V., 2008, TABELA AVALIACAO CON; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Rolls BJ, 2014, INT J OBESITY, V38, pS1, DOI 10.1038/ijo.2014.82; Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182; Rolls BJ, 2004, APPETITE, V42, P63, DOI 10.1016/S0195-6663(03)00117-X; Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207; Sichieri Rosely, 2003, Cad. Saúde Pública, V19, pS47, DOI 10.1590/S0102-311X2003000700006; Smiciklas-Wright H, 2003, J AM DIET ASSOC, V103, P41, DOI 10.1053/jada.2003.50000; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011; Tontisirin K., 2003, FOOD ENERGY METHODS; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Verly E, 2012, J ACAD NUTR DIET, V112, P1015, DOI 10.1016/j.jand.2012.03.028; Vernarelli JA, 2015, EUR J NUTR, V54, P59, DOI 10.1007/s00394-014-0685-0; Wansink B, 2007, J AM DIET ASSOC, V107, P1103, DOI 10.1016/j.jada.2007.05.019; *WHO, 2003, TECH REP SERV, V916, pR1; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164127	10.1371/journal.pone.0164127	http://dx.doi.org/10.1371/journal.pone.0164127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706222	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200087
J	Zhou, ZY; Jin, Q; Yu, L; Wu, LQ; He, B				Zhou, Zhaoye; Jin, Qi; Yu, Long; Wu, Liqun; He, Bin			Noninvasive Imaging of Human Atrial Activation during Atrial Flutter and Normal Rhythm from Body Surface Potential Maps	PLOS ONE			English	Article							VENTRICULAR ELECTRICAL ACTIVATION; EQUIVALENT CURRENT-DENSITY; CARDIAC ACTIVATION; EPICARDIAL POTENTIALS; EXCITATION MODEL; INVERSE SOLUTION; SWINE MODEL; HEART-MODEL; ELECTROPHYSIOLOGY; RECONSTRUCTION	Background Knowledge of atrial electrophysiological properties is crucial for clinical intervention of atrial arrhythmias and the investigation of the underlying mechanism. This study aims to evaluate the feasibility of a novel noninvasive cardiac electrical imaging technique in imaging bi-atrial activation sequences from body surface potential maps (BSPMs). Methods The study includes 7 subjects, with 3 atrial flutter patients, and 4 healthy subjects with normal atrial activations. The subject-specific heart-torso geometries were obtained from MRI/ CT images. The equivalent current densities were reconstructed from 208-channel BSPMs by solving the inverse problem using individual heart-torso geometry models. The activation times were estimated from the time instant corresponding to the highest peak in the time course of the equivalent current densities. To evaluate the performance, a total of 32 cycles of atrial flutter were analyzed. The imaged activation maps obtained from single beats were compared with the average maps and the activation maps measured from CARTO, by using correlation coefficient (CC) and relative error (RE). Results The cardiac electrical imaging technique is capable of imaging both focal and reentrant activations. The imaged activation maps for normal atrial activations are consistent with findings from isolated human hearts. Activation maps for isthmus-dependent counterclockwise reentry were reconstructed on three patients with typical atrial flutter. The method was capable of imaging macro counterclockwise reentrant loop in the right atrium and showed inter-atria electrical conduction through coronary sinus. The imaged activation sequences obtained from single beats showed good correlation with both the average activation maps (CC = 0.91 +/- 0.03, RE = 0.29 +/- 0.05) and the clinical endocardial findings using CARTO (CC = 0.70 +/- 0.04, RE = 0.42 +/- 0.05). Conclusions The noninvasive cardiac electrical imaging technique is able to reconstruct complex atrial reentrant activations and focal activation patterns in good consistency with clinical electrophysiological mapping. It offers the potential to assist in radio-frequency ablation of atrial arrhythmia and help defining the underlying arrhythmic mechanism.	[Zhou, Zhaoye; Yu, Long; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Jin, Qi; Wu, Liqun] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China; [He, Bin] Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities	He, B (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.; He, B (corresponding author), Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA.	binhe@umn.edu			NIH [R01HL080093, RO1HL080093]; NSF [CBET-0756331]; Chinese "111 Project" [B08020]; Institute of Engineering in Medicine from University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Chinese "111 Project"; Institute of Engineering in Medicine from University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH R01HL080093 and NSF CBET-0756331, the Chinese "111 Project" (B08020), and a grant from the Institute of Engineering in Medicine from the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NIH RO1HL080093 and NSF CBET-0756331, the Chinese "111 Project" (B08020), and a grant from the Institute of Engineering in Medicine from the University of Minnesota.	Arevalo HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11437; Armoundas AA, 2003, ANN BIOMED ENG, V31, P564, DOI 10.1114/1.1567281; BARR RC, 1977, IEEE T BIO-MED ENG, V24, P1, DOI 10.1109/TBME.1977.326201; Cakulev I, 2013, CIRC-ARRHYTHMIA ELEC, V6, P68, DOI 10.1161/CIRCEP.112.975813; Compumedics, 2008, CURRY USER GUIDE; CUPPEN JJM, 1984, IEEE T BIO-MED ENG, V31, P652, DOI 10.1109/TBME.1984.325315; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Greensite F, 1998, IEEE T BIO-MED ENG, V45, P98, DOI 10.1109/10.650360; GULRAJANI RM, 1984, IEEE T BIO-MED ENG, V31, P903, DOI 10.1109/TBME.1984.325257; Han CZ, 2015, AM J PHYSIOL-HEART C, V308, pH108, DOI 10.1152/ajpheart.00196.2014; Han CZ, 2013, HEART RHYTHM, V10, P1509, DOI 10.1016/j.hrthm.2013.06.010; Han CZ, 2012, AM J PHYSIOL-HEART C, V302, pH244, DOI 10.1152/ajpheart.00618.2011; Han CZ, 2011, HEART RHYTHM, V8, P1266, DOI 10.1016/j.hrthm.2011.03.014; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; He B, 2003, IEEE T BIO-MED ENG, V50, P1190, DOI 10.1109/TBME.2003.817637; He B, 2002, PHYS MED BIOL, V47, P4063, DOI 10.1088/0031-9155/47/22/310; He B, 2001, IEEE T INF TECHNOL B, V5, P181, DOI 10.1109/4233.945288; He B, 2010, CARDIAC ELECTROPHYSIOLOGY METHODS AND MODELS, P357, DOI 10.1007/978-1-4419-6658-2_18; Henriquez CS, 2014, IEEE T BIO-MED ENG, V61, P1457, DOI 10.1109/TBME.2014.2310515; Huiskamp G, 1997, IEEE T BIO-MED ENG, V44, P433, DOI 10.1109/10.581930; Jamison C, 2011, IEEE T BIO-MED ENG, V58, P876, DOI 10.1109/TBME.2010.2093525; Lai DK, 2010, IEEE T INF TECHNOL B, V14, P1318, DOI 10.1109/TITB.2010.2051448; Li GL, 2001, IEEE T BIO-MED ENG, V48, P660, DOI 10.1109/10.923784; Liu C, 2008, J CARDIOVASC ELECTR, V19, P535, DOI 10.1111/j.1540-8167.2007.01066.x; Liu ZM, 2006, IEEE T MED IMAGING, V25, P1307, DOI 10.1109/TMI.2006.882140; Modre R, 2003, J CARDIOVASC ELECTR, V14, P712, DOI 10.1046/j.1540-8167.2003.02558.x; Ng J, 2014, IEEE T BIO-MED ENG, V61, P273, DOI 10.1109/TBME.2013.2290003; Nielsen BF, 2007, MATH BIOSCI, V210, P523, DOI 10.1016/j.mbs.2007.06.003; Ohyu S, 2002, IEEE T BIO-MED ENG, V49, P509, DOI 10.1109/TBME.2002.1001964; Oster HS, 1997, CIRCULATION, V96, P1012; Pascual-Marqui R, 1995, COMMUNICATION, P16; Perlman O, 2014, IEEE T BIO-MED ENG, V61, P1034, DOI 10.1109/TBME.2013.2292930; Prakosa A, 2014, IEEE T BIO-MED ENG, V61, P235, DOI 10.1109/TBME.2013.2281619; Pullan AJ, 2001, ANN BIOMED ENG, V29, P817, DOI 10.1114/1.1408921; Rahimi A, 2015, IEEE T BIO-MED ENG, V62, P1563, DOI 10.1109/TBME.2015.2395387; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; Revishvili AS, 2015, EUROPACE, V17, P1282, DOI 10.1093/europace/euu339; Roten L, 2012, J CARDIOVASC ELECTR, V23, P553, DOI 10.1111/j.1540-8167.2011.02250.x; Seger M, 2006, COMPUT CARDIOL, V2006, P601; Shah AJ, 2013, J AM COLL CARDIOL, V62, P889, DOI 10.1016/j.jacc.2013.03.082; Skipa O, 2002, INT J BIOELECTROMAGN, V4, P17; Tilg B, 2003, MED IMAGE ANAL, V7, P391, DOI 10.1016/S1361-8415(03)00013-6; Tilg B, 2002, IEEE T MED IMAGING, V21, P1031, DOI 10.1109/TMI.2002.804438; Tilg B, 2001, FUNCTIONAL IMAGING M, P148; Wang DF, 2013, J COMPUT PHYS, V250, P403, DOI 10.1016/j.jcp.2013.05.027; WANG JZ, 1992, IEEE T BIO-MED ENG, V39, P665, DOI 10.1109/10.142641; Wang LW, 2010, IEEE T BIO-MED ENG, V57, P296, DOI 10.1109/TBME.2009.2024531; Wang Y, 2007, HEART RHYTHM, V4, P1565, DOI 10.1016/j.hrthm.2007.08.019; Wang Y, 2007, HEART RHYTHM, V4, P1081, DOI 10.1016/j.hrthm.2007.04.014; Yu L, 2015, IEEE T MED IMAGING, V34, P2309, DOI 10.1109/TMI.2015.2429134; Zhang X, 2005, AM J PHYSIOL-HEART C, V289, pH2724, DOI 10.1152/ajpheart.00639.2005; Zhou ZY, 2015, IEEE T BIO-MED ENG, V62, P468, DOI 10.1109/TBME.2014.2358618	53	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163445	10.1371/journal.pone.0163445	http://dx.doi.org/10.1371/journal.pone.0163445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706179	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200045
J	Faber, BW; Hellwig, S; Houard, S; Havelange, N; Drossard, J; Mertens, H; Croon, A; Kastilan, R; Byrne, R; van der Werff, N; van der Eijk, M; Thomas, AW; Kooken, CHM; Remarque, EJ				Faber, Bart W.; Hellwig, Stephan; Houard, Sophie; Havelange, Nicolas; Drossard, Jurgen; Mertens, Hubert; Croon, Alexander; Kastilan, Robin; Byrne, Richard; van der Werff, Nicole; van der Eijk, Marjolein; Thomas, Alan W.; Kooken, Clemens H. M.; Remarque, Edmond J.			Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; HIGH-LEVEL EXPRESSION; OVINE INTERFERON-TAU; PICHIA-PASTORIS; ERYTHROCYTE INVASION; CANDIDATE; FERMENTATION; IMMUNIZATION; TRIAL; AMA1	Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading asexual blood stage vaccine candidate for malaria. In preparation for clinical trials, three Diversity Covering (DiCo) PfAMA1 ectodomain proteins, designed to overcome the intrinsic polymorphism that is present in PfAMA1, were produced under Good Manufacturing Practice (GMP) in Pichia pastoris. Using identical methodology, the 3 strains were cultivated in 70-L scale fed-batch fermentations and PfAMA1-DiCos were purified by two chromatography steps, an ultrafiltration/diafiltration procedure and size exclusion chromatography, resulting in highly pure (>95%) PfAMA1-DiCo1, PfAMA1 DiCo2 and PfAMA1 DiCo3, with final yields of 1.8, 1.9 and 1.3 gram, respectively. N-terminal determinations showed that approximately 50% of each of the proteins lost 12 residues from their N-terminus, in accordance with SDS-PAGE (2 main bands) and MS-data. Under reducing conditions a site of limited proteolytic cleavage within a disulphide bonded region became evident. The three proteins quantitatively bound to the mAb 4G2 that recognizes a conformational epitope, suggesting proper folding of the proteins. The lyophilized Drug Product (1: 1: 1 mixture of PfAMA1-DiCo1, DiCo2, DiCo3) fulfilled all pre-set release criteria (appearance, dissolution rate, identity, purity, protein content, moisture content, sub-visible particles, immuno-potency (after reconstitution with adjuvant), abnormal toxicity, sterility and endotoxin), was stable in accelerated and real-time stability studies at -20 degrees C for over 24 months. When formulated with adjuvants selected for clinical phase I evaluation, the Drug Product did not show adverse effect in a repeated-dose toxicity study in rabbits. The Drug Product has entered a phase Ia/Ib clinical trial.	[Faber, Bart W.; van der Werff, Nicole; van der Eijk, Marjolein; Thomas, Alan W.; Kooken, Clemens H. M.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Hellwig, Stephan; Drossard, Jurgen; Mertens, Hubert; Croon, Alexander; Kastilan, Robin] Fraunhofer IME, Aachen, Germany; [Houard, Sophie; Havelange, Nicolas] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany; [Byrne, Richard] Nova Labs Ltd, Martin House, Leicester, Leics, England	Ruprecht Karls University Heidelberg	Faber, BW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	Faber@bprc.nl	Remarque, Ed/AAE-8643-2020	Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	European (Malaria) Vaccine Initiative; DGIS Netherlands; BPRC; Bill and Melinda Gates Foundation [42387]	European (Malaria) Vaccine Initiative; DGIS Netherlands; BPRC; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work received financial support from the European (Malaria) Vaccine Initiative, DGIS Netherlands and BPRC. We thank Odile Leroy for support and Henk van Westbroek and Francisca van Hassel for support in preparing the figures. We are grateful to Anna Marie Beckmann and Randy Howard from The Infectious Disease Research Institute (IDRI) for providing the GLA-SE adjuvant under Bill and Melinda Gates Foundation grant 42387 to Steven G Reed.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Belew M, 2008, SEP SCI TECHNOL, V43, P3134, DOI 10.1080/01496390802221857; Brunel L, 2004, J BIOTECHNOL, V111, P41, DOI 10.1016/j.jbiotec.2004.03.007; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; Damasceno LM, 2004, PROTEIN EXPRES PURIF, V37, P18, DOI 10.1016/j.pep.2004.03.019; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; DIGAN ME, 1989, BIO-TECHNOL, V7, P160, DOI 10.1038/nbt0289-160; DOE J, 1999, EUROPEAN PHARMACOPOE; EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761; Faber BW, 2013, INFECT IMMUN, V81, P1479, DOI 10.1128/IAI.01267-12; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Fricke J, 2013, BIOTECHNOL J, V8, P738, DOI 10.1002/biot.201200190; Fricke J, 2011, BIOTECHNOL J, V6, P437, DOI 10.1002/biot.201000385; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Hellwig S, 1999, BIOTECHNOL APPL BIOC, V30, P267; Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-6; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Martens S, 2011, ENG LIFE SCI, V11, P429, DOI 10.1002/elsc.201000163; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Payne RO, 2016, J INFECT DIS, V213, P1743, DOI 10.1093/infdis/jiw039; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigoillot M, 2012, APPL MICROBIOL BIOT, V96, P1253, DOI 10.1007/s00253-012-3897-3; Sinha J, 2005, BIOTECHNOL BIOENG, V89, P102, DOI 10.1002/bit.20318; Sinha J, 2003, BIOTECHNOL PROGR, V19, P794, DOI 10.1021/bp025744q; Sinha J, 2007, J BIOTECHNOL, V127, P462, DOI 10.1016/j.jbiotec.2006.07.022; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Toikkanen JH, 2007, J BIOTECHNOL, V130, P161, DOI 10.1016/j.jbiotec.2007.03.004; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281; WHO, 2013, WORLD MALARIA REPORT 2013, P1	46	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164053	10.1371/journal.pone.0164053	http://dx.doi.org/10.1371/journal.pone.0164053			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695087	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100081
J	Korshoej, AR; Saturnino, GB; Rasmussen, LK; von Oettingen, G; Sorensen, JCH; Thielscher, A				Korshoej, Anders Rosendal; Saturnino, Guilherme Bicalho; Rasmussen, Line Kirkegaard; von Oettingen, Gorm; Sorensen, Jens Christian Hedemann; Thielscher, Axel			Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study	PLOS ONE			English	Article							PHYSICIANS CHOICE CHEMOTHERAPY; RANDOMIZED PHASE-III; ADJUVANT TEMOZOLOMIDE; DIELECTRIC-PROPERTIES; BRAIN; CONDUCTIVITY; NOVOTTF-100A; TISSUE; RADIOTHERAPY; CONCOMITANT	Objective The present work proposes a new clinical approach to TTFields therapy of glioblastoma. The approach combines targeted surgical skull removal (craniectomy) with TTFields therapy to enhance the induced electrical field in the underlying tumor tissue. Using computer simulations, we explore the potential of the intervention to improve the clinical efficacy of TTFields therapy of brain cancer. Methods We used finite element analysis to calculate the electrical field distribution in realistic head models based on MRI data from two patients: One with left cortical/subcortical glioblastoma and one with deeply seated right thalamic anaplastic astrocytoma. Field strength was assessed in the tumor regions before and after virtual removal of bone areas of varying shape and size (10 to 100 mm) immediately above the tumor. Field strength was evaluated before and after tumor resection to assess realistic clinical scenarios. Results For the superficial tumor, removal of a standard craniotomy bone flap increased the electrical field strength by 60-70% in the tumor. The percentage of tissue in expected growth arrest or regression was increased from negligible values to 30-50%. The observed effects were highly focal and targeted at the regions of pathology underlying the craniectomy. No significant changes were observed in surrounding healthy tissues. Median field strengths in tumor tissue increased with increasing craniectomy diameter up to 50-70 mm. Multiple smaller burr holes were more efficient than single craniectomies of equivalent area. Craniectomy caused no significant field enhancement in the deeply seated tumor, but rather a focal enhancement in the brain tissue underlying the skull defect. Conclusions Our results provide theoretical evidence that small and clinically feasible craniectomies may provide significant enhancement of TTFields intensity in cerebral hemispheric tumors without severely compromising brain protection or causing unacceptable heating in healthy tissues. A clinical trial is being planned to validate safety and efficacy.	[Korshoej, Anders Rosendal; Rasmussen, Line Kirkegaard; von Oettingen, Gorm; Sorensen, Jens Christian Hedemann] Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark; [Saturnino, Guilherme Bicalho; Thielscher, Axel] Univ Copenhagen, Danish Res Ctr Magnet Resonance, Hvidovre Hosp, Hvidovre, Denmark; [Saturnino, Guilherme Bicalho; Thielscher, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Thielscher, Axel] Tech Univ Denmark, Biomed Engn, DTU Elektro, Lyngby, Denmark	Aarhus University; University of Copenhagen; Max Planck Society; Technical University of Denmark	Korshoej, AR (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark.	andekors@rm.dk		Bicalho Saturnino, Guilherme/0000-0002-3466-8725; Thielscher, Axel/0000-0002-4752-5854	Eva og Henry Frarkels Mindefond; Danish Council for Independent Research, Medical Sciences, Lundbeckfonden [R118-A11308, R59 A5399]; NovoNordiskfonden [11413]; Brazilian Ministry of Science and Technology; Lundbeck Foundation [R118-2012-11308] Funding Source: researchfish	Eva og Henry Frarkels Mindefond; Danish Council for Independent Research, Medical Sciences, Lundbeckfonden; NovoNordiskfonden(Novo Nordisk Foundation); Brazilian Ministry of Science and Technology; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Eva og Henry Frarkels Mindefond (PI: Anders R. Korshoej), The Danish Council for Independent Research, Medical Sciences, Lundbeckfonden (PI: Axel Thielscher; Grant Nr. R118-A11308 and PI: Hartwig Siebner; Grant Nr. R59 A5399, Grant of Excellence "ContAct"), an Interdisciplinary Synergy Grant "Basics" sponsored by NovoNordiskfonden (recipients: Hartwig Siebner, Axel Thielscher & Lars K. Hansen, Grant Nr. 11413) and a Science Without Borders Scholarship from the Brazilian Ministry of Science and Technology (Recipient: Guilherme B. Saturnino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2014.09.009, DOI 10.1053/J.SEMINONCOL.2014.09.009]; [Anonymous], 2011, P 19 SCI M INT SOC M; [Anonymous], 2015, ASCO ANN M P; [Anonymous], 2014, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2014.09.010, DOI 10.1053/J.SEMINONCOL.2014.09.010]; [Anonymous], 2013, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2013.10.002, DOI 10.1053/J.SEMINONCOL.2013.10.002]; [Anonymous], 2011, P ISMRM; Becker KP, 2012, CANCER J, V18, P12, DOI 10.1097/PPO.0b013e318244d7eb; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Go K G, 1972, Acta Neurochir (Wien), V27, P113, DOI 10.1007/BF01401876; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Korshoej AR, 2015, PHYS BIOL MED UNPUB; Korshoej AR, 2015, J NEUROONC UNPUB OCT; Latikka J, 2001, PHYS MED BIOL, V46, P1611, DOI 10.1088/0031-9155/46/6/302; Lok E, 2015, CANCER MED-US, V4, P1697, DOI 10.1002/cam4.519; LU Y, 1992, INT J HYPERTHER, V8, P755, DOI 10.3109/02656739209005023; Mannas JP, 2014, J CLIN NEUROSCI, V21, P121, DOI 10.1016/j.jocn.2013.03.039; Miranda PC, 2014, PHYS MED BIOL, V59, P4137, DOI 10.1088/0031-9155/59/15/4137; Mrugala MM, 2013, DISCOV MED, V15, P221; Muftuler LT, 2006, TECHNOL CANCER RES T, V5, P381; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; PELOSO R, 1984, IEEE T BIO-MED ENG, V31, P725, DOI 10.1109/TBME.1984.325399; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Rulseh AM, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-220; Saturnino GB, 2015, NEUROIMAGE, V120, P25, DOI 10.1016/j.neuroimage.2015.06.067; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou265.40; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Turner SG, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-162; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Weathers Shiao-Pei, 2014, F1000Prime Rep, V6, P46, DOI 10.12703/P6-46; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wenger C, ALTERNATING ELECT FI; Wenger C, 2015, IEEE ENG MED BIO, P6892, DOI 10.1109/EMBC.2015.7319977; Wenger C, 2015, PHYS MED BIOL, V60, P7339, DOI 10.1088/0031-9155/60/18/7339; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Wong ET, 2014, CANCER MED-US, V3, P592, DOI 10.1002/cam4.210; Wong ET, 2014, NEUROONCOLOGY S5, V16, pv74; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	47	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164051	10.1371/journal.pone.0164051	http://dx.doi.org/10.1371/journal.pone.0164051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695068	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100080
J	Borowski, Z; Swislocka, M; Matosiuk, M; Mirski, P; Krysiuk, K; Czajkowska, M; Borkowska, A; Ratkiewicz, M				Borowski, Zbigniew; Swislocka, Magdalena; Matosiuk, Maciej; Mirski, Pawel; Krysiuk, Kamil; Czajkowska, Magdalena; Borkowska, Anetta; Ratkiewicz, Miroslaw			Purifying Selection, Density Blocking and Unnoticed Mitochondrial DNA Diversity in the Red Deer, Cervus elaphus	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION; GENETIC-STRUCTURE; PHYLOGEOGRAPHY; IDENTIFICATION; RESPONSES; CERVIDAE; SEQUENCE; ANCIENT; HISTORY; CLIMATE	The trajectories of postglacial range expansions, the occurrence of lineage patches and the formation and maintenance of secondary contact between lineages may mostly reflect neutral demographic processes, including density blocking, that may leave long-lasting genetic signatures. However, a few studies have recently shown that climate may also play a role. We used red deer, a large, mobile herbivore that is assumed to be sensitive to climate change, to test hypotheses of possible selection on the mitochondrial DNA cytochrome b gene (mtDNA cytb) and competitive and/or density-blocking (using mtDNA control region). We searched for a possible link between the phylogeographic structure and abiotic climatic variables. Finally, we tested for isolation by distance and isolation by environment and assessed the impact of human-mediated translocations on the genetic structure of red deer. Our analysis of 30 red deer populations in Poland using the mtDNA control region (N = 357) and cytochrome b (N = 50) markers not only confirmed the presence of the Western and South-Eastern lineages of the species but also indicated the presence of a previously unnoticed, rare relic haplotype that grouped together C. e. italicus from Italy (the Mesola deer). No significant signs of positive selection were detected for the mtDNA cytb gene in the studied red deer. However, a significant signal for purifying selection was found in our study that may explain the narrowness of the contact zone because gene flow between the Western and South-Eastern lineages should drive relatively strong mito-nuclear incompatibilities. MtDNA control region differentiation among red deer populations in Poland correlated with different abiotic climatic variables. Strikingly, the southernmost ice sheet limits during the Elsterian was the most important factor, and it explained the largest amount of variation. However, neither isolation by distance (IBD) nor isolation by environment (IBE) were recorded, and a very limited impact of human translocations was evident. The abovementioned results suggest that in contemporary red deer populations in Poland, the phylogeographic pattern is well preserved, and long-term processes (density and/or competitive blocking) still play a major role.	[Borowski, Zbigniew; Krysiuk, Kamil] Forest Res Inst, Dept Forest Ecol, Raszyn, Poland; [Swislocka, Magdalena; Matosiuk, Maciej; Mirski, Pawel; Czajkowska, Magdalena; Borkowska, Anetta; Ratkiewicz, Miroslaw] Univ Bialystok, Inst Biol, Bialystok, Poland	Forest Research Institute; University of Bialystok	Swislocka, M (corresponding author), Univ Bialystok, Inst Biol, Bialystok, Poland.	magdaswi@uwb.edu.pl	Ratkiewicz, Mirosław/AAI-9035-2020; Borowski, Zbigniew/AAL-6483-2021; Borowski, Zbigniew/AAI-6571-2020; Mirski, Paweł/GXM-8764-2022; Borowski, Zbigniew/AAF-5230-2020	Ratkiewicz, Mirosław/0000-0003-2929-3612; Borowski, Zbigniew/0000-0003-4109-5205; Matosiuk, Maciej/0000-0001-9595-690X; Swislocka, Magdalena/0000-0002-1808-9037; Mirski, Pawel/0000-0003-1251-6365; Czajkowska, Magdalena/0000-0001-8851-9664; Borkowska, Anetta/0000-0002-8711-454X	Forest Research Institute [24-01-08]; General Directorate of Polish Forestry [500-430]; University of Bialystok [BST-102]	Forest Research Institute; General Directorate of Polish Forestry; University of Bialystok	Funded by Forest Research Institute, grant no. 24-01-08 to ZB; General Directorate of Polish Forestry (grant no. 500-430 to ZB; University of Bialystok, BST-102 to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Anderson M. J, 2004, DISTLM V 5 FORTRAN C, P10; Balloux F, 2009, P ROY SOC B-BIOL SCI, V276, P3447, DOI 10.1098/rspb.2009.0752; Borowik T, 2013, ACTA THERIOL, V58, P403, DOI 10.1007/s13364-013-0153-x; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Chikuni K, 1995, J MOL EVOL, V41, P859, DOI 10.1007/BF00173165; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ehlers J, 2004, DEV QUA SCI, V2, P135; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feulner PGD, 2004, HEREDITY, V93, P299, DOI 10.1038/sj.hdy.6800504; Filipi K, 2015, MOL PHYLOGENET EVOL, V82, P245, DOI 10.1016/j.ympev.2014.10.016; Fink S, 2004, MOL ECOL, V13, P3501, DOI 10.1111/j.1365-294X.2004.02351.x; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Krojerova-Prokesova J, 2015, J HERED, V106, P375, DOI 10.1093/jhered/esv018; Lorenc H., 2005, ATLAS KLIMATU POLSKI, P116; Lorenzini R, 2015, J ZOOL SYST EVOL RES, V53, P340, DOI 10.1111/jzs.12104; Matosiuk M, 2014, MOL ECOL, V23, P2559, DOI 10.1111/mec.12745; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Meiri M, 2013, MOL ECOL, V22, P4711, DOI 10.1111/mec.12420; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Niedzialkowska M, 2012, CAN J ZOOL, V90, P150, DOI [10.1139/Z11-122, 10.1139/z11-122]; Niedzialkowska M, 2011, ACTA THERIOL, V56, P1, DOI 10.1007/s13364-010-0002-0; Pakeman RJ, 2004, J ECOL, V92, P893, DOI 10.1111/j.0022-0477.2004.00928.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Searle JB, 2009, P ROY SOC LOND B BIO, DOI [10.1098/j.666.2009.1422, DOI 10.1098/4666.2009.1422]; Skog A, 2009, J BIOGEOGR, V36, P66, DOI 10.1111/j.1365-2699.2008.01986.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stojak J, 2015, BIOL J LINN SOC, V115, P927, DOI 10.1111/bij.12535; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wojcik JM, 2010, J ZOOL, V281, P249, DOI 10.1111/j.1469-7998.2010.00699.x; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zachos FE, 2014, ITAL J ZOOL, V81, P136, DOI 10.1080/11250003.2014.895060; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	45	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163191	10.1371/journal.pone.0163191	http://dx.doi.org/10.1371/journal.pone.0163191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649313	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100065
J	Bourgeois, JS; Jacob, J; Garewal, A; Ndahayo, R; Paxson, J				Bourgeois, Jeffrey S.; Jacob, Jeeva; Garewal, Aram; Ndahayo, Renata; Paxson, Julia			The Bioavailability of Soluble Cigarette Smoke Extract Is Reduced through Interactions with Cells and Affects the Cellular Response to CSE Exposure	PLOS ONE			English	Article							IN-VITRO; LUNG FIBROBLASTS; OXIDATIVE STRESS; DISEASE; VIVO; TOXICITY; DAMAGE; COPD	Cellular exposure to cigarette smoke leads to an array of complex responses including apoptosis, cellular senescence, telomere dysfunction, cellular aging, and neoplastic transformation. To study the cellular response to cigarette smoke, a common in vitro model exposes cultured cells to a nominal concentration (i.e. initial concentration) of soluble cigarette smoke extract (CSE). However, we report that use of the nominal concentration of CSE as the only measure of cellular exposure is inadequate. Instead, we demonstrate that cellular response to CSE exposure is dependent not only on the nominal concentration of CSE, but also on specific experimental variables, including the total cell number, and the volume of CSE solution used. As found in other similar xenobiotic assays, our work suggests that the effective dose of CSE is more accurately related to the amount of bioavailable chemicals per cell. In particular, interactions of CSE components both with cells and other physical factors limit CSE bioavailability, as demonstrated by a quantifiably reduced cellular response to CSE that is first modified by such interactions. This has broad implications for the nature of cellular response to CSE exposure, and for the design of in vitro assays using CSE.	[Bourgeois, Jeffrey S.; Jacob, Jeeva; Garewal, Aram; Ndahayo, Renata; Paxson, Julia] Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA	College of the Holy Cross	Paxson, J (corresponding author), Coll Holy Cross, Dept Biol, Worcester, MA 01610 USA.	jpaxson@holycross.edu		Bourgeois, Jeffrey/0000-0001-9037-8418	College of the Holy Cross; Holy Cross Summer Research Fund	College of the Holy Cross; Holy Cross Summer Research Fund	Funding was provided by the College of the Holy Cross, and by the Holy Cross Summer Research Fund.	Ahmed A, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-25; Birch J, 2015, AM J PHYSIOL-LUNG C, V309, pL1124, DOI 10.1152/ajplung.00293.2015; Burney P, 2015, INT J TUBERC LUNG D, V19, P10, DOI 10.5588/ijtld.14.0446; Camlin NJ, 2014, TOXICOL APPL PHARM, V281, P266, DOI 10.1016/j.taap.2014.10.010; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Doskey CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132572; Fariss MW, 2013, TOXICOL SCI, V132, P253, DOI 10.1093/toxsci/kft001; Fowles J, 2003, TOB CONTROL, V12, P424, DOI 10.1136/tc.12.4.424; Franks TJ, 2015, ARCH PATHOL LAB MED, V139, P974, DOI 10.5858/arpa.2013-0384-RA; Groothuis FA, 2015, TOXICOLOGY, V332, P30, DOI 10.1016/j.tox.2013.08.012; Gulden M, 2015, TOXICOLOGY, V332, P41, DOI 10.1016/j.tox.2013.11.006; Higashi T, 2016, BIOL PHARM BULL, V39, P898, DOI 10.1248/bpb.b16-00062; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Jack J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-109; Jennings P, 2015, TOXICOL IN VITRO, V29, P1217, DOI 10.1016/j.tiv.2014.08.011; Jiang B, 2013, J MED FOOD, V16, P481, DOI 10.1089/jmf.2012.2686; Johnson MD, 2009, CANCER EPIDEM BIOMAR, V18, P3263, DOI [10.1158/1055-9965.EPI-09-0965, DOI 10.1158/1055-9965.EPI-09-0965]; Kanaji N, 2014, AM J PHYSIOL-LUNG C, V307, pL364, DOI 10.1152/ajplung.00041.2014; Kim SY, 2012, AM J PHYSIOL-LUNG C, V302, pL891, DOI 10.1152/ajplung.00288.2011; Lallier TE, 2015, J PERIODONTOL, V86, P91, DOI 10.1902/jop.2014.140319; Lee CH, 2015, ONCOTARGET, V6, P25188, DOI 10.18632/oncotarget.4512; Lee H, 2016, TOXICOL LETT, V240, P140, DOI 10.1016/j.toxlet.2015.10.030; Lemaitre V, 2011, TOXICOL SCI, V123, P542, DOI 10.1093/toxsci/kfr181; Lu B, 2007, TOXICOL SCI, V98, P469, DOI 10.1093/toxsci/kfm112; Marcilla A, 2012, FOOD CHEM TOXICOL, V50, P1317, DOI 10.1016/j.fct.2012.01.046; Ojo O, 2014, PULM PHARMACOL THER, V29, P121, DOI 10.1016/j.pupt.2014.04.004; SHERMAN CB, 1991, CLIN CHEST MED, V12, P643; Stewart R, 2014, EUR HEART J, V35, P2265; Tew KD, 2011, FREE RADICAL BIO MED, V51, P299, DOI 10.1016/j.freeradbiomed.2011.04.013; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Zuo L, 2014, AM J PHYSIOL-LUNG C, V307, pL205, DOI 10.1152/ajplung.00330.2013	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163182	10.1371/journal.pone.0163182	http://dx.doi.org/10.1371/journal.pone.0163182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649082	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100064
J	Dawson, KS; Bryant, RA				Dawson, Katie S.; Bryant, Richard A.			Children's Vantage Point of Recalling Traumatic Events	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MATERNAL REMINISCING STYLE; LONG-TERM RETENTION; AUTOBIOGRAPHICAL MEMORY; FOLLOW-UP; GENDER-DIFFERENCES; EARLIEST MEMORIES; SELF-DESCRIPTION; ADOLESCENTS; EMERGENCE	This study investigated the recollections of child survivors of the 2004 Asian tsunami in terms of their vantage point and posttraumatic stress disorder (PTSD) responses. Five years after the tsunami, 110 children (aged 7-13 years) living in Aceh, Indonesia were assessed for source of memories of the tsunami (personal memory or second-hand source), vantage point of the memory, and were administered the Children's Revised Impact of Event Scale-13. Fifty-three children (48%) met criteria for PTSD. Two-thirds of children reported direct memories of the tsunami and one-third reported having memories based on reports from other people. More children (97%) who reported an indirect memory of the tsunami recalled the event from an onlooker's perspective to some extent than those who recalled the event directly (63%). Boys were more likely to rely on stories from others to reconstruct their memory of the tsunami, and to adopt an observer perspective. Boys who adopted an observer's perspective had less severe PTSD than those who adopted a field perspective. These findings suggest that, at least in the case of boys, an observer perspectives of trauma can be associated with levels of PTSD.	[Dawson, Katie S.; Bryant, Richard A.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Bryant, RA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X	Australian Research Council Linkage Grant [LP100100702]	Australian Research Council Linkage Grant(Australian Research Council)	This project was funded by the Australian Research Council Linkage Grant (LP100100702) awarded to RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by an ARC Linkage Grant (LP100100702).	Bauer P.J., 2007, REMEMBERING TIMES OU; Bauer PJ, 2007, CURR DIR PSYCHOL SCI, V16, P142, DOI 10.1111/j.1467-8721.2007.00492.x; Bauer PJ, 2003, MEMORY, V11, P27, DOI 10.1080/741938176; Berntsen D, 2006, PSYCHOL AGING, V21, P127, DOI 10.1037/0882-7974.21.1.127; Berntsen D, 2006, COGNITION EMOTION, V20, P1193, DOI 10.1080/02699930500371190; BRAINERD CJ, 1990, MONOGR SOC RES CHILD, V55, P1, DOI 10.1111/j.1540-5834.1990.tb00287.x; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Correa S, 2014, APA HDB SEXUALITY PS, V2, P267; Dawson K, 2014, E SUSSEX ROUTLEDGE, P210; Dawson KS, 2014, PSYCHOL TRAUMA-US, V6, P580, DOI 10.1037/a0037140; Dawson KS, TRANSCULT P IN PRESS; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fivush R, 2003, AUTOBIOGRAPHICAL MEMORY AND THE CONSTRUCTION OF A NARRATIVE SELF: DEVELOPMENTAL AND CULTURAL PERSPECTIVES, P149; Fivush R, 2006, CHILD DEV, V77, P1568, DOI 10.1111/j.1467-8624.2006.00960.x; Fivush R, 2011, ANNU REV PSYCHOL, V62, P559, DOI 10.1146/annurev.psych.121208.131702; Fletcher Kenneth E., 1996, P242; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; GREEN BL, 1994, J AM ACAD CHILD PSY, V33, P71, DOI 10.1097/00004583-199401000-00011; Grysman A, 2013, DEV REV, V33, P239, DOI 10.1016/j.dr.2013.07.004; HOWE ML, 1994, CONSCIOUS COGN, V3, P327, DOI 10.1006/ccog.1994.1019; HOWE ML, 1995, DEV PSYCHOL, V31, P579, DOI 10.1037/0012-1649.31.4.579; Jack F, 2009, CHILD DEV, V80, P496, DOI 10.1111/j.1467-8624.2009.01274.x; Jobson L, 2008, BRIT J CLIN PSYCHOL, V47, P95, DOI 10.1348/014466507X235953; Kenny LM, 2007, BEHAV RES THER, V45, P1915, DOI 10.1016/j.brat.2006.09.004; Kenny LM, 2009, PSYCHOL SCI, V20, P1049, DOI 10.1111/j.1467-9280.2009.02393.x; Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50; MacDonald S, 2000, MEMORY, V8, P365, DOI 10.1080/09658210050156822; McAdams D.P., 2001, REV GEN PSYCHOL, V5, P100, DOI [10.1037/1089-2680.5.2.100, DOI 10.1037/1089-2680.5.2.100]; McIsaac H. K., 2002, PSYCHONOMIC B REV, V9, P409; McIsaac HK, 2004, PSYCHOL SCI, V15, P248, DOI 10.1111/j.0956-7976.2004.00660.x; McNally Richard J., 2003, REMEMBERING TRAUMA; Meiser-Stedman R, 2002, CLIN CHILD FAM PSYCH, V5, P217, DOI 10.1023/A:1020982122107; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; Tan NT, 2007, J SOC WORK DISABIL R, V5, P43, DOI 10.1300/J198v05n03_03; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norton GR, 2004, COGNITIVE BEHAV THER, V33, P112; Perrin S, 2005, BEHAV COGN PSYCHOTH, V33, P487, DOI 10.1017/S1352465805002419; Peterson C, 2011, CHILD DEV, V82, P1092, DOI 10.1111/j.1467-8624.2011.01597.x; Pfefferbaum B, 2001, PSYCHIATRY, V64, P202, DOI 10.1521/psyc.64.3.202.18462; Pohl RF, 2005, APPL COGNITIVE PSYCH, V19, P745, DOI 10.1002/acp.1104; ROSENHECK R, 1985, HOSP COMMUNITY PSYCH, V36, P538; Rubin DC, 2000, MEMORY, V8, P265, DOI 10.1080/096582100406810; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Shaw JA, 1996, J AM ACAD CHILD PSY, V35, P359, DOI 10.1097/00004583-199603000-00018; Smith P, 2003, PERS INDIV DIFFER, V34, P315, DOI 10.1016/S0191-8869(02)00047-8; Smith P, 2001, J CHILD PSYCHOL PSYC, V42, P395, DOI 10.1017/S0021963001007065; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Wang Q, 2004, DEV PSYCHOL, V40, P3, DOI 10.1037/0012-1649.40.1.3; Wang Q, 2001, J PERS SOC PSYCHOL, V81, P220, DOI 10.1037//0022-3514.81.2.220; Wickrama KAS, 2007, SOC SCI MED, V64, P713, DOI 10.1016/j.socscimed.2006.09.031; Williams AD, 2007, BEHAV RES THER, V45, P1141, DOI 10.1016/j.brat.2006.09.005	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162030	10.1371/journal.pone.0162030	http://dx.doi.org/10.1371/journal.pone.0162030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649299	Green Published, gold			2022-12-26	WOS:000383892100011
J	McCarthy, D; Windsor, PA; Harris, C; Lomax, S; White, PJ				McCarthy, Dominique; Windsor, Peter Andrew; Harris, Charissa; Lomax, Sabrina; White, Peter John			Effect of Topically Applied Anaesthetic Formulation on the Sensitivity of Scoop Dehorning Wounds in Calves	PLOS ONE			English	Article							CORTISOL RESPONSES; LOCAL-ANESTHESIA; TAIL DOCKING; BEEF-CATTLE; PAIN; ALLEVIATION; DURATION; LAMBS	The post-operative effects of three formulations of topical anaesthetic and a cornual nerve block on the sensitivity of scoop dehorning wounds in calves were compared in two trials. In Trial 1, 21 female Holstein dairy calves aged 8 to 24 weeks were randomly allocated to two groups: (1) scoop dehorning with a post-operative application of a novel topical anaesthetic powder (DTAP, n = 10); and (2) scoop dehorning with a post-operative application of a novel topical anaesthetic ethanol liquid (DTAE, n = 11). In Trial 2, 18 castrated male and 18 female Hereford beef calves aged 16 to 20 weeks were randomly allocated to four groups: (1) scoop dehorning with a pre-operative cornual nerve block of lignocaine (DCB, n = 9); (2) scoop dehorning with a post-operative application of the novel topical anaesthetic ethanol liquid from Trial 1 (DTAE, n = 9); (3) scoop dehorning with a post-operative application of a topical anaesthetic gel (DTAG, n = 9); and (4) sham dehorning (CON, n = 9). Sensitivity was assessed by scoring the behavioural response of calves to stimulation of the wound or skin at time points before and after treatment. In Trial 1, DTAP calves had a greater probability of displaying more severe responses than DTAE calves at 90 and 180 min (P < 0.001). In Trial 2, at 1 h, DTAG calves had a greater probability of displaying more severe responses than CON calves. At 2 h onwards, all dehorned calves had a greater probability of displaying more severe responses than CON calves (P < 0.001). There were no differences between the responses of DCB, DTAG and DTAE calves at any time point. Topical anaesthetic formulations result in almost immediate but temporary anaesthesia of the wound following scoop dehorning in calves and may provide a practical option for pain relief on-farm.	[McCarthy, Dominique; Windsor, Peter Andrew; Harris, Charissa; Lomax, Sabrina; White, Peter John] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Sydney	McCarthy, D (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	dominique.mccarthy@sydney.edu.au	White, Peter J/B-5208-2013; Van der Saag, Dominique/Z-2878-2019	Van der Saag, Dominique/0000-0002-1127-7529; Lomax, Sabrina/0000-0002-6417-5788	Meat and Livestock Australia [P.PSH.0654]	Meat and Livestock Australia(Meat and Livestock Australia)	This work was funded by Meat and Livestock Australia (http://www.mla.com.au/Home). The grant number for this funding is P.PSH.0654. Topical anaesthetic products were supplied by Bayer Animal Health Australia (https://www.bayer.com.au/en/about/profile-and-organisation/animal-health/). Meat and Livestock Australia and Bayer Animal Health Australia had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Meat and Livestock Australia approves the publication of this manuscript.	Brofeldt B T, 1989, J Burn Care Rehabil, V10, P63, DOI 10.1097/00004630-198901000-00009; Clarke K. W., 2014, VET ANAESTHESIA, P313; CSIRO, 2015, BREED HORNL CATTL; Edmondson MA, 2014, FARM ANIMAL ANESTHESIA: CATTLE, SMALL RUMINANTS, CAMELIDS, AND PIGS, P136; Espinoza C, 2013, J DAIRY SCI, V96, P2894, DOI 10.3168/jds.2012-5954; Espinoza C., 2015, ANIM PROD SCI; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Irwin J, 1998, DEHORNING CATTLE; Kupczynski R, 2014, ANN ANIM SCI, V14, P231, DOI 10.2478/aoas-2014-0016; Lomax S, 2008, AUST VET J, V86, P159, DOI 10.1111/j.1751-0813.2008.00285.x; Lomax S, 2013, J ANIM SCI, V91, P4945, DOI 10.2527/jas.2012-5984; Lomax S, 2013, AUST VET J, V91, P160, DOI 10.1111/avj.12031; Lomax S, 2010, AUST VET J, V88, P67, DOI 10.1111/j.1751-0813.2009.00546.x; McMeekan CM, 1998, AUST VET J, V76, P281, DOI 10.1111/j.1751-0813.1998.tb10160.x; Meyer RA, 2005, J HOPKINS APL TECH D, V26, P56; Petherick JC, 2005, APPL ANIM BEHAV SCI, V92, P211, DOI 10.1016/j.applanim.2005.05.009; Petrie NJ, 1996, NEW ZEAL VET J, V44, P4, DOI 10.1080/00480169.1996.35923; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Redua MA, 2002, VET ANAESTH ANALG, V29, P200, DOI 10.1046/j.1467-2995.2002.00083.x; Stafford K. J., 2009, Improving animal welfare: a practical approach, P88, DOI 10.1079/9781845935412.0088; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Sutherland MA, 2002, RES VET SCI, V73, P115, DOI 10.1016/S0034-5288(02)00005-X; Sylvester SP, 2004, AUST VET J, V82, P697, DOI 10.1111/j.1751-0813.2004.tb12162.x; Sylvester SP, 1998, AUST VET J, V76, P118, DOI 10.1111/j.1751-0813.1998.tb14542.x; Thompson T., 2015, ABARES RES REPORT PR; Windsor PA, 2016, SMALL RUMIN IN PRESS	26	4	4	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163181	10.1371/journal.pone.0163181	http://dx.doi.org/10.1371/journal.pone.0163181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648948	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100063
J	Peng, YF; Chen, WC; Xiao, K; Xu, L; Wang, L; Wan, X				Peng, Yun-Feng; Chen, Wen-Chao; Xiao, Kang; Xu, Lin; Wang, Lian; Wan, Xia			DHA Production in Escherichia coli by Expressing Reconstituted Key Genes of Polyketide Synthase Pathway from Marine Bacteria	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PHOSPHOPANTETHEINYL TRANSFERASE GENE; PHOTOBACTERIUM-PROFUNDUM SS9; CUNNINGHAMELLA-ECHINULATA; RECOMBINANT PRODUCTION; DOCOSAHEXAENOIC ACID; STRAIN MP-1; BIOSYNTHESIS; OMEGA-3-FATTY-ACIDS; CERULENIN	The gene encoding phosphopantetheinyl transferase (PPTase), pfaE, a component of the polyketide synthase (PKS) pathway, is crucial for the production of docosahexaenoic acid (DHA, 22: 6 omega 3), along with the other pfa cluster members pfaA, pfaB, pfaC and pfaD. DHA was produced in Escherichia coli by co-expressing pfaABCD from DHA-producing Colwellia psychrerythraea34H with one of four pfaE genes from bacteria producing arachidonic acid (ARA, 20: 4 omega 6), eicosapentaenoic acid (EPA, 20: 5 omega 3) or DHA, respectively. Substitution of the pfaE gene from different strain source in E. coli did not influence the function of the PKS pathway producing DHA, although they led to different DHA yields and fatty acid profiles. This result suggested that the pfaE gene could be switchable between these strains for the production of DHA. The DHA production by expressing the reconstituted PKS pathway was also investigated in different E. coli strains, at different temperatures, or with the treatment of cerulenin. The highest DHA production, 2.2 mg of DHA per gram of dry cell weight or 4.1% of total fatty acids, was obtained by co-expressing pfaE(EPA) from the EPA-producing strain Shewanella baltica with pfaABCD in DH5 alpha. Incubation at low temperature (10-15 degrees C) resulted in higher accumulation of DHA compared to higher temperatures. The addition of cerulenin to the medium increased the proportion of DHA and saturated fatty acids, including C12:0, C14:0 and C16:0, at the expense of monounsaturated fatty acids, including C16: 1 and C18:1. Supplementation with 1 mg/L cerulenin resulted in the highest DHA yield of 2.4 mg/L upon co-expression of pfaE(DHA) from C. psychrerythraea.	[Peng, Yun-Feng; Chen, Wen-Chao; Xiao, Kang; Xu, Lin; Wang, Lian; Wan, Xia] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Wan, Xia] Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wan, X (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.; Wan, X (corresponding author), Hubei Key Lab Lipid Chem & Nutr, Wuhan, Peoples R China.	wanxia@oilcrops.cn			National Natural Science Foundation of China [3100078]; 948 project [2015-Z3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 948 project(Ministry of Agriculture & Rural Affairs)	Support was provided by the National Natural Science Foundation of China (3100078) and 948 project (2015-Z3) to XW.	Allen EE, 1999, APPL ENVIRON MICROB, V65, P1710; Amiri-Jami M, 2010, J APPL MICROBIOL, V109, P1897, DOI 10.1111/j.1365-2672.2010.04817.x; Amiri-Jami M, 2014, APPL MICROBIOL BIOT, V98, P3071, DOI 10.1007/s00253-013-5381-0; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Bunet R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087607; Dubois N, 2006, EUR J LIPID SCI TECH, V108, P28, DOI 10.1002/ejlt.200501217; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Gong YM, 2014, PROG LIPID RES, V56, P19, DOI 10.1016/j.plipres.2014.07.001; Guan X, 2015, PLANT J, V84, P718, DOI 10.1111/tpj.13034; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Matsuda T, 2012, J LIPID RES, V53, P2806, DOI 10.1194/jlr.M024935ERR; Morita N, 2005, BIOTECHNOL LETT, V27, P389, DOI 10.1007/s10529-005-1532-4; Napier JA, 2002, TRENDS PLANT SCI, V7, P51, DOI 10.1016/S1360-1385(01)02191-4; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Orikasa Y, 2006, BIOTECHNOL LETT, V28, P1841, DOI 10.1007/s10529-006-9168-6; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Song XJ, 2013, J AGR FOOD CHEM, V61, P9876, DOI 10.1021/jf403153p; Sugihara S, 2008, BIOTECHNOL LETT, V30, P411, DOI 10.1007/s10529-007-9579-z; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Timmusk S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00387; Trajtenberg F, 2014, FEBS J, V281, P2324, DOI 10.1111/febs.12785; Ujihara T, 2014, FEBS LETT, V588, P4032, DOI 10.1016/j.febslet.2014.09.023; Wan X, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0431-9; Wan X, 2013, MOL BIOL REP, V40, P4483, DOI 10.1007/s11033-013-2540-4; Wan X, 2009, J MICROBIOL BIOTECHN, V19, P1098, DOI 10.4014/jmb.0902.071; Zhou XR, 2013, PHYTOCHEMISTRY, V92, P42, DOI 10.1016/j.phytochem.2013.05.006	32	15	19	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162861	10.1371/journal.pone.0162861	http://dx.doi.org/10.1371/journal.pone.0162861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649078	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100037
J	Zhao, WM; Wang, XY; Ransohoff, RM; Zhou, L				Zhao, Wanming; Wang, Xingyu; Ransohoff, Richard M.; Zhou, Lan			CCR2 deficiency does not provide sustained improvement of muscular dystrophy in mdx(5cv) mice	FASEB JOURNAL			English	Article						fibrosis; inflammation; macrophages; regeneration	SKELETAL-MUSCLE INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TISSUE-RESIDENT MACROPHAGES; CHEMOKINE RECEPTOR 2; GROWTH-FACTOR-I; MDX MICE; FIBROSIS; EXPRESSION; MONOCYTES; CELLS	Genetic ablation or pharmacologic inhibition of CC chemokine receptor type 2 (CCR2) reduced macrophage (MP) infiltration and improved muscle pathology and function in mdx diaphragm muscle at early stages. We addressed whether CCR2 deficiency resulted in sustained improvement of mdx(5cv)-Ccr2(-/-) diaphragm. Compared to mdx(5cv) controls, CCR2 deficiency in mdx(5cv)-Ccr2(-/-) mice markedly reduced intramuscular Ly6C(hi) MPs at all stages, but it reduced Ly6C(low) MPs only at early stages (4 and 9 wk). CCR2 deficiency reduced quadriceps and diaphragm muscle damage and fibrosis at 14 wk but not at 6 mo, and it improved diaphragm muscle regeneration and respiratory function at 14 wk but not at 6 mo. Intramuscular MPs in mdx(5cv)-Ccr2(-/-) diaphragm expressed a low level of IL-1 beta, IL-6, and IFN-gamma genes, a similar level of TNF-alpha, TGF-beta 1, and platelet-derived growth factor a genes, and a high level of IGF-1 and osteopontin genes compared to mdx5cv controls. Diaphragm fibroblasts at 14 wk showed a similar cell number with a similar level of collagen and profibrogenic growth factor gene expression in mdx(5cv)-Ccr2(-/-) and mdx5cv mice. Diaphragm MPs from both mdx(5cv)-Ccr2(-/-) and mdx5cv mice stimulated collagen gene expression by cocultured fibroblasts. The findings suggest that CCR2 deficiency does not provide a sustained benefit and that Ly6C(low) MPs may contribute to the progressive fibrosis and dysfunction of mdx(5cv) diaphragm.	[Zhao, Wanming; Wang, Xingyu; Zhou, Lan] Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA; [Ransohoff, Richard M.] Biogen, Neuroimmunol, Cambridge, MA USA	Icahn School of Medicine at Mount Sinai; Biogen	Zhou, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA.	lan.zhou@mssm.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059702]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01AR059702 (to L.Z.). The authors thank the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai for technical support.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; Capote J, 2016, J CELL BIOL, V213, P275, DOI 10.1083/jcb.201510086; Carter PH, 2013, EXPERT OPIN THER PAT, V23, P549, DOI 10.1517/13543776.2013.771168; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Krempen K, 1999, GENE EXPRESSION, V8, P151; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	51	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					35	46		10.1096/fj.201600619R	http://dx.doi.org/10.1096/fj.201600619R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27655900	Green Published			2022-12-26	WOS:000392177600007
J	Wakabayashi, S; Sawamura, N; Voelzmann, A; Broemer, M; Asahi, T; Hoch, M				Wakabayashi, Satoru; Sawamura, Naoya; Voelzmann, Andre; Broemer, Meike; Asahi, Toru; Hoch, Michael			Ohgata, the Single Drosophila Ortholog of Human Cereblon, Regulates Insulin Signaling-dependent Organismic Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; BAYESIAN PHYLOGENETIC INFERENCE; DNA-BINDING PROTEIN-1; POTASSIUM CHANNEL; CELLS; LENALIDOMIDE; COMPLEX; DEGRADATION; PROMOTES; SYSTEM	Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that is highly conserved in animals and plants. CRBN proteins have been implicated in various biological processes such as development, metabolism, learning, and memory formation, and their impairment has been linked to autosomal recessive non-syndromic intellectual disability and cancer. Furthermore, human CRBN was identified as the primary target of thalidomide teratogenicity. Data on functional analysis of CRBN family members in vivo, however, are still scarce. Here we identify Ohgata (OHGT), the Drosophila ortholog of CRBN, as a regulator of insulin signaling-mediated growth. Using ohgt mutants that we generated by targeted mutagenesis, we show that its loss results in increased body weight and organ size without changes of the body proportions. We demonstrate that ohgt knockdown in the fat body, an organ analogous to mammalian liver and adipose tissue, phenocopies the growth phenotypes. We further show that overgrowth is due to an elevation of insulin signaling in ohgt mutants and to the down-regulation of inhibitory cofactors of circulating Drosophila insulin-like peptides (DILPs), named acid-labile subunit and imaginal morphogenesis protein-late 2. The two inhibitory proteins were previously shown to be components of a heterotrimeric complex with growth-promoting DILP2 and DILP5. Our study reveals OHGT as a novel regulator of insulin-dependent organismic growth in Drosophila.	[Wakabayashi, Satoru; Sawamura, Naoya; Asahi, Toru] Waseda Univ, Fac Sci & Engn, TWIns, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan; [Sawamura, Naoya; Asahi, Toru] Waseda Univ, Res Org Nanolife Innovat, Shinjuku Ku, Tokyo 1620041, Japan; [Voelzmann, Andre] Univ Manchester, Fac Biol Med & Hlth, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Broemer, Meike] German Ctr Neurodegenerat Dis DZNE, Life & Med Sci LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany; [Hoch, Michael] Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Lab Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany	Waseda University; Waseda University; University of Manchester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Sawamura, N; Asahi, T (corresponding author), Waseda Univ, Fac Sci & Engn, TWIns, Shinjuku Ku, 2-2 Wakamatsu, Tokyo 1628480, Japan.; Hoch, M (corresponding author), Univ Bonn, LIMES Inst, Program Unit Dev Genet & Mol Physiol, Lab Mol Dev Biol, Carl Troll Str 31, D-53115 Bonn, Germany.	naoya.sawamura@gmail.com; tasahi@waseda.jp; m.hoch@uni-bonn.de	Sawamura, Naoya/K-1663-2018	Sawamura, Naoya/0000-0003-4753-1119; Voelzmann, Andre/0000-0002-7682-5637	Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG) [VO 2071/1-1]; DFG [SFB 645, TRR83]; Helmholtz cross program topic "Metabolic Dysfunction"; DFG Excellence Cluster ImmunoSensation	Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Helmholtz cross program topic "Metabolic Dysfunction"; DFG Excellence Cluster ImmunoSensation(German Research Foundation (DFG))	This work was supported by the Leading Graduate Program in Science and Engineering, Waseda University from MEXT, Japan; the European Union Institute in Japan at Waseda University (EUIJ Waseda); Deutsche Forschungsgemeinschaft (DFG) Grant VO 2071/1-1 (to A. V.); and DFG Grants SFB 645 and TRR83, the Helmholtz cross program topic "Metabolic Dysfunction," and the DFG Excellence Cluster ImmunoSensation (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal N, 2016, CELL METAB, V23, P675, DOI 10.1016/j.cmet.2016.03.003; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bauer R, 2006, CELL COMMUN ADHES, V13, P103, DOI 10.1080/15419060600631839; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boisclair YR, 2001, J ENDOCRINOL, V170, P63, DOI 10.1677/joe.0.1700063; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; GARBE JC, 1993, DEVELOPMENT, V119, P1237; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gundner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097332; Hahn I, 2013, J CELL SCI, V126, P2470, DOI 10.1242/jcs.120964; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Kang JA, 2016, P NATL ACAD SCI USA, V113, P8771, DOI 10.1073/pnas.1502166113; Kataoka K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29986; Kim HK, 2016, PFLUG ARCH EUR J PHY, V468, P1299, DOI 10.1007/s00424-016-1854-1; Koyama T, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002392, 10.1371/journal.pbio.1002551]; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kwon Y, 2015, DEV CELL, V33, P36, DOI 10.1016/j.devcel.2015.02.012; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pignoni F, 1997, DEVELOPMENT, V124, P271; Qiu WR, 2015, J BIOMOL STRUCT DYN, V33, P1731, DOI 10.1080/07391102.2014.968875; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodenfels J, 2014, GENE DEV, V28, P2636, DOI 10.1101/gad.249763.114; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sano H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005209; Sawamura N, 2015, BIOCHEM BIOPH RES CO, V464, P1054, DOI 10.1016/j.bbrc.2015.07.068; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Shimanouchi K, 2006, J BIOCHEM, V139, P51, DOI 10.1093/jb/mvj006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wada T, 2016, BIOCHEM BIOPH RES CO, V477, P388, DOI 10.1016/j.bbrc.2016.06.091; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	72	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25120	25132		10.1074/jbc.M116.757823	http://dx.doi.org/10.1074/jbc.M116.757823			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27702999	Green Published, hybrid			2022-12-26	WOS:000388880100027
J	Libby, AE; Bales, E; Orlicky, DJ; McManaman, JL				Libby, Andrew E.; Bales, Elise; Orlicky, David J.; McManaman, James L.			Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); gene knockout; lipid droplet; lipid metabolism; lipogenesis; liver metabolism; mass spectrometry (MS); membrane lipid; metabolic disease; perilipin-2	FATTY LIVER-DISEASE; DIFFERENTIATION-RELATED PROTEIN; STEAROYL-COA DESATURASE; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; ACID SYNTHESIS; ANTISENSE OLIGONUCLEOTIDE; PROTEASOMAL DEGRADATION; TRANSCRIPTION FACTOR	Perilipin-2 (PLIN2) is a constitutively associated cytoplasmic lipid droplet coat protein that has been implicated in fatty liver formation in non-alcoholic fatty liver disease. Mice with or without whole-body deletion of perilipin-2 (Plin2-null) were fed either Western or control diets for 30 weeks. Perilipin-2 deletion prevents obesity and insulin resistance in Western diet-fed mice and dramatically reduces hepatic triglyceride and cholesterol levels in mice fed Western or control diets. Gene and protein expression studies reveal that PLIN2 deletion suppressed SREBP-1 and SREBP-2 target genes involved in de novo lipogenesis and cholesterol biosynthetic pathways in livers of mice on either diet. GC-MS lipidomics demonstrate that this reduction correlated with profound alterations in the hepatic lipidome with significant reductions in both desaturation and elongation of hepatic neutral lipid species. To examine the possibility that lipidomic actions of PLIN2 deletion contribute to suppression of SREBP activation, we isolated endoplasmic reticulum membrane fractions from long-term Western diet-fed wild type (WT) and Plin2-null mice. Lipidomic analyses reveal that endoplasmic reticulum membranes from Plin2-null mice are markedly enriched in -3 and -6 long-chain polyunsaturated fatty acids, which others have shown inhibit SREBP activation and de novo lipogenesis. Our results identify PLIN2 as a determinant of global changes in the hepatic lipidome and suggest the hypothesis that these actions contribute to SREBP-regulated de novo lipogenesis involved in non-alcoholic fatty liver disease.	[Libby, Andrew E.; McManaman, James L.] Univ Colorado, Integrated Physiol Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Bales, Elise; McManaman, James L.] Univ Colorado, Div Reprod Sci, Anschutz Med Campus,12700 E 19th Ave,Rm 3013, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	McManaman, JL (corresponding author), Univ Colorado, Div Reprod Sci, Anschutz Med Campus,12700 E 19th Ave,Rm 3013, Aurora, CO 80045 USA.	jim.mcmanaman@ucdenver.edu			National Institutes of Health [2RO1-HD045965]; University of Colorado CCTSI/National Institutes of Health [TL1-TR001081]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD038129, R01HD045965, R01HD075285] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001081, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado CCTSI/National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 2RO1-HD045965 (to J.L.M.) and University of Colorado CCTSI/National Institutes of Health Grant TL1-TR001081 (to A.E.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Carr RM, 2016, EXP CELL RES, V340, P187, DOI 10.1016/j.yexcr.2015.10.021; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; GARG ML, 1988, J NUTR, V118, P661, DOI 10.1093/jn/118.6.661; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imai Y, 2012, PHYSIOL GENOMICS, V44, P1125, DOI 10.1152/physiolgenomics.00045.2012; Jump DB, 2008, CHEM PHYS LIPIDS, V153, P3, DOI 10.1016/j.chemphyslip.2008.02.007; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Langhi C, 2014, J HEPATOL, V61, P358, DOI 10.1016/j.jhep.2014.04.009; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V450, P117, DOI 10.1016/j.bbrc.2014.05.072; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Madison BB, 2016, J LIPID RES, V57, P333, DOI 10.1194/jlr.C066712; Manrique C, 2013, ENDOCRINOLOGY, V154, P3632, DOI 10.1210/en.2013-1256; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Scorletti E, 2013, ANNU REV NUTR, V33, P231, DOI 10.1146/annurev-nutr-071812-161230; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Tailleux A, 2012, BBA-MOL CELL BIOL L, V1821, P809, DOI 10.1016/j.bbalip.2011.10.016; Takahashi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20975; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Torres DM, 2012, SEMIN LIVER DIS, V32, P30, DOI 10.1055/s-0032-1306424; Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062; Tripathy S, 2013, J LIPID RES, V54, P71, DOI 10.1194/jlr.M028787; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang Y, 2005, J LIPID RES, V46, P706, DOI 10.1194/jlr.M400335-JLR200; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554	68	51	56	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24231	24246		10.1074/jbc.M116.759795	http://dx.doi.org/10.1074/jbc.M116.759795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679530	hybrid, Green Published			2022-12-26	WOS:000388498100036
J	Zhang, DM; Marlin, MC; Liang, ZM; Ahmad, M; Ashpole, NM; Sonntag, WE; Zhao, ZJ; Li, GP				Zhang, Dongmei; Marlin, M. Caleb; Liang, Zhimin; Ahmad, Mohiuddin; Ashpole, Nicole M.; Sonntag, William E.; Zhao, Zhizhuang Joe; Li, Guangpu			The Protein Tyrosine Phosphatase MEG2 Regulates the Transport and Signal Transduction of Tropomyosin Receptor Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophosphorylation; membrane trafficking; neuron; receptor tyrosine kinase; tyrosine-protein phosphatase (tyrosine phosphatase); PTP-MEG2; PTPN9; TrkA	NERVE GROWTH-FACTOR; T-CELLS; ACTIVATION; POLYPHOSPHOINOSITIDES; TRAFFICKING; EXPRESSION; HOMOLOGY; PTP-MEG2; SEC14P	Protein tyrosine phosphatase MEG2 (PTP-MEG2) is a unique nonreceptor tyrosine phosphatase associated with transport vesicles, where it facilitates membrane trafficking by dephosphorylation of the N-ethylmaleimide-sensitive fusion factor. In this study, we identify the neurotrophin receptor TrkA as a novel cargo whose transport to the cell surface requires PTP-MEG2 activity. In addition, TrkA is also a novel substrate of PTP-MEG2, which dephosphorylates both Tyr-490 and Tyr-674/Tyr-675 of TrkA. As a result, overexpression of PTP-MEG2 down-regulates NGF/TrkA signaling and blocks neurite outgrowth and differentiation in PC12 cells and cortical neurons.	[Zhang, Dongmei] Fujian Agr & Forestry Univ, Coll Plant Protect, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Zhang, Dongmei; Marlin, M. Caleb; Liang, Zhimin; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Ahmad, Mohiuddin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Ashpole, Nicole M.; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Zhao, Zhizhuang Joe; Li, Guangpu] Univ Oklahoma Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73104 USA	Fujian Agriculture & Forestry University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Li, GP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022	Ahmad, Mohiuddin/0000-0001-9123-0618; sonntag, William/0000-0003-1850-2407; Marlin, M. Caleb/0000-0003-0453-5355	Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR15-089]; National Institutes of Health [R01GM074692]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038747] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology (OCAST); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Oklahoma Center for the Advancement of Science and Technology (OCAST) Grant HR15-089 and National Institutes of Health Grant R01GM074692 (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad M, 2012, NEURON, V73, P260, DOI 10.1016/j.neuron.2011.11.020; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Huynh H, 2003, J IMMUNOL, V171, P6661, DOI 10.4049/jimmunol.171.12.6661; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kruger JM, 2002, J BIOL CHEM, V277, P2620, DOI 10.1074/jbc.M104550200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Saito K, 2007, J BIOL CHEM, V282, P15170, DOI 10.1074/jbc.M608682200; Wang XD, 2002, J IMMUNOL, V168, P4612, DOI 10.4049/jimmunol.168.9.4612; Wang YC, 2005, J EXP MED, V202, P1587, DOI 10.1084/jem.20051108; Xu MJ, 2003, BLOOD, V102, P4354, DOI 10.1182/blood-2003-04-1308; Zhao RX, 2003, J BIOL CHEM, V278, P22609, DOI 10.1074/jbc.M301560200; ZHOU J, 1995, J NEUROCHEM, V65, P1146	17	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23895	23905		10.1074/jbc.M116.728550	http://dx.doi.org/10.1074/jbc.M116.728550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27655914	hybrid, Green Published			2022-12-26	WOS:000388498100005
J	Cheng, DM; Xu, X; Simon, T; Boudyguina, E; Deng, ZY; VerHague, M; Lee, AH; Shelness, GS; Weinberg, RB; Parks, JS				Cheng, Dongmei; Xu, Xu; Simon, Trang; Boudyguina, Elena; Deng, Zhiyong; VerHague, Melissa; Lee, Ann-Hwee; Shelness, Gregory S.; Weinberg, Richard B.; Parks, John S.			Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; cAMP response element-binding protein (CREB); lipoprotein; lipoprotein secretion; liver; secretion; microsomal triglyceride transfer protein; hepatosteatosis; very low density lipoproteins	TRIGLYCERIDE TRANSFER PROTEIN; FATTY LIVER-DISEASE; LIPID-METABOLISM; MESSENGER-RNA; APO-B; SECRETION; TISSUE; CELLS; OVEREXPRESSION; STEATOSIS	Hepatic apolipoprotein A-IV (apoA-IV) expression is correlated with hepatic triglyceride (TG) content in mouse models of chronic hepatosteatosis, and steatosis-induced hepatic apoA-IV gene expression is regulated by nuclear transcription factor cAMP-responsive element-binding protein H (CREBH) processing. To define what aspects of TG homeostasis regulate hepatic CREBH processing and apoA-IV gene expression, several mouse models of attenuated VLDL particle assembly were subjected to acute hepatosteatosis induced by an overnight fast or short term ketogenic diet feeding. Compared with chow-fed C57BL/6 mice, fasted or ketogenic diet-fed mice displayed increased hepatic TG content, which was highly correlated (r(2) = 0.95) with apoA-IV gene expression, and secretion of larger, TG-enriched VLDL, despite a lower rate of TG secretion and a similar or reduced rate of apoB100 secretion. When VLDL particle assembly and secretion was inhibited by hepatic shRNA-induced apoB silencing or genetic or pharmacologic reduction in microsomal triglyceride transfer protein (MTP) activity, hepatic TG content increased dramatically; however, CREBH processing and apoA-IV gene expression were attenuated compared with controls. Adenovirus-mediated reconstitution of MTP expression proportionately restored CREBH processing and apoA-IV expression in liver-specific MTP knock-out mice. These results reveal that hepatic TG content, per se, does not regulate CREBH processing. Instead, TG mobilization into the endoplasmic reticulum for nascent VLDL particle assembly activates CREBH processing and enhances apoA-IV gene expression in the setting of acute steatosis. We conclude that VLDL assembly and CREBH activation play key roles in the response to hepatic steatosis by up-regulating apoA-IV and promoting assembly and secretion of larger, more TG-enriched VLDL particles.	[Cheng, Dongmei; Boudyguina, Elena; VerHague, Melissa; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Simon, Trang; Weinberg, Richard B.] Wake Forest Sch Med, Dept Internal Med, Gastroenterol Sect, Winston Salem, NC 27157 USA; [Deng, Zhiyong] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Xu, Xu; Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Cornell University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu			National Institutes of Health [R01 HL119983, R01 DK089211]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119962, R01HL119983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 HL119983 (to J. S. P.) and R01 DK089211 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Black DD, 2007, AM J PHYSIOL-GASTR L, V293, pG519, DOI 10.1152/ajpgi.00189.2007; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Cheng DM, 2010, J LIPID RES, V51, P849, DOI 10.1194/jlr.D002709; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882; ELSHOURBAGY NA, 1986, J BIOL CHEM, V261, P1998; Evert M, 2003, PATHOL RES PRACT, V199, P373, DOI 10.1078/0344-0338-00433; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hamilton RL, 1998, J LIPID RES, V39, P1543; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Kalogeris TJ, 1997, J NUTR, V127, pS537, DOI 10.1093/jn/127.3.537S; KARATHANASIS SK, 1986, BIOCHEMISTRY-US, V25, P3962, DOI 10.1021/bi00361a034; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Liang Y, 2004, MOL ENDOCRINOL, V18, P2000, DOI 10.1210/me.2003-0477; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Lu S, 2002, J BIOL CHEM, V277, P31929, DOI 10.1074/jbc.M201418200; Nguyen AT, 2006, BBA-MOL CELL BIOL L, V1761, P182, DOI 10.1016/j.bbalip.2006.02.004; Otvos JD, 2011, J CLIN LIPIDOL, V5, P105, DOI 10.1016/j.jacl.2011.02.001; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Sanecka A, 2012, MOL IMMUNOL, V50, P66, DOI 10.1016/j.molimm.2011.12.003; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; SWANEY JB, 1977, BIOCHEMISTRY-US, V16, P271, DOI 10.1021/bi00621a018; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Wang F, 2015, J LIPID RES, V56, P1403, DOI 10.1194/jlr.R052753; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; WEISGRABER KH, 1978, BIOCHEM BIOPH RES CO, V85, P287, DOI 10.1016/S0006-291X(78)80041-2; WU AL, 1978, J BIOL CHEM, V253, P2525; Xu X, 2014, J LIPID RES, V55, P850, DOI 10.1194/jlr.M045104	46	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23793	23803		10.1074/jbc.M116.749283	http://dx.doi.org/10.1074/jbc.M116.749283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655915	hybrid, Green Published			2022-12-26	WOS:000387884400038
J	Rompler, K; Muller, T; Juris, L; Wissel, M; Vukotic, M; Hofmann, K; Deckers, M				Roempler, Katharina; Mueller, Tobias; Juris, Lisa; Wissel, Mirjam; Vukotic, Milena; Hofmann, Kay; Deckers, Markus			Overlapping Role of Respiratory Supercomplex Factor Rcf2 and Its N-terminal Homolog Rcf3 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c oxidase (complex IV); membrane protein; mitochondria; protein assembly; respiratory chain	CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-MEMBRANE PROTEIN; OXIDATIVE-PHOSPHORYLATION; CHAIN SUPERCOMPLEXES; YEAST; COMPLEX; ORGANIZATION; CARDIOLIPIN; BIOGENESIS; COMPONENTS	The mitochondrial electron transport chain consists of individual protein complexes arranged into large macromolecular structures, termed respiratory chain supercomplexes or respirasomes. In the yeast Saccharomyces cerevisiae, respiratory chain supercomplexes form by association of the bc(1) complex with the cytochrome c oxidase. Formation and maintenance of these assemblies are promoted by specific respiratory supercomplex factors, the Rcf proteins. For these proteins a regulatory function in bridging the electron transfer within supercomplexes has been proposed. Here we report on the maturation of Rcf2 into an N- and C-terminal peptide. We show that the previously uncharacterized Rcf3 (YBR255c-A) is a homolog of the N-terminal Rcf2 peptide, whereas Rcf1 is homologous to the C-terminal portion. Both Rcf3 and the C-terminal fragment of Rcf2 associate with monomeric cytochrome c oxidase and respiratory chain supercomplexes. A lack of Rcf2 and Rcf3 increases oxygen flux through the respiratory chain by up-regulation of the cytochrome c oxidase activity. A double gene deletion of RCF2 and RCF3 affects cellular survival under non-fermentable growth conditions, suggesting an overlapping role for both proteins in the regulation of the OXPHOS activity. Furthermore, our data suggest an association of all three Rcf proteins with the bc(1) complex in the absence of a functional cytochrome c oxidase and identify a supercomplex independent interaction network of the Rcf proteins.	[Roempler, Katharina; Mueller, Tobias; Juris, Lisa; Wissel, Mirjam; Vukotic, Milena; Deckers, Markus] Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany; [Hofmann, Kay] Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Gottingen; University of Cologne	Deckers, M (corresponding author), Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.	markus.deckers@medizin.uni-goettingen.de			Deutsche Forschungsgemeinschaft [DE 2277/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DE 2277/1-1. The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bareth B, 2013, MOL CELL BIOL, V33, P4128, DOI 10.1128/MCB.00747-13; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Deckers M, 2014, FEBS LETT, V588, P2985, DOI 10.1016/j.febslet.2014.06.006; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Helbig AO, 2009, PROTEOMICS, V9, P4787, DOI 10.1002/pmic.200800951; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Levchenko M, 2016, BBA-MOL CELL RES, V1863, P1624, DOI 10.1016/j.bbamcr.2016.04.007; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lundin CR, 2016, P NATL ACAD SCI USA, V113, pE4476, DOI 10.1073/pnas.1601196113; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; ONISHI T, 1967, EUR J BIOCHEM, V1, P301, DOI 10.1111/j.1432-1033.1967.tb00074.x; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Ryan M. T., 2001, PROTEIN TRANSLOCATIO; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; TAANMAN JW, 1993, J BIOL CHEM, V268, P18754; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23769	23778		10.1074/jbc.M116.734665	http://dx.doi.org/10.1074/jbc.M116.734665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662906	Green Published, hybrid			2022-12-26	WOS:000387884400036
J	Bruchmann, M; Korsukewitz, C; Kramer, J; Wiendl, H; Meuth, SG				Bruchmann, Maximilian; Korsukewitz, Catharina; Kraemer, Julia; Wiendl, Heinz; Meuth, Sven G.			Dichoptic Metacontrast Masking Functions to Infer Transmission Delay in Optic Neuritis	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; MULTIPLE-SCLEROSIS; RETROBULBAR NEURITIS; BACKWARD-MASKING; BRIGHTNESS; PERCEPTION; VISIBILITY; REVERSAL; STIMULUS; ACCESS	Optic neuritis (ON) has detrimental effects on the transmission of neuronal signals generated at the earliest stages of visual information processing. The amount, as well as the speed of transmitted visual signals is impaired. Measurements of visual evoked potentials (VEP) are often implemented in clinical routine. However, the specificity of VEPs is limited because multiple cortical areas are involved in the generation of P1 potentials, including feedback signals from higher cortical areas. Here, we show that dichoptic metacontrast masking can be used to estimate the temporal delay caused by ON. A group of 15 patients with unilateral ON, nine of which had sufficient visual acuity and volunteered to participate, and a group of healthy control subjects (N = 8) were presented with flashes of gray disks to one eye and flashes of gray annuli to the corresponding retinal location of the other eye. By asking subjects to report the subjective visibility of the target (i.e. the disk) while varying the stimulus onset asynchrony (SOA) between disk and annulus, we obtained typical U-shaped masking functions. From these functions we inferred the critical SOA(max) at which the mask (i.e. the annulus) optimally suppressed the visibility of the target. ON-associated transmission delay was estimated by comparing the SOA(max) between conditions in which the disk had been presented to the affected and the mask to the other eye, and vice versa. SOA(max) differed on average by 28 ms, suggesting a reduction in transmission speed in the affected eye. Compared to previously reported methods assessing perceptual consequences of altered neuronal transmission speed the presented method is more accurate as it is not limited by the observers' ability to judge subtle variations in perceived synchrony.	[Bruchmann, Maximilian] Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany; [Bruchmann, Maximilian] Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Korsukewitz, Catharina; Kraemer, Julia; Wiendl, Heinz; Meuth, Sven G.] Univ Munster, Dept Neurol, Munster, Germany	University of Munster; University of Munster; University of Munster	Bruchmann, M (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany.; Bruchmann, M (corresponding author), Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany.	Maximilian.Bruchmann@uni-muenster.de	Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [BR 3832/1-2]; German Research Foundation (DFG) [BR3832/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	MB received funding from the Deutsche Forschungsgemeinschaft (www.dfg.de), grant number BR 3832/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the German Research Foundation (DFG), BR3832/1-2.	ALPERN M, 1953, J OPT SOC AM, V43, P648, DOI 10.1364/JOSA.43.000648; Bachmann T, 2005, PERCEPTION, V34, P139, DOI 10.1068/p5344b; Bachmann T, 2004, VISION RES, V44, P241, DOI 10.1016/j.visres.2003.10.012; Bachmann T, 1997, CONSCIOUS COGN, V6, P491, DOI 10.1006/ccog.1997.0320; Bachmann T, 2009, SPATIAL VISION, V22, P127, DOI 10.1163/156856809787465645; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B., 2006, VISUAL MASKING; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Breitmeyer BG, 2006, VISION RES, V46, P2645, DOI 10.1016/j.visres.2005.10.020; Bruchmann M, 2010, J VISION, V10, DOI 10.1167/10.6.12; DALEY ML, 1979, ARCH NEUROL-CHICAGO, V36, P292, DOI 10.1001/archneur.1979.00500410070010; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; HALLIDAY AM, 1972, LANCET, V1, P982; HERON JR, 1974, BRAIN, V97, P69, DOI 10.1093/brain/97.1.69; JONES SJ, 1993, J NEUROL, V240, P489, DOI 10.1007/BF00874118; Kirt T, 2013, CONSCIOUS COGN, V22, P330, DOI 10.1016/j.concog.2012.07.007; Kleiner M, 2007, WHATS NEW PSYCHTOOLB, P14; KOLERS PA, 1960, AM J PSYCHOL, V73, P2, DOI 10.2307/1419113; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MARX MS, 1984, DOC OPHTHALMOL, V56, P243, DOI 10.1007/BF00159076; Meuth SG, 2011, MULT SCLER J, V17, P198, DOI 10.1177/1352458510386998; Parsons MP, 1957, AMA ARCH NEUROL PSYC, V77, P134, DOI [10.1001/archneurpsyc.1957.02330320032004, DOI 10.1001/ARCHNEURPSYC.1957.02330320032004]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841; REGAN D, 1976, BRAIN, V99, P43, DOI 10.1093/brain/99.1.43; Reuter F, 2007, NEUROPSYCHOLOGIA, V45, P2683, DOI 10.1016/j.neuropsychologia.2007.04.010; Reuter F, 2009, NEUROIMAGE, V44, P590, DOI 10.1016/j.neuroimage.2008.08.024; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; SCHILLER PH, 1968, PERCEPT PSYCHOPHYS, V3, P237, DOI 10.3758/BF03212735; Stigler R, 1926, HDB BIOL ARBEITSMETH, P949; Stromeyer CF, 2003, VISION RES, V43, P285, DOI 10.1016/S0042-6989(02)00412-1; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575	40	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163375	10.1371/journal.pone.0163375	http://dx.doi.org/10.1371/journal.pone.0163375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711139	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600022
J	Rueda-Martinez, C; Fernandez, MC; Soto-Navarrete, MT; Jimenez-Navarro, M; Duran, AC; Fernandez, B				Rueda-Martinez, Carmen; Carmen Fernandez, M.; Teresa Soto-Navarrete, Maria; Jimenez-Navarro, Manuel; Carmen Duran, Ana; Fernandez, Borja			Identification of Reference Genes for Quantitative Real Time PCR Assays in Aortic Tissue of Syrian Hamsters with Bicuspid Aortic Valve	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VALVULAR HEART-DISEASE; EXPRESSION; ANEURYSMS; MODEL; QUANTIFICATION; NORMALIZATION; EFFICIENCY; DILATATION; SELECTION	Bicuspid aortic valve (BAV) is the most frequent congenital cardiac malformation in humans, and appears frequently associated with dilatation of the ascending aorta. This association is likely the result of a common aetiology. Currently, a Syrian hamster strain with a relatively high (similar to 40%) incidence of BAV constitutes the only spontaneous animal model of BAV disease. The characterization of molecular alterations in the aorta of hamsters with BAV may serve to identify pathophysiological mechanisms and molecular markers of disease in humans. In this report, we evaluate the expression of ten candidate reference genes in aortic tissue of hamsters in order to identify housekeeping genes for normalization using quantitative real time PCR (RT-qPCR) assays. A total of 51 adult (180- 240 days old) and 56 old (300-440 days old) animals were used. They belonged to a control strain of hamsters with normal, tricuspid aortic valve (TAV; n = 30), or to the affected strain of hamsters with TAV (n = 45) or BAV (n = 32). The expression stability of the candidate reference genes was determined by RT-qPCR using three statistical algorithms, GeNorm, NormFinder and Bestkeeper. The expression analyses showed that the most stable reference genes for the three algorithms employed were Cdkn1 beta, G3pdh and Polr2a. We propose the use of Cdkn1 beta, or both Cdkn1 beta and G3pdh as reference genes for mRNA expression analyses in Syrian hamster aorta.	[Rueda-Martinez, Carmen; Jimenez-Navarro, Manuel] Univ Malaga, RIC, Hosp Univ Virgen Victoria, UGC Corazon, Malaga, Spain; [Carmen Fernandez, M.; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja] Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain; [Jimenez-Navarro, Manuel] Univ Malaga, Fac Med, Dept Med, Malaga, Spain; [Jimenez-Navarro, Manuel; Carmen Duran, Ana; Fernandez, Borja] Inst Invest Biomed Malaga IBIMA, Malaga, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Fernandez, B (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain.; Fernandez, B (corresponding author), Inst Invest Biomed Malaga IBIMA, Malaga, Spain.	borjafe@uma.es	/AAG-9282-2020; jimenez-navarro, manuel/AAJ-3236-2020; Corujo, Francisco Borja Fernández/AAG-8258-2020; Soto-Navarrete, Maria Teresa/AAG-7163-2020	Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Jimenez Navarro, Manuel Francisco/0000-0002-6759-0514; Rueda Martinez, Carmen/0000-0002-3278-8475; Fernandez, M. Carmen/0000-0002-9051-8668	Junta de Andalucia (Sevilla, Spain) [P10-6068/2010, PI-0689/2010]; Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain)	Junta de Andalucia (Sevilla, Spain)(Junta de Andalucia); Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain)	This work was supported by Grants P10-6068/2010 and PI-0689/2010 from Junta de Andalucia (Sevilla, Spain); and Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; Bechtel JFM, 2003, J HEART VALVE DIS, V12, P54; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Butany J, 2009, CARDIOVASC PATHOL, V18, P11, DOI 10.1016/j.carpath.2007.12.004; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cotrufo M, 2005, J THORAC CARDIOV SUR, V130, P504, DOI 10.1016/j.jtcvs.2005.01.016; Della Corte A, 2008, J THORAC CARDIOV SUR, V135, P8, DOI 10.1016/j.jtcvs.2007.09.009; EDWARDS JE, 1961, CIRCULATION, V23, P485, DOI 10.1161/01.CIR.23.4.485; Espitia CM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-31; Fedak PWM, 2008, EUR HEART J, V29, P432, DOI 10.1093/eurheartj/ehm609; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Fernandez B, 2014, REV ESP CARDIOL, V67, P712; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fernandez MC, 2000, LAB ANIM-UK, V34, P145, DOI 10.1258/002367700780457545; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Grewal N, 2014, NETH HEART J, V22, P363, DOI 10.1007/s12471-014-0576-2; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; LaHaye S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0487-2; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Lincoln J, 2014, CIRC J, V78, P1801, DOI 10.1253/circj.CJ-14-0510; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Maleki S, 2013, J MOL MED, V91, P129, DOI 10.1007/s00109-012-0942-8; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Paloschi V, 2011, ARTERIOSCL THROM VAS, V31, P691, DOI 10.1161/ATVBAHA.110.218461; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Phillippi JA, 2010, ANN THORAC SURG, V90, P1893, DOI 10.1016/j.athoracsur.2010.07.069; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rueda-Martinez C, 2017, EUR J CARDIO-THORAC, V51, P104, DOI 10.1093/ejcts/ezw277; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sans-Coma V, 2012, J ANAT, V220, P92, DOI 10.1111/j.1469-7580.2011.01440.x; SansComa V, 1996, ANAT RECORD, V244, P490, DOI 10.1002/(SICI)1097-0185(199604)244:4<490::AID-AR7>3.0.CO;2-Z; Sciacca S, 2013, HEART VESSELS, V28, P268, DOI 10.1007/s00380-012-0238-5; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	55	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164070	10.1371/journal.pone.0164070	http://dx.doi.org/10.1371/journal.pone.0164070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711171	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600073
J	Asaolu, IO; Gunn, JK; Center, KE; Koss, MP; Iwelunmor, JI; Ehiri, JE				Asaolu, Ibitola O.; Gunn, Jayleen K.; Center, Katherine E.; Koss, Mary P.; Iwelunmor, Juliet I.; Ehiri, John E.			Predictors of HIV Testing among Youth in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; STI/HIV COINFECTIONS; TRANSMISSION; PREVALENCE; ADOLESCENTS; LINKAGE; WOMEN; CARE; MEN	Introduction In spite of a high prevalence of HIV infection among adolescents and young adults in sub-Saharan Africa, uptake of HIV testing and counseling among youth in the region remains sub-optimal. The objective of this study was to assess factors that influence uptake of HIV testing and counseling among youth aged 15-24 years in sub-Saharan Africa. Methods This study used the Demographic and Health Survey (DHS) data from countries that represent four geographic regions of sub-Saharan Africa: Congo (Brazzaville), representing central Africa (DHS 2011-2012); Mozambique, representing southern Africa (DHS 2011); Nigeria, representing western Africa (DHS 2013); and Uganda, representing eastern Africa (DHS 2011). Analyses were restricted to 23,367 male and female respondents aged 15-24 years with complete data on the variables of interest. Chi-square tests and logistic regression models were used to assess predictors of HIV testing. Statistical significance was set at p<0.01. Results The analysis revealed that a majority of the respondents were female (78.1%) and aged 20-24-years (60.7%). Only a limited proportion of respondents (36.5%) had ever tested for HIV and even fewer (25.7%) demonstrated comprehensive knowledge of HIV/AIDS. There was a significant association between HIV testing and respondents' gender, age, age at sexual debut, and comprehensive knowledge of HIV in the pooled sample. Older youth (adjusted OR (aOR) = 2.19; 99% CI = 1.99-2.40) and those with comprehensive knowledge of HIV (aOR = 1.98; 1.76-2.22) had significantly higher odds of ever being tested for HIV than younger respondents and those with limited HIV/AIDS knowledge respectively. Furthermore, men had lower odds of HIV testing than women (aOR = 0.32; 0.28-0.37). Conclusions Reaching youth in sub-Saharan Africa for HIV testing continues to be a challenge. Public health programs that seek to increase HIV counseling and testing among youth should pay particular attention to efforts that target high-risk subpopulations of youth. The results further suggest that these initiatives would be strengthened by including strategies to increase HIV comprehensive knowledge.	[Asaolu, Ibitola O.; Koss, Mary P.; Ehiri, John E.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85724 USA; [Gunn, Jayleen K.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, 1295 N Martin Ave, Tucson, AZ 85724 USA; [Center, Katherine E.] Univ Arizona, Dept Obstet & Gynecol, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Iwelunmor, Juliet I.] Univ Illinois, Dept Kinesiol & Community Hlth, 1206 S 4th St, Champaign, IL 61820 USA	University of Arizona; University of Arizona; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign	Ehiri, JE (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85724 USA.	jehiri@email.arizona.edu						Alene GD, 2004, AIDS CARE, V16, P57, DOI 10.1080/09540120310001633976; Anderson KG, 2007, INT FAM PLAN PERSPEC, V33, P98, DOI 10.1363/3309807; [Anonymous], 2010, NATL HIV AIDS STRATE; Breakwell G M, 1996, J Health Psychol, V1, P79, DOI 10.1177/135910539600100107; Centers for Disease Control Prevention, 2011, ANN EMERG MED, V58, P67, DOI [10.1016/j.annemergmed.2011.04.006, DOI 10.1016/J.ANNEMERGMED.2011.04.006]; Ezeanolue EE, 2015, LANCET GLOB HEALTH, V3, pE692, DOI 10.1016/S2214-109X(15)00195-3; Fox K., 2013, HIV ADOLESCENTS GUID; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; ICF International, 2012, SAMPL HOUS LIST MAN; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Kehinde AO, 2005, J R SOC PROMO HEALTH, V125, P186, DOI 10.1177/146642400512500413; Khan, 2008, DHS COMP REPORTS, V19; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; Lapsley DK, BIANN M SOC RES CHIL, V8; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Oginni A, 2014, AIDS RES HUM RETROV, V30, pA113, DOI 10.1089/aid.2014.5216.abstract; Omoigberale AI, 2007, NIGER J CLIN PRACT, V9, P11; Pharr JR, 2016, JAIDS-J ACQ IMM DEF, V72, pS154, DOI 10.1097/QAI.0000000000001051; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Sam-Agudu NA, 2016, PEDIATR RES, V79, P838, DOI 10.1038/pr.2016.28; Sanga Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1771-9; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; The Republic of Uganda, 2015, HIV AIDS UG COUNTR P; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; UNAIDS, 2015, UNAIDS GAP REP 2014; UNICEF, 2012, PROGR CHILDR REP CAR; United Republic of Tanzania, 2007, NAT AIDS CONTR PROGR; who, AD HLTH RISKS SOL; WHO, 2015, CONSOLIDATED GUIDELI; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1	36	72	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164052	10.1371/journal.pone.0164052	http://dx.doi.org/10.1371/journal.pone.0164052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706252	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200080
J	Gonzalez, EB; Knutsen, H; Jorde, PE				Gonzalez, Enrique Blanco; Knutsen, Halvor; Jorde, Per Erik			Habitat Discontinuities Separate Genetically Divergent Populations of a Rocky Shore Marine Fish	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SEASCAPE GENETICS; PHYLOGEOGRAPHIC BREAKS; CORKWING WRASSE; CLIMATE-CHANGE; DIFFERENTIATION; CONNECTIVITY; ADAPTATION; DISPERSAL; DIVERSITY	Habitat fragmentation has been suggested to be responsible for major genetic differentiations in a range of marine organisms. In this study, we combined genetic data and environmental information to unravel the relative role of geography and habitat heterogeneity on patterns of genetic population structure of corkwing wrasse (Symphodus melops), a rocky shore species at the northern limit of its distribution range in Scandinavia. Our results revealed a major genetic break separating populations inhabiting the western and southern coasts of Norway. This genetic break coincides with the longest stretch of sand in the whole study area, suggesting habitat fragmentation as a major driver of genetic differentiation of this obligate rocky shore benthic fish in Scandinavia. The complex fjords systems extending along the western coast of Norway appeared responsible for further regional genetic structuring. Our findings indicate that habitat discontinuities may lead to significant genetic fragmentation over short geographical distances, even for marine species with a pelagic larval phase, as for this rocky shore fish.	[Gonzalez, Enrique Blanco; Knutsen, Halvor] Univ Agder, Ctr Coastal Res, N-4604 Kristiansand, Norway; [Knutsen, Halvor] IMR, N-4817 His, Norway; [Knutsen, Halvor; Jorde, Per Erik] Univ Oslo, CEES, Dept Biosci, POB 1066 Blindern, N-0316 Oslo, Norway	University of Agder; Institute of Marine Research - Norway; University of Oslo	Gonzalez, EB (corresponding author), Univ Agder, Ctr Coastal Res, N-4604 Kristiansand, Norway.	enrique.blanco@uia.no	Gonzalez, Enrique Blanco/O-7721-2019; Knutsen, Halvor/A-4261-2009	Gonzalez, Enrique Blanco/0000-0002-2631-2331; Knutsen, Halvor/0000-0002-7627-7634; Jorde, Per Erik/0000-0001-5515-7257	MarinERA program of the European Science Foundation [189570]; Havkyst program of the Norwegian Research Council [234328/MO]; EU Interreg (Kattegat-Skagerrak-Oresund) project [MarGen]	MarinERA program of the European Science Foundation; Havkyst program of the Norwegian Research Council; EU Interreg (Kattegat-Skagerrak-Oresund) project	This work was funded under the MarinERA program of the European Science Foundation (project # 189570, "Marine phylogenetic structuring during climate change: the signature of leading and rear edge of range shifting population"; http://biocongroup.eu/MarinEra/Welcome.html) and the Havkyst program of the Norwegian Research Council (project #234328/MO "Adaptation or plasticity as response to large scale translocations and harvesting over a climatic gradient in the marine ecosystem?"; https://corkwingadapt.wordpress.com/). HK and PEJ were also funded by the EU Interreg (Kattegat-Skagerrak-Oresund) project #"MarGen", http://interreg.no/prosjektbank/margen/.	Araki H., 2010, AQUACULTURE S1, V308, P52, DOI DOI 10.1016/j.aquaculture.2010.05.036; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Barcelo C, 2016, GLOBAL CHANGE BIOL, V22, P1155, DOI 10.1111/gcb.13047; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Belkhir K, 2004, 5000 CNRS UMR LAB GE; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Blanco Gonzalez E, 2011, ANAL GENETIC VARIATI, P217; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Corner GD, PHYS GEOGRAPHY FENNO, P203; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Darwall WRY, 2002, J FISH BIOL SB, V41, P111; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Espeland SH, 2010, KUNNSKAPSSTATUS LEPP; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gonzalez EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125743; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Halvorsen KT, 2016, ICES J MAR SCI, V73, P2586, DOI 10.1093/icesjms/fsw135; Hansen Michael Moller, 2007, J Biol, V6, P6, DOI 10.1186/jbiol59; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hellberg ME, 2002, B MAR SCI, V70, P273; Hickey AJR, 2009, MOL ECOL, V18, P680, DOI 10.1111/j.1365-294X.2008.04052.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Jorde PE, 2007, MAR ECOL PROG SER, V343, P229, DOI 10.3354/meps06922; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Knutsen H, 2015, ICES J MAR SCI, V72, P863, DOI 10.1093/icesjms/fsu204; Knutsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067492; Knutsen H, 2009, CONSERV GENET RESOUR, V1, P433, DOI 10.1007/s12686-009-9100-1; Knutsen H, 2009, MOL ECOL, V18, P3151, DOI 10.1111/j.1365-294X.2009.04253.x; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Olsen JL, 2013, MAR ECOL PROG SER, V486, P121, DOI 10.3354/meps10373; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pritchard JK, 2000, GENETICS, V155, P945; QGIS Development Team, 2009, QUANT GIS GEOGR INF; Quignard J.-P., 1986, P919; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raventos N, 2001, MAR BIOL, V138, P1115; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Satre R., 2007, NORWEGIAN COASTAL CU; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Sivasundar A, 2010, MAR BIOL, V157, P1433, DOI 10.1007/s00227-010-1419-3; Skiftesvik AB, 2014, MAR BIOL RES, V10, P289, DOI 10.1080/17451000.2013.810760; Sodeland M, 2016, GENOME BIOL EVOL, V8, P1012, DOI 10.1093/gbe/evw057; Takezaki N., 2000, POPTREE POPULATION T; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Toms JA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0330; Uglem I, 2002, ENVIRON BIOL FISH, V63, P17, DOI 10.1023/A:1013886112191; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Von der Heyden S., 2013, FRONTIERS BIOGEOGRAP, V5, P29, DOI [10.21425/f5fbg13391, DOI 10.21425/F55113391, DOI 10.21425/F5FBG13391]; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114	73	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163052	10.1371/journal.pone.0163052	http://dx.doi.org/10.1371/journal.pone.0163052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706178	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200032
J	Liu, Y; Cao, F; Xiong, H; Shen, YB; Wang, M				Liu, Yang; Cao, Fei; Xiong, Hui; Shen, Yanbing; Wang, Min			Application of 2,4-Dinitrophenylhydrazine (DNPH) in High-ThroughputScreening for Microorganism Mutants Accumulating 9 alpha-Hydroxyandrost-4-ene-3,17-dione (9 alpha-OHAD)	PLOS ONE			English	Article							RHODOCOCCUS-ERYTHROPOLIS; 3-KETOSTEROID DELTA(1)-DEHYDROGENASE; MYCOBACTERIUM-NEOAURUM; CELLS; FORMALDEHYDE; ALDEHYDES; STEROLS; GENE	To develop a quick method for the preliminarily screening of mutant strains that can accumulate 9 alpha-hydroxyandrost-4-ene-3,17-dione (9 alpha-OH-AD), a high-throughput screening method was presented by applying the principle that 2,4-dinitrophenylhydrazine (DNPH) can react with ketones to produce precipitation. The optimal color assay conditions were the substrate androst-4-ene-3,17-dione (AD) concentration at 2.0 g/L, the ratio of AD to DNPH solution at 1: 4, and the sulfuric acid and ethanol solution percentages in DNPH solution at 2% and 35%, respectively. This method was used to preliminarily screen the mutants of Rhodococcus rhodochrous DSM43269, from which the three ones obtained could produce more 9 alpha-OH-AD. This DNPH color assay method not only broadens screening methods and increases screening efficiency in microbial mutation breeding but also establishes a good foundation for obtaining strains for industrial application.	[Liu, Yang; Cao, Fei; Xiong, Hui; Shen, Yanbing; Wang, Min] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Wang, M (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China.	minw@tust.edu.cn			National Natural Science Foundation of China [21276196]; The National Natural Science Foundation of China [21406167]; Key Project of Chinese Ministry of Education [213004A]; Student's Platform for Innovation and Entrepreneurship Training Program [201510057059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Student's Platform for Innovation and Entrepreneurship Training Program	Support was provided by: the National Natural Science Foundation of China (21276196, http://www.nsfc.gov.cn/): MW; the National Natural Science Foundation of China (21406167, http://www.nsfc.gov.cn/): YS; the Key Project of Chinese Ministry of Education (213004A, http://www.moe.gov.cn/): MW; the Student's Platform for Innovation and Entrepreneurship Training Program (201510057059, http://www.tjmec.gov.cn/): YS. All of these funders had important roles in the study design, experiments performed and preparation of the manuscript.	Andryushina VA, 2011, APPL BIOCHEM MICRO+, V47, P270, DOI 10.1134/S0003683811030021; Angelova B, 2005, ENZYME MICROB TECH, V37, P718, DOI 10.1016/j.enzmictec.2005.04.014; Carpova-Rodina NV, 2011, APPL BIOCHEM MICRO+, V47, P386, DOI 10.1134/S0003683811040041; de las Heras LF, 2012, J STEROID BIOCHEM, V132, P271, DOI 10.1016/j.jsbmb.2012.06.005; Kang HK, 1997, ARCH PHARM RES, V20, P519, DOI 10.1007/BF02975204; Kim YU, 2007, ARCH PHARM, V340, P209, DOI 10.1002/ardp.200600175; LIPARI F, 1982, J CHROMATOGR, V247, P297, DOI 10.1016/S0021-9673(00)85953-1; Liu C, 2015, J ZHEJIANG UNIV-SC B, V16, P286, DOI 10.1631/jzus.B1400274; Medvedev VS, 2012, PHARM CHEM J+, V46, P573, DOI 10.1007/s11094-012-0849-2; Sandner F, 2001, INT J HYG ENVIR HEAL, V203, P275, DOI 10.1078/S1438-4639(04)70038-3; Sukhodolskaya GV, 2007, APPL MICROBIOL BIOT, V74, P867, DOI 10.1007/s00253-006-0728-4; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Yao K, 2013, METAB ENG, V15, P75, DOI 10.1016/j.ymben.2012.10.005; Zhang QY, 2015, ANN MICROBIOL, V65, P1961, DOI 10.1007/s13213-015-1034-0	15	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163836	10.1371/journal.pone.0163836	http://dx.doi.org/10.1371/journal.pone.0163836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706217	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200063
J	Petrovan, SO; Schmidt, BR				Petrovan, Silviu O.; Schmidt, Benedikt R.			Volunteer Conservation Action Data Reveals Large-Scale and Long-Term Negative Population Trends of a Widespread Amphibian, the Common Toad (Bufo bufo)	PLOS ONE			English	Article							CITIZEN SCIENCE; DECLINES; ABUNDANCE; LANDSCAPE; MORTALITY; VIABILITY; COLLAPSE; INVASION; ECOLOGY; MODELS	Rare and threatened species are the most frequent focus of conservation science and action. With the ongoing shift from single-species conservation towards the preservation of ecosystem services, there is a greater need to understand abundance trends of common species because declines in common species can disproportionately impact ecosystems function. We used volunteer-collected data in two European countries, the United Kingdom (UK) and Switzerland, since the 1970s to assess national and regional trends for one of Europe's most abundant amphibian species, the common toad (Bufo bufo). Millions of toads were moved by volunteers across roads during this period in an effort to protect them from road traffic. For Switzerland, we additionally estimated trends for the common frog (Rana temporaria), a similarly widespread and common amphibian species. We used state-space models to account for variability in detection and effort and included only populations with at least 5 years of data; 153 populations for the UK and 141 for Switzerland. Common toads declined continuously in each decade in both countries since the 1980s. Given the declines, this common species almost qualifies for International Union for the Conservation of Nature (IUCN) red-listing over this period despite volunteer conservation efforts. Reasons for the declines and wider impacts remain unknown. By contrast, common frog populations were stable or increasing in Switzerland, although there was evidence of declines after 2003. "Toads on Roads" schemes are vital citizen conservation action projects, and the data from such projects can be used for large scale trend estimations of widespread amphibians. We highlight the need for increased research into the status of common amphibian species in addition to conservation efforts focusing on rare and threatened species.	[Petrovan, Silviu O.] Froglife, 1 Loxley, Peterborough PE45BW, Cambs, England; [Petrovan, Silviu O.] Univ Hull, Ctr Environm & Marine Sci, Scarborough Campus,Filey Rd, Scarborough YO11 3AZ, England; [Schmidt, Benedikt R.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Passage Maximilien De Meuron 6, CH-2000 Neuchatel, Switzerland	University of Hull; University of Zurich	Schmidt, BR (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Schmidt, BR (corresponding author), KARCH, Passage Maximilien De Meuron 6, CH-2000 Neuchatel, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Petrovan, Silviu/ADM-9976-2022; Schmidt, Benedikt R./B-8491-2008; Petrovan, Silviu/AAZ-9299-2021	Petrovan, Silviu/0000-0002-3984-2403; Schmidt, Benedikt R./0000-0002-4023-1001; Petrovan, Silviu/0000-0002-3984-2403	Esmee Fairbairn Foundation [14-0534]; WWF-UK; Department of Transport	Esmee Fairbairn Foundation; WWF-UK; Department of Transport	SP is supported by a grant from Esmee Fairbairn Foundation to Froglife (grant ref nr 14-0534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Volunteer conservation action is generally not financially supported. Sometimes volunteers are supported by local authorities (e.g. supply of materials, help with setting up drift fences).; This analysis would not be possible without the thousands of dedicated volunteers who have tirelessly given their time for toad patrols, data collection and submission over the last 30 or more years. In the UK, Froglife was supported by a range of NGOs including WWF-UK and government bodies, including the Department of Transport. County and local Amphibian and Reptile Groups (ARGs) as well as some Wildlife Trusts have supported these efforts over the years. We are grateful to Tom Langton for developing and promoting Toads on Roads in the UK since its inception as a national project in 1984. Chris Monk, John Heaser and others have greatly contributed as regional patrol coordinators. Natural England has supported Froglife on amphibian road research. In Switzerland, the Swiss Federal Office of the Environment supports KARCH, the Swiss Amphibian and Reptile Conservation Program, which allowed collection and maintenance of all the Swiss data. SP is supported by a grant from Esmee Fairbairn Foundation. We thank Richard Chandler and Marc Kery for help with help with the statistical analysis of the data and Silvia Zumbach and three anonymous reviewers for comments on the manuscript.	Agasyan A, 2009, IUCN RED LIST THREAT, V2009; [Anonymous], 2014, R LANG ENV STAT COMP; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Buckley J, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12052; Carrier JA, 2003, BIOL CONSERV, V111, P395, DOI 10.1016/S0006-3207(02)00308-7; Cooke Arnold, 2011, Nature in Cambridgeshire, V53, P45; COOKE AS, 1972, J ZOOL, V167, P161; Cosentino BJ, 2014, BIOL CONSERV, V180, P31, DOI 10.1016/j.biocon.2014.09.027; Cruickshank SS, 2016, CONSERV BIOL, V30, P1112, DOI 10.1111/cobi.12688; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Departmentfor Transport, 2014, VEH LIC STAT 2013 ST; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; Dixon PM, 2005, ECOLOGY, V86, P1751, DOI 10.1890/04-1343; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Hartel T, 2009, NORTH-WEST J ZOOL, V5, P130; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; Hocking DJ, 2013, BIOL CONSERV, V167, P194, DOI 10.1016/j.biocon.2013.08.006; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hostetler JA, 2015, ECOLOGY, V96, P1713, DOI 10.1890/14-1487.1; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Kamp J, 2015, CONSERV BIOL, V29, P1684, DOI 10.1111/cobi.12537; Kellner K., JAGSUI WRAPPER RJAGS; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kuzmin S, 2009, IUCN RED LIST THREAT, V2009; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Langton T.E.S., 1989, P TOAD TUNN C RENDSB; Langton TES, 2015, WILDL MANAGE CONSERV, P7; Lawson B, 2015, ECOHEALTH, V12, P693, DOI 10.1007/s10393-015-1054-z; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Marsh DM, 2001, BIOL CONSERV, V101, P327, DOI 10.1016/S0006-3207(01)00076-3; Mazerolle MJ, 2014, WETL ECOL MANAG, V22, P325, DOI 10.1007/s11273-013-9332-4; Meisterhans K, 1970, AMPHIBIEN IHRE LEBEN; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; Muller P., 1968, Naturforsch Ges Schaffhausen (2), VNo. 3, P1; OECD Road Traffic Vehicles and Networks, 2013, ROAD TRAFF VEH NETW; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Redford KH, 2013, ORYX, V47, P157, DOI 10.1017/S0030605313000331; Schmidt Benedikt R., 2008, P157; Schmidt BR, 2008, J NAT CONSERV, V16, P157, DOI 10.1016/j.jnc.2008.05.001; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; VANGELDER JJ, 1973, OECOLOGIA, V13, P93, DOI 10.1007/BF00379622; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Zylstra ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125670	59	60	66	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161943	10.1371/journal.pone.0161943	http://dx.doi.org/10.1371/journal.pone.0161943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706154	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000385697200004
J	Cooper, GE; Pounce, ZC; Wallington, JC; Bastidas-Legarda, LY; Nicholas, B; Chidomere, C; Robinson, EC; Martin, K; Tocheva, AS; Christodoulides, M; Djukanovic, R; Wilkinson, TMA; Staples, KJ				Cooper, Grace E.; Pounce, Zoe C.; Wallington, Joshua C.; Bastidas-Legarda, Leidy Y.; Nicholas, Ben; Chidomere, Chiamaka; Robinson, Emily C.; Martin, Kirstin; Tocheva, Anna S.; Christodoulides, Myron; Djukanovic, Ratko; Wilkinson, Tom M. A.; Staples, Karl J.			Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36	PLOS ONE			English	Article							INFLUENZA-VIRUS; IFN-BETA; RECEPTOR; INTERFERON; CELLS; RECOGNITION; NEUTROPHILS; IMPAIRMENT; ACTIVATION; EXPRESSION	Macrophages are essential to maintaining lung homoeostasis and recent work has demonstrated that influenza-infected lung macrophages downregulate their expression of the scavenger receptor CD36. This receptor has also been shown to be involved in phagocytosis of Streptococcus pneumoniae, a primary agent associated with pneumonia secondary to viral infection. The aim of this study was to investigate the role of CD36 in the effects of viral infection on macrophage phagocytic function. Human monocyte-derived macrophages (MDM) were exposed to H3N2 X31 influenza virus, M37 respiratory syncytial virus (RSV) or UV-irradiated virus. No infection of MDM was seen upon exposure to UV-irradiated virus but incubation with live X31 or M37 resulted in significant levels of viral detection by flow cytometry or RT-PCR respectively. Infection resulted in significantly diminished uptake of S. pneumoniae by MDM and significantly decreased expression of CD36 at both the cell surface and mRNA level. Concurrently, there was a significant increase in IFN beta gene expression in response to infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFN beta. Knockdown of CD36 by siRNA resulted in decreased phagocytosis, but this was mimicked by transfection reagent alone. When MDM were incubated with CD36 blocking antibodies no effect on phagocytic ability was observed. These data indicate that autologous IFN beta production by virally-infected cells can inhibit bacterial phagocytosis, but that decreased CD36 expression by these cells does not play a major role in this functional deficiency.	[Cooper, Grace E.; Pounce, Zoe C.; Wallington, Joshua C.; Bastidas-Legarda, Leidy Y.; Nicholas, Ben; Chidomere, Chiamaka; Robinson, Emily C.; Martin, Kirstin; Tocheva, Anna S.; Christodoulides, Myron; Djukanovic, Ratko; Wilkinson, Tom M. A.; Staples, Karl J.] Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs, Tremona Rd, Southampton SO16 6YD, Hants, England; [Djukanovic, Ratko; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Tremona Rd, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs, Tremona Rd, Southampton SO16 6YD, Hants, England.	k.staples@southampton.ac.uk	Christodoulides, Myron/C-6699-2011	Christodoulides, Myron/0000-0002-9663-4731; Pounce, Zoe/0000-0002-1874-6842; Nicholas, Benjamin/0000-0003-1467-9643; Staples, Karl/0000-0003-3844-6457; Djukanovic, Ratko/0000-0001-6039-5612; Wilkinson, Tom/0000-0003-1771-3851; Cooper, Grace/0000-0002-4125-6278	Medical Research Council [1585540, 1560673] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10085] Funding Source: researchfish; Asthma UK [08/026] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Cardone M, 2014, J LEUKOCYTE BIOL, V95, P161, DOI 10.1189/jlb.0313168; Chan A, 2003, GLIA, V43, P231, DOI 10.1002/glia.10258; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Do TTH, 2011, MICROBIOL IMMUNOL, V55, P751, DOI 10.1111/j.1348-0421.2011.00383.x; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Hoeve MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029443; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Ludewick HP, 2011, J GEN VIROL, V92, P1662, DOI 10.1099/vir.0.030825-0; Martin-Fuentes P, 2007, J IMMUNOL, V179, P3242, DOI 10.4049/jimmunol.179.5.3242; McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nicholas B, 2015, J IMMUNOL, V194, P6144, DOI 10.4049/jimmunol.1402283; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; RODGERS BC, 1982, INFECT IMMUN, V36, P1154, DOI 10.1128/IAI.36.3.1154-1159.1982; RODGERS BC, 1982, J MED VIROL, V9, P177, DOI 10.1002/jmv.1890090304; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Staples KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121527; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; WARSHAUER D, 1977, AM REV RESPIR DIS, V115, P269; Weigert A, 2009, BIOL CHEM, V390, P379, DOI 10.1515/BC.2009.048; Wright AKA, 2009, J LEUKOCYTE BIOL, V86, P479, DOI 10.1189/jlb.1108699	35	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163889	10.1371/journal.pone.0163889	http://dx.doi.org/10.1371/journal.pone.0163889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701435	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000385696900027
J	Foratori, GA; de Andrade, FJP; Mosquim, V; Peres, MDS; Ceneviva, R; Chaim, EA; Peres, SHDS				Foratori Junior, Gerson Aparecido; Pires de Andrade, Francisco Juliherme; Mosquim, Victor; Sales Peres, Matheus de Carvalho; Ceneviva, Reginaldo; Chaim, Elinton Adami; de Carvalho Sales Peres, Silvia Helena			Presence of Serum Ferritin before and after Bariatric Surgery: Analysis in Dentate and Edentulous Patients	PLOS ONE			English	Article							Y GASTRIC BYPASS; WEIGHT-LOSS; INSULIN-RESISTANCE; IRON-DEFICIENCY; MORBID-OBESITY; LONG-TERM; ANEMIA; RISK; DISEASE; PERIODONTITIS	Society has changed its own lifestyle, specially its eating habits and physical activities, leading to excessive weight and a sedentary behavior, which has contributed to obesity increase. Bariatric surgery is the most effective treatment to obesity, allowing weight loss and its maintenance. However, it has been related high levels of iron deficiency after surgery. A person's nutritional status might be affected by total or partial tooth loss. The aim of this longitudinal prospective cohort study was to evaluate the levels of serum ferritin before and after bariatric surgery and to identify if there is a relation with tooth loss. The sample was composed of 50 patients selected and assisted at Amaral Carvalho Hospital, located in Jau A city, Brazil. The use and necessity of prosthesis, dental absence or presence, and serum ferritin dosage were evaluated. Student's t test, Univariate analysis, Chi-square and Odds Ratio were adopted (p<0.05). There was no significant difference regarding the serum ferritin levels between dentate and edentulous patients prior to surgery (p = 0.436). After surgery, the serum ferritin levels were higher in edentulous patients (prosthesis users) when compared to the pre-surgical levels, and the post-surgical levels presented significant difference regarding the dentate patients (p = 0.024). It can be concluded that rehabilitated patients in postoperative period showed better levels of serum ferritin after surgical intervention.	[Foratori Junior, Gerson Aparecido; Pires de Andrade, Francisco Juliherme; Mosquim, Victor; de Carvalho Sales Peres, Silvia Helena] Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Sao Paulo, Brazil; [Sales Peres, Matheus de Carvalho] Univ State Sao Paulo, Botucatu Sch Med, Dept Gen Surg, Sao Paulo, Brazil; [Ceneviva, Reginaldo] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, Sao Paulo, Brazil; [Chaim, Elinton Adami] Univ Estadual Campinas, Fac Med Sci Campinas, Dept Surg, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Peres, SHDS (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Sao Paulo, Brazil.	shcperes@usp.br	Mosquim, Victor/U-8419-2019; Chaim, Elinton A/C-7518-2019; Sales-Peres, SILVIA/C-2714-2012; Foratori-Junior, Gerson Aparecido/P-5143-2019	Mosquim, Victor/0000-0003-0442-5690; Chaim, Elinton A/0000-0003-4627-0631; Sales-Peres, SILVIA/0000-0003-3811-7899; Foratori-Junior, Gerson Aparecido/0000-0003-4760-8948; Chaim, Elinton/0000-0001-9370-9518	CNPq; FAPESP [2012/10994-0, 2015/05749-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CNPq and FAPESP (Proc. 2012/10994-0 and 2015/05749-5).	Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; AKEEL R, 1992, SWED DENT J, V16, P191; Albert TE, 2003, J ORAL REHABIL, V30, P720, DOI 10.1046/j.1365-2842.2003.01155.x; Allen F, 2002, CLIN ORAL IMPLAN RES, V13, P320, DOI 10.1034/j.1600-0501.2002.130313.x; ANDERSON D J, 1956, J Dent Res, V35, P664, DOI 10.1177/00220345560350050201; [Anonymous], 2008, AM J CLIN NUTR, V87, P362; Arasaki CH, 2005, OBES SURG, V15, P1408, DOI 10.1381/096089205774859209; Aron-Wisnewsky J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149588; Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868; Baceviciene M, 2009, MEDICINA-LITHUANIA, V45, P565, DOI 10.3390/medicina45070075; Bal B, 2010, NAT REV GASTRO HEPAT, V7, P320, DOI 10.1038/nrgastro.2010.60; Balsa JA, 2008, J ENDOCRINOL INVEST, V31, P845, DOI 10.1007/BF03346429; Balsiger BM, 2000, MAYO CLIN PROC, V75, P673; Barugahara E. I., 2013, African Journal of Food, Agriculture, Nutrition and Development, V13, P7679; Bavaresco M, 2010, OBES SURG, V20, P716, DOI 10.1007/s11695-008-9721-6; Beard J, 2001, J NUTR, V131, p563S, DOI 10.1093/jn/131.2.563S; Benevides Márcio Luiz, 2006, Rev. Bras. Anestesiol., V56, P408, DOI 10.1590/S0034-70942006000400009; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; BRASIL, 2012, SB BRASIL 2010 PESQU; Brasil. Ministerio da Saude, 2014, VIG FAT RISC PROT DO, V37; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Bundy Donald, 2005, Food and Nutrition Bulletin, V26, pS186; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Censo, 2010, IBGE CENS 2010; Chang CY, 2010, OBES SURG, V20, P1121, DOI 10.1007/s11695-008-9513-z; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; CHAUNCEY HH, 1984, INT DENT J, V34, P98; CHONGSHAN S, 1990, J ORAL REHABIL, V17, P611, DOI 10.1111/j.1365-2842.1990.tb01432.x; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Corti MC, 1997, ANN EPIDEMIOL, V7, P62, DOI 10.1016/S1047-2797(96)00112-3; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Sales-Peres SHD, 2015, J CLIN PERIODONTOL, V42, P530, DOI 10.1111/jcpe.12410; de Moura-Grec PG, 2014, CIENC SAUDE COLETIVA, V19, P1763, DOI 10.1590/1413-81232014196.13482013; de Moura-Grec PG, 2014, INT DENT J, V64, P144, DOI 10.1111/idj.12090; De Prisco C, 2005, AM J MED SCI, V329, P57, DOI 10.1097/00000441-200502000-00001; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Djokic D, 2010, HIPPOKRATIA, V14, P252; EDGERTON VR, 1979, BRIT MED J, V2, P1546, DOI 10.1136/bmj.2.6204.1546; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Ettinger JEMTM, 2007, OBES SURG, V17, P525, DOI 10.1007/s11695-007-9091-5; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; FINCH CA, 1986, WESTERN J MED, V145, P657; Flancbaum L, 2006, J GASTROINTEST SURG, V10, P1033, DOI 10.1016/j.gassur.2006.03.004; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Gasteyger C, 2008, AM J CLIN NUTR, V87, P1128, DOI 10.1093/ajcn/87.5.1128; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Gesquiere I, 2014, OBES SURG, V24, P56, DOI 10.1007/s11695-013-1042-8; GEY KF, 1993, BRIT MED BULL, V49, P679, DOI 10.1093/oxfordjournals.bmb.a072640; Haap M, 2003, ANN INTERN MED, V139, P869, DOI 10.7326/0003-4819-139-10-200311180-00029; Haffajee AD, 2009, J CLIN PERIODONTOL, V36, P89, DOI 10.1111/j.1600-051X.2008.01356.x; Hague Anne L, 2008, J Dent Hyg, V82, P22; Harris AA, 2010, J MIDWIFERY WOM HEAL, V55, P529, DOI 10.1016/j.jmwh.2010.06.018; Heling I, 2006, OBES SURG, V16, P1131, DOI 10.1381/096089206778392211; HOWELL AH, 1950, J DENT RES, V29, P133, DOI 10.1177/00220345500290020401; International Nutritional Anemia Consultative Group (INACG), 1985, MEAS IR STAT; Isaksson Helen, 2013, Swed Dent J Suppl, P1; Kassebaum NJ, 2014, J DENT RES, V93, P20, DOI 10.1177/0022034514537828; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Levine R, 2012, BRIT DENT J, V213, P453, DOI 10.1038/sj.bdj.2012.1009; Lopez-Jimenez F, 2011, REV ESP CARDIOL, V64, P140, DOI 10.1016/j.recesp.2010.10.010; Love AL, 2008, AM J HEMATOL, V83, P403, DOI 10.1002/ajh.21106; Madan AK, 2006, OBES SURG, V16, P603, DOI 10.1381/096089206776945057; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Malinowski SS, 2006, AM J MED SCI, V331, P219, DOI 10.1097/00000441-200604000-00009; Marinella MA, 2008, SOUTH MED J, V101, P1024, DOI 10.1097/SMJ.0b013e31817cf7b7; Marsicano Juliane A, 2012, Eur J Dent, V6, P191; Mathus-Vliegen EMH, 2007, INT DENT J, V57, P249; Mattes RD, 1997, J AM DIET ASSOC, V97, P406, DOI 10.1016/S0002-8223(97)00101-6; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Mesfin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123615; MICHAEL CG, 1990, J PROSTHET DENT, V63, P549, DOI 10.1016/0022-3913(90)90074-M; Moize V, 2011, OBES SURG, V21, P1382, DOI 10.1007/s11695-011-0360-y; Moura-Grec PG, 2012, ABCD-ARQ BRAS CIR DI, V25, P173, DOI 10.1590/S0102-67202012000300008; Mulugeta A, 2010, FASEB J, V24; National Center for Health Statistics, 2015, HLTH US 2015 SPEC FE, P107; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oliveira Verenice Martins de, 2004, Arch. Clin. Psychiatry (São Paulo), V31, P199; Pataro AL, 2012, J PERIODONTOL, V83, P257, DOI 10.1902/jop.2011.100782; Prema A., 2011, INT J NUTR PHARM NEU, V1, P184, DOI [10.4103/2231-0738.84212, DOI 10.4103/2231-0738.84212]; Prinz JF, 2000, J ORAL REHABIL, V27, P765, DOI 10.1046/j.1365-2842.2000.00577.x; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; Reji P, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.198; Saini R, 2010, ANN CARD ANAESTH, V13, P159, DOI 10.4103/0971-9784.62936; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sarwer DB, 2011, SURG OBES RELAT DIS, V7, P644, DOI 10.1016/j.soard.2011.06.016; Sato H, 2003, J ORAL REHABIL, V30, P68, DOI 10.1046/j.1365-2842.2003.01049.x; Shinogle JA, 2005, OBES RES, V13, P2202, DOI 10.1038/oby.2005.273; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SMITH CD, 1993, ANN SURG, V218, P91, DOI 10.1097/00000658-199307000-00014; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Trevisan M, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.030; Tsakos G, 2010, J DENT RES, V89, P462, DOI 10.1177/0022034510363247; Tsiftsis DDA, 2009, OBES SURG, V19, P1497, DOI 10.1007/s11695-009-9938-z; Tucker ON, 2007, MED CLIN N AM, V91, P499, DOI 10.1016/j.mcna.2007.01.006; Valderas JP, 2009, OBES SURG, V19, P1132, DOI 10.1007/s11695-009-9890-y; Vandenbroucke JP, 2007, LANCET, V4, P297; Vargas-Ruiz AG, 2008, OBES SURG, V18, P288, DOI 10.1007/s11695-007-9310-0; von Drygalski A, 2009, NUTR CLIN PRACT, V24, P217, DOI 10.1177/0884533609332174; Wang Angela, 2009, Am J Orthop (Belle Mead NJ), V38, P77; Weng TC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006964; WIDMARK G, 1995, J ORAL REHABIL, V22, P589, DOI 10.1111/j.1365-2842.1995.tb01054.x; Williams SE, 2008, CLEV CLIN J MED, V75, P333, DOI 10.3949/ccjm.75.5.333; Yamashita JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129687; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	110	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164084	10.1371/journal.pone.0164084	http://dx.doi.org/10.1371/journal.pone.0164084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695053	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100087
J	Haley, BJ; Kim, SW; Pettengill, J; Luo, Y; Karns, JS; Van Kessel, JAS				Haley, Bradd J.; Kim, Seon Woo; Pettengill, James; Luo, Yan; Karns, Jeffrey S.; Van Kessel, Jo Ann S.			Genomic and Evolutionary Analysis of Two Salmonella enterica Serovar Kentucky Sequence Types Isolated from Bovine and Poultry Sources in North America	PLOS ONE			English	Article							SIALIC-ACID; ANTIMICROBIAL RESISTANCE; POPULATION-STRUCTURE; EFFECTOR PROTEINS; HEMOLYSIN-III; PREVALENCE; VIRULENCE; SEROTYPES; EPIDEMIC; FARM	Salmonella enterica subsp. enterica serovar Kentucky is frequently isolated from healthy poultry and dairy cows and is occasionally isolated from people with clinical disease. A genomic analysis of 119 isolates collected in the United States from dairy cows, ground beef, poultry and poultry products, and human clinical cases was conducted. Results of the analysis demonstrated that the majority of poultry and bovine-associated S. Kentucky were sequence type (ST) 152. Several bovine-associated (n = 3) and food product isolates (n = 3) collected from the United States and the majority of human clinical isolates were ST198, a sequence type that is frequently isolated from poultry and occasionally from human clinical cases in Northern Africa, Europe and Southeast Asia. A phylogenetic analysis indicated that both STs are more closely related to other Salmonella serovars than they are to each other. Additionally, there was strong evidence of an evolutionary divergence between the poultry-associated and bovine-associated ST152 isolates that was due to polymorphisms in four core genome genes. The ST198 isolates recovered from dairy farms in the United States were phylogenetically distinct from those collected from human clinical cases with 66 core genome SNPs differentiating the two groups, but more isolates are needed to determine the significance of this distinction. Identification of S. Kentucky ST198 from dairy animals in the United States suggests that the presence of this pathogen should be monitored in food-producing animals.	[Haley, Bradd J.; Kim, Seon Woo; Karns, Jeffrey S.; Van Kessel, Jo Ann S.] ARS, Environm Microbial & Food Safety Lab, Beltsville Area Res Ctr, USDA, Beltsville, MD 20705 USA; [Pettengill, James; Luo, Yan] US FDA, Off Analyt & Outreach, Ctr Food Safety & Appl Nutr, College Pk, MD USA	United States Department of Agriculture (USDA); US Food & Drug Administration (FDA)	Van Kessel, JAS (corresponding author), ARS, Environm Microbial & Food Safety Lab, Beltsville Area Res Ctr, USDA, Beltsville, MD 20705 USA.	joann.vankessel@ars.usda.gov	Haley, Bradd/AAB-9164-2020	Haley, Bradd/0000-0001-7996-1143	internal USDA/ARS research funding	internal USDA/ARS research funding	This project was supported by internal USDA/ARS research funding.; We gratefully acknowledge Jakeitha Sonnier for laboratory assistance. This project was supported by internal USDA/ARS research funding. The mention of a trade name, proprietary product, or specific equipment does not constitute guarantee or warranty by the USDA and does not imply approval to the exclusion of other products that might be suitable.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Albert MJ, 2014, J CLIN MICROBIOL, V52, P4090, DOI 10.1128/JCM.01775-14; Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Baida GE, 1996, BBA-BIOMEMBRANES, V1284, P122, DOI 10.1016/S0005-2736(96)00168-X; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baucheron S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00213; Blau DM, 2005, J FOOD PROTECT, V68, P696, DOI 10.4315/0362-028X-68.4.696; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Callaway TR, 2014, FOODBORNE PATHOG DIS, V11, P791, DOI 10.1089/fpd.2014.1800; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carlson JC, 2015, VET MICROBIOL, V179, P109, DOI 10.1016/j.vetmic.2015.03.015; Centers for Disease Control and Prevention, 2011, SALM ANN SUMM TABL 2; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chen YC, 2004, CURR MICROBIOL, V49, P175, DOI 10.1007/s00284-004-4288-5; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edrington TS, 2004, LETT APPL MICROBIOL, V38, P366, DOI 10.1111/j.1472-765X.2004.01495.x; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Haley BJ, 2015, EPIDEMIOL INFECT, V143, P682, DOI 10.1017/S0950268814001289; Hamidian M, 2015, J ANTIMICROB CHEMOTH, V70, P305, DOI 10.1093/jac/dku331; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Herrera-Leon S, 2007, RES MICROBIOL, V158, P122, DOI 10.1016/j.resmic.2006.09.009; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Karns JS, 2015, J FOOD PROTECT, V78, P1182, DOI 10.4315/0362-028X.JFP-14-475; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Kingsley RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/j.1365-2958.2002.02805.x; Kingsley RA, 2000, INFECT IMMUN, V68, P2720, DOI 10.1128/IAI.68.5.2720-2727.2000; Kroger C, 2009, J BACTERIOL, V191, P545, DOI 10.1128/JB.01253-08; Ladely SR, 2016, FOODBORNE PATHOG DIS, V13, P309, DOI 10.1089/fpd.2015.2102; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2012, ANTIMICROB AGENTS CH, V56, P5096, DOI 10.1128/AAC.00732-12; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Santos FBO, 2007, J FOOD PROTECT, V70, P1328, DOI 10.4315/0362-028X-70.6.1328; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Van Kessel JAS, 2013, FOODBORNE PATHOG DIS, V10, P448, DOI 10.1089/fpd.2012.1380; Van Kessel JAS, 2012, FOODBORNE PATHOG DIS, V9, P319, DOI 10.1089/fpd.2011.1054; Van Kessel JAS, 2011, J FOOD PROTECT, V74, P759, DOI 10.4315/0362-028X.JFP-10-423; Wells SJ, 2001, J FOOD PROTECT, V64, P3, DOI 10.4315/0362-028X-64.1.3; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	62	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0161225	10.1371/journal.pone.0161225	http://dx.doi.org/10.1371/journal.pone.0161225			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695032	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100008
J	Hamann, M; Biggs, R; Reyers, B				Hamann, Maike; Biggs, Reinette; Reyers, Belinda			An Exploration of Human Well-Being Bundles as Identifiers of Ecosystem Service Use Patterns	PLOS ONE			English	Article							LIFE SATISFACTION; UNEMPLOYMENT; POVERTY; NEED; LIVELIHOODS; HOUSEHOLDS; LINKAGES; SECURITY	We take a social-ecological systems perspective to investigate the linkages between ecosystem services and human well-being in South Africa. A recent paper identified different types of social-ecological systems in the country, based on distinct bundles of ecosystem service use. These system types were found to represent increasingly weak direct feed-backs between nature and people, from rural "green-loop" communities to urban "red-loop" societies. Here we construct human well-being bundles and explore whether the well-being bundles can be used to identify the same social-ecological system types that were identified using bundles of ecosystem service use. Based on national census data, we found three distinct well-being bundle types that are mainly characterized by differences in income, unemployment and property ownership. The distribution of these well-being bundles approximates the distribution of ecosystem service use bundles to a substantial degree: High levels of income and education generally coincided with areas characterised by low levels of direct ecosystem service use (or red-loop systems), while the majority of low well-being areas coincided with medium and high levels of direct ecosystem service use (or transition and green-loop systems). However, our results indicate that transformations from green-loop to red-loop systems do not always entail an immediate improvement in well-being, which we suggest may be due to a time lag between changes in the different system components. Using human well-being bundles as an indicator of social-ecological dynamics may be useful in other contexts since it is based on socio-economic data commonly collected by governments, and provides important insights into the connections between ecosystem services and human well-being at policy-relevant sub-national scales.	[Hamann, Maike; Biggs, Reinette; Reyers, Belinda] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Hamann, Maike; Biggs, Reinette] Univ Stellenbosch, Ctr Complex Syst Transit, Stellenbosch, South Africa; [Reyers, Belinda] CSIR, Nat Resources & Environm, Stellenbosch, South Africa	Stockholm University; Stellenbosch University; Council for Scientific & Industrial Research (CSIR) - South Africa	Hamann, M (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Hamann, M (corresponding author), Univ Stellenbosch, Ctr Complex Syst Transit, Stellenbosch, South Africa.	maike.hamann@su.se	Reyers, Belinda/AAF-6225-2019; Biggs, Reinette/A-5155-2010	Reyers, Belinda/0000-0002-2194-8656; Biggs, Reinette/0000-0003-0300-4149; Hamann, Maike/0000-0003-2906-4043	Swedish International Development Cooperation Agency (Sida); Swedish Research Council (VR); Branco Weiss Society in Science Fellowship; DST/NRF South African Research Chairs Initiative [93097]; WISER project by the Ecosystem Services for Poverty Alleviation program (ESPA) [NE/L001322/1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); NERC [NE/L001284/1] Funding Source: UKRI; Natural Environment Research Council [NE/L001284/1] Funding Source: researchfish	Swedish International Development Cooperation Agency (Sida); Swedish Research Council (VR)(Swedish Research Council); Branco Weiss Society in Science Fellowship; DST/NRF South African Research Chairs Initiative(Department of Science & Technology (India)); WISER project by the Ecosystem Services for Poverty Alleviation program (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a grant from the Swedish International Development Cooperation Agency (Sida) and the Swedish Research Council (VR). RB is supported by a Branco Weiss Society in Science Fellowship and the DST/NRF South African Research Chairs Initiative (Grant No 93097). BR received support from the WISER project (NE/L001322/1) funded by the Ecosystem Services for Poverty Alleviation program (ESPA). ESPA receives its funding from the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2002, WORLD DEV, V30, P181, DOI 10.1016/S0305-750X(01)00109-7; Angelsen A, 2014, WORLD DEV, V64, pS12, DOI 10.1016/j.worlddev.2014.03.006; Baiphethi MN, 2009, AGREKON, V48, P459, DOI 10.1080/03031853.2009.9523836; Bank World, 1993, HOUS EN MARK WORK; Bennett EM, 2015, CURR OPIN ENV SUST, V14, P76, DOI 10.1016/j.cosust.2015.03.007; Bennett Thomas W., 2004, CUSTOMARY LAW S AFRI; BLAAUW D., 2013, J EC FINANCIAL SERVI, V6, P179, DOI DOI 10.4102/jef.v6i1.283; Booysen F, 2002, SOC INDIC RES, V59, P115, DOI 10.1023/A:1016275505152; Borg I, 2010, MODERN MULTIDIMENSIO; Bostic RW, 2008, HOMEOWNERSHIP AM DRE; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Collinson M., 2006, MIGRATION CHANGING S; Cousins B., 2005, WILL FORMALISING PRO, V18, P1; Cox D., 1990, World Bank Research Observer, V5, P205, DOI 10.1093/wbro/5.2.205; Croissant Y., 2013, PACKAGE MLOGIT MULTI; Cumming GS, 2014, NATURE, V515, P50, DOI 10.1038/nature13945; Cummins R.A., 2000, J HAPPINESS STUDIES, V1, P133, DOI DOI 10.1023/A:1010079728426; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Dawson N, 2015, ECOL ECON, V117, P62, DOI 10.1016/j.ecolecon.2015.06.018; De Soto H., 2000, MYSTERY CAPITAL; DFID, 2002, REPORT COMMITTEE EXP; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037/0022-3514.69.5.851; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2009, SOC INDIC RES SER, V37, P201, DOI 10.1007/978-90-481-2350-6_9; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Earth Future, 2015, FUT EARTH RES GLOB S; Ebrahim A, 2013, DEV SO AFR, V30, P168, DOI 10.1080/0376835X.2013.797227; Edmark K, 2005, SCAND J ECON, V107, P353, DOI 10.1111/j.1467-9442.2005.00412.x; ESRI, 2011, ARCGIS DESKT REL 10; Fernandes Edesio, 2002, INFLUENCE SOTOS MYST, P5; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Glaeser EL, 2007, J ECON GROWTH, V12, P77, DOI 10.1007/s10887-007-9015-1; HAGEN-ZANKER J, 2011, S AFRICAS CASH SOCIA; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hamann M, 2015, GLOBAL ENVIRON CHANG, V34, P218, DOI 10.1016/j.gloenvcha.2015.07.008; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hulse K, 2012, WHAT ARE BENEFITS RI; Jensen RT, 2004, J PUBLIC ECON, V88, P89, DOI 10.1016/S0047-2727(02)00085-3; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Klugman J, 2011, J ECON INEQUAL, V9, P249, DOI 10.1007/s10888-011-9178-z; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Leibbrandt M., 2010, WORKING PAPER NO 101, DOI [10.1787/5kmms0t7p1ms-en, DOI 10.1787/5KMMS0T7P1MS-EN]; Lemanski C, 2011, INT J URBAN REGIONAL, V35, P57, DOI 10.1111/j.1468-2427.2010.00945.x; MA, 2005, EC HUM WELL BEING SY; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Masemola M, 2012, 429 UNISA BUR MARK R; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Naude A, 2007, GEOSPATIAL ANAL PLAT; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Pereira E, 2005, ECOL SOC, V10; Phillips J, 2012, SOC SCI RES, V41, P681, DOI 10.1016/j.ssresearch.2012.01.001; Posel D, 2001, SOC DYNAMICS, V27, P165; POTTS D, 1990, J S AFR STUD, V16, P677, DOI 10.1080/03057079008708256; R Development Core Team, 2012, R LANG ENV STAT COMP; Raphael S, 2001, J LAW ECON, V44, P259, DOI 10.1086/320275; Raudsepp-Hearne C, 2010, BIOSCIENCE, V60, P576, DOI 10.1525/bio.2010.60.8.4; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rigg J, 2006, WORLD DEV, V34, P180, DOI 10.1016/j.worlddev.2005.07.015; Selomane O, 2015, ECOL ECON, V118, P140, DOI 10.1016/j.ecolecon.2015.07.024; Shackleton C. M., 2001, Development Southern Africa, V18, P581, DOI 10.1080/03768350120097441; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sirgy MJ, 2006, SOC INDIC RES, V76, P343, DOI 10.1007/s11205-005-2877-8; Smit W, 1998, ENVIRON URBAN, V10, P77, DOI 10.1177/095624789801000119; Stats S.A., 2012, FIND STAT; Stats S.A., 2013, MIDYEAR POPULATION E; Stats SA, 2008, COMMUNITY SURVEY 200; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; TIGGEMANN M, 1984, J OCCUP PSYCHOL, V57, P33, DOI 10.1111/j.2044-8325.1984.tb00145.x; UNDP, 1990, HUM DEV REP 1990, DOI [10.1016/j.ecolecon.2015.06.018, DOI 10.1016/J.ECOLECON.2015.06.018]; Van Gelder JL, 2009, INT J URBAN REGIONAL, V33, P126, DOI 10.1111/j.1468-2427.2009.00833.x; Vemuri AW, 2006, ECOL ECON, V58, P119, DOI 10.1016/j.ecolecon.2005.02.008; Walker BH, 2012, ECOL SOC, V17, DOI 10.5751/ES-05063-170330; Wei T., 2013, CORRPLOT VISUALIZATI; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; WRI, 2005, MILLENNIUM DEV GOALS; Wright G, 2009, S AFRICAN INDEX MULT	79	30	32	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163476	10.1371/journal.pone.0163476	http://dx.doi.org/10.1371/journal.pone.0163476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695120	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100034
J	Rosario, R; Filis, P; Tessyman, V; Kinnell, H; Childs, AJ; Gray, NK; Anderson, RA				Rosario, Roseanne; Filis, Panagiotis; Tessyman, Victoria; Kinnell, Hazel; Childs, Andrew J.; Gray, Nicola K.; Anderson, Richard A.			FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte	PLOS ONE			English	Article							FRAGILE-X PREMUTATION; PRIMARY OVARIAN INSUFFICIENCY; GERM-CELL PROLIFERATION; PROCESSING BODIES; STRESS GRANULES; RNA GRANULES; P BODIES; PCR DATA; EXPRESSION; PROTEIN	Germ cell development and primordial follicle formation during fetal life is critical in establishing the pool of oocytes that subsequently determines the reproductive lifespan of women. Fragile X-associated primary ovarian insufficiency (FXPOI) is caused by inheritance of the FMR1 premutation allele and approximately 20% of women with the premutation allele develop ovarian dysfunction and premature ovarian insufficiency. However, the underlying disease mechanism remains obscure, and a potential role of FMRP in human ovarian development has not been explored. We have characterised the expression of FMR1 and FMRP in the human fetal ovary at the time of germ cell entry into meiosis through to primordial follicle formation. FMRP expression is exclusively in germ cells in the human fetal ovary. Increased FMRP expression in germ cells coincides with the loss of pluripotency-associated protein expression, and entry into meiosis is associated with FMRP granulation. In addition, we have uncovered FMRP association with components of P-bodies and stress granules, suggesting it may have a role in mRNA metabolism at the time of onset of meiosis. Therefore, this data support the hypothesis that FMRP plays a role regulating mRNAs during pivotal maturational processes in fetal germ cells, and ovarian dysfunction resulting from FMR1 premutation may have its origins during these stages of oocyte development.	[Rosario, Roseanne; Filis, Panagiotis; Tessyman, Victoria; Kinnell, Hazel; Childs, Andrew J.; Gray, Nicola K.; Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Filis, Panagiotis] Univ Aberdeen, Inst Med Sci, Med Sci &Nutr, Foresterhill Campus,Foresterhill, Aberdeen AB25 2ZD, Scotland; [Childs, Andrew J.] Royal Vet Coll, Dept Comparat Biomed Sci, London NW1 0TU, England	University of Edinburgh; University of Aberdeen; University of London; University of London Royal Veterinary College	Anderson, RA (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	richard.anderson@ed.ac.uk		Tessyman, Victoria/0000-0001-7755-814X; gray, nicola/0000-0002-0413-1767; Filis, Panagiotis/0000-0002-4121-9354	United Kingdom Medical Research Council [WBS: U.1276.00.002.00001.01]; Medical Research Council [G1100357, MC_U127692697, G117/564] Funding Source: researchfish; MRC [G117/564, G1100357, MC_U127692697] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the United Kingdom Medical Research Council (WBS: U.1276.00.002.00001.01 to RAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Mora MI, 2015, GENE, V571, P52, DOI 10.1016/j.gene.2015.06.039; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Bibi G, 2010, FERTIL STERIL, V94, P869, DOI 10.1016/j.fertnstert.2009.04.047; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2012, METHODS MOL BIOL, V825, P199, DOI 10.1007/978-1-61779-436-0_15; Clarke Hugh J, 2012, Results Probl Cell Differ, V55, P1, DOI 10.1007/978-3-642-30406-4_1; Damell JC, 2011, CELL, V146, P247, DOI DOI 10.1016/J.CELL.2011.06.013; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Hoffman GE, 2012, J HISTOCHEM CYTOCHEM, V60, P439, DOI 10.1369/0022155412441002; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Nguyen-Chi M, 2011, REPRODUCTION, V142, P803, DOI 10.1530/REP-11-0257; Mailick MR, 2014, AM J MED GENET B, V165, P705, DOI 10.1002/ajmg.b.32277; Oh B, 2000, DEVELOPMENT, V127, P3795; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rife M, 2004, AM J MED GENET A, V124A, P129, DOI 10.1002/ajmg.a.20342; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schuettler J, 2011, HUM REPROD, V26, P1241, DOI 10.1093/humrep/der018; Sengupta MS, 2012, IUBMB LIFE, V64, P586, DOI 10.1002/iub.1039; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Sherman SL, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-26; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tanaka SS, 2000, GENE DEV, V14, P841; Tassone F, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-22; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163987	10.1371/journal.pone.0163987	http://dx.doi.org/10.1371/journal.pone.0163987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695106	Green Published, Green Accepted, gold			2022-12-26	WOS:000385553100072
J	Burian, A; Wang, KL; Finton, KAK; Lee, N; Ishitani, A; Strong, RK; Geraghty, DE				Burian, Aura; Wang, Kevin L.; Finton, Kathryn A. K.; Lee, Ni; Ishitani, Akiko; Strong, Roland K.; Geraghty, Daniel E.			HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1	PLOS ONE			English	Article							NK CELLS; RECOGNITION; EXPRESSION; MOLECULES; ACTIVATION; LIGANDS; COMPLEX; PROTEIN; SURFACE; ALLELE	Based on previous findings supporting HLA-F as a ligand for KIR3DL2 and KIR2DS4, we investigated the potential for MHC-I open conformers (OCs) as ligands for KIR3DS1 and KIR3DL1 through interactions measured by surface plasmon resonance. These measurements showed physical binding of KIR3DS1 but not KIR3DL1 with HLA-F and other MHC-I OC while also confirming the allotype specific binding of KIR3DL1 with MHC-I peptide complex. Concordant results were obtained with biochemical pull-down from cell lines and biochemical heterodimerization experiments with recombinant proteins. In addition, surface binding of HLA-F and KIR3DS1 to native and activated NK and T cells was coincident with specific expression of the putative ligand or receptor. A functional response of KIR3DS1 was indicated by increased granule exocytosis in activated cells incubated with HLA-F bound to surfaces. The data extend a model for interaction between MHC-I open conformers and activating KIR receptors expressed during an inflammatory response, potentially contributing to communication between the innate and adaptive immune response.	[Burian, Aura; Wang, Kevin L.; Lee, Ni; Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Finton, Kathryn A. K.; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Ishitani, Akiko] Nara Med Univ, Kashihara, Nara 634, Japan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Nara Medical University	Geraghty, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave N, Seattle, WA 98109 USA.	geraghty@fhcrc.org			NICHD [HD45813]; University of Washington Center for AIDS Research (CFAR); NIH [P30 AI027757]; NIH Institute and Center (NIAID); NIH Institute and Center (NCI); NIH Institute and Center (NIMH); NIH Institute and Center (NIDA); NIH Institute and Center (NICHD); NIH Institute and Center (NHLBI); NIH Institute and Center (NCCAM); Clinical Research Division at the Fred Hutchinson Cancer Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institute and Center (NIAID); NIH Institute and Center (NCI); NIH Institute and Center (NIMH); NIH Institute and Center (NIDA); NIH Institute and Center (NICHD); NIH Institute and Center (NHLBI); NIH Institute and Center (NCCAM); Clinical Research Division at the Fred Hutchinson Cancer Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support from NICHD (www.nichd.nih.gov) grant HD45813 to D.E.G. is acknowledged. Support from the University of Washington Center for AIDS Research (CFAR-depts.washington.edu/cfar/home), a NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) also contributed to this work. Interim funding support from the Clinical Research Division at the Fred Hutchinson Cancer Research Center (fredhutch.org) to D.E.G. is gratefully acknowledged.; Support from NICHD grant HD45813 to D.E.G. is acknowledged. Support from the University of Washington Center for AIDS Research (CFAR), a NIH funded program (P30 AI027757) which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM) also contributed to this work. Interim funding support from the Clinical Research Division at the Fred Hutchinson Cancer Research Center to D.E.G. is gratefully acknowledged.	Bashirova AA, 2011, ANNU REV IMMUNOL, V29, P295, DOI 10.1146/annurev-immunol-031210-101332; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Carrington M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007070; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Finton KA, 2012, IMMUNOL REV, V250, P239, DOI 10.1111/j.1600-065X.2012.01168.x; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2013, J IMMUNOL, V191, P1567, DOI 10.4049/jimmunol.1300080; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Ishitani A, 2003, J IMMUNOL, V171, P1376, DOI 10.4049/jimmunol.171.3.1376; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Lash GE, 2010, PLACENTA, V31, pS87, DOI 10.1016/j.placenta.2009.12.022; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Male V, 2010, METHODS MOL BIOL, V612, P447, DOI 10.1007/978-1-60761-362-6_30; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Morvan M, 2009, J IMMUNOL, V182, P6727, DOI 10.4049/jimmunol.0900212; Parham P, 2012, PHILOS T R SOC B, V367, P800, DOI 10.1098/rstb.2011.0266; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Pascal V, 2007, J IMMUNOL, V179, P1625, DOI 10.4049/jimmunol.179.3.1625; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Velardi A, 2012, CURR OPIN HEMATOL, V19, P319, DOI 10.1097/MOH.0b013e32835423c3; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517	27	81	81	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163297	10.1371/journal.pone.0163297	http://dx.doi.org/10.1371/journal.pone.0163297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649529	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100077
J	Ng, HKH; Harikumar, KG; Miller, LJ; Chow, BKC				Ng, Hans K. H.; Harikumar, Kaleeckal G.; Miller, Laurence J.; Chow, Billy K. C.			Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus	PLOS ONE			English	Article							COUPLED RECEPTOR DIMERIZATION; V2 VASOPRESSIN RECEPTORS; BODY-WATER HOMEOSTASIS; FUNCTIONAL-CHARACTERIZATION; INAPPROPRIATE ANTIDIURESIS; SECRETIN RECEPTOR; BETA-ARRESTINS; RAT-KIDNEY; AQUAPORIN-2; MUTATIONS	The involvement of secretin (SCT) and secretin receptor (SCTR) in regulating body water homeostasis is well established. Identified as one of the vasopressin (Vp)-independent mechanisms in fluid balance, SCT regulates aquaporin 2 (AQP2) in the kidney distal collecting duct cells through activating intracellular cAMP production. This ability to bypass Vp-mediated water reabsorption in kidney implicates SCT's potential to treat nephrogenic diabetes insipidus (NDI). Research on NDI in the past has largely been focused on the searching for mutations in vasopressin receptor 2 (AVPR2), while the functional relationship between SCTR, AVPR2 and NDI remains unclear. Here, we demonstrate the interaction between SCTR and AVPR2 to modulate cellular signaling in vitro. Interestingly, we show in this report that upon heteromer formation with SCTR, R137H, a NDI-causing AVPR2 mutant that is defective in trafficking to cell surface, can functionally be rescued. Our data may provide an explanation for this clinically mild case of NDI, and insights into the pathological development of NDI in the future.	[Ng, Hans K. H.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	University of Hong Kong; Mayo Clinic; Mayo Clinic Phoenix	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Government Research Grants Council [HKU 765011M, 764812M, 765113M, HKU6/CRF/11G]	Hong Kong Government Research Grants Council(Hong Kong Research Grants Council)	This project was supported by the Hong Kong Government Research Grants Council grants (http://www.ugc.edu.hk/eng/rgc/) HKU 765011M, 764812M, 765113M and HKU6/CRF/11G to BKCC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065885; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Bockenhauer D, 2010, NEPHRON PHYSIOL, V114, P1, DOI 10.1159/000245059; Boselt I, 2012, NEPHROL DIAL TRANSPL, V27, P1521, DOI 10.1093/ndt/gfr487; Cheng CYY, 2009, J MOL ENDOCRINOL, V43, P81, DOI 10.1677/JME-08-0123; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2011, KIDNEY INT, V79, P280, DOI 10.1038/ki.2010.397; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; Kim S, 2015, AM J PHYSIOL-RENAL, V309, pF474, DOI 10.1152/ajprenal.00477.2014; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lemaire M, 2009, CLIN KIDNEY J, V2, P20, DOI 10.1093/ndtplus/sfn163; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Michimata M, 2003, KIDNEY INT, V64, P933, DOI 10.1046/j.1523-1755.2003.00182.x; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Neocleous V, 2012, METABOLISM, V61, P922, DOI 10.1016/j.metabol.2012.01.005; Okamoto Takayuki, 2006, Clin Pediatr Endocrinol, V15, P41, DOI 10.1297/cpe.15.41; Olesen ETB, 2011, P NATL ACAD SCI USA, V108, P12949, DOI 10.1073/pnas.1104691108; Pendergraft WF, 2016, BRENNER RECTORS KIDN, V1, P1072; Procino G, 2014, KIDNEY INT, V86, P127, DOI 10.1038/ki.2014.10; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; Schoneberg T, 1997, J CLIN INVEST, V100, P1547, DOI 10.1172/JCI119678; Shoji Y, 1998, HUM MUTAT, pS278; Siu FKY, 2006, REGUL PEPTIDES, V137, P95, DOI 10.1016/j.regpep.2006.02.011; Spanakis E, 2008, J CELL PHYSIOL, V217, P605, DOI 10.1002/jcp.21552; Tajima Asako, 2005, Clin Pediatr Endocrinol, V14, P27, DOI 10.1297/cpe.14.27; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052; VargasPoussou R, 1997, J AM SOC NEPHROL, V8, P1855; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; Wilke C, 2005, KIDNEY INT, V67, P201, DOI 10.1111/j.1523-1755.2005.00071.x	39	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163086	10.1371/journal.pone.0163086	http://dx.doi.org/10.1371/journal.pone.0163086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649563	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100051
J	Paramanandam, M; O'Byrne, M; Ghosh, B; Mammen, JJ; Manipadam, MT; Thamburaj, R; Pakrashi, V				Paramanandam, Maqlin; O'Byrne, Michael; Ghosh, Bidisha; Mammen, Joy John; Manipadam, Marie Therese; Thamburaj, Robinson; Pakrashi, Vikram			Automated Segmentation of Nuclei in Breast Cancer Histopathology Images	PLOS ONE			English	Article							ACTIVE CONTOUR; BOUNDARY	The process of Nuclei detection in high-grade breast cancer images is quite challenging in the case of image processing techniques due to certain heterogeneous characteristics of cancer nuclei such as enlarged and irregularly shaped nuclei, highly coarse chromatin marginalized to the nuclei periphery and visible nucleoli. Recent reviews state that existing techniques show appreciable segmentation accuracy on breast histopathology images whose nuclei are dispersed and regular in texture and shape; however, typical cancer nuclei are often clustered and have irregular texture and shape properties. This paper proposes a novel segmentation algorithm for detecting individual nuclei from Hematoxylin and Eosin (H&E) stained breast histopathology images. This detection framework estimates a nuclei saliency map using tensor voting followed by boundary extraction of the nuclei on the saliency map using a Loopy Back Propagation (LBP) algorithm on a Markov Random Field (MRF). The method was tested on both whole-slide images and frames of breast cancer histopathology images. Experimental results demonstrate high segmentation performance with efficient precision, recall and dice-coefficient rates, upon testing high-grade breast cancer images containing several thousand nuclei. In addition to the optimal performance on the highly complex images presented in this paper, this method also gave appreciable results in comparison with two recently published methods-Wienert et al. (2012) and Veta et al. (2013), which were tested using their own datasets.	[Paramanandam, Maqlin; Thamburaj, Robinson] Madras Christian Coll, Dept Math, Chennai, Tamil Nadu, India; [O'Byrne, Michael; Pakrashi, Vikram] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Ghosh, Bidisha] Trinity Coll Dublin, Dept Civil Struct & Environm Engn, Dublin, Ireland; [Mammen, Joy John] Christian Med Coll & Hosp, Dept Transfus Med & Immunohematol, Vellore, Tamil Nadu, India; [Manipadam, Marie Therese] Christian Med Coll & Hosp, Dept Pathol, Vellore, Tamil Nadu, India	University College Dublin; Trinity College Dublin; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Ghosh, B (corresponding author), Trinity Coll Dublin, Dept Civil Struct & Environm Engn, Dublin, Ireland.	BGHOSH@tcd.ie	Thamburaj, Robinson/AAY-1062-2020; Ghosh, Bidisha/Y-8034-2018	Thamburaj, Robinson/0000-0001-8507-4196; Pakrashi, Vikram/0000-0002-8318-3521; Ghosh, Bidisha/0000-0002-1924-3040; Mammen, Joy/0000-0002-7349-5660	SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program [12/ISCA/2493]	SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program(Science Foundation Ireland)	The study was supported by SFI-ISCA (Science Foundation Ireland - International Strategic Cooperation Award) program grant no. 12/ISCA/2493 to BG and VP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305; Breen EJ, 1996, COMPUT VIS IMAGE UND, V64, P377, DOI 10.1006/cviu.1996.0066; Ciresan DC, 2013, LECT NOTES COMPUTER; Cosatto E, 2008, INT C PATT RECOG, P672; Cucoranu IC, 2014, J PATHOL INFORM, V5; Dalle JR., 2009, WACV; Elston C W, 2002, Histopathology, V41, P154; Fatakdawala H, 2010, IEEE T BIO-MED ENG, V57, P1676, DOI 10.1109/TBME.2010.2041232; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Gelasca ED, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-368; Guy G, 1997, IEEE T PATTERN ANAL, V19, P1265, DOI 10.1109/34.632985; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Meijer GA, 1997, J CLIN PATHOL, V50, P365, DOI 10.1136/jcp.50.5.365; Paramanandam M, 2014, LECT NOTES COMPUT SC, V8466, P250, DOI 10.1007/978-3-319-07148-0_22; Qi X, 2012, IEEE T BIO-MED ENG, V59, P754, DOI 10.1109/TBME.2011.2179298; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Roux Ludovic, 2013, J Pathol Inform, V4, P8, DOI 10.4103/2153-3539.112693; Veta M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070221, DOI 10.1371/J0URNAL.P0NE.0070221]; Veta M, 2015, MED IMAGE ANAL, V20, P237, DOI 10.1016/j.media.2014.11.010; Veta M, 2014, IEEE T BIO-MED ENG, V61, P1400, DOI 10.1109/TBME.2014.2303852; Weinstein RS, 2009, HUM PATHOL, V40, P1057, DOI 10.1016/j.humpath.2009.04.006; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Xu J, 2011, MED IMAGE ANAL, V15, P851, DOI 10.1016/j.media.2011.04.002	24	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162053	10.1371/journal.pone.0162053	http://dx.doi.org/10.1371/journal.pone.0162053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649496	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100013
J	Crossland, H; Atherton, PJ; Stromberg, A; Gustafsson, T; Timmons, JA				Crossland, Hannah; Atherton, Philip J.; Stromberg, Anna; Gustafsson, Thomas; Timmons, James A.			A reverse genetics cell-based evaluation of genes linked to healthy human tissue age	FASEB JOURNAL			English	Article						epigenetic; neuromuscular; rapamycin; siRNA	EXTENDS LIFE-SPAN; CALORIC RESTRICTION; CD36 EXPRESSION; SKELETAL-MUSCLE; RESVERATROL; RAPAMYCIN; COMPLEX; ACTIVATORS; SURVIVAL; PROFILE	We recently developed a binary (i.e., young vs. old) classifier using human muscle RNA profiles that accurately distinguished the age of multiple tissue types. Pathway analysis did not reveal regulators of these 150 genes, so we used reverse genetics and pharmacologic methods to explore regulation of gene expression. Using small interfering RNA, well-studied age-related factors (i.e., rapamycin, resveratrol, TNF-alpha, and staurosporine), quantitative real-time PCR and clustering analysis, we studied gene-gene interactions in human skeletal muscle andrenal epithelial cells. Individual knockdown of 10 different age genes yielded a consistent pattern of gene expression in muscle and renal cells, similar to in vivo. Potential epigenetic interactions included HIST1H3E knockdown, leading to decreased PHF19 and PCDH9, and increased ICAM5 in muscle and renal cells, while ICAM5 knockdown reduced HIST1H3E expression. Resveratrol, staurosporine, and TNF-alpha significantly regulated the in vivo aging genes, while only rapamycin perturbed the healthy-age gene expression signature in a manner consistent with in vivo. In vitro coordination of gene expression for this in vivo tissue age signature indicates a degree of direct coordination, and the observed link with mTOR activity suggests a direct link between a robust biomarker of healthy neuromuscular age and a major axis of life span in model systems.-Crossland, H., Atherton, P. J., Stromberg, A., Gustafsson, T., Timmons, J. A. A reverse genetics cell-based evaluation of genes linked to healthy human tissue age.	[Crossland, Hannah; Timmons, James A.] Kings Coll London, Guys Hosp, Div Genet & Mol Med, 8th Floor,Tower Wing, London SE1 9RT, England; [Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England; [Stromberg, Anna; Gustafsson, Thomas] Karolinska Univ Hosp, Clin Physiol, Dept Lab Med, Stockholm, Sweden	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham; Karolinska Institutet; Karolinska University Hospital	Timmons, JA (corresponding author), Kings Coll London, Guys Hosp, Div Genet & Mol Med, 8th Floor,Tower Wing, London SE1 9RT, England.	james.timmons@kcl.ac.uk	Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019; Gustafsson, Thomas/AAH-1056-2019; Crossland, Hannah/GMW-8128-2022	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Atherton, Philip/0000-0002-7286-046X; Gustafsson, Thomas/0000-0002-1559-4206	Medical Research Council [G1100015]; MRC [G1100015] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in part, by a Medical Research Council grant (G1100015), studying muscle aging(to J.T.).	Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Picard E, 2010, AGING-US, V2, P981, DOI 10.18632/aging.100218; Pojednic RM, 2015, CALCIFIED TISSUE INT, V96, P256, DOI 10.1007/s00223-014-9932-x; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puig-Kroger A, 2006, J IMMUNOL, V177, P2107, DOI 10.4049/jimmunol.177.4.2107; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sood S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0750-x; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; van den Akker EB, 2014, AGING CELL, V13, P216, DOI 10.1111/acel.12160; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	47	7	7	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					96	108		10.1096/fj.201600296RRR	http://dx.doi.org/10.1096/fj.201600296RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27698205	Green Published, hybrid			2022-12-26	WOS:000392177600012
J	Murgia, A; Veronesi, E; Candini, O; Caselli, A; D'souza, N; Rasini, V; Giorgini, A; Catani, F; Iughetti, L; Dominici, M; Burns, JS				Murgia, Alba; Veronesi, Elena; Candini, Olivia; Caselli, Anna; D'souza, Naomi; Rasini, Valeria; Giorgini, Andrea; Catani, Fabio; Iughetti, Lorenzo; Dominici, Massimo; Burns, Jorge S.			Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN PLATELET LYSATE; STEM-CELLS; IN-VITRO; TGF-BETA; OSTEOBLAST DIFFERENTIATION; FORMING CAPACITY; MORPHOGENETIC PROTEIN-2; EXTRACELLULAR-MATRIX; INTERFERON-GAMMA	In skeletal regeneration approaches using human bone marrow derived mesenchymal stromal cells (hBM-MSC), functional evaluation before implantation has traditionally used biomarkers identified using fetal bovine serum-based osteogenic induction media and time courses of at least two weeks. However, emerging pre-clinical evidence indicates donor-dependent discrepancies between these ex vivo measurements and the ability to form bone, calling for improved tests. Therefore, we adopted a multiparametric approach aiming to generate an osteogenic potency assay with improved correlation. hBM-MSC populations from six donors, each expanded under clinical-grade (cGMP) conditions, showed heterogeneity for ex vivo growth response, mineralization and bone-forming ability in a murine xenograft assay. A subset of literature-based biomarker genes was reproducibly upregulated to a significant extent across all populations as cells responded to two different osteogenic induction media. These 12 biomarkers were also measurable in a one-week assay, befitting clinical cell expansion time frames and cGMP growth conditions. They were selected for further challenge using a combinatorial approach aimed at determining ex vivo and in vivo consistency. We identified five globally relevant osteogenic signature genes, notably TGF-beta 1 pathway interactors; ALPL, COL1A2, DCN, ELN and RUNX2. Used in agglomerative cluster analysis, they correctly grouped the bone-forming cell populations as distinct. Although donor #6 cells were correlation slope outliers, they contrastingly formed bone without showing ex vivo mineralization. Mathematical expression level normalization of the most discrepantly upregulated signature gene COL1A2, sufficed to cluster donor #6 with the bone-forming classification. Moreover, attenuating factors causing genuine COL1A2 gene down-regulation, restored ex vivo mineralization. This suggested that the signature gene had an osteogenically influential role; nonetheless no single biomarker was fully deterministic whereas all five signature genes together led to accurate cluster analysis. We show proof of principle for an osteogenic potency assay providing early characterization of primary cGMP-hBM-MSC cultures according to their donor-specific bone-forming potential.	[Murgia, Alba; Veronesi, Elena; Candini, Olivia; D'souza, Naomi; Rasini, Valeria; Iughetti, Lorenzo; Dominici, Massimo; Burns, Jorge S.] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy; [Veronesi, Elena; Dominici, Massimo; Burns, Jorge S.] TPM, Sci & Technol Pk Med, Modena, Italy; [Caselli, Anna] Osped Pediat Giovanni XXIII, CVBF Consorzio Valutaz Biol & Farmacol, Bari, Italy; [Giorgini, Andrea; Catani, Fabio] Univ Hosp Modena & Reggio Emilia, Dept Orthoped Surg, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Dominici, M; Burns, JS (corresponding author), Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy.; Dominici, M; Burns, JS (corresponding author), TPM, Sci & Technol Pk Med, Modena, Italy.	massimo.dominici@unimore.it; jorge.burns@unimore.it	Dominici, Massimo/K-8014-2016; Burns, Jorge S./J-3395-2012; Burns, Jorge/AAF-5291-2019; Iughetti, Lorenzo/I-4602-2014; Catani, Fabio/B-3642-2017	Burns, Jorge S./0000-0002-8602-1536; Iughetti, Lorenzo/0000-0003-0370-7872; Catani, Fabio/0000-0002-1078-7666; Candini, Olivia/0000-0002-5749-9100; Veronesi, Elena/0000-0001-6262-1388; Dominici, Massimo/0000-0002-4007-1503	European Commission through REBORNE project [241879]	European Commission through REBORNE project	This work was supported in parts by the European Commission Seventh Framework Programme (FP7/2007-2013) (grant no. 241879), through the REBORNE project.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100; Acil Y, 2014, J CRANIO MAXILL SURG, V42, P2002, DOI 10.1016/j.jcms.2014.09.006; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Aldahmash A, 2011, STEM CELL REV REP, V7, P860, DOI 10.1007/s12015-011-9274-2; Alm JJ, 2012, TISSUE ENG PART C-ME, V18, P658, DOI [10.1089/ten.tec.2011.0675, 10.1089/ten.TEC.2011.0675]; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Cruz ACC, 2012, J APPL ORAL SCI, V20, P628, DOI 10.1590/S1678-77572012000600007; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Chappuis V, 2012, BONE, V51, P800, DOI 10.1016/j.bone.2012.07.017; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen Jiani, 2005, Journal of Medical and Dental Sciences, V52, P27; Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Cordonnier T, 2014, J TISSUE ENG REGEN M, V8, P364, DOI 10.1002/term.1529; Couchourel D, 2009, ARTHRITIS RHEUM-US, V60, P1438, DOI 10.1002/art.24489; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; De Bari C, 2008, ARTHRITIS RHEUM, V58, P240, DOI 10.1002/art.23143; DelMonaco M, 1997, J INVEST DERMATOL, V108, P938, DOI 10.1111/1523-1747.ep12295241; Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1; Duque G, 2011, J BONE MINER RES, V26, P1472, DOI 10.1002/jbmr.350; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Fiorentini E, 2011, INT J ARTIF ORGANS, V34, P998, DOI 10.5301/ijao.5000001; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Gothard D, 2013, CELL TISSUE RES, V352, P237, DOI 10.1007/s00441-013-1564-3; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hee CK, 2011, CYTOTHERAPY, V13, P528, DOI 10.3109/14653249.2010.542454; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Isaksson H, 2008, J THEOR BIOL, V255, P26, DOI 10.1016/j.jtbi.2008.07.037; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Jung S, 2012, BIOTECHNOL APPL BIOC, V59, P106, DOI 10.1002/bab.1006; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Khanna-Jain R, 2010, GROWTH FACTORS, V28, P437, DOI 10.3109/08977194.2010.495719; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; Lian J B, 1995, Iowa Orthop J, V15, P118; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Madras N, 2002, STEM CELLS, V20, P230, DOI 10.1634/stemcells.20-3-230; Manferdini C, 2011, J CELL PHYSIOL, V226, P2675, DOI 10.1002/jcp.22618; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21; Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001; Mizuno D, 2010, GROWTH FACTORS, V28, P34, DOI 10.3109/08977190903326362; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Mostafa NZ, 2012, CONNECT TISSUE RES, V53, P117, DOI 10.3109/03008207.2011.611601; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Prins HJ, 2014, STEM CELL RES, V12, P428, DOI 10.1016/j.scr.2013.12.001; Prins HJ, 2009, TISSUE ENG PT A, V15, P3741, DOI [10.1089/ten.tea.2008.0666, 10.1089/ten.TEA.2008.0666]; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Quarto N, 2012, STEM CELLS, V30, P2709, DOI 10.1002/stem.1250; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Quivy V, 2004, CLONING STEM CELLS, V6, P140, DOI 10.1089/1536230041372454; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Razzouk Sleiman, 2012, N Y State Dent J, V78, P37; Rich CB, 1999, J BIOL CHEM, V274, P33433, DOI 10.1074/jbc.274.47.33433; Russell KC, 2011, BIOTECHNOL BIOENG, V108, P2716, DOI 10.1002/bit.23193; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x; Seiler C, 2014, J TISSUE ENG REGEN M, V8, P737, DOI 10.1002/term.1575; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sibiya SJ, 2013, J BIOMED MATER RES A, V101, P641, DOI 10.1002/jbm.a.34365; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Tachi K, 2011, TISSUE ENG PT A, V17, P597, DOI [10.1089/ten.tea.2010.0094, 10.1089/ten.TEA.2010.0094]; Tohma Y, 2012, J TISSUE ENG REGEN M, V6, P96, DOI 10.1002/term.401; TURNER RT, 1991, AM J PHYSIOL, V261, pE348, DOI 10.1152/ajpendo.1991.261.3.E348; Veronesi E, 2014, TISSUE ENG PART C-ME, V20, P239, DOI [10.1089/ten.tec.2013.0250, 10.1089/ten.TEC.2013.0250]; Volk SW, 2014, CALCIFIED TISSUE INT, V94, P621, DOI 10.1007/s00223-014-9843-x; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang HY, 2012, CYTOTHERAPY, V14, P423, DOI 10.3109/14653249.2011.652735; Wegman F, 2013, TISSUE ENG PT A, V19, P2686, DOI [10.1089/ten.tea.2012.0569, 10.1089/ten.TEA.2012.0569]; Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361; Yamagiwa H, 2001, J BONE MINER METAB, V19, P20, DOI 10.1007/s007740170056; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054645	105	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163629	10.1371/journal.pone.0163629	http://dx.doi.org/10.1371/journal.pone.0163629			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711115	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600032
J	Paul, K; Padalhin, AR; Linh, NTB; Kim, B; Sarkar, SK; Lee, BT				Paul, Kallyanashis; Padalhin, Andrew R.; Nguyen Thuy Ba Linh; Kim, Boram; Sarkar, Swapan Kumar; Lee, Byong Taek			A Study of BMP-2-Loaded Bipotential Electrolytic Complex around a Biphasic Calcium Phosphate-Derived (BCP) Scaffold for Repair of Large Segmental Bone Defect	PLOS ONE			English	Article							TGF-BETA; BMP-2; DIFFERENTIATION; DELIVERY	A bipotential polyelectrolyte complex with biphasic calcium phosphate (BCP) powder dispersion provides an excellent option for protein adsorption and cell attachment and can facilitate enhanced bone regeneration. Application of the bipotential polyelectrolyte complex embedded in a spongy scaffold for faster healing of large segmental bone defects (LSBD) can be a promising endeavor in tissue engineering application. In the present study, a hollow scaffold suitable for segmental long bone replacement was fabricated by the sponge replica method applying the microwave sintering process. The fabricated scaffold was coated with calcium alginate at the shell surface, and genipin-crosslinked chitosan with biphasic calcium phosphate (BCP) dispersion was loaded at the central hollow core. The chitosan core was subsequently loaded with BMP-2. The electrolytic complex was characterized using SEM, porosity measurement, FTIR spectroscopy and BMP-2 release for 30 days. In vitro studies such as MTT, live/dead, cell proliferation and cell differentiation were performed. The scaffold was implanted into a 12 mm critical size defect of a rabbit radius. The efficacy of this complex is evaluated through an in vivo study, one and two month post implantation. BV/TV ratio for BMP-2 loaded sample was (42 +/- 1.76) higher compared with hollow BCP scaffold (32 +/- 0.225).	[Paul, Kallyanashis; Padalhin, Andrew R.; Kim, Boram; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, South Korea; [Nguyen Thuy Ba Linh; Sarkar, Swapan Kumar; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, South Korea.; Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, South Korea.	lbt@sch.ac.kr	Padalhin, Andrew/ABF-4523-2021	Padalhin, Andrew/0000-0002-3869-5720; Paul, Kallyanashis/0000-0002-0953-3263; Lee, Byong-Taek/0000-0001-9072-0033; Nguyen, Linh/0000-0002-8532-8296	Soonchunhyang University [20150000]; basic science research program through national research foundation of Republic of Korea (NRF) - ministry of education [2015R1A6A1A03032522]; Soonchunhyang University	Soonchunhyang University; basic science research program through national research foundation of Republic of Korea (NRF) - ministry of education; Soonchunhyang University	This work was supported by Mid-career Research Program through Soonchunhyang University Research Fund only (No. 20150000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by basic science research program through the national research foundation of Republic of Korea (NRF) funded by the ministry of education (2015R1A6A1A03032522) and was partially supported by Soonchunhyang University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Dr. Hae Il Jung and Mr. Shin-Woo Kim for their contributions to the in vivo operation.	Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bi LX, 2014, MAT SCI ENG C-MATER, V42, P816, DOI 10.1016/j.msec.2014.06.022; BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cheng LJ, 2012, APPL SURF SCI, V262, P188, DOI 10.1016/j.apsusc.2012.04.122; Cipitria A, 2012, J BONE MINER RES, V27, P1275, DOI 10.1002/jbmr.1589; Detzel CJ, 2011, TISSUE ENG PART B-RE, V17, P101, DOI [10.1089/ten.teb.2010.0548, 10.1089/ten.TEB.2010.0548]; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021; Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955; Henrionnet C, 2010, BIO-MED MATER ENG, V20, P175, DOI 10.3233/BME-2010-0629; Hesse E, 2010, BONE, V46, P1457, DOI 10.1016/j.bone.2010.02.011; Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439; Jin HH, 2012, INT J BIOL MACROMOL, V51, P1079, DOI 10.1016/j.ijbiomac.2012.08.027; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Lee YT, 2007, MATER CHEM PHYS, V104, P249, DOI 10.1016/j.matchemphys.2007.02.009; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Lu ZF, 2015, NANOMED-NANOTECHNOL, V11, P219, DOI 10.1016/j.nano.2014.09.008; Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nath SD, 2015, CARBOHYD POLYM, V115, P160, DOI 10.1016/j.carbpol.2014.08.077; Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018; Ohta S, 2006, INT J CANCER, V119, P2236, DOI 10.1002/ijc.22127; Paderni Stefania, 2009, Chir Organi Mov, V93, P89, DOI 10.1007/s12306-009-0028-0; Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497; Rhim JW, 2004, LEBENSM-WISS TECHNOL, V37, P323, DOI 10.1016/j.lwt.2003.09.008; SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Shen BJ, 2009, TISSUE ENG PT A, V15, P1311, DOI 10.1089/ten.tea.2008.0132; Son SR, 2014, J BIOMATER APPL; Nguyen TBL, 2014, TISSUE ENG PT A, V20, P1993, DOI [10.1089/ten.tea.2013.0352, 10.1089/ten.TEA.2013.0352]; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020; van der Linden Jacqueline C, 2006, Drug Discov Today Technol, V3, P213, DOI 10.1016/j.ddtec.2006.06.006; Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003	41	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163708	10.1371/journal.pone.0163708	http://dx.doi.org/10.1371/journal.pone.0163708			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711142	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600036
J	Auty, H; Cleaveland, S; Malele, I; Masoy, J; Lembo, T; Bessell, P; Torr, S; Picozzi, K; Welburn, SC				Auty, Harriet; Cleaveland, Sarah; Malele, Imna; Masoy, Joseph; Lembo, Tiziana; Bessell, Paul; Torr, Stephen; Picozzi, Kim; Welburn, Susan C.			Quantifying Heterogeneity in Host-Vector Contact: Tsetse (Glossina swynnertoni and G. pallidipes) Host Choice in Serengeti National Park, Tanzania	PLOS ONE			English	Article							WEST-NILE-VIRUS; TRYPANOSOMA-BRUCEI; LUANGWA VALLEY; FLIES DIPTERA; SLEEPING-SICKNESS; RESPONSES; IDENTIFICATION; TRANSMISSION; RHODESIENSE; PREFERENCES	Background Identifying hosts of blood-feeding insect vectors is crucial in understanding their role in disease transmission. Rhodesian human African trypanosomiasis (rHAT), also known as acute sleeping sickness is caused by Trypanosoma brucei rhodesiense and transmitted by tsetse flies. The disease is commonly associated with wilderness areas of east and southern Africa. Such areas hold a diverse range of species which form communities of hosts for disease maintenance. The relative importance of different wildlife hosts remains unclear. This study quantified tsetse feeding preferences in a wilderness area of great host species richness, Serengeti National Park, Tanzania, assessing tsetse feeding and host density contemporaneously. Methods Glossina swynnertoni and G. pallidipes were collected from six study sites. Bloodmeal sources were identified through matching Cytochrome B sequences amplified from bloodmeals from recently fed flies to published sequences. Densities of large mammal species in each site were quantified, and feeding indices calculated to assess the relative selection or avoidance of each host species by tsetse. Results The host species most commonly identified in G. swynnertoni bloodmeals, warthog (94/220), buffalo (48/220) and giraffe (46/220), were found at relatively low densities (3-11/km(2)) and fed on up to 15 times more frequently than expected by their relative density. Wildebeest, zebra, impala and Thomson's gazelle, found at the highest densities, were never identified in bloodmeals. Commonly identified hosts for G. pallidipes were buffalo (26/46), giraffe (9/46) and elephant (5/46). Conclusions This study is the first to quantify tsetse host range by molecular analysis of tsetse diet with simultaneous assessment of host density in a wilderness area. Although G. swynnertoni and G. pallidipes can feed on a range of species, they are highly selective. Many host species are rarely fed on, despite being present in areas where tsetse are abundant. These feeding patterns, along with the ability of key host species to maintain and transmit T. b. rhodesiense, drive the epidemiology of rHAT in wilderness areas.	[Auty, Harriet] SRUC, Epidemiol Res Unit, Inverness, Scotland; [Auty, Harriet; Picozzi, Kim; Welburn, Susan C.] Univ Edinburgh, Edinburgh Med Sch, Sch Biomed Sci, Div Pathway & Infect Med,Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Cleaveland, Sarah; Lembo, Tiziana] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Malele, Imna] TTRI, Tanga, Tanzania; [Masoy, Joseph] Tanzania Wildlife Res Inst, Serengeti Biodivers Project, Arusha, Tanzania; [Bessell, Paul] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Torr, Stephen] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Torr, Stephen] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England	University of Edinburgh; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Liverpool School of Tropical Medicine; University of Warwick	Auty, H (corresponding author), SRUC, Epidemiol Res Unit, Inverness, Scotland.; Auty, H; Welburn, SC (corresponding author), Univ Edinburgh, Edinburgh Med Sch, Sch Biomed Sci, Div Pathway & Infect Med,Ctr Infect Dis, Edinburgh, Midlothian, Scotland.	harriet.auty@sruc.ac.uk; Sue.Welburn@ed.ac.uk	; Torr, Stephen/N-7161-2016	Auty, Harriet/0000-0002-6181-3780; Torr, Stephen/0000-0001-9550-4030; Malele, Imna/0000-0002-9343-7150	DFID RNRRS Animal Health Programme; University of Edinburgh	DFID RNRRS Animal Health Programme; University of Edinburgh	The authors are grateful for support from DFID RNRRS Animal Health Programme (SCW, KP, SC, HA). HA was a beneficiary of an MRC studentship, awarded by University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-68; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; Anderson NE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001211; Auty H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001828; Auty HK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001501; AWAN MAQ, 1979, ACTA TROP, V36, P343; Baker JR, 1968, S ZOOLOGICAL SOC LON, V24, P147; Buckland S.T., 2001, pi; Calvo JH, 2012, B ENTOMOL RES, V102, P692, DOI 10.1017/S0007485312000284; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; DILLMANN JSS, 1979, ACTA TROP, V36, P349; Fairbairn H., 1948, Tropical Diseases Bulletin London, V45, P1; GEIGY R, 1971, Acta Tropica, V28, P211; GEIGY R, 1973, Acta Tropica, V30, P12; Geigy R, 1973, ACTA TROP, V30, P50; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; GLASGOW JP, 1958, J ANIM ECOL, V27, P59, DOI 10.2307/2174; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; HARGROVE JW, 1995, B ENTOMOL RES, V85, P215, DOI 10.1017/S0007485300034295; HARGROVE JW, 1990, B ENTOMOL RES, V80, P397, DOI 10.1017/S0007485300050653; HARGROVE JW, 1978, B ENTOMOL RES, V68, P607, DOI 10.1017/S0007485300009573; HARGROVE JW, 1995, MED VET ENTOMOL, V9, P109, DOI 10.1111/j.1365-2915.1995.tb00166.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; IRVIN AD, 1973, VET REC, V93, P200, DOI 10.1136/vr.93.7.200; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; Kaare Magai T, 2007, Travel Med Infect Dis, V5, P117, DOI 10.1016/j.tmaid.2006.01.014; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LAMPREY HF, 1962, J ANIM ECOL, V31, P151, DOI 10.2307/2336; Lardeux F, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-8; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mduma SAR, 2008, SERENGETI; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; MOLOO S K, 1971, Acta Tropica, V28, P189; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Ripamonti D, 2002, CLIN INFECT DIS, V34, pE18, DOI 10.1086/338157; ROBSON J, 1972, B WORLD HEALTH ORGAN, V46, P765; ROGERS D, 1973, Acta Tropica, V30, P24; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; STAAK C, 1986, TROP MED PARASITOL, V37, P59; Tanzania Wildlife Research Institute, 2010, AER CENS SER EC WET; Thomas L., 2009, DISTANCE 6 0 RELEASE; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; TORR SJ, 1994, B ENTOMOL RES, V84, P411, DOI 10.1017/S0007485300032545; VALE GA, 1977, B ENTOMOL RES, V67, P635, DOI 10.1017/S0007485300007008; VALE GA, 1974, B ENTOMOL RES, V64, P545, DOI 10.1017/S0007485300035860; VANDERPLANK FL, 1947, ANN TROP MED PARASIT, V41, P365, DOI 10.1080/00034983.1947.11685339; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351; WEITZ B, 1963, B WORLD HEALTH ORGAN, V28, P711; Welburn SC, 2005, CONSERVATION AND DEVELOPMENT INTERVENTIONS AT THE WILDLIFE/LIVESTOCK INTERFACE, P55; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Welburn S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000347	64	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161291	10.1371/journal.pone.0161291	http://dx.doi.org/10.1371/journal.pone.0161291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706167	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000385697200003
J	Blas, J; Abaurrea, T; D'Amico, M; Barcellona, F; Revilla, E; Roman, J; Carrete, M				Blas, Julio; Abaurrea, Teresa; D'Amico, Marcello; Barcellona, Francesca; Revilla, Eloy; Roman, Jacinto; Carrete, Martina			Management-Related Traffic as a Stressor Eliciting Parental Care in a Roadside-Nesting Bird: The European Bee-Eater Merops apiaster	PLOS ONE			English	Article							HUMAN DISTURBANCE; RESPONSES; NETWORKS; BEHAVIOR; IMPACT; COSTS	Traffic is often acknowledged as a threat to biodiversity, but its effects have been mostly studied on roads subjected to high traffic intensity. The impact of lower traffic intensity such as those affecting protected areas is generally neglected, but conservation-oriented activities entailing motorized traffic could paradoxically transform suitable habitats into ecological traps. Here we questioned whether roadside-nesting bee-eaters Merops apiaster perceived low traffic intensity as a stressor eliciting risk-avoidance behaviors (alarm calls and flock flushes) and reducing parental care. Comparisons were established within Donana National Park (Spain), between birds exposed to either negligible traffic (ca. 0-10 vehicles per day) or low traffic intensity (ca. 10-90 vehicles per day) associated to management and research activities. The frequencies of alarm calls and flock flushes were greater in areas of higher traffic intensity, which resulted in direct mortality at moderate vehicle speeds (<= 40 km/h). Parental feeding rates paralleled changes in traffic intensity, but contrary to our predictions. Indeed, feeding rates were highest in traffic-exposed nests, during working days and traffic rush-hours. Traffic-avoidance responses were systematic and likely involved costs (energy expenditure and mortality), but vehicle transit positively influenced the reproductive performance of bee-eaters through an increase of nestling feeding rates. Because the expected outcome of traffic on individual performance can be opposed when responses are monitored during mating (i.e. negative effect by increase of alarm calls and flock flushes) or nestling-feeding period (i.e. at least short-term positive effect by increase of nestling feeding rates), caution should be taken before inferring fitness consequences only from isolated behaviors or specific life history stages.	[Blas, Julio; Abaurrea, Teresa; D'Amico, Marcello; Barcellona, Francesca; Revilla, Eloy; Roman, Jacinto; Carrete, Martina] Estn Biol Donana CSIC, Dept Conservat Biol, Seville 41092, Spain; [Carrete, Martina] Pablo Olavide Univ, Dept Phys Chem & Nat Syst, Ctra Utrera Km 1, Seville 41013, Spain; [Abaurrea, Teresa] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9JP, Fife, Scotland; [D'Amico, Marcello] Univ Porto, CIBIO InBIO, REN Biodivers Chair, P-1349017 Lisbon, Portugal; [D'Amico, Marcello] Univ Lisbon, CEABN InBIO, P-1349017 Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; University of St Andrews; Universidade do Porto; Universidade de Lisboa	D'Amico, M (corresponding author), Estn Biol Donana CSIC, Dept Conservat Biol, Seville 41092, Spain.; D'Amico, M (corresponding author), Univ Porto, CIBIO InBIO, REN Biodivers Chair, P-1349017 Lisbon, Portugal.; D'Amico, M (corresponding author), Univ Lisbon, CEABN InBIO, P-1349017 Lisbon, Portugal.	damico@ebd.csic.es	Revilla, Eloy/B-5100-2008; Abaurrea, Teresa/AAJ-6839-2021; Blas, Julio/A-2487-2012; Carrete, Martina/D-2618-2017; D'Amico, Marcello/B-5322-2016; Carrete, Martina/A-6376-2009	Revilla, Eloy/0000-0001-5534-5581; Abaurrea, Teresa/0000-0003-4304-9819; Blas, Julio/0000-0003-0589-3322; D'Amico, Marcello/0000-0002-0573-9184; Carrete, Martina/0000-0002-0491-2950	Ramon y Cajal; JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO); Ministerio de Economia y Competitividad MINECO - Feder funds [CGL2012-32544]; Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA [511/2012]	Ramon y Cajal(Spanish Government); JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO); Ministerio de Economia y Competitividad MINECO - Feder funds; Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA	J.B. and M.G. were supported by Ramon y Cajal contracts and M.D. by a JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO). We acknowledge grants CGL2012-32544 (Ministerio de Economia y Competitividad MINECO - Feder funds) and 511/2012 (Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA).	Alvarez F., 1974, Donana Acta vert, V1, P61; Ardia DR, 2007, CAN J ZOOL, V85, P847, DOI 10.1139/Z07-070; Barton K., 2012, MUMIN MULTIMODEL INF; Baudains TP, 2007, ANIM CONSERV, V10, P400, DOI 10.1111/j.1469-1795.2007.00126.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Bennett VJ, 2013, LANDSCAPE ECOL, V28, P979, DOI 10.1007/s10980-013-9874-0; Bergstrom CT, 2001, ANIM BEHAV, V61, P535, DOI 10.1006/anbe.2000.1636; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Bolker B., 2012, GETTING STARTED GLMM; BOSWALL J, 1970, Bulletin of the British Ornithologists' Club, V90, P92; Bryant DM, 1988, FUNCT ECOL, V2, P23, DOI 10.2307/2389456; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1007/978-1-4757-2917-73, DOI 10.1007/978-1-4757-2917-73]; Cardoni DA, 2008, BIOL CONSERV, V141, P797, DOI 10.1016/j.biocon.2007.12.024; Casas-Criville A, 2005, J ARID ENVIRON, V60, P227, DOI 10.1016/j.jaridenv.2004.03.012; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cramp S., 1985, HDB BIRDS EUROPE MID, VIV; D'Amico M, 2015, BIOL CONSERV, V191, P234, DOI 10.1016/j.biocon.2015.06.010; D'Amico M, 2016, J APPL ECOL, V53, P181, DOI 10.1111/1365-2664.12572; D'Amico Marcello, 2013, Oecologia Australis, V17, P86; DEAN WRJ, 1981, OSTRICH, V52, P135, DOI 10.1080/00306525.1981.9633599; Fajardo Inigo, 1998, Alauda, V66, P49; FERNANDEZJURICIC E, 2003, CONDOR, V105, P316; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Garcia-Novo F, 2006, WATER BIOSPHERE; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gonzalez-Gallina A, 2013, BIODIVERS CONSERV, V22, P325, DOI 10.1007/s10531-012-0396-x; Grimwood I., 1964, B BRIT ORNITHOL CLUB, V84, P105; GUTZWILLER KJ, 1994, AUK, V111, P28, DOI 10.2307/4088502; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; JILKA A, 1980, Egretta, V23, P8; KALAS JA, 1995, AM NAT, V146, P59, DOI 10.1086/285787; Kuitunen MT, 2003, ENVIRON MANAGE, V31, P79, DOI 10.1007/s00267-002-2694-7; McGowan CP, 2006, WILSON J ORNITHOL, V118, P485, DOI 10.1676/05-084.1; Morgan GM, 2010, AUK, V127, P581, DOI 10.1525/auk.2010.09033; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; R Core Team, 2013, R LANG ENV STAT COMP; Rees EC, 2005, BIOL CONSERV, V121, P369, DOI 10.1016/j.biocon.2004.05.009; Roman J, 2010, EVALUACION EFECTOS T; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Teixeira Fernanda Z., 2013, Oecologia Australis, V17, P36; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Valera F, 1758, ENCICLOPEDIA VIRTUAL; VALVERDE J. A., 1958, BRIT BIRDS, V51, P1; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Yamac E, 2012, EKOLOJI, V21, P1, DOI 10.5053/ekoloji.2012.831; [No title captured]	47	1	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164371	10.1371/journal.pone.0164371	http://dx.doi.org/10.1371/journal.pone.0164371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706229	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200102
J	Ma, LH; Trinh, T; Ren, YF; Dirksen, RT; Liu, XX				Ma, Lihua; Thu Trinh; Ren, Yanfang; Dirksen, Robert T.; Liu, Xiuxin			Neuronal NTPDase3 Mediates Extracellular ATP Degradation in Trigeminal Nociceptive Pathway	PLOS ONE			English	Article							NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-3; MEDULLARY DORSAL-HORN; CENTRAL SENSITIZATION; PURINERGIC RECEPTORS; PAIN; ECTONUCLEOTIDASES; NUCLEOTIDES; PHOSPHATASE; EXPRESSION; ADENOSINE	ATP induces pain via activation of purinergic receptors in nociceptive sensory nerves. ATP signaling is terminated by ATP hydrolysis mediated by cell surface-localized ecto-nucleotidases. Using enzymatic histochemical staining, we show that ecto-ATPase activity is present in mouse trigeminal nerves. Using immunofluorescence staining, we found that ecto-NTPDase3 is expressed in trigeminal nociceptive neurons and their projections to the brainstem. In addition, ecto-ATPase activity and ecto-NTPDase3 are also detected in the nociceptive outermost layer of the trigeminal subnucleus caudalis. Furthermore, we demonstrate that incubation with anti-NTPDase3 serum reduces extracellular ATP degradation in the nociceptive lamina of both the trigeminal subnucleus caudalis and the spinal cord dorsal horn. These results are consistent with neuronal NTPDase3 activity modulating pain signal transduction and transmission by affecting extracellular ATP hydrolysis within the trigeminal nociceptive pathway. Thus, disruption of trigeminal neuronal NTPDase3 expression and localization to presynaptic terminals during chronic inflammation, local constriction and injury may contribute to the pathogenesis of orofacial neuropathic pain.	[Ma, Lihua; Thu Trinh; Ren, Yanfang; Liu, Xiuxin] Univ Rochester, Sch Med & Dent, Eastman Inst Oral Hlth, Dept Dent, Rochester, NY 14611 USA; [Ma, Lihua] Zhengzhou Univ, Sch Stomatol, Dept Dent, Zhengzhou, Peoples R China; [Dirksen, Robert T.; Liu, Xiuxin] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14611 USA	University of Rochester; Zhengzhou University; University of Rochester	Liu, XX (corresponding author), Univ Rochester, Sch Med & Dent, Eastman Inst Oral Hlth, Dept Dent, Rochester, NY 14611 USA.; Liu, XX (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14611 USA.	xiuxin_liu@urmc.rochester.edu	Ren, Yan-Fang/N-9369-2019	Ren, Yan-Fang/0000-0001-6428-2252	University of Rochester Clinical and Translational Science Award from National Center for Advancing Translational Sciences of the National Institutes of Health [KL2 TR000095]; National Institutes of Health [AR059646]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646] Funding Source: NIH RePORTER	University of Rochester Clinical and Translational Science Award from National Center for Advancing Translational Sciences of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by a University of Rochester Clinical and Translational Science Award from the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2 TR000095 to X.L.) and a research grant from the National Institutes of Health (AR059646 to R.T.D.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambalavanar R, 2005, PAIN, V117, P280, DOI 10.1016/j.pain.2005.06.029; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Bae JY, 2015, J COMP NEUROL, V523, P126, DOI 10.1002/cne.23672; Belcher SM, 2006, NEUROSCIENCE, V137, P1331, DOI 10.1016/j.neuroscience.2005.08.086; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Cardoso AM, 2015, AUTON NEUROSCI-BASIC, V191, P25, DOI 10.1016/j.autneu.2015.04.014; Cherkas PS, 2012, NEUROSCI LETT, V526, P160, DOI 10.1016/j.neulet.2012.08.007; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Fabbretti E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00236; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Hamilton Sara G, 2002, Pain Pract, V2, P289, DOI 10.1046/j.1533-2500.2002.02041.x; Hamilton SG, 2000, J AUTONOM NERV SYST, V81, P187, DOI 10.1016/S0165-1838(00)00137-5; Itoh K, 2011, NEUROSCIENCE, V192, P721, DOI 10.1016/j.neuroscience.2011.06.083; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Li N, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-21; Liu X, 2015, J DENT RES, V94, P1259, DOI 10.1177/0022034515592858; Liu X, 2012, J DENT RES, V91, P261, DOI 10.1177/0022034511431582; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; McCoy Eric, 2014, F1000Res, V3, P163, DOI 10.12688/f1000research.4563.2; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vongtau HO, 2011, NEUROSCIENCE, V193, P387, DOI 10.1016/j.neuroscience.2011.07.044; Wink MR, 2006, NEUROSCIENCE, V138, P421, DOI 10.1016/j.neuroscience.2005.11.039; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164028	10.1371/journal.pone.0164028	http://dx.doi.org/10.1371/journal.pone.0164028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706204	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200075
J	Mittnik, A; Wang, CC; Svoboda, J; Krause, J				Mittnik, Alissa; Wang, Chuan-Chao; Svoboda, Jiri; Krause, Johannes			A Molecular Approach to the Sexing of the Triple Burial at the Upper Paleolithic Site of Dolni Vestonice	PLOS ONE			English	Article							ANCIENT DNA	In the past decades ancient DNA research has brought numerous insights to archaeological research where traditional approaches were limited. The determination of sex in human skeletal remains is often challenging for physical anthropologists when dealing with incomplete, juvenile or pathological specimens. Molecular approaches allow sexing on the basis of sex-specific markers or by calculating the ratio of DNA derived from different chromosomes. Here we propose a novel approach that relies on the ratio of X chromosome-derived shotgun sequencing data to the autosomal coverage, thus establishing the probability of an XX or XY karyotype. Applying this approach to the individuals of the Upper Paleolithic triple burial of Dolni Vestonice reveals that all three skeletons, including the individual DV 15, whose sex has long been debated due to a pathological condition, were male.	[Mittnik, Alissa; Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Mittnik, Alissa; Wang, Chuan-Chao; Krause, Johannes] Univ Tubingen, Inst Archeol Sci, D-72070 Tubingen, Germany; [Wang, Chuan-Chao] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Svoboda, Jiri] Masaryk Univ, Fac Sci, Dept Anthropol, CS-61137 Brno, Czech Republic; [Svoboda, Jiri] Acad Sci Czech Republ, Inst Archaeol, Dolni Vestonice 69129, Czech Republic	Eberhard Karls University of Tubingen; Harvard University; Harvard Medical School; Masaryk University Brno; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Brno	Mittnik, A (corresponding author), Max Planck Inst Sci Human Hist, D-07745 Jena, Germany.; Mittnik, A (corresponding author), Univ Tubingen, Inst Archeol Sci, D-72070 Tubingen, Germany.	mittnik@shh.mpg.de	Svoboda, Jiří/H-4621-2014; Krause, Johannes/AFP-2642-2022; Wang, Chuan-Chao/B-2975-2011; Wang, Chuan-Chao/AGY-2940-2022	Svoboda, Jiří/0000-0003-4256-9708; Krause, Johannes/0000-0001-9144-3920; Wang, Chuan-Chao/0000-0001-9628-0307; Wang, Chuan-Chao/0000-0003-4630-5232	Deutsche Forschungsgemeinschaft [KR 4015/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (KR 4015/1-1 to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Alt KW, 1997, AM J PHYS ANTHROPOL, V102, P123, DOI 10.1002/(SICI)1096-8644(199701)102:1<123::AID-AJPA10>3.0.CO;2-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aughton DJ, 2003, AM J MED GENET A, V116A, P255, DOI 10.1002/ajmg.a.10852; Bruzek J, 2006, EARLY MODERN HUMAN E, P46; Cerny Milan, 1992, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V48, P130; Daskalaki E, 2011, J ARCHAEOL SCI, V38, P1326, DOI 10.1016/j.jas.2011.01.009; Formicola V, 2001, AM J PHYS ANTHROPOL, V115, P372, DOI 10.1002/ajpa.1093; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gibbon V, 2009, FORENSIC SCI INT-GEN, V3, P74, DOI 10.1016/j.fsigen.2008.10.007; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; HUMMEL S, 1991, NATURWISSENSCHAFTEN, V78, P266, DOI 10.1007/BF01134353; Jelinek J., 1992, AVENTURE HUMAINE 500, V56, P207; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; KLIMA B, 1987, J HUM EVOL, V16, P831, DOI 10.1016/0047-2484(87)90027-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Milunsky JM, 2003, AM J MED GENET A, V116A, P249, DOI 10.1002/ajmg.a.10849; Novotny V., 1992, SBORNIK NARODNIHO B, V48, P152; Peltzer A, EAGER EFFIC IN PRESS, P700, DOI [10.1073/pnas.1519905112, DOI 10.1073/PNAS.1519905112]; Quincey D, 2013, SCI JUSTICE, V53, P253, DOI 10.1016/j.scijus.2013.04.003; Rivollat M, 2014, INT J PALEOPATHOL, V7, P8, DOI 10.1016/j.ijpp.2014.05.004; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sladek V., 2000, SKELETAL CATALOGUE O; Svoboda JA, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P27, DOI 10.1007/978-3-211-49294-9_3; Vlcek E, 1991, MAMMUTJAGER DOLNI VE, P22	34	52	53	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163019	10.1371/journal.pone.0163019	http://dx.doi.org/10.1371/journal.pone.0163019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706187	gold, Green Submitted, Green Published			2022-12-26	WOS:000385697200030
J	Yamada, H; Yaguchi, H; Tomatsu, S; Takei, T; Oya, T; Seki, K				Yamada, Hiroshi; Yaguchi, Hiroaki; Tomatsu, Saeka; Takei, Tomohiko; Oya, Tomomichi; Seki, Kazuhiko			Representation of Afferent Signals from Forearm Muscle and Cutaneous Nerves in the Primary Somatosensory Cortex of the Macaque Monkey	PLOS ONE			English	Article							LOW-THRESHOLD MUSCLE; PRIMARY MOTOR CORTEX; PYRAMIDAL CELL STRUCTURE; CORTICAL AREA 3A; CEREBRAL-CORTEX; HUMAN HAND; PROPRIOCEPTIVE REPRESENTATION; INTRACELLULAR INJECTION; CINGULATE GYRUS; SENSORY INPUTS	Proprioception is one's overall sense of the relative positions and movements of the various parts of one's body. The primary somatosensory cortex (SI) is involved in generating the proprioception by receiving peripheral sensory inputs from both cutaneous and muscle afferents. In particular, area 3a receives input from muscle afferents and areas 3b and 1 from cutaneous afferents. However, segregation of two sensory inputs to these cortical areas has not been evaluated quantitatively because of methodological difficulties in distinguishing the incoming signals. To overcome this, we applied electrical stimulation separately to two forearm nerves innervating muscle (deep radial nerve) and skin (superficial radial nerve), and examined the spatiotemporal distribution of sensory evoked potentials (SEPs) in SI of anaesthetized macaques. The SEPs arising from the deep radial nerve were observed exclusively at the bottom of central sulcus (CS), which was identified as area 3a using histological reconstruction. In contrast, SEPs evoked by stimulation of the superficial radial nerve were observed in the superficial part of SI, identified as areas 3b and 1. In addition to these earlier, larger potentials, we also found small and slightly delayed SEPs evoked by cutaneous nerve stimulation in area 3a. Coexistence of the SEPs from both deep and superficial radial nerves suggests that area 3a could integrate muscle and cutaneous signals to shape proprioception.	[Yamada, Hiroshi; Yaguchi, Hiroaki; Tomatsu, Saeka; Takei, Tomohiko; Oya, Tomomichi; Seki, Kazuhiko] Natl Ctr Neurol & Psychiat, Dept Neurophysiol, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Yamada, Hiroshi] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Yamada, Hiroshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Seki, Kazuhiko] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	National Center for Neurology & Psychiatry - Japan; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Seki, K (corresponding author), Natl Ctr Neurol & Psychiat, Dept Neurophysiol, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan.; Seki, K (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.	seki@ncnp.go.jp	Takei, Tomohiko/F-1384-2010; Yamada, Hiroshi/V-7433-2018	Takei, Tomohiko/0000-0002-6429-5798; hu song, cai hua/0000-0001-6542-980X; Yamada, Hiroshi/0000-0001-8155-8847; Seki, Kazuhiko/0000-0002-4262-9590	Grants-in-Aid for Scientific Research [26250013] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ASANUMA H, 1982, J NEUROPHYSIOL, V48, P1048, DOI 10.1152/jn.1982.48.4.1048; AVENDANO C, 1992, J COMP NEUROL, V321, P373, DOI 10.1002/cne.903210306; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CAMPBELL JN, 1979, J NEUROPHYSIOL, V42, P1669, DOI 10.1152/jn.1979.42.6.1669; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Collins DF, 2000, J PHYSIOL-LONDON, V529, P505, DOI 10.1111/j.1469-7793.2000.00505.x; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1992, J NEUROPHYSIOL, V67, P1105, DOI 10.1152/jn.1992.67.5.1105; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; Elston GN, 2005, EXP BRAIN RES, V167, P315, DOI 10.1007/s00221-005-0043-9; Elston GN, 2005, NEUROSCI LETT, V387, P130, DOI 10.1016/j.neulet.2005.06.010; FRIEDMAN DP, 1981, J NEUROPHYSIOL, V45, P59, DOI 10.1152/jn.1981.45.1.59; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; GOODWN GM, 1972, J PHYSIOL-LONDON, V221, pP8; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; HEATH CJ, 1976, J PHYSIOL-LONDON, V257, P199, DOI 10.1113/jphysiol.1976.sp011364; HUERTA MF, 1990, BRAIN RES, V537, P367, DOI 10.1016/0006-8993(90)90388-R; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; HULLIGER M, 1979, J PHYSIOL-LONDON, V291, P233, DOI 10.1113/jphysiol.1979.sp012809; JONES EG, 1980, BRAIN RES REV, V2, P1, DOI 10.1016/0165-0173(80)90002-8; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES EG, 1979, J COMP NEUROL, V183, P833, DOI 10.1002/cne.901830410; Jorntell H, 2014, NEURON, V83, P1444, DOI 10.1016/j.neuron.2014.07.038; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; KANG R, 1985, EXP BRAIN RES, V57, P271; Kim SS, 2015, NEURON, V86, P555, DOI 10.1016/j.neuron.2015.03.020; LUCIER GE, 1975, J PHYSIOL-LONDON, V251, P833, DOI 10.1113/jphysiol.1975.sp011125; MACGILLIS M, 1983, BRAIN RES, V276, P329, DOI 10.1016/0006-8993(83)90741-2; Moscatelli A, 2016, CURR BIOL, V26, P1159, DOI 10.1016/j.cub.2016.02.052; Mountcastle V. B., 2005, SENSORY HAND NEURAL; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; OSCARSSON O, 1966, J PHYSIOL-LONDON, V182, P164, DOI 10.1113/jphysiol.1966.sp007816; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; Pruszynski JA, 2014, NAT NEUROSCI, V17, P1404, DOI 10.1038/nn.3804; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; SANES JN, 1984, P NATL ACAD SCI-BIOL, V81, P979, DOI 10.1073/pnas.81.3.979; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; TANJI J, 1975, BRAIN RES, V88, P549, DOI 10.1016/0006-8993(75)90669-1; TANJI J, 1976, BRAIN RES, V115, P328, DOI 10.1016/0006-8993(76)90518-7; van den Broeke EN, 2016, J PHYSIOL-LONDON, V594, P6767, DOI 10.1113/JP272599; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; Weerakkody NS, 2007, J PHYSIOL-LONDON, V581, P971, DOI 10.1113/jphysiol.2006.126854; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Xu YX, 2011, J NEUROPHYSIOL, V106, P71, DOI 10.1152/jn.00668.2010; YUMIYA H, 1974, BRAIN RES, V78, P169, DOI 10.1016/0006-8993(74)90544-7; ZARZECKI P, 1978, EXP BRAIN RES, V33, P269; ZARZECKI P, 1982, EXP BRAIN RES, V48, P28; Zhang MS, 2008, PROG BRAIN RES, V171, P37, DOI 10.1016/S0079-6123(08)00606-7	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163948	10.1371/journal.pone.0163948	http://dx.doi.org/10.1371/journal.pone.0163948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701434	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900037
J	Das, A; Srinivasan, M; Ghosh, TS; Mande, SS				Das, Anubhav; Srinivasan, Meenakshi; Ghosh, Tarini Shankar; Mande, Sharmila S.			Xenobiotic Metabolism and Gut Microbiomes	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; INTESTINAL BACTERIA; FLORA; DRUG; ENZYMES; MICROFLORA; SEQUENCE; RATS; ATHEROSCLEROSIS; BIOACTIVATION	Humans are exposed to numerous xenobiotics, a majority of which are in the form of pharmaceuticals. Apart from human enzymes, recent studies have indicated the role of the gut bacterial community (microbiome) in metabolizing xenobiotics. However, little is known about the contribution of the plethora of gut microbiome in xenobiotic metabolism. The present study reports the results of analyses on xenobiotic metabolizing enzymes in various human gut microbiomes. A total of 397 available gut metagenomes from individuals of varying age groups from 8 nationalities were analyzed. Based on the diversities and abundances of the xenobiotic metabolizing enzymes, various bacterial taxa were classified into three groups, namely, least versatile, intermediately versatile and highly versatile xenobiotic metabolizers. Most interestingly, specific relationships were observed between the overall drug consumption profile and the abundance and diversity of the xenobiotic metabolizing repertoire in various geographies. The obtained differential abundance patterns of xenobiotic metabolizing enzymes and bacterial genera harboring them, suggest their links to pharmacokinetic variations among individuals. Additional analyses of a few well studied classes of drug modifying enzymes (DMEs) also indicate geographic as well as age specific trends.	[Das, Anubhav; Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India; [Srinivasan, Meenakshi] Manipal Univ, Manipal Coll Pharmaceut Sci, Manipal, Karnataka, India	Tata Sons; Tata Consultancy Services Limited (TCS); Manipal Academy of Higher Education (MAHE)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India.	sharmila.mande@tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				Al-Asmakh M, 2012, GUT MICROBES, V3, P366, DOI 10.4161/gmic.21287; Alomar MJ, 2014, SAUDI PHARM J, V22, P83, DOI 10.1016/j.jsps.2013.02.003; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bhattacharya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142038; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; DRASAR BS, 1972, BIOCHEM J, V129, P881, DOI 10.1042/bj1290881; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Ghosh TS, 2011, BIOINFORMATION, V6, P91, DOI 10.6026/97320630006091; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083823; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Grilo NM, 2014, TOXICOL LETT, V224, P416, DOI 10.1016/j.toxlet.2013.10.036; Grundmann O., 2010, J DRUG METAB TOXICOL, V1, P104, DOI DOI 10.4172/2157-7609.1000104; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ishizuka T, 2010, J BIOL CHEM, V285, P11892, DOI 10.1074/jbc.M109.072629; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Jung Lee Woo, 2015, Gastroenterol Hepatol (N Y), V11, P24; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; KOCH RL, 1980, BIOCHEM PHARMACOL, V29, P3281, DOI 10.1016/0006-2952(80)90304-4; KOCH RL, 1979, BIOCHEM PHARMACOL, V28, P3611, DOI 10.1016/0006-2952(79)90407-6; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laine JE, 2009, XENOBIOTICA, V39, P11, DOI [10.1080/00498250802512830, 10.1080/00498250802512830 ]; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lhoste EF, 2003, FOOD CHEM TOXICOL, V41, P695, DOI 10.1016/S0278-6915(03)00010-3; Li H, 2013, NATURE, V94, P1; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; MATHAN VI, 1989, GUT, V30, P971, DOI 10.1136/gut.30.7.971; Nash DB, 2012, AM HEALTH DRUG BENEF, V5, P423; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Penner N., 2012, ADME ENABLING TECHNO, V1st ed., P545; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rafii F, 2007, COMPARATIVE MED, V57, P282; ROWLAND IR, 1988, TOXICOL PATHOL, V16, P147, DOI 10.1177/019262338801600207; Saad R, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-16; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Shah RR, 2007, PHARMACOGENOMICS ADM, P180; SHU YZ, 1991, XENOBIOTICA, V21, P737, DOI 10.3109/00498259109039513; Smith HF, 2013, CR PALEVOL, V12, P339, DOI 10.1016/j.crpv.2012.12.001; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Springael D, 2004, TRENDS MICROBIOL, V12, P53, DOI 10.1016/j.tim.2003.12.010; STRONG HA, 1987, XENOBIOTICA, V17, P685, DOI 10.3109/00498258709043976; Suicide, 2012, HLTH GLANC EUR 2012, P28; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	70	31	33	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163099	10.1371/journal.pone.0163099	http://dx.doi.org/10.1371/journal.pone.0163099			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695034	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100024
J	Gutierrez, D; Hidalgo-Cantabrana, C; Rodriguez, A; Garcia, P; Ruas-Madiedo, P				Gutierrez, Diana; Hidalgo-Cantabrana, Claudio; Rodriguez, Ana; Garcia, Pilar; Ruas-Madiedo, Patricia			Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; PSEUDOMONAS-AERUGINOSA; MICROBIAL BIOFILMS; FOOD-INDUSTRY; IN-VITRO; AUREUS; GROWTH; ANTIBIOTICS; INFECTIONS; CARIES	Bacteria found in diverse ecosystems grow in a community of aggregated cells that favors their survival and colonization. Different extracellular polymeric substances are used to entrap this multispecies community forming a biofilm, which can be associated to biotic and abiotic surfaces. This widespread and successful way of bacterial life, however, can lead to negative effects for human activity since many pathogen and spoiling bacteria form biofilms which are not easy to eradicate. Therefore, the search for novel anti-biofilm bio-active molecules is a very active research area for which simple, reliable, and fast screening methods are demanded. In this work we have successfully validated an impedance-based method, initially developed for the study of adherent eukaryotic cells, to monitor the formation of single-species biofilms of three model bacteria in real time. The xCelligence real time cell analyzer (RTCA) equipment uses specific microtiter E-plates coated with gold-microelectrodes that detect the attachment of adherent cells, thus modifying the impedance signal. In the current study, this technology allowed the distinction between biofilm-producers and non-producers of Staphylococcus aureus and Staphylococcus epidermidis, as well as the formation of Streptococcus mutans biofilms only when sucrose was present in the culture medium. Besides, different impedance values permitted discrimination among the biofilm-producing strains tested regardless of the nature of the polymeric biofilm matrix. Finally, we have continuously monitored the inhibition of staphylococcal biofilm formation by the bacteriophage phi-IPLA7 and the bacteriophage-encoded endolysin LysH5, as well as the removal of a preformed biofilm by this last antimicrobial treatment. Results observed with the impedance-based method showed high correlation with those obtained with standard approaches, such as crystal violet staining and bacteria enumeration, as well as with those obtained upon other abiotic surfaces (polystyrene and stainless steel). Therefore, this RTCA technology opens new opportunities in the biofilm research arena and its application could be further explored for other bacterial genera as well as for different bio-active molecules.	[Gutierrez, Diana; Hidalgo-Cantabrana, Claudio; Rodriguez, Ana; Garcia, Pilar; Ruas-Madiedo, Patricia] IPLA CSIC, Villaviciosa, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Ruas-Madiedo, P (corresponding author), IPLA CSIC, Villaviciosa, Asturias, Spain.	ruas-madiedo@ipla.csic.es	Suárez, Pilar García/H-2544-2012; Hidalgo-Cantabrana, Claudio/AAA-9952-2019; Rodriguez, Ana/H-4846-2012; Rodríguez, Ana/GQR-0554-2022; Gutiérrez, Diana/E-8712-2017; Rodriguez, Ana/GLQ-7829-2022; Garcia, Pilar/AAP-3768-2020; Ruas-Madiedo, Patricia/H-2502-2012	Suárez, Pilar García/0000-0003-1213-8165; Rodriguez, Ana/0000-0002-1577-9905; Gutiérrez, Diana/0000-0002-0473-1447; Rodriguez, Ana/0000-0002-1577-9905; Garcia, Pilar/0000-0003-1213-8165; Ruas-Madiedo, Patricia/0000-0001-6158-9320	FEDER European Union from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO) [AGL2015-64901-R, AGL2015-65673-R]; Program of Science, Technology and Innovation, Principado de Asturias [EQUIP11, GRUPIN14-139]; MINECO	FEDER European Union from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO); Program of Science, Technology and Innovation, Principado de Asturias; MINECO(Spanish Government)	This work was financed by the FEDER European Union funds through the projects AGL2015-64901-R and AGL2015-65673-R from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO) and through the grants EQUIP11 and GRUPIN14-139 (Program of Science, Technology and Innovation, Principado de Asturias). DG and CH-C hold FPI-scholarships of MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Cihalova K, 2015, INT J MOL SCI, V16, P24656, DOI 10.3390/ijms161024656; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Meira QGD, 2012, FOOD CONTROL, V25, P469, DOI 10.1016/j.foodcont.2011.11.030; Delgado S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-82; Dheilly A, 2008, APPL MICROBIOL BIOT, V79, P157, DOI 10.1007/s00253-008-1404-7; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Estrada-Leypon O, 2015, BIOELECTROCHEMISTRY, V105, P56, DOI 10.1016/j.bioelechem.2015.05.006; Fenton Mark, 2013, Int J Microbiol, V2013, P625341, DOI 10.1155/2013/625341; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Gula G, 2012, SENSOR ACTUAT B-CHEM, V175, P34, DOI 10.1016/j.snb.2011.11.044; Gutierrez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107307; Gutierrez D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-228; Gutierrez D, 2010, CURR MICROBIOL, V61, P601, DOI 10.1007/s00284-010-9659-5; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Hidalgo-Cantabrana C, 2014, J FUNCT FOODS, V6, P348, DOI 10.1016/j.jff.2013.11.001; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Junka AF, 2012, POL J MICROBIOL, V61, P191, DOI 10.33073/pjm-2012-024; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Knezevic P, 2011, J APPL MICROBIOL, V111, P245, DOI 10.1111/j.1365-2672.2011.05043.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Mashima I, 2015, J BACTERIOL, V197, P2104, DOI 10.1128/JB.02512-14; Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11; Navarro G, 2014, ANTIMICROB AGENTS CH, V58, P1092, DOI 10.1128/AAC.01781-13; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Ramirez MDF, 2015, INT J FOOD MICROBIOL, V207, P23, DOI 10.1016/j.ijfoodmicro.2015.04.030; Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587; Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042; Simon-Soro A, 2015, TRENDS MICROBIOL, V23, P76, DOI 10.1016/j.tim.2014.10.010; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Soderling EM, 2008, CURR MICROBIOL, V56, P382, DOI 10.1007/s00284-007-9076-6; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Tremblay YDN, 2015, APPL ENVIRON MICROB, V81, P2827, DOI 10.1128/AEM.04208-14; Valdes L, 2015, J MICROBIOL METH, V119, P66, DOI 10.1016/j.mimet.2015.09.022; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wang Y, 2015, ANN MICROBIOL, V65, P1159, DOI 10.1007/s13213-014-0883-2; Whitehead KA, 2015, CURR OPIN FOOD SCI, V2, P84, DOI 10.1016/j.cofs.2015.02.003; Zhao W, 2014, NUTRIENTS, V6, P3572, DOI 10.3390/nu6093572	54	57	58	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163966	10.1371/journal.pone.0163966	http://dx.doi.org/10.1371/journal.pone.0163966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695058	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100070
J	Horiguchi, K; Yako, H; Yoshida, S; Fujiwara, K; Tsukada, T; Kanno, N; Ueharu, H; Nishihara, H; Kato, T; Yashiro, T; Kato, Y				Horiguchi, Kotaro; Yako, Hideji; Yoshida, Saishu; Fujiwara, Ken; Tsukada, Takehiro; Kanno, Naoko; Ueharu, Hiroki; Nishihara, Hiroto; Kato, Takako; Yashiro, Takashi; Kato, Yukio			S100 beta-Positive Cells of Mesenchymal Origin Reside in the Anterior Lobe of the Embryonic Pituitary Gland	PLOS ONE			English	Article							FOLLICULO-STELLATE CELLS; EARLY NEURAL PRIMORDIUM; QUAIL CHICK CHIMERAS; STEM/PROGENITOR CELLS; STEM-CELLS; RAT PITUITARY; S100 PROTEINS; BRAIN ASTROCYTES; PROGENITOR CELLS; GENE-EXPRESSION	The anterior and intermediate lobes of the pituitary gland develop through invagination of the oral ectoderm and as they are endocrine tissues, they participate in the maintenance of vital functions via the synthesis and secretion of numerous hormones. We recently observed that several extrapituitary cells invade the anterior lobe of the developing pituitary gland. This raised the question of the origin(s) of these S100 beta-positive cells, which are not classic endocrine cells but instead comprise a heterogeneous cell population with plural roles, especially as stem/progenitor cells. To better understand the roles of these S100 beta-positive cells, we performed immunohistochemical analysis using several markers in S100 beta/GFP-TG rats, which express GFP in S100 beta-expressing cells under control of the S100 beta promoter. GFP-positive cells were present as mesenchymal cells surrounding the developing pituitary gland and at Atwell's recess but were not present in the anterior lobe on embryonic day 15.5. These cells were negative for SOX2, a pituitary stem/progenitor marker, and PRRX1, a mesenchyme and pituitary stem/progenitor marker. However, three days later, GFP-positive and PRRX1-positive (but SOX2-negative) cells were observed in the parenchyma of the anterior lobe. Furthermore, some GFP-positive cells were positive for vimentin, p75, isolectin B4, DESMIN, and Ki67. These data suggest that S100 beta-positive cells of extrapituitary origin invade the anterior lobe, undergoing proliferation and diverse transformation during pituitary organogenesis.	[Horiguchi, Kotaro] Kyorin Univ, Dept Hlth Sci, Lab Anat & Cell Biol, Mitaka, Tokyo, Japan; [Horiguchi, Kotaro; Yoshida, Saishu; Kato, Takako; Kato, Yukio] Meiji Univ, Inst Endocrinol, Kawasaki, Kanagawa, Japan; [Yako, Hideji; Yoshida, Saishu; Kanno, Naoko; Ueharu, Hiroki; Nishihara, Hiroto; Kato, Yukio] Meiji Univ, Grad Sch Agr, Div Life Sci, Kawasaki, Kanagawa, Japan; [Fujiwara, Ken; Tsukada, Takehiro; Yashiro, Takashi] Jichi Med Univ, Sch Med, Dept Anat, Div Histol & Cell Biol, Shimotsuke, Tochigi, Japan	Kyorin University; Meiji University; Meiji University; Jichi Medical University	Kato, Y (corresponding author), Meiji Univ, Inst Endocrinol, Kawasaki, Kanagawa, Japan.; Kato, Y (corresponding author), Meiji Univ, Grad Sch Agr, Div Life Sci, Kawasaki, Kanagawa, Japan.	yukato@meiji.ac.jp		Yako, Hideji/0000-0003-2632-8488	Grants-in-Aid for Scientific Research [16K08475] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Allaerts W, 1996, J NEUROENDOCRINOL, V8, P17, DOI 10.1111/j.1365-2826.1996.tb00682.x; Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; BORSON S, 1994, NEUROENDOCRINOLOGY, V59, P466, DOI 10.1159/000126693; Boyd NL, 2007, EXP BIOL MED, V232, P833; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; COULY GF, 1985, DEV BIOL, V110, P422, DOI 10.1016/0012-1606(85)90101-0; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; DAIKOKU S, 1981, ARCH HISTOL JAPON, V44, P103, DOI 10.1679/aohc1950.44.103; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Davis SW, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0118-9; DEJONG R, 1993, DEV BIOL, V157, P133, DOI 10.1006/dbio.1993.1118; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fauquier T, 2001, P NATL ACAD SCI USA, V98, P8891, DOI 10.1073/pnas.151339598; Gleiberman AS, 1999, DEV BIOL, V213, P340, DOI 10.1006/dbio.1999.9386; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Higuchi M, 2015, CELL TISSUE RES, V361, P557, DOI 10.1007/s00441-015-2128-5; Higuchi M, 2014, CELL TISSUE RES, V357, P767, DOI 10.1007/s00441-014-1890-0; Higuchi M, 2013, CELL TISSUE RES, V353, P27, DOI 10.1007/s00441-013-1632-8; HOFLER H, 1984, VIRCHOWS ARCH A, V404, P359, DOI 10.1007/BF00695220; Horiguchi K, 2014, CELL TISSUE RES, V358, P515, DOI 10.1007/s00441-014-1958-x; Horiguchi K, 2014, CELL TISSUE RES, V357, P757, DOI 10.1007/s00441-014-1864-2; Horiguchi K, 2014, CELL TISSUE RES, V357, P301, DOI 10.1007/s00441-014-1817-9; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Inoue K, 1999, ARCH HISTOL CYTOL, V62, P205, DOI 10.1679/aohc.62.205; INOUE K, 1987, ARCH HISTOL CYTOL, V50, P567, DOI 10.1679/aohc.50.567; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Kouki T, 2001, DEVELOPMENT, V128, P959; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Kurz H, 2008, HISTOCHEM CELL BIOL, V130, P1027, DOI 10.1007/s00418-008-0478-8; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Liu HX, 2012, DEV BIOL, V368, P294, DOI 10.1016/j.ydbio.2012.05.028; Mogi C, 2004, EXP CELL RES, V292, P288, DOI 10.1016/j.yexcr.2003.09.018; Motohashi T, 2014, DEV DYNAM, V243, P368, DOI 10.1002/dvdy.24072; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Osuna M, 2012, J ENDOCRINOL, V213, P231, DOI 10.1530/JOE-12-0043; Qiao B, 2012, BIOL CELL, V104, P476, DOI 10.1111/boc.201100077; RINEHART JF, 1953, J HISTOCHEM CYTOCHEM, V1, P93, DOI 10.1177/1.2.93; ROSS AH, 1984, P NATL ACAD SCI-BIOL, V81, P6681, DOI 10.1073/pnas.81.21.6681; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Shimozaki K, 2013, J NEUROSCI, V33, P4066, DOI 10.1523/JNEUROSCI.4586-12.2013; SOJI T, 1989, ANAT RECORD, V224, P523, DOI 10.1002/ar.1092240410; Susa T, 2012, J NEUROENDOCRINOL, V24, P1201, DOI 10.1111/j.1365-2826.2012.02336.x; TACHIBANA O, 1988, ACTA NEUROPATHOL, V76, P458, DOI 10.1007/BF00686384; Trost A, 2013, INVEST OPHTH VIS SCI, V54, P7910, DOI 10.1167/iovs.13-12946; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Vankelecom H, 2012, CURR STEM CELL RES T, V7, P36, DOI 10.2174/157488812798483467; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Woodhoo A, 2004, MOL CELL NEUROSCI, V25, P30, DOI 10.1016/j.mcn.2003.09.006; Yako H, 2013, CELL TISSUE RES, V354, P837, DOI 10.1007/s00441-013-1717-4; Yoshida S, 2013, J NEUROENDOCRINOL, V25, P779, DOI 10.1111/jne.12077; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Zhu XY, 2004, CURR OPIN GENET DEV, V14, P567, DOI 10.1016/j.gde.2004.08.006	58	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163981	10.1371/journal.pone.0163981	http://dx.doi.org/10.1371/journal.pone.0163981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695124	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100071
J	Latsko, MS; Gilman, TL; Matt, LM; Nylocks, KM; Coifman, KG; Jasnow, AM				Latsko, Maeson S.; Gilman, T. Lee; Matt, Lindsey M.; Nylocks, K. Maria; Coifman, Karin G.; Jasnow, Aaron M.			A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR; SEROTONIN TRANSPORTER; VAL66MET POLYMORPHISM; PROMOTER REGION; HUMAN-MEMORY; ANXIETY; DEPRESSION; ALLELE; STROOP	Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-related phenotype for common affective diseases (e.g., unipolar depressive, anxiety disorders). The current study employed a candidate-gene approach in order to most effectively examine this complex behavioral phenotype. We examined the novel interaction between BDNF (Val(66)Met) and TPH2 (rs4570625) polymorphisms and their influence on behavioral inhibition of negative emotion in two independent investigations of healthy adults. BDNF Met carriers consistently report greater symptoms of affective disease and display corresponding behavioral rigidity, while TPH2 T carriers display poor inhibitory processing. These genotypes are traditionally perceived as 'risk' genotypes when compared to their respective major Val and G homozygous genotypes, but evidence is mixed. Recent studies in humans and mutant mouse models suggest biological epistasis between BDNF and genes involved in serotonin regulation. Moreover, polymorphisms in the TPH2 gene may have greater influence on serotonergic function than other more commonly studied polymorphisms (e.g., 5-HTTLPR). We observed consistent evidence across two different emotion-inhibition paradigms, one with high internal validity (Study 1, n = 119) and one with high ecological validity (Study 2, n = 115) that the combination of Val/Val and G/G genotypes was clearly associated with impaired inhibition of negative emotional content. This was followed by individuals carrying the BDNF-Met allele (including Met/Val and Met/Met) when combined with the TPH2-T allele (including T/G and T/T combinations). The consistency of these results across tasks and studies suggests that these two groups may be particularly vulnerable to the most common psychiatric disorders and should be targets for future clinical investigation.	[Latsko, Maeson S.; Gilman, T. Lee; Matt, Lindsey M.; Nylocks, K. Maria; Coifman, Karin G.; Jasnow, Aaron M.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Jasnow, AM (corresponding author), Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA.	ajasnow@kent.edu	Coifman, Karin/AAR-5286-2021; Gilman, T. Lee/P-4041-2014	Coifman, Karin/0000-0002-2372-0081; Gilman, T. Lee/0000-0001-8398-0195	Institute for Clinical and Translational Research, Kent State University; Applied Psychology Center, Department of Psychological Sciences	Institute for Clinical and Translational Research, Kent State University; Applied Psychology Center, Department of Psychological Sciences	The research described in this manuscript was funded, in part, by the Institute for Clinical and Translational Research, Kent State University; and The Applied Psychology Center, Department of Psychological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfimova MV, 2012, B EXP BIOL MED+, V152, P606, DOI 10.1007/s10517-012-1587-x; Anchordoquy HC, 2003, BEHAV GENET, V33, P73, DOI 10.1023/A:1021007701808; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; Anttila S, 2007, J NEURAL TRANSM, V114, P1065, DOI 10.1007/s00702-007-0705-9; Bargh John A., 2007, HDB EMOTION REGULATI, P429, DOI DOI 10.1037/A0017745; Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532; Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Canli T, 2009, NEUROSCIENCE, V164, P43, DOI 10.1016/j.neuroscience.2009.06.049; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Cohen JE, 2013, HUM BRAIN MAPP, V34, P1344, DOI 10.1002/hbm.21516; Coifman KG, 2010, J ABNORM PSYCHOL, V119, P479, DOI 10.1037/a0020113; Cuellar AK, 2005, CLIN PSYCHOL REV, V25, P307, DOI 10.1016/j.cpr.2004.12.002; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; Diminich ED, 2014, J ABNORM PSYCHOL, V123, P350, DOI 10.1037/a0036398; Dougherty LR, 2010, BIOL PSYCHOL, V83, P93, DOI 10.1016/j.biopsycho.2009.10.009; Drago A, 2009, INT J ENV RES PUB HE, V6, P1980, DOI 10.3390/ijerph6071980; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EMDE RN, 1992, CHILD DEV, V63, P1437, DOI 10.1111/j.1467-8624.1992.tb01706.x; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Fisher AJ, 2013, BIOL PSYCHOL, V93, P65, DOI 10.1016/j.biopsycho.2013.01.012; Foland-Ross LC, 2013, PSYCHOL SCI, V24, P334, DOI 10.1177/0956797612457380; Freund N, 2013, NEUROSCIENCE, V249, P88, DOI 10.1016/j.neuroscience.2013.06.066; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Galter D, 2000, J NEUROSCI RES, V61, P295, DOI 10.1002/1097-4547(20000801)61:3<295::AID-JNR7>3.0.CO;2-4; Galvin C, 2015, NEUROPSYCHOPHARMACOL, V40, P2269, DOI 10.1038/npp.2015.76; Gao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036721; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gilman T.L., 2015, PSYCHOL NEUROSCIENCE, V8, P397, DOI [10.1037/pne0000017, DOI 10.1037/PNE0000017, 10.1037/pne0000017.]; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Gyekis JP, 2013, AM J MED GENET B, V162B, P61, DOI 10.1002/ajmg.b.32122; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Havranek M, 2015, NEUROPSYCHOPHARMACOL; Hayden EP, 2010, PSYCHOL SCI, V21, P1678, DOI 10.1177/0956797610385357; Henningsson S, 2009, BIOL PSYCHIAT, V66, P477, DOI 10.1016/j.biopsych.2009.04.009; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Janes AC, 2010, BIOL PSYCHIAT, V67, P722, DOI 10.1016/j.biopsych.2009.12.034; Jansson M, 2007, BEHAV RES THER, V45, P511, DOI 10.1016/j.brat.2006.04.003; Johnson DC, 2015, DEV COGN NEUROS-NETH, V11, P42, DOI 10.1016/j.dcn.2014.07.006; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kepser LJ, 2015, BEHAV BRAIN RES, V277, P3, DOI 10.1016/j.bbr.2014.05.022; Kronenberg G, 2015, EUROPEAN ARCH PSYCHI, P1; Lan MJ, 2014, NEUROIMAGE, V94, P33, DOI 10.1016/j.neuroimage.2014.02.027; LeDoux J, 2012, EMOT REV, V4, P375, DOI 10.1177/1754073912445822; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lehto K, 2015, PROG NEURO-PSYCHOPH, V57, P31, DOI 10.1016/j.pnpbp.2014.10.005; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Li M, 2016, GENET EPIDEMIOL, V40, P341, DOI 10.1002/gepi.21970; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mandell D, 2014, J ABNORM PSYCHOL, V123, P35, DOI 10.1037/a0035834; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; McLaughlin KA, 2011, BEHAV RES THER, V49, P186, DOI 10.1016/j.brat.2010.12.006; McRae K, 2012, SOC COGN AFFECT NEUR, V7, P253, DOI 10.1093/scan/nsq103; Mennin DS, 2013, CLIN PSYCHOL-SCI PR, V20, P258, DOI 10.1111/cpsp.12038; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Murphy DL, 2003, GENES BRAIN BEHAV, V2, P350, DOI 10.1046/j.1601-1848.2003.00049.x; Naumenko VS, 2012, NEUROSCIENCE, V214, P59, DOI 10.1016/j.neuroscience.2012.04.031; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Osinsky R, 2009, BEHAV BRAIN RES, V198, P404, DOI 10.1016/j.bbr.2008.11.022; Payer DE, 2012, EMOTION, V12, P229, DOI 10.1037/a0027421; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ren-Patterson RF, 2006, CELL MOL NEUROBIOL, V26, P755, DOI 10.1007/s10571-006-9048-6; Ren-Patterson RF, 2005, J NEUROSCI RES, V79, P756, DOI 10.1002/jnr.20410; Reuter M, 2007, INT J NEUROPSYCHOPH, V10, P401, DOI 10.1017/S1461145706007073; Reuter M, 2007, J COGNITIVE NEUROSCI, V19, P401, DOI 10.1162/jocn.2007.19.3.401; Rotberg B, 2013, J CHILD ADOL PSYCHOP, V23, P117, DOI 10.1089/cap.2012.0020; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Siuciak JA, 1996, BRAIN RES, V710, P11, DOI 10.1016/0006-8993(95)01289-3; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Soussignan R, 2009, INFANT BEHAV DEV, V32, P1, DOI 10.1016/j.infbeh.2008.09.002; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; Tukey JW, 1977, EXPLORATORY DATA ANA; UDENFRIEND S, 1956, J BIOL CHEM, V219, P335; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Whitmer AJ, 2012, J ABNORM PSYCHOL, V121, P570, DOI 10.1037/a0027474; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	114	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162585	10.1371/journal.pone.0162585	http://dx.doi.org/10.1371/journal.pone.0162585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695066	gold, Green Published			2022-12-26	WOS:000385553100015
J	Blanchard, AA; Zelinski, T; Xie, JY; Cooper, S; Penner, C; Leygue, E; Myal, Y				Blanchard, Anne A.; Zelinski, Teresa; Xie, Jiuyong; Cooper, Steven; Penner, Carla; Leygue, Etienne; Myal, Yvonne			Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TIGHT JUNCTION; UP-REGULATION; COLORECTAL-CANCER; PARACELLULAR PERMEABILITY; DECREASED EXPRESSION; RECURRENCE STATUS; PROTEIN; CLDN1; OVEREXPRESSION	Background The claudin 1 tight junction protein, solely responsible for the barrier function of epithelial cells, is frequently down regulated in invasive human breast cancer. The underlying mechanism is largely unknown, and no obvious mutations in the claudin 1 gene (CLDN1) have been identified to date in breast cancer. Since many genes have been shown to undergo deregulation through splicing and mis-splicing events in cancer, the current study was undertaken to investigate the occurrence of transcript variants for CLDN1 in human invasive breast cancer. Methods RT-PCR analysis of CLDN1 transcripts was conducted on RNA isolated from 12 human invasive breast tumors. The PCR products from each tumor were resolved by agarose gel electrophoresis, cloned and sequenced. Genomic DNA was also isolated from each of the 12 tumors and amplified using PCR CLDN1 specific primers. Sanger sequencing and single nucleotide polymorphism (SNP) analyses were conducted. Results A number of CLDN1 transcript variants were identified in these breast tumors. All variants were shorter than the classical CLDN1 transcript. Sequence analysis of the PCR products revealed several splice variants, primarily in exon 1 of CLDN1; resulting in truncated proteins. One variant, V1, resulted in a premature stop codon and thus likely led to nonsense mediated decay. Interestingly, another transcript variant, V2, was not detected in normal breast tissue samples. Further, sequence analysis of the tumor genomic DNA revealed SNPs in 3 of the 4 coding exons, including a rare missense SNP (rs140846629) in exon 2 which represents an Ala124Thr substitution. To our knowledge this is the first report of CLDN1 transcript variants in human invasive breast cancer. These studies suggest that alternate splicing may also be a mechanism by which claudin 1 is down regulated at both the mRNA and protein levels in invasive breast cancer and may provide novel insights into how CLDN1 is reduced or silenced in human breast cancer.	[Blanchard, Anne A.; Cooper, Steven; Penner, Carla; Myal, Yvonne] Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada; [Blanchard, Anne A.; Xie, Jiuyong; Myal, Yvonne] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Zelinski, Teresa] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Zelinski, Teresa; Leygue, Etienne] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Leygue, Etienne; Myal, Yvonne] Manitoba Inst Cell Biol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Myal, Y (corresponding author), Univ Manitoba, Dept Pathol, Winnipeg, MB, Canada.; Myal, Y (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.; Myal, Y (corresponding author), Manitoba Inst Cell Biol, Winnipeg, MB, Canada.	yvonne.myal@umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; , Anne/0000-0002-6752-6280	Canadian Breast Cancer Foundation; Winnipeg RH Institute Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Winnipeg RH Institute Foundation	This study was supported by a grant from the Canadian Breast Cancer Foundation (to YM) and a grant from the Winnipeg RH Institute Foundation (to TZ).; The authors would like to thank the personnel at the Manitoba Breast Tumor Bank for technical support, particularly Andrea Fritensky and Michelle Parisien. This study was supported by a grant from the Canadian Breast Cancer Foundation (to YM) and a grant from the Winnipeg Rh Institute Foundation (to TZ).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; [Anonymous], 2016, EX VAR SERV; [Anonymous], 2016, UCSC GEN BIOINF UCSC; [Anonymous], 2016, CBIO PORT CANC GEN; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Balda MS, 1998, J CELL SCI, V111, P541; Bekker V, 2010, J VIRAL HEPATITIS, V17, P192, DOI 10.1111/j.1365-2893.2009.01166.x; Blanchard AA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-268; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chen JJ, 2015, INT J CLIN EXP MED, V8, P1247; Cohn ML, 2005, J CUTAN PATHOL, V32, P533, DOI 10.1111/j.0303-6987.2005.00324.x; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Di Cello F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068630; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Higashi Y, 2007, J SURG RES, V139, P68, DOI 10.1016/j.jss.2006.08.038; Ho MF, 2016, MOL ENDOCRINOL, V30, P382, DOI 10.1210/me.2015-1267; Ingr M, 2015, J THEOR BIOL, V382, P178, DOI 10.1016/j.jtbi.2015.06.048; Katz TA, 2014, ANN MED, V46, P397, DOI 10.3109/07853890.2014.923740; Kinugasa T, 2007, ANTICANCER RES, V27, P3729; Kleinberg L, 2008, HUM PATHOL, V39, P747, DOI 10.1016/j.humpath.2007.10.002; Kominsky SL, 2004, AM J PATHOL, V164, P1627, DOI 10.1016/S0002-9440(10)63721-2; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Liu M, 2013, MOL ENDOCRINOL, V27, P657, DOI 10.1210/me.2012-1397; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Miyamoto K, 2008, BIOMED RES-TOKYO, V29, P71, DOI 10.2220/biomedres.29.71; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2012, TIGHT JUNCTIONS CANC; Nemeth J, 2009, PATHOLONCOLRES; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Pope JL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-167; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Takehara M, 2009, BIOL PHARM BULL, V32, P825, DOI 10.1248/bpb.32.825; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; van Voss MRH, 2014, HISTOPATHOLOGY, V65, P814, DOI 10.1111/his.12490; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu YL, 2008, WORLD J GASTROENTERO, V14, P4943, DOI 10.3748/wjg.14.4943; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yadav BK, 2015, J STROKE CEREBROVASC, V24, P1662, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.038; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	51	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163387	10.1371/journal.pone.0163387	http://dx.doi.org/10.1371/journal.pone.0163387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649506	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100085
J	Brink, H; Smith, RJ; Skinner, K; Leader-Williams, N				Brink, Henry; Smith, Robert J.; Skinner, Kirsten; Leader-Williams, Nigel			Sustainability and Long Term-Tenure: Lion Trophy Hunting in Tanzania	PLOS ONE			English	Article							PROTECTED AREAS; PANTHERA-LEO; CONSERVATION; POPULATIONS; MANAGEMENT; PRIVATE; HELP	It is argued that trophy hunting of large, charismatic mammal species can have considerable conservation benefits but only if undertaken sustainably. Social-ecological theory suggests such sustainability only results from developing governance systems that balance financial and biological requirements. Here we use lion (Panthera leo) trophy hunting data from Tanzania to investigate how resource ownership patterns influence hunting revenue and offtake levels. Tanzania contains up to half of the global population of free-ranging lions and is also the main location for lion trophy hunting in Africa. However, there are concerns that current hunting levels are unsustainable. The lion hunting industry in Tanzania is run by the private sector, although the government leases each hunting block to companies, enforces hunting regulation, and allocates them a species-specific annual quota per block. The length of these leases varies and theories surrounding property rights and tenure suggest hunting levels would be less sustainable in blocks experiencing a high turnover of short-termleases. We explored this issue using lion data collected from 1996 to 2008 in the Selous Game Reserve (SGR), the most important trophy hunting destination in Tanzania. We found that blocks in SGR with the highest lion hunting offtake were also those that experienced the steepest declines in trophy offtake. In addition, we found this high hunting offtake and the resultant offtake decline tended to be in blocks under short-termtenure. In contrast, lion hunting levels in blocks under long-termtenure matched more closely the recommended sustainable offtake of 0.92 lions per 1000 km(2). However, annual financial returnswere higher from blocks under short-termtenure, providing $ 133 per km(2) of government revenue as compared to $ 62 per km(2) from long-termtenure blocks. Our results provide evidence for the importance of property rights in conservation, and support calls for an overhaul of the system in Tanzania by developing competitive market-based approaches for block allocation based on long-termtenure of ten years.	[Brink, Henry; Skinner, Kirsten] Selous Lion Project, POB 34514, Dar Es Salaam, Tanzania; [Brink, Henry; Smith, Robert J.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England; [Skinner, Kirsten] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Leader-Williams, Nigel] Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England	University of Kent; University of Queensland; University of Cambridge	Brink, H (corresponding author), Selous Lion Project, POB 34514, Dar Es Salaam, Tanzania.; Brink, H (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England.	selouslion@gmail.com	Smith, Robert J/D-9660-2011	Smith, Robert J/0000-0003-1599-9171	National Geographic [EC0274-06]; Panthera	National Geographic(National Geographic Society); Panthera	The research has been made possible by grants from National Geographic (Grant # EC0274-06) and Panthera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2004, EXTINCTION STORY CON, DOI 10.4324/9781849770415; Agrawal A, 2011, ENVIRON CONSERV, V38, P199, DOI 10.1017/S0376892910000925; [Anonymous], 2012, COMMUNITY RIGHTS CON; [Anonymous], 2009, RECREATIONAL HUNTING; Ayre G, 2005, GOVERNANCE SUSTAINAB; Baldus RD, 2004, LION CONSERVATION TA; Baldus RD, 2004, TOURIST HUNTING ITS; Baldus RD, 2006, CRUCIAL ROLE GOVERNA; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Berkes F., 2002, LINKING SOCIAL ECOLO; Booth Vernon R, 2009, RECREATIONAL HUNTING, P282; Bouche P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155763; Breakthrough Attorneys, 2015, INV WILDL SECT NEW H; Brink H, 2013, AFR J ECOL, V51, P366, DOI 10.1111/aje.12051; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; Caro T, 2016, CONSERV BIOL, V30, P716, DOI 10.1111/cobi.12658; Carter E, 2008, ORYX, V42, P177, DOI 10.1017/S0030605308007655; Chapron G, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2939; Chardonnet P., 2002, CONSERVATION AFRICAN; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; Edwards CTT, 2014, P NATL ACAD SCI USA, V111, P539, DOI 10.1073/pnas.1219615110; Fitzherbert E, 2014, BIOL CONSERV, V174, P84, DOI 10.1016/j.biocon.2014.03.012; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Githiru M, 2015, BIOL CONSERV, V191, P819, DOI 10.1016/j.biocon.2015.07.033; Group ICS, 2006, CONSERVATION STRATEG; Harris RB, 2013, CONSERV BIOL, V27, P945, DOI 10.1111/cobi.12115; IUCN, 2008, RED LIST THREATENED; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James A. N., 1999, GLOBAL REV PROTECTED; Jones T. B., 2009, RECREATIONAL HUNTING, P157; Kiffner C, 2009, ORYX, V43, P52, DOI 10.1017/S0030605307002335; Langholz JA, 2001, BIOSCIENCE, V51, P1079, DOI 10.1641/0006-3568(2001)051[1079:PAPOPO]2.0.CO;2; Leader-Williams N, 2005, PEOPLE WILDLIFE CONF, P150; Leader-Williams N., 2009, RECREATIONAL HUNTING, P9; Leader-Williams N, 1996, TOURIST HUNTING TANZ; Lewis D, 2005, CONSERV BIOL SER, V9, P239; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge A.J., 2006, KEY TOPICS CONSERVAT, P224; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Ministry of Natural Resources and Tourism, 1995, POL MAN PLAN TOUR HU; Mitchell B, 2005, PARKS, V15, P1; Naidoo R, 2016, CONSERV BIOL, V30, P628, DOI 10.1111/cobi.12643; Nelson F., 2007, CONSERV SOC, V5, P232; Nelson F, 2013, ORYX, V47, P509, DOI 10.1017/S0030605313001178; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rohwer R, 2009, WILD HEART AFRICA SE, P189; Tucker CM, 1999, HUM ECOL, V27, P201, DOI 10.1023/A:1018721826964; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395	62	12	12	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162610	10.1371/journal.pone.0162610	http://dx.doi.org/10.1371/journal.pone.0162610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648566	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000383892100025
J	Lee, MY; Chang, WJ; Kim, HS; Lee, JY; Lim, SH; Lee, JE; Kim, SW; Nam, SJ; Ahn, JS; Im, YH; Park, YH				Lee, Min-Young; Chang, Won Jin; Kim, Hae Su; Lee, Ji Yun; Lim, Sung Hee; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee			Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; TUMOR RECURRENCE; CONSERVING THERAPY; LOCAL RECURRENCE; MASTECTOMY; CHEMOTHERAPY; SURGERY; RELAPSE; TRIAL	Purpose The purpose of this study was to investigate the clinicopathologic features and prognostic factors affecting outcome in patients with isolated locoregional recurrence of breast cancer (ILRR). Methods We retrospectively analyzed the medical records of 104 patients who were diagnosed with ILRR and underwent curative surgery from January 2000 to December 2010 at Samsung Medical Center. Results Among 104 patients, 43 (41%) underwent total mastectomy and 61 (59%) underwent breast-conserving surgery for primary breast cancer. The median time from initial operation to ILRR was 35.7 months (4.5-132.3 months). After diagnosis of ILRR, 45 (43%) patients were treated with mastectomy, 41 (39%) with excision of recurred lesion, and 18 (17%) with node dissection. During a median follow-up of 8.9 years, the 5-year overall survival was 77% and 5-year distant metastasis-free survival (DMFS) was 54%. On multivariate analysis, younger age (< 35 years), higher stage, early onset of elapse (<= 24 months), lymph node recurrences, and subtype of triple negative breast cancer (TNBC) were found to be independently associated with DMFS. Patients in the no chemotherapy group showed a longer DMFS after surgery for ILRR than those treated with chemotherapy (median 101.5 vs. 48.0 months, p = 0.072) but without statistical significance. Conclusion Our analysis showed that younger age (< 35 years), higher stage, early onset of relapse (<= 24 months), lymph node recurrence, and subtype of TNBC are the worst prognostic factors for ILRR.	[Lee, Min-Young; Chang, Won Jin; Kim, Hae Su; Lee, Ji Yun; Lim, Sung Hee; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol,Dept Med, Seoul, South Korea; [Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol & Oncol,Dept Med, Seoul, South Korea.	yhparkhmo@skku.edu						Abe O, 2005, LANCET, V366, P2087; Aebi S, 2014, LANCET ONCOL, V15, P156, DOI 10.1016/S1470-2045(13)70589-8; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; Botteri E, 2009, ANN ONCOL, V20, P1008, DOI 10.1093/annonc/mdn732; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Clemons M, 2001, CANCER TREAT REV, V27, P67, DOI 10.1053/ctrv.2000.0204; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Freedman GM, 2000, ONCOLOGY-NY, V14, P1561; Gentilini O, 2007, ANN ONCOL, V18, P468, DOI 10.1093/annonc/mdl424; Gentilini O, 2012, ANN SURG ONCOL, V19, P3771, DOI 10.1245/s10434-012-2404-5; Haffty BG, 1996, J CLIN ONCOL, V14, P52, DOI 10.1200/JCO.1996.14.1.52; HAFFTY BG, 1991, INT J RADIAT ONCOL, V21, P293, DOI 10.1016/0360-3016(91)90774-X; Huang E, 2002, CANCER, V95, P2059, DOI 10.1002/cncr.10952; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Shikama N, 2011, BREAST CANCER-TOKYO, V18, P252, DOI 10.1007/s12282-010-0206-9; Simmons C, 2009, ANN ONCOL, V20, P1499, DOI 10.1093/annonc/mdp028; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273; Wapnir IL, 2008, CLIN BREAST CANCER, V8, P287, DOI 10.3816/CBC.2008.n.035; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163254	10.1371/journal.pone.0163254	http://dx.doi.org/10.1371/journal.pone.0163254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648567	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100070
J	Premchandar, A; Mucke, N; Poznanski, J; Wedig, T; Kaus-Drobek, M; Herrmann, H; Dadlez, M				Premchandar, Aiswarya; Mucke, Norbert; Poznanski, Jaroslaw; Wedig, Tatjana; Kaus-Drobek, Magdalena; Herrmann, Harald; Dadlez, Michal			Structural Dynamics of the Vimentin Coiled-coil Contact Regions Involved in Filament Assembly as Revealed by Hydrogen-Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; KERATIN INTERMEDIATE-FILAMENTS; IN-VITRO; ATOMIC-STRUCTURE; 2B; DOMAINS; DESMIN; DIMER; ROD; ARCHITECTURE	Intermediate filaments (IF) are major constituents of the cytoskeleton of metazoan cells. They are not only responsible for the mechanical properties but also for various physiological activities in different cells and tissues. The building blocks of IFs are extended coiled-coil-forming proteins exhibiting a characteristic central alpha-helical domain ("rod"). The fundamental principles of the filament assembly mechanism and the network formation have been widely elucidated for the cytoplasmic IF protein vimentin. Also, a comprehensive structural model for the tetrameric complex of vimentin has been obtained by X-ray crystallography in combination with various biochemical and biophysical techniques. To extend these static data and to investigate the dynamic properties of the full-length proteins in solution during the various assembly steps, we analyzed the patterns of hydrogen-deuterium exchange in vimentin and in four variants carrying point mutations in the IF consensus motifs present at either end of the alpha-helical rod that cause an assembly arrest at the unit-length filament (ULF) stage. The results yielded unique insights into the structural properties of subdomains within the full-length vimentin, in particular in regions of contact in alpha-helical and linker segments that stabilize different oligomeric forms such as tetramers, ULFs, and mature filaments. Moreover, hydrogen-deuterium exchange analysis of the point-mutated variants directly demonstrated the active role of the IF consensus motifs in the oligomerization mechanism of tetramers during ULF formation. Ultimately, using molecular dynamics simulation procedures, we provide a structural model for the subdomain-mediated tetramer/tetramer interaction via "cross-coiling" as the first step of the assembly process.	[Premchandar, Aiswarya; Poznanski, Jaroslaw; Kaus-Drobek, Magdalena; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland; [Dadlez, Michal] Univ Warsaw, Inst Genet & Biotechnol, Dept Biol, Miecznikowa 3, PL-02106 Warsaw, Poland; [Mucke, Norbert; Wedig, Tatjana] German Canc Res Ctr, Biophys Macromol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Herrmann, Harald] Univ Hosp Erlangen, Inst Neuropathol, D-91054 Erlangen, Germany	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg	Herrmann, H (corresponding author), Univ Hosp Erlangen, Inst Neuropathol, D-91054 Erlangen, Germany.; Dadlez, M (corresponding author), Inst Biochem & Biophys, Dept Biophys, PL-02106 Warsaw, Poland.	harald.herrmann@uk-erlangen.de; michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014; Premchandar, Aiswarya/AAD-1077-2019	Poznanski, Jaroslaw/0000-0003-2684-1775; Premchandar, Aiswarya/0000-0002-5664-496X; Mucke, Norbert/0000-0002-0683-4386; Kaus-Drobek, Magdalena/0000-0001-6202-4567; Dadlez, Michal/0000-0001-8811-5176	Foundation for Polish Science Grant [TEAM/2011-7/1]; European Union Centre for Preclinical Research and Technology (CePT) Grant [POIG.02.02.00-14-024/08-00]; NanoFun Program [POIGT.02.02.00-00-025/09-00]; German Research Foundation (DFG) [HE1853/11-1]; MAESTRO Grant from the National Science Centre, Poland [2014/14/A/NZ1/0030]	Foundation for Polish Science Grant; European Union Centre for Preclinical Research and Technology (CePT) Grant; NanoFun Program; German Research Foundation (DFG)(German Research Foundation (DFG)); MAESTRO Grant from the National Science Centre, Poland	This work was supported by Foundation for Polish Science Grant TEAM/2011-7/1, European Union Centre for Preclinical Research and Technology (CePT) Grant POIG.02.02.00-14-024/08-00, and NanoFun Program Grant POIGT.02.02.00-00-025/09-00. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by German Research Foundation (DFG) Grant HE1853/11-1. To whom correspondence may be addressed: Institute of Neuropathology, University Hospital Erlangen, D-91054 Erlangen, Germany. Tel.: 49-9131-85-34782; Fax: 49-9131-85-26033; E-mail: harald.herrmann@uk-erlangen.de.r Supported by MAESTRO Grant 2014/14/A/NZ1/0030 from the National Science Centre, Poland. To whom correspondence may be addressed: Institute of Biochemistry and Biophysics, Dept. of Biophysics, 02-106 Warsaw, Poland. Tel.: 48-22-5923-471; Fax: 48-22-658-4766; E-mail: michald@ibb.waw.pl.	Aziz A, 2012, J BIOL CHEM, V287, P28349, DOI 10.1074/jbc.M111.334011; Aziz A, 2010, J BIOL CHEM, V285, P15278, DOI 10.1074/jbc.M109.075598; Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068; Chernyatina AA, 2015, CURR OPIN CELL BIOL, V32, P65, DOI 10.1016/j.ceb.2014.12.007; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Colas J, 2012, HUM MOL GENET, V21, P623, DOI 10.1093/hmg/ddr496; GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200; Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kapinos LE, 2010, J MOL BIOL, V396, P719, DOI 10.1016/j.jmb.2009.12.001; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Koster S, 2015, CURR OPIN CELL BIOL, V32, P82, DOI 10.1016/j.ceb.2015.01.001; Kowlessur D, 2012, J BIOL CHEM, V287, P42299, DOI 10.1074/jbc.M112.423459; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lichtenstern T, 2012, J STRUCT BIOL, V177, P54, DOI 10.1016/j.jsb.2011.11.003; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Noding B, 2014, BIOPHYS J, V107, P2914, DOI 10.1016/j.bpj.2014.09.050; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; PARRY DAD, 1995, INTERMEDIATE FILAMEN; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017; Premchandar A, 2015, J STRUCT BIOL, V192, P426, DOI 10.1016/j.jsb.2015.10.001; Quinlan RA, 1999, EYE, V13, P409, DOI 10.1038/eye.1999.115; Richter MM, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150238; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Winheim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019202; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539	51	28	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24931	24950		10.1074/jbc.M116.748145	http://dx.doi.org/10.1074/jbc.M116.748145			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694444	Green Published, hybrid			2022-12-26	WOS:000388880100013
J	Gravina, HD; Goes, AM; Murta, SMF; Ropert, C				Gravina, Humberto Doriguetto; Goes, Alfredo Miranda; Fonseca Murta, Silvane Maria; Ropert, Catherine			MyD88 Adapter-like (Mal)/TIRAP Is Required for Cytokine Production by Splenic Ly6C(lo)TLR2(hi) but Not by Ly6C(hi)TLR2(hi) Monocytes during Trypanosoma cruzi Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; flow cytometry; infection; inflammation; innate immunity; MAL; TIRAP; monocyte; Toll-like receptor (TLR)	TOLL-LIKE RECEPTOR-2; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; CUTTING EDGE; TLR2; ACTIVATION; EXPRESSION; INFLAMMATION; MACROPHAGES; RECOGNITION	This study continues to explore the plasticity of Toll-like receptor 2 (TLR2) previously described in immune response during Trypanosoma cruzi infection. Here, we have shown that Ly6C(hi)TLR2(hi) monocytes were involved in TNF- and IL-12 production, whereas Ly6C(lo)TLR2(hi) monocytes were mainly committed to IL-10 and TNF- production during T. cruzi infection independently of TLR agonist used (i.e. TLR2 or TLR9 agonists). Another difference between the monocyte populations is that the adapter Mal (encoded by TIRAP) has appeared crucial for the cytokine production by Ly6C(lo) but not by Ly6C(hi) monocytes. The protein Mal was necessary to induce cytokine synthesis by Ly6C(lo) monocytes after triggering TLR2 or TLR9. Finally, our data have suggested that TLR2, TLR9, and Mal/TIRAP controlled differentially the emergence of the different TLR2(hi) monocyte populations in the spleen. In summary, this study highlights the central role of the TLR2/Mal tandem in the distinct activity among the monocyte subsets during T. cruzi infection. Such findings provide a basis for understanding the challenge posed by the use of TLR2 agonist in immunotherapy.	[Gravina, Humberto Doriguetto; Goes, Alfredo Miranda; Ropert, Catherine] Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270910 Belo Horizonte, MG, Brazil; [Fonseca Murta, Silvane Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz	Ropert, C (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270910 Belo Horizonte, MG, Brazil.; Ropert, C (corresponding author), Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	ropertcatherine@gmail.com	Ropert, Catherine/G-2463-2012; Gravina, H D/F-2831-2016; Murta, Silvane Fonseca Murta/ABE-9410-2021; Ropert, Catherine/AAL-7302-2021	Gravina, H D/0000-0002-5006-8869; Murta, Silvane Fonseca Murta/0000-0002-8523-2155; Ropert, Catherine/0000-0002-3077-714X				Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Aviello G, 2014, AM J PHYSIOL-GASTR L, V306, pG769, DOI 10.1152/ajpgi.00399.2013; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Bernard NJ, 2013, IUBMB LIFE, V65, P777, DOI 10.1002/iub.1201; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Cheallaigh CN, 2016, IMMUNITY, V44, P368, DOI 10.1016/j.immuni.2016.01.019; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Cole LE, 2010, J LEUKOCYTE BIOL, V87, P275, DOI 10.1189/jlb.0909619; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gravina HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063100; Heggelund L, 2004, CLIN INFECT DIS, V39, P264, DOI 10.1086/421780; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Ropert C, 2004, J ENDOTOXIN RES, V10, P425, DOI 10.1179/096805104225006507; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Shmuel-Galia L, 2016, EMBO J, V35, P685, DOI 10.15252/embj.201592649; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takeda K, 2004, J DERMATOL SCI, V34, P73, DOI 10.1016/j.jdermsci.2003.10.002; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Bergenhenegouwen J, 2013, J LEUKOCYTE BIOL, V94, P885, DOI 10.1189/jlb.0113003; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23832	23841		10.1074/jbc.M116.729509	http://dx.doi.org/10.1074/jbc.M116.729509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646001	hybrid, Green Published			2022-12-26	WOS:000387884400042
J	Trinh, TT; Yatich, N; Ngomoa, R; McGrath, CJ; Richardson, BA; Sakr, SR; Langat, A; John-Stewart, GC; Chung, MH				Trinh, T. Tony; Yatich, Nelly; Ngomoa, Richard; McGrath, Christine J.; Richardson, Barbra A.; Sakr, Samah R.; Langat, Agnes; John-Stewart, Grace C.; Chung, Michael H.			Partner Disclosure and Early CD4 Response among HIV-Infected Adults Initiating Antiretroviral Treatment in Nairobi Kenya	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; SOCIAL SUPPORT; POSITIVE MEN; THERAPY; PREVENTION; WOMEN; TRANSMISSION; ADHERENCE; TANZANIA; BARRIERS	Background Disclosure of HIV serostatus can have significant benefits for people living with HIV/AIDS. However, there is limited data on whether partner disclosure influences ART treatment response. Methods We conducted a retrospective cohort study of newly diagnosed, ART-naive HIV-infected adults (>18 years) who enrolled at the Coptic Hope Center in Nairobi, Kenya between January 1st 2009 and July 1st 2011 and initiated ART within 3 months. Analysis was restricted to adults who reported to have either disclosed or not disclosed their HIV status to their partner. Analysis of CD4 response at 6 and 12 months post-ART was stratified by age group. Results Among 615 adults newly initiating ART with partner disclosure data and 12 month follow-up, mean age was 38 years and 52% were male; 76% reported that they had disclosed their HIV-status to their partner. Those who disclosed were significantly younger and more likely to be married/cohabitating than non-disclosers. At baseline, median CD4 counts were similar between disclosure groups. Among younger adults (<38 years) those who disclosed had higher CD4 recovery than those who did not at 6 months post-ART (mean difference = 31, 95% CI 3 to 58 p = 0.03) but not at 12 months (mean difference = 17, 95% CI -19 to 52, p = 0.4). Among older adults (>= 38years) there was no observed difference in CD4 recovery at 6 or 12 months between disclosure groups. Conclusion Among younger adults, disclosure of HIV status to partners may be associated with CD4 recovery following ART.	[Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [John-Stewart, Grace C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Yatich, Nelly; Ngomoa, Richard; Sakr, Samah R.] Copt Hosp, Nairobi, Kenya; [McGrath, Christine J.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Langat, Agnes] US Ctr Dis Control & Prevent, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston	Trinh, TT (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Trinh, TT (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Trinh, TT (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.	ttonytrinh@gmail.com	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	John-Stewart, Grace/0000-0002-4301-1573	NIH/NIAID [5T32AI7044-38]; NIH/NRSA [T32AI007140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NIAID Grant 5T32AI7044-38 (TTT) and NIH/NRSA T32AI007140 (CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GEND DIM HIV STAT DI; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1062; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Dima AL, 2014, SOC SCI MED, V108, P166, DOI 10.1016/j.socscimed.2014.02.045; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Halperin J, 2013, AIDS PATIENT CARE ST, V27, P375, DOI 10.1089/apc.2013.0037; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Larkins S, 2005, AIDS CARE, V17, P521, DOI 10.1080/09540120512331314321; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Przybyla SM, 2013, AIDS CARE, V25, P566, DOI 10.1080/09540121.2012.722601; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Shacham E, 2012, AIDS PATIENT CARE ST, V26, P29, DOI 10.1089/apc.2011.0183; Skogmar S, 2006, AIDS CARE, V18, P725, DOI 10.1080/09540120500307248; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Waddell EN, 2006, AIDS BEHAV, V10, P263, DOI 10.1007/s10461-005-9042-x	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163594	10.1371/journal.pone.0163594	http://dx.doi.org/10.1371/journal.pone.0163594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711164	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600031
J	Hoffman, S; Exner, TM; Lince-Deroche, N; Leu, CS; Phillip, JL; Kelvin, EA; Gandhi, AD; Levin, B; Singh, D; Mantell, JE; Blanchard, K; Ramjee, G				Hoffman, Susie; Exner, Theresa M.; Lince-Deroche, Naomi; Leu, Cheng-Shiun; Phillip, Jessica L.; Kelvin, Elizabeth A.; Gandhi, Anisha D.; Levin, Bruce; Singh, Dinesh; Mantell, Joanne E.; Blanchard, Kelly; Ramjee, Gita			Immediate Blood Draw for CD4+Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ART INITIATION; RETENTION; DIAGNOSIS; SCALE; SITES	Background Timely linkage to care by newly-diagnosed HIV+ individuals remains a significant challenge to achieving UNAIDS 90-90-90 goals. Current World Health Organization (WHO) guidelines recommend initiating anti-retroviral treatment (ART) regardless of CD4+ count, with priority given to those with CD4+ <350 cells/mu l. We evaluated the impact of not having a day-of-diagnosis CD4+ count blood draw, as recommended by South African guidelines, on time to linkage, using data from a prospective cohort study. Methods Individuals (N = 2773) were interviewed prior to HIV counseling and testing at three public sector primary care clinics in the greater Durban area; 785 were newly-diagnosed and eligible for the cohort study; 459 (58.5%) joined and were followed for eight months with three structured assessments. Linkage to care, defined as returning to clinic for CD4+ count results, and day-of-diagnosis blood draw were self-reported. Results Overall, 72.5% did not have a day-of-diagnosis CD4+ count blood draw, and 19.2% of these never returned. Compared with a day-of-diagnosis blood draw, the adjusted hazard ratio of linkage (AHR(linkage)) associated with not having day-of-diagnosis blood draw was 0.66 (95% CI: 0.51, 0.85). By 4 months, 54.8% of those without day-of-diagnosis blood draw vs. 75.2% with one were linked to care (chi-squared p = 0.004). Of those who deferred blood draw, 48.3% cited clinic-related and 51.7% cited personal reasons. AHRlinkage was 0.60 (95% CI: 0.44, 0.82) for clinic-related and 0.53 (95% CI: 0.38, 0.75) for personal reasons relative to having day-of-diagnosis blood draw. Conclusions Newly-diagnosed HIV+ individuals who did not undergo CD4+ count blood draw on the day they were diagnosed-regardless of the reason for deferring-had delayed linkage to care relative to those with same-day blood draw. To enhance prompt linkage to care even when test and treat protocols are implemented, all diagnostic testing required before ART initiation should be performed on the same day as HIV testing/diagnosis. This may require modifying clinic procedures to enable overnight blood storage if same-day draws cannot be performed, and providing additional counseling to encourage newly-diagnosed individuals to complete day-of-diagnosis testing. Tracking HIV+ individuals via clinic registries should commence immediately from diagnosis to reduce these early losses to care.	[Hoffman, Susie; Exner, Theresa M.; Leu, Cheng-Shiun; Gandhi, Anisha D.; Levin, Bruce; Mantell, Joanne E.] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA; [Hoffman, Susie] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Lince-Deroche, Naomi] Ibis Reprod Hlth, Johannesburg, South Africa; [Leu, Cheng-Shiun; Levin, Bruce] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Phillip, Jessica L.; Singh, Dinesh; Ramjee, Gita] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Kelvin, Elizabeth A.] CUNY, Grad Sch Publ Hlth & Hlth Policy, Epidemiol & Biostat Program, New York, NY 10021 USA; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA; [Lince-Deroche, Naomi] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Phillip, Jessica L.] Hlth Syst Trust, Midrand, South Africa	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; South African Medical Research Council; City University of New York (CUNY) System; University of Witwatersrand	Hoffman, S (corresponding author), Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA.; Hoffman, S (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	sh51@cumc.columbia.edu		Lince-Deroche, Naomi/0000-0003-3689-4205; Kelvin, Elizabeth/0000-0002-0566-8697	National Institute of Mental Health [R01 MH83561, R01 MH083561-03S1, T32 MH19139]; Columbia University [P30-MH43520]; South African Medical Research Council HIV Prevention Research Unit (MRC HPRU); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083561, P30MH043520, T32MH019139] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Columbia University; South African Medical Research Council HIV Prevention Research Unit (MRC HPRU); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health (R01 MH83561 and R01 MH083561-03S1; Principal Investigator: Susie Hoffman, DrPH), and by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University [P30-MH43520; Principal Investigators: Anke A. Ehrhardt (1987-2013)/Robert H. Remien, Ph.D. (2013-2018)]. Dr. Gandhi was supported by a training grant from the National Institute of Mental Health (T32 MH19139, Behavioral Sciences Research in HIV Infection; Principal Investigator: Theo Sandfort, Ph.D.). Additional support was provided by the South African Medical Research Council HIV Prevention Research Unit (MRC HPRU). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the MRC HPRU.	Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Fishbein M, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P3; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hoffman S, 2014, AIDS, V28, P2429, DOI 10.1097/QAD.0000000000000427; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; National Department of Health Republic of South Africa, 2010, CLIN GUID MAN HIV AI; National Department of Health Republic of South Africa, 2015, NAT CONS GUID PREV M; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shisana O, 2014, S AFRICAN NATL HIV P; Skhosana M, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.444; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; UNAIDS, 2014, 90 90 90 AMB TREATM; World Health Organization, 2015, GUID START ANT THER	25	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162085	10.1371/journal.pone.0162085	http://dx.doi.org/10.1371/journal.pone.0162085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706150	Green Published, gold			2022-12-26	WOS:000385697200007
J	Patel, NM; Moore, JD; Blackwell, HE; Amador-Noguez, D				Patel, Nishaben M.; Moore, Joseph D.; Blackwell, Helen E.; Amador-Noguez, Daniel			Identification of Unanticipatedand Novel N-Acyl L-Homoserine Lactones (AHLs) Using a Sensitive Non-Targeted LC-MS/MS Method	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; PSEUDOMONAS-AERUGINOSA; ACYLHOMOSERINE LACTONES; BIOFILM FORMATION; EXOPOLYSACCHARIDE PRODUCTION; YERSINIA-PSEUDOTUBERCULOSIS; MOLECULES; SYSTEM; VIRULENCE; GROWTH	N-acyl L-homoserine lactones (AHLs) constitute a predominant class of quorum-sensing signaling molecules used by Gram-negative bacteria. Here, we report a sensitive and non-targeted HPLC-MS/MS method based on parallel reaction monitoring (PRM) to identify and quantitate known, unanticipated, and novel AHLs in microbial samples. Using a hybrid quadrupole-high resolution mass analyzer, this method integrates MS scans and all-ion fragmentation MS/MS scans to allow simultaneous detection of AHL parent-ion masses and generation of full mass spectra at high resolution and high mass accuracy in a single chromatographic run. We applied this method to screen for AHL production in a variety of Gram-negative bacteria (i.e. B. cepacia, E. tarda, E. carotovora, E. herbicola, P. stewartii, P. aeruginosa, P. aureofaciens, and R. sphaeroides) and discovered that nearly all of them produce a larger set of AHLs than previously reported. Furthermore, we identified production of an uncommon AHL (i.e. 3-oxo-C7-HL) in E. carotovora and P. stewartii, whose production has only been previously observed within the genera Serratia and Yersinia. Finally, we used our method to quantitate AHL degradation in B. cepacia, E. carotovora, E. herbicola, P. stewartii, P. aeruginosa, P. aureofaciens, the non-AHL producer E. coli, and the Gram-positive bacterium B. subtilis. We found that AHL degradation ability varies widely across these microbes, of which B. subtilis and E. carotovora are the best degraders, and observed that there is a general trend for AHLs containing long acyl chains (>= 10 carbons) to be degraded at faster rates than AHLs with short acyl chains (<= 6 carbons).	[Patel, Nishaben M.; Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA; [Patel, Nishaben M.] Univ Wisconsin, Sci Bacteriol Program, Madison, WI 53706 USA; [Moore, Joseph D.; Blackwell, Helen E.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Amador-Noguez, D (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	amadornoguez@wisc.edu		Patel, Nishaben/0000-0003-4724-5710	NSF [CHE-1213526]; Burroughs Welcome Fund; UW-Madison NIH Biotechnology Training Program [5 T32 GM008349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Welcome Fund(Burroughs Wellcome Fund); UW-Madison NIH Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.E.B. acknowledges the NSF (CHE-1213526) and the Burroughs Welcome Fund for support of this work in her laboratory. J.D.M was supported in part by the UW-Madison NIH Biotechnology Training Program (5 T32 GM008349).	Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Burton EO, 2005, APPL ENVIRON MICROB, V71, P4906, DOI 10.1128/AEM.71.8.4906-4909.2005; Charlesworth J, 2015, J MICROBIOL METH, V118, P164, DOI 10.1016/j.mimet.2015.09.012; Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Fetzner S, 2015, J BIOTECHNOL, V201, P2, DOI 10.1016/j.jbiotec.2014.09.001; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Han Y, 2010, J APPL MICROBIOL, V108, P139, DOI 10.1111/j.1365-2672.2009.04405.x; Hong KW, 2012, SENSORS-BASEL, V12, P4661, DOI 10.3390/s120404661; Horng YT, 2002, MOL MICROBIOL, V45, P1655, DOI 10.1046/j.1365-2958.2002.03117.x; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Lindemann A, 2011, P NATL ACAD SCI USA, V108, P16765, DOI 10.1073/pnas.1114125108; Lithgow JK, 2000, MOL MICROBIOL, V37, P81, DOI 10.1046/j.1365-2958.2000.01960.x; Liu M, 2007, J APPL MICROBIOL, V103, P2174, DOI 10.1111/j.1365-2672.2007.03488.x; Liu X, 2010, WORLD J MICROB BIOT, V26, P1465, DOI 10.1007/s11274-010-0321-y; Liu XG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-26; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Marketon MM, 2003, J BACTERIOL, V185, P325, DOI 10.1128/JB.185.1.325-331.2003; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; Medina-Martinez MS, 2007, APPL ENVIRON MICROB, V73, P2329, DOI 10.1128/AEM.01993-06; Minogue TD, 2002, MOL MICROBIOL, V44, P1625, DOI 10.1046/j.1365-2958.2002.02987.x; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002; Penalver CGN, 2006, FEBS LETT, V580, P561, DOI 10.1016/j.febslet.2005.12.062; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Purohit AA, 2013, J APPL MICROBIOL, V115, P835, DOI 10.1111/jam.12264; Puskas A, 1997, J BACTERIOL, V179, P7530, DOI 10.1128/jb.179.23.7530-7537.1997; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schu DJ, 2009, J BACTERIOL, V191, P7402, DOI 10.1128/JB.00994-09; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Uroz S, 2008, FEMS MICROBIOL ECOL, V65, P271, DOI 10.1111/j.1574-6941.2008.00477.x; Venturi V, 2004, RES MICROBIOL, V155, P238, DOI 10.1016/j.resmic.2004.01.006; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welsh MA, 2016, FEMS MICROBIOL REV, V40, P774, DOI 10.1093/femsre/fuw009; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wisniewski-Dye F, 2002, J BACTERIOL, V184, P1597, DOI 10.1128/JB.184.6.1597-1606.2002; Wisniewski-Dye F, 2002, ANTON LEEUW INT J G, V81, P397, DOI 10.1023/A:1020501104051; Wood DW, 1997, J BACTERIOL, V179, P7663, DOI 10.1128/jb.179.24.7663-7670.1997; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang Z, 2011, APPL ENVIRON MICROB, V67, P4305, DOI [10.1128/AEM.67.9.4305, DOI 10.1128/AEM.67.9.4305]; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998	72	39	40	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163469	10.1371/journal.pone.0163469	http://dx.doi.org/10.1371/journal.pone.0163469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706219	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200046
J	Wilson, C; Perkin, OJ; McGuigan, MP; Stokes, KA				Wilson, Cassie; Perkin, Oliver J.; McGuigan, Miranda P.; Stokes, Keith A.			The Effect of Age on Technique Variability and Outcome Variability during a Leg Press	PLOS ONE			English	Article							RELATIVE PHASE; MUSCLE POWER; ADULTS; COORDINATION; STRENGTH; HEALTHY	The aim of this study was to determine the effect of aging on power generation and joint coordination during a leg press, in order to increase understanding of how functional movements are affected during the aging process. 44 older and 24 younger adults performed eight sub-maximal power repetitions on a seated leg press dynamometer. Peak power and velocity (at 40% maximum resistance) were measured along with the coordination (coupling angle) of the lower limb joints using the vector coding technique. The younger adults produced significantly greater peak power than the older adults (mean +/- SD; 762W +/- 245 vs 361W +/- 162, p < 0.01) and at higher peak velocities (mean +/- SD; 1.37 m/s +/- 0.05 vs 1.00 m/s +/- 0.06, p < 0.01). The older adults produced less consistent values of peak power than younger adults, evidenced by a higher coefficient of variation (mean +/- SD; 7.6% +/- 5.2 vs 5.0% +/- 3.0, p < 0.01), however, there was significantly less variability in the coupling angles displayed by the older adults compared to the younger adults (mean +/- SD; 2.0 degrees +/- 1.1 vs 3.5 degrees +/- 2.7, p < 0.01 (ankle-knee); 1.7 degrees +/- 0.6 vs 4.1 degrees +/- 3.0, p < 0.01 (knee-hip)). The results of this study demonstrate that older adults display higher outcome variability but lower variability in technique (coordination). The more rigid movement strategies displayed by the older adults potentially reflects an increased risk of overuse injury due to repetitive demands on the same structures, or the reduced ability to respond to unexpected situations due to a lack of flexibility in joint control.	[Wilson, Cassie; Perkin, Oliver J.; McGuigan, Miranda P.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Perkin, Oliver J.; Stokes, Keith A.] Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Bath, Avon, England	University of Bath	Wilson, C (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	c.wilson3@bath.ac.uk	; Stokes, Keith/C-2605-2009	Perkin, Oliver/0000-0001-8921-8708; Stokes, Keith/0000-0002-5049-2838				ARUTYUNYAN GA, 1969, BIOPHYS-USSR, V14, P1162; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Batschelet E, 1981, CIRCULAR STAT BIOL; Bemben MG, 1999, J STRENGTH COND RES, V13, P330; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; BROOKS SV, 1991, J GERONTOL, V46, pB28, DOI 10.1093/geronj/46.1.B28; BURGESSLIMERICK R, 1993, J BIOMECH, V26, P91, DOI 10.1016/0021-9290(93)90617-N; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Cofre LE, 2010, IFMBE PROC, V31, P301, DOI 10.1007/978-3-642-14515-5_78; Cohen J.E., 1988, STAT POWER ANAL BEHA; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-31; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haguenauer M, 2005, J APPL BIOMECH, V21, P236, DOI 10.1123/jab.21.3.236; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hein T, 2012, HUM MOVEMENT SCI, V31, P683, DOI 10.1016/j.humov.2011.07.008; Hsu WL, 2014, EUR J APPL PHYSIOL, V114, P261, DOI 10.1007/s00421-013-2768-7; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MAYHEW JL, 1990, EUR J APPL PHYSIOL, V60, P133, DOI 10.1007/BF00846033; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Michel-Pellegrino V, 2008, J AGING PHYS ACTIV, V16, P171, DOI 10.1123/japa.16.2.171; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MORGAN M, 1994, J GERONTOL, V49, pM133, DOI 10.1093/geronj/49.3.M133; O'Connor KM, 2009, MED SCI SPORT EXER, V41, P867, DOI 10.1249/MSS.0b013e31818f8743; Reid KF, 2014, EUR J APPL PHYSIOL, V114, P29, DOI 10.1007/s00421-013-2728-2; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Schmorrow D, 2009, FDN AUGMENTED COGNIT; Seidler-Dobrin R D, 1998, Motor Control, V2, P314; Sleimen-Malkoun R, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-145; SPARROW WA, 1987, J MOTOR BEHAV, V19, P115, DOI 10.1080/00222895.1987.10735403; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Wheat JS, 2006, MOVEMENT SYSTEM VARI, P153; Wilson C, 2008, SPORT BIOMECH, V7, P2, DOI 10.1080/14763140701682983	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163764	10.1371/journal.pone.0163764	http://dx.doi.org/10.1371/journal.pone.0163764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701431	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900019
J	Gil, B; Hwang, EJ; Lee, S; Jang, J; Choi, HS; Jung, SL; Ahn, KJ; Kim, BS				Gil, Bomi; Hwang, Eo-Jin; Lee, Song; Jang, Jinhee; Choi, Hyun Seok; Jung, So-Lyung; Ahn, Kook-Jin; Kim, Bum-soo			Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images	PLOS ONE			English	Article							BRAIN METASTASIS; MR; ECHO; EXPERIENCE; DIAGNOSIS; TUMORS	Introduction To compare the diagnostic accuracy of contrast-enhanced 3D(dimensional) T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolutions (T1-SPACE), 2D fluid attenuated inversion recovery (FLAIR) images and 2D contrast-enhanced T1-weighted image in detection of leptomeningeal metastasis except for invasive procedures such as a CSF tapping. Materials and Methods Three groups of patients were included retrospectively for 9 months (from 2013-04-01 to 2013-12-31). Group 1 patients with positive malignant cells in CSF cytology (n = 22); group 2, stroke patients with steno-occlusion in ICA or MCA (n = 16); and group 3, patients with negative results on MRI, whose symptom were dizziness or headache (n = 25). A total of 63 sets of MR images are separately collected and randomly arranged: (1) CE 3D T1SPACE; (2) 2D FLAIR; and (3) CE T1-GRE using a 3-Tesla MR system. A faculty neuroradiologist with 8-year-experience and another 2nd grade trainee in radiology reviewed each MR image-blinded by the results of CSF cytology and coded their observations as positives or negatives of leptomeningeal metastasis. The CSF cytology result was considered as a gold standard. Sensitivity and specificity of each MR images were calculated. Diagnostic accuracy was compared using a McNemar's test. A Cohen's kappa analysis was performed to assess inter-observer agreements. Results Diagnostic accuracy was not different between 3D T1-SPACE and CSF cytology by both raters. However, the accuracy test of 2D FLAIR and 2D contrast-enhanced T1-weighted GRE was inconsistent by the two raters. The Kappa statistic results were 0.657 (3D T1-SPACE), 0.420 (2D FLAIR), and 0.160 (2D contrast-enhanced T1-weighted GRE). The 3D T1-SPACE images showed the highest inter-observer agreements between the raters. Conclusions Compared to 2D FLAIR and 2D contrast-enhanced T1-weighted GRE, contrast-enhanced 3D T1 SPACE showed a better detection rate of leptomeningeal metastasis.	[Gil, Bomi; Hwang, Eo-Jin; Lee, Song; Jang, Jinhee; Choi, Hyun Seok; Jung, So-Lyung; Ahn, Kook-Jin; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Choi, HS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	hschoi@catholic.ac.kr		Kim, Bum-soo/0000-0002-3870-6813; Choi, Hyun Seok/0000-0003-4999-8513				BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; CHAMBERLAIN MC, 1990, NEUROLOGY, V40, P435, DOI 10.1212/WNL.40.3_Part_1.435; Chou M S, 1994, Gaoxiong Yi Xue Ke Xue Za Zhi, V10, P186; DAVIS PC, 1987, RADIOLOGY, V163, P449, DOI 10.1148/radiology.163.2.3562825; FREILICH RJ, 1995, ANN NEUROL, V38, P51, DOI 10.1002/ana.410380111; Kaal EC, 2005, LANCET NEUROL, V4, P289, DOI 10.1016/S1474-4422(05)70072-7; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Kim ES, 2010, AM J NEURORADIOL, V31, P1055, DOI 10.3174/ajnr.A2010; Kitajima M, 2012, AM J NEURORADIOL, V33, P922, DOI 10.3174/ajnr.A2874; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; MUGLER JP, 1993, JMRI-J MAGN RESON IM, V3, P761, DOI 10.1002/jmri.1880030512; Naganawa S, 2015, MAGN RESON MED SCI, V14, P203, DOI [10.2463/mrms.mp.2015-0065, 10.2463/mrms.2014-0112]; Pakdaman MN, 2016, AM J NEURORADIOL, V37, P1903, DOI 10.3174/ajnr.A4822; ROGERS LR, 1992, NEUROLOGY, V42, P1239, DOI 10.1212/WNL.42.6.1239; Singh SK, 2000, RADIOLOGY, V217, P50, DOI 10.1148/radiology.217.1.r00oc3550; Singh SK, 2002, AM J NEURORADIOL, V23, P817; SZE G, 1989, AM J ROENTGENOL, V153, P1039, DOI 10.2214/ajr.153.5.1039; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7; WENZ F, 1994, MAGN RESON IMAGING, V12, P553, DOI 10.1016/0730-725X(94)92449-X; Yang S, 2013, INVEST RADIOL, V48, P113, DOI 10.1097/RLI.0b013e318277f078	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163081	10.1371/journal.pone.0163081	http://dx.doi.org/10.1371/journal.pone.0163081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695096	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100023
J	Pruyne, D				Pruyne, David			Revisiting the Phylogeny of the Animal Formins: Two New Subtypes, Relationships with Multiple Wing Hairs Proteins, and a Lost Human Formin	PLOS ONE			English	Article							F-ACTIN; DOMAIN; ACTIVATION; MUTATIONS; ALIGNMENT; WORMBASE; POSITION; DISEASE; SEARCH; GENES	Formins are a widespread family of eukaryotic cytoskeleton-organizing proteins. Many species encode multiple formin isoforms, and for animals, much of this reflects the presence of multiple conserved subtypes. Earlier phylogenetic analyses identified seven major formin subtypes in animals (DAAM, DIAPH, FHOD, FMN, FMNL, INF, and GRID2IP/delphilin), but left a handful of formins, particularly from nematodes, unassigned. In this new analysis drawing from genomic data from a wider range of taxa, nine formin subtypes are identified that encompass all the animal formins analyzed here. Included in this analysis are Multiple Wing Hairs proteins (MWH), which bear homology to formin N-terminal domains. Originally identified in Drosophila melanogaster and other arthropods, MWH-related proteins are also identified here in some nematodes (including Caenorhabditis elegans), and are shown to be related to a novel MWH-related formin (MWHF) subtype. One surprising result of this work is the discovery that a family of pleckstrin homology domain-containing formins (PHCFs) is represented in many vertebrates, but is strikingly absent from placental mammals. Consistent with a relatively recent loss of this formin, the human genome retains fragments of a defunct homologous formin gene.	[Pruyne, David] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Pruyne, D (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	pruyned@upstate.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [R01AR064760]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064760] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	DP was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, http://www.niams.nih.gov/, through grant number R01AR064760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin NM, 2007, DEVELOPMENT, V134, P19, DOI 10.1242/dev.02709; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Bohnert KA, 2013, BIOCHEM SOC T, V41, P1750, DOI 10.1042/BST20130208; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Brown Elizabeth J, 2010, Nat Genet, V42, P72, DOI 10.1038/ng.505; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Halanych KM, 2015, J EXP BIOL, V218, P592, DOI 10.1242/jeb.111872; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heimsath Ernest G Jr, 2012, J Biol Chem, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Law R, 2014, AM J HUM GENET, V95, P721, DOI 10.1016/j.ajhg.2014.10.016; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lu QH, 2015, DEVELOPMENT, V142, P2478, DOI 10.1242/dev.122119; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Nei M., 2000, MOL EVOLUTION PHYLOG; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaye DD, 2015, DEV CELL, V32, P743, DOI 10.1016/j.devcel.2015.01.009; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Swan KA, 1998, J CELL SCI, V111, P2017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 2004, DEV BIOL, V274, P413, DOI 10.1016/j.ydbio.2004.07.035; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	54	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164067	10.1371/journal.pone.0164067	http://dx.doi.org/10.1371/journal.pone.0164067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695129	Green Submitted, gold, Green Published			2022-12-26	WOS:000385553100084
J	Wang, J; Kalhor, N; Hu, JH; Wang, BC; Chu, HL; Zhang, BC; Gum, YP; Wu, Y				Wang, Jun; Kalhor, Neda; Hu, Jianhua; Wang, Baocheng; Chu, Huili; Zhang, Bicheng; Gum, Yaping; Wu, Yun			Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL/LYMPHOCYTE RATIO; PROGNOSTIC-FACTOR; PREOPERATIVE NEUTROPHIL; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; INFLAMMATION; PREDICTOR; RESECTION; PLATELET	Background Neutrophil-to-lymphocyte ratio (NLR) has been shown to be a prognostic indicator in several types of cancer. We aimed to investigate the association between NLR and survival in surgery-treated non-small cell lung cancer (NSCLC) patients. Study Design This large retrospective study included 1,245 patients who underwent initial surgery for stage I-III NSCLC at The University of Texas MD Anderson Cancer Center between December 2002 and November 2010. We analyzed the relationship of NLR with clinicopathological variables, local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), recurrence-free survival (RFS), overall survival (OS), and disease-specific survival (DSS) in patients with high or low NLR using Kaplan-Meier method. Hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the prognostic strength of NLR. Results There was a statistically significant association between the pretreatment NLR and histology type (P = 0.003) and tumor grade (P = 0.028). At a median follow-up time of 50.6 months, high NLR was associated with reduced DRFS (P = 0.011), OS (P < 0.0001) and DSS (P = 0.004); it was not associated with LRFS and RFS. Multivariable Cox analysis further revealed that NLR (P = 0.027), pathologic stage (P < 0.0001) and lymphovascular invasion (P < 0.0001) were strong independent predictors for DRFS. NLR was also an independent marker predicting poor OS (P = 0.002) and DSS (P = 0.017). Conclusion The pretreatment NLR can serve as a biomarker to predict distant recurrence and death in stage I-III NSCLC patients. Combination of NLR and pathologic stage can better predict the OS and DSS in stage I-II NSCLC patients.	[Wang, Jun; Wang, Baocheng; Chu, Huili; Gum, Yaping] Gen Hosp, Dept Oncol, Jinan Command Peoples Liberat Army, Jinan, Peoples R China; [Wang, Jun; Kalhor, Neda; Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hu, Jianhua] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Zhang, Bicheng] Wuhan Gen Hosp, Dept Oncol, Guangzhou Command Peoples Liberat Army, Wuhan, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	yunwu@mdanderson.org	Wang, Jun/AAZ-2098-2020		National Nature Science Foundation of China [81272619, 81572875]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Nature Science Foundation of China (grants 81272619 and 81572875 to JW).	ALBERTI W, 1995, BRIT MED J, V311, P899; Alifano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106914; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Botta C, 2013, CANCER BIOL THER, V14, P469, DOI 10.4161/cbt.24425; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Cannon NA, 2015, J THORAC ONCOL, V10, P280, DOI 10.1097/JTO.0000000000000399; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fang HY, 2013, LARYNGOSCOPE, V123, P2690, DOI 10.1002/lary.24105; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Go SI, 2014, LUNG CANCER, V84, P79, DOI 10.1016/j.lungcan.2014.01.014; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Kacan T, 2014, ASIAN PAC J CANCER P, V15, P2089, DOI 10.7314/APJCP.2014.15.5.2089; Kameyama K, 2002, J THORAC CARDIOV SUR, V124, P503, DOI 10.1067/mtc.2002.123810; Kaneko M, 2012, ONCOLOGY-BASEL, V82, P261, DOI 10.1159/000337228; Kang MH, 2014, BRIT J CANCER, V111, P452, DOI 10.1038/bjc.2014.317; Kemal Y, 2014, ASIAN PAC J CANCER P, V15, P2651, DOI 10.7314/APJCP.2014.15.6.2651; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Lin GN, 2017, ASIA-PAC J CLIN ONCO, V13, pE189, DOI 10.1111/ajco.12273; MacDonald Neil, 2007, J Support Oncol, V5, P157; Mascaux C, 2006, BRIT J CANCER, V95, P139, DOI 10.1038/sj.bjc.6603226; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Miyazaki T, 2015, EUR J CARDIO-THORAC, V47, pE140, DOI 10.1093/ejcts/ezu514; Nakayama Y, 2014, SURG TODAY, V44, P2146, DOI 10.1007/s00595-014-0917-1; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; PETRIE HT, 1985, J IMMUNOL, V134, P230; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; SHAU H, 1988, J IMMUNOL, V141, P4395; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Srimuninnimit Vichien, 2012, J Med Assoc Thai, V95 Suppl 2, pS199; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Takahashi Y, 2015, ANN SURG ONCOL, V22, pS1324, DOI 10.1245/s10434-015-4735-5; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Tomita M, 2011, ANTICANCER RES, V31, P2995; Troppan K, 2014, BRIT J CANCER, V110, P369, DOI 10.1038/bjc.2013.763; Unal D, 2013, ASIAN PAC J CANCER P, V14, P5237, DOI 10.7314/APJCP.2013.14.9.5237; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052704; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028844; Williams KA, 2014, GYNECOL ONCOL, V132, P542, DOI 10.1016/j.ygyno.2014.01.026; Zhang H, 2015, AM J SURG, V210, P526, DOI 10.1016/j.amjsurg.2015.03.022; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126496	53	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163397	10.1371/journal.pone.0163397	http://dx.doi.org/10.1371/journal.pone.0163397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695079	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100032
J	Zee, BM; Dibona, AB; Alekseyenko, AA; French, CA; Kuroda, MI				Zee, Barry M.; Dibona, Amy B.; Alekseyenko, Artyom A.; French, Christopher A.; Kuroda, Mitzi I.			The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns	PLOS ONE			English	Article							NUT MIDLINE CARCINOMA; TRANSCRIPTION; ACETYLATION; CHROMATIN; ACTIVATION; CANCER; DIFFERENTIATION; EXPRESSION; COMPLEXES; PROTEINS	Defects in chromatin proteins frequently manifest in diseases. A striking case of a chromatin-centric disease is NUT-midline carcinoma (NMC), which is characterized by expression of NUT as a fusion partner most frequently with BRD4. ChIP-sequencing studies from NMC patients revealed that BRD4-NUT (B4N) covers large genomic regions and elevates transcription within these domains. To investigate how B4N modulates chromatin, we performed affinity purification of B4N when ectopically expressed in 293-TREx cells and quantified the associated histone posttranslational modifications (PTM) using proteomics. We observed significant enrichment of acetylation particularly on H3 K18 and of combinatorial patterns such as H3 K27 acetylation paired with K36 methylation. We postulate that B4N complexes override the preexisting histone code with new PTM patterns that reflect aberrant transcription and that epigenetically modulate the nucleosome environment toward the NMC state.	[Zee, Barry M.; Alekseyenko, Artyom A.; Kuroda, Mitzi I.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zee, Barry M.; Alekseyenko, Artyom A.; Kuroda, Mitzi I.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Dibona, Amy B.; French, Christopher A.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Kuroda, MI (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Kuroda, MI (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mkuroda@genetics.med.harvard.edu		Zee, Barry/0000-0002-3123-8375	National Institute of General Medical Sciences [R01 GM101958]; Jane Coffin Childs Memorial Fund for Medical Research Fellowship [61-1571]; National Institutes of Health [2 T32 HL 7627-31]; National Cancer Institute [5R01CA124633-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101958] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jane Coffin Childs Memorial Fund for Medical Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences grant R01 GM101958 to MIK, a Jane Coffin Childs Memorial Fund for Medical Research Fellowship 61-1571 to BMZ, a National Institutes of Health grant 2 T32 HL 7627-31 to ABD, and a National Cancer Institute grant 5R01CA124633-10 to CAF.	Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Beesley AH, 2014, BRIT J CANCER, V110, P1189, DOI 10.1038/bjc.2014.54; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Brookes E, 2014, ANNU REV GENET, V48, P237, DOI 10.1146/annurev-genet-120213-092518; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2014, CANCER DISCOV, V4, P928, DOI 10.1158/2159-8290.CD-14-0014; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; Hayashi-Takanaka Y, 2015, CHROMOSOME RES, V23, P753, DOI 10.1007/s10577-015-9486-4; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suzuki S, 2015, PATHOL RES PRACT, V211, P404, DOI 10.1016/j.prp.2014.10.013; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thompson-Wicking K, 2013, ONCOGENE, V32, P4664, DOI 10.1038/onc.2012.487; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wang RR, 2015, J BIOL CHEM, V290, P2744, DOI 10.1074/jbc.M114.600759; Wang RR, 2014, CANCER RES, V74, P3332, DOI 10.1158/0008-5472.CAN-13-2658; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zee BM, 2016, P NATL ACAD SCI USA, V113, P1784, DOI 10.1073/pnas.1522750113	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163820	10.1371/journal.pone.0163820	http://dx.doi.org/10.1371/journal.pone.0163820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27698495	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100056
J	Bock, O; Akpinar, S				Bock, Otmar; Akpinar, Selcuk			Performance of Older Persons in a Simulated Shopping Task Is Influenced by Priming with Age Stereotypes	PLOS ONE			English	Article							ECOLOGICAL VALIDITY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; SUPERMARKET; BEHAVIOR; MATTER	Previous research suggests that older persons show cognitive deficits in standardized laboratory tests, but not in more natural tests such as the Multiple Errands Task (MET). The absence of deficits in the latter tests has been attributed to the compensation of deficits by strategies based on life-long experience. To scrutinize this view, we primed older participants with positive or negative stereotypes about old age before administering MET. We found that compared to unprimed controls, priming with positive age stereotypes reduced the number of errors without changing response times, while priming with negative stereotypes changed neither errors not response times. We interpret our findings as evidence that positive age priming improved participants' cognitive functions while leaving intact their experience-based compensation, and that negative age priming degraded participants' cognitive functions which, however, was balanced by an even stronger experience-based compensation.	[Bock, Otmar] German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany; [Akpinar, Selcuk] Nevsehir Haci Bektas Veli Univ, Dept Phys Educ & Sport Educ, Nevsehir Merkez Nevsehir, Turkey	German Sport University Cologne; Nevsehir Haci Bektas Veli University	Bock, O (corresponding author), German Sport Univ Cologne, Inst Physiol & Anat, Cologne, Germany.	bock@dshs-koeln.de	Akpinar, Selcuk/M-5579-2018	Bock, Otmar/0000-0003-0485-6765	Deutsche Forschungsgemeinschaft [BO 649/21-1]; German Research Foundation (DFG) [BO 649/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by Grant BO 649/21-1 by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by travel grant BO 649/21-1 from the German Research Foundation (DFG). We thank Thomas Kesnerus for programming the tablet version of the MET.	Abrams D., 2011, 735 DEP WORK PENS; Akozer M, 2011, AILE TOPLUM, V12, P103; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bock O, 2012, AGEING RES, V3, P48; Bock O, 2010, GAIT POSTURE, V32, P645, DOI 10.1016/j.gaitpost.2010.09.009; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cohen S., 1985, SOCIAL SUPPORT THEOR, P73, DOI [10.1007/978-94-009-5115-0_5, DOI 10.1007/978-94-009-5115-0_5]; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Farrimond S, 2006, APPL COGNITIVE PSYCH, V20, P533, DOI 10.1002/acp.1202; Garden SE, 2001, NEUROPSYCHOLOGY, V15, P472, DOI 10.1037//0894-4105.15.4.472; Hausdorff JM, 1999, J AM GERIATR SOC, V47, P1346, DOI 10.1111/j.1532-5415.1999.tb07437.x; Ilieva, 2013, PSYCHOLOGY, V04, P1014, DOI [10.4236/psych.2013.412147, DOI 10.4236/PSYCH.2013.412147]; Jerusalem M., 1992, SELF EFFICACY THOUGH, P195, DOI DOI 10.4324/9781315800820; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Kirchner C, 2015, PSYCHOLOGY, V6, P133, DOI DOI 10.4236/PSYCH.2015.62012; Levy B, 1996, J PERS SOC PSYCHOL, V71, P1092, DOI 10.1037/0022-3514.71.6.1092; Levy B., 2000, J GERIATR PSYCHIAT, V33, P81; Levy BR, 2009, PSYCHOL AGING, V24, P230, DOI 10.1037/a0014563; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Levy BR, 2000, J GERONTOL B-PSYCHOL, V55, pP205, DOI 10.1093/geronb/55.4.P205; Meisner BA, 2012, J GERONTOL B-PSYCHOL, V67, P13, DOI 10.1093/geronb/gbr062; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Phillips LH, 2006, INT J AGING HUM DEV, V62, P175, DOI 10.2190/EM1W-HAYC-TMLM-WW8X; Raspelli S, 2010, STUD HEALTH TECHNOL, V154, P115, DOI 10.3233/978-1-60750-561-7-115; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Shah A, 2007, MED SCI LAW, V47, P244, DOI 10.1258/rsmmsl.47.3.244; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Slobounov S, 1997, J APPL SPORT PSYCHOL, V9, P171, DOI 10.1080/10413209708406480; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; World Health Organization, 2002, COMMON LANGUAGE FUNC	35	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0160739	10.1371/journal.pone.0160739	http://dx.doi.org/10.1371/journal.pone.0160739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649296	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100002
J	Civardi, C; Van den Bulcke, J; Schubert, M; Michel, E; Butron, MI; Boone, MN; Dierick, M; Van Acker, J; Wick, P; Schwarze, FWMR				Civardi, Chiara; Van den Bulcke, Jan; Schubert, Mark; Michel, Elisabeth; Butron, Maria Isabel; Boone, Matthieu N.; Dierick, Manuel; Van Acker, Joris; Wick, Peter; Schwarze, Francis W. M. R.			Penetration and Effectiveness of Micronized Copper in Refractory Wood Species	PLOS ONE			English	Article							PHASE; IMAGE; FLOW	The North American wood decking market mostly relies on easily treatable Southern yellow pine (SYP), which is being impregnated with micronized copper (MC) wood preservatives since 2006. These formulations are composed of copper (Cu) carbonate particles (CuCO3 center dot Cu(OH)(2)), with sizes ranging from 1 nm to 250 mu m, according to manufacturers. MC-treated SYP wood is protected against decay by solubilized Cu2+ ions and unreacted CuCO3 center dot Cu(OH)(2) particles that successively release Cu2+ ions (reservoir effect). The wood species used for the European wood decking market differ from the North American SYP. One of the most common species is Norway spruce wood, which is poorly treatable i.e. refractory due to the anatomical properties, like pore size and structure, and chemical composition, like pit membrane components or presence of wood extractives. Therefore, MC formulations may not suitable for refractory wood species common in the European market, despite their good performance in SYP. We evaluated the penetration effectiveness of MC azole (MCA) in easily treatable Scots pine and in refractory Norway spruce wood. We assessed the effectiveness against the Cu-tolerant wood-destroying fungus Rhodonia placenta. Our findings show that MCA cannot easily penetrate refractory wood species and could not confirm the presence of a reservoir effect.	[Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Civardi, Chiara; Schubert, Mark; Butron, Maria Isabel; Schwarze, Francis W. M. R.] Empa, Appl Wood Mat, Dubendorf, Switzerland; Univ Ghent, Fac Biosci Engn, Dept Forest & Water Management, UGCT Woodlab UGent,Lab Wood Technol, Ghent, Belgium; Empa, Adv Fibers, St Gallen, Switzerland; [Boone, Matthieu N.; Dierick, Manuel] Univ Ghent, Dept Phys & Astron, UGCT Radiat Phys, Proeftuinstr 86-N12, B-9000 Ghent, Belgium; [Wick, Peter] Empa, Particles Biol Interact, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Ghent University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Ghent University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Civardi, C (corresponding author), ETH, Inst Bldg Mat, Zurich, Switzerland.; Civardi, C; Schwarze, FWMR (corresponding author), Empa, Appl Wood Mat, Dubendorf, Switzerland.	civardic@student.ethz.ch; francis.schwarze@empa.ch	Boone, Matthieu N/I-2664-2013; Van Acker, Joris/AAS-6030-2020; Schwarze, Francis/Y-2157-2018	Boone, Matthieu N/0000-0002-5478-4141; Van Acker, Joris/0000-0002-8961-0176; Schwarze, Francis/0000-0003-3306-8303; Schubert, Mark/0000-0002-6900-0370	Swiss National Research Foundation [406440_141618]; EC [284181]	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); EC(European CommissionEuropean Commission Joint Research Centre)	The work is financially supported by the Swiss National Research Foundation (http://www.nrp64.ch/en, Grant No. 406440_141618) and the Transnational Access to Research Infrastructures activity in the 7th Framework Program of the EC under the Trees4Future project (Trees4Future, http://www.trees4future.eu/, 284181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Daniel Heer for the technical assistance. The work is financially supported by the Swiss National Research Foundation (Grant No. 406440_141618) and the Transnational Access to Research Infrastructures activity in the 7th Framework Program of the EC under the Trees4Future project (Trees4Future, 284181).	[Anonymous], 1994, 3502 EN; [Anonymous], 2013, 335 EN; Arsenault RD, 1973, WOOD DETERIORATION I, V2, P121; Baines EF, 1981, BIODETERIORATION, V5, P26; Berger M., 1998, NIST STAND REF DATAB, V8, P3587; Boone MN, 2012, J OPT SOC AM A, V29, P2667, DOI 10.1364/JOSAA.29.002667; Boone MN, 2012, MICROSC MICROANAL, V18, P399, DOI 10.1017/S1431927611012529; Brabant L, 2011, MICROSC MICROANAL, V17, P252, DOI 10.1017/S1431927610094389; Civardi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142578; Courtois H., 1964, Holzforschung und Holzverwertung, V16, P21; Dierick M, 2010, J X-RAY SCI TECHNOL, V18, P451, DOI 10.3233/XST-2010-0268; Dierick M, 2014, NUCL INSTRUM METH B, V324, P35, DOI 10.1016/j.nimb.2013.10.051; European Committee for Standardization, 1997, 113 EN; Evans P, 2012, P IRG ANN M 2012 MAY; Evans P, 2013, P IRG ANN M 2013 JUN; FLYNN KA, 1995, WOOD FIBER SCI, V27, P278; Freeman M, 2013, P IRG ANN M 2013 JUN; Habicht J, 2008, NORD WOOD PRES M; HALE MD, 1986, T BRIT MYCOL SOC, V86, P585, DOI 10.1016/S0007-1536(86)80060-2; Hughes A., 2006, P FIN C 2004 MAR 22; LEACH RM, 2005, Patent No. 2005104841; LEACH RM, 2004, Patent No. 2004091875; Lee MJ, 2014, HOLZFORSCHUNG, V68, P477, DOI 10.1515/hf-2013-0088; Matsunaga H, 2007, P IRG ANN M 2007 MAY; Matsunaga H, 2010, P IRG ANN M 2010 MAY; Matsunaga H, 2009, J NANOPART RES, V11, P1087, DOI 10.1007/s11051-008-9512-y; McIntyre C, 2010, P IRG ANN M 2010 MAY; Morris PI, 1994, P IRG ANN M 1994 MAY; Olsson T, 2001, J WOOD SCI, V47, P282, DOI 10.1007/BF00766714; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; PERRIN PW, 1978, FOREST PROD J, V28, P27; Platten WE, 2014, EPA600R14365; Ray M, 2010, P IRG ANN M 2010 MAY; Ryan K. G., 1988, Journal of the Institute of Wood Science, V11, P108; SIMPSON WT, 1987, WOOD FIBER SCI, V19, P9; Southern Pine Council, 2002, SURV 2000 TREAT SO P; Stirling R, 2008, P IRG ANN M 2008 MAY; SUTTER HP, 1983, MATER ORGANISMEN, V18, P241; Usta Ilker, 2005, Maderas, Cienc. tecnol., V7, P121, DOI 10.4067/S0718-221X2005000200006; Usta I., 2004, P IRG ANN M 2004 JUN; Vidondo, 2014, 4 NATL FOREST INVENT; Vlassenbroeck J, 2007, NUCL INSTRUM METH A, V580, P442, DOI 10.1016/j.nima.2007.05.073; Xue W, 2014, P IRG ANN M 2014 MAY; Xue W, 2015, HOLZFORSCHUNG, V69, P509, DOI 10.1515/hf-2014-0128	44	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163124	10.1371/journal.pone.0163124	http://dx.doi.org/10.1371/journal.pone.0163124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649315	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100056
J	Sayah, MY; Chabir, R; Benyahia, H; Kandri, YR; Chahdi, FO; Touzani, H; Errachidi, F				Sayah, Mohamed Yassine; Chabir, Rachida; Benyahia, Hamid; Kandri, Youssef Rodi; Chahdi, Fouad Ouazzani; Touzani, Hanan; Errachidi, Faouzi			Yield, Esterification Degree and Molecular Weight Evaluation of Pectins Isolated from Orange and Grapefruit Peels under Different Conditions	PLOS ONE			English	Article							MODIFIED CITRUS PECTIN; RHEOLOGICAL PROPERTIES; EXTRACTION; VISCOSITY; ACID; FRUIT; MICROWAVE; GROWTH; SUGARS; CONFORMATION	Orange (Citrus sinensis) and grapefruit (Citrus paradise) peels were used as a source of pectin, which was extracted under different conditions. The peels are used under two states: fresh and residual (after essential oil extraction). Organic acid (citric acid) and mineral acid (sulfuric acid) were used in the pectin extraction. The aim of this study is the evaluation the effect of extraction conditions on pectin yield, degree of esterification "DE" and on molecular weight "Mw". Results showed that the pectin yield was higher using the residual peels. Moreover, both peels allow the obtainment of a high methoxyl pectin with DE >50%. The molecular weight was calculated using Mark-Houwink-Sakurada equation which describes its relationship with intrinsic viscosity. This later was determined using four equations; Huggins equation, kramer, Schulz-Blaschke and Martin equation. The molecular weight varied from 1.538x10(05) to 2.47x10(05) g/mol for grapefruit pectin and from 1.639x10(05) to 2.471x10(05) g/mol for orange pectin.	[Sayah, Mohamed Yassine; Kandri, Youssef Rodi; Chahdi, Fouad Ouazzani; Touzani, Hanan] Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Appl Organ Chem, Fes, Morocco; [Chabir, Rachida] Univ Sidi Mohamed Ben Abdellah, Fac Med & Pharm, Lab Pathophysiol & Nutr, Fes, Morocco; [Benyahia, Hamid] INRA, Lab Ameliorat & Biotechnol Agrumes, Kenitra, Morocco; [Errachidi, Faouzi] Univ Hassan II Ain Chock, Fac Sci, Lab Physiol & Mol Genet, Casablanca, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University of Casablanca	Sayah, MY (corresponding author), Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Appl Organ Chem, Fes, Morocco.	mohamedyassine.sayah@usmba.ac.ma						Bagherian H, 2011, CHEM ENG PROCESS, V50, P1237, DOI 10.1016/j.cep.2011.08.002; BATISSE C, 1994, J FOOD SCI, V59, P389, DOI 10.1111/j.1365-2621.1994.tb06974.x; Brain C, 1985, US patents, Patent No. [4,532,143, 4532143]; Brown L, 1999, AM J CLIN NUTR, V69, P30; Chamberlain EK, 2000, FOOD HYDROCOLLOID, V14, P163, DOI 10.1016/S0268-005X(99)00063-6; Chen CH, 2006, BIOCHEM PHARMACOL, V72, P1001, DOI 10.1016/j.bcp.2006.07.001; CHEN TS, 1967, J COLLOID INTERF SCI, V25, P346, DOI 10.1016/0021-9797(67)90040-9; CHOU TD, 1987, J FOOD SCI, V52, P1658, DOI 10.1111/j.1365-2621.1987.tb05900.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Eddy NO, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/254347; El Madani, 2014, INT J INNOV RES SCI, V03, P15658, DOI DOI 10.15680/IJIRSET.2014.0308078; Eliaz I, 2006, PHYTOTHER RES, V20, P859, DOI 10.1002/ptr.1953; Evageliou V, 2005, FOOD HYDROCOLLOID, V19, P1032, DOI 10.1016/j.foodhyd.2005.01.004; Fishman ML, 2003, BIOMACROMOLECULES, V4, P880, DOI 10.1021/bm020122e; Fishman ML, 2000, CARBOHYD RES, V323, P126; Guo XF, 2012, CARBOHYD POLYM, V88, P441, DOI 10.1016/j.carbpol.2011.12.026; HARDING SE, 1991, CARBOHYD POLYM, V16, P1, DOI 10.1016/0144-8617(91)90069-O; Higiro J, 2007, FOOD RES INT, V40, P435, DOI 10.1016/j.foodres.2006.02.002; HM Shekhar Pandharipande, 2012, ENG RES STUD; Hua X, 2015, FOOD HYDROCOLLOID, V44, P122, DOI 10.1016/j.foodhyd.2014.09.026; Hwang J, 1998, J FOOD SCI, V63, P10, DOI [10.1111/j.1365-2621.1998.tb17911.x, DOI 10.1111/J.1365-2621]; Iacomini M, 2005, FITOTERAPIA, V76, P676, DOI 10.1016/j.fitote.2005.08.017; Kanmani P., 2014, IRANICA J ENERGY ENV, V5, P303, DOI DOI 10.5829/IDOSI.IJEE.2014.05.03.10; Kar F, 1999, CARBOHYD POLYM, V40, P285, DOI 10.1016/S0144-8617(99)00063-6; Kar F, 1999, CARBOHYD POLYM, V40, P277, DOI 10.1016/S0144-8617(99)00062-4; KRATCHANOVA M, 1994, CARBOHYD POLYM, V25, P141, DOI 10.1016/0144-8617(94)90197-X; Kurita O, 2008, CARBOHYD POLYM, V74, P725, DOI 10.1016/j.carbpol.2008.04.033; Kuuva T, 2003, FOOD HYDROCOLLOID, V17, P679, DOI 10.1016/S0268-005X(03)00034-1; Lapasin R., 1995, RHEOLOGY IND POLYSAC, P134, DOI DOI 10.1007/978-1-4615-2185-3_2; Liu Y, 2002, J SCI FOOD AGR, V82, P469, DOI 10.1002/jsfa.1037; Liu Y, 2001, J AGR FOOD CHEM, V49, P3051, DOI 10.1021/jf001020n; Methacanon P, 2014, FOOD HYDROCOLLOID, V35, P383, DOI 10.1016/j.foodhyd.2013.06.018; Minjares-Fuentes R, 2014, CARBOHYD POLYM, V106, P179, DOI 10.1016/j.carbpol.2014.02.013; Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4; Morris GA, 2000, FOOD HYDROCOLLOID, V14, P227, DOI 10.1016/S0268-005X(00)00007-2; Morris GA, 2008, FOOD HYDROCOLLOID, V22, P1435, DOI 10.1016/j.foodhyd.2007.09.005; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2002, TRENDS MOL MED, V8, P187, DOI 10.1016/S1471-4914(02)02295-5; Niture S. K., 2013, American Journal of Pharmacology and Toxicology, V8, P9; PANCHEV I, 1988, INT J FOOD SCI TECH, V23, P337; PHATAK L, 1988, J FOOD SCI, V53, P830, DOI 10.1111/j.1365-2621.1988.tb08964.x; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Popov SV, 1999, INT J IMMUNOPHARMACO, V21, P617, DOI 10.1016/S0192-0561(99)00032-6; Ralet MC, 2001, CARBOHYD RES, V336, P117, DOI 10.1016/S0008-6215(01)00248-8; Rao DG, 1993, J FOOD SCI TECHNOLOG, P66; Rlcxiillan DE, 1974, COMP 5 METHODS OBTAI, V13, P1367; Ross-Murphy S.B., 1994, PHYS TECHNIQUES STUD, DOI [10.1007/978-1-4615-2101-3, DOI 10.1007/978-1-4615-2101-3]; SABIR MA, 1976, J AGR FOOD CHEM, V24, P348, DOI 10.1021/jf60204a049; Santos JDG, 2013, CARBOHYD POLYM, V92, P1997, DOI 10.1016/j.carbpol.2012.11.089; Sayah M. Y., 2014, International Journal of Innovation and Applied Studies, V7, P1642; SMIDSROD O, 1971, BIOPOLYMERS, V10, P1213, DOI 10.1002/bip.360100711; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Wai WW, 2010, FOOD BIOPROD PROCESS, V88, P209, DOI 10.1016/j.fbp.2010.01.010; Wanchoo RK, 2003, EUR POLYM J, V39, P1481, DOI 10.1016/S0014-3057(02)00386-5; Wang XS, 2005, CARBOHYD POLYM, V60, P95, DOI 10.1016/j.carbpol.2004.11.031; Yapo BM, 2009, J AGR FOOD CHEM, V57, P1572, DOI 10.1021/jf802969m; Yoo SH, 2006, FOOD HYDROCOLLOID, V20, P62, DOI 10.1016/j.foodhyd.2005.03.003; Zhou JH, 2008, J CENT SOUTH UNIV T, V15, P520, DOI 10.1007/s11771-008-0413-0	58	59	60	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0161751	10.1371/journal.pone.0161751	http://dx.doi.org/10.1371/journal.pone.0161751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644093	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900004
J	Daly, CS; Shaw, P; Ordonez, LD; Williams, GT; Quist, J; Grigoriadis, A; Van Es, JH; Clevers, H; Clarke, AR; Reed, KR				Daly, C. S.; Shaw, P.; Ordonez, L. D.; Williams, G. T.; Quist, J.; Grigoriadis, A.; Van Es, J. H.; Clevers, H.; Clarke, A. R.; Reed, K. R.			Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium	ONCOGENE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; PRIMARY BREAST CANCERS; BETA-CATENIN; TUMOR-SUPPRESSOR; E-CADHERIN; C-MYC; CYTOPLASMIC LOCALIZATION; MESENCHYMAL TRANSITION; GENE PROMOTER; FREQUENT LOSS	Aberrant Wnt signaling within breast cancer is associated with poor prognosis, but regulation of this pathway in breast tissue remains poorly understood and the consequences of immediate or long-term dysregulation remain elusive. The exact contribution of the Wnt-regulating proteins adenomatous polyposis coli (APC) and APC2 in the pathogenesis of human breast cancer are ill-defined, but our analysis of publically available array data sets indicates that tumors with concomitant low expression of both proteins occurs more frequently in the 'triple negative' phenotype, which is a subtype of breast cancer with particularly poor prognosis. We have used mouse transgenics to delete Apc and/or Apc2 from mouse mammary epithelium to elucidate the significance of these proteins in mammary homeostasis and delineate their influences on Wnt signaling and tumorigenesis. Loss of either protein alone failed to affect Wnt signaling levels or tissue homeostasis. Strikingly, concomitant loss led to local disruption of beta-catenin status, disruption in epithelial integrity, cohesion and polarity, increased cell division and a distinctive form of ductal hyperplasia with 'squamoid' ghost cell nodules in young animals. Upon aging, the development of Wnt activated mammary carcinomas with squamous differentiation was accompanied by a significantly reduced survival. This novel Wnt-driven mammary tumor model highlights the importance of functional redundancies existing between the Apc proteins both in normal homeostasis and in tumorigenesis.	[Daly, C. S.; Shaw, P.; Ordonez, L. D.; Clarke, A. R.; Reed, K. R.] Cardiff Univ, Sch Biosci, European Canc Stem Cell Res Inst, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales; [Williams, G. T.] Cardiff Univ, Sch Med, Div Canc & Genet, Cardiff, S Glam, Wales; [Quist, J.; Grigoriadis, A.] Kings Coll London, Guys Hosp London, Breast Canc Now Unit, London, England; [Quist, J.; Grigoriadis, A.] Kings Coll London, Guys Hosp London, Canc Bioinformat, London, England; [Van Es, J. H.; Clevers, H.] Netherlands Inst Dev Biol, Hubrecht Lab, Utrecht, Netherlands	Cardiff University; Cardiff University; University of London; King's College London; University of London; King's College London; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Reed, KR (corresponding author), Cardiff Univ, Sch Biosci, European Canc Stem Cell Res Inst, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.	ReedKR@Cardiff.ac.uk	van+Es, Johan/ABD-5411-2021; Reed, Karen/B-8813-2011	Reed, Karen/0000-0002-7467-1718; Grigoriadis, Anita/0000-0003-3434-201X	Biotechnology and Biomedical Sciences Research Council; Cancer Research UK [C1295/A15937]; Wales Gene Park; NIHR Biomedical Research Centre at Guy's and St Thomas; Breast Cancer NOW; Cancer Research UK [15937] Funding Source: researchfish	Biotechnology and Biomedical Sciences Research Council; Cancer Research UK(Cancer Research UK); Wales Gene Park; NIHR Biomedical Research Centre at Guy's and St Thomas; Breast Cancer NOW; Cancer Research UK(Cancer Research UK)	This project was funded by Biotechnology and Biomedical Sciences Research Council and Cancer Research UK (ARC Program grant C1295/A15937). GTW is supported by the Wales Gene Park. Jelmar Quist is funded by a PhD studentship from the NIHR Biomedical Research Centre at Guy's and St Thomas. Anita Grigoriadis is supported by Breast Cancer NOW (former Breakthrough Breast Cancer Research). We thank Luke Bradshaw, Oro Asby, Bridget Allen and Elaine Taylor for assistance with mouse husbandry. We would also like to thank Mark Bishop and Matthew Zverev for technical support and genotyping and Derek Scarborough and Marc Isaacs for their assistance in histology.	Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bray K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3487; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Gallagher RCJ, 2002, ONCOGENE, V21, P6446, DOI 10.1038/sj.onc.1205892; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hassanein AM, 2003, AM J CLIN PATHOL, V120, P732, DOI 10.1309/EALEG7LD6W7167PX; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Ho KYK, 1999, HISTOPATHOLOGY, V35, P249; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Irshad S, 2011, CURR OPIN ONCOL, V23, P566, DOI 10.1097/CCO.0b013e32834bf8ae; Jarrett CR, 2001, CANCER RES, V61, P7978; Jin Z, 2001, BRIT J CANCER, V85, P69, DOI 10.1054/bjoc.2001.1853; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; KASHIWABA M, 1994, J CANCER RES CLIN, V120, P727, DOI 10.1007/BF01194271; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lesko AC, 2014, CURR DRUG TARGETS, V15, P90, DOI 10.2174/1389450114666131108155418; Liao DJ, 2000, ENDOCR-RELAT CANCER, V7, P143, DOI 10.1677/erc.0.0070143; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Nelson S, 2013, J CELL SCI, V126, P873, DOI 10.1242/jcs.100479; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Roberts DM, 2012, MOL BIOL CELL, V23, P2041, DOI 10.1091/mbc.E11-11-0965; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Schlosshauer PW, 2000, MODERN PATHOL, V13, P1066, DOI 10.1038/modpathol.3880196; Schneikert J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068072; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Sobottka SB, 2000, J NEURO-ONCOL, V49, P187, DOI 10.1023/A:1006442024874; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tanaka A, 2007, J ORAL PATHOL MED, V36, P400, DOI 10.1111/j.1600-0714.2007.00550.x; THOMPSON AM, 1993, BRIT J CANCER, V68, P64, DOI 10.1038/bjc.1993.287; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; van der Meer M, 2001, TRANSGENIC RES, V10, P399, DOI 10.1023/A:1012244404020; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang ZJ, 1999, BRIT J CANCER, V80, P70, DOI 10.1038/sj.bjc.6690323; Watkins J, 2015, CANCER DISCOV, V5, P488, DOI 10.1158/2159-8290.CD-14-1092; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Yang TL, 2004, GENE CHROMOSOME CANC, V41, P250, DOI 10.1002/gcc.20080; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385	63	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1793	1803		10.1038/onc.2016.342	http://dx.doi.org/10.1038/onc.2016.342			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27694902	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000398128900005
J	Van Aelst, B; Devloo, R; Zachee, P; t'Kindt, R; Sandra, K; Vandekerckhove, P; Compernolle, V; Feys, HB				Van Aelst, Britt; Devloo, Rosalie; Zachee, Pierre; t'Kindt, Ruben; Sandra, Koen; Vandekerckhove, Philippe; Compernolle, Veerle; Feys, Hendrik B.			Psoralen and Ultraviolet A Light Treatment Directly Affects Phosphatidylinositol 3-Kinase Signal Transduction by Altering Plasma Membrane Packing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET ACTIVATION; LIPID PACKING; EXTRACORPOREAL PHOTOPHERESIS; PHOTOCHEMICAL INACTIVATION; IMMUNE SUPPRESSION; THROMBUS FORMATION; MASS-SPECTROMETRY; NUCLEIC-ACID; PUVA THERAPY; IN-VITRO	Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease. DNA damage is well described, but the direct effects of PUVA on cell signal transduction are poorly understood. Because platelets are anucleate and contain archetypal signal transduction machinery, they are ideally suited to address this. Lipidomics on platelet membrane extracts showed that psoralen forms adducts with unsaturated carbon bonds of fatty acyls in all major phospholipid classes after PUVA. Such adducts increased lipid packing as measured by a blue shift of an environment-sensitive fluorescent probe in model liposomes. Furthermore, the interaction of these liposomes with lipid order-sensitive proteins like amphipathic lipid-packing sensor and a-synuclein was inhibited by PUVA. In platelets, PUVA caused poor membrane binding of Akt and Bruton's tyrosine kinase effectors following activation of the collagen glycoprotein VI and thrombin protease-activated receptor (PAR) 1. This resulted in defective Akt phosphorylation despite unaltered phosphatidylinositol 3,4,5-trisphosphate levels. Downstream integrin activation was furthermore affected similarly by PUVA following PAR1 (effective half-maximal concentration (EC), 8.4 +/- 1.1 versus 4.3 +/- 1.1 mu M) and glycoprotein VI (EC50, 1.61 +/- 0.85 versus 0.26 +/- 0.21 mu g/ml) but not PAR4 (EC50, 50 +/- 1 versus 58 +/- 1 mu m) signal transduction. Our findings were confirmed in T-cells ftom graft-versus-host disease patients treated with extracorporeal photopheresis, a form of systemic PUVA. In conclusion, PUVA increases the order of lipid phases by covalent modification of phospholipids, thereby inhibiting membrane recruitment of effector kinases.	[Van Aelst, Britt; Devloo, Rosalie; Compernolle, Veerle; Feys, Hendrik B.] Belgian Red Cross Flanders, Transfus Res Ctr, Ottergemsesteenweg 413, B-9000 Ghent, Belgium; [Zachee, Pierre] Hosp Network Antwerp, Dept Hematol, B-2000 Antwerp, Belgium; [t'Kindt, Ruben; Sandra, Koen] Res Inst Chromatog, B-8500 Kortrijk, Belgium; [Vandekerckhove, Philippe; Compernolle, Veerle] Belgian Red Cross Flanders, Blood Serv, B-2800 Mechelen, Belgium; [Vandekerckhove, Philippe] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium; [Vandekerckhove, Philippe; Compernolle, Veerle] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	KU Leuven; Ghent University	Feys, HB (corresponding author), Belgian Red Cross Flanders, Transfus Res Ctr, Ottergemsesteenweg 413, B-9000 Ghent, Belgium.	hendrik.feys@rodekruis.be	Zachee, Pierre/B-5391-2018	Zachee, Pierre/0000-0002-2275-5143; Feys, Hendrik/0000-0003-0052-8852	Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service	Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service	This work was supported by the Foundation for Research and Development of the Belgian Red Cross-Flanders Blood Service. The authors declare that they have no conflicts of interest with the contents of this article.	Anthony FA, 1997, PHOTODERMATOL PHOTO, V13, P9, DOI 10.1111/j.1600-0781.1997.tb00101.x; Badolia R, 2015, BLOOD, V125, P175, DOI 10.1182/blood-2014-05-576306; Bernal-Perez LF, 2012, ANAL BIOCHEM, V428, P13, DOI 10.1016/j.ab.2012.05.026; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; BOHM F, 1986, ARCH DERMATOL RES, V279, P16, DOI 10.1007/BF00404352; Byrd JC, 2014, NEW ENGL J MED, V371, P213, DOI 10.1056/NEJMoa1400376; Caffieri S, 1996, ACTA BIOCHIM POL, V43, P241; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13; Chen X, 2013, BLOOD, V121, P3718, DOI 10.1182/blood-2012-10-461897; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Dardare N, 2002, PHOTOCHEM PHOTOBIOL, V75, P561, DOI 10.1562/0031-8655(2002)075<0561:BAOCES>2.0.CO;2; Darwich Z, 2012, BBA-BIOMEMBRANES, V1818, P3048, DOI 10.1016/j.bbamem.2012.07.017; Del Fante C, 2016, BONE MARROW TRANSPL, V51, P728, DOI 10.1038/bmt.2015.324; dos Santos DJVA, 2011, PHYS CHEM CHEM PHYS, V13, P10174, DOI 10.1039/c0cp02245d; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flesch FM, 2005, BIOCHEM J, V389, P435, DOI 10.1042/BJ20041721; Frank S, 1998, J PHOTOCH PHOTOBIO B, V44, P39, DOI 10.1016/S1011-1344(98)00103-1; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Greinix HT, 2012, EXTRACORPOREAL PHOTOPHERESIS: CELLULAR PHOTOIMMUNOTHERAPY, P1, DOI 10.1515/9783110276138; Hardwick J, 2008, ISBT SCI SER, V3, P148, DOI 10.1111/j.1751-2824.2008.00195.x; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Knutson F, 2000, VOX SANG, V78, P209, DOI 10.1159/000031183; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; LASKIN JD, 1985, P NATL ACAD SCI USA, V82, P6158, DOI 10.1073/pnas.82.18.6158; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li XY, 2005, PHOTOCHEM PHOTOBIOL, V81, P1153, DOI 10.1562/2005-03-21-RA-467; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; Ling TC, 2016, BRIT J DERMATOL, V174, P24, DOI 10.1111/bjd.14317; Locke D, 2002, J BIOL CHEM, V277, P18801, DOI 10.1074/jbc.M111520200; Lumb CN, 2011, STRUCTURE, V19, P1338, DOI 10.1016/j.str.2011.04.010; Mischnik M, 2013, MOL BIOSYST, V9, P1326, DOI 10.1039/c3mb25597b; Pathak MA, 1992, AD J PHOTOCHEM PHO B, V14, P3, DOI DOI 10.1016/1011-1344(92)85080-E; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Riehle RD, 2013, ADV EXP MED BIOL, V991, P105, DOI 10.1007/978-94-007-6331-9_7; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Sanford KW, 2012, J CLIN APHERESIS, V27, P126, DOI 10.1002/jca.21217; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; t'kindt R, 2015, ANAL CHEM, V87, P4957, DOI 10.1021/acs.analchem.5b00732; Van Aelst B, 2015, VOX SANG, V108, P328, DOI 10.1111/vox.12231; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANHENEGOUWEN GMJB, 1989, J PHOTOCH PHOTOBIO B, V3, P631, DOI 10.1016/1011-1344(89)80086-7; vanIperen HP, 1996, PHOTOCHEM PHOTOBIOL, V63, P577, DOI 10.1111/j.1751-1097.1996.tb05659.x; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; WAKSVIK H, 1977, HUM GENET, V38, P195, DOI 10.1007/BF00527403; Wolf P, 2016, BRIT J DERMATOL, V174, P11, DOI 10.1111/bjd.14341; Wolf P, 2006, AM J PATHOL, V169, P795, DOI 10.2353/ajpath.2006.060079; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; ZAREBSKA Z, 1994, J PHOTOCH PHOTOBIO B, V23, P101, DOI 10.1016/1011-1344(94)06944-1	57	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24364	24376		10.1074/jbc.M116.735126	http://dx.doi.org/10.1074/jbc.M116.735126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27687726	Green Published, hybrid			2022-12-26	WOS:000388875500004
J	Ackermann, KL; Florke, RR; Reyes, SS; Tader, BR; Hamann, MJ				Ackermann, Karly L.; Florke, Rebecca R.; Reyes, Shannon S.; Tader, Brooke R.; Hamann, Michael J.			TCL/RhoJ Plasma Membrane Localization and Nucleotide Exchange Is Coordinately Regulated by Amino Acids within the N Terminus and a Distal Loop Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; CDC42; cell biology; GTPase; membrane trafficking; Rho (Rho GTPase); small GTPase; vesicles; RhoJ; TCL	RHO-FAMILY GTPASES; MULTIPLE SEQUENCE ALIGNMENT; CELL-MIGRATION; RAS ISOFORMS; H-RAS; CDC42; PROTEINS; PALMITOYLATION; ACTIVATION; ANGIOGENESIS	TCL/RhoJ is a Cdc42-related Rho GTPase with reported activities in endothelial cell biology and angiogenesis, metastatic melanoma, and corneal epithelial cells; however, less is known about how it is inherently regulated in comparison to its closest homologues TC10 and Cdc42. TCL has an N-terminal extension of 18 amino acids in comparison to Cdc42, but the function of this amino acid sequence has not been elucidated. A truncation mutant lacking the N terminus (N) was found to alter TCL plasma membrane localization and nucleotide binding, and additional truncation and point mutants mapped the alterations of TCL biochemistry to amino acids 17-20. Interestingly, whereas the TCL N mutant clearly influenced nucleotide exchange, deletion of the N terminus from its closest homologue, TC10, did not have a similar effect. Chimeras of TCL and TC10 revealed amino acids 121-129 of TCL contributed to the differences in nucleotide loading. Together, these results identify amino acids within the N terminus and a loop region distal to the nucleotide binding pocket of TCL capable of allosterically regulating nucleotide exchange and thus influence membrane association of the protein.	[Ackermann, Karly L.; Florke, Rebecca R.; Reyes, Shannon S.; Tader, Brooke R.; Hamann, Michael J.] Bemidji State Univ, Dept Biol, Bemidji, MN 56601 USA	Minnesota State Colleges & Universities; Bemidji State University	Hamann, MJ (corresponding author), Bemidji State Univ, 1500 Birchmont Dr NE 27, Bemidji, MN 56601 USA.	mhamann@bemidjistate.edu		Gee, Rebecca/0000-0002-4736-3154	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health [1P30GM103329]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Dan Billadeau (Mayo Clinic, Rochester, MN) for providing the pCI2.F.YFP and pGEX constructs, as well as constitutively active and dominant-negative TCL mutants, Dr. Bryon Grove and Sarah Abrahamson (UND, Grand Forks, ND) for their assistance with the confocal microscopy, and Dr. Holly LaFerriere for editorial comments. We also acknowledge use of the Edward C. Carlson Imaging and Image Analysis Core Facility, which is supported in part by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences, National Institutes of Health Grant 1P30GM103329.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Anderson EL, 2012, BIOCHEM J, V441, P869, DOI 10.1042/BJ20111111; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Benard V, 2002, METHOD ENZYMOL, V345, P349; Braun AC, 2015, CELL SIGNAL, V27, P1643, DOI 10.1016/j.cellsig.2015.04.003; Bridges D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042451; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Ho H, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12058; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; Hou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077107; Hou JCQ, 2003, MOL BIOL CELL, V14, P3578, DOI 10.1091/mbc.E03-02-0012; Jack ER, 2008, MOL MEMBR BIOL, V25, P14, DOI 10.1080/09687680701494007; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim C, 2014, CANCER CELL, V25, P102, DOI 10.1016/j.ccr.2013.12.010; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kusuhara S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045858; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Leszczynska K, 2011, BIOCHEM SOC T, V39, P1606, DOI 10.1042/BST20110702; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marcus K, 2015, CLIN CANCER RES, V21, P1810, DOI 10.1158/1078-0432.CCR-14-2148; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Shutes A, 2006, METHOD ENZYMOL, V406, P11, DOI 10.1016/S0076-6879(06)06002-2; Shutes A, 2004, CURR BIOL, V14, P2052, DOI 10.1016/j.cub.2004.11.011; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969	47	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23604	23617		10.1074/jbc.M116.750026	http://dx.doi.org/10.1074/jbc.M116.750026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27660391	Green Published, hybrid			2022-12-26	WOS:000387884400021
J	Choi, HG; Choi, S; Back, YW; Park, HS; Bae, HS; Choi, CH; Kim, HJ				Choi, Han-Gyu; Choi, Seunga; Back, Yong Woo; Park, Hye-Soo; Bae, Hyun Shik; Choi, Chul Hee; Kim, Hwa-Jung			Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINES; INTERFERON-GAMMA; INFECTION; LIPOPROTEIN; MICE; MATURATION	Macrophages constitute the first line of defense against Mycobacterium tuberculosis and are critical in linking innate and adaptive immunity. Therefore, the identification and characterization of mycobacterial proteins that modulate macrophage function are essential for understanding tuberculosis pathogenesis. In this study, we identified the novel macrophage- activating protein, Rv2882c, from M. tuberculosis culture filtrate proteins. Recombinant Rv2882c protein activated macrophages to secrete pro-inflammatory cytokines and express co-stimulatory and major histocompatibility complex molecules via Toll-like receptor 4, myeloid differentiation primary response protein 88, and Toll/IL-1 receptor-domaincontaining adaptor inducing IFN-beta. Mitogen-activated protein kinases and NF-kappa B signaling pathways were involved in Rv2882c-induced macrophage activation. Further, Rv2882c-treated macrophages induced expansion of the effector/memory T cell population and Th1 immune responses. In addition, boosting Bacillus Calmette-Guerin vaccination with Rv2882c improved protective efficacy against M. tuberculosis in our model system. These results suggest that Rv2882c is an antigen that could be used for tuberculosis vaccine development.	[Choi, Han-Gyu; Choi, Seunga; Back, Yong Woo; Park, Hye-Soo; Bae, Hyun Shik; Choi, Chul Hee; Kim, Hwa-Jung] Chungnam Natl Univ, Coll Med, Dept Microbiol & Med Sci, Daejeon 301747, South Korea	Chungnam National University	Kim, HJ (corresponding author), Chungnam Natl Univ, Coll Med, Dept Microbiol & Med Sci, Daejeon 301747, South Korea.	hjukim@cnu.ac.kr		Kim, Hwa-Jung/0000-0002-1127-0909; Choi, Chul Hee/0000-0003-2373-048X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A1A03069903]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A1A03069903).	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Byun EH, 2012, J MOL MED, V90, P285, DOI 10.1007/s00109-011-0819-2; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chen ST, 2012, J IMMUNOL, V188, P668, DOI 10.4049/jimmunol.1102177; Choi HG, 2015, EUR J IMMUNOL, V45, P1957, DOI 10.1002/eji.201445329; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Deng WY, 2014, CELL PHYSIOL BIOCHEM, V33, P273, DOI 10.1159/000356668; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CMC, 2003, MICROBES INFECT, V5, P1070, DOI 10.1016/j.micinf.2003.06.001; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kim KH, 2011, IMMUNE NETW, V11, P123, DOI DOI 10.4110/IN.2011.11.2.123; Kim K, 2012, IMMUNOLOGY, V136, P231, DOI 10.1111/j.1365-2567.2012.03575.x; Lata M, 2015, J PROTEOMICS, V127, P114, DOI 10.1016/j.jprot.2015.07.031; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Lim JH, 2004, FEMS MICROBIOL LETT, V232, P51, DOI 10.1016/S0378-1097(04)00018-7; Maggioli MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122571; Majumder N, 2008, SCAND J IMMUNOL, V67, P329, DOI 10.1111/j.1365-3083.2008.02070.x; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shin AR, 2008, CLIN VACCINE IMMUNOL, V15, P1788, DOI 10.1128/CVI.00231-08; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vashishtha VM, 2009, INDIAN PEDIATR, V46, P401; Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10; Weir RE, 2004, INFECT IMMUN, V72, P1807, DOI 10.1128/IAI.72.3.1807-1811.2004; Xu Y, 2015, J MOL MED, V93, P645, DOI 10.1007/s00109-014-1243-1; Zygmunt BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018032	56	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164458	10.1371/journal.pone.0164458	http://dx.doi.org/10.1371/journal.pone.0164458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711141	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600128
J	Neufeld, C; Kramer, SE; Lapinskaya, N; Heffner, CC; Malko, A; Lau, EF				Neufeld, Chris; Kramer, Stephanie E.; Lapinskaya, Natalia; Heffner, Christopher C.; Malko, Anton; Lau, Ellen F.			The Electrophysiology of Basic Phrase Building	PLOS ONE			English	Article							ANTERIOR TEMPORAL-LOBE; SUPERIOR PARIETAL CORTEX; TIME-COURSE; LANGUAGE PRODUCTION; BRAIN POTENTIALS; CORTICAL REPRESENTATION; SEMANTIC CONTEXT; WORD; COMPREHENSION; N400	A defining trait of linguistic competence is the ability to combine elements into increasingly complex structures to denote, and to comprehend, a potentially infinite number of meanings. Recent magnetoencephalography (MEG) work has investigated these processes by comparing the response to nouns in combinatorial (blue car) and non-combinatorial (rnsh car) contexts. In the current study we extended this paradigm using electroencephalography (EEG) to dissociate the role of semantic content from phonological well-formedness (yerl car). We used event-related potential (ERP) recordings in order to better relate the observed neurophysiological correlates of basic combinatorial operations to prior ERP work on comprehension. We found that nouns in combinatorial contexts (blue car) elicited a greater centro-parietal negativity between 180-400ms, independent of the phonological well-formedness of the context word. We discuss the potential relationship between this 'combinatorial' effect and classic N400 effects. We also report preliminary evidence for an early anterior negative deflection immediately preceding the critical noun in combinatorial contexts, which we tentatively interpret as an electrophysiological reflex of syntactic structure initialization.	[Neufeld, Chris; Lapinskaya, Natalia; Heffner, Christopher C.; Malko, Anton; Lau, Ellen F.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Kramer, Stephanie E.] Georgetown Univ, Dept Linguist, Washington, DC USA; [Heffner, Christopher C.; Lau, Ellen F.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Heffner, Christopher C.] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Georgetown University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Neufeld, C (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	neufeldc@umd.edu			Natural Sciences and Engineering Research Council of Canada [D3-443975-2013]; National Science Foundation, NSF Graduate Research Fellowship; Bagget Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation, NSF Graduate Research Fellowship(National Science Foundation (NSF)); Bagget Fellowship	This work was supported by Natural Sciences and Engineering Research Council of Canada, PGS D3-443975-2013, http:/www.nserc-crsng.gc.ca/index_eng.asp, CN; National Science Foundation, NSF Graduate Research Fellowship (no grant number), hyttps:/www.nsfgrfp.org/, CCH; and Bagget Fellowship (no grant number), http://ling.umd.edu/baggett/#fellowship, NL. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Baggio G, 2010, J COGNITIVE NEUROSCI, V22, P2131, DOI 10.1162/jocn.2009.21303; Bai C, 2008, NEUROREPORT, V19, P695, DOI 10.1097/WNR.0b013e3282fc1eb7; BARSALOU LW, 1982, MEM COGNITION, V10, P82, DOI 10.3758/BF03197629; Bartke S, 2005, J NEUROLINGUIST, V18, P29, DOI 10.1016/j.jneuroling.2004.10.001; Bemis DK, 2013, CEREB CORTEX, V23, P1859, DOI 10.1093/cercor/bhs170; Bemis DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073949; Bemis Douglas K, 2012, Front Psychol, V3, P583, DOI 10.3389/fpsyg.2012.00583; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Blanco-Elorrieta E, 2016, NEUROIMAGE, V124, P194, DOI 10.1016/j.neuroimage.2015.08.049; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Coch D, 2010, BRAIN RES, V1329, P159, DOI 10.1016/j.brainres.2010.02.084; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Davies M., 2008, CORPUS CONT AM ENGLI; Dikker S, 2013, BRAIN LANG, V127, P55, DOI 10.1016/j.bandl.2012.08.004; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Graves WW, 2010, NEUROIMAGE, V53, P638, DOI 10.1016/j.neuroimage.2010.06.055; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hale J, 2003, J PSYCHOLINGUIST RES, V32, P101, DOI 10.1023/A:1022492123056; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Janssen U, 2006, J NEUROLINGUIST, V19, P466, DOI 10.1016/j.jneuroling.2006.04.002; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kuperberg GR, 2010, J COGNITIVE NEUROSCI, V22, P2685, DOI 10.1162/jocn.2009.21333; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, DIRECT COMP N4 UNPUB; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Lau EF, 2016, CEREB CORTEX, V26, P1377, DOI 10.1093/cercor/bhu219; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; NOBRE AC, 1995, J NEUROSCI, V15, P1090; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Price AR, 2015, J NEUROSCI, V35, P3276, DOI 10.1523/JNEUROSCI.3446-14.2015; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Pylkkanen L, 2014, COGNITION, V133, P371, DOI 10.1016/j.cognition.2014.07.001; Pylkkanen L, 2009, LANG COGNITIVE PROC, V24, P1313, DOI 10.1080/01690960903120176; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Steinhauer K, 2001, J PSYCHOLINGUIST RES, V30, P267, DOI 10.1023/A:1010443001646; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Tse CY, 2007, P NATL ACAD SCI USA, V104, P17157, DOI 10.1073/pnas.0707901104; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Westerlund M, 2014, NEUROPSYCHOLOGIA, V57, P59, DOI 10.1016/j.neuropsychologia.2014.03.001; Wilson SM, 2014, J COGNITIVE NEUROSCI, V26, P970, DOI 10.1162/jocn_a_00550; Yoshida M, 2013, LANG COGNITIVE PROC, V28, P272, DOI 10.1080/01690965.2011.622905; Zhang LM, 2015, NEUROIMAGE, V111, P228, DOI 10.1016/j.neuroimage.2015.02.028; Ziegler JC, 1997, J COGNITIVE NEUROSCI, V9, P758, DOI 10.1162/jocn.1997.9.6.758	68	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0158446	10.1371/journal.pone.0158446	http://dx.doi.org/10.1371/journal.pone.0158446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711111	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600001
J	Bandeira, KLN; Simbras, FM; Machado, EB; Campos, DD; Oliveira, GR; Kellner, AWA				Bandeira, Kamila L. N.; Simbras, Felipe Medeiros; Machado, Elaine Batista; Campos, Diogenes de Almeida; Oliveira, Gustavo R.; Kellner, Alexander W. A.			A New Giant Titanosauria (Dinosauria: Sauropoda) from the Late Cretaceous Bauru Group, Brazil	PLOS ONE			English	Article							VERTEBRAL PNEUMATICITY; SP-NOV.; PATAGONIA; NEUQUEN; GEN.; NOMENCLATURE; EVOLUTION; SPECIMEN; BASIN	Titanosaurian dinosaurs include some of the largest land-living animals that ever existed, and most were discovered in Cretaceous deposits of Argentina. Here we describe the first Brazilian gigantic titanosaur, Austroposeidon magnificus gen. et sp. nov., from the Late Cretaceous Presidente Prudente Formation (Bauru Group, Parana A Basin), Sao Paulo State, southeast Brazil. The size of this animal is estimated around 25 meters. It consists of a partial vertebral column composed by the last two cervical and the first dorsal vertebrae, all fairly complete and incomplete portions of at least one sacral and seven dorsal elements. The new species displays four autapomorphies: robust and tall centropostzygapophyseal laminae (cpol) in the last cervical vertebrae; last cervical vertebra bearing the posterior centrodiapophyseal lamina (pcdl) bifurcated; first dorsal vertebra with the anterior and posterior centrodiapophyseal laminae (acdl/pcdl) curved ventrolaterally, and the diapophysis reaching the dorsal margin of the centrum; posterior dorsal vertebra bearing forked spinoprezygapophyseal laminae (sprl). The phylogenetic analysis presented here reveals that Austroposeidon magnificus is the sister group of the Lognkosauria. CT scans reveal some new osteological internal features in the cervical vertebrae such as the intercalation of dense growth rings with camellae, reported for the first time in sauropods. The new taxon further shows that giant titanosaurs were also present in Brazil during the Late Cretaceous and provides new information about the evolution and internal osteological structures in the vertebrae of the Titanosauria clade.	[Bandeira, Kamila L. N.; Machado, Elaine Batista; Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Sistemat & Tafon Vertebrados Fosseis, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil; [Simbras, Felipe Medeiros] Petr Brasileiro SA PETROBRAS, Ave Republ Chile 330,17 Andar, Rio De Janeiro, RJ, Brazil; [Machado, Elaine Batista] Univ Estacio Sa, Rua Andre Rocha 838, BR-22710560 Rio De Janeiro, RJ, Brazil; [Campos, Diogenes de Almeida] CPRM, Museu Ciencias Terra, Av Pasteur 404, BR-22290240 Rio De Janeiro, RJ, Brazil; [Oliveira, Gustavo R.] Univ Fed Rural Pernambuco, Dept Biol, Rua Dom Manuel de Medeiros S-N, BR-52171900 Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Petrobras; Universidade Estacio de Sa; Universidade Federal Rural de Pernambuco (UFRPE)	Bandeira, KLN; Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Sistemat & Tafon Vertebrados Fosseis, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil.	kamilabandeira@yahoo.com.br; kellner@mn.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020; Oliveira, Gustavo R/F-7432-2012	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447; Oliveira, Gustavo R/0000-0002-9871-1235; L.N. Bandeira, Kamila/0000-0002-2744-8126	Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/102.327/2010]; Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/ 202.893/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304780/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for this project was provided by the Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (E-26/102.327/2010 and FAPERJ #E-26/ 202.893/2015 to AWAK) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #304780/2013-8 to AWAK). KLNB also is grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarship of her master degree studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Bittencourt JS, 2011, AN ACAD BRAS CIENC, V83, P23, DOI 10.1590/S0001-37652011000100003; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; CALVO J O, 1991, Ameghiniana, V28, P303; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo JO, 2007, AN ACAD BRAS CIENC, V79, P529, DOI 10.1590/S0001-37652007000300013; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Campos DA, 1978, CARTA GEOLOGICA BRAS, P46; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Coria RA, 2013, ZOOTAXA, V3683, P357, DOI 10.11646/zootaxa.3683.4.2; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; de Azevedo RPF, 2013, CRETACEOUS RES, V40, P131, DOI 10.1016/j.cretres.2012.06.004; Fernandes LA, 2007, SEDIMENT GEOL, V199, P51, DOI 10.1016/j.sedgeo.2005.12.030; Filippi LS, 2011, GEOL ACTA, V9, P1, DOI 10.1344/105.000001648; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Fowler DW, 2011, ACTA PALAEONTOL POL, V56, P685, DOI 10.4202/app.2010.0105; Gallina PA, 2011, AN ACAD BRAS CIENC, V83, P235, DOI 10.1590/S0001-37652011005000001; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Gilmore C. W., 1922, Smithsonian Miscellaneous Collections, V72, P1; Goloboff P.A., 2008, TNT TREE ANAL USING; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; GONZALEZ RIGA B, 2005, AMEGHINIANA, V42, P535; Riga BJG, 2014, AMEGHINIANA, V51, P3, DOI 10.5710/AMEGH.26.12.1013.1889; Gorscak E, 2014, J VERTEBR PALEONTOL, V34, P1133, DOI 10.1080/02724634.2014.845568; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Huene F. V., 1933, PALEONT INDICA, V21, P1; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; Kellner AWA, 2007, B MUSEU NAC, V74, P1; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lautenschlager S, 2014, PALAEONTOL Z, V88, P111, DOI 10.1007/s12542-013-0184-2; Le Loeuff J., 1993, REV PALENBIOLOGIE, P107; Lehman TM, 2002, J PALEONTOL, V76, P156, DOI 10.1666/0022-3360(2002)076<0156:AJSOTS>2.0.CO;2; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Li LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085979; Lu JC, 2008, ACTA GEOL SIN-ENGL, V82, P225; Lydekker R., 1893, ANALES MUSEO LA PLAT, V2, P1; Machado EB, 2013, ZOOTAXA, V3701, P301, DOI 10.11646/zootaxa.3701.3.1; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; McIntosh J.S., 1990, P345; Nava WR, 2011, AN ACAD BRAS CIENC, V83, P291, DOI 10.1590/S0001-37652011000100017; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P37; OLIVEIRA GR, 2007, ARQ MUS NAC RIO J, V65, P113; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Powell J. E., 2003, RECORDS QUEEN VICTOR, V111; Powell J.E., 1990, ACT 5 C ARG PAL BIOE, V1, P123, DOI DOI 10.1016/J.GEOBIOS.2005.06.001; Powell JE, 1987, C BRAS PAL RIO DE JA, V10, P155; Remes K, 2007, PALAEONTOLOGY, V50, P653, DOI 10.1111/j.1475-4983.2007.00652.x; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Sales MAF, 2014, AN ACAD BRAS CIENC, V86, P127, DOI 10.1590/0001-37652013100412; Salgado L, 2005, J VERTEBR PALEONTOL, V25, P623, DOI 10.1671/0272-4634(2005)025[0623:ANSONA]2.0.CO;2; Salgado L, 2008, PALAEONTOLOGY, V51, P881, DOI 10.1111/j.1475-4983.2008.00781.x; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Santucci RM, 2011, ZOOTAXA, P1; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Upchurch P, 2005, NAT SCI MUS MONO, V26, P1; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; WEDEL MJ, 2004, P 19 INT C ZOOL BEIJ, P443; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA., 2012, CONTRIB MUS PALEONTO, V32, P91; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; You HL, 2009, P ROY SOC B-BIOL SCI, V276, P4077, DOI 10.1098/rspb.2009.1278; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	76	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163373	10.1371/journal.pone.0163373	http://dx.doi.org/10.1371/journal.pone.0163373			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706250	gold, Green Published			2022-12-26	WOS:000385697200042
J	Chang, YT; Huang, MY; Yeh, YS; Huang, CW; Tsai, HL; Cheng, TL; Wang, JY				Chang, Yu -Tang; Huang, Ming-Yii; Yeh, Yung-Sung; Huang, Ching-Wen; Tsai, Hsiang-Lin; Cheng, Tian-Lu; Wang, Jaw-Yuan			A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; MULTIPLE MOLECULAR MARKERS; MEMBRANE-ARRAY METHOD; PERIPHERAL-BLOOD; COLON-CANCER; CURATIVE RESECTION; MESSENGER-RNA; CARCINOMA; ONCOGENE; DISEASE	Background Circulating biomarkers can predict clinical outcomes in colorectal cancer patients. The aim of the study was to evaluate the feasibility of our multigene biomarker chip for detecting circulating tumor cells for postoperative surveillance of stage I-III colorectal cancer patients. Materials and Methods In total, 298 stage I-III colorectal cancer patients were analyzed after curative resection between June 2010 and October 2014. During each follow-up, a postoperative surveillance strategy, including ESMO Guidelines Working Group recommendations and the biochip, was used. Results After a 28.4-month median follow-up, 48 (16.1%) patients had postoperative relapse. Univariate analysis revealed that the postoperative relapse risk factors were rectal tumor, perineural invasion, elevated preoperative and postoperative serum carcinoembryonic antigen levels, and positive biochip results (all P < 0.05). Multivariate analyses revealed that postoperative relapse correlated significantly with elevated postoperative serum carcinoembryonic antigen levels (odds ratio = 4.136, P = 0.008) and positive biochip results (odds ratio = 66.878, P < 0.001). However, the sensitivity (P = 0.003), specificity (P = 0.003), positive (P = 0.002) and negative (P = 0.006) predictive values, and accuracy (P < 0.001) of the biochip for predicting postoperative relapse were significantly higher than those of elevated postoperative serum carcinoembryonic antigen levels. Moreover, the median lead time between positive biochip result and postoperative relapse detection was significantly earlier than that between elevated postoperative serum carcinoembryonic antigen level and postoperative relapse detection (10.7 vs. 2.8 months, P < 0.001). Furthermore, positive biochip results correlated strongly with lower disease-free survival and overall survival of colorectal cancer patients (both P < 0.001). Conclusion Compared with conventional serum carcinoembryonic antigen detection, our multigene chip aided more accurate and earlier prediction of postoperative relapse during stage I-III colorectal cancer patient surveillance. In clinical practice, this biochip may facilitate early postoperative relapse diagnosis in colorectal cancer patients.	[Chang, Yu -Tang; Yeh, Yung-Sung; Huang, Ching-Wen; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gastroenterol & Gen Surg, Kaohsiung, Taiwan; [Chang, Yu -Tang; Yeh, Yung-Sung; Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Chang, Yu -Tang; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chang, Yu -Tang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pediat Surg, Dept Surg, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Ctr Canc, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ, Dept Radiat Oncol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Huang, Ming-Yii; Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Huang, Ching-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Trauma & Crit Care, Dept Surg, Kaohsiung, Taiwan; [Yeh, Yung-Sung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ Hosp, Div Gen Surg Med, Dept Surg, Kaohsiung, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gastroenterol & Gen Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022; Huang, Ming-Yii/AAS-8132-2021	Jaw-Yuan, Wang/0000-0002-7705-2621; Cheng, Tian-Lu/0000-0002-7263-2766				Chen YF, 2005, CANCER LETT, V229, P115, DOI 10.1016/j.canlet.2004.12.026; De Salvo L, 1997, EUR J SURG ONCOL, V23, P522, DOI 10.1016/S0748-7983(97)93045-6; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Edge SB, 2010, AJCC CANC STAGING MA; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Graham RA, 1998, ANN SURG, V228, P59, DOI 10.1097/00000658-199807000-00009; HINE KR, 1984, BRIT J CANCER, V49, P689, DOI 10.1038/bjc.1984.109; Hsiung SK, 2009, FOOYIN J HLTH SCI, V1, P72, DOI DOI 10.1016/S1877-8607(10); Hsiung SK, 2011, BIOMEDICAL ENGINEERING, TRENDS, RESEARCH AND TECHNOLOGIES, P151; Huang MY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-147; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; Lu CY, 2013, BRIT J CANCER, V108, P791, DOI 10.1038/bjc.2012.595; MARTIN EW, 1980, J SURG RES, V28, P389, DOI 10.1016/0022-4804(80)90100-6; MCCALL JL, 1994, DIS COLON RECTUM, V37, P875, DOI 10.1007/BF02052591; MINTON JP, 1985, CANCER, V55, P1284, DOI 10.1002/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO;2-B; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; ROCKLIN MS, 1991, DIS COLON RECTUM, V34, P794, DOI 10.1007/BF02051073; Scheer Adena, 2009, Clin Colon Rectal Surg, V22, P242, DOI 10.1055/s-0029-1242464; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; SLENTZ K, 1994, AM SURGEON, V60, P528; Tsao DA, 2010, LUNG CANCER, V68, P51, DOI 10.1016/j.lungcan.2009.05.023; Uen YH, 2007, ANN SURG, V246, P1040, DOI 10.1097/SLA.0b013e318142d918; WANEBO HJ, 1989, SURG GYNECOL OBSTET, V169, P479; Wang JY, 2007, CLIN CANCER RES, V13, P2406, DOI 10.1158/1078-0432.CCR-06-2054; Wang JY, 2006, WORLD J SURG, V30, P1007, DOI 10.1007/s00268-005-0485-z; Wang JY, 2006, INT J MOL MED, V17, P737; Wang JY, 2005, ONCOL REP, V14, P65; Weitz J, 1998, CLIN CANCER RES, V4, P343; Wharton RQ, 1999, CLIN CANCER RES, V5, P4158; Wiratkapun S, 2001, DIS COLON RECTUM, V44, P231, DOI 10.1007/BF02234298; Wong IHN, 2001, CANCER LETT, V162, P65, DOI 10.1016/S0304-3835(00)00630-3; Yang MJ, 2010, ANN SURG ONCOL, V17, P624, DOI 10.1245/s10434-009-0831-8; Yeh CS, 2006, INT J ONCOL, V28, P411	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163264	10.1371/journal.pone.0163264	http://dx.doi.org/10.1371/journal.pone.0163264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701415	Green Submitted, gold, Green Published			2022-12-26	WOS:000385696900005
J	Sanaie, A; Mergenthaler, C; Nasrat, A; Seddiq, MK; Mahmoodi, SD; Stevens, RH; Creswell, J				Sanaie, A.; Mergenthaler, C.; Nasrat, A.; Seddiq, M. K.; Mahmoodi, S. D.; Stevens, R. H.; Creswell, J.			An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CASE-FINDING STRATEGIES; PULMONARY TUBERCULOSIS; RANDOMIZED TRIAL; HEALTH-CARE; IMPACT; METAANALYSIS; DIAGNOSIS; BURDEN; INTERVENTIONS	Background In Afghanistan, improving TB case detection remains challenging. In 2014, only half of the estimated incident TB cases were notified, and notifications have decreased since peaking in 2007. Active case finding has been increasingly considered to improve TB case notifications. While access to health services has improved in Afghanistan, it remains poor and many people seeking health services won't receive proper care. Methods From October 2011 through December 2012 we conducted three separate case finding strategies in six provinces of Afghanistan and measured impact on TB case notification. Systematically screening cough among attendees at 47 health facilities, active household contact investigation of smear-positive index TB patients, and active screening at 15 camps for internally displaced people were conducted. We collected both intervention yield and official quarterly notification data. Additional TB notifications were calculated by comparing numbers of cases notified during the intervention with those notified before the intervention, then adjusting for secular trends in notification. Results We screened 2,022,127 people for TB symptoms during the intervention, tested 59,838 with smear microscopy and detected 5,046 people with smear-positive TB. Most cases (81.7%, 4,125) were identified in health facilities while nearly 20% were found through active case finding. A 56% increase in smear-positive TB notifications was observed between the baseline and intervention periods among the 47 health facilities, where cases detected by all three strategies were notified. Discussion While most people with TB are likely to be identified through health facility screening, there are many people who remain without a proper diagnosis if outreach is not attempted. This is especially true in places like Afghanistan where access to general services is poor. Targeted active case finding can improve the number of people who are detected and treated for TB and can push towards the targets of the Stop TB Global Plan and End TB Strategy.	[Sanaie, A.] AntiTB Assoc Afghanistan, Kabul, Afghanistan; [Mergenthaler, C.; Creswell, J.] Stop TB Partnership, Geneva, Switzerland; [Nasrat, A.] ACREOD, Kabul, Afghanistan; [Seddiq, M. K.; Mahmoodi, S. D.] Natl TB Program, Kabul, Afghanistan; [Stevens, R. H.] Mott McDonald, London, England		Mergenthaler, C (corresponding author), Stop TB Partnership, Geneva, Switzerland.	christinamergenthaler@gmail.com		Creswell, Jacob/0000-0002-4885-940X				Afghanistan's National Tuberculosis Control Program, 2006, AFGH NAT TUB CONTR P; Ahmadzai H, 2008, INT J TUBERC LUNG D, V12, P180; [Anonymous], 2009, PLOS ONE, V4, pe5443, DOI [10.1371/journal.pone.0005443, DOI 10.1371/JOURNAL.PONE.0005443]; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dieleman M., 2006, IMPROVING HLTH WORKE; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Internal Displacement Monitoring Centre (IDMC), 2014, GLOB OV 2014 PEOPL I; John S, 2015, INT J TUBERC LUNG D, V19, P463, DOI 10.5588/ijtld.14.0679; Joshi B, 2015, PUBLIC HEALTH ACTION, V5, P93, DOI 10.5588/pha.15.0004; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mauch V, 2010, HEALTH POLICY, V96, P118, DOI 10.1016/j.healthpol.2010.01.003; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Muyoyeta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093757; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Reilley B, 2004, AM J PUBLIC HEALTH, V94, P1686, DOI 10.2105/AJPH.94.10.1686; Sabawoon W, 2012, MYCOBAC DIS, V2, P115, DOI [10.4172/2161-1068.1000115, DOI 10.4172/2161-1068.1000115]; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Somashekar N, 2014, INT J TUBERC LUNG D, V18, P1243, DOI 10.5588/ijtld.14.0141; Stop TB Partnership, 2015, PAR SHIFT GLOB PLAN; The Global Fund, 2014, GLOB FUND COUNTR ALL; The Global Fund, GLOB FUND STRAT FRAM; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; USAID, 2014, AFGH HLTH SECT FACTS; Van Rie A, 2014, INT J TUBERC LUNG D, V18, P377, DOI 10.5588/ijtld.13.0924; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yanjindulam P, 2012, INT J TUBERC LUNG D, V16, P327, DOI 10.5588/ijtld.11.0251; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163813	10.1371/journal.pone.0163813	http://dx.doi.org/10.1371/journal.pone.0163813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701446	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900021
J	Steiber, N				Steiber, Nadia			Strong or Weak Handgrip? Normative Reference Values for the German Population across the Life Course Stratified by Sex, Age, and Body Height	PLOS ONE			English	Article							GRIP STRENGTH; JAMAR DYNAMOMETER; PROGNOSTIC VALUE; MUSCLE STRENGTH; HEALTHY-ADULTS; METAANALYSIS; SARCOPENIA; GENDER; COHORT; OLDER	Handgrip strength is an important biomarker of healthy ageing and a powerful predictor of future morbidity and mortality both in younger and older populations. Therefore, the measurement of handgrip strength is increasingly used as a simple but efficient screening tool for health vulnerability. This study presents normative reference values for handgrip strength in Germany for use in research and clinical practice. It is the first study to provide normative data across the life course that is stratified by sex, age, and body height. The study used a nationally representative sample of test participants ages 17-90. It was based on pooled data from five waves of the German Socio-Economic Panel (2006-2014) and involved a total of 11,790 persons living in Germany (providing 25,285 observations). Handgrip strength was measured with a Smedley dynamometer. Results showed that peak mean values of handgrip strength are reached in men's and women's 30s and 40s after which handgrip strength declines in linear fashion with age. Following published recommendations, the study used a cut-off at 2 SD below the sex-specific peak mean value across the life course to define a 'weak grip'. Less than 10% of women and men aged 65-69 were classified as weak according to this definition, shares increasing to about half of the population aged 80-90. Based on survival analysis that linked handgrip strength to a relevant outcome, however, a 'critically weak grip' that warrants further examination was estimated to commence already at 1 SD below the group-specific mean value.	[Steiber, Nadia] IIASA, Wittgenstein Ctr Demog & Global Human Capital IIA, VID OAW, WU, Laxenburg, Austria; [Steiber, Nadia] Univ Vienna, Dept Econ Sociol, Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); University of Vienna	Steiber, N (corresponding author), IIASA, Wittgenstein Ctr Demog & Global Human Capital IIA, VID OAW, WU, Laxenburg, Austria.; Steiber, N (corresponding author), Univ Vienna, Dept Econ Sociol, Vienna, Austria.	steiber@iiasa.ac.at		Steiber, Nadia/0000-0002-9425-8840				Ambrasat J, 2011, 54 DIW BERL GERM I E; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Eibich P, 2014, REG SCI URBAN ECON, V49, P305, DOI 10.1016/j.regsciurbeco.2014.06.005; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Hanten W P, 1999, J Hand Ther, V12, P193; Horder H, 2015, AGE AGEING, V44, P817, DOI 10.1093/ageing/afv084; Kamide N, 2015, ENVIRON HEALTH PREV, V20, P441, DOI 10.1007/s12199-015-0485-z; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Martin-Ruiz C, 2014, P NUTR SOC, V73, P422, DOI 10.1017/S0029665114000147; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Nilsen T, 2012, SCAND J OCCUP THER, V19, P288, DOI 10.3109/11038128.2011.553687; Peters MJH, 2011, J PERIPHER NERV SYST, V16, P47, DOI 10.1111/j.1529-8027.2011.00318.x; Peterson MD, 2015, AM J PREV MED, V49, P935, DOI 10.1016/j.amepre.2015.05.013; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Schlussel MM, 2008, CLIN NUTR, V27, P601, DOI 10.1016/j.clnu.2008.04.004; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Steiber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136583; Werle S, 2009, J HAND SURG-EUR VOL, V34E, P76, DOI 10.1177/1753193408096763; Wu SW, 2009, APPL ERGON, V40, P811, DOI 10.1016/j.apergo.2008.08.006; Yorke AM, 2015, J GERIATR PHYS THER, V38, P115, DOI 10.1519/JPT.0000000000000037; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1	42	69	70	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163917	10.1371/journal.pone.0163917	http://dx.doi.org/10.1371/journal.pone.0163917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701433	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000385696900032
J	Liu, JM; Wang, BY; Tai, C; Wu, L; Zhao, H; Guan, JD; Chen, LY				Liu, Jianmin; Wang, Baoyu; Tai, Chao; Wu, Li; Zhao, Han; Guan, Jiadong; Chen, Linyong			An Effective Method to Detect Volatile Intermediates Generated in the Bioconversion of Coal to Methane by Gas Chromatography-Mass Spectrometry after In-Situ Extraction Using Headspace Solid-Phase Micro-Extraction under Strict Anaerobic Conditions	PLOS ONE			English	Article							FATTY-ACIDS; MICROEXTRACTION; SPME; METHANOGENESIS; DEGRADATION; BIOGEOCHEMISTRY; HYDROCARBONS; METABOLOMICS; STIMULATION; BIOANALYSIS	Bioconversion of coal to methane has gained increased attention in recent decades because of its economic and environmental advantages. However, the mechanism of this process is difficult to study in depth, partly because of difficulties associated with the analysis of intermediates generated in coal bioconversion. In this investigation, we report on an effective method to analyze volatile intermediates generated in the bioconversion of coal under strict anaerobic conditions. We conduct in-situ extraction of intermediates using headspace solid-phase micro-extraction followed by detection by gas chromatography-mass spectrometry. Bioconversion simulation equipment was modified and combined with a solid-phase micro-extraction device. In-situ extraction could be achieved by using the combined units, to avoid a breakdown in anaerobic conditions and to maintain the experiment continuity. More than 30 intermediates were identified qualitatively in the conversion process, and the variation in trends of some typical intermediates has been discussed. Volatile organic acids (C2-C7) were chosen for a quantitative study of the intermediates because of their importance during coal bioconversion to methane. Fiber coating, extraction time, and solution acidity were optimized in the solid-phase micro-extraction procedure. The pressure was enhanced during the bioconversion process to investigate the influence of headspace pressure on analyte extraction. The detection limits of the method ranged from 0.0006 to 0.02 mmol/L for the volatile organic acids and the relative standard deviations were between 4.6% and 11.5%. The volatile organic acids (C2-C7) generated in the bioconversion process were 0.01-1.15 mmol/L with a recovery range from 80% to 105%. The developed method is useful for further in-depth research on the bioconversion of coal to methane.	[Liu, Jianmin; Tai, Chao; Wu, Li] Henan Polytech Univ, Inst Resources & Environm, Jiaozuo, Peoples R China; [Liu, Jianmin; Wang, Baoyu; Tai, Chao; Zhao, Han; Guan, Jiadong; Chen, Linyong] Natl Key Lab Coal & Coal Bed Methane Simultaneous, Jincheng, Peoples R China	Henan Polytechnic University	Tai, C (corresponding author), Henan Polytech Univ, Inst Resources & Environm, Jiaozuo, Peoples R China.; Tai, C (corresponding author), Natl Key Lab Coal & Coal Bed Methane Simultaneous, Jincheng, Peoples R China.	taichao@126.com			Coal-bed Methane Collaborative Fund of Shanxi [2013012016, 2012012013]; National Natural Science Foundation of China [41202113]; Foundation and Frontier Project of Henan [122300410241]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [16IRTSTHN014]	Coal-bed Methane Collaborative Fund of Shanxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation and Frontier Project of Henan; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This study was supported jointly by Coal-bed Methane Collaborative Fund of Shanxi (2013012016, 2012012013), the National Natural Science Foundation of China (41202113), Foundation and Frontier Project of Henan (122300410241), and Program for Innovative Research Team (in Science and Technology) in University of Henan Province (16IRTSTHN014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos M, 2000, J CHROMATOGR A, V873, P107, DOI 10.1016/S0021-9673(99)01263-7; Abu Laban N, 2010, ENVIRON MICROBIOL, V12, P2783, DOI 10.1111/j.1462-2920.2010.02248.x; Ahmad S, 2013, BIOANALYSIS, V5, P2897, DOI 10.4155/bio.13.260; Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Beller HR, 2008, ENVIRON SCI TECHNOL, V42, P6065, DOI 10.1021/es8009666; Bessonneau V, 2015, ANAL CHIM ACTA, V856, P35, DOI 10.1016/j.aca.2014.11.029; Birjandi AP, 2014, ANAL CHEM, V86, P12022, DOI 10.1021/ac502627w; Bojko B, 2014, TRAC-TREND ANAL CHEM, V61, P168, DOI 10.1016/j.trac.2014.07.005; Bojko B, 2014, BIOANALYSIS, V6, P1227, DOI 10.4155/bio.14.91; Boll M., 2010, HDB HYDROCARBON LIPI, P1011, DOI DOI 10.1007/978-3-540-77587-4_71; Fakoussa RM, 1999, APPL MICROBIOL BIOT, V52, P25, DOI 10.1007/s002530051483; Fallgren PH, 2013, INT J COAL GEOL, V115, P92, DOI 10.1016/j.coal.2013.01.014; Ferry JG, 2011, CURR OPIN BIOTECH, V22, P351, DOI 10.1016/j.copbio.2011.04.011; Furmann A, 2013, CHEM GEOL, V339, P226, DOI 10.1016/j.chemgeo.2012.08.010; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; Haider R, 2013, FUEL, V104, P717, DOI 10.1016/j.fuel.2012.05.015; Holker U, 2002, J IND MICROBIOL BIOT, V28, P207, DOI 10.1038/sj/jim/7000232; Hossain SMZ, 2013, ANAL CHIM ACTA, V776, P41, DOI 10.1016/j.aca.2013.03.018; Hosseini SE, 2013, RENEW SUST ENERG REV, V19, P454, DOI 10.1016/j.rser.2012.11.008; Huang ZX, 2013, FUEL, V111, P813, DOI 10.1016/j.fuel.2013.03.079; Jones EJP, 2013, INT J COAL GEOL, V115, P54, DOI 10.1016/j.coal.2013.03.011; Jones EJP, 2010, APPL ENVIRON MICROB, V76, P7013, DOI 10.1128/AEM.00728-10; Li DM, 2008, INT J COAL GEOL, V76, P14, DOI 10.1016/j.coal.2008.04.007; McIntosh J, 2008, INT J COAL GEOL, V76, P111, DOI 10.1016/j.coal.2008.03.004; Mesle M, 2013, RES MICROBIOL, V164, P959, DOI 10.1016/j.resmic.2013.07.004; Midgley DJ, 2010, INT J COAL GEOL, V82, P232, DOI 10.1016/j.coal.2010.01.009; Mushtaq F, 2014, RENEW SUST ENERG REV, V39, P555, DOI 10.1016/j.rser.2014.07.073; Noventa S, 2015, ANAL CHIM ACTA, V858, P66, DOI 10.1016/j.aca.2014.11.028; Orem WH, 2010, ORG GEOCHEM, V41, P997, DOI 10.1016/j.orggeochem.2010.03.005; PAN L, 1995, ANAL CHEM, V67, P4396, DOI 10.1021/ac00119a031; Parisi VA, 2009, MICROB BIOTECHNOL, V2, P202, DOI 10.1111/j.1751-7915.2009.00077.x; Singh AL, 2012, ENERG EXPLOR EXPLOIT, V30, P837, DOI 10.1260/0144-5987.30.5.837; Stephen A, 2014, RSC ADV, V4, P22779, DOI 10.1039/c4ra01628a; Strapoc D, 2011, ANNU REV EARTH PL SC, V39, P617, DOI 10.1146/annurev-earth-040610-133343; Tchapda AH, 2014, ENERGIES, V7, P1098, DOI 10.3390/en7031098; Wawrik B, 2012, FEMS MICROBIOL ECOL, V81, P26, DOI 10.1111/j.1574-6941.2011.01272.x; Yo SP, 1999, CHEMOSPHERE, V38, P823, DOI 10.1016/S0045-6535(98)00223-9	38	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163949	10.1371/journal.pone.0163949	http://dx.doi.org/10.1371/journal.pone.0163949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695055	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100068
J	Cuadrado, I; Castejon, B; Martin, AM; Saura, M; Reventun-Torralba, P; Zamorano, JL; Zaragoza, C				Cuadrado, Irene; Castejon, Borja; Martin, Ana M.; Saura, Marta; Reventun-Torralba, Paula; Luis Zamorano, Jose; Zaragoza, Carlos			Nitric Oxide Induces Cardiac Protection by Preventing Extracellular Matrix Degradation through the Complex Caveolin-3/EMMPRIN in Cardiac Myocytes	PLOS ONE			English	Article							DIABETIC-RATS; CAVEOLIN-1; EXPRESSION; EMMPRIN; CD147; DYSFUNCTION; ACTIVATION; ISCHEMIA; RECEPTOR; ARTERY	Inhibition of Extracellular Matrix degradation by nitric oxide (NO) induces cardiac protection against coronary ischemia/reperfusion (IR). Glycosylation of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) stimulates enzymatic activation of matrix metalloproteinases (MMPs) in the heart, although the mechanisms leading to EMMPRIN glycosylation are poorly understood. We sought to determine if NO may induce cardiac protection by preventing glycosylation of EMMPRIN in a mouse model of IR. Here we found that Caveolin-3 binds to low glycosylated EMMPRIN (LG-EMMPRIN) in cardiac cells and in the hearts of healthy mice, whereas IR disrupted the complex in nitric oxide synthase 2 (NOS2) knockout (KO) mice. By contrast, the binding was partially restored when mice were fed with an NO donor (DEA-NO) in the drinking water, showing a significant reduction on infarct size (NOS2KO: 34.6 +/- 5 vs NOS2KO+DEA-NO:20.7 +/- 9), in expression of matrix metalloproteinases, and cardiac performance was improved (left ventricular ejection fraction (LVEF). NOS2KO: 31 +/- 4 vs NOS2KO+DEA-NO:46 +/- 6). The role of Caveolin-3/EMMPRIN in NO-mediated cardiac protection was further assayed in Caveolin-3 KO mice, showing no significant improvement on infarct size (Caveolin-3 KO:34.8 +/- 3 vs Caveolin-3 KO+DEA-NO:33.7 +/- 5), or in the expression of MMPs, suggesting that stabilization of the complex Caveolin-3/LG-EMMPRIN may play a significant role in the cardioprotective effect of NO against IR.	[Castejon, Borja; Martin, Ana M.; Zaragoza, Carlos] Univ Francisco Vitoria, Hosp Ramon y Cajal Res Unit IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain; [Cuadrado, Irene; Saura, Marta; Reventun-Torralba, Paula] Univ Alcala, Dept Syst Biol Physiol, Ctra Madrid Barcelona,Km 3,300, Madrid 28875, Spain; [Luis Zamorano, Jose] Univ Hosp Ramon y Cajal IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain	Universidad Francisco de Vitoria; Universidad de Alcala	Zaragoza, C (corresponding author), Univ Francisco Vitoria, Hosp Ramon y Cajal Res Unit IRYCIS, Dept Cardiol, Ctra Colmenar Viejo,Km 9100, Madrid 28034, Spain.	c.zaragoza.prof@ufv.es	Reventun, Paula/C-7764-2018; Reventun, Paula/AAK-9265-2020; Cuadrado-Berrocal, Irene/P-1360-2014; Cuadrado-Berrocal, Irene/AAZ-1917-2021; Zaragoza, Carlos/AAH-9275-2019	Reventun, Paula/0000-0002-6221-8780; Reventun, Paula/0000-0002-6221-8780; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Cuadrado-Berrocal, Irene/0000-0003-0727-9633; Zaragoza, Carlos/0000-0002-1706-8592	Instituto de Salud Carlos III (Plan Estatal de I+D+i) [PI14/02022]; European Development Regional Fund "A way to achieve Europe'' (ERDF); Ministerio de Economia y Competitividad [SAF 2012-35141]	Instituto de Salud Carlos III (Plan Estatal de I+D+i); European Development Regional Fund "A way to achieve Europe'' (ERDF)(European Commission); Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by Instituto de Salud Carlos III (Plan Estatal de I+D+i 2013-2016) PI14/02022, and cofinanced by the European Development Regional Fund "A way to achieve Europe'' (ERDF), and Ministerio de Economia y Competitividad SAF 2012-35141.	Chen DB, 2006, BIOL REPROD, V74, P832, DOI 10.1095/biolreprod.105.049700; Chen ZF, 2015, INT J CLIN EXP PATHO, V8, P4614; Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463; Horikawa YT, 2008, J MOL CELL CARDIOL, V44, P123, DOI 10.1016/j.yjmcc.2007.10.003; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Jasmin JF, 2011, AM J PHYSIOL-HEART C, V300, pH1274, DOI 10.1152/ajpheart.01173.2010; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Liu Y, 2015, CLIN SCI, V129, P331, DOI 10.1042/CS20140789; Lizarbe TR, 2008, FASEB J, V22, P3207, DOI 10.1096/fj.07-103804; Lizarbe TR, 2009, AM J PATHOL, V175, P1421, DOI 10.2353/ajpath.2009.080845; Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102; Matsunaga T, 2005, INT J CARDIOL, V105, P203, DOI 10.1016/j.ijcard.2005.01.011; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Rodriguez-Feo JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002612; Sangwung P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031564; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schmidt R, 2008, CIRC RES, V102, P302, DOI 10.1161/CIRCRESAHA.107.157990; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; Sellers SL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00280; Sturhan H, 2015, THROMB RES, V135, P1160, DOI 10.1016/j.thromres.2015.03.022; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tarin C, 2011, FREE RADICAL BIO MED, V51, P387, DOI 10.1016/j.freeradbiomed.2011.04.021; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Tsutsumi YM, 2010, ANESTHESIOLOGY, V112, P1136, DOI 10.1097/ALN.0b013e3181d3d624; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162912	10.1371/journal.pone.0162912	http://dx.doi.org/10.1371/journal.pone.0162912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649573	Green Published, gold			2022-12-26	WOS:000383892100042
J	Gong, YC; Ai, ZJ; Sun, X; Fu, BW				Gong, Yinchun; Ai, Zhijiu; Sun, Xu; Fu, Biwei			The Effects of Boundary Conditions and Friction on the Helical Buckling of Coiled Tubing in an Inclined Wellbore	PLOS ONE			English	Article							CYLINDER-IN-CYLINDER; HORIZONTAL CYLINDER; LOCK-UP; WELLS; BEHAVIOR	Analytical buckling models are important for down-hole operations to ensure the structural integrity of the drill string. A literature survey shows that most published analytical buckling models do not address the effects of inclination angle, boundary conditions or friction. The objective of this paper is to study the effects of boundary conditions, friction and angular inclination on the helical buckling of coiled tubing in an inclined wellbore. In this paper, a new theoretical model is established to describe the buckling behavior of coiled tubing. The buckling equations are derived by applying the principles of virtualwork and minimum potential energy. The proper solution for the post-buckling configuration is determined based on geometric and natural boundary conditions. The effects of angular inclination and boundary conditions on the helical buckling of coiled tubing are considered. Many significant conclusions are obtained from this study. When the dimensionless length of the coiled tubing is greater than 40, the effects of the boundary conditions can be ignored. The critical load required for helical buckling increases as the angle of inclination and the friction coefficient increase. The post-buckling behavior of coiled tubing in different configurations and for different axial loads is determined using the proposed analytical method. Practical examples are provided that illustrate the influence of the angular inclination on the axial force. The rate of change of the axial force decreases with increasing angular inclination. Moreover, the total axial friction also decreases with an increasing inclination angle. These results will help researchers to better understand helical buckling in coiled tubing. Using this knowledge, measures can be taken to prevent buckling in coiled tubing during down-hole operations.	[Gong, Yinchun; Ai, Zhijiu; Fu, Biwei] Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China; [Sun, Xu] China Natl Offshore Oil Corp, Shenzhen Ltd, Shenzhen, Peoples R China	Southwest Petroleum University; China National Offshore Oil Corporation (CNOOC)	Gong, YC (corresponding author), Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China.	gongyinchun@126.com			National Natural Science Foundation of China [51074132]; Shenzen Limited	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzen Limited	This study is supported by National Natural Science Foundation of China (grant no. 51074132). Shenzen Limited provided funding via salary to Xu Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheatham J. B., 1984, HELICAL POSTBUCKLING, DOI [10.2118/10854-PA, DOI 10.2118/10854-PA]; CHEN YC, 1990, J PETROL TECHNOL, V42, P140, DOI 10.2118/19176-PA; Chen YC, 2015, MEASUREMENT, V65, P227, DOI 10.1016/j.measurement.2015.01.008; DAWSON R, 1984, J PETROL TECHNOL, V36, P1734, DOI 10.2118/11167-PA; Gao D., 2002, PROGR NATURALENCE, V12; Gao G., 2010, SPE PROD OP S 4 8 AP; Guan F, 2014, APPL OCEAN RES, V44, P13, DOI 10.1016/j.apor.2013.10.009; Gulyaev VI, 2008, STRENGTH MATER+, V40, P648, DOI 10.1007/s11223-008-9083-2; HE XJ, 1995, SPE DRILL COMPLETION, V10, P10, DOI 10.2118/25370-PA; Huang GX, 2016, SHIPS OFFSHORE STRUC, V11, P561, DOI 10.1080/17445302.2015.1038867; Huang N. C., 2000, SAUDI MED J, V33, P367; Lubinski A., 1962, J PET TECHNOL, V14, P655, DOI DOI 10.2118/178-PA; McCann R.C., 1994, OFFSH TECHN C HOUST; Miller JT, 2015, EXTREME MECH LETT, V3, P36, DOI 10.1016/j.eml.2015.03.002; Miller JT, 2015, INT J SOLIDS STRUCT, V72, P153, DOI 10.1016/j.ijsolstr.2015.07.025; Miska S., 1995, ANAL HELICAL BUCKLIN, DOI [10.2118/29460-MS, DOI 10.2118/29460-MS]; Mitchell R. F., 2013, SPE DRILL COMPLETION, V12, P63; Mitchell R. F., 2002, NEW BUCKLING SOLUTIO, DOI [10.2118/74566-MS, DOI 10.2118/74566-MS]; Mitchell R.F., 1986, SPE DRILL ENG, V1, P457, DOI DOI 10.2118/13064-PA; Mitchell R.F., 1988, SPE DRILL ENG, V3, P303, DOI DOI 10.2118/15470-PA; Paslay P. R., 1964, J APPL MECH, V31; Qin X, 2016, J NAT GAS SCI ENG, V30, P182, DOI 10.1016/j.jngse.2016.02.016; Wicks N, 2008, INT J MECH SCI, V50, P538, DOI 10.1016/j.ijmecsci.2007.08.005; Wu J., 1993, SPE PROD OP S OKL US, P10; Yuan Z, 2012, INT J NONLIN MECH, V47, P699, DOI 10.1016/j.ijnonlinmec.2011.11.008	25	1	1	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162741	10.1371/journal.pone.0162741	http://dx.doi.org/10.1371/journal.pone.0162741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649535	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100032
J	Tao, Z; Kokas, A; Zhang, R; Cohan, DS; Wallach, D				Tao, Zhu; Kokas, Aynne; Zhang, Rui; Cohan, Daniel S.; Wallach, Dan			Inferring Atmospheric Particulate Matter Concentrations from Chinese Social Media Data	PLOS ONE			English	Article							TWITTER	Although studies have increasingly linked air pollution to specific health outcomes, less well understood is how public perceptions of air quality respond to changing pollutant levels. The growing availability of air pollution measurements and the proliferation of social media provide an opportunity to gauge public discussion of air quality conditions. In this paper, we consider particulate matter (PM) measurements from four Chinese megacities (Beijing, Shanghai, Guangzhou, and Chengdu) together with 112 million posts on Weibo (a popular Chinese microblogging system) from corresponding days in 2011-2013 to identify terms whose frequency was most correlated with PM levels. These correlations are used to construct an Air Discussion Index (ADI) for estimating daily PM based on the content of Weibo posts. In Beijing, the Chinese city with the most PM as measured by U.S. Embassy monitor stations, we found a strong correlation (R = 0.88) between the ADI and measured PM. In other Chinese cities with lower pollution levels, the correlation was weaker. Nonetheless, our results show that social media may be a useful proxy measurement for pollution, particularly when traditional measurement stations are unavailable, censored or misreported.	[Tao, Zhu; Wallach, Dan] Rice Univ, Dept Comp Sci, Houston, TX 77005 USA; [Kokas, Aynne] Univ Virginia, Dept Media Studies, Charlottesville, VA USA; [Zhang, Rui; Cohan, Daniel S.] Rice Univ, Dept Civil & Environm Engn, Houston, TX USA; [Tao, Zhu] Googleplex, Mountain View, CA USA	Rice University; University of Virginia; Rice University	Wallach, D (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77005 USA.	dwallach@rice.edu	Cohan, Daniel S/E-6595-2010	Cohan, Daniel S/0000-0003-0415-7980				Ao J, 2014, PROCEDIA COMPUT SCI, V31, P731, DOI 10.1016/j.procs.2014.05.321; Cao B, 2012, BLOOMBERG       0228; Chen JY, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P505, DOI 10.1145/2567948.2576941; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Crooks A, 2013, T GIS, V17, P124, DOI 10.1111/j.1467-9671.2012.01359.x; Dhar V, 2009, J INTERACT MARK, V23, P300, DOI 10.1016/j.intmar.2009.07.004; Earle PS, 2011, ANN GEOPHYS-ITALY, V54, P708, DOI 10.4401/ag-5364; Economy E, 2014, ALL MEANS NECESSARY; Forman C, 2008, INFORM SYST RES, V19, P291, DOI 10.1287/isre.1080.0193; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; HBase Development Team, 2012, HBASE DISTR DAT LARG; Hsu A, 2012, ENVIRON DEV, V3, P39, DOI 10.1016/j.envdev.2012.05.001; Huilei He, 2013, Advanced Data Mining and Applications. 9th International Conference, ADMA 2013. Proceedings: LNCS 8346, P372, DOI 10.1007/978-3-642-53914-5_32; Jiang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134142; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Kreyszig E, 1993, ADV ENG MATH, V1022; Lampos V, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2337542.2337557; Lin MY, 1993, P ROCLING 6, P119; Liu LX, 2012, ENVIRON SCI POLICY, V21, P106, DOI 10.1016/j.envsci.2012.05.001; Martin RV, 2008, ATMOS ENVIRON, V42, P7823, DOI 10.1016/j.atmosenv.2008.07.018; Mendoza M, 2010, ACM 2010, P71; Mishne G., 2006, AAAI SPRING S COMP A, P155; Miyabe M, 2012, USE TREND ANAL TWITT, P175, DOI [10.1145/2141512.2141571, DOI 10.1145/2141512.2141571]; Muralidharan S, 2011, PUBLIC RELAT REV, V37, P175, DOI 10.1016/j.pubrev.2011.01.010; Power R., 2013, P AUSTR LANG TECHN A, P80; RIVEST R, 1992, MD5 MESSAGE DIGEST A; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shvachko Konstantin, 2010, MSST, DOI [10.1109/MSST.2010.5496972, DOI 10.1109/MSST.2010.5496972]; Song P, 2012, P 2012 INT C NAT LAN; Spann M, 2003, MANAGE SCI, V49, P1310, DOI 10.1287/mnsc.49.10.1310.17314; The-Minh Nguyen, 2011, 2011 IEEE International Conference on Granular Computing, P496, DOI 10.1109/GRC.2011.6122647; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; World Health Organization, 2014, BURD DIS AMB AIR POL; Xinjiang Lu, 2013, 2013 IEEE International Conference on Green Computing and Communications (GreenCom) and IEEE Internet of Things (iThings) and IEEE Cyber, Physical and Social Computing (CPSCom), P962, DOI 10.1109/GreenCom-iThings-CPSCom.2013.166; Zhang HP, 2014, INT J AUTOM COMPUT, V11, P119, DOI 10.1007/s11633-014-0774-9; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhu T, 2013, 22 USENIX SEC S USEN, P227; Zhuang XL, 2014, J ENVIRON SCI, V26, P2, DOI 10.1016/S1001-0742(13)60376-9	39	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161389	10.1371/journal.pone.0161389	http://dx.doi.org/10.1371/journal.pone.0161389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649530	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100005
J	Hisamichi, M; Kamijo-Ikemori, A; Sugaya, T; Ichikawa, D; Natsuki, T; Hoshino, S; Kimura, K; Shibagaki, Y				Hisamichi, Mikako; Kamijo-Ikemori, Atsuko; Sugaya, Takeshi; Ichikawa, Daisuke; Natsuki, Takayuki; Hoshino, Seiko; Kimura, Kenjiro; Shibagaki, Yugo			Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension	FASEB JOURNAL			English	Article						Ang II AT1a receptor; DOCA; hypertension; L-FABP	ACID-BINDING PROTEIN; CHRONIC KIDNEY-DISEASE; URINARY-EXCRETION; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL EXPRESSION; MORPHOMETRIC-ANALYSIS; BLOOD-FLOW; RENIN; PROGRESSION; AT(1)	The aim of this study was to investigate the in vivo role of angiotensin II type 1a (AT1a) receptor in renal damage as a result of hypertension by using transgenic mice with AT1a receptor gene disruption. Transgenic mice that express human liver-type fatty acid binding protein (L-FABP) with or without disruption of the AT1a receptor gene (L-FABP(+/-) AT1a(-/-), and L-FABP(+/-) AT1a(+/+), respectively) were used with urinary L-FABP as an indicator of tubulointerstitial damage. Those female mice were administered subcutaneously deoxycorticosterone acetate (DOCA)-salt tablets plus drinking water that contained 1% saline for 28 d after uninephrectomy. InL-FABP(+/-) AT1a(+/+) mice that received DOCA-salt treatment, hypertension was induced and slight expansion of glomerular area, glomerular sclerosis, and tubulointerstitial damage were observed. In L-FABP(+/-) AT1a(-/-) mice that received DOCA-salt treatment, hypertension was similarly induced and the degree of glomerular damage was significantly more severe than in L-FABP(+/-) AT1a(+/+)-DOCAmice. Urinary L-FABP levels were significantly higher in L-FABP(+/-) AT1a(-/-)-DOCA mice compared with those in L-FABP(+/-) AT1a(+/+)-DOCAmice. Hydralazine treatment significantly attenuated renal damage that was found in L-FABP(+/-) AT1a(-/-)-DOCA mice along with a reduction in blood pressure. In summary, activation of the AT1a receptor may contribute to maintenance of the glomerular structure against hypertensive renal damage.	[Hisamichi, Mikako; Kamijo-Ikemori, Atsuko; Sugaya, Takeshi; Ichikawa, Daisuke; Shibagaki, Yugo] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Kamijo-Ikemori, Atsuko; Hoshino, Seiko] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan; [Natsuki, Takayuki] St Marianna Univ, Sch Med, Inst Ultrastruct Morphol, Kawasaki, Kanagawa, Japan; [Kimura, Kenjiro] Tokyo Takanawa Hosp, Japan Community Hlth Care Org, Dept Internal Med, Tokyo, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University	Kamijo-Ikemori, A (corresponding author), St Marianna Univ, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	a2kamijo@marianna-u.ac.jp			Naito Foundation; Takeda Science Foundation	Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank Kimie Katayama, Jyunko Asano, and Keiichi Ohata (Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine) for technical assistance. This work was supported by the Naito Foundation and Takeda Science Foundation.	Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Appel LJ, 2008, ARCH INTERN MED, V168, P832, DOI 10.1001/archinte.168.8.832; Ardaillou R, 1999, J AM SOC NEPHROL, V10, pS40; Bergijk EC, 1998, J PATHOL, V184, P307; Blodow S, 2014, PFLUG ARCH EUR J PHY, V466, P1343, DOI 10.1007/s00424-013-1372-3; Bouby N, 1997, J AM SOC NEPHROL, V8, P1658; Burke M, 2014, CURR VASC PHARMACOL, V12, P845, DOI 10.2174/15701611113116660149; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; DEGASPARO M, 1995, HYPERTENSION, V25, P924, DOI 10.1161/01.HYP.25.5.924; Elgendy IY, 2015, AM J HYPERTENS, V28, P576, DOI 10.1093/ajh/hpu209; GAVRAS H, 1975, CIRC RES, V36, P300, DOI 10.1161/01.RES.36.2.300; Giachini FR, 2010, HYPERTENSION, V55, P172, DOI 10.1161/HYPERTENSIONAHA.109.140459; GOODWIN FJ, 1969, AM J PHYSIOL, V216, P1476, DOI 10.1152/ajplegacy.1969.216.6.1476; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170, DOI 10.1152/ajprenal.1997.273.1.F170; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Ichikawa D, 2015, AM J PHYSIOL-RENAL, V308, pF114, DOI 10.1152/ajprenal.00469.2014; Ichikawa D, 2014, AM J PHYSIOL-RENAL, V306, pF655, DOI 10.1152/ajprenal.00460.2013; Ichikawa D, 2012, HYPERTENSION, V60, P973, DOI 10.1161/HYPERTENSIONAHA.112.199828; Inokuchi S, 1998, VIRCHOWS ARCH, V433, P349, DOI 10.1007/s004280050259; KAKINUMA Y, 1992, KIDNEY INT, V42, P46, DOI 10.1038/ki.1992.259; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; KIM S, 1994, HYPERTENSION, V24, P195, DOI 10.1161/01.HYP.24.2.195; KIMURA K, 1989, VIRCHOWS ARCH A, V415, P565, DOI 10.1007/BF00718651; KIMURA K, 1990, VIRCHOWS ARCH A, V417, P319, DOI 10.1007/BF01605783; Kimura K, 1997, KIDNEY INT, pS201; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lee GSL, 1998, KIDNEY INT, V53, P1389, DOI 10.1046/j.1523-1755.1998.00871.x; Ma LJ, 2011, AM J PHYSIOL-RENAL, V300, pF1203, DOI 10.1152/ajprenal.00468.2010; MAKRIDES SC, 1988, HYPERTENSION, V12, P405, DOI 10.1161/01.HYP.12.4.405; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; PAXTON WG, 1993, AM J PHYSIOL, V264, pF989, DOI 10.1152/ajprenal.1993.264.6.F989; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; RISDON RA, 1968, LANCET, V2, P363; Schleifenbaum J, 2014, CIRC RES, V115, P263, DOI 10.1161/CIRCRESAHA.115.302882; Sparks MA, 2015, J AM SOC NEPHROL, V26, P2953, DOI 10.1681/ASN.2014080816; Storch U, 2015, ARTERIOSCL THROM VAS, V35, P121, DOI 10.1161/ATVBAHA.114.304844; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Yang CW, 1997, LAB INVEST, V76, P467; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	48	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					72	84		10.1096/fj.201600684RR	http://dx.doi.org/10.1096/fj.201600684RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27663860	Green Published, hybrid			2022-12-26	WOS:000392177600010
J	Boubakri, M; Chaya, T; Hirata, H; Kajimura, N; Kuwahara, R; Ueno, A; Malicki, J; Furukawa, T; Omori, Y				Boubakri, Meriam; Chaya, Taro; Hirata, Hiromi; Kajimura, Naoko; Kuwahara, Ryusuke; Ueno, Akiko; Malicki, Jarema; Furukawa, Takahisa; Omori, Yoshihiro			Loss of ift122, a Retrograde Intraflagellar Transport (IFT) Complex Component, Leads to Slow, Progressive Photoreceptor Degeneration Due to Inefficient Opsin Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINITIS-PIGMENTOSA; VERTEBRATE PHOTORECEPTOR; ZEBRAFISH RETINA; KUPFFERS VESICLE; CILIARY LENGTH; KINASE MAK; GENE; MUTATIONS; CILIOGENESIS; TRAFFICKING	In the retina, aberrant opsin transport from cell bodies to outer segments leads to retinal degenerative diseases such as retinitis pigmentosa. Opsin transport is facilitated by the intra-flagellar transport (LET) system that mediates the bidirectional movement of proteins within cilia. In contrast to functions of the anterograde transport executed by IFT complex B (IFT-B), the precise functions of the retrograde transport mediated by LET complex A (IFT-A) have not been well studied in photoreceptor cilia. Here, we analyzed developing zebrafish larvae carrying a null mutation in ift122 encoding a component of IFT-A. ift122 mutant larvae show unexpectedly mild phenotypes, compared with those of mutants defective in IFT-B. ift122 mutants exhibit a slow onset of progressive photoreceptor degeneration mainly after 7 days post-fertilization. ift122 mutant larvae also develop cystic kidney but not curly body, both of which are typically observed in various ciliary mutants. ift122 mutants display a loss of cilia in the inner ear hair cells and nasal pit epithelia. Loss of ift122 causes disorganization of outer segment discs. Ectopic accumulation of an IFT-B component, ift88, is observed in the ift122 mutant photoreceptor cilia. In addition, pulse chase experiments using GFP-opsin fusion proteins revealed that ift122 is required for the efficient transport of opsin and the distal elongation of outer segments. These results show that IFT-A is essential for the efficient transport of outer segment proteins, including opsin, and for the survival of retinal photo-receptor cells, rendering the ift122 mutant a unique model for human retinal degenerative diseases.	[Boubakri, Meriam; Chaya, Taro; Ueno, Akiko; Furukawa, Takahisa; Omori, Yoshihiro] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Chaya, Taro; Omori, Yoshihiro] Japan Sci & Technol Agcy JST, PRESTO, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Hirata, Hiromi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, 5-10-1 Fuchinobe, Sagamihara, Kanagawa 2525258, Japan; [Kajimura, Naoko; Kuwahara, Ryusuke] Osaka Univ, Res Ctr Ultrahigh Voltage Electron Microscopy, 7-1 Mihogaoka, Osaka 5670047, Japan; [Malicki, Jarema] Univ Sheffield, Dept Biomed Sci, Bateson Ctr, Firth Court Western Bank, Sheffield S10 2TN, S Yorkshire, England	Osaka University; Japan Science & Technology Agency (JST); Aoyama Gakuin University; Osaka University; University of Sheffield	Omori, Y (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yoshihiro.omori@protein.osaka-u.ac.jp	malicki, jarema/G-8611-2014; Kajimura, Naoko/R-9267-2019; Kuwahara, Ryusuke/J-5024-2015	malicki, jarema/0000-0002-5947-8805; Kuwahara, Ryusuke/0000-0002-7041-0828; Hirata, Hiromi/0000-0002-3769-7441	Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [JP25113519, JP15H04669, JP25293070, JP16K08583, JP15K18955]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [12024046]; Takeda Science Foundation; Uehara Memorial Foundation; Novartis Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation; Send Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Suzuken Memorial Foundation; Osaka Community Foundation; NIG Collaborative Research Program [201685]; National Institutes of Health from the NEI [EY018176]; Medical Research Council [MR/N000714/1] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY018176] Funding Source: NIH RePORTER; MRC [MR/N000714/1] Funding Source: UKRI	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Novartis Foundation(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Naito Foundation(Naito Memorial Foundation); Send Life Science Foundation; Kato Memorial Bioscience Foundation; Daiichi-Sankyo Foundation of Life Science; Suzuken Memorial Foundation; Osaka Community Foundation; NIG Collaborative Research Program; National Institutes of Health from the NEI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by PRESTO from the Japan Science and Technology Agency (JST); Grant-in-aid for Scientific Research on Innovative Areas JP25113519, Grants-in-aid for Scientific Research (B) JP15H04669 and JP25293070; Grant-in-aid for Scientific Research (C) JP16K08583; Young Scientists (B) Grant JP15K18955 from Japan Society for the Promotion of Science (JSPS); Nanotechnology Platform Grant 12024046 from The Ministry of Education, Culture, Sports, Science and Technology (MEXT); The Takeda Science Foundation; The Uehara Memorial Foundation; The Novartis Foundation; The Mochida Memorial Foundation for Medical and Pharmaceutical Research; The Naito Foundation; The Send Life Science Foundation; The Kato Memorial Bioscience Foundation; The Daiichi-Sankyo Foundation of Life Science; The Suzuken Memorial Foundation; The Osaka Community Foundation; NIG Collaborative Research Program Grant 201685; the initial stages of this project were supported by National Institutes of Health RO1 Award EY018176 from the NEI (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Doerre G, 2002, MECH DEVELOP, V110, P125, DOI 10.1016/S0925-4773(01)00571-8; Fadool JM, 2003, DEV BIOL, V258, P277, DOI 10.1016/S0012-1606(03)00125-8; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hartong Dyonne T, 2006, Lancet, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; KANE DA, 1993, DEVELOPMENT, V119, P447; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krock BL, 2009, INVEST OPHTH VIS SCI, V50, P5463, DOI 10.1167/iovs.09-3828; Li JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027365; Malicki J, 2002, METHODS, V28, P427, DOI 10.1016/S1046-2023(02)00262-1; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Omori Y, 2006, CURR BIOL, V16, P945, DOI 10.1016/j.cub.2006.03.058; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ozgul RK, 2011, AM J HUM GENET, V89, P253, DOI 10.1016/j.ajhg.2011.07.005; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; TOKUYASU K, 1959, J BIOPHYS BIOCHEM CY, V6, P225, DOI 10.1083/jcb.6.2.225; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Tucker BA, 2011, P NATL ACAD SCI USA, V108, pE569, DOI 10.1073/pnas.1108918108; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	45	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24465	24474		10.1074/jbc.M116.738658	http://dx.doi.org/10.1074/jbc.M116.738658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681595	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000388875500011
J	Liu, B; Kong, L; Han, KP; Hong, H; Marcus, WD; Chen, XY; Jeng, EK; Alter, S; Zhu, XY; Rubinstein, MP; Shi, SX; Rhode, PR; Cai, WB; Wong, HC				Liu, Bai; Kong, Lin; Han, Kaiping; Hong, Hao; Marcus, Warren D.; Chen, Xiaoyue; Jeng, Emily K.; Alter, Sarah; Zhu, Xiaoyun; Rubinstein, Mark P.; Shi, Sixiang; Rhode, Peter R.; Cai, Weibo; Wong, Hing C.			A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; fusion protein; immunotherapy; interleukin; scaffold protein	IMMUNE-RESPONSE; MONOCLONAL-ANTIBODIES; FAB FRAGMENT; FC-RECEPTOR; CELLS; COMPLEX; IMMUNOTHERAPY; CHLORAMBUCIL; PROTECTION; RITUXIMAB	IL-15 and its receptor (IL-15R) are co-expressed on antigen-presenting cells, allowing transpresentation of IL-15 to immune cells bearing IL-2R(C) and stimulation of effector immune responses. We reported previously that the high-affinity interactions between an IL-15 superagonist (IL-15N72D) and the extracellular IL-15R sushi domain (IL-15RSu) could be exploited to create a functional scaffold for the design of multivalent disease-targeted complexes. The IL-15N72DIL-15RSuFc complex, also known as ALT-803, is a multimeric complex constructed by fusing IL-15N72DIL-15RSu to the Fc domain of IgG1. ALT-803 is an IL-15 superagonist complex that has been developed as a potent antitumor immunotherapeutic agent and is in clinical trials. Here we describe the creation of a novel fusion molecule, 2B8T2M, using the ALT-803 scaffold fused to four single chains of the tumor-targeting monoclonal antibody rituximab. This molecule displays trispecific binding activity through its recognition of the CD20 molecule on tumor cells, stimulation via IL-2R(C) displayed on immune effector cells, and binding to Fc receptors on natural killer cells and macrophages. 2B8T2M activates natural killer cells to enhance antibody-dependent cellular cytotoxicity, mediates complement-dependent cytotoxicity, and induces apoptosis of B-lymphoma cells. Compared with rituximab, 2B8T2M exhibits significantly stronger antitumor activity in a xenograft SCID mouse model and depletes B cells in cynomolgus monkeys more efficiently. Thus, ALT-803 can be modified as a functional scaffold for creating multispecific, targeted IL-15-based immunotherapeutic agents and may serve as a novel platform to improve the antitumor activity and clinical efficacy of therapeutic antibodies.	[Liu, Bai; Kong, Lin; Han, Kaiping; Marcus, Warren D.; Chen, Xiaoyue; Jeng, Emily K.; Alter, Sarah; Zhu, Xiaoyun; Rhode, Peter R.; Wong, Hing C.] Altor BioSci Corp, 2810 N Commerce Pkwy, Miramar, FL 33025 USA; [Hong, Hao; Shi, Sixiang; Cai, Weibo] Univ Wisconsin, Dept Radiol & Med Phys, Madison, WI 53706 USA; [Rubinstein, Mark P.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Rubinstein, Mark P.] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	University of Wisconsin System; University of Wisconsin Madison; Medical University of South Carolina; Medical University of South Carolina	Wong, HC (corresponding author), Altor BioSci Corp, 2810 N Commerce Pkwy, Miramar, FL 33025 USA.	hingwong@altorbioscience.com		Shi, Sixiang/0000-0002-8354-7620; Wong, Hing C./0000-0002-6865-4313	National Institute of Health [1R43CA174091-01]; American Cancer Society [125246-RSG-13-099-01-CCE]; NATIONAL CANCER INSTITUTE [R43CA174091] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part by National Institute of Health Grant 1R43CA174091-01 (to H.C.W.) and American Cancer Society Grant 125246-RSG-13-099-01-CCE (to W.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Beers SA, 2010, SEMIN HEMATOL, V47, P107, DOI 10.1053/j.seminhematol.2010.01.001; DiLillo DJ, 2015, CELL, V161, P1035, DOI 10.1016/j.cell.2015.04.016; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Ghetie MA, 2001, BLOOD, V97, P1392, DOI 10.1182/blood.V97.5.1392; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hilchey SP, 2009, BLOOD, V113, P3809, DOI 10.1182/blood-2008-10-185280; Hillmen P, 2015, LANCET, V385, P1873, DOI 10.1016/S0140-6736(15)60027-7; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Li BH, 2008, CANCER RES, V68, P2400, DOI 10.1158/0008-5472.CAN-07-6663; Mathios D, 2016, INT J CANCER, V138, P187, DOI 10.1002/ijc.29686; Nishida M, 2007, INT J ONCOL, V31, P29; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T; Rosario M, 2016, CLIN CANCER RES, V22, P596, DOI 10.1158/1078-0432.CCR-15-1419; Seay K, 2015, J VIROL, V89, P6264, DOI 10.1128/JVI.00563-15; Shi SX, 2015, EUR J NUCL MED MOL I, V42, P1295, DOI 10.1007/s00259-015-3038-1; Shi SX, 2015, J NUCL MED, V56, P927, DOI 10.2967/jnumed.114.153098; Sips M, 2016, MUCOSAL IMMUNOL, V9, P1584, DOI 10.1038/mi.2016.12; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; van Meerten T, 2010, SEMIN HEMATOL, V47, P199, DOI 10.1053/j.seminhematol.2010.01.007; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang W, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00368; Wong HC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26442; Wong RL, 2011, PROTEIN ENG DES SEL, V24, P373, DOI 10.1093/protein/gzq116; Xu WX, 2013, CANCER RES, V73, P3075, DOI 10.1158/0008-5472.CAN-12-2357; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004; Zhu XY, 2009, J IMMUNOL, V183, P3598, DOI 10.4049/jimmunol.0901244	30	45	53	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23869	23881		10.1074/jbc.M116.733600	http://dx.doi.org/10.1074/jbc.M116.733600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650494	hybrid, Green Published			2022-12-26	WOS:000388498100003
J	Lee, SH; Sud, N; Lee, N; Subramaniyam, S; Chung, CY				Lee, Sang-Hyun; Sud, Neetu; Lee, Narae; Subramaniyam, Selvaraj; Chung, Chang Y.			Regulation of Integrin 6 Recycling by Calcium-independent Phospholipase A(2) (iPLA(2)) to Promote Microglia Chemotaxis on Laminin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemotaxis; focal adhesion; integrin; microglia; phospholipase A	HUMAN MONOCYTE CHEMOTAXIS; EXTRACELLULAR-MATRIX; CELL-ADHESION; BRAIN-INJURY; EXPRESSION; TRAFFICKING; CYTOKINES; TRANSPORT; KINESIN; ACCUMULATION	Microglia are the immune effector cells that are activated in response to pathological changes in the central nervous system. Microglial activation is accompanied by the alteration of integrin expression on the microglia surface. However, changes of integrin expression upon chemoattractant (ADP) stimulation still remain unknown. In this study, we investigated whether ADP induces the alteration of integrin species on the cell surface, leading to changes in chemotactic ability on different extracellular matrix proteins. Flow cytometry scans and on-cell Western assays showed that ADP stimulation induced a significant increase of 6 integrin-GFP, but not 5, on the surface of microglia cells. Microglia also showed a greater motility increase on laminin than fibronectin after ADP stimulation. Time lapse microscopy and integrin endocytosis assay revealed the essential role of calcium-independent phospholipase A(2) activity for the recycling of 6 integrin-GFP from the endosomal recycling complex to the plasma membrane. Lack of calcium-independent phospholipase A(2) activity caused a reduced rate of focal adhesion formation on laminin at the leading edge. Our results suggest that the alteration of integrin-mediated adhesion may regulate the extent of microglial infiltration into the site of damage by controlling their chemotactic ability.	[Lee, Sang-Hyun; Sud, Neetu; Lee, Narae; Chung, Chang Y.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, 468 Robinson Res Bldg MRB 1, Nashville, TN 37232 USA; [Lee, Sang-Hyun] Korea Res Inst Biosci & Biotechnol, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Subramaniyam, Selvaraj; Chung, Chang Y.] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China	Vanderbilt University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Tianjin University	Chung, CY (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, 468 Robinson Res Bldg MRB 1, Nashville, TN 37232 USA.	chang.chung@vanderbilt.edu	Chung, Chang Y/G-7522-2012	Min, Jeong-Ki/0000-0003-4924-8739; Lee, Sang-Hyun/0000-0002-9682-1473	National Institutes of Health [GM68097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM68097 (to C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Boddeke EWGH, 1999, EUR J PHARMACOL, V374, P309, DOI 10.1016/S0014-2999(99)00307-6; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; CHAMAK B, 1991, NEUROSCIENCE, V45, P513, DOI 10.1016/0306-4522(91)90267-R; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; de Figueiredo P, 2001, J BIOL CHEM, V276, P47361, DOI 10.1074/jbc.M108508200; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jucker M, 1996, MOL CHEM NEUROPATHOL, V28, P209, DOI 10.1007/BF02815224; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee S, 2009, MOL CELL NEUROSCI, V42, P382, DOI 10.1016/j.mcn.2009.08.010; Lee SH, 2011, TRAFFIC, V12, P878, DOI 10.1111/j.1600-0854.2011.01195.x; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Milner R, 2006, MOL CELL NEUROSCI, V33, P429, DOI 10.1016/j.mcn.2006.09.004; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MONNING U, 1995, J BIOL CHEM, V270, P7104, DOI 10.1074/jbc.270.13.7104; Pechoux C, 2005, BBA-MOL CELL RES, V1743, P317, DOI 10.1016/j.bbamcr.2005.01.006; Schmidt D, 2003, ROFO-FORTSCHR RONTG, V175, P967; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tran H, 2002, J CELL SCI, V115, P2031; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; Yanaka K, 1997, J CEREBR BLOOD F MET, V17, P605; Yu NC, 1998, NEUROIMMUNOMODULAT, V5, P42, DOI 10.1159/000026325	35	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23645	23653		10.1074/jbc.M116.732610	http://dx.doi.org/10.1074/jbc.M116.732610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27655917	Green Published, hybrid			2022-12-26	WOS:000387884400024
J	Reifschneider, O; Marx, C; Jacobs, J; Kollipara, L; Sickmann, A; Wolters, D; Kuck, U				Reifschneider, Olga; Marx, Christina; Jacobs, Jessica; Kollipara, Laxmikanth; Sickmann, Albert; Wolters, Dirk; Kueck, Ulrich			A Ribonucleoprotein Supercomplex Involved in trans-Splicing of Organelle Group II Introns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN PROTEIN FUNCTIONS; CHLAMYDOMONAS-REINHARDTII; MAIZE CHLOROPLASTS; CRYSTAL-STRUCTURE; REPEAT PROTEIN; RNA; COMPLEX; IDENTIFICATION; GENES; TRANSFORMATION	In the chloroplast of the green alga Chlamydomonas reinhardtii, two discontinuous group II introns, psaA-i1 and psaA-i2, splice in trans, and thus their excision process resembles the nuclear spliceosomal splicing pathway. Here, we address the question whether fragmentation of trans-acting RNAs is accompanied by the formation of a chloroplast spliceosome-like machinery. Using a combination of liquid chromatographymass spectrometry (LC-MS), size exclusion chromatography, and quantitative RT-PCR, we provide the first characterization of a high molecular weight ribonucleoprotein apparatus participating in psaA mRNA splicing. This supercomplex contains two subcomplexes (I and II) that are responsible for trans-splicing of either psaA-i1 or psaA-i2. We further demonstrate that both subcomplexes are associated with intron RNA, which is a prerequisite for the correct assembly of subcomplex I. This study contributes further to our view of how the eukaryotic nuclear spliceosome evolved after bacterial endosymbiosis through fragmentation of self-splicing group II introns into a dynamic, protein-rich RNP machinery.	[Reifschneider, Olga; Marx, Christina; Jacobs, Jessica; Kueck, Ulrich] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Univ Str 150, D-44801 Bochum, Germany; [Sickmann, Albert] Ruhr Univ Bochum, Med Fak, MPC, Univ Str 150, D-44801 Bochum, Germany; [Wolters, Dirk] Ruhr Univ Bochum, Dept Analyt Chem, Univ Str 150, D-44801 Bochum, Germany; [Kollipara, Laxmikanth; Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS eV, Otto Hahn Str 6b, D-44227 Dortmund, Germany; [Sickmann, Albert] Univ Aberdeen, Sch Nat & Comp Sci, Meston Bldg, Meston Walk AB24 3UE, Old Aberdeen, Scotland; [Marx, Christina] WFG Herne, Westring 303, D-44629 Herne, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Aberdeen	Kuck, U (corresponding author), Ruhr Univ Bochum, Dept Gen & Mol Bot, Univ Str 150, D-44801 Bochum, Germany.	ulrich.kueck@rub.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Marx, Christina/0000-0002-0698-0674; Laxmikanth, Kollipara/0000-0002-2673-0488; Kuck, Ulrich/0000-0002-2998-8230	Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany) [KU 517/13-1, JA 2296/1-1]	Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Bonn Bad-Godesberg, Germany) Grants KU 517/13-1 (to U.K.) and JA 2296/1-1 (to J.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Balczun C, 2005, PLANT J, V43, P636, DOI 10.1111/j.1365-313X.2005.02478.x; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Brown GG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00035; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Chen WJ, 2015, CURR BIOL, V25, pR181, DOI 10.1016/j.cub.2014.11.059; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; Dlakic M, 2011, RNA, V17, P799, DOI 10.1261/rna.2396011; Eberhard S, 2011, PLANT J, V67, P1055, DOI 10.1111/j.1365-313X.2011.04657.x; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Glanz S, 2012, PLANT J, V69, P421, DOI 10.1111/j.1365-313X.2011.04801.x; Glanz S, 2009, BIOESSAYS, V31, P921, DOI 10.1002/bies.200900036; GOLDSCHMIDTCLERMONT M, 1991, CELL, V65, P135, DOI 10.1016/0092-8674(91)90415-U; Hammani K, 2014, NUCLEIC ACIDS RES, V42, P5033, DOI 10.1093/nar/gku112; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Hsu Y. W., 2014, PLOS ONE, V11; Jacobs J, 2013, MOL CELL PROTEOMICS, V12, P1912, DOI 10.1074/mcp.M112.026583; James P, 1996, GENETICS, V144, P1425; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Klein R M, 1992, Biotechnology, V24, P384; Kleinknecht L, 2014, PLANT CELL, V26, P777, DOI 10.1105/tpc.114.122853; Kotzer-Nevo H, 2014, INT J MOL SCI, V15, P11637, DOI 10.3390/ijms150711637; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; KUCK U, 1987, EMBO J, V6, P2185, DOI 10.1002/j.1460-2075.1987.tb02489.x; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; Lefebvre-Legendre L, 2016, PLANT J, V85, P57, DOI 10.1111/tpj.13089; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Marx C, 2015, EUKARYOT CELL, V14, P998, DOI 10.1128/EC.00096-15; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merendino L, 2006, NUCLEIC ACIDS RES, V34, P262, DOI 10.1093/nar/gkj429; NEWMAN SM, 1990, GENETICS, V126, P875; Perron K, 1999, EMBO J, V18, P6481, DOI 10.1093/emboj/18.22.6481; Perron K, 2004, RNA, V10, P704, DOI 10.1261/rna.5237804; Rahire M, 2012, PLANT J, V72, P652, DOI 10.1111/j.1365-313X.2012.05111.x; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; Robart AR, 2014, NATURE, V514, P193, DOI 10.1038/nature13790; Shahheydari H, 2014, MOL BIOL REP, V41, P4565, DOI 10.1007/s11033-014-3327-y; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Smith DR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-83; Smith DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-132; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Teichert I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004582; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Watkins KP, 2007, PLANT CELL, V19, P2606, DOI 10.1105/tpc.107.053736; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5	53	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23330	23342		10.1074/jbc.M116.750570	http://dx.doi.org/10.1074/jbc.M116.750570			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27645995	Green Published, hybrid			2022-12-26	WOS:000387224800040
J	Jakubkova, M; Dzugasova, V; Truban, D; Abelovska, L; Bhatia-Kissova, I; Valachovic, M; Klobucnikova, V; Zeiselova, L; Griac, P; Nosek, J; Tomaska, L				Jakubkova, Michaela; Dzugasova, Vladimira; Truban, Dominika; Abelovska, Lenka; Bhatia-Kissova, Ingrid; Valachovic, Martin; Klobucnikova, Vlasta; Zeiselova, Lucia; Griac, Peter; Nosek, Jozef; Tomaska, Lubomir			Identification of Yeast Mutants Exhibiting Altered Sensitivity to Valinomycin and Nigericin Demonstrate Pleiotropic Effects of Ionophores on Cellular Processes	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MITOCHONDRIAL INNER MEMBRANE; FATTY-ACID ELONGATION; STEROL C-14 REDUCTASE; VACUOLAR MEMBRANE; PROTEIN-SYNTHESIS; K+/H+ EXCHANGE; INTACT-CELLS; LIFE-SPAN; GENE	Ionophores such as valinomycin and nigericin are potent tools for studying the impact of ion perturbance on cellular functions. To obtain a broader picture about molecular components involved in mediating the effects of these drugs on yeast cells under respiratory growth conditions, we performed a screening of the haploid deletion mutant library covering the Saccharomyces cerevisiae nonessential genes. We identified nearly 130 genes whose absence leads either to resistance or to hypersensitivity to valinomycin and/or nigericin. The processes affected by their protein products range from mitochondrial functions through ribosome biogenesis and telomere maintenance to vacuolar biogenesis and stress response. Comparison of the results with independent screenings performed by our and other laboratories demonstrates that although mitochondria might represent the main target for both ionophores, cellular response to the drugs is very complex and involves an intricate network of proteins connecting mitochondria, vacuoles, and other membrane compartments.	[Jakubkova, Michaela; Truban, Dominika; Abelovska, Lenka; Bhatia-Kissova, Ingrid; Nosek, Jozef] Comenius Univ, Fac Nat Sci, Dept Biochem, Ilkovicova 6, Bratislava 84215, Slovakia; [Dzugasova, Vladimira; Abelovska, Lenka; Zeiselova, Lucia; Tomaska, Lubomir] Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia; [Valachovic, Martin; Klobucnikova, Vlasta; Griac, Peter] Slovak Acad Sci, Dept Biochem Biomembranes, Inst Anim Biochem & Genet, Moyzesova 61, Ivanka Pri Dunaji 90028, Slovakia	Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences	Nosek, J (corresponding author), Comenius Univ, Fac Nat Sci, Dept Biochem, Ilkovicova 6, Bratislava 84215, Slovakia.; Tomaska, L (corresponding author), Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia.	nosek@fns.uniba.sk; tomaska@fns.uniba.sk	, Peter/ABA-9227-2020; Valachovic, Martin/O-5962-2017; Fricova, Dominika/L-9216-2015; Bhatia, Ingrid/H-7016-2016; Nosek, Jozef/A-7581-2008; Tomaska, Lubomir/I-3071-2014	, Peter/0000-0003-3538-0405; Valachovic, Martin/0000-0001-7096-9325; Fricova, Dominika/0000-0002-6417-0370; Nosek, Jozef/0000-0002-1020-5451; Tomaska, Lubomir/0000-0003-4886-1910	Slovak Grant Agency VEGA [1/0311/12, 1/0052/16, 1/0333/15, 2/0111/15, 2/0185/14]; Slovak Grant Agency APVV [APVV-0035-11, APVV-15-0022, APVV-14-0253]; Howard Hughes Medical Institute [55005622]	Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Slovak Grant Agency APVV(Slovak Research and Development Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Slovak Grant Agencies VEGA (1/0311/12 and 1/0052/16 (L.T.), 1/0333/15 (J.N.), 2/0111/15 (P.G.), 2/0185/14 (M.V.)) and APVV (APVV-0035-11 and APVV-15-0022 (L.T.), APVV-14-0253 (J.N.)), and Howard Hughes Medical Institute (55005622 (J. N.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, J BIOL CHEM, V276, P26923, DOI 10.1074/jbc.M102179200; Abelovska L, 2011, GEN PHYSIOL BIOPHYS, V30, pS13, DOI 10.4149/gpb_2011_SI1_13; Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Batova M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-153; Bhuiyan MSA, 2007, LIPIDS, V42, P69, DOI 10.1007/s11745-006-1001-4; BREITBART H, 1975, MOL BIOL REP, V2, P167, DOI 10.1007/BF00357548; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BROWN GC, 1986, BIOCHEM J, V234, P75, DOI 10.1042/bj2340075; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; CHOW JM, 1990, APPL ENVIRON MICROB, V56, P1588, DOI 10.1128/AEM.56.6.1588-1593.1990; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fricova D, 2006, THESIS; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hersh MN, 2004, RES MICROBIOL, V155, P352, DOI 10.1016/j.resmic.2004.01.020; HERZBERG M, 1980, MOL BIOL REP, V6, P163, DOI 10.1007/BF00775411; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jungwirth H, 2008, FEBS LETT, V582, P2882, DOI 10.1016/j.febslet.2008.07.023; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P349, DOI 10.1016/0167-4889(82)90089-1; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P341, DOI 10.1016/0167-4889(82)90088-X; Kovac L, 1983, MITOCHONDRIA, P65; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Kucejova B, 2005, GENETICS, V171, P517, DOI 10.1534/genetics.105.046540; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lees ND, 2004, TOP CURR GENET, V6, P213; Lehner KR, 2007, GENETICS, V177, P1951, DOI 10.1534/genetics.107.079368; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; LORENZ RT, 1992, DNA CELL BIOL, V11, P685, DOI 10.1089/dna.1992.11.685; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; MOREHEAD MC, 1992, APPL ENVIRON MICROB, V58, P1617, DOI 10.1128/AEM.58.5.1617-1623.1992; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; NICHOLLS DG, 2001, BIOENERGETICS, V3, P17; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Petrezselyova S, 2008, MITOCHONDRION, V8, P117, DOI 10.1016/j.mito.2007.10.003; Pircher A, 2014, MOL CELL, V54, P147, DOI 10.1016/j.molcel.2014.02.024; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Ruggles KV, 2014, J BIOL CHEM, V289, P4417, DOI 10.1074/jbc.M113.515197; Safiulina D, 2006, J CELL PHYSIOL, V206, P347, DOI 10.1002/jcp.20476; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Shachar R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Silve S, 1996, MOL CELL BIOL, V16, P2719; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Stephan J, 2013, AGING CELL, V12, P574, DOI 10.1111/acel.12077; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeviani Massimo, 2003, Curr Neurol Neurosci Rep, V3, P423, DOI 10.1007/s11910-003-0026-9	83	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164175	10.1371/journal.pone.0164175	http://dx.doi.org/10.1371/journal.pone.0164175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711131	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600092
J	Arnold, WK; Savage, CR; Brissette, CA; Seshu, J; Livny, J; Stevenson, B				Arnold, William K.; Savage, Christina R.; Brissette, Catherine A.; Seshu, Janakiram; Livny, Jonathan; Stevenson, Brian			RNA-Seq of Borrelia burgdorferi in Multiple Phases of Growth Reveals Insights into the Dynamics of Gene Expression, Transcriptome Architecture, and Noncoding RNAs	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; DIFFERENTIAL EXPRESSION; RESPONSE REGULATOR; SURFACE-PROTEINS; PLASMID CONTENT; INFECTION; RPOS; SEQUENCE; GENOME; OSPC	Borrelia burgdorferi, the agent of Lyme disease, differentially expresses numerous genes and proteins as it cycles between mammalian hosts and tick vectors. Insights on regulatory mechanisms have been provided by earlier studies that examined B. burgdorferi gene expression patterns during cultivation. However, prior studies examined bacteria at only a single time point of cultivation, providing only a snapshot of what is likely a dynamic transcriptional program driving B. burgdorferi adaptations to changes during culture growth phases. To address that concern, we performed RNA sequencing (RNA-Seq) analysis of B. burgdorferi cultures at early-exponential, mid-exponential, and early-stationary phases of growth. We found that expression of nearly 18% of annotated B. burgdorferi genes changed significantly during culture maturation. Moreover, genome-wide mapping of the B. burgdorferi transcriptome in different growth phases enabled insight on transcript boundaries, operon structures, and identified numerous putative non-coding RNAs. These RNA-Seq data are discussed and presented as a resource for the community of researchers seeking to better understand B. burgdorferi biology and pathogenesis.	[Arnold, William K.; Savage, Christina R.; Stevenson, Brian] Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Brissette, Catherine A.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA; [Seshu, Janakiram] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Livny, Jonathan] Broad Inst MIT & Harvard, Cambridge, MA USA	University of Kentucky; University of North Dakota Grand Forks; University of Texas System; University of Texas at San Antonio (UTSA); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Stevenson, B (corresponding author), Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	brian.stevenson@uky.edu		Brissette, Catherine/0000-0003-0792-1403; Arnold, Will/0000-0003-2447-3489	National Institutes of Health [R03-AI113648, R21-AI120602]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI113648, R21AI120602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R03-AI113648 to B. Stevenson, J. Seshu, and J. Livny, and R21-AI120602 to B. Stevenson.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Bugrysheva JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118063; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Caimano MJ, 2015, INFECT IMMUN, V83, P3043, DOI 10.1128/IAI.00315-15; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Cloud JL, 1997, GENE, V194, P137, DOI 10.1016/S0378-1119(97)00196-0; Dobrikova EY, 2001, MOL MICROBIOL, V39, P370, DOI 10.1046/j.1365-2958.2001.02220.x; Drecktrah D, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1005160, 10.1371/journal.ppat.1005242]; Eggers CH, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P35; Elias AF, 2000, J BACTERIOL, V182, P2909, DOI 10.1128/JB.182.10.2909-2918.2000; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gaultney RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075643; Gautam A, 2009, FEMS MICROBIOL LETT, V293, P278, DOI 10.1111/j.1574-6968.2009.01542.x; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2006, MICROBIOL-SGM, V152, P2599, DOI 10.1099/mic.0.28996-0; Indest KJ, 1997, INFECT IMMUN, V65, P1165, DOI 10.1128/IAI.65.4.1165-1171.1997; Iqbal H, 2016, MOL MICROBIOL, V102, P757, DOI 10.1111/mmi.13492; Iyer R, 2016, MICROARRAYS, V5; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Jutras BL, 2013, J BACTERIOL, V195, P4915, DOI 10.1128/JB.00819-13; Jutras BL, 2013, J BIOL CHEM, V288, P26220, DOI 10.1074/jbc.M113.491357; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Li H, 2009, BIOINFORMATICS, V25, DOI 10.1093/bioinformatics/btp324; Livny J, 2014, NUCLEIC ACIDS RES, V42, P12212, DOI 10.1093/nar/gku891; Livny Jonathan, 2012, Methods Mol Biol, V905, P3, DOI 10.1007/978-1-61779-949-5_1; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; MARCONI RT, 1993, J BACTERIOL, V175, P926, DOI 10.1128/JB.175.4.926-932.1993; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller Jennifer C, 2005, Curr Protoc Microbiol, VChapter 1D, DOI 10.1002/9780471729259.mc01d03s00; Morrison TB, 1999, J CLIN MICROBIOL, V37, P987, DOI 10.1128/JCM.37.4.987-992.1999; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Nichols TL, 2000, FEMS MICROBIOL LETT, V183, P37, DOI 10.1111/j.1574-6968.2000.tb08930.x; Ojaimi C, 2005, INFECT IMMUN, V73, P6791, DOI 10.1128/IAI.73.10.6791-6802.2005; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Oliva G, 2015, FEMS MICROBIOL REV, V39, P331, DOI 10.1093/femsre/fuv022; Ostberg Y, 2004, J BACTERIOL, V186, P8472, DOI 10.1128/JB.186.24.8472-8477.2004; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthy R, 2005, J BACTERIOL, V187, P2592, DOI 10.1128/JB.187.8.2592-2600.2005; Ramamoorthy R, 1998, INFECT IMMUN, V66, P5119, DOI 10.1128/IAI.66.11.5119-5124.1998; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rhodes RG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-108; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Savage CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125440; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Stevenson B, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P87; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Wang YJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1555-8; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang HM, 2005, J BACTERIOL, V187, P7985, DOI 10.1128/JB.187.23.7985-7995.2005; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	88	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164165	10.1371/journal.pone.0164165	http://dx.doi.org/10.1371/journal.pone.0164165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706236	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200092
J	Reuter, L; Ritala, A; Linder, M; Joensuu, J				Reuter, Lauri; Ritala, Anneli; Linder, Markus; Joensuu, Jussi			Novel Hydrophobin Fusion Tags for Plant-Produced Fusion Proteins	PLOS ONE			English	Article							TRICHODERMA-REESEI; RECOMBINANT PROTEINS; NICOTIANA-BENTHAMIANA; 2-PHASE SYSTEMS; BODY FORMATION; PURIFICATION; HFBI; EXPRESSION; CELLS	Hydrophobin fusion technology has been applied in the expression of several recombinant proteins in plants. Until now, the technology has relied exclusively on the Trichoderma reesei hydrophobin HFBI. We screened eight novel hydrophobin tags, T. reesei HFBII, HFBIII, HFBIV, HFBV, HFBVI and Fusarium verticillioides derived HYD3, HYD4 and HYD5, for production of fusion proteins in plants and purification by two-phase separation. To study the properties of the hydrophobins, we used N-terminal and C-terminal GFP as a fusion partner. Transient expression of the hydrophobin fusions in Nicotiana benthamiana revealed large variability in accumulation levels, which was also reflected in formation of protein bodies. In two-phase separations, only HFBII and HFBIV were able to concentrate GFP into the surfactant phase from a plant extract. The separation efficiency of both tags was comparable to HFBI. When the accumulation was tested side by side, HFBII-GFP gave a better yield than HFBI-GFP, while the yield of HFBIV-GFP remained lower. Thus we present here two alternatives for HFBI as functional fusion tags for plant-based protein production and first step purification.	[Reuter, Lauri; Ritala, Anneli; Linder, Markus; Joensuu, Jussi] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Linder, Markus] Aalto Univ, Dept Biotechnol & Chem Technol, Espoo, Finland	VTT Technical Research Center Finland; Aalto University	Reuter, L (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	lauri.reuter@vtt.fi	Linder, Markus B/E-5879-2011; Linder, Markus/N-8043-2019	Linder, Markus B/0000-0002-7271-6441; Linder, Markus/0000-0002-7271-6441	Academy of Finland [252442]; Centres of Excellence Programme HYBER; Eurostars grant Hydropro [5320]; VTT Technical Research Centre of Finland Ltd.	Academy of Finland(Academy of Finland); Centres of Excellence Programme HYBER; Eurostars grant Hydropro; VTT Technical Research Centre of Finland Ltd.	We have received funding from Academy of Finland Grant number 252442 (AR LR JJ) and Centres of Excellence Programme HYBER (JJ ML) (http://www.aka.fi/) and Eurostars grant Hydropro 5320 (JJ) (www.eurostars-eureka.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are, or have been, employed by VTT Technical research Centre of Finland. VTT Technical Research Centre of Finland Ltd., provided support in the form of salaries for authors [LR, AR, ML, JJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P419, DOI 10.1111/j.1467-7652.2011.00596.x; Cox AR, 2009, FOOD HYDROCOLLOID, V23, P366, DOI 10.1016/j.foodhyd.2008.03.001; Espino-Rammer L, 2013, APPL ENVIRON MICROB, V79, P4230, DOI 10.1128/AEM.01132-13; Fuchs U, 2004, FUNGAL GENET BIOL, V41, P852, DOI 10.1016/j.fgb.2004.04.004; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099347; Jacquet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115944; Joensuu JJ, 2012, METHODS MOL BIOL, V824, P527, DOI 10.1007/978-1-61779-433-9_28; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kisko K, 2007, J APPL CRYSTALLOGR, V40, pS355, DOI 10.1107/S0021889807001331; Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014; Lienemann M, 2013, APPL ENVIRON MICROB, V79, P5533, DOI 10.1128/AEM.01493-13; Linder M, 2002, PROTEIN SCI, V11, P2257, DOI 10.1110/ps.0207902; Linder M, 2001, BIOMACROMOLECULES, V2, P511, DOI 10.1021/bm0001493; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Miletic S, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01221; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; NakariSetala T, 1997, EUR J BIOCHEM, V248, P415, DOI 10.1111/j.1432-1033.1997.00415.x; Pereira EO, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-59; Reuter LJ, 2014, PLANT BIOTECHNOL J, V12, P402, DOI 10.1111/pbi.12147; Saberianfar R, 2015, PLANT BIOTECHNOL J, V13, P927, DOI 10.1111/pbi.12329; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Valo HK, 2010, ACS NANO, V4, P1750, DOI 10.1021/nn9017558; Varjonen S, 2011, SOFT MATTER, V7, P2402, DOI 10.1039/c0sm01114b	26	12	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164032	10.1371/journal.pone.0164032	http://dx.doi.org/10.1371/journal.pone.0164032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706254	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200076
J	Hayano, T; Matsui, H; Nakaoka, H; Ohtake, N; Hosomichi, K; Suzuki, K; Inoue, I				Hayano, Takahide; Matsui, Hiroshi; Nakaoka, Hirofumi; Ohtake, Nobuaki; Hosomichi, Kazuyoshi; Suzuki, Kazuhiro; Inoue, Ituro			Germline Variants of Prostate Cancer in Japanese Families	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; SUSCEPTIBILITY LOCI; SOMATIC MUTATIONS; BRCA2 MUTATIONS; BREAST-CANCER; DISCOVERY; GENOME; GENES; FRAMEWORK; HOXB13	Prostate cancer (PC) is the second most common cancer in men. Family history is the major risk factor for PC. Only two susceptibility genes were identified in PC, BRCA2 and HOXB13. A comprehensive search of germline variants for patients with PC has not been reported in Japanese families. In this study, we conducted exome sequencing followed by Sanger sequencing to explore responsible germline variants in 140 Japanese patients with PC from 66 families. In addition to known susceptibility genes, BRCA2 and HOXB13, we identified TRRAP variants in a mutually exclusive manner in seven large PC families (three or four patients per family). We also found shared variants of BRCA2, HOXB13, and TRRAP from 59 additional small PC families (two patients per family). We identified two deleterious HOXB13 variants (F127C and G132E). Further exploration of the shared variants in rest of the families revealed deleterious variants of the so-called cancer genes (ATP1A1, BRIP1, FANCA, FGFR3, FLT3, HOXD11, MUTYH, PDGFRA, SMARCA4, and TCF3). The germline variant profile provides a new insight to clarify the genetic etiology and heterogeneity of PC among Japanese men.	[Hayano, Takahide; Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Mishima, Shizuoka, Japan; [Matsui, Hiroshi; Ohtake, Nobuaki; Suzuki, Kazuhiro] Gunma Univ, Grad Sch Med, Dept Urol, Maebashi, Gunma, Japan; [Hosomichi, Kazuyoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa 9201192, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Gunma University; Kanazawa University	Inoue, I (corresponding author), Natl Inst Genet, Div Human Genet, Mishima, Shizuoka, Japan.	itinoue@nig.ac.jp	Hosomichi, Kazuyoshi/K-9477-2015	Hosomichi, Kazuyoshi/0000-0003-2712-1825; Nakaoka, Hirofumi/0000-0002-8454-1159				Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bourdeaut F, 2013, AM J MED GENET A, V161A, P382, DOI 10.1002/ajmg.a.35719; Cavanagh H, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-015-0038-x; Choi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ellingson MS, 2015, BREAST CANCER RES TR, V153, P435, DOI 10.1007/s10549-015-3545-6; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu W, 2015, NATURE, V493, P216; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Hirotsu Y, 2015, MOL GENET GENOM MED, V3, P121, DOI 10.1002/mgg3.120; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Hoffmann TJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004930; Hu N, 2004, ONCOGENE, V23, P852, DOI 10.1038/sj.onc.1207150; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leongamornlert D, 2014, BRIT J CANCER, V110, P1663, DOI 10.1038/bjc.2014.30; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin XL, 2013, PROSTATE, V73, P169, DOI 10.1002/pros.22552; Maia S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132728; Marugame T, 2006, JPN J CLIN ONCOL, V36, P399, DOI 10.1093/jjco/hyl049; Matsui H, 2004, J HUM GENET, V49, P9, DOI 10.1007/s10038-003-0099-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorman AV, 2016, HAEMATOLOGICA, V101, P407, DOI 10.3324/haematol.2015.141101; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Postow MA, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-16; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Raval SH, 2016, VET WORLD, V9, P80, DOI 10.14202/vetworld.2016.80-90; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Taketani T, 2002, CANCER RES, V62, P33; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Wang J, 2016, J BREAST CANCER, V19, P61, DOI 10.4048/jbc.2016.19.1.61; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Yamaguchi-Kabata Yumi, 2015, Hum Genome Var, V2, P15050, DOI 10.1038/hgv.2015.50	50	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164233	10.1371/journal.pone.0164233	http://dx.doi.org/10.1371/journal.pone.0164233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701467	Green Submitted, gold, Green Published			2022-12-26	WOS:000385696900052
J	Jain, CV; Jessmon, P; Kilburn, BA; Jodar, M; Sendler, E; Krawetz, SA; Armant, DR				Jain, Chandni V.; Jessmon, Philip; Kilburn, Brian A.; Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.; Armant, D. Randall			Regulation of HBEGF by Micro-RNA for Survival of Developing Human Trophoblast Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEIN-SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; MESSENGER-RNA; GENE-EXPRESSION; BINDING; PREECLAMPSIA; PHOSPHORYLATION; TRANSLATION; BIOGENESIS	Introduction The growth factor HBEGF is upregulated post-transcriptionally in the low O-2 environment of the human placenta during the first 10 weeks of pregnancy. We have examined the possible roles of HBEGF turnover and micro-RNA (miRNA) in its regulation by O-2 in human first trimester trophoblast. Methods HTR-8/SVneo trophoblast cells were cultured at 2% or 20% O-2. The cells were transfected with a dual luciferase reporter construct (psiCHECK-2) containing no insert (control), the HBEGF 3' untranslated region (3' UTR), or sub-regions of the 3' UTR, as well as with siRNA for DGCR8. RNA was extracted from trophoblast cells cultured at 2% O-2 for 0-4 h for next-generation sequencing. HBEGF was quantified by ELISA. HBEGF, DGCR8, and beta-actin were examined by western blotting. Results Protein turnover studies, using 10 mu g/ml cyclohexamide, 1 mu g/ml lactocystin, or 100 mu g/ml MG132, demonstrated faster HBEGF degradation at 20% O-2 than 2% O-2, mediated by the proteasome. However, proteasome inhibition failed to initiate HBEGF accumulation at 20% O-2. Reporter assays, comparing to empty vector, demonstrated that the intact HBEGF 3' UTR inhibited expression (0.26), while fragments containing only its flanking regions increased reporter activity (3.15; 3.43). No differential expression of miRNAs was found in trophoblast cells cultured at 2% and 20% O-2. Nevertheless, HBEGF upregulation at 2% O-2 was blocked when the miRNA-processing protein DGCR8 was silenced, suggesting a role for miRNA. Conclusion Our findings suggest involvement of flanking regions of the 3'UTR in activating HBEGF protein synthesis in response to 2% O-2, possibly through a miRNA-mediated mechanism.	[Jain, Chandni V.; Jessmon, Philip] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Jain, Chandni V.; Kilburn, Brian A.; Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.; Armant, D. Randall] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Jessmon, Philip; Armant, D. Randall] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.] Wayne State Univ, Sch Med, Dept Ctr Mol Med & Genet, Detroit, MI USA; [Armant, D. Randall] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, US Dept HHS, Bethesda, MD 20892 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Armant, DR (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Armant, DR (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Armant, DR (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, US Dept HHS, Bethesda, MD 20892 USA.	d.armant@wayne.edu	krawetz, stephen/GQQ-3308-2022; Jodar, Meritxell/F-1961-2016	Jodar, Meritxell/0000-0002-3272-0163	NICHD NIH HHS [R21 HD071408] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Armant DR, 2015, PLACENTA, V36, P270, DOI 10.1016/j.placenta.2014.12.006; Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; DiFederico E, 1999, AM J PATHOL, V155, P293, DOI 10.1016/S0002-9440(10)65123-1; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kilburn BA, 2000, BIOL REPROD, V62, P739, DOI 10.1095/biolreprod62.3.739; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Leach RE, 1999, J CLIN ENDOCR METAB, V84, P3355, DOI 10.1210/jc.84.9.3355; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; Leach RE, 2002, LANCET, V360, P1215, DOI 10.1016/S0140-6736(02)11283-9; Leach RE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.009; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pang ALY, 2009, BIOL REPROD, V81, P302, DOI 10.1095/biolreprod.108.073221; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yoo HJ, 1997, DEV GENET, V21, P102, DOI 10.1002/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C; Yukawa K, 1999, MOL BRAIN RES, V69, P124, DOI 10.1016/S0169-328X(99)00086-8; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	70	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163913	10.1371/journal.pone.0163913	http://dx.doi.org/10.1371/journal.pone.0163913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701455	Green Submitted, gold, Green Published			2022-12-26	WOS:000385696900031
J	Lee, HJ; Kim, SJ				Lee, Haeng Jin; Kim, Seong-Joon			Factors Associated with Visual Fatigue from Curved Monitor Use: A Prospective Study of Healthy Subjects	PLOS ONE			English	Article							TRANSIENT MYOPIA; 3D DISPLAYS; DRY EYE; ASTHENOPIA; ACCOMMODATION; PUPILLARY; SYMPTOMS; NEARWORK	Purpose To investigate the factors associated with visual fatigue using monitors with various radii of curvature. Methods Twenty normal healthy adults (8 men, 12 women; mean age, 26.2 +/- 2.5 years) prospectively watched five types of monitors including flat, 4000R, 3000R, 2000R, and 1000R curved monitors for 30 min. An experienced examiner measured the ophthalmological factors including near point of accommodation (NPA), near point of convergence (NPC), refraction, parameters during pupil response at light and saccadic movement just before and after the visual tasks. The questionnaires about subjective ocular symptoms were also investigated just before and after the visual tasks. Results The NPA increased after the visual tasks with a flat monitor compared with the curved monitors, with the 1000R curved monitor showing the smallest change (p = 0.020). The NPC increased for every monitor after the visual tasks; the largest increase occurred with the flat monitor (p = 0.001). There was no difference in refractive error, pupil response, or saccadic movement in the comparison of before and after the visual tasks. Among the nine factors in the questionnaire, the score of "eyepain" was significantly higher for the flat monitor versus the 1000R curved monitor after the visual tasks (p = 0.034). Conclusions We identified NPA, NPC, and eye pain as factors associated with visual fatigue. Also, the curvature of the monitor was related to the visual fatigue.	[Lee, Haeng Jin; Kim, Seong-Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Seong-Joon] Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Kim, SJ (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Seoul, South Korea.	ophjun@snu.ac.kr						Butzon Steve P, 2002, Optometry, V73, P221; Byron Jones MGK, 2003, DESIGN ANAL CROSS OV; Ciuffreda KJ, 2008, OPHTHAL PHYSL OPT, V28, P103, DOI 10.1111/j.1475-1313.2008.00550.x; CIUFFREDA KJ, 1995, OPTOMETRY VISION SCI, V72, P506, DOI 10.1097/00006324-199507000-00011; DAIN SJ, 1988, AM J OPTOM PHYS OPT, V65, P162; EHRLICH DL, 1987, OPHTHAL PHYSL OPT, V7, P353, DOI 10.1111/j.1475-1313.1987.tb00760.x; GUR S, 1994, OCCUP MED-OXFORD, V44, P201, DOI 10.1093/occmed/44.4.201; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HIKICHI T, 1995, GRAEF ARCH CLIN EXP, V233, P555, DOI 10.1007/BF00404705; Iwasaki T, 2002, OPHTHAL PHYSL OPT, V22, P113, DOI 10.1046/j.1475-1313.2002.00014.x; IWASAKI T, 1988, ERGONOMICS, V31, P1743, DOI 10.1080/00140138808966825; Matsuda T, 2008, JPN J OPHTHALMOL, V52, P79, DOI 10.1007/s10384-007-0515-5; Salibello C, 1995, J Am Optom Assoc, V66, P479; Scheiman M, 1996, J Am Optom Assoc, V67, P531; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Thomson WD, 1998, OPHTHAL PHYSL OPT, V18, P111, DOI 10.1016/S0275-5408(97)00067-7; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Wee SW, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-29; Wee SW, 2012, BRIT J OPHTHALMOL, V96, P1391, DOI 10.1136/bjophthalmol-2012-301690	21	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164022	10.1371/journal.pone.0164022	http://dx.doi.org/10.1371/journal.pone.0164022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701441	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900039
J	Suriyanarayanan, T; Periasamy, S; Lin, MH; Ishihama, Y; Swarup, S				Suriyanarayanan, Tanujaa; Periasamy, Saravanan; Lin, Miao-Hsia; Ishihama, Yasushi; Swarup, Sanjay			Flagellin FliC Phosphorylation Affects Type 2 Protease Secretion and Biofilm Dispersal in Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							III SECRETION; SER/THR/TYR PHOSPHOPROTEOME; SYSTEMS; GENE; PILI; ATTACHMENT; EXPRESSION; RESISTANCE; PEPTIDES; PROTEINS	Protein phosphorylation has a major role in controlling the life-cycle and infection stages of bacteria. Proteome-wide occurrence of S/T/Y phosphorylation has been reported for many prokaryotic systems. Previously, we reported the phosphoproteome of Pseudomonas aeruginosa and Pseudomonas putida. In this study, we show the role of S/T phosphorylation of one motility protein, FliC, in regulating multiple surface-associated phenomena of P. aeruginosa PAO1. This is the first report of occurrence of phosphorylation in the flagellar protein, flagellin FliC in its highly conserved N-terminal NDO domain across several Gram negative bacteria. This phosphorylation is likely a well-regulated phenomenon as it is growth phase dependent in planktonic cells. The absence of phosphorylation in the conserved T27 and S28 residues of FliC, interestingly, did not affect swimming motility, but affected the secretome of type 2 secretion system (T2SS) and biofilm formation of PAO1. FliC phosphomutants had increased levels and activities of type 2 secretome proteins. The secretion efficiency of T2SS machinery is associated with flagellin phosphorylation. FliC phosphomutants also formed reduced biofilms at 24 h under static conditions and had delayed biofilm dispersal under dynamic flow conditions, respectively. The levels of type 2 secretome and biofilm formation under static conditions had an inverse correlation. Hence, increase in type 2 secretome levels was accompanied by reduced biofilm formation in the FliC phosphomutants. As T2SS is involved in nutrient acquisition and biofilm dispersal during survival and spread of P. aeruginosa, we propose that FliC phosphorylation has a role in ecological adaptation of this opportunistic environmental pathogen. Altogether, we found a system of phosphorylation that affects key surface related processes such as proteases secretion by T2SS, biofilm formation and dispersal.	[Suriyanarayanan, Tanujaa; Swarup, Sanjay] Natl Univ Singapore, Metabolites Biol Lab, Dept Biol Sci, Singapore, Singapore; [Suriyanarayanan, Tanujaa] Natl Univ Singapore, Microbiol Lab, Fac Dent, Singapore, Singapore; [Swarup, Sanjay] Natl Univ Singapore, NERI, Singapore, Singapore; [Periasamy, Saravanan; Swarup, Sanjay] Nanyang Technol Univ, SCELSE, Singapore, Singapore; [Swarup, Sanjay] Natl Univ Singapore, Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore, Singapore; [Periasamy, Saravanan] Rajalakshmi Engn Coll, Madras, Tamil Nadu, India; [Lin, Miao-Hsia; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Bioanal, Kyoto, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Rajalakshmi Engineering College; Kyoto University	Swarup, S (corresponding author), Natl Univ Singapore, Metabolites Biol Lab, Dept Biol Sci, Singapore, Singapore.; Swarup, S (corresponding author), Natl Univ Singapore, NERI, Singapore, Singapore.; Swarup, S (corresponding author), Nanyang Technol Univ, SCELSE, Singapore, Singapore.; Swarup, S (corresponding author), Natl Univ Singapore, Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore, Singapore.	sanjay@nus.edu.sg	Ishihama, Yasushi/B-3101-2016; Swarup, Sanjay/I-1592-2012; periasamy, saravanan/AAF-2860-2020	Ishihama, Yasushi/0000-0001-7714-203X; Swarup, Sanjay/0000-0001-6391-0624; 	Mechanobiology Institute (MBI), National University of Singapore, Singapore [R714-010-006-271]	Mechanobiology Institute (MBI), National University of Singapore, Singapore(National University of Singapore)	This work was supported by grant number R714-010-006-271 from Mechanobiology Institute (MBI), National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; FLETCHER EL, 1993, CURR EYE RES, V12, P1067, DOI 10.3109/02713689309033504; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jarrell KF, 2011, FEMS MICROBIOL LETT, V319, P44, DOI 10.1111/j.1574-6968.2011.02264.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Kuang ZZ, 2011, MOL MICROBIOL, V79, P1220, DOI 10.1111/j.1365-2958.2010.07516.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194; Lemon KP, 2015, CURR TOP MICROBIOL I, V322, P1, DOI [10.1007/978-3-540-75418-3, DOI 10.1007/978-3-540-75418-3_1]; Levine A, 2006, PROTEOMICS, V6, P2157, DOI 10.1002/pmic.200500352; Lin MH, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3117; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Macek B, 2011, PROTEOMICS, V11, P3002, DOI 10.1002/pmic.201100012; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Ravichandran A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123805; Ravichandran A, 2009, PROTEOMICS, V9, P2764, DOI 10.1002/pmic.200800655; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robert V, 2005, RES MICROBIOL, V156, P880, DOI 10.1016/j.resmic.2005.04.002; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Senf F, 2008, MICROBIOL-SGM, V154, P3025, DOI 10.1099/mic.0.2008/018069-0; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Sun XS, 2010, J PROTEOME RES, V9, P275, DOI 10.1021/pr900612v; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	54	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164155	10.1371/journal.pone.0164155	http://dx.doi.org/10.1371/journal.pone.0164155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701473	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900046
J	Nunes, IKD; de Souza, ET; Cardozo, SVS; Carvalho, VD; Romeiro, NC; Silva, PMRE; Martins, MA; Barreiro, EJ; Lima, LM				da Costa Nunes, Isabelle Karine; de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Carvalho, Vinicius de Frias; Romeiro, Nelilma Correia; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira			Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SWISS-MODEL WORKSPACE; PDE4 INHIBITORS; AIRWAY INFLAMMATION; DRUG DISCOVERY; ASTHMA; EOSINOPHILS; POTENT; SELECTIVITY; STRATEGY	Prior investigations showed that increased levels of cyclic AMP down-regulate lung inflammatory changes, stimulating the interest in phosphodiesterase (PDE) 4 as therapeutic target. Here, we described the synthesis, pharmacological profile and docking properties of a novel sulfonamide series (5 and 6a-k) designed as PDE4 inhibitors. Compounds were screened for their selectivity against the four isoforms of human PDE4 using an IMAP fluorescence polarized protocol. The effect on allergen-or LPS-induced lung inflammation and airway hyperreactivity (AHR) was studied in A/J mice, while the xylazine/ketamine-induced anesthesia test was employed as a behavioral correlate of emesis in rodents. As compared to rolipram, the most promising screened compound, 6a (LASSBio-448) presented a better inhibitory index concerning PDE4D/PDE4A or PDE4D/PDE4B. Accordingly, docking analyses of the putative interactions of LASSBio-448 revealed similar poses in the active site of PDE4A and PDE4C, but slight unlike orientations in PDE4B and PDE4D. LASSBio-448 (100 mg/kg, oral), 1 h before provocation, inhibited allergen-induced eosinophil accumulation in BAL fluid and lung tissue samples. Under an interventional approach, LASSBio-448 reversed ongoing lung eosinophilic infiltration, mucus exacerbation, peribronchiolar fibrosis and AHR by allergen provocation, in a mechanism clearly associated with blockade of pro-inflammatory mediators such as IL-4, IL-5, IL-13 and eotaxin-2. LASSBio-448 (2.5 and 10 mg/kg) also prevented inflammation and AHR induced by LPS. Finally, the sulfonamide derivative was shown to be less pro-emetic than rolipram and cilomilast in the assay employed. These findings suggest that LASSBio-448 is a new PDE4 inhibitor with marked potential to prevent and reverse pivotal pathological features of diseases characterized by lung inflammation, such as asthma.	[da Costa Nunes, Isabelle Karine; Carvalho, Vinicius de Frias; Romeiro, Nelilma Correia; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [da Costa Nunes, Isabelle Karine; de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Carvalho, Vinicius de Frias; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio] Inst Oswaldo Cruz Fiocruz, Lab Inflamacao, Rio De Janeiro, Brazil; [Romeiro, Nelilma Correia] Univ Fed Rio de Janeiro, Nucl Pesquisas Ecol & Desenvolvimento Social Maca, Macae, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Martins, MA; Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Inst Ciencias Biomed, Rio De Janeiro, Brazil.; Martins, MA; Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil.; Martins, MA (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Inflamacao, Rio De Janeiro, Brazil.	mam2856@gmail.com; lidia@lassbio.icb.ufrj.br	Lima, Lidia M/D-9587-2015; Carvalho, Vinicius F/M-4762-2016; Barreiro, Eliezer J/B-1131-2011; SILVA, PATRICIA MACHADO RODRIGUES E/AAS-4906-2020	Lima, Lidia M/0000-0002-8625-6351; Barreiro, Eliezer J/0000-0003-1759-0038; 	CNPq; FAPERJ; FAPEAL; CAPES; INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPEAL(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-INOFAR	This work was supported by CNPq, FAPERJ, FAPEAL, CAPES, and INCT-INOFAR (573.564/2008-6 and E-26/170.020/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARCO A, 1973, SYNTHESIS-STUTTGART, P316; Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Card GL, 2005, NAT BIOTECHNOL, V23, P201, DOI 10.1038/nbt1059; Cheng R.K.Y., 2009, Crystal structure of human PDE4a with 4-(3-butoxy-4-methoxyphenyl)methyl-2- imidazolidone, DOI [10.2210/pdb3i8v/pdb, DOI 10.2210/PDB3I8V/PDB]; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Chung KF, 2012, CURR OPIN PULM MED, V18, P35, DOI 10.1097/MCP.0b013e32834d09a5; Coelho LP, 2008, J PHARMACOL EXP THER, V327, P206, DOI 10.1124/jpet.108.138032; Nunes IKC, 2014, CURR TOP MED CHEM, V14, P1388, DOI 10.2174/1568026614666140506123718; DeNinno MP, 2012, BIOORG MED CHEM LETT, V22, P6794, DOI 10.1016/j.bmcl.2012.09.028; Ferreira TPT, 2013, J IMMUNOL, V191, P5220, DOI 10.4049/jimmunol.1203551; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gewald R, 2013, BIOORG MED CHEM LETT, V23, P4308, DOI 10.1016/j.bmcl.2013.05.099; Giembycz MA, 2001, EXPERT OPIN INV DRUG, V10, P1361, DOI 10.1517/13543784.10.7.1361; Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Kobayashi M, 2011, INT IMMUNOPHARMACOL, V11, P732, DOI 10.1016/j.intimp.2011.01.023; Kodimuthali A, 2008, J MED CHEM, V51, P5471, DOI 10.1021/jm800582j; Lima L M, 1999, Pharm Acta Helv, V73, P281, DOI 10.1016/S0031-6865(99)00004-7; Lima LMA, 2005, CURR MED CHEM, V12, P23, DOI 10.2174/0929867053363540; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Montana JG, 1998, BIOORG MED CHEM LETT, V8, P2635, DOI 10.1016/S0960-894X(98)00491-0; Moretto N, 2015, J PHARMACOL EXP THER, V352, P559, DOI 10.1124/jpet.114.220541; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Nials AT, 2011, J PHARMACOL EXP THER, V337, P137, DOI 10.1124/jpet.110.173641; Niu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082360; O'Byrne PM, 2013, CAN RESPIR J, V20, P23, DOI 10.1155/2013/183948; Olsen PC, 2011, CLIN EXP ALLERGY, V41, P250, DOI 10.1111/j.1365-2222.2010.03580.x; Olsen PC, 2012, EUR J PHARMACOL, V680, P102, DOI 10.1016/j.ejphar.2012.01.040; Page CP, 2014, INT ARCH ALLERGY IMM, V165, P152, DOI 10.1159/000368800; Patel M, 2015, CHRON RESP DIS, V12, P165, DOI 10.1177/1479972315573529; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Saglani S, 2015, EUR RESPIR J, V46, P1796, DOI 10.1183/13993003.01196-2014; Serra MF, 2016, ANESTHESIOLOGY, V124, P109, DOI 10.1097/ALN.0000000000000919; Serra MF, 2012, ANESTHESIOLOGY, V117, P580, DOI 10.1097/ALN.0b013e31826687d5; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Villetti G, 2015, J PHARMACOL EXP THER, V352, P568, DOI 10.1124/jpet.114.220558; Walsh ER, 2010, DISCOV MED, V9, P357; Wang HC, 2007, BIOCHEM J, V408, P193, DOI 10.1042/BJ20070970; Wills-Karp M, 2004, SCIENCE, V305, P1726, DOI 10.1126/science.1104134	51	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162895	10.1371/journal.pone.0162895	http://dx.doi.org/10.1371/journal.pone.0162895			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695125	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100017
J	Jerczynski, O; Lacroix-Pepin, N; Boilard, E; Calvo, E; Bernet, A; Fortier, MA; Bjorkgren, I; Sipila, P; Belleannee, C				Jerczynski, Olivia; Lacroix-Pepin, Nicolas; Boilard, Eric; Calvo, Ezequiel; Bernet, Agathe; Fortier, Michel A.; Bjorkgren, Ida; Sipila, Petra; Belleannee, Clemence			Role of Dicer1-DependentFactors in the Paracrine Regulation of Epididymal Gene Expression	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; INTERCELLULAR COMMUNICATION; MICRORNA BIOGENESIS; SPERM; PROSTASOMES; SED1/MFG-E8; SPERMATOZOA; POPULATION; SECRETION; MEMBRANE	Dicer1 is an endoribonuclease involved in the biogenesis of functional molecules such as microRNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs). These small non-coding RNAs are important regulators of post-transcriptional gene expression and participate in the control of male fertility. With the knowledge that 1) Dicer1-dependent factors are required for proper sperm maturation in the epididymis, and that 2) miRNAs are potent mediators of intercellular communication in most biological systems, we investigated the role of Dicer1-dependent factors produced by the proximal epididymis (initial segment/caput)-including miRNAs-on the regulation of epididymal gene expression in the distal epididymis regions (i.e. corpus and cauda). To this end, we performed comparative microarray and ANOVA analyses on control vs. Defb41(iCre/wt); Dicer1(fl/fl) mice in which functional Dicer1 is absent from the principal cells of the proximal epididymis. We identified 35 and 33 transcripts that displayed significant expression level changes in the corpus and cauda regions (Fold change > 2 or < -2; p < 0.002), respectively. Among these transcripts, Zn-alpha 2-glycoprotein (Azgp1) encodes for a sperm equatorial protein whose expression in the epididymis of Dicer1 cKO mice is significantly increased compared to controls. In addition, 154 miRNAs, including miR-210, miR-672, miR-191 and miR-204, showed significantly impaired biogenesis in the absence of Dicer1 from the principal cells of the proximal epididymis (Fold change > 2 or < -2; p < 0.01). These miRNAs are secreted via extracellular vesicles (EVs) derived from the DC2 epididymal principal cell line, and their expression correlates with target transcripts involved in distinct biological pathways, as evidenced by in silico analysis. Albeit correlative and based on in silico approach, our study proposes that Dicer1-dependent factors trigger-directly or not-significant genes expression changes in distinct regions of this organ. The paracrine control of functions important to post-testicular sperm maturation by Dicer1-dependent factors may open new avenues for the identification of molecular targets important to male fertility control.	[Jerczynski, Olivia; Lacroix-Pepin, Nicolas; Bernet, Agathe; Fortier, Michel A.; Belleannee, Clemence] Univ Laval, Dept Obstet Gynecol & Reprod, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada; [Boilard, Eric] Univ Laval, Dept Immun & Infect Dis, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada; [Calvo, Ezequiel] CHU Quebec Res Ctr CHUL, Endocrinol Unit, Quebec City, PQ, Canada; [Bjorkgren, Ida] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Bjorkgren, Ida] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA USA	Laval University; Laval University; Laval University; University of Turku; University of Turku; University of California System; University of California Berkeley	Belleannee, C (corresponding author), Univ Laval, Dept Obstet Gynecol & Reprod, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada.	Clemence.Belleannee@crchudequebec.ulaval.ca	Sipilä, Petra/GYE-3323-2022	Sipila, Petra/0000-0001-8187-7143; Bjorkgren, Ida/0000-0001-6678-2672	NSERC [CG109194, CG81470]; Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship	This work was supported by NSERC discovery grants CG109194 (to C.B) and CG81470 (to MAF). OJ is recipient of a Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2002, J ANDROL, V23, P854; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belleannee C, 2013, BIOL REPROD, DOI [10.1095/bioireprod.113.110486, DOI 10.1095/BIOIREPROD.113.110486]; Belleannee C, 2013, HUM REPROD, V28, P1455, DOI 10.1093/humrep/det088; Belleannee C, 2012, CELL TISSUE RES, V349, P717, DOI 10.1007/s00441-012-1381-0; Belleannee C, 2010, AM J PHYSIOL-CELL PH, V298, pC817, DOI 10.1152/ajpcell.00460.2009; Bjorkgren I, 2015, FASEB J, V29, P433, DOI 10.1096/fj.14-259382; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cloutier N, 2013, EMBO MOL MED, V5, P235, DOI 10.1002/emmm.201201846; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; Cooper TG, 1996, ANDROLOGIA, V28, P57; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; Ding ZD, 2007, MOL REPROD DEV, V74, P1124, DOI 10.1002/mrd.20624; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680; Hubert A, 2015, JAIDS-J ACQ IMM DEF, V70, P219, DOI 10.1097/QAI.0000000000000756; Jerczynski O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163876; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Kaur Gurvinder, 2012, Spermatogenesis, V2, P1; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mello CC, 2007, ANGEW CHEM INT EDIT, V46, P6985, DOI 10.1002/anie.200701713; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajesh A, 2015, J REPROD IMMUNOL, V110, P117, DOI 10.1016/j.jri.2015.02.009; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Raymond AS, 2010, MOL REPROD DEV, V77, P550, DOI 10.1002/mrd.21189; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Ronquist G, 2012, J INTERN MED, V271, P400, DOI 10.1111/j.1365-2796.2011.02487.x; Ronquist GK, 2012, PROSTATE, V72, P1736, DOI 10.1002/pros.22526; Rousseau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116812; Ruan YC, 2012, J PHYSIOL-LONDON, V590, P4209, DOI 10.1113/jphysiol.2012.230581; Rybak-Wolf A, 2014, CELL, V159, P1153, DOI 10.1016/j.cell.2014.10.040; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Shrimal S, 2013, J CELL SCI, V126, P5513, DOI 10.1242/jcs.139584; Shur BD, 2004, CURR OPIN CELL BIOL, V16, P477, DOI 10.1016/j.ceb.2004.07.005; Sullivan R, 2015, ASIAN J ANDROL, V17, P726, DOI 10.4103/1008-682X.155255; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; Suryawanshi AR, 2012, J ANDROL, V33, P963, DOI 10.2164/jandrol.111.014753; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Turunen HT, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-128; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yuan SQ, 2016, DEVELOPMENT, V143, P635, DOI 10.1242/dev.131755; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023	71	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163876	10.1371/journal.pone.0163876	http://dx.doi.org/10.1371/journal.pone.0163876			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695046	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100060
J	Magalhaes, A; Matias, I; Palmela, I; Brito, MA; Dias, S				Magalhaes, Ana; Matias, Ines; Palmela, Ines; Brito, Maria Alexandra; Dias, Sergio			LDL-Cholesterol Increases the Transcytosis of Molecules through Endothelial Monolayers	PLOS ONE			English	Article							VASCULAR-PERMEABILITY; ALZHEIMERS-DISEASE; BARRIER FUNCTION; METASTASIS; KINASE; ATHEROSCLEROSIS; DYSFUNCTION; ACTIVATION; INTEGRITY; PATHWAYS	Cholesterol has been identified as a causative factor in numerous pathologies including atherosclerosis and cancer. One of the frequent effects of elevated cholesterol levels in humans is the compromise of endothelial function due to activation of pro-inflammatory signalling pathways. While the mechanisms involved in endothelial activation by cholesterol during an inflammatory response are well established, less is known about the mechanisms by which cholesterol may affect endothelial barrier function, which were the subject of the present study. Here we show that low density lipoprotein (LDL) increases the permeability of endothelial monolayers to high molecular weight dextrans in an LDL receptor and cholesterol-dependent manner. The increased permeability seen upon LDL treatment was not caused by disruption of cell-to-cell junctions as determined by a normal localization of VE-Cadherin and ZO-1 proteins, and no major alterations in transendothelial electrical resistance or permeability to fluorescein. We show instead that LDL increases the level of high molecular weight transcytosis and that this occurs in an LDL receptor, cholesterol and caveolae-dependent way. Our findings contribute to our understanding of the systemic pathological effects of elevated cholesterol and the transport of cargo through endothelial monolayers.	[Magalhaes, Ana; Matias, Ines; Dias, Sergio] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Palmela, Ines; Brito, Maria Alexandra] Univ Lisbon, Fac Med, Res Inst Med, Lisbon, Portugal; [Brito, Maria Alexandra] Univ Lisbon, Fac Farm, Dept Biochem & Human Biol, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Dias, S (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	sergiodias@fm.ul.pt	brito, maria/M-8278-2013; iMed.ULisboa, NeuronGliaBiol/B-5403-2014; brito, maria/HDO-2541-2022; Dias, Sergio/L-1250-2014	brito, maria/0000-0002-8493-4649; Dias, Sergio/0000-0002-7603-4616; Magalhaes, Ana/0000-0001-9929-3218	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government; FCT [SFRH/BPD/73691/2010, SFRH/BD/61646/2009]	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government A. Magalhaes and Ines Palmela were recipients of FCT fellowships (SFRH/BPD/73691/2010 and SFRH/BD/61646/2009, respectivelly). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; dos Santos CR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-132; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Garcia-Roman J, 2013, CANCER LETT, V335, P259, DOI 10.1016/j.canlet.2013.03.005; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han JY, 2013, BLOOD, V122, P4140, DOI 10.1182/blood-2013-03-491423; Jiang X., 2012, INT J ALZHEIMERS DIS, V2012, P109324, DOI DOI 10.1155/2012/109324; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; LIAO LX, 1995, ARTERIOSCL THROM VAS, V15, P2305, DOI 10.1161/01.ATV.15.12.2305; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Notarnicola M, 2005, ONCOLOGY-BASEL, V68, P371, DOI 10.1159/000086977; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Rangaswamy S, 1997, CIRC RES, V80, P37, DOI 10.1161/01.RES.80.1.37; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Stancu CS, 2012, CELL TISSUE RES, V349, P433, DOI 10.1007/s00441-012-1437-1; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zhu Y, 2000, ARTERIOSCL THROM VAS, V20, P2465, DOI 10.1161/01.ATV.20.11.2465; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	27	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163988	10.1371/journal.pone.0163988	http://dx.doi.org/10.1371/journal.pone.0163988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695052	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100073
J	Francis, SS; Plucinski, MM; Wallace, AD; Riley, LW				Francis, Stephen Starko; Plucinski, Mateusz M.; Wallace, Amelia D.; Riley, Lee W.			Genotyping Oral Commensal Bacteria to Predict Social Contact and Structure	PLOS ONE			English	Article							HOST-RESISTANCE; TRANSMISSION; NETWORKS	Social network structure is a fundamental determinant of human health, from infectious to chronic diseases. However, quantitative and unbiased approaches to measuring social network structure are lacking. We hypothesized that genetic relatedness of oral commensal bacteria could be used to infer social contact between humans, just as genetic relatedness of pathogens can be used to determine transmission chains of pathogens. We used a traditional, questionnaire survey-based method to characterize the contact network of the School of Public Health at a large research university. We then collected saliva from a subset of individuals to analyze their oral microflora using a modified deep sequencing multilocus sequence typing (MLST) procedure. We examined micro-evolutionary changes in the S. viridans group to uncover transmission patterns reflecting social network structure. We amplified seven housekeeping gene loci from the Streptococcus viridans group, a group of ubiquitous commensal bacteria, and sequenced the PCR products using next-generation sequencing. By comparing the generated S. viridans reads between pairs of individuals, we reconstructed the social network of the sampled individuals and compared it to the network derived from the questionnaire survey-based method. The genetic relatedness significantly (p-value < 0.001) correlated with social distance in the questionnaire-based network, and the reconstructed network closely matched the network derived from the questionnaire survey-based method. Oral commensal bacterial are thus likely transmitted through routine physical contact or shared environment. Their genetic relatedness can be used to represent a combination of social contact and shared physical space, therefore reconstructing networks of contact. This study provides the first step in developing a method to measure direct social contact based on commensal organism genotyping, potentially capable of unmasking hidden social networks that contribute to pathogen transmission.	[Francis, Stephen Starko; Plucinski, Mateusz M.; Wallace, Amelia D.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Francis, Stephen Starko] Univ Calif San Francisco, Div Epidemiol & Biostat, San Francisco, CA 94143 USA; [Plucinski, Mateusz M.] Univ Calif Berkeley, Dept Environm Sci & Policy Management, Berkeley, CA 94720 USA; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Francis, SS; Plucinski, MM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.; Francis, SS (corresponding author), Univ Calif San Francisco, Div Epidemiol & Biostat, San Francisco, CA 94143 USA.; Plucinski, MM (corresponding author), Univ Calif Berkeley, Dept Environm Sci & Policy Management, Berkeley, CA 94720 USA.	stephen.francis@ucsf.edu; mplucinski@gmail.com		Plucinski, Mateusz/0000-0002-7322-4625	Berkeley Population Center [NICHD R21 HD056581]; National Cancer Institute [NCI 1T32CA151022-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD073964] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA151022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG012839] Funding Source: NIH RePORTER	Berkeley Population Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Berkeley Population Center (NICHD R21 HD056581) SSF, MMP, LWR (http://www.popcenter.berkeley.edu) and National Cancer Institute (NCI 1T32CA151022-01) SSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants of our study. The study was supported by grants from the Berkeley Population Center (NICHD R21 HD056581) and National Cancer Institute (NCI 1T32CA151022-01).	BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Cottam EM, 2008, P ROY SOC B-BIOL SCI, V275, P887, DOI 10.1098/rspb.2007.1442; Didelot X, 2014, MOL BIOL EVOL; Diez-Roux AV, 2011, EPIDEMIOLOGY, V22, P40, DOI 10.1097/EDE.0b013e318200d122; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Plucinski MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022685; Rivers CM, 2014, ARXIV14094607; Rojas IG, 2002, BRAIN BEHAV IMMUN, V16, P74, DOI 10.1006/brbi.2000.0619; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; VanderWaal KL, 2014, J ANIM ECOL, V83, P406, DOI 10.1111/1365-2656.12137; Worby CJ, 2014, ARXIV14011749; Ypma R, 2011, P ROYAL SOC B	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0160201	10.1371/journal.pone.0160201	http://dx.doi.org/10.1371/journal.pone.0160201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CV	27684062	Green Published, gold, Green Submitted			2022-12-26	WOS:000384328500005
J	Dewar, S; Sienkiewicz, N; Ong, HB; Wall, RJ; Horn, D; Fairlamb, AH				Dewar, Simon; Sienkiewicz, Natasha; Ong, Han B.; Wall, Richard J.; Horn, David; Fairlamb, Alan H.			The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOZOAN PARASITE LEISHMANIA; HUMAN AFRICAN TRYPANOSOMIASIS; ANTIOPPORTUNISTIC INFECTION AGENTS; PTERIDINE REDUCTASE 1; BLOOD-STREAM FORMS; SLEEPING SICKNESS; DIHYDROFOLATE-REDUCTASE; THYMIDYLATE SYNTHASE; FOLIC-ACID; METHOTREXATE RESISTANCE	The aim of this study was to identify and characterize mechanisms of resistance to antifolate drugs in African trypanosomes. Genome-wide RNAi library screens were undertaken in bloodstream form Trypanosoma brucei exposed to the antifolates methotrexate and raltitrexed. In conjunction with drug susceptibility and folate transport studies, RNAi knockdown was used to validate the functions of the putative folate transporters. The transport kinetics of folate and methotrexate were further characterized in whole cells. RNA interference target sequencing experiments identified a tandem array of genes encoding a folate transporter family, TbFT1-3, as major contributors to antifolate drug uptake. RNAi knockdown of TbFT1-3 substantially reduced folate transport into trypanosomes and reduced the parasite's susceptibly to the classical antifolates methotrexate and raltitrexed. In contrast, knockdown of TKFT1-3 increased susceptibly to the non-classical antifolates pyrimethamine and nolatrexed. Both folate and methotrexate transport were inhibited by classical antifolates but not by non-classical antifolates or biopterin. Thus, TbFT1-3 mediates the uptake of folate and classical antifolates in trypanosomes, and TbFT1-3 loss-of-function is a mechanism of antifolate drug resistance.	[Dewar, Simon; Sienkiewicz, Natasha; Ong, Han B.; Wall, Richard J.; Horn, David; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland; [Ong, Han B.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Dundee; Wellcome Trust Sanger Institute	Fairlamb, AH (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bldg, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329; Horn, David/0000-0001-5173-9284; Ong, Han/0000-0003-3369-8196; Wall, Richard J./0000-0003-3487-3187	Wellcome Trust [104242, 100320, 105021, 079838]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants 104242 studentship (to S. D.), 100320 (to D. H.), and 105021 and 079838 (to A. H. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chatelain E, 2011, DRUG DES DEV THER, V5, P175, DOI 10.2147/DDDT.S16381; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Dridi L, 2010, J BIOL CHEM, V285, P19767, DOI 10.1074/jbc.M110.114520; Dridi L, 2010, BIOCHEM PHARMACOL, V79, P30, DOI 10.1016/j.bcp.2009.07.019; Eadsforth TC, 2012, MOL BIOCHEM PARASIT, V181, P178, DOI 10.1016/j.molbiopara.2011.11.004; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Fairlamb AH, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.92, 10.1038/nmicrobiol.2016.92]; Fairlamb AH, 2012, NATURE, V482, P167, DOI 10.1038/482167a; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gazanion E, 2016, P NATL ACAD SCI USA, V113, pE3012, DOI 10.1073/pnas.1520693113; Gibson MW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004714; Glover L, 2015, NAT PROTOC, V10, P106, DOI 10.1038/nprot.2015.005; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; Graf FE, 2015, INT J PARASITOL-DRUG, V5, P65, DOI 10.1016/j.ijpddr.2015.04.002; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; JACKSON RC, 1984, ADV ENZYME REGUL, V22, P187, DOI 10.1016/0065-2571(84)90014-1; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jansen G, 1999, MOL PHARMACOL, V55, P761; Jones DC, 2010, BIOCHEM PHARMACOL, V80, P1478, DOI 10.1016/j.bcp.2010.07.038; Klaus SMJ, 2005, J BIOL CHEM, V280, P38457, DOI 10.1074/jbc.M507432200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Massimine KM, 2005, MOL BIOCHEM PARASIT, V144, P44, DOI 10.1016/j.molbiopara.2005.07.006; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Meiser J, 2016, FEBS J, V283, P3695, DOI 10.1111/febs.13731; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Odiit M, 1997, E AFR MED J, V74, P792; Ong HB, 2013, MOL MICROBIOL, V90, P443, DOI 10.1111/mmi.12376; Ouameur AA, 2008, MOL BIOCHEM PARASIT, V162, P155, DOI 10.1016/j.molbiopara.2008.08.007; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Pelphrey PM, 2007, J MED CHEM, V50, P940, DOI 10.1021/jm061027h; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Richard D, 2004, J BIOL CHEM, V279, P54494, DOI 10.1074/jbc.M409264200; Richard D, 2002, J BIOL CHEM, V277, P29460, DOI 10.1074/jbc.M204796200; Robays J, 2004, TROP MED INT HEALTH, V9, P542, DOI 10.1111/j.1365-3156.2004.01240.x; Shanks EJ, 2010, ANAL BIOCHEM, V396, P194, DOI 10.1016/j.ab.2009.09.003; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sienkiewicz N, 2010, MOL MICROBIOL, V77, P658, DOI 10.1111/j.1365-2958.2010.07236.x; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; SIROTNAK FM, 1985, CANCER RES, V45, P3992; Sokolova AY, 2010, ANTIMICROB AGENTS CH, V54, P2893, DOI 10.1128/AAC.00332-10; Spinks D, 2011, CHEMMEDCHEM, V6, P302, DOI 10.1002/cmdc.201000450; Synold TW, 1996, LEUKEMIA LYMPHOMA, V21, P9, DOI 10.3109/10428199609067573; Tan THP, 2002, P NATL ACAD SCI USA, V99, P1152, DOI 10.1073/pnas.022522299; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Vickers TJ, 2009, MOL BIOCHEM PARASIT, V166, P142, DOI 10.1016/j.molbiopara.2009.03.009; Vincent IM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001204; Wahlin A, 2002, PUBLIC HEALTH NUTR, V5, P505, DOI 10.1079/PHN200167; Wang P, 2007, MOL BIOCHEM PARASIT, V154, P40, DOI 10.1016/j.molbiopara.2007.04.002; WEBBER SE, 1993, J MED CHEM, V36, P733, DOI 10.1021/jm00058a010; WHO, 2012, ACC WORK OV GLOB IMP, P13; Widemann BC, 1999, CANCER CHEMOTH PHARM, V44, P439, DOI 10.1007/s002800051116	67	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24768	24778		10.1074/jbc.M116.750422	http://dx.doi.org/10.1074/jbc.M116.750422			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703008	hybrid, Green Published			2022-12-26	WOS:000388875500034
J	Park, M; Kaddai, V; Ching, JH; Fridianto, KT; Sieli, RJ; Sugii, S; Summers, SA				Park, Min; Kaddai, Vincent; Ching, Jianhong; Fridianto, Kevin T.; Sieli, Ryan J.; Sugii, Shigeki; Summers, Scott A.			A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; ceramide; insulin resistance; lipotoxicity; mitochondria; skeletal muscle; sphingolipid	PLECKSTRIN HOMOLOGY DOMAIN; SATURATED FATTY-ACIDS; ACCUMULATION; RESISTANCE; INHIBITION; OBESITY; DIACYLGLYCEROL; ACTIVATION; PREVENTS; SYNTHASE	The accumulation of sphingolipids in obesity leads to impairments in insulin sensitivity and mitochondrial metabolism, but the precise species driving these defects is unclear. We have modeled these obesity-induced effects in cultured C2C12 myotubes, using BSA-conjugated palmitate to increase synthesis of endogenous sphingolipids and to inhibit insulin signaling and oxidative phosphorylation. Palmitate (a) induced the accumulation of sphingomyelin (SM) precursors such as sphinganine, dihydroceramide, and ceramide; (b) inhibited insulin stimulation of a central modulator of anabolic metabolism, Akt/PKB; (c) inhibited insulin-stimulated glycogen synthesis; and (d) decreased oxygen consumption and ATP synthesis. Under these conditions, palmitate failed to alter levels of SMs, which are the most abundant sphingolipids, suggesting that they are not the primary intermediates accounting for the deleterious palmitate effects. Treating cells with a pharmacological inhibitor of SM synthase or using CRISPR to knock out the Sms2 gene recapitulated the palmitate effects by inducing the accumulation of SM precursors and impairing insulin signaling and mitochondrial metabolism. To profile the sphingolipids that accumulate in obesity, we performed lipidomics on quadriceps muscles from obese mice with impaired glucose tolerance. Like the cultured myotubes, these tissues accumulated ceramides but not SMs. Collectively, these data suggest that SM precursors such as ceramides, rather than SMs, are likely nutritional antagonists of metabolic function in skeletal muscle.	[Park, Min; Ching, Jianhong; Fridianto, Kevin T.; Sugii, Shigeki] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore; [Sugii, Shigeki] ASTAR, Singapore Bioimaging Consortium, Singapore 138667, Singapore; [Kaddai, Vincent; Summers, Scott A.] Baker IDI Heart & Diabet Inst, Translat & Metab Hlth Lab, Melbourne, Vic 3004, Australia; [Sieli, Ryan J.; Summers, Scott A.] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Baker Heart and Diabetes Institute; Utah System of Higher Education; University of Utah	Summers, SA (corresponding author), Baker IDI Heart & Diabet Inst, Translat & Metab Hlth Lab, Melbourne, Vic 3004, Australia.; Summers, SA (corresponding author), Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA.	scott.a.summers@health.utah.edu	/AAE-5384-2020; Fridianto, Kevin Timothy/AAW-8474-2020	Fridianto, Kevin Timothy/0000-0003-1842-7048; Sugii, Shigeki/0000-0002-2537-9534; Summers, Scott/0000-0002-4919-0592	National Health and Medical Research Council Senior Research Fellowship [APP1112502]; Victorian State Government OIS scheme; A*STAR Singapore-China Joint Research Grant [1412424003]	National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government OIS scheme; A*STAR Singapore-China Joint Research Grant(Agency for Science Technology & Research (A*STAR))	This work was supported by National Health and Medical Research Council Senior Research Fellowship APP1112502 (to S. A. S.), by the Victorian State Government OIS scheme, and by A*STAR Singapore-China Joint Research Grant 1412424003 (to S. S. and S. A. S.). S. A. S. is a cofounder and consultant of Centaurus Therapeutics, Inc.	Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Chakraborty M, 2013, ADV EXP MED BIOL, V991, P1, DOI 10.1007/978-94-007-6331-9_1; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Lipina C, 2015, FEBS LETT, V589, P3221, DOI 10.1016/j.febslet.2015.09.018; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Meng AM, 2004, EXP CELL RES, V292, P385, DOI 10.1016/j.yexcr.2003.10.001; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nilsson A, 2006, J LIPID RES, V47, P154, DOI 10.1194/jlr.M500357-JLR200; Petersen MC, 2016, J PHYSIOL-LONDON, V594, P3171, DOI 10.1113/JP271677; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Sugimoto M, 2016, BBA-MOL CELL BIOL L, V1861, P688, DOI 10.1016/j.bbalip.2016.04.019; Summers SA, 2016, J PHYSIOL-LONDON, V594, P3167, DOI 10.1113/JP271676; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Zama K, 2012, CHEM PHYS LIPIDS, V165, P760, DOI 10.1016/j.chemphyslip.2012.09.003	34	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23978	23988		10.1074/jbc.M116.737684	http://dx.doi.org/10.1074/jbc.M116.737684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703011	Green Published, hybrid			2022-12-26	WOS:000388498100014
J	Pinte, S; Caetano, B; Le Bras, A; Havet, C; Villain, G; Dernayka, R; Duez, C; Mattot, V; Soncin, F				Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Duez, Catherine; Mattot, Virginie; Soncin, Fabrice			Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; endothelium; inflammation; leukocyte; NF-kappa B (NF-KB); vascular biology	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; FACTOR ERG; TRANSENDOTHELIAL MIGRATION; LEUKOCYTE ADHESION; INHIBITOR; VCAM-1; ICAM-1; PHOSPHORYLATION	Activation of the blood vessel endothelium is a critical step during inflammation. Endothelial cells stimulated by pro-inflammatory cytokines play an essential part in the adhesion and extravasation of circulating leukocytes into inflamed tissues. The endothelial egfl7 gene (VE-statin) represses endothelial cell activation in tumors, and prior observations suggested that it could also participate in the regulation of endothelial cell activation during inflammation. We show here that Egfl7 expression is strongly repressed in mouse lung endothelial cells during LPS- and TNF-induced inflammation in vivo. LPS have a limited effect on Egfl7 expression by endothelial cells in vitro, whereas the pro-inflammatory cytokine TNF strongly represses Egfl7 expression in endothelial cells. TNF regulates the egfl7 gene promoter through regions located between -7585 and -5550 bp ahead of the main transcription start site and via an NF-B-dependent mechanism. Conversely, Egfl7 regulates the response of endothelial cells to TNF by restraining the induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin, resulting in a decreased adhesion of leukocytes onto endothelial cells stimulated by TNF. Egfl7 regulates the expression of these adhesion molecules through the NF-B and MEK/Erk pathways, in particular by preventing the proteasome-mediated degradation of IkB both in non-activated endothelial cells and during activation. Egfl7 is thus an endogenous and constitutive repressor of blood vessel endothelial cell activation in normal and inflammatory conditions and participates in a loop of regulation of activation of these cells by pro-inflammatory cytokines.	[Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Mattot, Virginie; Soncin, Fabrice] Univ Lille, UMR 8161 M3T, Mech Tumorigenesis & Targeted Therapies, F-59000 Lille, France; [Duez, Catherine] Univ Lille, Ctr Infect & Immun Lille, U1019 UMR 8204, F-59000 Lille, France; [Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Mattot, Virginie; Soncin, Fabrice] CNRS, UMR 8161, F-59000 Lille, France; [Duez, Catherine] CNRS, UMR 8204, F-59000 Lille, France; [Duez, Catherine] INSERM, U1019, F-59000 Lille, France; [Pinte, Sebastien; Caetano, Bertrand; Le Bras, Alexandra; Havet, Chantal; Villain, Gaelle; Dernayka, Racha; Duez, Catherine; Mattot, Virginie; Soncin, Fabrice] Inst Pasteur, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Soncin, F (corresponding author), Inst Biol Lille, 1 Rue Pr Calmette, F-59019 Lille, France.	fabrice.soncin@ibl.cnrs.fr	SONCIN, Fabrice/A-1475-2009; Duez, Catherine/B-8425-2018	SONCIN, Fabrice/0000-0001-6312-0673; Duez, Catherine/0000-0002-2327-1095; Le Bras, Alexandra/0000-0001-7898-4618	Fondation ARC pour la Recherche sur le Cancer; Ligue contre le Cancer; Institut National du Cancer	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer, Ligue contre le Cancer and the Institut National du Cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Badiwala MV, 2011, CIRCULATION, V124, pS197, DOI 10.1161/CIRCULATIONAHA.110.011734; Badiwala MV, 2010, CIRCULATION, V122, pS156, DOI 10.1161/CIRCULATIONAHA.109.927715; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; BENEZRA D, 1990, ARCH OPHTHALMOL-CHIC, V108, P573, DOI 10.1001/archopht.1990.01070060121061; Campagnolo L, 2005, AM J PATHOL, V167, P275, DOI 10.1016/S0002-9440(10)62972-0; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Charpentier MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116086; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Delfortrie S, 2011, CANCER RES, V71, P7176, DOI 10.1158/0008-5472.CAN-11-1301; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Dryden NH, 2012, J BIOL CHEM, V287, P12331, DOI 10.1074/jbc.M112.346791; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Gustavsson M, 2007, J CEREBR BLOOD F MET, V27, P928, DOI 10.1038/sj.jcbfm.9600408; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Le Bras A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012156; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeng YS, 2006, CELL SIGNAL, V18, P994, DOI 10.1016/j.cellsig.2005.08.007; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Pannier D, 2016, ONCOL LETT, V12, P1422, DOI 10.3892/ol.2016.4791; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Patel CV, 1999, J BIOL CHEM, V274, P1415, DOI 10.1074/jbc.274.3.1415; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Poissonnier L, 2014, CARDIOVASC RES, V102, P436, DOI 10.1093/cvr/cvu040; Poissonnier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090455; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Verginelli F, 2015, ONCOTARGET, V6, P43216, DOI 10.18632/oncotarget.6456; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Winsauer G, 2007, THROMB HAEMOSTASIS, V97, P364, DOI 10.1160/TH06-08-0473; Xu D, 2008, AM J PHYSIOL-LUNG C, V294, pL17, DOI 10.1152/ajplung.00178.2007; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	55	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24017	24028		10.1074/jbc.M116.731331	http://dx.doi.org/10.1074/jbc.M116.731331			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650497	Green Published, hybrid			2022-12-26	WOS:000388498100018
J	Izumikawa, T; Dejima, K; Watamoto, Y; Nomura, KH; Kanaki, N; Rikitake, M; Tou, M; Murata, D; Yanagita, E; Kano, A; Mitani, S; Nomura, K; Kitagawa, H				Izumikawa, Tomomi; Dejima, Katsufumi; Watamoto, Yukiko; Nomura, Kazuko H.; Kanaki, Nanako; Rikitake, Marika; Tou, Mai; Murata, Daisuke; Yanagita, Eri; Kano, Ai; Mitani, Shohei; Nomura, Kazuya; Kitagawa, Hiroshi			Chondroitin 4-O-Sulfotransferase Is Indispensable for Sulfation of Chondroitin and Plays an Important Role in Maintaining Normal Life Span and Oxidative Stress Responses in Nematodes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CAENORHABDITIS-ELEGANS; N-ACETYLGALACTOSAMINYLTRANSFERASE; POLYMERIZING FACTOR; LARVAL DEVELOPMENT; CELL-DIVISION; EXPRESSION; BIOSYNTHESIS; GLUCURONOSYLTRANSFERASE; SYNTHASE	Chondroitin sulfate (CS)/chondroitin (Chn) chains are indispensable for embryonic cell division and cytokinesis in the early developmental stages in Caenorhabditis elegans and mice, whereas heparan sulfate (HS) is essential for axon guidance during nervous system development. These data indicate that the fundamental functions of CS and HS are conserved from worms to mammals and that the function of CS/Chn differs from that of HS. Although previous studies have shown that C. elegans produces HS and non-sulfated Chn, whether the organism produces CS remains unclear. Here, we demonstrate that C. elegans produces a small amount of 4-O-sulfated Chn and report the identification of C41C4.1, an orthologue of the human chondroitin 4-O-sulfotransferase gene. Loss of C41C4.1 in C. elegans resulted in a decline in 4-O-sulfation of CS and an increase in the number of sulfated units in HS. C41C4.1 deletion mutants exhibited reduced survival rates after synchronization with sodium hypochlorite. Collectively, these results show for the first time that CS glycans are present in C. elegans and that the Chn 4-O-sulfotransferase responsible for the sulfation plays an important role in protecting nematodes from oxidative stress.	[Izumikawa, Tomomi; Watamoto, Yukiko; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan; [Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Dejima, Katsufumi; Nomura, Kazuko H.; Kanaki, Nanako; Rikitake, Marika; Tou, Mai; Murata, Daisuke; Yanagita, Eri; Kano, Ai; Nomura, Kazuya] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan	Kobe Pharmaceutical University; Tokyo Women's Medical University; Kyushu University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.; Nomura, K (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka 8190395, Japan.	knomuscb@kyushu-u.org; kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp.; Mizutani Foundation [120140];  [23110003];  [25293014];  [16H05088];  [16K07298]; Grants-in-Aid for Scientific Research [16K07298] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp.(Core Research for Evolutional Science and Technology (CREST)); Mizutani Foundation; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT)-supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.) and by Grants-in-aid for Scientific Research on Innovative Areas (23110003 to H. K.), Scientific Research B (25293014 and 16H05088 to H. K.), and Scientific Research C (16K07298 to K. N.). This work was also supported by grants from the Japan Society for the Promotion of Science (JSPS) and the Core Research for Evolutional Science and Technology (CREST) Program of the Japan Science and Technology Corp. (to K. N.) and by Grant 120140 from the Mizutani Foundation (to K. N.). The authors declare that they have no conflicts of interest with respect to the contents of this article.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Albertini R, 1997, FEBS LETT, V403, P154, DOI 10.1016/S0014-5793(97)00043-4; Albertini R, 1999, ARCH BIOCHEM BIOPHYS, V365, P143, DOI 10.1006/abbi.1999.1150; Bacaj T, 2008, SCIENCE, V322, P744, DOI [10.1126/science.1163074, 10.1126/science.1161473]; Bhattacharya R, 2009, J CELL SCI, V122, P4492, DOI 10.1242/jcs.050732; Bruckner G, 1999, NEUROSCIENCE, V92, P791, DOI 10.1016/S0306-4522(99)00071-8; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dejima K, 2006, J BIOL CHEM, V281, P11431, DOI 10.1074/jbc.M601509200; Dejima K, 2010, J BIOL CHEM, V285, P24717, DOI 10.1074/jbc.M109.088229; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Fu XM, 2015, BIOCHEM BIOPH RES CO, V458, P896, DOI 10.1016/j.bbrc.2015.02.055; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; HABUCHI H, 1986, J BIOL CHEM, V261, P1031; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Izumikawa T, 2010, J BIOL CHEM, V285, P12190, DOI 10.1074/jbc.M110.100941; Johnston WL, 2012, GENESIS, V50, P333, DOI 10.1002/dvg.20823; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kinnunen T, 2005, P NATL ACAD SCI USA, V102, P1507, DOI 10.1073/pnas.0401591102; Kiselova N, 2014, BIOCHEM BIOPH RES CO, V450, P598, DOI 10.1016/j.bbrc.2014.06.011; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2007, J BIOL CHEM, V282, P8533, DOI 10.1074/jbc.M611107200; Kitagawa H, 2014, BIOL PHARM BULL, V37, P1705, DOI 10.1248/bpb.b14-00613; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Koike T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08994; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; MATHEWS MB, 1966, J CLIN INVEST, V45, P1103, DOI 10.1172/JCI105416; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Miyata S, 2015, J BIOCHEM, V157, P13, DOI 10.1093/jb/mvu067; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Mizuguchi S, 2009, TRENDS GLYCOSCI GLYC, V21, P179, DOI 10.4052/tigg.21.179; Morawski M, 2004, EXP NEUROL, V188, P309, DOI 10.1016/j.expneurol.2004.04.017; Ohkura K, 2011, BIOCHEM BIOPH RES CO, V406, P188, DOI 10.1016/j.bbrc.2011.02.003; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Shaham S., 2006, METHOD CELL BIOL, DOI [10.1895/wormbook.1.49.1, DOI 10.1895/WORMBOOK.1.49.1]; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yutsudo N, 2015, EXP NEUROL, V274, P126, DOI 10.1016/j.expneurol.2015.07.009	65	15	16	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23294	23304		10.1074/jbc.M116.757328	http://dx.doi.org/10.1074/jbc.M116.757328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27645998	hybrid, Green Published			2022-12-26	WOS:000387224800037
J	An, DR; Im, HN; Jang, JY; Kim, HS; Kim, J; Yoon, HJ; Hesek, D; Lee, M; Mobashery, S; Kim, SJ; Suh, SW				An, Doo Ri; Im, Ha Na; Jang, Jun Young; Kim, Hyoun Sook; Kim, Jieun; Yoon, Hye Jin; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar; Kim, Soon-Jong; Suh, Se Won			Structural Basis of the Heterodimer Formation between Cell Shape-Determining Proteins Csd1 and Csd2 from Helicobacter pylori	PLOS ONE			English	Article							PEPTIDOGLYCAN STRUCTURE; HELICAL SHAPE; LYTM-DOMAIN; COLONIZATION; MOTILITY; GROWTH; CAMPYLOBACTER; ARCHITECTURE; HYDROLASES; COMPONENTS	Colonization of the human gastric mucosa by Helicobacter pylori requires its high motility, which depends on the helical cell shape. In H. pylori, several genes (csd1, csd2, csd3/hdpA, ccmA, csd4, csd5, and csd6) play key roles in determining the cell shape by alteration of cross-linking or by trimming of peptidoglycan stem peptides. H. pylori Csd1, Csd2, and Csd3/HdpA are M23B metallopeptidase family members and may act as D,D-endopeptidases to cleave the D-Ala(4)-mDAP(3) peptide bond of cross-linked dimer muropeptides. Csd3 functions also as the D, D-carboxypeptidase to cleave the D-Ala(4)-D-Ala(5) bond of the muramyl pentapeptide. To provide a basis for understanding molecular functions of Csd1 and Csd2, we have carried out their structural characterizations. We have discovered that (i) Csd2 exists in monomer-dimer equilibrium and (ii) Csd1 and Csd2 form a heterodimer. We have determined crystal structures of the Csd2(121-308) homodimer and the heterodimer between Csd1(125-312) and Csd2(121-308). Overall structures of Csd1(125-312) and Csd2(121-308) monomers are similar to each other, consisting of a helical domain and a LytM domain. The helical domains of both Csd1 and Csd2 play a key role in the formation of homodimers or heterodimers. The Csd1 LytM domain contains a catalytic site with a Zn2+ ion, which is coordinated by three conserved ligands and two water molecules, whereas the Csd2 LytM domain has incomplete metal ligands and no metal ion is bound. Structural knowledge of these proteins sheds light on the events that regulate the cell wall in H. pylori.	[An, Doo Ri; Im, Ha Na; Suh, Se Won] Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul, South Korea; [Jang, Jun Young; Kim, Jieun; Yoon, Hye Jin; Suh, Se Won] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea; [Kim, Hyoun Sook] Natl Canc Ctr, Biomol Funct Res Branch, Div Precis Med & Canc Informat, Res Inst, Gyeonggi, South Korea; [Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Notre Dame; Mokpo National University	Suh, SW (corresponding author), Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul, South Korea.; Suh, SW (corresponding author), Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea.	sewonsuh@snu.ac.kr	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427	Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea [2013R1A2A1A05067303]; Innovative Drug Research Center for Metabolic and Inflammatory Disease; Korea Ministry of Education, the NRF of Korea [2015R1D1A4A01020265, 2014R1A1A3A04050250]; National Institutes of Health [AI090348, GM61629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061629] Funding Source: NIH RePORTER	Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea; Innovative Drug Research Center for Metabolic and Inflammatory Disease; Korea Ministry of Education, the NRF of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea (2013R1A2A1A05067303), and Innovative Drug Research Center for Metabolic and Inflammatory Disease to SWS. HSK and HJY were supported by the Korea Ministry of Education, the NRF of Korea (2015R1D1A4A01020265 and 2014R1A1A3A04050250, respectively). The work in the US was supported by grant from the National Institutes of Health (AI090348 and GM61629).	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; An DR, 2015, ACTA CRYSTALLOGR D, V71, P675, DOI 10.1107/S1399004715000152; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chan ACK, 2015, J BIOL CHEM, V290, P3622, DOI 10.1074/jbc.M114.624734; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschi F, 2015, HELICOBACTER, V20, P40, DOI 10.1111/hel.12256; Goley ED, 2010, MOL MICROBIOL, V77, P56, DOI 10.1111/j.1365-2958.2010.07222.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grabowska M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14833; Green, 2015, PRACTICAL HDB MICROB, P221, DOI [10.1201/b17871-17, DOI 10.1201/B17871-17]; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kim HS, 2015, J BIOL CHEM, V290, P25103, DOI 10.1074/jbc.M115.658781; Kim HS, 2014, ACTA CRYSTALLOGR D, V70, P2800, DOI 10.1107/S1399004714018732; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Lee TK, 2013, CURR OPIN MICROBIOL, V16, P760, DOI 10.1016/j.mib.2013.08.005; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Liu YJ, 2016, ACS CHEM BIOL, V11, P981, DOI 10.1021/acschembio.5b01039; Malfertheiner P, 2012, CURR OPIN GASTROEN, V28, P608, DOI 10.1097/MOG.0b013e32835918a7; Meisner J, 2012, P NATL ACAD SCI USA, V109, P5446, DOI 10.1073/pnas.1120113109; Meisner J, 2011, J BACTERIOL, V193, P591, DOI 10.1128/JB.01270-10; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI [10.1111/j.1365-2958.2010.07244.x, DOI 10.1111/J.1365-2958.2010.07244.X]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Roesler BM, 2014, CLIN MED INSIGHTS-GA, V7, P9, DOI 10.4137/CGast.S13760; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; Vasa S, 2015, P NATL ACAD SCI USA, V112, pE127, DOI 10.1073/pnas.1418450112; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2012, MOL MICROBIOL, V86, P1031, DOI 10.1111/mmi.12059; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P4122, DOI [10.1111/febs.12929, DOI 10.1111/FEBS.12929]; Worku ML, 1999, MICROBIOL-SGM, V145, P2803, DOI 10.1099/00221287-145-10-2803; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003	62	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164243	10.1371/journal.pone.0164243	http://dx.doi.org/10.1371/journal.pone.0164243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711177	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600104
J	Kowalska, JD; Shepherd, L; Ankiersztejn-Bartczak, M; Cybula, A; Czeszko-Paprocka, H; Firlag-Burkacka, E; Mocroft, A; Horban, A				Kowalska, Justyna D.; Shepherd, Leah; Ankiersztejn-Bartczak, Magdalena; Cybula, Aneta; Czeszko-Paprocka, Hanna; Firlag-Burkacka, Ewa; Mocroft, Amanda; Horban, Andrzej			Poor Linkage to Care Despite Significant Improvement in Access to Early cART in Central Poland - Data from Test and Keep in Care (TAK) Project	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV DIAGNOSIS; INFECTION; PEOPLE; EUROPE	Background The main objective of the TAK project is investigating barriers in accessing HIV care after HIV-diagnosis at the CBVCTs of central Poland. Here we describe factors associated with and changes over time in linkage to care and access to cART. Method Data collected in 2010-2013 in CBVCTs were linked with HIV clinics records using unique identifiers. Individuals were followed from the day of CBVCTs visit until first clinical visit or 4/06/2014. Cox-proportional hazard models were used to identify factors associated with being linked to care and starting cART. Results In total 232 persons were diagnosed HIV-positive and 144 (62.1% 95% CI: 55.5-68.3) persons were linked to care. There was no change over time in linkage to care (p = 0.48), while time to starting cART decreased (p = 0.02). Multivariate factors associated with a lower rate of linkage to care were hetero/bisexual sexual orientation, lower education, not having an HIV-positive partner and not using condoms in a stable relationship. Multivariate factors associated with starting cART were lower education, recent year of linked to care, and first HIV RNA and CD4 cell count. Conclusions Benefits of linkage to care, measured by access to early treatment, steadily improved in recent years. However at least 1 in 3 persons aware of their HIV status in central Poland remained outside professional healthcare. Persons at higher risk of remaining outside care, thus target population for future interventions, are bi/heterosexuals and those with lower levels of education.	[Kowalska, Justyna D.; Czeszko-Paprocka, Hanna; Firlag-Burkacka, Ewa; Horban, Andrzej] Hosp Infect Dis, HIV Out Patient Clin, Warsaw, Poland; [Kowalska, Justyna D.; Horban, Andrzej] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [Shepherd, Leah; Mocroft, Amanda] UCL, Dept Infect & Populat Hlth, London, England; [Ankiersztejn-Bartczak, Magdalena] FES, Warsaw, Poland; [Cybula, Aneta] Med Univ Warsaw, Dept Infect & Trop Dis & Hepatol, Warsaw, Poland	Medical University of Warsaw; University of London; University College London; Medical University of Warsaw	Kowalska, JD (corresponding author), Hosp Infect Dis, HIV Out Patient Clin, Warsaw, Poland.; Kowalska, JD (corresponding author), Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland.	jdkowalska@gmail.com	Cybula, Aneta/U-4130-2018	Cybula, Aneta/0000-0001-8071-7455	Research Development Foundation in Hospital for Infectious Diseases; Abbvie Poland; Gilead Sciences Poland	Research Development Foundation in Hospital for Infectious Diseases; Abbvie Poland(AbbVie); Gilead Sciences Poland(Gilead Sciences)	The TAK project received unrestricted research grants from Research Development Foundation in Hospital for Infectious Diseases, Abbvie Poland and Gilead Sciences Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.r The TAK project received unrestricted research grants from Research Development Foundation in Hospital for Infectious Diseases, Abbvie Poland and Gilead Sciences Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors of this paper declare no conflict of interest.	Ankiersztejn-Bartczak M, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12175; [Anonymous], HIV TEST INCR UPT EF; Antinori A, 2010, ANTIVIR THER, V15, P1, DOI 10.3851/IMP1521; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bednarczyk M, 2004, N J MED S, V101, P52; Bednarczyk Marlene, 2004, N J Med, V101, P45; BHIVA, 2013, STAND CAR PEOPL LIV; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; Casado JL, 2016, HIV MED, V17, P46, DOI 10.1111/hiv.12280; Chkhartishvili N, 2015, HIV MED, V16, P62, DOI 10.1111/hiv.12172; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Delpech V, 2013, HIV MED, V14, P19, DOI 10.1111/hiv.12070; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Lange JMA, 2011, CLIN INFECT DIS, V52, P801, DOI 10.1093/cid/ciq254; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Oliva J, 2014, ENFERM INFEC MICR CL, V32, P170, DOI 10.1016/j.eimc.2013.09.007; Raben D, 2013, HIV MED, V14, P1, DOI 10.1111/hiv.12062; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Reyes-Uruena J, 2017, INT J STD AIDS, V28, P28, DOI 10.1177/0956462415623402; Rosinska M, 2013, AIDS RES HUM RETROV, V29, P805, DOI [10.1089/aid.2012.0314, 10.1089/AID.2012.0314]; WHO HIV/AIDS Programme, 2011, RET HIV PROGR DEF CH; World Health Organization, 2015, CONS STRAT INF GUID	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162739	10.1371/journal.pone.0162739	http://dx.doi.org/10.1371/journal.pone.0162739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711159	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600009
J	Blankley, S; Graham, CM; Turner, J; Berry, MPR; Bloom, CI; Xu, ZH; Pascual, V; Banchereau, J; Chaussabel, D; Breen, R; Santis, G; Blankenship, DM; Lipman, M; O'Garra, A				Blankley, Simon; Graham, Christine M.; Turner, Jacob; Berry, Matthew P. R.; Bloom, Chloe I.; Xu, Zhaohui; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; Breen, Ronan; Santis, George; Blankenship, Derek M.; Lipman, Marc; O'Garra, Anne			The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis	PLOS ONE			English	Article							BLOOD; EXPRESSION; DIAGNOSIS; PATTERNS; CELLS; RISK	Background Mycobacterium tuberculosis infection is a leading cause of infectious death worldwide. Gene-expression microarray studies profiling the blood transcriptional response of tuberculosis (TB) patients have been undertaken in order to better understand the host immune response as well as to identify potential biomarkers of disease. To date most of these studies have focused on pulmonary TB patients with gene-expression profiles of extra-pulmonary TB patients yet to be compared to those of patients with pulmonary TB or sarcoidosis. Methods A novel cohort of patients with extra-pulmonary TB and sarcoidosis was recruited and the transcriptional response of these patients compared to those with pulmonary TB using a variety of transcriptomic approaches including testing a previously defined 380 gene meta-signature of active TB. Results The 380 meta-signature broadly differentiated active TB from healthy controls in this new dataset consisting of pulmonary and extra-pulmonary TB. The top 15 genes from this meta-signature had a lower sensitivity for differentiating extra-pulmonary TB from healthy controls as compared to pulmonary TB. We found the blood transcriptional responses in pulmonary and extra-pulmonary TB to be heterogeneous and to reflect the extent of symptoms of disease. Conclusions The transcriptional signature in extra-pulmonary TB demonstrated heterogeneity of gene expression reflective of symptom status, while the signature of pulmonary TB was distinct, based on a higher proportion of symptomatic individuals. These findings are of importance for the rational design and implementation of mRNA based TB diagnostics.	[Blankley, Simon; Graham, Christine M.; Berry, Matthew P. R.; Bloom, Chloe I.; O'Garra, Anne] Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England; [Turner, Jacob; Blankenship, Derek M.] Baylor Scott & White, Baylor Res Inst, Dallas, TX USA; [Berry, Matthew P. R.] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Resp Med, London, England; [Xu, Zhaohui; Pascual, Virginia] INSERM, ANRS Ctr Human Vaccines, Baylor Inst Immunol Res, Dallas, TX USA; [Banchereau, Jacques] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Breen, Ronan; Santis, George] Kings Coll London, Dept Resp Med, London, England; [Santis, George] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Lipman, Marc] Royal Free London NHS Fdn Trust, Dept Resp Med, London, England; [Lipman, Marc] UCL, Div Med, London, England; [O'Garra, Anne] Imperial Coll, NHLI, Dept Med, London, England	Francis Crick Institute; Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; Imperial College London; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Jackson Laboratory; Sidra Medical & Research Center; University of London; King's College London; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Imperial College London	O'Garra, A (corresponding author), Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Imperial Coll, NHLI, Dept Med, London, England.	anne.ogarra@crick.ac.uk	Chaussabel, Damien/AAX-1909-2020; Pascual, Virginia/ABD-3099-2020; Bloom, Chloe/ABC-1693-2020	Bloom, Chloe/0000-0003-1285-7602; Blankley, Simon/0000-0001-9602-9075; Graham, Christine/0000-0001-9329-6231; Xu, Zhaohui/0000-0003-0645-1737; O'Garra, Anne/0000-0001-9845-6134; Chaussabel, Damien/0000-0002-6131-7242; Lipman, Marc/0000-0001-7501-4448	Francis Crick Institute; Cancer Research UK [FC001126]; U.K. Medical Research Council [FC001126]; Wellcome Trust [FC001126]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID [MR/J010723/1]; Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; King's College London; SILA; Medical Research Council [MR/J010723/1, 1105853, 1365570, MC_U117565642] Funding Source: researchfish; The Francis Crick Institute [10127, 10126] Funding Source: researchfish; MRC [MC_U117565642, MR/J010723/1] Funding Source: UKRI	Francis Crick Institute; Cancer Research UK(Cancer Research UK); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; King's College London; SILA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AOG and this work is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001126), the U.K. Medical Research Council (FC001126) and the Wellcome Trust (FC001126). SB was jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (MR/J010723/1). GS was supported in part by the Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service Foundation Trust in partnership with King's College London. This study received financial support from SILA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blankley S, 2016, EUR RESPIR J, V47, P1873, DOI 10.1183/13993003.02121-2015; Blankley S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0427; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092340; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Milman N, 1990, Sarcoidosis, V7, P113; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Public Health England, 2014, TUB UK 2014 REP; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Solovic I, 2013, EURO SURVEILLANCE B, V18; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Theron G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05658; Veenstra H, 2006, CLIN EXP IMMUNOL, V145, P252, DOI 10.1111/j.1365-2249.2006.03144.x; World Health Organization, 2014, GLOBAL TUBERCULOSIS; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	35	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162220	10.1371/journal.pone.0162220	http://dx.doi.org/10.1371/journal.pone.0162220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706152	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200008
J	Chaverri, G; Garin, I; Alberdi, A; Jimenez, L; Castillo-Salazar, C; Aihartza, J				Chaverri, Gloriana; Garin, Inazio; Alberdi, Antton; Jimenez, Lide; Castillo-Salazar, Cristian; Aihartza, Joxerra			Unveiling the Hidden Bat Diversity of a Neotropical Montane Forest	PLOS ONE			English	Article							SPECIES-RICHNESS; EVOLUTIONARY HISTORY; ELEVATIONAL GRADIENT; CRYPTIC DIVERSITY; COMMUNITY STRUCTURE; CONTINENTAL-SCALE; FRUIT BATS; DNA; PATTERNS; CHIROPTERA	Mountain environments, characterized by high levels of endemism, are at risk of experiencing significant biodiversity loss due to current trends in global warming. While many acknowledge their importance and vulnerability, these ecosystems still remain poorly studied, particularly for taxa that are difficult to sample such as bats. Aiming to estimate the amount of cryptic diversity among bats of a Neotropical montane cloud forest in Talamanca Range-south-east Central America-, we performed a 15-night sampling campaign, which resulted in 90 captured bats belonging to 8 species. We sequenced their mitochondrial cytochrome c oxidase subunit I (COI) and screened their inter-and intraspecific genetic variation. Phylogenetic relations with conspecifics and closely related species from other geographic regions were established using Maximum Likelihood and Bayesian inference methods, as well as median-joining haplotype networks. Mitochondrial lineages highly divergent from hitherto characterized populations (> 9% COI dissimilarity) were found in Myotis oxyotus and Hylonycteris underwoodi. Sturnira burtonlimi and M. keaysi also showed distinct mitochondrial structure with sibling species and/or populations. These results suggest that mountains in the region hold a high degree of endemicity potential that has previously been ignored in bats. They also warn of the high extinction risk montane bats may be facing due to climatic change, particularly in isolated mountain systems like Talamanca Range.	[Chaverri, Gloriana] Univ Costa Rica, Golfito, Costa Rica; [Garin, Inazio; Alberdi, Antton; Jimenez, Lide; Aihartza, Joxerra] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain; [Alberdi, Antton] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Castillo-Salazar, Cristian] Univ Nacl Costa Rica, Heredia, Costa Rica	Universidad Costa Rica; University of Basque Country; University of Copenhagen; Universidad Nacional Costa Rica	Chaverri, G (corresponding author), Univ Costa Rica, Golfito, Costa Rica.	gloriana.chaverri@ucr.ac.cr	Aihartza, Joxerra/GSO-2446-2022; Chaverri, Gloriana/J-4798-2012; Garin, Inazio/B-8115-2009; Aihartza, Joxerra/Z-3061-2019; Alberdi, Antton/M-2423-2017	Chaverri, Gloriana/0000-0002-1155-432X; Aihartza, Joxerra/0000-0003-0882-8964; Alberdi, Antton/0000-0002-2875-6446	Government of the Basque Country [IT754-13]	Government of the Basque Country	This project was supported by the Government of the Basque Country (project IT754-13) to JA and IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Alberdi A, 2015, J BIOGEOGR, V42, P1689, DOI 10.1111/jbi.12535; Alberdi A, 2013, ACTA CHIROPTEROL, V15, P451, DOI 10.3161/150811013X679071; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barquez R, 2008, IUCN RED LIST THREAT; Barrera-Guzman AO, 2012, MOL PHYLOGENET EVOL, V62, P907, DOI 10.1016/j.ympev.2011.11.020; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Bogdanowicz W, 2015, ZOOL J LINN SOC-LOND, V174, P635, DOI 10.1111/zoj.12248; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Bowie RCK, 2009, IBIS, V151, P709, DOI 10.1111/j.1474-919X.2009.00954.x; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Buzan EV, 2008, FOLIA ZOOL, V57, P274; Cadena C. D., 2011, P ROYAL SOC B, V279, P194, DOI DOI 10.1098/RSPB.2011.0720; Carothers JH, 1996, REV CHIL HIST NAT, V69, P301; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carvalho WD, 2013, MAMMALIA, V77, P341, DOI 10.1515/mammalia-2012-0012; Cerny T, 2015, APPL VEG SCI, V18, P5, DOI 10.1111/avsc.12124; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-26; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delciellos Ana Claudia, 2012, Check List, V8, P675; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Flaquer C, 2007, J MAMMAL, V88, P526, DOI 10.1644/06-MAMM-A-135R1.1; Flores-Saldaña Mónica Gabriela, 2008, Mastozool. neotrop., V15, P309; Garcia-Paris M, 2000, P NATL ACAD SCI USA, V97, P1640, DOI 10.1073/pnas.97.4.1640; Garcia-Rodriguez A, 2012, DIVERS DISTRIB, V18, P204, DOI 10.1111/j.1472-4642.2011.00862.x; GRAHAM GL, 1983, J MAMMAL, V64, P559, DOI 10.2307/1380511; GRAHAM GL, 1990, J BIOGEOGR, V17, P657, DOI 10.2307/2845147; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvey CA, 2006, BIODIVERS CONSERV, V15, P555, DOI 10.1007/s10531-005-2088-2; Hassanin A, 2015, CR BIOL, V338, P197, DOI 10.1016/j.crvi.2014.12.003; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Meza Beatriz, 2005, Mammalian Species, P1; Holdridge L. R., 1967, Life zone ecology.; Holzhaider J, 2001, MAMM BIOL, V66, P144; Hsieh TC, 2013, ECOL MONOGR; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Jones Jr JK, 1974, HYLONYCTERIS UNDERWO, P1; JUSTE J, 1995, J TROP ECOL, V11, P141; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koopman K.F., 1978, American Museum Novitates, P1; Koopman K.F., 1983, P412; Larsen RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046578; LaVal R.K., 1973, Science Bull nat Hist Mus Los Ang Cty, V15, P1; LaVal RK, 2002, MARCIELAGOS COSTA RI; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lopez-Vinyallonga S, 2015, MOL PHYLOGENET EVOL, V92, P243, DOI 10.1016/j.ympev.2015.06.018; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Magige FJ, 2013, AFR J ECOL, V51, P618, DOI 10.1111/aje.12075; Mantilla H, 2008, ANOURA CULTRATA HAND; Mantilla-Meluk H, 2014, ZOOTAXA, V3793, P60, DOI 10.11646/zootaxa.3793.1.2; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Merckx VSFT, 2015, NATURE, V524, P347, DOI 10.1038/nature14949; Meyer CFJ, 2011, J APPL ECOL, V48, P777, DOI 10.1111/j.1365-2664.2011.01976.x; Moras Ligiane M, 2013, Mastozool. neotrop., V20, P269; Moratelli R, 2011, MAMM BIOL, V76, P592, DOI 10.1016/j.mambio.2011.01.003; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Morueta-Holme N, 2015, P NATL ACAD SCI USA, V112, P12741, DOI 10.1073/pnas.1509938112; Munoz Arango J., 1990, Studies on Neotropical Fauna and Environment, V25, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro L. D., 1995, REV MEXICANA MASTOZO, V1, P9, DOI DOI 10.22201/IE.20074484E.1995.1.1.156; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1996, J ZOOL, V240, P637, DOI 10.1111/j.1469-7998.1996.tb05313.x; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Pech-Canche Juan M., 2010, Therya, V1, P221, DOI 10.12933/therya-10-17; Pech-Canche JM, 2011, REV MEX BIODIVERS, V82, P896; Pierson ED, 2006, DISTRIBUTION STATUS; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rakotoarivelo AR, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0510-2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2015, MOL ECOL, V24, P5267, DOI 10.1111/mec.13379; RODRIGUEZ-HERRERA B, 1999, OCCASIONAL PAPERS CO, V5, P1; Rodriguez-Posada ME, 2010, CALDASIA, V32, P205; Ronquist F., 2011, MAN MRBAYES, P1; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Soto Solis A, 2010, PRINC EC PARQ INT AM; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stocker TF, 2013, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]; Taylor DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-336; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Thomas O., 1903, Annals of Natural History, V(7), P286; Timm Robert M., 1999, Brenesia, V52, P1; TUTTLE M D, 1970, University of Kansas Science Bulletin, V49, P45; Vargas Espinoza Aideé, 2008, Mastozool. neotrop., V15, P297; Velazco PM, 2014, ZOOKEYS, P42, DOI 10.3897/zookeys.402.7228; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	116	13	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162712	10.1371/journal.pone.0162712	http://dx.doi.org/10.1371/journal.pone.0162712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706168	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200020
J	Cheng, CW; Liu, FC; Lin, JR; Tsai, YF; Chen, HP; Yu, HP				Cheng, Chih-Wen; Liu, Fu-Chao; Lin, Jr-Rung; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping			The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study	PLOS ONE			English	Article							CANCER SURGERY; OUTCOME RELATIONSHIP; LEARNING-CURVE; HOSPITALS; SURVIVAL; CASELOAD	The aim of this study was to assess whether the case volume of surgeons and hospitals affects the rates of postoperative complications and survival after liver transplantation. This population-based retrospective cohort study included 2938 recipients of liver transplantation performed between 1998 and 2012, enrolled from the Taiwan National Health Insurance Research Database. They were divided into two groups, according to the cumulative case volume of their operating surgeons and the case volume of their hospitals. The duration of intensive care unit stay and post-transplantation hospitalization, postoperative complications, and mortality were analyzed. The results showed that, in the low and high case volume surgeons groups, respectively, acute renal failure occurred at the rate of 14.11% and 5.86% (p<0.0001), and the overall mortality rates were 19.61% and 12.44% (p<0.0001). In the low and high case volume hospital groups, respectively, acute renal failure occurred in 11% and 7.11% of the recipients (p = 0.0004), and the overall mortality was 18.44% and 12.86% (p<0.0001). These findings suggest that liver transplantation recipients operated on higher case volume surgeons or in higher case volume hospitals have a lower rate of acute renal failure and mortality.	[Cheng, Chih-Wen; Liu, Fu-Chao; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan; [Cheng, Chih-Wen; Liu, Fu-Chao; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan 333, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Grad Inst Clin Med, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan.; Yu, HP (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053; Lin, Jr-Rung/0000-0002-8522-6601	Chang Gung Memorial Hospital [CORPG3E0131]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the Chang Gung Memorial Hospital (CORPG3E0131) to Huang-Ping Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Albornoz CR, 2013, PLAST RECONSTR SURG, V132, p192E, DOI 10.1097/PRS.0b013e31829586c1; Alsfasser G, 2016, BRIT J SURG, V103, P136, DOI 10.1002/bjs.9958; Archampong D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005391.pub3; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Chang CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086444; Chen HP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002320; Donkervoort SC, 2014, DIGEST DIS SCI, V59, P39, DOI 10.1007/s10620-013-2885-5; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Fox AN, 2012, CLIN LIVER DIS, V16, P435, DOI 10.1016/j.cld.2012.03.014; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Hayanga JA, 2016, AM J SURG, V211, P671, DOI 10.1016/j.amjsurg.2015.12.010; Li C, 2012, DIGEST LIVER DIS, V44, P597, DOI 10.1016/j.dld.2012.01.016; Marin-Gomez LM, 2014, TRANSPL P, V46, P3092, DOI 10.1016/j.transproceed.2014.09.176; Michihata N, 2016, PEDIATR INT, V58, P1171, DOI 10.1111/ped.13008; Nathan H, 2009, J AM COLL SURGEONS, V208, P528, DOI 10.1016/j.jamcollsurg.2009.01.007; Osada H, 2007, GEN THORAC CARDIOVAS, V55, P360, DOI 10.1007/s11748-007-0114-x; Paul JC, 2015, SPINE J, V15, P1963, DOI 10.1016/j.spinee.2015.04.028; Renzulli P, 2006, SURGERY, V139, P296, DOI 10.1016/j.surg.2005.08.023; Schreiber RA, 2010, J PEDIATR GASTR NUTR, V51, P61, DOI 10.1097/MPG.0b013e3181d67e5e; Sioris T, 2008, LUNG CANCER, V59, P119, DOI 10.1016/j.lungcan.2007.07.020; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Weng SF, 2014, INT J MED SCI, V11, P918, DOI 10.7150/ijms.8850; Yalavarthy Rajesh, 2007, Hemodial Int, V11 Suppl 3, pS7, DOI 10.1111/j.1542-4758.2007.00223.x	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162992	10.1371/journal.pone.0162992	http://dx.doi.org/10.1371/journal.pone.0162992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706183	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200028
J	Natusch, DJD; Lyons, JA; Brown, G; Shine, R				Natusch, Daniel J. D.; Lyons, Jessica A.; Brown, Gregory; Shine, Richard			Communally Nesting Migratory Birds Create Ecological Hot-Spots in Tropical Australia	PLOS ONE			English	Article							SNAKES; BEHAVIOR; DEFENSE; ISLAND	Large numbers of metallic starlings (Aplonis metallica) migrate annually from New Guinea to the rainforests of tropical Australia, where they nest communally in single emergent trees (up to 1,000 birds). These aggregations create dense and species-rich faunal "hot-spots", attracting a diverse assemblage of local consumers that utilise this seasonal resource. The starlings nested primarily in poison-dart trees (Antiaris toxicaria) near the rainforest-woodland boundary. Surveys underneath these colonies revealed that bird-derived nutrients massively increased densities of soil invertebrates and mammals (primarily wild pigs) beneath trees, year-round. Flying invertebrates, nocturnal birds, reptiles, and amphibians congregated beneath the trees when starlings were nesting (the wet-season). Diurnal birds (primarily cockatoos and bush turkeys) aggregated beneath the trees during the dry-season to utilise residual nutrients when the starlings were not nesting. The abundance of several taxa was considerably higher (to > 1000-fold) under colony trees than under nearby trees. The system strikingly resembles utilisation of bird nesting colonies by predators in other parts of the world but this spectacular system has never been described, emphasizing the continuing need for detailed natural-history studies in tropical Australia.	[Natusch, Daniel J. D.; Brown, Gregory; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Natusch, Daniel J. D.; Lyons, Jessica A.] Resource Evaluat & Dev, Bamaga, Qld, Australia	University of Sydney	Natusch, DJD (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; Natusch, DJD (corresponding author), Resource Evaluat & Dev, Bamaga, Qld, Australia.	d_natusch_14@hotmail.com	Brown, Gregory P./F-9897-2011	Brown, Gregory P./0000-0002-2924-9040; Lyons, Jessica A./0000-0002-7579-447X	Australian Research Council; Holsworth Wildlife Research Trust; Skyrail Rainforest Foundation	Australian Research Council(Australian Research Council); Holsworth Wildlife Research Trust; Skyrail Rainforest Foundation	Funding was provided by the Australian Research Council, the Holsworth Wildlife Research Trust, and the Skyrail Rainforest Foundation. The funders had no role in the design of this study.	Ainley DG, 2005, ANTARCT SCI, V17, P335, DOI 10.1017/S0954102005002750; Banfield E, 1917, EMU, V17, P212, DOI [10.1071/MU917212, DOI 10.1071/MU917212]; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Bonnet X, 1999, BEHAV ECOL SOCIOBIOL, V46, P267, DOI 10.1007/s002650050619; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; Boveng PL, 1998, ECOLOGY, V79, P2863, DOI 10.2307/176522; Bureau of Meteorology, 2015, MONTHL CLIM STAT; Coulson John C., 2002, P87; Covas R., 2002, THESIS PERCY FITZPAT; DUFFY DC, 1983, ECOLOGY, V64, P110, DOI 10.2307/1937334; Feare C., 2010, STARLINGS AND MYNAS; GILBERT MA, 1987, AUST J EXP AGR, V27, P863, DOI 10.1071/EA9870863; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Hunter MD, 1992, EFFECTS RESOURCE DIS; Kennedy A.S., 2014, ANIMALS SERENGETI NG; Kimanzi JK, 2015, ORYX, V49, P295, DOI 10.1017/S0030605313000689; Klaus G., 1998, Mammalia, V62, P481; Letnic M, 2015, J APPL ECOL, V52, P341, DOI 10.1111/1365-2664.12390; Long DJ, 1996, GREAT WHITE SHARKS B; Magarry A., 1987, North Queensland Naturalist, P7; McIntyre NE, 1999, LANDSCAPE ECOL, V14, P437, DOI 10.1023/A:1008074407036; Natusch DJD, 2014, J HERPETOL, V48, P317, DOI 10.1670/12-207; Neldner V.J., 1995, VEGETATION CAPE YORK; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; ROBINSON SK, 1985, AUK, V102, P506, DOI 10.1093/auk/102.3.506; Sattler P., 1999, CONSERVATION QUEENSL; Shine R, 2004, BIOL CONSERV, V120, P201, DOI 10.1016/j.biocon.2004.02.014; Thiollay JM, 1998, IBIS, V140, P382, DOI 10.1111/j.1474-919X.1998.tb04599.x; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Zuur Alain F., 2009, P1	30	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162651	10.1371/journal.pone.0162651	http://dx.doi.org/10.1371/journal.pone.0162651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706197	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200018
J	Swanson, CJ; Sommese, RF; Petersen, KJ; Ritt, M; Karslake, J; Thomas, DD; Sivaramakrishnan, S				Swanson, Carter J.; Sommese, Ruth F.; Petersen, Karl J.; Ritt, Michael; Karslake, Joshua; Thomas, David D.; Sivaramakrishnan, Sivaraj			Calcium Stimulates Self-Assembly of Protein Kinase C alpha In Vitro	PLOS ONE			English	Article							SUPRAMOLECULAR CHEMISTRY; HOMO-FRET; PKC-ALPHA; DOMAIN; ACTIVATION; CA2+; ORGANIZATION; MICROSCOPY; MEMBRANES; COMPLEX	Protein kinase C alpha (PKC alpha) is a nodal regulator in several intracellular signaling networks. PKC alpha is composed of modular domains that interact with each other to dynamically regulate spatial-temporal function. We find that PKC alpha specifically, rapidly and reversibly self-assembles in the presence of calcium in vitro. This phenomenon is dependent on, and can be modulated by an intramolecular interaction between the C1a and C2 protein domains of PKC alpha. Next, we monitor self-assembly of PKC-mCitrine fusion proteins using time-resolved and steady-state homoFRET. HomoFRET between full-length PKC alpha molecules is observed when in solution with both calcium and liposomes containing either diacylglycerol (DAG) or phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Surprisingly, the C2 domain is sufficient to cluster on liposomes containing PI(4,5)P-2, indicating the C1a domain is not required for self-assembly in this context. We conclude that three distinct clustered states of PKC alpha can be formed depending on what combination of cofactors are bound, but Ca2+ is minimally required and sufficient for clustering.	[Swanson, Carter J.; Karslake, Joshua] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Sommese, Ruth F.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Petersen, Karl J.; Thomas, David D.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	sivaraj@umn.edu		Thomas, David D./0000-0002-8822-2040	NIH Small Business Technology Transfer grant [R42 DA037622]; American Heart Association Scientist Development Grant [13SDG14270009]; NIH [1DP2 CA186752-01, 1-R01-GM-105646-01-A1, T32 AR007612]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R42DA037622] Funding Source: NIH RePORTER	NIH Small Business Technology Transfer grant; American Heart Association Scientist Development Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The reported time-resolved fluorescence measurements were performed in the Biophysical Technology Center, University of Minnesota, with support from an NIH Small Business Technology Transfer grant (R42 DA037622). This study was supported by the American Heart Association Scientist Development Grant (13SDG14270009) & the NIH (1DP2 CA186752-01 & 1-R01-GM-105646-01-A1) to S.S. K.J.P. was supported by an NIH training grant (T32 AR007612). R.F.S. is a Life Sciences Research Foundation postdoctoral fellow.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chinthalapudi K, 2014, J CELL BIOL, V207, P643, DOI 10.1083/jcb.201404128; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Egea-Jimenez AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095973; Egea-Jimenez AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069041; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Huang SM, 1999, BIOCHEMISTRY-US, V38, P12020, DOI 10.1021/bi990594m; Kang CH, 2013, MOL CELLS, V35, P381, DOI 10.1007/s10059-013-2185-0; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Petersen KJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4900727; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ramakrishnan NA, 2014, J BIOL CHEM, V289, P8750, DOI 10.1074/jbc.M113.480533; Reither G, 2006, J CELL BIOL, V174, P521, DOI 10.1083/jcb.200604033; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sando JJ, 1998, J BIOL CHEM, V273, P34022, DOI 10.1074/jbc.273.51.34022; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yang L, 1996, BIOCHEMISTRY-US, V35, P13966, DOI 10.1021/bi9610008; Ziemba BP, 2016, BIOPHYS J, V110, P1811, DOI 10.1016/j.bpj.2016.03.001	43	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162331	10.1371/journal.pone.0162331	http://dx.doi.org/10.1371/journal.pone.0162331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706148	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200009
J	Young, AE; Choi, Y				Young, Amanda E.; Choi, YoonSun			Work-Related Factors Considered by Sickness-Absent Employees When Estimating Timeframes for Returning to Work	PLOS ONE			English	Article							LOW-BACK-PAIN; QUALITATIVE DESCRIPTION; RECOVERY EXPECTATIONS; OCCUPATIONAL INJURY; WORKPLACE INJURY; PREDICTORS; OUTCOMES; PATIENT; REHABILITATION; INTERVENTIONS	Introduction Work-related factors have been found to be influential in shaping a number of return-to-work outcomes including return-to-work expectations. Based on the idea that work-related factors have the potential for modification through workplace-based initiatives, this study involved a detailed examination of work-related factors referenced by workers as being taken into consideration when estimating timeframes for returning to work. Methods Focus groups were conducted with 30 employees, currently off work (<= 3 months) due to a musculoskeletal condition. During the focus groups, participants wrote and spoke about the factors that they considered when forming their expectations for returning to work. Data were subjected to thematic content analysis. Results Discussions revealed that participants' considerations tended to differ depending on whether or not they had a job to return to. Those with jobs (n = 23) referenced specific influences such as working relationships, accommodations, physical and practical limitations, as well as concerns about their ability to do their job. Those without a job to return to (n = 7) talked about the ways they would go about finding work, and how long they thought this would take. Both groups mentioned the influence of wanting to find the "right" job, retraining and being limited due to the need for income. Conclusion Findings indicate that employees reference numerous work-related factors when estimating their timeframes for returning to work, and that many of these have been previously identified as relating to other return-to-work outcomes. Findings suggest the potential to improve return-to-work expectation through addressing work-related influences, and helping people work through the tasks they need to complete in order to move forward in the return-to-work process.	[Young, Amanda E.; Choi, YoonSun] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA	Liberty Mutual Research Institute for Safety	Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA.	amandae.young@libertymutual.com	Normandeau, Amanda/HHN-8881-2022; Young, Amanda Ellen/HDN-1629-2022	Young, Amanda Ellen/0000-0002-7288-3469				Boot CRL, 2014, INT ARCH OCC ENV HEA, V87, P871, DOI 10.1007/s00420-014-0928-7; Bultmann U, 2009, J OCCUP REHABIL, V19, P81, DOI 10.1007/s10926-009-9162-7; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Durand M-J, 2013, HDB WORK DISABILITY, P229, DOI [10.1007/978-3-319-08825-9_5, DOI 10.1007/978-3-319-08825-9_5]; Ebrahim S, 2015, J OCCUP REHABIL, V25, P240, DOI 10.1007/s10926-014-9535-4; Ekberg K, 2015, J OCCUP REHABIL, V25, P627, DOI 10.1007/s10926-015-9570-9; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Hepburn CG, 2010, J OCCUP HEALTH PSYCH, V15, P409, DOI 10.1037/a0021001; Iles RA, 2012, J REHABIL MED, V44, P781, DOI 10.2340/16501977-1019; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Johnston V, 2015, J OCCUP REHABIL, V25, P3, DOI 10.1007/s10926-014-9511-z; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Levvic C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2013-004321, DOI 10.1136/BMJOPEN-2013-004321]; Marnetoft S.-U., 2015, HDB VOCATIONAL REHAB, P73, DOI [10.1007/978-3-319-08825-9_5, DOI 10.1007/978-3-319-08825-9_5]; Murphy GC, 2006, INT J DISABILITY MAN, V1, P125; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Nevala N, 2015, J OCCUP REHABIL, V25, P432, DOI 10.1007/s10926-014-9548-z; OLIVER RL, 1987, J ECON PSYCHOL, V8, P469, DOI 10.1016/0167-4870(87)90037-7; Peerdeman KJ, 2016, PAIN, V157, P1179, DOI 10.1097/j.pain.0000000000000540; Quaigrain R, 2014, 30 ARCOM ANN C; Rushworth N., 2008, BRAIN INJURY A UNPUB; Sampere M, 2012, J OCCUP REHABIL, V22, P15, DOI 10.1007/s10926-011-9313-5; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Seing I, 2015, DISABIL REHABIL, V37, P1760, DOI 10.3109/09638288.2014.978509; Shaw WS, 2013, J OCCUP ENVIRON MED, V55, P885, DOI 10.1097/JOM.0b013e318289ee6c; Shaw WS, 2009, J OCCUP REHABIL, V19, P64, DOI 10.1007/s10926-008-9159-7; Steenstra IA, 2015, J OCCUP REHABIL, V25, P267, DOI 10.1007/s10926-014-9534-5; Stergiou-Kita M, 2014, J BURN CARE RES, V35, P498, DOI 10.1097/BCR.0000000000000041; Stochkendahl MJ, 2015, J OCCUP REHABIL, V25, P752, DOI 10.1007/s10926-015-9583-4; Street TD, 2015, WORK, V51, P373, DOI 10.3233/WOR-141980; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Young AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143330; Young AE, 2015, DISABIL REHABIL, V37, P1808, DOI 10.3109/09638288.2014.979299; Young AE, 2014, DISABIL REHABIL, V36, P914, DOI 10.3109/09638288.2013.824033; Young AE, 2010, SCAND J WORK ENV HEA, V36, P473, DOI 10.5271/sjweh.2986	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163674	10.1371/journal.pone.0163674	http://dx.doi.org/10.1371/journal.pone.0163674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706194	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200052
J	de Araujo, MA; Marques, TEBS; Octacilio-Silva, S; de Arroxelas-Silva, CL; Pereira, MGAG; Peixoto-Santos, JE; Kandratavicius, L; Leite, JP; Garcia-Cairasco, N; Castro, OW; Duzzioni, M; Passos, GA; Paco-Larson, ML; Gitai, DLG				de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Octacilio-Silva, Shirley; de Arroxelas-Silva, Carmem Lucia; Alves Goulart Pereira, Marina Gabriella; Peixoto-Santos, Jose Eduardo; Kandratavicius, Ludmyla; Leite, Joao Pereira; Garcia-Cairasco, Norberto; Castro, Olagide Wagner; Duzzioni, Marcelo; Passos, Geraldo Aleixo; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PI3K/AKT/MTOR SIGNALING PATHWAY; RAT MODEL; NEURONAL EXCITABILITY; GENE-EXPRESSION; MOUSE MODELS; SEIZURE; HIPPOCAMPUS; PROFILES; BRAIN	The involvement of miRNA in mesial temporal lobe epilepsy (MTLE) pathogenesis has increasingly become a focus of epigenetic studies. Despite advances, the number of known miRNAs with a consistent expression response during epileptogenesis is still small. Addressing this situation requires additional miRNA profiling studies coupled to detailed individual expression analyses. Here, we perform a miRNA microarray analysis of the hippocampus of Wistar rats 24 hours after intra-hippocampal pilocarpine-induced Status Epilepticus (H-PILO SE). We identified 73 miRNAs that undergo significant changes, of which 36 were up-regulated and 37 were down-regulated. To validate, we selected 5 of these (10a-5p, 128a-3p, 196b-5p, 352 and 324-3p) for RT-qPCR analysis. Our results confirmed that miR-352 and 196b-5p levels were significantly higher and miR-128a-3p levels were significantly lower in the hippocampus of H-PILO SE rats. We also evaluated whether the 3 miRNAs show a dysregulated hippocampal expression at three time periods (0h, 24h and chronic phase) after systemic pilocarpine-induced status epilepticus (S-PILO SE). We demonstrate that miR-128a-3p transcripts are significantly reduced at all time points compared to the naive group. Moreover, miR-196b-5p was significantly higher only at 24h post-SE, while miR-352 transcripts were significantly up-regulated after 24h and in chronic phase (epileptic) rats. Finally, when we compared hippocampi of epileptic and non-epileptic humans, we observed that transcript levels of miRNAs show similar trends to the animal models. In summary, we successfully identified two novel dysregulated miRNAs (196b-5p and 352) and confirmed miR-128a-3p downregulation in SE-induced epileptogenesis. Further functional assays are required to understand the role of these miRNAs in MTLE pathogenesis.	[de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; de Arroxelas-Silva, Carmem Lucia; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Dept Cellular & Mol Biol, Inst Biol Sci & Hlth, Maceio, Alagoas, Brazil; [Octacilio-Silva, Shirley] Univ Fed Sergipe, Dept Morphol, Hlth & Biol Sci Ctr, Aracaju, Sergipe, Brazil; [Alves Goulart Pereira, Marina Gabriella] Univ Fed Alfenas, Inst Biol Sci, Dept Biochem, Alfenas, MG, Brazil; [Peixoto-Santos, Jose Eduardo; Kandratavicius, Ludmyla; Leite, Joao Pereira] Univ Sao Paulo, Ribeirao Preto Sch Med, Div Neurol, Dept Neurosci & Behav Sci, Sao Paulo, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Castro, Olagide Wagner; Duzzioni, Marcelo] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Physiol & Pharmacol, Maceio, Alagoas, Brazil; [Passos, Geraldo Aleixo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Sao Paulo, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Med Sch, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade Federal de Sergipe; Universidade Federal de Alfenas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Dept Cellular & Mol Biol, Inst Biol Sci & Hlth, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	Duzzioni, Marcelo/C-6797-2015; Peixoto-Santos, Jose Eduardo/L-5123-2013; Gitai, Daniel LG/A-7982-2019; Kandratavicius, Ludmyla/H-2494-2013; Leite, Joao/B-9070-2012; Passos, Geraldo A/A-2899-2008; Passos, Geraldo Aleixo/ABE-3251-2020; Castro, Olagide/C-6781-2015; de Araújo, Mykaella Andrade/X-3778-2018; Paço-Larson, Maria L/I-8613-2012; Cairasco, Norberto Garcia/E-3250-2015	Peixoto-Santos, Jose Eduardo/0000-0001-7461-1902; Gitai, Daniel LG/0000-0001-7056-2373; Kandratavicius, Ludmyla/0000-0003-4387-5977; Leite, Joao/0000-0003-0558-3519; Passos, Geraldo A/0000-0002-4408-140X; Passos, Geraldo Aleixo/0000-0002-4408-140X; Castro, Olagide/0000-0002-1874-509X; Cairasco, Norberto Garcia/0000-0001-8857-3775; Araujo, Mykaella/0000-0002-6425-2595	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484911/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/17590-3, 2015/208409]; Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number: 484911/2012-0; DLG, JPL, NGC, MLP; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL), DLG, TEBSM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), MM, TEBSM; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers: 2016/17590-3 and 2015/208409, JPL, NGC, MLP; and Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP), JPL, NGC, MLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharafi W, 2015, CNS NEUROL DISORD-DR, V14, P1096, DOI 10.2174/1871527314666150317225945; Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Coulter DA, 1999, EPILEPSIA, V40, pS23, DOI 10.1111/j.1528-1157.1999.tb00875.x; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Santos EAD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141121; Dai EY, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau023; de Araujo MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100529; Dogini DB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00172; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elliott RC, 2003, J NEUROSCI, V23, P2218; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel T, 2013, BRAIN, V136, P577, DOI 10.1093/brain/aws337; Engel Tobias, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P97; Fiorenza A, 2016, CEREB CORTEX, V26, P1619, DOI 10.1093/cercor/bhu332; Gaignard P, 2013, GENE, V512, P521, DOI 10.1016/j.gene.2012.09.124; Gall CM, 2004, ADV EXP MED BIOL, V548, P12; Gitai DLG, 2011, BRAIN RES, V1367, P114, DOI 10.1016/j.brainres.2010.10.069; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Hansen KF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06930; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Henshall DC, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00037; Henshall DC, 2013, EPILEPSIA, V54, P17, DOI 10.1111/epi.12267; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kim GW, 2009, NEUROBIOL DIS, V36, P169, DOI 10.1016/j.nbd.2009.07.008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kretschmann A, 2015, J MOL NEUROSCI, V55, P466, DOI 10.1007/s12031-014-0368-6; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lee DY, 2015, BIOCHEM BIOPH RES CO, V462, P433, DOI 10.1016/j.bbrc.2015.04.149; Lewis DV, 2005, EPILEPSIA, V46, P39, DOI 10.1111/j.1528-1167.2005.00306.x; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Li N, 2016, ONCOL LETT, V11, P1745, DOI 10.3892/ol.2016.4141; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; Magwire MM, 2003, NEUROSCIENCE, V18, P2792, DOI [10.1371/journal.pgen.1002337, DOI 10.1371/JOURNAL.PGEN.1002337]; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; MELDRUM B, 1991, EPILEPSY RES, V10, P55, DOI 10.1016/0920-1211(91)90095-W; Miller-Delaney SFC, 2015, BRAIN, V138, P616, DOI 10.1093/brain/awu373; Moon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085617; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rami A, 2016, NEUROCHEM RES, V41, P53, DOI 10.1007/s11064-015-1704-0; Reschke CR, 2015, ADV EXP MED BIOL, V888, P41, DOI 10.1007/978-3-319-22671-2_4; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schouten M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12448; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tao J, 2015, NEUROSCIENCE, V305, P1, DOI 10.1016/j.neuroscience.2015.07.064; Torres-Peraza JF, 2013, BRAIN, V136, P1161, DOI 10.1093/brain/awt044; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Weinberg MS, 2013, EXP NEUROL, V247, P429, DOI 10.1016/j.expneurol.2013.01.011; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; You G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046218; Zhang J, 2011, J BIOL CHEM, V286, P7669, DOI 10.1074/jbc.M110.156299	83	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163855	10.1371/journal.pone.0163855	http://dx.doi.org/10.1371/journal.pone.0163855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695061	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100057
J	Sawin, EA; Stroup, BM; Murali, SG; O'Neill, LM; Ntambi, JM; Ney, DM				Sawin, Emily A.; Stroup, Bridget M.; Murali, Sangita G.; O'Neill, Lucas M.; Ntambi, James M.; Ney, Denise M.			Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; WHEY-PROTEIN; BOVINE GLYCOMACROPEPTIDE; ABDOMINAL ADIPOSITY; MINERAL DENSITY; SKELETAL-MUSCLE; RECEPTOR-ALPHA; ENERGY-INTAKE; BODY-MASS; OBESITY	Background Glycomacropeptide (GMP) is a 64-amino acid glycophosphopeptide released from kappa-casein during cheesemaking that promotes satiety, reduces body fat, increases bone mass and infers prebiotic and anti-inflammatory effects. The impact of adiposity and gender on bone health is unclear. Objective To determine how feeding female mice diets providing 60% Fat Kcal (high-fat) or 13% Fat Kcal (control) with either GMP or casein as the protein source impacts: body composition, ex vivo fatty acid oxidation, bone (femoral) biomechanical performance, and the relationship between body composition and bone. Methods Weanling female C57Bl/6 mice were fed high-fat (60% Fat Kcal) or control diets (13% Fat Kcal) with GMP or casein from 3 to 32 weeks of age with assessment of body weight and food intake. Body composition was assessed by dual-energy X-ray absorptiometry (DXA). Fatty acid oxidation was measured in liver, muscle, and fat tissues using 14 C-palmitate. Plasma concentrations of hormones and cytokines were determined. Bone biomechanical performance was assessed by the 3-point bending test. Results Female mice fed high-fat diets showed increased fatty acid oxidation capacity in both gastrocnemius muscle and brown adipose tissue compared to mice fed the control diets with a lower fat content. Despite increased fat mass in mice fed the high-fat diets, there was little evidence of glucose impairment or inflammation. Mice fed the high-fat diets had significantly greater total body bone mineral density (BMD), femoral BMD, and femoral cross-sectional area than mice fed the control diets. Femora of mice fed the high-fat diets had increased yield load and maximum load before fracture, consistent with greater bone strength, but reduced post-yield displacement or ductility, consistent with bone brittleness. Female mice fed a high-fat GMP diet displayed increased fat oxidation capacity in subcutaneous fat relative to mice fed the high-fat casein diet. Regardless of dietary fat content, GMP increased total body bone mineral content and femur length. The prebiotic properties of GMP may mediate the beneficial effects of GMP on bone. Conclusions Female mice adapt to high-fat feeding by increasing oxidative capacity in muscle tissue and to a lesser extent brown adipose tissue. High-fat feeding in female mice leads to development of a bone phenotype where femora show increased BMD and are stronger, yet more brittle. The increased brittleness of bone was associated with increased body fat content due to high-fat feeding. In summary, high-fat feeding in female mice increases mineralization of bone, but negatively impacts bone quality resulting in brittle bones.	[Sawin, Emily A.; Stroup, Bridget M.; Murali, Sangita G.; Ney, Denise M.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [O'Neill, Lucas M.; Ntambi, James M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ney, DM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	ney@nutrsci.wisc.edu	Stroup, Bridget/AAR-7645-2021	Ney, Denise/0000-0002-2260-5313; Stroup, Bridget M./0000-0001-9755-7937	Wisconsin Alumni Research Foundation; National Institutes of Health [T32 DK 007665]; United States Department of Agriculture HATCH grant [WIS01790]; American Diabetes Association [7-13-BS-540118]; United States Department of Agriculture HATCH [WIS02005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER	Wisconsin Alumni Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture HATCH grant; American Diabetes Association(American Diabetes Association); United States Department of Agriculture HATCH(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Wisconsin Alumni Research Foundation Accelerator Grant, to DMN; National Institutes of Health T32 DK 007665, to DMN; United States Department of Agriculture HATCH grant WIS01790, to DMN; American Diabetes Association 7-13-BS-540118, to JMN; and United States Department of Agriculture HATCH WIS02005, to JMN. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimutis WR, 2004, J NUTR, V134, p989S, DOI 10.1093/jn/134.4.989S; Becker R, 1988, COMPUTER SCI SERIES; BEUCHER S, 1994, J NUTR BIOCHEM, V5, P578, DOI 10.1016/0955-2863(94)90012-4; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Burns P, 2015, INT DAIRY J, V44, P15, DOI 10.1016/j.idairyj.2014.12.005; Burton-Freeman BM, 2008, PHYSIOL BEHAV, V93, P379, DOI 10.1016/j.physbeh.2007.09.010; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; Clifton PM, 2009, AUST J DAIRY TECHNOL, V64, P29; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; DELFOUR A, 1965, BIOCHEM BIOPH RES CO, V19, P452, DOI 10.1016/0006-291X(65)90145-2; Etzel MR, 2004, J NUTR, V134, p996S, DOI 10.1093/jn/134.4.996S; FORBES GB, 1983, INT J OBESITY, V7, P99; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Guilloteau P, 2010, REGUL PEPTIDES, V159, P129, DOI 10.1016/j.regpep.2009.09.003; Hegarty BD, 2002, DIABETES, V51, P1477, DOI 10.2337/diabetes.51.5.1477; Henagan TM, 2015, BRIT J PHARMACOL, V172, P2782, DOI 10.1111/bph.13058; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ionova-Martin SS, 2010, BONE, V46, P217, DOI 10.1016/j.bone.2009.10.015; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Keogh JB, 2008, AM J CLIN NUTR, V87, P1602, DOI 10.1093/ajcn/87.6.1602; Lam SMSCC, 2009, PHYSIOL BEHAV, V96, P162, DOI 10.1016/j.physbeh.2008.09.022; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Li CJ, 2008, DEV BIOLOGICALS, V132, P391, DOI 10.1159/000317190; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Posadas R, 2010, J NUTR, V140, P2014, DOI 10.3945/jn.109.118448; MacLeod EL, 2010, MOL GENET METAB, V100, P303, DOI 10.1016/j.ymgme.2010.04.003; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Neeser JR E, INVENTORMILK PROTEIN; Nguyen ND, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-11; Nielson CM, 2012, J BONE MINER RES, V27, P1, DOI 10.1002/jbmr.1486; *NRC, 1995, NUTR REQ LAB AN, P80, DOI DOI 10.1038/NATURE08778; Ohlsson C, 2015, TRENDS ENDOCRIN MET, V26, P69, DOI 10.1016/j.tem.2014.11.004; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Requena P, 2008, BRIT J PHARMACOL, V154, P825, DOI 10.1038/bjp.2008.138; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Royle PJ, 2008, BRIT J NUTR, V100, P88, DOI 10.1017/S0007114507883000; Saless N, 2011, BONE, V48, P647, DOI 10.1016/j.bone.2010.10.165; Saless N, 2009, FASEB J, V23, P2142, DOI 10.1096/fj.08-118679; Sawin EA, 2015, AM J PHYSIOL-GASTR L, V309, pG590, DOI 10.1152/ajpgi.00211.2015; Solomon G, 2014, AM J PHYSIOL-ENDOC M, V306, pE14, DOI 10.1152/ajpendo.00155.2013; Solverson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045165; Solverson P, 2012, AM J PHYSIOL-ENDOC M, V302, pE885, DOI 10.1152/ajpendo.00647.2011; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Stroup B, 2015, FASEB J, V29, P274; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thoma-Worringer C, 2006, INT DAIRY J, V16, P1324, DOI 10.1016/j.idairyj.2006.06.012; Travison TG, 2008, J BONE MINER RES, V23, P189, DOI 10.1359/JBMR.071016; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Calcar SC, 2012, J ACAD NUTR DIET, V112, P1201, DOI 10.1016/j.jand.2012.05.004; Veldhorst MAB, 2009, APPETITE, V52, P388, DOI 10.1016/j.appet.2008.11.014; Venables WN, 2002, MODERN APPL STAT S, DOI [10.1007/978-0-387-21708-2, DOI 10.1007/978-0-387-21708-2]; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu SP, 2013, FOOD CHEM TOXICOL, V56, P1, DOI 10.1016/j.fct.2013.01.027; Yonezawa T, 2007, CELL SIGNAL, V19, P185, DOI 10.1016/j.cellsig.2006.06.004; Yoo HJ, 2012, J BONE MINER METAB, V30, P47, DOI 10.1007/s00774-011-0283-7; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	71	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163234	10.1371/journal.pone.0163234	http://dx.doi.org/10.1371/journal.pone.0163234			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695036	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100026
J	Zhou, QQ; Sun, WJ; Liu, XY; Wang, XL; Xiao, YC; Bi, DR; Yin, JD; Shi, DS				Zhou, Qiongqiong; Sun, Wenjuan; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Yin, Jingdong; Shi, Deshi			Third-Generation Sequencing and Analysis of Four Complete Pig Liver Esterase Gene Sequences in Clones Identified by Screening BAC Library	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; PICHIA-PASTORIS; CLONING; ISOENZYMES; CARBOXYLESTERASE	Aim Pig liver carboxylesterase (PLE) gene sequences in GenBank are incomplete, which has led to difficulties in studying the genetic structure and regulation mechanisms of gene expression of PLE family genes. The aim of this study was to obtain and analysis of complete gene sequences of PLE family by screening from a Rongchang pig BAC library and third-generation PacBio gene sequencing. Methods After a number of existing incomplete PLE isoform gene sequences were analysed, primers were designed based on conserved regions in PLE exons, and the whole pig genome used as a template for Polymerase chain reaction (PCR) amplification. Specific primers were then selected based on the PCR amplification results. A three-step PCR screening method was used to identify PLE-positive clones by screening a Rongchang pig BAC library and PacBio third-generation sequencing was performed. BLAST comparisons and other bioinformatics methods were applied for sequence analysis. Results Five PLE-positive BAC clones, designated BAC-10, BAC-70, BAC-75, BAC-119 and BAC-206, were identified. Sequence analysis yielded the complete sequences of four PLE genes, PLE1, PLE-B9, PLE-C4, and PLE-G2. Complete PLE gene sequences were defined as those containing regulatory sequences, exons, and introns. It was found that, not only did the PLE exon sequences of the four genes show a high degree of homology, but also that the intron sequences were highly similar. Additionally, the regulatory region of the genes contained two 720bps reverse complement sequences that may have an important function in the regulation of PLE gene expression. Significance This is the first report to confirm the complete sequences of four PLE genes. In addition, the study demonstrates that each PLE isoform is encoded by a single gene and that the various genes exhibit a high degree of sequence homology, suggesting that the PLE family evolved from a single ancestral gene. Obtaining the complete sequences of these PLE genes provides the necessary foundation for investigation of the genetic structure, function, and regulatory mechanisms of the PLE gene family.	[Zhou, Qiongqiong; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Shi, Deshi] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhou, Qiongqiong; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Shi, Deshi] Huazhong Agr Univ, Coll Vet Med, Key Lab Dev Vet Diagnost Prod, Minist Agr, Wuhan, Hubei, Peoples R China; [Sun, Wenjuan; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, Key Lab Dev Vet Diagnost Prod, Minist Agr, Wuhan, Hubei, Peoples R China.; Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	yinjd@cau.edu.cn; rock@mail.hzau.edu.cn		Yin, Jingdong/0000-0003-4623-0568	China National Natural Science Foundation of China [31372484]; National Key Technology R&D Program of China [2015BAD03B02]	China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by: Deshi Shi: China National Natural Science Foundation of China (grant number 31372484) and the National Key Technology R&D Program of China (grant number 2015BAD03B02).	ADLER AJ, 1961, J BIOL CHEM, V236, P3240; Brusehaber E, 2009, BIOORGAN MED CHEM, V17, P7878, DOI 10.1016/j.bmc.2009.10.033; David L, 1998, EUR J BIOCHEM, V257, P142, DOI 10.1046/j.1432-1327.1998.2570142.x; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; FARB D, 1980, ARCH BIOCHEM BIOPHYS, V203, P214, DOI 10.1016/0003-9861(80)90171-X; Hasenpusch D, 2011, J MOL MODEL, V17, P1493, DOI 10.1007/s00894-010-0846-x; Hermann M, 2008, J BIOTECHNOL, V133, P301, DOI 10.1016/j.jbiotec.2007.10.010; Hummel A, 2007, ANGEW CHEM INT EDIT, V46, P8492, DOI 10.1002/anie.200703256; JUNGE W, 1979, EUR J BIOCHEM, V95, P519, DOI 10.1111/j.1432-1033.1979.tb12992.x; Lange S, 2001, CHEMBIOCHEM, V2, P576, DOI 10.1002/1439-7633(20010803)2:7/8<576::AID-CBIC576>3.3.CO;2-P; Liu L, 2010, BIOCHEM BIOPH RES CO, V391, P1280, DOI 10.1016/j.bbrc.2009.12.060; Liu ZQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0064-8; Morris Andrew P, 2008, Drug Metab Lett, V2, P275, DOI 10.2174/187231208786734111; Musidlowska A, 2001, ANGEW CHEM INT EDIT, V40, P2851, DOI 10.1002/1521-3773(20010803)40:15<2851::AID-ANIE2851>3.0.CO;2-V; Musidlowska-Persson A, 2003, PROTEIN ENG, V16, P1139, DOI 10.1093/protein/gzg120; Roberti M, 2000, TETRAHEDRON-ASYMMETR, V11, P4397, DOI 10.1016/S0957-4166(00)00404-3; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714	17	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163295	10.1371/journal.pone.0163295	http://dx.doi.org/10.1371/journal.pone.0163295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695062	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100029
J	Klingler, JJ				Klingler, Jeremy J.			On the Morphological Description of Tracheal and Esophageal Displacement and Its Phylogenetic Distribution in Avialae	PLOS ONE			English	Article							BIRDS; EVOLUTION; MUSCLES; SPHENODON; ANATOMY	This research examines the evolution and phylogenetic distribution of a peculiar and often overlooked character seen in birds, herein called tracheal and esophageal displacement. Tracheal and esophageal displacement refers to an asymmetrically situated trachea and/or esophagus along the length of the neck. This contrasts with what would be perceived as the "normal" (midsagittal) placement of these organs, wherein the two organs are situated along the ventral midline of the neck with no deviation. A total of forty-two bird species were examined (thirty-six of which came from dissections whereas six came from comments from previous literature or personal observations), as well as turtles, lizards, crocodylians, and mammals. This study found that essentially all birds have a laterally displaced trachea and/or esophagus. Lizards and mammals were seen to have normal, midsagittally placed tracheae and esophagi. Crocodylians were interesting in that alligators were defined by a normally situated trachea and esophagus whereas some crocodiles were characterized by displacement. In birds, the displacement may occur gradually along the neck, or it may happen immediately upon exiting the oropharynx. Displacement of these organs in birds is the result of a heavily modified neck whereinmuscles that restrict mobility of the trachea and esophagus in lizards, alligators, and mammals (e.g., m. episternocleidomastoideus, m. omohyoideus, and m. sternohyoideus) no longer substantially restrict positions of the trachea and esophagus in birds. Rather, thesemuscles are modified in ways which may assist with making tracheal movements. The implications of this study may provide interesting insights for future comparisons in extinct taxa.	[Klingler, Jeremy J.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Klingler, Jeremy J.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Northern Illinois University; Utah System of Higher Education; University of Utah	Klingler, JJ (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.; Klingler, JJ (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	jeremy.j.klingler@gmail.com						Al-Hassawi A.M.A., 2004, DISCOVERY; Ashley LM, 1962, LAB ANATOMY TURTLE; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; BEEBE WILLIAM, 1926, ZOOLOGICA, V7, P1; BEZUIDENHOUT AJ, 1986, ONDERSTEPOORT J VET, V53, P111; Bezuidenhout AJ, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P13; Blache D, 2005, ENCY ANIMAL SCI, P763; Boker H., 1931, Gegenbaurs Morphologisches Jahrbuch, V66, P220; Britton SW, 1941, Q REV BIOL, V16, P13, DOI 10.1086/394620; Britton WS, 1941, Q REV BIOL, V16, P190, DOI 10.1086/394628; Cong L., 1998, GROSS ANATOMY ALLIGA; Deeming DC, 1996, P RAT C MANCH ENGL, P1; Ehrat H, 1943, Z WISS ZOOL, V156, P290; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fuarbringer M., 1902, JENA Z NATURW, V36, P289; Furbringer M, 1900, JENAISCHE Z NATURWIS, V36, P289; Furbringer M, 1876, MORPHOLOGISCHES JB, V1, P636; G- H Schumacher, 1973, MORPHOLOGY, V4, P101; GADOW H, 1891, KLASSEN ORDNUNGEN TH; Gans C., 1976, P357; George JC, 1966, AVIAN MYOLOGY; Goffart M., 1971, FUNCTION FORM SLOTH; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harmon L, 2015, PACKAGE GEIGER R PAC; Hass G, 1973, BIOL REPTILIA, V4, P285; Hayssen Virginia, 2009, Mammalian Species, P1, DOI 10.1644/839.1; HOMBERGER DG, 1989, AM J ANAT, V186, P217, DOI 10.1002/aja.1001860302; HUCHZERMEYER FW, 1998, DIS OSTRICHES OTHER; Huelsenbeck JP, 2003, SYST BIOL, V52, P131, DOI 10.1080/10635150309342; HUMPHREY PHILIP S., 1958, CONDOR, V60, P303, DOI 10.2307/1365156; Jones MEH, 2009, PALAEONTOL ELECTRON, V12; King AS, 1984, BIRDS THEIR STRUCTUR, P334; Lubosch W., 1933, Gegenbaurs Morphologisches Jahrbuch, V72, P584; MACALISTER A, 1864, P ROY IRISH ACAD, V9, P1; MCLELLAND J, 1989, FORM FUNCTION BIRDS, V0004, P00069; Niethammer G, 1933, Z WISS ZOOL ABT A, V144, P12; Owen R, 1876, CLASSIFICATION MAMMA; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poglayen-Neuwall I., 1953, Zeitschrift fuer Wissenschaftliche Zoologie, V157, P57; Rathke C, 1866, UNTERSUCHUNGEN ENTWI; Reese A. M., 1915, ALLIGATOR ITS ALLIES; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RIEPPEL O, 1978, ANAT ANZEIGER, V144, P429; Sakas PS, 2002, ESSENTIALS AVIAN MED, V2nd; Sawaya P, 1936, REV OTOLARYNG SAO PA, V4, P1; Schachner ER, 2013, PEERJ, V1, DOI 10.7717/peerj.60; Shane S. M., 1996, RATITE MANAGEMENT ME; Simon L, 1902, ARCH NATURGESCH, V68, P239; Snively E, 2006, THESIS; Tivane C, 2008, THESIS, P99; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Valente ALS, 2007, VET J, V174, P362, DOI 10.1016/j.tvjl.2006.08.018; van der Leeuw AHJ, 2001, AM ZOOL, V41, P1352, DOI 10.1668/0003-1569(2001)041[1352:COTCCS]2.0.CO;2; Vanden Berge JC, 1975, SISSON GROSSMANS ANA, P1802; Versluys J., 1898, ZOOL JB CHER ABTEILU, V12, P161; WALLACH V, 1998, BIOL REPTILIA, V19, P93; Weber M, 1928, DIE SAUGETIERE; Weber M, 1904, DIE SAUGETIERE; Wislocki GB, 1928, J MORPHOL PHYSIOL, V46, P317, DOI 10.1002/jmor.1050460202; Zehtabvar O., 2014, Iranian Journal of Veterinary Surgery, V9, P9; [No title captured]; [No title captured]; [No title captured]	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163348	10.1371/journal.pone.0163348	http://dx.doi.org/10.1371/journal.pone.0163348			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648952	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100081
J	Koch, M; Lunde, LK; Gjulem, T; Knardahl, S; Veiersted, KB				Koch, Markus; Lunde, Lars-Kristian; Gjulem, Tonje; Knardahl, Stein; Veiersted, Kaj Bo			Validity of Questionnaire and Representativeness of Objective Methods for Measurements of Mechanical Exposures in Construction and Health Care Work	PLOS ONE			English	Article							MEASURED PHYSICAL-ACTIVITY; HEART-RATE; MUSCULOSKELETAL DISORDERS; RISK-FACTORS; SELF-REPORTS; EPIDEMIOLOGY; RELIABILITY; MOVEMENT; POSTURES; CLEANERS	Objectives To determine the criterion validity of a questionnaire on physical exposures compared to objective measurements at construction and health care sites and to examine exposure variation over several working days. Methods Five hundred ninety-four construction and health care workers answered a baseline questionnaire. The daily activities (standing, moving, sitting, number of steps), postures (inclination of the arm and the trunk), and relative heart rate of 125 participants were recorded continuously over 3-4 working days. At the end of the first measurement day, the participants answered a second questionnaire (workday questionnaire). Results All objective activity measurements had significant correlations to their respective questions. Among health care workers, there were no correlations between postures and relative heart rate and the baseline questionnaire. The questionnaires overestimated the exposure durations. The highest explained variance in the adjusted models with self-reported variables were found for objectively measured sitting (R-2 = 0.559) and arm inclination >60 degrees (R-2 = 0.420). Objective measurements over several days showed a higher reliability compared to single day measurements. Conclusions Questionnaires cannot provide an accurate description of mechanical exposures. Objective measurements over several days are recommended in occupations with varying tasks.	[Koch, Markus; Lunde, Lars-Kristian; Gjulem, Tonje; Knardahl, Stein; Veiersted, Kaj Bo] Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway; [Gjulem, Tonje] Oslo Univ Hosp, Oslo, Norway	University of Oslo	Koch, M (corresponding author), Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway.	Markus.Koch@stami.no			Research Council of Norway; Norwegian Research council	Research Council of Norway(Research Council of Norway); Norwegian Research council(Research Council of NorwayEuropean Commission)	This project was funded by a grant from the Research Council of Norway (www.forskningsradet.no). No individuals employed or contracted by the funder played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The Norwegian Research council supported this study. Gunn-Helen Moen, Therese N. Hanvold, Elisabeth Petersen, Daniel Pietz Jacobsen, Monica Wigemyr and Morten Waersted provided technical assistance.	Barrero LH, 2009, SCAND J WORK ENV HEA, V35, P245, DOI 10.5271/sjweh.1335; Bernal D, 2015, INT J NURS STUD, V52, P635, DOI 10.1016/j.ijnurstu.2014.11.003; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; David GC, 2005, OCCUP MED-OXFORD, V55, P190, DOI 10.1093/occmed/kqi082; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Gupta N, 2016, SCAND J WORK ENV HEA, V42, P237, DOI 10.5271/sjweh.3561; Hansson GA, 2001, SCAND J WORK ENV HEA, V27, P30, DOI 10.5271/sjweh.584; KARVONEN J, 1988, SPORTS MED, V5, P303, DOI 10.2165/00007256-198805050-00002; Korshoj M, 2014, ERGONOMICS, V57, P247, DOI 10.1080/00140139.2013.869358; Korshoj M, 2013, ERGONOMICS, V56, P935, DOI 10.1080/00140139.2013.782427; Kristiansen J, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-27; Kwak L, 2011, SCAND J WORK ENV HEA, V37, P6, DOI 10.5271/sjweh.3085; Lunde LK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1075; Magnusson ML, 1998, J SOUND VIB, V215, P965, DOI 10.1006/jsvi.1998.1677; Mathiassen SE, 2003, AIHA J-J SCI OCCUP E, V64, P196, DOI 10.1202/1542-8125(2003)64<196:EOSOMJ>2.0.CO;2; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Shimaoka M, 1998, EUR J APPL PHYSIOL O, V77, P10; Skotte J, 2014, J PHYS ACT HEALTH, V11, P76, DOI 10.1123/jpah.2011-0347; Statistics Norway, 2009, STAT NORW LEV 2009; Steingrimsdottir OA, 2004, PAIN, V110, P130, DOI 10.1016/j.pain.2004.03.016; Stemland I, 2015, ERGONOMICS, V58, P953, DOI 10.1080/00140139.2014.998724; Stock SR, 2005, SCAND J WORK ENV HEA, V31, P409, DOI 10.5271/sjweh.947; Takala EP, 2010, SCAND J WORK ENV HEA, V36, P3, DOI 10.5271/sjweh.2876; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Teschke K, 2009, ERGONOMICS, V52, P1067, DOI 10.1080/00140130902912811; Unge J, 2005, ERGONOMICS, V48, P12, DOI 10.1080/00140130412331293364; van der Beek AJ, 1998, OCCUP ENVIRON MED, V55, P291, DOI 10.1136/oem.55.5.291; Veiersted KB, 1996, ERGONOMICS, V39, P797, DOI 10.1080/00140139608964499; Westgaard RH, 1996, APPL ERGON, V27, P79, DOI 10.1016/0003-6870(95)00062-3; Wu HC, 2002, ERGONOMICS, V45, P280, DOI 10.1080/00140130210123499; Yassi A, 2013, INT J OCCUP ENV HEAL, V19, P223, DOI 10.1179/2049396713Y.0000000027	37	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162881	10.1371/journal.pone.0162881	http://dx.doi.org/10.1371/journal.pone.0162881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649499	gold, Green Published, Green Accepted			2022-12-26	WOS:000383892100040
J	Nascimento, FF; Rodrigo, AG				Nascimento, Fabricia F.; Rodrigo, Allen G.			Computational Evaluation of the Strict Master and Random Template Models of Endogenous Retrovirus Evolution	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; HUMAN GENOME; PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCES; VIRAL EVOLUTION; COPY NUMBER; DYNAMICS; GENES; TREES; RETROTRANSPOSONS	Transposable elements (TEs) are DNA sequences that are able to replicate and move within and between host genomes. Their mechanism of replication is also shared with endogenous retroviruses (ERVs), which are also a type of TE that represent an ancient retroviral infection within animal genomes. Two models have been proposed to explain TE proliferation in host genomes: the strict master model (SMM), and the random template (or transposon) model (TM). In SMM only a single copy of a given TE lineage is able to replicate, and all other genomic copies of TEs are derived from that master copy. In TM, any element of a given family is able to replicate in the host genome. In this paper, we simulated ERV phylogenetic trees under variations of SMM and TM. To test whether current phylogenetic programs can recover the simulated ERV phylogenies, DNA sequence alignments were simulated and maximum likelihood trees were reconstructed and compared to the simulated phylogenies. Results indicate that visual inspection of phylogenetic trees alone can be misleading. However, if a set of statistical summaries is calculated, we are able to distinguish between models with high accuracy by using a data mining algorithm that we introduce here. We also demonstrate the use of our data mining algorithm with empirical data for the porcine endogenous retrovirus (PERV), an ERV that is able to replicate in human and pig cells in vitro.	[Nascimento, Fabricia F.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [Nascimento, Fabricia F.] Univ Oxford, Dept Zool, Oxford, England; [Rodrigo, Allen G.] Australian Natl Univ, Res Sch Biol, Acton, Australia	The National Evolutionary Synthesis Center; University of Oxford; Australian National University	Nascimento, FF (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC 27705 USA.; Nascimento, FF (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	fabricia.nascimento@zoo.ox.ac.uk	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317; Nascimento, Fabricia/0000-0001-9426-6835	National Evolutionary Synthesis Center-National Science Foundation [EF-0905606]; Royal Society; British Academy-Newton International Fellowship [NF 140338]	National Evolutionary Synthesis Center-National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London); British Academy-Newton International Fellowship	This work was supported by the National Evolutionary Synthesis Center-National Science Foundation grant number EF-0905606 (http://www.nsf.gov/) to FFN and AR, and The Royal Society and British Academy-Newton International Fellowship NF 140338 to FFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Barrio AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019832; Belancio VP, 2009, GENOME MED, V1, DOI 10.1186/gm97; Belshaw R, 2005, MOL BIOL EVOL, V22, P814, DOI 10.1093/molbev/msi088; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Boeke JD, 1997, RETROVIRUSES; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Bouckaert R.R., 2013, WEKA MANUAL VERSION; Boyd M, 2015, PHYLOTOP PHYLOGENETI; Buzdin A, 2003, GENOMICS, V81, P149, DOI 10.1016/S0888-7543(02)00027-7; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Clough JE, 1996, J MOL EVOL, V42, P52, DOI 10.1007/BF00163211; Coffin JM, 1996, FIELDS VIROLOGY, P1767; Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Costas J, 2001, J MOL EVOL, V53, P237, DOI 10.1007/s002390010213; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; do Nascimento FF, 2011, INFECT GENET EVOL, V11, P686, DOI 10.1016/j.meegid.2011.01.010; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Dupressoir A, 2012, PLACENTA, V33, P663, DOI 10.1016/j.placenta.2012.05.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabryova H, 2015, VIROLOGY, V485, P96, DOI 10.1016/j.virol.2015.07.003; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Flutre Timothee, 2011, Mob Genet Elements, V1, P151; Friedli M, 2015, ANNU REV CELL DEV BI, V31, P429, DOI 10.1146/annurev-cellbio-100814-125514; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hayward A, 2013, P NATL ACAD SCI USA, V110, P20146, DOI 10.1073/pnas.1315419110; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Johnson WE, 2015, ANNU REV VIROL, V2, P135, DOI 10.1146/annurev-virology-100114-054945; JUKES T H, 1969, P21; Katzourakis A, 2005, TRENDS MICROBIOL, V13, P463, DOI 10.1016/j.tim.2005.08.004; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Klymiuk N, 2006, J GEN VIROL, V87, P977, DOI 10.1099/vir.0.81552-0; Kurth R, 2010, INT J CANCER, V126, P306, DOI 10.1002/ijc.24902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Magiorkinis G, 2012, P NATL ACAD SCI USA, V109, P7385, DOI 10.1073/pnas.1200913109; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; McKenzie A, 2000, MATH BIOSCI, V164, P81, DOI 10.1016/S0025-5564(99)00060-7; Mita P, 2016, CURR OPIN GENET DEV, V37, P90, DOI 10.1016/j.gde.2016.01.001; Nascimento FF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-139; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; R Core Team, 2014, R LANG ENV STAT COMP; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Rein A, 2011, ADV VIROL, V2011, DOI 10.1155/2011/403419; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Solyom S, 2012, GENOME MED, V4, DOI 10.1186/gm311; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEEL MA, 1993, SYST BIOL, V42, P126, DOI 10.2307/2992536; Stoye JP, 2012, NAT REV MICROBIOL, V10, P395, DOI 10.1038/nrmicro2783; Stoye JP, 2001, CURR BIOL, V11, pR914, DOI 10.1016/S0960-9822(01)00553-X; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Weiss RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0494; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZB, 1994, J MOL EVOL, V39, P105; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155	87	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162454	10.1371/journal.pone.0162454	http://dx.doi.org/10.1371/journal.pone.0162454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649303	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100020
J	Dougherty, EJ; Elinoff, JM; Ferreyra, GA; Hou, A; Cai, RM; Sun, JF; Blaine, KP; Wang, SB; Danner, RL				Dougherty, Edward J.; Elinoff, Jason M.; Ferreyra, Gabriela A.; Hou, Angela; Cai, Rongman; Sun, Junfeng; Blaine, Kevin P.; Wang, Shuibang; Danner, Robert L.			Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP-1); glucocorticoid receptor; inflammation; mineralocorticoid receptor; NF-B transcription factor; nuclear receptor; trans-repression	NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; RESPONSE ELEMENTS; TATA BOX; FOS-JUN; ALDOSTERONE; REPRESSION; TRANSCRIPTION; TRANSREPRESSION; ACTIVATION	Glucocorticoids are commonly used to treat inflammatory disorders. The glucocorticoid receptor (GR) can tether to inflammatory transcription factor complexes, such as NFB and AP-1, and trans-repress the transcription of cytokines, chemokines, and adhesion molecules. In contrast, aldosterone and the mineralocorticoid receptor (MR) primarily promote cardiovascular inflammation by incompletely understood mechanisms. Although MR has been shown to weakly repress NFB, its role in modulating AP-1 has not been established. Here, the effects of GR and MR on NFB and AP-1 signaling were directly compared using a variety of ligands, two different AP-1 consensus sequences, GR and MR DNA-binding domain mutants, and siRNA knockdown or overexpression of core AP-1 family members. Both GR and MR repressed an NFB reporter without influencing p65 or p50 binding to DNA. Likewise, neither GR nor MR affected AP-1 binding, but repression or activation of AP-1 reporters occurred in a ligand-, AP-1 consensus sequence-, and AP-1 family member-specific manner. Notably, aldosterone interactions with both GR and MR demonstrated a potential to activate AP-1. DNA-binding domain mutations that eliminated the ability of GR and MR to cis-activate a hormone response element-driven reporter variably affected the strength and polarity of these responses. Importantly, MR modulation of NFB and AP-1 signaling was consistent with a trans-mechanism, and AP-1 effects were confirmed for specific gene targets in primary human cells. Steroid nuclear receptor trans-effects on inflammatory signaling are context-dependent and influenced by nuclear receptor conformation, DNA sequence, and the expression of heterologous binding partners. Aldosterone activation of AP-1 may contribute to its proinflammatory effects in the vasculature.	[Dougherty, Edward J.; Elinoff, Jason M.; Ferreyra, Gabriela A.; Hou, Angela; Cai, Rongman; Sun, Junfeng; Blaine, Kevin P.; Wang, Shuibang; Danner, Robert L.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Hou, Angela] NYU, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); New York University; NYU Langone Medical Center	Dougherty, EJ; Danner, RL (corresponding author), NIH, Dept Crit Care Med, 10 Ctr Dr,Rm 2C145, Bethesda, MD 20892 USA.	doughertye@cc.nih.gov; rdanner@nih.gov			National Institutes of Health intramural funds; CLINICAL CENTER [ZIACL000188] Funding Source: NIH RePORTER	National Institutes of Health intramural funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported by National Institutes of Health intramural funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bladh LG, 2005, MOL PHARMACOL, V67, P815, DOI 10.1124/mol.104.005801; Brown NJ, 2008, HYPERTENSION, V51, P161, DOI 10.1161/HYPERTENSIONAHA.107.095489; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Cerillo G, 1998, J STEROID BIOCHEM, V67, P79, DOI 10.1016/S0960-0760(98)00078-8; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Diefenbacher M, 2008, MOL ENDOCRINOL, V22, P1767, DOI 10.1210/me.2007-0574; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Fukuda S, 2011, CLIN EXP NEPHROL, V15, P41, DOI 10.1007/s10157-010-0373-1; Funder JW, 2004, MOL CELL ENDOCRINOL, V217, P263, DOI 10.1016/j.mce.2003.10.054; Gilbert KC, 2010, CURR OPIN ENDOCRINOL, V17, P199, DOI 10.1097/MED.0b013e3283391989; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; GuiochonMantel A, 1996, J STEROID BIOCHEM, V56, P3, DOI 10.1016/0960-0760(95)00268-5; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HENCH PS, 1949, ANN RHEUM DIS, V8, P97, DOI 10.1136/ard.8.2.97; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KONIG H, 1992, EMBO J, V11, P2241, DOI 10.1002/j.1460-2075.1992.tb05283.x; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lemarie CA, 2009, CIRC RES, V105, P852, DOI 10.1161/CIRCRESAHA.109.196576; Leroy V, 2009, J AM SOC NEPHROL, V20, P131, DOI 10.1681/ASN.2008020232; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meijer OC, 2000, J NEUROENDOCRINOL, V12, P245; Mertens I, 2002, Obes Rev, V3, P85, DOI 10.1046/j.1467-789X.2002.00056.x; Meyer T, 1997, J BIOL CHEM, V272, P21090, DOI 10.1074/jbc.272.34.21090; Miller DT, 2007, J AM COLL CARDIOL, V49, P1589, DOI 10.1016/j.jacc.2006.12.045; MINER JN, 1992, GENE DEV, V6, P2491, DOI 10.1101/gad.6.12b.2491; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Moss ME, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00153; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nishikawa T, 2005, J STEROID BIOCHEM, V96, P309, DOI 10.1016/j.jsbmb.2005.03.005; Nishiyama A, 2005, HYPERTENSION, V45, P710, DOI 10.1161/01.HYP.0000154681.38944.9a; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Pierotti S, 2010, HORM MOL BIOL CLIN I, V4, P483, DOI 10.1515/HMBCI.2010.059; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rajaram N, 1997, EMBO J, V16, P2917, DOI 10.1093/emboj/16.10.2917; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; Rollins DA, 2015, MOL ENDOCRINOL, V29, P502, DOI 10.1210/me.2015-1005; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; RUPPRECHT R, 1993, EUR J PHARM-MOLEC PH, V247, P145, DOI 10.1016/0922-4106(93)90072-H; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Sonder SUS, 2006, BRIT J PHARMACOL, V148, P46, DOI 10.1038/sj.bjp.0706700; Starr DB, 1996, GENE DEV, V10, P1271, DOI 10.1101/gad.10.10.1271; STROMSTEDT PE, 1991, MOL CELL BIOL, V11, P3379, DOI 10.1128/MCB.11.6.3379; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Suzukawa K, 2002, ONCOGENE, V21, P2181, DOI 10.1038/sj.onc.1205281; Terada Y, 2012, CLIN EXP NEPHROL, V16, P81, DOI 10.1007/s10157-011-0498-x; Teyssier C, 2003, MOL ENDOCRINOL, V17, P287, DOI 10.1210/me.2002-0324; Tostes RCA, 2002, CLIN SCI, V103, p25S, DOI 10.1042/CS103S025S; Vinson GP, 2011, J ENDOCRINOL, V211, P3, DOI 10.1530/JOE-11-0178; Zhou HM, 2005, DNA RES, V12, P139, DOI 10.1093/dnares/12.2.139; Zhu CJ, 2012, ACTA PHARMACOL SIN, V33, P873, DOI 10.1038/aps.2012.36; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	76	7	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23628	23644		10.1074/jbc.M116.732248	http://dx.doi.org/10.1074/jbc.M116.732248			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27650495	Green Published, hybrid			2022-12-26	WOS:000387884400023
J	Patel, D; Antwi, J; Koneru, PC; Serrao, E; Forli, S; Kessl, JJ; Feng, L; Deng, NJ; Levy, RM; Fuchs, JR; Olson, AJ; Engelman, AN; Bauman, JD; Kvaratskhelia, M; Arnold, E				Patel, Disha; Antwi, Janet; Koneru, Pratibha C.; Serrao, Erik; Forli, Stefano; Kessl, Jacques J.; Feng, Lei; Deng, Nanjie; Levy, Ronald M.; Fuchs, James R.; Olson, Arthur J.; Engelman, Alan N.; Bauman, Joseph D.; Kvaratskhelia, Mamuka; Arnold, Eddy			A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; drug screening; human immunodeficiency virus (HIV); integrase; medicinal chemistry; X-ray crystallography; HIV-1; HIV-1 integrase; allosteric inhibitor; fragment screening	SMALL-MOLECULE INHIBITORS; HIGH-THROUGHPUT; LEDGF/P75; PROTEIN; MULTIMERIZATION; REPLICATION; DISCOVERY; MECHANISM; EFFICIENCY; INFECTIVITY	HIV-1 integrase (IN) is essential for virus replication and represents an important multifunctional therapeutic target. Recently discovered quinoline-based allosteric IN inhibitors (ALLINIs) potently impair HIV-1 replication and are currently in clinical trials. ALLINIs exhibit a multimodal mechanism of action by inducing aberrant IN multimerization during virion morphogenesis and by competing with IN for binding to its cognate cellular cofactor LEDGF/p75 during early steps of HIV-1 infection. However, quinoline-based ALLINIs impose a low genetic barrier for the evolution of resistant phenotypes, which highlights a need for discovery of second-generation inhibitors. Using crystallographic screening of a library of 971 fragments against the HIV-1 IN catalytic core domain (CCD) followed by a fragment expansion approach, we have identified thiophenecarboxylic acid derivatives that bind at the CCD-CCD dimer interface at the principal lens epithelium-derived growth factor (LEDGF)/p75 binding pocket. The most active derivative (5) inhibited LEDGF/p75-dependent HIV-1 IN activity in vitro with an IC50 of 72 m and impaired HIV-1 infection of T cells at an EC50 of 36 m. The identified lead compound, with a relatively small molecular weight (221 Da), provides an optimal building block for developing a new class of inhibitors. Furthermore, although structurally distinct thiophenecarboxylic acid derivatives target a similar pocket at the IN dimer interface as the quinoline-based ALLINIs, the lead compound, 5, inhibited IN mutants that confer resistance to quinoline-based compounds. Collectively, our findings provide a plausible path for structure-based development of second-generation ALLINIs.	[Patel, Disha; Bauman, Joseph D.; Arnold, Eddy] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Antwi, Janet; Fuchs, James R.] Ohio State Univ, Div Med Chem & Pharmacognosy, Coll Pharm, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Koneru, Pratibha C.; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Serrao, Erik; Engelman, Alan N.] Harvard Med Sch, Dept Canc Immunol & Virol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Serrao, Erik; Engelman, Alan N.] Harvard Med Sch, Dept Med, Boston, MA 02215 USA; [Forli, Stefano; Olson, Arthur J.] Scripps Res Inst, Mol Graph Lab, Dept Integrat Struct & Computat Biol, MB 112, La Jolla, CA 92037 USA; [Kessl, Jacques J.] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Deng, Nanjie; Levy, Ronald M.] Temple Univ, Ctr Biophys & Computat Biol, Philadelphia, PA 19122 USA	Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; University of Southern Mississippi; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Arnold, E (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.; Kvaratskhelia, M (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu; arnold@cabm.rutgers.edu	Kessl, Jacques/AAV-2526-2021; Forli, Stefano/AFR-7638-2022	Forli, Stefano/0000-0002-5964-7111; Koneru, Pratibha Chowdary/0000-0003-3955-4548; ANTWI, JANET/0000-0002-8089-9540; Fuchs, James/0000-0002-8743-6389	National Institutes of Health [P50GM103368, R01AI110310, R21AI127282]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110270, R01AI110310, R21AI127282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030580, P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grants P50GM103368 (to E. A., M. K., A. N. E., R. M. L., and A. J. O.), R01AI110310 (to M. K. and J. R. F.), and R21AI127282 (to J. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balakrishnan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074163; Bauman JD, 2013, J MED CHEM, V56, P2738, DOI 10.1021/jm301271j; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cherepanov P, 2010, EMBO REP, V11, P328, DOI 10.1038/embor.2010.58; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; De Luca L, 2010, BIOORGAN MED CHEM, V18, P7515, DOI 10.1016/j.bmc.2010.08.051; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; Deng NJ, 2011, J PHYS CHEM B, V115, P11902, DOI 10.1021/jp204047b; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0024-2014; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Fader LD, 2014, ACS MED CHEM LETT, V5, P422, DOI 10.1021/ml500002n; Feng L, 2016, ACS CHEM BIOL, V11, P1313, DOI 10.1021/acschembio.6b00167; Feng L, 2015, CURR TOP MICROBIOL, V389, P93, DOI 10.1007/82_2015_439; Feng L, 2013, J BIOL CHEM, V288, P15813, DOI 10.1074/jbc.M112.443390; Fontana J, 2015, J VIROL, V89, P9765, DOI 10.1128/JVI.01522-15; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Gupta K, 2014, J BIOL CHEM, V289, P20477, DOI 10.1074/jbc.M114.551119; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hayouka Z, 2010, BIOORGAN MED CHEM, V18, P8388, DOI 10.1016/j.bmc.2010.09.046; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Jurado KA, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.15; Kessl JJ, 2016, METHODS MOL BIOL, V1354, P149, DOI 10.1007/978-1-4939-3046-3_10; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Rouzic E, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-144; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Otwinowski Z, 2001, INT TABLES CRYSTAL F, VF, P226; Pandey KK, 2014, HIV AIDS-RES PALLIAT, V6, P81, DOI 10.2147/HIV.S39178; Patel D, 2014, PROG BIOPHYS MOL BIO, V116, P92, DOI 10.1016/j.pbiomolbio.2014.08.004; Peat TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040147; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rault S, 1996, J MED CHEM, V39, P2068, DOI 10.1021/jm950543x; Serrao E, 2013, J MED CHEM, V56, P2311, DOI 10.1021/jm301632e; Sharma A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004171; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2007, J VIROL, V81, P166, DOI 10.1128/JVI.01953-06; Slaughter A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0100-1; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534; van Bel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103552; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Wang H, 2012, NUCLEIC ACIDS RES, V40, P11518, DOI 10.1093/nar/gks913; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2005, J BIOMOL SCREEN, V10, P456, DOI 10.1177/1087057105275212	64	16	16	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23569	23577		10.1074/jbc.M116.753384	http://dx.doi.org/10.1074/jbc.M116.753384			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645997	Green Published, hybrid			2022-12-26	WOS:000387884400018
J	Xiao, XJ; Jones, G; Sevilla, WA; Stolz, DB; Magee, KE; Haughney, M; Mukherjee, A; Wang, Y; Lowe, ME				Xiao, Xunjun; Jones, Gabrielle; Sevilla, Wednesday A.; Stolz, Donna B.; Magee, Kelsey E.; Haughney, Margaret; Mukherjee, Amitava; Wang, Yan; Lowe, Mark E.			A Carboxyl Ester Lipase (CEL) Mutant Causes Chronic Pancreatitis by Forming Intracellular Aggregates That Activate Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SALT-STIMULATED LIPASE; UNFOLDED PROTEIN RESPONSE; EXOCRINE DYSFUNCTION; HEREDITARY PANCREATITIS; DIGESTIVE ENZYMES; DEPENDENT LIPASE; ACINAR-CELLS; MUTATIONS; SECRETION	Patients with chronic pancreatitis (CP) frequently have genetic risk factors for disease. Many of the identified genes have been connected to trypsinogen activation or trypsin inactivation. The description of CP in patients with mutations in the variable number of tandem repeat (VNTR) domain of carboxyl ester lipase (CEL) presents an opportunity to study the pathogenesis of CP independently of trypsin pathways. We tested the hypothesis that a deletion and frameshift mutation (C563fsX673) in the CEL VNTR causes CP through proteotoxic gain-of-function activation of maladaptive cell signaling pathways including cell death pathways. HEK293 or AR42J cells were transfected with constructs expressing CEL with 14 repeats in the VNTR (CEL14R) or C563fsX673 CEL (CEL maturity onset diabetes of youth with a deletion mutation in the VNTR (MODY)). In both cell types, CEL MODY formed intracellular aggregates. Secretion of CEL MODY was decreased compared with that of CEL14R. Expression of CEL MODY increased endoplasmic reticulum stress, activated the unfolded protein response, and caused cell death by apoptosis. Our results demonstrate that disorders of protein homeostasis can lead to CP and suggest that novel therapies to decrease the intracellular accumulation of misfolded protein may be successful in some patients with CP.	[Xiao, Xunjun; Jones, Gabrielle; Sevilla, Wednesday A.; Magee, Kelsey E.; Haughney, Margaret; Mukherjee, Amitava; Wang, Yan; Lowe, Mark E.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lowe, ME (corresponding author), Childrens Hosp Pittsburgh, One Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	loweme2@upmc.edu		Magee, Kelsey/0000-0003-4220-3984; Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [DK808820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097241, R01DK080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK808820. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Back SH, 2006, J BIOL CHEM, V281, P18691, DOI 10.1074/jbc.M602030200; Baek JH, 2016, NEUROPATH APPL NEURO, V42, P352, DOI 10.1111/nan.12260; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; Bruneau N, 2000, MICROSC RES TECHNIQ, V49, P329, DOI 10.1002/(SICI)1097-0029(20000515)49:4<329::AID-JEMT2>3.0.CO;2-H; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; Bruneau N, 1998, J CELL SCI, V111, P2665; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Fagenholz PJ, 2007, PANCREAS, V35, P302, DOI 10.1097/MPA.0b013e3180cac24b; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Gukovsky I, 1998, AM J PHYSIOL-GASTR L, V275, pG1402, DOI 10.1152/ajpgi.1998.275.6.G1402; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Ji BA, 2011, GASTROENTEROLOGY, V141, P1972, DOI 10.1053/j.gastro.2011.10.021; Jin S., 2015, GASTROENTEROLOGY, V149; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch CH, 2006, AM J PHYSIOL-GASTR L, V291, pG238, DOI 10.1152/ajpgi.00471.2005; Kubisch Constanze H, 2008, Expert Rev Gastroenterol Hepatol, V2, P249, DOI 10.1586/17474124.2.2.249; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Logsdon CD, 2013, NAT REV GASTRO HEPAT, V10, P362, DOI 10.1038/nrgastro.2013.36; MacDonald RJ, 2010, PROG MOL BIOL TRANSL, V97, P1, DOI 10.1016/B978-0-12-385233-5.00001-5; Moore SA, 2001, J MOL BIOL, V312, P511, DOI 10.1006/jmbi.2001.4979; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Pandol SJ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00008; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; Raeder H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060229; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Sah RP, 2014, J BIOL CHEM, V289, P27551, DOI 10.1074/jbc.M113.528174; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Seyhun E, 2011, AM J PHYSIOL-GASTR L, V301, pG773, DOI 10.1152/ajpgi.00483.2010; Stromqvist M, 1997, ARCH BIOCHEM BIOPHYS, V347, P30, DOI 10.1006/abbi.1997.0307; Szabo A, 2015, BBA-MOL BASIS DIS, V1852, P1372, DOI 10.1016/j.bbadis.2015.04.002; Szmola R, 2010, GUT, V59, P365, DOI 10.1136/gut.2009.198903; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vesterhus M, 2008, DIABETES CARE, V31, P1738, DOI 10.2337/dc07-2217; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Witt H, 2013, NAT GENET, V45, P1216, DOI 10.1038/ng.2730; Xiao XJ, 2011, J BIOL CHEM, V286, P26353, DOI 10.1074/jbc.M111.249813; Zou WB, 2016, GASTROENTEROLOGY, V150, P1558, DOI 10.1053/j.gastro.2016.02.071	44	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23224	23236		10.1074/jbc.M116.734384	http://dx.doi.org/10.1074/jbc.M116.734384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650499	Green Published, hybrid			2022-12-26	WOS:000387224800031
J	Horie, T; Inomata, M; Into, T; Hasegawa, Y; Kitai, N; Yoshimura, F; Murakami, Y				Horie, Toshi; Inomata, Megumi; Into, Takeshi; Hasegawa, Yoshiaki; Kitai, Noriyuki; Yoshimura, Fuminobu; Murakami, Yukitaka			Identification of OmpA-Like Protein of Tannerella forsythia as an O-Linked Glycoprotein and Its Binding Capability to Lectins	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; DC-SIGN; POSTTRANSLATIONAL MODIFICATION; MYCOBACTERIUM-TUBERCULOSIS; GLYCOSYLATION SYSTEM; SIALIC ACIDS; IN-VIVO; OLIGOSACCHARIDES; RECOGNITION	Bacterial glycoproteins are associated with physiological and pathogenic functions of bacteria. It remains unclear whether bacterial glycoproteins can bind to specific classes of lectins expressed on host cells. Tannerella forsythia is a gram-negative oral anaerobe that contributes to the development of periodontitis. In this study, we aimed to find lectin-binding glycoproteins in T. forsythia. We performed affinity chromatography of wheat germ agglutinin, which binds to N-acetylglucosamine (GlcNAc) and sialic acid (Sia), and identified OmpA-like protein as the glycoprotein that has the highest affinity. Mass spectrometry revealed that OmpA-like protein contains O-type N-acetylhexosamine and hexose. Fluorometry quantitatively showed that OmpA-like protein contains Sia. OmpA-like protein was found to bind to lectins including E-selectin, P-selectin, L-selectin, Siglec-5, Siglec-9, Siglec-10, and DC-SIGN. The binding of OmpA-like protein to these lectins, except for the Siglecs, depends on the presence of calcium. N-acetylneuraminic acid (NeuAc), which is the most abundant Sia, inhibited the binding of OmpA-like protein to all of these lectins, whereas GlcNAc and mannose only inhibited the binding to DC-SIGN. We further found that T. forsythia adhered to human oral epithelial cells, which express E-selectin and Pselectin, and that this adhesion was inhibited by addition of NeuAc. Moreover, adhesion of an OmpA-like protein-deficient T. forsythia strain to the cells was reduced compared to that of the wild-type strain. Our findings indicate that OmpA-like protein of T. forsythia contains O-linked sugar chains that can mediate interactions with specific lectins. This interaction is suggested to facilitate adhesion of T. forsythia to the surface of host cells.	[Horie, Toshi; Inomata, Megumi; Into, Takeshi; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci,Mizuho Ku, Gifu, Japan; [Horie, Toshi; Kitai, Noriyuki] Asahi Univ, Sch Dent, Dept Orthodont, Div Oral Struct Funct & Dev,Mizuho Ku, Gifu, Japan; [Hasegawa, Yoshiaki; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi, Japan	Asahi University; Asahi University; Aichi Gakuin University	Inomata, M (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci,Mizuho Ku, Gifu, Japan.	inomata@dent.asahi-u.ac.jp			 [25861782];  [15K11094]	; 	This study was supported by Grant-in-Aid forYoung Scientists (B; 25861782 to MI) and Grant-in-Aid for Scientific Research (C; 15K11094 to MI)	Abe T, 2011, MOL ORAL MICROBIOL, V26, P374, DOI 10.1111/j.2041-1014.2011.00625.x; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Dias RD, 2015, MOLECULES, V20, P519, DOI 10.3390/molecules20010519; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Inomata M, 2013, BIOCHEM BIOPH RES CO, V437, P509, DOI 10.1016/j.bbrc.2013.06.094; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Into T, 2007, J BIOL CHEM, V282, P8134, DOI 10.1074/jbc.M609962200; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Masuda T, 2006, APPL ENVIRON MICROB, V72, P3458, DOI 10.1128/AEM.72.5.3458-3467.2006; Miron J, 1999, APPL MICROBIOL BIOT, V51, P491, DOI 10.1007/s002530051422; Mishima E, 2011, MICROBIOL-SGM, V157, P2382, DOI 10.1099/mic.0.048975-0; Murakami Y, 2014, INFECT IMMUN, V82, P4563, DOI 10.1128/IAI.02069-14; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; ONeill RA, 1996, J CHROMATOGR A, V720, P201, DOI 10.1016/0021-9673(95)00502-1; PATEL TP, 1994, METHOD ENZYMOL, V230, P57; Posch G, 2013, GLYCOBIOLOGY, V23, P568, DOI 10.1093/glycob/cws172; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Tan FYY, 2015, TRENDS BIOCHEM SCI, V40, P342, DOI 10.1016/j.tibs.2015.03.016; Tang YXP, 2000, INFECT IMMUN, V68, P415, DOI 10.1128/IAI.68.1.415-419.2000; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10; Zeituni AE, 2009, J IMMUNOL, V183, P5694, DOI 10.4049/jimmunol.0901030; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163974	10.1371/journal.pone.0163974	http://dx.doi.org/10.1371/journal.pone.0163974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711121	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600056
J	Risso, DS; Kozlitina, J; Sainz, E; Gutierrez, J; Wooding, S; Getachew, B; Luiselli, D; Berg, CJ; Drayna, D				Risso, Davide S.; Kozlitina, Julia; Sainz, Eduardo; Gutierrez, Joanne; Wooding, Stephen; Getachew, Betelihem; Luiselli, Donata; Berg, Carla J.; Drayna, Dennis			Genetic Variation in the TAS2R38 Bitter Taste Receptor and Smoking Behaviors	PLOS ONE			English	Article							PHENYLTHIOCARBAMIDE; SENSITIVITY; EVOLUTION; NICOTINE; POLYMORPHISMS; ASSOCIATION; PERCEPTION; DEPENDENCE; PTC	Common TAS2R38 taste receptor gene variants specify the ability to taste phenylthiocarbamide (PTC), 6-n-propylthiouracil (PROP) and structurally related compounds. Tobacco smoke contains a complex mixture of chemical substances of varying structure and functionality, some of which activate different taste receptors. Accordingly, it has been suggested that non-taster individuals may be more likely to smoke because of their inability to taste bitter compounds present in tobacco smoke, but results to date have been conflicting. We studied three cohorts: 237 European-Americans from the state of Georgia, 1,353 European-Americans and 2,363 African-Americans from the Dallas Heart Study (DHS), and 4,973 African-Americans from the Dallas Biobank. Tobacco use data was collected and TAS2R38 polymorphisms were genotyped for all participants, and PTC taste sensitivity was assessed in the Georgia population. In the Georgia group, PTC tasters were less common among those who smoke: 71.5% of smokers were PTC tasters while 82.5% of nonsmokers were PTC tasters (P = 0.03). The frequency of the TAS2R38 PAV taster haplotype showed a trend toward being lower in smokers (38.4%) than in non-smokers (43.1%), although this was not statistically significant (P = 0.31). In the DHS European-Americans, the taster haplotype was less common in smokers (37.0% vs. 44.0% in non-smokers, P = 0.003), and conversely the frequency of the non-taster haplotype was more common in smokers (58.7% vs. 51.5% in non-smokers, P = 0.002). No difference in the frequency of these haplotypes was observed in African Americans in either the Dallas Heart Study or the Dallas Biobank. We conclude that TAS2R38 haplotypes are associated with smoking status in European-Americans but not in African-American populations. PTC taster status may play a role in protecting individuals from cigarette smoking in specific populations.	[Risso, Davide S.; Sainz, Eduardo; Gutierrez, Joanne; Drayna, Dennis] NIDCD, Lab Commun Disorders, NIH, Bethesda, MD 20892 USA; [Risso, Davide S.; Luiselli, Donata] Univ Bologna, Lab Mol Anthropol, Bologna, Italy; [Risso, Davide S.; Luiselli, Donata] Univ Bologna, Ctr Genome Biol, Dept Biol Geol & Environm Sci, Bologna, Italy; [Kozlitina, Julia] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Wooding, Stephen] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Getachew, Betelihem; Berg, Carla J.] Emory Univ, Dept Behav Sci & Hlth Educ, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Bologna; University of Bologna; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Merced; Emory University	Drayna, D (corresponding author), NIDCD, Lab Commun Disorders, NIH, Bethesda, MD 20892 USA.	drayna@nidcd.nih..gov	Risso, Davide/AAI-4201-2021	Risso, Davide/0000-0001-9848-8996; Kozlitina, Julia/0000-0001-7720-2290; Drayna, Dennis/0000-0002-1730-4532	National Institute on Deafness and Other Communication Disorders Intramural grant [Z1A-000046-16]; National Institutes of Health [HHSN263201300011C-03]; National Cancer Institute [1R01CA179422-01]; Georgia Cancer Coalition grant; National Center for Advancing Translational Sciences [UL1TR001105]; National Institutes of Health; NIH intramural research program; FDA; NATIONAL CANCER INSTITUTE [R01CA179422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders Intramural grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the National Institute on Deafness and Other Communication Disorders Intramural grant number Z1A-000046-16 to DD, by the National Institutes of Health grant (HHSN263201300011C-03; OLAO) to JK, and by National Cancer Institute grant number 1R01CA179422-01 to CB, as well as a Georgia Cancer Coalition grant to CB. The Dallas Heart Study is supported by the National Center for Advancing Translational Sciences award number UL1TR001105, and the Dallas Biobank was funded by the National Institutes of Health. Research reported in this publication was supported by the NIH intramural research program and the FDA through funds obtained under the Family Smoking Prevention and Tobacco Control Act. The content was not reviewed by the Food and Drug Administration, but underwent the standard manuscript clearance process for scientific papers published from the NIH intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aoki M, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-12; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Berg CJ, 2016, AM J HEALTH BEHAV, V40, P310, DOI 10.5993/AJHB.40.3.3; Berg CJ, 2010, NICOTINE TOB RES, V12, P963, DOI 10.1093/ntr/ntq123; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; DASTAN S, 2015, TURJAF, V3, P418; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; HALL AR, 1945, P NATL ACAD SCI USA, V31, P390, DOI 10.1073/pnas.31.12.390; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Keller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080512; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Oncken C, 2015, NICOTINE TOB RES, V17, P1416, DOI 10.1093/ntr/ntv042; Ortega FJ, 2016, MOL NUTR FOOD RES, V60, P1673, DOI 10.1002/mnfr.201500804; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Risso D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0198-8; Risso DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25506; Risso DS, 2015, NUTR RES, V35, P1122, DOI 10.1016/j.nutres.2015.09.011; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith SS, 2010, NICOTINE TOB RES, V12, P489, DOI 10.1093/ntr/ntq032; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	33	28	29	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164157	10.1371/journal.pone.0164157	http://dx.doi.org/10.1371/journal.pone.0164157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711175	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600089
J	Wiehr, S; Rolle, AM; Warnke, P; Kohlhofer, U; Quintanilla-Martinez, L; Reischl, G; Autenrieth, IB; Pichler, BJ; Autenrieth, SE				Wiehr, Stefan; Rolle, Anna-Maria; Warnke, Philipp; Kohlhofer, Ursula; Quintanilla-Martinez, Leticia; Reischl, Gerald; Autenrieth, Ingo B.; Pichler, Bernd J.; Autenrieth, Stella E.			The Positron Emission Tomography Tracer 3 '-Deoxy-3 '-[F-18] Fluorothymidine ([F-18]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice	PLOS ONE			English	Article							THYMIDINE CONCENTRATIONS; IMAGING PROLIFERATION; IN-VIVO; PET; TUMOR; MODEL; RODENTS	Most frequently, gram-negative bacterial infections in humans are caused by Enterobacteriaceae and remain a major challenge in medical diagnostics. We non-invasively imaged moderate and severe systemic Yersinia enterocolitica infections in mice using the positron emission tomography (PET) tracer 3'-deoxy-3'-[F-18] fluorothymidine ([F-18]FLT), which is a marker of proliferation, and compared the in vivo results to the ex vivo biodistributions, bacterial loads, and histologies of the corresponding organs. Y. enterocolitica infection is detectable with histology using H&E staining and immunohistochemistry for Ki 67. [F-18]FLT revealed only background uptake in the spleen, which is the main manifestation site of systemic Y. enterocolitica-infected mice. The uptake was independent of the infection dose. Antibody-based thymidine kinase 1 (Tk-1) staining confirmed the negative [F-18]FLT-PET data. Histological alterations of spleen tissue, observed via Ki 67-antibody-based staining, can not be detected by [F-18]FLT-PET in this model. Thus, the proliferation marker [F-18]FLT is not a suitable tracer for the diagnosis of systemic Y. enterocolitica infection in the C57BL/6 animal model of yersiniosis.	[Wiehr, Stefan; Rolle, Anna-Maria; Reischl, Gerald; Pichler, Bernd J.] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany; [Warnke, Philipp; Autenrieth, Ingo B.] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Kohlhofer, Ursula; Quintanilla-Martinez, Leticia] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Autenrieth, Stella E.] Univ Tubingen Hosp, Dept Internal Med 2, Tubingen, Germany; [Warnke, Philipp] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany	Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Rostock	Autenrieth, SE (corresponding author), Univ Tubingen Hosp, Dept Internal Med 2, Tubingen, Germany.	Stella.Autenrieth@med.uni-tuebingen.de	Autenrieth, Stella/GOG-8744-2022		European Social Fund Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [WI 3777/1-2]; Werner Siemens Foundation	European Social Fund Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Werner Siemens Foundation	The research leading to these results has received funding from the European Social Fund Baden-Wurttemberg (to SEA), from the Deutsche Forschungsgemeinschaft (grant WI 3777/1-2; to SW) and the Werner Siemens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Autenrieth SE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002552; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Becker W, 2001, Lancet Infect Dis, V1, P326, DOI 10.1016/S1473-3099(01)00146-3; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Buck AK, 2002, CANCER RES, V62, P3331; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Bunschoten A, 2013, BIOCONJUGATE CHEM, V24, P1971, DOI 10.1021/bc4003037; Fuchs K, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00042; Fuchs K, 2012, J NUCL MED, V53, P823, DOI 10.2967/jnumed.111.101808; Glaudemans AWJM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/623036; Glaudemans AWJM, 2012, EUR J NUCL MED MOL I, V39, P745, DOI 10.1007/s00259-012-2060-9; HEESEMANN J, 1993, APMIS, V101, P417, DOI 10.1111/j.1699-0463.1993.tb00130.x; Heinzmann K, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0218-3; Jang SJ, 2012, INT J MED MICROBIOL, V302, P101, DOI 10.1016/j.ijmm.2011.11.002; Krieger-Hinck N, 2006, ANTICANCER RES, V26, P3467; McKinley ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108193; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058938; Mills B, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0095-1; Ning XH, 2014, ANGEW CHEM INT EDIT, V53, P14096, DOI 10.1002/anie.201408533; NOTTEBROCK H, 1977, BIOCHEM PHARMACOL, V26, P2175, DOI 10.1016/0006-2952(77)90271-4; Porot C, 2014, IEEE ENG MED BIO, P5587, DOI 10.1109/EMBC.2014.6944893; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Reischl G, 2006, RADIOCHIM ACTA, V94, P447, DOI 10.1524/ract.2006.94.8.447; Rolle AM, 2016, P NATL ACAD SCI USA, V113, pE1026, DOI 10.1073/pnas.1518836113; Rolle AM, 2015, MOL IMAGING BIOL, V17, P512, DOI 10.1007/s11307-014-0815-3; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Schindler MKH, 2012, J IMMUNOL, V189, P4900, DOI 10.4049/jimmunol.1201383; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8; Tan YY, 2014, EXP THER MED, V8, P69, DOI 10.3892/etm.2014.1687; van Waarde A, 2004, J NUCL MED, V45, P695; Wagner M, 2003, CANCER RES, V63, P2681; Wehrl HF, 2014, J NUCL MED, V55, p11S, DOI 10.2967/jnumed.113.129221; Weinstein EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009815; Wiehr S, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7770; Wiehr S, 2016, ONCOTARGET, V7, P10990, DOI 10.18632/oncotarget.7770; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	40	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164163	10.1371/journal.pone.0164163	http://dx.doi.org/10.1371/journal.pone.0164163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701464	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900047
J	Dudek, B; Krzyzewska, E; Kapczynska, K; Rybka, J; Pawlak, A; Korzekwa, K; Klausa, E; Bugla-Ploskonska, G				Dudek, Bartlomiej; Krzyzewska, Eva; Kapczynska, Katarzyna; Rybka, Jacek; Pawlak, Aleksandra; Korzekwa, Kamila; Klausa, Elzbieta; Bugla-Ploskonska, Gabriela			Proteomic Analysis of Outer Membrane Proteins from Salmonella Enteritidis Strains with Different Sensitivity to Human Serum	PLOS ONE			English	Article							COMPLEMENT CLASSICAL PATHWAY; ANTIGEN CHAIN-LENGTH; KLEBSIELLA-PNEUMONIAE; O-ANTIGEN; 2-DIMENSIONAL ELECTROPHORESIS; POLYACRYLAMIDE-GELS; ESCHERICHIA-COLI; C1Q BINDING; TYPHIMURIUM; RESISTANCE	Differential analysis of outer membrane composition of S. Enteritidis strains, resistant to 50% normal human serum (NHS) was performed in order to find factors influencing the resistance to higher concentrations of NHS. Ten S. Enteritidis clinical strains, resistant to 50% NHS, all producing very long lipopolysaccharide, were subjected to the challenge of 75% NHS. Five extreme strains: two resistant and three sensitive to 75% NHS, were chosen for the further analysis of outer membrane proteins composition. Substantial differences were found in the levels of particular outer membrane proteins between resistant and sensitive strains, i.e. outer membrane protease E (PgtE) was present mainly in resistant strains, while sensitive strains possessed a high level of flagellar hook-associated protein 2 (FliD) and significantly higher levels of outer membrane protein A (OmpA).	[Dudek, Bartlomiej; Pawlak, Aleksandra; Korzekwa, Kamila; Bugla-Ploskonska, Gabriela] Univ Wroclaw, Fac Biol Sci, Inst Genet & Microbiol, Dept Microbiol, Wroclaw, Poland; [Krzyzewska, Eva; Kapczynska, Katarzyna; Rybka, Jacek] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunol Infect Dis, Wroclaw, Poland; [Korzekwa, Kamila] Dialab Lab, Wroclaw, Poland; [Klausa, Elzbieta] Reg Ctr Transfus Med, Wroclaw, Poland; [Klausa, Elzbieta] Blood Bank, Wroclaw, Poland	University of Wroclaw; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Bugla-Ploskonska, G (corresponding author), Univ Wroclaw, Fac Biol Sci, Inst Genet & Microbiol, Dept Microbiol, Wroclaw, Poland.	gabriela.bugla-ploskonska@uwr.edu.pl	Helena, Gabriela/D-2336-2017	Helena, Gabriela/0000-0002-1222-201X; Krzyzewska-Dudek, Eva/0000-0002-5581-1690; Kapczynska, Katarzyna/0000-0003-2722-9596; Rybka, Jacek/0000-0003-4499-1574; korzekwa, kamila/0000-0002-2792-8752; Pawlak, Aleksandra/0000-0001-8697-1278; Dudek, Bartlomiej/0000-0002-6181-3772	National Science Center [DEC-2013/11/N/NZ9/00069]; University of Wroclaw [2109/M/IGM/14, 1212/M/IGM/15]	National Science Center(National Science Centre, Poland); University of Wroclaw	The project was financed from the National Science Center Grant No DEC-2013/11/N/NZ9/00069 and co-financed from the University of Wroclaw Grant number 2109/M/IGM/14 and 1212/M/IGM/15.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; ALBERTI S, 1993, INFECT IMMUN, V61, P852; Alberti S, 1996, INFECT IMMUN, V64, P4719; Bednarz-Misa I, 2014, J MICROBIOL METH, V107, P74, DOI 10.1016/j.mimet.2014.09.004; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Bugla-Ploskonska G, 2011, MICROB ECOL, V61, P41, DOI 10.1007/s00248-010-9677-7; Bugla-Ploskonska G, 2010, MICROB ECOL, V59, P601, DOI 10.1007/s00248-009-9600-2; Bugla-Ploskonska G, 2009, POL J MICROBIOL, V58, P205; Cho Y, 2015, J MICROBIOL BIOTECHN, V25, P288, DOI 10.4014/jmb.1410.10052; Cho Y, 2014, ELECTROPHORESIS, V35, P888, DOI 10.1002/elps.201300199; Chooneea D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-44; Crawford RW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002918; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Doroszkiewicz Wlodzimierz, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P235; Encheva V, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-42; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Ho DK, 2010, J IMMUNOL, V185, P1763, DOI 10.4049/jimmunol.1001244; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Merino S, 1998, INFECT IMMUN, V66, P3825, DOI 10.1128/IAI.66.8.3825-3831.1998; MURPHY TF, 1989, INFECT IMMUN, V57, P2938, DOI 10.1128/IAI.57.10.2938-2941.1989; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nishio M, 2005, MICROBIOL-SGM, V151, P863, DOI 10.1099/mic.0.27654-0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PRAMOONJAGO P, 1992, J IMMUNOL, V148, P827; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; Riva R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00063; Sadkowska-Todys M, SALMONELLOSIS POLAND; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh R, 2007, CLIN EXP IMMUNOL, V148, P486, DOI 10.1111/j.1365-2249.2007.03362.x; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; TOMAS JM, 1986, INFECT IMMUN, V54, P85; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; ZOLLINGER WD, 1987, A VAN LEEUW J MICROB, V53, P403, DOI 10.1007/BF00415494	45	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164069	10.1371/journal.pone.0164069	http://dx.doi.org/10.1371/journal.pone.0164069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695090	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100085
J	Jung, SY; Kim, HY; Park, HS; Yin, XY; Chung, SM; Kim, HS				Jung, Soo Yeon; Kim, Ha Yeong; Park, Hae Sang; Yin, Xiang Yun; Chung, Sung Min; Kim, Han Su			Standardization of A Physiologic Hypoparathyroidism Animal Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HIGH PHOSPHORUS DIET; VITAMIN-D; RATS; METABOLISM; THERAPY	Ideal hypoparathyroidism animal models are a prerequisite to developing new treatment modalities for this disorder. The purpose of this study was to evaluate the feasibility of a model whereby rats were parathyroidectomized (PTX) using a fluorescent-identification method and the ideal calcium content of the diet was determined. Thirty male rats were divided into surgical sham (SHAM, n = 5) and PTX plus 0, 0.5, and 2% calcium diet groups (PTX-FC (n = 5), PTX-NC (n = 10), and PTX-HC (n = 10), respectively). Serum parathyroid hormone levels decreased to non-detectable levels in all PTX groups. All animals in the PTX-FC group died within 4 days after the operation. All animals survived when supplied calcium in the diet. However, serum calcium levels were higher in the PTX-HC than the SHAM group. The PTX-NC group demonstrated the most representative modeling of primary hypothyroidism. Serum calcium levels decreased and phosphorus levels increased, and bone volume was increased. All animals survived without further treatment and did not show nephrotoxicity including calcium deposits. These findings demonstrate that PTX animal models produced by using the fluorescent-identification method, and fed a 0.5% calcium diet, are appropriate for hypoparathyroidism treatment studies.	[Jung, Soo Yeon; Chung, Sung Min; Kim, Han Su] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Ha Yeong] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Park, Hae Sang] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Chunchon, South Korea; [Yin, Xiang Yun] Ajou Univ, Sch Med, Dept Orthopaed Surg, Suwon, South Korea	Ewha Womans University; Ewha Womans University; Hallym University; Ajou University	Kim, HS (corresponding author), Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	sevent@ewha.ac.kr	Kim, Han Su/AAT-3295-2021	Kim, Han Su/0000-0003-2239-0225; Kim, Ha Yeong/0000-0003-0561-4792; Jung, Soo Yeon/0000-0001-7497-3057	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea [HI14C-1557-010015]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2015R1D1A1A09058485]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C-1557-010015, URL: https://www.khidi.or.kr) and by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1D1A1A09058485, URL: http://www.nrf.re.kr/) Grant receiver: HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter KJ, 1999, J NUTR, V129, P923, DOI 10.1093/jn/129.5.923; Chou FF, 2009, HUM GENE THER, V20, P1344, DOI 10.1089/hum.2009.015; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Hymoller L, 2010, J DAIRY SCI, V93, P2025, DOI 10.3168/jds.2009-2991; Kalueff AV, 2004, PHYSIOL BEHAV, V82, P405, DOI 10.1016/j.physbeh.2004.04.010; Katsumata S, 2004, BIOFACTORS, V22, P33, DOI 10.1002/biof.5520220106; Katsumata S, 2004, BIOSCI BIOTECH BIOCH, V68, P243, DOI 10.1271/bbb.68.243; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Liao HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133278; Park HS, 2015, EUR ARCH OTO-RHINO-L, V272, P2969, DOI 10.1007/s00405-014-3262-5; Park YS, 2016, ACTA BIOMATER, V35, P215, DOI 10.1016/j.actbio.2016.03.003; Park YS, 2015, BIOMATERIALS, V65, P140, DOI 10.1016/j.biomaterials.2015.06.044; PITKIN RM, 1978, J CLIN ENDOCR METAB, V47, P626, DOI 10.1210/jcem-47-3-626; Rauchenzauner M, 2007, J CLIN ENDOCR METAB, V92, P443, DOI 10.1210/jc.2006-1706; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rejnmark L, 2013, OSTEOPOROSIS INT, V24, P1529, DOI 10.1007/s00198-012-2230-4; Rubin MR, 2010, OSTEOPOROSIS INT, V21, P1927, DOI 10.1007/s00198-009-1149-x; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163911	10.1371/journal.pone.0163911	http://dx.doi.org/10.1371/journal.pone.0163911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695051	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100064
J	Leyvraz, M; Wirth, JP; Woodruff, BA; Sankar, R; Sodani, PR; Sharma, ND; Aaron, GJ				Leyvraz, Magali; Wirth, James P.; Woodruff, Bradley A.; Sankar, Rajan; Sodani, Prahlad R.; Sharma, Narottam D.; Aaron, Grant J.			High Coverage and Utilization of Fortified Take-Home Rations among Children 6-35 Months of Age Provided through the Integrated Child Development Services Program: Findings from a Cross-Sectional Survey in Telangana, India	PLOS ONE			English	Article								The Integrated Child Development Services (ICDS) in the State of Telangana, India, freely provides a fortified complementary food product, Bal Amrutham, as a take-home ration to children 6-35 months of age. In order to understand the potential for impact of any intervention, it is essential to assess coverage and utilization of the program and to address the barriers to its coverage and utilization. A two-stage, stratified cross-sectional cluster survey was conducted to estimate the coverage and utilization of Bal Amrutham and to identify their barriers and drivers. In randomly selected catchment areas of ICDS centers, children under 36 months of age were randomly selected. A questionnaire, constructed from different validated and standard modules and designed to collect coverage data on nutrition programs, was administered to caregivers. A total of 1,077 children were enrolled in the survey. The coverage of the fortified take-home ration was found to be high among the target population. Nearly all caregivers (93.7%) had heard of Bal Amrutham and 86.8% had already received the product for the target child. Among the children surveyed, 57.2% consumed the product regularly. The ICDS program's services were not found to be a barrier to product coverage. In fact, the ICDS program was found to be widely available, accessible, accepted, and utilized by the population in both urban and rural catchment areas, as well as among poor and non-poor households. However, two barriers to optimal coverage were found: the irregular supply of the product to the beneficiaries and the intra-household sharing of the product. Although sharing was common, the product was estimated to provide the target children with significant proportions of the daily requirements of macro-and micronutrients. Bal Amrutham is widely available, accepted, and consumed among the target population in the catchment areas of ICDS centers. The coverage of the product could be further increased by improving the supply chain.	[Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Wirth, James P.; Woodruff, Bradley A.] GroundWork, Flasch, Switzerland; [Sankar, Rajan] TATA Trusts, New Delhi, India; [Sodani, Prahlad R.; Sharma, Narottam D.] Indian Inst Hlth Management Res, Jaipur, Rajasthan, India		Leyvraz, M (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	magali.leyvraz@gmail.com	Sodani, Prahlad Rai/CAG-5905-2022	Sodani, Prahlad Rai/0000-0003-4419-1243; Wirth, James P/0000-0002-4733-0379; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation; Bill & Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of the Indian Institute of Health Management Research which supported the survey. We would also like to thank Ms. Amrapali Katta from the Women Development and Child Welfare Department, Government of Telangana, for her support in conducting the survey and the AWWs for their help and cooperation in collecting the data. This study is part of a nutrition project implemented by AP Foods, the ICDS program, and GAIN, with the support of the Bill & Melinda Gates Foundation.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2007, NAT FAM HLTH SURV NF; [Anonymous], 2008, NAT FAM HLTH SURV NF; [Anonymous], 2014, CAS STUD BETT BUS PR; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; AVSM YS, 1995, J TROP PEDIATRICS, V41, P123, DOI 10.1093/tropej/41.2.123; BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; Brown K, 2016, MATERN CHILD NUTR, V12, P262, DOI 10.1111/mcn.12141; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Cohuet S, 2012, APPETITE, V59, P698, DOI 10.1016/j.appet.2012.07.019; Ghassemi H, 1992, Asia Pac J Clin Nutr, V1, P195; Gragnolati M., 2006, Economic and Political Weekly, V41, P1193; Group ICoMRE Research ICoM (India) NIoN, 2010, NUTR REQ REC DIET AL; Guevarra E, 2014, FIELD EXCHANGE, V47; Gupta AK, 2014, INT J MANAGEMENT SOC, V3; Kapil Umesh, 2002, Indian Journal of Pediatrics, V69, P597, DOI 10.1007/BF02722688; Kapil U, 2011, INDIAN J PEDIATR, V78, P1069, DOI 10.1007/s12098-011-0379-z; Kodish SR, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12234; National Sample Survey Organization, 2012, 540 NAT SAMPL SURV O; Santos Iná S., 2005, Cad. Saúde Pública, V21, P776, DOI 10.1590/S0102-311X2005000300011; Skau J., 2009, OUTCOME EVALUATION S; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Wirth JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158554	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0160814	10.1371/journal.pone.0160814	http://dx.doi.org/10.1371/journal.pone.0160814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695118	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100006
J	Muralidharan, S; Dirda, NDA; Katz, EJ; Tang, CM; Bandyopadhyay, S; Kanold, PO; Kao, JPY				Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Katz, Elizabeth J.; Tang, Cha-Min; Bandyopadhyay, Sharba; Kanold, Patrick O.; Kao, Joseph P. Y.			Ncm, a Photolabile Group for Preparation of Caged Molecules: Synthesis and Biological Application	PLOS ONE			English	Article							ACID ESTER PRODRUGS; ORTHO-NITROBENZYL ESTERS; IN-VITRO; ARYLNITROSO COMPOUNDS; REDUCED GLUTATHIONE; CHEMICAL-STABILITY; PROTECTING GROUP; AUDITORY-CORTEX; DRUG-DELIVERY; THIOLS	Ncm, 6-nitrocoumarin-7-ylmethyl, is a photolabile protective group useful for making "caged" molecules. Ncm marries the reliable photochemistry of 2-nitrobenzyl systems with the excellent stability and spectroscopic properties of the coumarin chromophore. From simple, commercially available starting materials, preparation of Ncm and its caged derivatives is both quick and easy. Photorelease of Ncm-caged molecules occurs on the microsecond time scale, with quantum efficiencies of 0.05-0.08. We report the synthesis and physical properties of Ncm and its caged derivatives. The utility of Ncm-caged glutamate for neuronal photostimulation is demonstrated in cultured hippocampal neurons and in brain slice preparations.	[Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Kao, Joseph P. Y.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Kao, Joseph P. Y.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Katz, Elizabeth J.; Tang, Cha-Min; Kao, Joseph P. Y.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA; [Katz, Elizabeth J.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Bandyopadhyay, Sharba; Kanold, Patrick O.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Katz, Elizabeth J.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Kao, JPY (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Kao, JPY (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Kao, JPY (corresponding author), Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA.	jkao@umaryland.edu		Kanold, Patrick/0000-0002-7529-5435; Kao, Joseph/0000-0002-8875-2180	U.S. National Institutes of Health [DC009607, GM056481]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009607] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Research grants DC009607 (POK) and GM056481 (JPYK) from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; Akahoshi A, 2014, BIOORG MED CHEM LETT, V24, P5369, DOI 10.1016/j.bmcl.2014.10.053; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; BEAUCHAMP LM, 1992, ANTIVIR CHEM CHEMOTH, V3, P157, DOI 10.1177/095632029200300305; Boinapally S, 2014, J ORG CHEM, V79, P7822, DOI 10.1021/jo501425p; Bort G, 2013, ANGEW CHEM INT EDIT, V52, P4526, DOI 10.1002/anie.201204203; Buhr F, 2015, ANGEW CHEM INT EDIT, V54, P3717, DOI 10.1002/anie.201410940; BUNDGAARD H, 1984, INT J PHARM, V18, P79, DOI 10.1016/0378-5173(84)90109-1; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Callan HE, 2009, CHEM RES TOXICOL, V22, P937, DOI 10.1021/tx900034r; Chow YL, 1982, CHEM AMINO NITRO NIT, P291; DEMAYO P, 1976, CREATION DETECTION E, V4, P139; Deshmukh M, 2010, J MED CHEM, V53, P1038, DOI 10.1021/jm901029n; DIEPOLD C, 1982, ADV EXP MED BIOL, V136, P1173; DOLLE B, 1980, XENOBIOTICA, V10, P527; ELLIS MK, 1992, CHEM-BIOL INTERACT, V82, P151, DOI 10.1016/0009-2797(92)90107-V; EYER P, 1994, ENVIRON HEALTH PERSP, V102, P123, DOI 10.2307/3432165; EYER P, 1983, BIOCHEM PHARMACOL, V32, P1029, DOI 10.1016/0006-2952(83)90621-4; EYER P, 1979, CHEM-BIOL INTERACT, V24, P227, DOI 10.1016/0009-2797(79)90011-5; FIERABRACCI V, 1991, J CHROMATOGR-BIOMED, V570, P285, DOI 10.1016/0378-4347(91)80531-G; GALLEMANN D, 1994, ENVIRON HEALTH PERSP, V102, P137, DOI 10.2307/3432167; Hagen V, 1996, BIOCHEMISTRY-US, V35, P7762, DOI 10.1021/bi952895b; HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102; Heinbockel T, 2005, J NEUROSCI, V25, P9449, DOI 10.1523/JNEUROSCI.2078-05.2005; Hess George P, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top084152; Huang YHH, 2005, NEUROPHARMACOLOGY, V49, P831, DOI 10.1016/j.neuropharm.2005.07.018; Kao J. P. Y., 1993, OPTICAL MICROSCOPY E, P27; Kao Joseph P Y, 2013, Methods Mol Biol, V995, P57, DOI 10.1007/978-1-62703-345-9_5; KAO JP, 2006, CURR PROTOC NEUROSCI, pCH6, DOI DOI 10.1002/0471142301,NS0620S37; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; KAZANIS S, 1992, J AM CHEM SOC, V114, P3052, DOI 10.1021/ja00034a043; KLEHR H, 1985, BIOL CHEM H-S, V366, P755, DOI 10.1515/bchm3.1985.366.2.755; Landowski CP, 2005, MOL CANCER THER, V4, P659, DOI 10.1158/1535-7163.MCT-04-0290; Lawrence DS, 2005, CURR OPIN CHEM BIOL, V9, P570, DOI 10.1016/j.cbpa.2005.09.002; LIN ST, 1995, J CHEM RES-S, P372; Liu L, 2008, CHEM RES TOXICOL, V21, P2005, DOI 10.1021/tx800215h; Marriott G, 1999, TRENDS PLANT SCI, V4, P330, DOI 10.1016/S1360-1385(99)01452-1; MARRIOTT G, 1994, BIOCHEMISTRY-US, V33, P9092, DOI 10.1021/bi00197a010; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Meng XY, 2015, CELL REP, V12, P955, DOI 10.1016/j.celrep.2015.07.018; Meng XY, 2014, J NEUROSCI, V34, P8855, DOI 10.1523/JNEUROSCI.0233-14.2014; Montanari S, 1999, J ORG CHEM, V64, P3422, DOI 10.1021/jo981889t; MURALIDHARAN S, 1995, J PHOTOCH PHOTOBIO B, V27, P123, DOI 10.1016/1011-1344(94)07063-T; Nakayama K, 2011, PHOTOCHEM PHOTOBIOL, V87, P1031, DOI 10.1111/j.1751-1097.2011.00957.x; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; Niu L, 1996, BIOCHEMISTRY-US, V35, P8136, DOI 10.1021/bi952364n; PAGE MI, 1986, J CHEM SOC PERK T 2, P867, DOI 10.1039/p29860000867; RAMESH D, 1993, P NATL ACAD SCI USA, V90, P11074, DOI 10.1073/pnas.90.23.11074; Rautio J, 1999, PHARMACEUT RES, V16, P1172, DOI 10.1023/A:1018981010047; Rossi FM, 1997, J BIOL CHEM, V272, P32933, DOI 10.1074/jbc.272.52.32933; Salierno M, 2010, J INORG BIOCHEM, V104, P418, DOI 10.1016/j.jinorgbio.2009.12.004; Santos MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037542; Sauers DJ, 2010, ACS CHEM BIOL, V5, P313, DOI 10.1021/cb9002305; SCHUPP H, 1987, J PHOTOCHEM, V36, P85, DOI 10.1016/0047-2670(87)87064-8; Shembekar VR, 2005, BIOCHEMISTRY-US, V44, P7107, DOI 10.1021/bi047665o; Shigeri Y, 2001, PHARMACOL THERAPEUT, V91, P85, DOI 10.1016/S0163-7258(01)00148-6; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; UMEMOTO A, 1988, CHEM-BIOL INTERACT, V68, P57, DOI 10.1016/0009-2797(88)90006-3; Viswanathan S, 2012, J NEUROSCI, V32, P1589, DOI 10.1523/JNEUROSCI.4748-11.2012; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Watkins PV, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00015; WHEELER WJ, 1979, J MED CHEM, V22, P657, DOI 10.1021/jm00192a010; WILCOX M, 1990, J ORG CHEM, V55, P1585, DOI 10.1021/jo00292a038; YIP RW, 1991, J PHYS CHEM-US, V95, P6078, DOI 10.1021/j100169a009; YIP RW, 1985, J PHYS CHEM-US, V89, P5328, DOI 10.1021/j100271a002; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang ZY, 1999, BIOCONJUGATE CHEM, V10, P1150, DOI 10.1021/bc990087h; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009; Zhao J, 2006, BIOCHEMISTRY-US, V45, P4915, DOI 10.1021/bi052082f; ZHU QQ, 1987, J PHOTOCHEM, V39, P317, DOI 10.1016/0047-2670(87)80041-2; ZUMAN P, 1994, CHEM REV, V94, P1621, DOI 10.1021/cr00030a007	74	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163937	10.1371/journal.pone.0163937	http://dx.doi.org/10.1371/journal.pone.0163937			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695074	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100066
J	Qu, JZ; Ma, C; Feng, JJ; Xu, ST; Wang, L; Li, FF; Li, YB; Zhang, RH; Zhang, XH; Xue, JQ; Guo, DW				Qu, Jianzhou; Ma, Chuang; Feng, Jiaojiao; Xu, Shutu; Wang, Lei; Li, Feifei; Li, Yibo; Zhang, Renhe; Zhang, Xinghua; Xue, Jiquan; Guo, Dongwei			Transcriptome Dynamics during Maize Endosperm Development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; METABOLISM; LANDSCAPE; PATTERNS; EMBRYO; SEED	The endosperm is a major organ of the seed that plays vital roles in determining seed weight and quality. However, genome-wide transcriptome patterns throughout maize endosperm development have not been comprehensively investigated to date. Accordingly, we performed a high-throughput RNA sequencing (RNA-seq) analysis of the maize endosperm transcriptome at 5, 10, 15 and 20 days after pollination (DAP). We found that more than 11,000 protein-coding genes underwent alternative splicing (AS) events during the four developmental stages studied. These genes were mainly involved in intracellular protein transport, signal transmission, cellular carbohydrate metabolism, cellular lipid metabolism, lipid biosynthesis, protein modification, histone modification, cellular amino acid metabolism, and DNA repair. Additionally, 7,633 genes, including 473 transcription factors (TFs), were differentially expressed among the four developmental stages. The differentially expressed TFs were from 50 families, including the bZIP, WRKY, GeBP and ARF families. Further analysis of the stage-specific TFs showed that binding, nucleus and ligand-dependent nuclear receptor activities might be important at 5 DAP, that immune responses, signalling, binding and lumen development are involved at 10 DAP, that protein metabolic processes and the cytoplasm might be important at 15 DAP, and that the responses to various stimuli are different at 20 DAP compared with the other developmental stages. This RNA-seq analysis provides novel, comprehensive insights into the transcriptome dynamics during early endosperm development in maize.	[Qu, Jianzhou; Feng, Jiaojiao; Xu, Shutu; Wang, Lei; Li, Feifei; Li, Yibo; Zhang, Renhe; Zhang, Xinghua; Xue, Jiquan; Guo, Dongwei] Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China; [Ma, Chuang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Xue, JQ; Guo, DW (corresponding author), Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China.	xjq2934@163.com; gdwei@nwsuaf.edu.cn	Xu, Shutu/HII-5636-2022		Tang Foundation [A212021207]; National Natural Science Foundation of China [31371626]; Shaanxi Province Science and Technology Innovation [2015KTZDNY01-01-01]; Fund of Northwest AF University [Z111021403, Z109021514]	Tang Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Innovation; Fund of Northwest AF University	This work was supported by Tang Foundation (A212021207), National Natural Science Foundation of China (31371626), Shaanxi Province Science and Technology Innovation coordination Project 2015KTZDNY01-01-01 and the Fund of Northwest A&F University (Z111021403; Z109021514); grant holders: DWG.	Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Becraft PW, 2001, SEMIN CELL DEV BIOL, V12, P387, DOI 10.1006/scdb.2001.0268; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Dante RA, 2014, PLANTA, V239, P493, DOI 10.1007/s00425-013-1990-1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng LN, 2009, PLANT MOL BIOL, V69, P649, DOI 10.1007/s11103-008-9444-z; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Jin ZW, 2014, PLANTA, V239, P299, DOI 10.1007/s00425-013-1979-9; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Lai JS, 2004, GENOME RES, V14, P1932, DOI 10.1101/gr.2780504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leroux BM, 2014, AM J BOT, V101, P1259, DOI 10.3732/ajb.1400083; Li GS, 2014, P NATL ACAD SCI USA, V111, P7582, DOI 10.1073/pnas.1406383111; Lian T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0578-2; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPES MA, 1993, PLANT CELL, V5, P1383, DOI 10.1105/tpc.5.10.1383; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Rogers MF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r4; Rousseau D, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0050-1; Sabelli PA, 2009, SEX PLANT REPROD, V22, P207, DOI 10.1007/s00497-009-0105-4; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Wang XN, 2015, FUNGAL GENET BIOL, V81, P221, DOI 10.1016/j.fgb.2015.03.010; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Wu YR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00240; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Zhan JP, 2015, PLANT CELL, V27, P513, DOI 10.1105/tpc.114.135657; Zhang W, 2014, MOL GENET GENOMICS, V289, P1061, DOI 10.1007/s00438-014-0867-8; Zou XL, 2011, ANN BOT-LONDON, V108, P1323, DOI 10.1093/aob/mcr223	54	18	19	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163814	10.1371/journal.pone.0163814	http://dx.doi.org/10.1371/journal.pone.0163814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695101	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100055
J	Chen, YY; Hu, HY; Chu, DC; Chen, HH; Chang, CK; Chou, P				Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chang, Chin-Kuo; Chou, Pesus			Patients with Primary Open-Angle Glaucoma May Develop Ischemic Heart Disease More Often than Those without Glaucoma: An 11-Year Population-Based Cohort Study	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; SILENT-MYOCARDIAL-ISCHEMIA; RISK-FACTORS; PRESSURE; PREVALENCE; EYE; METAANALYSIS; NUTRITION; ALCOHOL; SMOKING	Objectives To investigate whether patients with primary open angle glaucoma (POAG) have a higher proportion of ischemic heart disease (IHD) development. Design A population-based retrospective cohort study, using the National Health Insurance Database (NHID) from 1st January, 2001, to 31st December, 2011, in Taiwan. Methods 3510 subjects with POAG were enrolled into the POAG group and 14040 subjects without glaucoma into the comparison group. The comparison group consisted of randomly selected individuals, matched with the POAG group based on age, gender, and index date (date of enrollment) at a ratio of 1:4. The participants of both groups should have no IHD before the index date, and they were followed until the end of 2011 to see whether they had new-onset IHD or not. Kaplan-Meier curves were used to compare the cumulative incidence of IHD between the two groups. Frailty model, a specialized form of Cox regression analysis, was used to estimate the crude and adjusted hazard ratio (HR) of IHD. Analyses were adjusted by age, gender, and systemic comorbidities (i.e. diabetes, hypertension, hyperlipidemia, atrial fibrillation and congestive heart failure). Results The mean age of the cohort was 57.6 +/- 11.0 years. There were slightly more males than females (51.6% vs. 48.4%). A log-rank test comparing Kaplan-Meier curves of the two groups revealed a significantly higher cumulative incidence of IHD in the POAG group (p-value<0.001). In the univariate analysis by Frailty model, POAG patients had a significantly higher hazard of IHD (unadjusted HR = 2.32; 95% confidence interval 1.93 to 2.79). After adjustment, results remained significant (adjusted HR = 1.41; 95% confidence interval 1.16 to 1.72). Conclusion People with POAG may suffer from IHD more often than those without glaucoma.	[Chen, Yu-Yen; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yu-Yen] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Taiwan; [Hu, Hsiao-Yun] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chu, Dachen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Taipei, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chang, Chin-Kuo] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England	National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Chung Shan Medical University; Taichung Veterans General Hospital; University of London; King's College London	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chang, CK (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England.	chin-kuo.chang@kcl.ac.uk; pschou@ym.edu.tw	Chang, Chin-Kuo/E-4991-2010	Chang, Chin-Kuo/0000-0002-8338-7196				American Academy of Ophthalmology Glaucoma Panel, 2010, PREF PRACT PATT GUID; Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Balaratnasingam C, 2011, BRAIN RES, V1417, P67, DOI 10.1016/j.brainres.2011.08.022; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bonow RO, 2012, BRAUNWALDS HEART DIS; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cioffi GA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1517, DOI 10.1001/archopht.122.10.1517; Cioffi George A, 2005, Trans Am Ophthalmol Soc, V103, P592; Emre M, 2005, BRIT J OPHTHALMOL, V89, P60, DOI 10.1136/bjo.2004.046755; Emre M, 2004, BRIT J OPHTHALMOL, V88, P662, DOI 10.1136/bjo.2003.032110; Flammer J, 2001, PROG RETIN EYE RES, V20, P319, DOI 10.1016/S1350-9462(00)00028-8; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Flammer J, 2013, EUR HEART J, V34, P1270, DOI 10.1093/eurheartj/eht023; French DD, 2011, J GLAUCOMA, V20, P452, DOI 10.1097/IJG.0b013e3181f7b134; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Galassi F, 1998, INT OPHTHALMOL, V22, P299, DOI 10.1023/A:1006347509491; Gasser P, 1999, J GLAUCOMA, V8, P8; Gherghel D, 2004, INVEST OPHTH VIS SCI, V45, P3546, DOI 10.1167/iovs.04-0290; Gherghel D, 2004, SURV OPHTHALMOL, V49, P491, DOI 10.1016/j.survophthal.2004.06.003; Gherghel D, 2007, OPHTHAL PHYSL OPT, V27, P336, DOI 10.1111/j.1475-1313.2007.00485.x; Grieshaber Matthias C, 2005, Curr Opin Ophthalmol, V16, P79, DOI 10.1097/01.icu.0000156134.38495.0b; Hougaard P, 1995, Lifetime Data Anal, V1, P255; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; Kang JH, 2003, ARCH OPHTHALMOL-CHIC, V121, P1762, DOI 10.1001/archopht.121.12.1762; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; KLEIN BEK, 1993, OPHTHALMOLOGY, V100, P1609; Kleinblaum D, 1982, EPIDEMIOLOGIC RES; Kolettis TM, 2013, CARDIOL REV, V21, P249, DOI 10.1097/CRD.0b013e318283f65a; Konieczka K, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-11; Lagrange F, 1922, GLAUCOME LHYPOTONIE; Lanza G A, 1999, Cardiologia, V44, P913; Lanza GA, 1996, J AM COLL CARDIOL, V28, P1249, DOI 10.1016/S0735-1097(96)00309-9; Leske M C, 1996, Ophthalmic Epidemiol, V3, P85, DOI 10.3109/09286589609080113; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Lin HC, 2010, OPHTHALMOLOGY, V117, P2088, DOI 10.1016/j.ophtha.2010.03.003; Liu Xu-yang, 2010, Zhonghua Yan Ke Za Zhi, V46, P1062; Longo DL, 2012, HARRISONS PRINCIPLES; McMonnies CW, 2016, J OPTOM IN PRESS; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Pache M, 2006, SURV OPHTHALMOL, V51, P179, DOI 10.1016/j.survophthal.2006.02.008; Pasquale LR, 2009, J GLAUCOMA, V18, P423, DOI 10.1097/IJG.0b013e31818d3899; PERASALO R, 1992, GRAEF ARCH CLIN EXP, V230, P213, DOI 10.1007/BF00176290; PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8; Qiu C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133189; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Ren RJ, 2011, ACTA OPHTHALMOL, V89, pE142, DOI 10.1111/j.1755-3768.2010.02015.x; Riccadonna M, 2003, J GLAUCOMA, V12, P156, DOI 10.1097/00061198-200304000-00011; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Ronkko S, 2007, MOL VIS, V13, P408; Sihota R, 2006, OPTOMETRY VISION SCI, V83, P520, DOI 10.1097/01.opx.0000225910.51370.02; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; The Taiwan National Health Research Institutes, NAT HLTH INS RES DAT; Waldmann E, 1996, GRAEF ARCH CLIN EXP, V234, P595, DOI 10.1007/BF00185290; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wostyn P, 2010, MED HYPOTHESES, V74, P973, DOI 10.1016/j.mehy.2009.12.019; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P3399, DOI 10.1167/iovs.09-4867; Zhou MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102972	62	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163210	10.1371/journal.pone.0163210	http://dx.doi.org/10.1371/journal.pone.0163210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649414	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100066
J	Chutiwitoonchai, N; Siarot, L; Takeda, E; Shioda, T; Ueda, M; Aida, Y				Chutiwitoonchai, Nopporn; Siarot, Lowela; Takeda, Eri; Shioda, Tatsuo; Ueda, Motoki; Aida, Yoko			HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; PROTEIN-DEGRADATION; ESCRT MACHINERY; TYPE-1 VPR; ARREST; DOMAIN; TRAFFICKING; INTERACTS; COMPLEX; P6	HIV-1 budding requires interaction between Gag and cellular TSG101 to initiate viral particle assembly and release via the endosomal sorting complexes required for transport (ESCRT) pathway. However, some reports show that overexpression of TSG101 inhibits virus release by disruption of Gag targeting process. Since a HIV-1 accessory protein, Vpr binds to Gag p6 domain at the position close to the binding site for TSG101, whether Vpr implicates TSG101 overexpression effect has not been investigated. Here, we found that Vpr abrogates TSG101 overexpression effect to rescue viral production. Co-transfection of TSG101 and Gag with Vpr prevented TSG101-induced Gag accumulation in endosomes and lysosomes. In addition, Vpr rescued virus-like particle (VLP) production in a similar manner as a lysosomal inhibitor, Bafilomycin A1 indicating that Vpr inhibits TSG101-induced Gag downregulation via lysosomal pathway. Vpr and Gag interaction is required to counteract TSG101 overexpression effect since Vpr A30F mutant which is unable to interact with Gag and incorporate into virions, reduced ability to prevent Gag accumulation and to rescue VLP production. In addition, GST pull-down assays and Biacore analysis revealed that Vpr competed with TSG101 for Gag binding. These results indicate that Vpr overcomes the effects of TSG101 overexpression to support viral production by competing with TSG101 to bind Gag.	[Chutiwitoonchai, Nopporn; Siarot, Lowela; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Chutiwitoonchai, Nopporn] Japan Fdn AIDS Prevent, Chiyoda Ku, Tokyo, Japan; [Siarot, Lowela] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Takeda, Eri; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka, Japan; [Ueda, Motoki] RIKEN, Nano Med Engn Lab, Wako, Saitama, Japan	RIKEN; University of Tokyo; Osaka University; RIKEN	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp	ueda, motoki/I-3686-2019; Ueda, Motoki/Y-8976-2018	ueda, motoki/0000-0002-1675-809X; Ueda, Motoki/0000-0002-1675-809X	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) [10103951, 13801920, 15fk0410010h0002]; Grants-in-Aid for Scientific Research [15F15416, 16H05194] Funding Source: KAKEN	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS), http://www.mhlw.go.jp/index.shtml. Grant numbers: 10103951, 13801920, 15fk0410010h0002. Recipient: YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kenzo Tokunaga for providing pNL43 Luc E-R<SUP>+</SUP> (Vpr<SUP>+</SUP>) and pNL43 Luc E-R (Vpr<SUP>-</SUP>), Dr. Akio Adashi for providing pNF462, Dr. Atsushi Miyawaki for providing pCS2/Venus and pCS2/eCFP, Dr. Hirotaka Sato for constructing pCAGGS/Venus and pCAGGS/eCFP, and Dr. Ken Kono for constructing pcDNA/YFP-Vpr. We are grateful to the RIKEN BSI Research Resources Center for help with DNA sequencing analysis. This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS).	Bachand F, 1999, J BIOL CHEM, V274, P9083, DOI 10.1074/jbc.274.13.9083; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Bouamr F, 2007, J VIROL, V81, P2909, DOI 10.1128/JVI.01413-06; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; Chutiwitoonchai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105081; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Im YJ, 2010, STRUCTURE, V18, P1536, DOI 10.1016/j.str.2010.08.010; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Kondo E, 1996, J VIROL, V70, P159, DOI 10.1128/JVI.70.1.159-164.1996; Kono K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072531; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Qian J, 2014, EXP THER MED, V8, P1375, DOI 10.3892/etm.2014.1928; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Salgado GF, 2009, BIOCHEMISTRY-US, V48, P2355, DOI 10.1021/bi801794v; Sawaya BE, 1999, GENE THER, V6, P947, DOI 10.1038/sj.gt.3300907; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Valiathan RR, 2004, J VIROL, V78, P12386, DOI 10.1128/JVI.78.22.12386-12394.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319; Zhu Henghu, 2004, Retrovirology, V1, P26, DOI 10.1186/1742-4690-1-26	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163100	10.1371/journal.pone.0163100	http://dx.doi.org/10.1371/journal.pone.0163100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648839	Green Submitted, gold, Green Published			2022-12-26	WOS:000383892100053
J	Conlisk, E; Swab, R; Martinez-Berdeja, A; Daugherty, MP				Conlisk, Erin; Swab, Rebecca; Martinez-Berdeja, Alejandra; Daugherty, Matthew P.			Post-Fire Recovery in Coastal Sage Scrub: Seed Rain and Community Trajectory	PLOS ONE			English	Article							EXOTIC ANNUAL BROMUS; SOUTHERN CALIFORNIA; FIRE; INVASION; RESTORATION; DISTURBANCE; ECOREGIONS; ABUNDANCE	Disturbance is a primary mechanism structuring ecological communities. However, human activity has the potential to alter the frequency and intensity of natural disturbance regimes, with subsequent effects on ecosystem processes. In Southern California, human development has led to increased fire frequency close to urban areas that can forma positive feedback with invasive plant spread. Understanding how abiotic and biotic factors structure post-fire plant communities is a critical component of post-fire management and restoration. In this study we considered a variety of mechanisms affecting post-fire vegetation recovery in Riversidean sage scrub. Comparing recently burned plots to unburned plots, we found that burning significantly reduced species richness and percent cover of exotic vegetation the first two years following a 100-hectare wildfire. Seed rain was higher in burned plots, with more native forb seeds, while unburned plots had more exotic grass seeds. Moreover, there were significant correlations between seed rain composition and plant cover composition the year prior and the year after. Collectively, this case study suggests that fire can alter community composition, but there was not compelling evidence of a vegetation-type conversion. Instead, the changes in the community composition were temporary and convergence in community composition was apparent within two years post-fire.	[Conlisk, Erin] San Diego State Univ, 5500 Campanile Dr, San Diego, CA 92182 USA; [Swab, Rebecca] The Wilds, 14000 Int Dr, Cumberland, OH 43732 USA; [Martinez-Berdeja, Alejandra] Univ Calif Davis, Dept Ecol & Evolut, One Shields Ave, Davis, CA 95616 USA; [Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, 900 Univ Ave, Riverside, CA 92521 USA	California State University System; San Diego State University; University of California System; University of California Davis; University of California System; University of California Riverside	Conlisk, E (corresponding author), San Diego State Univ, 5500 Campanile Dr, San Diego, CA 92182 USA.	erin.conlisk@gmail.com			Riverside County Habitat Conservation Agency [005973002]	Riverside County Habitat Conservation Agency	This work was supported by Riverside County Habitat Conservation Agency (grant # 005973002).; The authors would like to acknowledge the Riverside County Habitat Conservation Agency for funding (grant 005973002). Tremendous thanks to A. Sanders at the UCR Herbarium and L. Lippit for plant and seed identification. Thanks also to D. Lee. Finally, thanks to K. Halama for logistical support at the Motte Rimrock Reserve; H. Regan, D. Jenerrette, and K. Anderson for the use of their labs, and A. Ayyaz, J. Gotoc, V. Duong, E. Roman, N. Freeman, N. Warounthorn, and J. Chen for help in the field and in the lab.	Allen EB., 2000, 2 INTERFACE ECOLOGY, P253; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Auld TD, 2001, BIOL CONSERV, V97, P377, DOI 10.1016/S0006-3207(00)00136-1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brooks ML, 2016, SPRINGER SER ENV MAN, P11, DOI 10.1007/978-3-319-24930-8_2; Brooks ML, 2011, RANGELAND ECOL MANAG, V64, P431, DOI 10.2111/REM-D-09-00165.1; Cox RD, 2008, J APPL ECOL, V45, P495, DOI 10.1111/j.1365-2664.2007.01437.x; De Mendiburu F, 2009, THESIS; DeSimone SA, 1999, ECOLOGY, V80, P2018, DOI 10.1890/0012-9658(1999)080[2018:SSRIUC]2.0.CO;2; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Egerton-Warburton LM, 1998, J EXP BOT, V49, P1317, DOI 10.1093/jexbot/49.325.1317; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Fleming GM, 2009, ECOL APPL, V19, P2210, DOI 10.1890/07-1959.1; Fox J., 2018, R COMPANION APPL REG, VThird; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Keeley JE, 2006, ECOL MONOGR, V76, P235, DOI 10.1890/0012-9615(2006)076[0235:DPOPRI]2.0.CO;2; Keeley JE, 2003, DIVERS DISTRIB, V9, P253, DOI 10.1046/j.1472-4642.2003.00017.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Keeley JE, 2012, OECOLOGIA, V169, P1043, DOI 10.1007/s00442-012-2253-8; Keeley JE, 2011, ECOL STUD-ANAL SYNTH, V213, P193, DOI 10.1007/978-94-007-0301-8_8; Krawchuck MA, 2012, CALIFORNIA ENERGY CO, VCEC-500-2012-026; Lambert AM., 2010, FREMONTIA, V38, P29; Link SO, 2006, INT J WILDLAND FIRE, V15, P113, DOI 10.1071/WF05001; MORGAN KR, 1992, ECOLOGY, V73, P2260, DOI 10.2307/1941473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; O'FARRELL M J, 1987, Wasmann Journal of Biology, V45, P34; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pinheiro J, 2020, R PACKAGE VERSION 31; Price MV, 1995, BRUSHFIRES CALIFORNI, P51; Pyke DA, 2016, SPRINGER SER ENV MAN, P307, DOI 10.1007/978-3-319-24930-8_11; R Core Team, 2021, R LANGUAGE ENV STAT; Rubinoff D, 2001, CONSERV BIOL, V15, P1374, DOI 10.1046/j.1523-1739.2001.00176.x; Sandel B, 2012, GLOBAL CHANGE BIOL, V18, P277, DOI 10.1111/j.1365-2486.2011.02480.x; Schwede DB, 2014, ATMOS ENVIRON, V92, P207, DOI 10.1016/j.atmosenv.2014.04.008; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Talluto MV, 2008, LANDSCAPE ECOL, V23, P803, DOI 10.1007/s10980-008-9238-3; Wainwright CE, 2012, J APPL ECOL, V49, P234, DOI 10.1111/j.1365-2664.2011.02088.x; Yelenik SG, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2009.00598.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	44	4	4	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162777	10.1371/journal.pone.0162777	http://dx.doi.org/10.1371/journal.pone.0162777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649564	Green Published, gold			2022-12-26	WOS:000383892100033
J	Kim, D; Kupfer, JA				Kim, Daehyun; Kupfer, John A.			Tri-Variate Relationships among Vegetation, Soil, and Topography along Gradients of Fluvial Biogeomorphic Succession	PLOS ONE			English	Article							MOUNT ST-HELENS; SPECIES DISTRIBUTION; RIPARIAN VEGETATION; POPULUS-NIGRA; RIVER; EVOLUTION; CHANNEL; DISTURBANCE; TEMPERATE; PATHWAYS	This research investigated how the strength of vegetation-soil-topography couplings varied along a gradient of biogeomorphic succession in two distinct fluvial systems: a forested river floodplain and a coastal salt marsh creek. The strength of couplings was quantified as tri-variance, which was calculated by correlating three singular axes, one each extracted using three-block partial least squares from vegetation, soil, and topography data blocks. Within each system, tri-variance was examined at low-, mid-, and high-elevation sites, which represented early-, intermediate-, and late-successional phases, respectively, and corresponded to differences in ongoing disturbance frequency and intensity. Both systems exhibited clearly increasing tri-variance from the early- to late-successional stages. The lowest-lying sites underwent frequent and intense hydrogeomorphic forcings that dynamically reworked soil substrates, restructured surface landforms, and controlled the colonization of plant species. Such conditions led vegetation, soil, and topography to show discrete, stochastic, and individualistic behaviors over space and time, resulting in a loose coupling among the three ecosystem components. In the highest-elevation sites, in contrast, disturbances that might disrupt the existing biotic-abiotic relationships were less common. Hence, ecological succession, soil-forming processes, and landform evolution occurred in tight conjunction with one another over a prolonged period, thereby strengthening couplings among them; namely, the three behaved in unity over space and time. We propose that the recurrence interval of physical disturbance is important to-and potentially serves as an indicator of-the intensity and mechanisms of vegetation-soil-topography feedbacks in fluvial biogeomorphic systems.	[Kim, Daehyun] Univ Kentucky, Dept Geog, Biogeomorphol Res & Anal Grp, Lexington, KY 40506 USA; [Kupfer, John A.] Univ South Carolina, Dept Geog, Columbia, SC 29208 USA	University of Kentucky; University of South Carolina System; University of South Carolina Columbia	Kim, D (corresponding author), Univ Kentucky, Dept Geog, Biogeomorphol Res & Anal Grp, Lexington, KY 40506 USA.	biogeokim@uky.edu			National Science Foundation [BCS-0825753]; U.S. Department of the Interior National Park Service	National Science Foundation(National Science Foundation (NSF)); U.S. Department of the Interior National Park Service	This research was supported by the National Science Foundation (BCS-0825753) and the U.S. Department of the Interior National Park Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, PARTIAL LEAST SQUARE; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Batz N, 2015, CATENA, V126, P86, DOI 10.1016/j.catena.2014.10.013; BAKER WL, 1995, ANN ASSOC AM GEOGR, V85, P320, DOI 10.1111/j.1467-8306.1995.tb01797.x; Balke T, 2014, J ECOL, V102, P700, DOI 10.1111/1365-2745.12241; Baptist M.J, 2005, MODELLING FLOODPLAIN; Barsoum N, 2001, EVOL ECOL, V15, P255, DOI 10.1023/A:1016028730129; Bartholdy AT, 2010, MAR GEOL, V278, P31, DOI 10.1016/j.margeo.2010.09.001; Bartholdy J, 2004, MAR GEOL, V203, P1, DOI 10.1016/S0025-3227(03)00337-2; Bartholdy J., 1997, GEOGR TIDSSKR-DEN, V97, P11, DOI 10.1080/00167223.1997.10649389; Bartholdy J, 2007, SEDIMENT GEOL, V202, P436, DOI 10.1016/j.sedgeo.2007.03.008; Bendix J, 2000, HYDROL PROCESS, V14, P2977, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2977::AID-HYP130&gt;3.0.CO;2-4; BERTNESS MD, 1994, AM NAT, V144, P363, DOI 10.1086/285681; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Brookes CJ, 2000, CATENA, V40, P93, DOI 10.1016/S0341-8162(99)00065-X; Brooks AP, 2003, GEOMORPHOLOGY, V51, P7, DOI 10.1016/S0169-555X(02)00323-9; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Cooper DJ, 2003, J ECOL, V91, P182, DOI 10.1046/j.1365-2745.2003.00766.x; Corenblit D, 2007, EARTH-SCI REV, V84, P56, DOI 10.1016/j.earscirev.2007.05.004; Corenblit D, 2015, GLOBAL ECOL BIOGEOGR, V24, P1363, DOI 10.1111/geb.12373; Corenblit D, 2010, ECOGRAPHY, V33, P1136, DOI 10.1111/j.1600-0587.2010.05894.x; Corenblit D, 2009, EARTH SURF PROC LAND, V34, P1790, DOI 10.1002/esp.1876; Crain CM, 2006, BIOSCIENCE, V56, P211; Davies NS, 2013, EARTH-SCI REV, V120, P40, DOI 10.1016/j.earscirev.2013.02.004; DELMORAL R, 1995, J VEG SCI, V6, P107, DOI 10.2307/3236262; Eichel J, 2013, GEOMORPHOLOGY, V201, P98, DOI 10.1016/j.geomorph.2013.06.012; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Francis RA, 2009, AQUAT SCI, V71, P290, DOI 10.1007/s00027-009-9182-6; Franklin J, 2009, MAPPING SPECIES DIST; Geerling GW, 2006, HYDROBIOLOGIA, V565, P71, DOI 10.1007/s10750-005-1906-6; Ginter CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034481; Guilloy-Froget H, 2002, WETLANDS, V22, P478, DOI 10.1672/0277-5212(2002)022[0478:DGASOP]2.0.CO;2; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gurnell AM, 2016, AQUAT SCI, V78, P135, DOI 10.1007/s00027-015-0436-1; Gurnell AM, 2002, FRESHWATER BIOL, V47, P581, DOI 10.1046/j.1365-2427.2002.00923.x; Gurnell A, 2014, EARTH SURF PROC LAND, V39, P4, DOI 10.1002/esp.3397; Gurnell AM, 2012, EARTH-SCI REV, V111, P129, DOI 10.1016/j.earscirev.2011.11.005; HALPERN CB, 1990, J VEG SCI, V1, P181, DOI 10.2307/3235657; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jones CG, 2012, GEOMORPHOLOGY, V157, P75, DOI 10.1016/j.geomorph.2011.04.039; Kim D, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-0074.1; Kim D, 2014, ECOL RES, V29, P661, DOI 10.1007/s11284-014-1157-y; Kim D, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00028.1; Kim D, 2012, ANN ASSOC AM GEOGR, V102, P276, DOI 10.1080/00045608.2011.620520; Kim D, 2010, PHYS GEOGR, V31, P58, DOI 10.2747/0272-3646.31.1.58; Kupfer JA, 1996, J VEG SCI, V7, P247, DOI 10.2307/3236325; Kupfer JA, 2010, FOREST ECOL MANAG, V259, P1880, DOI 10.1016/j.foreco.2010.01.050; Larsen LG, 2010, AM NAT, V176, pE66, DOI 10.1086/655215; Malanson G.P., 1993, RIPARIAN LANDSCAPES; Marani M, 2013, P NATL ACAD SCI USA, V110, P3259, DOI 10.1073/pnas.1218327110; Matthews B, 2014, ECOL MONOGR, V84, P245, DOI 10.1890/13-0953.1; McCune B, 1997, ECOLOGY, V78, P2617; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; Naylor LA, 2012, GEOMORPHOLOGY, V157, P17, DOI 10.1016/j.geomorph.2011.07.015; Nilsson C, 2002, ENVIRON MANAGE, V30, P468, DOI 10.1007/s00267-002-2735-2; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; PALMER MW, 1993, ECOLOGY, V74, P2215, DOI 10.2307/1939575; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Phillips JD, 2016, EARTH SURF PROC LAND, V41, P16, DOI 10.1002/esp.3764; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIELOU E. C., 1984, INTERPRETATION ECOLO; Pollock MM, 1998, ECOLOGY, V79, P94; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rood SB, 2000, TREES-STRUCT FUNCT, V14, P248, DOI 10.1007/s004680050010; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Shipley B., 2000, CAUSE CORRELATIONS B; SRIVASTAVA DS, 1995, J ECOL, V83, P421, DOI 10.2307/2261595; Stallins JA, 2006, GEOMORPHOLOGY, V77, P207, DOI 10.1016/j.geomorph.2006.01.005; Steiger J, 2005, RIVER RES APPL, V21, P719, DOI 10.1002/rra.879; Tabacchi E, 2005, RIVER RES APPL, V21, P299, DOI 10.1002/rra.848; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; *USDA NRCS, 2008, WEB SOIL SURV; Van Dyke C, 2015, PROG PHYS GEOG, V39, P594, DOI 10.1177/0309133315581700; Viles HA, 2008, EARTH SURF PROC LAND, V33, P1419, DOI 10.1002/esp.1717; Wang, 2010, HDB PARTIAL LEAST SQ, P47, DOI [10.1007/978-3-540-32827-8_3, DOI 10.1007/978-3-540-32827-8]; Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56; Wolner CWV, 2013, GEOMORPHOLOGY, V199, P115, DOI 10.1016/j.geomorph.2013.03.035; Wright JT, 2012, ECOLOGY, V93, P1262, DOI 10.1890/11-1740.1	83	8	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163223	10.1371/journal.pone.0163223	http://dx.doi.org/10.1371/journal.pone.0163223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649497	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100067
J	Wang, MJ; Tang, WB; Xin, H; Zhu, YZ				Wang, Minjun; Tang, Wenbo; Xin, Hong; Zhu, Yi Zhun			S-Propargyl-Cysteine, a Novel Hydrogen Sulfide Donor, Inhibits Inflammatory Hepcidin and Relieves Anemia of Inflammation by Inhibiting IL-6/STAT3 Pathway	PLOS ONE			English	Article							MYOCARDIAL-ISCHEMIA; MORTALITY; STAT3; ERYTHROPOIESIS; ACTIVATION; MANAGEMENT; CAPACITY; MEDIATOR; HYPOXIA; DISEASE	Anemia of inflammation (AI) is clinically prevalent and greatly threatens public health. Traditional remedies have raised controversy during clinical practice, calling for alternative therapies. We have recently found that hydrogen sulfide (H2S) inhibits inflammatory hepcidin, the critical mediator of AI. However, due to the chemical property of H2S, there remains an urgent need for a stable H2S donor in AI treatment. Here we reported that S-propargyl-cysteine (SPRC), a novel water-soluble H2S donor, suppressed hepatic hepcidin and corrected hypoferremia induced by lipopolysaccharide. The effects of SPRC were reversed by inhibition of cystathionine gamma-lyase, one of the major endogenous H2S synthases. Moreover, SPRC reduced serum hepcidin, improved transferrin saturation, and maintained erythrocyte membrane integrity in a chronic mouse AI model. Consistently, splenomegaly was ameliorated and splenic iron accumulation relieved. Mechanism study indicated that serum IL-6 content and hepatic Il-6 mRNA were decreased by SPRC, in parallel with reduced hepatic JAK2/STAT3 activation. On the whole, our data reveal the inhibition of inflammatory hepcidin by SPRC, and suggest SPRC as a potential remedy against AI.	[Wang, Minjun; Xin, Hong; Zhu, Yi Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, Shanghai 201203, Peoples R China; [Tang, Wenbo] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Wang, Minjun; Zhu, Yi Zhun] Macau Univ Sci & Technol, Dept Pharmacol, Sch Pharm, Macau, Peoples R China	Fudan University; Fudan University; Macau University of Science & Technology	Zhu, YZ (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai Key Lab Bioact Small Mol, Shanghai 201203, Peoples R China.; Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Dept Pharmacol, Sch Pharm, Macau, Peoples R China.	zhuyz@fudan.edu.cn	Xin, Hong/AAF-5786-2020; Zhu, Yi Zhun/ABG-8449-2021	Zhu, Yi Zhun/0000-0001-7700-8041	National Natural Science Foundation of China [81330080, 81573421]; Shanghai Committee of Science and Technology of China [14JC1401100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology of China	This work was supported by grants from National Natural Science Foundation of China (No. 81330080; 81573421) and Shanghai Committee of Science and Technology of China (No. 14JC1401100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Brookhart MA, 2010, JAMA-J AM MED ASSOC, V303, P857, DOI 10.1001/jama.2010.206; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gasche C, 2007, INFLAMM BOWEL DIS, V13, P1545, DOI 10.1002/ibd.20285; Gong QH, 2011, BRAIN BEHAV IMMUN, V25, P110, DOI 10.1016/j.bbi.2010.09.001; Gong QH, 2010, PHARMACOL BIOCHEM BE, V96, P52, DOI 10.1016/j.pbb.2010.04.006; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Kan JT, 2014, ANTIOXID REDOX SIGN, V20, P2303, DOI 10.1089/ars.2013.5449; Langdon JM, 2014, AM J HEMATOL, V89, P470, DOI 10.1002/ajh.23670; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Miao L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22363; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Painter P, 2002, AM J KIDNEY DIS, V39, P257, DOI 10.1053/ajkd.2002.30544; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c; Roviezzo F, 2015, PHARMACOL RES, V100, P85, DOI 10.1016/j.phrs.2015.07.032; Sakamori R, 2010, J GASTROENTEROL, V45, P244, DOI 10.1007/s00535-009-0159-y; Shen YQ, 2015, ANTIOXID REDOX SIGN, V22, P224, DOI 10.1089/ars.2014.5909; Sidhapuriwala JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032574; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Teehan GS, 2004, CLIN INFECT DIS, V38, P1090, DOI 10.1086/382878; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Tonelli Marcello, 2009, CMAJ, V180, pE62, DOI 10.1503/cmaj.090470; Vandiver MS, 2012, J MOL MED, V90, P255, DOI 10.1007/s00109-012-0873-4; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Wang Q, 2010, ANTIOXID REDOX SIGN, V12, P1155, DOI 10.1089/ars.2009.2947; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Xin H, 2016, ANTIOXID REDOX SIGN, V24, P70, DOI 10.1089/ars.2015.6315; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang Q, 2014, PHARMACOL RES, V84, P32, DOI 10.1016/j.phrs.2014.04.009; Zheng YT, 2012, XENOBIOTICA, V42, P304, DOI 10.3109/00498254.2011.617848; Zheng YT, 2011, J PHARMACEUT BIOMED, V54, P1187, DOI 10.1016/j.jpba.2010.11.027	46	22	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163289	10.1371/journal.pone.0163289	http://dx.doi.org/10.1371/journal.pone.0163289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649298	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100074
J	Ramirez-Escudero, M; del Pozo, MV; Marin-Navarro, J; Gonzalez, B; Golyshin, PN; Polaina, J; Ferrer, M; Sanz-Aparicio, J				Ramirez-Escudero, Mercedes; del Pozo, Mercedes V.; Marin-Navarro, Julia; Gonzalez, Beatriz; Golyshin, Peter N.; Polaina, Julio; Ferrer, Manuel; Sanz-Aparicio, Julia			Structural and Functional Characterization of a Ruminal -Glycosidase Defines a Novel Subfamily of Glycoside Hydrolase Family 3 with Permuted Domain Topology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme structure; glycoside hydrolase; metagenomics; protein structure; X-ray crystallography; GH3 family; -glycosidase; enzymology; permuted domains topology; phylogenetic analysis	BETA-GLUCOSIDASE; 3-DIMENSIONAL STRUCTURE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; BACTERIUM; GLUCOHYDROLASE; COMBINATION; SEQUENCE; CLONING; SOIL	Metagenomics has opened up a vast pool of genes for putative, yet uncharacterized, enzymes. It widens our knowledge on the enzyme diversity world and discloses new families for which a clear classification is still needed, as is exemplified by glycoside hydrolase family-3 (GH3) proteins. Herein, we describe a GH3 enzyme (GlyA(1)) from resident microbial communities in strained ruminal fluid. The enzyme is a -glucosidase/-xylosidase that also shows -galactosidase, -fucosidase, -arabinofuranosidase, and -arabinopyranosidase activities. Short cello- and xylo-oligosaccharides, sophorose and gentibiose, are among the preferred substrates, with the large polysaccharide lichenan also being hydrolyzed by GlyA(1). The determination of the crystal structure of the enzyme in combination with deletion and site-directed mutagenesis allowed identification of its unusual domain composition and the active site architecture. Complexes of GlyA(1) with glucose, galactose, and xylose allowed picturing the catalytic pocket and illustrated the molecular basis of the substrate specificity. A hydrophobic platform defined by residues Trp-711 and Trp-106, located in a highly mobile loop, appears able to allocate differently -linked bioses. GlyA(1) includes an additional C-terminal domain previously unobserved in GH3 members, but crystallization of the full-length enzyme was unsuccessful. Therefore, small angle x-ray experiments have been performed to investigate the molecular flexibility and overall putative shape. This study provided evidence that GlyA(1) defines a new subfamily of GH3 proteins with a novel permuted domain topology. Phylogenetic analysis indicates that this topology is associated with microbes inhabiting the digestive tracts of ruminants and other animals, feeding on chemically diverse plant polymeric materials.	[Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, Madrid 28006, Spain; [del Pozo, Mercedes V.; Ferrer, Manuel] CSIC, Inst Catalysis & Petrochem, Marie Curie 2, Madrid 28049, Spain; [Marin-Navarro, Julia; Polaina, Julio] CSIC, Inst Agrochem & Food Technol, Carrer Catedrat Agustin Escardino Benlloch 7, Valencia 46980, Spain; [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Golyshin, Peter N.] Immanuel Kant Balt Fed Univ, Kaliningrad 236040, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Bangor University; Immanuel Kant Baltic Federal University	Sanz-Aparicio, J (corresponding author), CSIC, Inst Phys Chem Rocasolano, Dept Crystallog & Struct Biol, Serrano 119, Madrid 28006, Spain.; Ferrer, M (corresponding author), CSIC, Inst Catalysis & Petrochem, Marie Curie 2, Madrid 28049, Spain.	mferrer@icp.csic.es	Polaina, Julio/H-4498-2012; Gonzalez, Beatriz/M-1219-2014; ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Sanz-Aparicio, Julia/F-6201-2013; Escudero, Mercedes Ramirez/O-1690-2019	Gonzalez, Beatriz/0000-0002-0710-0202; ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Sanz-Aparicio, Julia/0000-0002-6849-8621; Escudero, Mercedes Ramirez/0000-0001-7253-9572; Golyshin, Peter/0000-0002-5433-0350	European Community [283570]; BBSRC [BB/M029085/1] Funding Source: UKRI	European Community(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the German Electron Synchrotron (Hamburg, Germany) for assistance at Petra III P13 Beamline, the Diamond Synchrotron Radiation Source (Daresbury, UK) for assistance at I03 Beamline, and funding from the European Community's Seventh Framework Programme under BioStruct-X (Grant 283570). We also thank the staff of the European Synchrotron Radiation Facility at Grenoble (ESRF, France) for providing access and technical assistance at beamlines ID23-1 and BM29, and the Spanish Synchrotron at Barcelona (Alba, Spain) for assistance at XALOC beamline. We also acknowledge Rafael Bargiela for excellent support in the preparation of Figs. 1 and 5 and Oleg N. Reva for critical contribution to the compositional similarities analysis.	Agirre J, 2016, ACTA CRYSTALLOGR D, V72, P254, DOI 10.1107/S2059798315024237; Alcaide M, 2015, ENVIRON MICROBIOL, V17, P332, DOI 10.1111/1462-2920.12660; Alcaide M, 2013, BIOCHEM J, V454, P157, DOI 10.1042/BJ20130552; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Deboy RT, 2008, J BACTERIOL, V190, P5455, DOI 10.1128/JB.01701-07; Del Pozo MV, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-73; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer M, 2016, MICROB BIOTECHNOL, V9, P22, DOI 10.1111/1751-7915.12309; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hrmova M, 2005, BIOCHEMISTRY-US, V44, P16529, DOI 10.1021/bi0514818; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P121, DOI 10.1007/s00253-010-2845-3; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; Menigaud S, 2012, BIOINFORMATICS, V28, P1270, DOI 10.1093/bioinformatics/bts118; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MEB, 2012, ENVIRON MICROBIOL, V14, P207, DOI 10.1111/j.1462-2920.2011.02593.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakatani Y, 2012, FEBS J, V279, P464, DOI 10.1111/j.1742-4658.2011.08439.x; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pitta DW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00689; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zhou J, 2012, LETT APPL MICROBIOL, V54, P79, DOI 10.1111/j.1472-765X.2011.03175.x; Zmudka MW, 2013, PROTEIN SCI, V22, P883, DOI 10.1002/pro.2204	50	13	14	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24200	24214		10.1074/jbc.M116.747527	http://dx.doi.org/10.1074/jbc.M116.747527			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679487	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000388498100034
J	Jain, A; Kuryatov, A; Wang, JY; Kamenecka, TM; Lindstrom, J				Jain, Akansha; Kuryatov, Alexander; Wang, Jingyi; Kamenecka, Theodore M.; Lindstrom, Jon			Unorthodox Acetylcholine Binding Sites Formed by alpha 5 and beta 3 Accessory Subunits in alpha 4 beta 2*Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; electrophysiology; ion channel; nicotinic acetylcholine receptors (nAChR); site-directed mutagenesis; Xenopus	POSITIVE ALLOSTERIC MODULATOR; NEURONAL NICOTINIC RECEPTOR; AGONIST-BINDING; ALPHA-5 SUBUNIT; TOBACCO DEPENDENCE; CA2+ PERMEABILITY; BETA 2; STOICHIOMETRY; INTERFACE; ACTIVATION	All nicotinic acetylcholine receptors (nAChRs) evolved from homomeric nAChRs in which all five subunits are involved in forming acetylcholine (ACh) binding sites at their interfaces. Heteromeric 42* nAChRs typically have two ACh binding sites at 4/2 interfaces and a fifth accessory subunit surrounding the central cation channel. 2 accessory subunits do not form ACh binding sites, but 4 accessory subunits do at the 4/4 interface in (42)(2)4 nAChRs. 5 and 3 are closely related subunits that had been thought to act only as accessory subunits and not take part in forming ACh binding sites. The effect of agonists at various subunit interfaces was determined by blocking homologous sites at these interfaces using the thioreactive agent 2-((trimethylammonium)ethyl) methanethiosulfonate (MTSET). We found that 5/4 and 3/4 interfaces formed ACh binding sites in (42)(2)5 and (42)(2)3 nAChRs. The 4/5 interface in (24)(2)5 nAChRs also formed an ACh binding site. Blocking of these sites with MTSET reduced the maximal ACh evoked responses of these nAChRs by 30-50%. However, site-selective agonists NS9283 (for the 4/4 site) and sazetidine-A (for the 4/2 site) did not act on the ACh sites formed by the 5/4 or 3/4 interfaces. This suggests that unorthodox sites formed by 5 and 3 subunits have unique ligand selectivity. Agonists or antagonists for these unorthodox sites might be selective and effective drugs for modulating nAChR function to treat nicotine addiction and other disorders.	[Jain, Akansha; Kuryatov, Alexander; Lindstrom, Jon] Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA; [Wang, Jingyi] Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; [Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Austin; Scripps Research Institute	Lindstrom, J (corresponding author), Univ Penn, Dept Neurosci, Perelman Sch Med, 130A John Morgan Bldg, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Institutes of Health National Institute on Drug Abuse [DA030929]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health National Institute on Drug Abuse Grant DA030929. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Bailey CDC, 2010, J NEUROSCI, V30, P9241, DOI 10.1523/JNEUROSCI.2258-10.2010; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Brunzell Darlene H, 2015, Curr Addict Rep, V2, P33; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Crooks PA, 2014, ADV PHARMACOL, V69, P513, DOI 10.1016/B978-0-12-420118-7.00013-5; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Fowler CD, 2014, NEUROPHARMACOLOGY, V76, P533, DOI 10.1016/j.neuropharm.2013.09.008; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gangitano D, 2009, GENES BRAIN BEHAV, V8, P398, DOI 10.1111/j.1601-183X.2009.00476.x; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hoft NR, 2009, NEUROPSYCHOPHARMACOL, V34, P698, DOI 10.1038/npp.2008.122; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin Z, 2014, BIOORG MED CHEM LETT, V24, P674, DOI 10.1016/j.bmcl.2013.11.049; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lucero LM, 2016, J BIOL CHEM, V291, P2444, DOI 10.1074/jbc.M115.684373; Mao D, 2008, J NEUROCHEM, V104, P446, DOI 10.1111/j.1471-4159.2007.05011.x; Marotta CB, 2014, NEUROPHARMACOLOGY, V77, P342, DOI 10.1016/j.neuropharm.2013.09.028; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Papke RL, 2010, METHODS, V51, P121, DOI 10.1016/j.ymeth.2010.01.012; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Williams DK, 2011, J GEN PHYSIOL, V137, P369, DOI 10.1085/jgp.201010587; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	49	20	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23452	23463		10.1074/jbc.M116.749150	http://dx.doi.org/10.1074/jbc.M116.749150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645992	Green Published, hybrid			2022-12-26	WOS:000387884400008
J	Azar, A; Devlin, K; Mell, JC; Giovannetti, T; Pirrone, V; Nonnemacher, MR; Passic, S; Kercher, K; Williams, JW; Jacobson, JM; Wigdahl, B; Dampier, W; Libon, DJ; Sell, C				Azar, Ashley; Devlin, Kathryn; Mell, Joshua Chang; Giovannetti, Tania; Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Jacobson, Jeffery M.; Wigdahl, Brian; Dampier, William; Libon, David J.; Sell, Christian			Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEUROCOGNITIVE DISORDERS; HIV-1 INFECTION; DNA HAPLOGROUPS; HUMAN MTDNA; DISEASE; AFRICAN; ERA; SUSCEPTIBILITY; ALZHEIMERS	Evolutionary divergence of the mitochondrial genome has given rise to distinct haplogroups. These haplogroups have arisen in specific geographical locations and are responsible for subtle functional changes in the mitochondria that may provide an evolutionary advantage in a given environment. Based on these functional differences, haplogroups could define disease susceptibility in chronic settings. In this study, we undertook a detailed neuropsychological analysis of a cohort of long-term HIV-1-infected individuals in conjunction with sequencing of their mitochondrial genomes. Stepwise regression analysis showed that the best model for predicting both working memory and declarative memory were age and years since diagnosis. In contrast, years since diagnosis and sub-haplogroup were significantly predictive of psychomotor speed. Consistent with this, patients with haplogroup L3e obtained better scores on psychomotor speed and dexterity tasks when compared to the remainder of the cohort, suggesting that this haplogroup provides a protective advantage when faced with the combined stress of HIV-1 infection and long-term antiretroviral therapies. Differential performance on declarative memory tasks was noted for individuals with other sub-L haplogroups, but these differences were not as robust as the association between L3e and psychomotor speed and dexterity tasks. This work provides evidence that mitochondrial haplogroup is related to neuropsychological test performance among patients in chronic disease settings such as HIV-1 infection.	[Azar, Ashley; Sell, Christian] Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA; [Devlin, Kathryn; Giovannetti, Tania] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Mell, Joshua Chang; Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Wigdahl, Brian; Dampier, William] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Mell, Joshua Chang] Drexel Univ, Ctr Genom Sci, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Wigdahl, Brian; Dampier, William] Drexel Univ, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffery M.] Temple Univ, Dept Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Jacobson, Jeffery M.] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Wigdahl, Brian] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Libon, David J.] Rowan Univ, Dept Geriatr & Gerontol, New Jersey Inst Successful Aging, Sch Osteopath Med, Stratford, NJ USA	Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine	Sell, C (corresponding author), Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA.	christian.sell@drexelmed.edu	Giovannetti, Tania/H-3491-2019	Giovannetti, Tania/0000-0001-5661-152X; Mell, Joshua/0000-0003-0222-5636	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke [NS32092, NS46263]; National Institute of Drug Abuse [DA19807, NS089435]; National Institute of Mental Health [P30 MH092177]; National Institute of Mental Health under Ruth L. Kirschstein National Research Service Award [T32 MH079785]; NIH; PA Department of Health, CURE Formula funds [4100062203]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089435] Funding Source: NIH RePORTER	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health under Ruth L. Kirschstein National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PA Department of Health, CURE Formula funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All Funding is from government agencies. These studies were funded in part by the Public Health Service, National Institutes of Health through grants from the National Institute of Neurological Disorders and Stroke, NS32092 and NS46263, the National Institute of Drug Abuse, DA19807 (Dr. Brian Wigdahl, Principal Investigator), NS089435 (Dr. Michael Nonnemacher, Principal Investigator), National Institute of Mental Health, P30 MH092177, and under the Ruth L. Kirschstein National Research Service Award T32 MH079785. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and PA Department of Health, CURE Formula funds to Drexel University 4100062203. Sponsors had no role in the research.	Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; DeVaughn S, 2015, NEUROPSYCHOL REV, V25, P424, DOI 10.1007/s11065-015-9305-x; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 1994, UTILITY CLIN RATINGS; Hulgan T, 2015, CLIN INFECT DIS, V61, P1476, DOI 10.1093/cid/civ527; Kampira E, 2013, JAIDS-J ACQ IMM DEF, V63, P647, DOI 10.1097/QAI.0b013e3182968ea5; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Klave H, 1963, GROOVED PEGBOARD; Lee S, 2013, SKAT SNP SET SEQUENC; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lojek E, 2005, J CLIN EXP NEUROPSYC, V27, P665, DOI 10.1081/13803390490918426; Manfredi R, 2004, AGEING RES REV, V3, P31, DOI 10.1016/j.arr.2003.07.001; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mungas D, 2004, PSYCHOL ASSESSMENT, V16, P347, DOI 10.1037/1040-3590.16.4.347; Nacarelli T, 2016, FREE RADICAL BIO MED, V95, P133, DOI 10.1016/j.freeradbiomed.2016.03.008; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Reitan R, 1992, TRAIL MAKING TEST; Ridge PG, 2012, MITOCHONDRIAL GENOMI; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Rosa A, 2011, J ANTHROPOL SCI, V89, P25, DOI 10.4436/jass.89006; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Schretlen D.J., 2010, CALIBRATED NEUROPSYC; Silva M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12526; Soares Pedro, 2011, MOL BIOL EVOLUTION; Stoff DM, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200401001-00001; Valcour V, 2008, J NEUROVIROL, V14, P362, DOI 10.1080/13550280802216494; van Gorp W. G., 1993, NEUROPSYCHOLOGY, V7, P62, DOI DOI 10.1037/0894-4105.7.1.62; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wilson TW, 2013, J NEUROIMMUNE PHARM, V8, P965, DOI 10.1007/s11481-013-9477-1; Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399; Zheng X, 2012, SNPRELATE PARRALLEL, P95	46	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163772	10.1371/journal.pone.0163772	http://dx.doi.org/10.1371/journal.pone.0163772			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711166	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600041
J	Dewey, RB; O'Suilleabhain, PE; Sanghera, M; Patel, N; Khemani, P; Lacritz, LH; Chitnis, S; Whitworth, LA; Dewey, RB				Dewey, Richard B., III; O'Suilleabhain, Padraig E.; Sanghera, Manjit; Patel, Neepa; Khemani, Pravin; Lacritz, Laura H.; Chitnis, Shilpa; Whitworth, Louis A.; Dewey, Richard B., Jr.			Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; RATING-SCALE; PATIENT SELECTION; SCREENING TOOL; DBS; RELIABILITY; IMPAIRMENT; VALIDATION; MANAGEMENT; DISORDERS	Objective To develop a process to improve patient outcomes from deep brain stimulation (DBS) surgery for Parkinson disease (PD), essential tremor (ET), and dystonia. Methods We employed standard quality improvement methodology using the Plan-Do-Study-Act process to improve patient selection, surgical DBS lead implantation, postoperative programming, and ongoing assessment of patient outcomes. Results The result of this quality improvement process was the development of a neuromodulation network. The key aspect of this program is rigorous patient assessment of both motor and non-motor outcomes tracked longitudinally using a REDCap database. We describe how this information is used to identify problems and to initiate Plan-Do-Study-Act cycles to address them. Preliminary outcomes data is presented for the cohort of PD and ET patients who have received surgery since the creation of the neuromodulation network. Conclusions Careful outcomes tracking is essential to ensure quality in a complex therapeutic endeavor like DBS surgery for movement disorders. The REDCap database system is well suited to store outcomes data for the purpose of ongoing quality assurance monitoring.	[Dewey, Richard B., III; O'Suilleabhain, Padraig E.; Sanghera, Manjit; Patel, Neepa; Khemani, Pravin; Chitnis, Shilpa; Dewey, Richard B., Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Lacritz, Laura H.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Whitworth, Louis A.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dewey, RB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	Richard.dewey@utsouthwestern.edu	Dewey, Richard B/A-4288-2013	Dewey, Richard B/0000-0002-6615-5035; O'Suilleabhain, Padraig/0000-0002-2981-4791	UT Southwestern; Department of Neurology and Neurotherapeutics	UT Southwestern; Department of Neurology and Neurotherapeutics	UT Southwestern funded the effort of the investigators to perform the QI project described through salary support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mark Goldberg, M.D., chairman of the Department of Neurology and Neurotherapeutics, for his financial support of this QI project. We also thank Benjamin Nguyen, MD for assistance in developing physical therapy assessment protocols and Janet Moeller, Kelly Johnson, Kristen Qualls-Yturralde, and Andrea Hassink for performing PT assessments on patients and entering this data into REDCap; Lesley Childs, MD and Ted Mau, MD, PhD for developing the speech assessment battery and Laura Toles, Janis Deane, and Amy Hamilton for performing speech assessments, and Angela Brodrick-Donohue for entering speech data into REDCap; and Judy Shaw, Leigh Carpenter, Alyssa Lee, and Shradhdha Joshi for entering neuropsychological test data into REDCap.	Bronte-Stewart H, 2011, MOVEMENT DISORD, V26, pS5, DOI 10.1002/mds.23482; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; DeLong M, 2012, ANN NY ACAD SCI, V1265, P1, DOI 10.1111/j.1749-6632.2012.06608.x; Deuschl G, 2002, MOVEMENT DISORD, V17, pS102, DOI 10.1002/mds.10150; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kempster GB, 2009, AM J SPEECH-LANG PAT, V18, P124, DOI 10.1044/1058-0360(2008/08-0017); Kupsch A, 2011, MOVEMENT DISORD, V26, pS41, DOI 10.1002/mds.23624; Lang AE, 2002, MOVEMENT DISORD, V17, pS94, DOI 10.1002/mds.10149; Langley GL, 2009, IMPROVEMENT GUIDE PR, DOI [10.1097/NPT.0b013e31821a620c, DOI 10.1097/NPT.0B013E31821A620C]; Leddy AL, 2011, J NEUROL PHYS THER, V35, P90, DOI 10.1097/NPT.0b013e31821a620c; Mancini M, 2012, J BIOENG BIOMED SC S, VS1, P1, DOI DOI 10.4172/2155-9538.S1-007; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Miocinovic S, 2014, PARKINSONISM RELAT D, V20, P1434, DOI 10.1016/j.parkreldis.2014.10.011; Morishita T, 2011, NEUROLOGIST, V17, P263, DOI 10.1097/NRL.0b013e31822d1069; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Rosen CA, 2004, LARYNGOSCOPE, V114, P1549, DOI 10.1097/00005537-200409000-00009; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Shukla AW, 2014, NEUROTHERAPEUTICS, V11, P47, DOI 10.1007/s13311-013-0235-0; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Zrinzo L, 2009, J NEUROSURG, V110, P1283, DOI 10.3171/2008.12.JNS08885	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164154	10.1371/journal.pone.0164154	http://dx.doi.org/10.1371/journal.pone.0164154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711133	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600088
J	Gavett, BE; Gurnani, AS; Saurman, JL; Chapman, KR; Steinberg, EG; Martin, B; Chaisson, CE; Mez, J; Tripodis, Y; Stern, RA				Gavett, Brandon E.; Gurnani, Ashita S.; Saurman, Jessica L.; Chapman, Kimberly R.; Steinberg, Eric G.; Martin, Brett; Chaisson, Christine E.; Mez, Jesse; Tripodis, Yorghos; Stern, Robert A.			Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION WORKGROUPS; TEST-RETEST RELIABILITY; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; VERBAL MEMORY; DISEASE; DEMENTIA; NORMS; ROBUST	Two of the most commonly used methods to assess memory functioning in studies of cognitive aging and dementia are story memory and list learning tests. We hypothesized that the most commonly used story memory test, Wechsler's Logical Memory, would generate more pronounced practice effects than a well validated but less common list learning test, the Neuropsychological Assessment Battery (NAB) List Learning test. Two hundred eighty-seven older adults, ages 51 to 100 at baseline, completed both tests as part of a larger neuropsychological test battery on an annual basis. Up to five years of recall scores from participants who were diagnosed as cognitively normal (n = 96) or with mild cognitive impairment (MCI; n = 72) or Alzheimer's disease (AD; n = 121) at their most recent visit were analyzed with linear mixed effects regression to examine the interaction between the type of test and the number of times exposed to the test. Other variables, including age at baseline, sex, education, race, time (years) since baseline, and clinical diagnosis were also entered as fixed effects predictor variables. The results indicated that both tests produced significant practice effects in controls and MCI participants; in contrast, participants with AD declined or remained stable. However, for the delayed D but not the immediate D recall condition, Logical Memory generated more pronounced practice effects than NAB List Learning (b = 0.16, p < .01 for controls). These differential practice effects were moderated by clinical diagnosis, such that controls and MCI participants D but not participants with AD D improved more on Logical Memory delayed recall than on delayed NAB List Learning delayed recall over five annual assessments. Because the Logical Memory test is ubiquitous in cognitive aging and neurodegenerative disease research, its tendency to produce marked practice effects D especially on the delayed recall condition D suggests a threat to its validity as a measure of new learning, an essential construct for dementia diagnosis.	[Gavett, Brandon E.; Gurnani, Ashita S.; Saurman, Jessica L.] Univ Colorado Colorado Springs, Dept Psychol, Colorado Springs, CO USA; [Chapman, Kimberly R.; Steinberg, Eric G.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Martin, Brett; Chaisson, Christine E.; Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Colorado System; University of Colorado at Colorado Springs; Boston University; Boston University	Stern, RA (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Tripodis, Yorghos/GRY-0583-2022	Gavett, Brandon/0000-0003-1938-1854; Tripodis, Yorghos/0000-0003-2190-7608	National Institute on Aging [P30 AG013846]; NATIONAL INSTITUTE ON AGING [K23AG046377, P30AG013846] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (https://www.nia.nih.gov/) grant P30 AG013846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Blasi S, 2009, NEUROPSYCHOLOGY, V23, P189, DOI 10.1037/a0014079; Brandt J., 2001, HOPKINS VERBAL LEARN; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Chapman KR, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0176-z; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; De Santi S, 2008, NEUROPSYCHOLOGY, V22, P469, DOI 10.1037/0894-4105.22.4.469; Delis DC., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Duff K, 2011, AM J GERIAT PSYCHIAT, V19, P932, DOI 10.1097/JGP.0b013e318209dd3a; Estevez-Gonzalez A, 2003, INT J GERIATR PSYCH, V18, P1021, DOI 10.1002/gps.1010; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Gavett BE, 2015, J INT NEUROPSYCH SOC, V21, P558, DOI 10.1017/S1355617715000582; Gavett BE, 2010, J INT NEUROPSYCH SOC, V16, P651, DOI 10.1017/S1355617710000421; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Gurnani AS, NEUROPSYCHO IN PRESS; Hassenstab J, 2015, NEUROPSYCHOLOGY, V29, P940, DOI 10.1037/neu0000208; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; HODGES JR, 1995, NEUROPSYCHOLOGIA, V33, P441, DOI 10.1016/0028-3932(94)00127-B; Holtzer R, 2008, ARCH CLIN NEUROPSYCH, V23, P531, DOI 10.1016/j.acn.2008.05.004; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P405, DOI 10.1016/j.acn.2006.06.001; Johnson DK, 2003, NEUROPSYCHOLOGY, V17, P82, DOI 10.1037/0894-4105.17.1.82; Kaltreider LB, 2000, CLIN NEUROPSYCHOL, V14, P269, DOI 10.1076/1385-4046(200008)14:3;1-P;FT269; Karrasch M, 2005, ACTA NEUROL SCAND, V111, P172, DOI 10.1111/j.1600-0404.2005.00380.x; Kave G, 2004, CLIN NEUROPSYCHOL, V18, P362, DOI 10.1080/13854040490052418; Kent P, 2013, APPL NEUROPSYCH-ADUL, V20, P277, DOI 10.1080/09084282.2012.689267; Kuslansky G, 2004, ARCH CLIN NEUROPSYCH, V19, P89, DOI 10.1016/S0887-6177(02)00217-2; Kuznetsova A., 2015, LMERTEST TESTS IN LI; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; Libon DJ, 2015, AM J ALZHEIMERS DIS, V30, P622, DOI 10.1177/1533317515577184; Machulda MM, 2013, CLIN NEUROPSYCHOL, V27, P1247, DOI 10.1080/13854046.2013.836567; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McCaffrey R. J., 2000, PRACTITIONERS GUIDE; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Pedraza O, 2010, ARCH CLIN NEUROPSYCH, V25, P347, DOI 10.1093/arclin/acq030; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabin LA, 2009, AGING NEUROPSYCHOL C, V16, P357, DOI 10.1080/13825580902825220; Rey A, 1964, EXAMEN CLIN PSYCHOL, P222; Rubin EH, 1998, ARCH NEUROL-CHICAGO, V55, P395, DOI 10.1001/archneur.55.3.395; Salmon D. P., 2000, HDB NEUROPSYCHOLOGY, V2, P155; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Silva D, 2012, DEMENT GER COGN D EX, V2, P120, DOI 10.1159/000336224; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; STORANDT M, 1989, ARCH NEUROL-CHICAGO, V46, P383, DOI 10.1001/archneur.1989.00520400037017; Sullivan K, 1996, J CLIN EXP NEUROPSYC, V18, P707, DOI 10.1080/01688639608408293; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	66	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164492	10.1371/journal.pone.0164492	http://dx.doi.org/10.1371/journal.pone.0164492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711147	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697600129
J	Xia, H; Zhang, LB; Wu, G; Fu, CH; Long, Y; Xiang, J; Gan, JP; Zhou, YH; Yu, LJ; Li, MT				Xia, Heng; Zhang, Libin; Wu, Gang; Fu, Chunhua; Long, Yan; Xiang, Jun; Gan, Jianping; Zhou, Yanhong; Yu, Longjiang; Li, Maoteng			Genome-Wide Identification and Characterization of MicroRNAs and Target Genes in Lonicera japonica	PLOS ONE			English	Article							SMALL RNAS; DISCOVERY; PROTEINS; BINDING; ROLES	MiRNAs function in post-transcriptional regulation of gene expression and play very important roles in plant development. Lonicera japonica is one of the important medicinal plants in China. However, few studies on the discovery of conserved and novel miRNAs from L. japonica were reported. In this study, we employed deep sequencing technology to identify miRNAs in leaf and flower tissues of L. japonica. A total of 22.97 million clean reads from flower and leaf tissues were obtained, which generated 146 conserved miRNAs distributed in 20 families and 110 novel miRNAs. Accordingly, 72 differentially expressed miRNAs (P <= 0.001) between leaves and flowers and their potential target genes were identified and validated. The qRT-PCR validation showed that majority of the differentially expressed miRNAs showed significant tissue-specific expression in L. japonica. Furthermore, the miRNA-mRNA and mRNA-mRNA regulatory networks were constructed using Cytoscape software. Taken together, this study identified a large number of miRNAs and target genes in L. japonica, which not only provides the first global miRNA expression profiles, but also sheds light on functional genomics research on L. japonica in the future.	[Xia, Heng; Zhang, Libin; Wu, Gang; Fu, Chunhua; Zhou, Yanhong; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Long, Yan; Li, Maoteng] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China; [Xiang, Jun; Gan, Jianping] Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement &, Huanggang 438000, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Agricultural Sciences; Huanggang Normal University	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.; Li, MT (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China.	limaoteng426@mail.hust.edu.cn	Gan, Jianping/AAJ-6821-2021	Gan, Jianping/0000-0001-9827-7929	National Natural Science Foundation of China [31270373, 31540083]; open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture; Wuhan Botanical Garden; Chinese Academy of Sciences [Y052801t03]; Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains [2015TD03]; New Century Talents Support Program by the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture; Wuhan Botanical Garden(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains; New Century Talents Support Program by the Ministry of Education of China	The research was supported by the National Natural Science Foundation of China (31270373, 31540083), the open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences (Y052801t03), Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains (2015TD03) and New Century Talents Support Program by the Ministry of Education of China (NCET110172).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Kazuoka T, 2000, PLANT J, V24, P191, DOI 10.1046/j.1365-313x.2000.00864.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schierenbeck KA, 2004, CRIT REV PLANT SCI, V23, P391, DOI 10.1080/07352680490505141; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang ZJ, 2012, PLANTA, V236, P613, DOI 10.1007/s00425-012-1634-x; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095489; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	40	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164140	10.1371/journal.pone.0164140	http://dx.doi.org/10.1371/journal.pone.0164140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711182	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600085
J	Axenov-Gribanov, D; Bedulina, D; Shatilina, Z; Jakob, L; Vereshchagina, K; Lubyaga, Y; Gurkov, A; Shchapova, E; Luckenbach, T; Lucassen, M; Sartoris, FJ; Portner, HO; Timofeyev, M				Axenov-Gribanov, Denis; Bedulina, Daria; Shatilina, Zhanna; Jakob, Lena; Vereshchagina, Kseniya; Lubyaga, Yulia; Gurkov, Anton; Shchapova, Ekaterina; Luckenbach, Till; Lucassen, Magnus; Sartoris, Franz Josef; Poertner, Hans-Otto; Timofeyev, Maxim			Thermal Preference Ranges Correlate with Stable Signals of Universal Stress Markers in Lake Baikal Endemic and Holarctic Amphipods	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; CLIMATE-CHANGE; OXYGEN LIMITATION; LIEBIGS LAW; HSP70 GENES; TOLERANCE; RESPONSES; EXPRESSION; PATTERNS; MINIMUM	Temperature is the most pervasive abiotic environmental factor for aquatic organisms. Fluctuations in temperature range lead to changes in metabolic performance. Here, we aimed to identify whether surpassing the thermal preference zones is correlated with shifts in universal cellular stress markers of protein integrity, responses to oxidative stress and lactate content, as indicators of anaerobic metabolism. Exposure of the Lake Baikal endemic amphipod species Eulimnogammarus verrucosus (Gerstfeldt, 1858), Ommatogammarus flavus (Dybowski, 1874) and of the Holarctic amphipod Gammarus lacustris Sars 1863 (Amphipoda, Crustacea) to increasing temperatures resulted in elevated heat shock protein 70 (Hsp70) and lactate content, elevated antioxidant enzyme activities (i.e., catalase and peroxidase), and reduced lactate dehydrogenase and glutathione S-transferase activities. Thus, the zone of stability (absence of any significant changes) of the studied molecular and biochemical markers correlated with the behaviorally preferred temperatures. We conclude that the thermal behavioral responses of the studied amphipods are directly related to metabolic processes at the cellular level. Thus, the determined thermal ranges may possibly correspond to the thermal optima. This relationship between species-specific behavioral reactions and stress response metabolism may have significant ecological consequences that result in a thermal zone-specific distribution (i.e., depths, feed spectrum, etc.) of species. As a consequence, by separating species with different temperature preferences, interspecific competition is reduced, which, in turn, increases a species' Darwinian fitness in its environment.	[Axenov-Gribanov, Denis; Bedulina, Daria; Shatilina, Zhanna; Vereshchagina, Kseniya; Lubyaga, Yulia; Gurkov, Anton; Shchapova, Ekaterina; Timofeyev, Maxim] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Jakob, Lena; Lucassen, Magnus; Sartoris, Franz Josef; Poertner, Hans-Otto] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Jakob, Lena; Poertner, Hans-Otto] Univ Bremen, Bremen, Germany; [Axenov-Gribanov, Denis; Shatilina, Zhanna] Baikal Res Ctr, Irkutsk, Russia	Irkutsk State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen	Timofeyev, M (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk, Russia.	m.a.timofeyev@gmail.com	Lucassen, Magnus/ABA-8396-2021; Axenov-Gribanov, Denis V./F-7360-2017; Lubyaga, Yuliya A./H-1034-2017; Vereshchagina, Kseniya/R-7060-2016; Pörtner, Hans-O./K-9429-2016; Timofeyev, Maxim/F-2071-2010; Lucassen, Magnus/E-8433-2011; Shatilina, Zhanna Mikhailovna/CAF-0020-2022; Gurkov, Anton/M-8708-2014; Luckenbach, Till/G-6482-2015; Axenov-Gribanov, Denis/J-5204-2019	Lucassen, Magnus/0000-0003-4276-4781; Axenov-Gribanov, Denis V./0000-0003-2020-6084; Vereshchagina, Kseniya/0000-0002-4843-5287; Pörtner, Hans-O./0000-0001-6535-6575; Timofeyev, Maxim/0000-0002-5250-6818; Lucassen, Magnus/0000-0003-4276-4781; Gurkov, Anton/0000-0002-8390-1570; Luckenbach, Till/0000-0001-6204-1033; Axenov-Gribanov, Denis/0000-0003-2020-6084; Lubyaga, Yulia/0000-0002-2494-8723; Shchapova, Ekaterina/0000-0001-9084-7675; Sartoris, Franz-Josef/0000-0001-7228-3220; Shatilina, Zhanna/0000-0002-5926-4612; Jakob, Lena/0000-0002-1762-4704	Russian Science Foundation [N 14-14-00400]; Russian Foundation for Basic Research [N 14-04-00501, 15-04-06685, 16-34-60060, 15-29-01003]; Goszadanie project [1354-2014/51, 6.731.2016DAAD, 6.734.2016DAAD, 6.742.2016DAAD]; "LabEglo" project - program "Helmholtz-Russia Joint Research Groups" (HRJRG) [HRJRG-221]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Goszadanie project; "LabEglo" project - program "Helmholtz-Russia Joint Research Groups" (HRJRG)	This research was primary supported by the Russian Science Foundation (projects N 14-14-00400), and Russian Foundation for Basic Research (projects N 14-04-00501, 15-04-06685, 16-34-60060,15-29-01003), Goszadanie project (1354-2014/51, 6.731.2016DAAD, 6.734.2016DAAD, 6.742.2016DAAD) and within the "LabEglo" project HRJRG-221 financed by the bilateral funding program "Helmholtz-Russia Joint Research Groups" (HRJRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Afonso LOB, 2008, J FISH BIOL, V72, P157, DOI 10.1111/j.1095-8649.2007.01697.x; Alabaster J.S., 2013, WATER QUALITY CRITER; Axenov-Gribanov DV, 2014, COMP BIOCHEM PHYS B, V167, P16, DOI 10.1016/j.cbpb.2013.09.006; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; Brown A, 2014, BIOL REV, V89, P406, DOI 10.1111/brv.12061; Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P314, DOI 10.1086/499989; Cottin D, 2015, J COMP PHYSIOL B, V185, P303, DOI 10.1007/s00360-014-0885-1; Cottin D, 2012, COMP BIOCHEM PHYS A, V162, P357, DOI 10.1016/j.cbpa.2012.04.005; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; DROTAR A, 1985, PLANT SCI, V42, P35, DOI 10.1016/0168-9452(85)90025-1; Elder LE, 2015, COMP BIOCHEM PHYS A, V187, P20, DOI 10.1016/j.cbpa.2015.04.008; FORWARD RB, 1990, BIOL BULL-US, V178, P195, DOI 10.2307/1541819; Galaziy G.I., 1987, BAIKAL QUESTIONS ANS; GERRITSEN J, 1982, LIMNOL OCEANOGR, V27, P254, DOI 10.4319/lo.1982.27.2.0254; Gonçalves Rodrigo J, 2010, Ecol. austral, V20, P129; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hiddink JG, 2005, ECOGRAPHY, V28, P264, DOI 10.1111/j.0906-7590.2005.04063.x; HOCHACHKA PW, 2014, BIOCH ADAPTATION; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Hofmann GE, 2005, INTEGR COMP BIOL, V45, P247, DOI 10.1093/icb/45.2.247; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jakob L, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1308; Jost JA, 2012, ENHANCING THERMAL TO; Kaarniranta K, 1998, P NATL ACAD SCI USA, V95, P2319, DOI 10.1073/pnas.95.5.2319; Kamaltynov RM, 1999, CRUSTACEANA, V72, P933, DOI 10.1163/156854099503834; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Lagerspetz KYH, 2006, BIOL REV, V81, P237, DOI 10.1017/S1464793105006998; Larade K., 2002, CELL MOL RESPONSES S, P27, DOI DOI 10.1016/S1568-1254(02)80005-5; Lenz PH, 2005, BIOL BULL-US, V209, P75, DOI 10.2307/3593143; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Madeira D, 2012, CELL STRESS CHAPERON, V17, P707, DOI 10.1007/s12192-012-0345-3; Nelson D.L, 2013, LEHNINGER PRINCIPLES, V6th; Newell RC., 2013, ADAPTATION ENV ESSAY; Peng J, 2014, COMP BIOCHEM PHYS A, V176, P32, DOI 10.1016/j.cbpa.2014.07.005; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Piscart C, 2010, BIOL INVASIONS, V12, P853, DOI 10.1007/s10530-009-9506-4; Pohlmann K, 2011, CELL STRESS CHAPERON, V16, P621, DOI 10.1007/s12192-011-0272-8; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Proviz VI, 2011, ANNOTATED LIST FAUNA; Rusinek O. T., 2012, BAICALOGY, V1; Safronov GP, 1993, COMPOSITION ECOLOGY; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shatilina ZM, 2011, J THERM BIOL, V36, P142, DOI 10.1016/j.jtherbio.2010.12.008; SHELFORD V. E., 1931, ECOLOGY, V12, P455, DOI 10.2307/1928991; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Sung YY, 2011, REV AQUACULT, V3, P120, DOI 10.1111/j.1753-5131.2011.01049.x; Sutcliffe D.W., 1992, Freshwater Forum, V2, P102; Takhteev VV, 2015, ARTHROPODA SEL, V24, P335; Takhteev VV, 2000, ESSAYS LAKE BAIKAL A; Timofeyev M, 2006, COMP BIOCHEM PHYS B, V145, P197, DOI 10.1016/j.cbpb.2006.07.004; Timofeyev M. A., 2001, Arthropoda Selecta, V10, P93; Timofeyev MA, 2010, ECOLOGICAL PHYSL ASP; Timofeyev M, 2007, CRUSTACEANA, V80, P129, DOI 10.1163/156854007780121393; Timofeyev MA, 2009, J THERM BIOL, V34, P281, DOI 10.1016/j.jtherbio.2009.03.008; Timoshkin OA, 2001, INDEX ANIMAL SPECIES, V1; Timoshkin OA, 2008, LIF DEV RESP AB CHAN, P344; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Verbitsky V B, 2014, Dokl Biol Sci, V455, P91, DOI 10.1134/S0012496614020069; Weinberg IV, 1995, WATER RES, V22, P446; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]	71	24	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164226	10.1371/journal.pone.0164226	http://dx.doi.org/10.1371/journal.pone.0164226			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706227	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200099
J	Louw-du Toit, R; Perkins, MS; Snoep, JL; Storbeck, KH; Africander, D				Louw-du Toit, Renate; Perkins, Meghan S.; Snoep, Jacky L.; Storbeck, Karl-Heinz; Africander, Donita			Fourth-Generation Progestins Inhibit 3 beta-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids	PLOS ONE			English	Article							DOSE MEDROXYPROGESTERONE ACETATE; BREAST-CANCER; CELL-LINE; SYNTHETIC PROGESTINS; ADRENAL STEROIDOGENESIS; NORETHISTERONE ACETATE; NOMEGESTROL ACETATE; ORAL-CONTRACEPTIVES; ANDROGEN RECEPTOR; GENE-EXPRESSION	Progestins used in contraception and hormone replacement therapy are synthetic compounds designed to mimic the actions of the natural hormone progesterone and are classed into four consecutive generations. The biological actions of progestins are primarily determined by their interactions with steroid receptors, and factors such as metabolism, pharmacokinetics, bioavailability and the regulation of endogenous steroid hormone biosynthesis are often overlooked. Although some studies have investigated the effects of select progestins on a few steroidogenic enzymes, studies comparing the effects of progestins from different generations are lacking. This study therefore explored the putative modulatory effects of progestins on de novo steroid synthesis in the adrenal by comparing the effects of select progestins from the respective generations, on endogenous steroid hormone production by the H295R human adrenocortical carcinoma cell line. Ultra-performance liquid chromatography/tandem mass spectrometry analysis showed that the fourth-generation progestins, nestorone (NES), nomegestrol acetate (NoMAC) and drospirenone (DRSP), unlike the progestins selected from the first three generations, modulate the biosynthesis of several endogenous steroids. Subsequent assays performed in COS-1 cells expressing human 3 beta HSD2, suggest that these progestins modulate the biosynthesis of steroid hormones by inhibiting the activity of 3 beta HSD2. The K-i values determined for the inhibition of human 3 beta HSD2 by NES (9.5 +/- 0.96 nM), NoMAC (29 +/- 7.1 nM) and DRSP (232 +/- 38 nM) were within the reported concentration ranges for the contraceptive use of these progestins in vivo. Taken together, our results suggest that newer, fourth-generation progestins may exert both positive and negative physiological effects via the modulation of endogenous steroid hormone biosynthesis.	[Louw-du Toit, Renate; Perkins, Meghan S.; Snoep, Jacky L.; Storbeck, Karl-Heinz; Africander, Donita] Univ Stellenbosch, Dept Biochem, Private Bag X1, ZA-7602 Matieland, South Africa	Stellenbosch University	Africander, D (corresponding author), Univ Stellenbosch, Dept Biochem, Private Bag X1, ZA-7602 Matieland, South Africa.	drho@sun.ac.za	Perkins, Meghan/I-3256-2018; Storbeck, Karl/AAF-5126-2020; Perkins, Meghan/R-9497-2019; Snoep, Jacky/ABI-6302-2020	Perkins, Meghan/0000-0002-7046-8747; Perkins, Meghan/0000-0002-7046-8747; Snoep, Jacky/0000-0002-0405-8854; Storbeck, Karl-Heinz/0000-0003-1669-6383	National Research Foundation (NRF) in South Africa [85233]; Stellenbosch University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083026] Funding Source: NIH RePORTER	National Research Foundation (NRF) in South Africa(National Research Foundation - South Africa); Stellenbosch University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant to RLdT from the National Research Foundation (NRF) in South Africa (grant number 85233; www.nrf.ac.za), and grants to KS and DA from Stellenbosch University (www.sun.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors, and therefore the NRF does not accept any liability in regard thereto.	Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Africander DJ, 2014, J STEROID BIOCHEM, V143, P404, DOI 10.1016/j.jsbmb.2014.05.007; Agren UM, 2011, EUR J CONTRACEP REPR, V16, P458, DOI 10.3109/13625187.2011.614363; ARAKAWA S, 1989, ENDOCRINOL JAPON, V36, P387; Bahamondes L, 2014, INT J WOMENS HEALTH, V6, P221, DOI 10.2147/IJWH.S46811; BARBIERI RL, 1980, ACTA ENDOCRINOL-COP, V94, P419, DOI 10.1530/acta.0.0940419; Berrino F, 1996, JNCI-J NATL CANCER I, V88, P291, DOI 10.1093/jnci/88.5.291; Birrell SN, 2007, FASEB J, V21, P2285, DOI 10.1096/fj.06-7518com; Blode H, 2001, EUR J CONTRACEP REPR, V6, P167, DOI 10.1080/713604233; Blode H, 2012, EUR J CONTRACEP REPR, V17, P284, DOI 10.3109/13625187.2012.677076; Brache V, 2001, CONTRACEPTION, V63, P257, DOI 10.1016/S0010-7824(01)00199-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chrousos GP, 1998, J CLIN ENDOCR METAB, V83, P1842, DOI 10.1210/jc.83.6.1842; De Leo V, 2007, FERTIL STERIL, V88, P113, DOI 10.1016/j.fertnstert.2006.11.137; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dorgan JF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2779; DOWSETT M, 1987, BRIT J CANCER, V55, P311, DOI 10.1038/bjc.1987.61; Eliassen AH, 2006, J CLIN ONCOL, V24, P1823, DOI 10.1200/JCO.2005.03.7432; Focan C, 2001, BRIT J CANCER, V85, P1, DOI 10.1054/bjoc.2001.1829; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Freshney RI, 1987, CULTURE ANIMAL CELLS, P81, DOI [10.1021/jf063588n, DOI 10.1021/JF063588N]; Fuhrmann U, 1996, CONTRACEPTION, V54, P243, DOI 10.1016/S0010-7824(96)00195-3; GAZDAR AF, 1990, CANCER RES, V50, P5488; Gerrits MGF, 2013, CONTRACEPTION, V87, P193, DOI 10.1016/j.contraception.2012.07.001; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Hapgood JP, 2014, J STEROID BIOCHEM, V142, P39, DOI 10.1016/j.jsbmb.2013.08.001; Hassan-Smith ZK, 2015, J CLIN ENDOCR METAB, V100, P2673, DOI 10.1210/jc.2015-1516; Hecker M, 2006, TOXICOL APPL PHARM, V217, P114, DOI 10.1016/j.taap.2006.07.007; HELLMAN L, 1976, J CLIN ENDOCR METAB, V42, P912, DOI 10.1210/jcem-42-5-912; Hilscherova K, 2004, TOXICOL SCI, V81, P78, DOI 10.1093/toxsci/kfh191; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Ito F, 2016, EUR J OBSTET GYN R B, V201, P113, DOI 10.1016/j.ejogrb.2016.03.044; JONES JR, 1974, CONTRACEPTION, V10, P1, DOI 10.1016/0010-7824(74)90127-9; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Kovalevsky G, 2010, FERTIL STERIL, V93, P1997, DOI 10.1016/j.fertnstert.2008.12.095; Krattenmacher R, 2000, CONTRACEPTION, V62, P29, DOI 10.1016/S0010-7824(00)00133-5; LABRIE F, 1992, J STEROID BIOCHEM, V43, P805, DOI 10.1016/0960-0760(92)90308-6; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; LANG I, 1990, CANCER, V66, P1949, DOI 10.1002/1097-0142(19901101)66:9<1949::AID-CNCR2820660917>3.0.CO;2-E; Lee TC, 1999, J CLIN ENDOCR METAB, V84, P2104, DOI 10.1210/jc.84.6.2104; Louw-du Toit R, 2014, J BIOL CHEM, V289, P31136, DOI 10.1074/jbc.M114.587311; Massai MR, 2001, CONTRACEPTION, V64, P369, DOI 10.1016/S0010-7824(01)00259-1; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; MIZUTANI T, 1992, ENDOCRINOL JAPON, V39, P615; Overturf MD, 2014, AQUAT TOXICOL, V148, P152, DOI 10.1016/j.aquatox.2014.01.012; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Proverbs-Singh T, 2015, ENDOCR-RELAT CANCER, V22, pR87, DOI 10.1530/ERC-14-0543; Quanson JL, 2016, J CHROMATOGR B, V1031, P131, DOI 10.1016/j.jchromb.2016.07.024; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; Rijk JCW, 2012, CHEM RES TOXICOL, V25, P1720, DOI 10.1021/tx3001779; Robbins A, 1997, ANN NY ACAD SCI, V828, P38, DOI 10.1111/j.1749-6632.1997.tb48522.x; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; SATYASWAROOP PG, 1978, ENDOCRINOLOGY, V102, P1761, DOI 10.1210/endo-102-6-1761; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Schloms L, 2012, J STEROID BIOCHEM, V128, P128, DOI 10.1016/j.jsbmb.2011.11.003; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sitruk-Ware R, 2006, HUM REPROD UPDATE, V12, P169, DOI 10.1093/humupd/dmi046; Sitruk-Ware R, 2004, DRUG AGING, V21, P865, DOI 10.2165/00002512-200421130-00004; Sitruk-Ware R, 2008, MATURITAS, V61, P151, DOI 10.1016/j.maturitas.2004.01.001; Speroff L., 1996, CLIN GUIDE CONTRACEP; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stanczyk Frank Z, 2002, Rev Endocr Metab Disord, V3, P211, DOI 10.1023/A:1020072325818; Thigpen JT, 1999, J CLIN ONCOL, V17, P1736, DOI 10.1200/JCO.1999.17.6.1736; Thomas JL, 2010, J STEROID BIOCHEM, V120, P192, DOI 10.1016/j.jsbmb.2010.04.015; Tomlinson JW, 2005, NAT CLIN PRACT ENDOC, V1, P92, DOI 10.1038/ncpendmet0023; VanItallie TB, 2002, METABOLISM, V51, P1, DOI 10.1053/meta.2002.33182; VANVEELEN H, 1984, CANCER CHEMOTH PHARM, V12, P83, DOI 10.1007/BF00254594; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; Vinson GP, 2007, MED HYPOTHESES, V68, P1200, DOI 10.1016/j.mehy.2006.09.065; Wenzel J, 2009, AM J PHYSIOL-REG I, V297, pR1601, DOI 10.1152/ajpregu.91034.2008; Wu CQ, 2013, BJOG-INT J OBSTET GY, V120, P801, DOI 10.1111/1471-0528.12210	78	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164170	10.1371/journal.pone.0164170	http://dx.doi.org/10.1371/journal.pone.0164170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706226	Green Published, gold			2022-12-26	WOS:000385697200093
J	Martinelli, AG; Soares, MB; Schwanke, C				Martinelli, Agustin G.; Soares, Marina Bento; Schwanke, Cibele			Two New Cynodonts (Therapsida) from the Middle-Early Late Triassic of Brazil and Comments on South American Probainognathians	PLOS ONE			English	Article							GRANDE-DO-SUL; SANTA-MARIA FORMATION; ISCHIGUALASTO FORMATION; NONMAMMALIAN CYNODONTS; FAUNA; TRITHELEDONTIDAE; EUCYNODONTIA; ASSEMBLAGE; ARGENTINA; ORIGIN	We describe two new cynodonts from the early Late Triassic of southern Brazil. One taxon, Bonacynodon schultzi gen. et sp. nov., comes from the lower Carnian Dinodontosaurus AZ, being correlated with the faunal association at the upper half of the lower member of the Chanares Formation (Ischigualasto-Villa Union Basin, Argentina). Phylogenetically, Bonacynodon is a closer relative to Probainognathus jenseni than to any other probainognathian, bearing conspicuous canines with a denticulate distal margin. The other new taxon is Santacruzgnathus abdalai gen. et sp. nov. from the Carnian Santacruzodon AZ. Although based exclusively on a partial lower jaw, it represents a probainognathian close to Prozostrodon from the Hyperodapedon AZ and to Brasilodon, Brasilitherium and Botucaraitherium from the Riograndia AZ. The two new cynodonts and the phylogenetic hypothesis presented herein indicate the degree to which our knowledge on probainognathian cynodonts is incomplete and also the relevance of the South American fossil record for understanding their evolutionary significance. The taxonomic diversity and abundance of probainognathians from Brazil and Argentina will form the basis of deep and complex studies to address the evolutionary transformations of cynodonts leading to mammals.	[Martinelli, Agustin G.; Soares, Marina Bento] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Ave Bento Goncalves 9500, BR-91540000 Porto Alegre, RS, Brazil; [Schwanke, Cibele] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul, Ctr Hist, Campus Porto Alegre,Rua Coronel Vicente 281, BR-90030040 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Instituto Federal do Rio Grande do Sul (IFRS)	Martinelli, AG (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Ave Bento Goncalves 9500, BR-91540000 Porto Alegre, RS, Brazil.	agustin_martinelli@yahoo.com.ar	Soares, Marina Bento/M-9477-2017; Soares, Marina/AAN-8513-2020; Martinelli, Agustin G./D-4632-2015	Soares, Marina Bento/0000-0002-8393-2406; Soares, Marina/0000-0002-8393-2406; Martinelli, Agustin/0000-0003-4489-0888	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304143/2012-0]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funds were provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 304143/2012-0) and the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS).	Abdala F, 2003, ZOOL J LINN SOC-LOND, V139, P529, DOI 10.1111/j.1096-3642.2003.00096.x; Abdala F, 2002, PALAEONTOLOGY, V45, P1151, DOI 10.1111/1475-4983.00280; Abdala F, 2001, NEUES JAHRB GEOL P-M, P669; Abdala F, 2000, AMEGHINIANA, V37, P463; Abdala F., 1996, THESIS; Abdala F, 2007, PALAEONTOLOGY, V50, P591, DOI 10.1111/j.1475-4983.2007.00646.x; Abdala F, 2013, J VERTEBR PALEONTOL, V33, P1408, DOI 10.1080/02724634.2013.775140; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abdala F, 2009, J VERTEBR PALEONTOL, V29, P837, DOI 10.1671/039.029.0303; Abdala Fernando, 2000, Geodiversitas, V22, P589; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; [Anonymous], 1980, AN 31 C BRAS GEOL CA; Barberena M.C., 1977, PESQUISAS, V7, P111; Barberena MC, 1978, PESQUISAS, V9; BATTAIL B, 1991, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V13, P17; Battail B., 1982, GEOBIOS MEMOIRE SPEC, V6, P157; BeltrAo R, 1965, B I CIENCIAS NATURAI, V2, P5; Bonaparte J.F., 1994, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" e Instituto Nacional de Investigacion de las Ciencias Naturales Paleontologia, V5, P1; Bonaparte J.F., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P599; Bonaparte J.F., 1978, Opera Lilloana, V26, P1; Bonaparte J. F., 1966, Acta Geologica Lilloana, V8, P157; BONAPARTE J F, 1972, Ameghiniana, V9, P343; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J.F., 1971, OPERA LILLOANA, V22, P1; Bonaparte J.F., 1980, 2 C ARG PAL BIOESTR, P123; BONAPARTE JF, 1975, J PALEONTOL, V49, P931; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte JF, 2015, PROTOMAMIFEROS MAMIF; Bonaparte JF, 2002, LEXICO ESTRATIGRAF B, V26, P250; Bonaparte JF, 2000, B ACAD NACL CIENCIAS, V64, P147; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte Jose F., 2012, Historia Natural (Corrientes), V2, P5; Bonaparte JF, 2013, HIST BIOL, V25, P643, DOI 10.1080/08912963.2012.731154; Bonaparte JF, 2012, HIST BIOL, V24, P43, DOI 10.1080/08912963.2011.559079; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 2001, Bulletin of the Museum of Comparative Zoology, V156, P59; Brink KS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4269; Clack JA, 2004, SPR HDB AUD, V22, P128; Crompton A.W., 1972, P231; CROMPTON A. W., 1963, ANN S AFRICAN MUS, V46, P479; Crompton A.W., 1979, P59; CROMPTON A. W., 1955, PROC ZOOL SOC LONDON, V125, P617; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Das DP, 2012, J GEOL SOC INDIA, V79, P175, DOI 10.1007/s12594-012-0022-2; Datta PM, 2004, ANN CARNEGIE MUS, V73, P72; De Oliveira TV, 2011, ZOOTAXA, P19; Dias-da-Silva S, 2013, B N MEX MUS NAT HIST, V61, P1; Fernandez E, 2011, AMEGHINIANA SR, V48, P107; Fiorelli LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep03348; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gordon Jr M, 1947, NOTAS PRELIMINARES E, V38, P1; GOW CE, 1980, PROC R SOC SER B-BIO, V208, P461, DOI 10.1098/rspb.1980.0063; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; Hahn G., 1984, Bulletin de la Societe Belge de Geologie, V93, P357; Hahn G, 1987, MEM EXPL CARTES GEOL, V25, P1; Hahn Gerhard, 1994, Geologica et Palaeontologica, V28, P141; Hopson J.A., 1991, P635; Hopson J.A., 1986, P83; HOPSON J A, 1972, Palaeontologia Africana, V14, P71; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Huene F. von, 1936, LIEFERUNG, V2, P93; Kemp TS, 2009, J VERTEBR PALEONTOL, V29, P1188, DOI 10.1671/039.029.0430; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; Kermack DM, 1984, EVOLUTION MAMMALIAN; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kokogian DA., 2001, FUNDACION MUSEO PLAT, P23; Lacerda MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118563; Langer M. C., 2007, NEW MEXICO MUSEUM NA, V41, P201; Langer MC, 2005, J S AM EARTH SCI, V19, P205, DOI 10.1016/j.jsames.2005.04.003; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; Marsicano C., 2001, SISTEMA TRIASICO ARG, P131; Marsicano CA, 2016, P NATL ACAD SCI USA, V113, P509, DOI 10.1073/pnas.1512541112; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, DINOSAURIOS PALEONTO, P179; Martinelli AG, 2016, CONTRIB MUS ARG CIEN, V6, P183; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinez RN, 2015, AMEGHINIANA, V52, P379, DOI 10.5710/AMGH.27.04.2015.2889; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2013, REV BRAS PALEONTOLOG, V16, P61, DOI 10.4072/rbp.2013.1.05; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P285, DOI 10.1080/02724634.1996.10011315; Melo TP, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.1002562; Oliveira EV, 2006, GEODIVERSITAS, V28, P447; Oliveira T.V., 2011, PALAEONTOL Z, V85, P67, DOI DOI 10.1007/S12542-010-0078-5; Oliveira TV, ACTA PALAEONTOL POL; Oliveira TV, 2010, ZOOTAXA, V2382, P1; PAGE RDM, 2000, NEXUS DATA EDITOR WI; Philipp R.P., 2013, AN 8 S INT TECT 14 S, P154; Price L.I., 1947, B DIVISAO GEOLOGIA M, V122, P7; QUIROGA JC, 1984, J HIRNFORSCH, V25, P285; QUIROGA JC, 1980, J HIRNFORSCH, V21, P299; Raugust T, 2013, GEOL SOC SPEC PUBL, V379, P303, DOI 10.1144/SP379.22; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Rodrigues PG, 2013, J MAMM EVOL, V20, P291, DOI 10.1007/s10914-012-9221-2; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A.S., 1973, Breviora, VNo. 401, P1; Romer A. S., 1969, Breviora, VNo. 332, P1; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S., 1969, BREVIORA, V333, P1; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Ruff I, 2014, ANAT REC, V297, P2018; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2414; Schultz C. L., 2000, REV BRASILEIRA GEOCI, V30, P491; Schwanke C, 2009, VERTEBRADOS FOSSEIS, P279; Shapiro Michael D., 2001, Bulletin of the Museum of Comparative Zoology, V156, P49; Sindor CA, 2006, J PALEONTOL, V80, P333; Soares MB, 2014, AN ACAD BRAS CIENC, V86, P1673, DOI 10.1590/0001-3765201420140455; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Soares MB, 2011, GEODIVERSITAS, V33, P265, DOI 10.5252/g2011n2a4; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Sues Hans-Dieter, 2001, Bulletin of the Museum of Comparative Zoology, V156, P37; Wible J.R., 1991, Journal of Vertebrate Paleontology, V11, P1; Zavattieri AM, 2007, AMEGHINIANA, V44, P133; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	123	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162945	10.1371/journal.pone.0162945	http://dx.doi.org/10.1371/journal.pone.0162945			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706191	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200025
J	Zhao, K; Ren, FF; Han, FT; Liu, QW; Wu, GG; Xu, Y; Zhang, J; Wu, X; Wang, JB; Li, P; Shi, W; Zhu, H; Lv, JJ; Zhao, X; Tang, XM				Zhao, Kai; Ren, Fangfang; Han, Fangting; Liu, Qiwen; Wu, Guogan; Xu, Yan; Zhang, Jian; Wu, Xiao; Wang, Jinbin; Li, Peng; Shi, Wei; Zhu, Hong; Lv, Jianjun; Zhao, Xiao; Tang, Xueming			Edible Safety Assessment of Genetically Modified Rice T1C-1 for Sprague Dawley Rats through Horizontal Gene Transfer, Allergenicity and Intestinal Microbiota	PLOS ONE			English	Article							TRANSGENIC PLANTS; RESISTANT; PROTEIN; MAIZE; DNA; DIGESTIBILITY; CRY1C; CROPS; FATE; MICE	In this study, assessment of the safety of transgenic rice T1C-1 expressing Cry1C was carried out by: (1) studying horizontal gene transfer (HGT) in Sprague Dawley rats fed transgenic rice for 90 d; (2) examining the effect of Cry1C protein in vitro on digestibility and allergenicity; and (3) studying the changes of intestinal microbiota in rats fed with transgenic rice T1C-1 in acute and subchronic toxicity tests. Sprague Dawley rats were fed a diet containing either 60% GM Bacillus thuringiensis (Bt) rice T1C-1 expressing Cry1C protein, the parental rice Minghui 63, or a basic diet for 90 d. The GM Bt rice T1C-1 showed no evidence of HGT between rats and transgenic rice. Sequence searching of the Cry1C protein showed no homology with known allergens or toxins. Cry1C protein was rapidly degraded in vitro with simulated gastric and intestinal fluids. The expressed Cry1C protein did not induce high levels of specific IgG and IgE antibodies in rats. The intestinal microbiota of rats fed T1C-1 was also analyzed in acute and subchronic toxicity tests by DGGE. Cluster analysis of DGGE profiles revealed significant individual differences in the rats' intestinal microbiota.	[Zhao, Kai; Wu, Guogan; Wu, Xiao; Wang, Jinbin; Li, Peng; Zhu, Hong; Tang, Xueming] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Zhao, Kai; Wu, Guogan; Wu, Xiao; Wang, Jinbin; Li, Peng; Tang, Xueming] Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China; [Ren, Fangfang; Han, Fangting; Liu, Qiwen; Xu, Yan; Shi, Wei] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Zhang, Jian] Alberta Innovates Technol Futures, Vegreville, AB, Canada; [Lv, Jianjun] Beijing Econ Technol Dev Area, Natl Ctr Safety Evaluat Drugs, Beijing, Peoples R China; [Zhao, Xiao] Ningxia Univ, Life Sci Coll, Yinchuan, Ningxia, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences; Shanghai Normal University; Alberta Innovates; Ningxia University	Tang, XM (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China.; Tang, XM (corresponding author), Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China.	saas_xmtang@foxmail.com		wang, jinbin/0000-0001-7080-4264	Shanghai Agricultural Science Committee foundation of China [6-4]; Shanghai Agricultural Science Key Research Foundation [1-8]; Public Research Platform Foundation of Shanghai Science and Technology Committee [13DZ2290700]; Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences [2013(14), 2012(8)]	Shanghai Agricultural Science Committee foundation of China; Shanghai Agricultural Science Key Research Foundation; Public Research Platform Foundation of Shanghai Science and Technology Committee; Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences	This work was supported by Shanghai Agricultural Science Committee foundation of China, grant no.6-4 (2009),http://e-nw.shac.gov.cn/index.html. Shanghai Agricultural Science Key Research Foundation grant no.1-8 (2011), http://e-nw.shac.gov.cn/index.html. The Public Research Platform Foundation of Shanghai Science and Technology Committee, grant no. 13DZ2290700, http.//www.stcsm.gov.cn/. The Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences,2013(14), http://www.saas.sh.cn/. The Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences,2012(8), http://www.saas.sh.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash J, 2000, POULT SCI S1, V79, P26; Cao J, 1999, MOL BREEDING, V5, P131, DOI 10.1023/A:1009619924620; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Chambers PA, 2002, J ANTIMICROB CHEMOTH, V49, P161, DOI 10.1093/jac/49.1.161; Chesson A, 2003, WORLD POULTRY SCI J, V59, P201, DOI 10.1079/WPS20030012; Codex Alimentarius Commission, 2009, FOODS DER MOD BIOT, V2nd, P1; Ellstrand NC, 2001, PLANT PHYSIOL, V125, P1543, DOI 10.1104/pp.125.4.1543; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; Flachowsky G, 2001, J ANIM FEED SCI, V10, P181, DOI 10.22358/jafs/70020/2001; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Gatehouse AMR, 1998, PESTIC SCI, V52, P165, DOI 10.1002/(SICI)1096-9063(199802)52:2&lt;165::AID-PS679&gt;3.0.CO;2-7; Gendel SM, 1998, ADV FOOD NUTR RES, V42, P45, DOI 10.1016/S1043-4526(08)60092-3; Guo Xing, 2010, Journal of Agricultural Biotechnology, V18, P346; Han LZ, 2007, J INVERTEBR PATHOL, V96, P71, DOI 10.1016/j.jip.2007.02.015; Hernandez M, 2004, J CEREAL SCI, V39, P99, DOI 10.1016/S0733-5210(03)00071-7; Jennings I, 2003, J THROMB HAEMOST, V1, P1112, DOI 10.1046/j.1538-7836.2003.00215.x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; MONETTE R, 1994, J INSECT PHYSIOL, V40, P273, DOI 10.1016/0022-1910(94)90067-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Papst C, 2005, AGRON J, V97, P219; Phipps RH, 2002, LIVEST PROD SCI, V74, P269, DOI 10.1016/S0301-6226(02)00038-6; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Sambrook J, 1999, MOL CLONING LAB MANU, P1723; Sambrook JF, 1999, MOL CLONING LAB MANU, P1252; Schubbert R, 1998, MOL GEN GENET, V259, P569, DOI 10.1007/s004380050850; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Sinagawa-Garcia SR, 2004, J AGR FOOD CHEM, V52, P2709, DOI 10.1021/jf035487k; Snow AA, 2002, NAT BIOTECHNOL, V20, P542, DOI 10.1038/nbt0602-542; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029	37	5	6	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163352	10.1371/journal.pone.0163352	http://dx.doi.org/10.1371/journal.pone.0163352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706188	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200039
J	Garcia-Rubio, R; Gil, H; Monteiro, MC; Pelaez, T; Mellado, E				Garcia-Rubio, Rocio; Gil, Horacio; Candida Monteiro, Maria; Pelaez, Teresa; Mellado, Emilia			A New Aspergillus fumigatus Typing Method Based on Hypervariable Tandem Repeats Located within Exons of Surface Protein Coding Genes (TRESP)	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MOLECULAR EPIDEMIOLOGY; RANDOM AMPLIFICATION; RESISTANCE; OUTBREAK; UTILITY; ASSAY	Aspergillus fumigatus is a saprotrophic mold fungus ubiquitously found in the environment and is the most common species causing invasive aspergillosis in immunocompromised individuals. For A. fumigatus genotyping, the short tandem repeat method (STRAf) is widely accepted as the first choice. However, difficulties associated with PCR product size and required technology have encouraged the development of novel typing techniques. In this study, a new genotyping method based on hypervariable tandem repeats within exons of surface protein coding genes (TRESP) was designed. A. fumigatus isolates were characterized by PCR amplification and sequencing with a panel of three TRESP encoding genes: cell surface protein A; MP-2 antigenic galactomannan protein; and hypothetical protein with a CFEM domain. The allele sequence repeats of each of the three targets were combined to assign a specific genotype. For the evaluation of this method, 126 unrelated A. fumigatus strains were analyzed and 96 different genotypes were identified, showing a high level of discrimination [Simpson's index of diversity (D) 0.994]. In addition, 49 azole resistant strains were analyzed identifying 26 genotypes and showing a lower D value (0.890) among them. This value could indicate that these resistant strains are closely related and share a common origin, although more studies are needed to confirm this hypothesis. In summary, a novel genotyping method for A. fumigatus has been developed which is reproducible, easy to perform, highly discriminatory and could be especially useful for studying outbreaks.	[Garcia-Rubio, Rocio; Gil, Horacio; Candida Monteiro, Maria; Mellado, Emilia] Inst Salud Carlos III, Ctr Nacl Microbiol, Mycol Deparment, Madrid, Spain; [Garcia-Rubio, Rocio; Pelaez, Teresa] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Gil, Horacio] European Program Publ Hlth Microbiol Training EUP, European Ctr Dis Prevent & Control, ECDC, Stockholm, Sweden	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); General University Gregorio Maranon Hospital; European Centre for Disease Prevention & Control	Mellado, E (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Mycol Deparment, Madrid, Spain.	emellado@isciii.es	Garcia-Rubio, Rocio/AAD-8119-2021	Garcia-Rubio, Rocio/0000-0003-4610-2996; Mellado, Emilia/0000-0002-9801-0260; Gil, Horacio/0000-0002-7114-6686				Abdolrasouli A, 2015, MBIO, V6, DOI 10.1128/mBio.00536-15; Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; [Anonymous], 1994, MOL BIOL PATHOGENIC; AUFAUVREBROWN A, 1992, J CLIN MICROBIOL, V30, P2991, DOI 10.1128/JCM.30.11.2991-2993.1992; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998; Bart-Delabesse E, 2001, J CLIN MICROBIOL, V39, P2683, DOI 10.1128/JCM.39.7.2683-2686.2001; Bertout S, 2001, J CLIN MICROBIOL, V39, P1731, DOI 10.1128/JCM.39.5.1731-1737.2001; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Cerqueira GC, 2013, NUCLEIC ACIDS RES, V4, P705; de Ruiter MT, 2007, J MICROBIOL METH, V70, P528, DOI 10.1016/j.mimet.2007.06.009; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Escribano P, 2015, J CLIN MICROBIOL, V53, P667, DOI 10.1128/JCM.02636-14; Gao LJ, 2013, MED MYCOL, V51, P683, DOI 10.3109/13693786.2013.770609; Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd SE, 2009, J MICROBIOL METH, V78, P223, DOI 10.1016/j.mimet.2009.06.003; Klaassen CHW, 2007, STUD MYCOL, P47, DOI 10.3114/sim.2007.59.06; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Levdansky Emma, 2008, Fungal Biology Reviews, V22, P85, DOI 10.1016/j.fbr.2008.08.001; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; LOUDON KW, 1993, J CLIN MICROBIOL, V31, P1117, DOI 10.1128/JCM.31.5.1117-1121.1993; Mondon P, 1997, FEMS IMMUNOL MED MIC, V17, P95, DOI 10.1111/j.1574-695X.1997.tb01001.x; Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003	34	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163869	10.1371/journal.pone.0163869	http://dx.doi.org/10.1371/journal.pone.0163869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701437	Green Published, gold			2022-12-26	WOS:000385696900025
J	Key, AJM				Key, Alastair J. M.			Manual Loading Distribution During Carrying Behaviors: Implications for the Evolution of the Hominin Hand	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; 3RD METACARPAL; WEST TURKANA; STONE TOOLS; APES VIEW; OLDOWAN; TRANSPORT; HUMANS; GRIPS; PLEISTOCENE	The human hand is unparalleled amongst primates in its ability to manipulate objects forcefully and dexterously. Previous research has predominantly sought to explain the evolution of these capabilities through an adaptive relationship between more modern human-like anatomical features in the upper limb and increased stone tool production and use proficiency. To date, however, we know little about the influence that other manipulatively demanding behaviors may have had upon the evolution of the human hand. The present study addresses one aspect of this deficiency by examining the recruitment of the distal phalanges during a range of manual transportation (i.e., carrying) events related to hominin behavioral repertoires during the Plio-Pleistocene. Specifically, forces on the volar pad of each digit are recorded during the transportation of stones and wooden branches that vary in weight and size. Results indicate that in most instances, the index and middle fingers are recruited to a significantly greater extent than the other three digits during carrying events. Relative force differences between digits were, however, dependent upon the size and weight of the object transported. Carrying behaviors therefore appear unlikely to have contributed to the evolution of the robust thumb anatomy observed in the human hand. Rather, results suggest that the manual transportation of objects may plausibly have influenced the evolution of the human gripping capabilities and the 3rd metacarpal styloid process.	[Key, Alastair J. M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England	University of Kent	Key, AJM (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England.	a.j.m.key@kent.ac.uk		Key, Alastair/0000-0001-5576-1200				Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Almecija S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8717; Almecija S, 2014, J HUM EVOL, V73, P88, DOI 10.1016/j.jhevol.2014.02.006; Almecija S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011727; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; Blumenschine RJ, 2008, J ARCHAEOL SCI, V35, P76, DOI 10.1016/j.jas.2007.02.009; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Boesch C., 1993, HANDS PRIMATES, P109, DOI [10.1007/978-3-7091-6914-8_4, DOI 10.1007/978-3-7091-6914-8_4]; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Braun DR, 2008, J ARCHAEOL SCI, V35, P2329, DOI 10.1016/j.jas.2008.03.004; Bunn HT, 2010, QUATERNARY RES, V74, P355, DOI 10.1016/j.yqres.2010.06.004; Campbell SC, 2000, INT J IND ERGONOM, V25, P349, DOI 10.1016/S0169-8141(99)00023-2; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Close AE, 1996, CURR ANTHROPOL, V37, P545, DOI 10.1086/204517; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Diogo R, 2012, J HUM EVOL, V63, P64, DOI 10.1016/j.jhevol.2012.04.001; Ditchfield K, 2016, J ARCHAEOL SCI, V65, P44, DOI 10.1016/j.jas.2015.10.012; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dominguez-Rodrigo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8987; Eren MI, 2013, AM ANTIQUITY, V78, P166, DOI 10.7183/0002-7316.78.1.166; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Gowlett JAJ, 2009, J HUM EVOL, V57, P401, DOI 10.1016/j.jhevol.2009.04.011; Hamrick MW, 1998, J HUM EVOL, V34, P123, DOI 10.1006/jhev.1997.0177; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HEWES GW, 1961, AM ANTHROPOL, V63, P687, DOI 10.1525/aa.1961.63.4.02a00020; Hiscock P, 2015, LITHIC TECHNOL, V40, P342, DOI 10.1179/2051618515Y.0000000021; Humle T., 1999, GUINEA PAN AFRICA NE, V6, P3; Isaac G., 1983, EARLY STAGES EVOLUTI; ISAAC GL, 1981, PHILOS T R SOC B, V292, P177, DOI 10.1098/rstb.1981.0026; KELLY RL, 1983, J ANTHROPOL RES, V39, P277, DOI 10.1086/jar.39.3.3629672; Key AJM, 2017, ARCHAEOL ANTHROP SCI, V9, P737, DOI 10.1007/s12520-015-0300-1; Key AJM, 2016, ETHNOARCHAEOLOGY, V8, P69, DOI 10.1080/19442890.2016.1150626; Key AJM, 2015, J HUM EVOL, V78, P60, DOI 10.1016/j.jhevol.2014.08.006; Key AJM, 2011, J ARCHAEOL SCI, V38, P1663, DOI 10.1016/j.jas.2011.02.032; Kinoshita H, 1996, ERGONOMICS, V39, P1163, DOI 10.1080/00140139608964536; Kivell TL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0105; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Komi ER, 2007, P I MECH ENG C-J MEC, V221, P1687, DOI 10.1243/09544062JMES700; Kramer PA, 2004, RES ECON ANTHROPOL, V23, P249, DOI 10.1016/S0190-1281(04)23010-4; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lorenzo C, 2015, J HUM EVOL, V78, P114, DOI 10.1016/j.jhevol.2014.08.007; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Maki Julia, 2011, Paleoanthropology, V2011, P62; Marzke MW, 2015, AM J PHYS ANTHROPOL, V156, P317, DOI 10.1002/ajpa.22651; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; Marzke MW, 1996, INT J PRIMATOL, V17, P117, DOI 10.1007/BF02696162; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; MARZKE MW, 1987, AM J PHYS ANTHROPOL, V73, P415, DOI 10.1002/ajpa.1330730403; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; Mrotek LA, 2004, EXP BRAIN RES, V155, P413, DOI 10.1007/s00221-003-1748-2; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Napier J.R., 1980, HANDS; Neufuss J, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22589; Neufuss J, 2015, FOLIA PRIMATOL, V86, P329; Ng PK, 2014, THEOR ISS ERGON SCI, V15, P305, DOI 10.1080/1463922X.2012.729619; Niewoehner WA, 2001, P NATL ACAD SCI USA, V98, P2979, DOI 10.1073/pnas.041588898; OCONNELL JF, 1988, J ANTHROPOL RES, V44, P113, DOI 10.1086/jar.44.2.3630053; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; Pouydebat E, 2011, BEHAV BRAIN RES, V218, P21, DOI 10.1016/j.bbr.2010.11.021; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Rein R, 2013, AM J PHYS ANTHROPOL, V150, P539, DOI 10.1002/ajpa.22224; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Roux V., 2005, STONE KNAPPING NECES, P243; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; Sanz C, 2009, BIOL LETTERS, V5, P293, DOI 10.1098/rsbl.2008.0786; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shea J., 2007, EVOLUTION HUMAN DIET, P212; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Sirianni G, 2015, ANIM BEHAV, V100, P152, DOI 10.1016/j.anbehav.2014.11.022; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; SUSMAN RL, 1988, SCIENCE, V240, P781, DOI 10.1126/science.3129783; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Videan EN, 2002, AM J PHYS ANTHROPOL, V118, P184, DOI 10.1002/ajpa.10058; Villa P, 2001, J HUM EVOL, V41, P69, DOI 10.1006/jhev.2001.0479; Visalberghi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0351; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wang WJ, 2004, J ANAT, V204, P417, DOI 10.1111/j.0021-8782.2004.00295.x; Ward CV, 2014, P NATL ACAD SCI USA, V111, P121, DOI 10.1073/pnas.1316014110; Watson J, 2009, FOLIA PRIMATOL, V80, P309, DOI 10.1159/000258646; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Williams EM, 2010, AM J PHYS ANTHROPOL, V143, P134, DOI 10.1002/ajpa.21302; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005; Wood M., 2003, MAKING SENSE STAT NO; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	107	11	11	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163801	10.1371/journal.pone.0163801	http://dx.doi.org/10.1371/journal.pone.0163801			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695044	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000385553100054
J	Maroun, R; Maunoury, F; Benjamin, L; Nachbaur, G; Durand-Zaleski, I				Maroun, Rana; Maunoury, Franck; Benjamin, Laure; Nachbaur, Gaelle; Durand-Zaleski, Isabelle			In-Hospital Economic Burden of Metastatic Renal Cell Carcinoma in France in the Era of Targeted Therapies: Analysis of the French National Hospital Database from 2008 to 2013	PLOS ONE			English	Article							CANCER	Background & Objectives The aim of this study was to assess the economic burden of hospitalisations for metastatic renal cell carcinoma (mRCC), to describe the patterns of prescribing expensive drugs and to explore the impact of geographic and socio-demographic factors on the use of these drugs. Methods We performed a retrospective analysis from the French national hospitals database. Hospital stays for mRCC between 2008 and 2013 were identified by combining the 10th revision of the International Classification of Diseases (ICD-10) codes for renal cell carcinoma (C64) and codes for metastases (C77 to C79). Incident cases were identified out of all hospital stays and followed till December 2013. Descriptive analyses were performed with a focus on hospital stays and patient characteristics. Costs were assessed from the perspective of the French National Health Insurance and were obtained from official diagnosis-related group tariffs for public and private hospitals. Results A total of 15,752 adult patients were hospitalised for mRCC, corresponding to 102,613 hospital stays. Of those patients, 68% were men and the median age at first hospitalisation was 69 years [Min-Max: 18-102]. Over the study period, the hospital mortality rate reached 37%. The annual cost of managing mRCC at hospital varied between 28M(sic) in 2008 and 42M(sic) in 2012 and was mainly driven by inpatient costs. The mean annual per capita cost of hospital management of mRCC varied across the study period from 8,993(sic) (SD: (sic)8,906) in 2008 to 10,216(sic) (SD: (sic)10,527) in 2012. Analysis of the determinants of prescribing expensive drugs at hospital did not show social or territorial differences in the use of these drugs. Conclusion This study is the first to investigate the in-hospital economic burden of mRCC in France. Results showed that in-hospital costs of managing mRCC are mainly driven by expensive drugs and inpatient costs.	[Maroun, Rana; Benjamin, Laure; Nachbaur, Gaelle] GlaxoSmithKline, Marly Le Roi, France; [Maunoury, Franck] Statesia, Le Mans, France; [Durand-Zaleski, Isabelle] AP HP, URC Eco Ile de France, Paris, France; [Maroun, Rana; Durand-Zaleski, Isabelle] INSERM, ECEVE, Paris, France	GlaxoSmithKline; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Maroun, R (corresponding author), GlaxoSmithKline, Marly Le Roi, France.; Maroun, R (corresponding author), INSERM, ECEVE, Paris, France.	rana.r.maroun@gsk.com	; Maroun, Rana/D-5897-2017	Nachbaur, Gaelle/0000-0001-5116-0723; DUPONT-BENJAMIN, Laure/0000-0001-7748-0768; Maroun, Rana/0000-0002-6592-5739	GlaxoSmithKline; Association Nationale de la Recherche et de la Technologie (ANRT)	GlaxoSmithKline(GlaxoSmithKline); Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR))	This work is a part of a PhD program (CIFRE, Convention Industrielle de Formation par la REcherche) funded by GlaxoSmithKline and the Association Nationale de la Recherche et de la Technologie (ANRT).	A.R. Tu. R, 2016, TUMEURS REIN GEN EPI; Assurance Maladie, 2016, DONN MENS ANN MED RE; Benjamin L, 2015, CURR MED RES OPIN, V31, P323, DOI 10.1185/03007995.2014.986324; Casez P, 2015, MED MALADIES INFECT, V45, P446, DOI 10.1016/j.medmal.2015.10.004; Charles T, 2010, EMC UROLOGIE, V4, P1, DOI [10.1016/S1762-0953(10)52713-4, DOI 10.1016/S1762-0953(10)52713-4]; Geynisman Daniel M, 2015, Clin Genitourin Cancer, V13, pe93, DOI 10.1016/j.clgc.2014.08.013; Hansen RN, 2015, J MANAG CARE SPEC PH, V21, P37, DOI 10.18553/jmcp.2015.21.1.37; InCa, 2014, CANC FRANC; Institut National Du Cancer, 2015, INC NAT CANC; Larkin J, 2013, EXPERT OPIN PHARMACO, V14, P27, DOI 10.1517/14656566.2013.758713; Pal SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063341; Rey G, 2009, BMC PUBLIC HEALTH, V9, P33, DOI DOI 10.1186/1471-2458-9-33; Scherpereel A, 2015, VALUE HEALTH, V18, pA341, DOI 10.1016/j.jval.2015.09.145; Soerensen AV, 2015, EUR UROL, V68, P516, DOI 10.1016/j.eururo.2014.12.017; Windenberger F, 2012, EUR J PUBLIC HEALTH, V22, P347, DOI 10.1093/eurpub/ckr029	15	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162864	10.1371/journal.pone.0162864	http://dx.doi.org/10.1371/journal.pone.0162864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649305	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100038
J	White, D; Coombe, D; Rezania, V; Tuszynski, J				White, Diana; Coombe, Dennis; Rezania, Vahid; Tuszynski, Jack			Building a 3D Virtual Liver: Methods for Simulating Blood Flow and Hepatic Clearance on 3D Structures	PLOS ONE			English	Article							CONSTRAINED CONSTRUCTIVE OPTIMIZATION; ARTERIAL TREE MODELS; PACLITAXEL METABOLISM; VASCULAR TREES; NETWORK MODEL; HEMODYNAMICS	In this paper, we develop a spatio-temporal modeling approach to describe blood and drug flow, as well as drug uptake and elimination, on an approximation of the liver. Extending on previously developed computational approaches, we generate an approximation of a liver, which consists of a portal and hepatic vein vasculature structure, embedded in the surrounding liver tissue. The vasculature is generated via constrained constructive optimization, and then converted to a spatial grid of a selected grid size. Estimates for surrounding upscaled lobule tissue properties are then presented appropriate to the same grid size. Simulation of fluid flow and drug metabolism (hepatic clearance) are completed using discretized forms of the relevant convective-diffusive-reactive partial differential equations for these processes. This results in a single stage, uniformly consistent method to simulate equations for blood and drug flow, as well as drug metabolism, on a 3D structure representative of a liver.	[White, Diana] Clarkson Univ, Dept Math, Potsdam, NY USA; [Coombe, Dennis] Comp Modelling Grp Ltd, Calgary, AB, Canada; [Rezania, Vahid] MacEwan Univ, Dept Phys Sci, Edmonton, AB, Canada; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Tuszynski, Jack] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Clarkson University; University of Alberta; University of Alberta	Tuszynski, J (corresponding author), Univ Alberta, Dept Phys, Edmonton, AB, Canada.; Tuszynski, J (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	jackt@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429	Modelling Group Ltd.	Modelling Group Ltd.	The computer Modelling Group Ltd. only provided financial support in the form of author salary (DC) and access to research material (STARS software package). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arias M., 2009, LIVER BIOL PATHOLOGY, V5; ARTS T, 1979, AM J PHYSIOL, V237, pH469, DOI 10.1152/ajpheart.1979.237.4.H469; Bartholomew-Biggs M, 2008, SPRINGER SER OPTIM A, V19, P1, DOI 10.1007/978-0-387-78723-7_1; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; CMG Limited, 2013, STARS US GUID ADV PR; D'Alessandro LA, 2015, PROG BIOPHYS MOL BIO, V117, P78, DOI 10.1016/j.pbiomolbio.2014.11.005; Debbaut C, 2011, IEEE T BIO-MED ENG, V58, P25, DOI 10.1109/TBME.2010.2065229; Dullien F., 1992, POROUS MEDIA FLUID T, Vv2; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Goulet G., 2009, B APPL MECH, V5, P6; Goulet GC, 2009, ANN BIOMED ENG, V37, P1390, DOI 10.1007/s10439-009-9706-1; Hahn HK, 2005, MATH BIOSCI INTERAC, P55, DOI 10.1007/3-7643-7412-8_5; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Ierapetritou MG, 2009, CTS-CLIN TRANSL SCI, V2, P228, DOI 10.1111/j.1752-8062.2009.00092.x; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Johnson TN, 2010, CLIN PHARMACOKINET, V49, P189, DOI 10.2165/11318160-000000000-00000; KAMIYA A, 1972, B MATH BIOPHYS, V34, P431, DOI 10.1007/BF02476705; Karch R, 1999, COMPUT BIOL MED, V29, P19, DOI 10.1016/S0010-4825(98)00045-6; Kretowski M, 2003, COMPUT METH PROG BIO, V70, P129, DOI 10.1016/S0169-2607(01)00200-0; Louman-Gardiner KM, 2011, COMPUT METHOD BIOMEC, V14, P1071, DOI 10.1080/10255842.2010.508037; Monsarrat B, 1998, DRUG METAB DISPOS, V26, P229; Rezania V, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0034-5; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-53; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-52; Risoe C., 1991, BLOOD VOLUME CHANGES, V261, P1763; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schreiner W, 1997, J THEOR BIOL, V187, P147, DOI 10.1006/jtbi.1997.0413; SCHREINER W, 1993, J BIOMED ENG, V15, P148, DOI 10.1016/0141-5425(93)90046-2; SCHREINER W, 1995, J GEN PHYSIOL, V106, P583, DOI 10.1085/jgp.106.4.583; SCHREINER W, 1994, J GEN PHYSIOL, V103, P975, DOI 10.1085/jgp.103.6.975; SCHREINER W, 1993, IEEE T BIO-MED ENG, V40, P482, DOI 10.1109/10.243413; Schreiner W, 2006, MED ENG PHYS, V28, P416, DOI 10.1016/j.medengphy.2005.07.019; Schwen LO, 2016, COMPUT BIOL MED, V73, P108, DOI 10.1016/j.compbiomed.2016.04.004; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Selle D, 2002, IEEE T MED IMAGING, V21, P1344, DOI 10.1109/TMI.2002.801166; SHOEMAKER CP, 1964, CIRC RES, V15, P216, DOI 10.1161/01.RES.15.3.216; Taniguchi R, 2005, J PHARMACOL SCI, V97, P83, DOI 10.1254/jphs.FP0040603; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666; Van Der Plaats A, 2004, INT J ARTIF ORGANS, V27, P222, DOI 10.1177/039139880402700309; Willmann Stefan, 2005, Expert Opin Drug Metab Toxicol, V1, P159, DOI 10.1517/17425255.1.1.159; ZAMIR M, 1988, J GEN PHYSIOL, V91, P725, DOI 10.1085/jgp.91.5.725; Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892	43	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162215	10.1371/journal.pone.0162215	http://dx.doi.org/10.1371/journal.pone.0162215			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649537	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100014
J	Yu, SJ; Ding, LL; Luo, R; Li, XJ; Yang, J; Liu, HQ; Cong, L; Ran, C				Yu, Shijiang; Ding, Lili; Luo, Ren; Li, Xiaojiao; Yang, Juan; Liu, Haoqiang; Cong, Lin; Ran, Chun			Identification of Immunity-Related Genes in Dialeurodes citri against Entomopathogenic Fungus Lecanicillium attenuatum by RNA-Seq Analysis	PLOS ONE			English	Article							COTTON APHID; BOMBYX-MORI; TRIALEURODES-VAPORARIORUM; VERTICILLIUM-LECANII; MOLECULAR-CLONING; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; EXPRESSION; RESISTANCE; DROSOPHILA	Dialeurodes citri is a major pest in citrus producing areas, and large-scale outbreaks have occurred increasingly often in recent years. Lecanicillium attenuatum is an important ento-mopathogenic fungus that can parasitize and kill D. citri. We separated the fungus from corpses of D. citri larvae. However, the sound immune defense system of pests makes infection by an entomopathogenic fungus difficult. Here we used RNA sequencing technology (RNA-Seq) to build a transcriptome database for D. citri and performed digital gene expression profiling to screen genes that act in the immune defense of D. citri larvae infected with a pathogenic fungus. De novo assembly generated 84,733 unigenes with mean length of 772 nt. All unigenes were searched against GO, Nr, Swiss-Prot, COG, and KEGG databases and a total of 28,190 (33.3%) unigenes were annotated. We identified 129 immunity-related unigenes in transcriptome database that were related to pattern recognition receptors, information transduction factors and response factors. From the digital gene expression profile, we identified 441 unigenes that were differentially expressed in D. citri infected with L. attenuatum. Through calculated Log(2)Ratio values, we identified genes for which fold changes in expression were obvious, including cuticle protein, vitellogenin, cathepsin, prophenoloxidase, clip-domain serine protease, lysozyme, and others. Subsequent quantitative real-time polymerase chain reaction analysis verified the results. The identified genes may serve as target genes for microbial control of D. citri.	[Yu, Shijiang; Ding, Lili; Luo, Ren; Li, Xiaojiao; Yang, Juan; Liu, Haoqiang; Cong, Lin; Ran, Chun] Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Natl Engn Res Ctr Citrus, Chongqing 400712, Peoples R China	Chinese Academy of Agricultural Sciences; Southwest University - China	Ran, C (corresponding author), Southwest Univ, Citrus Res Inst, Chinese Acad Agr Sci, Natl Engn Res Ctr Citrus, Chongqing 400712, Peoples R China.	ranchun@cric.cn			National Science and Technology Support Program [2012BAD19B06]; National Sparking Plan Project [2012GA811001]; Technological Projects of Chongqing [cstc2014yykfB80007, cstc2014fazktjcsf80033]	National Science and Technology Support Program; National Sparking Plan Project; Technological Projects of Chongqing	This work was supported by the National Science and Technology Support Program (2012BAD19B06), the National Sparking Plan Project (2012GA811001), and Technological Projects of Chongqing (cstc2014yykfB80007, cstc2014fazktjcsf80033).	Ahmed A, 1999, P NATL ACAD SCI USA, V96, P14795, DOI 10.1073/pnas.96.26.14795; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Asano T, 2013, INSECT BIOCHEM MOLEC, V43, P344, DOI 10.1016/j.ibmb.2013.01.001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Chen EH, 2014, INSECT MOL BIOL, V23, P52, DOI 10.1111/imb.12060; Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Fasulo TR, 1999, CITRUS WHITEFLY DIAL, V128, P1; Ford L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000377; Futahashi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064557; Gao YH, 2015, BIORESOURCES, V10, P10; GILL G, 2001, NZ BIOSECURITY, V26, P19; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Guo JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043567; HALL RA, 1982, ANN APPL BIOL, V101, P1, DOI 10.1111/j.1744-7348.1982.tb00794.x; He NJ, 2007, INSECT BIOCHEM MOLEC, V37, P135, DOI 10.1016/j.ibmb.2006.10.011; Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Karatolos N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031077; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Kim JJ, 2007, BIOCONTROL, V52, P789, DOI 10.1007/s10526-006-9050-4; Kim JJ, 2007, BIOL CONTROL, V40, P327, DOI 10.1016/j.biocontrol.2006.12.002; Kim Jeong Jun, 2008, Journal of Asia-Pacific Entomology, V11, P1, DOI 10.1016/j.aspen.2008.02.001; Kocks C, 2003, MOL CELL PROTEOMICS, V2, P1188, DOI 10.1074/mcp.M300067-MCP200; Korolev N, 1999, MYCOL RES, V103, P833, DOI 10.1017/S0953756298007953; Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mound LA, 1978, WHITEFLY WORLD SYSTE; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; NGUYEN R, 1993, CATALOG ALEYRODIDAE; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purac J, 2008, J INSECT PHYSIOL, V54, P1356, DOI 10.1016/j.jinsphys.2008.07.012; Pyle K, 2009, CURRENT STATUS EC IM, P27; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; Soderhall K., 1997, Developmental and Comparative Immunology, V21, P137, DOI 10.1016/S0145-305X(97)88601-6; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sultana K., 2000, Pakistan Journal of Phytopathology, V12, P42; Taft AS, 2001, INSECT MOL BIOL, V10, P97, DOI 10.1046/j.1365-2583.2001.00242.x; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Teets NM, 2014, J EXP BIOL, V217, P84, DOI 10.1242/jeb.089490; Wang RJ, 2015, FISH SHELLFISH IMMUN, V47, P582, DOI 10.1016/j.fsi.2015.09.047; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x; Zhang K, 2015, MOL IMMUNOL, V66, P409, DOI 10.1016/j.molimm.2015.04.008	49	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162659	10.1371/journal.pone.0162659	http://dx.doi.org/10.1371/journal.pone.0162659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644092	gold, Green Published, Green Submitted			2022-12-26	WOS:000383891900013
J	Zhao, P; Yang, XX; Yang, L; Li, MS; Wood, K; Liu, Q; Zhu, XD				Zhao, Peng; Yang, Xiaoxia; Yang, Liu; Li, Minshu; Wood, Kristofer; Liu, Qiang; Zhu, Xiaodong			Neuroprotective effects of fingolimod in mouse models of Parkinson's disease	FASEB JOURNAL			English	Article						S1PR; neurotoxicity; neuroprotection	NATURAL-KILLER-CELLS; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; ANIMAL-MODELS; BRAIN; FTY720; SPHINGOSINE-1-PHOSPHATE; NEURONS; RECEPTORS; MODULATION	Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons with limited treatment options. Emerging evidence shows that FTY720 protects against neural injury via modulation of the sphingosine-1-phosphate 1 receptor (S1PR1). However, it remains unclear whether FTY720 could influence neurodegeneration in PD. Therefore, the present study was designed to determine the impact of fingolimod (FTY720), a sphingosine-1-phosphate receptor (S1PR) agonist, on 2 mouse models of PD. We found that FTY720 significantly reduced the deficit of motor function, diminished the loss of tyrosine hydroxylase-positive neurons in the substantia nigra, and attenuated the decrease of striatal dopamine and metabolite levels in mice receiving 6-hydroxydopamine (6-OHDA) or rotenone to simulate PD. An S1PR1-selective antagonist, W146, blocked the neuroprotective effects of FTY720. Of note, FTY720 retained the phosphorylation of ERK, together with a decreased expression of cleaved caspase-3 in mice treated with 6-OHDA or rotenone. In vitro studies revealed that FTY720 also attenuated 6-OHDA-or rotenone-induced toxicity in SH-SY5Y cells. These findings suggest the potential of S1PR modulation as a treatment for PD.-Zhao, P., Yang, X., Yang, L., Li, M., Wood, K., Liu, Q., Zhu, X. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.	[Zhao, Peng; Yang, Xiaoxia; Yang, Liu; Li, Minshu; Liu, Qiang; Zhu, Xiaodong] Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Li, Minshu; Wood, Kristofer; Liu, Qiang; Zhu, Xiaodong] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Liu, Q; Zhu, XD (corresponding author), Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	qliu@tmu.edu.cn; zxd3516@163.com	Liu, Qiang/HHZ-3181-2022		American Heart Association [16SDG27250236]; National Science Foundation of China [81471535]; Tianjin Education Commission Foundation [14JCYBJC42000, 15JCYBJC50000]	American Heart Association(American Heart Association); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Education Commission Foundation	This study was supported in part by American Heart Association Grant 16SDG27250236 (to Q.L.), National Science Foundation of China Grant 81471535 (to Q.L.). and Tianjin Education Commission Foundation Grants 14JCYBJC42000 (to Q.L.) and 15JCYBJC50000 (to X.Z.).	Abbott A, 2010, NATURE, V466, pS6, DOI 10.1038/466S6a; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cipriani R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0308-6; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Avila-Gomez IC, 2010, BASIC CLIN PHARMACOL, V106, P53, DOI 10.1111/j.1742-7843.2009.00472.x; da Conceicao Fabio S L, 2010, J Vis Exp, DOI 10.3791/1376; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Guadano A, 1998, MUTAT RES-GEN TOX EN, V414, P1, DOI 10.1016/S1383-5718(98)00032-1; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Liu Q, 2014, NEUROSCIENCE, V256, P170, DOI 10.1016/j.neuroscience.2013.10.049; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Liu Q, 2015, NEUROPHARMACOLOGY, V97, P457, DOI 10.1016/j.neuropharm.2015.04.025; Liu Q, 2013, J NEUROSCI, V33, P7253, DOI 10.1523/JNEUROSCI.3235-12.2013; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Sivasubramanian M, 2015, NEUROSCIENCE, V290, P636, DOI 10.1016/j.neuroscience.2015.01.032; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316	33	59	61	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					172	179		10.1096/fj.201600751R	http://dx.doi.org/10.1096/fj.201600751R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27671228				2022-12-26	WOS:000392177600018
J	Gorelik, A; Heinz, LX; Illes, K; Superti-Furga, G; Nagar, B				Gorelik, Alexei; Heinz, Leonhard X.; Illes, Katalin; Superti-Furga, Giulio; Nagar, Bhushan			Crystal Structure of the Acid Sphingomyelinase-like Phosphodiesterase SMPDL3B Provides Insights into Determinants of Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface enzyme; crystal structure; lipid metabolism; sphingomyelinase; substrate specificity; SMPDL3B	PROTEOMIC ANALYSIS; IDENTIFICATION; PHOSPHATIDYLCHOLINE; PHENIX	The enzyme acid sphingomyelinase-like phosphodiesterase 3B (SMPDL3B) was shown to act as a negative regulator of innate immune signaling, affecting cellular lipid composition and membrane fluidity. Furthermore, several reports identified this enzyme as an off target of the therapeutic antibody rituximab, with implications in kidney disorders. However, structural information for this protein is lacking. Here we present the high resolution crystal structure of murine SMPDL3B, which reveals a substrate binding site strikingly different from its paralogs. The active site is located in a narrow boot-shaped cavity. We identify a unique loop near the active site that appears to impose size constraints on incoming substrates. A structure in complex with phosphocholine indicates that the protein recognizes this head group via an aromatic box, a typical choline-binding motif. Although a potential substrate for SMPDL3B is sphingomyelin, we identify other possible substrates such as CDP-choline, ATP, and ADP. Functional experiments employing structure-guided mutagenesis in macrophages highlight amino acid residues potentially involved in recognition of endogenous substrates. Our study is an important step toward elucidating the specific function of this poorly characterized enzyme.	[Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Gorelik, Alexei; Illes, Katalin; Nagar, Bhushan] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Heinz, Leonhard X.; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	McGill University; McGill University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Nagar, B (corresponding author), Rm 464,3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	bhushan.nagar@mcgill.ca	Superti-Furga, Giulio/AAE-5681-2019	Gorelik, Alexei/0000-0001-6236-4633; Heinz, Leonhard/0000-0002-6921-1493	National Science Foundation; National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation [DMR-1332208]; National Institute of General Medical Sciences of the National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Guennadi Kozlov for crystallographic data collection. This work is based upon research conducted at the Cornell High Energy Synchrotron Source, which is supported by the National Science Foundation and the National Institutes of Health/National Institute of General Medical Sciences under National Science Foundation award DMR-1332208, using the Macromolecular Diffraction facility at the Cornell High Energy Synchrotron Source, which is supported by award GM-103485 from the National Institute of General Medical Sciences of the National Institutes of Health. We also thank Dr. Shaun Labiuk for crystallographic data collection performed at Beamline 08ID-1 at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; Cornell RB, 2015, PROG LIPID RES, V59, P147, DOI 10.1016/j.plipres.2015.07.001; Cortes LK, 2014, PROTEOMICS, V14, P2471, DOI 10.1002/pmic.201400148; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gorelik A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12196; Gorelik A, 2016, J BIOL CHEM, V291, P6376, DOI 10.1074/jbc.M115.711085; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Kornhuber J, 2015, BIOL CHEM, V396, P707, DOI 10.1515/hsz-2015-0109; Lim SM, 2016, FEBS J, V283, P1107, DOI 10.1111/febs.13655; Masuishi Y, 2013, J PROTEOME RES, V12, P4617, DOI 10.1021/pr4004807; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noto PB, 2012, MOL PHARMACOL, V82, P719, DOI 10.1124/mol.112.078865; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Picariello G, 2012, J CHROMATOGR A, V1227, P219, DOI 10.1016/j.chroma.2012.01.014; Rindler MJ, 2007, J PROTEOME RES, V6, P2978, DOI 10.1021/pr0607029; Sleat DE, 2007, PROTEOM CLIN APPL, V1, P1134, DOI 10.1002/prca.200700250; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Takahashi Y, 2017, NEPHROLOGY, V22, P49, DOI 10.1111/nep.12737; Tasaki M, 2014, J AM SOC NEPHROL, V25, P737, DOI 10.1681/ASN.2013040363; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thouvenot E, 2008, J PROTEOME RES, V7, P4409, DOI 10.1021/pr8003858; Traini M, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.612341; Wu J, 2005, BIOCHEM J, V386, P153, DOI 10.1042/BJ20041455; Xiong ZJ, 2016, J MOL BIOL, V428, P3026, DOI 10.1016/j.jmb.2016.06.012; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213	33	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24054	24064		10.1074/jbc.M116.755801	http://dx.doi.org/10.1074/jbc.M116.755801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687724	Green Published, hybrid			2022-12-26	WOS:000388498100022
J	Sridharan, R; Connelly, SM; Naider, F; Dumont, ME				Sridharan, Rajashri; Connelly, Sara M.; Naider, Fred; Dumont, Mark E.			Variable Dependence of Signaling Output on Agonist Occupancy of Ste2p, a G Protein-coupled Receptor in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein; G protein-coupled receptor (GPCR); pheromone; receptor; regulator of G protein signaling (RGS); signal transduction; signaling; yeast	ALPHA-FACTOR RECEPTOR; AFFECTING SEXUAL CONJUGATION; DOMINANT-NEGATIVE MUTATIONS; FACTOR PHEROMONE RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SACCHAROMYCES-CEREVISIAE; ADENYLYL-CYCLASE; BETA-2-ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; EXTRACELLULAR ENDS	We report here on the relationship between ligand binding and signaling responses in the yeast pheromone response pathway, a well characterized G protein-coupled receptor system. Responses to agonist (-factor) by cells expressing widely varying numbers of receptors depend primarily on fractional occupancy, not the absolute number of agonist-bound receptors. Furthermore, the concentration of competitive antagonist required to inhibit -factor-dependent signaling is more than 10-fold higher than predicted based on the known ligand affinities. Thus, responses to a particular number of agonist-bound receptors can vary greatly, depending on whether there are unoccupied or antagonist-bound receptors present on the same cell surface. This behavior does not appear to be due to pre-coupling of receptors to G protein or to the Sst2p regulator of G protein signaling. The results are consistent with a signaling response that is determined by the integration of positive signals from agonist-occupied receptors and inhibitory signals from unoccupied receptors, where the inhibitory signals can be diminished by antagonist binding.	[Sridharan, Rajashri; Connelly, Sara M.; Dumont, Mark E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, POB 712, Rochester, NY 14642 USA; [Naider, Fred] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10314 USA; [Naider, Fred] CUNY Coll Staten Isl, Macromol Assembly Inst, Staten Isl, NY 10314 USA; [Naider, Fred] CUNY, Grad Ctr, PhD Programs Biochem & Chem, New York, NY 10016 USA; [Sridharan, Rajashri] Dept Microbiol & Immunol, 115 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA	University of Rochester; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System	Dumont, ME (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, POB 712, Rochester, NY 14642 USA.	mark_dumont@urmc.rochester.edu			National Institutes of Health [R01GM084083, RO1GM059357, R01GM114974, R01GM22087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022087, R01GM059357, R01GM084083, R01GM114974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM084083, RO1GM059357, and R01GM114974 (to M.E.D.) and Grant R01GM22087 (to F.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MG, 1998, BBA-MOL CELL RES, V1448, P12, DOI 10.1016/S0167-4889(98)00109-8; Andrews SS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000705; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Bajaj A, 2007, BBA-MOL CELL RES, V1773, P707, DOI 10.1016/j.bbamcr.2007.02.002; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BOUVIER M, 1988, MOL PHARMACOL, V33, P133; Brent R, 2009, FEBS LETT, V583, P4019, DOI 10.1016/j.febslet.2009.11.029; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Bukusoglu G, 1996, MOL CELL BIOL, V16, P4818; Burchett SA, 2001, J BIOL CHEM, V276, P26472, DOI 10.1074/jbc.M103436200; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Celic Andjelka, 2004, Methods Mol Biol, V237, P105; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claeysen S, 2000, MOL PHARMACOL, V58, P136, DOI 10.1124/mol.58.1.136; Crowe ML, 2000, J RECEPT SIGNAL TR R, V20, P61, DOI 10.3109/10799890009150037; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dosil M, 1998, MOL CELL BIOL, V18, P5981, DOI 10.1128/MCB.18.10.5981; ERIOTOUBARGIOTA E, 1992, BIOCHEMISTRY-US, V31, P551, DOI 10.1021/bi00117a036; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; Gehret AU, 2012, EUKARYOT CELL, V11, P1276, DOI 10.1128/EC.00172-12; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; HARTWELL LH, 1980, J CELL BIOL, V85, P811, DOI 10.1083/jcb.85.3.811; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Kim H, 2009, BIOCHEMISTRY-US, V48, P10976, DOI 10.1021/bi901291c; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Leavitt LM, 1999, MOL GEN GENET, V261, P917, DOI 10.1007/s004380051039; Limbird L. E., 2004, CELL SURFACE RECEPTO, P7; Lin JC, 2003, BIOCHEMISTRY-US, V42, P293, DOI 10.1021/bi026766o; MACKAY V, 1974, GENETICS, V76, P273; MACKAY V, 1974, GENETICS, V76, P255; MARSH L, 1992, MOL CELL BIOL, V12, P3959, DOI 10.1128/MCB.12.9.3959; Marunaka Y, 2005, J MEMBRANE BIOL, V203, P31, DOI 10.1007/s00232-004-0729-0; Mathew E, 2011, J MOL BIOL, V409, P513, DOI 10.1016/j.jmb.2011.03.059; Medici R, 1997, EMBO J, V16, P7241, DOI 10.1093/emboj/16.24.7241; MELLER E, 1990, MOL PHARMACOL, V37, P231; NEUBIG RR, 1988, BIOCHEMISTRY-US, V27, P2374, DOI 10.1021/bi00407a019; NICKERSON M, 1956, NATURE, V178, P697, DOI 10.1038/178697b0; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Pincus D, 2010, YEAST, V27, P423, DOI 10.1002/yea.1758; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Redka DS, 2013, BIOCHEMISTRY-US, V52, P7405, DOI 10.1021/bi4003869; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; SCHILD HO, 1957, PHARMACOL REV, V9, P242; Shah A, 1996, BIOCHEM BIOPH RES CO, V226, P242, DOI 10.1006/bbrc.1996.1340; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; SIKORSKI RS, 1989, GENETICS, V122, P19; Sommers CM, 2000, BIOCHEMISTRY-US, V39, P6898, DOI 10.1021/bi992616a; SPRAGUE GF, 1981, NATURE, V289, P250, DOI 10.1038/289250a0; STEFAN CJ, 1994, MOL CELL BIOL, V14, P3339, DOI 10.1128/MCB.14.5.3339; Stefan CJ, 1998, MOL BIOL CELL, V9, P885, DOI 10.1091/mbc.9.4.885; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; TOLKOVSKY AM, 1981, J CYCLIC NUCL PROT, V7, P139; VARRAULT A, 1992, MOL PHARMACOL, V41, P999; VOGEL WK, 1995, J BIOL CHEM, V270, P15485, DOI 10.1074/jbc.270.26.15485; Whaley B. S., 1995, PHARM COMMUN, V6, P203; WHALEY BS, 1994, MOL PHARMACOL, V45, P481; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WREGGETT KA, 1984, MOL PHARMACOL, V26, P214; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873; Yi TM, 2003, P NATL ACAD SCI USA, V100, P10764, DOI 10.1073/pnas.1834247100; Yildirim N, 2004, METHOD ENZYMOL, V389, P383; Yin DZ, 2005, BIOCHEM BIOPH RES CO, V329, P281, DOI 10.1016/j.bbrc.2005.01.130; Yu RC, 2008, IET SYST BIOL, V2, P222, DOI 10.1049/iet-syb:20080127; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; ZHU BT, 1993, J PHARMACOL TOXICOL, V29, P85, DOI 10.1016/1056-8719(93)90055-J; Zolk O, 1998, BIOCHEM BIOPH RES CO, V248, P801, DOI 10.1006/bbrc.1998.9030	90	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24261	24279		10.1074/jbc.M116.733006	http://dx.doi.org/10.1074/jbc.M116.733006			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27646004	hybrid, Green Published			2022-12-26	WOS:000388498100038
J	Aicart-Ramos, C; He, SDQ; Land, M; Rubin, CS				Aicart-Ramos, Clara; He, Sophia Dan Qing; Land, Marianne; Rubin, Charles S.			A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY xref ref-type="fn" rid="FN1"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); innate immunity; protein kinase D (PKD); secretion; signal transduction; heterodimer; homodimer; native Mr; oligomerization domain	TRANS-GOLGI NETWORK; CAENORHABDITIS-ELEGANS; IN-VIVO; PANCREATIC ADENOCARCINOMA; MEMBRANE FISSION; GEL-FILTRATION; D ENZYMES; T-CELLS; EXPRESSION; ACTIVATION	Protein kinase D (PKD) isoforms are protein kinase C effectors in signaling pathways regulated by diacylglycerol. Important physiological processes (including secretion, immune responses, motility, and transcription) are placed under diacylglycerol control by the distinctive substrate specificity and subcellular distribution of PKDs. Potentially, broadly co-expressed PKD polypeptides may interact to generate homo- or heteromultimeric regulatory complexes. However, the frequency, molecular basis, regulatory significance, and physiological relevance of stable PKD-PKD interactions are largely unknown. Here, we demonstrate that mammalian PKDs 1-3 and the prototypical Caenorhabditis elegans PKD, DKF-2A, are exclusively (homo- or hetero-) dimers in cell extracts and intact cells. We discovered and characterized a novel, highly conserved N-terminal domain, comprising 92 amino acids, which mediates dimerization of PKD1, PKD2, and PKD3 monomers. A similar domain directs DKF-2A homodimerization. Dimerization occurred independently of properties of the regulatory and kinase domains of PKDs. Disruption of PKD dimerization abrogates secretion of PAUF, a protein carried in small trans-Golgi network-derived vesicles. In addition, disruption of DKF-2A homodimerization in C. elegans intestine impaired and degraded the immune defense of the intact animal against an ingested bacterial pathogen. Finally, dimerization was indispensable for the strong, dominant negative effect of catalytically inactive PKDs. Overall, the structural integrity and function of the novel dimerization domain are essential for PKD-mediated regulation of a key aspect of cell physiology, secretion, and innate immunity in vivo.	[Aicart-Ramos, Clara; He, Sophia Dan Qing; Land, Marianne; Rubin, Charles S.] Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Rubin, CS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Atran Labs, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	charles.rubin@einstein.yu.edu	Aicart-Ramos, Clara/C-7301-2016	Aicart-Ramos, Clara/0000-0002-1114-4259	NIGMS, National Institutes of Health [GM080615]; Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080615] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS, National Institutes of Health Grant GM080615 (to C. S. R.) and a Fellowship from the Alfonso Martin Escudero Foundation (to C. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borges S, 2015, MOL CANCER THER, V14, P1306, DOI 10.1158/1535-7163.MCT-14-0945; Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Doppler H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098090; Durand N, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020020; Durand N, 2015, CELL MOL LIFE SCI, V72, P4369, DOI 10.1007/s00018-015-2011-2; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Ellwanger K, 2013, IUBMB LIFE, V65, P98, DOI 10.1002/iub.1116; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Feng H, 2007, J BIOL CHEM, V282, P31273, DOI 10.1074/jbc.M701532200; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Fu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000224; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Kim SJ, 2013, ONCOGENE, V32, P3638, DOI 10.1038/onc.2012.366; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; LAND M, 1994, J BIOL CHEM, V269, P9234; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liou GY, 2015, EXPERT REV GASTROENT, V9, P1143, DOI 10.1586/17474124.2015.1069706; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Navarro MN, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005477; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Park HD, 2011, ONCOGENE, V30, P201, DOI 10.1038/onc.2010.401; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003; Tandon M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075601, 10.1371/journal.pone.0081521]; von Wicher G, 2008, CELL SIGNAL, V20, P925, DOI 10.1016/j.cellsig.2008.01.003; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Wille Christoph, 2014, Bioarchitecture, V4, P111, DOI 10.4161/bioa.29273; Wu SL, 1998, J BIOL CHEM, V273, P1130, DOI 10.1074/jbc.273.2.1130; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zou ZP, 2012, J CELL SCI, V125, P4800, DOI 10.1242/jcs.106542	55	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23516	23531		10.1074/jbc.M116.735399	http://dx.doi.org/10.1074/jbc.M116.735399			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662904	Green Published, hybrid			2022-12-26	WOS:000387884400014
J	Moafian, Z; Khoshaman, K; Oryan, A; Kurganov, BI; Yousefi, R				Moafian, Zeinab; Khoshaman, Kazem; Oryan, Ahmad; Kurganov, Boris I.; Yousefi, Reza			Protective Effects of Acetylation on the Pathological Reactions of the Lens Crystallins with Homocysteine Thiolactone	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; HUMAN-SERUM ALBUMIN; CHAPERONE ACTIVITY; BETA-CRYSTALLIN; N-HOMOCYSTEINYLATION; STRUCTURAL-CHANGES; ASPIRIN PREVENTS; IN-VITRO; PROTEINS; AGGREGATION	Various post-translational lens crystallins modifications result in structural and functional insults, contributing to the development of lens opacity and cataract disorders. Lens crystallins are potential targets of homocysteinylation, particularly under hyperhomocysteinemia which has been indicated in various eye diseases. Since both homocysteinylation and acetylation primarily occur on protein free amino groups, we applied different spectroscopic methods and gel mobility shift analysis to examine the possible preventive role of acetylation against homocysteinylation. Lens crystallins were extensively acetylated in the presence of acetic anhydride and then subjected to homocysteinylation in the presence of homocysteine thiolactone (HCTL). Extensive acetylation of the lens crystallins results in partial structural alteration and enhancement of their stability, as well as improvement of alpha-crystallin chaperone-like activity. In addition, acetylation partially prevents HCTL-induced structural alteration and aggregation of lens crystallins. Also, acetylation protects against HCTL-induced loss of alpha-crystallin chaperone activity. Additionally, subsequent acetylation and homocysteinylation cause significant proteolytic degradation of crystallins. Therefore, further experimentation is required in order to judge effectively the preventative role of acetylation on the structural and functional insults induced by homocysteinylation of lens crystallins.	[Moafian, Zeinab; Khoshaman, Kazem; Yousefi, Reza] Shiraz Univ, Coll Sci, Dept Biol, Prot Chem Lab, Shiraz, Iran; [Oryan, Ahmad] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran; [Kurganov, Boris I.] Russian Acad Sci, Biotechnol Res Ctr, Bach Inst Biochem, Leninsky Pr 33, Moscow 119071, Russia	Shiraz University; Shiraz University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Yousefi, R (corresponding author), Shiraz Univ, Coll Sci, Dept Biol, Prot Chem Lab, Shiraz, Iran.	ryousefi@shirazu.ac.ir	Kurganov, Boris/M-1286-2019; Yousefi, Reza/S-8243-2017; Oryan, Ahmad/J-6539-2014	Yousefi, Reza/0000-0001-7396-7720; Oryan, Ahmad/0000-0003-1697-2376	Iran National Science Foundation (INSF) [92001695]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This study was financially supported by Iran National Science Foundation (INSF, www.insf.org) (grant no. 92001695), and RY received this funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Ajith TA, 2015, CLIN CHIM ACTA, V450, P316, DOI 10.1016/j.cca.2015.09.007; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Booth AA, 1997, J BIOL CHEM, V272, P5430, DOI 10.1074/jbc.272.9.5430; Callis PR, 2003, CHEM PHYS LETT, V369, P409, DOI 10.1016/S0009-2614(02)02046-8; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; CROMPTON M, 1985, EXP EYE RES, V40, P297, DOI 10.1016/0014-4835(85)90014-4; DAVID LL, 1994, INVEST OPHTH VIS SCI, V35, P785; DiMauro MA, 2014, BIOCHEMISTRY-US, V53, P7269, DOI 10.1021/bi501004y; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Fayle SE, 2001, ELECTROPHORESIS, V22, P1518, DOI 10.1002/1522-2683(200105)22:8&lt;1518::AID-ELPS1518&gt;3.0.CO;2-U; Finamore F, 2014, EUPA OPEN PROTEOMICS, V3, P100, DOI DOI 10.1016/J.EUPR0T.2014.02.001; HARRINGTON CR, 1994, NATURE, V370, P247, DOI 10.1038/370247a0; HAWKINS D, 1969, J CLIN INVEST, V48, P536, DOI 10.1172/JCI106011; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Khalili-Hezarjaribi H, 2012, PROTEIN PEPTIDE LETT, V19, P450, DOI 10.2174/092986612799789396; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; Khoshaman K, 2015, FREE RADICAL BIO MED, V89, P819, DOI 10.1016/j.freeradbiomed.2015.09.013; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Lin PPP, 1998, PROTEIN SCI, V7, P1451, DOI 10.1002/pro.5560070622; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; Nahomi RB, 2013, BIOCHEMISTRY-US, V52, P8126, DOI 10.1021/bi400638s; Nahomi RB, 2013, BBA-MOL BASIS DIS, V1832, P195, DOI 10.1016/j.bbadis.2012.08.015; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perna AF, 2006, KIDNEY INT, V69, P869, DOI 10.1038/sj.ki.5000070; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Ponce A, 2006, MOL VIS, V12, P879; RAO GN, 1988, BIOCHEM BIOPH RES CO, V151, P991, DOI 10.1016/S0006-291X(88)80463-7; Schaefer H, 2003, ANAL BIOANAL CHEM, V376, P966, DOI 10.1007/s00216-003-1983-1; Schmid FX, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0003142, DOI 10.1038/NPG.ELS.0003142]; Sharma GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116386; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Yan H, 2003, EYE, V17, P637, DOI 10.1038/sj.eye.6700419; Yousefi R, 2013, PROTEIN PEPTIDE LETT, V20, P932, DOI 10.2174/0929866511320080011; YVON M, 1988, FEBS LETT, V239, P237, DOI 10.1016/0014-5793(88)80924-4; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou C, 2015, ANAL BIOCHEM, V472, P7, DOI 10.1016/j.ab.2014.11.016	61	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164139	10.1371/journal.pone.0164139	http://dx.doi.org/10.1371/journal.pone.0164139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706231	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200090
J	Nakase, T; Tobisawa, M; Sasaki, M; Suzuki, A				Nakase, Taizen; Tobisawa, Maiko; Sasaki, Masahiro; Suzuki, Akifumi			Outstanding Symptoms of Poststroke Depression during the Acute Phase of Stroke	PLOS ONE			English	Article							REPORT QIDS-SR; LESION LOCATION; SELF-REPORT; PSYCHOMETRIC EVALUATION; QUICK INVENTORY; FOLLOW-UP; SYMPTOMATOLOGY; MOOD	Poststroke depression (PSD) is a critical complication which might lead to unfavorable outcomes. However, most cases of PSD in the acute phase, during the 2 or 3 weeks following a stroke, are neglected because of the variable comorbid conditions. In this study, aimed at revealing the outstanding symptoms of PSD during the acute phase, consecutive patients with intracranial hemorrhage (ICH) or brain infarction (BI) were asked to fill out a depression questionnaire (Quick Inventory of Depressive Symptomatology Self-Report: QIDS-SR) at 1 week and 1 month following stroke onset. Patients with disturbed consciousness or aphasia were excluded from this study. Forty-nine ICH patients and 222 BI patients completed the QIDS-SR at 1 week and 27 of ICH and 62 of BI at 1 month. The PSD rate was 67% and 46% at 1 week in ICH and BI, respectively. Although sleep disturbance was the most frequent symptom of PSD, psychomotor agitation and appetite disturbance were the most distinguishing symptoms in ICH at 1 week and fatigue at 1 month. On the other hand, most of the depressive symptoms addressed in QIDS-SR were observed in PSD of BI patients both at 1 week and 1 month. In conclusion, while sleep disturbance was a frequent but non-specific symptom, appetite disturbance and fatigue might be critical symptoms to suggest PSD during the acute phase of stroke.	[Nakase, Taizen; Tobisawa, Maiko; Sasaki, Masahiro; Suzuki, Akifumi] Res Inst Brain & Blood Vessels, Dept Stroke Sci, Akita, Japan		Nakase, T (corresponding author), Res Inst Brain & Blood Vessels, Dept Stroke Sci, Akita, Japan.	nakase@akita-noken.jp	Nakase, Taizen/AAP-5288-2020	Nakase, Taizen/0000-0002-1796-5859				Benaim C, 2004, STROKE, V35, P1692, DOI 10.1161/01.STR.0000130591.95710.20; Berg A, 2003, STROKE, V34, P138, DOI 10.1161/01.STR.0000048149.84268.07; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; Capaldi VF, 2010, PSYCHOL RES BEHAV MA, V3, P109, DOI 10.2147/PRBM.S10035; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; de Coster L, 2005, INT J GERIATR PSYCH, V20, P358, DOI 10.1002/gps.1290; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; HERRMANN M, 1993, J NEUROL NEUROSUR PS, V56, P672, DOI 10.1136/jnnp.56.6.672; Jiang XG, 2014, EUR REV MED PHARMACO, V18, P1315; *JOINT COMM GUID M, 2009, JAP GUID MAN STROK 2; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; Kouwenhoven SE, 2011, DISABIL REHABIL, V33, P539, DOI 10.3109/09638288.2010.505997; Laska AC, 2007, CEREBROVASC DIS, V24, P74, DOI 10.1159/000103119; Lokk J, 2010, NEUROPSYCH DIS TREAT, V6, P539, DOI 10.2147/NDT.S7637; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P153; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; Narushima K, 2003, J NERV MENT DIS, V191, P645, DOI 10.1097/01.nmd.0000092197.97693.d2; Nishiyama Y, 2010, J STROKE CEREBROVASC, V19, P184, DOI 10.1016/j.jstrokecerebrovasdis.2009.04.002; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Rush AJ, 2006, PSYCHIAT SERV, V57, P829, DOI 10.1176/appi.ps.57.6.829; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; SCHWARTZ JA, 1993, BIOL PSYCHIAT, V33, P694, DOI 10.1016/0006-3223(93)90118-W; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Skaner Y, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-61; Sneed JR, 2006, BIOL PSYCHIAT, V60, P1295, DOI 10.1016/j.biopsych.2006.06.018; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163038	10.1371/journal.pone.0163038	http://dx.doi.org/10.1371/journal.pone.0163038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706193	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200031
J	Liu, YK; Yao, YY; Li, H; Qiao, F; Wu, JL; Du, ZY; Zhang, M				Liu, Yukun; Yao, Yayun; Li, Huan; Qiao, Fang; Wu, Junlin; Du, Zhen-yu; Zhang, Meiling			Influence of Endogenous and Exogenous Estrogenic Endocrine on Intestinal Microbiota in Zebrafish	PLOS ONE			English	Article							SEX-DIFFERENCES; GUT MICROBIOME; EXPOSURE; BACTERIA; BEHAVIOR; GENES	Gender is one of the factors influencing the intestinal microbial composition in mammals, but whether fish also have gender-specific intestinal microbial patterns remains unknown. In this decade, endocrine disrupting chemicals in surface and ground water of many areas and increasing observation of freshwater male fish displaying female sexual characteristics have been reported. Here we identified the difference in intestinal microbiota between male and female zebrafish, and revealed the influence of endocrine disrupting chemicals on zebrafish intestinal microbiota by using high-throughput sequencing. The results indicated that Fusobacteria, Bacteroidetes and Proteobacteria were dominant in the gut of zebrafish and there were no obvious gender-specific intestinal microbial patterns. Two endocrine disrupting chemicals, Estradiol (E2) and Bisphenol A (BPA), were selected to treat male zebrafish for 5 weeks. E2 and BPA increased vitellogenin expression in the liver of male zebrafish and altered the intestinal microbial composition with the abundance of the phylum CKC4 increased significantly. Our results suggested that because of the developmental character and living environment, gender did not influence the assembly of intestinal microbiota in zebrafish as it does in mammals, but exposure extra to endocrine disrupting chemicals disturbed the intestinal microbial composition, which may be related to changes in host physiological metabolism.	[Liu, Yukun; Yao, Yayun; Qiao, Fang; Wu, Junlin; Du, Zhen-yu; Zhang, Meiling] East China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China; [Li, Huan] Next Biosci Co Ltd, Wuhan 430073, Peoples R China	East China Normal University	Du, ZY; Zhang, M (corresponding author), East China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China.	zydu@bio.ecnu.edu.cn; mlzhang@bio.ecnu.edu.cn	Zhang, Meiling/AEQ-4299-2022	Du, Zhen-Yu/0000-0001-6581-5313				ADLERCREUTZ H, 1984, J STEROID BIOCHEM, V20, P217, DOI 10.1016/0022-4731(84)90208-5; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Apprill A, 2011, ENV MICROBIOL REP, V3, P223, DOI 10.1111/j.1758-2229.2010.00213.x; Arentsen Tim, 2015, Microbial Ecology in Health and Disease, V26, P29719, DOI 10.3402/mehd.v26.29719; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Bjerregaard LB, 2008, ECOTOXICOLOGY, V17, P252, DOI 10.1007/s10646-008-0192-2; Boursi B, 2015, EUR J CANCER, V51, P2655, DOI 10.1016/j.ejca.2015.08.015; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cong XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152751; Dkhil MA, 2015, PARASITOL RES; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engen PA, 2015, ALCOHOL RES-CURR REV, V37, P223; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flak MB, 2013, SCIENCE, V339, P1044, DOI 10.1126/science.1236226; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Gomez A, 2015, CLIN IMMUNOL, V159, P154, DOI 10.1016/j.clim.2015.04.016; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Hevia A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01285; Inagaki T, 2016, NEUROTOXICOLOGY, V52, P188, DOI 10.1016/j.neuro.2015.12.003; Leifheit-Limson EC, 2015, J AM COLL CARDIOL, V66, P1949, DOI 10.1016/j.jacc.2015.08.859; Luzio A, 2015, AQUAT TOXICOL, V166, P83, DOI 10.1016/j.aquatox.2015.07.015; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Miller PG, 2015, J IMMUNOL, V195, P4668, DOI 10.4049/jimmunol.1501664; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shastri P, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0031-0; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh P, 2016, ANN EPIDEMIOL, V26, P380, DOI 10.1016/j.annepidem.2016.03.007; Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Valencia A, 2017, GEN COMP ENDOCR, V245, P10, DOI 10.1016/j.ygcen.2016.06.017; Whary MT, 2014, MICROBES INFECT, V16, P345, DOI 10.1016/j.micinf.2014.01.005; Witorsch RJ, 2002, REGUL TOXICOL PHARM, V36, P118, DOI 10.1006/rtph.2002.1564; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562	44	43	45	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163895	10.1371/journal.pone.0163895	http://dx.doi.org/10.1371/journal.pone.0163895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701432	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900028
J	Pujari-Palmer, M; Pujari-Palmer, S; Lu, X; Lind, T; Melhus, H; Engstrand, T; Karlsson-Ott, M; Engqvist, H				Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Lu, Xi; Lind, Thomas; Melhus, Hakan; Engstrand, Thomas; Karlsson-Ott, Marjam; Engqvist, Hakan			Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; DIHYDRATE CRYSTALS; INORGANIC PYROPHOSPHATE; VASCULAR CALCIFICATION; ASCORBIC-ACID; IN-VITRO; CELLS; BONE; MINERALIZATION; FIBROBLASTS	Pyrophosphate is a potent mitogen, capable of stimulating proliferation in multiple cell types, and a critical participant in bone mineralization. Pyrophosphate can also affect the resorption rate and bioactivity of orthopedic ceramics. The present study investigated whether calcium pyrophosphate affected proliferation, differentiation and gene expression in early (MC3T3 pre-osteoblast) and late stage (SAOS-2 osteosarcoma) osteoblasts. Pyrophosphate stimulated peak alkaline phosphatase activity by 50% and 150% at 100 mu M and 0.1 mu M in MC3T3, and by 40% in SAOS-2. The expression of differentiation markers collagen 1 (COL1), alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN) were increased by an average of 1.5, 2, 2 and 3 fold, by high concentrations of sodium pyrophosphate (100 mu M) after 7 days of exposure in MC3T3. COX-2 and ANK expression did not differ significantly from controls in either treatment group. Though both high and low concentrations of pyrophosphate stimulate ALP activity, only high concentrations (100 mu M) stimulated osteogenic gene expression. Pyrophosphate did not affect proliferation in either cell type. The results of this study confirm that chronic exposure to pyrophosphate exerts a physiological effect upon osteoblast differentiation and ALP activity, specifically by stimulating osteoblast differentiation markers and extracellular matrix gene expression.	[Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Lu, Xi; Karlsson-Ott, Marjam; Engqvist, Hakan] Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Uppsala, Sweden; [Lind, Thomas; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Engstrand, Thomas] Karolinska Univ Hosp, Stockholm Craniofacial Ctr, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Engstrand, Thomas] Uppsala Univ, Polymer sect, Dept Chem Mat, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Karlsson-Ott, M (corresponding author), Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Uppsala, Sweden.	marjam.ott@angstrorm.uu.se	Pujari-Palmer, michael/W-4362-2018	Pujari-Palmer, michael/0000-0001-7004-2853; Lind, Thomas/0000-0003-2791-688X				Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; ANDERSON HC, 1973, DEV BIOL, V34, P211, DOI 10.1016/0012-1606(73)90351-5; Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; BENNETT RM, 1975, J CLIN INVEST, V56, P1571, DOI 10.1172/JCI108239; Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123; Bouchard L, 2002, J IMMUNOL, V168, P5310, DOI 10.4049/jimmunol.168.10.5310; Carr G, 2009, CELL PHYSIOL BIOCHEM, V24, P595, DOI 10.1159/000257515; Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043; CHEUNG HS, 1984, ARTHRITIS RHEUM-US, V27, P668, DOI 10.1002/art.1780270610; Engstrand T, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000467; Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360; EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Gras P, 2013, EUR J INORG CHEM, P5886, DOI 10.1002/ejic.201300955; Grover LM, 2013, BIOMATERIALS, V34, P6631, DOI 10.1016/j.biomaterials.2013.05.001; HARADA S, 1991, J BONE MINER RES, V6, P903; Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Kapustin AN, 2011, ARTERIOSCL THROM VAS, V31, P2169, DOI 10.1161/ATVBAHA.111.233601; Kim HJ, 2010, J BONE MINER RES, V25, P1771, DOI 10.1002/jbmr.60; Kim MK, 2004, J ORG CHEM, V69, P8186, DOI 10.1021/jo049101w; Leeuwen MV K., 2012, RSC ADV, V2, P2534, DOI [10.1039/c2ra00449f, DOI 10.1039/C2RA00449F]; Li JQ, 2016, J BONE MINER METAB, V34, P367, DOI 10.1007/s00774-015-0734-7; LIN FH, 1995, BIOMATERIALS, V16, P793, DOI 10.1016/0142-9612(95)99642-Y; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2014, KIDNEY INT, V85, P1351, DOI 10.1038/ki.2013.521; Molloy ES, 2008, RHEUMATOLOGY, V47, P965, DOI 10.1093/rheumatology/ken144; Okada S, 2013, TOHOKU J EXP MED, V231, P145, DOI 10.1620/tjem.231.145; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Reuben PM, 2004, J BIOL CHEM, V279, P35719, DOI 10.1074/jbc.M403406200; RUBIN AH, 1979, J CELL PHYSIOL, V98, P81, DOI 10.1002/jcp.1040980110; RUBIN H, 1977, P NATL ACAD SCI USA, V74, P5026, DOI 10.1073/pnas.74.11.5026; Safronova TV, 2013, PROCESS APPL CERAM, V7, P9, DOI 10.2298/PAC1301009S; SAUER GR, 1988, J BIOL CHEM, V263, P13718; Shinozaki T, 1996, J RHEUMATOL, V23, P677; Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2; Sun YB, 2003, BIOCHEM BIOPH RES CO, V312, P1053, DOI 10.1016/j.bbrc.2003.11.048; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Thouverey C, 2009, OSTEOARTHR CARTILAGE, V17, P64, DOI 10.1016/j.joca.2008.05.020; Whited BM, 2006, J BIOMED MATER RES A, V76A, P596, DOI 10.1002/jbm.a.30573; Whited BM, 2011, BIOMATERIALS, V32, P2294, DOI 10.1016/j.biomaterials.2010.12.003; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; XU Y, 1991, J RHEUMATOL, V18, P1606; Zhou XY, 2012, INT J BIOL SCI, V8, P778, DOI 10.7150/ijbs.4538; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	50	35	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163530	10.1371/journal.pone.0163530	http://dx.doi.org/10.1371/journal.pone.0163530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701417	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900011
J	Tellez, GF; Willemse, BWM; Brouwer, U; Nijboer-Brinksma, S; Vandepoele, K; Noordhoek, JA; Heijink, I; de Vries, M; Smithers, NP; Postma, DS; Timens, W; Wiffen, L; van Roy, F; Holloway, JW; Leckie, PM; Nawijn, MC; Koppelman, GH				Tellez, Grissel Faura; Willemse, Brigitte W. M.; Brouwer, Uilke; Nijboer-Brinksma, Susan; Vandepoele, Karl; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Smithers, Natalie P.; Postma, Dirkje S.; Timens, Wim; Wiffen, Laura; van Roy, Frans; Holloway, John W.; Leckie, Peter M.; Nawijn, Martijn C.; Koppelman, Gerard H.			Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma	PLOS ONE			English	Article							BARRIER FUNCTION; ECZEMA; CADHERIN; FAMILY; GENE; DIFFERENTIATION; POLYMORPHISMS; POPULATION; EXPRESSION; CHILDHOOD	Background The asthma gene PCDH1 encodes Protocadherin-1, a putative adhesion molecule of unknown function expressed in the airway epithelium. Here, we characterize the localization, differential expression, homotypic adhesion specificity and function of PCDH1 in airway epithelial cells in asthma. Methods We performed confocal fluorescence microscopy to determine subcellular localization of PCDH1 in 16HBE cells and primary bronchial epithelial cells (PBECs) grown at air-liquid interface. Next, to compare PCDH1 expression and localization in asthma and controls we performed qRT-PCR and fluorescence microscopy in PBECs and immunohistochemistry on airway wall biopsies. We examined homotypic adhesion specificity of HEK293T clones overexpressing fluorescently tagged-PCDH1 isoforms. Finally, to evaluate the role for PCDH1 in epithelial barrier formation and repair, we performed siRNA knockdown-studies and measured epithelial resistance. Results PCDH1 localized to the cell membrane at cell-cell contact sites, baso-lateral to adherens junctions, with increasing expression during epithelial differentiation. No differences in gene expression or localization of PCDH1 isoforms expressing the extracellular domain were observed in either PBECs or airway wall biopsies between asthma patients and controls. Overexpression of PCDH1 mediated homotypic interaction, whereas downregulation of PCDH1 reduced epithelial barrier formation, and impaired repair after wounding. Conclusions In conclusion, PCDH1 is localized to the cell membrane of bronchial epithelial cells basolateral to the adherens junction. Expression of PCDH1 is not reduced nor delocalized in asthma even though PCDH1 contributes to homotypic adhesion, epithelial barrier formation and repair.	[Tellez, Grissel Faura; Willemse, Brigitte W. M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Groningen, Netherlands; [Tellez, Grissel Faura; Brouwer, Uilke; Nijboer-Brinksma, Susan; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Expt Pulmonol & Inflammat Res, Groningen, Netherlands; [Tellez, Grissel Faura; Willemse, Brigitte W. M.; Brouwer, Uilke; Nijboer-Brinksma, Susan; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Postma, Dirkje S.; Timens, Wim; Nawijn, Martijn C.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Vandepoele, Karl; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Vandepoele, Karl; van Roy, Frans] VIB, Inflammat Res Ctr, Ghent, Belgium; [Vandepoele, Karl] Ghent Univ Hosp, Lab Mol Diagnost Hematol, Ghent, Belgium; [Tellez, Grissel Faura; Wiffen, Laura; Holloway, John W.; Leckie, Peter M.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Wiffen, Laura; Holloway, John W.] Univ Southampton, Fac Med, Human Genet & Genom Med, Human Dev & Hlth, Southampton, Hants, England; [de Vries, Maaike; Smithers, Natalie P.] Univ Southampton, Fac Med, Southampton Univ Hosp, Brooke Lab,Acad Unit Clin & Expt Sci, Southampton, Hants, England; [Noordhoek, Jacobien A.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University Hospital; University of Southampton; University of Southampton; University of Southampton; University of Groningen; University of Groningen	Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Groningen, Netherlands.; Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.	g.h.koppelman@umcg.nl	van Roy, Frans M/C-6123-2009; Koppelman, Gerard/AAG-9187-2020; Timens, Wim/K-5570-2013; Vandepoele, Karl/C-1197-2009; Holloway, John W/B-5424-2009	van Roy, Frans M/0000-0003-4358-1039; Timens, Wim/0000-0002-4146-6363; Vandepoele, Karl/0000-0002-0025-5594; Holloway, John W/0000-0001-9998-0464; Wiffen, Laura/0000-0003-3688-7662; Koppelman, Gerard/0000-0001-8567-3252; Nawijn, Martijn/0000-0003-3372-6521; Holloway, Courtney Jean/0000-0003-3661-1957; de Vries, Maaike/0000-0001-7210-8174	Asthma UK [11/010] Funding Source: researchfish	Asthma UK		Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Heijink IH, 2014, CLIN EXP ALLERGY, V44, P620, DOI 10.1111/cea.12296; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Knight DA, 2011, J ALLERGY CLIN IMMUN, V128, P557, DOI 10.1016/j.jaci.2011.07.031; Koning H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098197; Koning H, 2012, PEDIAT ALLERG IMM-UK, V23, P270, DOI 10.1111/j.1399-3038.2011.01201.x; Koning H, 2012, FASEB J, V26, P439, DOI 10.1096/fj.11-185207; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Kozu Y, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0078-z; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Mortensen LJ, 2014, EUR RESPIR J, V43, P792, DOI 10.1183/09031936.00021613; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Roth HM, 2012, PULM PHARMACOL THER, V25, P420, DOI 10.1016/j.pupt.2012.09.004; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tellez GF, 2015, AM J PHYSIOL-LUNG C, V309, pL725, DOI 10.1152/ajplung.00346.2014; Tellez GF, 2014, EUR RESPIR J, V43, P671, DOI 10.1183/09031936.00179713; Toncheva AA, 2012, PEDIAT ALLERG IMM-UK, V23, P636, DOI 10.1111/j.1399-3038.2012.01334.x; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	31	13	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163967	10.1371/journal.pone.0163967	http://dx.doi.org/10.1371/journal.pone.0163967			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701444	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000385696900038
J	Thompson, RB; Pagano, JJ; Mathewson, KW; Paterson, I; Dyck, JR; Kitzman, DW; Haykowsky, MJ				Thompson, Richard B.; Pagano, Joseph J.; Mathewson, Kory W.; Paterson, Ian; Dyck, Jason R.; Kitzman, Dalane W.; Haykowsky, Mark J.			Differential Responses of Post-Exercise Recovery of Leg Blood Flow and Oxygen Uptake Kinetics in HFpEF versus HFrEF	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; SUBMAXIMAL EXERCISE; MAXIMAL EXERCISE; CARDIAC-OUTPUT; OFF-TRANSIENT; ON-TRANSIENT; CAPACITY; REPRODUCIBILITY; SPECTROSCOPY	The goals of the current study were to compare leg blood flow, oxygen extraction and oxygen uptake (VO2) after constant load sub-maximal unilateral knee extension (ULKE) exercise in patients with heart failure with reduced ejection fraction (HFrEF) compared to those with preserved ejection fraction (HFpEF). Previously, it has been shown that prolonged whole body VO2 recovery kinetics are directly related to disease severity and all-cause mortality in HFrEF patients. To date, no study has simultaneously measured muscle-specific blood flow and oxygen extraction post exercise recovery kinetics in HFrEF or HFpEF patients; therefore it is unknown if muscle VO2 recovery kinetics, and more specifically, the recovery kinetics of blood flow and oxygen extraction at the level of the muscle, differ between HF phenotypes. Ten older (68 +/- 10yrs) HFrEF (n = 5) and HFpEF (n = 5) patients performed sub-maximal (85% of maximal weight lifted during an incremental test) ULKE exercise for 4 minutes. Femoral venous blood flow and venous O-2 saturation were measured continuously from the onset of end-exercise, using a novel MRI method, to determine off-kinetics (mean response times, MRT) for leg VO2 and its determinants. HFpEF and HFrEF patients had similar end-exercise leg blood flow (1.1 +/- 0.6 vs. 1.2 +/- 0.6 L/min, p>0.05), venous saturation (42 +/- 12 vs. 41 +/- 11%, p>0.05) and VO2 (0.13 +/- 0.08 vs. 0.11 +/- 0.05 L/min, p>0.05); however HFrEF had significantly delayed recovery MRT for flow (292 +/- 135sec. vs 105 +/- 63sec., p = 0.004) and VO2 (95 +/- 37sec. vs. 47 +/- 15sec., p = 0.005) compared to HFpEF. Impaired muscle VO2 recovery kinetics following ULKE exercise differentiated HFrEF from HFpEF patients and suggests distinct underlying pathology and potential therapeutic approaches in these populations.	[Thompson, Richard B.; Pagano, Joseph J.; Mathewson, Kory W.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Paterson, Ian] Univ Alberta, Mazankowski Alberta Heart Inst, Div Cardiol, Edmonton, AB, Canada; [Dyck, Jason R.] Univ Alberta, Dept Pediat & Pharmacol, Edmonton, AB, Canada; [Kitzman, Dalane W.] Wake Forest Sch Med, Cardiol & Geriatr, Winston Salem, NC USA; [Haykowsky, Mark J.] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA	University of Alberta; University of Alberta; University of Alberta; Wake Forest University; University of Texas System; University of Texas Arlington	Thompson, RB (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	richard.thompson@ualberta.ca		Paterson, David Ian/0000-0003-4529-3102; Dyck, Jason/0000-0002-7045-2884; Thompson, Richard/0000-0003-3319-4377; Haykowsky, Mark/0000-0002-7217-2747	NATIONAL INSTITUTE ON AGING [R37AG018915] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG018915] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Belardinelli R, 1997, AM J CARDIOL, V80, P1319, DOI 10.1016/S0002-9149(97)00672-3; Bhella PS, 2011, EUR J HEART FAIL, V13, P1296, DOI 10.1093/eurjhf/hfr133; COHENSOLAL A, 1995, CIRCULATION, V91, P2924, DOI 10.1161/01.CIR.91.12.2924; deGroote P, 1996, J AM COLL CARDIOL, V28, P168, DOI 10.1016/0735-1097(96)00126-X; Esposito F, 2010, J AM COLL CARDIOL, V55, P1945, DOI 10.1016/j.jacc.2009.11.086; Ezekowitz JA, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-91; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Fortin M, 2015, CAN J CARDIOL, V31, P1259, DOI 10.1016/j.cjca.2015.02.015; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Hanada A, 2000, HEART, V83, P161, DOI 10.1136/heart.83.2.161; Haykowsky MJ, 2015, J APPL PHYSIOL, V119, P739, DOI 10.1152/japplphysiol.00049.2015; Haykowsky MJ, 2013, AM J CARDIOL, V111, P1466, DOI 10.1016/j.amjcard.2013.01.303; Kemps HM, 2010, INT J CARDIOL, V142, P138, DOI 10.1016/j.ijcard.2008.12.088; Kemps HMC, 2007, EUR J APPL PHYSIOL, V100, P45, DOI 10.1007/s00421-007-0398-7; Kemps HMC, 2010, CLIN SCI, V118, P203, DOI 10.1042/CS20090220; Kilding AE, 2005, EUR J APPL PHYSIOL, V93, P588, DOI 10.1007/s00421-004-1232-0; Mathewson KW, 2015, MAGN RESON MED, V74, P1640, DOI 10.1002/mrm.25564; Nanas S, 2001, EUR J HEART FAIL, V3, P685, DOI 10.1016/S1388-9842(01)00187-8; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; Pavia L, 1999, CHEST, V116, P808, DOI 10.1378/chest.116.3.808; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Puntawangkoon C, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-48; Scrutinio D, 1998, INT J CARDIOL, V64, P117, DOI 10.1016/S0167-5273(98)00019-9; Tanabe Y, 2000, J AM COLL CARDIOL, V35, P1228, DOI 10.1016/S0735-1097(00)00517-9; TAYLOR DJ, 1984, GERONTOLOGY, V30, P2, DOI 10.1159/000212599; Thompson RB, 2003, MAGNET RESON MED, V50, P1248, DOI 10.1002/mrm.10637; Tomczak CR, 2011, J APPL PHYSIOL, V110, P398, DOI 10.1152/japplphysiol.01114.2010; van Beest PA, 2012, CRIT CARE MED, V40, P3196, DOI 10.1097/CCM.0b013e3182657591; YOSHIDA T, 1993, EUR J APPL PHYSIOL O, V66, P494, DOI 10.1007/BF00634298	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163513	10.1371/journal.pone.0163513	http://dx.doi.org/10.1371/journal.pone.0163513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701422	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900010
J	Yhnell, E; Dunnett, SB; Brooks, SP				Yhnell, Emma; Dunnett, Stephen B.; Brooks, Simon P.			A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the Hdh(Q111) Mouse Model of Huntington's Disease	PLOS ONE			English	Article							KNOCK-IN MOUSE; QUALITY-OF-LIFE; LEARNING-TASK SILT; REACTION-TIME-TASK; ATTENTIONAL DEFICITS; TRANSGENIC MICE; PREDICT-HD; PERFORMANCE; IMPLICIT; PHENOTYPE	Huntington's disease (HD) is characterised by motor symptoms which are often preceded by cognitive and behavioural changes, that can significantly contribute to disease burden for people living with HD. Numerous knock-in mouse models of HD are currently available for scientific research. However, before their use, they must be behaviourally characterised to determine their suitability in recapitulating the symptoms of the human condition. Thus, we sought to longitudinally characterise the nature, severity and time course of cognitive and behavioural changes observed in Hdh(Q111) heterozygous knock-in mice. To determine changes in cognition and behaviour an extensive battery of operant tests including: fixed ratio, progressive ratio, the five choice serial reaction time task and the serial implicit learning task, were applied longitudinally to Hdh(Q111) and wild type mice. The operant test battery was conducted at 6, 12 and 18 months of age. Significant deficits were observed in Hdh(Q111) animals in comparison to wild type animals in all operant tests indicating altered cognition (attentional and executive function) and motivation. However, the cognitive and behavioural deficits observed were not shown to be progressive over time in the longitudinal testing paradigm that was utilised. The results therefore demonstrate that the Hdh(Q111) mouse model of HD reflects some features of the cognitive and behavioural changes shown in the human condition of HD. Although, the cognitive and behavioural deficits demonstrated were not shown to be progressive over time.	[Yhnell, Emma] Cardiff Univ, Neurosci & Mental Hlth Res Inst, 3rd Floor,Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales; [Yhnell, Emma; Dunnett, Stephen B.; Brooks, Simon P.] Cardiff Univ, Brain Repair Grp, Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Yhnell, E (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, 3rd Floor,Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.; Yhnell, E (corresponding author), Cardiff Univ, Brain Repair Grp, Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	YhnellE@cardiff.ac.uk	Dunnett, Stephen B/A-5869-2010	Dunnett, Stephen B/0000-0003-1826-1578; Yhnell, Emma/0000-0003-3960-5181; Brooks, Simon/0000-0001-9853-6177	Medical Research Council [MR/K500859/1]; MRC [MC_PC_15043] Funding Source: UKRI; Medical Research Council [1221455] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank the Medical Research Council for funding this work via a PhD studentship (grant number MR/K500859/1) awarded to E.Y.	Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/jocn.2003.15.5.629; Balci F, 2009, BEHAV NEUROSCI, V123, P1353, DOI 10.1037/a0017650; BRADSHAW JL, 1992, J CLIN EXP NEUROPSYC, V14, P179, DOI 10.1080/01688639208402822; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks S, 2012, BRAIN RES BULL, V88, P148, DOI 10.1016/j.brainresbull.2010.05.003; Brooks S, 2012, BRAIN RES BULL, V88, P113, DOI 10.1016/j.brainresbull.2010.05.005; Brooks SP, 2012, BRAIN RES BULL, V88, P130, DOI 10.1016/j.brainresbull.2011.06.008; Brooks SP, 2012, BRAIN RES BULL, V88, P121, DOI 10.1016/j.brainresbull.2011.05.010; Brooks SP, 2012, BRAIN RES BULL, V88, P94, DOI 10.1016/j.brainresbull.2011.01.010; Brooks SP, 2006, BRAIN RES BULL, V69, P452, DOI 10.1016/j.brainresbull.2006.02.011; Brown RG, 2001, BRAIN, V124, P2188, DOI 10.1093/brain/124.11.2188; BURNS A, 1990, J NERV MENT DIS, V178, P20, DOI 10.1097/00005053-199001000-00004; BYLSMA FW, 1991, NEUROPSYCHOLOGIA, V29, P1213, DOI 10.1016/0028-3932(91)90035-7; Claus JJ, 1996, ACTA NEUROL SCAND, V93, P346; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Delval A, 2008, MOVEMENT DISORD, V23, P684, DOI 10.1002/mds.21896; DIAMOND R, 1992, J CLIN EXP NEUROPSYC, V14, P961, DOI 10.1080/01688639208402547; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Finke K, 2006, BRAIN, V129, P1137, DOI 10.1093/brain/awl040; Ghilardi MF, 2008, PARKINSONISM RELAT D, V14, P457, DOI 10.1016/j.parkreldis.2007.11.009; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; HEFTER H, 1987, BRAIN, V110, P585, DOI 10.1093/brain/110.3.585; HEINDEL WC, 1988, BEHAV NEUROSCI, V102, P141, DOI 10.1037/0735-7044.102.1.141; Helder DI, 2001, MOVEMENT DISORD, V16, P325, DOI 10.1002/mds.1056; Ho AK, 2009, MOVEMENT DISORD, V24, P574, DOI 10.1002/mds.22412; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Kremer H, 1996, UNIFIED HUNTINGTONS; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lelos MJ, 2012, EUR J NEUROSCI, V36, P3420, DOI 10.1111/j.1460-9568.2012.08256.x; Lione LA, 1999, J NEUROSCI, V19, P10428; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Oakeshott S, 2012, PLOS CURR, V4, DOI [10.1371/4f972cffe82c0, DOI 10.1371/4F972CFFE82C0]; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Ready RE, 2008, MOVEMENT DISORD, V23, P721, DOI 10.1002/mds.21920; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; SPRENGELMEYER R, 1995, BRAIN, V118, P145, DOI 10.1093/brain/118.1.145; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; Thompson JC, 2010, NEUROPSYCHOLOGIA, V48, P171, DOI 10.1016/j.neuropsychologia.2009.09.002; Trueman RC, 2012, BRAIN RES BULL, V88, P163, DOI 10.1016/j.brainresbull.2011.10.019; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Trueman RC, 2008, BEHAV BRAIN RES, V189, P317, DOI 10.1016/j.bbr.2008.01.020; Trueman RC, 2007, EUR J NEUROSCI, V25, P551, DOI 10.1111/j.1460-9568.2007.05307.x; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wahlin TBR, 2007, NEUROPSYCHOLOGY, V21, P31, DOI 10.1037/0894-4105.21.1.31; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yhnell E, 2016, J HUNTINGTONS DIS, V5, P149, DOI 10.3233/JHD-160191; Yhnell E, 2016, EXP NEUROL, V282, P19, DOI 10.1016/j.expneurol.2016.05.008; Yhnell E, 2016, J NEUROSCI METH, V265, P72, DOI 10.1016/j.jneumeth.2015.08.022	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164072	10.1371/journal.pone.0164072	http://dx.doi.org/10.1371/journal.pone.0164072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701442	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000385696900041
J	de Ruiter, CJ; van Oeveren, B; Francke, A; Zijlstra, P; van Dieen, JH				de Ruiter, Cornelis J.; van Oeveren, Ben; Francke, Agnieta; Zijlstra, Patrick; van Dieen, Jaap H.			Running Speed Can Be Predicted from Foot Contact Time during Outdoor over Ground Running	PLOS ONE			English	Article							REACTION FORCES; VALIDITY; RUNNERS; ECONOMY; WALKING; POWER; COST	The number of validation studies of commercially available foot pods that provide estimates of running speed is limited and these studies have been conducted under laboratory conditions. Moreover, internal data handling and algorithms used to derive speed from these pods are proprietary and thereby unclear. The present study investigates the use of foot contact time (CT) for running speed estimations, which potentially can be used in addition to the global positioning system (GPS) in situations where GPS performance is limited. CT was measured with tri axial inertial sensors attached to the feet of 14 runners, during natural over ground outdoor running, under optimized conditions for GPS. The individual relationships between running speed and CT were established during short runs at different speeds on two days. These relations were subsequently used to predict instantaneous speed during a straight line 4 km run with a single turning point halfway. Stopwatch derived speed, measured for each of 32 consecutive 125m intervals during the 4 km runs, was used as reference. Individual speed-CT relations were strong (r(2) > 0.96 for all trials) and consistent between days. During the 4km runs, median error (ranges) in predicted speed from CT 2.5% (5.2) was higher (P<0.05) than for GPS 1.6% (0.8). However, around the turning point and during the first and last 125m interval, error for GPS-speed increased to 5.0% (4.5) and became greater (P<0.05) than the error predicted from CT: 2.7% (4.4). Small speed fluctuations during 4km runs were adequately monitored with both methods: CT and GPS respectively explained 85% and 73% of the total speed variance during 4km runs. In conclusion, running speed estimates bases on speed-CT relations, have acceptable accuracy and could serve to backup or substitute for GPS during tarmac running on flat terrain whenever GPS performance is limited.	[de Ruiter, Cornelis J.; van Oeveren, Ben; Francke, Agnieta; Zijlstra, Patrick; van Dieen, Jaap H.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Behav & Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	de Ruiter, CJ (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Behav & Movement Sci, Amsterdam, Netherlands.	c.j.de.ruiter@vu.nl	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; van Oeveren, Benjamin/0000-0001-5090-7637; de Ruiter, Jo/0000-0003-0278-4235				CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Chapman RF, 2012, MED SCI SPORT EXER, V44, P917, DOI 10.1249/MSS.0b013e3182400520; Dalleau G, 1998, EUR J APPL PHYSIOL O, V77, P257, DOI 10.1007/s004210050330; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hausswirth C, 2009, INT J SPORTS MED, V30, P354, DOI 10.1055/s-0028-1105936; Hoyt DF, 2000, J EXP BIOL, V203, P221; Kane NA, 2010, INT J SPORTS MED, V31, P101, DOI 10.1055/s-0029-1242810; Neville J, 2011, PROCEDIA ENGINEER, V13, P487, DOI 10.1016/j.proeng.2011.05.119; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nummela A, 2007, INT J SPORTS MED, V28, P655, DOI 10.1055/s-2007-964896; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Rawstorn JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093693; Varley MC, 2012, J SPORT SCI, V30, P121, DOI 10.1080/02640414.2011.627941; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Weyand PG, 2001, J APPL PHYSIOL, V91, P451, DOI 10.1152/jappl.2001.91.1.451; Yang SZ, 2011, GAIT POSTURE, V34, P462, DOI 10.1016/j.gaitpost.2011.06.019	16	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163023	10.1371/journal.pone.0163023	http://dx.doi.org/10.1371/journal.pone.0163023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648946	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100045
J	Zhou, JY; Zhao, J; Zheng, J; Kong, M; Sun, K; Wang, B; Chen, X; Ding, W; Zhou, JY				Zhou, Jianya; Zhao, Jing; Zheng, Jing; Kong, Mei; Sun, Ke; Wang, Bo; Chen, Xi; Ding, Wei; Zhou, Jianying			A Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features	PLOS ONE			English	Article							CANCER; MUTATIONS	Aims To identify the clinical and histological characteristics of ROS1-rearranged non-small-cell lung carcinomas (NSCLCs) and build a prediction model to prescreen suitable patients for molecular testing. Methods and Results We identified 27 cases of ROS1-rearranged lung adenocarcinomas in 1165 patients with NSCLCs confirmed by real-time PCR and FISH and performed univariate and multivariate analyses to identify predictive factors associated with ROS1 rearrangement and finally developed prediction model. Detected with ROS1 immunochemistry, 59 cases of 1165 patients had a certain degree of ROS1 expression. Among these cases, 19 cases (68%, 19/28) with 3+ and 8 cases (47%, 8/17) with 2+ staining were ROS1 rearrangement verified by real-time PCR and FISH. In the resected group, the acinar-predominant growth pattern was the most commonly observed (57%, 8/14), while in the biopsy group, solid patterns were the most frequently observed (78%, 7/13). Based on multiple logistic regression analysis, we determined that female sex, cribriform structure and the presence of psammoma body were the three most powerful indicators of ROS1 rearrangement, and we have developed a predictive model for the presence of ROS1 rearrangements in lung adenocarcinomas. Conclusions Female, cribriform structure and presence of psammoma body were the three most powerful indicator of ROS1 rearrangement status, and predictive formula was helpful in screening ROS1-rearranged NSCLC, especially for ROS1 immunochemistry equivocal cases.	[Zhou, Jianya; Zheng, Jing; Chen, Xi; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou, Zhejiang, Peoples R China; [Zhao, Jing; Kong, Mei; Sun, Ke; Wang, Bo; Ding, Wei] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis,Thorac Dis Ctr, Hangzhou, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn			Medicine and Health Project of Zhejiang Province, China [2015104004]; National Natural Science Foundation of China [81101768]	Medicine and Health Project of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Medicine and Health Project of Zhejiang Province, China (Grant No. 2015104004), (www.zjmed.org.cn), Jing Zhao and the National Natural Science Foundation of China (Grant No. 81101768), (http://www.nsfc.gov.cn/), Jianya Zhou. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; This work was supported by grants from the Medicine and Health Project of Zhejiang Province, China (Grant No. 2015104004) and the National Natural Science Foundation of China (Grant No. 81101768). The authors thank Ms. Shicui Liu for editing assistance.	Cai W, 2013, ANN ONCOL, V24, P1822, DOI 10.1093/annonc/mdt071; Chen YF, 2014, J THORAC ONCOL, V9, P1171, DOI 10.1097/JTO.0000000000000232; Egashira Y, 2004, MODERN PATHOL, V17, P503, DOI 10.1038/modpathol.3800030; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Go H, 2013, J THORAC ONCOL, V8, P1445, DOI 10.1097/JTO.0b013e3182a4dd6e; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadota K, 2013, MODERN PATHOLOGY, P1; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee SE, 2015, MODERN PATHOL, V28, P468, DOI 10.1038/modpathol.2014.107; Lee YS, 2014, WORLD J SURG, V38, P1738, DOI 10.1007/s00268-014-2460-z; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7; Stumpfova M, 2012, CLIN CANCER RES, V18, P4222, DOI 10.1158/1078-0432.CCR-12-1812; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wen YS, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000296; Yoshida A, 2013, AM J SURG PATHOL, V37, P554, DOI 10.1097/PAS.0b013e3182758fe6; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]	20	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161861	10.1371/journal.pone.0161861	http://dx.doi.org/10.1371/journal.pone.0161861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648828	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100008
J	Grant, EJ; Josephs, TM; Valkenburg, SA; Wooldridge, L; Hellard, M; Rossjohn, J; Bharadwaj, M; Kedzierska, K; Gras, S				Grant, Emma J.; Josephs, Tracy M.; Valkenburg, Sophie A.; Wooldridge, Linda; Hellard, Margaret; Rossjohn, Jamie; Bharadwaj, Mandvi; Kedzierska, Katherine; Gras, Stephanie			Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct alpha beta T Cell Receptor Signatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; INFLUENZA-A; EPSTEIN-BARR; CLASS-I; STRUCTURAL FEATURES; ANTIVIRAL IMMUNITY; MOLECULAR-BASIS; TCR; MEMORY; RECOGNITION	alpha beta T cell receptor (TCR) genetic diversity is outnumbered by the quantity of pathogenic epitopes to be recognized. To provide efficient protective anti-viral immunity, a single TCR ideally needs to cross-react with a multitude of pathogenic epitopes. However, the frequency, extent, and mechanisms of TCR cross reactivity remain unclear, with conflicting results on anti-viral T cell cross-reactivity observed in humans. Namely, both the presence and lack of T cell cross-reactivity have been reported with HLA-A*02:01-restricted epitopes from the Epstein-Barr and influenza viruses (BMIT-1 and M1(58), respectively) or with the hepatitis C and influenza viruses (NS3(1073) and NA(231), respectively). Given the high sequence similarity of these paired viral epitopes (56 and 88%, respectively), the ubiquitous nature of the three viruses, and the high frequency of the HLA-A*02:01 allele, we selected these epitopes to establish the extent of T cell cross reactivity. We combined ex vivo and in vitro functional assays, single-cell alpha beta TCR repertoire sequencing, and structural analysis of these four epitopes in complex with HI,A-A*02:01 to determine whether they could lead to heterologous T cell cross-reactivity. Our data show that sequence similarity does not translate to structural mimicry of the paired epitopes in complexes with HLA-A*02:01, resulting in induction of distinct alpha beta TCR repertoires. The differences in epitope architecture might be an obstacle for TCR recognition, explaining the lack of T cell cross-reactivity observed. In conclusion, sequence similarity does not necessarily result in structural mimicry, and despite the need for cross-reactivity, antigen-specific TCR repertoires can remain highly specific.	[Grant, Emma J.; Valkenburg, Sophie A.; Bharadwaj, Mandvi; Kedzierska, Katherine] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Josephs, Tracy M.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Wooldridge, Linda] Univ Bristol, Fac Hlth Sci, Bristol BS8 1TD, Avon, England; [Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic 3004, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; Monash University; Monash University; Monash University; University of Bristol; Burnet Institute; Cardiff University	Kedzierska, K (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.; Gras, S (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic 3800, Australia.	kkedz@unimelb.edu.au; Stephanie.Gras@monash.edu	Grant, Emma/AAR-3766-2021; Bharadwaj, Mandvi/C-4446-2014; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Wooldridge, Linda/0000-0002-6213-347X; gras, stephanie/0000-0001-7416-038X; Kedzierska, Katherine/0000-0001-6141-335X; Grant, Emma/0000-0001-7193-9427; Valkenburg, Sophie A/0000-0002-0768-9926	Australian NHMRC Project [AI1008854, AI1071916]; NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship; Douglas and Lola Douglas Scholarship in Medical Science; NHMRC C. J. Martin Fellowship; NHMRC Australia Fellowship [AF50]; Australian Research Council (ARC) [FF120100416]; NHMRC Senior Research Fellow level B (SRFB) Fellowship	Australian NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Douglas and Lola Douglas Scholarship in Medical Science; NHMRC C. J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC Senior Research Fellow level B (SRFB) Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian NHMRC Project Grant AI1008854 and Program Grant AI1071916 (to K. K.), an NHMRC Aboriginal and Torres Strait Islander Health Research Scholarship (to E. J. G.), a Douglas and Lola Douglas Scholarship in Medical Science (to E. J. G.), an NHMRC C. J. Martin Fellowship (to E. J. G.), NHMRC Australia Fellowship AF50 (to J. R.), Australian Research Council (ARC) Future Fellowship FF120100416 (to S. G.), and an NHMRC Senior Research Fellow level B (SRFB) Fellowship (to K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2016, NAT IMMUNOL, V17, P87, DOI 10.1038/ni.3310; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chen AT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002633; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Clute SC, 2010, J IMMUNOL, V185, P6753, DOI 10.4049/jimmunol.1000812; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kasprowicz V, 2008, J CLIN INVEST, V118, P1143, DOI 10.1172/JCI33082; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Liu YC, 2014, J BIOL CHEM, V289, P16688, DOI 10.1074/jbc.M114.563502; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Neveu B, 2008, HEPATOLOGY, V48, P713, DOI 10.1002/hep.22379; Nguyen THO, 2014, J IMMUNOL, V192, P5039, DOI 10.4049/jimmunol.1303147; Odumade OA, 2012, J EXP MED, V209, P471, DOI 10.1084/jem.20112401; Pasetto A, 2012, J GEN VIROL, V93, P247, DOI 10.1099/vir.0.037903-0; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser JB, 2014, J IMMUNOL, V193, P5816, DOI 10.4049/jimmunol.1303084; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Selin LK, 2011, AUTOIMMUNITY, V44, P328, DOI 10.3109/08916934.2011.523277; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; Shen ZT, 2013, J IMMUNOL, V191, P5139, DOI 10.4049/jimmunol.1300852; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Wooldridge L, 2007, EUR J IMMUNOL, V37, P1323, DOI 10.1002/eji.200636765; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	54	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24335	24351		10.1074/jbc.M116.753988	http://dx.doi.org/10.1074/jbc.M116.753988			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27645996	hybrid, Green Published			2022-12-26	WOS:000388875500002
J	Opelt, M; Eroglu, E; Waldeck-Weiermair, M; Russwurm, M; Koesling, D; Malli, R; Graier, WF; Fassett, JT; Schrammel, A; Mayer, B				Opelt, Marissa; Eroglu, Emrah; Waldeck-Weiermair, Markus; Russwurm, Michael; Koesling, Doris; Malli, Roland; Graier, Wolfgang F.; Fassett, John T.; Schrammel, Astrid; Mayer, Bernd			Formation of Nitric Oxide by Aldehyde Dehydrogenase-2 Is Necessary and Sufficient for Vascular Bioactivation of Nitroglycerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); metabolism; mutagenesis in vitro; nitric oxide; vascular smooth muscle cells; aldehyde dehydrogenase-2; nitroglycerin; site-directed mutagenesis	SOLUBLE GUANYLATE-CYCLASE; GLYCERYL TRINITRATE; NITRATE TOLERANCE; ORGANIC NITRATES; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; IN-VIVO; MITOCHONDRIAL; BIOTRANSFORMATION; ACTIVATION	Aldehyde dehydrogenase-2 (ALDH2) catalyzes vascular bioactivation of the antianginal drug nitroglycerin (GTN), resulting in activation of soluble guanylate cyclase (sGC) and cGMP-mediated vasodilation. We have previously shown that a minor reaction of ALDH2-catalyzed GTN bioconversion, accounting for about 5% of the main clearance-based turnover yielding inorganic nitrite, results in direct NO formation and concluded that this minor pathway could provide the link between vascular GTN metabolism and activation of sGC. However, lack of detectable NO at therapeutically relevant GTN concentrations (1 m) in vascular tissue called into question the biological significance of NO formation by purified ALDH2. We addressed this issue and used a novel, highly sensitive genetically encoded fluorescent NO probe (geNOp) to visualize intracellular NO formation at low GTN concentrations (1 m) in cultured vascular smooth muscle cells (VSMC) expressing an ALDH2 mutant that reduces GTN to NO but lacks clearance-based GTN denitration activity. NO formation was compared with GTN-induced activation of sGC. The addition of 1 m GTN to VSMC expressing either wild-type or C301S/C303S ALDH2 resulted in pronounced intracellular NO elevation, with maximal concentrations of 7 and 17 nm, respectively. Formation of GTN-derived NO correlated well with activation of purified sGC in VSMC lysates and cGMP accumulation in intact porcine aortic endothelial cells infected with wild-type or mutant ALDH2. Formation of NO and cGMP accumulation were inhibited by ALDH inhibitors chloral hydrate and daidzin. The present study demonstrates that ALDH2-catalyzed NO formation is necessary and sufficient for GTN bioactivation in VSMC.	[Opelt, Marissa; Fassett, John T.; Schrammel, Astrid; Mayer, Bernd] Graz Univ, Inst Pharmaceut Sci, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Eroglu, Emrah; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany	University of Graz; Medical University of Graz; Ruhr University Bochum	Mayer, B (corresponding author), Graz Univ, Dept Pharmacol & Toxicol, Humboldtstr 46-1, A-8010 Graz, Austria.	mayer@uni-graz.at	Waldeck-Weiermair, Markus/AAV-5193-2020; Eroglu, Emrah/X-3119-2019; Graier, Wolfgang F./B-7052-2008	Waldeck-Weiermair, Markus/0000-0002-5792-6766; Eroglu, Emrah/0000-0002-9373-0808; Graier, Wolfgang F./0000-0003-1871-3298; Mayer, Bernd/0000-0002-2921-3494; Malli, Roland/0000-0001-6327-8729	Austrian Science Fund (FWF) [P24946, W1226, P28529]; Nikon, Austria within the NIKON-Center of Excellence; Graz within the Doctoral School "MolMed" at the Medical University of Graz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Nikon, Austria within the NIKON-Center of Excellence; Graz within the Doctoral School "MolMed" at the Medical University of Graz	This work was supported by Austrian Science Fund (FWF) Grants P24946, W1226, and P28529. This work was also supported by Nikon, Austria within the NIKON-Center of Excellence, Graz within the Doctoral School "MolMed" at the Medical University of Graz (to E.E.). The authors declare that they have no conflicts of interest with the contents of this article. We acknowledge the technical assistance of Dr. Rene Rost.	ALHEID U, 1987, BRIT J PHARMACOL, V92, P237, DOI 10.1111/j.1476-5381.1987.tb11317.x; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Beretta M, 2012, CIRC RES, V110, P385, DOI 10.1161/CIRCRESAHA.111.245837; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; De la Lande IS, 1999, EUR J PHARMACOL, V374, P71, DOI 10.1016/S0014-2999(99)00319-2; de la Lande IS, 2004, EUR J PHARMACOL, V496, P141, DOI 10.1016/j.ejphar.2004.06.010; Eroglu E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10623; FEELISCH M, 1991, BIOCHEM BIOPH RES CO, V180, P286, DOI 10.1016/S0006-291X(05)81290-2; FUNG HL, 1984, J PHARMACOL EXP THER, V228, P334; IGNARRO LJ, 1980, BIOCHIM BIOPHYS ACTA, V631, P221, DOI 10.1016/0304-4165(80)90297-4; Janero DR, 2004, P NATL ACAD SCI USA, V101, P16958, DOI 10.1073/pnas.0406075101; Kleschyov AL, 2003, CIRC RES, V93, pE104, DOI 10.1161/01.RES.0000100067.62876.50; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Kollau A, 2009, NITRIC OXIDE-BIOL CH, V20, P53, DOI 10.1016/j.niox.2008.09.003; MALTA E, 1989, N-S ARCH PHARMACOL, V339, P236; MARKS GS, 1992, CAN J PHYSIOL PHARM, V70, P308, DOI 10.1139/y92-039; Martens D, 2001, BRIT J PHARMACOL, V132, P30, DOI 10.1038/sj.bjp.0703768; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Miller MR, 2008, J VASC RES, V45, P375, DOI 10.1159/000121407; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Munzel T, 2011, CIRCULATION, V123, P2132, DOI 10.1161/CIRCULATIONAHA.110.981407; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nunez C, 2005, CIRC RES, V97, P1063, DOI 10.1161/01.RES.0000190588.84680.34; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SCHMIDT K, 1989, EUR J PHARMACOL, V170, P157, DOI 10.1016/0014-2999(89)90536-0; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Wenzl MV, 2011, MOL PHARMACOL, V80, P258, DOI 10.1124/mol.111.071704; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; Wolkart G, 2013, BRIT J PHARMACOL, V168, P1868, DOI 10.1111/bph.12081; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	35	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24076	24084		10.1074/jbc.M116.752071	http://dx.doi.org/10.1074/jbc.M116.752071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679490	hybrid, Green Published			2022-12-26	WOS:000388498100024
J	Sahni, JM; Gayle, SS; Bonk, KLW; Vite, LC; Yori, JL; Webb, B; Ramos, EK; Seachrist, DD; Landis, MD; Chang, JC; Bradner, JE; Keri, RA				Sahni, Jennifer M.; Gayle, Sylvia S.; Bonk, Kristen L. Weber; Vite, Leslie Cuellar; Yori, Jennifer L.; Webb, Bryan; Ramos, Erika K.; Seachrist, Darcie D.; Landis, Melissa D.; Chang, Jenny C.; Bradner, James E.; Keri, Ruth A.			Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; breast cancer; bromodomain-containing protein 4 (BRD4); cellular senescence; inhibition mechanism; Aurora kinase	SELECTIVE-INHIBITION; GENE-EXPRESSION; CELLS; SUBTYPES; PROGRESSION; RESISTANCE; TUMORS; MODELS; BRD4; OVEREXPRESSION	Bromodomain and extraterminal (BET) proteins are epigenetic readers that recognize acetylated histones and mark areas of the genome for transcription. BRD4, a BET family member protein, has been implicated in a number of types of cancer, and BET protein inhibitors (BETi) are efficacious in many preclinical cancer models. However, the drivers of response to BETi vary depending on tumor type, and little is known regarding the target genes conveying BETi activity in triple-negative breast cancer (TNBC). Here, we show that BETi repress growth of multiple in vitro and in vivo models of TNBC by inducing two terminal responses: apoptosis and senescence. Unlike in other cancers, response to BETi in TNBC is not dependent upon suppression of MYC. Instead, both end points are preceded by the appearance of polyploid cells caused by the suppression of Aurora kinases A and B (AURKA/B), which are critical mediators of mitosis. In addition, AURKA/B inhibitors phenocopy the effects of BETi. These results indicate that Aurora kinases play an important role in the growth suppressive activity of BETi in TNBC. Elucidating the mechanism of response to BETi in TNBC should 1) facilitate the prediction of how distinct TNBC tumors will respond to BETi and 2) inform the rational design of drug combination therapies.	[Sahni, Jennifer M.; Gayle, Sylvia S.; Bonk, Kristen L. Weber; Vite, Leslie Cuellar; Yori, Jennifer L.; Webb, Bryan; Ramos, Erika K.; Seachrist, Darcie D.; Keri, Ruth A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Keri, Ruth A.] Case Western Reserve Univ, Dept Genet & Genome Sci & Gen Med Sci Oncol, Cleveland, OH 44106 USA; [Landis, Melissa D.; Chang, Jenny C.] Houston Methodist Hosp, Methodist Canc Ctr, Houston, TX 77030 USA; [Bradner, James E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bradner, James E.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Case Western Reserve University; Case Western Reserve University; The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Dana-Farber Cancer Institute; Novartis	Keri, RA (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.; Keri, RA (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci & Gen Med Sci Oncol, Cleveland, OH 44106 USA.	keri@case.edu	Keri, Ruth/ABF-2209-2021	Keri, Ruth/0000-0002-1640-3088; Sahni, Jennifer/0000-0002-2735-1789	National Institutes of Health [P30043703, T32CA059366, R25GM075207, T32GM008056, RO1CA154384, RO1CA206505]; NATIONAL CANCER INSTITUTE [T32CA059366, P30CA043703, R01CA206505, R01CA154384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803, R25GM075207, T32GM008056, T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P30043703 (to the Core Facilities of the Case Comprehensive Cancer Center), T32CA059366 (to J.M.S. and S. S. G.), R25GM075207 (to L. C. V. and E. K. R.), T32GM008056 (to L. C. V.), RO1CA154384 (to R. A. K.), and RO1CA206505 (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Bolanos-Garcia VM, 2005, INT J BIOCHEM CELL B, V37, P1572, DOI 10.1016/j.biocel.2005.02.021; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Sadaie M, 2015, MOL BIOL CELL, V26, P2971, DOI 10.1091/mbc.E15-01-0003; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Tatsuka M, 1998, CANCER RES, V58, P4811; Tolani B, 2014, ONCOGENE, V33, P2928, DOI 10.1038/onc.2013.242; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	44	37	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23756	23768		10.1074/jbc.M116.738666	http://dx.doi.org/10.1074/jbc.M116.738666			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27650498	hybrid, Green Published			2022-12-26	WOS:000387884400035
J	Heppner, DE; Hristova, M; Dustin, CM; Danyal, K; Habibovic, A; van der Vliet, A				Heppner, David E.; Hristova, Milena; Dustin, Christopher M.; Danyal, Karamatullah; Habibovic, Aida; van der Vliet, Albert			The NADPH Oxidases DUOX1 and NOX2 Play Distinct Roles in Redox Regulation of Epidermal Growth Factor Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; EPITHELIAL-CELL MIGRATION; ACTIVE-SITE CYSTEINE; KINASE INHIBITORS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; PROTEIN-KINASES; DUAL OXIDASE-1; LUNG-CANCER; SRC	The epidermal growth factor receptor (EGFR) plays a critical role in regulating airway epithelial homeostasis and responses to injury. Activation of EGFR is regulated by redox-dependent processes involving reversible cysteine oxidation by reactive oxygen species (ROS) and involves both ligand-dependent and -independent mechanisms, but the precise source(s) of ROS and the molecular mechanisms that control tyrosine kinase activity are incompletely understood. Here, we demonstrate that stimulation of EGFR activation by ATP in airway epithelial cells is closely associated with dynamic reversible oxidation of cysteine residues via sequential sulfenylation and S-glutathionylation within EGFR and the non-receptor-tyrosine kinase Src. Moreover, the intrinsic kinase activity of recombinant Src or EGFR was in both cases enhanced byH(2)O(2) but not by GSSG, indicating that the intermediate sulfenylation is the activating modification. H2O2-induced increase in EGFR tyrosine kinase activity was not observed with the C797S variant, confirming Cys-797 as the redox-sensitive cysteine residue that regulates kinase activity. Redox-dependent regulation of EGFR activation in airway epithelial cells was found to strongly depend on activation of either the NADPH oxidase DUOX1 or the homolog NOX2, depending on the activation mechanism. Whereas DUOX1 and Src play a primary role in EGFR transactivation by wound-derived signals such as ATP, direct ligand-dependent EGFR activation primarily involves NOX2 with a secondary role for DUOX1 and Src. Collectively, our findings establish that redox-dependent EGFR kinase activation involves a dynamic and reversible cysteine oxidation mechanism and that this activation mechanism variably involves DUOX1 and NOX2.	[Heppner, David E.; Hristova, Milena; Dustin, Christopher M.; Danyal, Karamatullah; Habibovic, Aida; van der Vliet, Albert] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA	University of Vermont	van der Vliet, A (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Coll Med, Hlth Sci Res Facil 216, 149 Beaumont Ave, Burlington, VT 05405 USA.	albert.van-der-vliet@med.uvm.edu	Heppner, David E./A-7029-2018	Heppner, David E./0000-0002-0722-5160	National Institutes of Health [R01 HL085646, R01 ES021476, T32 HL076122, F32 HL129706]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085646, F32HL129706, T32HL076122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL085646 and R01 ES021476 (to A. v. d. V.) and post-doctoral Fellowships T32 HL076122 and F32 HL129706 (to D. E. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Chiarugi P, 2008, MOL CELLS, V26, P329; Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Defelipe LA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004051; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gorissen SH, 2013, AM J RESP CELL MOL, V48, P337, DOI 10.1165/rcmb.2012-0393OC; Gupta V, 2016, CHEM SCI, V7, P400, DOI 10.1039/c5sc02569a; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Gupte SA, 2009, AM J PHYSIOL-HEART C, V296, pH1048, DOI 10.1152/ajpheart.00491.2008; Gushwa NN, 2012, J AM CHEM SOC, V134, P20214, DOI 10.1021/ja310659j; Heppner DE, 2016, REDOX BIOL, V8, P24, DOI 10.1016/j.redox.2015.12.002; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hristova M, 2016, J ALLERGY CLIN IMMUN, V137, P1545, DOI 10.1016/j.jaci.2015.10.003; Hristova M, 2014, REDOX BIOL, V2, P436, DOI 10.1016/j.redox.2013.12.030; Jagadeesha DK, 2012, CARDIOVASC RES, V93, P406, DOI 10.1093/cvr/cvr308; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kehasse A, 2013, AM J PATHOL, V183, P1841, DOI 10.1016/j.ajpath.2013.08.015; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kwarcinski FE, 2012, ACS CHEM BIOL, V7, P1910, DOI 10.1021/cb300337u; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030335; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Perkins A, 2014, BIOCHEMISTRY-US, V53, P7693, DOI 10.1021/bi5013222; Poole TH, 2014, J AM CHEM SOC, V136, P6167, DOI 10.1021/ja500364r; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Rigutto S, 2009, J BIOL CHEM, V284, P6725, DOI 10.1074/jbc.M806893200; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Ruddraraju KV, 2015, J ORG CHEM, V80, P12015, DOI 10.1021/acs.joc.5b01949; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schwartz PA, 2014, P NATL ACAD SCI USA, V111, P173, DOI 10.1073/pnas.1313733111; Seiner DR, 2007, CHEM RES TOXICOL, V20, P1315, DOI 10.1021/tx700213s; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Sham D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054391; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Sirokmany G, 2016, FREE RADICAL BIO MED, V97, P204, DOI 10.1016/j.freeradbiomed.2016.05.028; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Sun GQ, 2009, CELL CYCLE, V8, P2353, DOI 10.4161/cc.8.15.9225; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Truong TH, 2016, CELL CHEM BIOL, V23, P837, DOI 10.1016/j.chembiol.2016.05.017; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang HQ, 2015, ARCH BIOCHEM BIOPHYS, V568, P1, DOI 10.1016/j.abb.2015.01.001; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	73	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23282	23293		10.1074/jbc.M116.749028	http://dx.doi.org/10.1074/jbc.M116.749028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650496	hybrid, Green Published			2022-12-26	WOS:000387224800036
J	Clusa, L; Ardura, A; Gower, F; Miralles, L; Tsartsianidou, V; Zaiko, A; Garcia-Vazquez, E				Clusa, Laura; Ardura, Alba; Gower, Fiona; Miralles, Laura; Tsartsianidou, Valentina; Zaiko, Anastasija; Garcia-Vazquez, Eva			An Easy Phylogenetically Informative Method to Trace the Globally Invasive Potamopyrgus Mud Snail from River's eDNA	PLOS ONE			English	Article							NEW-ZEALAND MUDSNAILS; ANTIPODARUM HYDROBIIDAE; ENVIRONMENTAL DNA; MITOCHONDRIAL-DNA; MOLLUSCA; SALINITY; INVERTEBRATES; BIODIVERSITY; GASTROPOD; ABUNDANCE	Potamopyrgus antipodarum (New Zealand mud snail) is a prosobranch mollusk native to New Zealand with a wide invasive distribution range. Its non-indigenous populations are reported from Australia, Asia, Europe and North America. Being an extremely tolerant species, Potamopyrgus is capable to survive in a great range of salinity and temperature conditions, which explains its high invasiveness and successful spread outside the native range. Here we report the first finding of Potamopyrgus antipodarum in a basin of the Cantabrian corridor in North Iberia (Bay of Biscay, Spain). Two haplotypes already described in Europe were found in different sectors of River Nora (Nalon basin), suggesting the secondary introductions from earlier established invasive populations. To enhance the surveillance of the species and tracking its further spread in the region, we developed a specific set of primers for the genus Potamopyrgus that amplify a fragment of 16S rDNA. The sequences obtained from PCR on DNA extracted from tissue and water samples (environmental DNA, eDNA) were identical in each location, suggesting clonal reproduction of the introduced individuals. Multiple introduction events from different source populations were inferred from our sequence data. The eDNA tool developed here can serve for tracing New Zealand mud snail populations outside its native range, and for inventorying mud snail population assemblages in the native settings if high throughput sequencing methodologies are employed.	[Clusa, Laura; Miralles, Laura; Tsartsianidou, Valentina; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, E-33006 Oviedo, Spain; [Ardura, Alba] Univ Perpignan, CBETM, CRIOBE CNRS EPHE UPVD USR3278, Lab Excellence CORAIL, 58 Rue Paul Alduy, F-66860 Perpignan, France; [Gower, Fiona; Zaiko, Anastasija] Cawthron Inst, Coastal & Freshwater Grp, 98 Halifax St East, Nelson 7010, New Zealand; [Zaiko, Anastasija] Klaipeda Univ, Marine Sci & Technol Ctr, H Manto 84, LT-92294 Klaipeda, Lithuania	University of Oviedo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Cawthron Institute; Klaipeda University	Clusa, L (corresponding author), Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, E-33006 Oviedo, Spain.	lauraclusa@gmail.com	Garcia-Vazquez, Eva/Y-7293-2019	Miralles, Laura/0000-0002-7146-9776; Garcia-Vazquez, Eva/0000-0002-8429-838X; Ardura Gutierrez, Alba/0000-0003-2598-6534; Clusa, Laura/0000-0002-3503-2331	Spanish project [MINECO-13-CGL2013-42415-R]; Asturias Regional Grant [GRUPIN-2014-093]; PCTI Grant from the Asturias Regional Government [BP14-145]; Marie Curie grant COFUND-CLARIN	Spanish project(Spanish Government); Asturias Regional Grant; PCTI Grant from the Asturias Regional Government; Marie Curie grant COFUND-CLARIN	This work was supported by the Spanish project MINECO-13-CGL2013-42415-R and the Asturias Regional Grant GRUPIN-2014-093. Laura Clusa holds a PCTI Grant from the Asturias Regional Government, referenced BP14-145. Alba Ardura holds a regional postdoctoral Marie Curie grant COFUND-CLARIN.	Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; Alonso Alvaro, 2012, NeoBiota, V14, P67; Alonso A, 2012, AQUAT SCI, V74, P375, DOI 10.1007/s00027-012-0254-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ardura A, 2015, MAR ENVIRON RES, V112, P48, DOI 10.1016/j.marenvres.2015.09.013; Bersine K, 2008, BIOL INVASIONS, V10, P1381, DOI 10.1007/s10530-007-9213-y; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Bruce RL, 2009, N AM J AQUACULT, V71, P287, DOI 10.1577/A08-033.1; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Chown SL, 2015, EVOL APPL, V8, P23, DOI 10.1111/eva.12234; Costil K, 2001, BIODIVERS CONSERV, V10, P1, DOI 10.1023/A:1016670708413; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Davidson Timothy M., 2008, Aquatic Invasions, V3, P349, DOI 10.3391/ai.2008.3.3.12; Devloo-Delva F, 2016, MARINE POLLUTION B; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gerard C, 2003, HYDROBIOLOGIA, V493, P167, DOI 10.1023/A:1025443910836; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Grant A, 1998, MAR POLLUT BULL, V36, P540, DOI 10.1016/S0025-326X(98)00012-5; Gustavson MS, 2015, J FISH BIOL, V87, P1254, DOI 10.1111/jfb.12781; Hall R, 2003, FRONT ECOL ENVIRON, V1, P407, DOI 10.1890/1540-9295(2003)001[0407:ESDNAC]2.0.CO;2; Hall RO, 2006, ECOL APPL, V16, P1121, DOI 10.1890/1051-0761(2006)016[1121:EHSPOI]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamada K, 2013, LIMNOLOGY, V14, P223, DOI 10.1007/s10201-013-0405-0; Hoy M, 2012, AQUAT ECOL, V46, P249, DOI 10.1007/s10452-012-9396-x; Jacobsen R, 1997, FUNCT ECOL, V11, P260, DOI 10.1046/j.1365-2435.1997.00082.x; Larson MD, 2016, HYDROBIOLOGIA, V763, P147, DOI 10.1007/s10750-015-2369-z; LASSEN HH, 1975, OECOLOGIA, V19, P1, DOI 10.1007/BF00377585; Leprieur Fabien, 2008, PLoS Biol, V6, pe28, DOI 10.1371/journal.pbio.0060028; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Milwright R. D. P., 2006, Ringing & Migration, V23, P21; Moffitt CM, 2012, FRESHW SCI, V31, P1035, DOI 10.1899/11-160.1; Murria C, 2008, FUND APPL LIMNOL, V171, P131, DOI 10.1127/1863-9135/2008/0171-0131; Naser Murtada D., 2009, Aquatic Invasions, V4, P369, DOI 10.3391/ai.2009.4.2.11; Olenin S, 2011, MAR POLLUT BULL, V62, P2598, DOI 10.1016/j.marpolbul.2011.08.011; Palumbi SR, 1991, SIMPLE FOOLS GUIDE P, P28; Radea Canella, 2008, Aquatic Invasions, V3, P341, DOI 10.3391/ai.2008.3.3.10; Riley LA, 2015, FRESHWATER BIOL, V60, P1308, DOI 10.1111/fwb.12566; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanderson BL, 2009, BIOSCIENCE, V59, P245, DOI 10.1525/bio.2009.59.3.9; Schmidlin S, 2012, HYDROBIOLOGIA, V679, P233, DOI 10.1007/s10750-011-0889-8; Schreiber E. S. G., 2002, Biological Invasions, V4, P317, DOI 10.1023/A:1020925022843; Shimada Kumiko, 2003, Venus (Tokyo), V62, P39; Spyra A, 2015, ENVIRON MANAGE, V56, P233, DOI 10.1007/s00267-015-0483-3; Stadler T, 2005, MOL ECOL, V14, P2465, DOI 10.1111/j.1365-294X.2005.02603.x; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Telleria JL, 2009, J BIOGEOGR, V36, P220, DOI 10.1111/j.1365-2699.2008.01983.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen MS, 2009, HELGOLAND MAR RES, V63, P159, DOI 10.1007/s10152-008-0142-7; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Vinson MR, 2008, N AM J FISH MANAGE, V28, P701, DOI 10.1577/M06-039.1; WINTERBOURN M, 1970, Malacologia, V10, P283; Zaiko A, 2015, MAR ENVIRON RES, V112, P64, DOI 10.1016/j.marenvres.2015.07.002; Zaranko DT, 1997, CAN J FISH AQUAT SCI, V54, P809, DOI 10.1139/cjfas-54-4-809	58	18	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162899	10.1371/journal.pone.0162899	http://dx.doi.org/10.1371/journal.pone.0162899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706172	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200022
J	Imai, R; Tsuda, Y; Matsumoto, S; Ebihara, A; Watano, Y				Imai, Ryosuke; Tsuda, Yoshiaki; Matsumoto, Sadamu; Ebihara, Atsushi; Watano, Yasuyuki			The Relationship between Mating System and Genetic Diversity in Diploid Sexual Populations of Cyrtomium falcatum in Japan	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; LONG-DISTANCE DISPERSAL; SELF-FERTILIZATION; MICROSATELLITE MARKERS; BETULA-MAXIMOWICZIANA; DIFFERENTIATION; EVOLUTION; SOFTWARE; HISTORY; RANGE	The impact of variation in mating system on genetic diversity is a well-debated topic in evolutionary biology. The diploid sexual race of Cyrtomium falcatum (Japanese holly fern) shows mating system variation, i.e., it displays two different types of sexual expression (gametangia formation) in gametophytes: mixed (M) type and separate (S) type. We examined whether there is variation in the selfing rate among populations of this species, and evaluated the relationship between mating system, genetic diversity and effective population size using microsatellites. In this study, we developed eight new microsatellite markers and evaluated genetic diversity and structure of seven populations (four M-type and three S-type). Past effective population sizes (Ne) were inferred using Approximate Bayesian computation (ABC). The values of fixation index (F-IS), allelic richness (A(R)) and gene diversity (h) differed significantly between the M-type (F-IS: 0.626, A(R): 1.999, h: 0.152) and the S-type (F-IS: 0.208, A(R): 2.718, h: 0.367) populations (when admixed individuals were removed from two populations). Although evidence of past bottleneck events was detected in all populations by ABC, the current N-e of the M-type populations was about a third of that of the S-type populations. These results suggest that the M-type populations have experienced more frequent bottlenecks, which could be related to their higher colonization ability via gametophytic selfing. Although high population differentiation among populations was detected (F-ST = 0.581, F-ST' = 0.739), there was no clear genetic differentiation between the M- and S-types. Instead, significant isolation by distance was detected among all populations. These results suggest that mating system variation in this species is generated by the selection for single spore colonization during local extinction and recolonization events and there is no genetic structure due to mating system.	[Imai, Ryosuke; Watano, Yasuyuki] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan; [Tsuda, Yoshiaki] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano, Japan; [Matsumoto, Sadamu; Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Chiba University; University of Tsukuba; National Museum of Nature and Science	Watano, Y (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan.	watano@faculty.chiba-u.jp		Watano, Yasuyuki/0000-0001-5814-9658	Research Support Program Fund from Chiba University; Ministry of Education, Science and Culture of Japan [15K07180]	Research Support Program Fund from Chiba University; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Research Support Program Fund 2014 to YW from Chiba University and a Grant-in-Aid (No. 15K07180 to YW) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Busch JW, 2012, ANN BOT-LONDON, V109, P553, DOI 10.1093/aob/mcr219; Bystriakova N, 2014, ANN BOT-LONDON, V113, P453, DOI 10.1093/aob/mct274; Chung MY, 2013, AM J BOT, V100, P2240, DOI 10.3732/ajb.1300134; Chung MY, 2012, AM FERN J, V102, P256, DOI 10.1640/0002-8444-102.4.256; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Darwin CR, 1876, EFFECTS CROSS SELF F; David C., 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, DOI 10.2307/2409206]; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HEDRICK PW, 1987, EVOLUTION, V41, P1282, DOI 10.1111/j.1558-5646.1987.tb02466.x; Huang YM, 2004, ANN BOT-LONDON, V94, P229, DOI 10.1093/aob/mch142; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iwaizumi MG, 2013, FOREST ECOL MANAG, V304, P407, DOI 10.1016/j.foreco.2013.05.026; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jimenez A, 2010, ANN BOT-LONDON, V106, P149, DOI 10.1093/aob/mcq094; Klekowski EJ, 1969, BOT J LINN SOC, V62, P347, DOI DOI 10.1111/J.1095-8339.1969.TB01972.X; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Lian CL, 2001, J PLANT RES, V114, P381, DOI 10.1007/PL00014001; MASUYAMA S, 1975, Science Reports of the Tokyo Kyoiku Daigaku Section B, V16, P47; Matsumoto S., 2003, ANN TSUKUBA BOT GARD, V22, P1; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Morgan MT, 2005, EVOLUTION, V59, P1143, DOI 10.1111/j.0014-3820.2005.tb01050.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2000, GENETICS, V154, P923; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; POLLAK E, 1987, GENETICS, V117, P353; Pritchard JK, 2000, GENETICS, V155, P945; Ranker TA, 2002, AM FERN J, V92, P112, DOI 10.1640/0002-8444(2002)092[0112:IGSITL]2.0.CO;2; Ranker TA, 2000, EVOLUTION, V54, P828; Rousset F, 1997, GENETICS, V145, P1219; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaguchi S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2182; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Semerikov VL, 2013, MOL ECOL, V22, P4958, DOI 10.1111/mec.12433; Sessa EB, 2016, NEW PHYTOL, V211, P1108, DOI 10.1111/nph.13985; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Shimizu KK, 2015, ANNU REV ECOL EVOL S, V46, P593, DOI 10.1146/annurev-ecolsys-112414-054249; SOLTIS P S, 1990, Plant Species Biology, V5, P1, DOI 10.1111/j.1442-1984.1990.tb00187.x; Takayama K, 2011, TAXON, V60, P1442, DOI 10.1002/tax.605019; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Tsuda Y, 2015, MOL ECOL, V24, P1403, DOI 10.1111/mec.13123; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; WATANO Y., 1986, MODERN ASPECTS SPECI, P211; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yuzawa Y., 2012, J PHYTOGEOGR TAXON, V61, P1	64	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163683	10.1371/journal.pone.0163683	http://dx.doi.org/10.1371/journal.pone.0163683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706257	gold, Green Submitted, Green Published			2022-12-26	WOS:000385697200053
J	Lee, MH; Jung, SY; Kang, SH; Song, EJ; Park, IH; Kong, SY; Kwon, YM; Lee, KS; Kang, HS; Lee, ES				Lee, Moo Hyun; Jung, So-Youn; Kang, Sun Hee; Song, Eun Jin; Park, In Hae; Kong, Sun-Young; Kwon, Young Mee; Lee, Keun Seok; Kang, Han-Sung; Lee, Eun Sook			The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients	PLOS ONE			English	Article							EXTRACELLULAR DOMAIN; PROGNOSTIC-SIGNIFICANCE; CLINICAL UTILITY; PREDICTIVE-VALUE; HER-2/NEU; CHEMOTHERAPY; TRASTUZUMAB; RECEPTOR; PROTEIN; ONCOPROTEIN	Purpose This study evaluated the association of serum HER2 (sHER2) levels at diagnosis with clinicopathologic parameters and disease free survival (DFS) in operable breast cancer patients according to intrinsic subtype. Methods The sHER2 levels were measured using a chemiluminescence immunoassay. The HER2 status in all tumor tissues was determined by immunohistochemistry, and confirmed in equivocal cases by fluorescence in situ. Results There were 436 consecutive stage I-III breast cancer patients with sHER2 result at diagnosis between Nov 2004 and Dec 2011. High sHER2 levels (>= 15 ng/ml) were reported in 52 patients (11.9%) and HER2 overexpression in tumor tissue was observed in 111 patients (25.5%). High sHER2 levels were associated significantly with advanced stage (P < 0.001), mastectomy (P = 0.012), neoadjuvant chemotherapy (P < 0.001), anti-HER2 therapy (P < 0.001) and hormone therapy (P = 0.022). The patients with high sHER2 levels had a worse DFS (P < 0.001). In multivariate analysis, high sHER2 levels were associated significantly with worse DFS (HR = 2.25, 95% CI 1.27-3.99, P = 0.005). High sHER2 levels were associated with worse DFS in the HR+/HER2-, HR+/HER2+ and HR-/HER2+ subtypes (P = 0.043, 0.003 and 0.041, respectively). Conclusions These results show that the sHER2 level at diagnosis is a useful prognostic factor in patients with operable breast cancer, especially in the HR+/HER2-, HR+/HER2+ and HR-/ HER2+ subtypes.	[Lee, Moo Hyun; Jung, So-Youn; Song, Eun Jin; Park, In Hae; Kwon, Young Mee; Lee, Keun Seok; Kang, Han-Sung; Lee, Eun Sook] Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang, Gyeonggi, South Korea; [Kang, Sun Hee] Keimyung Univ, Sch Med, Dept Surg, Daegu, South Korea; [Kong, Sun-Young] Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang, South Korea	National Cancer Center - Korea (NCC); Keimyung University; National Cancer Center - Korea (NCC)	Lee, ES (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang, Gyeonggi, South Korea.	eslee@ncc.re.kr	Kong, Sun-Young/ABB-7914-2021	Lee, Moo Hyun/0000-0003-3634-5230	National Cancer Center, Korea [NCC-1410691-2]	National Cancer Center, Korea	ESL was supported by the National Cancer Center, Korea (NCC-1410691-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2001, CLIN CANCER RES, V7, P2605; Bramwell VHC, 2009, BREAST CANCER RES TR, V114, P503, DOI 10.1007/s10549-008-0033-2; Carney WP, 2003, CLIN CHEM, V49, P1579, DOI 10.1373/49.10.1579; Christianson TA, 1998, CANCER RES, V58, P5123; Codony-Servat J, 1999, CANCER RES, V59, P1196; Cook GB, 2001, ANTICANCER RES, V21, P1465; Garoufali A, 2008, J BUON, V13, P409; Harris LN, 2001, J CLIN ONCOL, V19, P1698, DOI 10.1200/JCO.2001.19.6.1698; Hayes DF, 2001, CLIN CANCER RES, V7, P2703; Kang SH, 2010, J KOREAN SURG SOC, V78, P271, DOI 10.4174/jkss.2010.78.5.271; Kong Sun-Young, 2006, Cancer Res Treat, V38, P35, DOI 10.4143/crt.2006.38.1.35; Krainer M, 1997, ONCOLOGY, V54, P475; Lee JS, 2012, J BREAST CANCER, V15, P189, DOI 10.4048/jbc.2012.15.2.189; Lee SB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-929; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Mehta RR, 1998, J CLIN ONCOL, V16, P2409, DOI 10.1200/JCO.1998.16.7.2409; Molina MA, 2002, CLIN CANCER RES, V8, P347; Molina MA, 2001, CANCER RES, V61, P4744; Molina R, 2003, ANTICANCER RES, V23, P1043; Moreno-Aspitia A, 2013, CANCER-AM CANCER SOC, V119, P2675, DOI 10.1002/cncr.28130; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Saghatchian M, 2004, INT J BIOL MARKER, V19, P14, DOI 10.1177/172460080401900102; Schwartz MK, 2000, INT J BIOL MARKER, V15, P324, DOI 10.1177/172460080001500409; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Willsher PC, 1996, BREAST CANCER RES TR, V40, P251, DOI 10.1007/BF01806813; Witzel I, 2012, BRIT J CANCER, V107, P956, DOI 10.1038/bjc.2012.353	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163370	10.1371/journal.pone.0163370	http://dx.doi.org/10.1371/journal.pone.0163370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706242	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200041
J	Li, SJ; Cao, W; Ren, HY; Lu, L; Zhuang, DF; Liu, QY				Li, Shujuan; Cao, Wei; Ren, Hongyan; Lu, Liang; Zhuang, Dafang; Liu, Qiyong			Time Series Analysis of Hemorrhagic Fever with Renal Syndrome: A Case Study in Jiaonan County, China	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; VARIABILITY	Exact prediction of Hemorrhagic fever with renal syndrome (HFRS) epidemics must improve to establish effective preventive measures in China. A Seasonal Autoregressive Integrated Moving Average (SARIMA) model was applied to establish a highly predictive model of HFRS. Meteorological factors were considered external variables through a cross correlation analysis. Then, these factors were included in the SARIMA model to determine if they could improve the predictive ability of HFRS epidemics in the region. The optimal univariate SARIMA model was identified as (0,0,2)(1,1,1)(12). The R-2 of the prediction of HFRS cases from January 2014 to December 2014 was 0.857, and the Root mean square error (RMSE) was 2.708. However, the inclusion of meteorological variables as external regressors did not significantly improve the SARIMA model. This result is likely because seasonal variations in meteorological variables were included in the seasonal characteristics of the HFRS itself.	[Li, Shujuan; Cao, Wei; Ren, Hongyan; Zhuang, Dafang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, 11A Datun Rd, Beijing 100101, Peoples R China; [Li, Shujuan] Univ Chinese Acad Sci, Coll Resources & Environm, 19 Yuquan Rd, Beijing 100049, Peoples R China; [Lu, Liang; Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, 5 Changbai Rd, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ren, HY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, 11A Datun Rd, Beijing 100101, Peoples R China.	renhy@igsnrr.ac.cn			National Program on Major Scientific Research Project - MOST of China [2012CB955500-955504]; Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China [GW2014-4]	National Program on Major Scientific Research Project - MOST of China; Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China	This work was supported by the National Program on Major Scientific Research Project granted by MOST of China (Grant No. 2012CB955500-955504), http://www.most.gov.cn/, H.R.; the funder conceived and designed the experiments, and also contributed to the writing of the manuscript; and by Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China (Grant No. GW2014-4), http://sph.fudan.edu.cn/, H.R.; the funder conceived and designed the experiments, and also contributed to the writing of the manuscript.	Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Chen Y, 2008, MODERN PREVENTIVE ME, V35, P1414; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Lee HW, 1989, PROG MED VIROL, V41; Li SJ, 2014, INT J ENV RES PUB HE, V11, P12129, DOI 10.3390/ijerph111212129; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Lin HL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-130; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Song YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117296; Tao B, 2009, PREV MED TRIB, V15, P4; Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yi Jing, 2007, Zhonghua Yufang Yixue Zazhi, V41, P118; Zhang S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-384	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163771	10.1371/journal.pone.0163771	http://dx.doi.org/10.1371/journal.pone.0163771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706256	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200056
J	Machowska, A; Sun, J; Qureshi, AR; Isoyama, N; Leurs, P; Anderstam, B; Heimburger, O; Barany, P; Stenvinkel, P; Lindholm, B				Machowska, Anna; Sun, Jia; Qureshi, Abdul Rashid; Isoyama, Naohito; Leurs, Paul; Anderstam, Bjorn; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Lindholm, Bengt			Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; OXIDATION PROTEIN PRODUCTS; PERITONEAL-DIALYSIS PATIENTS; CARDIOVASCULAR RISK-FACTORS; INCREASED SERUM-LEVELS; C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; TOTAL HOMOCYSTEINE; RENAL-FAILURE; ALL-CAUSE	Background Circulating advanced glycated end-products (AGEs) including pentosidine accumulating in chronic kidney disease (CKD) patients due to retention and increased formation are thought to contribute to cardiovascular disease (CVD). Here we evaluated factors linked to increased plasma pentosidine and its association with mortality in patients with different stages of CKD and undergoing different treatments. Methods Plasma pentosidine, biomarkers of inflammation, oxidative stress and nutritional status were investigated in CKD 1-2 (n = 37), CKD 3-4 (n = 54), CKD 5 non-dialyzed (CKD5-ND; n = 386), peritoneal dialysis (PD; n = 74) and hemodialysis (HD; n = 195) patients. Factors predicting plasma pentosidine were analysed by multivariate regression analysis and mortality risk was assessed by GENMOD procedure. Results Plasma pentosidine levels, which were higher in CKD5-ND, PD and HD groups than in CKD 1-2 group, were significantly lower in PD than in HD patients, and not different between PD patients and CKD5-ND patients. Pentosidine associated inversely with glomerular filtration rate (GFR), and additionally in PD with 8-hydroxy-2'-deoxyguanosine (8-OHdG), and interleukin 6 (IL-6); in HD with age, IL-6 and body mass index (BMI); in CKD5-ND with age, 8-OHdG, IL-6, high-sensitive C-reactive protein (hsCRP), and soluble vascular cell adhesion protein-1 (sVCAM-1); in CKD 3-4 with 8-OHdG and sVCAM-1; and in CKD 1-2 with age and sVCAM-1. In multivariate analysis, age (one standard deviation, 1-SD higher), malnutrition (subjective global assessment, SGA), oxidative stress (8-OHdG, 1-SD higher), and belonging to CKD5-ND, HD and PD cohorts associated with 1-SD higher pentosidine. In GENMOD, 1-SD higher pentosidine independently predicted all-cause mortality (relative risk, RR = 1.04; 95% confidence interval, CI, 1.01-1.08, p = 0.01) and CVD mortality (RR = 1.03; 95% CI, 1.01-1.06, p = 0.03) after adjusting for all confounders. Conclusions Plasma pentosidine is markedly elevated in CKD and associates with low GFR, oxidative stress and inflammation, and is an independent predictor of mortality in CKD patients.	[Machowska, Anna; Sun, Jia; Qureshi, Abdul Rashid; Isoyama, Naohito; Leurs, Paul; Anderstam, Bjorn; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Lindholm, Bengt] Karolinska Inst, Renal Med & Baxter Novum, Stockholm, Sweden; [Isoyama, Naohito] Yamaguchi Univ, Dept Urol, Ube, Yamaguchi, Japan; [Leurs, Paul] Admiraal de Ruyter Hosp, Goes, Netherlands	Karolinska Institutet; Yamaguchi University	Lindholm, B (corresponding author), Karolinska Inst, Renal Med & Baxter Novum, Stockholm, Sweden.	Bengt.Lindholm@ki.se	; Lindholm, Bengt/P-1334-2017	Stenvinkel, Peter/0000-0002-8785-4820; Heimburger, Olof/0000-0003-0901-4145; Lindholm, Bengt/0000-0003-4269-4293; Barany, Peter/0000-0001-6501-8293				BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Busch M, 2004, KIDNEY INT, V66, P338, DOI 10.1111/j.1523-1755.2004.00736.x; Furuya R, 2012, CLIN EXP NEPHROL, V16, P421, DOI 10.1007/s10157-011-0573-3; Furuya R, 2009, NEPHRON CLIN PRACT, V112, pC255, DOI 10.1159/000224792; Ghanavatian S, 2014, ANGIOLOGY, V65, P443, DOI 10.1177/0003319713483000; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Kilhovd BK, 2009, ATHEROSCLEROSIS, V205, P590, DOI 10.1016/j.atherosclerosis.2008.12.041; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Koyama H, 2010, EUR J CLIN INVEST, V40, P623, DOI 10.1111/j.1365-2362.2010.02298.x; Leurs P, 2013, ARCH MED RES, V44, P601, DOI 10.1016/j.arcmed.2013.11.002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Machowska A, 2016, TRANSL RES, V167, P204, DOI 10.1016/j.trsl.2015.06.012; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2009, AM J KIDNEY DIS, V53, P138, DOI 10.1053/j.ajkd.2008.08.031; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Nakayama M, 1997, KIDNEY INT, V51, P182, DOI 10.1038/ki.1997.22; Nin JW, 2011, DIABETES CARE, V34, P442, DOI 10.2337/dc10-1087; Pachaly MA, 2008, BLOOD PURIFICAT, V26, P204, DOI 10.1159/000117438; Park SH, 2012, J RENAL NUTR, V22, P120, DOI 10.1053/j.jrn.2011.10.021; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Semba RD, 2009, J AM GERIATR SOC, V57, P1874, DOI 10.1111/j.1532-5415.2009.02438.x; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Stein G, 2003, AM J KIDNEY DIS, V41, pS52, DOI 10.1053/ajkd.2003.50085; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sugiyama S, 1998, J AM SOC NEPHROL, V9, P1681; Suliman ME, 2006, CLIN NEPHROL, V66, P418; Suliman ME, 2003, J AM SOC NEPHROL, V14, P1614, DOI 10.1097/01.ASN.0000067413.32377.CF; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Utescu MS, 2013, HYPERTENSION, V62, P154, DOI 10.1161/HYPERTENSIONAHA.113.01200; Xu H, 2015, PERITON DIALYSIS INT, V35, P460, DOI 10.3747/pdi.2013.00064; Zhou YL, 2010, ARTIF ORGANS, V34, P193, DOI 10.1111/j.1525-1594.2009.00801.x; Zoccali C, 2001, J NEPHROL, V14, P293	34	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163826	10.1371/journal.pone.0163826	http://dx.doi.org/10.1371/journal.pone.0163826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701453	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900023
J	Thamm, K; Graupner, S; Werner, C; Huttner, WB; Corbeil, D				Thamm, Kristina; Graupner, Sylvi; Werner, Carsten; Huttner, Wieland B.; Corbeil, Denis			Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)	PLOS ONE			English	Article							POLYTOPIC MEMBRANE-PROTEIN; HUMAN HEMATOPOIETIC STEM; CENTRAL-NERVOUS-SYSTEM; EPITHELIAL-CELLS; SPLICE VARIANTS; MARKER CD133; NEURAL PROGENITORS; DISTINCT MEMBER; KIDNEY PROMININ; GENE-EXPRESSION	The pentaspan membrane glycoprotein prominin-1 (CD133) is widely used in medicine as a cell surface marker of stem and cancer stem cells. It has opened new avenues in stem cell-based regenerative therapy and oncology. This molecule is largely used with human samples or the mouse model, and consequently most biological tools including antibodies are directed against human and murine prominin-1. Although the general structure of prominin-1 including its membrane topology is conserved throughout the animal kingdom, its primary sequence is poorly conserved. Thus, it is unclear if anti-human and -mouse prominin-1 antibodies cross-react with their orthologs in other species, especially dog. Answering this issue is imperative in light of the growing number of studies using canine prominin-1 as an antigenic marker. Here, we address this issue by cloning the canine prominin-1 and use its overexpression as a green fluorescent protein fusion protein in Madin-Darby canine kidney cells to determine its immunoreactivity with antibodies against human or mouse prominin-1. We used immunocytochemistry, flow cytometry and immunoblotting techniques and surprisingly found no cross-species immunoreactivity. These results raise some caution in data interpretation when anti-prominin-1 antibodies are used in interspecies studies.	[Thamm, Kristina; Graupner, Sylvi; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Dresden, Germany; [Werner, Carsten; Corbeil, Denis] Tech Univ Dresden, DFG Res Ctr, Dresden, Germany; [Werner, Carsten; Corbeil, Denis] Tech Univ Dresden, Cluster Excellence Regenerat Therapies Dresden CR, Dresden, Germany; [Werner, Carsten] Leibniz Inst Polymer Res Dresden, Inst Biofunct Polymer Mat, Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Leibniz Institut fur Polymerforschung Dresden; Max Planck Society	Corbeil, D (corresponding author), Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Dresden, Germany.; Corbeil, D (corresponding author), Tech Univ Dresden, DFG Res Ctr, Dresden, Germany.; Corbeil, D (corresponding author), Tech Univ Dresden, Cluster Excellence Regenerat Therapies Dresden CR, Dresden, Germany.	corbeil@biotec.tu-dresden.de	Corbeil, Denis/A-6519-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Werner, Carsten/F-8127-2010; Huttner, Wieland B./P-4080-2018; Werner, Carsten/AAF-1510-2019	Corbeil, Denis/0000-0003-1181-3659; Werner, Carsten/0000-0003-0189-3448; 	Deutsche Forschungsgemeinschaft (DFG) [SFB655-B3, CO298/5-1]; Bundesministerium fur Bildung und Forschung (BMBF) [01DN13019]; Sachsisches Staatsministerium fur Wissenschaft und Kunst [4-7531.60/29/31]; DFG [SFB655]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Sachsisches Staatsministerium fur Wissenschaft und Kunst; DFG(German Research Foundation (DFG))	DC was supported by Deutsche Forschungsgemeinschaft (DFG, SFB655-B3; CO298/5-1), Bundesministerium fur Bildung und Forschung (BMBF, 01DN13019) and Sachsisches Staatsministerium fur Wissenschaft und Kunst (4-7531.60/29/31). CW and WBH were supported by DFG (SFB655-B2, SFB655-A2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belicchi M, 2004, J NEUROSCI RES, V77, P475, DOI 10.1002/jnr.20151; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Blacking TM, 2012, VET COMP ONCOL, V10, P252, DOI 10.1111/j.1476-5829.2011.00293.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Cocola C, 2009, REPROD DOMEST ANIM, V44, P214, DOI 10.1111/j.1439-0531.2009.01413.x; Cogliati B, 2010, VET COMP ONCOL, V8, P112, DOI 10.1111/j.1476-5829.2010.00210.x; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00091; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Fernandez F, 2016, VET J, V209, P125, DOI 10.1016/j.tvjl.2015.10.039; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Fujimoto A, 2013, J VET MED SCI, V75, P831, DOI 10.1292/jvms.12-0549; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Green CL, 2000, LEUKEMIA, V14, P770, DOI 10.1038/sj.leu.2401736; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gurudev N, 2013, ADV EXP MED BIOL, V777, P55, DOI 10.1007/978-1-4614-5894-4_4; Guth AM, 2014, VET IMMUNOL IMMUNOP, V161, P132, DOI 10.1016/j.vetimm.2014.07.006; Han Z, 2011, MOL VIS, V17, P1381; Hermansen SK, 2011, J HISTOCHEM CYTOCHEM, V59, P391, DOI 10.1369/0022155411400867; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Ito D, 2011, J VET INTERN MED, V25, P890, DOI 10.1111/j.1939-1676.2011.0756.x; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2015, NEURAL SURFACE ANTIG, P113; Jaszai J, 2008, HISTOCHEM CELL BIOL, V130, P749, DOI 10.1007/s00418-008-0445-4; Jaszai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063457; Jaszai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017590; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kemper K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012325; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu W, 2015, ANTICANCER RES, V35, P1917; Lorico A, 2013, ADV EXP MED BIOL, V777, P197, DOI 10.1007/978-1-4614-5894-4_13; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; McMahill BG, 2015, STEM CELL REV REP, V11, P180, DOI 10.1007/s12015-014-9553-9; Michishita M, 2014, RES VET SCI, V96, P315, DOI 10.1016/j.rvsc.2014.01.004; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Miraglia S, 1998, BLOOD, V91, P4390, DOI 10.1182/blood.V91.11.4390; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Moulay M, 2013, ANTICANCER RES, V33, P5421; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Osmond TL, 2010, INT J MOL MED, V25, P883, DOI 10.3892/ijmm_00000418; Potgens AJG, 2002, J HISTOCHEM CYTOCHEM, V50, P1131, DOI 10.1177/002215540205000814; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmohl JU, 2016, TOXINS, V8, DOI 10.3390/toxins8060165; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki S, 2015, VET PATHOL, V52, P456, DOI 10.1177/0300985814546051; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tabu K, 2013, ADV EXP MED BIOL, V777, P73, DOI 10.1007/978-1-4614-5894-4_5; Tanabe A, 2016, VET COMP ONCOL, V14, pE93, DOI 10.1111/vco.12110; Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Valenzuela MJ, 2008, STEM CELLS DEV, V17, P1087, DOI 10.1089/scd.2008.0008; Walton RM, 2013, HISTOCHEM CELL BIOL, V139, P415, DOI 10.1007/s00418-012-1053-x; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu YF, 2006, ANN VASC SURG, V20, P387, DOI 10.1007/s10016-006-9047-6; Xia J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03320; Xia L, 2009, J PHYSIOL SCI, V59, P429, DOI 10.1007/s12576-009-0053-7; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	97	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164079	10.1371/journal.pone.0164079	http://dx.doi.org/10.1371/journal.pone.0164079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701459	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900042
J	Yao, X; Pham, T; Temple, B; Gray, S; Cannon, C; Chen, RW; Abdel-Mageed, AB; Biliran, H				Yao, Xin; Tri Pham; Temple, Brandi; Gray, Selena; Cannon, Cornita; Chen, Renwei; Abdel-Mageed, Asim B.; Biliran, Hector			The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COREPRESSOR CTBP; PROTEIN; INTEGRINS; BINDING; TLE1; TRANSFORMATION; TRANSCRIPTION; SUPPRESSION; METASTASIS	The mitochondrial Bcl-2 inhibitor of transcription 1 (Bit1) protein is part of an anoikis-regulating pathway that is selectively dependent on integrins. We previously demonstrated that the caspase-independent apoptotic effector Bit1 exerts tumor suppressive function in lung cancer in part by inhibiting anoikis resistance and anchorage-independent growth in vitro and tumorigenicity in vivo. Herein we show a novel function of Bit1 as an inhibitor cell migration and epithelial - mesenchymal transition (EMT) in the human lung adenocarcinoma A549 cell line. Suppression of endogenous Bit1 expression via siRNA and shRNA strategies promoted mesenchymal phenotypes, including enhanced fibroblastoid morphology and cell migratory potential with concomitant downregulation of the epithelial marker E-cadherin expression. Conversely, ectopic Bit1 expression in A549 cells promoted epithelial transition characterized by cuboidal-like epithelial cell phenotype, reduced cell motility, and upregulated E-cadherin expression. Specific downregulation of E-cadherin in Bit1-transfected cells was sufficient to block Bit1-mediated inhibition of cell motility while forced expression of E-cadherin alone attenuated the enhanced migration of Bit1 knockdown cells, indicating that E-cadherin is a downstream target of Bit1 in regulating cell motility. Furthermore, quantitative real-time PCR and reporter analyses revealed that Bit1 upregulates E-cadherin expression at the transcriptional level through the transcriptional regulator Amino-terminal Enhancer of Split (AES) protein. Importantly, the Bit1/AES pathway induction of E-cadherin expression involves inhibition of the TLE1-mediated repression of E-cadherin, by decreasing TLE1 corepressor occupancy at the E-cadherin promoter as revealed by chromatin immunoprecipitation assays. Consistent with its EMT inhibitory function, exogenous Bit1 expression significantly suppressed the formation of lung metastases of A549 cells in an in vivo experimental metastasis model. Taken together, our studies indicate Bit1 is an inhibitor of EMT and metastasis in lung cancer and hence can serve as a molecular target in curbing lung cancer aggressiveness.	[Yao, Xin; Tri Pham; Temple, Brandi; Gray, Selena; Cannon, Cornita; Biliran, Hector] Xavier Univ Louisiana, Dept Biol & Publ Hlth Sci, New Orleans, LA 70125 USA; [Chen, Renwei] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA; [Abdel-Mageed, Asim B.] Tulane Univ, Sch Med, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA	Xavier University of Louisiana; University of California System; University of California Santa Barbara; Tulane University	Biliran, H (corresponding author), Xavier Univ Louisiana, Dept Biol & Publ Hlth Sci, New Orleans, LA 70125 USA.	hbiliran@xula.edu		Abdel-Mageed, Asim/0000-0001-8590-783X; Glover, Brandi/0000-0002-5760-8143	National Cancer Institute [NIH 2R15 CA158677-02]; National Institute of General Medical Sciences of the National Institutes of Health [R25GM060926]; NIH [2R15CA158677-02]; NATIONAL CANCER INSTITUTE [R15CA158677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060926] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Cancer Institute (NIH 2R15 CA158677-02). This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R25GM060926 to Xavier University of Louisiana and NIH 2R15CA158677-02 Grant to Hector Biliran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Brunquell C, 2012, MOL CANCER RES, V10, P1482, DOI 10.1158/1541-7786.MCR-12-0144; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen RW, 2013, CANCER RES, V73, P1352, DOI 10.1158/0008-5472.CAN-12-1979; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Griffiths GS, 2011, J BIOL CHEM, V286, P14713, DOI 10.1074/jbc.M111.228387; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Karmali PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023840; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Seo SW, 2011, J ORTHOP RES, V29, P1131, DOI 10.1002/jor.21318; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Yao X, 2014, BIOCHEM BIOPH RES CO, V455, P277, DOI 10.1016/j.bbrc.2014.11.007; Yao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101564; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	25	9	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2016	11	9							e0163228	10.1371/journal.pone.0163228	http://dx.doi.org/10.1371/journal.pone.0163228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GK	27655370	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892700045
J	Bruder-Nascimento, T; Callera, G; Montezano, AC; Antunes, TT; He, Y; Cat, AND; Ferreira, NS; Barreto, PA; Olivon, VC; Tostes, RC; Touyz, RM				Bruder-Nascimento, Thiago; Callera, Glaucia; Montezano, Augusto Cesar; Antunes, Tayze T.; He, Ying; Cat, Aurelie Nguyen Dinh; Ferreira, Nathanne S.; Barreto, Pedro A.; Olivon, Vania C.; Tostes, Rita C.; Touyz, Rhian M.			Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3	PLOS ONE			English	Article							KINASE INHIBITOR; AKT ACTIVATION; KIDNEY; NEPHROPATHY; ALDOSTERONE; DISEASE; PROLIFERATION; ROSUVASTATIN; HYPERTENSION; PITAVASTATIN	Potential benefits of statins in the treatment of chronic kidney disease beyond lipid-lowering effects have been described. However, molecular mechanisms involved in renoprotective actions of statins have not been fully elucidated. We questioned whether statins influence development of diabetic nephropathy through reactive oxygen species, RhoA and Akt/GSK3 pathway, known to be important in renal pathology. Diabetic mice (db/db) and their control counterparts(db/+) were treated with atorvastatin (10 mg/Kg/day, p.o., for 2 weeks). Diabetes-associated renal injurywas characterized by albuminuria (albumin: creatinine ratio, db/+: 3.2 +/- 0.6 vs. db/db: 12.5 +/- 3.1*; * P<0.05), increased glomerular/mesangial surface area, and kidney hypertrophy. Renal injurywas attenuated in atorvastatin-treated db/db mice. Increased ROS generation in the renal cortex of db/db mice was also inhibited by atorvastatin. ERK1/2 phosphorylation was increased in the renal cortex of db/db mice. Increased renal expression of Nox4 and proliferating cell nuclear antigen, observed in db/db mice, were abrogated by statin treatment. Atorvastatin also upregulated Akt/GSK3 beta phosphorylation in the renal cortex of db/db mice. Our findings suggest that atorvastatin attenuates diabetes-associated renal injury by reducing ROS generation, RhoA activity and normalizing Akt/GSK3 beta signaling pathways. The present study provides some new insights into molecular mechanisms whereby statins may protect against renal injury in diabetes.	[Bruder-Nascimento, Thiago; Ferreira, Nathanne S.; Barreto, Pedro A.; Olivon, Vania C.; Tostes, Rita C.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, Brazil; [Bruder-Nascimento, Thiago; Callera, Glaucia; Antunes, Tayze T.; He, Ying; Touyz, Rhian M.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [Montezano, Augusto Cesar; Cat, Aurelie Nguyen Dinh; Touyz, Rhian M.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Universidade de Sao Paulo; University of Ottawa; Ottawa Hospital Research Institute; University of Glasgow	Touyz, RM (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada.; Touyz, RM (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Rhian.Touyz@glasgow.ac.uk	CAT, Aurelie NGUYEN DINH/H-8182-2013; Olivon, Vania Claudia/GNH-1889-2022; Bruder-Nascimento, Thiago/M-7051-2013; Tostes, Rita C/C-1025-2012; deng, qiongxia/A-3206-2017; Touyz, Rhian/AAM-3564-2020	Olivon, Vania Claudia/0000-0001-6689-0972; Tostes, Rita C/0000-0002-9446-0707; Touyz, Rhian/0000-0003-0670-0887	Sao Paulo Research Foundation (FAPESP) [2010/522146, 2011/01785-6, 2011/22035-5]; Coordination for the Improvement of Higher Education Personnel (CAPES) [88887.092495/2015-00]; Agence Universitaire de la Francophonie (AUF); Canadian Institutes of Health Research; British Heart Foundation (BHF) [29762, 30099]; British Heart Foundation [RG/13/7/30099] Funding Source: researchfish	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Agence Universitaire de la Francophonie (AUF); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by grants from Sao Paulo Research Foundation (FAPESP) [2010/522146 (RCT); 2011/01785-6; 2011/22035-5 (TBN)], Coordination for the Improvement of Higher Education Personnel (CAPES) [88887.092495/2015-00 (TBN)], Agence Universitaire de la Francophonie (AUF), Canadian Institutes of Health Research and the British Heart Foundation (BHF) [#29762, 30099 (RMT)].	Antunes TT, 2016, HYPERTENSION, V67, P763, DOI 10.1161/HYPERTENSIONAHA.115.07021; Athyros VG, 2007, NEPHROL DIAL TRANSPL, V22, P118, DOI 10.1093/ndt/gfl538; Brennan E, 2013, GENES-BASEL, V4, P596, DOI 10.3390/genes4040596; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Bruder-Nascimento T, 2015, CLIN SCI, V128, P411, DOI 10.1042/CS20140456; Chen C, 2009, NEPHRON EXP NEPHROL, V113, pE26, DOI 10.1159/000228080; Coupel S, 2004, J AM SOC NEPHROL, V15, P2429, DOI 10.1097/01.ASN.0000138237.42675.45; Davignon J, 2004, CORONARY ARTERY DIS, V15, P251, DOI 10.1097/01.mca.0000131573.31966.34; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Fellstrom B, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-9; Fujii M, 2007, KIDNEY INT, V72, P473, DOI 10.1038/sj.ki.5002366; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Gotto A M Jr, 1999, Circulation, V99, pE1; Hall JE, 2004, ADV RENAL REPLACE TH, V11, P41, DOI 10.1053/j.arrt.2003.10.007; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Jin LM, 2006, J PHARMACOL EXP THER, V318, P288, DOI 10.1124/jpet.105.100735; KASISKE BL, 1988, CIRC RES, V62, P367, DOI 10.1161/01.RES.62.2.367; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Lim S, 2014, ATHEROSCLEROSIS, V233, P721, DOI 10.1016/j.atherosclerosis.2014.01.051; Maric-Bilkan C, 2013, MED CLIN N AM, V97, P59, DOI 10.1016/j.mcna.2012.10.010; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Nagaoka T, 2006, J APPL PHYSIOL, V100, P996, DOI 10.1152/japplphysiol.01028.2005; Peng HB, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-321; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep20304; Pinho-Gomes AC, 2014, ANTIOXID REDOX SIGN, V20, P1268, DOI 10.1089/ars.2013.5542; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takazakura A, 2015, J DIABETES INVEST, V6, P346, DOI 10.1111/jdi.12296; Tamura Y, 2011, INT J MOL MED, V28, P683, DOI 10.3892/ijmm.2011.769; Toba H, 2010, CLIN EXP PHARMACOL P, V37, P1064, DOI 10.1111/j.1440-1681.2010.05436.x; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Xiao HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059233; Xu F, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/289327; Yin HP, 2013, INT J MOL SCI, V14, P20282, DOI 10.3390/ijms141020282; Yogi A, 2011, J HYPERTENS, V29, P1400, DOI 10.1097/HJH.0b013e32834786d6; Yokota T, 1999, KIDNEY INT, V56, pS178, DOI 10.1046/j.1523-1755.1999.07146.x; Zhang Z, 2009, FEBS LETT, V583, P2009, DOI 10.1016/j.febslet.2009.05.021; Zhou SX, 2014, EUR J PHARMACOL, V740, P9, DOI 10.1016/j.ejphar.2014.06.055	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162731	10.1371/journal.pone.0162731	http://dx.doi.org/10.1371/journal.pone.0162731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649495	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000383892100031
J	Monecke, S; Jatzwauk, L; Muller, E; Nitschke, H; Pfohl, K; Slickers, P; Reissig, A; Ruppelt-Lorz, A; Ehricht, R				Monecke, Stefan; Jatzwauk, Lutz; Mueller, Elke; Nitschke, Hedda; Pfohl, Katharina; Slickers, Peter; Reissig, Annett; Ruppelt-Lorz, Antje; Ehricht, Ralf			Diversity of SCCmec Elements in Staphylococcus aureus as Observed in South-Eastern Germany	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; CASSETTE CHROMOSOME RECOMBINASE; FUSIDIC ACID; MEC; EVOLUTION; STRAIN; EPIDEMIOLOGY; RESISTANCE; EMERGENCE	SCCmec elements are very important mobile genetic elements in Staphylococci that carry beta-lactam resistance genes mecA/mecC, recombinase genes and a variety of accessory genes. Twelve main types and a couple of variants have yet been described. In addition, there are also other SCC elements harbouring other markers. In order to subtype strains of methicillin-resistant S. aureus (MRSA) based on variations within their SCCmec elements, 86 markers were selected from published SCC sequences for an assay based on multiplexed primer extension reactions followed by hybridisation to the specific probes. These included mecA/mecC, fusC, regulatory genes, recombinase genes, genes from ACME and heavy metal resistance loci as well as several genes of unknown function. Hybridisation patterns for published genome or SCC sequences were theoretically predicted. For validation of the microarray based assay and for stringent hybridisation protocol optimization, real hybridization experiments with fully sequenced reference strains were performed modifying protocols until yielded the results were in concordance to the theoretical predictions. Subsequently, 226 clinical isolates from two hospitals in the city of Dresden, Germany, were characterised in detail. Beside previously described types and subtypes, a wide variety of additional SCC types or subtypes and pseudoSCC elements were observed as well as numerous composite elements. Within the study collection, 61 different such elements have been identified. Since hybridisation cannot recognise the localisation of target genes, gene duplications or inversions, this is a rather conservative estimate. Interestingly, some widespread epidemic strains engulf distinct variants with different SCCmec subtypes. Notable examples are ST239-MRSA-III, CC5-, CC22-, CC30-, and CC45-MRSA-IV or CC398MRSA- V. Conversely, identical SCC elements were observed in different strains with SCCmec IVa being spread among the highest number of Clonal Complexes. The proposed microarray can help to distinguish isolates that appear similar or identical by other typing methods and it can be used as high-throughput screening tool for the detection of putative new SCC types or variants that warrant further investigation and sequencing. The high degree of diversity of SCC elements even within so-called strains could be helpful for epidemiological typing. It also raises the question on scale and speed of the evolution of SCC elements.	[Monecke, Stefan; Pfohl, Katharina; Ruppelt-Lorz, Antje] Tech Univ Dresden, IMMH, Dresden, Germany; [Jatzwauk, Lutz] Dresden Univ Hosp, Dept Hosp Infect Control, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Slickers, Peter; Reissig, Annett; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Nitschke, Hedda] Hosp Dresden Neustadt, Dept Lab Med, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Slickers, Peter; Reissig, Annett; Ehricht, Ralf] InfectoGnost Res Campus, Jena, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alere; Technische Universitat Dresden; Municipal Hospital Dresden	Monecke, S (corresponding author), Tech Univ Dresden, IMMH, Dresden, Germany.; Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.; Monecke, S (corresponding author), InfectoGnost Res Campus, Jena, Germany.	monecke@rocketmail.com			Alere Technologies	Alere Technologies	There was no external funding for this work. Each of the participating institutions covered the costs of experiments performed in the respective institutions, as well as granted the time needed to perform this study. Alere Technologies provided support in the form of salaries for authors EM, AR, PS, RE, and SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Baines SL, 2016, ANTIMICROB AGENTS CH, V60, P2359, DOI 10.1128/AAC.03020-15; Coombs GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043037; Dauwalder O, 2008, J CLIN MICROBIOL, V46, P3454, DOI 10.1128/JCM.01050-08; Dijkshoorn L, 2000, J MED MICROBIOL, V49, P397, DOI 10.1099/0022-1317-49-5-397; Ellington MJ, 2015, INT J ANTIMICROB AG, V45, P477, DOI 10.1016/j.ijantimicag.2015.01.009; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Laham NA, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0120008; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke Stefan, 2013, BMC Res Notes, V6, P548, DOI 10.1186/1756-0500-6-548; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Williamson DA, 2014, CLIN INFECT DIS, V59, P1451, DOI 10.1093/cid/ciu658; Witte W, 2001, INT J MED MICROBIOL, V290, P677, DOI 10.1016/S1438-4221(01)80006-0; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15	35	55	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162654	10.1371/journal.pone.0162654	http://dx.doi.org/10.1371/journal.pone.0162654			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648947	Green Submitted, gold, Green Published			2022-12-26	WOS:000383892100027
J	Salazar-Vidal, MN; Acosta-Segovia, E; Sanchez-Leon, N; Ahern, KR; Brutnell, TP; Sawers, RJH				Salazar-Vidal, M. Nancy; Acosta-Segovia, Edith; Sanchez-Leon, Nidia; Ahern, Kevin R.; Brutnell, Thomas P.; Sawers, Ruairidh J. H.			Characterization and Transposon Mutagenesis of the Maize (Zea mays) Pho1 Gene Family	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; PHOSPHATE HOMEOSTASIS; DISSOCIATION ELEMENTS; ACTIVATOR AC; KEY ROLE; ARABIDOPSIS; EVOLUTION; SHOOT	Phosphorus is an essential nutrient for all plants, but also one of the least mobile, and consequently least available, in the soil. Plants have evolved a series of molecular, metabolic and developmental adaptations to increase the acquisition of phosphorus and to maximize the efficiency of use within the plant. In Arabidopsis (Arabidopsis thaliana), the AtPHO1 protein regulates and facilitates the distribution of phosphorus. To investigate the role of PHO1 proteins in maize (Zea mays), the B73 reference genome was searched for homologous sequences, and four genes identified that were designated ZmPho1; 1, ZmPho1; 2a, ZmPho1; 2b and ZmPho1; 3. ZmPho1; 2a and ZmPho1; 2b are the most similar to AtPHO1, and represent candidate co-orthologs that we hypothesize to have been retained following whole genome duplication. Evidence was obtained for the production of natural anti-sense transcripts associated with both ZmPho1; 2a and ZmPho1; 2b, suggesting the possibility of regulatory crosstalk between paralogs. To characterize functional divergence between ZmPho1; 2a and ZmPho1; 2b, a program of transposon mutagenesis was initiated using the Ac/Ds system, and, here, we report the generation of novel alleles of ZmPho1; 2a and ZmPho1; 2b.	[Salazar-Vidal, M. Nancy; Acosta-Segovia, Edith; Sanchez-Leon, Nidia; Sawers, Ruairidh J. H.] CINVESTAV IPN, LANGEBIO, Unidad Genom Avanzada, Guanajuato 36821, Mexico; [Ahern, Kevin R.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Brutnell, Thomas P.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Cornell University; Boyce Thompson Institute for Plant Research; Donald Danforth Plant Science Center	Sawers, RJH (corresponding author), CINVESTAV IPN, LANGEBIO, Unidad Genom Avanzada, Guanajuato 36821, Mexico.	rusawers@cinvestav.mx	Brutnell, Thomas/M-2840-2013	Brutnell, Thomas/0000-0002-3581-8211; Salazar Vidal, Miriam Nancy/0000-0003-4894-9795; Sawers, Ruairidh James Hay/0000-0002-8945-3078	National Science Foundation [IOS-0922701]; Consejo Nacional de Ciencia y Technologia (Mexico) [CB2012-151947]; Mexican National Council of Science and Technology (CONACYT) [CB2012-151947]	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Technologia (Mexico); Mexican National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Science Foundation (www.nsf.gov) award IOS-0922701 to TB and Consejo Nacional de Ciencia y Technologia (Mexico; www.conacyt.mx) award CB2012-151947 to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Juan M. Estevez-Palmas for valuable comments on the manuscript. This work was supported by the National Science Foundation grant IOS-0922701 to TB and the Mexican National Council of Science and Technology (CONACYT) grant CB2012-151947 to RS.	Ahern KR, 2009, METHODS, V49, P248, DOI 10.1016/j.ymeth.2009.04.009; ALLEMAN M, 1993, GENETICS, V135, P189; Bai L, 2007, GENETICS, V175, P981, DOI 10.1534/genetics.106.066837; Brutnell TP, 2003, METH MOL B, V236, P157; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Conrad LJ, 2005, GENETICS, V171, P1999, DOI 10.1534/genetics.105.046623; DOONER HK, 1989, GENETICS, V122, P447; Gonzalez-Munoz E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00341; Hoagland DR, 1936, PLANT PHYSIOL, V11, P471, DOI 10.1104/pp.11.3.471; Hughes TE, 2014, GENOME RES, V24, P1348, DOI 10.1101/gr.172684.114; Jabnoune M, 2013, PLANT CELL, V25, P4166, DOI 10.1105/tpc.113.116251; Kolkman JM, 2005, GENETICS, V169, P981, DOI 10.1534/genetics.104.033738; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Ribot C, 2008, PLANT PHYSIOL, V147, P696, DOI 10.1104/pp.108.119321; Rouached H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-19; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Secco D, 2012, NEW PHYTOL, V193, P842, DOI 10.1111/j.1469-8137.2011.04002.x; Secco D, 2010, PLANT PHYSIOL, V152, P1693, DOI 10.1104/pp.109.149872; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Vance CP, 2014, UPDATE STATE NITROGE; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Vollbrecht E, 2010, PLANT CELL, V22, P1667, DOI 10.1105/tpc.109.073452; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; Wege S, 2015, PLANT PHYSL; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	27	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161882	10.1371/journal.pone.0161882	http://dx.doi.org/10.1371/journal.pone.0161882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648940	Green Submitted, gold, Green Published			2022-12-26	WOS:000383892100009
J	Adachi, K; Takahashi, S; Yamauchi, K; Mounai, N; Tanabu, R; Nakazawa, M				Adachi, Kobu; Takahashi, Shizuka; Yamauchi, Kodai; Mounai, Natsuki; Tanabu, Reiko; Nakazawa, Mitsuru			Optical Coherence Tomography of Retinal Degeneration in Royal College of Surgeons Rats and Its Correlation with Morphology and Electroretinography	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; RCS RAT; SD-OCT; GENE-TRANSFER; MOUSE MODELS; DYSTROPHY; MUTATIONS; THICKNESS; RECEPTOR; MERTK	Purpose To evaluate the correlation between optical coherence tomography (OCT) and the histological, ultrastructural and electroretinography (ERG) findings of retinal degeneration in Royal College of Surgeons (RCS-/-) rats. Materials and Methods Using OCT, we qualitatively and quantitatively observed the continual retinal degeneration in RCS-/- rats, from postnatal (PN) day 17 until PN day 111. These findings were compared with the corresponding histological, electron microscopic, and ERG findings. We also compared them to OCT findings in wild type RCS+/+ rats, which were used as controls. Results After PN day 17, the hyperreflective band at the apical side of the photoreceptor layer became blurred. The inner segment (IS) ellipsoid zone then became obscured, and the photoreceptor IS and outer segment (OS) layers became diffusely hyperreflective after PN day 21. These changes correlated with histological and electron microscopic findings showing extracellular lamellar material that accumulated in the photoreceptor OS layer. After PN day 26, the outer nuclear layer became significantly thinner (P < 0.01) and hyperreflective compared with that in the controls; conversely, the photoreceptor IS and OS layers, as well as the inner retinal layers, became significantly thicker (P < 0.001 and P = 0.05, respectively). The apical hyperreflective band, as well as the IS ellipsoid zone, gradually disappeared between PN day 20 and PN day 30; concurrently, the ERG a- and b-wave amplitudes deteriorated. In contrast, the thicknesses of the combined retinal pigment epithelium and choroid did not differ significantly between RCS-/- and RCS+/+ rats. Conclusion Our results suggest that OCT demonstrates histologically validated photoreceptor degeneration in RCS rats, and that OCT findings partly correlate with ERG findings. We propose that OCT is a less invasive and useful method for evaluating photoreceptor degeneration in animal models of retinitis pigmentosa.	[Adachi, Kobu; Takahashi, Shizuka; Yamauchi, Kodai; Mounai, Natsuki; Tanabu, Reiko; Nakazawa, Mitsuru] Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan	Hirosaki University	Nakazawa, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Ophthalmol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	mitsuru@hirosaki-u.ac.jp	Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712; Takahashi, Shizuka/0000-0001-7225-979X	Japan Society for the Promotion of Science [15K20246, 16K11313]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by the Grant-in Aid for Scientific Research (15K20246 and 16K11313) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported, in part, by the Grant-in-Aids for Scientific Research (15K20246 and 16K11313) from the Japan Society for the Promotion for Science.	Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Birch DG, 2013, JAMA OPHTHALMOL, V131, P1143, DOI 10.1001/jamaophthalmol.2013.4160; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dhoot DS, 2013, BRIT J OPHTHALMOL, V97, P66, DOI 10.1136/bjophthalmol-2012-301917; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Ghazi NG, 2016, HUM GENET, V135, P327, DOI 10.1007/s00439-016-1637-y; Grover S, 2006, AM J OPHTHALMOL, V141, P850, DOI 10.1016/j.ajo.2005.12.030; Hamada S, 2000, OPHTHALMIC SURG LAS, V31, P253; Hasegawa T, 2016, JPN J OPHTHALMOL, V60, P111, DOI 10.1007/s10384-015-0422-0; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Ikeda HO, 2014, SCI REP-UK, V4, DOI 10.1038/srep05970; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Levine ES, 2014, VISION RES, V102, P71, DOI 10.1016/j.visres.2014.07.011; LI ZY, 1995, J NEUROSCI, V15, P5429; Lim JI, 2008, AM J OPHTHALMOL, V146, P417, DOI 10.1016/j.ajo.2008.05.018; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Oishi M, 2014, INVEST OPHTH VIS SCI, V55, P7369, DOI 10.1167/iovs.14-15458; Orhan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127319; Sandberg MA, 2008, INVEST OPHTH VIS SCI, V49, P4568, DOI 10.1167/iovs.08-1992; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Schatz P, 2003, ACTA OPHTHALMOL SCAN, V81, P500, DOI 10.1034/j.1600-0420.2003.00134.x; Smith AJ, 2003, MOL THER, V8, P188, DOI 10.1016/S1525-0016(03)00144-8; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Sugita T, 2008, INVEST OPHTH VIS SCI, V49, P3551, DOI 10.1167/iovs.08-1954; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wen Y, 2012, INVEST OPHTH VIS SCI, V53, P833, DOI 10.1167/iovs.11-8410; Witkin AJ, 2006, AM J OPHTHALMOL, V142, P945, DOI 10.1016/j.ajo.2006.07.024; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162835	10.1371/journal.pone.0162835	http://dx.doi.org/10.1371/journal.pone.0162835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644042	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900021
J	Zhou, LN; Dai, HF; Wu, J; Zhou, M; Yuan, H; Du, J; Yang, L; Wu, XW; Xu, H; Hua, YJ; Xu, J; Zheng, L; Shen, BH				Zhou, Lina; Dai, Huifang; Wu, Jian; Zhou, Mian; Yuan, Hua; Du, Juan; Yang, Lu; Wu, Xiwei; Xu, Hong; Hua, Yuejin; Xu, Jian; Zheng, Li; Shen, Binghui			Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development	FASEB JOURNAL			English	Article						flap endonuclease 1; p53 signaling; G(1)-phase arrest; dilated heart	BASE EXCISION-REPAIR; HUMAN FLAP ENDONUCLEASE-1; OXIDATIVE DNA-DAMAGE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; AP ENDONUCLEASE-1; GENOME STABILITY; REPLICATION FORK; GAMMA-RADIATION; 3 EXONUCLEASE	Flap endonuclease 1 (FEN1) phosphorylation is proposed to regulate the action of FEN1 in DNA repair as well as Okazaki fragment maturation. However, the biologic significance of FEN1 phosphorylation in response to DNA damage remains unknown. Here, we report an in vivo role for FEN1 phosphorylation, using a mouse line carrying S187A FEN1, which abolishes FEN1 phosphorylation. Although S187A mouse embryonic fibroblast cells showed normal proliferation under low oxygen levels (2%), the mutant cells accumulated oxidative DNA damage, activated DNA damage checkpoints, and showed G1-phase arrest at atmospheric oxygen levels (21%). This suggests an essential role for FEN1 phosphorylation in repairing oxygen-induced DNA damage and maintaining proper cell cycle progression. Consistently, the mutant cardiomyocytes showed G1-phase arrest due to activation of the p53-mediated DNA damage response at the neonatal stage, which reduces the proliferation potential of the cardiomyocytes and impairs heart development. Nearly 50% of newborns with the S187 A mutant died in the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dependent switch from glycolysis to fatty acid oxidation. The adult mutant mice developed dilated hearts and showed significantly shorter life spans. Altogether, our results reveal an important role of FEN1 phosphorylation to counteract oxygen-induced stress in the heart during the fetal-to-neonatal transition.-Zhou, L., Dai, H., Wu, J., Zhou, M., Yuan, H., Du, J., Yang, L., Wu, X., Xu, H., Hua, Y., Xu, J., Zheng, L., Shen, B. Role of FEN1S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.	[Zhou, Lina] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Hong; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Key Lab, Chinese Minist Agr Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Lina; Dai, Huifang; Zhou, Mian; Du, Juan; Zheng, Li; Shen, Binghui] Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Yang, Lu; Wu, Xiwei] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA; [Wu, Jian; Xu, Jian] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA; [Yuan, Hua] Shaoxing Women & Childrens Hosp, Dept Diagnost Ultrasound, Shaoxing, Peoples R China	Zhejiang University; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Southern California	Zheng, L; Shen, BH (corresponding author), Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA.	lzheng@coh.org; bshen@coh.org	Wu, Jian/H-9404-2019; Xu, Jian/AAE-1415-2019	Wu, Jian/0000-0002-9272-5732; Shen, Binghui/0000-0002-4408-407X	U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) [R01 CA073764]; National Natural Sciences Foundation of China [31210103904]; NIH/NCI-designated Comprehensive Cancer Center support Grant [P30 CA033572]; NATIONAL CANCER INSTITUTE [R50CA211397, P30CA033572, R01CA073764] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/NCI-designated Comprehensive Cancer Center support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank W. Tsark for technical assistance in generation of transgenic mice, Lufen Chang for technical assistance and stimulating discussion, the Light Microscopy/Digital Imaging Core at City of Hope for microscopic analysis, and Nancy Linford (all from City of Hope) for editorial assistance. This work was supported by U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) Grant R01 CA073764 (to B.H.S.), and by an international corporation grant from National Natural Sciences Foundation of China (Grant 31210103904) (to Y.J.H.). The core facilities at City of Hope used in the current study are supported by NIH/NCI-designated Comprehensive Cancer Center support Grant P30 CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P5955, DOI 10.1021/bi962890u; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; Camporeale A, 2014, CANCERS, V6, P1579, DOI 10.3390/cancers6031579; Chai Q, 2003, BIOCHEMISTRY-US, V42, P15045, DOI 10.1021/bi035364t; Chung L, 2015, ONCOGENE, V34, P902, DOI 10.1038/onc.2014.19; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Djouadi F, 1999, PROSTAG LEUKOTR ESS, V60, P339, DOI 10.1016/S0952-3278(99)80009-X; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu SB, 2015, EMBO J, V34, P1829, DOI 10.15252/embj.201489865; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nakamura K, 2008, J BIOL CHEM, V283, P17702, DOI 10.1074/jbc.M802589200; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; Rancourt RC, 2002, J CELL PHYSIOL, V193, P26, DOI 10.1002/jcp.10146; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Xu H, 2011, ONCOGENE, V30, P1072, DOI 10.1038/onc.2010.482; Yucel D, 1998, CLIN CHEM, V44, P148; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825; Zheng L, 2011, CELL RES, V21, P1052, DOI 10.1038/cr.2011.35; Zhu FX, 1997, BIOCHEMISTRY-US, V36, P5947, DOI 10.1021/bi962889v	61	5	6	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					132	+		10.1096/fj.201600631R	http://dx.doi.org/10.1096/fj.201600631R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27694478	Green Published			2022-12-26	WOS:000392177600015
J	Valiente, E; Bouche, L; Hitchen, P; Faulds-Pain, A; Songane, M; Dawson, LF; Donahue, E; Stabler, RA; Panico, M; Morris, HR; Bajaj-Elliott, M; Logan, SM; Dell, A; Wren, BW				Valiente, Esmeralda; Bouche, Laura; Hitchen, Paul; Faulds-Pain, Alexandra; Songane, Mario; Dawson, Lisa F.; Donahue, Elizabeth; Stabler, Richard A.; Panico, Maria; Morris, Howard R.; Bajaj-Elliott, Mona; Logan, Susan M.; Dell, Anne; Wren, Brendan W.			Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; biofilm; glycosylation; glycosyltransferase; mutant; Clostridium difficile; flagella; gram positive bacteria	CAMPYLOBACTER-JEJUNI; GLYCOSYLATION ISLAND; ESCHERICHIA-COLI; TOXIN-B; PROTEIN; COLONIZATION; INFECTION; BIOSYNTHESIS; EPIDEMIOLOGY; VIRULENCE	Clostridium difficile is the principal cause of nosocomial infectious diarrhea worldwide. The pathogen modifies its flagellin with either a type A or type B O-linked glycosylation system, which has a contributory role in pathogenesis. We study the functional role of glycosyltransferases modifying type B flagellin in the 023 and 027 hypervirulent C. difficile lineages by mutagenesis of five putative glycosyltransferases and biosynthetic genes. We reveal their roles in the biosynthesis of the flagellin glycan chain and demonstrate that flagellar post-translational modification affects motility and adhesion-related bacterial properties of these strains. We show that the glycosyltransferases 1 and 2 (GT1 and GT2) are responsible for the sequential addition of a GlcNAc and two rhamnoses, respectively, and that GT3 is associated with the incorporation of a novel sulfonated peptidyl-amido sugar moiety whose structure is reported in our accompanying paper (Bouche, L., Panico, M., Hitchen, P., Binet, D., Sastre, F., Faulds-Pain, A., Valiente, E., Vinogradov, E., Aubry, A., Fulton, K., Twine, S., Logan, S. M., Wren, B. W., Dell, A., and Morris, H. R. (2016) J. Biol. Chem. 291, 25439-25449). GT2 is also responsible for methylation of the rhamnoses. Whereas type B modification is not required for flagellar assembly, some mutations that result in truncation or abolition of the glycan reduce bacterial motility and promote autoaggregation and biofilm formation. The complete lack of flagellin modification also significantly reduces adhesion of C. difficile to Caco-2 intestinal epithelial cells but does not affect activation of human TLR5. Our study advances our understanding of the genes involved in flagellar glycosylation and their biological roles in emerging hypervirulent C. difficile strains.	[Valiente, Esmeralda; Faulds-Pain, Alexandra; Dawson, Lisa F.; Donahue, Elizabeth; Stabler, Richard A.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England; [Bouche, Laura; Hitchen, Paul; Panico, Maria; Morris, Howard R.; Dell, Anne] Imperial Coll London, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Songane, Mario; Bajaj-Elliott, Mona] UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Logan, Susan M.] CNR, Vaccine Program, Human Hlth Therapeut Portfolio, Ottawa, ON K1A 0R6, Canada; [Morris, Howard R.] BioPharmaSpec Ltd, Lido Med Ctr, Suite 3-1,St Saviours Rd, Jersey JE2 7LA, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; National Research Council Canada	Wren, BW (corresponding author), London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	Brendan.wren@lshtm.ac.uk		Stabler, Richard/0000-0002-2402-6630; Bajaj-Elliott, Mona/0000-0002-5234-576X; Dell, Anne/0000-0003-1380-2347	Wellcome Trust [102979/Z/13/Z, 105609/Z/14/Z]; Medical Research Council [MR/K000551/1]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207-CDI]; Commonwealth Scholarship [MZCS-2011-280]; BBSRC [BB/D521849/1, BB/F008309/1, BB/K016164/1] Funding Source: UKRI; MRC [MR/K000551/1, G1000214] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D521849/1] Funding Source: researchfish; Medical Research Council [G1000214] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie Intra-European Fellowship(European Commission); Commonwealth Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust Grants 102979/Z/13/Z and 105609/Z/14/Z, Medical Research Council Grant MR/K000551/1, and Biotechnology and Biological Sciences Research Council Grants BB/K016164/1 and BB/F008309/1. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Marie Curie Intra-European Fellowship for Career Development PIEF-GA-2009-252207-CDI.; Recipient of Commonwealth Scholarship MZCS-2011-280.	Arora SK, 2004, J BACTERIOL, V186, P2115, DOI 10.1128/JB.186.7.2115-2122.2004; Baban ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073026; Barketi-Klai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096876; Batah J, 2016, ANAEROBE, V38, P116, DOI 10.1016/j.anaerobe.2016.01.002; Bouche L, 2016, J BIOL CHEM, V291, P25439, DOI 10.1074/jbc.M116.749481; Cairns MD, 2012, FUTURE MICROBIOL, V7, P945, DOI [10.2217/FMB.12.73, 10.2217/fmb.12.73]; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Faulds-Pain A, 2014, MOL MICROBIOL, V94, P272, DOI 10.1111/mmi.12755; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hanuszkiewicz A, 2014, J BIOL CHEM, V289, P19231, DOI 10.1074/jbc.M114.562603; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Hitchen PG, 2010, BIOCHEM SOC T, V38, P1307, DOI 10.1042/BST0381307; Howard SL, 2009, INFECT IMMUN, V77, P2544, DOI 10.1128/IAI.01425-08; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McFarland LV, 2008, NAT CLIN PRACT GASTR, V5, P40, DOI 10.1038/ncpgasthep1029; Misawa N, 2000, INFECT IMMUN, V68, P6168, DOI 10.1128/IAI.68.11.6168-6175.2000; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; ROGGENKAMP A, 1995, MOL MICROBIOL, V16, P1207, DOI 10.1111/j.1365-2958.1995.tb02343.x; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Schutze GE, 2013, PEDIATRICS, V131, P196, DOI 10.1542/peds.2012-2992; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stephenson HN, 2014, J INFECT DIS, V210, P1487, DOI 10.1093/infdis/jiu287; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; Vijay-Kumar M, 2008, SEMIN IMMUNOPATHOL, V30, P11, DOI 10.1007/s00281-007-0100-5; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988; Wren MWD, 2009, BRIT J BIOMED SCI, V66, P175, DOI 10.1080/09674845.2009.11730269; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173; Zawadzka-Skomial J, 2006, J BACTERIOL, V188, P1875, DOI 10.1128/JB.188.5.1875-1881.2006	54	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25450	25461		10.1074/jbc.M116.749523	http://dx.doi.org/10.1074/jbc.M116.749523			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27703012	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000390095300015
J	Petrey, AC; de la Motte, CA				Petrey, Aaron C.; de la Motte, Carol A.			Thrombin Cleavage of Inter-alpha-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN AMNIOTIC MEMBRANE; EXTRACELLULAR-MATRIX; TRYPSIN INHIBITOR; RHEUMATOID-ARTHRITIS; ACTIVATED RECEPTORS; BLOOD-COAGULATION; ENDOTHELIAL-CELLS; SYNOVIAL-FLUID; CD44	Dynamic alterations of the extracellular matrix in response to injury directly modulate inflammation and consequently the promotion and resolution of disease. During inflammation, hyaluronan (HA) is increased at sites of inflammation where it may be covalently modified with the heavy chains (HC) of inter-alpha-trypsin inhibitor. Deposition of this unique, pathological form of HA (HC-HA) leads to the formation of cable-like structures that promote adhesion of leukocytes. Naive mononuclear leukocytes bind specifically to inflammation-associated HA matrices but do not adhere to HA constitutively expressed under homeostatic conditions. In this study, we have directly investigated a role for the blood-coagulation protease thrombin in regulating the adhesion of monocytic cells to smooth muscle cells producing an inflammatory matrix. Our data demonstrate that the proteolytic activity of thrombin negatively regulates the adhesion of monocytes to an inflammatory HG-HA complex. This effect is independent of protease-activated receptor activation but requires proteolytic activity toward a novel substrate. Components of HC-HA complexes were predicted to contain conserved thrombin-susceptible cleavage sites based on sequence analysis, and heavy chain 1 (HC1) was confirmed to be a substrate of thrombin. Thrombin treatment is sufficient to cleave HC1 associated with either cell-surface HA or serum inter-alpha-trypsin inhibitor. Furthermore, thrombin treatment of the inflammatory matrix leads to dissolution of HC-HA cable structures and abolishes leukocyte adhesion. These data establish a novel mechanism whereby thrombin cleavage of HC1 regulates the adhesive properties of an inflammatory HA matrix.	[Petrey, Aaron C.; de la Motte, Carol A.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	de la Motte, CA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	delamoc@ccf.org	Petrey, Aaron C./AAD-8623-2020	Petrey, Aaron C./0000-0002-2696-599X	National Institutes of Health Programs of Excellence in Glycosciences Grant from the NHLBI [HL107147]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948] Funding Source: NIH RePORTER	National Institutes of Health Programs of Excellence in Glycosciences Grant from the NHLBI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Programs of Excellence in Glycosciences Grant HL107147 from the NHLBI (to C. A. d. I. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albeiroti S, 2015, BLOOD, V125, P1460, DOI 10.1182/blood-2014-07-590513; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Black KE, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-23; Blom AM, 1997, BIOCHEM J, V328, P185; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRATT T, 1993, BIOCHIM BIOPHYS ACTA, V1157, P147, DOI 10.1016/0304-4165(93)90058-G; Chamouard P, 1995, EUR J GASTROEN HEPAT, V7, P1183; CHAN P, 1995, BIOCHEM J, V306, P505, DOI 10.1042/bj3060505; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817; Daveau M, 1998, ARCH BIOCHEM BIOPHYS, V350, P315, DOI 10.1006/abbi.1997.0515; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; DICORLETO PE, 1989, BIOCHEM J, V264, P71, DOI 10.1042/bj2640071; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; Evanko SP, 1998, AM J PATHOL, V152, P533; Evanko SP, 2009, J HISTOCHEM CYTOCHEM, V57, P1041, DOI 10.1369/jhc.2009.953802; FOGELMAN AM, 1988, J LIPID RES, V29, P1243; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Kaplan ZS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8835; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kessler S. P., 2015, INT J CELL BIOL, V2015; Kessler S, 2008, CTS-CLIN TRANSL SCI, V1, P57, DOI 10.1111/j.1752-8062.2008.00025.x; KOIZUMI M, 1992, GASTROENTEROLOGY, V103, P840, DOI 10.1016/0016-5085(92)90015-Q; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Lewis A, 2008, HISTOL HISTOPATHOL, V23, P731, DOI 10.14670/HH-23.731; LINDQVIST A, 1992, BIOCHIM BIOPHYS ACTA, V1130, P63, DOI 10.1016/0167-4781(92)90462-9; LIOTTA LA, 1981, CANCER RES, V41, P4629; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MAHADEVAN P, 1995, DIABETOLOGIA, V38, P298, DOI 10.1007/s001250050285; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mizon C, 1996, J IMMUNOL METHODS, V190, P61, DOI 10.1016/0022-1759(95)00257-X; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; NISHIMURA H, 1995, FEBS LETT, V357, P207; Olszewska-Pazdrak Barbara, 2009, P115, DOI 10.1007/978-0-387-09637-7_7; PAKIANATHAN DR, 1995, J LEUKOCYTE BIOL, V57, P699, DOI 10.1002/jlb.57.5.699a; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; POZSGAY M, 1981, EUR J BIOCHEM, V115, P491; Rohatgi T, 2004, NEUROSCIENTIST, V10, P501, DOI 10.1177/1073858404269955; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SAGE H, 1981, BIOCHEMISTRY-US, V20, P3778, DOI 10.1021/bi00516a017; SALIER JP, 1993, BIOCHEM J, V296, P85, DOI 10.1042/bj2960085; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wilkins MR, 1999, METH MOL B, V112, P531; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873	77	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24324	24334		10.1074/jbc.M116.755660	http://dx.doi.org/10.1074/jbc.M116.755660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27679489	Green Published, hybrid			2022-12-26	WOS:000388875500001
J	Pozner, A; Terooatea, TW; Buck-Koehntop, BA				Pozner, Amir; Terooatea, Tommy W.; Buck-Koehntop, Bethany A.			Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; TRANSCRIPTIONAL REPRESSOR; NUCLEAR-LOCALIZATION; PARTNER KAISO; BINDING; CANCER; EXPRESSION; PROMOTES	The correlation between aberrant DNA methylation with cancer promotion and progression has prompted an interest in discerning the associated regulatory mechanisms. Kaiso (ZBTB33) is a specialized transcription factor that selectively recognizes methylated CpG-containing sites as well as a sequence-specific DNA target. Increasing reports link ZBTB33 overexpression and transcriptional activities with metastatic potential and poor prognosis in cancer, although there is little mechanistic insight into how cells harness ZBTB33 transcriptional capabilities to promote and progress disease. Here we report mechanistic details for how ZBTB33 mediates cell-specific cell cycle regulation. By utilizing ZBTB33 depletion and overexpression studies, it was determined that in HeLa cells ZBTB33 directly occupies the promoters of cyclin D1 and cyclin El, inducing proliferation by promoting retinoblastoma phosphorylation and allowing for E2F transcriptional activity that accelerates G(1)- to S-phase transition. Conversely, in HEK293 cells ZBTB33 indirectly regulates cyclin E abundance resulting in reduced retinoblastoma phosphorylation, decreased E2F activity, and decelerated G(1) transition. Thus, we identified a novel mechanism by which ZBTB33 mediates the cyclin D-1/cyclin El/RB1/E2E pathway, controlling passage through the G(1) restriction point and accelerating cancer cell proliferation.	[Pozner, Amir; Terooatea, Tommy W.; Buck-Koehntop, Bethany A.] Univ Utah, Dept Chem, 315 South 1400 East,Rm 2020, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Buck-Koehntop, BA (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East,Rm 2020, Salt Lake City, UT 84112 USA.	koehntop@chern.utah.edu	Buck-Koehntop, Bethany A./ABI-2583-2020		Department of Chemistry, University of Utah; American Cancer Society [RSG-14-185-01-DMC]; National Institutes of Health from the NCI [P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	Department of Chemistry, University of Utah; American Cancer Society(American Cancer Society); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Chemistry, University of Utah, Grant RSG-14-185-01-DMC from the American Cancer Society, and National Institutes of Health Award P30CA042014 from the NCI for Huntsman Cancer Institute core facilities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Bassey-Archibong BI, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.17; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Buck-Koehntop BA, 2012, FEBS LETT, V586, P734, DOI 10.1016/j.febslet.2012.01.045; Capecchi MR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9763; Chano T, 2006, INT J MOL MED, V18, P425; Chaudhary R., 2013, PLOS ONE, V8; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cofre J, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-28; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Donaldson NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050398; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Jones J, 2016, CANCER LETT, V380, P513, DOI 10.1016/j.canlet.2016.06.025; Jones J, 2014, CLIN EXP METASTAS, V31, P497, DOI 10.1007/s10585-014-9644-7; Jones J, 2012, AM J PATHOL, V181, P1836, DOI 10.1016/j.ajpath.2012.08.008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Koh DI, 2013, BIOCHEM BIOPH RES CO, V442, P177, DOI 10.1016/j.bbrc.2013.11.046; Kulikov AV, 2016, BEHAV BRAIN RES, V297, P76, DOI 10.1016/j.bbr.2015.10.003; Lents NH, 2004, TRENDS ENDOCRIN MET, V15, P1, DOI 10.1016/j.tem.2003.10.011; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Ozbek E., 2000, TURKISH J CANC, V30, P15; Pierre CC, 2015, BBA-GENE REGUL MECH, V1849, P1432, DOI 10.1016/j.bbagrm.2015.10.018; Pierre CC, 2015, BBA-MOL BASIS DIS, V1852, P1846, DOI 10.1016/j.bbadis.2015.06.011; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Soubry A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009203; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Spruijt CG, 2014, NAT STRUCT MOL BIOL, V21, P949, DOI 10.1038/nsmb.2910; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vance KW, 2010, MOL BIOL CELL, V21, P2770, DOI 10.1091/mbc.E09-12-1029; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Wang HH, 2016, ONCOTARGET, V7, P5677, DOI 10.18632/oncotarget.6801; Wang XD, 2003, ONCOGENE, V22, P769, DOI 10.1038/sj.onc.1206166; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	62	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24538	24550		10.1074/jbc.M116.746370	http://dx.doi.org/10.1074/jbc.M116.746370			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27694442	hybrid, Green Published			2022-12-26	WOS:000388875500017
J	Colon, S; Bhave, G				Colon, Selene; Bhave, Gautam			Proprotein Convertase Processing Enhances Peroxidasin Activity to Reinforce Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basement membrane; collagen; extracellular matrix; furin; peroxidase; collagen IV; proprotein convertase; sulfilimine bond; peroxidasin	EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; PROTEIN; ARCHITECTURE; EVOLUTION; CLEAVAGE; FURIN; BOND	The basement membrane (BM) is a form of extracellular matrix that underlies cell layers in nearly all animal tissues. Type IV collagen, a major constituent of BMs, is critical for tissue development and architecture. The enzyme peroxidasin (Pxdn), an extracellular matrix-associated protein, catalyzes the formation of structurally reinforcing sulfilimine cross-links within the collagen IV network, an event essential to basement membrane integrity. Although the catalytic function of Pxdn is known, the regulation of its activity remains unclear. In this work we show through N-terminal sequencing, pharmacologic studies, and mutational analysis that proprotein convertases (PCs) proteolytically process human Pxdn at Arg-1336, a location relatively close to its C terminus. PC processing enhances the enzymatic activity of Pxdn and facilitates the formation of sulfilimine cross-links in collagen IV. Thus, PC processing of Pxdn is a key regulatory step that contributes to its function and, therefore, supports BM integrity and homeostasis.	[Colon, Selene; Bhave, Gautam] Vanderbilt Univ, Div Nephrol & Hypertens, Dept Med, Med Ctr, Nashville, TN 37232 USA; [Colon, Selene] Tennessee State Univ, Dept Biol Sci, Nashville, TN 37209 USA; [Colon, Selene; Bhave, Gautam] Vanderbilt Univ, Vanderbilt Ctr Kidney Dis, Med Ctr, Nashville, TN 37232 USA; [Bhave, Gautam] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University; Tennessee State University; Vanderbilt University; Vanderbilt University	Bhave, G (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, S-3223 Med Ctr North, Nashville, TN 37232 USA.	gautam.bhave@vanderbilt.edu			National Institutes of Health [K08 DK 097306]; Burroughs-Wellcome Fund Career Award for Medical Scientists [13030995]; Vanderbilt University Division of Nephrology and Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK097306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Vanderbilt University Division of Nephrology and Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 DK 097306 (to G.B.). This work was also supported by a Burroughs-Wellcome Fund Career Award for Medical Scientists (13030995) and developmental funds from the Vanderbilt University Division of Nephrology and Hypertension (to G.B.). S.C. presented this work in partial fulfillment of her doctoral dissertation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bhave G, 2012, NAT CHEM BIOL, V8, P784, DOI [10.1038/NCHEMBIO.1038, 10.1038/nchembio.1038]; Brandes RP, 2011, CARDIOVASC RES, V91, P1, DOI 10.1093/cvr/cvr120; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Ero-Tolliver IA, 2015, J BIOL CHEM, V290, P21741, DOI 10.1074/jbc.M115.673996; Fidler AL, 2014, P NATL ACAD SCI USA, V111, P331, DOI 10.1073/pnas.1318499111; Gotenstein JR, 2010, DEVELOPMENT, V137, P3603, DOI 10.1242/dev.049189; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Imamura Y, 1998, J BIOL CHEM, V273, P27511, DOI 10.1074/jbc.273.42.27511; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Lazar E, 2015, FREE RADICAL BIO MED, V83, P273, DOI 10.1016/j.freeradbiomed.2015.02.015; Le Fourn V, 2005, J BIOL CHEM, V280, P4568, DOI 10.1074/jbc.M408042200; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peterfi Z, 2009, AM J PATHOL, V175, P725, DOI 10.2353/ajpath.2009.080693; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Raghunath M, 1999, J CELL SCI, V112, P1093; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Soudi M, 2015, J BIOL CHEM, V290, P10876, DOI 10.1074/jbc.M114.632273; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950	24	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24009	24016		10.1074/jbc.M116.745935	http://dx.doi.org/10.1074/jbc.M116.745935			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697841	Green Published, hybrid			2022-12-26	WOS:000388498100017
J	Patra, A; Zhang, QQ; Guengerich, FP; Egli, M				Patra, Amitraj; Zhang, Qianqian; Guengerich, F. Peter; Egli, Martin			Mechanisms of Insertion of dCTP and dTTP Opposite the DNA Lesion O-6-Methyl-2 '-deoxyguanosine by Human DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; enzyme kinetics; mass spectrometry (MS); X-ray crystallography	TRIPHOSPHATE INCORPORATION OPPOSITE; STRUCTURAL BASIS; MOLECULAR-STRUCTURE; KINETIC-ANALYSIS; O-6-METHYLGUANINE; BYPASS; SITE; DPO4; KAPPA; O-6-ALKYLGUANINE	O-6-Methyl-2-deoxyguanosine (O-6-MeG) is a ubiquitous DNA lesion, formed not only by xenobiotic carcinogens but also by the endogenous methylating agent S-adenosylmethionine. It can introduce mutations during DNA replication, with different DNA polymerases displaying different ratios of correct or incorrect incorporation opposite this nucleoside. Of the translesion Y-family human DNA polymerases (hpols), hpol is most efficient in incorporating equal numbers of correct and incorrect C and T bases. However, the mechanistic basis for this specific yet indiscriminate activity is not known. To explore this question, we report biochemical and structural analysis of the catalytic core of hpol . Activity assays showed the truncated form displayed similar misincorporation properties as the full-length enzyme, incorporating C and T equally and extending from both. X-ray crystal structures of both dC and dT paired with O-6-MeG were solved in both insertion and extension modes. The structures revealed a Watson-Crick-like pairing between O-6-MeG and 2"-deoxythymidine-5"-[(, )-imido]triphosphate (approximating dT) at both the insertion and extension stages with formation of two H-bonds. Conversely, both the structures with O-6- MeG opposite dCTP and dC display sheared configuration of base pairs but to different degrees, with formation of two bifurcated H-bonds and two single H-bonds in the structures trapped in the insertion and extension states, respectively. The structural data are consistent with the observed tendency of hpol to insert both dC and dT opposite the O-6-MeG lesion with similar efficiencies. Comparison of the hpol active site configurations with either O-6-MeG:dC or O-6-MeG:dT bound compared with the corresponding situations in structures of complexes of Sulfolobus solfataricus Dpo4, a bypass pol that favors C relative to T by a factor of approximate to 4, helps rationalize the more error-prone synthesis opposite the lesion by hpol eta.	[Patra, Amitraj; Zhang, Qianqian; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Zhang, Qianqian] Waters Corp, Bldg 13,1000 Jinhai Rd, Shanghai 201206, Peoples R China	Vanderbilt University	Guengerich, FP (corresponding author), Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu; egli@vanderbilt.edu			National Institutes of Health [R01 ES010375, R01 ES010546, P01 CA160032]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010546, R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and R01 ES010546 (to F. G.) and P01 CA160032 (to M. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARROWS LR, 1981, TOXICOL APPL PHARM, V60, P334, DOI 10.1016/0041-008X(91)90236-8; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BROOKES P, 1961, J CHEM SOC, P3923, DOI 10.1039/jr9610003923; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Chowdhury G, 2011, CURR PROT NUCL ACID, DOI [10.1002/0471142700.nc0716s47, DOI 10.1002/0471142700.NC0716S47]; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; GAFFNEY BL, 1984, BIOCHEMISTRY-US, V23, P5686, DOI 10.1021/bi00319a004; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; GINELL SL, 1990, BIOCHEMISTRY-US, V29, P10461, DOI 10.1021/bi00498a005; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Irimia A, 2010, ACTA CRYSTALLOGR F, V66, P1013, DOI 10.1107/S1744309110029374; LAWLEY PD, 1995, BIOESSAYS, V17, P561, DOI 10.1002/bies.950170615; LEONARD GA, 1990, P NATL ACAD SCI USA, V87, P9573, DOI 10.1073/pnas.87.24.9573; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; Lupari E, 2012, DNA REPAIR, V11, P579, DOI 10.1016/j.dnarep.2012.03.004; O'Flaherty DK, 2016, CHEM SCI, V7, P4896, DOI 10.1039/c6sc00666c; O'Flaherty D. K., 2014, CURR PROTOC NUCL ACI, V59, DOI [10.1002/0471142700.nc0721s5, DOI 10.1002/0471142700.NC0721S5]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1036, DOI 10.1021/bi00353a013; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2015, J AM CHEM SOC, V137, P7011, DOI 10.1021/jacs.5b02701; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Peng CH, 2016, CANCER RES, V76, P2340, DOI 10.1158/0008-5472.CAN-15-1884; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SRIRAM M, 1992, EMBO J, V11, P225, DOI 10.1002/j.1460-2075.1992.tb05045.x; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	42	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24304	24313		10.1074/jbc.M116.755462	http://dx.doi.org/10.1074/jbc.M116.755462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27694439	hybrid, Green Published			2022-12-26	WOS:000388498100041
J	Sassa, A; Caglayan, M; Rodriguez, Y; Beard, WA; Wilson, SH; Nohmi, T; Honma, M; Yasui, M				Sassa, Akira; Caglayan, Melike; Rodriguez, Yesenia; Beard, William A.; Wilson, Samuel H.; Nohmi, Takehiko; Honma, Masamitsu; Yasui, Manabu			Impact of Ribonucleotide Backbone on Translesion Synthesis and Repair of 7,8-Dihydro-8-oxoguanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); base excision repair (BER); DNA damage; DNA polymerase; oxidative stress; ribonucleotide; translesion DNA synthesis	DNA-POLYMERASE-KAPPA; ERROR-FREE; EXCISION-REPAIR; BYPASS; LESION; EXTENSION; 8-OXOGUANINE; SUBSTRATE; EFFICIENT; MECHANISM	Numerous ribonucleotides are incorporated into the genome during DNA replication. Oxidized ribonucleotides can also be erroneously incorporated into DNA. Embedded ribonucleotides destabilize the structure of DNA and retard DNA synthesis by DNA polymerases (pols), leading to genomic instability. Mammalian cells possess translesion DNA synthesis (TLS) pols that bypass DNA damage. The mechanism of TLS and repair of oxidized ribonucleotides remains to be elucidated. To address this, we analyzed the miscoding properties of the ribonucleotides riboguanosine (rG) and 7,8-dihydro-8-oxo-riboguanosine (8-oxo-rG) during TLS catalyzed by the human TLS pols and in vitro. The primer extension reaction catalyzed by human replicative pol was strongly blocked by 8-oxo-rG. pol inefficiently bypassed rG and 8-oxo-rG compared with dG and 7,8-dihydro-8-oxo-2-deoxyguanosine (8-oxo-dG), whereas pol easily bypassed the ribonucleotides. pol exclusively inserted dAMP opposite 8-oxo-rG. Interestingly, pol preferentially inserted dCMP opposite 8-oxo-rG, whereas the insertion of dAMP was favored opposite 8-oxo-dG. In addition, pol accurately bypassed 8-oxo-rG. Furthermore, we examined the activity of the base excision repair (BER) enzymes 8-oxoguanine DNA glycosylase (OGG1) and apurinic/apyrimidinic endonuclease 1 on the substrates, including rG and 8-oxo-rG. Both BER enzymes were completely inactive against 8-oxo-rG in DNA. However, OGG1 suppressed 8-oxo-rG excision by RNase H2, which is involved in the removal of ribonucleotides from DNA. These results suggest that the different sugar backbones between 8-oxo-rG and 8-oxo-dG alter the capacity of TLS and repair of 8-oxoguanine.	[Sassa, Akira; Nohmi, Takehiko; Honma, Masamitsu; Yasui, Manabu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan; [Caglayan, Melike; Rodriguez, Yesenia; Beard, William A.; Wilson, Samuel H.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institute of Health Sciences - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Sassa, A; Yasui, M (corresponding author), Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	a-sassa@nihs.go.jp; m-yasui@nihs.go.jp	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293; Sassa, Akira/0000-0003-2454-0223; CAGLAYAN, MELIKE/0000-0003-1107-1042	Ministry of Education, Culture, Sports, Science and Technology in Japan [16K16195, 25281022]; Intramural Research Program of the National Institutes of Health, NIEHS [Z01 ES050158, Z01 ES050159]; Grants-in-Aid for Scientific Research [16K16195] Funding Source: KAKEN; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Program of the National Institutes of Health, NIEHS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant-in-Aid for Young Scientists B (16K16195) and for Scientific Research B (25281022) from the Ministry of Education, Culture, Sports, Science and Technology in Japan and the Intramural Research Program of the National Institutes of Health, NIEHS Grants Z01 ES050158 and Z01 ES050159. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Calabretta A, 2015, NUCLEIC ACIDS RES, V43, P4713, DOI 10.1093/nar/gkv377; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Cilli P, 2015, J BIOL CHEM, V290, P26259, DOI 10.1074/jbc.M115.679209; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kamiya H, 2007, FREE RADICAL BIO MED, V43, P837, DOI 10.1016/j.freeradbiomed.2007.05.034; Kamiya H, 2012, CHEM RES TOXICOL, V25, P1771, DOI 10.1021/tx300259x; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kupfer PA, 2007, NUCLEIC ACIDS RES, V35, P58, DOI 10.1093/nar/gkl948; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Ordonez H, 2014, NUCLEIC ACIDS RES, V42, P12722, DOI 10.1093/nar/gku1027; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rodriguez GP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003682; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Sassa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142218; Sassa A, 2014, J BIOL CHEM, V289, P13996, DOI 10.1074/jbc.M114.557769; Sassa A, 2013, JOVE-J VIS EXP, DOI 10.3791/50695; Sassa A, 2011, J MOL BIOL, V406, P679, DOI 10.1016/j.jmb.2011.01.005; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SHIBUTANI S, 1993, CHEM RES TOXICOL, V6, P625, DOI 10.1021/tx00035a006; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tominaga Y, 2004, NUCLEIC ACIDS RES, V32, P3198, DOI 10.1093/nar/gkh642; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsuzuki T, 2007, CANCER SCI, V98, P465, DOI 10.1111/j.1349-7006.2007.00409.x; UESUGI S, 1977, J AM CHEM SOC, V99, P3250, DOI 10.1021/ja00452a008; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834; Yasui M, 2008, J MOL BIOL, V377, P1015, DOI 10.1016/j.jmb.2008.01.033; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2002, DNA REPAIR, V1, P559, DOI 10.1016/S1568-7864(02)00055-1	54	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24314	24323		10.1074/jbc.M116.738732	http://dx.doi.org/10.1074/jbc.M116.738732			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27660390	Green Published, hybrid			2022-12-26	WOS:000388498100042
J	Colak, D; Alaiya, AA; Kaya, N; Muiya, NP; AlHarazi, O; Shinwari, Z; Andres, E; Dzimiri, N				Colak, Dilek; Alaiya, Ayodele A.; Kaya, Namik; Muiya, Nzioka P.; AlHarazi, Olfat; Shinwari, Zakia; Andres, Editha; Dzimiri, Nduna			Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; MESSENGER-RNA; SUPEROXIDE-DISMUTASE; MYOCARDIAL INJURY; MICROARRAY; DATABASE; DYSFUNCTION; DEFICIENCY; THERAPY	Aims The disease pathways leading to idiopathic dilated cardiomyopathy (DCM) are still elusive. The present study investigated integrated global transcriptional and translational changes in human DCM for disease biomarker discovery. Methods We used identical myocardial tissues from five DCM hearts compared to five non-failing (NF) donor hearts for both transcriptome profiling using the ABI high-density oligonucleotide microarrays and proteome expression with One-Dimensional Nano Acquity liquid chromatography coupled with tandem mass spectrometry on the Synapt G2 system. Results We identified 1262 differentially expressed genes (DEGs) and 269 proteins (DEPs) between DCM cases and healthy controls. Among the most significantly upregulated (>5-fold) proteins were GRK5, APOA2, IGHG3, ANXA6, HSP90AA1, and ATP5C1 (p< 0.01). On the other hand, the most significantly downregulated proteins were GSTM5, COX17, CAV1 and ANXA3. At least ten entities were concomitantly upregulated on the two analysis platforms: GOT1, ALDH4A1, PDHB, BDH1, SLC2A11, HSP90AA1, HSP90AB1, H2AFV, HSPA5 and NDUFV1. Gene ontology analyses of DEGs and DEPs revealed significant overlap with enrichment of genes/proteins related to metabolic process, biosynthetic process, cellular component organization, oxidative phosphorylation, alterations in glycolysis and ATP synthesis, Alzheimer's disease, chemokine-mediated inflammation and cytokine signalling pathways. Conclusion The concomitant use of transcriptome and proteome expression to evaluate global changes in DCM has led to the identification of sixteen commonly altered entities as well as novel genes, proteins and pathways whose cardiac functions have yet to be deciphered. This data should contribute towards better management of the disease.	[Colak, Dilek; AlHarazi, Olfat] King Faisal Specialist Hosp & Res Ctr, Biostat Epidemiol & Sci Comp Dept, Riyadh 11211, Saudi Arabia; [Alaiya, Ayodele A.; Shinwari, Zakia] King Faisal Specialist Hosp & Res Ctr, Prote Unit, Stem Cell Tissue Reengn Program, Riyadh 11211, Saudi Arabia; [Kaya, Namik; Muiya, Nzioka P.; Andres, Editha; Dzimiri, Nduna] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Dzimiri, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	dzimiri@kfshrc.edu.sa	Andres, E/AAY-3767-2020	Dzimiri, Nduna/0000-0003-3395-5754; Colak, Dilek/0000-0001-6485-8768	Royal Research Grant through the King Faisal Specialist Hospital and Research Centre [2100020]; National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology [11-6102072-20]	Royal Research Grant through the King Faisal Specialist Hospital and Research Centre; National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology	This work was supported by the Royal Research Grant 2100020 through the King Faisal Specialist Hospital and Research Centre and National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology grant 11-6102072-20. The authors would like to express their gratitude to the King Faisal Specialist Hospital and Research Centre for the financial support and National Plan for Science, Technology and Innovation program (NSTIP/KACST) for supporting Dr. Dilek Colak.; This work was supported by the Royal Research Grant 2100020 through the King Faisal Specialist Hospital and Research Centre and National Plan for Science, Technology and Innovation program/King Abdulaziz City for Science and Technology grant 11-BI02072-20. The authors would like to express their gratitude the King Faisal Specialist Hospital and Research Centre for the financial support and National Plan for Science, Technology and Innovation program (NSTIP/KACST) for supporting Dr. Dilek Colak.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Al-Moghrabi N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-830; Alaiya A, 2014, CANCER GENOM PROTEOM, V11, P39; Arimura T, 2007, Acta Myol, V26, P153; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Barrett AB, 2008, IEEE ENG MED BIO, P5660, DOI 10.1109/IEMBS.2008.4650498; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Charniot JC, 2011, FREE RADICAL RES, V45, P379, DOI 10.3109/10715762.2010.532792; Chuang LY, 2009, 2 STAGE FEATURE SELE; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Datta A, 2013, J PROTEOMICS, V91, P556, DOI 10.1016/j.jprot.2013.08.017; Denham J, 2015, J APPL PHYSL; Dzimiri N, 1999, PHARMACOL REV, V51, P465; Engebretsen KVT, 2013, J APPL PHYSIOL, V114, P988, DOI 10.1152/japplphysiol.00793.2012; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036; Kaab S, 2004, J MOL MED, V82, P308, DOI 10.1007/s00109-004-0527-2; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang YF, 2011, LAB INVEST, V91, P12, DOI 10.1038/labinvest.2010.156; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Mahmoudabady M, 2008, J CARD FAIL, V14, P703, DOI 10.1016/j.cardfail.2008.05.003; McCloskey DT, 2008, AM J PHYSIOL-HEART C, V294, pH205, DOI 10.1152/ajpheart.00829.2007; Mittmann C, 1998, CARDIOVASC RES, V39, P267, DOI 10.1016/S0008-6363(98)00139-4; Ono H, 2010, INTERNAL MED, V49, P2039, DOI 10.2169/internalmedicine.49.3710; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pedotti P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-124; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006; Ross J, 2002, CIRC J, V66, P219, DOI 10.1253/circj.66.219; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh KK, 2014, J THORAC CARDIOV SUR, V147, P1065, DOI 10.1016/j.jtcvs.2013.04.042; Singla Sandeep, 2011, Ther Adv Cardiovasc Dis, V5, P305, DOI 10.1177/1753944711429715; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Yeung ES, 2011, ANGEW CHEM INT EDIT, V50, P583, DOI 10.1002/anie.201005969	49	25	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162669	10.1371/journal.pone.0162669	http://dx.doi.org/10.1371/journal.pone.0162669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711126	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600008
J	Dahan, A; Noy, L; Hart, Y; Mayo, A; Alon, U				Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri			Exit from Synchrony in Joint Improvised Motion	PLOS ONE			English	Article							TO-FACE INTERACTION; PHASE-TRANSITIONS; INTERPERSONAL COORDINATION; SOCIAL COORDINATION; MOVEMENT SYNCHRONY; RHYTHMIC MOVEMENT; MANUAL TRACKING; MODEL; BEHAVIOR; MOTHER	Motion synchrony correlates with effective and well-rated human interaction. However, people do not remain locked in synchrony; Instead, they repeatedly enter and exit synchrony. In many important interactions, such as therapy, marriage and parent-infant communication, it is the ability to exit and then re-enter synchrony that is thought to build strong relationship. The phenomenon of entry into zero-phase synchrony is well-studied experimentally and in terms of mathematical modeling. In contrast, exit-from-synchrony is understudied. Here, we focus on human motion coordination, and examine the exit-from-synchrony phenomenon using experimental data from the mirror game paradigm, in which people perform joint improvised motion, and from human tracking of computer-generated stimuli. We present a mathematical mechanism that captures aspects of exit-from-synchrony in human motion. The mechanism adds a random motion component when the accumulated velocity error between the players is small. We introduce this mechanism to several models for human coordinated motion, including the widely studied HKB model, and the predictor-corrector model of Noy, Dekel and Alon. In all models, the new mechanism produces realistic simulated behavior when compared to experimental data from the mirror game and from tracking of computer generated stimuli, including repeated entry and exit from zero-phase synchrony that generates a complexity of motion similar to that of human players. We hope that these results can inform future research on exit-from-synchrony, to better understand the dynamics of coordinated	[Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Theatre Lab, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Alon, U (corresponding author), Weizmann Inst Sci, Theatre Lab, Rehovot, Israel.	uri.alon@weizmann.ac.il	mayo, avi/N-3756-2019; Hart, Yuval/HGD-6424-2022; Noy, Lior/GQZ-3657-2022	mayo, avi/0000-0002-4479-3423; 	Humanities, at the Weizmann Institute of Science	Humanities, at the Weizmann Institute of Science	We thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science, for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair.	Bardy BG, 2014, IEEE SYS MAN CYBERN, P772, DOI 10.1109/SMC.2014.6974004; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Bingham GP, 2004, ECOL PSYCHOL, V16, P45, DOI 10.1207/s15326969eco1601_6; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chao Zhai FA, 2014, NOVEL COGNITIVE ARCH, DOI [10.1109/SMC.2014.6974001, DOI 10.1109/SMC.2014.6974001]; COHN JF, 1987, DEV PSYCHOL, V23, P68, DOI 10.1037/0012-1649.23.1.68; COHN JF, 1988, DEV PSYCHOL, V24, P386, DOI 10.1037/0012-1649.24.3.386; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Crown C. L., 1991, J LANG SOC PSYCHOL, V10, P29, DOI DOI 10.1177/0261927X91101002; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; ECKERMAN CO, 1990, DEV PSYCHOL, V26, P370, DOI 10.1037/0012-1649.26.3.370; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Fogel A, 1993, DEV RELATIONSHIPS OR; Galantucci B, 2009, TOP COGN SCI, V1, P255, DOI 10.1111/j.1756-8765.2009.01017.x; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Garrod S, 2009, TOP COGN SCI, V1, P292, DOI 10.1111/j.1756-8765.2009.01020.x; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hari R, 2013, TRENDS COGN SCI, V17, P105, DOI 10.1016/j.tics.2013.01.003; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Hoffman G, 2010, IEEE INT CONF ROBOT, P582, DOI 10.1109/ROBOT.2010.5509182; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Johnstone Keith, 1987, IMPRO IMPROVISATION; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; KELSO JAS, 1987, PHYS SCRIPTA, V35, P79, DOI 10.1088/0031-8949/35/1/020; Kelso S., 1995, DYNAMIC PATTERNS SEL; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Khoramshahi M., 2014, 2014 IEEE INT C SYST; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lewis JM, 2000, AM J PSYCHIAT, V157, P1375, DOI 10.1176/appi.ajp.157.9.1375; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Masumoto J, 2013, J NEUROPHYSIOL, V109, P1307, DOI 10.1152/jn.00776.2012; McNeill W. H., 1995, KEEPING TOGETHER TIM; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Noy L, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00187, 10.3389/fnhum.2015.00187]; Noy L, 2015, EXP BRAIN RES, V233, P1307, DOI 10.1007/s00221-015-4204-1; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Richardson MJ, 2007, J EXP PSYCHOL HUMAN, V33, P845, DOI 10.1037/0096-1523.33.4.845; Sawyer R, 2001, CREATING CONVERSATIO, DOI [10.1177/0261927X91101002, DOI 10.1177/0261927X91101002]; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Slowinski P, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1093; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Tanaka F, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P419, DOI 10.1109/ROMAN.2004.1374797; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959; Zhai C., 2014, ADAPTIVE TRACKING CO; Zhang JJ, 2013, IEEE INT CONF ROBOT, P2201, DOI 10.1109/ICRA.2013.6630873	72	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0160747	10.1371/journal.pone.0160747	http://dx.doi.org/10.1371/journal.pone.0160747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711185	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600002
J	Vela-Corcia, D; Bautista, R; de Vicente, A; Spanu, PD; Perez-Garcia, A				Vela-Corcia, David; Bautista, Rocio; de Vicente, Antonio; Spanu, Pietro D.; Perez-Garcia, Alejandro			De novo Analysis of the Epiphytic Transcriptome of the Cucurbit Powdery Mildew Fungus Podosphaera xanthii and Identification of Candidate Secreted Effector Proteins	PLOS ONE			English	Article							INDUCED POINT MUTATION; BLUMERIA-GRAMINIS; SACCHAROMYCES-CEREVISIAE; GENE; OBLIGATE; SEQUENCE; PATHOGEN; GENOME; VIRULENCE; REVEALS	The cucurbit powdery mildew fungus Podosphaera xanthii is a major limiting factor for cucurbit production worldwide. Despite the fungus's agronomic and economic importance, very little is known about fundamental aspects of P. xanthii biology, such as obligate biotrophy or pathogenesis. To design more durable control strategies, genomic information about P. xanthii is needed. Powdery mildews are fungal pathogens with large genomes compared with those of other fungi, which contain vast amounts of repetitive DNA sequences, much of which is composed of retrotransposons. To reduce genome complexity, in this work we aimed to obtain and analyse the epiphytic transcriptome of P. xanthii as a starting point for genomic research. Total RNA was isolated from epiphytic fungal material, and the corresponding cDNA library was sequenced using a 454 GS FLX platform. Over 676,562 reads were obtained and assembled into 37,241 contigs. Annotation data identified 8,798 putative genes with different orthologues. As described for other powdery mildew fungi, a similar set of missing core ascomycete genes was found, which may explain obligate biotrophy. To gain insight into the plant-pathogen relationships, special attention was focused on the analysis of the secretome. After this analysis, 137 putative secreted proteins were identified, including 53 candidate secreted effector proteins (CSEPs). Consistent with a putative role in pathogenesis, the expression profile observed for some of these CSEPs showed expression maxima at the beginning of the infection process at 24 h after inoculation, when the primary appressoria are mostly formed. Our data mark the onset of genomics research into this very important pathogen of cucurbits and shed some light on the intimate relationship between this pathogen and its host plant.	[Vela-Corcia, David; de Vicente, Antonio; Perez-Garcia, Alejandro] Univ Malaga, Inst Hortofruticultura Subtrop & Mediterranea La, Consejo Super Invest Cient IHSM UMA CSIC, Dept Microbiol,Fac Ciencias, Malaga, Spain; [Bautista, Rocio] Plataforma Andaluza Bioinformat, Edificio Bioinnovac,Parque Tecnol Andalucia, Malaga, Spain; [Spanu, Pietro D.] Imperial Coll London, Dept Life Sci, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Imperial College London	Perez-Garcia, A (corresponding author), Univ Malaga, Inst Hortofruticultura Subtrop & Mediterranea La, Consejo Super Invest Cient IHSM UMA CSIC, Dept Microbiol,Fac Ciencias, Malaga, Spain.	aperez@uma.es	Spanu, Pietro/P-5859-2019; VELA-CORCIA, DAVID/B-7163-2019; de Vicente, Antonio/G-4405-2011; Moreno, Rocío Bautista/P-7143-2019; Perez-Garcia, Alejandro/D-9373-2013; Bautista, Rocio/L-1155-2014	Spanu, Pietro/0000-0001-8928-6049; VELA-CORCIA, DAVID/0000-0002-8641-9288; de Vicente, Antonio/0000-0003-2716-9861; Moreno, Rocío Bautista/0000-0003-1685-8119; Perez-Garcia, Alejandro/0000-0002-1065-0360; Bautista, Rocio/0000-0003-1685-8119	Ministerio de Economia y Competitividad (MINECO) by FEDER funds (EU) [AGL2013-41939-R]; FPI program of MICINN; BBSRC [BB/E000983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000983/1] Funding Source: researchfish	Ministerio de Economia y Competitividad (MINECO) by FEDER funds (EU); FPI program of MICINN; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by funding from the former "Ministerio de Ciencia e Innovacion (MICINN)" (AGL2010-21848-CO2-01/ AGR) and current "Ministerio de Economia y Competitividad (MINECO)" (AGL2013-41939-R), both cofinanced by FEDER funds (EU). DVC was supported by a PhD fellowship from the FPI program of MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; Both M, 2005, MOL PLANT MICROBE IN, V18, P125, DOI 10.1094/MPMI-18-0125; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; Chevreux B, 1999, GER C BIOINF, DOI DOI 10.1093/DNARES/DSS036; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; del Pino D, 2002, PHYTOPARASITICA, V30, P459, DOI 10.1007/BF02979750; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Ortuno D, 2006, EUR J PLANT PATHOL, V115, P215, DOI 10.1007/s10658-006-9014-7; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Grell MN, 2003, GENE, V311, P181, DOI 10.1016/S0378-1119(03)00610-3; Guerrero-Fernandez D., 2012, 11 JORN BIOINF BARC, P38; Guyon K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-336; Hane JK, 2015, FUNG BIOL-US, P55, DOI 10.1007/978-3-319-10503-1_4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jain M, 2011, CURR SCI INDIA, V101, P1435; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Perez-Garcia A, 2006, J PHYTOPATHOL, V154, P190, DOI 10.1111/j.1439-0434.2006.01086.x; Perez-Garcia A, 2009, MOL PLANT PATHOL, V10, P153, DOI 10.1111/j.1364-3703.2008.00527.x; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sbrana F, 2007, EUR BIOPHYS J BIOPHY, V36, P727, DOI 10.1007/s00249-007-0159-x; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Soanes DM, 2006, MOL PLANT PATHOL, V7, P61, DOI 10.1111/J.1364-3703.2005.00317.X; Sohn J, 2000, MOL PLANT MICROBE IN, V13, P629, DOI 10.1094/MPMI.2000.13.6.629; Spanu PD, 2012, ANNU REV PHYTOPATHOL, V50, P91, DOI 10.1146/annurev-phyto-081211-173024; Spanu PD, 2012, NEW PHYTOL, V195, P20, DOI 10.1111/j.1469-8137.2012.04173.x; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas SW, 2001, FUNGAL GENET BIOL, V33, P195, DOI 10.1006/fgbi.2001.1281; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Torus, 1997, B N SANIDAD VEGETAL, V23, P283; Vela-Corcia D, 2014, FUNGAL BIOL-UK, V118, P228, DOI 10.1016/j.funbio.2013.12.001; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4849	61	25	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163379	10.1371/journal.pone.0163379	http://dx.doi.org/10.1371/journal.pone.0163379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711117	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600023
J	Biswas, H; Longmore, GD				Biswas, Hirak; Longmore, Gregory D.			Action of SNAIL1 in Cardiac Myofibroblasts Is Important for Cardiac Fibrosis following Hypoxic Injury	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MYOCARDIAL-INFARCTION; COLLAGEN; FIBROBLASTS; EXPRESSION; CELLS; MATRIX; RED	Hypoxic injury to the heart results in cardiac fibrosis that leads to cardiac dysfunction and heart failure. SNAIL1 is a zinc finger transcription factor implicated in fibrosis following organ injury and cancer. To determine if the action of SNAIL1 contributed to cardiac fibrosis following hypoxic injury, we used an endogenous SNAIL1 bioluminescence reporter mice, and SNAIL1 knockout mouse models. Here we report that SNAIL1 expression is upregulated in the infarcted heart, especially in the myofibroblasts. Utilizing primary cardiac fibroblasts in ex vivo cultures we find that pro-fibrotic factors and collagen I increase SNAIL1 protein level. SNAIL1 is required in cardiac fibroblasts for the adoption of myofibroblast fate, collagen I expression and expression of fibrosis-related genes. Taken together this data suggests that SNAIL1 expression is induced in the cardiac fibroblasts after hypoxic injury and contributes to myofibroblast phenotype and a fibrotic scar formation. Resultant collagen deposition in the scar can maintain elevated SNAIL1 expression in the myofibroblasts and help propagate fibrosis.	[Longmore, Gregory D.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Biswas, Hirak; Longmore, Gregory D.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Biswas, Hirak; Longmore, Gregory D.] Washington Univ, ICCE Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Longmore, GD (corresponding author), Washington Univ, Dept Med, St Louis, MO 63110 USA.; Longmore, GD (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Longmore, GD (corresponding author), Washington Univ, ICCE Inst, St Louis, MO 63110 USA.	glongmore@wustl.edu			American Heart Association (AHA) [14PRE18680005]; NIH [GM080673-09]; Komen Foundation [KG110889]; NATIONAL CANCER INSTITUTE [R01CA196205, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080673] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HB was supported by an American Heart Association predoctoral fellowship (AHA Award #14PRE18680005). This work was supported, in part, by NIH grant GM080673-09 (GDL) and the Komen Foundation KG110889 (GDL).	CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Lee SW, 2013, MOL THER, V21, P1767, DOI 10.1038/mt.2013.146; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P902, DOI 10.1093/abbs/gms085; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; O'Connor JW, 2015, J CELL PHYSIOL, V230, P1829, DOI 10.1002/jcp.24895; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stanisavljevic J, 2015, CANCER RES, V75, P284, DOI 10.1158/0008-5472.CAN-14-1903; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wehrend A, 2004, ANAT HISTOL EMBRYOL, V33, P180, DOI 10.1111/j.1439-0264.2004.00532.x; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang K, 2016, J CELL SCI, V129, P1989, DOI 10.1242/jcs.180539; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162636	10.1371/journal.pone.0162636	http://dx.doi.org/10.1371/journal.pone.0162636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706205	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200017
J	Correa, MS; Giacobbo, BL; Vedovelli, K; de Lima, DB; Ferrari, P; Argimon, IID; Walz, JC; Bromberg, E				Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Ferrari, Pamela; de Lima Argimon, Irani Iracema; Walz, Julio Cesar; Bromberg, Elke			Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DEHYDROEPIANDROSTERONE DHEA; SALIVARY CORTISOL; MAJOR DEPRESSION; CHRONIC STRESS; SERUM-LEVELS; BDNF LEVELS; BRAIN; DEMENTIA; GENDER	Objectives Older familial caregivers of Alzheimer's disease patients are subjected to stress-related cognitive and psychophysiological dysfunctions that may affect their quality of life and ability to provide care. Younger caregivers have never been properly evaluated. We hypothesized that they would show qualitatively similar cognitive and psychophysiological alterations to those of older caregivers. Method The cognitive measures of 17 young (31-58 years) and 18 old (63-84 years) caregivers and of 17 young (37-57 years) and 18 old (62-84 years) non-caregiver controls were evaluated together with their salivary cortisol and dehydroepiandrosterone (DHEA) levels, as measured by radioimmunoassays and ELISA assays of brain-derived neurotrophic factor (BDNF) in serum. Results Although younger caregivers had milder impairments in memory and executive functions than older caregivers, their performances fell to the same or lower levels as those of the healthy older controls. Decreases in DHEA and BDNF levels were correlated with the cognitive dysfunctions observed in the older and younger caregivers, respectively. Cortisol at 10PM increased in both caregiver groups. Discussion Younger caregivers were prone to cognitive impairments similar to older caregivers, although the degree and the neuropsychological correlates of the cognitive dysfunctions were somewhat different between the two groups. This work has implications for caregiver and care-recipient health and for research on the neurobiology of stress-related cognitive dysfunctions.	[Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Lab Biol & Desenvolvimento Sistema Nervoso, Fac Biociencias, Porto Alegre, RS, Brazil; [Correa, Marcio Silveira; Giacobbo, Bruno Lima; de Lima, Daiane Borba; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Vedovelli, Kelem; de Lima Argimon, Irani Iracema; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Inst Geriatriae & Gerontol, Porto Alegre, RS, Brazil; [Ferrari, Pamela; Walz, Julio Cesar] Hosp Clin Porto Alegre, Lab Psiquiatria Mol, Porto Alegre, RS, Brazil; [Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Ferrari, Pamela; Walz, Julio Cesar; Bromberg, Elke] INCT TM, Porto Alegre, RS, Brazil; [Walz, Julio Cesar] Fac Unilasalle, Canoas, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Centro Universitario La Salle	Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Lab Biol & Desenvolvimento Sistema Nervoso, Fac Biociencias, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Geriatriae & Gerontol, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), INCT TM, Porto Alegre, RS, Brazil.	bromberg@pucrs.br	Bromberg, Elke/G-4512-2012	Bromberg, Elke/0000-0002-2900-3673; S. Correa, Marcio/0000-0002-8866-8384	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) [485015/2012-9]; FAPERGS/CAPES fellowship	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS/CAPES fellowship	Financial support for this study was provided by Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) to Elke Bromberg (grant number 485015/2012-9, http://cnpqbr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this study was provided by a CNPq grant (485015/2012-9) awarded to E. Bromberg. I.I. Argimon and E. Bromberg are CNPq research fellows. M.S. Correa is funded by a FAPERGS/CAPES fellowship. K. Vedovelli and B.L. Giacobbo have a CAPES fellowship. We thank Dr. Flavio Kapczinski for help with ELISA assays and Mrs. Iara Portugal for her support in recruiting the caregivers at the ABRAZ-Porto Alegre.	Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bedrosian TA, 2013, EXP NEUROL, V243, P67, DOI 10.1016/j.expneurol.2012.05.005; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Carlino D, 2011, J PSYCHIATR RES, V45, P273, DOI 10.1016/j.jpsychires.2010.06.012; Caswell LW, 2003, EXP AGING RES, V29, P303, DOI 10.1080/03610730303721; Collins LG, 2011, AM FAM PHYSICIAN, V83, P1309; Correa MS, 2015, NEUROSCIENCE, V286, P371, DOI 10.1016/j.neuroscience.2014.11.052; Correa MS, 2012, BIOL PSYCHOL, V89, P293, DOI 10.1016/j.biopsycho.2011.11.001; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Cunha J, 2001, CASA DO PSICOLOGO; Daughters SB, 2013, J ABNORM CHILD PSYCH, V41, P749, DOI 10.1007/s10802-013-9713-4; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2006, AGE AGEING, V35, P160, DOI 10.1093/ageing/afj044; de Vugt ME, 2005, J NEUROPSYCH CLIN N, V17, P201, DOI 10.1176/appi.neuropsych.17.2.201; Dias Rachel, 2015, Trends Psychiatry Psychother., V37, P12, DOI 10.1590/2237-6089-2014-0032; Evans PD, 2011, INT J PSYCHOPHYSIOL, V79, P371, DOI 10.1016/j.ijpsycho.2010.12.006; Ferrara M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-93; Ferrari E, 2008, AGEING RES REV, V7, P225, DOI 10.1016/j.arr.2008.07.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher-Thompson D, 2006, AM J GERIAT PSYCHIAT, V14, P334, DOI 10.1097/01.JGP.0000206485.73618.87; Guazzo EP, 1996, J CLIN ENDOCR METAB, V81, P3951, DOI 10.1210/jc.81.11.3951; Guerrero-Berroa E, 2014, INT J GERIATR PSYCH, V29, P299, DOI 10.1002/gps.4008; Hucklebridge F, 2005, PSYCHONEUROENDOCRINO, V30, P51, DOI 10.1016/j.psyneuen.2004.04.007; Iughetti L, 2011, NEUROPEPTIDES, V45, P205, DOI 10.1016/j.npep.2011.02.002; Jeanneteau F, 2013, NEUROSCIENCE, V239, P173, DOI 10.1016/j.neuroscience.2012.09.017; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Kozlov AI, 2004, HUM PHYSL, V40, P224; Lee S, 2004, J NERV MENT DIS, V192, P51, DOI 10.1097/01.nmd.0000106000.02232.30; Lennartsson AK, 2012, BIOL PSYCHOL, V90, P143, DOI 10.1016/j.biopsycho.2012.03.003; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mackenzie CS, 2009, J GERONTOL B-PSYCHOL, V64, P742, DOI 10.1093/geronb/gbp076; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Norton MC, 2010, GREATER RISK DEMENTI, P895; Oken BS, 2011, J GERIATR PSYCH NEUR, V24, P191, DOI 10.1177/0891988711422524; Oral E, 2012, BRAIN RES BULL, V88, P454, DOI 10.1016/j.brainresbull.2012.03.005; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Perna G, 2016, ARE ANXIETY DISORDER, V2016; Pivonello R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00129; Pluchino N, 2013, NEUROSCIENCE, V239, P271, DOI 10.1016/j.neuroscience.2013.01.025; RABBITT P, 1995, PSYCHOL AGING, V10, P307, DOI 10.1037/0882-7974.10.3.307; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Richardson TJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0367-2; Seeman TE, 1997, J CLIN ENDOCR METAB, V82, P2458, DOI 10.1210/jc.82.8.2458; Shansky RM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00123; Strauss E, 2006, COMPENDIUM NEUROPSYC; Suri D, 2013, NEUROSCIENCE, V239, P196, DOI 10.1016/j.neuroscience.2012.08.065; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; Ventriglia M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901082; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x; Vitaliano PP, 2010, J AM GERIATR SOC, V58, P976, DOI 10.1111/j.1532-5415.2010.02843.x; Vitaliano PP, 2005, AM J GERIAT PSYCHIAT, V13, P834, DOI 10.1176/appi.ajgp.13.10.834; Wahbeh H, 2008, ALZ DIS ASSOC DIS, V22, P181, DOI 10.1097/WAD.0b013e31815a9dff; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D, 1987, MANUAL WESCHSLER MEM; Palma KAXA, 2011, ALZ DIS ASSOC DIS, V25, P262, DOI 10.1097/WAD.0b013e318209e453; Young AH, 2002, AM J PSYCHIAT, V159, P1237, DOI 10.1176/appi.ajp.159.7.1237	69	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162619	10.1371/journal.pone.0162619	http://dx.doi.org/10.1371/journal.pone.0162619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706235	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200016
J	Staiger, JF; Loucif, AJC; Schubert, D; Mock, M				Staiger, Jochen F.; Loucif, Alexandre J. C.; Schubert, Dirk; Moeck, Martin			Morphological Characteristics of Electrophysiologically Characterized Layer Vb Pyramidal Cells in Rat Barrel Cortex	PLOS ONE			English	Article							IV SPINY NEURONS; SOMATOSENSORY CORTEX; VISUAL-CORTEX; PHYSIOLOGICAL-PROPERTIES; REGULAR SPIKING; FUNCTIONAL CONNECTIVITY; NEOCORTICAL NEURONS; INTRINSIC CIRCUITRY; CEREBRAL-CORTEX; SMI CORTEX	Layer Vb pyramidal cells are the major output neurons of the neocortex and transmit the outcome of cortical columnar signal processing to distant target areas. At the same time they contribute to local tactile information processing by emitting recurrent axonal collaterals into the columnar microcircuitry. It is, however, not known how exactly the two types of pyramidal cells, called slender-tufted and thick-tufted, contribute to the local circuitry. Here, we investigated in the rat barrel cortex the detailed quantitative morphology of biocytin-filled layer Vb pyramidal cells in vitro, which were characterized for their intrinsic electrophysiology with special emphasis on their action potential firing pattern. Since we stained the same slices for cytochrome oxidase, we could also perform layer-and column-related analyses. Our results suggest that in layer Vb the unambiguous action potential firing patterns "regular spiking (RS)" and "repetitive burst spiking (RB)" (previously called intrinsically burst spiking) correlate well with a distinct morphology. RS pyramidal cells are somatodendritically of the slender-tufted type and possess numerous local intralaminar and intracolumnar axonal collaterals, mostly reaching layer I. By contrast, their transcolumnar projections are less well developed. The RB pyramidal cells are somatodendritically of the thick-tufted type and show only relatively sparse local axonal collaterals, which are preferentially emitted as long horizontal or oblique infragranular collaterals. However, contrary to many previous slice studies, a substantial number of these neurons also showed axonal collaterals reaching layer I. Thus, electrophysiologically defined pyramidal cells of layer Vb show an input and output pattern which suggests RS cells to be more "locally segregating" signal processors whereas RB cells seem to act more on a "global integrative" scale.	[Staiger, Jochen F.; Moeck, Martin] Univ Gottingen, Univ Med Ctr, Inst Neuroanat, Gottingen, Germany; [Loucif, Alexandre J. C.] Univ Freiburg, Inst Neuroanat, Freiburg, Germany; [Schubert, Dirk] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Loucif, Alexandre J. C.] Pfizer Worldwide Res & Dev, Neurosci & Pain Res, Portway Bldg,Granta Pk, Cambridge, England	University of Gottingen; University of Freiburg; Radboud University Nijmegen; Pfizer	Staiger, JF (corresponding author), Univ Gottingen, Univ Med Ctr, Inst Neuroanat, Gottingen, Germany.	jochen.staiger@med.uni-goettingen.de	Schubert, Dirk/B-4339-2011	Schubert, Dirk/0000-0002-1202-4363	Deutsche Forschungsgemeinschaft [STA 431/5-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (STA 431/5-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo MC, 1999, J NEUROSCI, V19, P1566; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Balduzzi D, 2013, THEOR BIOSCI, V132, P27, DOI 10.1007/s12064-012-0165-0; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Egger R, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00129; Egger V, 2008, CEREB CORTEX, V18, P876, DOI 10.1093/cercor/bhm126; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; LARKMAN A, 1990, J NEUROSCI, V10, P1407; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lorincz ML, 2015, J NEUROSCI, V35, P5442, DOI 10.1523/JNEUROSCI.3603-14.2015; Lubke J, 1996, J NEUROSCI, V16, P3209; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1990, J NEUROSCI, V10, P1415; Meyer HS, 2013, P NATL ACAD SCI USA, V110, P19113, DOI 10.1073/pnas.1312691110; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Narayanan RT, 2015, CEREB CORTEX, V25, P4450, DOI 10.1093/cercor/bhv053; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Staiger JF, 2015, BRAIN STRUCT FUNCT, V220, P1317, DOI 10.1007/s00429-014-0726-8; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; VANBREDERODE JFM, 1992, NEUROSCIENCE, V50, P315, DOI 10.1016/0306-4522(92)90426-3; Wagener RJ, 2010, J NEUROSCI, V30, P15700, DOI 10.1523/JNEUROSCI.3707-10.2010; WANG Z, 1993, J NEUROSCI, V13, P2199; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; WHITE EL, 1994, J COMP NEUROL, V342, P1, DOI 10.1002/cne.903420102; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wright AK, 2001, NEUROSCIENCE, V103, P87, DOI 10.1016/S0306-4522(00)00564-9; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009	64	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164004	10.1371/journal.pone.0164004	http://dx.doi.org/10.1371/journal.pone.0164004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706253	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200074
J	Vogan, PJ; Schoettle, AW				Vogan, Patrick J.; Schoettle, Anna W.			Carbon Costs of Constitutive and Expressed Resistance to a Non-Native Pathogen in Limber Pine	PLOS ONE			English	Article							GENE-MEDIATED RESISTANCE; BLISTER RUST; WHITE-PINE; DISEASE RESISTANCE; FITNESS COSTS; GROWTH; CONSEQUENCES; COEVOLUTION; METABOLISM; INFECTION	Increasing the frequency of resistance to the non-native fungus Cronartium ribicola (causative agent of white pine blister rust, WPBR) in limber pine populations is a primary management objective to sustain high-elevation forest communities. However, it is not known to what extent genetic disease resistance is costly to plant growth or carbon economy. In this study, we measured growth and leaf-level physiology in (1) seedling families from seed trees that have previously been inferred to carry or not carry Cr4, the dominant R gene allele conferring complete, gene-for-gene resistance to WPBR in limber pine, and (2) populations that were and were not infected with C. ribicola. We found that, in the absence of C. ribicola exposure, there was no significant difference in carbon relations between families born from seed trees that harbor the resistance allele compared to those that lack it, either to plant growth and phenology or leaf-level photosynthetic traits. However, post-infection with C. ribicola, growth was significantly reduced in inoculation survivors expressing complete resistance compared to uninoculated seedlings. Furthermore, inoculation survivors exhibited significant increases in a suite of traits including photosynthetic rate, respiration rate, leaf N, and stomatal conductance and a decrease in photosynthetic water-use efficiency. The lack of constitutive carbon costs associated with Cr4 resistance in non-stressed limber pine is consistent with a previous report that the R gene allele is not under selection in the absence of C. ribicola and suggests that host resistance may not bear a constitutive cost in pathosystems that have not coevolved. However, under challenge by C. ribicola, complete resistance to WPBR in limber pine has a significant cost to plant growth, though enhanced carbon acquisition post-infection may offset this somewhat. These costs and effects on performance further complicate predictions of this species' response in warmer future climates in the presence of WPBR.	[Vogan, Patrick J.] Mt Studies Inst, POB 426, Silverton, CO 81433 USA; [Vogan, Patrick J.; Schoettle, Anna W.] US Forest Serv, USDA, Rocky Mt Res Stn, 240 West Prospect Rd, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA); United States Forest Service	Schoettle, AW (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, 240 West Prospect Rd, Ft Collins, CO 80526 USA.	aschoettle@fs.fed.us			United States Department of Agriculture Forest Service, Rocky Mountain Research Station; United States Department of Interior National Park Service, Rocky Mountain National Park	United States Department of Agriculture Forest Service, Rocky Mountain Research Station; United States Department of Interior National Park Service, Rocky Mountain National Park	Funding was provided by United States Department of Agriculture Forest Service, Rocky Mountain Research Station to AWS, and United States Department of Interior National Park Service, Rocky Mountain National Park to AWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Anderson KM, 2011, J ECON ENTOMOL, V104, P1393, DOI 10.1603/EC11004; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Brown JKM, 2013, PLANT PATHOL, V62, P83, DOI 10.1111/ppa.12163; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Burns KS, 2008RMRSGTR206 USDA; Cleaver CM, 2015, FOREST ECOL MANAG, V358, P139, DOI 10.1016/j.foreco.2015.09.010; Dietrich R, 2005, PLANT CELL ENVIRON, V28, P211, DOI 10.1111/j.1365-3040.2004.01265.x; Egger B, 1996, PHYSIOL PLANTARUM, V96, P91, DOI 10.1111/j.1399-3054.1996.tb00188.x; Ennos RA, 2015, FORESTRY, V88, P41, DOI 10.1093/forestry/cpu048; Gibson K, 2008R108020 USDA FOR; Government of Alberta, 2010, SPEC RISK PUBL REG S; Hoch G, 2005, FUNCT ECOL, V19, P941, DOI 10.1111/j.1365-2435.2005.01040.x; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Jermstad KD, 2011, TREE GENET GENOMES, V7, P457, DOI 10.1007/s11295-010-0347-1; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keane RE, 2012RMRSGTR279 USDA; Keith R, 2013, PLANT PATHOL, V62, P122, DOI 10.1111/ppa.12134; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P691, DOI 10.1094/PHYTO.2003.93.6.691; Kinloch BB, 2002, PHYTOPATHOLOGY, V92, P278, DOI 10.1094/PHYTO.2002.92.3.278; Korner C, 1999, ALPINE PLANT LIFE FU; Korves T, 2004, AM NAT, V163, P489, DOI 10.1086/382552; Krist F.J., 2014, 2013 2027 NATL INSEC; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Liu J-J, 2015, ANN C AM PHYT SOC AP; MacQueen A, 2016, J EXP BOT, V67, P2093, DOI 10.1093/jxb/erv530; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Mielke P. W., 2001, PERMUTATION METHODS; Moyes AB, 2013, OECOLOGIA, V171, P271, DOI 10.1007/s00442-012-2410-0; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Reinhardt K, 2011, TREE PHYSIOL, V31, P615, DOI 10.1093/treephys/tpr055; Samman SA, 1982, BREEDING INSECT DIS, P133; Schoettle AW, 2014, PHYTOPATHOLOGY, V104, P163, DOI 10.1094/PHYTO-04-13-0092-R; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; SMEDEGAARDPETERSEN V, 1980, PHYTOPATHOL Z, V99, P54; SMEDEGAARDPETERSEN V, 1981, PHYTOPATHOLOGY, V71, P396, DOI 10.1094/Phyto-71-396; Smith CM, 2013, CAN J FOREST RES, V43, P919, DOI 10.1139/cjfr-2013-0072; Smith WK, 2003, TREE PHYSIOL, V23, P1101, DOI 10.1093/treephys/23.16.1101; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Susi H, 2015, J ECOL, V103, P303, DOI 10.1111/1365-2745.12373; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vogan PJ, 2015, FOREST ECOL MANAG, V344, P110, DOI 10.1016/j.foreco.2015.01.029; Vogan PJ, 2011, PLANT CELL ENVIRON, V34, P1415, DOI 10.1111/j.1365-3040.2011.02340.x; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162913	10.1371/journal.pone.0162913	http://dx.doi.org/10.1371/journal.pone.0162913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706249	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200024
J	Zhao, T; Yang, HF; Sui, HX; Salvi, SS; Wang, Y; Sun, YC				Zhao, Tian; Yang, Huifang; Sui, Huaxin; Salvi, Satyajeet Sudhir; Wang, Yong; Sun, Yuchun			Accuracy of a Real-Time, Computerized, Binocular, Three-Dimensional Trajectory-Tracking Device for Recording Functional Mandibular Movements	PLOS ONE			English	Article								Objective Developments in digital technology have permitted researchers to study mandibular movements. Here, the accuracy of a real-time, computerized, binocular, three-dimensional (3D) trajectory-tracking device for recording functional mandibular movements was evaluated. Methods An occlusal splint without the occlusal region was created based on a plaster cast of the lower dentition. The splint was rigidly connected with a target on its labial side and seated on the cast. The cast was then rigidly attached to the stage of a high-precision triaxial electronic translator, which was used to move the target-cast-stage complex. Half-circular movements (5.00-mm radius) in three planes (XOY, XOZ, YOZ) and linear movements along the x-axis were performed at 5.00 mm/s. All trajectory points were recorded with the binocular 3D trajectory-tracking device and fitted to arcs or lines, respectively, with the Imageware software. To analyze the accuracy of the trajectory-tracking device, the mean distances between the trajectory points and the fitted arcs or lines were measured, and the mean differences between the lengths of the fitted arcs' radii and a set value (5.00 mm) were then calculated. A one-way analysis of variance was used to evaluate the spatial consistency of the recording accuracy in three different planes. Results The mean distances between the trajectory points and fitted arcs or lines were 0.076 +/- 0.033 mm or 0.089 +/- 0.014 mm. The mean difference between the lengths of the fitted arcs' radii and the set value (5.00 mm) was 0.025 +/- 0.071 mm. A one-way ANOVA showed that the recording errors in three different planes were not statistically significant. Conclusion These results suggest that the device can record certain movements at 5.00 mm/s, which is similar to the speed of functional mandibular movements. In addition, the recordings had an error of <0.1 mm and good spatial consistency. Thus, the device meets some of the requirements necessary for recording human mandibular movements.	[Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Salvi, Satyajeet Sudhir; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China	Peking University; Peking University	Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020					Feng HL, 2005, PROSTHODONTICS; JANKELSON B, 1975, J AM DENT ASSOC, V90, P834, DOI 10.14219/jada.archive.1975.0164; Kim DS, 2010, ORAL SURG ORAL MED O, V110, P648, DOI 10.1016/j.tripleo.2010.06.007; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095912; Santana-Mora U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059980; Yuan FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137507	6	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163934	10.1371/journal.pone.0163934	http://dx.doi.org/10.1371/journal.pone.0163934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701462	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900035
J	Martho, KFC; de Melo, AT; Takahashi, JPF; Guerra, JM; Santos, DCD; Purisco, SU; Melhem, MDC; Fazioli, RD; Phanord, C; Sartorelli, P; Vallim, MA; Pascon, RC				Cruz Martho, Kevin Felipe; de Melo, Amanda Teixeira; Fernandes Takahashi, Juliana Possato; Guerra, Juliana Mariotti; da Silva Santos, Dayane Cristina; Purisco, Sonia Ueda; Carvalho Melhem, Marcia de Souza; Fazioli, Raquel dos Anjos; Phanord, Clerlune; Sartorelli, Patricia; Vallim, Marcelo A.; Pascon, Renata C.			Amino Acid Permeases and Virulence in Cryptococcus neoformans	PLOS ONE			English	Article							HUMAN FUNGAL PATHOGEN; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENE; TRANSPORTERS; METABOLISM; ADAPTATION; SYNTHASE; GROWTH; FILAMENTATION	Fungal opportunistic pathogens colonize various environments, from plants and wood to human and animal tissue. Regarding human pathogens, one great challenge during contrasting niche occupation is the adaptation to different conditions, such as temperature, osmolarity, salinity, pressure, oxidative stress and nutritional availability, which may constitute sources of stress that need to be tolerated and overcome. As an opportunistic pathogen, C. neoformans faces exactly these situations during the transition from the environment to the human host, encountering nutritional constraints. Our previous and current research on amino acid biosynthetic pathways indicates that amino acid permeases are regulated by the presence of the amino acids, nitrogen and temperature. Saccharomyces cerevisiae and Candida albicans have twenty-four and twenty-seven genes encoding amino acid permeases, respectively; conversely, they are scarce in number in Basidiomycetes (C. neoformans, Coprinopsis cinerea and Ustilago maydis), where nine to ten permease genes can be found depending on the species. In this study, we have demonstrated that two amino acid permeases are essential for virulence in C. neoformans. Our data showed that C. neoformans uses two global and redundant amino acid permeases, Aap4 and Aap5 to respond correctly to thermal and oxidative stress. Double deletion of these permeases causes growth arrest in C. neoformans at 37 degrees C and in the presence of hydrogen peroxide. The inability to uptake amino acid at a higher temperature and under oxidative stress also led to virulence attenuation in vivo. Our data showed that thermosensitivity caused by the lack of permeases Aap4 and Aap5 can be remedied by alkaline conditions (higher pH) and salinity. Permeases Aap4 and Aap5 are also required during fluconazole stress and they are the target of the plant secondary metabolite eugenol, a potent antifungal inhibitor that targets amino acid permeases. In summary, our work unravels (i) interesting physiological property of C. neoformans regarding its amino acid uptake system; (ii) an important aspect of virulence, which is the need for amino acid permeases during thermal and oxidative stress resistance and, hence, host invasion and colonization; and (iii) provides a convenient prototype for antifungal development, which are the amino acid permeases Aap4/Aap5 and their inhibitor.	[Cruz Martho, Kevin Felipe; de Melo, Amanda Teixeira; Phanord, Clerlune; Sartorelli, Patricia; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Rua Arthur Ridel 275, Diadema, SP, Brazil; [Fernandes Takahashi, Juliana Possato; Guerra, Juliana Mariotti] Adolfo Lutz Inst, Quantitat Pathol Unit, Sao Paulo, Brazil; [da Silva Santos, Dayane Cristina; Purisco, Sonia Ueda; Carvalho Melhem, Marcia de Souza; Fazioli, Raquel dos Anjos] Secretary Hlth, Adolfo Lutz Inst, Mycol Unit, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Instituto Adolfo Lutz; Instituto Adolfo Lutz	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Rua Arthur Ridel 275, Diadema, SP, Brazil.	Renata.pascon@gmail.com	Sartorelli, Patricia/AAN-2911-2020; Pascon, Renata/E-1494-2012; de melo, amanda teixeira/U-1811-2019; Guerra, Juliana/H-5310-2012; Vallim, Marcelo/J-2624-2013	Pascon, Renata/0000-0001-9902-9396; de melo, amanda teixeira/0000-0003-3867-8522; Guerra, Juliana/0000-0002-0326-7187; Vallim, Marcelo/0000-0002-6929-0566; Sartorelli, Patricia/0000-0002-1624-8145	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51298-4, 2015/04400-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2011/51298-4 (RCP); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2015/04400-9 (MAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Alspaugh JA, 1998, FUNGAL GENET BIOL, V25, P1, DOI 10.1006/fgbi.1998.1079; Antinori Spinello, 2013, ISRN AIDS, V2013, P471363, DOI 10.1155/2013/471363; Ballou ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003687; Berger S., 2009, CLASSICS SPECTROSCOP; Biswas K, 2003, GENE, V323, P43, DOI 10.1016/j.gene.2003.09.005; Brega E, 2004, EUKARYOT CELL, V3, P135, DOI 10.1128/EC.3.1.135-143.2004; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131865; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; Dichtl K, 2016, CELL MICROBIOL, V18, P1228, DOI 10.1111/cmi.12612; Do E, 2016, BIOCHEM BIOPH RES CO, V477, P706, DOI 10.1016/j.bbrc.2016.06.123; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Han K, 2012, J MICROBIOL BIOTECHN, V22, P1644, DOI 10.4014/jmb.1209.09019; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Janbon G, 2004, FEMS YEAST RES, V4, P765, DOI 10.1016/j.femsyr.2004.04.003; Kaiser JC, 2015, INFECT IMMUN, V83, P1019, DOI 10.1128/IAI.02542-14; Kamatou GP, 2012, MOLECULES, V17, P6953, DOI 10.3390/molecules17066953; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Komalapriya C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137750; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Liu TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Martinez P, 2004, MOL MICROBIOL, V51, P371, DOI 10.1046/j.1365-2958.2003.03845.x; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; Ost KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005159; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pramod K, 2010, NAT PROD COMMUN, V5, P1999; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Fernandes JDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132369; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Schwartzman JA, 2016, TRENDS MICROBIOL, V24, P414, DOI 10.1016/j.tim.2016.02.012; Schweikhard ES, 2012, CURR TOP MEMBR, V70, P1, DOI 10.1016/B978-0-12-394316-3.00001-6; Shor E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004668; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Srikanta D, 2014, YEAST, V31, P47, DOI 10.1002/yea.2997; Sui Y, 2015, APPL ENVIRON MICROB, V81, P2968, DOI 10.1128/AEM.04203-14; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	73	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163919	10.1371/journal.pone.0163919	http://dx.doi.org/10.1371/journal.pone.0163919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695080	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100065
J	Nakajima, H; Terazawa, S; Niwano, T; Yamamoto, Y; Imokawa, G				Nakajima, Hiroaki; Terazawa, Shuko; Niwano, Takao; Yamamoto, Yorihiro; Imokawa, Genji			The Inhibitory Effects of Anti-Oxidants on Ultraviolet-Induced Up-Regulation of the Wrinkling-Inducing Enzyme Neutral Endopeptidase in Human Fibroblasts	PLOS ONE			English	Article							KAPPA-B P65; RADIATION-INDUCED FORMATION; AGE-RELATED-CHANGES; SELECTIVE-INHIBITION; HUMAN KERATINOCYTES; ELASTASE ACTIVITY; IN-VIVO; SKIN; ASTAXANTHIN; IRRADIATION	We recently reported that the over-expression of skin fibroblast-derived neutral endopeptidase (NEP) plays a pivotal role in impairing the three-dimensional architecture of dermal elastic fibers during the biological mechanism of ultraviolet (UV)-induced skin wrinkling. In that process, a UVB-associated epithelial-mesenchymal cytokine interaction as well as a direct UVA-induced cellular stimulation are associated with the up-regulation of NEP in human fibroblasts. In this study, we characterized the mode of action of ubiquinol(10) which may abrogate the up-regulation of NEP by dermal fibroblasts, resulting in a reported in vivo anti-wrinkling action, and compared that with 3 other anti-oxidants, astaxanthin (AX), riboflavin (RF) and flavin mononucleotide (FMN). Post-irradiation treatment with all 4 of those anti-oxidants elicited an interrupting effect on the UVB-associated epithelial-mesenchymal cytokine interaction leading to the up-regulation of NEP in human fibroblasts but with different modes of action. While AX mainly served as an inhibitor of the secretion of wrinkle-inducing cytokines, such as interleukin-1 alpha (IL-1 alpha) and granulocyte macrophage colony stimulatory factor (GM-CSF) in UVB-exposed epidermal keratinocytes, ubiquinol(10), RF and FMN predominantly interrupted the IL-1 alpha and GM-CSF-stimulated expression of NEP in dermal fibroblasts. On the other hand, as for the UVA-associated mechanism, similar to the abrogating effects reported for AX and FMN, ubiquinol(10) but not RF had the potential to abrogate the increased expression of NEP and matrix-metalloproteinase-1 in UVAexposed human fibroblasts. Our findings strongly support the in vivo anti-wrinkling effects of ubiquinol(10) and AX on human and animal skin and provide convincing proof of the UV-induced wrinkling mechanism that essentially focuses on the over-expression of NEP by dermal fibroblasts as an intrinsic causative factor.	[Nakajima, Hiroaki] Toyo Beauty Co Ltd, R&D Div, Osaka, Japan; [Nakajima, Hiroaki; Niwano, Takao; Yamamoto, Yorihiro] Tokyo Univ Technol, Sch Biosci & Biotechnol, Tokyo, Japan; [Terazawa, Shuko; Imokawa, Genji] Chubu Univ, Res Inst Biol Funct, Aichi, Japan	Tokyo University of Technology; Chubu University	Imokawa, G (corresponding author), Chubu Univ, Res Inst Biol Funct, Aichi, Japan.	imokawag@dream.ocn.ne.jp						Akazaki S, 2002, BRIT J DERMATOL, V147, P689, DOI 10.1046/j.1365-2133.2002.04874.x; [Anonymous], [No title captured]; Hayashi N, 2003, EXP DERMATOL, V12, P13, DOI 10.1034/j.1600-0625.12.s2.2.x; Hoppe U, 1999, BIOFACTORS, V9, P371, DOI 10.1002/biof.5520090238; Imayama Shuhei, 1994, Journal of Dermatological Science, V7, P32, DOI 10.1016/0923-1811(94)90019-1; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P254, DOI 10.1111/1523-1747.ep12317607; Imokawa G, 2015, INT J MOL SCI, V16, P7776, DOI 10.3390/ijms16047776; Imokawa G, 2015, INT J MOL SCI, V16, P7753, DOI 10.3390/ijms16047753; Inui M, 2008, BIOFACTORS, V32, P237, DOI 10.1002/biof.5520320128; Mizutani Y, 2005, JAP J COS CHEM, V29, P9; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Nakajima H, 2012, ARCH DERMATOL RES, V304, P803, DOI 10.1007/s00403-012-1248-y; Nakajima H, 2012, BIOCHEM J, V443, P297, DOI 10.1042/BJ20111876; Nakajima H, 2011, ARCH DERMATOL RES, V303, P263, DOI 10.1007/s00403-011-1143-y; Niwano T, 2015, CYTOKINE, V73, P184, DOI 10.1016/j.cyto.2015.02.006; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Suganuma K, 2012, JICHI MED U J, V35, P25; Suganuma K, 2010, J DERMATOL SCI, V58, P136, DOI 10.1016/j.jdermsci.2010.02.009; Tagashira H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128678; Takema Y, 1995, J SOC COSMET CHEM, V46, P163; Takema Y, 1998, DERMATOLOGY, V196, P397, DOI 10.1159/000017931; Tanino Y, 2005, J DERMATOL SCI, pS21, DOI 10.1016/j.descs.2005.06.003; Terazawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136311; Terazawa S, 2012, EXP DERMATOL, V21, P11, DOI 10.1111/j.1600-0625.2012.01496.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; Tsukahara K, 2004, BRIT J DERMATOL, V151, P984, DOI 10.1111/j.1365-2133.2004.06203.x; Tsukahara K, 2001, J INVEST DERMATOL, V117, P671, DOI 10.1046/j.0022-202x.2001.01450.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0161580	10.1371/journal.pone.0161580	http://dx.doi.org/10.1371/journal.pone.0161580			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648570	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100007
J	Reimondo, G; Chiodini, I; Puglisi, S; Pia, A; Morelli, V; Kastelan, D; Cannavo, S; Berchialla, P; Giachino, D; Perotti, P; Cuccurullo, A; Paccotti, P; Beck-Peccoz, P; De Marchi, M; Terzolo, M				Reimondo, Giuseppe; Chiodini, Iacopo; Puglisi, Soraya; Pia, Anna; Morelli, Valentina; Kastelan, Darko; Cannavo, Salvatore; Berchialla, Paola; Giachino, Daniela; Perotti, Paola; Cuccurullo, Alessandra; Paccotti, Piero; Beck-Peccoz, Paolo; De Marchi, Mario; Terzolo, Massimo			Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas	PLOS ONE			English	Article							METABOLIC PARAMETERS; WEIGHT-GAIN; IN-VIVO; SENSITIVITY; ASSOCIATION; MASS; CHOLESTEROL; MANAGEMENT; DIAGNOSIS; CORTISOL	Context Patients with adrenal incidentalomas (AI) may experience detrimental consequences due to a minimal cortisol excess sustained by adrenal adenoma. SNPs of the glucocorticoid receptor gene (NR3C1) modulate individual sensitivity to glucocorticoids and may interfere with the clinical presentation. Objective To compare the frequency of N363S, ER22/23EK and BclI SNPs in patients with AI with the general population and to evaluate whether these SNPs are linked to consequences of cortisol excess. Setting Multicentric, retrospective analysis of patients referred from 2010 to 2014 to 4 centers (Orbassano, Milano, Messina [Italy] and Zagreb [Croatia]). Patients 411 patients with AI; 153 males and 258 females and 186 from blood donors. Main outcomes measures All patients and controls were genotyped for BclI, N363S and ER22/23EK and SNPs frequency was associated with clinical and hormonal features. Results SNP frequency was: SNP frequency was: N363S 5.4% (MAF 0.027), BclI 54.7% (MAF 0.328), ER22/23EK 4.4% (MAF 0.022), without any significant difference between patients and controls. N363S was more frequent in hypertensive patients (p = 0.03) and was associated with hypertension (p = 0.015) in patients with suppressed cortisol after the 1-mg DST. Conclusions Our results demonstrate that SNPs of the glucocorticoid receptor gene do not play a pathogenetic role for AI. The impact of any single SNP on the phenotypic expression of minimal cortisol excess is limited and their analysis does not provide additional data that may be exploited for patient management.	[Reimondo, Giuseppe; Pia, Anna; Perotti, Paola; Paccotti, Piero; Terzolo, Massimo] Univ Turin, San Luigi Gonzaga Hosp, Internal Med 1, Dept Clin & Biol Sci, Orbassano, Italy; [Chiodini, Iacopo; Morelli, Valentina; Beck-Peccoz, Paolo] Univ Milan, Dept Clin Sci & Community Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Unit Endocrinol & Metab Dis, Milan, Italy; [Puglisi, Soraya; Cannavo, Salvatore] Univ Messina, Policlin G Martino Hosp, Dept Clin & Expt Med, Endocrine Unit, Messina, Italy; [Kastelan, Darko] Univ Hosp Zagreb, Dept Endocrinol, Zagreb, Croatia; [Berchialla, Paola] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Stat Unit, Orbassano, Italy; [Giachino, Daniela; Cuccurullo, Alessandra; De Marchi, Mario] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Med Genet, Orbassano, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Messina; University of Zagreb; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Turin	Reimondo, G (corresponding author), Univ Turin, San Luigi Gonzaga Hosp, Internal Med 1, Dept Clin & Biol Sci, Orbassano, Italy.	giuseppe.reimondo@unito.it	Iacopo, Chiodini/W-9911-2019; Kastelan, Darko/AAJ-4740-2020; Giachino, Daniela Francesca/L-9098-2019; De Marchi, Mario E./G-7558-2011; Perotti, Paola/AAC-4714-2022; Berchialla, Paola/A-3208-2009; Reimondo, Giuseppe/I-9156-2018; Puglisi, Soraya/AAQ-3894-2021; Puglisi, Soraya/AAB-9961-2019; MORELLI, Valentina/AAB-8866-2019; Cannavo, Salvatore/D-7608-2013	Iacopo, Chiodini/0000-0001-7594-3300; Giachino, Daniela Francesca/0000-0002-3186-6726; De Marchi, Mario E./0000-0002-6425-3205; Berchialla, Paola/0000-0001-5835-5638; Puglisi, Soraya/0000-0002-2883-6139; MORELLI, Valentina/0000-0002-6716-3045; REIMONDO, Giuseppe Matteo/0000-0001-9489-2094; Cannavo, Salvatore/0000-0001-8779-7283	University of Turin (Ricerca Locale)	University of Turin (Ricerca Locale)	The study was supported by grants from the University of Turin (Ricerca Locale 2013 and 2014) to GR and MT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2008, DIABETES CARE, P31; Bertalan R, 2009, GYNECOL ENDOCRINOL, V25, P379, DOI 10.1080/09513590902730762; Damjanovic SS, 2012, MOL MED, V18, P1456, DOI 10.2119/molmed.2012.00261; Di Blasio AM, 2003, CLIN ENDOCRINOL, V59, P68, DOI 10.1046/j.1365-2265.2003.01798.x; Echwald SM, 2001, INT J OBESITY, V25, P1563, DOI 10.1038/sj.ijo.0801744; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giordano R, 2012, CLIN ENDOCRINOL, V77, P863, DOI 10.1111/j.1365-2265.2012.04439.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamrahian AH, 2005, J CLIN ENDOCR METAB, V90, P871, DOI 10.1210/jc.2004-1627; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Koeijvoets KCMC, 2006, J CLIN ENDOCR METAB, V91, P4131, DOI 10.1210/jc.2006-0578; Koetz KR, 2013, CLIN ENDOCRINOL, V78, P831, DOI 10.1111/cen.12096; Koper JW, 2014, STEROIDS, V92, P62, DOI 10.1016/j.steroids.2014.07.015; Majnik J, 2006, J CLIN ENDOCR METAB, V91, P2796, DOI 10.1210/jc.2006-0066; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Manenschijn L, 2009, ANN NY ACAD SCI, V1179, P179, DOI 10.1111/j.1749-6632.2009.05013.x; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Marti A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-50; Morelli V, 2010, EUR J CLIN INVEST, V40, P803, DOI 10.1111/j.1365-2362.2010.02330.x; Nicolaides NC, 2016, EUR J CLIN INVEST, V46, P42, DOI 10.1111/eci.12563; R Core Team, 2021, R LANGUAGE ENV STAT; Ross IL, 2013, EUR J ENDOCRINOL, V168, P403, DOI 10.1530/EJE-12-0808; Ross IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086350; Syed AA, 2004, J CLIN ENDOCR METAB, V89, P232, DOI 10.1210/jc.2003-030995; Szappanos A, 2009, CLIN ENDOCRINOL, V71, P636, DOI 10.1111/j.1365-2265.2009.03528.x; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Trementino L, 2012, EUR J ENDOCRINOL, V166, P35, DOI 10.1530/EJE-11-0722; Tzanela M, 2012, J ENDOCRINOL INVEST, V35, P395, DOI 10.3275/7840; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; van Rossum EFC, 2004, AM J MED, V117, P158, DOI 10.1016/j.amjmed.2004.01.027; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; van Rossum EFC, 2003, CLIN ENDOCRINOL, V59, P585, DOI 10.1046/j.1365-2265.2003.01888.x; van Schoor NM, 2007, CLIN ENDOCRINOL, V67, P871, DOI 10.1111/j.1365-2265.2007.02978.x; WHO, 1997, PREV MAN GLOB EP OB; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zhukouskaya VV, 2015, J CLIN ENDOCR METAB, V100, P1417, DOI 10.1210/jc.2014-4177	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162437	10.1371/journal.pone.0162437	http://dx.doi.org/10.1371/journal.pone.0162437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649075	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000383892100019
J	Rodriguez-Cardenas, A; Rojas, AL; Conde-Gimenez, M; Velazquez-Campoy, A; Hurtado-Guerrero, R; Sancho, J				Rodriguez-Cardenas, Angela; Rojas, Adriana L.; Conde-Gimenez, Maria; Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier			Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target	PLOS ONE			English	Article							HELICOBACTER-PYLORI; FOLDING INTERMEDIATE; OXIDIZED FLAVODOXIN; VIRULENCE FACTORS; PROTEIN-STRUCTURE; ESCHERICHIA-COLI; COFACTOR BINDING; ESSENTIAL GENES; STABILIZATION; APOFLAVODOXIN	Streptococcus pneumoniae (Sp) strain TIGR4 is a virulent, encapsulated serotype that causes bacteremia, otitis media, meningitis and pneumonia. Increased bacterial resistance and limited efficacy of the available vaccine to some serotypes complicate the treatment of diseases associated to this microorganism. Flavodoxins are bacterial proteins involved in several important metabolic pathways. The Sp flavodoxin (Spfld) gene was recently reported to be essential for the establishment of meningitis in a rat model, which makes SpFld a potential drug target. To facilitate future pharmacological studies, we have cloned and expressed SpFld in E. coli and we have performed an extensive structural and biochemical characterization of both the apo form and its active complex with the FMN cofactor. SpFld is a short-chain flavodoxin containing 146 residues. Unlike the well-characterized long-chain apoflavodoxins, the Sp apoprotein displays a simple two-state thermal unfolding equilibrium and binds FMN with moderate affinity. The X-ray structures of the apo and holo forms of SpFld differ at the FMN binding site, where substantial rearrangement of residues at the 91 - 100 loop occurs to permit cofactor binding. This work will set up the basis for future studies aiming at discovering new potential drugs to treat S. pneumoniae diseases through the inhibition of SpFld.	[Rodriguez-Cardenas, Angela; Conde-Gimenez, Maria; Sancho, Javier] Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza, Spain; [Rodriguez-Cardenas, Angela; Conde-Gimenez, Maria; Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Joint Unit EEAD CSIC BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain; [Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon; Sancho, Javier] Univ Zaragoza, Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain; [Rojas, Adriana L.] CIC bioGUNE, Struct Biol Unit, Bizkaia Technol Pk, Derio, Spain; [Velazquez-Campoy, Adrian; Hurtado-Guerrero, Ramon] Govt Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; CIC bioGUNE	Sancho, J (corresponding author), Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza, Spain.; Hurtado-Guerrero, R; Sancho, J (corresponding author), Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit IQFR CSIC BIFI, Joint Unit EEAD CSIC BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain.; Hurtado-Guerrero, R; Sancho, J (corresponding author), Univ Zaragoza, Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain.; Hurtado-Guerrero, R (corresponding author), Govt Aragon, Fdn ARAID, Zaragoza, Spain.	rhurtado@bifi.es; jsancho@unizar.es	Rojas, Adriana/G-2403-2011; Sancho, javier/AAA-1225-2019; Velazquez-Campoy, Adrian/E-7946-2012	Rojas, Adriana/0000-0002-7358-3505; Sancho, javier/0000-0002-2879-9200; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; CONDE GIMENEZ, MARIA/0000-0003-4358-9110	Ministerio de Ciencia e Innovacion Spain [BFU2010-16297, BFU2010-19504]; Ministerio de Economia y Competitividad, Spain [BFU2013-47064-P, BIO2014-57314-REDT, CTQ2013-44367-C2-2-P]; DGA [B89]; FP7 [BIOSTRUCTX-7687]; Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship; Government of Aragon	Ministerio de Ciencia e Innovacion Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad, Spain(Spanish Government); DGA; FP7; Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship; Government of Aragon(Gobierno de Aragon)	We acknowledge financial support from BFU2010-16297 and BFU2010-19504 [Ministerio de Ciencia e Innovacion Spain], BFU2013-47064-P, BIO2014-57314-REDT and CTQ2013-44367-C2-2-P [Ministerio de Economia y Competitividad, Spain], and DGA (Protein Targets B89). We also thank synchrotron radiation sources DLS (Oxford), and in particular beamline I04-1 (experiment number MX8035-3 and MX8035-11). The research leading to these results has also received funding from the FP7 (2007-2013) under BIOSTRUCTX-7687. A.R.C. was funded by a Banco Santander Central Hispano/Universidad de Zaragoza predoctoral fellowship. M. C-G was recipient of a predoctoral fellowship from the Government of Aragon. We thank Dr. Ana Sanchez for help with the dithionite titration.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Ayuso-Tejedor S, 2011, BIOCHEMISTRY-US, V50, P8703, DOI 10.1021/bi201025y; Ayuso-Tejedor S, 2011, J MOL BIOL, V406, P604, DOI 10.1016/j.jmb.2010.12.027; Ayuso-Tejedor S, 2010, J MOL BIOL, V400, P922, DOI 10.1016/j.jmb.2010.05.050; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BURKHART BM, 1995, ACTA CRYSTALLOGR D, V51, P318, DOI 10.1107/S0907444994011716; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Campos LA, 2004, J MOL BIOL, V344, P223, DOI 10.1016/j.jmb.2004.09.047; Cooper A, 2000, PROTEIN LIGAND INTER, P287; Cremades N, 2008, BIOPHYS J, V95, P1913, DOI 10.1529/biophysj.108.130153; Cremades N, 2005, BIOPHYS CHEM, V115, P267, DOI 10.1016/j.bpc.2004.12.045; Cremades N, 2008, BIOCHEMISTRY, V47; Cremades N, 2008, J BIOL CHEM, V283, P2883, DOI 10.1074/jbc.M705677200; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; DANNA JA, 1972, BIOCHEMISTRY-US, V11, P1073, DOI 10.1021/bi00756a020; Di Guilmi AM, 2002, EMBO REP, V3, P728, DOI 10.1093/embo-reports/kvf152; EDMONDSON DE, 1971, BIOCHEMISTRY-US, V10, P124; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freigang J, 2002, PROTEIN SCI, V11, P253, DOI 10.1110/ps.28602; FUJII K, 1974, J BIOL CHEM, V249, P6745; Galano JJ, 2013, J MED CHEM, V56, P6248, DOI 10.1021/jm400786q; Genzor CG, 1996, NAT STRUCT BIOL, V3, P329, DOI 10.1038/nsb0496-329; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HILL S, 1980, J BACTERIOL, V141, P470, DOI 10.1128/JB.141.2.470-475.1980; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu YF, 2006, J BIOL CHEM, V281, P35454, DOI 10.1074/jbc.M607336200; IFUKU O, 1994, EUR J BIOCHEM, V224, P173, DOI 10.1111/j.1432-1033.1994.tb20009.x; Irun MP, 2001, PROTEIN ENG, V14, P173, DOI 10.1093/protein/14.3.173; Kahn P C, 1979, Methods Enzymol, V61, P339; Lamazares E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09129; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Martin M, 2003, NEW ENGLAND J MED, V348; Martinez-Julvez M, 2007, PROTEINS, V69, P581, DOI 10.1002/prot.21410; MAYHEW SG, 1969, J BIOL CHEM, V244, P794; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Murray TA, 2003, BIOCHEMISTRY-US, V42, P2307, DOI 10.1021/bi026967s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Perez-Dorado I, 2013, INT J MOL SCI, V14, P1152, DOI 10.3390/ijms14011152; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103; Reynolds CA, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-16; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Sancho J, 2013, ARCH BIOCHEM BIOPHYS, V531, P4, DOI 10.1016/j.abb.2012.10.014; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; WONG KK, 1993, BIOCHEMISTRY-US, V32, P14102, DOI 10.1021/bi00214a005; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	63	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161020	10.1371/journal.pone.0161020	http://dx.doi.org/10.1371/journal.pone.0161020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649488	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100004
J	Wang, S; Zheng, H; Liu, SH; Miao, YC; Li, J				Wang, Shu; Zheng, Hui; Liu, Shuhua; Miao, Yucong; Li, Jing			Numerical Study on the Stomatal Responses to Dry-Hot Wind Episodes and Its Effects on Land-Atmosphere Interactions	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; MAIZE PRODUCTION; CLIMATE-CHANGE; MODEL; TEMPERATURE; HEAT; CHINA; EVAPOTRANSPIRATION; PARAMETERIZATION; PHOTOSYNTHESIS	The wheat production in midland China is under serious threat by frequent Dry-Hot Wind (DHW) episodes with high temperature, low moisture and specific wind as well as intensive heat transfer and evapotranspiration. The numerical simulations of these episodes are important for monitoring grain yield and estimating agricultural water demand. However, uncertainties still remain despite that enormous experiments and modeling studies have been conducted concerning this issue, due to either inaccurate synoptic situation derived from mesoscale weather models or unrealistic parameterizations of stomatal physiology in land surface models. Hereby, we investigated the synoptic characteristics of DHW with widely-used mesoscale model Weather Research and Forecasting (WRF) and the effects of leaf physiology on surface evapotranspiration by comparing two land surface models: The Noah land surface model, and Peking University Land Model (PKULM) with stomata processes included. Results show that the WRF model could well replicate the synoptic situations of DHW. Two types of DHW were identified: (1) prevailing heated dry wind stream forces the formation of DHW along with intense sensible heating and (2) dry adiabatic processes overflowing mountains. Under both situations, the PKULM can reasonably model the stomatal closure phenomena, which significantly decreases both evapotranspiration and net ecosystem exchange of canopy, while these phenomena cannot be resolved in the Noah simulations. Therefore, our findings suggest that the WRF-PKULM coupled method may be a more reliable tool to investigate and forecast DHW as well as be instructive to crop models.	[Wang, Shu; Liu, Shuhua; Miao, Yucong; Li, Jing] Peking Univ, Dept Atmospher & Ocean Sci, Beijing, Peoples R China; [Zheng, Hui] Chinese Acad Sci, Key Lab Reg Climate Environm Res Temperate East A, Inst Atmospher Phys, Beijing, Peoples R China; [Zheng, Hui] Univ Texas Austin, Dept Geol Sci, John A & Katherine G Jackson Sch Geosci, Austin, TX USA	Peking University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; University of Texas System; University of Texas Austin	Wang, S; Liu, SH (corresponding author), Peking Univ, Dept Atmospher & Ocean Sci, Beijing, Peoples R China.	wangshu2011@pku.edu.cn; lshuhua@pku.edu.cn	Li, Jing/K-6290-2019; Miao, Yucong/AAJ-2361-2020	Wang, Shu/0000-0001-9239-9933	Chinese National Key Research and Development Projects - Ministry of Science and Technology of the People's Republic of China [2012BAH29B03]	Chinese National Key Research and Development Projects - Ministry of Science and Technology of the People's Republic of China	This research has been supported by Chinese National Key Research and Development Projects (grant NO. 2012BAH29B03), funded by Ministry of Science and Technology of the People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, STATE FOOD INWORLD; Bastos A, 2013, J GEOPHYS RES-BIOGEO, V118, P1247, DOI 10.1002/jgrg.20100; Betts AK, 2009, J ADV MODEL EARTH SY, V1, DOI 10.3894/JAMES.2009.1.4; Chen F, 2001, MON WEATHER REV, V129, P569, DOI 10.1175/1520-0493(2001)129<0569:CAALSH>2.0.CO;2; Chung U, 2014, WEATHER CLIM EXTREME, V5-6, P67, DOI 10.1016/j.wace.2014.07.002; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Dai YJ, 2004, J CLIMATE, V17, P2281, DOI 10.1175/1520-0442(2004)017&lt;2281:ATMFCT&gt;2.0.CO;2; Decker M, 2009, J ADV MODEL EARTH SY, V1, DOI 10.3894/JAMES.2009.1.5; Dickinson R.E., 1984, CLIM PROCESS CLIM SE, V29, P58, DOI DOI 10.1029/GM029P0058; Dickinson RE, 2013, MODELING EVAPOTRANSP, P58; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Gadgil S., 2006, ASIAN MONSOON, P651; Heilig GK, 2000, INT J SUST DEV WORLD, V7, P153, DOI 10.1080/13504500009470038; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; Hong SY, 2004, MON WEATHER REV, V132, P103, DOI 10.1175/1520-0493(2004)132<0103:ARATIM>2.0.CO;2; Hunt JE, 2002, AGR FOREST METEOROL, V111, P65, DOI 10.1016/S0168-1923(02)00006-0; Iacono MJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009944; Ingwersen J, 2011, AGR FOREST METEOROL, V151, P345, DOI 10.1016/j.agrformet.2010.11.010; Jagermeyr J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/2/025002; Keys PW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151993; Lawrence DM, 2007, J HYDROMETEOROL, V8, P862, DOI 10.1175/JHM596.1; Liu B, 2016, AGR FOREST METEOROL, V222, P45, DOI 10.1016/j.agrformet.2016.03.006; Liu SH, 2004, ADV ATMOS SCI, V21, P717, DOI 10.1007/BF02916369; Liu SH, 1996, ACTA SCI NATURALIUM, P69; [刘树华 Liu Shuhua], 2013, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V43, P1332; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; MANABE S, 1969, J ATMOS SCI, V26, P786, DOI 10.1175/1520-0469(1969)026<0786:CCWACO>2.0.CO;2; Murray F., 1967, J APPL METEOROL CLIM, V6, P203, DOI [10.1175/1520-0450(1967)0062.0.CO;2, DOI 10.1175/1520-0450(1967)0062.0.CO;2]; Nicholson SE, 1998, B AM METEOROL SOC, V79, P815, DOI 10.1175/1520-0477(1998)079<0815:DDASVA>2.0.CO;2; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P3102, DOI 10.1111/j.1365-2486.2011.02459.x; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pielke RA, 1998, GLOBAL CHANGE BIOL, V4, P461, DOI 10.1046/j.1365-2486.1998.t01-1-00176.x; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Ricchiazzi P, 1998, B AM METEOROL SOC, V79, P2101, DOI 10.1175/1520-0477(1998)079<2101:SARATS>2.0.CO;2; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Sellers PJ, 1996, J CLIMATE, V9, P676, DOI 10.1175/1520-0442(1996)009<0676:ARLSPF>2.0.CO;2; Sheng L, 2010, ENVIRON RES LETT, V5, P123; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Yang Z., 1978, METEROL SHAANXI, V3, P6; Ying S, 2012, J GEOPHYS RES-ATMOS, V117, P103; Zeng XB, 1998, J CLIMATE, V11, P2628, DOI 10.1175/1520-0442(1998)011<2628:IOBAAF>2.0.CO;2; Zhang Y, 2007, HYDROL PROCESS, V21, P2016, DOI 10.1002/hyp.6711; Zheng H, 2016, CHINESE J GEOPHYS-CH, V59, P79, DOI 10.6038/cjg20160107; Zheng H, 2012, CHINESE J GEOPHYS-CH, V55, P2514, DOI 10.6038/j.issn.0001-5733.2012.08.004; Zhu L, 2014, IEEE J-STARS, V7, P458, DOI 10.1109/JSTARS.2013.2280466	50	8	10	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162852	10.1371/journal.pone.0162852	http://dx.doi.org/10.1371/journal.pone.0162852			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648943	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100036
J	Yang, S; Park, J; Lee, H; Kim, S; Lee, BU; Chung, KY; Oh, B				Yang, Sejung; Park, Junhee; Lee, Hanuel; Kim, Soohyun; Lee, Byung-Uk; Chung, Kee-Yang; Oh, Byungho			Sequential Change of Wound Calculated by Image Analysis Using a Color Patch Method during a Secondary Intention Healing	PLOS ONE			English	Article							ACRAL LENTIGINOUS MELANOMA; GROWTH-FACTOR; EXCISION; RELIABILITY; FOOT	Background Photographs of skin wounds have the most important information during the secondary intention healing (SIH). However, there is no standard method for handling those images and analyzing them efficiently and conveniently. Objective To investigate the sequential changes of SIH depending on the body sites using a color patch method Methods We performed retrospective reviews of 30 patients (11 facial and 19 non-facial areas) who underwent SIH for the restoration of skin defects and captured sequential photographs with a color patch which is specially designed for automatically calculating defect and scar sizes. Results Using a novel image analysis method with a color patch, skin defects were calculated more accurately (range of error rate: -3.39% similar to+ 3.05%). All patients had smaller scar size than the original defect size after SIH treatment (rates of decrease: 18.8% similar to 86.1%), and facial area showed significantly higher decrease rate compared with the non-facial area such as scalp and extremities (67.05 +/- 12.48 vs. 53.29 +/- 18.11, P < 0.05). From the result of estimating the date corresponding to the half of the final decrement, all of the facial area showed improvements within two weeks (8.45 +/- 3.91), and non- facial area needed 14.33 +/- 9.78 days. Conclusion From the results of sequential changes of skin defects, SIH can be recommended as an alternative treatment method for restoration with more careful dressing for initial two weeks.	[Yang, Sejung] Ewha Womans Univ, Inst Art & Sci Convergence, Seoul, South Korea; [Park, Junhee; Lee, Hanuel; Lee, Byung-Uk] Ewha Womans Univ, Dept Elect Engn, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Chung, Kee-Yang] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Kim, Soohyun; Oh, Byungho] Keimyung Univ, Dept Dermatol, Coll Med, Daegu, South Korea; [Yang, Sejung] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA	Ewha Womans University; Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Keimyung University; Stanford University	Oh, B (corresponding author), Keimyung Univ, Dept Dermatol, Coll Med, Daegu, South Korea.	obh505@gmail.com		Oh, Byung Ho/0000-0001-9575-5665; Chung, Kee Yang/0000-0003-3257-0297	Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9B6055379]; Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015M3C8A7074199]	Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported in part by the Bio & Medical Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B6055379), and by Disaster-Safety Platform Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015M3C8A7074199) (http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2012, EUR J DERMATOL, V22, P46, DOI 10.1684/ejd.2011.1582; Ahn Chulhyun, 2008, Adv Skin Wound Care, V21, P85, DOI 10.1097/01.ASW.0000305411.58350.7d; BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6; Bieniek A, 2013, J EUR ACAD DERMATOL, V27, P1015, DOI 10.1111/j.1468-3083.2012.04646.x; BROWN GL, 1989, NEW ENGL J MED, V321, P76, DOI 10.1056/NEJM198907133210203; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Haghpanah S, 2006, ARCH PHYS MED REHAB, V87, P1396, DOI 10.1016/j.apmr.2006.06.014; Hoigne D, 2014, J HAND SURG-EUR VOL, V39, P505, DOI 10.1177/1753193413489639; Jung JY, 2011, DERMATOL SURG, V37, P1245, DOI 10.1111/j.1524-4725.2011.02043.x; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Leung A, 2012, CURR OPIN PEDIATR, V24, P371, DOI 10.1097/MOP.0b013e3283535790; Liu TW, 2008, PATTERN RECOGN LETT, V29, P90, DOI 10.1016/j.patrec.2007.08.015; MAJESKE C, 1992, PHYS THER, V72, P138, DOI 10.1093/ptj/72.2.138; Monaco JL, 2003, CLIN PLAST SURG, V30, P1, DOI 10.1016/S0094-1298(02)00070-6; Oh BH, 2013, BRIT J DERMATOL, V168, P333, DOI 10.1111/bjd.12099; Rogers Lee C, 2010, J Diabetes Sci Technol, V4, P799; Thorne C, 2007, GRABB SMITHS PLASTIC, pxix; van der Eerden PA, 2008, PLAST RECONSTR SURG, V122, P1747, DOI 10.1097/PRS.0b013e31818a9aaa; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; ZITELLI JA, 1983, J AM ACAD DERMATOL, V9, P407, DOI 10.1016/S0190-9622(83)70150-7	22	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163092	10.1371/journal.pone.0163092	http://dx.doi.org/10.1371/journal.pone.0163092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648569	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100052
J	Yang, TH; Li, W; Duan, X; Zhu, L; Fan, L; Qiao, YB; Wu, H				Yang, Tiehong; Li, Wei; Duan, Xiao; Zhu, Lin; Fan, Li; Qiao, Youbei; Wu, Hong			Preparation of Two Types of Polymeric Micelles Based on Poly(beta-L-Malic Acid) for Antitumor Drug Delivery	PLOS ONE			English	Article							TUMOR-SPECIFIC UPTAKE; CELLULAR DELIVERY; NANOPARTICLES; ANTIBODIES; SYSTEMS; GROWTH	Polymeric micelles represent an effective delivery system for poorlywater-soluble anticancer drugs. In this work, two types of CPT-conjugated polymers were synthesized based on poly(beta-L-malic acid) (PMLA) derivatives. Folic acid (FA) was introduced into the polymers as tumor targeting group. The micellization behaviors of these polymers and antitumor activity of different self-assembled micelles were investigated. Results indicate that poly (ethylene glycol)-poly(beta-L-malic acid)-campotothecin-I (PEG-PMLA-CPT-I, P1) is a grafted copolymer, and could formstar micelles in aqueous solution with a diameter of about 97 nm, also that PEG-PMLA-CPT-II (P2) is an amphiphilic block copolymer, and could form crew cut micelles with a diameter of about 76 nm. Both P1 and P2 micelles could improve the cellular uptake of CPT, especially the FA-modified micelles, while P2 micelles showed higher stability, higher drug loading efficiency, smaller size, and slower drug release rate than that of P1 micelles. These results suggested that the P2 (crew cut) micelles possess better stability than that of the P1 (star) micelles and might be a potential drug delivery system for cancer therapy.	[Yang, Tiehong; Li, Wei; Duan, Xiao; Fan, Li; Qiao, Youbei; Wu, Hong] Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Anal, Xian, Peoples R China; [Zhu, Lin] Texas A&M Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Irma Lerma Rangel Coll Pharm, Kingsville, TX 78363 USA	Air Force Military Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University Kingsville	Wu, H (corresponding author), Fourth Mil Med Univ, Sch Pharm, Dept Pharmaceut Anal, Xian, Peoples R China.	wuhong@fmmu.edu.cn	Zhu, Lin/O-3440-2018	Zhu, Lin/0000-0002-4047-1726	National Nature Science Foundation of China [81271687, 81571786, 81373948]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/); the grant number are 81271687 (HW), 81571786 (HW) and 81373948 (TY).; This work was supported by the National Natural Science Foundation of China (grants number 81271687, 81571786 and 81373948).	ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X; Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005; Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2; Chen KJ, 2012, BIOMATERIALS, V33, P1162, DOI 10.1016/j.biomaterials.2011.10.044; Chourpa I, 1998, BBA-GEN SUBJECTS, V1379, P353, DOI 10.1016/S0304-4165(97)00115-3; Dai M, 2011, CANCER LETT, V312, P189, DOI 10.1016/j.canlet.2011.08.007; Fujita M, 2007, J CONTROL RELEASE, V122, P356, DOI 10.1016/j.jconrel.2007.05.032; Garcia-Gonzalez CA, 2011, CARBOHYD POLYM, V86, P1425, DOI 10.1016/j.carbpol.2011.06.066; GIOVANELLA BC, 1991, CANCER RES, V51, P3052; Gong J, 2012, J CONTROL RELEASE, V159, P312, DOI 10.1016/j.jconrel.2011.12.012; Huang ZW, 2012, INT J PHARMACEUT, V423, P84, DOI 10.1016/j.ijpharm.2011.04.035; Jeanbat-Mimaud V, 2000, J BIOMAT SCI-POLYM E, V11, P979, DOI 10.1163/156856200744147; Jin YG, 2010, INT J PHARMACEUT, V386, P268, DOI 10.1016/j.ijpharm.2009.11.018; Kajiyama T, 2003, POLYM DEGRAD STABIL, V81, P525, DOI 10.1016/S0141-3910(03)00153-8; Kedar U, 2010, NANOMED-NANOTECHNOL, V6, P714, DOI 10.1016/j.nano.2010.05.005; Lee BS, 2000, FEMS MICROBIOL LETT, V193, P69, DOI 10.1111/j.1574-6968.2000.tb09404.x; Lee BS, 2006, BIOCONJUGATE CHEM, V17, P317, DOI 10.1021/bc0502457; Lenz M. Vert R. W., 1979, ACS POLYM PREPT, V20, P608; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Ljubimova JY, 2008, NANOMEDICINE-UK, V3, P247, DOI 10.2217/17435889.3.2.247; Ljubimova JY, 2008, CHEM-BIOL INTERACT, V171, P195, DOI 10.1016/j.cbi.2007.01.015; Malmsten M, 2010, CURR OPIN COLLOID IN, V15, P435, DOI 10.1016/j.cocis.2010.05.016; Petrov PD, 2009, J PHYS CHEM B, V113, P4218, DOI 10.1021/jp809598v; Portilla-Arias J, 2010, J NANOMATER, V2010, DOI 10.1155/2010/825363; Qiao YB, 2014, J POLYM RES, V21, DOI 10.1007/s10965-014-0397-4; Yang TH, 2015, POLYM CHEM-UK, V6, P1373, DOI 10.1039/c4py01403k; YOKOYAMA M, 2011, J EXP CLIN MED, V3, P151; Zhou Q, 2015, INT J NANOMED, V10, P1941, DOI 10.2147/IJN.S78547	28	13	15	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162607	10.1371/journal.pone.0162607	http://dx.doi.org/10.1371/journal.pone.0162607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649562	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100024
J	Li, Z; Bridges, B; Olson, J; Weinman, SA				Li, Z.; Bridges, B.; Olson, J.; Weinman, S. A.			The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3	ONCOGENE			English	Article							TRANSCRIPTION FACTOR FOXO3A; BREAST-CANCER; SIRT1; PROTEIN; DEACETYLATION; DEGRADATION; PROMOTES; STRESS; TUMORIGENESIS; METABOLISM	The multispecific transcription factor and tumor suppressor FOXO3 is an important mediator of apoptosis, but the mechanisms that control its proapoptotic function are poorly understood. There has long been evidence that acetylation promotes FOXO3driven apoptosis and recently a specific JNK (c-Jun N-terminal kinase)-dependent S574 phosphorylated form (p-FOXO3) has been shown to be specifically apoptotic. This study examined whether acetylation and S574 phosphorylation act independently or in concert to regulate the apoptotic function of FOXO3. We observed that both sirtuins 1 and 7 (SIRT1 and SIRT7) are able to deacetylate FOXO3 in vitro and in vivo, and that lipopolysaccharide (LPS) treatment of THP-1 monocytes induced a rapid increase of FOXO3 acetylation, partly by suppression of SIRT1 and SIRT7. Acetylation was required for S574 phosphorylation and cellular apoptosis. Deacetylation of FOXO3 by SIRT activation or SIRT1 or SIRT7 overexpression prevented its S574 phosphorylation and blocked apoptosis in response to LPS. We also found that acetylated FOXO3 preferentially bound JNK1, and a mutant FOXO3 lacking four known acetylation sites (K242, 259, 290 and 569R) abolished JNK1 binding and failed to induce apoptosis. This interplay of acetylation and phosphorylation also regulated cell death in primary human peripheral blood monocytes (PBMs). PBMs isolated from alcoholic hepatitis patients had high expression of SIRT1 and SIRT7 and failed to induce p-FOXO3 and apoptosis in response to LPS. PBMs from healthy controls had lower SIRT1 and SIRT7 and readily formed p-FOXO3 and underwent apoptosis when similarly treated. These results reveal that acetylation is permissive for generation of the apoptotic form of FOXO3 and the activity of SIRT1 and particularly SIRT7 regulate this process in vivo, allowing control of monocyte apoptosis in response to LPS.	[Li, Z.; Olson, J.; Weinman, S. A.] Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mailstop 1018, Kansas City, KS 66160 USA; [Bridges, B.; Weinman, S. A.] Univ Kansas, Med Ctr, Ctr Liver, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Weinman, SA (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, 3901 Rainbow Blvd,Mailstop 1018, Kansas City, KS 66160 USA.	sweinman@kumc.edu	Li, Zhuan/C-3196-2014	LI, ZHUAN/0000-0002-1310-4584	National Institute on Alcoholism and Alcohol Abuse [AA012863]; Biomedical Research Training Program of the University of Kansas Medical Center; Hubert and Richard Hanlon Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Biomedical Research Training Program of the University of Kansas Medical Center; Hubert and Richard Hanlon Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grant AA012863 from the National Institute on Alcoholism and Alcohol Abuse, a fellowship grant from the Biomedical Research Training Program of the University of Kansas Medical Center (to ZL) and by a grant from the Hubert and Richard Hanlon Trust. The human monocytes used in this study were provided by the University of Kansas Liver Center Tissue Bank. We thank Drs Charles Rice and Robert A Davey for providing reagents for these studies.	Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chung YW, 2011, J BIOL CHEM, V286, P29681, DOI 10.1074/jbc.M111.264945; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Lee SM, 2011, DIABETOLOGIA, V54, P1136, DOI 10.1007/s00125-011-2064-1; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MCKEEVER UM, 1983, LANCET, V2, P1492; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Roychowdhury S, 2009, HEPATOLOGY, V49, P1326, DOI 10.1002/hep.22776; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Su JL, 2011, CANCER RES, V71, P6878, DOI 10.1158/0008-5472.CAN-11-0295; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang YF, 2015, CELL STRESS CHAPERON, V20, P805, DOI 10.1007/s12192-015-0599-7; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	41	28	30	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1887	1898		10.1038/onc.2016.359	http://dx.doi.org/10.1038/onc.2016.359			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27669435	Green Accepted			2022-12-26	WOS:000398128900013
J	Wang, D; Shi, W; Tang, Y; Liu, Y; He, K; Hu, Y; Li, J; Yang, Y; Song, J				Wang, D.; Shi, W.; Tang, Y.; Liu, Y.; He, K.; Hu, Y.; Li, J.; Yang, Y.; Song, J.			Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; CHAPERONE; PROTEIN; GROWTH; IDENTIFICATION; INHIBITION; TRANSCRIPTION; METASTASIS; COMPLEX	Prefoldin (PFDN) is a co-chaperone protein that is primarily known for its classic cytoplasmic functions in the folding of actin and tubulin monomers during cytoskeletal assembly. Here, we report a marked increase in prefoldin subunit 1 (PFDN1) levels during the transforming growth factor (TGF)-beta 1-mediated epithelial-mesenchymal transition (EMT) and in human lung tumor tissues. Interestingly, the nuclear localization of PFDN1 was also detected. These observations suggest that PFDN1 may be essential for important novel functions. Overexpression of PFDN1 induced EMT and cell invasion. In sharp contrast, knockdown of PFDN1 generated the opposite effects. Overexpression of PFDN1 was also found to induce lung tumor growth and metastasis. Further experiments showed that PFDN1 overexpression inhibits the expression of cyclin A. PFDN1 suppressed cyclin A expression by directly interacting with the cyclin A promoter at the transcriptional start site. Strikingly, cyclin A overexpression abolished the above PFDN1-mediated effects on the behavior of lung cancer cells, whereas cyclin A knockdown alone induced EMT and increased cell migration and invasion ability. This study reveals that the TGF-beta 1/ PFDN1/ cyclin A axis is essential for EMT induction and metastasis of lung cancer cells.	[Wang, D.; Shi, W.; Tang, Y.; Liu, Y.; He, K.; Hu, Y.; Li, J.; Yang, Y.; Song, J.] Chinese Acad Sci, Innovat Ctr Cell Signaling Network, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,State Key Lab Cell Biol, 320 YueYang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, J (corresponding author), Chinese Acad Sci, Innovat Ctr Cell Signaling Network, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci,State Key Lab Cell Biol, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jgsong@sibcb.ac.cn			Natural Science Foundation of China [81472603]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (81472603). We thank Xinwang Yuan, Xiaojie Guo and Guoqing Cai for helpful discussion and technical assistance. We are especially grateful to Dr Lingling Chen for generous support to this work.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Arsic N, 2012, J CELL BIOL, V196, P147, DOI 10.1083/jcb.201102085; Asperger A, 2011, CANCER INVEST, V29, P272, DOI 10.3109/07357907.2010.550666; Barcellos KSA, 2013, J BIOL CHEM, V288, P2179, DOI 10.1074/jbc.M112.432716; Bendris N, 2014, CELL MOL LIFE SCI, V71, P4881, DOI 10.1007/s00018-014-1654-8; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Cheung CT, 2015, CARCINOGENESIS, V36, P914, DOI 10.1093/carcin/bgv069; Farooq M, 2013, ASIAN PAC J CANCER P, V14, P915, DOI 10.7314/APJCP.2013.14.2.915; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HENGLEIN B, 1994, P NATL ACAD SCI USA, V91, P5490, DOI 10.1073/pnas.91.12.5490; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Jacobs HW, 2001, EMBO J, V20, P2376, DOI 10.1093/emboj/20.10.2376; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kim HRC, 1999, CANCER RES, V59, P4148; Kim SY, 2008, BMB REP, V41, P158, DOI 10.5483/BMBRep.2008.41.2.158; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lopez V, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-182; Lundin VF, 2008, DEV BIOL, V313, P320, DOI 10.1016/j.ydbio.2007.10.022; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Ma XJ, 2015, CANCER RES, V75, P2822, DOI 10.1158/0008-5472.CAN-15-0125; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Millan-Zambrano G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140085; Millan-Zambrano G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003776; Miyoshi N, 2010, ANN SURG ONCOL, V17, P3030, DOI 10.1245/s10434-010-1138-5; Munnia A, 2001, ONCOGENE, V20, P4853, DOI 10.1038/sj.onc.1204650; Narita R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041891; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Ostrov DA, 2007, TISSUE ANTIGENS, V69, P181, DOI 10.1111/j.1399-0039.2006.00730.x; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Shiota M, 2013, CANCER RES, V73, P3109, DOI 10.1158/0008-5472.CAN-12-3979; Shiota M, 2012, CANCER RES, V72, P5261, DOI 10.1158/0008-5472.CAN-12-0254; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wang D, 2014, INT J ONCOL, V44, P161, DOI 10.3892/ijo.2013.2170; Wang DM, 2010, BIOL CELL, V102, P1, DOI 10.1042/BC20090070; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Yang Y, 2006, ONCOGENE, V25, P7235, DOI 10.1038/sj.onc.1209712; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yin XF, 2013, CLIN CANCER RES, V19, P5686, DOI 10.1158/1078-0432.CCR-13-0405; Yuan XW, 2013, J BIOL CHEM, V288, P31206, DOI 10.1074/jbc.M113.480285; Zhang LA, 2010, FEBS LETT, V584, P4646, DOI 10.1016/j.febslet.2010.10.038; Zhu JQ, 2015, CANCER RES, V75, P1580, DOI 10.1158/0008-5472.CAN-14-1027	52	36	37	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					885	898		10.1038/onc.2016.257	http://dx.doi.org/10.1038/onc.2016.257			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27694898	Green Published, hybrid			2022-12-26	WOS:000394169100002
J	Arras, SDM; Chua, SMH; Wizrah, MSI; Faint, JA; Yap, AS; Fraser, JA				Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.			Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							GENE DELETION; HOMOLOGOUS RECOMBINATION; VIRULENCE FACTOR; CAS SYSTEMS; DNA; ELECTROPORATION; SEQUENCE; REPEATS; TRANSFORMATION; DISRUPTION	Low rates of homologous integration have hindered molecular genetic studies in Cryptococcus neoformans over the past 20 years, and new tools that facilitate genome manipulation in this important pathogen are greatly needed. To this end, we have investigated the use of a Class 2 CRISPR system in C. neoformans (formerly C. neoformans var. grubii). We first expressed a derivative of the Streptococcus pyogenes Cas9 nuclease in C. neoformans, and showed that it has no effect on growth, production of virulence factors in vitro, or virulence in a murine inhalation model. In proof of principle experiments, we tested the CAS9 construct in combination with multiple self-cleaving guide RNAs targeting the well-characterized phosphoribosylaminoamidazole carboxylase-encoding ADE2 gene. Utilizing combinations of transient and stable expression of our constructs, we revealed that functionality of our CRISPR constructs in C. neoformans is dependent upon the CAS9 construct being stably integrated into the genome, whilst transient expression of the guide RNA is sufficient to enhance rates of homologous recombination in the CAS9 genetic background. Given that the presence of the CRISPR nuclease does not influence virulence in a murine inhalation model, we have successfully demonstrated that this system is compatible with studies of C. neoformans pathogenesis and represents a powerful tool that can be exploited by researchers in the field.	[Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.] Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Fraser, JA (corresponding author), Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012; Yap, Alpha S./J-1554-2014	Fraser, James A/0000-0001-5724-5285; Yap, Alpha S./0000-0002-1038-8956; Chua, Sheena/0000-0003-1501-7254	National Health and Medical Research Council [455980]; ARC Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Australian Postgraduate Award(Australian Research Council)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) 455980 (JA Fraser) and ARC Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards) (SDMA).	AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 2002, J ANTIMICROB CHEMOTH, V49, P57, DOI 10.1093/jac/49.suppl_1.57; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009; Idnurm A, 2015, FUNGAL GENET BIOL, V78, P1, DOI 10.1016/j.fgb.2015.05.002; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Lin XR, 2015, MED MYCOL, V53, P225, DOI 10.1093/mmy/myu083; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Neafsey DE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-119; Nelson RT, 2003, FUNGAL GENET BIOL, V38, P1, DOI 10.1016/S1087-1845(02)00510-8; Park J, 2014, MYCOSES, V57S1; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31145; Wang ZA, 2014, EUKARYOT CELL, V13, P832, DOI 10.1128/EC.00054-14; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zhang ZY, 2015, ADV MATH COMMUN, V9, P9, DOI 10.3934/amc.2015.9.9	55	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164322	10.1371/journal.pone.0164322	http://dx.doi.org/10.1371/journal.pone.0164322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711143	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600119
J	Yan, G; Zhang, T; Dai, ZZ; Yi, MZ; Jia, YL; Nie, TT; Zhang, HD; Xiao, G; Wu, RH				Yan, Gen; Zhang, Tao; Dai, Zhuozhi; Yi, Meizhi; Jia, Yanlong; Nie, Tingting; Zhang, Handi; Xiao, Gang; Wu, Renhua			A Potential Magnetic Resonance Imaging Technique Based on Chemical Exchange Saturation Transfer for In Vivo gamma-Aminobutyric Acid Imaging	PLOS ONE			English	Article							TRANSFER CEST; HUMAN BRAIN; ALZHEIMERS-DISEASE; GLUTAMATE; WATER; GABA; MRI; QUANTIFICATION; GLUCEST; H-1-MRS	Purpose We developed a novel magnetic resonance imaging (MRI) technique based on chemical exchange saturation transfer (CEST) for GABA imaging and investigated the concentration-dependent CEST effect ofGABA in a rat model of brain tumor with blood-brain barrier (BBB) disruption. Materials and Methods All MRI studies were performed using a 7.0-T Agilent MRI scanner. Z-spectra for GABA were acquired at 7.0 T, 37 degrees C, and a pH of 7.0 using varying B-1 amplitudes. CEST images of phantoms with different concentrations of GABA solutions (pH, 7.0) and other metabolites (glutamine, myoinositol, creatinine, and choline) were collected to investigate the concentration-dependent CEST effect of GABA and the potential contribution from other brain metabolites. CEST maps for GABA in rat brains with tumors were collected at baseline and 50 min, 1.5 h, and 2.0 h after the injection of GABA solution. Results The CEST effect of GABA was observed at approximately 2.75 parts per million(ppm) downfield from bulk water, and this effect increased with an increase in the B-1 amplitude and remained steady after the B-1 amplitude reached 6.0 mu T (255 Hz). The CEST effect of GABA was proportional to the GABA concentration in vitro. CEST imaging of GABA in a rat brain with a tumor and compromised BBB showed a gradual increase in the CEST effect after GABA injection. Conclusion The findings of this study demonstrate the feasibility and potential of CEST MRI with the optimal B-1 amplitude, which exhibits excellent spatial and temporal resolutions, to map changes in GABA.	[Yan, Gen] Jiangnan Univ, Dept Radiol, Affiliated Hosp, Wuxi 214062, Peoples R China; [Yan, Gen; Zhang, Tao; Dai, Zhuozhi; Yi, Meizhi; Jia, Yanlong; Nie, Tingting; Wu, Renhua] Shantou Univ, Coll Med, Dept Med Imaging, Affiliated Hosp 2, Shantou 515041, Peoples R China; [Zhang, Handi] Shantou Univ, Coll Med, Mental Hlth Ctr, Shantou, Peoples R China; [Xiao, Gang] Hanshan Normal Univ, Dept Math & Stat, Chaozhou 521041, Peoples R China	Jiangnan University; Shantou University; Shantou University; Hanshan Normal University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Dept Med Imaging, Affiliated Hosp 2, Shantou 515041, Peoples R China.; Xiao, G (corresponding author), Hanshan Normal Univ, Dept Math & Stat, Chaozhou 521041, Peoples R China.	xiao.math@foxmail.com; rhwu@stu.edu.cn			National High Technology Research and Development Program of China [2014AA021101]; NSFC [30930027]; NCF of Guangdong Province, China [S2013010013372]; NCF of Jiangsu province, China [BK20151106]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NCF of Guangdong Province, China; NCF of Jiangsu province, China	Renhua Wu acknowledges the financial support from the National High Technology Research and Development Program of China (2014AA021101) and NSFC (30930027). Gang Xiao was supported by a NCF of Guangdong Province, China (S2013010013372). Gen Yan was supported by a NCF of Jiangsu province, China (BK20151106).	Cai KJ, 2013, NMR BIOMED, V26, P1278, DOI 10.1002/nbm.2949; Cai K, 2012, NEUROPSYCHOPHARMACOL, V37, P2764, DOI 10.1038/npp.2012.142; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chang L, 2003, J CLIN PSYCHIAT, V64, P7; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Haris M, 2013, J NEUROSCI METH, V212, P87, DOI 10.1016/j.jneumeth.2012.09.025; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; KOBAYASHI N, 1980, J NEUROSURG, V53, P808, DOI 10.3171/jns.1980.53.6.0808; Kogan F, 2014, MAGN RESON MED, V71, P164, DOI 10.1002/mrm.24641; Kogan F, 2013, NEUROIMAGE, V77, P262, DOI 10.1016/j.neuroimage.2013.03.072; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Nasrallah FA, 2013, J CEREBR BLOOD F MET, V33, P1270, DOI 10.1038/jcbfm.2013.79; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; ROSSOR MN, 1982, BRAIN, V105, P313, DOI 10.1093/brain/105.2.313; Shen ZW, 2012, WORLD J GASTROENTERO, V18, P1130, DOI 10.3748/wjg.v18.i10.1130; Sun PZ, 2011, MAGN RESON MED, V65, P588, DOI 10.1002/mrm.22628; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	30	16	16	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163765	10.1371/journal.pone.0163765	http://dx.doi.org/10.1371/journal.pone.0163765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711138	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600040
J	Been, SK; van de Vijver, DAMC; Nieuwkerk, PT; Brito, I; Stutterheim, SE; Bos, AER; Wolfers, MEG; Pogany, K; Verbon, A				Been, Sabrina K.; van de Vijver, David A. M. C.; Nieuwkerk, Pythia T.; Brito, Ines; Stutterheim, Sarah E.; Bos, Arjan E. R.; Wolfers, Mireille E. G.; Pogany, Katalin; Verbon, Annelies			Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SELF-REPORTED ADHERENCE; HIV-1-INFECTED PATIENTS; VIROLOGICAL RESPONSE; CLINICAL-TRIALS; COHORT; PREDICTORS; OUTCOMES; AFRICAN; PEOPLE	In the Netherlands, immigrant people living with HIV (PLWH) have poorer psychological and treatment outcomes than Dutch PLWH. This cross-sectional field study examined risk factors for non-adherence to combination Antiretroviral Therapy (cART) among immigrant PLWH. First and second generation immigrant PLWH attending outpatient clinics at two HIV-treatment centers in Rotterdam were selected for this study. Socio-demographic and clinical characteristics for all eligible participants were collected from an existing database. Trained interviewers subsequently completed questionnaires together with consenting participants (n = 352) to gather additional data on socio-demographic characteristics, psychosocial variables, and self-reported adherence to cART. Univariable and multivariable logistic regression analyses were conducted among 301 participants who had used cART >= 6 months prior to inclusion. Independent risk factors for self-reported non-adherence were (I) not having attended formal education or only primary school (OR = 3.25; 95% CI: 1.28-8.26, versus University), (II) experiencing low levels of social support (OR = 2.56; 95% CI: 1.37-4.82), and (III) reporting low treatment adherence self-efficacy (OR = 2.99; 95% CI: 1.59-5.64). Additionally, HIV-RNA >50 copies/ml and internalized HIV-related stigma were marginally associated (P<0.10) with non-adherence (OR = 2.53; 95% CI: 0.91-7.06 and OR = 1.82; 95% CI: 0.97-3.43). The findings that low educational attainment, lack of social support, and low treatment adherence self-efficacy are associated with non-adherence point to the need for tailored supportive interventions. Establishing contact with peer immigrant PLWH who serve as role models might be a successful intervention for this specific population.	[Been, Sabrina K.; Brito, Ines; Verbon, Annelies] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [van de Vijver, David A. M. C.] Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands; [Nieuwkerk, Pythia T.] Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Stutterheim, Sarah E.; Bos, Arjan E. R.] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands; [Wolfers, Mireille E. G.] Municipal Publ Hlth Serv Rotterdam Rijnmond, Infect Dis Control Div, Rotterdam, Netherlands; [Pogany, Katalin] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Open University Netherlands; Maasstad Hospital	Been, SK (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.	s.been@erasmusmc.nl	Nieuwkerk, Pythia/S-4084-2017	Nieuwkerk, Pythia/0000-0002-2616-1414; Stutterheim, Sarah/0000-0001-9336-5022; van de Vijver, David/0000-0001-5877-8526; Been, Sabrina/0000-0002-5755-3306; Bos, Arjan/0000-0003-1000-5852	Dutch Aids Fonds [2011107]	Dutch Aids Fonds	This study was supported by a grant from the Dutch Aids Fonds. Grant number: 2011107. Website: http://www.aidsfonds.nl/about/organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; de Bruin M, 2009, HEALTH PSYCHOL, V28, P668, DOI 10.1037/a0015989; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Gras L, 2014, MONITORING REPORT 20; Health R., MED OUTCOMES STUDY S; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Moser A, 2012, J CLIN EPIDEMIOL, V65, P1107, DOI 10.1016/j.jclinepi.2012.04.007; Nellen JFJB, 2009, AIDS CARE, V21, P842, DOI 10.1080/09540120802612816; Nellen JF, 2004, JAIDS-J ACQ IMM DEF, V36, P943, DOI 10.1097/00126334-200408010-00008; Nieuwkerk P, 2001, ANTIVIR THER, V6, P97; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nieuwkerk PT, 2010, ANTIVIR THER, V15, P913, DOI 10.3851/IMP1644; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Pasternak AO, 2012, J INFECT DIS, V206, P1443, DOI 10.1093/infdis/jis502; Schouten Marjolijn, 2013, Ned Tijdschr Geneeskd, V157, pA5731; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Staehelin C, 2012, JAIDS-J ACQ IMM DEF, V59, P79, DOI 10.1097/QAI.0b013e318236be70; Stutterheim SE, 2012, PSYCHOL HEALTH, V27, P395, DOI 10.1080/08870446.2011.585426; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sumari-de Boer IM, 2012, AIDS BEHAV, V16, P1681, DOI 10.1007/s10461-011-0112-y; van den Berg JB, 2005, HIV MED, V6, P299, DOI 10.1111/j.1468-1293.2005.00304.x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162800	10.1371/journal.pone.0162800	http://dx.doi.org/10.1371/journal.pone.0162800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706251	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200021
J	Du, RJ; Dong, GG; Tian, LX; Wang, MG; Fang, GC; Shao, S				Du, Ruijin; Dong, Gaogao; Tian, Lixin; Wang, Minggang; Fang, Guochang; Shao, Shuai			Spatiotemporal Dynamics and Fitness Analysis of Global Oil Market: Based on Complex Network	PLOS ONE			English	Article							RANDOM-MATRIX THEORY; TRADE RELATIONSHIPS; EVOLUTION; SECURITY; PATTERNS; FEATURES; CHINA	We study the overall topological structure properties of global oil trade network, such as degree, strength, cumulative distribution, information entropy and weight clustering. The structural evolution of the network is investigated as well. We find the global oil import and export networks do not show typical scale-free distribution, but display disassortative property. Furthermore, based on the monthly data of oil import values during 2005.01-2014.12, by applying random matrix theory, we investigate the complex spatiotemporal dynamic from the country level and fitness evolution of the global oil market from a demand-side analysis. Abundant information about global oil market can be obtained from deviating eigenvalues. The result shows that the oil market has experienced five different periods, which is consistent with the evolution of country clusters. Moreover, we find the changing trend of fitness function agrees with that of gross domestic product (GDP), and suggest that the fitness evolution of oil market can be predicted by forecasting GDP values. To conclude, some suggestions are provided according to the results.	[Du, Ruijin; Dong, Gaogao; Tian, Lixin] Jiangsu Univ, Nonlinear Sci Res Ctr, Zhenjiang, Jiangsu, Peoples R China; [Tian, Lixin; Wang, Minggang] Nanjing Normal Univ, Sch Math Sci, Nanjing, Jiangsu, Peoples R China; [Fang, Guochang] Nanjing Univ Finance & Econ, Sch Econ, Nanjing 210023, Jiangsu, Peoples R China; [Shao, Shuai] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Shao, Shuai] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA	Jiangsu University; Nanjing Normal University; Nanjing University of Finance & Economics; Boston University; Boston University	Dong, GG; Tian, LX (corresponding author), Jiangsu Univ, Nonlinear Sci Res Ctr, Zhenjiang, Jiangsu, Peoples R China.; Tian, LX (corresponding author), Nanjing Normal Univ, Sch Math Sci, Nanjing, Jiangsu, Peoples R China.	gago999@126.com; tianlx@ujs.edu.cn	Wang, Minggang/R-7570-2019; fang, guochang/HHY-9120-2022	Wang, Minggang/0000-0002-0572-7204	National Natural Science Foundation of China [61403171, 71403105, 71303095, 71303205, 71503132]; Major Research plan of the National Natural Science Foundation of China [91546118]; Natural Science Foundation of Jiangsu Province [BK20140569, 14KJB120001]; Jiangsu Postdoctoral Science Foundation [140207713, 1501100B]; China Postdoctoral Science Foundation [2015M581738, 2015M80519]; Senior talents Foundation of Jiangsu University [14JDG143, 14JDG144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Senior talents Foundation of Jiangsu University	This work was supported by National Natural Science Foundation of China (Grant Nos. 61403171, 71403105, 71303095, 71303205, 71503132), Major Research plan of the National Natural Science Foundation of China (No. 91546118), Natural Science Foundation of Jiangsu Province (Grant Nos. BK20140569, 14KJB120001), Jiangsu Postdoctoral Science Foundation (Grant Nos. 140207713, 1501100B), China Postdoctoral Science Foundation (Grant Nos. 2015M581738, 2015M80519) and Senior talents Foundation of Jiangsu University (Grant Nos. 14JDG143, 14JDG144).	An HZ, 2014, APPL ENERG, V136, P1067, DOI 10.1016/j.apenergy.2014.07.081; An HZ, 2014, ENERGY, V74, P254, DOI 10.1016/j.energy.2014.06.095; Bai M, 2015, INT REV ECON FINANC, V39, P90, DOI 10.1016/j.iref.2015.06.005; Ben Fradj N, 2016, LAND USE POLICY, V52, P195, DOI 10.1016/j.landusepol.2015.12.027; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Cheng LF, 2004, COMPUT CHEM ENG, V28, P897, DOI 10.1016/j.compchemeng.2003.09.025; Dahlin J, 2015, RESOUR CONSERV RECY, V104, P152, DOI 10.1016/j.resconrec.2015.08.013; Fan Y, 2010, J POLICY MODEL, V32, P505, DOI 10.1016/j.jpolmod.2010.05.008; Feher K, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1667; Gao CX, 2015, APPL ENERG, V156, P542, DOI 10.1016/j.apenergy.2015.07.054; Giussani B., 1991, PAP REG SCI, V70, P201, DOI DOI 10.1007/BF01434329; Ji Q, 2014, ENERG CONVERS MANAGE, V85, P856, DOI 10.1016/j.enconman.2013.12.072; Kenny Henry J., 2004, ASIA PACIFIC REV, V11, P36, DOI DOI 10.1080/1343900042000292533; Kim YS, 2012, J HOUS ECON, V21, P169, DOI 10.1016/j.jhe.2012.01.002; Kritzman M, 2009, J FINANC ECON, V37, P112; Kumar S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026101; Leiby P.N, 2007, ORNLTM2007028; Lever J, 2012, J RURAL STUD, V28, P528, DOI 10.1016/j.jrurstud.2012.06.004; Lu WW, 2014, ENERG POLICY, V74, P406, DOI 10.1016/j.enpol.2014.08.037; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Munnix MC, 2010, PHYSICA A, V389, P767, DOI 10.1016/j.physa.2009.10.033; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Plerou V, 2000, PHYSICA A, V287, P374, DOI 10.1016/S0378-4371(00)00376-9; Potters M, 2005, ACTA PHYS POL B, V36, P2767; Pukthuanthong K, 2009, J FINANC ECON, V94, P214, DOI 10.1016/j.jfineco.2008.12.004; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; [谭跃进 Tan Yuejin], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P1; Wishart J, 1928, BIOMETRIKA, V20A, P32, DOI 10.2307/2331939; Yergin D, 2006, FOREIGN AFF, V85, P69, DOI 10.2307/20031912; Zhang HY, 2014, ENERG POLICY, V73, P312, DOI 10.1016/j.enpol.2014.06.020; Zhang HY, 2013, ENERG ECON, V38, P87, DOI 10.1016/j.eneco.2013.03.014; Zhang YG, 2010, ENERG ECON, V32, P186, DOI 10.1016/j.eneco.2009.09.016; Zhong WQ, 2014, PHYSICA A, V413, P42, DOI 10.1016/j.physa.2014.06.055	34	8	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162362	10.1371/journal.pone.0162362	http://dx.doi.org/10.1371/journal.pone.0162362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706147	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200011
J	Kia, E; Mackenzie, BW; Middleton, D; Lau, A; Waite, DW; Lewis, G; Chan, YK; Silvestre, M; Cooper, GJS; Poppitt, SD; Taylor, MW				Kia, Elahe; Mackenzie, Brett Wagner; Middleton, Danielle; Lau, Anna; Waite, David W.; Lewis, Gillian; Chan, Yih-Kai; Silvestre, Marta; Cooper, Garth J. S.; Poppitt, Sally D.; Taylor, Michael W.			Integrity of the Human Faecal Microbiota following Long-Term Sample Storage	PLOS ONE			English	Article								In studies of the human microbiome, faecal samples are frequently used as a non-invasive proxy for the study of the intestinal microbiota. To obtain reliable insights, the need for bacterial DNA of high quality and integrity following appropriate faecal sample collection and preservation steps is paramount. In a study of dietary mineral balance in the context of type 2 diabetes (T2D), faecal samples were collected from healthy and T2D individuals throughout a 13-day residential trial. These samples were freeze-dried, then stored mostly at -20 degrees C from the trial date in 2000/2001 until the current research in 2014. Given the relative antiquity of these samples (similar to 14 years), we sought to evaluate DNA quality and comparability to freshly collected human faecal samples. Following the extraction of bacterial DNA, gel electrophoresis indicated that our DNA extracts were more sheared than extracts made from freshly collected faecal samples, but still of sufficiently high molecular weight to support amplicon-based studies. Likewise, spectrophotometric assessment of extracts revealed that they were of high quality and quantity. A subset of bacterial 16S rRNA gene amplicons were sequenced using Illumina MiSeq and compared against publicly available sequence data representing a similar cohort analysed by the American Gut Project (AGP). Notably, our bacterial community profiles were highly consistent with those from the AGP data. Our results suggest that when faecal specimens are stored appropriately, the microbial profiles are preserved and robust to extended storage periods.	[Kia, Elahe; Middleton, Danielle; Lau, Anna; Waite, David W.; Lewis, Gillian; Chan, Yih-Kai; Silvestre, Marta; Cooper, Garth J. S.; Poppitt, Sally D.; Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Mackenzie, Brett Wagner] Univ Auckland, Dept Surg, Auckland, New Zealand; [Chan, Yih-Kai; Silvestre, Marta; Poppitt, Sally D.] Univ Auckland, Human Nutr Unit, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Taylor, MW (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	mw.taylor@auckland.ac.nz	Cooper, Garth JS/I-3201-2015; Lewis, Gillian/P-5538-2016	Cooper, Garth JS/0000-0001-5241-3163; Taylor, Michael/0000-0002-0463-7813; Lewis, Gillian/0000-0003-2904-7956; Wagner Mackenzie, Brett/0000-0002-5318-1808; Chan, Yih-Kai/0000-0003-3836-8145; Paulino Silvestre, Marta/0000-0001-9327-2897; Waite, David/0000-0002-0184-2942				Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke KR, 2015, PRIMER V7 USER MANUA; Cooper GJS, 2005, DIABETES, V54, P1468, DOI 10.2337/diabetes.54.5.1468; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	16	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163666	10.1371/journal.pone.0163666	http://dx.doi.org/10.1371/journal.pone.0163666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701448	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900015
J	Lyu, J; Cao, JF; Zhang, PM; Liu, Y; Cheng, HT				Lyu, Jie; Cao, Jinfeng; Zhang, Peiming; Liu, Yang; Cheng, Hongtao			Coupled Hybrid Continuum-Discrete Model of Tumor Angiogenesis and Growth	PLOS ONE			English	Article							NUMERICAL-SIMULATION; MICROENVIRONMENT; ENDOSTATIN; MORPHOLOGY	The processes governing tumor growth and angiogenesis are codependent. To study the relationship between them, we proposed a coupled hybrid continuum-discrete model. In this model, tumor cells, their microenvironment (extracellular matrixes, matrix-degrading enzymes, and tumor angiogenic factors), and their network of blood vessels, described by a series of discrete points, were considered. The results of numerical simulation reveal the process of tumor growth and the change in microenvironment from avascular to vascular stage, indicating that the network of blood vessels develops gradually as the tumor grows. Our findings also reveal that a tumor is divided into three regions: necrotic, semi-necrotic, and well-vascularized. The results agree well with the previous relevant studies and physiological facts, and this model represents a platform for further investigations of tumor therapy.	[Lyu, Jie; Zhang, Peiming; Liu, Yang; Cheng, Hongtao] Shanghai Univ Med & Hlth Sci, Med Instrumentat Sch, Shanghai 201318, Peoples R China; [Cao, Jinfeng] Shanghai Univ, Periodicals Agcy, Shanghai 200444, Peoples R China	Shanghai University of Medicine & Health Sciences; Shanghai University	Cao, JF (corresponding author), Shanghai Univ, Periodicals Agcy, Shanghai 200444, Peoples R China.	jfcao@shu.edu.cn	LYU, Jie/GYU-4137-2022	LYU, Jie/0000-0001-6926-1864				Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Cai Y, 2013, APPL MATH MECH-ENGL, V34, P1055, DOI 10.1007/s10483-013-1727-x; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Cai Y, 2009, APPL MATH MECH-ENGL, V30, P1247, DOI 10.1007/s10483-009-1004-z; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Lyu J, 2013, APPL MATH MECH-ENGL, V34, P1237, DOI 10.1007/s10483-013-1741-8; Rieger H, 2015, WIRES SYST BIOL MED, V7, P113, DOI 10.1002/wsbm.1295; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Wu JH, 2009, THESIS; Wu J, 2011, APPL MATH MECH-ENGL, V32, P437, DOI 10.1007/s10483-011-1428-7; Wu Jie, 2008, Molecular & Cellular Biomechanics, V5, P217; Wu J, 2009, J BIOMECH, V42, P712, DOI 10.1016/j.jbiomech.2009.01.009; Zhou Y, 2013, APPL MATH MECH-ENGL, V34, P327, DOI 10.1007/s10483-013-1673-6	19	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163173	10.1371/journal.pone.0163173	http://dx.doi.org/10.1371/journal.pone.0163173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701426	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900004
J	Brahimi, F; Maira, M; Barcelona, PF; Galan, A; Aboulkassim, T; Teske, K; Rogers, ML; Bertram, L; Wang, J; Yousefi, M; Rush, R; Fabian, M; Cashman, N; Saragovi, HU				Brahimi, Fouad; Maira, Mario; Barcelona, Pablo F.; Galan, Alba; Aboulkassim, Tahar; Teske, Katrina; Rogers, Mary-Louise; Bertram, Lisa; Wang, Jing; Yousefi, Masoud; Rush, Robert; Fabian, Marc; Cashman, Neil; Saragovi, H. Uri			The Paradoxical Signals of Two TrkC Receptor Isoforms Supports a Rationale for Novel Therapeutic Strategies in ALS	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SPINAL-CORD; NEUROTROPHIN RECEPTORS; SKELETAL-MUSCLE; NERVOUS-SYSTEM; P75; DEATH; ACTIVATION; SURVIVAL; VIVO	Full length TrkC (TrkC-FL) is a receptor tyrosine kinase whose mRNA can be spliced to a truncated TrkC. T1 isoform lacking the kinase domain. Neurotrophin-3 (NT-3) activates TrkC-FL to maintain motor neuron health and function and TrkC. T1 to produce neurotoxic TNF-alpha; hence resulting in opposing pathways. In mouse and human ALS spinal cord, the reduction of miR-128 that destabilizes TrkC. T1 mRNA results in up-regulated TrkC. T1 and TNF-alpha in astrocytes. We exploited conformational differences to develop an agonistic mAb 2B7 that selectively activates TrkC-FL, to circumvent TrkC. T1 activation. In mouse ALS, 2B7 activates spinal cord TrkC-FL signals, improves spinal cord motor neuron phenotype and function, and significantly prolongs life-span. Our results elucidate biological paradoxes of receptor isoforms and their role in disease progression, validate the concept of selectively targeting conformational epitopes in naturally occurring isoforms, and may guide the development of pro-neuroprotective (TrkC-FL) and anti-neurotoxic (TrkC.T1) therapeutic strategies.	[Brahimi, Fouad; Maira, Mario; Barcelona, Pablo F.; Galan, Alba; Aboulkassim, Tahar; Teske, Katrina; Fabian, Marc; Saragovi, H. Uri] McGill Univ, Lady Davis Inst, Translat Ctr, Jewish Gen Hosp, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Fabian, Marc] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Rogers, Mary-Louise; Rush, Robert] Flinders Univ S Australia, Dept Human Physiol, Ctr Neurosci, Adelaide, SA, Australia; [Bertram, Lisa; Wang, Jing; Yousefi, Masoud; Cashman, Neil] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; Flinders University South Australia; University of British Columbia	Saragovi, HU (corresponding author), McGill Univ, Lady Davis Inst, Translat Ctr, Jewish Gen Hosp, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	Uri.Saragovi@mcgill.ca	Barcelona, Pablo Federico/AAJ-8440-2020	Barcelona, Pablo/0000-0001-8248-2282; Rogers, Mary-Louise/0000-0002-3482-8741	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (Pharmacology, to HUS; and Proof-of-Principle, to HUS and NC).	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Barcelona PF, 2015, MOL CELL BIOL, V35, P3396, DOI 10.1128/MCB.00544-15; BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; Bartus RT, 2012, NEUROBIOL DIS, V48, P153, DOI 10.1016/j.nbd.2012.04.004; Brahimi F, 2010, BBA-GEN SUBJECTS, V1800, P1018, DOI 10.1016/j.bbagen.2010.06.007; Brahimi F, 2009, PEPTIDES, V30, P1833, DOI 10.1016/j.peptides.2009.07.015; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Chen DJ, 2009, ACS CHEM BIOL, V4, P769, DOI 10.1021/cb9001415; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Enomoto M, 2013, EXP NEUROL, V248, P170, DOI 10.1016/j.expneurol.2013.06.013; Esteban PF, 2006, J CELL BIOL, V173, P291, DOI 10.1083/jcb.200512013; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Guillemard V, 2010, DEV NEUROBIOL, V70, P150, DOI 10.1002/dneu.20776; Haase G, 1998, J NEUROL SCI, V160, pS97, DOI 10.1016/S0022-510X(98)00207-X; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hurko O, 2000, J NEUROL SCI, V180, P21, DOI 10.1016/S0022-510X(00)00419-6; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Josephy-Hernandez S, 2017, NEUROBIOL DIS, V97, P139, DOI 10.1016/j.nbd.2016.08.004; KERKHOFF H, 1991, ACTA NEUROPATHOL, V81, P649, DOI 10.1007/BF00296375; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LeSauteur L, 1996, J NEUROSCI, V16, P1308; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Messi ML, 2007, EXP NEUROL, V207, P52, DOI 10.1016/j.expneurol.2007.05.016; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; Pehar M, 2006, EUR J NEUROSCI, V24, P1575, DOI 10.1111/j.1460-9568.2006.05040.x; Reichardt LF, 2004, CELL, V118, P141, DOI 10.1016/j.cell.2004.07.008; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Saragovi HU, 2000, TRENDS PHARMACOL SCI, V21, P93, DOI 10.1016/S0165-6147(99)01444-3; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Shepheard SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087398; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Turner BJ, 2004, J NEUROSCI RES, V78, P193, DOI 10.1002/jnr.20256; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wyatt TJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/207230; YAN Q, 1988, J NEUROSCI, V8, P3481; Yanpallewar SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039946; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	52	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162307	10.1371/journal.pone.0162307	http://dx.doi.org/10.1371/journal.pone.0162307			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695040	Green Published, gold			2022-12-26	WOS:000385553100012
J	Dalton, AC; Shlamkovitch, T; Papo, N; Barton, WA				Dalton, Annamarie C.; Shlamkovitch, Tomer; Papo, Niv; Barton, William A.			Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1and Fibronectin	PLOS ONE			English	Article							GROWTH-FACTOR; ALPHA(V)BETA(3) INTEGRIN; ALPHA-5-BETA-1 INTEGRIN; CRYSTAL-STRUCTURES; CELL-CELL; ANGIOGENESIS; ACTIVATION; MIGRATION; ALPHA(5)BETA(1); BETA-1-INTEGRIN	Functional cross-talk between Tie2 and Integrin signaling pathways is essential to coordinate endothelial cell adhesion and migration in response to the extracellular matrix, yet the mechanisms behind this phenomenon are unclear. Here, we examine the possibility that receptor cross-talk is driven through uncharacterized Tie-integrin interactions on the endothelial surface. Using a live cell FRET-based proximity assay, we monitor Tie-integrin receptor recognition and demonstrate that both Tie1 and Tie2 readily associate with integrins alpha(5)beta(1) and alpha(V)beta(3) through their respective ectodomains. Although not required, Tie2-integrin association is significantly enhanced in the presence of the extracellular component and integrin ligand fibronectin. In vitro binding assays with purified components reveal that Tie-integrin recognition is direct, and further demonstrate that the receptor binding domain of the Tie2 ligand Ang-1, but not the receptor binding domain of Ang-2, can independently associate with alpha(5)beta(1) or alpha(V)beta(3). Finally, we reveal that cooperative Tie/integrin interactions selectively stimulate ERK/MAPK signaling in the presence of both Ang-1 and fibronectin, suggesting a molecular mechanism to sensitize Tie2 to extracellular matrix. We provide a mechanistic model highlighting the role of receptor localization and association in regulating distinct signaling cascades and in turn, the angiogenic switch.	[Dalton, Annamarie C.; Barton, William A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Shlamkovitch, Tomer; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-8410501 Beer Sheva, Israel; [Shlamkovitch, Tomer; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel	Virginia Commonwealth University; Ben Gurion University; Ben Gurion University	Barton, WA (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	william.barton@vcuhealth.org	Papo, Niv/R-3946-2017		National Cancer Institute of the National Institutes of Health [CA127501, F31CA165673]; NATIONAL CANCER INSTITUTE [F31CA165673] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA127501, http://www.cancer.gov, National Cancer Institute of the National Institutes of Health WAB. F31CA165673 http://www.cancer.gov National Cancer Institute of the National Institutes of Health ACD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Chen Y, 2006, J FLUORESC, V16, P95, DOI 10.1007/s10895-005-0024-1; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Dallabrida SM, 2008, FASEB J, V22, P3010, DOI 10.1096/fj.07-100966; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Lee EH, 2013, J CELL PHYSIOL, V228, P1038, DOI 10.1002/jcp.24251; Lee HS, 2014, J BIOL CHEM, V289, P31330, DOI 10.1074/jbc.M114.572594; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mehta RJ, 1998, BIOCHEM J, V330, P861; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Porat RM, 2004, CIRC RES, V94, P394, DOI 10.1161/01.RES.0000111803.92923.D6; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Velez-Montoya R, 2014, RETINA-J RET VIT DIS, V34, P423, DOI 10.1097/IAE.0000000000000036; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Woo KV, 2011, TRENDS CARDIOVAS MED, V21, P118, DOI 10.1016/j.tcm.2012.03.009; Woo KV, 2011, J CLIN INVEST, V121, P1624, DOI 10.1172/JCI42040; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	58	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163732	10.1371/journal.pone.0163732	http://dx.doi.org/10.1371/journal.pone.0163732			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695111	Green Published, gold			2022-12-26	WOS:000385553100050
J	Zhao, Z; Xue, YD; Yang, HL; Li, HM; Sun, GY; Zhao, XF; Ding, D; Tang, JH				Zhao, Zhan; Xue, Yadong; Yang, Huili; Li, Huimin; Sun, Gaoyang; Zhao, Xiaofeng; Ding, Dong; Tang, Jihua			Genome-Wide Identification of miRNAs and Their Targets Involved in the Developing Internodes under Maize Ears by Responding to Hormone Signaling	PLOS ONE			English	Article							ARABIDOPSIS GENE MONOPTEROS; BOX PROTEIN TIR1; TRANSCRIPTION FACTOR; PLANT HEIGHT; ABIOTIC STRESS; DWARF MUTANT; AUXIN; ROOT; MICRORNAS; RICE	Internode length is one of the decisive factors affecting plant height (PH) and ear height (EH), which are closely associated with the lodging resistance, biomass and grain yield of maize. miRNAs, currently recognized as important transcriptional/post-transcriptional regulators, play an essential role in plant growth and development. However, their roles in developing internodes under maize ears remain unclear. To identify the roles of miRNAs and their targets in the development of internodes under maize ears, six miRNA and two degradome libraries were constructed using the 7th, 8th and 9th internodes of two inbred lines, 'Xun928' and 'Xun9058', which had significantly different internode lengths. A total of 45 and 54 miRNAs showed significant changes for each pairwise comparison among the 7th, 8th and 9th internodes of 'Xun9058' and 'Xun928', respectively. The expression of 31 miRNAs showed significant changes were common to the corresponding comparison groups of the 7th, 8th and 9th internodes of 'Xun9058' and 'Xun928'. For the corresponding internodes of 'Xun9058' and 'Xun928', compared with the expression of miRNAs in the 7th, 8th and 9th internodes of 'Xun928', the numbers of up-regulated and down-regulated miRNAs were 11 and 36 in the 7th internode, 9 and 45 in the 8th internode, and 9 and 25 in the 9th internode of 'Xun9058', respectively. Moreover, 10 miRNA families containing 45 members showed significant changes at least in two internodes of 'Xun928' by comparing with the corresponding internodes of 'Xun9058'. Based on the sequencing data, 20 miRNAs related to hormone signaling among the candidates, belonging to five conserved miRNA families, were selected for expression profiling using quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The five miRNA families, zma-miR160, zma-miR167, zma-miR164, zma-miR169 and zma-miR393, targeted the genes encoding auxin response factor, N-acetylcysteine domain containing protein, nuclear transcription factor Y and auxin signaling F-BOX 2 through degradome sequencing. The miRNAs might regulate their targets to respond to hormone signaling, thereby regulating the internode elongation and development under maize ear. These results provide valuable reference for understanding the possible regulation mechanism of the ILs under the ear.	[Zhao, Zhan; Xue, Yadong; Yang, Huili; Li, Huimin; Sun, Gaoyang; Zhao, Xiaofeng; Ding, Dong; Tang, Jihua] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Agron, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Henan, Peoples R China; [Tang, Jihua] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434023, Hubei, Peoples R China	Henan Agricultural University; Yangtze University	Tang, JH (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Agron, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Henan, Peoples R China.; Tang, JH (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434023, Hubei, Peoples R China.	tangjihua1@163.com			National Nature Foundation of China [31370033]; State Key Basic Research and Development Plan of China [2014CB138203]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China(National Basic Research Program of China)	This work was supported by a grant from the National Nature Foundation of China (31370033) and the State Key Basic Research and Development Plan of China (2014CB138203).	Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Aida M, 2002, DEVELOPMENT, V129, P3965; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baksa I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2209-6; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Baloch IA, 2013, PURE APPL BIOL, V2, P83, DOI DOI 10.19045/BSPAB.2013.23002; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Chandler JW, 2015, PLANT CELL ENVIRON; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; D'haeseleer K, 2011, NEW PHYTOL, V191, P647, DOI 10.1111/j.1469-8137.2011.03719.x; Debernardi JM, 2014, PLANT J, V79, P413, DOI 10.1111/tpj.12567; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Flint-Garcia SA, 2003, CROP SCI, V43, P23, DOI 10.2135/cropsci2003.0023; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gyenes-Hegyi Z., 2002, Acta Agronomica Hungarica, V50, P75, DOI 10.1556/AAgr.50.2002.1.9; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hagen G, 2015, ESSAYS BIOCHEM, V58, P1, DOI [10.1042/BSE0580001, 10.1042/bse0580001]; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Jiang FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037040; Johri MM, 1996, GENETICA, V97, P291, DOI 10.1007/BF00055315; Iglesias MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107678; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Khaksefidi RE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00741; Knoller AS, 2010, J EXP BOT, V61, P3689, DOI 10.1093/jxb/erq180; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Kustchera U, 2015, PROTOPLASMA; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Lv HK, 2014, PLANT MOL BIOL, V84, P243, DOI 10.1007/s11103-013-0129-x; MARTIN MJ, 1984, CROP SCI, V24, P746, DOI 10.2135/cropsci1984.0011183X002400040028x; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; MORRISON TA, 1994, CROP SCI, V34, P1055, DOI 10.2135/cropsci1994.0011183X003400040040x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pilu R, 2007, MOL BREEDING, V20, P83, DOI 10.1007/s11032-006-9073-7; Pinthis M. J., 1973, Advances in Agronomy, V25, P209; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Saha J, 2013, COMPUT BIOL CHEM, V47, P81, DOI 10.1016/j.compbiolchem.2013.08.001; SAUTER M, 1992, PLANTA, V188, P362, DOI 10.1007/BF00192803; Sessions A, 1997, DEVELOPMENT, V124, P4481; Setter TL, 1997, FIELD CROP RES, V49, P95, DOI 10.1016/S0378-4290(96)01058-1; Siriwardana CL, 2014, PLANT MOL BIOL REP, V32, P971, DOI 10.1007/s11105-014-0704-6; Spray CR, 1996, P NATL ACAD SCI USA, V93, P10515, DOI 10.1073/pnas.93.19.10515; Sun XM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00595; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Takahashi N, 2005, PLANT J, V42, P13, DOI 10.1111/j.1365-313X.2005.02357.x; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang WF, 2014, CURR OPIN PLANT BIOL, V21, P147, DOI 10.1016/j.pbi.2014.07.012; Wang YH, 2006, PROG NAT SCI, V16, P701; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang WJ, 2014, J INTEGR AGR, V13, P63, DOI 10.1016/S2095-3119(13)60388-3; Zhang ZM, 2006, RUSS J GENET+, V42, P306, DOI 10.1134/S1022795406030112	77	14	15	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164026	10.1371/journal.pone.0164026	http://dx.doi.org/10.1371/journal.pone.0164026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695059	Green Submitted, gold, Green Published			2022-12-26	WOS:000385553100077
J	Medina, LS; Souza, BA; Queiroz, A; Guimaraes, LH; Machado, PRL; Carvalho, EM; Wilson, ME; Schriefer, A				Medina, Lilian S.; Souza, Bruno Araujo; Queiroz, Adriano; Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Wilson, Mary Edythe; Schriefer, Albert			The gp63 Gene Cluster Is Highly Polymorphic in Natural Leishmania (Viannia) braziliensis Populations, but Functional Sites Are Conserved	PLOS ONE			English	Article							MAJOR SURFACE GLYCOPROTEIN; DNA-SEQUENCE POLYMORPHISM; POLYMERASE-CHAIN-REACTION; CUTANEOUS LEISHMANIASIS; NORTHEASTERN BRAZIL; PROTEASE MSP; BALB/C MICE; VISCERAL LEISHMANIASIS; MEXICANA AMASTIGOTES; DONOVANI COMPLEX	GP63 or leishmanolysin is the major surface protease of Leishmania spp. involved in parasite virulence and host cell interaction. As such, GP63 is a potential target of eventual vaccines against these protozoa. In the current study we evaluate the polymorphism of gp63 in Leishmania (Viannia) braziliensis isolated from two sets of American tegumentary leishmaniasis (ATL) cases from Corte de Pedra, Brazil, including 35 cases diagnosed between 1994 and 2001 and 6 cases diagnosed between 2008 and 2011. Parasites were obtained from lesions by needle aspiration and cultivation. Genomic DNA was extracted, and 405 bp fragments, including sequences encoding the putative macrophage interacting sites, were amplified from gp63 genes of all isolates. DNA amplicons were cloned into plasmid vectors and ten clones per L. (V.) braziliensis isolate were sequenced. Alignment of cloned sequences showed extensive polymorphism among gp63 genes within, and between parasite isolates. Overall, 45 different polymorphic alleles were detected in all samples, which could be segregated into two clusters. Cluster one included 25, and cluster two included 20 such genotypes. The predicted peptides showed overall conservation below 50%. In marked contrast, the conservation at segments with putative functional domains approached 90% (Fisher's exact test p<0.0001). These findings show that gp63 is very polymorphic even among parasites from a same endemic focus, but the functional domains interacting with the mammalian host environment are conserved.	[Medina, Lilian S.; Souza, Bruno Araujo; Queiroz, Adriano; Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Schriefer, Albert] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Guimaraes, Luiz Henrique; Lima Machado, Paulo Roberto; Carvalho, Edgar M.; Schriefer, Albert] INCT DT, Brasilia, DF, Brazil; [Carvalho, Edgar M.] Ctr Pesquisa Goncalo Moniz Fiocruz, Salvador, BA, Brazil; [Wilson, Mary Edythe] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Wilson, Mary Edythe] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary Edythe] VA Med Ctr, Iowa City, IA USA; [Schriefer, Albert] Univ Fed Bahia, Inst Ciencias Saude, Dept Ciencias Biointeracao, Salvador, BA, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Universidade Federal da Bahia	Schriefer, A (corresponding author), Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Schriefer, A (corresponding author), INCT DT, Brasilia, DF, Brazil.; Schriefer, A (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Dept Ciencias Biointeracao, Salvador, BA, Brazil.	aschriefer@ufba.br	Queiroz, Adriano/AAQ-1164-2020; Schriefer, Albert/AAP-2765-2020; Henrique, Luiz/ABA-2621-2020; MACHADO, PAULO ROBERTO LIMA/AAP-2642-2020	Queiroz, Adriano/0000-0003-0080-6509; Schriefer, Albert/0000-0002-5496-6789; MACHADO, PAULO ROBERTO LIMA/0000-0003-1894-6171; Wilson, Mary/0000-0001-8680-7275	National Institutes of Health (NIH), USA [NIH P50-AI30639, NIH R03 A167663]; NIH [R03 A167663, P50-AI30639]; CAPES MS scholarship; CAPES PhD scholarship; CNPq Scientific Initiation Fellowship scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI030639] Funding Source: NIH RePORTER	National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES MS scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES PhD scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Scientific Initiation Fellowship scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH), USA, through grants NIH P50-AI30639 and NIH R03 A167663. AS and MW were recipients of NIH R03 A167663 and EMC, AS and MW were recipients of NIH P50-AI30639. LSM, AQ and LHG were recipients of CAPES MS and PhD scholarships. BAS was the recipient of a CNPq Scientific Initiation Fellowship scholarship.	Alexander J, 1998, J IMMUNOL, V161, P6794; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; AZULAY RD, 1995, INT J DERMATOL, V34, P303, DOI 10.1111/j.1365-4362.1995.tb03608.x; Bhowmick S, 2008, EXPERT OPIN DRUG DEL, V5, P789, DOI [10.1517/17425247.5.7.789, 10.1517/17425247.5.7.789 ]; Bianchini G, 2006, PROTEINS, V64, P385, DOI 10.1002/prot.21009; Brito G, 2014, AM J TROP MED HYG, V90, P617, DOI 10.4269/ajtmh.12-0729; CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; COOMBS GH, 1982, PARASITOLOGY, V84, P149, DOI 10.1017/S003118200005174X; COSTA JML, 1986, J TROP MED HYG, V89, P319; Cuervo P, 2008, ACTA TROP, V106, P143, DOI 10.1016/j.actatropica.2008.03.005; Dumonteil E, 2003, VACCINE, V21, P2161, DOI 10.1016/S0264-410X(02)00769-7; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Guerbouj S, 2001, PARASITOLOGY, V122, P25, DOI 10.1017/S0031182000007125; Guimaraes LH, 2009, T ROY SOC TROP MED H, V103, P712, DOI 10.1016/j.trstmh.2009.04.019; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Jaafari MR, 2006, VACCINE, V24, P5708, DOI 10.1016/j.vaccine.2006.04.062; Kaur T, 2011, PARASITE IMMUNOL, V33, P95, DOI 10.1111/j.1365-3024.2010.01253.x; Kaur Tejinder, 2013, J Parasit Dis, V37, P231, DOI 10.1007/s12639-012-0171-7; Lieke T, 2008, CLIN EXP IMMUNOL, V153, P221, DOI 10.1111/j.1365-2249.2008.03687.x; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Llanes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08550; Machado PR, 2011, T ROY SOC TROP MED H, V105, P438, DOI 10.1016/j.trstmh.2011.05.002; Machado PRL, 2015, CLIN INFECT DIS, V61, P945, DOI 10.1093/cid/civ416; Mauricio IL, 2007, INT J PARASITOL, V37, P565, DOI 10.1016/j.ijpara.2006.11.020; Mazumder S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001429; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Ministerio da Saude SdVe Saude, 2007, MAN VIG LEISHM TEG A; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Newlove T, 2011, AM J TROP MED HYG, V84, P551, DOI 10.4269/ajtmh.2011.10-0423; NORTH MJ, 1981, MOL BIOCHEM PARASIT, V3, P293, DOI 10.1016/0166-6851(81)90003-7; Pandey S, 2004, J BIOSCIENCES, V29, P15, DOI 10.1007/BF02702557; Papadopoulou G, 1998, VACCINE, V16, P885, DOI 10.1016/S0264-410X(97)00308-3; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Puentes F, 1999, EXP PARASITOL, V93, P7, DOI 10.1006/expr.1999.4427; PUPKIS MF, 1984, J GEN MICROBIOL, V130, P2375; Queiroz A, 2012, J CLIN MICROBIOL, V50, P4028, DOI 10.1128/JCM.02064-12; ROBERTS SC, 1993, MOL BIOCHEM PARASIT, V62, P157, DOI 10.1016/0166-6851(93)90106-8; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Romero GAS, 2001, ACTA TROP, V79, P225, DOI 10.1016/S0001-706X(01)00140-1; Rosenthal PJ, 1999, ADV PARASIT, V43, P105, DOI 10.1016/S0065-308X(08)60242-0; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; RUSSELL DG, 1986, J IMMUNOL, V136, P2613; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Sadlova J, 2006, FOLIA PARASIT, V53, P81, DOI 10.14411/fp.2006.011; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos JB, 2004, J INFECT DIS, V190, P1793, DOI 10.1086/424848; Schriefer A, 2004, INFECT IMMUN, V72, P508, DOI 10.1128/IAI.72.1.508-514.2004; Schriefer A, 2009, EMERG INFECT DIS, V15, P871, DOI 10.3201/eid1506.080406; SOTERIADOU KP, 1992, J BIOL CHEM, V267, P13980; STEINKRAUS HB, 1992, MOL BIOCHEM PARASIT, V52, P141, DOI 10.1016/0166-6851(92)90045-L; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772; Unger A, 2009, AM J TROP MED HYG, V80, P574, DOI 10.4269/ajtmh.2009.80.574; Victoir K, 2005, PARASITOLOGY, V131, P207, DOI 10.1017/S0031182005007535; VICTOIR K, 1995, PARASITOLOGY, V111, P265, DOI 10.1017/S0031182000081828; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Voth BR, 1998, MOL BIOCHEM PARASIT, V93, P31, DOI 10.1016/S0166-6851(98)00013-9; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11; (WHO) WHO, 2011, LEISHMANIASIS; XU D, 1995, IMMUNOLOGY, V84, P173; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	67	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163284	10.1371/journal.pone.0163284	http://dx.doi.org/10.1371/journal.pone.0163284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648939	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100072
J	Nakajima, R; Okano, H; Noce, T				Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki			JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; HISTONE DEMETHYLASE; LYSINE METHYLATION; SELF-RENEWAL; IDENTIFICATION; TRANSCRIPTION; DIFFERENTIATION; PLURIPOTENCY	Jmjd1C is one of the Jmjd1 family genes that encode putative demethylases against histone H3K9 and non-histone proteins and has been proven to play an indispensable role in mouse spermatogenesis. Here, we analyzed a newly-bred transgenic mouse strain carrying a Jmjd1C loss-of-function allele in which a beta-geo cassette was integrated into the intron of the Jmjd1C locus. Jmjd1C gene-trap homozygous testes exhibited malformations in postmeiotic processes and a deficiency in the long-term maintenance of undifferentiated spermatogonia. Some groups of spermatids in the homozygous testis showed abnormal organization and incomplete elongation from the first wave of spermatogenesis onwards. Moreover, histone H4K16 acetylation, which is required for the onset of chromatin remodeling, appeared to be remarkably decreased. These effects may not have been a result of the drastic decrease in gene expression related to the events but instead may have been due to the lack of interaction between JMJD1C and its partner proteins, such as MDC1 and HSP90. Additionally, significant decreases in Oct4 expression and NANOG- and OCT4-expressing spermatogonia were found in the Jmjd1C homozygous mature testis, suggesting that JMJD1C may participate in the maintenance of spermatogonial stem cell self-renewal by up-regulating Oct4 expression. These results indicate that JMJD1C has multiple functions during spermatogenesis through interactions with different partners during the spermatogenic stages.	[Nakajima, Ryusuke; Okano, Hideyuki; Noce, Toshiaki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo 1608582, Japan; [Noce, Toshiaki] Mitsubishi Kagaku Inst Life Sci, 11 Minami Ooya, Machida, Tokyo, Japan	Keio University; Mitsubishi Kagaku Institute of Life Sciences (MITILS)	Nakajima, R (corresponding author), Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, 35 Shinamomachi, Tokyo 1608582, Japan.	rnakajima@a3.keio.jp	Okano, Hideyuki/X-9131-2019; Okano, Hideyuki/I-7584-2019	Okano, Hideyuki/0000-0001-7482-5935; Nakajima, Ryusuke/0000-0002-0908-0292	Japan Society for the Promotion of Science Research Fellowship Program	Japan Society for the Promotion of Science Research Fellowship Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science Research Fellowship Program.; We thank Mr. Michio Satoh, Ms. Ako Tokumasu and Ms. Natsue Yoshida (former Mitsubishi-Kagaku Institute of Life Science), and Ms. Tomoko Suzuki (Keio University, School of Medicine) for their technical help. This study was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science Research Fellowship Program (to R.N.).	Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Castermans D, 2007, EUR J HUM GENET, V15, P422, DOI 10.1038/sj.ejhg.5201785; Chen M, 2015, GENE DEV, V29, P2123, DOI 10.1101/gad.267278.115; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; Dowdle JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003945; Ichijima Y, 2015, GENE DEV, V25, P959; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Kajiwara C, 2012, BIOL OPEN, V1, P977, DOI 10.1242/bio.2012646; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kasioulis I, 2014, MOL BIOL CELL, V25, P1216, DOI 10.1091/mbc.E13-08-0471; Katoh M, 2007, INT J ONCOL, V31, P219; Khor B, 2006, MOL CELL BIOL, V26, P2999, DOI 10.1128/MCB.26.8.2999-3007.2006; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Li WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4812; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Saez M A, 2015, GENET MED, V18, P1; Schmidt JA, 2011, BIOL REPROD, V84, P698, DOI 10.1095/biolreprod.110.088229; Shakya A, 2015, MOL CELL BIOL, V35, P1014, DOI 10.1128/MCB.01105-14; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Tsunekawa N, 1999, J VET MED SCI, V61, P381, DOI 10.1292/jvms.61.381; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang JL, 2014, J BIOL CHEM, V289, P2384, DOI 10.1074/jbc.M113.535799; Wang LH, 2014, NATURE, V511, P241, DOI 10.1038/nature13296; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Zhu N, 2016, J CLIN INVEST, V126, P997, DOI 10.1172/JCI82978; Zhuang TG, 2014, MECH DEVELOP, V131, P35, DOI 10.1016/j.mod.2013.10.005	43	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163466	10.1371/journal.pone.0163466	http://dx.doi.org/10.1371/journal.pone.0163466			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649575	Green Submitted, gold, Green Published			2022-12-26	WOS:000383892100087
J	Ricotti, V; Evans, MRB; Sinclair, CDJ; Butler, JW; Ridout, DA; Hogrel, JY; Emira, A; Morrow, JM; Reilly, MM; Hanna, MG; Janiczek, RL; Matthews, PM; Yousry, TA; Muntoni, F; Thornton, JS				Ricotti, Valeria; Evans, Matthew R. B.; Sinclair, Christopher D. J.; Butler, Jordan W.; Ridout, Deborah A.; Hogrel, Jean-Yves; Emira, Ahmed; Morrow, Jasper M.; Reilly, Mary M.; Hanna, Michael G.; Janiczek, Robert L.; Matthews, Paul M.; Yousry, Tarek A.; Muntoni, Francesco; Thornton, John S.			Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials	PLOS ONE			English	Article							3-POINT DIXON TECHNIQUE; DISEASE PROGRESSION; THIGH MUSCLES; BOYS; STRENGTH; INFILTRATION; RELIABILITY; ASSESSMENTS; PERFORMANCE; PHASE-2	Objective A number of promising experimental therapies for Duchenne muscular dystrophy (DMD) are emerging. Clinical trials currently rely on invasive biopsies or motivation-dependent functional tests to assess outcome. Quantitative muscle magnetic resonance imaging (MRI) could offer a valuable alternative and permit inclusion of non-ambulant DMD subjects. The aims of our study were to explore the responsiveness of upper-limb MRI muscle- fat measurement as a non-invasive objective endpoint for clinical trials in nonambulant DMD, and to investigate the relationship of these MRI measures to those of muscle force and function. Methods 15 non-ambulant DMD boys (mean age 13.3 y) and 10 age-gender matched healthy controls (mean age 14.6 y) were recruited. 3-Tesla MRI fat-water quantification was used to measure forearm muscle fat transformation in non-ambulant DMD boys compared with healthy controls. DMD boys were assessed at 4 time-points over 12 months, using 3-point Dixon MRI to measure muscle fat-fraction (f. f.). Images from ten forearm muscles were segmented and mean f. f. and cross-sectional area recorded. DMD subjects also underwent comprehensive upper limb function and force evaluation. Results Overall mean baseline forearm f. f. was higher in DMD than in healthy controls (p<0.001). A progressive f. f. increase was observed in DMD over 12 months, reaching significance from 6 months (p<0.001, n = 7), accompanied by a significant loss in pinch strength at 6 months (p<0.001, n = 9) and a loss of upper limb function and grip force observed over 12 months (p<0.001, n = 8). Conclusions These results support the use of MRI muscle f. f. as a biomarker to monitor disease progression in the upper limb in non-ambulant DMD, with sensitivity adequate to detect group-level change over time intervals practical for use in clinical trials. Clinical validity is supported by the association of the progressive fat transformation of muscle with loss of muscle force and function.	[Ricotti, Valeria; Butler, Jordan W.; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Ricotti, Valeria; Butler, Jordan W.; Ridout, Deborah A.; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Evans, Matthew R. B.; Sinclair, Christopher D. J.; Emira, Ahmed; Morrow, Jasper M.; Reilly, Mary M.; Hanna, Michael G.; Matthews, Paul M.; Yousry, Tarek A.; Muntoni, Francesco; Thornton, John S.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [Evans, Matthew R. B.; Sinclair, Christopher D. J.; Emira, Ahmed; Yousry, Tarek A.; Thornton, John S.] UCL Inst Neurol, Neuroradiol Acad Unit, London, England; [Ridout, Deborah A.] UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England; [Hogrel, Jean-Yves] GH Pitie Salpetriere, Inst Myol, Paris, France; [Janiczek, Robert L.] GlaxoSmithKline, London, England; [Matthews, Paul M.] Imperial Coll London, Div Brain Sci & Ctr Neurotechnol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline; Imperial College London	Ricotti, V (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England.; Ricotti, V (corresponding author), Great Ormond St Hosp Sick Children, London, England.	v.ricotti@ucl.ac.uk	Ridout, Deborah/C-1578-2008	Hanna, Michael/0000-0003-0825-4075; Hogrel, Jean-Yves/0000-0003-0045-7505; Reilly, Mary/0000-0003-0686-905X; Ridout, Deborah/0000-0003-1336-6450; Thornton, John/0000-0003-3248-8437	GlaxoSmithKline foundation; GlaxoSmithKline; EU grant SKIP-NMD [HEALTH-F4-2012-30537]; L'Association Francaise contre les Myopathies; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre; MRC; Muscular Dystrophy Campaign; Imperial College Healthcare Trust NIHR BRC; Edmond J Safra Foundation; Medical Research Council [MR/M009106/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10022] Funding Source: researchfish; MRC [MR/M009106/1] Funding Source: UKRI	GlaxoSmithKline foundation(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); EU grant SKIP-NMD; L'Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Imperial College Healthcare Trust NIHR BRC; Edmond J Safra Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GlaxoSmithKline foundation: Francesco Muntoni. GlaxoSmithKline funded this study. The funder provided financial support for the overall conduct of this study and contributed to study design and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section during the duration of this study VR was supported by the EU grant SKIP-NMD (No. HEALTH-F4-2012-30537) and L'Association Francaise contre les Myopathies (AFM). This study was supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (FM), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (JST, TAY). The MRC support to the Centre for Neuromuscular Diseases at UCL, and the support of the Muscular Dystrophy Campaign to the Neuromuscular Centres at GOSH and UCLH is also gratefully acknowledged. PMM gratefully acknowledges personal support from the Imperial College Healthcare Trust NIHR BRC and from the Edmond J Safra Foundation and Lily Safra.	Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; Alfano LN, 2014, NEUROMUSCULAR DISORD, V24, P860, DOI 10.1016/j.nmd.2014.06.224; Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Bishop C, 2015, NEUROLOGY S, V84; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Bushby K, 2014, MUSCLE NERVE, V50, P477, DOI 10.1002/mus.24332; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Ellis JA, 2013, NEUROMUSCULAR DISORD, V23, P682, DOI 10.1016/j.nmd.2013.05.008; Forbes SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106435; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Gaeta M, 2012, SKELETAL RADIOL, V41, P955, DOI 10.1007/s00256-011-1301-5; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hollingsworth KG, 2014, MAGN RESON MED, V72, P1610, DOI 10.1002/mrm.25072; Hollingsworth KG, 2013, MUSCLE NERVE, V48, P586, DOI 10.1002/mus.23879; Hollingsworth Kieren G, 2012, Neuromuscul Disord, V22 Suppl 2, pS54, DOI 10.1016/j.nmd.2012.06.005; Kim HK, 2013, PEDIATR RADIOL, V43, P1327, DOI 10.1007/s00247-013-2696-z; Kovanlikaya A, 2005, ACAD RADIOL, V12, P636, DOI 10.1016/j.acra.2005.01.019; Li WZ, 2015, NEUROMUSCULAR DISORD, V25, P375, DOI 10.1016/j.nmd.2015.01.003; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Steffensen B, 2001, Physiother Res Int, V6, P119, DOI 10.1002/pri.221; Straub Volker, 2012, Neuromuscul Disord, V22 Suppl 2, pS42, DOI 10.1016/j.nmd.2012.08.002; Vohra RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128915; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Wokke BH, 2014, NEUROMUSCULAR DISORD, V24, P409, DOI 10.1016/j.nmd.2014.01.015; Wokke BH, 2016, MUSCLE NERVE, V53, P38, DOI 10.1002/mus.24679; Wren TAL, 2008, AM J ROENTGENOL, V190, pW8, DOI 10.2214/AJR.07.2732; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	40	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162542	10.1371/journal.pone.0162542	http://dx.doi.org/10.1371/journal.pone.0162542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649492	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100022
J	Zhou, Q; Wang, X; Yu, Z; Wu, X; Chen, X; Li, J; Zhu, Z; Liu, B; Su, L				Zhou, Q.; Wang, X.; Yu, Z.; Wu, X.; Chen, X.; Li, J.; Zhu, Z.; Liu, B.; Su, L.			Transducin (beta)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; COREPRESSOR COMPLEX; FREQUENT GAIN; ACTIVATION; TBL1XR1; TRANSCRIPTION; GENES; TBLR1; IDENTIFICATION; METASTASIS	Gastric cancer (GC) is one of the most common types of cancer worldwide, and it involves extensive local tumour invasion, metastasis and poor prognosis. Understanding the mechanisms regulating the progression of GC is necessary for the development of effective therapeutic strategies. Transducin (beta)-like 1 X-linked receptor 1 (TBL1XR1) is an important regulator controlling gene activation and repression, which has been thought to be involved in tumorigenesis. However, the role of TBL1XR1 in human GC remains largely unknown. Here, we find that TBL1XR1 is aberrantly expressed in human GC tissues, and TBL1XR1 levels are highly correlated with local tumour invasion, late tumor, lymph node, metastasis (TNM) stage and poor prognosis. Knockdown of TBL1XR1 by shRNA inhibits GC cell proliferation, migration, invasion, epithelial-mesenchymal transition (EMT) in vitro, as well as tumorigenesis and peritoneal metastasis in vivo, whereas overexpression of TBL1XR1 produces the opposite effects. These effects are mediated by activation of the ERK1/2 signalling pathway, and inhibition of this pathway with a specific ERK1/2 inhibitor (U0126) significantly impairs the tumour-promoting effects induced by TBL1XR1. Moreover, TBL1XR1 mediated ERK1/2 activation is dependent on the beta-catenin/MMP7/EGFR signalling pathway. In conclusion, TBL1XR1 contributes to GC tumorigenesis and progression through the activation of the beta-catenin/MMP7/EGFR/ERK signalling pathway and may act as a new therapeutic target for GC.	[Zhou, Q.; Wang, X.; Yu, Z.; Wu, X.; Chen, X.; Li, J.; Zhu, Z.; Liu, B.; Su, L.] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Digest Surg,Dept Surg,Shanghai Key, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Liu, B; Su, L (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Digest Surg,Dept Surg,Shanghai Key, 197 Ruijin Er Rd, Shanghai 200025, Peoples R China.	liubingya@sjtu.edu.cn; suliping@shsmu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81572798, 81272749, 91229106, 91529302]; Key Projects in the National Science & Technology Pillar Program of China [2014BAI09B03]; Shanghai Municipal Education Commission [20152505]; Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program of China; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine	We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript. Support: This study was supported by grants from National Natural Science Foundation of China (No. 81572798, No. 81272749, No. 91229106 and No. 91529302), Key Projects in the National Science & Technology Pillar Program of China (No. 2014BAI09B03), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20152505), and Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201318).	Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Chen SP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-195; Chen XJ, 2014, CARCINOGENESIS, V35, P1707, DOI 10.1093/carcin/bgu023; Choi HK, 2011, MOL CELL, V43, P203, DOI 10.1016/j.molcel.2011.05.027; Daniels G, 2014, ENDOCR-RELAT CANCER, V21, P127, DOI 10.1530/ERC-13-0293; den Hoed Caroline M, 2016, Curr Gastroenterol Rep, V18, P34, DOI 10.1007/s11894-016-0506-0; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Goretsky T, 2016, J BIOL CHEM, V291, P4166, DOI 10.1074/jbc.M115.669416; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Ichikawa K, 2015, MOL CELL, V58, P35, DOI 10.1016/j.molcel.2015.01.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Komatsu N, 2015, ONCOGENE, V34, P5607, DOI 10.1038/onc.2015.16; Kuang XJ, 2016, DIGEST DIS SCI, V61, P489, DOI 10.1007/s10620-015-3879-2; Li JY, 2015, AM J CLIN EXP UROL, V3, P13; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li T, 2015, ONCOL REP, V34, P1469, DOI 10.3892/or.2015.4109; Li XL, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/870597; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pons L, 2015, AM J MED GENET A, V167, P164, DOI 10.1002/ajmg.a.36759; Qu Y, 2014, J GASTROENTEROL, V49, P408, DOI 10.1007/s00535-013-0809-y; Saitsu H, 2014, J HUM GENET, V59, P581, DOI 10.1038/jhg.2014.71; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Tabet AC, 2014, AM J MED GENET A, V164, P2335, DOI 10.1002/ajmg.a.36619; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tomita A, 2003, J BIOL CHEM, V278, P30788, DOI 10.1074/jbc.M303309200; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang J, 2014, BRIT J CANCER, V111, P112, DOI 10.1038/bjc.2014.278; Yanaka Y, 2015, CARCINOGENESIS, V36, P1363, DOI 10.1093/carcin/bgv106; Yang YC, 2001, CANCER GENET CYTOGEN, V131, P48, DOI 10.1016/S0165-4608(01)00510-6; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881; Zhang XM, 2000, EXP HEMATOL, V28, P1286, DOI 10.1016/S0301-472X(00)00539-7	44	27	27	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1873	1886		10.1038/onc.2016.352	http://dx.doi.org/10.1038/onc.2016.352			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27694893	Green Published, hybrid			2022-12-26	WOS:000398128900012
J	Zhuang, J; Kamp, WM; Li, J; Liu, CY; Kang, JG; Wang, PY; Hwang, PM				Zhuang, Jie; Kamp, William M.; Li, Jie; Liu, Chengyu; Kang, Ju-Gyeong; Wang, Ping-Yuan; Hwang, Paul M.			Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; ENDURANCE EXERCISE; PATHWAY; SIRT1; PHOSPHORYLATION; TRANSLOCATION; HOMEOSTASIS; BIOGENESIS; METABOLISM; TURNOVER	Although exercise is linked with improved health, the specific molecular mechanisms underlying its various benefits require further clarification. Here we report that exercise increases the nuclear localization and activity of p53 by acutely down-regulating coiled-coil-helix-coiled-coil-helix domain 4 (CHCHD4), a carrier protein that mediates p53 import into the mitochondria. This response to exercise is lost in transgenic mice with constitutive expression of CHCHD4. Mechanistically, exercise-induced nuclear transcription factor FOXO3 binds to the CHCHD4 promoter and represses its expression, preventing the translocation of p53 to the mitochondria and thereby increasing p53 nuclear localization. The synergistic increase in nuclear p53 and FOXO3 by exercise can facilitate their known interaction in transactivating Sirtuin 1 (SIRT1), a NAD(+)-dependent histone deacetylase that mediates adaptation to various stresses. Thus, our results reveal one mechanism by which exercise could be involved in preventing cancer and potentially other diseases associated with aging.	[Zhuang, Jie; Kamp, William M.; Li, Jie; Kang, Ju-Gyeong; Wang, Ping-Yuan; Hwang, Paul M.] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA; [Liu, Chengyu] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hwang, PM (corresponding author), 10CRC 5-5330,10 Ctr Dr, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov			Division of Intramural Research of the NHLBI, National Institutes of Health [HL005101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006051, ZICHL005907, ZIGHL006020, Z01HL005101] Funding Source: NIH RePORTER	Division of Intramural Research of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research of the NHLBI, National Institutes of Health Grant HL005101 (to P. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartlett JD, 2014, SPORTS MED, V44, P303, DOI 10.1007/s40279-013-0127-9; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hagenbuchner J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00147; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2015, PROG MOL BIOL TRANSL, V135, P99, DOI 10.1016/bs.pmbts.2015.07.007; Kamp WM, 2016, CURR OPIN GENET DEV, V38, P16, DOI 10.1016/j.gde.2016.02.007; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Menzies KJ, 2012, MITOCHONDRION, V12, P5, DOI 10.1016/j.mito.2011.03.001; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Park JH, 2016, FEBS LETT; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Rogers CJ, 2008, SPORTS MED, V38, P271, DOI 10.2165/00007256-200838040-00002; Saleem A, 2013, J PHYSIOL-LONDON, V591, P3625, DOI 10.1113/jphysiol.2013.252791; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Stefanetti RJ, 2015, PFLUG ARCH EUR J PHY, V467, P1523, DOI 10.1007/s00424-014-1587-y; Tachtsis B, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00144; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang PY, 2013, NEW ENGL J MED, V368, P1027, DOI 10.1056/NEJMoa1214091; Zhuang J, 2013, P NATL ACAD SCI USA, V110, P17356, DOI 10.1073/pnas.1310908110; Zhuang J, 2012, FREE RADICAL BIO MED, V53, P1279, DOI 10.1016/j.freeradbiomed.2012.07.026	37	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24819	24827		10.1074/jbc.M116.745737	http://dx.doi.org/10.1074/jbc.M116.745737			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27687729	Green Published, hybrid			2022-12-26	WOS:000388880100002
J	Saederup, KL; Stodkilde, K; Graversen, JH; Dickson, CF; Etzerodt, A; Hansen, SWK; Fago, A; Gell, D; Andersen, CBF; Moestrup, SK				Saederup, Kirstine Lindhardt; Stodkilde, Kristian; Graversen, Jonas Heilskov; Dickson, Claire F.; Etzerodt, Anders; Hansen, Soren Werner Karlskov; Fago, Angela; Gell, David; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh			The Staphylococcus aureus Protein IsdH Inhibits Host Hemoglobin Scavenging to Promote Heme Acquisition by the Pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; hemoglobin; iron; macrophage; Staphylococcus aureus (S; aureus); CD163; Iron-regulated Surface Determinant; IsdH; haptoglobin; heme acquisition	CYSTEINE-RICH DOMAIN; SURFACE PROTEIN; MOLECULAR-BASIS; RECEPTOR CD163; HAPTOGLOBIN; IRON; BINDING; SUSCEPTIBILITY; IDENTIFICATION; DETERMINANTS	Hemolysis is a complication in septic infections with Staphylococcus aureus, which utilizes the released Hb as an iron source. S. aureus can acquire heme in vitro from hemoglobin (Hb) by a heme-sequestering mechanism that involves proteins from the S. aureus iron-regulated surface determinant (Isd) system. However, the host has its own mechanism to recapture the free Hb via haptoglobin (Hp) binding and uptake of Hb-Hp by the CD163 receptor in macrophages. It has so far remained unclear how the Isd system competes with this host iron recycling system in situ to obtain the important nutrient. By binding and uptake studies, we now show that the IsdH protein, which serves as an Hb receptor in the Isd system, directly interferes with the CD163-mediated clearance by binding the Hb-Hp complex and inhibiting CD163 recognition. Analysis of truncated IsdH variants including one or more of three near iron transporter domains, IsdH(N1), IsdH(N2), and IsdH(N3), revealed that Hb binding of IsdH(N1) and IsdH(N2) accounted for the high affinity for Hb-Hp complexes. The third near iron transporter domain, IsdH(N3), exhibited redox-dependent heme extraction, when Hb in the Hb-Hp complex was in the oxidized met form but not in the reduced oxy form. IsdB, the other S. aureus Hb receptor, failed to extract heme from Hb-Hp, and it was a poor competitor for Hb-Hp binding to CD163. This indicates that Hb recognition by IsdH, but not by IsdB, sterically inhibits the receptor recognition of Hb-Hp. This function of IsdH may have an overall stimulatory effect on S. aureus heme acquisition and growth.	[Saederup, Kirstine Lindhardt; Graversen, Jonas Heilskov; Hansen, Soren Werner Karlskov; Moestrup, Soren Kragh] Univ Southern Denmark, Dept Mol Med, DK-5000 Odense, Denmark; [Stodkilde, Kristian; Etzerodt, Anders; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Fago, Angela] Aarhus Univ, Zoophysiol Sect, Dept Biosci, DK-8000 Aarhus, Denmark; [Dickson, Claire F.; Gell, David] Univ Tasmania, Sch Med, Hobart, Tas 7005, Australia; [Moestrup, Soren Kragh] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark	University of Southern Denmark; Aarhus University; Aarhus University; University of Tasmania; University of Southern Denmark; Odense University Hospital	Moestrup, SK (corresponding author), Univ Southern Denmark, Inst Mol Med, JB Winslows Vej 25, DK-5000 Odense C, Denmark.	smoestrup@health.sdu.dk	Moestrup, Søren Kragh/AAD-1735-2019; Etzerodt, Anders/O-9860-2019; Fago, Angela/J-5946-2013; Moestrup, Soren Kragh/A-1403-2014	Etzerodt, Anders/0000-0002-6757-2068; Hansen, Soren/0000-0002-8186-4630; Graversen, Jonas Heilskov/0000-0001-7119-2108; Stodkilde-Jorgensen, Kristian/0000-0002-7324-305X; Saederup, Kirstine Lindhardt/0000-0001-5724-491X; Fago, Angela/0000-0001-7315-2628; Moestrup, Soren Kragh/0000-0003-3862-2107; Gell, David/0000-0003-0382-1181	Novo Nordisk Foundation; Lundbeck Foundation; Danish Medical Research Council; European Research Council TROJA Grant [233312]; Lundbeck Foundation [R54-2010-5637, R180-2014-3649] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0008781, NNF14OC0011537] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council TROJA Grant; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Novo Nordisk Foundation, the Lundbeck Foundation, and Danish Medical Research Council and European Research Council TROJA Grant 233312). The authors declare that they have no conflicts of interest with the contents of this article.	Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Andersen C. B., 2016, ANTIOXIDANT IN PRESS; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V1; Boretti FS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00385; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2012, J CONTROL RELEASE, V160, P72, DOI 10.1016/j.jconrel.2012.01.034; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; HWANG PK, 1980, J BIOL CHEM, V255, P3038; JOHNSON MK, 1980, INFECT IMMUN, V29, P1028; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Nielsen MJ, 2006, J LEUKOCYTE BIOL, V79, P837, DOI 10.1189/jlb.1005602; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer DJ, 2002, BRIT J HAEMATOL, V119, P239, DOI 10.1046/j.1365-2141.2002.03790.x; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Sjodt M, 2016, J MOL BIOL, V428, P1107, DOI 10.1016/j.jmb.2015.02.008; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH HW, 1963, J PATHOL BACTERIOL, V85, P197, DOI 10.1002/path.1700850119; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Stodkilde K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6487; VALDES R, 1978, P NATL ACAD SCI USA, V75, P5493, DOI 10.1073/pnas.75.11.5493; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0	41	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23989	23998		10.1074/jbc.M116.755934	http://dx.doi.org/10.1074/jbc.M116.755934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27681593	Green Published, hybrid			2022-12-26	WOS:000388498100015
J	Fulham, MA; Mandrekar, P				Fulham, Melissa A.; Mandrekar, Pranoti			Sexual Dimorphism in Alcohol Induced Adipose Inflammation Relates to Liver Injury	PLOS ONE			English	Article							DIET-INDUCED OBESITY; FATTY LIVER; TISSUE MACROPHAGES; METABOLIC DISEASE; IMAGE-ANALYSIS; KUPFFER CELLS; ETHANOL; ADIPONECTIN; MICE; ACTIVATION	Alcoholic liver disease occurs due to chronic, heavy drinking and is driven both by metabolic alterations and immune cell activation. Women are at a higher risk than men for developing alcohol induced liver injury and this dimorphism is reflected in animal models of alcoholic liver disease. The importance of adipose tissue in alcoholic liver disease is emerging. Chronic alcohol consumption causes adipose tissue inflammation, which can influence liver injury. Sex differences in body fat composition are well known. However, it is still unclear if alcohol-induced adipose tissue inflammation occurs in a sex-dependent manner. Here we have employed the clinically relevant NIAAA model of chronic-binge alcohol consumption to investigate this sexual dimorphism. We report that female mice have greater liver injury than male mice despite lower alcohol consumption. Chronic-binge alcohol induces adipose tissue inflammation in vivo in female mice, which is illustrated by increased expression of TNF alpha, IL-6, and CCL2, compared to only IL-6 induction in male adipose tissue. Further, macrophage activation markers such as CD68 as well as the pro-inflammatory activation markers CD11b and CD11c were higher in female adipose tissue. Interestingly, alcohol induced expression of TLR2, 3, 4, and 9 in female but not male adipose tissue, without affecting the TLR adaptor, MyD88. Higher trends of serum endotoxin in female mice may likely contribute to adipose tissue inflammation. In vitro chronic alcohol-mediated sensitization of macrophages to endotoxin is independent of sex. In summary, we demonstrate for the first time that there is a sexual dimorphism in alcohol-induced adipose tissue inflammation and female mice exhibit a higher degree of inflammation than male mice.	[Fulham, Melissa A.; Mandrekar, Pranoti] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Fulham, Melissa A.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mandrekar, P (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Pranoti.Mandrekar@umassmed.edu			National Institutes of Health [AA017986-06A1, AA022770-02]; Department of Defense [DAMD/W81xWH-13-1-0498]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	PM was supported by grants from the National Institutes of Health (AA017986-06A1 and AA022770-02) and from the Department of Defense (DAMD/W81xWH-13-1-0498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024; Ambade A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/853175; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Buechler C, 2009, J GASTROEN HEPATOL, V24, P558, DOI 10.1111/j.1440-1746.2008.05693.x; Chen XC, 2007, AM J PHYSIOL-ENDOC M, V292, pE621, DOI 10.1152/ajpendo.00387.2006; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Dugum M, 2015, J CLIN TRANSL HEPATO, V3, P109, DOI 10.14218/JCTH.2015.00008; Enomoto N, 1999, AM J PHYSIOL-GASTR L, V277, pG671, DOI 10.1152/ajpgi.1999.277.3.G671; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Iimuro Y, 1997, AM J PHYSIOL-GASTR L, V272, pG1186, DOI 10.1152/ajpgi.1997.272.5.G1186; Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669, DOI 10.1152/ajpgi.1998.274.4.G669; Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P3020, DOI 10.3748/wjg.v21.i10.3020; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; Kasztelan-Szczerbinska B, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/148526; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lin HZ, 1998, ALCOHOL CLIN EXP RES, V22, p231S, DOI 10.1111/j.1530-0277.1998.tb04008.x; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; MARSHALL AW, 1983, HEPATOLOGY, V3, P701; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Naveau S, 2010, J HEPATOL, V52, P895, DOI 10.1016/j.jhep.2010.01.029; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Singer K, 2015, J BIOL CHEM, V290, P13250, DOI 10.1074/jbc.M114.634568; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Voican CS, 2015, LIVER INT, V35, P967, DOI 10.1111/liv.12575; Wang M, 2014, J LEUKOCYTE BIOL, V96, P657, DOI 10.1189/jlb.6A0114-004RR; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61	56	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164225	10.1371/journal.pone.0164225	http://dx.doi.org/10.1371/journal.pone.0164225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711160	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600099
J	Shen, HH; Liu, GS; Chow, SH; Wang, JH; He, Z; Nguyen, C; Lin, TW; Bui, BV				Shen, Hsin-Hui; Liu, Guei-Sheung; Chow, Seong Hoong; Wang, Jiang-Hui; He, Zheng; Nguyen, Christine; Lin, Tsung-Wu; Bui, Bang V.			Intraocular Pressure Induced Retinal Changes Identified Using Synchrotron Infrared Microscopy	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CORNEAL STEM-CELLS; LIPID-PEROXIDATION; OXIDATIVE STRESS; MICROSPECTROSCOPY; SPECTROSCOPY; RADIATION; TISSUE; DEATH; IR	Infrared (IR) spectroscopy has been used to quantify chemical and structural characteristics of a wide range of materials including biological tissues. In this study, we examined spatial changes in the chemical characteristics of rat retina in response to intraocular pressure (IOP) elevation using synchrotron infrared microscopy (SIRM), a non-destructive imaging approach. IOP elevation was induced by placing a suture around the eye of anaesthetised rats. Retinal sections were collected onto transparent CaF2 slides 10 days following IOP elevation. Using combined SIRM spectra and chemical mapping approaches it was possible to quantify IOP induced changes in protein conformation and chemical distribution in various layers of the rat retina. We showed that 10 days following IOP elevation there was an increase in lipid and protein levels in the inner nuclear layer (INL) and ganglion cell layer (GCL). IOP elevation also resulted in an increase in nucleic acids in the INL. Analysis of SIRM spectra revealed a shift in amide peaks to lower vibrational frequencies with a more prominent second shoulder, which is consistent with the presence of cell death in specific layers of the retina. These changes were more substantial in the INL and GCL layers compared with those occurring in the outer nuclear layer. These outcomes demonstrate the utility of SIRM to quantify the effect of IOP elevation on specific layers of the retina. Thus SIRM may be a useful tool for the study of localised tissue changes in glaucoma and other eye diseases.	[Shen, Hsin-Hui] Monash Univ, Fac Engn, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Shen, Hsin-Hui; Chow, Seong Hoong] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Shen, Hsin-Hui; Chow, Seong Hoong] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [He, Zheng; Nguyen, Christine; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia; [Lin, Tsung-Wu] Tunghai Univ, Dept Chem, Taichung, Taiwan	Monash University; Monash University; Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne; Tunghai University	Shen, HH (corresponding author), Monash Univ, Fac Engn, Dept Mat Sci & Engn, Clayton, Vic, Australia.; Shen, HH (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Shen, HH (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia.	hsin-hui.shen@monash.edu; bvb@unimelb.edu.au	Liu, Guei-Sheung/Q-6472-2018; Wang, Jiang-Hui/AAW-4653-2020; Bui, Bang/AAD-2679-2021; Chow, Seong Hoong/AAA-4698-2020	Liu, Guei-Sheung/0000-0003-3379-724X; Wang, Jiang-Hui/0000-0002-1551-9660; Bui, Bang/0000-0001-7298-1352; Chow, Seong Hoong/0000-0002-4392-3863; Shen, Hsin-Hui/0000-0002-8541-4370; Nguyen, Christine/0000-0002-3298-3086	National Health and Medical Research Council of Australia [1106798, 11081072, 1061912]; NHMRC [1106798, 1046203]; Australian Research Council [FT130100338]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government	This work was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) # 1106798 (HHS) #11081072 (GSL) #1061912 (JHW) NHMRC #1046203 (BVB) #1106798. BVB is supported by an Australian Research Council (www.arc.gov.au/) Future Fellowship (FT130100338). This work was also supported The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. (www.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIZHAYEV MA, 1989, ACTA OPHTHALMOL, V67, P371; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Bentley AJ, 2007, MOL VIS, V13, P237; Bui BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070513; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Calkins DJ, 2012, INVEST OPHTH VIS SCI, V53, P2482, DOI 10.1167/iovs.12-9483i; Choo LP, 1996, BIOPHYS J, V71, P1672, DOI 10.1016/S0006-3495(96)79411-0; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dritsa V, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P271; Faschinger C, 2006, OPHTHALMOLOGE, V103, P953, DOI 10.1007/s00347-006-1399-3; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Fogarty SW, 2013, ANALYST, V138, P240, DOI 10.1039/c2an36197c; German MJ, 2006, INVEST OPHTH VIS SCI, V47, P2417, DOI 10.1167/iovs.05-1254; HARIS PI, 1992, TRENDS BIOCHEM SCI, V17, P328, DOI 10.1016/0968-0004(92)90305-S; Holman HN, 2000, BIOPOLYMERS, V57, P329; Huang W, 2005, AM J PATHOL, V167, P673, DOI 10.1016/S0002-9440(10)62042-1; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kastyak-Ibrahim MZ, 2012, NEUROIMAGE, V60, P376, DOI 10.1016/j.neuroimage.2011.11.069; Liu HH, 2015, INVEST OPHTH VIS SCI, V56, P2811, DOI 10.1167/iovs.14-16009; Liu M, 2011, EXP EYE RES, V92, P244, DOI 10.1016/j.exer.2011.01.014; Mattson EC, 2012, ANAL CHEM, V84, P6173, DOI 10.1021/ac301080h; Miller LM, 1998, CELL MOL BIOL, V44, P117; Nakamura T, 2010, MOL VIS, V16, P359; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Pang JJ, 2015, P NATL ACAD SCI USA, V112, P2593, DOI 10.1073/pnas.1419921112; Peticolas WL, 1994, METHOD ENZYMOL, V246, P389, DOI [10.1016/0076-6879(95)46019-5, DOI 10.1016/0076-6879(95)46019-5]; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Siebert F, 1994, METHOD ENZYMOL, V246, P501, DOI [10.1016/0076-6879(95)46022-5, DOI 10.1016/0076-6879(95)46022-5]; SILLS RH, 1994, ANAL BIOCHEM, V218, P118, DOI 10.1006/abio.1994.1149; Stitt DM, 2012, VIB SPECTROSC, V60, P16, DOI 10.1016/j.vibspec.2011.10.016; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tobin MJ, 2004, FARADAY DISCUSS, V126, P27, DOI 10.1039/b306689d; Torii Hajime, 1996, P1; Weber AJ, 2005, INVEST OPHTH VIS SCI, V46, P3197, DOI 10.1167/iovs.04-0834; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wetzel DL, 2002, VIB SPECTROSC, V30, P101, DOI 10.1016/S0924-2031(02)00044-9; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; WONG PTT, 1991, APPL SPECTROSC, V45, P1563, DOI 10.1366/0003702914335580	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164035	10.1371/journal.pone.0164035	http://dx.doi.org/10.1371/journal.pone.0164035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711151	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600068
J	Gero, S; Whitehead, H				Gero, Shane; Whitehead, Hal			Critical Decline of the Eastern Caribbean Sperm Whale Population	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; SOCIAL UNITS; TOUR BOATS; NOISE; BEHAVIOR; CETACEANS	Sperm whale (Physeter macrocephalus) populations were expected to rebuild following the end of commercial whaling. We document the decline of the population in the eastern Caribbean by tracing demographic changes of well-studied social units. We address hypotheses that, over a ten-year period of dedicated effort (2005-2015), unit size, numbers of calves and/or calving rates have each declined. Across 16 units, the number of adults decreased in 12 units, increased in two, and showed no change in two. The number of adults per unit decreased at -0.195 individuals/yr (95% CI: -0.080 to -0.310; P = 0.001). The number of calves also declined, but the decline was not significant. This negative trend of -4.5% per year in unit size started in about 2010, with numbers being fairly stable until then. There are several natural and anthropogenic threats, but no well-substantiated cause for the decline.	[Gero, Shane] Aarhus Univ, Inst Biosci, Zoophysiol, Aarhus, Denmark; [Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Aarhus University; Dalhousie University	Gero, S (corresponding author), Aarhus Univ, Inst Biosci, Zoophysiol, Aarhus, Denmark.	shane.gero@bios.au.dk	Gero, Shane/G-8675-2015	Gero, Shane/0000-0001-6854-044X	Danish Council for Independent Research; Natural Sciences and Engineering Research Council of Canada	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SG received an FNU fellowship from the Danish Council for Independent Research, supplemented by a Sapere Aude Research Talent Award (http://ufm.dk/en/), Carlsberg Foundation Field Expedition Grant (http://www.carlsbergfondet.dk/?sc_lang=en), and Killam Trusts (CA). HW received operating and equipment grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 2011, ANIM BEHAV, V81, P723, DOI 10.1016/j.anbehav.2010.12.019; ARNBOM T, 1987, REPORT INT WHALING C, V37, P201; Baker C. S., 2002, ENCY GLOBAL ENV CHAN, P446; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Carroll G, 2014, ENDANGER SPECIES RES, V24, P33, DOI 10.3354/esr00584; Chiquet RA, 2013, ECOL MODEL, V248, P71, DOI 10.1016/j.ecolmodel.2012.09.023; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Coat S, 2006, AQUAT LIVING RESOUR, V19, P181, DOI 10.1051/alr:2006016; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Fais A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150660; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Gero Shane, 2007, Journal of Cetacean Research and Management, V9, P143; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Gero S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160061; Gero S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150372; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2014, MAR MAMMAL SCI, V30, P905, DOI 10.1111/mms.12086; Gero S, 2009, BEHAV ECOL, V20, P838, DOI 10.1093/beheco/arp068; Hoyt E, 2002, COAST MANAGE, V30, P381, DOI 10.1080/089207502900273; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Jimenez J, 2014, MAMMAL REV, V44, P177, DOI [10.1111/mam.12021, DOI 10.1111/MAM.12021]; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Moore JE, 2014, ENDANGER SPECIES RES, V25, P141, DOI 10.3354/esr00633; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Panigada S, 2009, SC61BC2 IWC; Robbins J., 2004, 43EANF030121 NE FISH; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Schulz TM, 2011, MAR MAMMAL SCI, V27, P149, DOI 10.1111/j.1748-7692.2010.00399.x; Schulz TM, 2008, ANIM BEHAV, V76, P1977, DOI 10.1016/j.anbehav.2008.07.032; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Veirs S, 2016, PEERJ, V4, DOI 10.7717/peerj.1657; Vidal Omar, 1994, Reports of the International Whaling Commission Special Issue, V15, P221; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H, 2015, ENDANGER SPECIES RES, V27, P207, DOI 10.3354/esr00657; Whitehead H, 2014, METHODS ECOL EVOL, V5, P27, DOI 10.1111/2041-210X.12124; Whitehead H, 2012, INT J PRIMATOL, V33, P1142, DOI 10.1007/s10764-012-9598-z; Whitt AD, 2015, AQUAT MAMM, V41, P252, DOI 10.1578/AM.41.3.2015.252; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x	44	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162019	10.1371/journal.pone.0162019	http://dx.doi.org/10.1371/journal.pone.0162019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706153	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200006
J	Li, X; Li, YB; Hong, L				Li, Xin; Li, Yanbo; Hong, Li			A Novel Self-Assembling DNA Nano Chip for Rapid Detection of Human Papillomavirus Genes	PLOS ONE			English	Article							NANOSCALE SHAPES; FOLDING DNA; HPV DNA; ORIGAMI; CARCINOMA; TILES; RNA	Rapid detection of tumor-associated DNA such as Human Papillomavirus (HPV) has important clinical value for the early screening of tumors. By attaching oligonucleotides or cDNA onto the chip surface, DNA chip technology provides a rapid method to analyze gene expression. However, challenges remain regarding increasing probe density and improving detection time. To address these challenges, we proposed a DNA chip that was self-assembled from single stranded DNA in combination with high probe density and a rapid detection method. Over 200 probes could be attached to the surface of this 100-nm diameter DNA chip. For detection, the chips were adsorbed onto a mica surface and then incubated for ten minutes with HPV-DNA; the results were directly observable using atomic force microscopy (AFM). This bottom-up fabricated DNA nano chip combined with high probe density and direct AFM detection at the single molecule level will likely have numerous potential clinical applications for gene screening and the early diagnosis of cancer.	[Li, Xin; Li, Yanbo; Hong, Li] Wuhan Univ, Renmin Hosp, Dept Gynecol 2, Wuhan 430060, Hubei, Peoples R China	Wuhan University	Li, X; Hong, L (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gynecol 2, Wuhan 430060, Hubei, Peoples R China.	lixinwhu@189.cn; hongliwhu@189.cn			National Natural Science Foundation of China [61272071, 61572213]; Natural Science Foundation of Hubei Province [2014CFB730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (61272071, 61572213) and the Natural Science Foundation of Hubei Province (2014CFB730).	Agorastos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119755; An HJ, 2003, CANCER-AM CANCER SOC, V97, P1672, DOI 10.1002/cncr.11235; Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Aslan F. G., 2015, TAF Preventive Medicine Bulletin, V14, P222, DOI 10.5455/pmb.1-1417459055; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding BQ, 2010, J AM CHEM SOC, V132, P3248, DOI 10.1021/ja9101198; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Ke YG, 2008, CHEM COMMUN, P5622, DOI 10.1039/b811332g; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Kuzyk A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235305; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Mei Q, 2013, NANO RES, V6, P712, DOI 10.1007/s12274-013-0347-1; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Shen WQ, 2009, J AM CHEM SOC, V131, P6660, DOI 10.1021/ja901407j; Shi LJ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145704; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2007, J AM CHEM SOC, V129, P14134, DOI 10.1021/ja075791k; Zhang Z, 2010, SMALL, V6, P1854, DOI 10.1002/smll.201000908; Zhang Z, 2010, ADV MATER, V22, P2672, DOI 10.1002/adma.201000151; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069856	28	5	4	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162975	10.1371/journal.pone.0162975	http://dx.doi.org/10.1371/journal.pone.0162975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706184	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200027
J	Shoeva, OY; Mock, HP; Kukoeva, TV; Borner, A; Khlestkina, EK				Shoeva, Olesya Yu; Mock, Hans-Peter; Kukoeva, Tatjana V.; Boerner, Andreas; Khlestkina, Elena K.			Regulation of the Flavonoid Biosynthesis Pathway Genes in Purple and Black Grains of Hordeum vulgare	PLOS ONE			English	Article							CONTROLLING ANTHOCYANIN PIGMENTATION; CHALCONE SYNTHASE; STRUCTURAL GENES; PROANTHOCYANIDIN SYNTHESIS; MICROSATELLITE MARKERS; GRAPE BERRIES; BARLEY ANT1; EXPRESSION; SEQUENCE; MAIZE	Barley grain at maturity can have yellow, purple, blue, and black pigmentations which are suggested to play a protective role under stress conditions. The first three types of the colors are caused by phenolic compounds flavonoids; the last one is caused by phytomelanins, oxidized and polymerized phenolic compounds. Although the genetic basis of the flavonoid biosynthesis pathway in barley has been thoroughly studied, there is no data yet on its regulation in purple and black barley grains. In the current study, genetic model of Hordeum vulgare 'Bowman' near-isogenic lines (NILs) was used to investigate the regulation of the flavonoid biosynthesis in white, purple, and black barley grains. Microsatellite genotyping revealed donor segments in the purple-and black-grained lines on chromosomes 2H (in region of the Ant2 gene determining purple color of grains) and 1H (in region of the Blp gene determining black lemma and pericarp), respectively. The isolated dominant Ant2 allele of the purple-grained line has high level of sequence similarity with the recessive Bowman's ant2 in coding region, whereas an insertion of 179 bp was detected in promoter region of ant2. This structural divergence between Ant2 and ant2 alleles may underlie their different expression in grain pericarp: Bowman's Ant2 is not transcribed, whereas it was up-regulated in the purple-grained line with coordinately co-expressed flavonoid biosynthesis structural genes (Chs, Chi, F3h, F3' h, Dfr, Ans). This led to total anthocyain content increase in purple-grained line identified by ultra-performance liquid chromatography (HPLC). Collectively, these results proved the regulatory function of the Ant2 gene in anthocyanin biosynthesis in barley grain pericarp. In the black-grained line, the specific transcriptional regulation of the flavonoid biosynthesis pathway genes was not detected, suggesting that flavonoid pigments are not involved in development of black lemma and pericarp trait.	[Shoeva, Olesya Yu; Kukoeva, Tatjana V.; Khlestkina, Elena K.] Russian Acad Sci, Siberian Branch, ICG, Novosibirsk, Russia; [Mock, Hans-Peter; Boerner, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Khlestkina, Elena K.] Novosibirsk State Univ, Food Secur Res Ctr, Novosibirsk, Russia	Russian Academy of Sciences; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Novosibirsk State University	Shoeva, OY (corresponding author), Russian Acad Sci, Siberian Branch, ICG, Novosibirsk, Russia.	olesya_ter@bionet.nsc.ru	Shoeva, Olesya/H-6767-2012; Mock, Hans-Peter/C-8202-2019; Khlestkina, Elena/T-2734-2017	Shoeva, Olesya/0000-0001-5289-8631; Mock, Hans-Peter/0000-0002-3983-3099; Khlestkina, Elena/0000-0002-8470-8254; Borner, Andreas/0000-0003-3301-9026	Russian Foundation for Basic Research [16-34-60052]; Institute of Cytology and Genetics SB RAS project [0324-2015-0005]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Institute of Cytology and Genetics SB RAS project	This work was supported by Russian Foundation for Basic Research (grant no. 16-34-60052, http://www.rfbr.ru/rffi/eng, OYuS) and Institute of Cytology and Genetics SB RAS project (No 0324-2015-0005, http://www.bionet.nsc.ru, EKK, TVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASTRUP S, 1984, CARLSBERG RES COMMUN, V49, P105, DOI 10.1007/BF02913969; [Аджиева В.Ф. Adzhieva V.F.], 2015, [Вавиловский журнал генетики и селекции, Russian Journal of Genetics: Applied Research, Vavilovskii zhurnal genetiki i selektsii], V19, P561, DOI 10.18699/VJ15.073; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Choo TM, 2015, CROP SCI, V55, P1096, DOI 10.2135/cropsci2014.05.0405; Choo TM, 2005, GENET RESOUR CROP EV, V52, P121, DOI 10.1007/s10722-003-3086-4; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Christensen AB, 1998, PLANT MOL BIOL, V37, P849, DOI 10.1023/A:1006031822141; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Colmsee C, 2015, MOL PLANT, V8, P964, DOI 10.1016/j.molp.2015.03.009; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DOONER HK, 1983, MOL GEN GENET, V189, P136, DOI 10.1007/BF00326066; Druka A, 2003, GENE, V302, P171, DOI 10.1016/S0378-1119(02)01105-8; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; FINCH RA, 1978, Z PFLANZENZUCHT, V81, P40; Franckowiak JD, 1997, BARLEY GENETICS NEWS, V26, P22; Garvin DF, 1998, CROP SCI, V38, P1250, DOI 10.2135/cropsci1998.0011183X003800050023x; Harlan HV, 1914, USDA B, P137, DOI [10.5962/bhl.title.109258, DOI 10.5962/BHL.TITLE.109258]; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Himi E, 2015, MOL GENET GENOMICS, V290, P1287, DOI 10.1007/s00438-015-0991-0; Himi E, 2012, EUPHYTICA, V188, P141, DOI 10.1007/s10681-011-0552-5; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Jana B.K., 2014, J PHARM BIOL, V4, P131; Jende-Strid B., 1984, Barley Genetics Newsletter, V14, P76; Jende-Strid B., 1978, Barley Genetics Newsletter, V8, P57; JENDESTRID B, 1993, HEREDITAS, V119, P187, DOI 10.1111/j.1601-5223.1993.00187.x; Jia QJ, 2016, EUPHYTICA, V208, P215, DOI 10.1007/s10681-015-1593-y; Khlestkina EK, 2013, CEREAL RES COMMUN, V41, P185, DOI 10.1556/CRC.2013.0004; Khlestkina EK, 2011, EUPHYTICA, V179, P333, DOI 10.1007/s10681-010-0337-2; Kim MJ, 2007, J AGR FOOD CHEM, V55, P4802, DOI 10.1021/jf0701943; KRISTIANSEN KN, 1991, MOL GEN GENET, V230, P49, DOI 10.1007/BF00290650; Lahaye T, 1998, THEOR APPL GENET, V97, P526, DOI 10.1007/s001220050927; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; MELDGAARD M, 1992, THEOR APPL GENET, V83, P695, DOI 10.1007/BF00226687; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Offerman J.D., 2003, INTRO BIOINFORMATICS, P345, DOI DOI 10.1007/978-1-59259-335-4; Pandey AK, 2001, CURR SCI INDIA, V80, P933; Pecchioni N, 1999, PLANT BREEDING, V118, P29, DOI 10.1046/j.1439-0523.1999.118001029.x; Petridis A, 2016, NEW PHYTOL, V211, P912, DOI 10.1111/nph.13986; Peukert M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-97; PLASCHKE J, 1995, THEOR APPL GENET, V91, P1001, DOI 10.1007/BF00223912; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramazzotti S, 2008, VITIS, V47, P147; Ramsay L, 2000, GENETICS, V156, P1997; Roder MS, 1998, GENETICS, V149, P2007; ROHDE W, 1991, PLANT MOL BIOL, V16, P1103, DOI 10.1007/BF00016087; Rohde W, 1987, BARLEY GENET, P553; Sakulsingharoj C, 2014, THAI J GENET, V7, P173, DOI 10.14456/tjg.2014.24; Sharma M, 2011, GENETICS, V188, P69, DOI 10.1534/genetics.110.126136; Shih CH, 2008, PLANTA, V228, P1043, DOI 10.1007/s00425-008-0806-1; Shoeva OY, 2015, PLANT BREEDING, V134, P400, DOI 10.1111/pbr.12277; Siebenhandl S, 2007, J AGR FOOD CHEM, V55, P8541, DOI 10.1021/jf072021j; Tarahovsky YS, 2013, FLAVONOIDS BIOCH BIO; Tereshchenko OY, 2013, J CEREAL SCI, V57, P10, DOI 10.1016/j.jcs.2012.09.010; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; WISE RP, 1990, PLANT MOL BIOL, V14, P277, DOI 10.1007/BF00018568; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yildiz M, 2013, THEOR APPL GENET, V126, P1689, DOI 10.1007/s00122-013-2084-y; Zhao ZC, 2012, MOL BIOL REP, V39, P6409, DOI 10.1007/s11033-011-1303-3	66	55	57	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163782	10.1371/journal.pone.0163782	http://dx.doi.org/10.1371/journal.pone.0163782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706214	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200060
J	Carlini, F; Ferreira, V; Buhler, S; Tous, A; Eliaou, JF; Rene, C; Chiaroni, J; Picard, C; Di Cristofaro, J				Carlini, Federico; Ferreira, Virginia; Buhler, Stephane; Tous, Audrey; Eliaou, Jean-Francois; Rene, Celine; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie			Association of HLA-A and Non-Classical HLA Class I Alleles	PLOS ONE			English	Article							CELL-SURFACE; LINKAGE DISEQUILIBRIUM; OPEN CONFORMERS; GRAFT-SURVIVAL; NK CELLS; GENE; MHC; EXPRESSION; POLYMORPHISM; RECEPTORS	The HLA-A locus is surrounded by HLA class Ib genes: HLA-E, HLA-H, HLA-G and HLA-F. HLA class Ib molecules are involved in immuno-modulation with a central role for HLA-G and HLA-E, an emerging role for HLA-F and a yet unknown function for HLA-H. Thus, the principal objective of this study was to describe the main allelic associations between HLAA and HLA-H, -G, -F and -E. Therefore, HLA-A, -E, -G, -H and -F coding polymorphisms, as well as HLA-G UnTranslated Region haplotypes (referred to as HLA-G UTRs), were explored in 191 voluntary blood donors. Allelic frequencies, Global Linkage Disequilibrium (GLD), Linkage Disequilibrium (LD) for specific pairs of alleles and two-loci haplotype frequencies were estimated. We showed that HLA-A, HLA-H, HLA-F, HLA-G and HLA-G UTRs were all in highly significant pairwise GLD, in contrast to HLA-E. Moreover, HLA-A displayed restricted associations with HLA-G UTR and HLA-H. We also confirmed several associations that were previously found to have a negative impact on transplantation outcome. In summary, our results suggest complex functional and clinical implications of the HLA-A genetic region.	[Carlini, Federico; Tous, Audrey; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie] Etab Francais Sang Alpes Mediterranee, Marseille, France; [Carlini, Federico; Ferreira, Virginia; Tous, Audrey; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie] Aix Marseille Univ, CNRS, EFS, ADES,Biol Grp Sanguins, Marseille, France; [Buhler, Stephane] Univ Geneva, Lab Anthropol Genet & Peopling Hist AGP, Dept Genet, Geneva, Switzerland; [Buhler, Stephane] Univ Geneva, Evolut Anthropol Unit, Geneva, Switzerland; [Buhler, Stephane] Univ Hosp Geneva, Transplantat Immunol Unit, Geneva, Switzerland; [Buhler, Stephane] Univ Hosp Geneva, Natl Reference Lab Histocompatibil, Dept Genet & Lab Med, Geneva, Switzerland; [Eliaou, Jean-Francois; Rene, Celine] Univ Hosp St Eloi, CHRU Montpellier, Dept Immunol, Montpellier, France; [Eliaou, Jean-Francois; Rene, Celine] Univ Montpellier I, Fac Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Di Cristofaro, J (corresponding author), Etab Francais Sang Alpes Mediterranee, Marseille, France.; Di Cristofaro, J (corresponding author), Aix Marseille Univ, CNRS, EFS, ADES,Biol Grp Sanguins, Marseille, France.	julie.dicristofaro@efs.sante.fr	Chiaroni, Jacques/ABA-2944-2021; Carlini, Federico/AAA-9050-2019	Chiaroni, Jacques/0000-0002-3133-8990; Carlini, Federico/0000-0003-3503-5169; Buhler, Stephane/0000-0001-6675-5287; Di Cristofaro, Julie/0000-0001-7867-6455				Agresti A, 2007, INTRO CATEGORICAL DA; Aldrich CL, 2001, MOL HUM REPROD, V7, P1167, DOI 10.1093/molehr/7.12.1167; Allan DSJ, 2002, J IMMUNOL METHODS, V268, P43, DOI 10.1016/S0022-1759(02)00199-0; Balan V, 2008, HEPATOLOGY, V48, P878, DOI 10.1002/hep.22435; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; BUCIN D, 1992, TRANSPLANT P, V24, P2473; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Carlini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082517; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Comiskey M, 2007, HUM IMMUNOL, V68, P1, DOI 10.1016/j.humimm.2006.09.005; Di Cristofaro J, 2015, AM J TRANSPLANT, V15, P2413, DOI 10.1111/ajt.13305; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; ELKAHLOUN A, 1992, IMMUNOGENETICS, V35, P183; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Foroni I, 2014, HLA ASS IMPORTANT DI; GERAGHTY DE, 1992, J IMMUNOL, V149, P1934; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2013, J IMMUNOL, V191, P1567, DOI 10.4049/jimmunol.1300080; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Grimsley C, 1998, MOL BIOL EVOL, V15, P1581, DOI 10.1093/oxfordjournals.molbev.a025886; Grimsley C, 1997, HUM IMMUNOL, V52, P33, DOI 10.1016/S0198-8859(96)00241-8; Hayes D, 2016, J HEART LUNG TRANSPL, V35, P186, DOI 10.1016/j.healun.2015.08.022; HEINRICHS H, 1990, IMMUNOL RES, V9, P265, DOI 10.1007/BF02935526; Jucaud V, 2016, CLIN EXP IMMUNOL, V183, P326, DOI 10.1111/cei.12724; Jucaud V RM, 2015, SOJ IMMUNOL, V3, P1, DOI [10.15226/2372-0948/3/4/00137, DOI 10.15226/2372-0948/3/4/00137]; Julie DC, 2011, TISSUE ANTIGENS, V77, P193, DOI 10.1111/j.1399-0039.2010.01599.x; Kamoun M, 2008, P NATL ACAD SCI USA, V105, P18883, DOI 10.1073/pnas.0810308105; Kochan G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26491; Kolte AM, 2010, HUM IMMUNOL, V71, P482, DOI 10.1016/j.humimm.2010.02.001; Kraemer T, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/352160; Kuroki K, 2007, EUR J IMMUNOL, V37, P1727, DOI 10.1002/eji.200737515; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Maier S, 2000, HUM IMMUNOL, V61, P1059, DOI 10.1016/S0198-8859(00)00190-7; Makhadiyeva D, 2012, IMMUNOLOGY, V135, P133, DOI 10.1111/j.1365-2567.2011.03518.x; Misra MK, 2014, HUM IMMUNOL, V75, P833, DOI 10.1016/j.humimm.2014.06.005; Morandi F, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00394; Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874; Nunes JM, 2014, TISSUE ANTIGENS, V83, P307, DOI 10.1111/tan.12356; Nunes JM, 2014, FIGSHARE; Nunes JM, 2015, EVOL BIOINFORM, V11, P19, DOI 10.4137/EBO.S32415; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; Pabon MA, 2014, TRANSPL P, V46, P2957, DOI 10.1016/j.transproceed.2014.07.010; Pascolo S, 2005, INT IMMUNOL, V17, P117, DOI 10.1093/intimm/dxh191; Pratheek B M, 2014, Indian J Hum Genet, V20, P129, DOI 10.4103/0971-6866.142855; Ravindranath MH, 2013, BLOOD, V121, P2013, DOI 10.1182/blood-2012-08-447771; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/297073; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Rizzo R, 2013, MOL CELL BIOCHEM, V381, P243, DOI 10.1007/s11010-013-1708-5; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Roelen DL, 2001, HUM IMMUNOL, V62, P661, DOI 10.1016/S0198-8859(01)00263-4; SCHMIDT CM, 1991, HUM IMMUNOL, V31, P180, DOI 10.1016/0198-8859(91)90024-4; Shao WS, 2006, HUM IMMUNOL, V67, pS118, DOI 10.1016/j.humimm.2006.08.180; SHUKLA H, 1991, GENOMICS, V10, P905, DOI 10.1016/0888-7543(91)90178-H; Tamouza R, 2007, HUM IMMUNOL, V68, P849, DOI 10.1016/j.humimm.2007.08.260; Tan CY, 2008, MOL HUM REPROD, V14, P317, DOI 10.1093/molehr/gan013; Vargas RG, 2011, HUM IMMUNOL, V72, P479, DOI 10.1016/j.humimm.2011.02.011; Veiga-Castelli LC, 2012, TISSUE ANTIGENS, V79, P15, DOI 10.1111/j.1399-0039.2011.01801.x; Walpole NG, 2010, J MOL BIOL, V397, P467, DOI 10.1016/j.jmb.2010.01.052; ZEMMOUR J, 1990, J IMMUNOL, V144, P3619; Zhang WQ, 2014, HUM IMMUNOL, V75, P182, DOI 10.1016/j.humimm.2013.11.001; Zhao LM, 2014, CELL IMMUNOL, V287, P23, DOI 10.1016/j.cellimm.2013.11.005	69	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163570	10.1371/journal.pone.0163570	http://dx.doi.org/10.1371/journal.pone.0163570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701438	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900012
J	Moosa, MR; Maree, JD; Chirehwa, MT; Benatar, SR				Moosa, Mohammed Rafique; Maree, Jonathan David; Chirehwa, Maxwell T.; Benatar, Solomon R.			Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEALTH-CARE; PATIENT SURVIVAL; GRAFT-SURVIVAL; LONG-TERM; TRANSPLANT RECIPIENTS; COST-EFFECTIVENESS; HIV; OUTCOMES	Universal access to renal replacement therapy is beyond the economic capability of most low and middle-income countries due to large patient numbers and the high recurrent cost of treating end stage kidney disease. In countries where limited access is available, no systems exist that allow for optimal use of the scarce dialysis facilities. We previously reported that using national guidelines to select patients for renal replacement therapy resulted in biased allocation. We reengineered selection guidelines using the 'Accountability for Reasonableness' (procedural fairness) framework in collaboration with relevant stakeholders, applying these in a novel way to categorize and prioritize patients in a unique hierarchical fashion. The guidelines were primarily premised on patients being transplantable. We examined whether the revised guidelines enhanced fairness of dialysis resource allocation. This is a descriptive study of 1101 end stage kidney failure patients presenting to a tertiary renal unit in a middle-income country, evaluated for dialysis treatment over a seven-year period. The Assessment Committee used the accountability for reasonableness-based guidelines to allocate patients to one of three assessment groups. Category 1 patients were guaranteed renal replacement therapy, Category 3 patients were palliated, and Category 2 were offered treatment if resources allowed. Only 25.2% of all end stage kidney disease patients assessed were accepted for renal replacement treatment. The majority of patients (48%) were allocated to Category 2. Of 134 Category 1 patients, 98% were accepted for treatment while 438 (99.5%) Category 3 patients were excluded. Compared with those palliated, patients accepted for dialysis treatment were almost 10 years younger, employed, married with children and not diabetic. Compared with our previous selection process our current method of priority setting based on procedural fairness arguably resulted in more equitable allocation of treatment but, more importantly, it is a model that is morally, legally and ethically more defensible.	[Moosa, Mohammed Rafique] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Nephrol, Cape Town, South Africa; [Moosa, Mohammed Rafique; Maree, Jonathan David] Tygerberg Acad Hosp, Renal Unit, Cape Town, South Africa; [Chirehwa, Maxwell T.] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Interdisciplinary Hlth Sci, Biostat Unit,Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Benatar, Solomon R.] Univ Cape Town, Ctr Bioeth, Cape Town, South Africa	Stellenbosch University; Stellenbosch University; University of Cape Town	Moosa, MR (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Nephrol, Cape Town, South Africa.; Moosa, MR (corresponding author), Tygerberg Acad Hosp, Renal Unit, Cape Town, South Africa.	rmm@sun.ac.za	Chirehwa, Maxwell T/P-5740-2018	Chirehwa, Maxwell T/0000-0002-1685-4882; Moosa, Mohammed/0000-0003-1696-0113				Aalten J, 2006, TRANSPLANT INT, V19, P901, DOI 10.1111/j.1432-2277.2006.00367.x; Alexander S., 1962, LIFE, P102; Bamgboye Ebun L, 2009, Ethn Dis, V19, pS1; Barsoum RS, 2003, KIDNEY INT, V63, P111, DOI 10.1046/j.1523-1755.63.s83.23.x; Bass D, 2005, SAMJ S AFR MED J, V95, P42; Benatar S, 2006, CAMB Q HEALTHC ETHIC, V15, P322; Benatar SR, 2011, AM J PUBLIC HEALTH, V101, P646, DOI 10.2105/AJPH.2009.188458; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Benatar SR, 2015, REFERENCE MODULE BIO, DOI [10.1097/01.ASN.0000120370.35927.40, DOI 10.1097/01.ASN.0000120370.35927.40]; Byskov Jens, 2009, Health Res Policy Syst, V7, P23, DOI 10.1186/1478-4505-7-23; Callahan D., 1995, SETTING LIMITS MED G; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Cosio FG, 2008, AM J TRANSPLANT, V8, P593, DOI 10.1111/j.1600-6143.2007.02101.x; Cosio FG, 2002, KIDNEY INT, V62, P1440, DOI 10.1111/j.1523-1755.2002.kid582.x; Cosio FG, 1999, CLIN TRANSPLANT, V13, P336, DOI 10.1034/j.1399-0012.1999.130410.x; Curran SP, 2014, TRANSPLANTATION, V97, P64, DOI 10.1097/TP.0b013e3182a688a4; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Daniels N., 2002, SETTING LIMITS FAIRL, DOI [10.1093/acprof:oso/9780195149364.001.0001, DOI 10.1093/ACPROF:OSO/9780195149364.001.0001]; Denhaerynck K, 2007, AM J TRANSPLANT, V7, P108, DOI 10.1111/j.1600-6143.2006.01611.x; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Etheredge HR, 2013, CLIN TRANSPLANT, V27, P684, DOI 10.1111/ctr.12200; Fabrizii V, 2004, J AM SOC NEPHROL, V15, P1052, DOI 10.1097/01.ASN.0000120370.35927.40; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; Gane E, 2002, TRANSPLANTATION, V74, P427, DOI 10.1097/00007890-200208270-00001; Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x; Gibson Jennifer, 2006, J Health Serv Res Policy, V11, P32, DOI 10.1258/135581906775094280; Gore JL, 2006, AM J TRANSPLANT, V6, P357, DOI 10.1111/j.1600-6143.2005.01198.x; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; HARNETT JD, 1987, TRANSPLANTATION, V44, P369, DOI 10.1097/00007890-198709000-00009; Hurst FP, 2011, TRANSPLANTATION, V92, P1101, DOI 10.1097/TP.0b013e3182336095; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kevany S, 2013, GLOB PUBLIC HEALTH, V8, P570, DOI 10.1080/17441692.2013.790461; Kher V, 2002, KIDNEY INT, V62, P350, DOI 10.1046/j.1523-1755.2002.00426.x; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Maluka S, 2010, SOC SCI MED, V71, P751, DOI 10.1016/j.socscimed.2010.04.035; Marckmann G, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00023; Martin D, 2003, HEALTH CARE ANAL, V11, P59, DOI 10.1023/A:1025338013629; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Moosa MR, 2016, SAMJ S AFR MED J, V106, P156, DOI [10.7196/SAMJ.2016.v106i2.9928, 10.7196/SAMJ.2016.V106I2.9928]; Moosa M. R., 2014, KIDNEY TRANSPLANTATI, P643; Moosa MR, 2003, SAMJ S AFR MED J, V93, P689; Moosa MR, 2013, GUIDELINE PRIORITY S; Muller E, 2010, NEW ENGL J MED, V362, P2336, DOI 10.1056/NEJMc0900837; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Naicker S, 2005, KIDNEY DIS DEV WORLD, P137, DOI [10.1201/b14128-8, DOI 10.1201/B14128-8]; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Norheim OF, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0624-4; Norheim OF, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-18; Norman Daniels, 1988, AM MY PARENTS KEEPER; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Revanur VK, 2001, CLIN TRANSPLANT, V15, P89, DOI 10.1034/j.1399-0012.2001.150202.x; Roland ME, 2008, AM J TRANSPLANT, V8, P355, DOI 10.1111/j.1600-6143.2007.02061.x; Rutecki GW., 2016, ETHIC MED, V27, P99; Sakhuja V, 2003, KIDNEY INT, V63, P115, DOI 10.1046/j.1523-1755.63.s83.24.x; Sakhuja Vinay, 2006, Ethn Dis, V16, pS2; Saudan P, 2001, NEPHROL DIAL TRANSPL, V16, P824, DOI 10.1093/ndt/16.4.824; Scheper-Hughes N, 2003, LANCET, V361, P1645, DOI 10.1016/S0140-6736(03)13305-3; Shaheen FAM, 2005, KIDNEY INT, V68, pS37, DOI 10.1111/j.1523-1755.2005.09807.x; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; United States Renal Data System, 2015, USRDS ANN DAT REP EP; Vachharajani TJ, 2014, NAT REV NEPHROL, V10, P116, DOI 10.1038/nrneph.2013.256; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Williams A, 1997, BRIT MED J, V314, P820, DOI 10.1136/bmj.314.7083.820; Yap DYH, 2014, WORLD J GASTROENTERO, V20, P468, DOI 10.3748/wjg.v20.i2.468; Yap DYH, 2010, TRANSPLANTATION, V90, P325, DOI 10.1097/TP.0b013e3181e5b811	70	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164201	10.1371/journal.pone.0164201	http://dx.doi.org/10.1371/journal.pone.0164201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701466	Green Published, gold			2022-12-26	WOS:000385696900049
J	Sha, JP; Dong, W; Liu, SL; Chen, XW; Zhao, N; Luo, MY; Dong, YY; Zhang, ZR				Sha, Jianping; Dong, Wei; Liu, Shelan; Chen, Xiaowen; Zhao, Na; Luo, Mengyun; Dong, Yuanyuan; Zhang, Zhiruo			Differences in the Epidemiology of Childhood Infections with Avian Influenza A H7N9 and H5N1 Viruses	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; RISK-FACTORS; ZHEJIANG PROVINCE; A(H7N9); CHINA; CHILDREN; MILD; CLUSTERS; A/H7N9; MARKET	The difference between childhood infections with avian influenza viruses A(H5N1) and A (H7N9) remains an unresolved but critically important question. We compared the epidemiological characteristics of 244 H5N1 and 41 H7N9 childhood cases (<15 years old), as well as the childhood cluster cases of the two viruses. Our findings revealed a higher proportion of H5N1 than H7N9 childhood infections (31.1% vs. 6.4%, p = 0.000). However, the two groups did not differ significantly in age (median age: 5.0 vs. 5.5 y, p = 0.0651). The proportion of clustered cases was significantly greater among children infected with H5N1 than among children infected with H7N9 [46.7% (71/152) vs. 23.6% (13/55), p = 0.005], and most of the childhood cases were identified as secondary cases [46.4% (45/97) vs. 33.3% (10/30), p = 0.000]. Mild status accounted for 79.49% and 22.66%, severe status for 17.95% and 2.34%, and fatal cases for 2.56% and 75.00% of the H7N9 and H5N1 childhood infection cases (all p<0.05), respectively. The fatality rates for the total, index and secondary childhood cluster cases were 52.86% (37/70), 88.5% (23/26) and 33.33% (15/45), respectively, in the H5N1 group, whereas no fatal H7N9 childhood cluster cases were identified. In conclusion, lower severity and greater transmission were found in the H7N9 childhood cases than in the H5N1 childhood cases.	[Sha, Jianping] Chinese Peoples Liberat Army, Hosp 421, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Dong, Wei; Luo, Mengyun; Dong, Yuanyuan; Zhang, Zhiruo] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China; [Liu, Shelan] Zhejiang Prov Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiaowen] 421 Hosp Chinese Peoples Liberat Army, Dept Senior Cadres, Guangzhou, Guangdong, Peoples R China; [Zhao, Na] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China	Shanghai Jiao Tong University; Zhejiang Provincial Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, ZR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China.	zhangzhiruo@sjtu.edu.cn		Luo, Mengyun/0000-0002-6482-7299	Key Program grant from the Science Technology Department of Zhejiang Province in China [2014C03039]; Zhejiang Provincial Health, and Family Planning Commission; Anhui Province of International Science and Technology Cooperation Program [1503062008]	Key Program grant from the Science Technology Department of Zhejiang Province in China; Zhejiang Provincial Health, and Family Planning Commission; Anhui Province of International Science and Technology Cooperation Program	This research was supported by the Key Program grant from the Science Technology Department of Zhejiang Province in China (grant numbers 2014C03039); epidemiology supporting grant from Zhejiang Provincial Health, and Family Planning Commission; and the Anhui Province of International Science and Technology Cooperation Program (grant number 1503062008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Key Program grant from the Science Technology Department of Zhejiang Province in China (grant numbers 2014C03039), an epidemiology supporting grant from Zhejiang Provincial Health and Family Planning Commission, and the Anhui Province of International Science and Technology Cooperation Program (grant number 1503062008).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Areechokchai D, 2006, GLOBAL EPIDEMIOLOGY, V55, P3; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Centers for Disease Control and Prevention (CDC), 2010, MMWR MORBIDITY MORTA, V59; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen ZQ, 2014, EMERG INFECT DIS, V20, P1535, DOI 10.3201/eid2009.140424; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Ding H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0698-6; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Jie ZJ, 2013, AM J RESP CRIT CARE, V188, P114, DOI 10.1164/rccm.201304-0797LE; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kawachi S, 2009, J INFECT DIS, V200, P510, DOI 10.1086/605034; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423; Liu SL, 2013, J INFECTION, V67, P595, DOI 10.1016/j.jinf.2013.08.007; Liu YS, 2015, J INFECT DEV COUNTR, V9, P122, DOI 10.3855/jidc.6759; Ma MJ, 2014, J CLIN VIROL, V59, P242, DOI 10.1016/j.jcv.2014.01.009; Mei Z, 2013, EMERG INFECT DIS, V19, P1179, DOI 10.3201/eid1907.130523; Nicoll A, 2008, ARCH DIS CHILD, V93, P433, DOI 10.1136/adc.2006.101477; Oner AF, 2012, CLIN INFECT DIS, V55, P26, DOI 10.1093/cid/cis295; Parry J, 2004, BRIT MED J, V328, P308, DOI 10.1136/bmj.328.7435.308; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Qin Y, 2015, CLIN INFECT DIS, V61, P563, DOI 10.1093/cid/civ345; Rudge JW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4730; Tang RB, 2013, J CHIN MED ASSOC, V76, P245, DOI 10.1016/j.jcma.2013.04.003; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang XH, 2014, INTERNATIONAL CONFERENCE ON ELECTRICAL, CONTROL AND AUTOMATION (ICECA 2014), P8; World Health Organization, 2014, HUM INF AV INFL A H7; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yi LN, 2015, J CLIN MICROBIOL, V53, P22, DOI 10.1128/JCM.02322-14; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yu XL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.41; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; Zeng XQ, 2015, PEDIATR INFECT DIS J, V34, P104, DOI 10.1097/INF.0000000000000492; Zhang Y, 2015, INT J ENV RES PUB HE, V12, P816, DOI 10.3390/ijerph120100816; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	46	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0161925	10.1371/journal.pone.0161925	http://dx.doi.org/10.1371/journal.pone.0161925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695069	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100009
J	Vigeland, CL; Collins, SL; Chan-Li, Y; Hughes, AH; Oh, MH; Powell, JD; Horton, MR				Vigeland, Christine L.; Collins, Samuel L.; Chan-Li, Yee; Hughes, Andrew H.; Oh, Min-Hee; Powell, Jonathan D.; Horton, Maureen R.			Deletion of mTORC1 Activity in CD4+T Cells Is Associated with Lung Fibrosis and Increased gamma delta T Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BLEOMYCIN; INFLAMMATION; PROMOTES; DIFFERENTIATION; PNEUMONIA; MICE	Pulmonary fibrosis is a devastating, incurable disease in which chronic inflammation and dysregulated, excessive wound healing lead to progressive fibrosis, lung dysfunction, and ultimately death. Prior studies have implicated the cytokine IL-17A and Th17 cells in promoting the development of fibrosis. We hypothesized that loss of Th17 cells via CD4-specific deletion of mTORC1 activity would abrogate the development of bleomycin-induced pulmonary fibrosis. However, in actuality loss of Th17 cells led to increased mortalityand fibrosis in response to bleomycin. We found that in the absence of Th17 cells, there was continued production of IL-17A by gamma delta T cells. These IL-17A+ gamma delta T cells were associated with increased lung neutrophils and M2 macrophages, accelerated development of fibrosis, and increased mortality. These data elucidate the critical role of IL-17A+ gamma delta T cells in promoting chronic inflammation and fibrosis, and reveal a novel therapeutic target for treatment of pulmonary fibrosis.	[Vigeland, Christine L.; Collins, Samuel L.; Chan-Li, Yee; Hughes, Andrew H.; Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Oh, Min-Hee; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Horton, MR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	mhorton2@jhmi.edu		Oh, Min-Hee/0000-0003-1581-4288; Vigeland, Christine/0000-0003-4468-374X	National Institutes of Health [F32 HL124887, PO1 HL010342, R21 HL111783]; Flight Attendant Medical Research Institute; Osborne Family Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL010342, R21HL111783, F32HL124887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; Osborne Family Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by: National Institutes of Health (https://www.nih.gov/) F32 HL124887 (CLV); National Institutes of Health (https://www.nih.gov/) PO1 HL010342 (MRH); National Institutes of Health (https://www.nih.gov/) R21 HL111783 (MRH); Flight Attendant Medical Research Institute (http://www.famri.org/intro/) (MRH); and the Osborne Family Research Fund (MRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Braun RK, 2008, INFLAMMATION, V31, P167, DOI 10.1007/s10753-008-9062-6; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Collins SL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.83116; Collins SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031299; Conte E, 2014, IMMUNOBIOLOGY, V219, P425, DOI 10.1016/j.imbio.2014.02.001; Daniil ZD, 1999, AM J RESP CRIT CARE, V160, P899, DOI 10.1164/ajrccm.160.3.9903021; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gharib SA, 2014, J LEUKOCYTE BIOL, V95, P9, DOI 10.1189/jlb.1112587; Gregory AD, 2015, J LEUKOCYTE BIOL, V98, P143, DOI 10.1189/jlb.3HI1014-493R; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Koenecke C, 2009, EUR J IMMUNOL, V39, P372, DOI 10.1002/eji.200838741; Kuhn C, 1993, MONOGR PATH, V78, P1; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Martinet Y, 1996, ARCH TOX S, V18, P127; Mathews JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131236; Mathews JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097707; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Parkinson RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087265; Pociask DA, 2011, AM J PATHOL, V178, P1167, DOI 10.1016/j.ajpath.2010.11.055; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Segawa S, 2016, CLIN EXP IMMUNOL, V185, P348, DOI 10.1111/cei.12802; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI [10.4049/jimmunol.1002907, DOI 10.4049/JIMMUN01.1002907]	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163288	10.1371/journal.pone.0163288	http://dx.doi.org/10.1371/journal.pone.0163288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649073	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100073
J	Yoon, MS; Jeong, JU; Nam, TK; Ahn, SJ; Chung, WK; Song, JY				Yoon, Mee Sun; Jeong, Jae-Uk; Nam, Taek-Keun; Ahn, Sung-Ja; Chung, Woong-Ki; Song, Ju-Young			Evaluation of Dose Distribution in Intensity Modulated Radiosurgery for Lung Cancer under Condition of Respiratory Motion	PLOS ONE			English	Article							STEREOTACTIC ABLATIVE RADIOTHERAPY; ARC THERAPY; ACCURACY	The dose of a real tumor target volume and surrounding organs at risk (OARs) under the effect of respiratory motion was calculated for a lung tumor plan, based on the target volume covering the whole tumor motion range for intensity modulated radiosurgery (IMRS). Two types of IMRS plans based on simulated respiratory motion were designed using humanoid and dynamic phantoms. Delivery quality assurance (DQA) was performed using Arc-CHECK and MapCHECK2 for several moving conditions of the tumor and the real dose inside the humanoid phantom was evaluated using the 3DVH program. This evaluated dose in the tumor target and OAR using the 3DVH program was higher than the calculated dose in the plan, and a greater difference was seen for the RapidArc treatment than for the standard intensity modulated radiation therapy (IMRT) with fixed gantry angle beams. The results of this study show that for IMRS plans based on target volume, including the whole tumor motion range, tighter constraints of the OAR should be considered in the optimization process. The method devised in this study can be applied effectively to analyze the dose distribution in the real volume of tumor target and OARs in IMRT plans targeting the whole tumor motion range.	[Yoon, Mee Sun; Jeong, Jae-Uk; Nam, Taek-Keun; Ahn, Sung-Ja; Chung, Woong-Ki; Song, Ju-Young] Chonnam Natl Univ, Dept Radiat Oncol, Sch Med, Gwangju, South Korea	Chonnam National University	Song, JY (corresponding author), Chonnam Natl Univ, Dept Radiat Oncol, Sch Med, Gwangju, South Korea.	jysong@jnu.ac.kr						Carrasco P, 2012, MED PHYS, V39, P5040, DOI 10.1118/1.4736949; Coleman L, 2013, MED PHYS, V40, DOI 10.1118/1.4824433; Godart J, 2011, PHYS MED BIOL, V56, P5029, DOI 10.1088/0031-9155/56/15/023; Guerrero E, 2016, LUNG CANCER, V92, P22, DOI 10.1016/j.lungcan.2015.11.015; Hauri P1, 2014, J APPL CLIN MED PHYS, V15, P4647, DOI DOI 10.1120/JACMP.V15I2.4647; Hrbacek J, 2014, MED PHYS, V41, DOI 10.1118/1.4866231; Infusino E, 2014, MED DOSIM, V39, P276, DOI 10.1016/j.meddos.2014.04.004; Kadoya N, 2015, J APPL CLIN MED PHYS, V16, P179, DOI 10.1120/jacmp.v16i3.5251; Kang H, 2010, J APPL CLIN MED PHYS, V11, P78, DOI 10.1120/jacmp.v11i3.3182; Murray L, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150628; Nakaguchi Y, 2015, J APPL CLIN MED PHYS, V16, P264, DOI 10.1120/jacmp.v16i1.5199; Nakaguchi Y, 2015, RADIOL PHYS TECHNOL, V8, P73, DOI 10.1007/s12194-014-0294-x; Nicolini G, 2010, PHYS MED BIOL, V55, pN347, DOI 10.1088/0031-9155/55/12/N01; Olch AJ, 2012, MED PHYS, V39, P81, DOI 10.1118/1.3666771; Quan K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00213; Riley C, 2014, MED PHYS, V41, DOI 10.1118/1.4855956; Seco J, 2008, MED PHYS, V35, P356, DOI 10.1118/1.2821704; Solberg TD, 2014, J APPL CLIN MED PHYS, V15, P4685, DOI DOI 10.1120/JACMP.V15I2.4685; Song JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119937; Subramanian SV, 2015, J APPL CLIN MED PHYS, V16, P112, DOI 10.1120/jacmp.v16i4.5415; Tjima Y, 2015, BRIT J RADIOL, V88, P1052; Watanabe Y, 2013, MED PHYS, V40, DOI 10.1118/1.4813301; Zou W, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0225-3	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163112	10.1371/journal.pone.0163112	http://dx.doi.org/10.1371/journal.pone.0163112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648949	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100054
J	Ni, J; Bao, SJ; Johnson, RI; Zhu, BB; Li, JH; Vadaparampil, J; Smith, CM; Campbell, KN; Grahammer, F; Huber, TB; He, JC; D'Agati, VD; Chan, A; Kaufman, L				Ni, Jie; Bao, Sujin; Johnson, Ruth I.; Zhu, Bingbing; Li, Jianhua; Vadaparampil, Justin; Smith, Christopher M.; Campbell, Kirk N.; Grahammer, Florian; Huber, Tobias B.; He, John C.; D'Agati, Vivette D.; Chan, Andrew; Kaufman, Lewis			MAGI-1 Interacts with Nephrin to Maintain Slit Diaphragm Structure through Enhanced Rap1 Activation in Podocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; RESISTANT NEPHROTIC SYNDROME; DROSOPHILA EYE; PROTEIN MAGI-1; CELL-DEATH; ADHESION; KIDNEY; GENE; EXPRESSION; JUNCTION	MAGI-1 is a multidomain cytosolic scaffolding protein that in the kidney is specifically located at the podocyte slit diaphragm, a specialized junction that is universally injured in proteinuric diseases. There it interacts with several essential molecules, including nephrin and nephl, which are required for slit diaphragm formation and as an intracellular signaling hub. Here, we show that diminished MAGI-1 expression in cultured podocytes reduced nephrin and nephl membrane localization and weakened tight junction integrity. Global magil knock-out mice, however, demonstrated normal glomerular histology and function into adulthood. We hypothesized that a second mild but complementary genetic insult might induce glomerular disease susceptibility in these mice. To identify such a gene, we utilized the developing fly eye to test for functional complementation between MAGI and its binding partners. In this way, we identified diminished expression of fly Hibris (nephrin) or Roughest (nephl) as dramatically exacerbating the effects of MAGI depletion. Indeed, when these combinations were studied in mice, the addition of nephrin, but not nephl, heterozygosity to homozygous deletion of MAGI-1 resulted in spontaneous glomerulosclerosis. In cultured podocytes, MAGI-1 depletion reduced intercellular contact-induced Rapl activation, a pathway critical for proper podocyte function. Similarly, magi1 knock-out mice showed diminished glomerular Rap1 activation, an effect dramatically enhanced by concomitant nephrin haploinsufficiency. Finally, combined overexpression of MAGI-1 and nephrin increased Rap 1 activation, but not when substituting a mutant MAGI-1 that cannot bind nephrin. We conclude that the interaction between nephrin and MAGI-1 regulates Rap1 activation in podocytes to maintain long term slit diaphragm structure.	[Ni, Jie; Zhu, Bingbing; Li, Jianhua; Vadaparampil, Justin; Smith, Christopher M.; Campbell, Kirk N.; He, John C.; Kaufman, Lewis] Icahn Sch Med Mt Sinai, Div Nephrol, New York, NY 10029 USA; [Ni, Jie] Harbin Med Univ, Affiliated Hosp 1, Div Nephrol, Harbin 150001, Peoples R China; [Bao, Sujin] Wesleyan Univ, St James Sch Med, St Vincent & Grenadines, Middletown, CT 06459 USA; [Johnson, Ruth I.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Zhu, Bingbing] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Lab Renal Dis, Dept Nephrol, Shanghai 200062, Peoples R China; [Grahammer, Florian; Huber, Tobias B.] Univ Freiburg, Dept Med 4, Med Ctr, Fac Med, D-79106 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, FRIAS, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, Ctr Syst Biol ZBSA, D-79104 Freiburg, Germany; [D'Agati, Vivette D.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10032 USA; [Chan, Andrew] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Icahn School of Medicine at Mount Sinai; Harbin Medical University; Wesleyan University; Wesleyan University; Shanghai University of Traditional Chinese Medicine; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Columbia University; Chinese University of Hong Kong	Kaufman, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Renal, One Gustave L Levy Pl,Box 1243, New York, NY 10029 USA.	lewis.kaufman@mssm.edu	Chan, Andrew Man-Lok/J-9497-2013; Chan, Andrew/AAC-1145-2020; Grahammer, Florian/ABB-7775-2021	Chan, Andrew Man-Lok/0000-0001-9923-5464; Chan, Andrew/0000-0001-9923-5464; Huber, Tobias B./0000-0001-7175-5062	NIDDK, National Institutes of Health [1R01DK104712-01A1]; German Research Foundation (DFG) [CRC 1140]; Heisenberg program; European Research Council (ERC) [616891]; BMBF-Joint Transnational Grant [STOP-FSGS 01GM1518C]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103022, R01DK104712] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); BMBF-Joint Transnational Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIDDK, National Institutes of Health, Grant 1R01DK104712-01A1 (to L. K.); by German Research Foundation (DFG) Grant CRC 1140 (to F. G. and T. B. H.) and the Heisenberg program (to T. B. H.); by European Research Council (ERC) Grant 616891 (to T. B. H.); and by the BMBF-Joint Transnational Grant STOP-FSGS 01GM1518C (to T. B. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balbas MD, 2014, P NATL ACAD SCI USA, V111, P14876, DOI 10.1073/pnas.1417297111; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Dworak HA, 2001, DEVELOPMENT, V128, P4265; George B, 2012, SEMIN NEPHROL, V32, P307, DOI 10.1016/j.semnephrol.2012.06.002; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Ihara KI, 2014, AM J PATHOL, V184, P2699, DOI 10.1016/j.ajpath.2014.06.019; Johnson RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007008; Kanwar YS, 2015, AM J PHYSIOL-RENAL, V308, pF420, DOI 10.1152/ajprenal.00640.2014; Kaufman L, 2010, J BIOL CHEM, V285, P25677, DOI 10.1074/jbc.M110.133959; Kawata A, 2006, J BIOCHEM, V139, P931, DOI 10.1093/jb/mvj105; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Lahdenkari AT, 2004, KIDNEY INT, V65, P1856, DOI 10.1111/j.1523-1755.2004.00583.x; Lefebvre J, 2015, KIDNEY INT, V88, P321, DOI 10.1038/ki.2015.140; Lowik M, 2008, NEPHROL DIAL TRANSPL, V23, P3146, DOI 10.1093/ndt/gfn208; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Philippe A, 2008, J AM SOC NEPHROL, V19, P1871, DOI 10.1681/ASN.2008010059; Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014; Potla U, 2014, J CLIN INVEST, V124, P1757, DOI 10.1172/JCI67846; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Santin S, 2009, KIDNEY INT, V76, P1268, DOI 10.1038/ki.2009.381; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; WOLFF T, 1991, DEVELOPMENT, V113, P825; Zaessinger S, 2015, DEVELOPMENT, V142, P1102, DOI 10.1242/dev.116277	36	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24406	24417		10.1074/jbc.M116.745026	http://dx.doi.org/10.1074/jbc.M116.745026			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27707879	hybrid, Green Published			2022-12-26	WOS:000388875500007
J	Luo, M; Gamage, TT; Arentson, BW; Schlasner, KN; Becker, DF; Tanner, JJ				Luo, Min; Gamage, Thameesha T.; Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.; Tanner, John J.			Structures of Proline Utilization A (PutA) Reveal the Fold and Functions of the Aldehyde Dehydrogenase Superfamily Domain of Unknown Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; flavoprotein; nicotinamide adenine dinucleotide (NAD); oligomerization; protein domain; small-angle X-ray scattering (SAXS); X-ray crystallography; aldehyde dehydrogenase superfamily; proline catabolism; proline utilization A	X-RAY-SCATTERING; ESCHERICHIA-COLI; PYRROLINE-5-CARBOXYLIC ACID; SUBSTRATE RECOGNITION; PROTEIN; STATE; SAXS; SEMIALDEHYDE; FLAVOENZYME; COMPUTATION	Aldehyde dehydrogenases (ALDHs) catalyze the NAD(P)(+)-dependent oxidation of aldehydes to carboxylic acids and are important for metabolism and detoxification. Although the ALDH superfamily fold is well established, some ALDHs contain an uncharacterized domain of unknown function (DUF) near the C terminus of the polypeptide chain. Herein, we report the first structure of a protein containing the ALDH superfamily DUF. Proline utilization A from Sinorhizobium meliloti (SmPutA) is a 1233-residue bifunctional enzyme that contains the DUF in addition to proline dehydrogenase and l-glutamate--semialdehyde dehydrogenase catalytic modules. Structures of SmPutA with a proline analog bound to the proline dehydrogenase site and NAD(+) bound to the ALDH site were determined in two space groups at 1.7-1.9 angstrom resolution. The DUF consists of a Rossmann dinucleotide-binding fold fused to a three-stranded -flap. The Rossmann domain resembles the classic ALDH superfamily NAD(+)-binding domain, whereas the flap is strikingly similar to the ALDH superfamily dimerization domain. Paradoxically, neither structural element performs its implied function. Electron density maps show that NAD(+) does not bind to the DUF Rossmann fold, and small-angle X-ray scattering reveals a novel dimer that has never been seen in the ALDH superfamily. The structure suggests that the DUF is an adapter domain that stabilizes the aldehyde substrate binding loop and seals the substrate-channeling tunnel via tertiary structural interactions that mimic the quaternary structural interactions found in non-DUF PutAs. Kinetic data for SmPutA indicate a substrate-channeling mechanism, in agreement with previous studies of other PutAs.	[Luo, Min; Gamage, Thameesha T.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Tanner, John J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Arentson, Benjamin W.; Schlasner, Katherine N.; Becker, Donald F.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Tanner, JJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	tannerjj@missouri.edu		Tanner, John/0000-0001-8314-113X	NIGMS [U54GM094662]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of Health project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065546, R01GM061068, U54GM094662, R01GM105404, P30GM103335] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1461240] Funding Source: National Science Foundation	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of Health project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Prof. Steve Almo and the NYSGRC for the SmPutA clone. The NYSGRC is supported by NIGMS Grant U54GM094662. We thank Dr. Jay Nix for help with X-ray diffraction data collection and Kevin Dyer for collecting the SAXS data through the SIBYLS mail-in program at the Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231. Additional support for the SYBILS beamline comes from the National Institute of Health project MINOS (R01GM105404).	ADAMS MJ, 1970, NATURE, V227, P1098, DOI 10.1038/2271098a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; Arentson BW, 2014, BIOCHEMISTRY-US, V53, P5150, DOI 10.1021/bi5007404; Arentson BW, 2012, FRONT BIOSCI-LANDMRK, V17, P375, DOI 10.2741/3932; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Becker DF, 2001, BIOCHEMISTRY-US, V40, P4714, DOI 10.1021/bi0019491; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; de Jong RM, 2003, EMBO J, V22, P4933, DOI 10.1093/emboj/cdg479; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Hanna MC, 2009, NEUROGENETICS, V10, P217, DOI 10.1007/s10048-009-0172-6; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lagautriere T, 2014, ACTA CRYSTALLOGR D, V70, P968, DOI 10.1107/S1399004713034391; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Luo M, 2015, BIOCHEMISTRY-US, V54, P5513, DOI 10.1021/acs.biochem.5b00754; Luo M, 2014, BIOCHEMISTRY-US, V53, P5661, DOI 10.1021/bi500693a; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Moxley MA, 2014, J BIOL CHEM, V289, P3639, DOI 10.1074/jbc.M113.523704; Pemberton TA, 2013, ARCH BIOCHEM BIOPHYS, V538, P34, DOI 10.1016/j.abb.2013.07.024; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Singh RK, 2011, J BIOL CHEM, V286, P43144, DOI 10.1074/jbc.M111.292474; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; Sulem P, 2011, NAT GENET, V43, P1127, DOI 10.1038/ng.972; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Tanner JJ, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P31; Vasiliou V, 2013, CHEM-BIOL INTERACT, V202, P22, DOI 10.1016/j.cbi.2012.12.018; Vlieg JETV, 2001, J BACTERIOL, V183, P5058, DOI 10.1128/JB.183.17.5058-5066.2001; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhou YZ, 2008, J MOL BIOL, V381, P174, DOI 10.1016/j.jmb.2008.05.084	47	26	26	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24065	24075		10.1074/jbc.M116.756965	http://dx.doi.org/10.1074/jbc.M116.756965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679491	hybrid, Green Published			2022-12-26	WOS:000388498100023
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			PvdN Enzyme Catalyzes a Periplasmic Pyoverdine Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decarboxylase; enzyme; iron; pyridoxal phosphate; siderophore; periplasmic tailoring; pyoverdines; siderophore maturation; periplasmic tailoring; Pseudomonas fluorescens	PYOCYANEUS-FLUORESCENS GROUP; PSEUDOMONAS-AERUGINOSA; POLYACRYLAMIDE GELS; BIOCHEMICAL RELATIONSHIPS; ELECTROPHORETIC TRANSFER; ESCHERICHIA-COLI; PROTEINS; SIDEROPHORES; BIOSYNTHESIS; NITROCELLULOSE	Pyoverdines are high affinity siderophores produced by a broad range of pseudomonads to enhance growth under iron deficiency. They are especially relevant for pathogenic and mutualistic strains that inhabit iron-limited environments. Pyoverdines are generated from non-ribosomally synthesized highly modified peptides. They all contain an aromatic chromophore that is formed in the periplasm by intramolecular cyclization steps. Although the cytoplasmic peptide synthesis and side-chain modifications are well characterized, the periplasmic maturation steps are far from understood. Out of five periplasmic enzymes, PvdM, PvdN, PvdO, PvdP, and PvdQ, functions have been attributed only to PvdP and PvdQ. The other three enzymes are also regarded as essential for siderophore biosynthesis. The structure of PvdN has been solved recently, but no function could be assigned. Here we present the first in-frame deletion of the PvdN-encoding gene. Unexpectedly, PvdN turned out to be required for a specific modification of pyoverdine, whereas the overall amount of fluorescent pyoverdines was not altered by the mutation. The mutant strain grew normally under iron-limiting conditions. Mass spectrometry identified the PvdN-dependent modification as a transformation of the N-terminal glutamic acid to a succinamide. We postulate a pathway for this transformation catalyzed by the enzyme PvdN, which is most likely functional in the case of all pyoverdines.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Research Foundation (DFG) [GRK1798]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) as a project of the GRK1798 "Signaling at the Plant-Soil Interface." The authors declare that they have no conflicts of interest with the contents of this article.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnow LE, 1937, J BIOL CHEM, V118, P531; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; Drake EJ, 2016, ACTA CRYSTALLOGR F, V72, P403, DOI 10.1107/S2053230X16006257; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Gessard M. C., 1892, ANN I PASTEUR, V4, P88; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Hartney SL, 2013, J BACTERIOL, V195, P765, DOI 10.1128/JB.01639-12; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jimenez PN, 2010, MICROBIOL-SGM, V156, P49, DOI 10.1099/mic.0.030973-0; KOEDAM N, 1994, BIOMETALS, V7, P287; Kvitko BH, 2011, METHODS MOL BIOL, V712, P109, DOI 10.1007/978-1-61737-998-7_10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Matsui D, 2009, APPL MICROBIOL BIOT, V83, P1045, DOI 10.1007/s00253-009-1942-7; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; MEYER JM, 1978, J GEN MICROBIOL, V107, P319, DOI 10.1099/00221287-107-2-319; Meyer JM, 1997, MICROBIOL-UK, V143, P35, DOI 10.1099/00221287-143-1-35; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nurizzo D, 2001, BIOCHEMISTRY-US, V40, P13857, DOI 10.1021/bi011355d; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHAFER H, 1991, Z NATURFORSCH C, V46, P398; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turfitt GE, 1936, BIOCHEM J, V30, P1323, DOI 10.1042/bj0301323; Turfitt GE, 1937, BIOCHEM J, V31, P212, DOI 10.1042/bj0310212; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Wang M, 2016, J AM CHEM SOC, V138, P6348, DOI 10.1021/jacs.6b01751; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0	47	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23929	23938		10.1074/jbc.M116.755611	http://dx.doi.org/10.1074/jbc.M116.755611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703013	hybrid, Green Published			2022-12-26	WOS:000388498100010
J	Lucas, R; Yue, Q; Alli, A; Duke, BJ; Al-Khalili, O; Thai, TL; Hamacher, J; Sridhar, S; Lebedyeva, I; Su, HB; Tzotzos, S; Fischer, B; Gameiro, AF; Loose, M; Chakraborty, T; Shabbir, W; Aufy, M; Lemmens-Gruber, R; Eaton, DC; Czikora, I				Lucas, Rudolf; Yue, Qiang; Alli, Abdel; Duke, Billie Jeanne; Al-Khalili, Otor; Thai, Tiffany L.; Hamacher, Juerg; Sridhar, Supriya; Lebedyeva, Iryna; Su, Huabo; Tzotzos, Susan; Fischer, Bernhard; Gameiro, Armanda Formigao; Loose, Maria; Chakraborty, Trinad; Shabbir, Waheed; Aufy, Mohammed; Lemmens-Gruber, Rosa; Eaton, Douglas C.; Czikora, Istvan			The Lectin-like Domain of TNF Increases ENaC Open Probability through a Novel Site at the Interface between the Second Transmembrane and C-terminal Domains of the -Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); peptides; Streptococcus; tumor necrosis factor (TNF); ubiquitylation (ubiquitination)	EPITHELIAL SODIUM-CHANNEL; TUMOR-NECROSIS-FACTOR; XENOPUS 2F3 CELLS; ACUTE LUNG INJURY; FACTOR-ALPHA; NA+ CHANNEL; EDEMA REABSORPTION; FLUID TRANSPORT; PULMONARY-EDEMA; TRAFFICKING	Regulation of the epithelial sodium channel (ENaC), which regulates fluid homeostasis and blood pressure, is complex and remains incompletely understood. The TIP peptide, a mimic of the lectin-like domain of TNF, activates ENaC by binding to glycosylated residues in the extracellular loop of ENaC-, as well as to a hitherto uncharacterized internal site. Molecular docking studies suggested three residues, Val(567), Glu(568), and Glu(571), located at the interface between the second transmembrane and C-terminal domains of ENaC-, as a critical site for binding of the TIP peptide. We generated Ala replacement mutants in this region of ENaC- and examined its interaction with TIP peptide (3M, V567A/E568A/E571A; 2M, V567A/E568A; and 1M, E571A). 3M and 2M ENaC-, but not 1M ENaC-, displayed significantly reduced binding capacity to TIP peptide and to TNF. When overexpressed in H441 cells, 3M mutant ENaC- formed functional channels with similar gating and density characteristics as the WT subunit and efficiently associated with the and subunits in the plasma membrane. We subsequently assayed for increased open probability time and membrane expression, both of which define ENaC activity, following addition of TIP peptide. TIP peptide increased open probability time in H441 cells overexpressing wild type and 1M ENaC- channels, but not 3M or 2M ENaC- channels. On the other hand, TIP peptide-mediated reduction in ENaC ubiquitination was similar in cells overexpressing either WT or 3M ENaC- subunits. In summary, this study has identified a novel site in ENaC- that is crucial for activation of the open probability of the channel, but not membrane expression, by the lectin-like domain of TNF.	[Lucas, Rudolf; Sridhar, Supriya; Su, Huabo; Czikora, Istvan] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Lucas, Rudolf] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Lucas, Rudolf] Med Coll Georgia, Div Pulm & Crit Care Med, Augusta, GA 30912 USA; [Lebedyeva, Iryna; Gameiro, Armanda Formigao] Augusta Univ, Dept Chem, Augusta, GA 30912 USA; [Yue, Qiang; Alli, Abdel; Duke, Billie Jeanne; Al-Khalili, Otor; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Alli, Abdel] Univ Florida, Coll Med, Dept Physiol & Funct Gen, Gainesville, FL 32610 USA; [Hamacher, Juerg] Univ Saarland, Dept Pulmonol, D-66421 Homburg, Germany; [Tzotzos, Susan; Fischer, Bernhard] Apeptico Res & Dev, A-1150 Vienna, Austria; [Loose, Maria; Chakraborty, Trinad] Justus Liebig Univ, Inst Med Microbiol, D-35390 Giessen, Germany; [Shabbir, Waheed; Aufy, Mohammed; Lemmens-Gruber, Rosa] Univ Vienna, Dept Pharmacol & Toxicol, A-1010 Vienna, Austria	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Emory University; State University System of Florida; University of Florida; Saarland University; Justus Liebig University Giessen; University of Vienna	Lucas, R; Czikora, I (corresponding author), Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA.; Lucas, R (corresponding author), Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.; Lucas, R (corresponding author), Med Coll Georgia, Div Pulm & Crit Care Med, Augusta, GA 30912 USA.; Eaton, DC (corresponding author), Emory Univ, Dept Physiol, Atlanta, GA 30322 USA.; Lucas, R; Czikora, I (corresponding author), Augusta Univ, Vasc Biol Ctr, Med Coll Georgia, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	rlucas@augusta.edu; deaton@emory.edu; iczikora@augusta.edu	Lucas, Rudolf/ABA-3011-2020	Czikora, Istvan/0000-0002-8247-9494; Lucas, Rudolf/0000-0003-3805-8868; Aufy, Mohammed/0000-0002-6693-4530; Loose, Maria/0000-0003-2319-7734; Su, Huabo/0000-0002-8475-2685	American Heart Association Postdoctoral Award [15POST22820021]; Bridge Funding Award from the vice-president for research at Augusta University; Deutsche Forschungsgemeinschaft [Transregio 84/2 SFB]; NIDDK, National Institutes of Health [R37 DK037963, R01 DK100564, K01 DK099617]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100564, K01DK099617, R37DK037963] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Award(American Heart Association); Bridge Funding Award from the vice-president for research at Augusta University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by American Heart Association Postdoctoral Award 15POST22820021, by a Bridge Funding Award from the vice-president for research at Augusta University, by a Transregio 84/2 SFB Grant from the Deutsche Forschungsgemeinschaft "Innate Immunity of the Lung," and by NIDDK, National Institutes of Health Grants R37 DK037963, R01 DK100564, and K01 DK099617. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Alli AA, 2012, J BIOL CHEM, V287, P30073, DOI 10.1074/jbc.M111.338574; Alli AA, 2010, J CELL BIOCHEM, V110, P985, DOI 10.1002/jcb.22612; Baldwin RL, 1996, P NATL ACAD SCI USA, V93, P1021, DOI 10.1073/pnas.93.3.1021; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Bertok S, 2012, THORAX, V67, P244, DOI 10.1136/thoraxjnl-2011-200590; Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009; Braun C, 2005, J IMMUNOL, V175, P3402, DOI 10.4049/jimmunol.175.5.3402; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen XJ, 2004, AM J PHYSIOL-LUNG C, V287, pL366, DOI 10.1152/ajplung.00011.2004; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; Czikora I, 2014, AM J RESP CRIT CARE, V190, P522, DOI 10.1164/rccm.201405-0833OC; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Elia N, 2003, AM J RESP CRIT CARE, V168, P1043, DOI 10.1164/rccm.200206-618OC; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; Lopitz-Otsoa F, 2012, J PROTEOMICS, V75, P2998, DOI 10.1016/j.jprot.2011.12.001; Lucas R, 2012, P NATL ACAD SCI USA, V109, P2084, DOI 10.1073/pnas.1121075109; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mall MA, 2015, J CYST FIBROS, V14, P561, DOI 10.1016/j.jcf.2015.06.002; Marquardt A, 2007, J PEPT SCI, V13, P803, DOI 10.1002/psc.902; Matalon S, 2015, AM J PHYSIOL-LUNG C, V309, pL1229, DOI 10.1152/ajplung.00319.2015; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Migneault F, 2013, AM J PHYSIOL-LUNG C, V305, pL747, DOI 10.1152/ajplung.00023.2013; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Ostrand A. B., 2015, AM J PHYSIOL-LUNG C, V308, pL22; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Reifenberger MS, 2014, AM J PHYSIOL-RENAL, V307, pF86, DOI 10.1152/ajprenal.00251.2013; Roux J, 2013, FASEB J, V27, P1095, DOI 10.1096/fj.12-219295; Shabbir W, 2015, BIOCHEM PHARMACOL, V98, P740, DOI 10.1016/j.bcp.2015.08.003; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Sieck GC, 2014, AM J RESP CRIT CARE, V190, P595, DOI 10.1164/rccm.201407-1364ED; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Wagener BM, 2015, ANESTHESIOLOGY, V122, P1084, DOI 10.1097/ALN.0000000000000595; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Yamagata T, 2009, RESP PHYSIOL NEUROBI, V166, P16, DOI 10.1016/j.resp.2008.12.008; Zhu J, 2012, FEBS J, V279, P2632, DOI 10.1111/j.1742-4658.2012.08642.x	54	15	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23440	23451		10.1074/jbc.M116.718163	http://dx.doi.org/10.1074/jbc.M116.718163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27645999	Green Published, hybrid			2022-12-26	WOS:000387884400007
J	Zhang, ZZZ; Lee, EE; Sudderth, J; Yue, YB; Zia, A; Glass, D; Deberardinis, RJ; Wang, RC				Zhang, Zhuzhen Z.; Lee, Eunice E.; Sudderth, Jessica; Yue, Yangbo; Zia, Ayesha; Glass, Donald; Deberardinis, Ralph J.; Wang, Richard C.			Glutathione Depletion, Pentose Phosphate Pathway Activation, and Hemolysis in Erythrocytes Protecting Cancer Cells from Vitamin C-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT DEHYDROASCORBIC ACID; ASCORBIC-ACID; G-6-PD DEFICIENCY; HOMEOSTASIS; BLOOD; GLUT1	The discovery that oxidized vitamin C, dehydroascorbate (DHA), can induce oxidative stress and cell death in cancer cells has rekindled interest in the use of high dose vitamin C (VC) as a cancer therapy. However, high dose VC has shown limited efficacy in clinical trials, possibly due to the decreased bioavailability of oral VC. Because human erythrocytes express high levels of Glut1, take up DHA, and reduce it to VC, we tested how erythrocytes might impact high dose VC therapies. Cancer cells are protected from VC-mediated cell death when co-cultured with physiologically relevant numbers of erythrocytes. Pharmacological doses of VC induce oxidative stress, GSH depletion, and increased glucose flux through the oxidative pentose phosphate pathway (PPP) in erythrocytes. Incubation of erythrocytes with VC induced hemolysis, which was exacerbated in erythrocytes from glucose-6-phosphate dehydrogenase (G6PD) patients and rescued by antioxidants. Thus, erythrocytes protect cancer cells from VC-induced oxidative stress and undergo hemolysis in vitro, despite activation of the PPP. These results have implications on the use of high dose VC in ongoing clinical trials and highlight the importance of the PPP in the response to oxidative stress.	[Zhang, Zhuzhen Z.; Lee, Eunice E.; Yue, Yangbo; Glass, Donald; Wang, Richard C.] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, NL08-110FB,5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Zia, Ayesha; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Sudderth, Jessica; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Glass, Donald; Deberardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, NL08-110FB,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	richard.wang@utsouthwestern.edu	Glass, Donald A/A-1908-2013; Glass, Donald/AGI-6735-2022; Wang, Richard/AAW-3066-2021; Zia, Ayesha/K-8063-2019	Glass, Donald/0000-0003-0866-770X; Wang, Richard/0000-0003-4543-8295; Zia, Ayesha/0000-0003-3283-0415; Zhang, Zhuzhen/0000-0001-6787-3920	National Institutes of Health [R01 CA157996, K23 AR069728, K23 HL132054, K08 CA164047]; Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS) [1010978]; Disease Oriented Clinical Scholar Awards; NATIONAL CANCER INSTITUTE [K08CA164047, R01CA157996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL132054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR069728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS); Disease Oriented Clinical Scholar Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 CA157996 (to R. J. D.), K23 AR069728 (to D. G.), K23 HL132054 (to A. Z.), and K08 CA164047 (to R. C. W.). This work was also supported by Burroughs Wellcome Fund Career Award for Medical Scientists (CAMS) (Grant 1010978) and Disease Oriented Clinical Scholar Awards (to R. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Arruda MM, 2013, BRIT J HAEMATOL, V160, P688, DOI 10.1111/bjh.12185; BRAM S, 1980, NATURE, V284, P629, DOI 10.1038/284629a0; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; DHARIWAL KR, 1991, AM J CLIN NUTR, V54, P712, DOI 10.1093/ajcn/54.4.712; Duconge J, 2008, P R HEALTH SCI J, V27, P7; Jacobs C, 2015, ONCOLOGIST, V20, P210, DOI 10.1634/theoncologist.2014-0381; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lang F, 2014, ANTIOXID REDOX SIGN, V21, P138, DOI 10.1089/ars.2013.5747; Lee EE, 2015, MOL CELL, V58, P845, DOI 10.1016/j.molcel.2015.04.015; May JM, 2001, BBA-GEN SUBJECTS, V1528, P159, DOI 10.1016/S0304-4165(01)00188-X; MAY JM, 1995, BIOCHEMISTRY-US, V34, P12721, DOI 10.1021/bi00039a031; MEHTA JB, 1990, LANCET, V336, P944, DOI 10.1016/0140-6736(90)92317-B; Mendiratta S, 1998, FREE RADICAL BIO MED, V24, P789, DOI 10.1016/S0891-5849(97)00351-1; Pallotta V, 2014, BLOOD TRANSFUS-ITALY, V12, P376, DOI 10.2450/2014.0266-13; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Sage JM, 2014, AM J PHYSIOL-CELL PH, V306, pC910, DOI 10.1152/ajpcell.00044.2014; TOTH KM, 1984, J CLIN INVEST, V74, P292, DOI 10.1172/JCI111414; Vani R., 2015, ADV HEMATOL, V2015; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004	23	32	35	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22861	22867		10.1074/jbc.C116.748848	http://dx.doi.org/10.1074/jbc.C116.748848			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27660392	Green Published, hybrid			2022-12-26	WOS:000387224800001
J	Ombura, IP; Onyango, N; Odera, S; Mutua, F; Nyagol, J				Ombura, Ida Pam; Onyango, Noel; Odera, Susan; Mutua, Florence; Nyagol, Joshua			Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; PULMONARY TUBERCULOSIS; HIV COINFECTION; MANAGEMENT	Background Although prevention and control of spread of multi-drug resistant tuberculosis strains is a global challenge, there is paucity of data on the prevalence of DR-TB in patients diagnosed with TB in referral hospitals in Kenya. The present study assessed patients' characteristics and prevalence of drug resistant TB in sputa smear positive TB patients presenting to Coast Provincial General Hospital (CPGH) in Mombasa, Kenya. Methods Drug resistance was evaluated in 258 randomly selected sputa smear TB positive cases between the periods of November 2011 to February 2012 at the CPGH-Mombasa. Basic demographic data was obtained using administered questionnaires, and clinical history extracted from the files. For laboratory analyses, 2mls of sputum was obtained, decontaminated and subjected to mycobacteria DNA analyses. Detection of first line drug resistance genes was done using MDRTDR plus kit. This was followed with random selection of 83 cases for second line drug resistance genes testing using Genotype MDRTBsl probe assay kit (HAINS Lifesciences, GmbH, Germany), in which ethambutol mutation probes were included. The data was then analyzed using SPSS statistical package version 19.0. Results Male to female ratio was 1:2. Age range was 9 to 75 years, with median of 30 years. New treatment cases constituted 253(98%), among which seven turned out to be PTB negative, and further grouped as 4 (1.6%) PTB negative and 3(1.1%) NTM. 237(91.7%) new cases were fully susceptible to INH and RIF. The remaining, 8 (3.1%) and 1(0.4%) had mono-resistance to INH and RIF, respectively. All the retreatment cases were fully susceptible to the first line drugs. HIV positivity was found in 48 (18.6%) cases, of which 46(17.8%) were co-infected with TB. Of these, 44 (17.1%) showed full susceptibility to TB drugs, while 2 (0.8%) were INH resistant. For the second line drugs, one case each showed mono resistance to both and FQ. Also, one case each showed drug cross poly resistance to both ETH and FQ, with second line injectable antibiotics. However, no significant statistical correlation was established between TB and resistance to the second line drugs p = 0.855. Conclusion The findings of this study showed the existence of resistance to both first and second line anti-tubercular drugs, but no MDR-TB and XDR-TB was detected among patients attending TB clinic at CPGH using molecular techniques.	[Ombura, Ida Pam; Odera, Susan; Mutua, Florence] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Nyagol, Joshua] Univ Nairobi, Dept Human Pathol, Immunol Unit, Nairobi, Kenya; [Onyango, Noel] Univ Nairobi, Dept Clin Med & Therapeut, Med Oncol Unit, Nairobi, Kenya	University of Nairobi; University of Nairobi; University of Nairobi	Nyagol, J (corresponding author), Univ Nairobi, Dept Human Pathol, Immunol Unit, Nairobi, Kenya.	joshua.nyagol@uonbi.ac.ke	MIZEKA, PANU/A-3952-2017		University of Nairobi, department of Medical Microbiology	University of Nairobi, department of Medical Microbiology	This work was supported by a Seed grant for post-graduate student's support, University of Nairobi, department of Medical Microbiology.	Ballif M, 2014, INT J TUBERC LUNG D, V18, P1327, DOI 10.5588/ijtld.14.0106; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Eduardo P, 2011, MOL BASIS MECH DRUG, P1417; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Jezmir J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154142; Katoch VM, 2004, INDIAN J MED RES, V120, P290; Khan R, 2013, STATISTICS-ABINGDON, P1; Ling Daphne I, 2008, Expert Rev Respir Med, V2, P583, DOI 10.1586/17476348.2.5.583; Maheswaran H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030457; Mekonnen F, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1202-7; Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x; Muwonge A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064745; National AIDS and SIIs Control Programme (NASCOP), 2013, KEN AIDS IND SURV 20, V20; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; Nyamogoba HDN, 2012, AFR HEALTH SCI, V12, P305, DOI 10.4314/ahs.v12i3.9; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Ogaro T.D., 2012, AFRICAN J HLTH SCI, V20, P21; Palomino JC, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI DOI 10.1093/JAC/DKR173; Pontali E, 2015, EXPERT OPIN PHARMACO, V16, P2737, DOI 10.1517/14656566.2015.1100169; Said HM, 2012, INT J TUBERC LUNG D, V16, P104, DOI 10.5588/ijtld.10.0600; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Tripathi K., 2014, INT J RECENT TRENDS, V10, P461; UNAIDS, 2013, UNAIDSJC25021E; Wells WA, 2013, LANCET INFECT DIS, V13, P449, DOI 10.1016/S1473-3099(13)70025-2; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2010, MULT EXT DRUG RES TB, P57; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	29	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163994	10.1371/journal.pone.0163994	http://dx.doi.org/10.1371/journal.pone.0163994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711122	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600058
J	Olatunji, MA; Khandaker, MU; Amin, YM; Mahmud, HNME				Olatunji, Michael Adekunle; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd; Mahmud, Habibun Nabi Muhammad Ekramul			Cadmium-109 Radioisotope Adsorption onto Polypyrrole Coated Sawdust of Dryobalanops aromatic: Kinetics and Adsorption Isotherms Modelling	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; CADMIUM REMOVAL; ION	A radiotracer study was conducted to investigate the removal characteristics of cadmium (Cd-109) from aqueous solution by polypyrrole/ sawdust composite. Several factors such as solution pH, sorbent dosage, initial concentration, contact time, temperature and interfering metal ions were found to have influence on the adsorption process. The kinetics of adsorption was relatively fast, reaching equilibrium within 3 hours. A lowering of the solution pH reduced the removal efficiency from 99.3 to similar to 46.7% and an ambient temperature of 25 degrees C was found to be optimum for maximum adsorption. The presence of sodium and potassium ions inhibited Cd-109 removal from its aqueous solution. The experimental data for Cd-109 adsorption showed a very good agreement with the Langmuir isotherm and a pseudo-first order kinetic model. The surface condition of the adsorbent before and after cadmium loading was investigated using BET, FESEM and FTIR. Considering the low cost of the precursor's materials and the toxicity of Cd-109 radioactive metal, polypyrrole synthesized on the sawdust of Dryobalanops aromatic could be used as an efficient adsorbent for the removal of Cd-109 radioisotope from radionuclide-containing effluents.	[Olatunji, Michael Adekunle; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd] Univ Malaya, Dept Phys, Appl Radiat Lab, Kuala Lumpur, Malaysia; [Mahmud, Habibun Nabi Muhammad Ekramul] Univ Malaya, Dept Chem, Polymer Lab, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Khandaker, MU (corresponding author), Univ Malaya, Dept Phys, Appl Radiat Lab, Kuala Lumpur, Malaysia.; Mahmud, HNME (corresponding author), Univ Malaya, Dept Chem, Polymer Lab, Kuala Lumpur, Malaysia.	mu_khandaker@um.edu.my; ekramul@um.edu.my	Mahmud, H. N. M. Ekramul/AAR-4953-2021; Mahmud, H. N. M. Ekramul/F-6696-2011; Olatunji, Michael/L-4701-2017; Khandaker, Mayeen Uddin/F-5376-2011	Mahmud, H. N. M. Ekramul/0000-0002-6294-2082; Mahmud, H. N. M. Ekramul/0000-0002-6294-2082; Olatunji, Michael/0000-0003-4400-7741; Khandaker, Mayeen Uddin/0000-0003-3772-294X	University of Malaya [PG027A-2014]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya Research grant (Grant No PG027A-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achak M, 2009, J HAZARD MATER, V166, P117, DOI 10.1016/j.jhazmat.2008.11.036; Ansari R, 2007, REACT FUNCT POLYM, V67, P367, DOI 10.1016/j.reactfunctpolym.2007.02.001; Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6; Deng X, 2007, J HAZARD MATER, V139, P340, DOI 10.1016/j.jhazmat.2006.06.043; Feng YA, 2010, CHEM ENG J, V162, P487, DOI 10.1016/j.cej.2010.05.049; Ghorbani M, 2010, DESALINATION, V263, P279, DOI 10.1016/j.desal.2010.06.072; Hao ZQ, 1999, APPL ENVIRON MICROB, V65, P4741; Javadian H, 2014, APPL SURF SCI, V289, P487, DOI 10.1016/j.apsusc.2013.11.020; Kalkan E, 2013, POL J ENVIRON STUD, V22, P417; Karthikeyan M, 2009, J HAZARD MATER, V167, P300, DOI 10.1016/j.jhazmat.2008.12.141; Khandaker MU, 2015, RADIAT PROT DOSIM, V167, P196, DOI 10.1093/rpd/ncv243; Kim SK, 2005, J BIOSCI BIOENG, V99, P109, DOI 10.1263/jbb.99.109; Kolodynska D, 2012, CHEM ENG J, V197, P295, DOI 10.1016/j.cej.2012.05.025; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; MAHMUD HNME, 2014, INT J TECHNICAL RES, V11, P04; Mansour MS, 2011, DESALINATION, V272, P301, DOI 10.1016/j.desal.2011.01.037; Memon SQ, 2007, J HAZARD MATER, V139, P116, DOI 10.1016/j.jhazmat.2006.06.013; Olatunji MA, 2015, RSC ADV, V5, P71658, DOI 10.1039/c5ra10598f; Olatunji MA, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/12/125002; Omraei M, 2011, DESALINATION, V271, P248, DOI 10.1016/j.desal.2010.12.038; Pignatello JJ, 2011, WILEY-IUPAC SER BIOP, P3; Rao RAK, 2016, ARAB J CHEM, V9, pS1233, DOI 10.1016/j.arabjc.2012.01.010; Regmi P, 2012, J ENVIRON MANAGE, V109, P61, DOI 10.1016/j.jenvman.2012.04.047; Salim R, 2008, CHEM ENG J, V102, P249; Seid L, 2014, J TAIWAN INST CHEM E, V45, P2969, DOI 10.1016/j.jtice.2014.08.030; Semerjian L, 2010, J HAZARD MATER, V173, P236, DOI 10.1016/j.jhazmat.2009.08.074; Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009; Wahab MA, 2010, BIORESOURCE TECHNOL, V101, P5070, DOI 10.1016/j.biortech.2010.01.121; Weidlich C, 2005, ELECTROCHIM ACTA, V50, P5247, DOI 10.1016/j.electacta.2005.02.083; Weidlich C, 2001, ELECTROCHIM ACTA, V47, P741, DOI 10.1016/S0013-4686(01)00754-X; Xia GS, 2001, ENVIRON SCI TECHNOL, V35, P84, DOI 10.1021/es001320l; Yu B, 2000, J HAZARD MATER, V80, P33, DOI 10.1016/S0304-3894(00)00278-8	32	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164119	10.1371/journal.pone.0164119	http://dx.doi.org/10.1371/journal.pone.0164119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706232	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200086
J	Tassia, MG; Cannon, JT; Konikoff, CE; Shenkar, N; Halanych, KM; Swalla, BJ				Tassia, Michael G.; Cannon, Johanna T.; Konikoff, Charlotte E.; Shenkar, Noa; Halanych, Kenneth M.; Swalla, Billie J.			The Global Diversity of Hemichordata	PLOS ONE			English	Review							ACORN WORM HEMICHORDATA; DEUTEROSTOME PHYLOGENY; SPECIES HEMICHORDATA; MOLECULAR PHYLOGENY; 18S RDNA; ENTEROPNEUSTA; HARRIMANIIDAE; RHABDOPLEURA; EXPRESSION; EVOLUTION	Phylum Hemichordata, composed of worm-like Enteropneusta and colonial Pterobranchia, has been reported to only contain about 100 species. However, recent studies of hemichordate phylogeny and taxonomy suggest the species number has been largely underestimated. One issue is that species must be described by experts, and historically few taxonomists have studied this group of marine invertebrates. Despite this previous lack of coverage, interest in hemichordates has piqued in the past couple of decades, as they are critical to understanding the evolution of chordates-as acorn worms likely resemble the deuterostome ancestor more closely than any other extant animal. This review provides an overview of our current knowledge of hemichordates, focusing specifically on their global biodiversity, geographic distribution, and taxonomy. Using information available in the World Register of Marine Species and published literature, we assembled a list of 130 described, extant species. The majority (83%) of these species are enteropneusts, and more taxonomic descriptions are forthcoming. Ptychoderidae contained the greatest number of species (41 species), closely followed by Harrimaniidae (40 species), of the recognized hemichordate families. Hemichordates are found throughout the world's oceans, with the highest reported numbers by regions with marine labs and diligent taxonomic efforts (e. g. North Pacific and North Atlantic). Pterobranchs are abundant in Antarctica, but have also been found at lower latitudes. We consider this a baseline report and expect new species of Hemichordata will continue to be discovered and described as new marine habitats are characterized and explored.	[Tassia, Michael G.; Konikoff, Charlotte E.; Shenkar, Noa; Swalla, Billie J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Tassia, Michael G.; Cannon, Johanna T.; Shenkar, Noa; Halanych, Kenneth M.; Swalla, Billie J.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Tassia, Michael G.; Cannon, Johanna T.; Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Cannon, Johanna T.] Nat Hist Riksmuseet, Dept Zool, SE-10405 Stockholm, Sweden; [Shenkar, Noa] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Tel Aviv, Israel	University of Washington; University of Washington Seattle; University of Washington; Auburn University System; Auburn University; Tel Aviv University	Swalla, BJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Swalla, BJ (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	bjswalla@u.washington.edu	Cannon, Johanna/V-3842-2019	Cannon, Johanna/0000-0002-3920-7741; Tassia, Michael/0000-0002-5485-8155				Allman G.J., 1869, REP BR ASS ADVMT SCI, V1868, P311; Andersson K, 1907, SCI RESULTS SWEDISH, V5, P1; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Barrington E. J., 1965, BIOL HEMICHORDATA PR; Bateson W, 1885, Q J MICROSC SCI, V25, P81; BEKLEMISHEV V. N., 1951, USPEKHI SOVREMENNOI BIOL, V32, P256; Benito-Gutierrez E, 2009, CURR BIOL, V19, pR640, DOI 10.1016/j.cub.2009.06.020; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Cameron CB, 2010, ZOOTAXA, P1; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cameron CB, 2002, BIOL BULL, V202, P182, DOI 10.2307/1543654; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Cannon JT, 2013, BIOL BULL-US, V225, P194, DOI 10.1086/BBLv225n3p194; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Caron JB, 2013, NATURE, V495, P503, DOI 10.1038/nature12017; Crowther P.R., 1981, Special Papers in Palaeontology, P1; Davidson B, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P443; Deland C, 2010, ZOOTAXA, P1; Department of Invertebrate Zoology, 2011, RES COLL INF SYST; ESCHSCHoLTZ J.F., 1825, ISIS OKEN, V16-17, P733; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; GILMOUR THJ, 1979, CAN J ZOOL, V57, P1136, DOI 10.1139/z79-143; Giray C, 1996, P BIOL SOC WASH, V109, P430; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Halanych KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3738; Halanych KM, 1996, BIOL BULL-US, V190, P1, DOI 10.2307/1542669; HALANYCH KM, 1993, BIOL BULL, V185, P417, DOI 10.2307/1542482; Harmer S., 1905, SIBOGA EXPEDITION MO, P1; HART MW, 1994, MAR BIOL, V120, P521, DOI 10.1007/BF00350072; Holland LZ, 2001, DEV BIOL, V232, P493, DOI 10.1006/dbio.2001.0160; Holland ND, 2005, NATURE, V434, P374, DOI 10.1038/nature03382; Holland ND, 2012, P BIOL SOC WASH, V125, P228, DOI 10.2988/12-11.1; Holland ND, 2012, J MORPHOL, V273, P661, DOI 10.1002/jmor.20013; Holland ND, 2009, ZOOSYSTEMA, V31, P333, DOI 10.5252/z2009n2a6; Hou XG, 2011, CURR BIOL, V21, P612, DOI 10.1016/j.cub.2011.03.005; Humphreys T, 2010, ZOOL SCI, V27, P91, DOI 10.2108/zsj.27.91; Hyman LH., 1959, INVERTEBRATES, VV; International Oceanic Commission of UNESCO, 2007, OC BIOG INF SYST 200; Jones DOB, 2013, DEEP-SEA RES PT II, V98, P374, DOI 10.1016/j.dsr2.2013.05.009; KING GM, 1994, P BIOL SOC WASH, V107, P383; KING GM, 1995, MAR BIOL, V123, P369, DOI 10.1007/BF00353628; KOZLOWSKI R, 1949, CR HEBD ACAD SCI, V228, P1505; Lankester R., 1877, HDB ZOOLOGIE ORDER B, P1; LESTER SM, 1985, MAR BIOL, V85, P263, DOI 10.1007/BF00393246; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Luttrell S, 2012, INTEGR COMP BIOL, V52, P829, DOI 10.1093/icb/ics117; Maletz J, 2014, PALAEOGEOGR PALAEOCL, V398, P16, DOI 10.1016/j.palaeo.2013.06.010; Metschnikoff V. E., 1881, ZOOL ANZ, V4, P139; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; MIntosh W.C., 1887, CHALLENGER REPORTS Z, V20, P1; Mitchell CE, 2013, LETHAIA, V46, P34, DOI 10.1111/j.1502-3931.2012.00319.x; Murray J., 1895, SUMMARY SCI RESULTS; Nakajima Y, 2004, ZOOL SCI, V21, P69, DOI 10.2108/zsj.21.69; NEWELL GE, 1952, P ZOOL SOC LOND, V121, P741; NOAA/NOS/NCCOS/CCMA/Biogeography Branch, 2011, USVI FISH ASS MON DA; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Okuda S., 1939, Journal of the Faculty of Science Hokkaido University Zoology, V7, P17; Osborn KJ, 2013, BIOL BULL-US, V225, P113, DOI 10.1086/BBLv225n2p113; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; Palomares M, 2011, SEALIFEBASE VANCOUVE; Peterson KJ, 2013, J EXP ZOOL PART B, V320, P368, DOI 10.1002/jez.b.22510; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Priede IG, 2012, INVERTEBR BIOL, V131, P244, DOI 10.1111/j.1744-7410.2012.00266.x; Punnett R., 1903, FAUNA GEOGRAPHY MALD, VII, P631; Ritter W. E., 1900, P WASH ACAD SCI, V2, P111; Ruggiero M, 2011, SPECIES 2000 ITIS CA; Rychel AL, 2008, DEV DYNAM, V237, P3222, DOI 10.1002/dvdy.21747; Rychel AL, 2009, STEM CELLS IN MARINE ORGANISMS, P245, DOI 10.1007/978-90-481-2767-2_10; Sato A, 2008, J MAR BIOL ASSOC UK, V88, P1033, DOI 10.1017/S0025315408001604; Sato A, 2009, P NATL ACAD SCI USA, V106, P7491, DOI 10.1073/pnas.0810430106; Sato A, 2008, LETHAIA, V41, P303, DOI 10.1111/j.1502-3931.2008.00123.x; Sato A, 2008, GENESIS, V46, P587, DOI 10.1002/dvg.20395; SATO TADAO, 1936, ZOOL ANZ, V115, P97; SAWAYA P, 1951, NATURE, V167, P730, DOI 10.1038/167730b0; SCHELTEMA RS, 1970, MAR BIOL, V7, P47, DOI 10.1007/BF00346807; Shenkar N, 2015, HEMICHORDATA WORLD D; Smith AB, 2008, EVOL DEV, V10, P493, DOI 10.1111/j.1525-142X.2008.00260.x; Smith SE, 2003, CAN J ZOOL, V81, P133, DOI 10.1139/Z02-228; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spengel J.W., 1893, ENTEROPNEUSTEN GOLFE; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Swalla BJ, 2007, PRINICPLES DEV GENET, DOI [1016/j.ympev.2009.03.027, 10.1098/rspb.2011.1916, DOI 10.1098/RSPB.2011.1916]; Takacs CM, 2002, EVOL DEV, V4, P405, DOI 10.1046/j.1525-142X.2002.02029.x; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Urata M, 2004, ZOOL SCI, V21, P533, DOI 10.2108/zsj.21.533; Urata M, 2014, EVOL DEV, V16, P149, DOI 10.1111/ede.12075; van der Horst C., 1939, BRONNS KLASSEN ORDNU; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; WELSCH U, 1970, Z ZELLFORSCH MIK ANA, V107, P234, DOI 10.1007/BF00335227; Willey A., 1899, WILLEYS ZOOLOGICAL R, VIII, P32, DOI DOI 10.5962/BHL.TITLE.82497; Woodwick Keith H., 1996, P251; WOODWICK KH, 1985, P BIOL SOC WASH, V98, P351; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051	100	22	22	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0162564	10.1371/journal.pone.0162564	http://dx.doi.org/10.1371/journal.pone.0162564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701429	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900002
J	Zhou, H; Wang, YP; Lv, QY; Zhang, J; Wang, Q; Gao, F; Hou, HL; Zhang, H; Zhang, W; Li, LJ				Zhou, Hong; Wang, Yapei; Lv, Qiongying; Zhang, Juan; Wang, Qing; Gao, Fei; Hou, Haoli; Zhang, Hao; Zhang, Wei; Li, Lijia			Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; DNA METHYLATION; HISTONE MODIFICATION; GENE; HYPERMETHYLATION; PROTEIN; EPIGENETICS; SUPPRESSION; EXPRESSION; TUMORS	The ribosomal RNA (rRNA) gene encodes rRNA for protein synthesis. Aberrant expression of the rRNA gene has been generally observed in tumor cells and levels of its promoter methylation as an epigenetic regulator affect rRNA gene transcription. The possible relationship between expression and promoter methylation of rDNA has not been examined in human clinical cervical cancer. Here we investigate rRNA gene expression by quantitative real time PCR, and promoter methylation levels by HpaII/MspI digestion and sodium bisulfite sequencing in the development of human cervical cancer. We find that indeed rRNA levels are elevated in most of cervical intraepithelial neoplasia (CIN) specimens as compared with non-cancer tissues. The rDNA promoter region in cervical intraepithelial neoplasia (CIN) tissues reveals significant hypomethylation at cytosines in the context of CpG dinucleotides, accompanied with rDNA chromatin decondensation. Furthermore treatment of HeLa cells with the methylation inhibitor drug 5-aza-2'-deoxycytidine (DAC) demonstrates the negative correlation between the expression of 45S rDNA and the methylation level in the rDNA promoter region. These data suggest that a decrease in rDNA promoter methylation levels can result in an increase of rRNA synthesis in the development of human cervical cancer.	[Zhou, Hong; Wang, Yapei; Wang, Qing; Gao, Fei; Hou, Haoli; Zhang, Hao; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China; [Lv, Qiongying; Zhang, Juan; Zhang, Wei] Wuhan Univ, Zhongnan Hosp, Dept Gynecol & Obstet, Wuhan, Peoples R China	Wuhan University; Wuhan University	Li, LJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China.; Zhang, W (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Gynecol & Obstet, Wuhan, Peoples R China.	zw6676@163.com; ljli@who.edu.cn			National Natural Science Foundation of China [31171186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31171186).	Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD A, 1981, CELL, V26, P381, DOI 10.1016/0092-8674(81)90207-5; Chan MWY, 2005, CLIN CANCER RES, V11, P7376, DOI 10.1158/1078-0432.CCR-05-1100; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Colot V, 1998, J SOC BIOL, V193, P29; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Derenzini M, 1998, AM J PATHOL, V152, P1291; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Esteller M, 1999, CANCER RES, V59, P67; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Huang M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone., DOI 10.1371/JOURNAL.PONE]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karahan G, 2015, ONCOL REP, V33, P3131, DOI 10.3892/or.2015.3940; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lim KY, 2000, CHROMOSOMA, V109, P161; Lima de Faria A, 1976, HEREDITAS; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; MacCARTY WM. CARPENTER, 1936, AMER JOUR CANCER, V26, P529; Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; McGowan PO, 2008, PROMOTER WIDE HYPERM; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Powell MA, 2002, CANCER-AM CANCER SOC, V94, P2941, DOI 10.1002/cncr.10559; Raval A, 2012, BLOOD, V120, P4812, DOI 10.1182/blood-2012-04-423111; Reddy KS, 1998, HUM GENET, V102, P653, DOI 10.1007/s004390050758; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Williamson D, 2006, GENE CHROMOSOME CANC, V45, P839, DOI 10.1002/gcc.20347; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Yu AD, 1998, HUM MOL GENET, V7, P609, DOI 10.1093/hmg/7.4.609	54	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163340	10.1371/journal.pone.0163340	http://dx.doi.org/10.1371/journal.pone.0163340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695092	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100030
J	Qiao, N; Wang, XY; Liu, L				Qiao, Niu; Wang, Xuan-Yi; Liu, Lei			Temporal Evolutionary Dynamics of Norovirus GII. 4 Variants in China between 2004 and 2015	PLOS ONE			English	Article							GASTROENTERITIS; OUTBREAKS; CLASSIFICATION; EMERGENCE; VIRUSES	Background Noroviruses are one of the major causes of acute human nonbacterial gastroenteritis, and genotype II. 4 (GII. 4) has accounted for the majority of adult outbreaks. In addition, novel epidemic strain emerges every 2 to 3 years and spreads globally in months. There are little data reporting the evolutionary dynamics of GII. 4 variants along a specific period in China. Methods All norovirus GII. 4 sequences in China were downloaded from GenBank Database. Phylogenetic tree was constructed by MEGA and Bayesian evolutionary inference techniques were applied by BEAST software to study the genetic relationships, evolution rate, evolutionary time scale and the demographic history of GII. 4 variants. Homology models were predicted by SWISS-MODEL to analyze the spatial structure changes. Results During the 12-year period, 624 GII. 4 sequences were subtyped into six GII. 4 variants (clusters). A rate of 4.74x10(-3), 6.99x10(-3) and 7.68x10(-3) nucleotide substitutions/site/year for the strict, uncorrelated log-normal and uncorrelated exponential derivation clocks were estimated, respectively. Three amino acid mutations (G255S, S393G and H414P) in both Den Haag_2006b sub-clusters and six mutations (I244T, N309S, A377T, T244I, T377A and S393G) in three Sydney_2012 sub-clusters were observed. Conclusions The temporal distribution pattern of noroviruses GII. 4 lineages in China was similar to the worldwide observation. The evolutionary rate of GII. 4 was consistent with the global studies. Amino acid changes in the vicinity of norovirus epitope may have profound influences on carbohydrate binding affinity between different sub-clusters of norovirus variants. Hence understanding the evolutionary dynamics of norovirus is of great value for developing effective prevention and control strategies.	[Qiao, Niu; Liu, Lei] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Qiao, Niu; Wang, Xuan-Yi; Liu, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Qiao, Niu; Wang, Xuan-Yi; Liu, Lei] Fudan Univ, Key Lab Med Mol Virol, MoE MoH, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, L (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Liu, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Liu, L (corresponding author), Fudan Univ, Key Lab Med Mol Virol, MoE MoH, Shanghai 200032, Peoples R China.	liulei_fdu@163.com			 [2015AA020104];  [2106YFC0901900]	; 	This work was supported by 2015AA020104 (http://loca.fudan.edu.cn/list.php?pid=34&ty=125), and 2106YFC0901900 (http://service.most.gov.cn/2015tztg_all/20160625/1127.html).	Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bok K, 2009, J VIROL, V83, P11890, DOI 10.1128/JVI.00864-09; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Bull RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000831; Cao S, 2007, J VIROL, V81, P5949, DOI 10.1128/JVI.00219-07; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Rougemont A, 2011, J VIROL, V85, P4057, DOI 10.1128/JVI.02077-10; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Debbink K, 2012, J VIROL, V86, P1214, DOI 10.1128/JVI.06189-11; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kroneman A, 2011, CLIN INFECT DIS, V51, P121, DOI [10.1016/j, 10. 1086/525259, DOI 10.1086/525259]; Lim KL, 2013, J MED VIROL, V85, P1842, DOI 10.1002/jmv.23669; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seto Y, 2005, MICROBIOL IMMUNOL, V49, P275, DOI 10.1111/j.1348-0421.2005.tb03718.x; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Yen C, 2011, CLIN INFECT DIS, V53, P568, DOI 10.1093/cid/cir478; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	42	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163166	10.1371/journal.pone.0163166	http://dx.doi.org/10.1371/journal.pone.0163166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649572	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100060
J	Witt, AE; Lee, CW; Lee, TI; Azzam, DJ; Wang, B; Caslini, C; Petrocca, F; Grosso, J; Jones, M; Cohick, EB; Gropper, AB; Wahlestedt, C; Richardson, AL; Shiekhattar, R; Young, RA; Ince, TA				Witt, A. E.; Lee, C-W; Lee, T. I.; Azzam, D. J.; Wang, B.; Caslini, C.; Petrocca, F.; Grosso, J.; Jones, M.; Cohick, E. B.; Gropper, A. B.; Wahlestedt, C.; Richardson, A. L.; Shiekhattar, R.; Young, R. A.; Ince, T. A.			Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer	ONCOGENE			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; TUMOR-INITIATING CELLS; POOR-PROGNOSIS; EXPRESSION; DIFFERENTIATION; INHIBITOR; MIR-34A; BENZAMIDE; SIGNATURE; CARCINOMA	Tumours are comprised of a highly heterogeneous population of cells, of which only a small subset of stem-like cells possess the ability to regenerate tumours in vivo. These cancer stem cells (CSCs) represent a significant clinical challenge as they are resistant to conventional cancer therapies and play essential roles in metastasis and tumour relapse. Despite this realization and great interest in CSCs, it has been difficult to develop CSC-targeted treatments due to our limited understanding of CSC biology. Here, we present evidence that specific histone deacetylases (HDACs) play essential roles in the CSC phenotype. Utilizing a novel CSC model, we discovered that the HDACs, HDAC1 and HDAC7, are specifically over-expressed in CSCs when compared to non-stem-tumour-cells (nsTCs). Furthermore, we determine that HDAC1 and HDAC7 are necessary to maintain CSCs, and that over-expression of HDAC7 is sufficient to augment the CSC phenotype. We also demonstrate that clinically available HDAC inhibitors (HDACi) targeting HDAC1 and HDAC7 can be used to preferentially target CSCs. These results provide actionable insights that can be rapidly translated into CSC-specific therapies.	[Witt, A. E.; Wang, B.; Caslini, C.; Grosso, J.; Jones, M.; Ince, T. A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr,Dept Pathol, Braman Family Breast Canc Inst,Interdisciplinary, Miami, FL 33136 USA; [Lee, C-W; Cohick, E. B.; Richardson, A. L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Lee, T. I.; Cohick, E. B.; Gropper, A. B.; Young, R. A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Azzam, D. J.; Wahlestedt, C.] Univ Miami, Miller Sch Med, Ctr Therapeut Innovat, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Petrocca, F.] Harvard Med Sch, Dept Pediat, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Shiekhattar, R.] Univ Miami, Miller Sch Med, Dept Human Genet, Sylvester Comprehens Canc, Biomed Res Bldg, Miami, FL 33136 USA	University of Miami; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Miami; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Miami	Ince, TA (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst,Dept Pathol,TA I, Braman Family Breast Canc Inst,Sylvester Comprehe, Biomed Res Bldg BRB Room 907, Miami, FL 33136 USA.	TInce@med.miami.edu	Azzam, Diana/ABB-8342-2021; Caslini, Corrado/W-6123-2019; Young, Richard A/F-6495-2012	Azzam, Diana/0000-0002-2605-8855; Caslini, Corrado/0000-0001-8326-8368; Young, Richard A/0000-0001-8855-8647; Cohick, Evan/0000-0002-0824-9148; Ince, Tan/0000-0003-0315-6425	Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami; Breast Cancer Research Foundation, New York, NY; Women's Cancer Association; DoD-CDMRP Ovarian Cancer Research Program Resource Development Grant [W81XWH-14-1-0160, OC130649]; National Cancer Institute, Roadmap Epigenomics project [R01-CA146445-01]; NATIONAL CANCER INSTITUTE [R01CA146445, K22CA184244, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105754, R01GM078455] Funding Source: NIH RePORTER	Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami; Breast Cancer Research Foundation, New York, NY; Women's Cancer Association; DoD-CDMRP Ovarian Cancer Research Program Resource Development Grant; National Cancer Institute, Roadmap Epigenomics project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from: (1) Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami (TAI); (2) Breast Cancer Research Foundation, New York, NY (TAI); (3) Women's Cancer Association (TAI); (4) DoD-CDMRP Ovarian Cancer Research Program (W81XWH-14-1-0160) Resource Development Grant OC130649 (TAI), and (5) National Cancer Institute, Roadmap Epigenomics project (R01-CA146445-01) to TAI, TIL and RAY. We thank Jayanta Debnath for his help with 3D morphogenesis assays, Dr Antonello Mai for providing MC1575, Chuck Harrell for help with mRNA expression array analysis, P.L. Guevara for help with FACs analysis, Noriyuki Kasahara and Sara Collins for transduction of OCI-P5x cell line with luciferase and F. Reinhardt for technical assistance.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Belsky DW, 2013, JAMA PSYCHIAT, V70, P534, DOI 10.1001/jamapsychiatry.2013.736; Boissinot M, 2012, LEUKEMIA RES, V36, P1304, DOI 10.1016/j.leukres.2012.07.002; Carrasco E, 2014, EUR J CLIN INVEST, V44, P678, DOI 10.1111/eci.12276; Chikamatsu K, 2013, CANCER SCI, V104, P1468, DOI 10.1111/cas.12271; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clocchiatti A, 2013, FASEB J, V27, P942, DOI 10.1096/fj.12-209346; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Debeb BG, 2012, STEM CELLS, V30, P2366, DOI 10.1002/stem.1219; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Galanis E, 2009, J CLIN ONCOL, V27, P2052, DOI 10.1200/JCO.2008.19.0694; Gao HF, 2013, J NEURO-ONCOL, V113, P221, DOI 10.1007/s11060-013-1119-1; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Higashijima J, 2011, ONCOL REP, V26, P343, DOI 10.3892/or.2011.1312; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Ince TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8419; Jiao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042564; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kasler HG, 2011, J IMMUNOL, V186, P4782, DOI 10.4049/jimmunol.1001179; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kok M, 2009, J PATHOL, V218, P316, DOI 10.1002/path.2544; Leth-Larsen R, 2012, MOL MED, V18, P1109, DOI 10.2119/molmed.2012.00091; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Merritt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080314; Milde T, 2010, CLIN CANCER RES, V16, P3240, DOI 10.1158/1078-0432.CCR-10-0395; Minamiya Y, 2011, LUNG CANCER, V74, P300, DOI 10.1016/j.lungcan.2011.02.019; Miyake K, 2008, PANCREAS, V36, pE1, DOI 10.1097/MPA.0b013e31815f2c2a; Munster PN, 2001, CANCER RES, V61, P8492; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Pasto A, 2014, ONCOTARGET, V5, P4305, DOI 10.18632/oncotarget.2010; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rowehl RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099091; Salvador MA, 2013, CLIN CANCER RES, V19, P6520, DOI 10.1158/1078-0432.CCR-13-0877; Sauder CAM, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-20; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stuelten CH, 2010, STEM CELLS, V28, P649, DOI 10.1002/stem.324; Van Damme M, 2012, EPIGENETICS-US, V7, P1403, DOI 10.4161/epi.22674; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Wang Y, 2015, AM J TRANSL RES, V7, P111; Williams K, 2013, EXP BIOL MED, V238, P324, DOI 10.1177/1535370213480714; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Wu MY, 2014, CANCER LETT, V354, P311, DOI 10.1016/j.canlet.2014.08.031; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Zhang L, 2010, J BIOL CHEM, V285, P38463, DOI 10.1074/jbc.M110.153999; Zhu CH, 2011, J MOL MED, V89, P279, DOI 10.1007/s00109-010-0701-7	59	97	102	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1707	1720		10.1038/onc.2016.337	http://dx.doi.org/10.1038/onc.2016.337			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27694895	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000397460600010
J	Roberts, BJ; Svoboda, RA; Overmiller, AM; Lewis, JD; Kowalczyk, AP; Mahoney, MG; Johnson, KR; Wahl, JK				Roberts, Brett J.; Svoboda, Robert A.; Overmiller, Andrew M.; Lewis, Joshua D.; Kowalczyk, Andrew P.; Mahoney, My G.; Johnson, Keith R.; Wahl, James K., III			Palmitoylation of Desmoglein 2 Is a Regulator of Assembly Dynamics and Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESMOSOME DYNAMICS; PLASMA-MEMBRANE; P120 CATENIN; CELLS; IDENTIFICATION; ACYLATION; DISEASE; DIFFERENTIATION; DESMOPLAKIN; JUNCTIONS	Desmosomes are prominent adhesive junctions present between many epithelial cells as well as cardiomyocytes. The mechanisms controlling desmosome assembly and remodeling in epithelial and cardiac tissue are poorly understood. We recently identified protein palmitoylation as a mechanism regulating desmosome dynamics. In this study, we have focused on the palmitoylation of the desmosomal cadherin desmoglein-2 (Dsg2) and characterized the role that palmitoylation of Dsg2 plays in its localization and stability in cultured cells. We identified two cysteine residues in the juxtamembrane (intracellular anchor) domain of Dsg2 that, when mutated, eliminate its palmitoylation. These cysteine residues are conserved in all four desmoglein family members. Although mutant Dsg2 localizes to endogenous desmosomes, there is a significant delay in its incorporation into junctions, and the mutant is also present in a cytoplasmic pool. Triton X-100 solubility assays demonstrate that mutant Dsg2 is more soluble than wild-type protein. Interestingly, trafficking of the mutant Dsg2 to the cell surface was delayed, and a pool of the non-palmitoylated Dsg2 co-localized with lysosomal markers. Taken together, these data suggest that palmitoylation of Dsg2 regulates protein transport to the plasma membrane. Modulation of the palmitoylation status of desmosomal cadherins can affect desmosome dynamics.	[Roberts, Brett J.; Svoboda, Robert A.; Johnson, Keith R.; Wahl, James K., III] Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA; [Johnson, Keith R.] Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Overmiller, Andrew M.; Mahoney, My G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Lewis, Joshua D.; Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Lewis, Joshua D.; Kowalczyk, Andrew P.] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center; Jefferson University; Emory University; Emory University	Wahl, JK (corresponding author), Univ Nebraska Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA.	jwahl@unmc.edu			Nebraska Research Initiative and the Eppley Cancer Center [P30CA036727]; Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health) [P30GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR065074, R01AR048266, F31AR066476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	Nebraska Research Initiative and the Eppley Cancer Center; Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Microscopy images were acquired and processed at the University of Nebraska Medical Center Advanced Microscopy Core Facility supported by the Nebraska Research Initiative and the Eppley Cancer Center (P30CA036727) and Nebraska Center for Cellular Signaling CoBRE (National Institutes of Health P30GM106397). The anti-Lamp-1 hybridoma supernatant developed by J. T. August and J. E. K. Hildreth was obtained from the Developmental Studies Hybridoma Bank, created by NICHD, National Institutes of Health and maintained at the Department of Biology, University of Iowa, Iowa City, IA 52242.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Allen E, 1996, J CELL BIOL, V133, P1367, DOI 10.1083/jcb.133.6.1367; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Broussard JA, 2015, CELL TISSUE RES, V360, P501, DOI 10.1007/s00441-015-2136-5; Chalker JM, 2009, CHEM-ASIAN J, V4, P630, DOI 10.1002/asia.200800427; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chum T, 2016, J CELL SCI, V129, P95, DOI 10.1242/jcs.175190; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; FALCONE D, 1991, MOL CELL BIOL, V11, P2656, DOI 10.1128/MCB.11.5.2656; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gehmlich K, 2010, HEART RHYTHM, V7, P1446, DOI 10.1016/j.hrthm.2010.08.007; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2014, J PATHOL, V233, P4, DOI 10.1002/path.4339; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Harmon RM, 2013, CELL COMMUN ADHES, V20, P171, DOI 10.3109/15419061.2013.855204; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu KM, 2015, J INVEST DERMATOL, V135, P2603, DOI 10.1038/jid.2015.240; McGuinn KP, 2014, METHODS MOL BIOL, V1195, P133, DOI 10.1007/7651_2014_71; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Nitoiu D, 2014, CELL COMMUN ADHES, V21, P129, DOI 10.3109/15419061.2014.908854; NUBER UA, 1995, EUR J CELL BIOL, V66, P69; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Roberts BJ, 2014, J CELL SCI, V127, P3782, DOI 10.1242/jcs.149849; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; SCHMELZ M, 1986, EUR J CELL BIOL, V42, P177; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Stahley SN, 2015, CELL TISSUE RES, V360, P439, DOI 10.1007/s00441-015-2155-2; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; Wahl JK, 2000, J CELL SCI, V113, P1737; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24857	24865		10.1074/jbc.M116.739458	http://dx.doi.org/10.1074/jbc.M116.739458			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27703000	Green Published, hybrid			2022-12-26	WOS:000388880100006
J	Park, SH; Kim, J; Yu, M; Park, JH; Kim, YS; Moon, Y				Park, Seong-Hwan; Kim, Juil; Yu, Mira; Park, Jae-Hong; Kim, Yong Sik; Moon, Yuseok			Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; ELEMENT-BINDING PROTEIN-2; PPAR-GAMMA; LIPID RAFTS; CELLS; ALPHA; TRANSCRIPTION; EXPRESSION; GENE; PHOSPHORYLATION	Patients with chronic intestinal ulcerative diseases, such as inflammatory bowel disease, tend to exhibit abnormal lipid profiles, which may affect the gut epithelial integrity. We hypothesized that epithelial cholesterol depletion may trigger inflammation-checking machinery via cholesterol sentinel signaling molecules whose disruption in patients may aggravate inflammation and disease progression. In the present study, sterol regulatory element-binding protein 2 (SREBP2) as the cholesterol sentinel was assessed for its involvement in the epithelial inflammatory responses in cholesterol-depleted enterocytes. Patients and experimental animals with intestinal ulcerative injuries showed suppression in epithelial SREBP2. Moreover, SREBP2-deficient enterocytes showed enhanced pro-inflammatory signals in response to inflammatory insults, indicating regulatory roles of SREBP2 in gut epithelial inflammation. However, epithelial cholesterol depletion transiently induced pro inflammatory chemokine expression regardless of the well known pro-inflammatory nuclear factor-kappa B signals. In contrast, cholesterol depletion also exerts regulatory actions to maintain epithelial homeostasis against excessive inflammation via SREBP2-associated signals in a negative feedback loop. Mechanistically, SREBP2 and its induced target EGR-1 were positively involved in induction of peroxisome proliferator-activated receptor gamma (PPAR gamma), a representative anti-inflammatory transcription factor. As a crucial target of the SREBP2-EGR-1-PPAR gamma-associated signaling pathways, the mRNA stabilizer, human antigen R (HuR) was retained in nuclei, leading to reduced stability of pro-inflammatory chemokine transcripts. This mechanistic investigation provides clinical insights into protective roles of the epithelial cholesterol deficiency against excessive inflammatory responses via the SREBP2-HuR circuit, although the deficiency triggers transient pro-inflammatory signals.	[Park, Seong-Hwan; Kim, Juil; Yu, Mira; Moon, Yuseok] Pusan Natl Univ, Sch Med, Lab Mucosal Exposome & Biomodulat, Dept Biomed Sci, Yangsan 50612, South Korea; [Park, Seong-Hwan; Kim, Juil; Yu, Mira; Moon, Yuseok] Pusan Natl Univ, Sch Med, Med Res Inst, Yangsan 50612, South Korea; [Park, Jae-Hong] Pusan Natl Univ, Dept Pediat, Yangsan 50612, South Korea; [Kim, Yong Sik] Seoul Natl Univ, Dept Pharmacol, Coll Med, Seoul 03080, South Korea; [Moon, Yuseok] Brain Busan 21 Project, Immunoregulatory Therapeut Grp, Busan 46241, South Korea	Pusan National University; Pusan National University; Pusan National University; Seoul National University (SNU)	Moon, Y (corresponding author), Pusan Natl Univ, Sch Med, Dept Biomed Sci, Yangsan 50612, South Korea.	moon@pnu.edu	Yuseok Moon, ATS/AAE-4364-2020; Yu, Mi Ra/AAF-2735-2020	Yu, Mi Ra/0000-0002-2141-0012; MOON, YUSEOK/0000-0001-8686-8166	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2015R1A2A1A15056056]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2015R1A2A1A15056056). The authors declare that they have no conflicts of interest with the contents of this article.	Abe J, 2013, CIRCULATION, V128, P579, DOI 10.1161/CIRCULATIONAHA.113.004390; Agouridis AP, 2011, ANN GASTROENTEROL, V24, P181; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Aoyagi Y, 2010, PEDIATR INT, V52, P729, DOI 10.1111/j.1442-200X.2010.03195.x; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Biyyani RSRS, 2010, J CLIN LIPIDOL, V4, P478, DOI 10.1016/j.jacl.2010.08.021; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Calleros L, 2006, CELL SIGNAL, V18, P2292, DOI 10.1016/j.cellsig.2006.05.012; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Choi HJ, 2013, INFECT IMMUN, V81, P1860, DOI 10.1128/IAI.00162-13; Choi HJ, 2009, TOXICOL APPL PHARM, V240, P46, DOI 10.1016/j.taap.2009.06.023; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Eckmann L, 2005, SPRINGER SEMIN IMMUN, V27, P181, DOI 10.1007/s00281-005-0207-5; FEINGOLD KR, 1989, DIABETES, V38, P141, DOI 10.2337/diabetes.38.2.141; Field FJ, 2001, J LIPID RES, V42, P1687; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fu MG, 2002, J BIOL CHEM, V277, P26808, DOI 10.1074/jbc.M203748200; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Klopotek A, 2006, EXP BIOL MED, V231, P1365, DOI 10.1177/153537020623100810; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; KWONG LK, 1991, DIABETES, V40, P1630, DOI 10.2337/diabetes.40.12.1630; LIU JW, 1993, CELL GROWTH DIFFER, V4, P611; Lyles BE, 2009, CELL CYCLE, V8, P268, DOI 10.4161/cc.8.2.7584; Lynch RD, 2007, EXP CELL RES, V313, P2597, DOI 10.1016/j.yexcr.2007.05.009; Miyata M, 2014, BIOCHEM BIOPH RES CO, V443, P477, DOI 10.1016/j.bbrc.2013.11.126; Moon Y, 2008, TOXICOL APPL PHARM, V231, P94, DOI 10.1016/j.taap.2008.03.016; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; Park SH, 2010, J IMMUNOL, V185, P5522, DOI 10.4049/jimmunol.1001315; Park SH, 2013, J IMMUNOL, V191, P5170, DOI 10.4049/jimmunol.1301145; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Pramfalk C, 2010, J LIPID RES, V51, P1354, DOI [10.1194/jlr.M900274-JLR200, 10.1194/jlr.M900274]; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Roth A, 2008, PHARMACOGENET GENOM, V18, P325, DOI 10.1097/FPC.0b013e3282f706e0; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Taylor HE, 2011, J VIROL, V85, P7699, DOI 10.1128/JVI.00337-11; Thebault S, 2006, PROTEOMICS, V6, P3926, DOI 10.1002/pmic.200500714; Triantafilou M, 2002, J CELL SCI, V115, P2603; von Knethen A, 2007, J CELL BIOL, V176, P681, DOI 10.1083/jcb.200605038; Warren CA, 2008, J INFECT DIS, V198, P143, DOI 10.1086/588819; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yamamoto-Furusho JK, 2011, INFLAMM BOWEL DIS, V17, P680, DOI 10.1002/ibd.21322; Yeh M, 2004, CIRC RES, V95, P780, DOI 10.1161/01.RES.0000146030.53089.18; Zhao RZ, 2014, BIOCHEM BIOPH RES CO, V448, P329, DOI 10.1016/j.bbrc.2014.04.052	52	9	9	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24641	24656		10.1074/jbc.M116.723973	http://dx.doi.org/10.1074/jbc.M116.723973			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703009	hybrid, Green Published			2022-12-26	WOS:000388875500025
J	Hill, RJ; Ringel, A; Knuepfer, E; Moon, RW; Blackman, MJ; van Ooij, C				Hill, Ross J.; Ringel, Alessa; Knuepfer, Ellen; Moon, Robert W.; Blackman, Michael J.; van Ooij, Christiaan			Regulation and Essentiality of the StAR-related Lipid Transfer (START) Domain-containing Phospholipid Transfer Protein PFA0210c in Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid transport; malaria; parasitology; phospholipid; plasmodium	PLASMODIUM-FALCIPARUM; PHOSPHATIDYLCHOLINE; ERYTHROCYTES; METABOLISM; TRANSPORT; VIRULENCE; INVASION; SEQUENCE; SYSTEM	StAR-related lipid transfer (START) domains are phospholipid- or sterol-binding modules that are present in many proteins. START domain-containing proteins (START proteins) play important functions in eukaryotic cells, including the redistribution of phospholipids to subcellular compartments and delivering sterols to the mitochondrion for steroid synthesis. How the activity of the START domain is regulated remains unknown for most of these proteins. The Plasmodium falciparum START protein PFA0210c (PF3D7_0104200) is a broad-spectrum phospholipid transfer protein that is conserved in all sequenced Plasmodium species and is most closely related to the mammalian START proteins STARD2 and STARD7. PFA0210c is unusual in that it contains a signal sequence and a PEXEL export motif that together mediate transfer of the protein from the parasite to the host erythrocyte. The protein also contains a C-terminal extension, which is very uncommon among mammalian START proteins. Whereas the biochemical properties of PFA0210c have been characterized, the function of the protein remains unknown. Here, we provide evidence that the unusual C-terminal extension negatively regulates phospholipid transfer activity. Furthermore, we use the genetically tractable Plasmodium knowlesi model and recently developed genetic technology in P. falciparum to show that the protein is essential for growth of the parasite during the clinically relevant asexual blood stage life cycle. Finally, we show that the regulation of phospholipid transfer by PFA0210c is required in vivo, and we identify a potential second regulatory domain. These findings provide insight into a novel mechanism of regulation of phospholipid transfer in vivo and may have important implications for the interaction of the malaria parasite with its host cell.	[Hill, Ross J.; Ringel, Alessa; Knuepfer, Ellen; Blackman, Michael J.; van Ooij, Christiaan] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Moon, Robert W.] London Sch Hyg & Trop Med, Dept Infect & Immun, London WC1E 7HT, England; [Blackman, Michael J.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Ringel, Alessa] Westfal Wilhelms Univ Munster, D-48149 Munster, Germany	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Munster	van Ooij, C (corresponding author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England.	christiaan.vanOoij@crick.ac.uk	Singh, Balbir/A-3610-2009; Moon, Robert/AAF-9808-2019	Moon, Robert/0000-0002-9070-4292; Hill, Ross/0000-0003-2847-6855; Knuepfer, Ellen/0000-0002-6090-1877; Ringel, Alessa/0000-0002-6392-6076	Cancer Research UK [FC001043]; MRC [MR/M021157/1] Funding Source: UKRI; Medical Research Council [MR/M021157/1] Funding Source: researchfish; The Francis Crick Institute [10044, 10043, 10320] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We are indebted to Prof. Shamshad Cockcroft and Nick Blunsom (University College London) for assistance with scintillation counting, Prof. Angelika Grundling (Imperial College London) for assistance with protein purification, and Dr. Marcus Lee (The Wellcome Trust Sanger Institute) for sharing the pDC2-cam-Cas9-U6-hDHFR plasmid. The Francis Crick Institute received its core funding from Cancer Research UK Grant FC001043.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Collins CR, 2013, MOL MICROBIOL, V88, P687, DOI 10.1111/mmi.12206; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Fougere A., 2016, PLOS PATHOG IN PRESS; Frech C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-427; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jones ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep21800; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; KASPER AM, 1981, BIOCHEMISTRY-US, V20, P146, DOI 10.1021/bi00504a024; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; MARKS PA, 1960, J BIOL CHEM, V235, P2579; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Mundwiler-Pachlatko E, 2013, P NATL ACAD SCI USA, V110, P19987, DOI 10.1073/pnas.1309247110; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Olayioye MA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701990200; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Sam-Yellowe TY, 2009, TRENDS PARASITOL, V25, P277, DOI 10.1016/j.pt.2009.03.009; Sherling ES, 2016, FEMS MICROBIOL REV, V40, P701, DOI 10.1093/femsre/fuw016; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; van Ooij C, 2013, J BIOL CHEM, V288, P31971, DOI 10.1074/jbc.M113.474189; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482	45	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24280	24292		10.1074/jbc.M116.740506	http://dx.doi.org/10.1074/jbc.M116.740506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27694132	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000388498100039
J	Harris, LW; Davies, TJ				Harris, Liam W.; Davies, T. Jonathan			A Complete Fossil-Calibrated Phylogeny of Seed Plant Families as a Tool for Comparative Analyses: Testing the 'Time for Speciation' Hypothesis	PLOS ONE			English	Article							ANGIOSPERM DIVERSIFICATION; SPECIES RICHNESS; EVOLUTION; RATES; AGE; PATTERNS; CLADES; DNA; CLASSIFICATION; RADIATIONS	Explaining the uneven distribution of species richness across the branches of the tree of life has been a major challenge for evolutionary biologists. Advances in phylogenetic reconstruction, allowing the generation of large, well-sampled, phylogenetic trees have provided an opportunity to contrast competing hypotheses. Here, we present a new time-calibrated phylogeny of seed plant families using Bayesian methods and 26 fossil calibrations. While there are various published phylogenetic trees for plants which have a greater density of species sampling, we are still a long way from generating a complete phylogeny for all similar to 300,000+ plants. Our phylogeny samples all seed plant families and is a useful tool for comparative analyses. We use this new phylogenetic hypothesis to contrast two alternative explanations for differences in species richness among higher taxa: time for speciation versus ecological limits. We calculated net diversification rate for each clade in the phylogeny and assessed the relationship between clade age and species richness. We then fit models of speciation and extinction to individual branches in the tree to identify major rate-shifts. Our data suggest that the majority of lineages are diversifying very slowly while a few lineages, distributed throughout the tree, are diversifying rapidly. Diversification is unrelated to clade age, no matter the age range of the clades being examined, contrary to both the assumption of an unbounded lineage increase through time, and the paradigm of fixed ecological limits. These findings are consistent with the idea that ecology plays a role in diversification, but rather than imposing a fixed limit, it may have variable effects on per lineage diversification rates through time.	[Harris, Liam W.; Davies, T. Jonathan] McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Davies, T. Jonathan] Univ Johannesburg, African Ctr DNA Barcoding, POB 524,Auckland Pk, ZA-2006 Johannesburg, South Africa	McGill University; University of Johannesburg	Davies, TJ (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, POB 524,Auckland Pk, ZA-2006 Johannesburg, South Africa.	j.davies@mcgill.ca		Harris, Liam/0000-0002-4995-904X	NSERC Discovery grant	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	JD was supported by an NSERC Discovery grant.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Augusto L, 2014, ECOL LETT, V17, P1326, DOI 10.1111/ele.12323; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bininda-Emonds O. R. P., 2004, PHYLOGENETIC SUPERTR, V4; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Britton T, 2006, PATHD8 A NEW METHOD; Bromham L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-126; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Coiffard C, 2013, TAXON, V62, P141, DOI 10.1002/tax.621012; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davies TJ, 2007, SYST ASSOC SPEC VOL, V72, P149; Davies TJ, 2005, AM NAT, V166, P418, DOI 10.1086/432022; Davies TJ, 2004, PHILOS T R SOC B, V359, P1645, DOI 10.1098/rstb.2004.1524; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; Farjon A, 2001, WORLD CHECKLIST BIBL; FUSCO G, 1995, J THEOR BIOL, V175, P235, DOI 10.1006/jtbi.1995.0136; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Morlon H, 2015, RPANDA R PACKAGE MAC; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Neinhuis C., 1998, FAMILIES GENERA VASC, P198; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rambaut A., 2007, TRACER V1 4; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Salamin N., 2004, COMPU BIOL, V4; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Schaefer H, 2011, TAXON, V60, P122, DOI 10.1002/tax.601011; Silvestro D, 2015, NEW PHYTOL, V207, P425, DOI 10.1111/nph.13247; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stadler T, 2014, AM NAT, V184, P447, DOI 10.1086/677676; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; Steel M, 2010, APPL MATH LETT, V23, P1315, DOI 10.1016/j.aml.2010.06.021; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Thomas GH, 2013, METHODS ECOL EVOL, V4, P1011, DOI 10.1111/2041-210X.12117; Vamosi JC, 2010, ECOL LETT, V13, P1270, DOI 10.1111/j.1461-0248.2010.01521.x; VOS RA, 2004, COMPU BIOL, V4, P281; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang ZH, 2009, J SYST EVOL, V47, P297, DOI 10.1111/j.1759-6831.2009.00035.x	77	21	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162907	10.1371/journal.pone.0162907	http://dx.doi.org/10.1371/journal.pone.0162907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706173	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200023
J	Vilajeliu-Pons, A; Baneras, L; Puig, S; Molognoni, D; Vila-Rovira, A; Hernandez-del Amo, E; Balaguer, MD; Colprim, J				Vilajeliu-Pons, Anna; Baneras, Lluis; Puig, Sebastia; Molognoni, Daniele; Vila-Rovira, Albert; Hernandez-del Amo, Elena; Balaguer, Maria D.; Colprim, Jesus			External Resistances Applied to MFC Affect Core Microbiome and Swine Manure Treatment Efficiencies	PLOS ONE			English	Article							DIRECT ELECTRON-TRANSFER; DOMESTIC WASTE-WATER; FUEL-CELL; BIOELECTROCHEMICAL SYSTEMS; ELECTRICITY-GENERATION; SHEWANELLA-ONEIDENSIS; COMMUNITY STRUCTURE; FLUID-DYNAMICS; RECOVERY; PERFORMANCE	Microbial fuel cells (MFCs) can be designed to combine water treatment with concomitant electricity production. Animal manure treatment has been poorly explored using MFCs, and its implementation at full-scale primarily relies on the bacterial distribution and activity within the treatment cell. This study reports the bacterial community changes at four positions within the anode of two almost identically operated MFCs fed swine manure. Changes in the microbiome structure are described according to the MFC fluid dynamics and the application of a maximum power point tracking system (MPPT) compared to a fixed resistance system (Ref-MFC). Both external resistance and cell hydrodynamics are thought to heavily influence MFC performance. The microbiome was characterised both quantitatively (qPCR) and qualitatively (454-pyrosequencing) by targeting bacterial 16S rRNA genes. The diversity of the microbial community in the MFC biofilm was reduced and differed from the influent swine manure. The adopted electric condition (MPPT vs fixed resistance) was more relevant than the fluid dynamics in shaping the MFC microbiome. MPPT control positively affected bacterial abundance and promoted the selection of putatively exoelectrogenic bacteria in the MFC core microbiome (Sedimentibacter sp. and gammaproteobacteria). These differences in the microbiome may be responsible for the two-fold increase in power production achieved by the MPPT-MFC compared to the Ref-MFC.	[Vilajeliu-Pons, Anna; Puig, Sebastia; Vila-Rovira, Albert; Balaguer, Maria D.; Colprim, Jesus] Univ Girona, Inst Environm, LEQUiA, Girona, Spain; [Baneras, Lluis; Hernandez-del Amo, Elena] Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain; [Molognoni, Daniele] Univ Pavia, Dept Civil Engn & Architecture DIC Ar, Pavia, Italy	Universitat de Girona; Universitat de Girona; University of Pavia	Baneras, L (corresponding author), Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain.	lluis.banyeras@udg.edu	Amo, Elena Hernández-del/AAR-7099-2020; Puig, Sebastià/L-8562-2014; Balaguer, M. Dolors/AAC-6114-2019; Colprim, Jesús/L-3087-2014; Rovira, Albert Vilà/Z-5665-2019; Bañeras, Lluis/K-6736-2017	Amo, Elena Hernández-del/0000-0001-9190-4221; Puig, Sebastià/0000-0003-2995-1443; Balaguer, M. Dolors/0000-0001-6231-2163; Colprim, Jesús/0000-0002-6000-069X; Rovira, Albert Vilà/0000-0002-3379-6346; Bañeras, Lluis/0000-0001-6908-3658				Aelterman P, 2006, ENVIRON SCI TECHNOL, V40, P3388, DOI 10.1021/es0525511; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Blanchet E, 2015, BIORESOURCE TECHNOL, V185, P106, DOI 10.1016/j.biortech.2015.02.097; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Borsje C, 2016, J POWER SOURCES, V325, P690, DOI 10.1016/j.jpowsour.2016.06.092; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Celmer D, 2008, WATER RES, V42, P3057, DOI 10.1016/j.watres.2008.02.031; Cotta MA, 2003, ENVIRON MICROBIOL, V5, P737, DOI 10.1046/j.1467-2920.2003.00467.x; Dolfing J, 2014, ISME J, V8, P4, DOI 10.1038/ismej.2013.198; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Feng YJ, 2014, BIORESOURCE TECHNOL, V156, P132, DOI 10.1016/j.biortech.2013.12.104; Garcia-Pena EI, 2011, BIORESOURCE TECHNOL, V102, P9447, DOI 10.1016/j.biortech.2011.07.068; Gardel EJ, 2012, ENVIRON SCI TECHNOL, V46, P5222, DOI 10.1021/es204622m; Han I, 2011, APPL MICROBIOL BIOT, V89, P835, DOI 10.1007/s00253-010-2893-8; Heidrich ES, 2013, APPL MICROBIOL BIOT, V97, P6979, DOI 10.1007/s00253-012-4456-7; Heidrich ES, 2014, BIORESOURCE TECHNOL, V173, P87, DOI 10.1016/j.biortech.2014.09.083; Jia JN, 2013, BIORESOURCE TECHNOL, V144, P94, DOI 10.1016/j.biortech.2013.06.072; Kelly PT, 2014, BIORESOURCE TECHNOL, V153, P351, DOI 10.1016/j.biortech.2013.12.046; Kim J, 2014, WATER SCI TECHNOL, V69, P1447, DOI 10.2166/wst.2014.041; Kim JR, 2012, J POWER SOURCES, V213, P382, DOI 10.1016/j.jpowsour.2012.03.040; Koch C, 2013, NAT PROTOC, V8, P190, DOI 10.1038/nprot.2012.149; Lee TK, 2010, APPL MICROBIOL BIOT, V87, P2335, DOI 10.1007/s00253-010-2680-6; Lesnik KL, 2014, APPL MICROBIOL BIOT, V98, P4187, DOI 10.1007/s00253-013-5502-9; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; Lovley DR, 2011, ENV MICROBIOL REP, V3, P27, DOI 10.1111/j.1758-2229.2010.00211.x; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Michie IS, 2014, BIORESOURCE TECHNOL, V165, P13, DOI 10.1016/j.biortech.2014.03.069; Min B, 2005, WATER RES, V39, P4961, DOI 10.1016/j.watres.2005.09.039; Miran W, 2015, ENVIRON SCI POLLUT R, V22, P13477, DOI 10.1007/s11356-015-4582-8; Molognoni D, 2016, J CHEM TECHNOL BIOT, V91, P1720, DOI 10.1002/jctb.4760; Molognoni D, 2014, J POWER SOURCES, V269, P403, DOI 10.1016/j.jpowsour.2014.07.033; Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Oliveira VB, 2013, BIOCHEM ENG J, V73, P53, DOI 10.1016/j.bej.2013.01.012; Patil SA, 2009, BIORESOURCE TECHNOL, V100, P5132, DOI 10.1016/j.biortech.2009.05.041; Pinto RP, 2011, WATER RES, V45, P1571, DOI 10.1016/j.watres.2010.11.033; Premier GC, 2011, J POWER SOURCES, V196, P2013, DOI 10.1016/j.jpowsour.2010.09.071; Puig S, 2011, J HAZARD MATER, V185, P763, DOI 10.1016/j.jhazmat.2010.09.086; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Regueiro L, 2014, J BIOTECHNOL, V192, P179, DOI 10.1016/j.jbiotec.2014.10.007; Rosenbaum M, 2010, BIOTECHNOL BIOENG, V105, P880, DOI 10.1002/bit.22621; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Sangcharoen A, 2015, PROCESS BIOCHEM, V50, P1648, DOI 10.1016/j.procbio.2015.06.013; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shen YJ, 2013, BIORESOURCE TECHNOL, V136, P707, DOI 10.1016/j.biortech.2013.02.069; Siegert M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00778; Sleutels THJA, 2011, BIORESOURCE TECHNOL, V102, P11172, DOI 10.1016/j.biortech.2011.09.078; Sutton AL, 1999, J ANIM SCI, V77, P430; Tao QQ, 2015, DESALINATION, V365, P92, DOI 10.1016/j.desal.2015.02.021; Trias R, 2012, APPL ENVIRON MICROB, V78, P318, DOI 10.1128/AEM.05904-11; Velasquez-Orta SB, 2011, BIORESOURCE TECHNOL, V102, P5105, DOI 10.1016/j.biortech.2011.01.059; Velvizhi G, 2015, WATER RES, V70, P52, DOI 10.1016/j.watres.2014.11.002; Velvizhi G, 2012, INT J HYDROGEN ENERG, V37, P5969, DOI 10.1016/j.ijhydene.2011.12.112; Vila-Rovira A, 2015, RSC ADV, V5, P78994, DOI 10.1039/c5ra11995b; Vilajeliu-Pons A, 2015, J HAZARD MATER, V288, P60, DOI 10.1016/j.jhazmat.2015.02.014; Vilar-Sanz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063460; Wagner M, 2015, NATURE, V526, P513, DOI 10.1038/526513a; Watanabe K, 2011, APPL MICROBIOL BIOT, V92, P1307, DOI 10.1007/s00253-011-3598-3; Wrighton KC, 2008, ISME J, V2, P1146, DOI 10.1038/ismej.2008.48; Zhang YF, 2015, BIOTECHNOL BIOENG, V112, P1478, DOI 10.1002/bit.25549; Zhang YF, 2015, BIORESOURCE TECHNOL, V177, P233, DOI 10.1016/j.biortech.2014.11.079; Zhuang L, 2012, BIORESOURCE TECHNOL, V106, P82, DOI 10.1016/j.biortech.2011.11.019	69	24	25	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164044	10.1371/journal.pone.0164044	http://dx.doi.org/10.1371/journal.pone.0164044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701451	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900040
J	Zhao, JJ; Li, XM				Zhao, Jijun; Li, Xinmin			Determinants of the Transmission Variation of Hand, Foot and Mouth Disease in China	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MEASLES; DYNAMICS; PATTERNS; IMPACT; POLIO	Severe outbreaks of hand, foot and mouth disease (HFMD) have occurred in China for decades. Our understanding of the HFMD transmission process and its determinants is still limited. In this paper, factors that affect the local variation of HFMD transmission process were studied. Three classes of factors, including meteorological, demographic and public health intervention factors, were carefully selected and their effects on HFMD transmission were investigated with Pearson's correlation coefficient and multiple linear regression models. The determining factors for the variation of HFMD transmission were different for the southeastern and the northwestern regions of China. In the northwest, fadeouts occurred yearly, and the average age at infection and the fadeout were negatively correlated with the population density. In the southeast, HFMD transmission was governed by the combined effects of the birth rate, the relative humidity and the interaction of the Health System Performance and the log of the population density. When the Health System Performance was low, HFMD transmission increased with the population density, but when the Health System Performance was high, the better health performance counteracted the transmission increase due to the higher population density.	[Zhao, Jijun] Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China; [Li, Xinmin] Qingdao Univ, Sch Math & Stat, Qingdao, Peoples R China	Qingdao University; Qingdao University	Zhao, JJ (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China.	jjzhao@qdu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018; Li, Xinmin/AGW-3734-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Li, Xinmin/0000-0002-2573-5236				ANDERSON R M, 1991; [Anonymous], 1989, APPL LINEAR REGRESSI; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Ferrari MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0141; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Li S, 2009, AM J EPIDEMIOL, V170, P257, DOI 10.1093/aje/kwp116; Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Manfredi Piero, 2005, Popul Health Metr, V3, P1, DOI 10.1186/1478-7954-3-1; Martinez-Bakker M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002172; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Metcalf CJE, 2011, EPIDEMIOL INFECT, V139, P1029, DOI 10.1017/S0950268810002165; Pica N, 2012, CURR OPIN VIROL, V2, P90, DOI 10.1016/j.coviro.2011.12.003; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y., 2009, ADV NEURAL INFORM PR, P2008, DOI DOI 10.1097/EDE.0B013E318231D67A; Webster P, 2005, LANCET, V366, P359, DOI 10.1016/S0140-6736(05)67008-0; Williams JR, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-23; Xie YH, 2015, EPIDEMIOL INFECT, V143, P1432, DOI 10.1017/S0950268814002301; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Zhao J, BMC INFECT IN PRESS; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051984	34	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163789	10.1371/journal.pone.0163789	http://dx.doi.org/10.1371/journal.pone.0163789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701445	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900020
J	Cheung, MB; Sampayo-Escobar, V; Green, R; Moore, ML; Mohapatra, S; Mohapatra, SS				Cheung, Michael B.; Sampayo-Escobar, Viviana; Green, Ryan; Moore, Martin L.; Mohapatra, Subhra; Mohapatra, Shyam S.			Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase	PLOS ONE			English	Article							HUMAN BONE-MARROW; PATTERN-RECOGNITION RECEPTORS; 2,3-DIOXYGENASE IDO ACTIVITY; IN-VITRO EXPANSION; INDOLEAMINE 2,3-DIOXYGENASE; STROMAL CELLS; PERIPHERAL-BLOOD; DENDRITIC CELLS; INNATE IMMUNITY; PROTEIN	Respiratory syncytial virus (RSV) has been reported to infect human mesenchymal stem cells (MSCs) but the consequences are poorly understood. MSCs are present in nearly every organ including the nasal mucosa and the lung and play a role in regulating immune responses and mediating tissue repair. We sought to determine whether RSV infection of MSCs enhances their immune regulatory functions and contributes to RSV-associated lung disease. RSV was shown to replicate in human MSCs by fluorescence microscopy, plaque assay, and expression of RSV transcripts. RSV-infected MSCs showed differentially altered expression of cytokines and chemokines such as IL-1 beta, IL6, IL-8 and SDF-1 compared to epithelial cells. Notably, RSV-infected MSCs exhibited significantly increased expression of IFN-beta (similar to 100-fold) and indoleamine-2,3-dioxygenase (IDO) (similar to 70-fold) than in mock-infected MSCs. IDO was identified in cytosolic protein of infected cells by Western blots and enzymatic activity was detected by tryptophan catabolism assay. Treatment of PBMCs with culture supernatants from RSV-infected MSCs reduced their proliferation in a dose dependent manner. This effect on PBMC activation was reversed by treatment of MSCs with the IDO inhibitors 1-methyltryptophan and vitamin K-3 during RSV infection, a result we confirmed by CRISPR/Cas9-mediated knockout of IDO in MSCs. Neutralizing IFN-beta prevented IDO expression and activity. Treatment of MSCs with an endosomal TLR inhibitor, as well as a specific inhibitor of the TLR3/dsRNA complex, prevented IFN-beta and IDO expression. Together, these results suggest that RSV infection of MSCs alters their immune regulatory function by upregulating IFN-beta and IDO, affecting immune cell proliferation, which may account for the lack of protective RSV immunity and for chronicity of RSV-associated lung diseases such as asthma and COPD.	[Cheung, Michael B.; Sampayo-Escobar, Viviana; Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley Vet Affairs Hosp, Tampa, FL 33613 USA; [Cheung, Michael B.; Sampayo-Escobar, Viviana; Green, Ryan; Mohapatra, Subhra; Mohapatra, Shyam S.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA; [Mohapatra, Shyam S.] Univ S Florida, Coll Pharm, Tampa, FL 33620 USA; [Moore, Martin L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Emory University; Children's Healthcare of Atlanta (CHOA)	Mohapatra, SS (corresponding author), James A Haley Vet Affairs Hosp, Tampa, FL 33613 USA.; Mohapatra, SS (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA.; Mohapatra, SS (corresponding author), Univ S Florida, Coll Pharm, Tampa, FL 33620 USA.	smohapat@health.usf.edu	Cheung, Michael/G-5459-2011	Cheung, Michael/0000-0002-0021-3802	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Research Career Scientist and Veterans Affairs Merit Review awards [51016X000954-02]; NIH [R01AI087798, U19AI095227]; American Heart Association [US 15PRE25760005]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Research Career Scientist and Veterans Affairs Merit Review awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. This research was financially supported by Research Career Scientist and Veterans Affairs Merit Review awards to Dr. Shyam Mohapatra (51016X000954-02). Dr. Martin L. Moore was supported by NIH R01AI087798 and NIH U19AI095227. Mr. Ryan Green was supported by the American Heart Association (US 15PRE25760005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajamian F, 2015, CLIN EXP ALLERGY, V45, P644, DOI 10.1111/cea.12498; Ajamian F, 2010, ALLERGY ASTHMA CL IM, V6, P1, DOI [10.1186/1710-1492-6-s3-p8, DOI 10.1186/1710-1492-6-S3-P8]; Arrevillaga G, 2012, INTERVIROLOGY, V55, P442, DOI 10.1159/000335548; Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z; Bassi EJ, 2012, STEM CELL REV REP, V8, P329, DOI 10.1007/s12015-011-9311-1; Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bentley JK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-127; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Borse RH, 2014, J PEDIAT INF DIS SOC, V3, P201, DOI 10.1093/jpids/pit072; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Cassatella MA, 2011, STEM CELLS, V29, P1001, DOI 10.1002/stem.651; Chen GY, 2009, J VIROL, V83, P10548, DOI 10.1128/JVI.01250-09; Chen J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/985814; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; Cheng K, 2011, J AM CHEM SOC, V133, P3764, DOI 10.1021/ja111312h; Cho KS, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt404; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Eisenhut M, 2006, CRIT CARE, V10, DOI 10.1186/cc4984; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fields B. N., 2001, FIELDS VIROLOGY, V4; Fox JM, 2014, J LEUKOCYTE BIOL, V96, P447, DOI 10.1189/jlb.3AB0114-046RR; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Girard SD, 2011, JOVE-J VIS EXP, DOI 10.3791/2762; Giuliani M, 2014, STEM CELLS, V32, P290, DOI 10.1002/stem.1563; Guerrero-Plata A, 2004, VIRUS RES, V99, P95, DOI 10.1016/j.virusres.2003.10.005; Guerrero-Plata A, 2001, VIRAL IMMUNOL, V14, P19, DOI 10.1089/08828240151061347; Hackstein H, 2011, CELL IMMUNOL, V271, P401, DOI 10.1016/j.cellimm.2011.08.008; Haddad N. EI, 2011, MESENCHYMAL STEM CEL; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Jorquera PA, 2013, EXPERT REV RESP MED, V7, P411, DOI 10.1586/17476348.2013.814409; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kim E, 2014, J VIROL, V88, P5100, DOI 10.1128/JVI.03194-13; Kong XY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-3; Kumar S, 2008, J MED CHEM, V51, P1706, DOI 10.1021/jm7014155; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Larsen S, 2011, PATHOLOGY, V43, P592, DOI 10.1097/PAT.0b013e32834ab72d; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Lindemans CA, 2006, J IMMUNOL, V176, P5529, DOI 10.4049/jimmunol.176.9.5529; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Littel-van den Hurk SV, 2012, CURR OPIN VIROL, V2, P300, DOI 10.1016/j.coviro.2012.01.008; Mallela J, 2013, STEM CELLS, V31, P1321, DOI 10.1002/stem.1376; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; Miller L., 2010, ANAL GELS W BLOTS IM; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; O'Donnell DR, 1998, J PEDIATR-US, V133, P272, DOI 10.1016/S0022-3476(98)70234-3; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Papin JF, 2013, INFANT BABOONS INFEC; Piedimonte G, 2002, RESP MED, V96, pS25, DOI 10.1053/rmed.2002.1297; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Rasband W.S., 1997, IMAGEJ; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Respiratory Syncytial Virus Activity-United States, 2011, 8 CDCP OFF SURV E LA; Respiratory syncytial virus-United States, 2007, 35 CDCP; Rezaee F, 2010, AM J RESP CRIT CARE, V181; Rezaee F, 2011, AM J RESP CELL MOL, V45, P277, DOI 10.1165/rcmb.2010-0121OC; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Sage LK, 2014, VIRAL IMMUNOL, V27, P112, DOI 10.1089/vim.2013.0105; Schmidt SV, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00384; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tasso R, 2012, INVEST OPHTH VIS SCI, V53, P786, DOI 10.1167/iovs.11-8211; Ugonna K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091855; Wong TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088764; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Yui I, 2003, J MED VIROL, V70, P481, DOI 10.1002/jmv.10421	93	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163709	10.1371/journal.pone.0163709	http://dx.doi.org/10.1371/journal.pone.0163709			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695127	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100049
J	Daher, AM; AlMashoor, SHA; Winn, T				Daher, Aqil M.; AlMashoor, Syed Hassan A.; Winn, Than			Performance of the Malay Audit of Diabetes Dependent Quality of Life-18 and Associates of Quality of Life among Patients with Type 2 Diabetes Mellitus from Major Ethnic Groups of Malaysia	PLOS ONE			English	Article							INSULIN GLARGINE; QUESTIONNAIRE; PREVALENCE; MANAGEMENT; THERAPY; IMPACT; PREDICTORS; VALIDITY; ADULTS; ASIA	Introduction Diabetes Mellitus (DM) is notorious for its metabolic effect, acute and chronic complications and impact on Quality of Life (QoL). Successful intervention to improve QoL necessitates a valid and reliable measurement tool to identify areas of concern to patients with diabetes. Objectives To (1) assess the factor structure of the Malay Audit of Diabetes Dependent Quality of Life-18 (ADDQoL-18) questionnaire; (2) determine the impact of DM on QoL; and (3) identify areas of concern to patients with type 2 DM from three major ethnic groups in Malaysia. Methods Data was obtained from a cross sectional study involving 256 patients with type 2 DM attending the diabetes clinic of the National University of Malaysia Medical Centre. The Malay version of ADDQoL-18 survey was translated from its English version according to standard guidelines and administered by a trained research assistant. Exploratory Factor Analysis (EFA) with oblimin rotation was used to determine factor structure of the data. Confirmatory Factor Analysis (CFA) was used to confirm the factor structure. Hierarchical liner regression was used to determine factors associated with QoL. Results Unforced factor solution yielded two factors for the whole sample. Forced one factor solution was ascertained for the whole sample and for each ethnic group. Loadings ranged between 0.588 and 0.949. Reliability coefficients were all higher than 0.955. CFA showed that the two factor model had better fit statistics. QoL was associated with the use of insulin and desired glycaemic control, longer diabetes duration, worry about diabetes, and diabetes complications. Conclusions The Malay ADDQoL-18 is a valid tool to be used among patients with diabetes from different ethnic groups in Malaysia. The use of insulin to achieve desired glycaemic control had more negative impact on QoL than the use of tablets and/or dietary changes.	[Daher, Aqil M.] Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Community Med, Kuala Lumpur, Malaysia; [AlMashoor, Syed Hassan A.] Univ Teknol MARA, Dept Psychiat, Fac Med, Batu Caves, Selangor, Malaysia; [Winn, Than] MAHSA Univ, Dept Community Med, Fac Med, Kuala Lumpur, Malaysia	Universiti Pertahanan Nasional Malaysia; Mahsa University	Daher, AM (corresponding author), Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Community Med, Kuala Lumpur, Malaysia.	Aqil702001@yahoo.com	DAHER, AQIL M/A-5821-2018	DAHER, AQIL M/0000-0002-3504-4340				Akinci F, 2008, DIABETES RES CLIN PR, V79, P117, DOI 10.1016/j.diabres.2007.07.003; Al-Habori M, 2004, DIABETES RES CLIN PR, V65, P275, DOI 10.1016/j.diabres.2004.02.001; Baiyewu O., 2006, HONG KONG J PSYCHIAT, V16, P27; Banegas JR, 2007, EUR J CARDIOV PREV R, V14, P456, DOI 10.1097/HJR.0b013e3280803f29; Bowden A, 2003, SOC SCI MED, V57, P1289, DOI 10.1016/S0277-9536(02)00503-8; Bradley C, 2001, LANCET, V357, P7, DOI 10.1016/S0140-6736(00)03562-5; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chiew KQ, 1999, META, V44, P604; Cohen J., 2013, APPL MULTIPLE REGRES; Costa Filipa Alves, 2006, Pharm Pract (Granada), V4, P123; de Grauw WJC, 2001, BRIT J GEN PRACT, V51, P527; Department of Statistics, 2011, POP DISTR BAS DEM CH; Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195; Eljedi A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-268; Fischer JS, 2004, CURR MED RES OPIN, V20, P1703, DOI 10.1185/030079904X5526; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Gurkova E, 2009, J CLIN NURS, V18, P1276, DOI 10.1111/j.1365-2702.2008.02602.x; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Houlden R, 2007, DIABETES RES CLIN PR, V78, P254, DOI 10.1016/j.diabres.2007.03.021; Imran M. Kamarul, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P398; Institute for Public Health, 2011, NAT HLTH MORB SURV 2, V1; International Diabetes Federation, 2011, DIAB ATL BRUSS; International Diabetes Federation, 2013, DIAB ATL BRUSS; International Diabetes Federation, 2014, DIAB ATL BRUSS; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kolotkin RL, 2003, DIABETES RES CLIN PR, V61, P125, DOI 10.1016/S0168-8227(03)00113-X; Lau C Y, 2004, J Postgrad Med, V50, P189; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Ostini R, 2012, QUAL LIFE RES, V21, P1471, DOI 10.1007/s11136-011-0043-0; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012; Pibernik-Okanovic M, 1998, PHARMACOECONOMICS, V14, P201, DOI 10.2165/00019053-199814020-00008; Quandt SA, 2007, ETHNIC DIS, V17, P471; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Shiu ATY, 2008, J CLIN NURS, V17, P125, DOI 10.1111/j.1365-2702.2007.02036.x; SNELL SA, 1992, ACAD MANAGE J, V35, P467, DOI 10.2307/256484; Speight J, 2013, DIABETIC MED, V30, P74, DOI 10.1111/j.1464-5491.2012.03748.x; Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002; Wee HL, 2006, PHARMACOECONOMICS, V24, P673, DOI 10.2165/00019053-200624070-00006; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2012, COUNTR REG DAT DIAB	46	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163701	10.1371/journal.pone.0163701	http://dx.doi.org/10.1371/journal.pone.0163701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695086	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100048
J	Sin, YW; Newman, C; Dugdale, HL; Buesching, C; Mannarelli, ME; Annavi, G; Burke, T; Macdonald, DW				Sin, Yung Wa; Newman, Chris; Dugdale, Hannah L.; Buesching, Christina; Mannarelli, Maria-Elena; Annavi, Geetha; Burke, Terry; Macdonald, David W.			No Compensatory Relationship between the Innate and Adaptive Immune System in Wild-Living European Badgers	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SUBCAUDAL GLAND SECRETION; IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; LEUKOCYTE COPING CAPACITY; MELES-MELES; CLASS-I; OXIDATIVE STRESS; MHC GENES; MULTIMODEL INFERENCE; POPULATION-DYNAMICS	The innate immune system provides the primary vertebrate defence system against pathogen invasion, but it is energetically costly and can have immune pathological effects. A previous study in sticklebacks found that intermediate major histocompatibility complex (MHC) diversity correlated with a lower leukocyte coping capacity (LCC), compared to individuals with fewer, or many, MHC alleles. The organization of the MHC genes in mammals, however, differs to the highly duplicated MHC genes in sticklebacks by having far fewer loci. Using European badgers (Meles meles), we therefore investigated whether innate immune activity, estimated functionally as the ability of an individual's leukocytes to produce a respiratory burst, was influenced by MHC diversity. We also investigated whether LCC was influenced by factors such as age-class, sex, body condition, season, year, neutrophil and lymphocyte counts, and intensity of infection with five different pathogens. We found that LCC was not associated with specific MHC haplotypes, MHC alleles, or MHC diversity, indicating that the innate immune system did not compensate for the adaptive immune system even when there were susceptible MHC alleles/haplotypes, or when the MHC diversity was low. We also identified a seasonal and annual variation of LCC. This temporal variation of innate immunity was potentially due to physiological trade-offs or temporal variation in pathogen infections. The innate immunity, estimated as LCC, does not compensate for MHC diversity suggests that the immune system may function differently between vertebrates with different MHC organizations, with implications for the evolution of immune systems in different taxa.	[Sin, Yung Wa; Newman, Chris; Buesching, Christina; Annavi, Geetha; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England; [Sin, Yung Wa; Mannarelli, Maria-Elena; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Sin, Yung Wa] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA; [Dugdale, Hannah L.] Univ Groningen, Groningen Inst Evolutionary Life Sci, POB 11103, NL-9700 CC Groningen, Netherlands; [Dugdale, Hannah L.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Mannarelli, Maria-Elena] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Annavi, Geetha] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia	University of Oxford; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; Harvard University; University of Groningen; University of Leeds; University of East Anglia; Universiti Putra Malaysia	Sin, YW (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England.; Sin, YW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England.; Sin, YW (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	yungwa.sin@gmail.com	Burke, Terry/B-3196-2011; Dugdale, Hannah L/C-7138-2008	Burke, Terry/0000-0003-3848-1244; Dugdale, Hannah L/0000-0001-8769-0099; Sin, Simon Yung Wa/0000-0003-2484-2897	Croucher Foundation (Hong Kong); Ministry of Education Malaysia; Netherlands Organization for Scientific Research (NWO); NERC [NE/I021748/1]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NE/I021748/1, NBAF010001] Funding Source: researchfish	Croucher Foundation (Hong Kong); Ministry of Education Malaysia(Ministry of Education, Malaysia); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	YWS was supported by the Croucher Foundation (Hong Kong), GA by the Ministry of Education Malaysia, and HD by the Netherlands Organization for Scientific Research (NWO) and a NERC fellowship (NE/I021748/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anderson D. R., 2008, MODEL BASED INFERENC; Annavi G, 2014, J EVOLUTION BIOL, V27, P2191, DOI 10.1111/jeb.12473; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bilham K, 2013, ETHOL ECOL EVOL, V25, P330, DOI 10.1080/03949370.2013.767861; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Blagojevic Dusko P, 2011, Front Biosci (Schol Ed), V3, P416, DOI 10.2741/s161; Bonneaud C, 2005, IMMUNOGENETICS, V57, P782, DOI 10.1007/s00251-005-0046-5; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Buesching CD, 2002, J CHEM ECOL, V28, P41, DOI 10.1023/A:1013558718057; Buesching CD, 2002, MAMM BIOL, V67, P147, DOI 10.1078/1616-5047-00022; Buesching CD, 2009, J COMP PHYSIOL A, V195, P865, DOI 10.1007/s00359-009-0465-0; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Buttemer WA, 2010, FUNCT ECOL, V24, P971, DOI 10.1111/j.1365-2435.2010.01740.x; CALLAHAN HL, 1988, PARASITOL TODAY, V4, P218, DOI 10.1016/0169-4758(88)90162-7; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; Charbonnel N, 2010, EVOL APPL, V3, P279, DOI 10.1111/j.1752-4571.2009.00108.x; Chiumiento L, 2009, PARASITOL RES, V105, P593, DOI 10.1007/s00436-009-1483-0; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Cox R, 1999, J INSECT BEHAV, V12, P245, DOI 10.1023/A:1020923001987; Culshaw S, 2008, IMMUNOL LETT, V118, P49, DOI 10.1016/j.imlet.2008.02.008; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Doxiadis GGM, 2001, IMMUNOL REV, V183, P76, DOI 10.1034/j.1600-065x.2001.1830106.x; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Dugdale HL, 2011, ANIM BEHAV, V82, P1287, DOI 10.1016/j.anbehav.2011.09.008; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Evsikov V. I., 1994, ADV BIOSCIENCES CHEM, V93, P303; Foreyt W.J, 2001, VET PARASITOLOGY REF, V5th; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gelling M, 2009, ANIM WELFARE, V18, P1; Gelman A, 2009, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Grueber CE, 2011, MOL ECOL, V20, P67, DOI 10.1111/j.1365-294X.2010.04930.x; Hidano A, 2014, INSECT MOL BIOL, V23, P466, DOI 10.1111/imb.12101; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; Lifjeld JT, 2002, OECOLOGIA, V130, P185, DOI 10.1007/s004420100798; Lozano GA, 2003, P ROY SOC B-BIOL SCI, V270, P1203, DOI 10.1098/rspb.2002.2309; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; Macdonald DW, 1999, J ZOOL, V247, P65, DOI 10.1111/j.1469-7998.1999.tb00193.x; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; MAKHATADZE NJ, 1995, HUM IMMUNOL, V42, P189, DOI 10.1016/0198-8859(94)00090-D; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; McLaren GW, 2005, VET ANAESTH ANALG, V32, P367, DOI 10.1111/j.1467-2995.2005.00206.x; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Montes I, 2007, LEUKOCYTE COPING CAP; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Newman C, 2001, PARASITOLOGY, V123, P133, DOI 10.1017/S0031182001008265; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Richardson DS, 2005, P ROY SOC B-BIOL SCI, V272, P759, DOI 10.1098/rspb.2004.3028; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; Sin YW, 2015, MOL ECOL, V24, P3138, DOI 10.1111/mec.13217; Sin YW, 2014, MOL ECOL, V23, P5072, DOI 10.1111/mec.12917; Sin YW, 2012, ECOL EVOL, V2, P1644, DOI 10.1002/ece3.285; Sin YW, 2012, FEMS MICROBIOL ECOL, V81, P648, DOI 10.1111/j.1574-6941.2012.01396.x; Sin YW, 2012, IMMUNOGENETICS, V64, P313, DOI 10.1007/s00251-011-0578-9; Sin YW, 2014, MAJOR HISTOCOMPATIBI; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Travers Paul, 1994, IMMUNOBIOLOGY; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; Wagner JL, 1999, J HERED, V90, P35, DOI 10.1093/jhered/90.1.35; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wedekind C, 1998, J CHEM ECOL, V24, P787, DOI 10.1023/A:1022365315836; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zuur Alain F., 2009, P1	97	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163773	10.1371/journal.pone.0163773	http://dx.doi.org/10.1371/journal.pone.0163773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695089	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100052
J	Johnson, JL; Ramadass, M; He, J; Brown, SJ; Zhang, JZ; Abgaryan, L; Biris, N; Gavathiotis, E; Rosen, H; Catz, SD				Johnson, Jennifer L.; Ramadass, Mahalakshmi; He, Jing; Brown, Steven J.; Zhang, Jinzhong; Abgaryan, Lusine; Biris, Nikolaos; Gavathiotis, Evripidis; Rosen, Hugh; Catz, Sergio D.			Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation DRUGGABILITY OF THE SMALL GTPase Rab27a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LUNG INJURY; NADPH OXIDASE; PLASMA-MEMBRANE; SUBCELLULAR-LOCALIZATION; RAB27A; MYELOPEROXIDASE; PROTEIN; TRAFFICKING; MECHANISMS; ELASTASE	Neutrophils constitute the first line of cellular defense in response to bacterial and fungal infections and rely on granular proteins to kill microorganisms, but uncontrolled secretion of neutrophil cargos is injurious to the host and should be closely regulated. Thus, increased plasma levels of neutrophil secretory proteins, including myeloperoxidase and elastase, are associated with tissue damage and are hallmarks of systemic inflammation. Here, we describe a novel high-throughput screening approach to identify small molecule inhibitors of the interaction between the small GTPase Rab27a and its effector JFC1, two central regulators of neutrophil exocytosis. Using this assay, we have identified small molecule inhibitors of Rab27a-JFC1 binding that were also active in cell-based neutrophil-specific exocytosis assays, demonstrating the druggability of Rab GTPases and their effectors. These compounds, named Nexinhibs (neutrophil exocytosis inhibitors), inhibit exocytosis of azurophilic granules in human neutrophils without affecting other important innate immune responses, including phagocytosis and neutrophil extracellular trap production. Furthermore, the compounds are reversible and potent inhibitors of the extracellular production of superoxide anion by preventing the up-regulation of the granule membrane-associated subunit of the NADPH oxidase at the plasma membrane. Nexinhibs also inhibit the upregulation of activation signature molecules, including the adhesion molecules CD11b and CD66b. Importantly, by using a mouse model of endotoxin-induced systemic inflammation, we show that these inhibitors have significant activity in vivo manifested by decreased plasma levels of neutrophil secretory proteins and significantly decreased tissue infiltration by inflammatory neutrophils. Altogether, our data present the first neutrophil exocytosis-specific inhibitor with in vivo anti-inflammatory activity, supporting its potential use as an inhibitor of systemic inflammation.	[Johnson, Jennifer L.; Ramadass, Mahalakshmi; He, Jing; Zhang, Jinzhong; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Brown, Steven J.; Abgaryan, Lusine; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Biris, Nikolaos; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [He, Jing; Zhang, Jinzhong] Cystinosis Res Fdn, Irvine, CA USA	Scripps Research Institute; Scripps Research Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.	scatz@scripps.edu	Zhang, Jinzhong/E-5670-2012	Zhang, Jinzhong/0000-0002-2540-2749; Catz, Sergio/0000-0002-1873-0277; Biris, Nikolaos/0000-0003-4055-5521; Gavathiotis, Evripidis/0000-0001-6319-8331	National Institutes of Health from USPHS [HL088256, GM105894]; American Heart Association	National Institutes of Health from USPHS; American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants HL088256 and GM105894 from USPHS (to S. D. C.) and by American Heart Association fellowships (to M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Berkowitz JKM, 2001, J BIOL CHEM, V276, P18855, DOI 10.1074/jbc.M011167200; BORREGAARD N, 1988, J BIOENERG BIOMEMBR, V20, P637, DOI 10.1007/BF00762546; Borregaard Niels, 1997, Blood, V89, P3503; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brovkovych V, 2008, AM J PHYSIOL-LUNG C, V295, pL96, DOI 10.1152/ajplung.00450.2007; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Catz SD, 2002, P NATL ACAD SCI USA, V99, P11652, DOI 10.1073/pnas.172382799; Catz SD, 2014, CELL MICROBIOL, V16, P1301, DOI 10.1111/cmi.12328; Chavas LMG, 2008, STRUCTURE, V16, P1468, DOI 10.1016/j.str.2008.07.015; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Croker BA, 2011, P NATL ACAD SCI USA, V108, P13135, DOI 10.1073/pnas.1110358108; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; Holt O, 2008, TRAFFIC, V9, P446, DOI 10.1111/j.1600-0854.2008.00714.x; Iwata K, 2010, INTERNAL MED, V49, P2423, DOI 10.2169/internalmedicine.49.4010; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Johnson JL, 2016, J BIOL CHEM, V291, P3423, DOI 10.1074/jbc.M115.705871; Johnson JL, 2013, MOL CELL BIOL, V33, P2950, DOI 10.1128/MCB.00417-13; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Johnson JL, 2005, TRAFFIC, V6, P667, DOI 10.1111/j.1600-0854.2005.00308.x; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; KLEMPNER MS, 1980, J CELL BIOL, V86, P21, DOI 10.1083/jcb.86.1.21; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Madoux F, 2008, MOL PHARMACOL, V73, P1776, DOI 10.1124/mol.108.045963; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Monfregola J, 2012, J BIOL CHEM, V287, P44603, DOI 10.1074/jbc.M112.414029; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; NUIJENS JH, 1992, J LAB CLIN MED, V119, P159; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Riddle SM, 2006, ANAL BIOCHEM, V356, P108, DOI 10.1016/j.ab.2006.05.017; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sergienko E, 2009, J BIOMOL SCREEN, V14, P824, DOI 10.1177/1087057109338517; Shimoda N, 2007, AM J PATHOL, V170, P930, DOI 10.2353/ajpath.2007.060486; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Uriarte SM, 2013, SHOCK, V39, P286, DOI 10.1097/SHK.0b013e318282c9a1; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Walsh JS, 2011, ANNU REV PHARMACOL, V51, P145, DOI 10.1146/annurev-pharmtox-010510-100514; Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Yamauchi A, 2001, MICROBIOL IMMUNOL, V45, P249, DOI 10.1111/j.1348-0421.2001.tb02614.x; Yoon J, 2007, J IMMUNOL, V179, P8454, DOI 10.4049/jimmunol.179.12.8454; Zhang CX, 2003, AM J PHYSIOL-HEART C, V285, pH2563, DOI 10.1152/ajpheart.00435.2003; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	62	50	50	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25965	25982		10.1074/jbc.M116.741884	http://dx.doi.org/10.1074/jbc.M116.741884			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27702998	Green Published, hybrid			2022-12-26	WOS:000390345200018
J	Mays, SG; Okafor, CD; Whitby, RJ; Goswami, D; Stec, J; Flynn, AR; Dugan, MC; Jui, NT; Griffin, PR; Ortlund, EA				Mays, Suzanne G.; Okafor, C. Denise; Whitby, Richard J.; Goswami, Devrishi; Stec, Jozef; Flynn, Autumn R.; Dugan, Michael C.; Jui, Nathan T.; Griffin, Patrick R.; Ortlund, Eric A.			Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; diabetes; molecular dynamics; nuclear receptor; phosphatidylcholine; lipids	MOLECULAR-DYNAMICS; GENE-EXPRESSION; WATER-MOLECULES; LRH-1; METABOLISM; ACTIVATION; SOFTWARE; SYSTEM; NR5A2	Liver receptor homolog 1 (NR5A2, LRH-1) is an orphan nuclear hormone receptor that regulates diverse biological processes, including metabolism, proliferation, and the resolution of endoplasmic reticulum stress. Although preclinical and cellular studies demonstrate that LRH-1 has great potential as a therapeutic target for metabolic diseases and cancer, development of LRH-1 modulators has been difficult. Recently, systematic modifications to one of the few known chemical scaffolds capable of activating LRH-1 failed to improve efficacy substantially. Moreover, mechanisms through which LRH-1 is activated by synthetic ligands are entirely unknown. Here, we use x-ray crystallography and other structural methods to explore conformational changes and receptor-ligand interactions associated with LRH-1 activation by a set of related agonists. Unlike phospholipid LRH-1 ligands, these agonists bind deep in the pocket and do not interact with residues near the mouth nor do they expand the pocket like phospholipids. Unexpectedly, two closely related agonists with similar efficacies (GSK8470 and RJW100) exhibit completely different binding modes. The dramatic repositioning is influenced by a differential ability to establish stable face-to-face --stacking with the LRH-1 residue His-390, as well as by a novel polar interaction mediated by the RJW100 hydroxyl group. The differing binding modes result in distinct mechanisms of action for the two agonists. Finally, we identify a network of conserved water molecules near the ligand-binding site that are important for activation by both agonists. This work reveals a previously unappreciated complexity associated with LRH-1 agonist development and offers insights into rational design strategies.	[Mays, Suzanne G.; Okafor, C. Denise; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Flynn, Autumn R.; Dugan, Michael C.; Jui, Nathan T.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Whitby, Richard J.; Stec, Jozef] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Jupiter, FL 33458 USA	Emory University; Emory University; University of Southampton; Scripps Research Institute	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029; Flynn, Autumn/0000-0003-2504-2365	National Institutes of Health [T32-GM008602, F31DK111171, R01DK095750]; Emory Catalyst Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750, F31DK111171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680, T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Catalyst Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants T32-GM008602 (to S. G. M.), F31DK111171 (to S. G. M.), and R01DK095750 (to E. A. O.) and an Emory Catalyst Grant (to E. A. O. and N. T. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barillari C, 2007, J AM CHEM SOC, V129, P2577, DOI 10.1021/ja066980q; Bayrer JR, 2015, P NATL ACAD SCI USA, V112, P2467, DOI 10.1073/pnas.1500978112; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Bianco S, 2014, CANCER RES, V74, P2015, DOI 10.1158/0008-5472.CAN-13-2351; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bolado-Carrancio A, 2014, BIOCHEM BIOPH RES CO, V446, P614, DOI 10.1016/j.bbrc.2014.03.010; Case D., 2014, AMBER TOOLS VERSION; Case D., 2012, AMBERTOOLS VERSION 1; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Klebe G, 2015, NAT REV DRUG DISCOV, V14, P95, DOI 10.1038/nrd4486; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Lalit M, 2013, J MOL STRUCT, V1049, P315, DOI 10.1016/j.molstruc.2013.06.035; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Lin QS, 2014, CANCER LETT, V345, P85, DOI 10.1016/j.canlet.2013.11.014; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mamrosh JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01694; Musille PM, 2016, J BIOL CHEM, V291, P1411, DOI 10.1074/jbc.M115.662874; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Ogata K, 2002, PROTEIN ENG, V15, P697, DOI 10.1093/protein/15.8.697; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sablin EP, 2015, J STRUCT BIOL, V192, P342, DOI 10.1016/j.jsb.2015.09.012; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Stec J, 2010, THESIS; Stein S, 2014, CELL METAB, V20, P603, DOI 10.1016/j.cmet.2014.07.023; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Zhang ZQ, 2007, BIOPHYS J, V93, P1484, DOI 10.1529/biophysj.106.100537	46	16	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25281	25291		10.1074/jbc.M116.753541	http://dx.doi.org/10.1074/jbc.M116.753541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27694446	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000390095300001
J	Chang, HHY; Watanabe, G; Gerodinnos, CA; Ochi, T; Blundell, TL; Jackson, SP; Lieber, MR				Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.; Lieber, Michael R.			Different DNA End Configurations Dictate Which NHEJ Components Are Most Important for Joining Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XRCC4-DNA LIGASE-IV; STRAND BREAK REPAIR; V(D)J RECOMBINATION; ARTEMIS; COMPLEX; PROTEIN; KU; XLF; PATHWAY; KINASE	The nonhomologous DNA end-joining (NHEJ) pathway is a key mechanism for repairing dsDNA breaks that occur often in eukaryotic cells. In the simplest model, these breaks are first recognized by Ku, which then interacts with other NHEJ proteins to improve their affinity at DNA ends. These include DNA-PKcs and Artemis for trimming the DNA ends; DNA polymerase mu and lambda to add nucleotides; and the DNA ligase IV complex to ligate the ends with the additional factors, XRCC4 (X-ray repair cross-complementing protein 4), XLF (XRCC4-like factor/Cernunos), and PAXX (paralog of XRCC4 and XLF). In vivo studies have demonstrated the degrees of importance of these NHEJ proteins in the mechanism of repair of dsDNA breaks, but interpretations can be confounded by other cellular processes. In vitro studies with NHEJ proteins have been performed to evaluate the nucleolytic resection, polymerization, and ligation steps, but a complete system has been elusive. Here we have developed a NHEJ reconstitution system that includes the nuclease, polymerase, and ligase components to evaluate relative NHEJ efficiency and analyze ligated junctional sequences for various types of DNA ends, including blunt, 5' overhangs, and 3' overhangs. We find that different dsDNA end structures have differential dependence on these enzymatic components. The dependence of some end joining on only Ku and XRCCLE DNA ligase IV allows us to formulate a physical model that incorporates nuclease and polymerase components as needed.	[Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Chang, Howard H. Y.; Watanabe, Go; Gerodinnos, Christina A.; Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Sect Mol & Computat Biol, Los Angeles, CA 90033 USA; [Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.] Univ Cambridge, Gordon Inst, Cambridge CB2 1QN, England; [Ochi, Takashi; Blundell, Tom L.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Ochi, Takashi] MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0OH, England	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Cambridge; University of Cambridge	Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Sect Mol & Computat Biol, Los Angeles, CA 90033 USA.	lieber@usc.edu	Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Ochi, Takashi/0000-0001-8546-6341; Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health; Cancer Research UK Program [C6/A11224, C6946/A14492]; Wellcome Trust [WT092096, WT 093167]; NATIONAL CANCER INSTITUTE [R01CA196671, R01CA100504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER; Cancer Research UK [18796] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK Program(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK)	This work was supported by a National Institutes of Health grant (to M. R. L.), Cancer Research UK Program Grants C6/A11224 and C6946/A14492 (to S. P. J.), and Wellcome Trust Grant WT092096. This work was also supported by Wellcome Trust Grant WT 093167 (to T.O. and T. L. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Chang HHY, 2015, J BIOL CHEM, V290, P24036, DOI 10.1074/jbc.M115.680900; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Franco S, 2008, J EXP MED, V205, P557, DOI 10.1084/jem.20080044; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Liang ZB, 2016, NUCLEIC ACIDS RES, V44, P2769, DOI 10.1093/nar/gkw013; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Pannunzio NR, 2014, DNA REPAIR, V17, P74, DOI 10.1016/j.dnarep.2014.02.006; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Roy S, 2015, MOL CELL BIOL, V35, P3017, DOI 10.1128/MCB.01503-14; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233	42	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24377	24389		10.1074/jbc.M116.752329	http://dx.doi.org/10.1074/jbc.M116.752329			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703001	hybrid, Green Published			2022-12-26	WOS:000388875500005
J	Baas, R; Sijm, A; van Teeffelen, HAAM; van Es, R; Vos, HR; Marc Timmers, HT				Baas, Roy; Sijm, Ayestha; van Teeffelen, Hetty A. A. M.; van Es, Robert; Vos, Harmjan R.; Marc Timmers, H. Th.			Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Factor Family Identifies Importin 5 as a Bone Morphogenic Protein Receptor SMAD-specific Importin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); nuclear translocation; proteomics; SMAD transcription factor; transcription regulation	GROWTH-FACTOR-BETA; NUCLEAR-LOCALIZATION SIGNAL; UBIQUITIN LIGASE; BINDING PROTEIN; BMP; INTERACTS; MEMBRANE; TARGETS; CLONING; MAN1	Gene-specific transcription factors (GSTFs) control gene transcription by DNA binding and specific protein complex recruitment, which regulates promoter accessibility for transcription initiation by RNA polymerase II. Mutations in the GSTFs Suppressor of Mothers Against Decapentaplegic 2 (SMAD2) and SMAD4 are frequently associated with colon and rectal carcinomas. These proteins play an important role in bone morphogenic protein (BMP) and transforming growth factor (TGF-) signaling pathways controlling cell fate and proliferation. To study the protein interactome of the SMAD protein family we generated a quantitative proteomics pipeline that allows for inducible expression of GFP-tagged SMAD proteins followed by affinity purification and quantitative mass spectrometry analysis. Data are available via ProteomeXchange with identifier PXD004529. The nuclear importin IPO5 was identified as a novel interacting protein of SMAD1. Overexpression of IPO5 in various cell lines specifically increases nuclear localization of BMP receptor-activated SMADs (R-SMADs) confirming a functional relationship between IPO5 and BMP but not TGF- R-SMADs. Finally, we provide evidence that variation in length of the lysine stretch of the nuclear localization sequence is a determinant for importin specificity.	[Marc Timmers, H. Th.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Stem Cells, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Marc Timmers, HT (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Regenerat Med Ctr, Ctr Mol Med, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	H.T.M.Timmers@umcutrecht.nl		Vos, Harmjan/0000-0002-4696-6068; Baas, Roy/0000-0002-3535-3565	NWO-Life Sciences Grant [821.02.012]	NWO-Life Sciences Grant	This work was supported by NWO-Life Sciences Grant 821.02.012 (to H. Th. M. T.). The authors declare that they have no conflict of interest with the contents of this article.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Baymaz HI, 2014, METHODS MOL BIOL, V1188, P207, DOI 10.1007/978-1-4939-1142-4_15; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen XC, 2010, MOL CELL BIOL, V30, P4022, DOI 10.1128/MCB.00124-10; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Guo X, 2013, MOL CELL, V51, P1, DOI 10.1016/j.molcel.2013.06.016; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Koster MJE, 2015, CELL, V161, P724, DOI 10.1016/j.cell.2015.04.033; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lebrun JJ, 1999, MOL ENDOCRINOL, V13, P15, DOI 10.1210/me.13.1.15; Lechleider RJ, 1996, J BIOL CHEM, V271, P17617, DOI 10.1074/jbc.271.30.17617; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; R Core Team, 2013, R LANG ENV STAT COMP; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tsubakihara Y, 2015, J BIOCHEM, V158, P61, DOI 10.1093/jb/mvv024; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xiao Z, 2003, ONCOGENE, V22, P1057, DOI 10.1038/sj.onc.1206212; Xiao Z, 2001, J BIOL CHEM, V276, P39404, DOI 10.1074/jbc.M103117200; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Yingling JM, 1996, P NATL ACAD SCI USA, V93, P8940, DOI 10.1073/pnas.93.17.8940; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	42	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24121	24132		10.1074/jbc.M116.748582	http://dx.doi.org/10.1074/jbc.M116.748582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703004	Green Published, hybrid			2022-12-26	WOS:000388498100028
J	Gladyshev, VN; Arner, ES; Berry, MJ; Brigelius-Flohe, R; Bruford, EA; Burk, RF; Carlson, BA; Castellano, S; Chavatte, L; Conrad, M; Copeland, PR; Diamond, AM; Driscoll, DM; Ferreiro, A; Flohe, L; Green, FR; Guigo, R; Handy, DE; Hatfield, DL; Hesketh, J; Hoffmann, PR; Holmgren, A; Hondal, RJ; Howard, MT; Huang, K; Kim, HY; Kim, IY; Kohrle, J; Krol, A; Kryukov, GV; Lee, BJ; Lee, BC; Lei, XG; Liu, Q; Lescure, A; Lobanov, AV; Loscalzo, J; Maiorino, M; Mariotti, M; Prabhu, KS; Rayman, MP; Rozovsky, S; Salinas, G; Schmidt, EE; Schomburg, L; Schweizer, U; Simonovic, M; Sunde, RA; Tsuji, PA; Tweedie, S; Ursini, F; Whanger, PD; Zhang, Y				Gladyshev, Vadim N.; Arner, Elias S.; Berry, Marla J.; Brigelius-Flohe, Regina; Bruford, Elspeth A.; Burk, Raymond F.; Carlson, Bradley A.; Castellano, Sergi; Chavatte, Laurent; Conrad, Marcus; Copeland, Paul R.; Diamond, Alan M.; Driscoll, Donna M.; Ferreiro, Ana; Flohe, Leopold; Green, Fiona R.; Guigo, Roderic; Handy, Diane E.; Hatfield, Dolph L.; Hesketh, John; Hoffmann, Peter R.; Holmgren, Arne; Hondal, Robert J.; Howard, Michael T.; Huang, Kaixun; Kim, Hwa-Young; Kim, Ick Young; Koehrle, Josef; Krol, Alain; Kryukov, Gregory V.; Lee, Byeong Jae; Lee, Byung Cheon; Lei, Xin Gen; Liu, Qiong; Lescure, Alain; Lobanov, Alexei V.; Loscalzo, Joseph; Maiorino, Matilde; Mariotti, Marco; Sandeep Prabhu, K.; Rayman, Margaret P.; Rozovsky, Sharon; Salinas, Gustavo; Schmidt, Edward E.; Schomburg, Lutz; Schweizer, Ulrich; Simonovic, Miljan; Sunde, Roger A.; Tsuji, Petra A.; Tweedie, Susan; Ursini, Fulvio; Whanger, Philip D.; Zhang, Yan			Selenoprotein Gene Nomenclature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genomics; selenium; selenocysteine; selenoprotein; structure-function; function; gene name; nomenclature	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; AMINO-ACID-SEQUENCE; THIOREDOXIN REDUCTASE; RAT-LIVER; IODOTHYRONINE 5-DEIODINASE; EUKARYOTIC SELENOPROTEINS; SELENIUM METABOLISM; CONTAINING PROTEINS; MESSENGER-RNA; SELENOCYSTEINE	The human genome contains 25 genes coding for selenocysteine-containing proteins (selenoproteins). These proteins are involved in a variety of functions, most notably redox homeostasis. Selenoprotein enzymes with known functions are designated according to these functions: TXNRD1, TXNRD2, and TXNRD3 (thioredoxin reductases), GPX1, GPX2, GPX3, GPX4, and GPX6 (glutathione peroxidases), DIO1, DIO2, and DIO3 (iodothyronine deiodinases), MSRB1 (methionine sulfoxide reductase B1), and SEPHS2 (selenophosphate synthetase 2). Selenoproteins without known functions have traditionally been denoted by SEL or SEP symbols. However, these symbols are sometimes ambiguous and conflict with the approved nomenclature for several other genes. Therefore, there is a need to implement a rational and coherent nomenclature system for selenoprotein-encoding genes. Our solution is to use the root symbol SELENO followed by a letter. This nomenclature applies to SELENOF (selenoprotein F, the 15-kDa selenoprotein, SEP15), SELENOH (selenoprotein H, SELH, C11orf31), SELENOI (selenoprotein I, SELI, EPT1), SELENOK (selenoprotein K, SELK), SELENOM (selenoprotein M, SELM), SELENON (selenoprotein N, SEPN1, SELN), SELENOO (selenoprotein O, SELO), SELENOP (selenoprotein P, SeP, SEPP1, SELP), SELENOS (selenoprotein S, SELS, SEPS1, VIMP), SELENOT (selenoprotein T, SELT), SELENOV (selenoprotein V, SELV), and SELENOW (selenoprotein W, SELW, SEPW1). This system, approved by the HUGO Gene Nomenclature Committee, also resolves conflicting, missing, and ambiguous designations for selenoprotein genes and is applicable to selenoproteins across vertebrates.	[Gladyshev, Vadim N.; Lobanov, Alexei V.; Mariotti, Marco] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Arner, Elias S.; Holmgren, Arne] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys MBB, SE-17177 Stockholm, Sweden; [Berry, Marla J.; Hoffmann, Peter R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Brigelius-Flohe, Regina] German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany; [Bruford, Elspeth A.; Tweedie, Susan] HUGOGene Nomenclature Comm HGNC, European Bioinformat Inst European Mol Biol Lab E, Hinxton CB10 1SD, England; [Burk, Raymond F.] Vanderbilt Univ, Div Gastroenterol Hepatol & Nutr, Dept Med, Sch Med, Nashville, TN 37232 USA; [Carlson, Bradley A.; Hatfield, Dolph L.] Ctr Canc Res, NIH, Mouse Canc Genet Program, Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Castellano, Sergi] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Chavatte, Laurent] INSERM, CIRI, U1111, F-69007 Lyon, France; [Chavatte, Laurent] CNRS, ENS UMR5308, F-69007 Lyon, France; [Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Copeland, Paul R.] Rutgers Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Diamond, Alan M.] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Driscoll, Donna M.] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Ferreiro, Ana] Univ Paris Diderot, Sorbonne Paris Cite, Pathophysiol Striated Muscles Lab, Unit Funct & Adapt Biol BFA,UMR CNRS 8251 BFA, F-75250 Paris, France; [Ferreiro, Ana] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Malad Neuromusculaires Paris Est, F-75013 Paris, France; [Flohe, Leopold] Univ Republica, Facultad Med, Dept Bioquim, Montevideo 11800, Uruguay; [Flohe, Leopold] Univ Padua, Dept Mol Med, I-35121 Padua, Italy; [Green, Fiona R.] Univ Manchester, Div Cardiovasc Sci, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Guigo, Roderic] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Guigo, Roderic] UPF, Barcelona 08002, Spain; [Handy, Diane E.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Handy, Diane E.] Harvard Med Sch, Boston, MA 02115 USA; [Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hesketh, John] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Hondal, Robert J.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Howard, Michael T.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Huang, Kaixun] Huazhong Univ Sci & Technol, Hubei Key Lab Bioinorgan Chem & Mat Med, Sch Chem & Chem Engn, Wuhan 430074, Peoples R China; [Kim, Hwa-Young] Yeungnam Univ, Dept Biochem & Mol Biol, Coll Med, Daegu 42415, South Korea; [Kim, Ick Young; Lee, Byung Cheon] Korea Univ, Coll Life Sci & Biotechnol, Seoul 02841, South Korea; [Koehrle, Josef; Schomburg, Lutz] Charite, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Krol, Alain; Lescure, Alain] Univ Strasbourg, Architecture & Reactivite ARN, Ctr Natl Rech Sci, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Kryukov, Gregory V.] KSQ Therapeut, Cambridge, MA 02139 USA; [Lee, Byeong Jae] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Lei, Xin Gen] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Liu, Qiong; Zhang, Yan] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Coll Life Sci, Shenzhen 518060, Guangdong Provi, Peoples R China; [Lescure, Alain] Ctr Natl Rech Sci, F-75794 Paris, France; [Loscalzo, Joseph] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Sandeep Prabhu, K.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Rayman, Margaret P.] Univ Surrey, Dept Nut Sci, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Rozovsky, Sharon] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Salinas, Gustavo] Inst Higiene, Catedra Inmunol, Fac Quim, Montevideo 11600, Uruguay; [Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Schweizer, Ulrich] Rhein Friedrich Wilhelms Univ Bonn, Inst Biochem & Molekularbiol, D-53115 Bonn, Germany; [Simonovic, Miljan] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Whanger, Philip D.] Oregon State Univ, Dept Environm & Mol Toxicol, Coll Agr Sci, Corvallis, OR 97331 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Karolinska Institutet; University of Hawaii System; University of Hawaii Manoa; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Max Planck Society; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cleveland Clinic Foundation; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universidad de la Republica, Uruguay; University of Padua; University of Manchester; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Vermont; Utah System of Higher Education; University of Utah; Huazhong University of Science & Technology; Yeungnam University; Korea University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Seoul National University (SNU); Cornell University; Shenzhen University; Centre National de la Recherche Scientifique (CNRS); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Surrey; University of Delaware; Universidad de la Republica, Uruguay; Montana State University System; Montana State University Bozeman; University of Bonn; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; Towson University; Oregon State University	Gladyshev, VN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA.; Gladyshev, VN (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	vgladyshev@rics.bwh.harvard.edu	Arnér, Elias/K-6737-2019; Tweedie, Susan/B-3695-2019; Köhrle, Josef/AAH-6438-2020; Ferreiro, Ana/F-5371-2011; Arnér, Elias S.J./J-5832-2012; Bruford, Elspeth/AAU-4961-2020; Loscalzo, Joseph/ABD-8980-2021; rozovsky, sharon/S-4534-2016; Liu, Qiong/AAK-1556-2021; Guigo, Roderic/D-1303-2010; Schomburg, Lutz/D-8096-2013; Conrad, Marcus/E-8792-2015; Mariotti, Marco/AAB-7136-2019; Castellano, Sergi/A-7437-2016	Arnér, Elias/0000-0002-4807-6114; Tweedie, Susan/0000-0003-1818-8243; Köhrle, Josef/0000-0002-9187-9078; Ferreiro, Ana/0000-0003-2806-5386; Arnér, Elias S.J./0000-0002-4807-6114; Bruford, Elspeth/0000-0002-8380-5247; rozovsky, sharon/0000-0003-4902-0777; Guigo, Roderic/0000-0002-5738-4477; Schomburg, Lutz/0000-0001-9445-1555; Conrad, Marcus/0000-0003-1140-5612; Mariotti, Marco/0000-0002-7411-4161; Simonovic, Miljan/0000-0002-1576-2222; Salinas, Gustavo/0000-0003-3350-3002; Handy, Diane/0000-0002-4310-8527; Kryukov, Gregory/0000-0002-6131-9483; Copeland, Paul/0000-0003-3343-0587; Gladyshev, Vadim/0000-0002-0372-7016; Castellano, Sergi/0000-0002-5819-4210; Chavatte, Laurent/0000-0001-7696-2431; Schweizer, Ulrich/0000-0003-1380-4780; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [GM061603]; NATIONAL CANCER INSTITUTE [R01CA193497, R01CA080946, R01CA162665, R21CA182103] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG003345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114291, R01GM061603, R01GM097042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG055022, R01AG040020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061603. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ansong E, 2014, MOL NUTR FOOD RES, V58, P117, DOI 10.1002/mnfr.201300543; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BEHNE D, 1990, BIOCHEM BIOPH RES CO, V173, P1143, DOI 10.1016/S0006-291X(05)80905-2; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BRIGELIUS-FLOHE R, 1994, J BIOL CHEM, V269, P7342; Burk RF, 2015, ANNU REV NUTR, V35, P109, DOI 10.1146/annurev-nutr-071714-034250; BURK RF, 1982, ARCH BIOCHEM BIOPHYS, V213, P73, DOI 10.1016/0003-9861(82)90441-6; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Castellano S, 2005, P NATL ACAD SCI USA, V102, P16188, DOI 10.1073/pnas.0505146102; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHU FF, 1993, J BIOL CHEM, V268, P2571; DAVEY JC, 1995, J BIOL CHEM, V270, P26786, DOI 10.1074/jbc.270.45.26786; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; Fradejas-Villar N., 2016, FASEB J; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Korotkov KV, 2002, MOL CELL BIOL, V22, P1402, DOI 10.1128/MCB.22.5.1402-1411.2002; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2000, GENES CELLS, V5, P1049, DOI 10.1046/j.1365-2443.2000.00392.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lescure A, 1999, J BIOL CHEM, V274, P38147, DOI 10.1074/jbc.274.53.38147; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; MILLS GC, 1957, J BIOL CHEM, V229, P189; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Novoselov SV, 2006, BIOCHEM J, V394, P575, DOI 10.1042/BJ20051569; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; TAKAHASHI K, 1990, J BIOCHEM-TOKYO, V108, P145, DOI 10.1093/oxfordjournals.jbchem.a123172; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; VENDELAND SC, 1995, P NATL ACAD SCI USA, V92, P8749, DOI 10.1073/pnas.92.19.8749; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	49	157	167	5	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24036	24040		10.1074/jbc.M116.756155	http://dx.doi.org/10.1074/jbc.M116.756155			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27645994	Green Published, hybrid			2022-12-26	WOS:000388498100020
J	Adachi, H; Nakayama, K; Hayashi, N; Matsui, Y; Fujimoto, K; Yamaya, H; Tonami, H; Yokoyama, H				Adachi, Hiroki; Nakayama, Kanae; Hayashi, Norifumi; Matsui, Yuki; Fujimoto, Keiji; Yamaya, Hideki; Tonami, Hisao; Yokoyama, Hitoshi			Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients	PLOS ONE			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; CORONARY-ARTERY-DISEASE; SUCCESSFUL KIDNEY-TRANSPLANTATION; ADIPOSE-SPECIFIC PROTEIN; INSULIN-RESISTANCE; VISCERAL ADIPOSITY; PLASMA; ASSOCIATION; AMERICANS; OBESITY	Background A few studies have investigated the role of adiponectin fraction for cardiovascular disease (CVD) in RTx recipients. Subjects and Methods We studied 57 adult subjects (39 males, 18 females; 10 cadaveric donors) with at least three years of allograft survival (median 251 months). We examined clinical backgrounds such as treated drugs, blood pressure (BP, mmHg), body mass index (BMI), and blood chemistry including cholesterol (total, LDL-C, HDL-C), glucose, glycated hemoglobin (HbA1c), and serum high and low-molecular-weight (HMW/LMW) ADPN fractions with regard to the associations of the visceral and subcutaneous fat areas on CT scan. We also analyzed the associations of CVD and post-transplant diabetes (PTDM) with ADPN fractions and the fat areas. Results The visceral fat area was inversely correlated with serum HMW and LMW ADPN levels and HMW ADPN ratio (r = -0.400, p = 0.002 and r = -0.296, p = 0.025 and r = -0.444, p<0.001, respectively). Furthermore, the visceral fat area was positively with the LMW ADPN ratio (r = 0.467, p<0.001), but no significant correlation was noted between the subcutaneous fat area and the ADPN ratio. On multiple regression analysis, eGFR and the visceral fat area were significant reducing factors of HMW ADPN levels, and the alteration of eGFR was identified as an increasing factor of HMW ADPN levels. Patients with CVD had larger visceral fat area (p = 0.004), lower HMW ADPN ratio (p = 0.022) and higher LMW ADPN ratio (p = 0.049). In addition, the higher HMW ADPN ratio and statin treatment were identified as reducing factors of the development of CVD, but the LDL-C level was an aggravating factor. Moreover, the higher LMW ADPN ratio and the visceral fat area were aggravating factors of PTDM. Conclusion Even in Japanese renal transplant recipients, visceral fat area and ADPN fractions were significant factors for the development of both CVD and PTDM.	[Adachi, Hiroki; Nakayama, Kanae; Hayashi, Norifumi; Matsui, Yuki; Fujimoto, Keiji; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan; [Tonami, Hisao] Kanazawa Med Univ, Sch Med, Dept Radiol, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University	Adachi, H (corresponding author), Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan.	m5240a@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [25461237, 24406029, 2530502]; Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; (C) no. 25461237, (B) no. 24406029, and (B) no. 2530502. This study was also supported by a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research and by grants from the Ministry of Health, Labour and Welfare of Japan (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2007, CLIN NEPHROL, V67, P381; Adamczak M, 2009, SEMIN DIALYSIS, V22, P391, DOI 10.1111/j.1525-139X.2009.00587.x; Aoqui C, 2013, EUR J CLIN NUTR, V67, P610, DOI 10.1038/ejcn.2013.66; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Cantarin MPM, 2013, KIDNEY INT, V83, P487, DOI 10.1038/ki.2012.421; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; Colvin RB, 2003, NEW ENGL J MED, V349, P2288, DOI 10.1056/NEJMp038178; Costacou T, 2008, KIDNEY INT, V74, P549, DOI 10.1038/ki.2008.262; Goto M, 2014, OBESITY, V22, P401, DOI 10.1002/oby.20553; Graessler J, 2011, GERONTOLOGY, V57, P316, DOI 10.1159/000316575; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kishida K, 2011, J ATHEROSCLER THROMB, V18, P592, DOI 10.5551/jat.7625; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh J, 2013, KIDNEY INT, V83, P546, DOI 10.1038/ki.2012.479; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; Saito T, 2012, ENDOCR J, V59, P39, DOI 10.1507/endocrj.EJ11-0132; Satoh M, 2009, CLIN THER, V31, P2113, DOI 10.1016/j.clinthera.2009.10.010; Schober F, 2007, BIOCHEM BIOPH RES CO, V361, P968, DOI 10.1016/j.bbrc.2007.07.106; Shen YY, 2007, METABOLISM, V56, P1201, DOI 10.1016/j.metabol.2007.04.016; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163899	10.1371/journal.pone.0163899	http://dx.doi.org/10.1371/journal.pone.0163899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706207	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200070
J	Dean, DC; Sojkova, J; Hurley, S; Kecskemeti, S; Okonkwo, O; Bendlin, BB; Theisen, F; Johnson, SC; Alexander, AL; Gallagher, CL				Dean, Douglas C., III; Sojkova, Jitka; Hurley, Samuel; Kecskemeti, Steven; Okonkwo, Ozioma; Bendlin, Barbara B.; Theisen, Frances; Johnson, Sterling C.; Alexander, Andrew L.; Gallagher, Catherine L.			Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study	PLOS ONE			English	Article							WHITE-MATTER; BRAIN MICROSTRUCTURE; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; WATER; RELAXATION; DIFFUSION; MODEL; STATE; REGISTRATION	Alterations to myelin may be a core pathological feature of neurodegenerative diseases. Although white matter microstructural differences have been described in Parkinson's disease (PD), it is unknown whether such differences include alterations of the brain's myelin content. Thus, the objective of the current study is to measure and compare brain myelin content between PD patients and age-matched controls. In this cross-sectional study, 63 participants from the Longitudinal MRI in Parkinson's Disease study underwent brain MRI, Unified Parkinson's Disease Rating Scale (UPDRS) scoring, and cognitive asessments. Subjects were imaged with the mcDEPSOT (multi-component driven equilibrium single pulse observation of T1 and T2), a multicomponent relaxometry technique that quantifies longitudinal and transverse relaxation rates (R-1 and R-2, respectively) and the myelin water fraction (VFM), a surrogate for myelin content. A voxel-wise approach was used to compare R-1, R-2, and VFM measures between PD and control groups, and to evaluate relationships with age as well as disease duration, UPDRS scores, and daily levodopa equivalent dose. PD subjects had higher VFM than controls in frontal and temporal white matter and bilateral thalamus. Greater age was strongly associated with lower VFM in both groups, while an age-by-group interaction suggested a slower rate of VFM decline in the left putamen with aging in PD. Within the PD group, measures of disease severity, including UPDRS, daily levodopa equivalent dose, and disease duration, were observed to be related with myelin content in diffuse brain regions. The age-by-group interaction suggests that either PD or dopaminergic therapies allay observed age-related myelin changes. The relationships between VFM and disease severity measures suggests that VFM may provide a surrogate marker for microstructural changes related to Parkinson's disease.	[Dean, Douglas C., III; Kecskemeti, Steven; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Sojkova, Jitka; Theisen, Frances; Johnson, Sterling C.; Gallagher, Catherine L.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Sojkova, Jitka; Theisen, Frances; Gallagher, Catherine L.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Hurley, Samuel] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, Oxon, England; [Okonkwo, Ozioma; Bendlin, Barbara B.; Johnson, Sterling C.; Gallagher, Catherine L.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Phys, Madison, WI USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gallagher, CL (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.; Gallagher, CL (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.; Gallagher, CL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA.	gallagher@neurology.wisc.edu	Alexander, Andrew/ABA-2806-2020; Hurley, Samuel A/H-7251-2019	Hurley, Samuel A/0000-0003-3965-9649	U.S. Department of Veterans Affairs [101CX000555]; National Institute of Child Health and Human Development [T32 HD007489, P30 HD003352, R21 HD078119]; National Institute on Aging [R01 AG027161, P50 AG033514, R01 AG037639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, R21HD078119, T32HD007489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG037639, R01AG037639, P50AG033514, R01AG027161] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000555] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. Department of Veterans Affairs 101CX000555 to CLG; National Institute of Child Health and Human Development T32 HD007489 to DCD; National Institute of Child Health and Human Development P30 HD003352 Waisman Center; National Institute on Aging R01 AG027161 to SCJ; National Institute on Aging P50 AG033514 University of Wisconsin Madison; National Institute of Child Health and Human Development R21 HD078119 to ALA and the National Institute on Aging R01 AG037639 to BBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Auning E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003976; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bartzokis G, 2004, NEUROBIOL AGING, V25, P49, DOI 10.1016/j.neurobiolaging.2003.08.001; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2012, SCHIZOPHR RES, V140, P122, DOI 10.1016/j.schres.2012.06.036; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Bertrand JA, 2012, MOVEMENT DISORD, V27, P1781, DOI 10.1002/mds.25272; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brandies R, 2008, NEUROSCI BIOBEHAV R, V32, P611, DOI 10.1016/j.neubiorev.2007.09.004; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dean DC, 2015, BRAIN STRUCT FUNCT, V220, P1921, DOI 10.1007/s00429-014-0763-3; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Dean DC, 2014, NEUROIMAGE, V84, P742, DOI 10.1016/j.neuroimage.2013.09.058; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2015, MAGN RESON MED, V73, P161, DOI 10.1002/mrm.25108; Deoni SCL, 2013, MAGN RESON MED, V70, P147, DOI 10.1002/mrm.24429; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Deoni SCL, 2011, METHODS MOL BIOL, V711, P65, DOI 10.1007/978-1-61737-992-5_4; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Ferrario JE, 2004, J NEUROCHEM, V90, P1348, DOI 10.1111/j.1471-4159.2004.02595.x; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher C, 2013, J INT NEUROPSYCH SOC, V19, P349, DOI 10.1017/S1355617712001373; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; Herz DM, 2015, BRAIN, V138, P1658, DOI 10.1093/brain/awv096; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurley S. A., 2010, P 18 ANN M ISMRM STO, V18, P4516; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Li CT, 2014, SYNAPSE, V68, P325, DOI 10.1002/syn.21745; Liu Y, 2013, DRUGS R&D, V13, P29, DOI 10.1007/s40268-012-0002-4; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MacKay AL, 2009, NEUROIMAG CLIN N AM, V19, P1, DOI 10.1016/j.nic.2008.09.007; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Nagae LM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00017; Novak G, 2013, SYNAPSE, V67, P179, DOI 10.1002/syn.21628; Odrobina EE, 2005, NMR BIOMED, V18, P277, DOI 10.1002/nbm.951; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spader HS, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.1.FOCUS12426; Team RC, 2014, R LANG ENV STAT COMP; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Wang HN, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv088; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang J, 2013, MAGN RESON MED, V73, P223; Zhang Y, 2015, MOVEMENT DISORD, V30, P1229, DOI 10.1002/mds.26251; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	77	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163774	10.1371/journal.pone.0163774	http://dx.doi.org/10.1371/journal.pone.0163774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706215	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200057
J	Deng, F; Sjostedt, N; Kidron, H				Deng, Feng; Sjostedt, Noora; Kidron, Heidi			The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; IN VIVO EXTRAPOLATION; DUBIN-JOHNSON-SYNDROME; BOVINE SERUM-ALBUMIN; K-M VALUES; DRUG CLEARANCE; FATTY-ACIDS; ABC TRANSPORTER; VITRO DATA; V-MAX	The ABC transporters multidrug resistance associated protein 2 (MRP2) and breast cancer resistance protein (BCRP) are of interest in drug development, since they affect the pharmacokinetics of several drugs. Membrane vesicle transport assays are widely used to study interactions with these proteins. Since albumin has been found to affect the kinetics of metabolic enzymes in similar membrane preparations, we investigated whether albumin affects the kinetic parameters of efflux transport. We found that albumin increased the V-max of 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) and estradiol-17-beta-D-glucuronide uptake into MRP2 vesicles in the presence of 0.1% bovine serum albumin (BSA) by 2 and 1.5-fold, respectively, while BSA increased Lucifer yellow uptake by 30% in BCRP vesicles. K-m values increased slightly, but the change was not statistically significant. The effect of BSA on substrate uptake was dependent on the vesicle amount, while increasing BSA concentration did not significantly improve substrate uptake. These results indicate a minor effect of albumin on MRP2 and BCRP, but it should be considered if albumin is added to transporter assays for example as a solubilizer, since the effect may be substrate or transporter specific.	[Deng, Feng; Sjostedt, Noora; Kidron, Heidi] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland	University of Helsinki	Kidron, H (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland.	heidi.kidron@helsinki.fi	; Kidron, Heidi/A-5826-2015	Deng, Feng/0000-0002-9173-6923; Sjostedt, Noora/0000-0001-6960-7757; Kidron, Heidi/0000-0001-6427-8042	Suomen Akatemia [257786]; University; Biocenter Finland	Suomen Akatemia(Academy of Finland); University; Biocenter Finland	HK: Suomen Akatemia, 257786, http://www.aka.fi/en/. NS: University funded Doctoral Programme in Drug Research doctoral candidate position, http://blogs.helsinki.fi/reenila/.; We would like to thank Dr Linda Ahonen and M.Sc Marja Hagstrom for the LC/MS analysis, lab coordinator Timo Oksanen for the UPLC analysis, Sami Tyrjy for technical assistance and Dr Moshe Finel for helpful discussions. We acknowledge the Drug Discovery and Chemical Biology Network, funded by Biocenter Finland, for providing access to screening instrumentation.	Arouri A, 2013, PROG LIPID RES, V52, P130, DOI 10.1016/j.plipres.2012.09.002; Aspenstrom-Fagerlund B, 2012, FOOD CHEM TOXICOL, V50, P3635, DOI 10.1016/j.fct.2012.07.015; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Brouwer KLR, 2013, CLIN PHARMACOL THER, V94, P95, DOI 10.1038/clpt.2013.81; Carlile DJ, 1999, BRIT J CLIN PHARMACO, V47, P625, DOI 10.1046/j.1365-2125.1999.00935.x; Chu XY, 2004, J PHARMACOL EXP THER, V309, P156, DOI 10.1124/jpet.103.062091; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Elsby R, 2011, XENOBIOTICA, V41, P764, DOI 10.3109/00498254.2011.578761; European Medicines Agency, GUID INV DRUG INT; Glavinas H, 2008, EXPERT OPIN DRUG MET, V4, P721, DOI 10.1517/17425255.4.6.721 ; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; He L, 2014, EUR J PHARMACOL, V724, P185, DOI 10.1016/j.ejphar.2013.12.008; Heredi-Szabo K, 2009, DRUG METAB DISPOS, V37, P794, DOI 10.1124/dmd.108.023895; Heredi-Szabo K, 2008, J BIOMOL SCREEN, V13, P295, DOI 10.1177/1087057108316702; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Hulot JS, 2005, PHARMACOGENET GENOM, V15, P277, DOI 10.1097/01213011-200505000-00002; Ito K, 2005, PHARM RES-DORDR, V22, P103, DOI 10.1007/s11095-004-9015-1; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Keskitalo JE, 2009, CLIN PHARMACOL THER, V86, P197, DOI 10.1038/clpt.2009.79; Kidron H, 2012, EUR J PHARM SCI, V46, P100, DOI 10.1016/j.ejps.2012.02.016; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Kivisto KT, 2005, DRUG METAB DISPOS, V33, P1593, DOI 10.1124/dmd.105.006262; Kruijtzer CMF, 2002, J CLIN ONCOL, V20, P2943, DOI 10.1200/JCO.2002.12.116; Ludden LK, 1997, J PHARMACOL EXP THER, V282, P391; Maliepaard M, 2001, CANCER RES, V61, P3458; Manevski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054767; Manevski N, 2011, DRUG METAB DISPOS, V39, P2117, DOI 10.1124/dmd.111.041418; Mao QC, 2015, AAPS J, V17, P65, DOI 10.1208/s12248-014-9668-6; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Niemi M, 2006, PHARMACOGENET GENOM, V16, P801, DOI 10.1097/01.fpc.0000230422.50962.91; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Rowland A, 2008, DRUG METAB DISPOS, V36, P870, DOI 10.1124/dmd.107.019885; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1124/jpet.106.118216; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Schaub TP, 1999, J AM SOC NEPHROL, V10, P1159; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Toh S, 1999, AM J HUM GENET, V64, P739, DOI 10.1086/302292; Uchaipichat V, 2006, BRIT J CLIN PHARMACO, V61, P427, DOI 10.1111/j.1365-2125.2006.02588.x; US Food and Drug Administration, 2012, DRUG INT ST IN PRESS; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1051, DOI 10.1124/dmd.111.043117; Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580; Wattanachai N, 2012, DRUG METAB DISPOS, V40, P982, DOI 10.1124/dmd.111.044057; Wattanachai N, 2011, EUR J CLIN PHARMACOL, V67, P815, DOI 10.1007/s00228-011-1001-z; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200	50	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163886	10.1371/journal.pone.0163886	http://dx.doi.org/10.1371/journal.pone.0163886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706255	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200068
J	Levesque, S; Lalancette, C; Bernard, K; Pacheco, AL; Dion, R; Longtin, J; Tremblay, C				Levesque, Simon; Lalancette, Cindy; Bernard, Kathryn; Pacheco, Ana Luisa; Dion, Rejean; Longtin, Jean; Tremblay, Cecile			Molecular Typing of Legionella pneumophila Isolates in the Province of Quebec from 2005 to 2015	PLOS ONE			English	Article							NOSOCOMIAL LEGIONNAIRES-DISEASE; ENVIRONMENTAL WATER SOURCES; SEQUENCE-BASED SCHEME; SEROGROUP 1; UNITED-STATES; NATIONAL SURVEILLANCE; DISTRIBUTION-SYSTEMS; STRAINS; COLONIZATION; HOSPITALS	Legionella is found in natural and man-made aquatic environments, such as cooling towers and hot water plumbing infrastructures. Legionella pneumophila serogroup 1 (Lp1) is the most common etiological agent causing waterborne disease in the United States and Canada. This study reports the molecular characterization of Lp strains during a 10 year period. We conducted sequence-based typing (SBT) analysis on a large set of Lp isolates (n = 284) to investigate the province of Quebec sequence types (STs) distribution in order to identify dominant clusters. From 2005 to 2015, 181 clinical Lp isolates were typed by SBT (141 sporadic cases and 40 outbreak related cases). From the same period of time, 103 environmental isolates were also typed. Amongst the 108 sporadic cases of Lp1 typed, ST-62 was the most frequent (16.6%), followed by ST-213 (10.2%), ST-1 (8.3%) and ST-37 (8.3%). Amongst other serogroups (SG), ST-1327 (SG5) (27.3%) and ST-378 (SG10) (12.2%) were the most frequent. From the environmental isolates, ST-1 represent the more frequent SBT type (26.5%). Unweighted pair group method with arithmetic mean (UPGMA) dendrogram from the 108 sporadic cases of SG1 contains 4 major clusters (A to D) of related STs. Cluster B contains the majority of the strains (n = 61) and the three most frequent STs in our database (ST-62, ST-213 and ST-1). During the study period, we observed an important increase in the incidence rate in Quebec. All the community associated outbreaks, potentially or confirmed to be associated with a cooling tower were caused by Lp1 strains, by opposition to hospital associated outbreaks that were caused by serogroups of Lp other than SG1. The recent major Quebec City outbreak caused by ST-62, and the fact that this genotype is the most common in the province supports whole genome sequencing characterization of this particular sequence type in order to understand its evolution and associated virulence factors.	[Levesque, Simon; Lalancette, Cindy; Dion, Rejean; Longtin, Jean] Inst Natl St Publ Quebec, Lab St Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Levesque, Simon; Tremblay, Cecile] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Levesque, Simon; Tremblay, Cecile] Univ Montreal, Ctr Rech, Ctr Hosp, Quebec City, PQ, Canada; [Bernard, Kathryn; Pacheco, Ana Luisa] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Dion, Rejean] Univ Montreal, Ecole St Publ, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Longtin, Jean] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada	Universite de Montreal; Laval University; Universite de Montreal; Public Health Agency of Canada; Universite de Montreal; Laval University	Levesque, S (corresponding author), Inst Natl St Publ Quebec, Lab St Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Levesque, S (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.; Levesque, S (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Quebec City, PQ, Canada.	simon.levesque@inspq.qc.ca		Levesque, Simon/0000-0002-4356-9702	Ministere de la sante et des services sociaux du Quebec; Fonds de recherche du Quebec-Sante	Ministere de la sante et des services sociaux du Quebec; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was in part funded by Ministere de la sante et des services sociaux du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the excellent technical assistance of the LSPQ employees. We also thank Patricia Corrado for English revision. Simon Levesque is a postdoctoral scholarship from Fonds de recherche du Quebec-Sante. Cecile Tremblay is a scholar from the Fonds de Recherche du Quebec-Sante and the Pfizer/University of Montreal Chair on HIV translational research.	ALARY M, 1992, J INFECT DIS, V165, P565, DOI 10.1093/infdis/165.3.565; Borchardt J, 2008, EUR J CLIN MICROBIOL, V27, P29, DOI 10.1007/s10096-007-0392-3; Brunkard Joan M., 2011, Morbidity and Mortality Weekly Report, V60, P38; Casini B, 2008, WATER SCI TECHNOL, V58, P683, DOI 10.2166/wst.2008.434; Chang FY, 1996, J INFECT DIS, V174, P1116, DOI 10.1093/infdis/174.5.1116; Chasqueira MJ, 2014, EUROSURVEILLANCE, V19, P33, DOI 10.2807/1560-7917.ES2014.19.46.20965; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Cunha BA, 2016, LANCET, V387, P376, DOI 10.1016/S0140-6736(15)60078-2; Farhat C, 2011, J CLIN MICROBIOL, V49, P4052, DOI 10.1128/JCM.00687-11; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferreira AP, 2004, INT J ENVIRON HEAL R, V14, P453, DOI 10.1080/09603120400012827; Fontana S, 2014, INT J MED MICROBIOL, V304, P597, DOI 10.1016/j.ijmm.2014.04.004; Fragou K, 2012, INT J ENVIRON HEAL R, V22, P340, DOI 10.1080/09603123.2011.643229; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Guo JY, 2015, INFECT GENET EVOL, V29, P35, DOI 10.1016/j.meegid.2014.10.023; Harrison TG, 2007, CLIN MICROBIOL INFEC, V13, P78, DOI 10.1111/j.1469-0691.2006.01558.x; Helbig JH, 2003, J CLIN MICROBIOL, V41, P838, DOI 10.1128/JCM.41.2.838-840.2003; Hicks LA, 2012, AM J TRANSPLANT, V12, P250, DOI 10.1111/j.1600-6143.2011.03938.x; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Kanatani J, 2013, J INFECT CHEMOTHER, V19, P644, DOI 10.1007/s10156-012-0537-x; Katsiaflaka A, 2016, APPL ENVIRON MICROB, V82, P6102, DOI 10.1128/AEM.01672-16; Kool JL, 1999, INFECT CONT HOSP EP, V20, P798, DOI 10.1086/501587; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Leoni E, 2005, J APPL MICROBIOL, V98, P373, DOI 10.1111/j.1365-2672.2004.02458.x; Levesque S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103852; LIU WK, 1993, J HOSP INFECT, V24, P1, DOI 10.1016/0195-6701(93)90084-D; Luck Christian, 2013, Methods Mol Biol, V954, P119, DOI 10.1007/978-1-62703-161-5_6; LUCK PC, 1995, APPL ENVIRON MICROB, V61, P2000; Napoli C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-660; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; OTT M, 1991, J CLIN MICROBIOL, V29, P813, DOI 10.1128/JCM.29.4.813-815.1991; Perola O, 2002, APMIS, V110, P863, DOI 10.1034/j.1600-0463.2002.1101204.x; Qin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21356; Quebec, 2021, ACC SERV MED PREM LI; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Sabria M, 2001, INFECT CONT HOSP EP, V22, P673, DOI 10.1086/501843; Sanchez-Buso L, 2015, APPL ENVIRON MICROB, V81, P7106, DOI 10.1128/AEM.02196-15; Scaturro A, 2005, J CLIN MICROBIOL, V43, P5348, DOI 10.1128/JCM.43.10.5348-4350.2005; SCHOONMAKER D, 1992, J CLIN MICROBIOL, V30, P1491, DOI 10.1128/JCM.30.6.1491-1498.1992; Stout JE, 2007, INFECT CONT HOSP EP, V28, P818, DOI 10.1086/518754; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tijet N, 2010, EMERG INFECT DIS, V16, P447, DOI 10.3201/eid1603.081689; TRAM C, 1990, J CLIN MICROBIOL, V28, P242, DOI 10.1128/JCM.28.2.242-245.1990; Underwood AP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-302; Unit for Surveillance and Control of Communicable Diseases, 2009, EURO SURVEILL, V14; Vekens E, 2012, EUROSURVEILLANCE, V17, P9; VICKERS RM, 1987, INFECT CONT HOSP EP, V8, P357, DOI 10.1017/S0195941700067412; Visca P, 1999, J CLIN MICROBIOL, V37, P2189, DOI 10.1128/JCM.37.7.2189-2196.1999; World Health Organization, 2007, LEGIONELLA PREVENTIO	52	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163818	10.1371/journal.pone.0163818	http://dx.doi.org/10.1371/journal.pone.0163818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706210	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200062
J	Masset, G; Mathias, KC; Vlassopoulos, A; Molenberg, F; Lehmann, U; Gibney, M; Drewnowski, A				Masset, Gabriel; Mathias, Kevin C.; Vlassopoulos, Antonis; Molenberg, Famke; Lehmann, Undine; Gibney, Mike; Drewnowski, Adam			Modeled Dietary Impact of Pizza Reformulations in US Children and Adolescents	PLOS ONE			English	Article							CHILDHOOD OBESITY; NUTRIENT INTAKE; REDUCTION; ENERGY; FOOD; HEALTH	Background and Objective Approximately 20% of US children and adolescents consume pizza on any given day; and pizza intake is associated with higher intakes of energy, sodium, and saturated fat. The reformulation of pizza products has yet to be evaluated as a viable option to improve diets of the US youth. This study modeled the effect on nutrient intakes of two potential pizza reformulation strategies based on the standards established by the Nestle A Nutritional Profiling System (NNPS). Methods Dietary intakes were retrieved from the first 24hr-recall of the National Health and Nutrition Examination Survey (NHANES) 2011-12, for 2655 participants aged 4-19 years. The composition of pizzas in the NHANES food database (n = 69) were compared against the NNPS standards for energy, total fat, saturated fat, sodium, added sugars, and protein. In a reformulation scenario, the nutrient content of pizzas was adjusted to the NNPS standards if these were not met. In a substitution scenario, pizzas that did not meet the standards were replaced by the closest pizza, based on nutrient content, that met all of the NNPS standards. Results Pizzas consistent with all the NNPS standards (29% of all pizzas) were significantly lower in energy, saturated fat and sodium than pizzas that were not. Among pizza consumers, modeled intakes in the reformulation and substitution scenarios were lower in energy (-14 and -45kcal, respectively), saturated fat (-1.2 and -2.7g), and sodium (-143 and -153mg) compared to baseline. Conclusions Potential industry wide reformulation of a single food category or intra-category food substitutions may positively impact dietary intakes of US children and adolescents. Further promotion and support of these complimentary strategies may facilitate the adoption and implementation of reformulation standards.	[Masset, Gabriel; Mathias, Kevin C.; Vlassopoulos, Antonis; Molenberg, Famke; Lehmann, Undine] Nestle Res Ctr, Publ Hlth Nutr, Lausanne, Switzerland; [Molenberg, Famke] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands; [Gibney, Mike] Univ Coll Dublin, Inst Food & Hlth, Dublin, Ireland; [Gibney, Mike] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland; [Drewnowski, Adam] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA	Nestle SA; Wageningen University & Research; University College Dublin; Ulster University; University of Washington; University of Washington Seattle	Masset, G (corresponding author), Nestle Res Ctr, Publ Hlth Nutr, Lausanne, Switzerland.	gabriel.masset@rdls.nestle.com	Drewnowski, Adam/HCI-4117-2022; Masset, Gabriel/I-4636-2019	Masset, Gabriel/0000-0001-6977-0247; Vlassopoulos, Antonis/0000-0001-7136-1039; Lehmann, Undine/0000-0001-8104-0490; Molenberg, Famke/0000-0002-5305-9730	Nestec SA	Nestec SA	The research presented herein was funded by Nestec SA. The funder provided support in the form of salaries for authors GM, KCM, AV, FM, and UL, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder agreed on the publication of the present study.	[Anonymous], 2014, FOOD NUTR DAT DIET S; Bruins MJ, 2015, NUTRIENTS, V7, P8010, DOI 10.3390/nu7095375; Buttriss JL, 2013, P NUTR SOC, V72, P61, DOI 10.1017/S0029665112002868; Choices Programme, 2016, POS LOG PRES THEMS T, VInternet; Cochrane T, 2016, AUST NZ J PUBL HEAL, V40, P62, DOI 10.1111/1753-6405.12474; Combet E, 2014, PUBLIC HEALTH NUTR, V17, P2577, DOI 10.1017/S1368980013002814; Combris P, 2011, PUBLIC HEALTH, V125, P717, DOI 10.1016/j.puhe.2011.07.004; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Dutch Presidency EU Conference for Food Product Improvement, 2016, DUTCH PRES EU C FOOD; Gortmaker SL, 2015, HEALTH AFFAIR, V34, P1932, DOI 10.1377/hlthaff.2015.0631; Insitute of Medicine, 2015, TABL DRI VAL SUMM; Kloss L., 2015, NFS Journal, V1, P9, DOI 10.1016/j.nfs.2015.03.001; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Leroy P, 2016, EUR J CLIN NUTR, V70, P694, DOI 10.1038/ejcn.2015.201; Ma Y, 2016, LANCET DIABETES ENDO, V4, P105, DOI 10.1016/S2213-8587(15)00477-5; Manickavasagan A., 2013, Food Science and Human Wellness, V2, P105; Marteau TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5863; McColl K., 2015, NUTR PROFILING CHANG; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Powell LM, 2015, PEDIATRICS, V135, P322, DOI 10.1542/peds.2014-1844; Requillart V, 2014, EUR REV AGRIC ECON, V41, P375, DOI 10.1093/erae/jbu010; Rhodes DG, 2014, 11 NHANES; Roodenburg AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072378; Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001; Thompson F., 2014, OVERCOMING OBESITY I; Trichterborn J, 2012, EUR J CLIN NUTR, V66, P466, DOI 10.1038/ejcn.2011.180; Tritt A, 2015, PUBLIC HEALTH NUTR, V18, P1407, DOI 10.1017/S1368980014001724; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; USDA Agricultural Research Service, 2014, FOOD PATT EQ DAT DAT; Vlassopoulos A, 2015, FASEB J, V29; Vlassopoulos A, 2017, EUR J NUTR, V56, P1105, DOI 10.1007/s00394-016-1161-9; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640; Wang YC, 2012, AM J PREV MED, V42, P437, DOI 10.1016/j.amepre.2012.01.018; WHO, 2008, WHO EUR ACT PLAN FOO; World Health Organization, 2004, GLOB STRAT DIET PHYS	36	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164197	10.1371/journal.pone.0164197	http://dx.doi.org/10.1371/journal.pone.0164197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706221	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200097
J	Wang, NL; Lu, YL; Zhang, P; Zhang, MH; Gong, JY; Lu, Y; Xie, XB; Qiu, YL; Yan, YY; Wu, BB; Wang, JS				Wang, Neng-Li; Lu, Yu-Lan; Zhang, Ping; Zhang, Mei-Hong; Gong, Jing-Yu; Lu, Yi; Xie, Xin-Bao; Qiu, Yi-Ling; Yan, Yan-Yan; Wu, Bing-bing; Wang, Jian-She			A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions	PLOS ONE			English	Article							MEDICAL GENETICS; AMERICAN-COLLEGE; MUTATIONS; ASSOCIATION; GUIDELINES; STANDARDS	Background and Aims Large indels are commonly identified in patients but are not detectable by routine Sanger sequencing and panel sequencing. We specially designed a multi-gene panel that could simultaneously test known large indels in addition to ordinary variants, and reported the diagnostic yield in patients with intrahepatic cholestasis. Methods The panel contains 61 genes associated with cholestasis and 25 known recurrent large indels. The amplicon library was sequenced on Ion PGM system. Sequencing data were analyzed using a routine data analysis protocol and an internal program encoded for large indels test simultaneously. The validation phase was performed using 54 patients with known genetic diagnosis, including 5 with large insertions. At implement phase, 141 patients with intrahepatic cholestasis were evaluated. Results At validation phase, 99.6% of the variations identified by Sanger sequencing could be detected by panel sequencing. Following the routine protocol, 99.8% of false positives could be filtered and 98.8% of retained variations were true positives. Large insertions in the 5 patients with known genetic diagnosis could be correctly detected using the internal program. At implementation phase, 96.9% of the retained variations, following the routine protocol, were confirmed to be true. Twenty-nine patients received a potential genetic diagnosis when panel sequencing data were analyzed using the routine protocol. Two additional patients, who were found to harbor large insertions in SLC25A13, obtained a potential genetic diagnosis when sequencing data were further analyzed using the internal program. A total of 31 (22.0%) patients obtained a potential genetic diagnosis. Nine different genetic disorders were diagnosed, and citrin deficiency was the commonest. Conclusion Specially designed multi-gene panel can correctly detect large indels simultaneously. By using it, we assigned a potential genetic diagnosis to 22.0% of patients with intrahepatic cholestasis.	[Wang, Neng-Li; Zhang, Mei-Hong; Gong, Jing-Yu; Yan, Yan-Yan] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai, Peoples R China; [Lu, Yu-Lan; Zhang, Ping; Wu, Bing-bing] Fudan Univ, Childrens Hosp, Pediat Res Inst, Shanghai Key Lab Birth Defects,Mol Genet Diag Ctr, Shanghai, Peoples R China; [Lu, Yi; Xie, Xin-Bao; Qiu, Yi-Ling; Wang, Jian-She] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, BB (corresponding author), Fudan Univ, Childrens Hosp, Pediat Res Inst, Shanghai Key Lab Birth Defects,Mol Genet Diag Ctr, Shanghai, Peoples R China.; Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai, Peoples R China.	bingbingwu2010@163.com; jshwang@shmu.edu.cn	wang, Jian-She/F-1154-2011	Wang, Neng-Li/0000-0001-6967-9873; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81361128006]; Shanghai Municipal Commission of Health and Family Planning [2013-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was funded by National Natural Science Foundation of China (NO. 81361128006) to Jian-She Wang, and Shanghai Municipal Commission of Health and Family Planning (NO.2013-27) to Jian-She Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri WF, 2005, HEPATOLOGY, V42, P222, DOI 10.1002/hep.20729; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Buckley RH, 2005, J CLIN INVEST, V115, P2974, DOI 10.1172/JCI26956; CHANG MH, 1987, J PEDIATR GASTR NUTR, V6, P203, DOI 10.1097/00005176-198703000-00006; Fang LJ, 2012, J PEDIATR GASTR NUTR, V55, P150, DOI 10.1097/MPG.0b013e31824ef36f; Gomez-Ospina N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10713; Gordo-Gilart R, 2015, GUT, V64, P147, DOI 10.1136/gutjnl-2014-306896; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Herbst SM, 2015, MOL CELL PROBE, V29, P291, DOI 10.1016/j.mcp.2015.03.001; Hinrichs JWJ, 2015, AM J CLIN PATHOL, V143, P573, DOI 10.1309/AJCP40XETVYAMJPY; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Khalaf R, 2016, PEDIATR GASTROENTERO, V19, P1, DOI 10.5223/pghn.2016.19.1.1; Li LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130355; Lin WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29732; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Matte U, 2010, J PEDIATR GASTR NUTR, V51, P488, DOI 10.1097/MPG.0b013e3181dffe8f; McKiernan P, 2012, CLIN RES HEPATOL GAS, V36, P287, DOI 10.1016/j.clinre.2012.03.028; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Song YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074544; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Tarabeux J, 2014, EUR J HUM GENET, V22, P535, DOI 10.1038/ejhg.2013.181; Togawa T, 2016, J PEDIATR-US, V171, P171, DOI 10.1016/j.jpeds.2016.01.006; Tomaiuolo R, 2008, J CYST FIBROS, V7, P347, DOI 10.1016/j.jcf.2007.12.004; Wang JS, 2006, EUR J PEDIATR, V165, P795, DOI 10.1007/s00431-006-0175-3; Wang NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153114; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089267; Zheng QQ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4124263; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	30	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164058	10.1371/journal.pone.0164058	http://dx.doi.org/10.1371/journal.pone.0164058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706244	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200082
J	Yuan, F; Kolb, R; Pandey, G; Li, W; Sun, L; Liu, FY; Sutterwala, FS; Liu, YH; Zhang, WZ				Yuan, Fang; Kolb, Ryan; Pandey, Gaurav; Li, Wei; Sun, Lin; Liu, Fuyou; Sutterwala, Fayyaz S.; Liu, Yinghong; Zhang, Weizhou			Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; INFLAMMASOME ACTIVATION; BACTERIAL LIGANDS; RECEPTOR; INJURY; TRANSCRIPTION; RECOGNITION; MACROPHAGES; EXPRESSION	Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. The role of inflammation in DN has only recently been recognized. It has been shown that the NLRP3-inflammasome contributes to DN development by inducing interleukin (IL)-1 beta processing and secretion. In an effort to understand other IL-1 beta activating mechanism during DN development, we examined the role of the NLRC4-inflammasome in DN and found that NLRC4 is a parallel mechanism, in addition to the NLRP3-inflammasome, to induce pro-IL-1 beta processing and activation. We found that the expression of NLRC4 is elevated in DN kidneys. NLRC4-deficiency results in diminished DN disease progression, as manifested by a decrease in blood glucose and albumin excretion, as well as preserved renal histology. We further found that DN kidneys have increased F4/80(+) macrophages, increased IL-1 beta production, and other signaling pathways related to kidney pathology such as activation of NF-kappa B and MAP kinase pathways, all of which were rescued by NLRC4-deficiency. This study demonstrates NLRC4-driven IL-1 beta production as critical for the progression of DN, which underscores the importance to target this pathway to alleviate this devastating disease.	[Yuan, Fang; Sun, Lin; Liu, Fuyou; Liu, Yinghong] Cent S Univ, Res Inst Nephrol, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Yuan, Fang; Kolb, Ryan; Pandey, Gaurav; Li, Wei; Liu, Yinghong; Zhang, Weizhou] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Kolb, Ryan; Zhang, Weizhou] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Zhang, Weizhou] Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Weizhou] Univ Iowa, Free Rad & Radiat Biol Program, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Weizhou] Univ Iowa, Canc Genes & Pathway Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA	Central South University; University of Iowa; University of Iowa; Cedars Sinai Medical Center; University of Iowa; University of Iowa; University of Iowa	Liu, YH (corresponding author), Cent S Univ, Res Inst Nephrol, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China.; Liu, YH; Zhang, WZ (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Free Rad & Radiat Biol Program, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Canc Genes & Pathway Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA.	liuyingh2002@139.com; weizhou-zhang@uiowa.edu	Sutterwala, Fayyaz/AAH-5859-2021; liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Kolb, Ryan/0000-0001-6305-2885	National Institutes of Health [K99/R00 CA158055, CA200673, CD203834]; V Foundation for Cancer Research; AI/NIAID [T32 AI007260]; NATIONAL CANCER INSTITUTE [R00CA158055, R01CA200673, R01CA203834, K99CA158055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; AI/NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WZ was supported by National Institutes of Health grants K99/R00 CA158055, CA200673, and CD203834, the V Scholar Award from the V Foundation for Cancer Research. RK was supported by T32 AI007260 AI/NIAID.	Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; de Borst MH, 2009, J PHARMACOL EXP THER, V331, P896, DOI 10.1124/jpet.109.154179; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Henquin JC, 2008, DIABETES OBES METAB, V10, P1, DOI 10.1111/j.1463-1326.2008.00968.x; Hinamoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107934; Janowski AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00370; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Kim SM, 2015, AM J PHYSIOL-RENAL, V308, pF993, DOI 10.1152/ajprenal.00637.2014; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kolb R, 2014, PROTEIN CELL, V5, P12, DOI 10.1007/s13238-013-0001-4; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lim AKH, 2010, DIABETOLOGIA, V53, P1772, DOI 10.1007/s00125-010-1757-1; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Liu P, 2014, DIABETES RES CLIN PR, V105, P206, DOI 10.1016/j.diabres.2014.04.020; Makino H, 1996, DIABETES, V45, P488, DOI 10.2337/diabetes.45.4.488; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriya R, 2004, DIABETOLOGIA, V47, P82, DOI 10.1007/s00125-003-1253-y; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Navarro JF, 1999, AM J KIDNEY DIS, V33, P458, DOI 10.1016/S0272-6386(99)70182-4; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; UEDA A, 1994, J IMMUNOL, V153, P2052; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wu CC, 2012, ADV CLIN CHEM, V56, P55, DOI 10.1016/B978-0-12-394317-0.00014-5; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Yuan F, 2014, MOL MED REP, V9, P2293, DOI 10.3892/mmr.2014.2133; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572	42	33	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164135	10.1371/journal.pone.0164135	http://dx.doi.org/10.1371/journal.pone.0164135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706238	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200089
J	Esposito, F; Jacquemyn, H; Waud, M; Tyteca, D				Esposito, Fabiana; Jacquemyn, Hans; Waud, Michael; Tyteca, Daniel			Mycorrhizal Fungal Diversity and Community Composition in Two Closely Related Platanthera (Orchidaceae) Species	PLOS ONE			English	Article							SYMBIOTIC GERMINATION; SPECIFICITY; SPECIATION; ASSOCIATIONS; COEXISTENCE; SEQUENCES; PRIMERS; FORESTS; RECORDS; BIFOLIA	While it is generally acknowledged that orchid species rely on mycorrhizal fungi for completion of their life cycle, little is yet known about how mycorrhizal fungal diversity and community composition vary within and between closely related orchid taxa. In this study, we used 454 amplicon pyrosequencing to investigate variation in mycorrhizal communities between pure (allopatric) and mixed (sympatric) populations of two closely related Platanthera species (Platanthera bifolia and P. chlorantha) and putative hybrids. Consistent with previous research, the two species primarily associated primarily with members of the Ceratobasidiaceae and, to a lesser extent, with members of the Sebacinales and Tulasnellaceae. In addition, a large number of ectomycorrhizal fungi belonging to various families were observed. Although a considerable number of mycorrhizal fungi were common to both species, the fungal communities were significantly different between the two species. Individuals with intermediate morphology showed communities similar to P. bifolia, confirming previous results based on the genetic architecture and fragrance composition that putative hybrids essentially belonged to one of the parental species (P. bifolia). Differences in mycorrhizal communities between species were smaller in mixed populations than between pure populations, suggesting that variation in mycorrhizal communities was largely controlled by local environmental conditions. The small differences in mycorrhizal communities in mixed populations suggests that mycorrhizal fungi are most likely not directly involved in maintaining species boundaries between the two Platanthera species. However, seed germination experiments are needed to unambiguously assess the contribution of mycorrhizal divergence to reproductive isolation.	[Esposito, Fabiana; Tyteca, Daniel] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Croix Sud 4-5 L7-07-04, B-1348 Louvain La Neuve, Belgium; [Jacquemyn, Hans; Waud, Michael] KULeuven, Dept Biol Plant Conservat & Populat Biol, B-3001 Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Tyteca, D (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Croix Sud 4-5 L7-07-04, B-1348 Louvain La Neuve, Belgium.	daniel.tyteca@uclouvain.be	Jacquemyn, Hans/AAC-4875-2019	Jacquemyn, Hans/0000-0001-9600-5794; Esposito, Fabiana/0000-0002-6119-4174	European Research Council [260601 - MYCASOR]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by the European Research Council (ERC Starting Grant 260601 - MYCASOR awarded to HJ). The operating budget of UCL (University catholique de Louvain) was used for operating expenses of FE and DT.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; Bateman R. M., 2008, Watsonia, V27, P1; Bateman R. M., 2012, New Journal of Botany, V2, P110, DOI 10.1179/2042349712Y.0000000013; Bateman RM, 2014, AM J BOT, V101, P979, DOI 10.3732/ajb.1300430; Batty AL, 2001, NEW PHYTOL, V152, P511, DOI 10.1046/j.0028-646X.2001.00277.x; Baumann H, 1998, FARN BLUTENPFLANZEN; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; BIONDINI ME, 1988, VEGETATIO, V75, P161; Chen X. Q., 2009, FLORA CHINA, V25, P101; Claessens J., 2006, J EUROPAISCHER ORCHI, V38, P3; CURRAH RS, 1987, CAN J BOT, V65, P2473, DOI 10.1139/b87-336; CURRAH RS, 1990, CAN J BOT, V68, P1171, DOI 10.1139/b90-149; Darwin C., 1862, VARIOUS CONTRIVANCES, DOI [10.1017/CBO9780511910197, DOI 10.1017/CBO9780511910197]; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Delforge P., 2006, ORCHIDS EUROPE N AFR; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esposito F, INTERMEDIATE P UNPUB; Hapeman Jeffrey R., 1997, P433; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; INOUE K, 1983, Journal of the Faculty of Science University of Tokyo Section III Botany, V13, P285; Jacquemyn H, 2016, ANN BOT-LONDON, V118, P105, DOI 10.1093/aob/mcw015; Jacquemyn H, 2015, NEW PHYTOL, V206, P1127, DOI 10.1111/nph.13281; Jacquemyn H, 2014, NEW PHYTOL, V202, P616, DOI 10.1111/nph.12640; Jacquemyn H, 2012, J ECOL, V100, P1328, DOI 10.1111/j.1365-2745.2012.01998.x; Jacquemyn H, 2012, NEW PHYTOL, V193, P454, DOI 10.1111/j.1469-8137.2011.03913.x; Jacquemyn H, 2010, MOL ECOL, V19, P4086, DOI 10.1111/j.1365-294X.2010.04785.x; Jin XH, 2012, NORD J BOT, V30, P291, DOI 10.1111/j.1756-1051.2011.01229.x; Lajtha K, 1999, LT EC RES NETWK SER, V2, P115; Leake JR, 2010, NEW PHYTOL, V185, P601, DOI 10.1111/j.1469-8137.2009.03153.x; Lievens B, 2010, J MICROBIOL METH, V80, P76, DOI 10.1016/j.mimet.2009.11.004; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Maad J, 2004, BIOL J LINN SOC, V83, P481, DOI 10.1111/j.1095-8312.2004.00406.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCormick MK, 2014, NEW PHYTOL, V202, P392, DOI 10.1111/nph.12639; Muller H., 1868, VERHANDLUNGEN NATURH, V25, P36; Neiland MRM, 1998, AM J BOT, V85, P1657, DOI 10.2307/2446499; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; NILSSON LA, 1983, BOT J LINN SOC, V87, P325, DOI 10.1111/j.1095-8339.1983.tb00997.x; NILSSON LA, 1985, NORD J BOT, V5, P407; Nosil P, 2005, EVOLUTION, V59, P705; Oja J, 2015, NEW PHYTOL, V205, P1608, DOI 10.1111/nph.13223; Pandey M, 2013, MOL ECOL, V22, P2341, DOI 10.1111/mec.12249; Prat D., 2005, ORCHIDEES FRANCE BEL; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Rasmussen HN., 1995, TERRESTRIAL ORCHIDS, DOI [10.1017/CBO9780511525452, DOI 10.1017/CBO9780511525452]; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Sharma J, 2003, SYMBIOSIS, V34, P145; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stokl J, 2008, AM J BOT, V95, P472, DOI 10.3732/ajb.95.4.472; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Tesitelova T, 2013, NEW PHYTOL, V199, P1022, DOI 10.1111/nph.12348; Tesitelova T, 2012, AM J BOT, V99, P1020, DOI 10.3732/ajb.1100503; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Waterman RJ, 2011, AM NAT, V177, pE54, DOI 10.1086/657955; Waud M, 2016, FUNGAL ECOL, V20, P155, DOI 10.1016/j.funeco.2015.12.008; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zelmer Carla D., 1996, Mycoscience, V37, P439, DOI 10.1007/BF02461001; Zelmer CD, 1995, CAN J BOT, V73, P1981, DOI 10.1139/b95-212; Zettler LW, 2011, AM MIDL NAT, V166, P29, DOI 10.1674/0003-0031-166.1.29	71	22	28	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164108	10.1371/journal.pone.0164108	http://dx.doi.org/10.1371/journal.pone.0164108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695108	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100090
J	Laux, G; Musselmann, B; Kiel, M; Szecsenyi, J; Joos, S				Laux, Gunter; Musselmann, Berthold; Kiel, Marion; Szecsenyi, Joachim; Joos, Stefanie			Differences between Practice Patterns of Conventional and Naturopathic GPs in Germany	PLOS ONE			English	Article							PRIMARY-CARE; ALTERNATIVE MEDICINE; COMPLEMENTARY; PRACTITIONERS	Background Limited evidence exists whether practice patterns of general practitioners (GPs) who have additionally completed training in naturopathy are different from those of conventional GPs. We aimed to assess and compare practice patterns of GPs in conventional and naturopathic GPs. Methods Routine data from 41 GPs (31 with and 11 without additional qualification in NP, respectively) and 180,789 patients, drawn from the CONTinuous morbidity registration Epidemiologic NeTwork (CONTENT)-registry and collected between 2009 and 2014, were used. To assess practice patterns determinants of (non-) phytopharmaceutical prescriptions, referrals and hospitalizations were analyzed using mixed-effects Poisson regression models. As explanatory variables, the qualification of the GP in NM, the age group and sex of the patient, as well as bivariate interactions between these variables were considered. Results GPs additionally qualified in naturopathy exhibited higher rates of phytopharmaceutical prescriptions (p<0.034; independent effect) compared to conventional GPs. This association was not observed with respect to non-phytopharmaceutical prescriptions. However, interaction effects between qualification and age group as well as sex were present with respect to both phytopharmaceutical and non-phytopharmaceutical prescriptions (all p<0.001). No further independent association existed between qualification and either referral rates or hospitalization rates, but again interactions between qualification and age group and sex (only referrals) were statistically significant (all p<0.0001). Conclusion The results show that the rate of phyto-pharmaceutical prescriptions are generally higher when the GP has an additional qualification in naturopathy. Further differences in practice patterns between conventional and naturopathy GPs could be subject to certain age groups and sex. However, the magnitude of these differences seem to be rather small.	[Laux, Gunter; Musselmann, Berthold; Kiel, Marion; Szecsenyi, Joachim; Joos, Stefanie] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Laux, G (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	g.laux@med.uni-heidelberg.de	Laux, Gunter/AAL-9020-2021		"Komitee Forschung Naturmedzin e.V." (KFN) [4/2001]; German Federal Ministry of Research and Education (BMBF) [01GK0301]	"Komitee Forschung Naturmedzin e.V." (KFN); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support for this study was received from the "Komitee Forschung Naturmedzin e.V." (KFN) (grant number 4/2001, to Prof. Dr. Gunter Laux). The implementation of CONTENT registry was funded by the German Federal Ministry of Research and Education (BMBF) (grant number 01GK0301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiner A, 2010, J ANTIMICROB CHEMOTH, V65, P1521, DOI 10.1093/jac/dkq151; Baars Erik W, 2014, BMJ Open, V4, pe005332, DOI 10.1136/bmjopen-2014-005332; Ben-Arye E, 2008, PATIENT EDUC COUNS, V70, P395, DOI 10.1016/j.pec.2007.11.019; De Sutter AI, 2001, FAM PRACT, V18, P209, DOI 10.1093/fampra/18.2.209; Eardley S, 2012, FORSCH KOMPLEMENTMED, V19, P18, DOI 10.1159/000342708; Fischer F, 2014, FORSCH KOMPLEMENTMED, V21, pE1, DOI 10.1159/000360744; Fleming SA, 2010, PRIMARY CARE, V37, P119, DOI 10.1016/j.pop.2009.09.002; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Joos S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/294638; Joos S, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-131; Joos S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep019; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; Kraft K, 2009, LEHRBUCH NATURHEILVE; Laux Gunter, 2005, Inform Prim Care, V13, P249; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; National Center for Complementary and Integrative Health (NCCIH), NAT WHAT NAT PRACT D; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Thanner M, 2014, GESUNDHEITSWESEN, V76, P715, DOI 10.1055/s-0033-1364013; WHO Collaborating Centre for Drug Statistics Methodology, AN THER CHEM ATC CLA	20	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163519	10.1371/journal.pone.0163519	http://dx.doi.org/10.1371/journal.pone.0163519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695071	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100041
J	Kakimoto, Y; Tanaka, M; Kamiguchi, H; Ochiai, E; Osawa, M				Kakimoto, Yu; Tanaka, Masayuki; Kamiguchi, Hiroshi; Ochiai, Eriko; Osawa, Motoki			MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content	PLOS ONE			English	Article							RNA SEQUENCING REVEALS; MESSENGER-RNA; NONCODING RNAS; HUMAN HEART; QUALITY; CANCER	MicroRNAs (miRNAs) are small non-coding RNAs responsible for fine-tuning of gene expression at post-transcriptional level. The alterations in miRNA expression levels profoundly affect human health and often lead to the development of severe diseases. Currently, high throughput analyses, such as microarray and deep sequencing, are performed in order to identify miRNA biomarkers, using archival patient tissue samples. MiRNAs are more robust than longer RNAs, and resistant to extreme temperatures, pH, and formalinfixed paraffin-embedding (FFPE) process. Here, we have compared the stability of miRNAs in FFPE cardiac tissues using next-generation sequencing. The mode read length in FFPE samples was 11 nucleotides (nt), while that in the matched frozen samples was 22 nt. Although the read counts were increased 1.7-fold in FFPE samples, compared with those in the frozen samples, the average miRNA mapping rate decreased from 32.0% to 9.4%. These results indicate that, in addition to the fragmentation of longer RNAs, miRNAs are to some extent degraded in FFPE tissues as well. The expression profiles of total miRNAs in two groups were highly correlated (0.88 < r < 0.92). However, the relative read count of each miRNA was different depending on the GC content (p<0.0001). The unequal degradation of each miRNA affected the abundance ranking in the library, and miR-133a was shown to be the most abundant in FFPE cardiac tissues instead of miR-1, which was predominant before fixation. Subsequent quantitative PCR (qPCR) analyses revealed that miRNAs with GC content of less than 40% are more degraded than GC-rich miRNAs (p<0.0001). We showed that deep sequencing data obtained using FFPE samples cannot be directly compared with that of fresh frozen samples. The combination of miRNA deep sequencing and other quantitative analyses, such as qPCR, may improve the utility of archival FFPE tissue samples.	[Kakimoto, Yu; Ochiai, Eriko; Osawa, Motoki] Tokai Univ, Dept Forens Med, Sch Med, Isehara, Kanagawa, Japan; [Tanaka, Masayuki; Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Osawa, M (corresponding author), Tokai Univ, Dept Forens Med, Sch Med, Isehara, Kanagawa, Japan.	osawa@is.icc.u-tokai.ac.jp		Tanaka, Masayuki/0000-0002-8682-8719	Japan Society for the Promotion of Science KAKENHI Grant [16K19300]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) KAKENHI Grant 16K19300. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen MY, 2014, MAR GENOM, V13, P39, DOI 10.1016/j.margen.2014.01.002; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Greytak SR, 2015, CANCER RES, V75, P1541, DOI 10.1158/0008-5472.CAN-14-2378; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Kakimoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129338; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Li P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0778-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez JP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0109-x; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Peng YD, 2014, CELL SIGNAL, V26, P1888, DOI 10.1016/j.cellsig.2014.05.006; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Stik G, 2014, J BIOTECHNOL, V181, P35, DOI 10.1016/j.jbiotec.2014.04.005; Tam S, 2014, LAB INVEST, V94, P350, DOI 10.1038/labinvest.2013.157; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zuo J, 2015, PLOS ONE, V10, DOI [10.1371/Journal.pcme.0124873, DOI 10.1371/JOURNAL.PCME.0124873]	37	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163125	10.1371/journal.pone.0163125	http://dx.doi.org/10.1371/journal.pone.0163125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649415	gold, Green Submitted, Green Published			2022-12-26	WOS:000383892100057
J	Murga-Zamalloa, CA; Mendoza-Reinoso, V; Sahasrabuddhe, AA; Rolland, D; Hwang, SR; McDonnell, SRP; Sciallis, AP; Wilcox, RA; Bashur, V; Elenitoba-Johnson, K; Lim, MS				Murga-Zamalloa, C. A.; Mendoza-Reinoso, V.; Sahasrabuddhe, A. A.; Rolland, D.; Hwang, S. R.; McDonnell, S. R. P.; Sciallis, A. P.; Wilcox, R. A.; Bashur, V.; Elenitoba-Johnson, K.; Lim, M. S.			NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma	ONCOGENE			English	Article							ALDRICH-SYNDROME PROTEIN; ACTIN POLYMERIZATION; KINASE ALK; INVADOPODIUM FORMATION; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; WIP; MACROPHAGES; PODOSOMES; DYNAMICS	Mechanisms by which NPM-ALK signaling regulates cell migration, invasion and contributes to the oncogenesis of anaplastic large cell lymphoma (ALCL) are not completely understood. In an attempt to identify novel actin signaling pathways regulated by NPM-ALK, a comprehensive phosphoproteome analysis of ALCL cell lines was performed in the presence or absence of NPM-ALK activity. Numerous phosphoproteins involved in actin dynamics including Wiskott-Aldrich syndrome protein (WASp) were regulated by NPM-ALK. Network analysis revealed that WASp is a central component of the NPM-ALK-dependent actin signaling pathway. Here we show that NPM-ALK phosphorylates WASp at its known activation site (Y290) as well as at a novel residue (Y102). Phosphorylation of WASp at Y102 negatively regulates its interaction with Wiskott-Aldrich interacting protein and decreases its protein stability. Phosphorylation of WASp at Y102 enhances anchorage-independent growth and tumor growth in an in vivo xenograft model and enhances invasive properties of ALCL. We show that knock-down of WASp or expression of Y102F mutant of WASp decreases colony formation and in vivo tumor growth. Our results show that WASp is a novel substrate of ALK and has a critical role in regulating invasiveness and oncogenesis of ALCL.	[Murga-Zamalloa, C. A.; Mendoza-Reinoso, V.; Sahasrabuddhe, A. A.; Rolland, D.; Hwang, S. R.; McDonnell, S. R. P.; Sciallis, A. P.; Bashur, V.; Elenitoba-Johnson, K.; Lim, M. S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rolland, D.; Elenitoba-Johnson, K.; Lim, M. S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Wilcox, R. A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Lim, MS (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	Megan.Lim@uphs.upenn.edu	Rolland, Delphine/ABG-2497-2021; Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066; Lim, Megan/0000-0002-0415-2867; Hwang, Steven/0000-0002-6536-1291; Mendoza-Reinoso, Veronica/0000-0003-1776-4229; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Rolland, Delphine/0000-0002-7801-6534	Department of Pathology, University of Michigan [R01 CA140806-01, R01 DE119249, R01 CA136905]; HONORS-ASH award	Department of Pathology, University of Michigan(University of Michigan System); HONORS-ASH award	This work was supported by the Department of Pathology, University of Michigan and R01 CA140806-01 (MSL), R01 DE119249, R01 CA136905 (KSJ-EJ) and HONORS-ASH award (CMZ).	Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Ambrogio C, 2008, CANCER RES, V68, P8899, DOI 10.1158/0008-5472.CAN-08-2568; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Badolato R, 1998, J IMMUNOL, V161, P1026; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Blundell MP, 2009, P NATL ACAD SCI USA, V106, P15738, DOI 10.1073/pnas.0904346106; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Cory GOC, 1996, J IMMUNOL, V157, P3791; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; de la Fuente MA, 2007, P NATL ACAD SCI USA, V104, P926, DOI 10.1073/pnas.0610275104; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Dupre L, 2002, IMMUNITY, V17, P157, DOI 10.1016/S1074-7613(02)00360-6; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jin P, 2011, DEV CELL, V20, P623, DOI 10.1016/j.devcel.2011.04.007; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Lagarrigue F, 2010, CANCER RES, V70, P6978, DOI 10.1158/0008-5472.CAN-10-0861; Lane J, 2014, CANCER GENOM PROTEOM, V11, P155; Lim MS, 2009, BLOOD, V114, P1585, DOI 10.1182/blood-2009-02-204735; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, IMMUNOL CELL BIOL, V81, P130, DOI 10.1046/j.0818-9641.2002.01147.x; McDonnell SRP, 2012, ONCOGENE, V31, P3733, DOI 10.1038/onc.2011.542; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Ochs HD, 2006, J ALLERGY CLIN IMMUN, V117, P725, DOI 10.1016/j.jaci.2006.02.005; Oda A, 2001, BLOOD, V97, P2633, DOI 10.1182/blood.V97.9.2633; Ott GR, 2011, J MED CHEM, V54, P6328, DOI 10.1021/jm200758k; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Slupianek A, 2001, CANCER RES, V61, P2194; Stewart DM, 1999, J IMMUNOL, V162, P5019; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tripathy R, 2011, BIOORG MED CHEM LETT, V21, P7261, DOI 10.1016/j.bmcl.2011.10.055; Volkman BF, 2002, CELL, V111, P565, DOI 10.1016/S0092-8674(02)01076-0; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	45	10	10	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2085	2094		10.1038/onc.2016.366	http://dx.doi.org/10.1038/onc.2016.366			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27694894				2022-12-26	WOS:000399782500005
J	Dizhoor, AM; Olshevskaya, EV; Peshenko, IV				Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.			The R838S Mutation in Retinal Guanylyl Cyclase 1 (RetGC1) Alters Calcium Sensitivity of cGMP Synthesis in the Retina and Causes Blindness in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; ACTIVATING PROTEINS GCAPS; AUTOSOMAL-DOMINANT CONE; CAUSES PHOTORECEPTOR DEGENERATION; KNOCK-OUT MICE; 3 RD3 PROTEIN; ROD DYSTROPHY; MOUSE MODEL; DIMERIZATION DOMAIN; GENE-THERAPY	Substitutions of Arg(838) in the dimerization domain of a human retinal membrane guanylyl cyclase 1 (RetGC1) linked to autosomal dominant cone-rod degeneration type 6 (CORD6) change RetGC1 regulation in vitro by Ca2+. In addition, we find that R838S substitution makes RetGC1 less sensitive to inhibition by retinal degeneration-3 protein (RD3). We selectively expressed human R838S RetGC1 in mouse rods and documented the decline in rod vision and rod survival. To verify that changes in rods were specifically caused by the CORD6 mutation, we used for comparison cones, which in the same mice did not express R838S RetGC1 from the transgenic construct. The R838S RetGC1 expression in rod outer segments reduced inhibition of cGMP production in the transgenic mouse retinas at the free calcium concentrations typical for dark-adapted rods. The transgenic mice demonstrated early-onset and rapidly progressed with age decline in visual responses from the targeted rods, in contrast to the longer lasting preservation of function in the non-targeted cones. The decline in rod function in the retina resulted from a progressive degeneration of rods between 1 and 6 months of age, with the severity and pace of the degeneration consistent with the extent to which the Ca2+ sensitivity of the retinal cGMP production was affected. Our study presents a new experimental model for exploring cellular mechanisms of the CORD6-related photoreceptor death. This mouse model provides the first direct biochemical and physiological in vivo evidence for the Ares substitutions in RetGC1 being the culprit behind the pathogenesis of the CORD6 congenital blindness.	[Dizhoor, Alexander M.; Olshevskaya, Elena V.; Peshenko, Igor V.] Salus Univ, Dept Res, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Res S416, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY11522 from the NEI and a CURE grant from Pennsylvania Department of Health. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Boye SL, 2015, HUM GENE THER, V26, P575, DOI 10.1089/hum.2015.053; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Collery RF, 2013, EXP EYE RES, V108, P120, DOI 10.1016/j.exer.2013.01.003; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; Garcia-Hoyos M, 2011, MOL VIS, V17, P1103; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; Helten A, 2007, J NEUROCHEM, V103, P1439, DOI 10.1111/j.1471-4159.2007.04923.x; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Ito S, 2004, JPN J OPHTHALMOL, V48, P228, DOI 10.1007/s10384-003-0050-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2008, INVEST OPHTH VIS SCI, V49, P5015, DOI 10.1167/iovs.08-1901; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Lazar CH, 2015, INVEST OPHTH VIS SCI, V56, P420, DOI 10.1167/iovs.14-15647; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Mihelec M, 2011, HUM GENE THER, V22, P1179, DOI 10.1089/hum.2011.069; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 2001, J MED GENET, V38, P611, DOI 10.1136/jmg.38.9.611; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Udar N, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9109; Weigell-Weber M, 2000, ARCH OPHTHALMOL-CHIC, V118, P300; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zagel P, 2013, BIOCHEMISTRY-US, V52, P5065, DOI 10.1021/bi400288p; Zhao X, 2013, MOL VIS, V19, P1039; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	76	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24504	24516		10.1074/jbc.M116.755553	http://dx.doi.org/10.1074/jbc.M116.755553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703005	Green Published, hybrid			2022-12-26	WOS:000388875500014
J	Zhang, CM; Zhao, NH; Chen, Y; Zhang, DH; Yan, JY; Zou, W; Zhang, KQ; Huang, XW				Zhang, Chunmei; Zhao, Ninghui; Chen, Yao; Zhang, Donghua; Yan, Jinyuan; Zou, Wei; Zhang, Keqin; Huang, Xiaowei			The Signaling Pathway of Caenorhabditis elegans Mediates Chemotaxis Response to the Attractant 2-Heptanone in a Trojan Horse-like Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; Caenorhabditis elegans (C; elegans); chemotaxis; G protein-coupled receptor (GPCR); signal transduction; 2-heptanone; chemotaxis response; co-evolution; microbial pathogens; olfactory pathway	NUCLEOTIDE-GATED CHANNEL; CHEMOSENSORY NEURONS; ODORANT RECEPTOR; G-PROTEINS; EXPRESSION; MUTATIONS; OLFACTION; FAMILY; GENES	The nematode Caenorhabditis elegans exhibits behavioral responses to a wide range of odorants associated with food and pathogens. A previous study described a Trojan Horse-like strategy of pathogenesis whereby the bacterium Bacillus nematocida B16 emits the volatile organic compound 2-heptanone to trap C. elegans for successful infection. Here, we further explored the receptor for 2-heptanone as well as the pathway involved in signal transduction in C. elegans. Our experiments showed that 2-heptanone sensing depended on the function of AWC neurons and a GPCR encoded by str-2. Consistent with the above observation, the HEK293 cells expressing STR-2 on their surfaces showed a transient elevation in intracellular Ca2+ levels after 2-heptanone applications. After combining the assays of RNA interference and gene mutants, we also identified the G subunits and their downstream components in the olfactory signal cascade that are necessary for responding to 2-heptanone, including G subunits of egl-30 and gpa-3, phospholipase C of plc-1and egl-8, and the calcium channel of cmk-1 and cal-1. Our work demonstrates for the first time that an integrated signaling pathway for 2-heptanone response in C. elegans involves recognition by GPCR STR-2, activation by G subunits of egl-30/gpa-3 and transfer to the PLC pathway, indicating that a potentially novel olfactory pathway exists in AWC neurons. Meanwhile, since 2-heptanone, a metabolite from the pathogenic bacterium B. nematocida B16, can be sensed by C. elegans and thus strongly attract its host, our current work also suggested coevolution between the pathogenic microorganism and the chemosensory system in C. elegans.	[Zhang, Chunmei; Chen, Yao; Zhang, Donghua; Zou, Wei; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Zhang, Chunmei; Chen, Yao; Zhang, Donghua; Zou, Wei; Zhang, Keqin; Huang, Xiaowei] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China; [Zhao, Ninghui] Kunming Med Univ, Hosp 2, Neurosurg, Kunming 650101, Peoples R China; [Yan, Jinyuan] Kunming Med Univ, Hosp 2, Ctr Lab, Kunming 650101, Peoples R China	Yunnan University; Yunnan University; Kunming Medical University; Kunming Medical University	Huang, XW (corresponding author), Yunnan Univ, State Key Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.; Huang, XW (corresponding author), Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	zhang, ke/AAH-8217-2019	Yan, Jinyuan/0000-0002-3398-3459	National Basic Research Program of China [2013CB127500]; National Natural Science Foundation Program of China [31370162, 31460024]; Department of Science and Technology of Yunnan Province, China [2014FA019]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation Program of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Grant no. 2013CB127500), the National Natural Science Foundation Program of China (Grants no. 31370162 and no. 31460024), and the Department of Science and Technology of Yunnan Province, China (Grant no. 2014FA019). The authors declare that they have no conflicts of interest with the contents of this article.	BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Birnby DA, 2000, GENETICS, V155, P85; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Deng Xinyang, 2013, ScientificWorldJournal, V2013, P123731, DOI 10.1155/2013/123731; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; GREWAL P S, 1992, Fundamental and Applied Nematology, V15, P159; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Mori I, 1997, BIOESSAYS, V19, P1055, DOI 10.1002/bies.950191204; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Niu QH, 2010, P NATL ACAD SCI USA, V107, P16631, DOI 10.1073/pnas.1007276107; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; STARICH TA, 1995, GENETICS, V139, P171; Torto B, 2007, P NATL ACAD SCI USA, V104, P8374, DOI 10.1073/pnas.0702813104; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Wood W. B., 1988, COMMUNITY C ELEGANS; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhang CM, 2014, BIOTECHNOL ADV, V32, P290, DOI 10.1016/j.biotechadv.2013.10.010; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P12162, DOI 10.1073/pnas.94.22.12162; Zwaal RR, 1997, GENETICS, V145, P715	34	28	33	4	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23618	23627		10.1074/jbc.M116.741132	http://dx.doi.org/10.1074/jbc.M116.741132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27660389	Green Published, hybrid			2022-12-26	WOS:000387884400022
J	Ashley, JW; Hancock, WD; Nelson, AJ; Bone, RN; Tse, HM; Wohltmann, M; Turk, J; Ramanadham, S				Ashley, Jason W.; Hancock, William D.; Nelson, Alexander J.; Bone, Robert N.; Tse, Hubert M.; Wohltmann, Mary; Turk, John; Ramanadham, Sasanka			Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA(2)beta (Group VIA Phospholipase A(2))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; ENDOPLASMIC-RETICULUM STRESS; HUMAN MONOCYTE CHEMOTAXIS; LYSOPHOSPHATIDIC ACID; CELL APOPTOSIS; PROINFLAMMATORY CYTOKINES; DIABETES-MELLITUS; OXIDATIVE STRESS; EXPRESS GROUP; T-CELLS	Macrophages are important in innate and adaptive immunity. Macrophage participation in inflammation or tissue repair is directed by various extracellular signals and mediated by multiple intracellular pathways. Activation of group VIA phospholipase A(2) (iPLA(2)beta) causes accumulation of arachidonic acid, lysophospholipids, and eicosanoids that can promote inflammation and pathologic states. We examined the role of iPLA(2)beta in peritoneal macrophage immune function by comparing wild type (WT) and iPLA(2)beta(-/-) mouse macrophages. Compared with WT, iPLA(2)beta(-/-) macrophages exhibited reduced proinflammatory M1 markers when classically activated. In contrast, antiinflammatory M2 markers were elevated under naive conditions and induced to higher levels by alternative activation in iPLA(2)beta(-/-) macrophages compared with WT. Induction of eicosanoid (12-lipoxygenase (12-LO) and cyclooxygenase 2 (COX2))-and reactive oxygen species (NADPH oxidase 4 (NOX4))-generating enzymes by classical activation pathways was also blunted in iPLA(2)beta(-/-) macrophages compared with WT. The effects of inhibitors of iPLA(2)beta, COX2, or 12-LO to reduce M1 polarization were greater than those to enhance M2 polarization. Certain lipids (lysophosphatidylcholine, lysophosphatidic acid, and prostaglandin E-2) recapitulated M1 phenotype in iPLA(2)beta(-/-) macrophages, but none tested promoted M2 phenotype. These findings suggest that (a) lipids generated by iPLA(2)beta and subsequently oxidized by cyclooxygenase and 12-LO favor macrophage inflammatory M1 polarization, and (b) the absence of iPLA(2)beta promotes macrophage M2 polarization. Reducing macrophage iPLA(2)beta activity and thereby attenuating macrophage M1 polarization might cause a shift from an inflammatory to a recovery/repair milieu.	[Ashley, Jason W.] Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA; [Hancock, William D.; Nelson, Alexander J.; Ramanadham, Sasanka] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, SHEL 1205,1720 2nd Ave S, Birmingham, AL 35294 USA; [Hancock, William D.; Nelson, Alexander J.; Tse, Hubert M.; Ramanadham, Sasanka] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Tse, Hubert M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Bone, Robert N.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Wohltmann, Mary; Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Eastern Washington University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Indiana University System; Indiana University Bloomington; Washington University (WUSTL)	Ramanadham, S (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, SHEL 1205,1720 2nd Ave S, Birmingham, AL 35294 USA.	sramvem@uab.edu	Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; Tse, Hubert/0000-0001-5861-7597; Bone, Robert/0000-0003-3222-8918	NIDDK, National Institutes of Health [DK-69455, DK-110292, DK-099550]; University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology; American Diabetes Association; United States Public Health Service by WUSM Dean's Bridge Funds [P41 GM103422, P30 DK056341, P30 DK020579]; WUSM Department Medicine Bridge Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099550, R01DK110292, P30DK056341, P30DK020579, R01DK069455, P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422, K12GM081259] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology; American Diabetes Association(American Diabetes Association); United States Public Health Service by WUSM Dean's Bridge Funds; WUSM Department Medicine Bridge Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK-69455 and DK-110292 (to S. R.) and DK-099550 (to H. M. T). This work was also supported by the University of Alabama at Birmingham Department of Cell, Developmental, and Integrative Biology and the American Diabetes Association (to S. R. and H. M. T.). Work at the Washington University School of Medicine (WUSM) (to J. T.) was supported by United States Public Health Service Grants P41 GM103422, P30 DK056341, and P30 DK020579 by WUSM Dean's Bridge Funds and WUSM Department Medicine Bridge Funds. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Ayilavarapu S, 2010, J IMMUNOL, V184, P1507, DOI 10.4049/jimmunol.0901219; Balboa MA, 2002, J BIOL CHEM, V277, P40384, DOI 10.1074/jbc.M206155200; Balboa MA, 2008, FEBS J, V275, P1915, DOI 10.1111/j.1742-4658.2008.06350.x; Balsinde J, 2000, J BIOL CHEM, V275, P22544, DOI 10.1074/jbc.M910163199; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/989372; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Ganapathy V, 2000, INT IMMUNOL, V12, P851, DOI 10.1093/intimm/12.6.851; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Topal JLG, 2006, J PHARMACOL EXP THER, V318, P1368, DOI 10.1124/jpet.106.103747; Green-Mitchell SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056763; Grewal S, 2003, J CELL SCI, V116, P2303, DOI 10.1242/jcs.00446; Grzesik WJ, 2015, J CLIN ENDOCR METAB, V100, pE387, DOI 10.1210/jc.2014-3630; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Hsu FF, 2000, J BIOL CHEM, V275, P16579, DOI 10.1074/jbc.M908342199; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lei XY, 2013, ISLETS, V5, P29, DOI 10.4161/isl.23758; Lei XY, 2012, AM J PHYSIOL-ENDOC M, V303, pE1386, DOI 10.1152/ajpendo.00234.2012; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Magrioti V, 2010, EXPERT OPIN THER PAT, V20, P1, DOI 10.1517/13543770903463905; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marathe C, 2006, J BIOL CHEM, V281, P32197, DOI 10.1074/jbc.M605237200; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez J, 2001, ARCH BIOCHEM BIOPHYS, V392, P257, DOI 10.1006/abbi.2001.2439; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; Norris Paul C., 2014, Advances in Biological Regulation, V54, P99, DOI 10.1016/j.jbior.2013.09.009; Padgett LE, 2015, DIABETES, V64, P937, DOI 10.2337/db14-0929; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Panni RZ, 2013, IMMUNOTHERAPY-UK, V5, P1075, DOI 10.2217/imt.13.102; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Perez-Chacon G, 2010, J IMMUNOL, V184, P1071, DOI 10.4049/jimmunol.0902257; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Song HW, 2014, J BIOL CHEM, V289, P14194, DOI 10.1074/jbc.M114.561910; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Tan CY, 2014, ARTERIOSCL THROM VAS, V34, P768, DOI 10.1161/ATVBAHA.113.302847; Teslenko V, 1997, BBA-LIPID LIPID MET, V1344, P189, DOI 10.1016/S0005-2760(96)00137-3; Ueno N, 2011, J BIOL CHEM, V286, P37249, DOI 10.1074/jbc.M111.290312; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; Vazquez-Medina JP, 2016, FASEB J, V30, P2885, DOI 10.1096/fj.201500146R; Vujanovic NL, 2011, IMMUNOL RES, V50, P159, DOI 10.1007/s12026-011-8228-8; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Zaitseva LG, 2000, B EXP BIOL MED+, V130, P879	80	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23268	23281		10.1074/jbc.M116.754945	http://dx.doi.org/10.1074/jbc.M116.754945			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27650501	hybrid, Green Published			2022-12-26	WOS:000387224800035
J	Busan, P; Del Ben, G; Bernardini, S; Natarelli, G; Bencich, M; Monti, F; Manganotti, P; Battaglini, PP				Busan, Pierpaolo; Del Ben, Giovanni; Bernardini, Simona; Natarelli, Giulia; Bencich, Marco; Monti, Fabrizio; Manganotti, Paolo; Battaglini, Piero Paolo			Altered Modulation of Silent Period in Tongue Motor Cortex of Persistent Developmental Stuttering in Relation to Stuttering Severity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BASAL GANGLIA ACTIVITY; FRONTAL ASLANT TRACT; FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; SYLLABLE PRODUCTION; STATISTICAL POWER; FLUENT SPEECH; ADULTS; INHIBITION	Motor balance in developmental stuttering (DS) was investigated with Transcranial Magnetic Stimulation (TMS), with the aim to define novel neural markers of persistent DS in adulthood. Eleven DS adult males were evaluated with TMS on tongue primary motor cortex, compared to 15 matched fluent speakers, in a "state" condition (i.e. stutterers vs. fluent speakers, no overt stuttering). Motor and silent period thresholds (SPT), recruitment curves, and silent period durations were acquired by recording tongue motor evoked potentials. Tongue silent period duration was increased in DS, especially in the left hemisphere (P< 0.05; Hedge's g or Cohen's d(unbiased) = 1.054, i.e. large effect size), suggesting a state condition of higher intracortical inhibition in left motor cortex networks. Differences in motor thresholds (different excitatory/inhibitory ratios in DS) were evident, as well as significant differences in SPT. In fluent speakers, the left hemisphere may be marginally more excitable than the right one in motor thresholds at lower muscular activation, while active motor thresholds and SPT were higher in the left hemisphere of DS with respect to the right one, resulting also in a positive correlation with stuttering severity. Pre-TMS electromyography data gave overlapping evidence. Findings suggest the existence of a complex intracortical balance in DS tongue primary motor cortex, with a particular interplay between excitatory and inhibitory mechanisms, also in neural substrates related to silent periods. Findings are discussed with respect to functional and structural impairments in stuttering, and are also proposed as novel neural markers of a stuttering "state" in persistent DS, helping to define more focused treatments (e.g. neuro-modulation).	[Busan, Pierpaolo] IRCCS Fdn Osped San Camillo, Venice, Italy; [Del Ben, Giovanni; Bencich, Marco; Battaglini, Piero Paolo] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Bernardini, Simona] ABC Balbuzie, Turin, Italy; [Natarelli, Giulia] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Monti, Fabrizio; Manganotti, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	IRCCS Ospedale San Camillo; University of Trieste; University of Padua; University of Trieste	Busan, P (corresponding author), IRCCS Fdn Osped San Camillo, Venice, Italy.	pbusan@units.it	Manganotti, Paolo/L-1763-2018	Manganotti, Paolo/0000-0001-5305-6268; DEL BEN, GIOVANNI/0000-0002-6082-1332; Battaglini, Piero Paolo/0000-0003-4697-8648	Beneficentia Stiftung; Vaduz; Liechtenstein	Beneficentia Stiftung; Vaduz; Liechtenstein	Funding was provided by Beneficentia Stiftung,Vaduz, Liechtenstein (no grant number and/or website available) to PB. ABC Balbuzie is a commercial affiliation, and it provided support in the form of salaries for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Alm PA, 2007, J COMMUN DISORD, V40, P1, DOI 10.1016/j.jcomdis.2006.04.001; Alm PA, 2014, J FLUENCY DISORD, V40, P5, DOI 10.1016/j.jfludis.2014.01.004; Alm PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076824; Barwood C. H. S., 2013, SPEECH LANGUAGE HEAR, V16, P18, DOI DOI 10.1179/2050571X12Z.0000000001; Beck AT., 1996, MANUAL BECK DEPRESSI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Bleek B, 2011, J COMMUN DISORD, V44, P218, DOI 10.1016/j.jcomdis.2010.11.001; Bloodstein O., 2008, HDB STUTTERING; Boldrini M, 2003, INT J NEUROPSYCHOPH, V6, P311, DOI 10.1017/S1461145703003584; Borenstein M., 2009, HDB RES SYNTHESIS ME, VVolume 2, P221, DOI DOI 10.7758/9781610441384; Borenstein M., 2009, INTRO METAANALYSIS; Bosshardt HG, 2002, J FLUENCY DISORD, V27, P93, DOI 10.1016/S0094-730X(02)00113-4; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Budde KS, 2014, BRAIN LANG, V139, P99, DOI 10.1016/j.bandl.2014.10.002; Busan P, 2013, CORTEX, V49, P781, DOI 10.1016/j.cortex.2011.12.002; Busan P, 2009, CLIN NEUROPHARMACOL, V32, P183, DOI 10.1097/WNF.0b013e31819817eb; Butler JE, 2012, CLIN NEUROPHYSIOL, V123, P1409, DOI 10.1016/j.clinph.2011.11.034; Cai S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00054; Cantello R, 2002, BRAIN RES REV, V38, P309, DOI 10.1016/S0165-0173(01)00158-8; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2015, BRAIN, V138, P694, DOI 10.1093/brain/awu400; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Civier O, 2015, BRAIN LANG, V143, P20, DOI 10.1016/j.bandl.2015.01.012; Classen J, 1997, BRAIN, V120, P605, DOI 10.1093/brain/120.4.605; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Craig-McQuaide A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00884; Curra A, 2000, NEUROLOGY, V54, P130, DOI 10.1212/WNL.54.1.130; Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; D'Ausilio A, 2011, NEUROPSYCHOLOGIA, V49, P3670, DOI 10.1016/j.neuropsychologia.2011.09.022; Daliri A, 2014, J SPEECH LANG HEAR R, V57, P2131, DOI 10.1044/2014_JSLHR-S-13-0333; Daliri A, 2013, J SPEECH LANG HEAR R, V56, P1774, DOI 10.1044/1092-4388(2013/12-0134); Davis S, 2007, J COMMUN DISORD, V40, P398, DOI 10.1016/j.jcomdis.2006.10.003; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Espay AJ, 2006, ANN NEUROL, V59, P825, DOI 10.1002/ana.20837; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Farzan F, 2013, NEUROIMAGE, V83, P120, DOI 10.1016/j.neuroimage.2013.06.059; Fisher SE, 2010, NEW ENGL J MED, V362, P750, DOI 10.1056/NEJMe0912594; Forster DC, 2001, DEV NEUROPSYCHOL, V19, P125, DOI 10.1207/S15326942DN1902_1; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Glass G. V., 1981, METAANALYSIS SOCIAL; Hallett M., 2005, MAGNETIC STIMULATION, V2nd; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Ingham RJ, 2004, J SPEECH LANG HEAR R, V47, P321, DOI 10.1044/1092-4388(2004/026); Ingham RJ, 2012, BRAIN LANG, V122, P11, DOI 10.1016/j.bandl.2012.04.002; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Iverach L, 2010, J COMMUN DISORD, V43, P120, DOI 10.1016/j.jcomdis.2009.12.001; Jancke L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-23; Jones M, 2002, J SPEECH LANG HEAR R, V45, P243, DOI 10.1044/1092-4388(2002/019); Kallioniemi E, 2014, CLIN NEUROPHYSIOL, V125, P2247, DOI 10.1016/j.clinph.2014.03.012; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; KELLY EM, 1995, J SPEECH HEAR RES, V38, P1025, DOI 10.1044/jshr.3805.1025; Kemerdere R, 2016, J NEUROL, V263, P157, DOI 10.1007/s00415-015-7949-3; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; Kinoshita M, 2015, BRAIN STRUCT FUNCT, V220, P3399, DOI 10.1007/s00429-014-0863-0; Kronfeld-Duenias V, 2016, BRAIN STRUCT FUNCT, V221, P365, DOI 10.1007/s00429-014-0912-8; Kumar A, 2007, CLIN NEUROPHARMACOL, V30, P58, DOI 10.1097/01.WNF.0000240950.18821.19; Lang N, 2008, NEUROPSYCHOPHARMACOL, V33, P2517, DOI 10.1038/sj.npp.1301645; Lo YL, 2005, J CLIN NEUROPHYSIOL, V22, P176; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Maguire GA, 2000, J CLIN PSYCHOPHARM, V20, P479, DOI 10.1097/00004714-200008000-00013; Maguire G, 2010, J CLIN PSYCHOPHARM, V30, P48, DOI 10.1097/JCP.0b013e3181caebbe; Maguire Gerald A, 2004, Ann Clin Psychiatry, V16, P63, DOI 10.1080/10401230490452834; Max L, 2005, J SPEECH LANG HEAR R, V48, P524, DOI 10.1044/1092-4388(2005/036); McDonald J.H, 2014, HDB BIOL STAT, V3rd; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; Mulligan HF, 2003, PARKINSONISM RELAT D, V9, P281, DOI 10.1016/S1353-8020(03)00002-6; Murdoch BE, 2013, SPEECH LANG HEAR, V16, P56, DOI [10.1179/2050571X13Z.0000000009, DOI 10.1179/2050571X13Z.0000000009]; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Narayana S, 2012, NEUROIMAGE, V62, P250, DOI 10.1016/j.neuroimage.2012.04.060; Neef NE, 2011, CLIN NEUROPHYSIOL, V122, P1802, DOI 10.1016/j.clinph.2011.02.003; Neef NE, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0579-4; Neef NE, 2015, BRAIN, V138, P712, DOI 10.1093/brain/awu390; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2009, J PSYCHOSOM RES, V67, P591, DOI 10.1016/j.jpsychores.2009.07.014; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Poston B, 2012, EUR J NEUROSCI, V36, P2964, DOI 10.1111/j.1460-9568.2012.08212.x; POULOS MG, 1991, J SPEECH HEAR RES, V34, P5, DOI 10.1044/jshr.3401.05; Preibisch C, 2003, NEUROIMAGE, V20, P1356, DOI 10.1016/S1053-8119(03)00376-8; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; Riley G., 2009, STUTTERING SEVERITY, V4th; Rogic Vidakovic M, 2015, C BRAIN STIM 1 INT B, V8, P317; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2003, MOVEMENT DISORD, V18, P826, DOI 10.1002/mds.10443; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Sommer M, 2009, MOVEMENT DISORD, V24, P769, DOI 10.1002/mds.22383; Suresh R, 2006, AM J HUM GENET, V78, P554, DOI 10.1086/501370; Tavano A, 2011, J CLIN PSYCHOPHARM, V31, P131, DOI 10.1097/JCP.0b013e318205694f; Toyomura A, 2015, NEUROIMAGE, V109, P458, DOI 10.1016/j.neuroimage.2015.01.024; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; Vanryckeghem M, 2012, J COMMUN DISORD, V45, P340, DOI 10.1016/j.jcomdis.2012.06.001; Vidakovic MR, 2016, COGN PROCESS, V17, P429, DOI 10.1007/s10339-016-0766-5; Walsh B, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9123-8; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WEBSTER WG, 1990, J MOTOR BEHAV, V22, P553; West B. T., 2014, LINEAR MIXED MODELS; Wu JC, 1997, NEUROREPORT, V8, P767, DOI 10.1097/00001756-199702100-00037; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Wymbs NF, 2013, BRAIN LANG, V124, P153, DOI 10.1016/j.bandl.2012.11.013; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7; Zlatar ZZ, 2013, J INT NEUROPSYCH SOC, V19, P625, DOI 10.1017/S1355617713000246; Zotti A.M., 1997, CBA 2 0 COGNITIVE BE	121	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163959	10.1371/journal.pone.0163959	http://dx.doi.org/10.1371/journal.pone.0163959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711148	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600054
J	Campos, NG; Sharma, M; Clark, A; Kim, JJ; Resch, SC				Campos, Nicole G.; Sharma, Monisha; Clark, Andrew; Kim, Jane J.; Resch, Stephen C.			Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; SUB-SAHARAN AFRICA; MODEL-BASED IMPACT; COST-EFFECTIVENESS; HPV-18 VACCINATION; VISUAL INSPECTION; ECONOMIC-IMPACT; POSITIVE WOMEN; RURAL INDIA; ACETIC-ACID	Background Cervical cancer is the fourth leading cause of cancer death in women, with 85% of cases and deaths occurring in developing countries. While organized screening programs have reduced cervical cancer incidence in high-income countries through detection and treatment of precancerous lesions, the implementation of organized screening has not been effective in low-resource settings due to lack of infrastructure and limited budgets. Our objective was to estimate the cost of comprehensive primary and secondary cervical cancer prevention in low-and middle-income countries. Methods and Findings We performed a modeling analysis to estimate 1) for girls aged 10 years, the cost of 2-dose human papillomavirus (HPV) vaccination; and 2) for women aged 30 to 49 years, the cost of cervical cancer screening (with visual inspection with acetic acid (VIA), HPV testing, or cytology) and preventive treatment in 102 low-and middle-income countries from 2015 to 2024. We used an Excel-based costing and service utilization model to estimate financial costs (2013 US$) based on prevalence of HPV, prevalence of precancerous lesions, and screening test performance. Where epidemiologic data were unavailable, we extrapolated from settings with data using an individual-based microsimulation model of cervical carcinogenesis (calibrated to 20 settings) and multivariate regression. Total HPV vaccination costs ranged from US$8.6 billion to US$24.2 billion for all scenarios considered (immediate, 5-year, or 10-year roll-out; price per dose US$4.55-US$70 by country income level). The total cost of screening and preventive treatment ranged from US$5.1 billion (10-year roll-out, screening once at age 35 years) to US$42.3 billion (immediate roll-out, high intensity screening). Limitations of this analysis include the assumption of standardized protocols by country income level that did not account for the potential presence of multiple screening modalities or management strategies within a country, and extrapolation of cost and epidemiologic data to settings where data were limited. Conclusions The estimated cost of comprehensive cervical cancer prevention with 2-dose HPV vaccination of 10-year-old girls and screening of women aged 30 to 49 years ranges from US$13.7 billion to US$66.5 billion, depending on speed of roll-out, vaccine price per dose, and screening test and frequency. Findings demonstrate the substantial impact of vaccine price in middle-income countries that are not eligible for assistance from Gavi, the Vaccine Alliance. Replacing routine cytology with HPV-based screening may reduce total costs. Data on the health impact and relative cost-effectiveness of strategies are needed to determine the best value for public health dollars.	[Campos, Nicole G.; Kim, Jane J.; Resch, Stephen C.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA; [Sharma, Monisha] Univ Washington, Dept Global Hlth, Int Clin Res Ctr, 908 Jefferson St, Seattle, WA 98104 USA; [Clark, Andrew] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Campos, NG (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	ncampos@hsph.harvard.edu			American Cancer Society [16300]	American Cancer Society(American Cancer Society)	The authors were supported by a grant from the American Cancer Society (16300) (www.cancer.org). The funders had no role in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the paper for publication.	[Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P221; Campos NG, 2015, INT J CANCER, V137, P893, DOI 10.1002/ijc.29438; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Cremer M, 2011, INT J GYNECOL OBSTET, V113, P68, DOI 10.1016/j.ijgo.2010.10.018; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny LA, 2013, VACCINE, V31, pF73, DOI 10.1016/j.vaccine.2012.11.077; Deodhar K, 2012, INT J CANCER, V131, pE954, DOI 10.1002/ijc.27633; Diaz M, 2008, BRIT J CANCER, V99, P230, DOI 10.1038/sj.bjc.6604462; Dieleman JL, 2016, LANCET; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Goldie SJ, 2012, REV PANAM SALUD PUBL, V32, P426, DOI 10.1590/S1020-49892012001400006; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Kim JJ, 2008, VACCINE, V26, P4015, DOI 10.1016/j.vaccine.2008.05.038; Kim JJ, 2013, VACCINE, V31, pF60, DOI 10.1016/j.vaccine.2012.07.093; Kim JJ, 2013, VACCINE, V31, pG65, DOI 10.1016/j.vaccine.2012.06.096; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; Muwonge R, 2014, INT J CANCER, V134, P2902, DOI 10.1002/ijc.28627; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Mvundura M, 2014, INT J GYNECOL OBSTET, V126, P151, DOI 10.1016/j.ijgo.2014.02.012; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; Programme for Research and Capacity Building in Sexual and Reproductive Health and HIV in Developing Countries, 2013, COSTS CERV CANC SCRE; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Qiao YL, 2014, INT J CANCER, V134, P2891, DOI 10.1002/ijc.28616; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sharma M, 2012, BJOG-INT J OBSTET GY, V119, P166, DOI 10.1111/j.1471-0528.2011.02974.x; Sharma M, 2013, INT J CANCER, V132, P1895, DOI 10.1002/ijc.27835; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; WHO, 2013, WHO GUID SCREEN TREA; World Bank, WORLD DEV IND	39	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164000	10.1371/journal.pone.0164000	http://dx.doi.org/10.1371/journal.pone.0164000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711124	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000385697600060
J	Matsuno, H; Kudoh, M; Watakabe, A; Yamamori, T; Shigemoto, R; Nagao, S				Matsuno, Hitomi; Kudoh, Moeko; Watakabe, Akiya; Yamamori, Tetsuo; Shigemoto, Ryuichi; Nagao, Soichi			Distribution and Structure of Synapses on Medial Vestibular Nuclear Neurons Targeted by Cerebellar Flocculus Purkinje Cells and Vestibular Nerve in Mice: Light and Electron Microscopy Studies	PLOS ONE			English	Article							RETROGRADE AXONAL-TRANSPORT; GAMMA-AMINOBUTYRIC-ACID; LONG-TERM DEPRESSION; HORSERADISH-PEROXIDASE; VESTIBULOOCULAR REFLEX; PREPOSITUS-HYPOGLOSSI; PIGMENTED RABBITS; OCULAR REFLEX; LENTIVIRAL VECTORS; TRANSGENIC MICE	Adaptations of vestibulo-ocular and optokinetic response eye movements have been studied as an experimental model of cerebellum-dependent motor learning. Several previous physiological and pharmacological studies have consistently suggested that the cerebellar flocculus (FL) Purkinje cells (P-cells) and the medial vestibular nucleus (MVN) neurons targeted by FL (FL-targeted MVN neurons) may respectively maintain the memory traces of short-and long-term adaptation. To study the basic structures of the FL-MVN synapses by light microscopy (LM) and electron microscopy (EM), we injected green florescence protein (GFP)-expressing lentivirus into FL to anterogradely label the FL P-cell axons in C57BL/6J mice. The FL P-cell axonal boutons were distributed in the magnocellular MVN and in the border region of parvocellular MVN and prepositus hypoglossi (PrH). In the magnocellular MVN, the FL-P cell axons mainly terminated on somata and proximal dendrites. On the other hand, in the parvocellular MVN/PrH, the FL P-cell axonal synaptic boutons mainly terminated on the relatively small-diameter (< 1 mu m) distal dendrites of MVN neurons, forming symmetrical synapses. The majority of such parvocellular MVN/PrH neurons were determined to be glutamatergic by immunocytochemistry and in-situ hybridization of GFP expressing transgenic mice. To further examine the spatial relationship between the synapses of FL P-cells and those of vestibular nerve on the neurons of the parvocellular MVN/PrH, we added injections of biotinylated dextran amine into the semicircular canal and anterogradely labeled vestibular nerve axons in some mice. The MVN dendrites receiving the FL P-cell axonal synaptic boutons often closely apposed vestibular nerve synaptic boutons in both LM and EM studies. Such a partial overlap of synaptic boutons of FL P-cell axons with those of vestibular nerve axons in the distal dendrites of MVN neurons suggests that inhibitory synapses of FL P-cells may influence the function of neighboring excitatory synapses of vestibular nerve in the parvocellular MVN/PrH neurons.	[Matsuno, Hitomi; Kudoh, Moeko; Nagao, Soichi] Riken Brain Sci Inst, Lab Motor Learning Control, Hirosawa 2-1, Wako, Saitama 3510198, Japan; [Watakabe, Akiya; Yamamori, Tetsuo] RIKEN Brain Sci Inst, Lab Mol Anal Higher Brain Funct, Hirosawa 2-1, Wako, Saitama 3510198, Japan; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Matsuno, Hitomi] Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan; [Shigemoto, Ryuichi] IST Austria, A-3400 Klosterneuburg, Austria; [Nagao, Soichi] Nozomi Hosp Higher Brain Funct Lab, Komuro 3170, Saitama 3620806, Japan	RIKEN; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Center for Neurology & Psychiatry - Japan; Institute of Science & Technology - Austria	Matsuno, H; Nagao, S (corresponding author), Riken Brain Sci Inst, Lab Motor Learning Control, Hirosawa 2-1, Wako, Saitama 3510198, Japan.; Matsuno, H (corresponding author), Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan.; Nagao, S (corresponding author), Nozomi Hosp Higher Brain Funct Lab, Komuro 3170, Saitama 3620806, Japan.	matsuno@brain.riken.jp; nagaos@brain.riken.jp	Yamamori, Tetsuo/N-6536-2015; Shigemoto, Ryuichi/E-3628-2013	Yamamori, Tetsuo/0000-0001-5016-0078; Shigemoto, Ryuichi/0000-0001-8761-9444	RIKEN; Japan Society for the Promotion of Science [22300112]	RIKEN; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by RIKEN[to SN]; Grant-in-Aid from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/e-grants/ [22300112 to SN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2003, J NEUROPHYSIOL, V89, P1738, DOI 10.1152/jn.01043.2002; Anzai M, 2010, NEUROSCI RES, V68, P191, DOI 10.1016/j.neures.2010.07.2038; Arts MP, 2000, J NEUROPHYSIOL, V84, P2552, DOI 10.1152/jn.2000.84.5.2552; Aziz W, 2014, P NATL ACAD SCI USA, V111, pE194, DOI 10.1073/pnas.1303317110; Bagnall MW, 2009, J NEUROSCI, V29, P10104, DOI 10.1523/JNEUROSCI.2087-09.2009; BALABAN CD, 1981, NEUROSCI LETT, V27, P101, DOI 10.1016/0304-3940(81)90251-2; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BRODAL A, 1964, Arch Ital Biol, V102, P1; BRODAL A, 1957, J ANAT, V91, P438; CHANPALAY V, 1982, P NATL ACAD SCI-BIOL, V79, P3355, DOI 10.1073/pnas.79.10.3355; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; DUFOSSE M, 1978, BRAIN RES, V150, P611, DOI 10.1016/0006-8993(78)90825-9; Eccles J C, 1964, PHYSL SYNAPSES, DOI [10.1007/978-3-642-64950-9, DOI 10.1007/978-3-642-64950-9]; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Highstein SM, 2006, PROG BRAIN RES, V151, P157, DOI 10.1016/S0079-6123(05)51006-9; Hisano S, 2002, MOL BRAIN RES, V107, P23, DOI 10.1016/S0169-328X(02)00442-4; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1984, CEREBELLUM NEURAL CO, DOI [10.1001/archneur.1985.04060040016006, DOI 10.1001/ARCHNEUR.1985.04060040016006]; Ito M, 2011, CEREBELLUM BRAIN IMP, DOI [10.1093/arclin/acs054, DOI 10.1093/ARCLIN/ACS054]; Ito M, 2014, PROG BRAIN RES, V210, P1, DOI 10.1016/B978-0-444-63356-9.00001-7; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; KAWAGUCHI Y, 1985, Neuroscience Research, V2, P434, DOI 10.1016/0168-0102(85)90016-1; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; LANGER T, 1986, J COMP NEUROL, V245, P379, DOI 10.1002/cne.902450307; LANGER T, 1985, J COMP NEUROL, V235, P26, DOI 10.1002/cne.902350103; McElvain LE, 2010, NEURON, V68, P763, DOI 10.1016/j.neuron.2010.09.025; MCMASTERS RE, 1966, AM J ANAT, V118, P163, DOI 10.1002/aja.1001180109; Menzies JRW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013182; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MUGNAINI E, 1967, EXP BRAIN RES, V4, P187; MUGNAINI E, 1967, EXP BRAIN RES, V4, P212; NAGAO S, 1989, EXP BRAIN RES, V77, P531; NAGAO S, 1988, EXP BRAIN RES, V73, P489, DOI 10.1007/BF00406606; Nagao S, 1997, NEUROSCI RES, V27, P257, DOI 10.1016/S0168-0102(97)01160-7; NAGAO S, 1983, EXP BRAIN RES, V53, P36; Nagao S, 1989, EXP BRAIN RES, V80, P451; Okamoto T, 2011, NEUROSCI LETT, V504, P53, DOI 10.1016/j.neulet.2011.08.056; Okamoto T, 2011, J NEUROSCI, V31, P8958, DOI 10.1523/JNEUROSCI.1151-11.2011; Paxinos G F K, 2012, MOUSE BRAIN STEROTAX, P10786, DOI [10.1523/JNEUROSCI.0768-11.2011, DOI 10.1523/JNEUROSCI.0768-11.2011]; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; SATO F, 1993, J COMP NEUROL, V333, P554, DOI 10.1002/cne.903330408; SATO F, 1989, J COMP NEUROL, V290, P423, DOI 10.1002/cne.902900310; SATO Y, 1988, BRAIN RES, V446, P225, DOI 10.1016/0006-8993(88)90881-5; SATO Y, 1982, BRAIN RES, V232, P1, DOI 10.1016/0006-8993(82)90606-0; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Sultan F, 2003, J COMP NEUROL, V455, P139, DOI 10.1002/cne.10443; Takazawa T, 2004, J NEUROPHYSIOL, V92, P3106, DOI 10.1152/jn.00494.2004; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; Todaka H, 2013, EUR J NEUROSCI, V37, P339, DOI 10.1111/ejn.12051; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; UMETANI T, 1992, BRAIN RES, V586, P91, DOI 10.1016/0006-8993(92)91376-P; Uusisaari MY, 2012, CEREBELLUM, V11, P420, DOI 10.1007/s12311-011-0350-6; van den Pol AN, 1998, J NEUROSCI, V18, P10640; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Wang W, 2014, P NATL ACAD SCI USA, V111, pE188, DOI 10.1073/pnas.1315541111; WATANABE E, 1985, Neuroscience Research, V3, P20, DOI 10.1016/0168-0102(85)90036-7; YAMAMOTO M, 1978, NEUROSCI LETT, V7, P197, DOI 10.1016/0304-3940(78)90167-2; YAMAMOTO M, 1977, NEUROSCI LETT, V5, P279, DOI 10.1016/0304-3940(77)90079-9; Yamazaki T, 2015, P NATL ACAD SCI USA, V112, P3541, DOI 10.1073/pnas.1413798112; YINGCHAROEN K, 1983, EXP BRAIN RES, V51, P192; Zhang W, 2006, J NEUROSCI, V26, P6935, DOI 10.1523/JNEUROSCI.0784-06.2006	75	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164037	10.1371/journal.pone.0164037	http://dx.doi.org/10.1371/journal.pone.0164037			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711146	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600069
J	Pucker, B; Holtgrawe, D; Sorensen, TR; Stracke, R; Viehover, P; Weisshaar, B				Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd			A De Novo Genome Sequence Assembly of the Arabidopsis thaliana Accession Niederzenz-1 Displays Presence/Absence Variation and Strong Synteny	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TRANSPOSABLE ELEMENTS; INFORMATION RESOURCE; STRUCTURAL VARIATION; CENTROMERIC REGION; CYTOSINE RESIDUES; GENE PREDICTION; REPETITIVE DNA; IDENTIFICATION; ORGANIZATION	Arabidopsis thaliana is the most important model organism for fundamental plant biology. The genome diversity of different accessions of this species has been intensively studied, for example in the 1001 genome project which led to the identification of many small nucleotide polymorphisms (SNPs) and small insertions and deletions (InDels). In addition, presence/absence variation (PAV), copy number variation (CNV) and mobile genetic elements contribute to genomic differences between A. thaliana accessions. To address larger genome rearrangements between the A. thaliana reference accession Columbia-0 (Col-0) and another accession of about average distance to Col-0, we created a de novo next generation sequencing (NGS)-based assembly from the accession Niederzenz-1 (Nd-1). The result was evaluated with respect to assembly strategy and synteny to Col-0. We provide a high quality genome sequence of the A. thaliana accession (Nd-1, LXSY01000000). The assembly displays an N50 of 0.590 Mbp and covers 99% of the Col-0 reference sequence. Scaffolds from the de novo assembly were positioned on the basis of sequence similarity to the reference. Errors in this automatic scaffold anchoring were manually corrected based on analyzing reciprocal best BLAST hits (RBHs) of genes. Comparison of the final Nd-1 assembly to the reference revealed duplications and deletions (PAV). We identified 826 insertions and 746 deletions in Nd-1. Randomly selected candidates of PAV were experimentally validated. Our Nd-1 de novo assembly allowed reliable identification of larger genic and intergenic variants, which was difficult or error-prone by short read mapping approaches alone. While overall sequence similarity as well as synteny is very high, we detected short and larger (affecting more than 100 bp) differences between Col-0 and Nd-1 based on bi-directional comparisons. The de novo assembly provided here and additional assemblies that will certainly be published in the future will allow to describe the pangenome of A. thaliana.	[Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd] Univ Bielefeld, Fac Biol, Bielefeld, Germany; [Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd] Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Weisshaar, B (corresponding author), Univ Bielefeld, Fac Biol, Bielefeld, Germany.; Weisshaar, B (corresponding author), Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany.	bernd.weisshaar@uni-bielefeld.de	Weisshaar, Bernd/B-3859-2014; Pucker, Boas/B-6549-2019	Weisshaar, Bernd/0000-0002-7635-3473; Pucker, Boas/0000-0002-3321-7471; Stracke, Ralf/0000-0002-9261-2279; Holtgrawe, Daniela/0000-0002-1062-4576	Chair of Genome Research at Bielefeld University; German Research Foundation (DFG); Bielefeld University	Chair of Genome Research at Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG)); Bielefeld University	This work was supported by institutional funds of the Chair of Genome Research at Bielefeld University. We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altenhoff AM, 2015, NUCLEIC ACIDS RES, V43, pD240, DOI 10.1093/nar/gku1158; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Friedberg EC, 2006, DNA REPAIR AND MUTAG; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Ishihara H, 2016, J EXP BOT, V67, P1505, DOI 10.1093/jxb/erv546; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Krishnakumar V, 2015, NUCLEIC ACIDS RES, V43, pD1003, DOI 10.1093/nar/gku1200; Kumekawa N, 2001, DNA RES, V8, P285, DOI 10.1093/dnares/8.6.285; Kumekawa N, 2000, DNA RES, V7, P315, DOI 10.1093/dnares/7.6.315; LAIBACH F., 1943, BOT ARCH [LEIPZIG], V44, P439; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Layat E, 2012, PLANT CELL PHYSIOL, V53, P267, DOI 10.1093/pcp/pcr177; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Macas J, 2002, BIOINFORMATICS, V18, P28, DOI 10.1093/bioinformatics/18.1.28; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marroni F, 2014, CURR OPIN PLANT BIOL, V18, P31, DOI 10.1016/j.pbi.2014.01.003; MARTINEZZAPATER JM, 1986, MOL GEN GENET, V204, P417, DOI 10.1007/BF00331018; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Munoz-Amatriain M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r58; Nagaki K, 2003, GENETICS, V163, P1221; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; O'Connell J, 2015, BIOINFORMATICS, V31, P2035, DOI 10.1093/bioinformatics/btv057; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reinert K, 2015, ANNU REV GENOM HUM G, V16, P133, DOI 10.1146/annurev-genom-090413-025358; RICHARDS EJ, 1991, NUCLEIC ACIDS RES, V19, P3351, DOI 10.1093/nar/19.12.3351; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Seoighe C, 2003, CURR OPIN GENET DEV, V13, P636, DOI 10.1016/j.gde.2003.10.005; Stadermann KB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0726-6; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson HL, 1996, NUCLEIC ACIDS RES, V24, P3017, DOI 10.1093/nar/24.15.3017; Thudi M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0690-3; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; Weigel D, 2015, ANNU REV GENET, V49, P315, DOI 10.1146/annurev-genet-120213-092110; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Yang CH, 1998, PHYTOPATHOLOGY, V88, P330, DOI 10.1094/PHYTO.1998.88.4.330; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zhang SJ, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.45; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476; Zytnicki M, 2014, BIOINFORMATICS, V30, P2656, DOI 10.1093/bioinformatics/btu365	89	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164321	10.1371/journal.pone.0164321	http://dx.doi.org/10.1371/journal.pone.0164321			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711162	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600118
J	Seidler, D; Griffin, M; Nymon, A; Koeppen, K; Ashare, A				Seidler, Darius; Griffin, Mary; Nymon, Amanda; Koeppen, Katja; Ashare, Alix			Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; PSEUDOMONAS-AERUGINOSA; OROPHARYNGEAL CULTURES; INFECTION-CONTROL; YOUNG-CHILDREN; INFLAMMATION; MICROBIOME; PATHOGENS; INFANTS	Background Due to frequent infections in cystic fibrosis (CF) patients, repeated respiratory cultures are obtained to inform treatment. When patients are unable to expectorate sputum, clinicians obtain throat swabs as a surrogate for lower respiratory cultures. There is no clear data in adult subjects demonstrating the adequacy of throat swabs as a surrogate for sputum or BAL. Our study was designed to determine the utility of throat swabs in identifying lung colonization with common organisms in adults with CF. Methods Adult CF subjects (n = 20) underwent bronchoscopy with BAL. Prior to bronchoscopy, a throat swab was obtained. A sputum sample was obtained from subjects who were able to spontaneously expectorate. All samples were sent for standard microbiology culture. Results Using BAL as the gold standard, we found the positive predictive value for Pseudomonas aeruginosa to be 100% in both sputum and throat swab compared to BAL. However, the negative predictive value for P. aeruginosa was 60% and 50% in sputum and throat swab, respectively. Conversely, the positive predictive value for Staphylococcus aureus was 57% in sputum and only 41% in throat swab and the negative predictive value of S. aureus was 100% in sputum and throat swab compared to BAL. Conclusions Our data show that positive sputum and throat culture findings of P. aeruginosa reflect results found on BAL fluid analysis, suggesting these are reasonable surrogates to determine lung colonization with P. aeruginosa. However, sputum and throat culture findings of S. aureus do not appear to reflect S. aureus colonization of the lung.	[Seidler, Darius; Griffin, Mary; Nymon, Amanda; Ashare, Alix] Dartmouth Hitchcock Med Ctr, Pulm & Crit Care Med, Lebanon, NH 03766 USA; [Koeppen, Katja; Ashare, Alix] Geisel Sch Med Dartmouth, Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Ashare, A (corresponding author), Dartmouth Hitchcock Med Ctr, Pulm & Crit Care Med, Lebanon, NH 03766 USA.; Ashare, A (corresponding author), Geisel Sch Med Dartmouth, Microbiol & Immunol, Hanover, NH 03755 USA.	alix.ashare@dartmouth.edu			Dartmouth Lung Biology Center (NIH) [COBRE P30GM106394]; Cystic Fibrosis Foundation [STANTO19R0, STANTO16GO]; National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL074175, R01HL122372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175, R01HL122372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	Dartmouth Lung Biology Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a pilot grant from the Dartmouth Lung Biology Center (funded by NIH COBRE P30GM106394 to B.A. Stanton), the Cystic Fibrosis Foundation (STANTO19R0, STANTO16GO) and the National Heart, Lung and Blood Institute of the National Institutes of Health (R01HL074175 to Stanton and R01HL122372 to Ashare). Apart from initial advice on study design in conjunction with the pilot grant funding, the funding sources played no role in study conduct, data analysis, manuscript preparation or manuscript review.	Ahmed B, 2014, ARCH DIS CHILDHOOD-E, V99, P181, DOI 10.1136/archdischild-2012-303408; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Caverly LJ, 2015, PEDIATR PULM, V50, pS31, DOI 10.1002/ppul.23243; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Emiralioglu N, 2016, J CLIN PHARM THER, V41, P419, DOI 10.1111/jcpt.12407; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hogan DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149998; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Jennings MT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-223; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Saiman L, 2003, AM J INFECT CONTROL, V31, pS6, DOI 10.1067/mic.2003.78; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Team RDC, 2019, R LANG ENV STAT COMP; Zampoli M, 2016, J CYST FIBROS, V15, P605, DOI 10.1016/j.jcf.2016.01.001; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC	24	22	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164232	10.1371/journal.pone.0164232	http://dx.doi.org/10.1371/journal.pone.0164232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711152	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600101
J	Takabatake, M; Blyth, BJ; Daino, K; Imaoka, T; Nishimura, M; Fukushi, M; Shimada, Y				Takabatake, Masaru; Blyth, Benjamin J.; Daino, Kazuhiro; Imaoka, Tatsuhiko; Nishimura, Mayumi; Fukushi, Masahiro; Shimada, Yoshiya			DNA Methylation Patterns in Rat Mammary Carcinomas Induced by Pre- and Post-Pubertal Irradiation	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; BREAST-CANCER; TRANSCRIPTIONAL REGULATION; MOLECULAR SUBTYPES; EPITHELIAL-CELLS; GENE-EXPRESSION; RADIATION; AGE; TUMORS; GLAND	Several lines of evidence indicate one's age at exposure to radiation strongly modifies the risk of radiation-induced breast cancer. We previously reported that rat mammary carcinomas induced by pre- and post-pubertal irradiation have distinct gene expression patterns, but the changes underlying these differences have not yet been characterized. The aim of this investigation was to see if differences in CpG DNA methylation were responsible for the differences in gene expression between age at exposure groups observed in our previous study. DNA was obtained from the mammary carcinomas arising in female Sprague-Dawley rats that were either untreated or irradiated (gamma-rays, 2 Gy) during the pre-or post-pubertal period (3 or 7 weeks old). The DNA methylation was analyzed using CpG island microarrays and the results compared to the gene expression data from the original study. Global DNA hypomethylation in tumors was accompanied by gene-specific hypermethylation, and occasionally, by unique tumor-specific patterns. We identified methylation-regulated gene expression candidates that distinguished the pre- and post-pubertal irradiation tumors, but these represented only 2 percent of the differentially expressed genes, suggesting that methylation is not a major or primary mechanism underlying the phenotypes. Functional analysis revealed that the candidate methylation-regulated genes were enriched for stem cell differentiation roles, which may be important in mammary cancer development and worth further investigation. However, the heterogeneity of human breast cancer means that the interpretation of molecular and phenotypic differences should be cautious, and take into account the co-variates such as hormone receptor status and cell-of-origin that may influence the associations.	[Takabatake, Masaru; Blyth, Benjamin J.; Daino, Kazuhiro; Imaoka, Tatsuhiko; Nishimura, Mayumi; Shimada, Yoshiya] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiat Effects Res, Chiba, Japan; [Takabatake, Masaru; Imaoka, Tatsuhiko; Fukushi, Masahiro; Shimada, Yoshiya] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan	National Institutes for Quantum Science & Technology; Tokyo Metropolitan University	Shimada, Y (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiat Effects Res, Chiba, Japan.; Shimada, Y (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan.	shimada.yoshiya@qst.go.jp	Imaoka, Tatsuhiko/E-5134-2012	Imaoka, Tatsuhiko/0000-0003-1507-585X; Blyth, Benjamin/0000-0003-4754-6249	Ministry of Health, Labor, and Welfare of Japan;  [24-7555]; Grants-in-Aid for Scientific Research [15H01834] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for the Third Comprehensive 10-year Strategy for Cancer Control and for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp) to KD, and for the Japan Society for the Promotion of Science Fellows (https.//www.jsps.go.jp) to MT (No. 24-7555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardowell SA, 2013, BREAST CANCER RES TR, V142, P365, DOI 10.1007/s10549-013-2738-0; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Blyth BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130666; BOICE JD, 1991, RADIAT RES, V125, P214, DOI 10.2307/3577890; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; de Candia P, 2004, ADV CANCER RES, V92, P81; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Huh SJ, 2015, STEM CELL REP, V4, P297, DOI 10.1016/j.stemcr.2014.12.009; Iizuka D, 2010, RADIAT RES, V174, P206, DOI 10.1667/RR2006.1; Imaoka T, 2011, MOL CARCINOGEN, V50, P539, DOI 10.1002/mc.20746; Ishida Y, 2010, CARCINOGENESIS, V31, P1694, DOI 10.1093/carcin/bgq145; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jang SM, 2015, BIOCHEM BIOPH RES CO, V463, P961, DOI 10.1016/j.bbrc.2015.06.042; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kakinuma S, 2012, MUTAT RES-FUND MOL M, V737, P43, DOI 10.1016/j.mrfmmm.2012.06.001; Kovalchuk IP, 2014, RADIAT RES, V182, P683, DOI 10.1667/RR13697.1; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Matsuu-Matsuyama M, 2015, J RADIAT RES, V56, P493, DOI 10.1093/jrr/rrv003; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; Russo J, 2015, TOXICOL PATHOL, V43, P145, DOI 10.1177/0192623314532036; Schellong G, 2014, DTSCH ARZTEBL INT, V111, P3, DOI 10.3238/arztebl.2014.0003; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shen QA, 2010, MOL CANCER RES, V8, P939, DOI 10.1158/1541-7786.MCR-09-0523; SHIMADA Y, 1994, RADIAT RES, V137, P118, DOI 10.2307/3578800; Simian M, 2001, DEVELOPMENT, V128, P3117; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Sunaoshi M, 2015, MUTAT RES-FUND MOL M, V779, P58, DOI 10.1016/j.mrfmmm.2015.06.004; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Zhai Y, 2011, ONCOGENE, V30, P4152, DOI 10.1038/onc.2011.123; Zhang Z, 2015, CANCER LETT, V361, P240, DOI 10.1016/j.canlet.2015.03.008	45	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164194	10.1371/journal.pone.0164194	http://dx.doi.org/10.1371/journal.pone.0164194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711132	Green Published, gold			2022-12-26	WOS:000385697600096
J	Wild, E; Cojocaru, MG				Wild, Erin; Cojocaru, Monica Gabriela			Runaway Competition: A Correction and Extension of Results for a Model of Competitive Helping	PLOS ONE			English	Article							BIOLOGICAL MARKETS; PRISONERS-DILEMMA; PARTNER CHOICE; COOPERATION; EVOLUTION; ALTRUISM; RECIPROCITY	We investigate and generalize an existing model of competitive helping within a biological market, first introduced for a population of competing individuals in which one individual provides help to all others; the rest compete for the help available from this individual by providing help themselves. Our generalized model comprises two strategies in which each individual of a specific type provides the same amount of help as all other individuals of that type. Each individual's fitness function is dependent on this level of help, the cost of providing the help, and the fact that help is proportionally reciprocated by other individuals. Competitive helping occurs when individuals actively try to help more than other individuals. To assess the emergence of equilibrium help strategies as adopted by proportions of the population, we examine the competition over available help within two settings: replicator dynamics and agent-based numerical simulations. To move one step further in our generalization, we use the agent-based model to study the N-person competitive helping game, where all individuals in the population are heterogeneous with respect to help provided. Our results show that helping does not increase indefinitely with the population size, as concluded previously, and while there are some instances of an increase in help provided as a result of competition, this competition can be detrimental to all individuals and in most cases, one type simply gives up (thus evolving to a "no help" strategy). The degree to which an individual's help is reciprocated by the others in the population has strong implications in the long-term behaviour of equilibrium help levels of types of individuals (and of individuals themselves); these equilibrium help levels diverge from existing conjectures in current literature. Lastly, small amounts of passively provided (costless) help results in runaway competition among all individuals.	[Wild, Erin; Cojocaru, Monica Gabriela] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada	University of Guelph	Wild, E (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON, Canada.	ewild@uoguelph.ca		Wild, Erin/0000-0003-1349-5850	Natural Sciences and Engineering Research Council of Canada [400684]; Ontario Graduate Scholarship, University of Guelph	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship, University of Guelph	This work was supported by Natural Sciences and Engineering Research Council of Canada - Discovery Grant - 400684 (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), MGC; and Ontario Graduate Scholarship, University of Guelph (https.//www.uoguelph.ca/graduatestudies/current/funding/scholarships/gov-fundedawards/ogs), EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Barclay P, 2011, J THEOR BIOL, V281, P47, DOI 10.1016/j.jtbi.2011.04.023; Barclay P, 2010, BRIT J PSYCHOL, V101, P123, DOI 10.1348/000712609X435733; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; DOMJAN M, 1993, PRINCIPLES LEARNING; Harkin ME, 2015, INT ENCY SOCIAL BEHA, V17, P11885; Luke S, 2004, MERSENNE TWISTER JAV; Matsumoto M, 1998, ACM T MODELING COMPU, V8; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vogel G, 2004, SCIENCE, V303, P1128, DOI 10.1126/science.303.5661.1128; WEARDEN JH, 1982, J EXP ANAL BEHAV, V38, P339, DOI 10.1901/jeab.1982.38-339; Williams B.A., 1988, STEVENS HDB EXPT PSY, V2, P167	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164188	10.1371/journal.pone.0164188	http://dx.doi.org/10.1371/journal.pone.0164188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711174	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600095
J	Yoo, HJ; Lee, JS; Kim, JE; Gu, J; Koh, Y; Kim, I; Kim, HK				Yoo, Hyun Ju; Lee, Jee-Soo; Kim, Ji-Eun; Gu, JaYoon; Koh, Youngil; Kim, Inho; Kim, Hyun Kyung			Extracellular Histone Released from Leukemic Cells Increases Their Adhesion to Endothelium and Protects them from Spontaneous and Chemotherapy-Induced Leukemic Cell Death	PLOS ONE			English	Article							APOPTOSIS	Introduction When leukocytes are stimulated by reactive oxygen species (ROS), they release nuclear contents into the extracellular milieu, called by extracellular traps (ET). The nuclear contents are mainly composed of the histone-DNA complex and neutrophil elastase. This study investigated whether leukemic cells could release ET and the released histone could induce endothelial activation, eventually resulting in leukemic progression. Methods The circulating ET were measured in 80 patients with hematologic diseases and 40 healthy controls. ET formation and ROS levels were investigated during leukemic cell proliferation in vitro. Histone-induced endothelial adhesion molecules expression and cell survival were measured by flow cytometry. Results Acute leukemia patients had high levels of ET, which correlated with peripheral blast count. Leukemic cells produced high ROS levels and released extracellular histone, which was significantly blocked by antioxidants. Histone significantly induced 3 endothelial adhesion molecules expression, and promoted leukemic cell adhesion to endothelial cells, which was inhibited by histone inhibitors (heparin, polysialic acid, and activated protein C), neutralizing antibodies against these adhesion molecules, and a Toll like receptor(TLR) 9 antagonist. When leukemic cells were co-cultured with endothelial cells, adherent leukemic cells showed better survival than the non-adherent ones, demonstrating that histone-treated endothelial cells protected leukemic cells from both spontaneous and chemotherapy-induced death. Conclusion Our data demonstrate for the first time that extracellular histone can be released from leukemic cells through a ROS-dependent mechanism. The released histone promotes leukemic cell adhesion by inducting the surface expression of endothelial adhesion molecules and eventually protects leukemic cells from cell death.	[Yoo, Hyun Ju; Lee, Jee-Soo; Kim, Ji-Eun; Gu, JaYoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yoo, Hyun Ju; Kim, Ji-Eun; Gu, JaYoon; Koh, Youngil; Kim, Inho; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Koh, Youngil; Kim, Inho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	lukekhk@snu.ac.kr			National Research Foundation of Korea [2013-068572]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea 2013-068572 M.D., to PhD Hyun Kyung Kim. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; COLLINS RJ, 1989, BRIT J HAEMATOL, V71, P343; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Kawata J, 2014, BIOTECHNOL LETT, V36, P241, DOI 10.1007/s10529-013-1364-6; Kim JE, 2015, THROMB RES, V135, P1064, DOI 10.1016/j.thromres.2015.03.014; Kim JE, 2011, BLOOD COAGUL FIBRIN, V22, P132, DOI 10.1097/MBC.0b013e32834356b6; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Nakayama T, 2015, CELL BIOL INT, V39, P355, DOI 10.1002/cbin.10396; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Pezeshkian B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060823; Poulos MG, 2014, EXP HEMATOL, V42, P976, DOI 10.1016/j.exphem.2014.08.003; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	20	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163982	10.1371/journal.pone.0163982	http://dx.doi.org/10.1371/journal.pone.0163982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706246	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200073
J	Chae, JW; Ng, T; Yeo, HL; Shwe, M; Gan, YX; Ho, HK; Chan, A				Chae, Jung-Woo; Ng, Terence; Yeo, Hui Ling; Shwe, Maung; Gan, Yan Xiang; Ho, Han Kiat; Chan, Alexandre			Impact of TNF-alpha (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PROMOTER POLYMORPHISM; GENETIC POLYMORPHISMS; FATIGUE-SYNDROME; CHEMOTHERAPY; CYTOKINES; INTERLEUKIN-6; SYMPTOMS; ASSOCIATION; TRANSCRIPTION	Objective Expression of pro-inflammatory cytokines is influenced by single nucleotide polymorphisms (SNPs) in the promoter regions of the pro-inflammatory cytokine genes, and cytokines are associated with the occurrence of post-chemotherapy cognitive impairment. Hence, the aim of this study was to evaluate the associations between two common pro-inflammatory cytokine gene polymorphisms namely, IL6-174 (rs1800795 G>C) and TNF-308 (rs1800629 G> A), and chemotherapy-associated cognitive impairment (CACI) among Asian earlystage breast cancer patients. In addition, the differential effect of these SNPs on plasma IL-6 and TNF-alpha levels, and the associations of plasma IL-6 and TNF-alpha levels with CACI were also assessed. Methods Asian early-stage breast cancer patients (Stage I to III) receiving chemotherapy were prospectively recruited from two cancer centers in Singapore. Patients' cognitive function was longitudinally assessed using the validated FACT-Cog (ver. 3) and an objective computerized battery, Headminder (TM) at three-time points. Plasma IL-6 and TNF-alpha levels were analyzed using the multiplex immunoassay, and genotyping was performed using Sanger sequencing. Regression analyses and generalized estimating equation were utilized for statistical analysis. Results A total of 125 patients were included (mean age: 50.3; Chinese: 80.8%; post-menopausal: 48.0%; 68.0% received anthracycline-based chemotherapy). 36.8% patients experienced self-perceived cognitive impairment, detected in memory (32.8%) and attention (34.2%) domains. Patients with higher levels of anxiety (p< 0.001) and insomnia (p = 0.003) also reported more self-perceived cognitive impairment. Higher plasma concentrations of IL-6 were associated with greater severity of self-perceived cognitive impairment (p = 0.001). Polymorphisms of cytokine genes were not associated with expression of plasma cytokines. Conclusion Present findings further contribute to the growing evidence that supports the role of the pro-inflammatory cytokine IL-6 in the occurrence of cognitive impairment post-chemotherapy. However, genetic polymorphism of these cytokines did not play a major role to the cytokine fluctuations as well as cognitive impairment in this cohort. With an increasing evidence to support the cytokine hypothesis, future studies should investigate the role of anti-inflammatory agents in mitigating the cognitive impairment associated with chemotherapy.	[Chae, Jung-Woo; Ng, Terence; Yeo, Hui Ling; Shwe, Maung; Ho, Han Kiat; Chan, Alexandre] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Gan, Yan Xiang; Chan, Alexandre] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore; [Chan, Alexandre] Duke NUS Grad Med Sch Singapore, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore	Chan, A (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore, Singapore.; Chan, A (corresponding author), Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore.; Chan, A (corresponding author), Duke NUS Grad Med Sch Singapore, Singapore, Singapore.	phaac@nus.edu.sg	Chan, Alexandre/D-5035-2016	Chan, Alexandre/0000-0003-4391-4219; CHAE, JUNG-WOO/0000-0001-6026-7063	National Medical Research Council Singapore [NMRC/CIRG/1386/2014]	National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by research grants awarded by the National Medical Research Council Singapore (NMRC/CIRG/1386/2014) (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) (Project investigatorAC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Billing-Ross P, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0771-6; Bower JE, 2013, J CLIN ONCOL, V31, P1656, DOI 10.1200/JCO.2012.46.2143; Castellon SA, 2004, J CLIN EXP NEUROPSYC, V26, P955, DOI 10.1080/13803390490510905; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Cheung YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081234; Chu Hongxia, 2012, J Cardiovasc Dis Res, V3, P84, DOI 10.4103/0975-3583.95359; Delbarba A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5923938; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Ganz PA, 2013, BRAIN BEHAV IMMUN, V30, pS99, DOI 10.1016/j.bbi.2012.07.015; Gao SP, 2014, INT J CLIN EXP MED, V7, P2851; Han XM, 2011, NEUROSCI LETT, V504, P4, DOI 10.1016/j.neulet.2011.06.055; Janelsins MC, 2012, SUPPORT CARE CANCER, V20, P831, DOI 10.1007/s00520-011-1158-0; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Kim JM, 2013, J AFFECT DISORDERS, V148, P57, DOI 10.1016/j.jad.2012.11.048; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024; Liu HL, 2008, EUR J CLIN PHARMACOL, V64, P663, DOI 10.1007/s00228-008-0483-9; Luo N, 2005, QUAL LIFE RES, V14, P1181, DOI 10.1007/s11136-004-4782-z; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Merriman JD, 2014, BIOL RES NURS, V16, P152, DOI 10.1177/1099800413479441; Myers JS, 2010, ADV EXP MED BIOL, V678, P119; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; Ng T, 2016, NEURO-ONCOLOGY, V18, P244, DOI 10.1093/neuonc/nov162; Olomolaiye O, 1998, EUR J IMMUNOGENET, V25, P267, DOI 10.1111/j.1744-313X.1998.tb01147.x; Pan M, 2011, J INVEST MED, V59, P272, DOI 10.231/JIM.0b013e318206ffad; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Tannock IF, 2004, J CLIN ONCOL, V22, P2233, DOI 10.1200/JCO.2004.08.094; Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134; Tartter M, 2015, BRAIN BEHAV IMMUN, V46, P104, DOI 10.1016/j.bbi.2015.01.003; Wang XM, 2015, CYTOKINE, V72, P86, DOI 10.1016/j.cyto.2014.12.006; Yang YH, 2015, INT J CLIN EXP PATHO, V8, P13739; Yoon SZ, 2009, J CARDIOTHOR VASC AN, V23, P646, DOI 10.1053/j.jvca.2009.03.004	36	27	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164204	10.1371/journal.pone.0164204	http://dx.doi.org/10.1371/journal.pone.0164204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701469	Green Published, gold			2022-12-26	WOS:000385696900050
J	Saaresranta, T; Hedner, J; Bonsignore, MR; Riha, RL; McNicholas, WT; Penzel, T; Anttalainen, U; Kvamme, JA; Pretl, M; Sliwinski, P; Verbraecken, J; Grote, L				Saaresranta, Tarja; Hedner, Jan; Bonsignore, Maria R.; Riha, Renata L.; McNicholas, Walter T.; Penzel, Thomas; Anttalainen, Ulla; Kvamme, John Arthur; Pretl, Martin; Sliwinski, Pawel; Verbraecken, Johan; Grote, Ludger		ESADA Study Grp	Clinical Phenotypes and Comorbidity in European Sleep Apnoea Patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; INSOMNIA SYMPTOMS; COMMON; HYPERTENSION; PREVALENCE; DEPRESSION; HYPOPNEA; THERAPY; DAYTIME	Background Clinical presentation phenotypes of obstructive sleep apnoea (OSA) and their association with comorbidity as well as impact on adherence to continuous positive airway pressure (CPAP) treatment have not been established. Methods A prospective follow-up cohort of adult patients with OSA (apnoea-hypopnoea index (AHI) of >= 5/h) from 17 European countries and Israel (n = 6,555) was divided into four clinical presentation phenotypes based on daytime symptoms labelled as excessive daytime sleepiness ("EDS") and nocturnal sleep problems other than OSA (labelled as "insomnia"): 1) EDS (daytime+/nighttime-), 2) EDS/insomnia (daytime+/nighttime+), 3) non-EDS/noninsomnia (daytime-/nighttime-), 4) and insomnia (daytime-/nighttime+) phenotype. Results The EDS phenotype comprised 20.7%, the non-EDS/non-insomnia type 25.8%, the EDS/insomnia type 23.7%, and the insomnia phenotype 29.8% of the entire cohort. Thus, clinical presentation phenotypes with insomnia symptoms were dominant with 53.5%, but only 5.6% had physician diagnosed insomnia. Cardiovascular comorbidity was less prevalent in the EDS and most common in the insomnia phenotype (48.9% vs. 56.8%, p<0.001) despite more severe OSA in the EDS group (AHI 35.0 +/- 25.5/h vs. 27.9 +/- 22.5/h, p<0.001, respectively). Psychiatric comorbidity was associated with insomnia like OSA phenotypes independent of age, gender and body mass index (HR 1.5 (1.188-1.905), p<0.001). The EDS phenotype tended to associate with higher CPAP usage (22.7 min/d, p = 0.069) when controlled for age, gender, BMI and sleep apnoea severity. Conclusions Phenotypes with insomnia symptoms comprised more than half of OSA patients and were more frequently linked with comorbidity than those with EDS, despite less severe OSA. CPAP usage was slightly higher in phenotypes with EDS.	[Saaresranta, Tarja; Anttalainen, Ulla] Turku Univ Hosp, Div Med, Dept Pulm Dis, Turku, Finland; [Saaresranta, Tarja; Anttalainen, Ulla] Univ Turku, Dept Physiol, Sleep Res Ctr, Turku, Finland; [Hedner, Jan; Grote, Ludger] Sahlgrens Univ Hosp, Dept Sleep Med, Gothenburg, Sweden; [Hedner, Jan; Grote, Ludger] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden; [Bonsignore, Maria R.] Univ Palermo, Biomed Dept Internal & Specialist Med DIBIMIS, Palermo, Italy; [Bonsignore, Maria R.] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Riha, Renata L.] Royal Infirm Edinburgh NHS Trust, Dept Sleep Med, Edinburgh, Midlothian, Scotland; [McNicholas, Walter T.] St Vincents Univ Hosp, Dept Resp & Sleep Med, Dublin, Ireland; [McNicholas, Walter T.] Univ Coll Dublin, Conway Res Inst, Dublin, Ireland; [Penzel, Thomas] Charite, Schlafmed Zentrum, Berlin, Germany; [Penzel, Thomas] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Kvamme, John Arthur] Forde Cent Hosp, Dept ENT, Forde, Norway; [Pretl, Martin] Charles Univ Prague, Fac Med 1, Dept Neurol, Ctr Sleep & Waking Disorders, Prague, Czech Republic; [Pretl, Martin] Inspamed, Neurol & Sleep Lab, Prague, Czech Republic; [Sliwinski, Pawel] Inst TB & Lung Dis, Dept Resp Med 4th, Warsaw, Poland; [Verbraecken, Johan] Univ Antwerp Hosp, Multidisciplinary Sleep Disorders Ctr, Antwerp, Belgium; [Verbraecken, Johan] Univ Antwerp, Antwerp, Belgium	University of Turku; University of Turku; Sahlgrenska University Hospital; University of Gothenburg; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Royal Infirmary of Edinburgh; University of Edinburgh; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; University of Antwerp; University of Antwerp	Saaresranta, T (corresponding author), Turku Univ Hosp, Div Med, Dept Pulm Dis, Turku, Finland.; Saaresranta, T (corresponding author), Univ Turku, Dept Physiol, Sleep Res Ctr, Turku, Finland.	tasaare@utu.fi	Verbraecken, Johan/ABD-8801-2021; Penzel, Thomas/M-2344-2014; LEVY, Patrick/AAX-2802-2020; Bonsignore, Maria/T-3983-2019; Bonsignore, Maria/U-6440-2017; Riha, Renata/AAN-9066-2020; Parati, Gianfranco/K-7151-2016; Barbe, Ferran/A-5988-2010	Penzel, Thomas/0000-0002-4304-0112; LEVY, Patrick/0000-0003-3174-7935; Bonsignore, Maria/0000-0002-4875-7796; Riha, Renata/0000-0001-8983-9985; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Parati, Gianfranco/0000-0001-9402-7439; Barbe, Ferran/0000-0002-2340-8928; Ryan, Silke/0000-0003-0963-255X; Marrone, Oreste/0000-0001-6819-7928; Lombardi, Carolina/0000-0003-1033-6053; Varoneckas, Giedrius/0000-0001-8073-4335; Saaresranta, Tarja/0000-0001-9328-963X				AMBROGETTI A, 1991, AUST NZ J MED, V21, P863, DOI 10.1111/j.1445-5994.1991.tb01408.x; Anttalainen U, 2010, SLEEP MED, V11, P49, DOI 10.1016/j.sleep.2008.12.015; Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Bjornsdottir E, 2013, SLEEP, V36, P1901, DOI 10.5665/sleep.3226; Bonsignore MR, 2012, EUR RESPIR J, V39, P1136, DOI 10.1183/09031936.00151110; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; de Zambotti M, 2014, INT J PSYCHOPHYSIOL, V93, P332, DOI 10.1016/j.ijpsycho.2014.06.014; Eckert DJ, 2013, AM J RESP CRIT CARE, V188, P996, DOI 10.1164/rccm.201303-0448OC; Fietze I, 2011, SLEEP MED, V12, P190, DOI 10.1016/j.sleep.2010.10.003; Franklin KA, 2013, EUR RESPIR J, V41, P610, DOI 10.1183/09031936.00212711; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Halaris A, 2013, MOD TR PHARMACOPSYCH, V28, P144, DOI 10.1159/000343981; Hedner J, 2011, EUR RESPIR J, V38, P635, DOI 10.1183/09031936.00046710; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kent BD, 2014, CHEST, V146, P982, DOI 10.1378/chest.13-2403; Kent BD, 2014, EUR RESPIR J, V44, P130, DOI 10.1183/09031936.00162713; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2006, SLEEP BREATH, V10, P16, DOI 10.1007/s11325-005-0037-7; Krakow B, 2008, J CLIN SLEEP MED, V4, P212; Lee RWW, 2010, SLEEP, V33, P1249, DOI 10.1093/sleep/33.9.1249; LUGARESI E, 1987, SEMIN NEUROL, V7, P259, DOI 10.1055/s-2008-1041426; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Montemurro LT, 2014, J CLIN SLEEP MED, V10, P271, DOI 10.5664/jcsm.3526; Owens RL, 2015, SLEEP, V38, P961, DOI 10.5665/sleep.4750; Pedrosa Rodrigo P, 2014, Chest, V146, P66, DOI 10.1378/chest.14-0097; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Pieh C, 2013, SLEEP BREATH, V17, P99, DOI 10.1007/s11325-012-0655-9; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Terrill PI, 2015, EUR RESPIR J, V45, P408, DOI 10.1183/09031936.00062914; THORPY M, 1994, SLEEP, V17, P372; Tkacova R, 2014, EUR RESPIR J, V44, P931, DOI 10.1183/09031936.00225113; Utriainen KT, 2013, EUR RESPIR J, V41, P616, DOI 10.1183/09031936.00227611; Vavougios GD, 2016, J SLEEP RES, V25, P31, DOI 10.1111/jsr.12344; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	40	90	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163439	10.1371/journal.pone.0163439	http://dx.doi.org/10.1371/journal.pone.0163439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701416	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900007
J	Tezval, H; Dubrowinskaja, N; Peters, I; Reese, C; Serth, K; Atschekzei, F; Hennenlotter, J; Stenzl, A; Kuczyk, MA; Serth, J				Tezval, Hossein; Dubrowinskaja, Natalia; Peters, Inga; Reese, Christel; Serth, Katrin; Atschekzei, Faranaz; Hennenlotter, Joerg; Stenzl, Arnulf; Kuczyk, Markus A.; Serth, Juergen			Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DISEASE; CANCER; GROWTH	The relevance of Corticotropin Releasing Hormone (CRH)-system in human malignancies is a question of growing interest. Here we investigated hypermethylation and epigenetic silencing of the CRH-Binding Protein (CRHBP) gene in clear cell renal cell cancer (ccRCC). Relative methylation of the CRHBP CpG island (CGI) was determined in 17 tumor cell lines as well as 86 ccRCC samples and 66 paired normal tissues using pyrosequencing and quantitative methylation specific PCR of bisulfite converted DNA. Results were statistically compared with relative mRNA expression levels of CRHBP and clinicopathological parameters of patients. Re-expression of CRHBP following 5-aza-2'-deoxycytidine treatment was investigated by quantitative mRNA expression analysis. Real-time impedance analysis was applied for analysis of invasiveness of renal tumor cells following si-RNA knockdown of CRHBP expression or ectopic expression of CRHBP. We found the CRHBP CGI to be frequently methylated in tumor cell lines of renal, prostatic, and bladder cancer. Comparison of methylation in normal and paired renal cancer tissue specimens revealed hypermethylation of the CRHBP CGI in tumors (p<1*10(-12)). DNA methylation and decreased mRNA expression were correlated (R = 0.83, p<1*10(-12)). Tumor cell lines showed 5-aza-2'-deoxycytidine dependent reduction of methylation and re-expression of CRHBP was associated with altered cellular invasiveness of renal cancer cells in real-time impedance invasion assays. Hypermethylation and inverse relationship with mRNA expression were validated in silico using the TCGA network data. We describe for the first time tumor specific epigenetic silencing of CRHBP and statistical association with aggressive tumors thus suggesting the CRH system to contribute to the development of kidney cancer.	[Tezval, Hossein; Dubrowinskaja, Natalia; Peters, Inga; Reese, Christel; Atschekzei, Faranaz; Kuczyk, Markus A.; Serth, Juergen] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Serth, Katrin] Hannover Med Sch, Dept Mol Biol, Hannover, Germany; [Hennenlotter, Joerg; Stenzl, Arnulf] Univ Tubingen, Dept Urol, Tubingen, Germany	Hannover Medical School; Hannover Medical School; Eberhard Karls University of Tubingen	Serth, J (corresponding author), Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.	serth.juergen@mh-hannover.de						Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; Jin L, 2011, J MOL ENDOCRINOL, V47, P219, DOI 10.1530/JME-11-0048; Kageyama K, 1999, ENDOCRINOLOGY, V140, P5651, DOI 10.1210/en.140.12.5651; Kaprara A, 2010, CELL MOL LIFE SCI, V67, P1293, DOI 10.1007/s00018-010-0265-2; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Peters I, 2012, BJU INT, V110, pE144, DOI 10.1111/j.1464-410X.2011.10862.x; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Tezval H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-199; Tezval H, 2009, WORLD J UROL, V27, P825, DOI 10.1007/s00345-009-0417-x; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Wang JJ, 2008, CANCER INVEST, V26, P359, DOI 10.1080/07357900701788106; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zhu C, 2014, CELL SIGNAL, V26, P1125, DOI 10.1016/j.cellsig.2014.02.002	25	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163873	10.1371/journal.pone.0163873	http://dx.doi.org/10.1371/journal.pone.0163873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695045	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100059
J	Yue, YL; Ke, SS; Zhou, W; Chang, J				Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin			In Vivo Imaging Reveals Composite Coding for Diagonal Motion in the Drosophila Visual System	PLOS ONE			English	Article							ORIENTATION SELECTIVITY; CORTEX; NEURONS; CIRCUIT; BEHAVIOR; VISION; FLIES; CAT	Understanding information coding is important for resolving the functions of visual neural circuits. The motion vision system is a classic model for studying information coding as it contains a concise and complete information-processing circuit. In Drosophila, the axon terminals of motion-detection neurons (T4 and T5) project to the lobula plate, which comprises four regions that respond to the four cardinal directions of motion. The lobula plate thus represents a topographic map on a transverse plane. This enables us to study the coding of diagonal motion by investigating its response pattern. By using in vivo two-photon calcium imaging, we found that the axon terminals of T4 and T5 cells in the lobula plate were activated during diagonal motion. Further experiments showed that the response to diagonal motion is distributed over the following two regions compared to the cardinal directions of motion-a diagonal motion selective response region and a non-selective response region-which overlap with the response regions of the two vector-correlated cardinal directions of motion. Interestingly, the sizes of the nonselective response regions are linearly correlated with the angle of the diagonal motion. These results revealed that the Drosophila visual system employs a composite coding for diagonal motion that includes both independent coding and vector decomposition coding.	[Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chang, J (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.; Chang, J (corresponding author), Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China.	changjin@mail.hust.edu.cn	Ke, Shanshan/HDL-7396-2022		National Basic Research Programme of China [2015CB352006]; Science Fund for Creative Research Group of China [61421064]; China Postdoctoral Science Foundation [2013M542010, 2015T80788]; Fundamental Research Funds for the Central Universities/HUST [2016YXMS034, 2014TS015]; Director Fund of WNLO; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Basic Research Programme of China(National Basic Research Program of China); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities/HUST(Fundamental Research Funds for the Central Universities); Director Fund of WNLO; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Basic Research Programme of China (Grant No. 2015CB352006), Science Fund for Creative Research Group of China (Grant No. 61421064), China Postdoctoral Science Foundation founded project (2013M542010, 2015T80788), Fundamental Research Funds for the Central Universities/HUST (2016YXMS034, 2014TS015), and the Director Fund of WNLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; GILBERT C, 1995, J COMP NEUROL, V361, P285, DOI 10.1002/cne.903610207; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gutig R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053063; Hopp E, 2014, J COMP PHYSIOL A, V200, P359, DOI 10.1007/s00359-014-0893-3; Hupe JM, 2004, VISION RES, V44, P489, DOI 10.1016/j.visres.2003.07.013; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Kremkow J, 2016, NATURE, V533, P52, DOI 10.1038/nature17936; Lee KS, 2016, NATURE, V533, P90, DOI 10.1038/nature17941; Lee YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126265; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Muijres FT, 2014, SCIENCE, V344, P172, DOI 10.1126/science.1248955; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Spalthoff C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-36; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tanabe S, 2013, NEUROSCI RES, V76, P101, DOI 10.1016/j.neures.2013.03.010; van Hemmen JL, 2008, BIOL CYBERN, V98, P509, DOI 10.1007/s00422-008-0215-3; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wasserman SM, 2015, CURR BIOL, V25, P467, DOI 10.1016/j.cub.2014.12.012; Ziskind AJ, 2015, J NEUROPHYSIOL, V113, P2555, DOI 10.1152/jn.00646.2014	32	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164020	10.1371/journal.pone.0164020	http://dx.doi.org/10.1371/journal.pone.0164020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695103	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100076
J	Contreras-Cubas, C; Sanchez-Hernandez, BE; Garcia-Ortiz, H; Martinez-Hernandez, A; Barajas-Olmos, F; Cid, M; Mendoza-Caamal, EC; Centeno-Cruz, F; Ortiz-Cruz, G; Jimenez-Lopez, JC; Cordova, EJ; Salas-Bautista, EG; Saldana-Alvarez, Y; Fernandez-Lopez, JC; Mutchinick, OM; Orozco, L				Contreras-Cubas, Cecilia; Sanchez-Hernandez, Beatriz E.; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Barajas-Olmos, Francisco; Cid, Miguel; Mendoza-Caamal, Elvia C.; Centeno-Cruz, Federico; Ortiz-Cruz, Gabriela; Concepcion Jimenez-Lopez, Jose; Cordova, Emilio J.; Gabriela Salas-Bautista, Eva; Saldana-Alvarez, Yolanda; Carlos Fernandez-Lopez, Juan; Mutchinick, Osvaldo M.; Orozco, Lorena			Heterogenous Distribution of MTHFR Gene Variants among Mestizos and Diverse Amerindian Groups from Mexico	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE GENE; METHYLENETETRAHYDROFOLATE-REDUCTASE; RISK-FACTOR; ETHNIC VARIATION; C677T; POPULATIONS; MUTATION; POLYMORPHISMS; ASSOCIATION	Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in folate metabolism. Folate deficiency has been related to several conditions, including neural tube defects (NTDs) and cardiovascular diseases. Hence, MTHFR genetic variants have been studied worldwide, particularly the C677T and A1298C. We genotyped the C677T and A1298C MTHFR polymorphisms in Mexican Amerindians (MAs), from the largest sample included in a genetic study (n = 2026, from 62 ethnic groups), and in a geographically-matched Mexican Mestizo population (MEZ, n = 638). The 677T allele was most frequent in Mexican individuals, particularly in MAs. The frequency of this allele in both MAs and MEZs was clearly enriched in the South region of the country, followed by the Central East and South East regions. In contrast, the frequency of the 1298C risk allele in Mexicans was one of the lowest in the world. Both in MAs and MEZs the variants 677T and 1298C displayed opposite allele frequency gradients from southern to northern Mexico. Our findings suggest that in Mestizos the 677T allele was derived from Amerindians while the 1298C allele was a European contribution. Some subgroups showed an allele frequency distribution that highlighted their genetic diversity. Notably, the distribution of the frequency of the 677T allele was consistent with that of the high incidence of NTDs reported in MEZ.	[Contreras-Cubas, Cecilia; Garcia-Ortiz, Humberto; Martinez-Hernandez, Angelica; Barajas-Olmos, Francisco; Cid, Miguel; Mendoza-Caamal, Elvia C.; Centeno-Cruz, Federico; Cordova, Emilio J.; Saldana-Alvarez, Yolanda; Orozco, Lorena] Inst Nacl Med Genom SS, Inmunogen & Metab Dis Lab, Mexico City, DF, Mexico; [Sanchez-Hernandez, Beatriz E.; Ortiz-Cruz, Gabriela; Mutchinick, Osvaldo M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran SS, Dept Genet, Mexico City, DF, Mexico; [Concepcion Jimenez-Lopez, Jose; Gabriela Salas-Bautista, Eva] Museo Nacl Antropol, Inst Nacl Antropol & Hist, Phys Anthropol Direct, Mexico City, DF, Mexico; [Carlos Fernandez-Lopez, Juan] Inst Nacl Med Genom, Computat Genom, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Instituto Nacional de Medicina Genomica	Orozco, L (corresponding author), Inst Nacl Med Genom SS, Inmunogen & Metab Dis Lab, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	HERNÁNDEZ, BEATRIZ E. SÁNCHEZ/AAZ-3922-2020	HERNÁNDEZ, BEATRIZ E. SÁNCHEZ/0000-0003-1255-0117	Consejo Nacional de Ciencia y Tecnologia [S008-2014-1, 233970, CB-2014-01-243587]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by Consejo Nacional de Ciencia y Tecnologia (http://www.conacyt.mx/) grants S008-2014-1 No. 233970 (LO) and CB-2014-01-243587 (EJC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Olaf Ivan Corro Labra and Jose Luis de Jesus Garcia Ruiz from the "Comision Nacional para el Desarrollo de los Pueblos Indigenas" for their support in this work. We would like to acknowledge to IBQ Julio Cesar Canseco M, and Biol. Alfredo Mendoza-Vargas from the USec INMEGEN for technical support. This study was supported by Consejo Nacional de Ciencia y Tecnologia grants S008-2014-1 No. 233970 and CB-2014-01-243587.	Alluri RV, 2005, EUR J NEUROL, V12, P40, DOI 10.1111/j.1468-1331.2004.00938.x; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonio-Vejar V, 2014, GENET MOL RES, V13, P7950, DOI 10.4238/2014.September.29.8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Binia A, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0421-7; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2007, SER, P56; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2003, PUEBL IND MEX CONT, P31; Comision Nacional para el Desarrollo de los Pueblos Indogenas (CDI), 2004, PAM, P31; Davalos IP, 2000, ANN GENET-PARIS, V43, P89, DOI 10.1016/S0003-3995(00)90012-1; de Franchis R, 1998, J MED GENET, V35, P1009, DOI 10.1136/jmg.35.12.1009; Fodil-Cornu N, 2009, GENES IMMUN, V10, P662, DOI 10.1038/gene.2009.50; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonzalez-Herrera L, 2002, CLIN GENET, V62, P394, DOI 10.1034/j.1399-0004.2002.620507.x; GOYETTE P, 1994, NAT GENET, V7, P551, DOI 10.1038/ng0894-551a; Gueant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701; INEGI, 2010, CENS POBL VIV 2010; Johnson NA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002410; Juarez-Velazquez R, 2010, DIS MARKERS, V28, P323, DOI [10.1155/2010/716542, 10.3233/DMA-2010-0712]; Kim YI., 1999, J NUTR BIOCH, V10, P66; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Melnick M, 1998, J CRAN GENET DEV BIO, V18, P233; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Mutchinick OM, 1999, MOL GENET METAB, V68, P461, DOI 10.1006/mgme.1999.2939; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; Ordonez G, 2015, CLIN NEUROL NEUROSUR, V130, P55, DOI 10.1016/j.clineuro.2014.11.026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rangel-Villalobos H, 2008, AM J PHYS ANTHROPOL, V135, P448, DOI 10.1002/ajpa.20765; Reddy MVPL, 2007, HUM GENET, V121, P721, DOI 10.1007/s00439-007-0367-6; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Valdes-Hernandez J, 2010, SALUD PUBLICA MEXICO, V52, P341; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; van der Put NMJ, 2000, EUR J OBSTET GYN R B, V92, P57, DOI 10.1016/S0301-2115(00)00426-7; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Varga EA, 2005, CIRCULATION, V111, pE289, DOI 10.1161/01.CIR.0000165142.37711.E7; Waes JG, 2005, BIRTH DEFECTS RES A, V73, P487, DOI 10.1002/bdra.20148; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	44	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163248	10.1371/journal.pone.0163248	http://dx.doi.org/10.1371/journal.pone.0163248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649570	Green Submitted, gold, Green Published			2022-12-26	WOS:000383892100069
J	Mangussi, F; Zanette, DH				Mangussi, Franco; Zanette, Damian H.			Internal Resonance in a Vibrating Beam: A Zoo of Nonlinear Resonance Peaks	PLOS ONE			English	Article								In oscillating mechanical systems, nonlinearity is responsible for the departure from proportionality between the forces that sustain their motion and the resulting vibration amplitude. Such effect may have both beneficial and harmful effects in a broad class of technological applications, ranging from microelectromechanical devices to edifice structures. The dependence of the oscillation frequency on the amplitude, in particular, jeopardizes the use of nonlinear oscillators in the design of time-keeping electronic components. Nonlinearity, however, can itself counteract this adverse response by triggering a resonant interaction between different oscillation modes, which transfers the excess of energy in the main oscillation to higher harmonics, and thus stabilizes its frequency. In this paper, we examine a model for internal resonance in a vibrating elastic beam clamped at its two ends. In this case, nonlinearity occurs in the form of a restoring force proportional to the cube of the oscillation amplitude, which induces resonance between modes whose frequencies are in a ratio close to 1:3. The model is based on a representation of the resonant modes as two Duffing oscillators, coupled through cubic interactions. Our focus is put on illustrating the diversity of behavior that internal resonance brings about in the dynamical response of the system, depending on the detailed form of the coupling forces. The mathematical treatment of the model is developed at several approximation levels. A qualitative comparison of our results with previous experiments and numerical calculations on elastic beams is outlined.	[Zanette, Damian H.] Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zanette, DH (corresponding author), Consejo Nacl Invest Cient & Tecn, Comis Nacl Energia Atom, Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	zanette@cab.cnea.gov.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-1611]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (URL: www.agencia.mincyt.gob.ar), grant number PICT 2014-1611. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834707; Agarwal M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2785018; Ando B., 2000, STOCHASTIC RESONANCE; Antonio D, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.034103; Antonio D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1813; Arroyo SI, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2015-60517-3; Chen LQ, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4029606; Drazin P.G., 1992, NONLINEAR SYSTEMS; Duffing G., 1918, ZAMM Z ANGEW MATH ME; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Gaffurius F, THEORICA MUSICAE; Habib G, 2015, MECH SYST SIGNAL PR, V52-53, P17, DOI 10.1016/j.ymssp.2014.08.009; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Kirkendall CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep22897; Kovacic I., 2011, DUFFING EQUATION NON; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lee CL., 1992, NONLINEAR DYNAM, V3, P465, DOI [10.1007/BF00045648, DOI 10.1007/BF00045648]; Lulla KJ, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/113040; Mangussi F, 2015, THESIS; Molteno TC, 2004, AM J PHYS, V72, P1157, DOI 10.1119/1.1764557; NARASIMHA R, 1968, J SOUND VIB, V8, P134, DOI 10.1016/0022-460X(68)90200-9; Nayfeh A H, 1995, NONLINEAR OSCILLATIO; Nayfeh AH., 1989, APPL MECH REV, V42, pS175; Nguyen CTC, 2007, IEEE T ULTRASON FERR, V54, P251, DOI 10.1109/TUFFC.2007.240; Postma HWC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1929098; Press W. H., 1992, NUMERICAL RECIPES FO, P372; RAO GV, 1991, J SOUND VIB, V149, P25, DOI 10.1016/0022-460X(91)90909-4; Ribeiro P, 1999, J SOUND VIB, V224, P591, DOI 10.1006/jvsi.1999.2193; Sancho J, 1989, NOISE NONLINEAR DYNA; Timoshenko S, 1953, HIST STRENGTH MAT; van Beek JTM, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/1/013001; Westra HJR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117205; Yang YS, 2015, PROC IEEE MICR ELECT, P1008, DOI 10.1109/MEMSYS.2015.7051132; YURKE B, 1995, PHYS REV A, V51, P4211, DOI 10.1103/PhysRevA.51.4211; Zanette DH, 2014, EUR PHYS J-SPEC TOP, V223, P2807, DOI 10.1140/epjst/e2014-02294-7	35	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162365	10.1371/journal.pone.0162365	http://dx.doi.org/10.1371/journal.pone.0162365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648829	Green Published, gold			2022-12-26	WOS:000383892100017
J	Zanello, G; Srinivasan, CS; Shankar, B				Zanello, Giacomo; Srinivasan, C. S.; Shankar, Bhavani			What Explains Cambodia's Success in Reducing Child Stunting-2000-2014?	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; UNDERNUTRITION; CONSEQUENCES; MALNUTRITION; NUTRITION; TRENDS; CARE; INTERVENTIONS; REDUCTION	In many developing countries, high levels of child undernutrition persist alongside rapid economic growth. There is considerable interest in the study of countries that have made rapid progress in child nutrition to uncover the driving forces behind these improvements. Cambodia is often cited as a success case having reduced the incidence of child stunting from 51% to 34% over the period 2000 to 2014. To what extent is this success driven by improvements in the underlying determinants of nutrition, such as wealth and education, ("covariate effects") and to what extent by changes in the strengths of association between these determinants and nutrition outcomes ("coefficient effects")? Using determinants derived from the widely-applied UNICEF framework for the analysis of child nutrition and data from four Demographic and Health Surveys datasets, we apply quantile regression based decomposition methods to quantify the covariate and coefficient effect contributions to this improvement in child nutrition. The method used in the study allows the covariate and coefficient effects to vary across the entire distribution of child nutrition outcomes. There are important differences in the drivers of improvements in child nutrition between severely stunted and moderately stunted children and between rural and urban areas. The translation of improvements in household endowments, characteristics and practices into improvements in child nutrition (the coefficient effects) may be influenced by macroeconomic shocks or other events such as natural calamities or civil disturbance and may vary substantially over different time periods. Our analysis also highlights the need to explicitly examine the contribution of targeted child health and nutrition interventions to improvements in child nutrition in developing countries.	[Zanello, Giacomo; Srinivasan, C. S.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Shankar, Bhavani] Univ London, Sch Oriental & African Studies, Ctr Dev Environm & Policy, London, England	University of Reading; University of London; University of London School Oriental & African Studies (SOAS)	Srinivasan, CS (corresponding author), Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England.	c.s.srinivasan@reading.ac.uk	Srinivasan, Chittur S/C-8509-2017	Srinivasan, Chittur S/0000-0003-2537-7675; Shankar, Bhavani/0000-0001-8102-321X; Zanello, Giacomo/0000-0002-0477-1385				ALEXANDER GR, 1995, FUTURE CHILD, V5, P103, DOI 10.2307/1602510; Bagriansky J, 2014, ASIA PAC J CLIN NUTR, V23, P524, DOI 10.6133/apjcn.2014.23.4.08; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Block SA, 2004, ECON HUM BIOL, V2, P21, DOI 10.1016/j.ehb.2003.12.007; Brinkman HJ, 2010, J NUTR, V140, p153S, DOI 10.3945/jn.109.110767; Chandararot K, 2009, RAPID ASSESSMENT IMP; Conkle J, 2007, EXCLUSIVE BREASTFEED; Darapheak Chau, 2013, Int Arch Med, V6, P29, DOI 10.1186/1755-7682-6-29; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; DiNardo J, 1996, ECONOMETRICA, V64, P1001, DOI 10.2307/2171954; Engle PL, 1999, WORLD DEV, V27, P1309, DOI 10.1016/S0305-750X(99)00059-5; Firpo S, 2009, ECONOMETRICA, V77, P953, DOI 10.3982/ECTA6822; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; IFPRI, 2015, GLOBAL NUTR REPORT 2; Ikeda N, 2013, B WORLD HEALTH ORGAN, V91, P341, DOI 10.2471/BLT.12.113381; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Kov P., 2013, GROWING TALLER TOILE; Laillou A, 2015, NUTRIENTS, V7, P4189, DOI 10.3390/nu7064189; Leroy J.L., 2011, ZSCORE06 STATA COMMA; Makoka D., 2013, IMPACT MATERNAL ED C; Marriott BP, 2010, MATERN CHILD NUTR, V6, P358, DOI 10.1111/j.1740-8709.2009.00217.x; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; NATIONAL INSTITUTE OF STATISTICS, 2001, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health and ICF International, 2015, CAMB DEM HLTH SURV 2; National Institute of Statistics Directorate General for Health and IM, 2010, CAMB DEM HLTH SURV 2; NCDM & UNDP, 2014, CAMB DIS LOSS DAM IN; NCDM WFP, 2012, 2012 CAMB POSTFL REL; NMCHC, 2014, NUTR STAT NUTR INT C; O'Donnell O, 2009, J DEV ECON, V88, P45, DOI 10.1016/j.jdeveco.2008.01.004; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Prak S, 2014, NUTRIENTS, V6, P2920, DOI 10.3390/nu6072920; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; RESULTS UK, 2014, UND LAND RIC WHY 3 S; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein S. O., 2004, DHS WEALTH INDEX; Sastry N, 1997, SOC SCI MED, V44, P989, DOI 10.1016/S0277-9536(96)00224-9; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Smith LC, 2001, AGR ECON-BLACKWELL, V26, P191, DOI 10.1111/j.1574-0862.2001.tb00063.x; SOTHATH Ngo, 2010, MORE VULNERABLE IMPA; Spears D, 2013, NUTR VALUE TOILETS M; Srinivasan CS, 2013, BMC PUBLIC HEALTH, P13; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Sunil TS, 2013, MATERNAL CHILD NUTR; UN in Cambodia, 2009, GLOB EC DOWNT OPP CR; UNICEF, 1990, STRAT IMPR NUTR WOM STRAT IMPR NUTR WOM; UNICEF, 2009, CAMB ANTHR SURV; UNICEF, 2012, PROGR DRINK WAT SAN; UNSCN, 2014, PRIOR NUTR IND POST; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2014, MAT INF YOUNG CHILD; WHO, 2006, WHO CHILD GROWTH STA; World Bank, 2012, WORLD DEV IND 2012; World Health Organization, 2008, IND ASS INF YOUNG CH; World Health Organization, 2015, WHO REC ROUT IMM SUM	63	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162668	10.1371/journal.pone.0162668	http://dx.doi.org/10.1371/journal.pone.0162668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649080	Green Accepted, Green Published, gold			2022-12-26	WOS:000383892100028
J	Horibata, Y; Ando, H; Zhang, PX; Vergnes, L; Aoyama, C; Itoh, M; Reue, K; Sugimoto, H				Horibata, Yasuhiro; Ando, Hiromi; Zhang, Peixiang; Vergnes, Laurent; Aoyama, Chieko; Itoh, Masahiko; Reue, Karen; Sugimoto, Hiroyuki			StarD7 Protein Deficiency Adversely Affects the Phosphatidylcholine Composition, Respiratory Activity, and Cristae Structure of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; LIPID TRANSPORT; MEMBRANE-FUSION; PHOSPHOLIPIDS; DOMAIN; OPA1	Phosphatidylcholine (PC) is a major phospholipid of mitochondria, comprising 40-50% of both the outer and the inner membranes. However, PC must be imported from its production organelles because mitochondria lack the enzymes essential for PC biosynthesis. In a previous study, we found that StarD7 mediates the intracellular transfer of PC to mitochondria. Therefore, in this study, we analyzed the contribution of StarD7 to the maintenance of mitochondrial phospholipid content and function using siRNA-mediated knockdown and knock-out (KO) of the StarD7 gene in HEPA-1 cells. Real time analysis of respiratory activity demonstrated that the oxygen consumption rate and activity of mitochondrial complexes were impaired in StarD7-KD cells. To confirm these results, we established StarD7-KO HEPA-1 cells by double nicking using CRISPR/Cas9n. As expected, StarD7-KD and - KO cells showed a significant reduction in mitochondrial PC content. The ATP level and growth rate of KO cells were notably lower compared with wild-type cells when cultured in glucose-free galactose-containing medium to force cells to rely on mitochondrial ATP production. In KO cells, the level of the MTCO1 protein, a primary subunit of complex IV, was reduced without a concomitant decrease in its mRNA, but the level was restored when StarD7-I was overexpressed. StarD7-KO cells showed impaired formation of the mitochondrial supercomplexes and exhibited a disorganized cristae structure, with no changes in optic atrophy 1 protein. These findings indicate that StarD7 plays important roles in maintaining the proper composition of mitochondrial phospholipids as well as mitochondrial function and morphogenesis.	[Horibata, Yasuhiro; Ando, Hiromi; Aoyama, Chieko; Itoh, Masahiko; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi, Japan; [Zhang, Peixiang; Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	Dokkyo Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sugimoto, H (corresponding author), Dokkyo Med Univ, Sch Med, Dept Biochem, 880 Kitakobayashi, Mibu, Tochigi, Japan.	h-sugi@dokkyomed.ac.jp		vergnes, laurent/0000-0002-8804-589X	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government [25870668]; U. S. Public Health Services [P01 HL028481]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026744] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); U. S. Public Health Services(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Grant-in-aid for Young Scientists (B) 25870668 from the Ministry of Education, Culture, Sports, Science and Technology, Japanese Government and U. S. Public Health Services Grant P01 HL028481. The authors declare that they have no conflicts of interest with the contents of this article.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Belenguer P, 2013, BBA-MOL CELL RES, V1833, P176, DOI 10.1016/j.bbamcr.2012.08.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fritz JM, 2015, ONCOTARGET, V6, P20744, DOI 10.18632/oncotarget.5233; GIRDLESTONE J, 1981, BIOCHEMISTRY-US, V20, P152, DOI 10.1021/bi00504a025; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jousse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104896; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Schenkel L.C., 2014, INT J CELL BIOL, V2014, P709828; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; VALPUESTA JM, 1988, BIOCHIM BIOPHYS ACTA, V942, P341, DOI 10.1016/0005-2736(88)90036-3; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang L, 2015, J IMMUNOL, V194, P5635, DOI 10.4049/jimmunol.1500231	33	18	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24880	24891		10.1074/jbc.M116.736793	http://dx.doi.org/10.1074/jbc.M116.736793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694445	hybrid, Green Published			2022-12-26	WOS:000388880100008
J	Wei, H; Cai, HY; Wu, JW; Wei, ZQ; Zhang, F; Huang, X; Ma, L; Feng, LL; Zhang, RX; Wang, YJ; Ragg, H; Zheng, Y; Zhou, AW				Wei, Hudie; Cai, Haiyan; Wu, Jiawei; Wei, Zhenquan; Zhang, Fei; Huang, Xin; Ma, Lina; Feng, Lingling; Zhang, Ruoxi; Wang, Yunjie; Ragg, Hermann; Zheng, Ying; Zhou, Aiwu			Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C INHIBITOR; COFACTOR-II; ALPHA-1-ANTITRYPSIN PITTSBURGH; CRYSTAL-STRUCTURES; SERPIN STRUCTURE; TERNARY COMPLEX; ANTI-THROMBIN; HELIX-D; ANTITHROMBIN; ACTIVATION	Lamprey angiotensinogen (l-ANT) is a hormone carrier in the regulation of blood pressure, but it is also a heparin-dependent thrombin inhibitor in lamprey blood coagulation system. The detailed mechanisms on how angiotensin is carried by l-ANT and how heparin binds l-ANT and mediates thrombin inhibition are unclear. Here we have solved the crystal structure of cleaved l-ANT at 2.7 angstrom resolution and characterized its properties in heparin binding and protease inhibition. The structure reveals that l-ANT has a conserved serpin fold with a labile N-terminal angiotensin peptide and undergoes a typical stressed-to-relaxed conformational change when the reactive center loop is cleaved. Heparin binds l-ANT tightly with a dissociation constant of similar to 10 nM involving similar to 8 monosaccharides and similar to 6 ionic interactions. The heparin binding site is located in an extensive positively charged surface area around helix D involving residues Lys-148, Lys-151, Arg-155, and Arg-380. Although l-ANT by itself is a poor thrombin inhibitor with a second order rate constant of 500 M-1 s(-1), its interaction with thrombin is accelerated 90-fold by high molecular weight heparin following a bell-shaped dose-dependent curve. Short heparin chains of 6-20 monosaccharide units are insufficient to promote thrombin inhibition. Furthermore, an l-ANT mutant with the P1 Ile mutated to Arg inhibits thrombin nearly 1500-fold faster than the wild type, which is further accelerated by high molecular weight heparin. Taken together, these results suggest that heparin binds l-ANT at a conserved heparin binding site around helix D and promotes the interaction between l-ANT and thrombin through a template mechanism conserved in vertebrates.	[Wei, Hudie; Cai, Haiyan; Wu, Jiawei; Wei, Zhenquan; Zhang, Fei; Huang, Xin; Ma, Lina; Feng, Lingling; Zhang, Ruoxi; Zheng, Ying; Zhou, Aiwu] Shanghai Jiao Tong Univ, Hongqiao Int Inst Med,Sch Med,Chinese Minist Educ, Shanghai Tongren Hosp,Fac Basic Med,Chem Biol Div, Key Lab Cell Differentiat & Apoptosis,Shanghai Un, Shanghai 200025, Peoples R China; [Wang, Yunjie; Ragg, Hermann] Univ Bielefeld, Fac Technol, D-33613 Bielefeld, Germany	Shanghai Jiao Tong University; University of Bielefeld	Zheng, Y; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, 280 Chongqing Rd, Shanghai 200025, Peoples R China.	aiwuzhou@gmail.com	Wang, Yunjie/AGT-2005-2022	ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China (973 Program) [2014CB910304]; National Natural Science Foundation of China [31370727, 31170724, 81572090]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission Grant [12ZZ113]; British Heart Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission Grant; British Heart Foundation(British Heart Foundation)	This work was supported in part by National Basic Research Program of China (973 Program) Grant 2014CB910304; National Natural Science Foundation of China Grants 31370727, 31170724, and 81572090; the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; the Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission Grant 12ZZ113. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a British Heart Foundation Senior Research Fellowship. To whom correspondence may be addressed: Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, 280 Chongqing Rd., Shanghai 200025, China. Tel.: 86-13916791990; E-mail: aiwuzhou@gmail.com.	Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beauchamp NJ, 1998, BLOOD, V92, P2696, DOI 10.1182/blood.V92.8.2696.420a43_2696_2706; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; Carrell R, 2011, METHOD ENZYMOL, V501, P89, DOI 10.1016/B978-0-12-385950-1.00006-7; Ciaccia AV, 1997, J BIOL CHEM, V272, P888, DOI 10.1074/jbc.272.2.888; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Di Cera E, 2007, J THROMB HAEMOST, V5, P196; Doolittle RF, 2009, COLD SH Q B, V74, P35, DOI 10.1101/sqb.2009.74.001; DOOLITTLE RF, 1983, SCIENCE, V222, P417, DOI 10.1126/science.6604942; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393; Fournier D, 2012, J MOL MED, V90, P495, DOI 10.1007/s00109-012-0894-z; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hua BL, 2009, HAEMATOL-HEMATOL J, V94, P881, DOI 10.3324/haematol.2008.004739; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington JA, 2013, J THROMB HAEMOST, V11, P254, DOI 10.1111/jth.12252; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KEIJER J, 1991, BLOOD, V78, P1254; Khakoo AY, 2008, CANCER RES, V68, P9112, DOI 10.1158/0008-5472.CAN-08-0851; Kumar A, 2015, PEERJ, V3, DOI 10.7717/peerj.1026; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; Li W, 2012, BLOOD, V120, P459, DOI 10.1182/blood-2012-03-415869; Li W, 2008, J BIOL CHEM, V283, P36039, DOI 10.1074/jbc.M805974200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Qi XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.171082; RAGG H, 1990, J BIOL CHEM, V265, P22386; Ragg H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-208; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Rau JC, 2011, SEMIN THROMB HEMOST, V37, P339, DOI 10.1055/s-0031-1276582; Rein CM, 2011, METHOD ENZYMOL, V501, P105, DOI 10.1016/B978-0-12-385950-1.00007-9; Ritchie AW, 2013, J PHYS CHEM B, V117, P11473, DOI 10.1021/jp404582w; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; STONE SR, 1994, BIOCHEMISTRY-US, V33, P7731, DOI 10.1021/bi00190a028; Tollefsen DM, 1997, ADV EXP MED BIOL, V425, P35; VIDAUD D, 1992, J CLIN INVEST, V89, P1537, DOI 10.1172/JCI115746; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YJ, 2011, FEBS LETT, V585, P2395, DOI 10.1016/j.febslet.2011.06.021; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wong MKS, 2011, J ENDOCRINOL, V209, P127, DOI 10.1530/JOE-10-0422; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	63	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24900	24911		10.1074/jbc.M116.725895	http://dx.doi.org/10.1074/jbc.M116.725895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27681598	hybrid, Green Published			2022-12-26	WOS:000388880100010
J	Cuny, H; Kompella, SN; Tae, HS; Yu, RL; Adams, DJ				Cuny, Hartmut; Kompella, Shiva N.; Tae, Han-Shen; Yu, Rilei; Adams, David J.			Key Structural Determinants in the Agonist Binding Loops of Human beta 2 and beta 4 Nicotinic Acetylcholine Receptor Subunits Contribute to alpha 3 beta 4 Subtype Selectivity of alpha-Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; homology modeling; molecular dynamics; nicotinic acetylcholine receptors (nAChR); oocyte; site-directed mutagenesis; toxin; Xenopus	REGIIA; ALPHA-4/7-CONOTOXIN; SENSITIVITY; RESIDUES; STATES; BUIA; LVIA; RAT	alpha-Conotoxins represent a large group of pharmacologically active peptides that antagonize nicotinic acetylcholine receptors (nAChRs). The 34 nAChR, a predominant subtype in the peripheral nervous system, has been implicated in various pathophysiological conditions. As many -conotoxins have multiple pharmacological targets, compounds specifically targeting individual nAChR subtypes are needed. In this study, we performed mutational analyses to evaluate the key structural components of human 2 aR. -Conotoxin RegIIA was used to evaluate the impact of non-conserved hund 4 nAChR subunits that determine -conotoxin selectivity for 34 nAChman 2 and 4 residues on peptide affinity. Two mutations, 32[T59K] and 32[S113R], strongly enhanced RegIIA affinity compared with wild-type 32, as seen by substantially increased inhibitory potency and slower off-rate kinetics. Opposite point mutations in 34 had the contrary effect, emphasizing the importance of loop D residue 59 and loop E residue 113 as determinants for RegIIA affinity. Molecular dynamics simulation revealed the side chains of 4 Lys(59) and 4 Arg(113) formed hydrogen bonds with RegIIA loop 2 atoms, whereas the 2 Thr(59) and 2 Ser(113) side chains were not long enough to form such interactions. Residue 4 Arg(113) has been identified for the first time as a crucial component facilitating antagonist binding. Another -conotoxin, AuIB, exhibited low activity at human 32 and 34 nAChRs. Molecular dynamics simulation indicated the key interactions with the subunit are different to RegIIA. Taken together, these data elucidate the interactions with specific individual subunit residues that critically determine affinity and pharmacological activity of -conotoxins RegIIA and AuIB at human nAChRs.	[Cuny, Hartmut; Tae, Han-Shen; Adams, David J.] Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia; [Cuny, Hartmut; Kompella, Shiva N.; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Yu, Rilei] Ocean Univ China, Sch Med & Pharm, Key Lab Marine Drugs, Chinese Minist Educ, Qingdao 266003, Peoples R China; [Kompella, Shiva N.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Wollongong; Royal Melbourne Institute of Technology (RMIT); Ocean University of China; University of Sydney	Adams, DJ (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst IHMRI, Wollongong, NSW 2522, Australia.	djadams@uow.edu.au	Tae, Han-Shen/AAA-1904-2020; Adams, David John/K-3578-2019; Yu, Rilei/G-2353-2014	Tae, Han-Shen/0000-0001-8961-7194; Adams, David John/0000-0002-7030-2288; Cuny, Hartmut/0000-0002-1551-2354; Kompella, Shiva/0000-0001-5625-2491; Yu, Rilei/0000-0001-6625-2014	Australian Research Council [DP150103990]; Natural Science Foundation of China [81502977]; Fundamental Research Funds for the Central Universities	Australian Research Council(Australian Research Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Australian Research Council Discovery Project Grant DP150103990 (to D. J. A.), Natural Science Foundation of China Grant 81502977 (to R. Y.), and Fundamental Research Funds for the Central Universities (to R. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; [Anonymous], 2008, AMBER 10; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grishin AA, 2013, J BIOL CHEM, V288, P34428, DOI 10.1074/jbc.M113.512582; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kompella SN, 2015, MOL PHARMACOL, V88, P993, DOI 10.1124/mol.115.100503; Kompella SN, 2015, J BIOL CHEM, V290, P1039, DOI 10.1074/jbc.M114.605592; Lebbe EKM, 2014, MAR DRUGS, V12, P2970, DOI 10.3390/md12052970; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2014, FASEB J, V28, P1842, DOI 10.1096/fj.13-244103; Luo SL, 2013, J MED CHEM, V56, P9655, DOI 10.1021/jm401254c; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011; Zhangsun DT, 2015, J BIOL CHEM, V290, P9855, DOI 10.1074/jbc.M114.632646; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	38	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23779	23792		10.1074/jbc.M116.730804	http://dx.doi.org/10.1074/jbc.M116.730804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646000	Green Published, hybrid			2022-12-26	WOS:000387884400037
J	Patel, MA; Mener, DJ; Garcia-Esquinas, E; Navas-Acien, A; Agrawal, Y; Lin, SY				Patel, Mira A.; Mener, David J.; Garcia-Esquinas, Esther; Navas-Acien, Ana; Agrawal, Yuri; Lin, Sandra Y.			Tobacco Smoke Exposure and Eustachian Tube Disorders in US Children and Adolescents	PLOS ONE			English	Article							MIDDLE-EAR EFFUSION; ACUTE OTITIS-MEDIA; PARENTAL SMOKING; PASSIVE SMOKING; CIGARETTE-SMOKE; RISK-FACTORS; CHILDHOOD; DISEASE; CARE	Objectives To describe the association between active, environmental tobacco smoke (ETS) exposure and the prevalence of eustachian tube dysfunction (ETD) in the U.S. pediatric population. Study Design Cross-sectional. Setting U.S. representative demographic and audiometric data from the National Health and Nutrition Examination Survey (NHANES); 2005-2010. Subjects and Methods The study consisted of 2,977 children aged 12-19 years. ETD was defined as middle ear pressure < 100mm H20. ETS was defined as non-active smoking in individuals with serum cotinine over the limit of detection (>= 0.015 ng/ mL) and < 10 ng/ mL(N = 1559). Results The prevalence of ETD was 6.1%. After multivariate adjustment for age, sex, body mass index, education level, ethnicity, or having a cold, sinus problem or earache during the last 24 hours, compared to unexposed children, the odds ratios (95% confidence interval) of ETD for those exposed to ETS ages 12-15 in the first, second and third tertile of cotinine concentrations were, respectively, 1.38 (0.53-3.60), 0.99 (0.53-3.60) and 2.67 (1.12-6.34). Similarly, the odds ratios (95% confidence interval) of ETD for those exposed to ETS ages 16-19 in the first, second and third tertile of cotinine concentrations were, respectively, 1.28 (0.48-3.41), 0.99 (0.40-2.48) and 2.86 (1.19-6.88). Conclusion These data suggest that children and adolescents exposed to high concentrations of ETS may have an increased prevalence of ETD.	[Patel, Mira A.; Mener, David J.; Agrawal, Yuri; Lin, Sandra Y.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Garcia-Esquinas, Esther; Navas-Acien, Ana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci & Epidemiol, Baltimore, MD USA; [Garcia-Esquinas, Esther] Univ Autonoma Madrid IdiPaz, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Garcia-Esquinas, Esther] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lin, SY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	slin30@jhmi.edu	garcia, esther/AAR-8372-2021	Patel, Mira/0000-0002-4926-5128; garcia-esquinas, Esther/0000-0002-8688-5174				Alpert HR, 2011, TOB CONTROL, V20, P207, DOI 10.1136/tc.2010.038711; BARR GS, 1991, BRIT MED J, V303, P1032, DOI 10.1136/bmj.303.6809.1032; Bennett KE, 1998, J EPIDEMIOL COMMUN H, V52, P786, DOI 10.1136/jech.52.12.786; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; BLAKLEY BW, 1995, OTOLARYNG HEAD NECK, V112, P441; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; Csakanyi Z, 2012, INT J PEDIATR OTORHI, V76, P989, DOI 10.1016/j.ijporl.2012.03.017; da Costa JL, 2004, INT J EPIDEMIOL, V33, P573, DOI 10.1093/ije/dyh071; Dubin MG, 2002, OTOLARYNG HEAD NECK, V126, P14, DOI 10.1067/mhn.2002.121320; ETZEL RA, 1992, PEDIATRICS, V90, P228; Gryczynska D, 1999, INT J PEDIATR OTORHI, V49, pS275; GULYA AJ, 1994, OTOLARYNG HEAD NECK, V111, P6, DOI 10.1177/019459989411100103; Haberg SE, 2010, ACTA PAEDIATR, V99, P99, DOI 10.1111/j.1651-2227.2009.01506.x; Hammaren-Malmi S, 2005, ACTA OTO-LARYNGOL, V125, P1051, DOI 10.1080/00016480510038040; HINTON AE, 1989, J LARYNGOL OTOL, V103, P559, DOI 10.1017/S0022215100109326; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Kong SK, 2009, AM J OTOLARYNG, V30, P376, DOI 10.1016/j.amjoto.2008.07.009; KRAEMER MJ, 1983, JAMA-J AM MED ASSOC, V249, P1022, DOI 10.1001/jama.249.8.1022; Lasisi AO, 2007, INT J PEDIATR OTORHI, V71, P1549, DOI 10.1016/j.ijporl.2007.06.005; Lee IW, 2006, OTOL NEUROTOL, V27, P433, DOI 10.1097/00129492-200604000-00023; Office on Smoking and Health, 2006, HLTH CONS INV EXP TO; OWEN MJ, 1993, J PEDIATR-US, V123, P702, DOI 10.1016/S0022-3476(05)80843-1; Preciado D, 2010, LARYNGOSCOPE, V120, P2508, DOI 10.1002/lary.21014; ROWEJONES JM, 1992, INT J PEDIATR OTORHI, V24, P19, DOI 10.1016/0165-5876(92)90062-T; STENSTROM R, 1993, INT J PEDIATR OTORHI, V27, P127, DOI 10.1016/0165-5876(93)90128-P; STRACHAN DP, 1990, J LARYNGOL OTOL, V104, P4, DOI 10.1017/S0022215100111648; STRACHAN DP, 1989, BRIT MED J, V298, P1549, DOI 10.1136/bmj.298.6687.1549; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086397	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163926	10.1371/journal.pone.0163926	http://dx.doi.org/10.1371/journal.pone.0163926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711178	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600053
J	Fukuda, T; Tanaka, T; Hamaguchi, Y; Kawanami, T; Nomiyama, T; Yanase, T				Fukuda, Takashi; Tanaka, Tomoko; Hamaguchi, Yuriko; Kawanami, Takako; Nomiyama, Takashi; Yanase, Toshihiko			Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line	PLOS ONE			English	Article							ISOLATED PITUITARY-ADENOMAS; TUMOR CELLS; AIP GENE; SOMATOSTATIN ANALOGS; ZAC1 EXPRESSION; CLONAL STRAINS; GH3 CELLS; MUTATIONS; PREVALENCE; OCTREOTIDE	Aryl hydrocarbon receptor interacting protein (AIP) is thought to be a tumor suppressor gene, as indicated by a mutational analysis of pituitary somatotroph adenomas. However, the physiological significance of AIP inactivation in somatotroph cells remains unclear. Using CRISPR/Cas9, we identified a GH3 cell clone (termed GH3-FTY) in which Aip was genetically disrupted, and subsequently investigated its character with respect to growth hormone (Gh) synthesis and proliferation. Compared with GH3, GH3-FTY cells showed remarkably increased Gh production and a slight increase in cell proliferation. Gh-induced Stat3 phosphorylation is known to be a mechanism of Gh oversecretion in GH3. Interestingly, phosphorylated-Stat3 expression in GH3-FTY cells was increased more compared with GH3 cells, suggesting a stronger drive for this mechanism in GH3-FTY. The phenotypes of GH3-FTY concerning Gh overproduction, cell proliferation, and increased Stat3 phosphorylation were significantly reversed by the exogenous expression of Aip. GH3-FTY cells were less sensitive to somatostatin than GH3 cells in the suppression of cell proliferation, which might be associated with the reduced expression of somatostatin receptor type 2. GH3-FTY xenografts in BALB/c nude mice (GH3-FTY mice) formed more mitotic somatotroph tumors than GH3 xenografts (GH3 mice), as also evidenced by increased Ki67 scores. GH3-FTY mice were also much larger and had significantly higher plasma Gh levels than GH3 mice. Furthermore, GH3-FTY mice showed relative insulin resistance compared with GH3 mice. In conclusion, we established a somatotroph cell line, GH3-FTY, which possessed prominent Gh secretion and mitotic features associated with the disruption of Aip.	[Fukuda, Takashi; Tanaka, Tomoko; Hamaguchi, Yuriko; Kawanami, Takako; Nomiyama, Takashi; Yanase, Toshihiko] Fukuoka Univ, Fac Med, Dept Endocrinol & Diabet Mellitus, Fukuoka, Japan; [Tanaka, Tomoko; Nomiyama, Takashi; Yanase, Toshihiko] Fukuoka Univ, Fac Med, Dept Bioregulatory Sci Life Related Dis, Fukuoka, Japan	Fukuoka University; Fukuoka University	Yanase, T (corresponding author), Fukuoka Univ, Fac Med, Dept Endocrinol & Diabet Mellitus, Fukuoka, Japan.; Yanase, T (corresponding author), Fukuoka Univ, Fac Med, Dept Bioregulatory Sci Life Related Dis, Fukuoka, Japan.	tyanase@fukuoka-u.ac.jp		Tanaka, Tomoko/0000-0002-3826-3653	Ministry of Health, Labour and Welfare, Japan [27070201]; Foundation for Growth Science, Japan; Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan); Grants-in-Aid for Scientific Research [16K09815] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Foundation for Growth Science, Japan; Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by an Intractable Disease Research Grant from the Ministry of Health, Labour and Welfare, Japan (ID: 27070201, URL: http://www.mhlw.go.jp) (TY), and by the Forum on Growth Hormone Research Grant (2016) from the Foundation for Growth Science, Japan (TF). The Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan) was supported financially by a donation from MSD K. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; BARRECA A, 1995, CLIN ENDOCRINOL, V42, P161, DOI 10.1111/j.1365-2265.1995.tb01857.x; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; BOOCKFOR FR, 1985, ENDOCRINOLOGY, V117, P418, DOI 10.1210/endo-117-1-418; Busto R, 2000, REGUL PEPTIDES, V95, P53, DOI 10.1016/S0167-0115(00)00129-4; Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Fieffe S, 2011, EUR J ENDOCRINOL, V164, P877, DOI 10.1530/EJE-10-1050; Florio T, 1999, MOL ENDOCRINOL, V13, P24, DOI 10.1210/me.13.1.24; Formosa R, 2013, ENDOCR-RELAT CANCER, V20, P495, DOI 10.1530/ERC-13-0043; Grozinsky-Glasberg S, 2008, NEUROENDOCRINOLOGY, V87, P168, DOI 10.1159/000111501; Gupta S, 2010, PROSTATE, V70, P1575, DOI 10.1002/pros.21193; Iacovazzo D, 2016, EUR J ENDOCRINOL, V174, P241, DOI 10.1530/EJE-15-0832; Iwata T, 2014, ENDOCR PATHOL, V25, P273, DOI 10.1007/s12022-014-9318-7; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; LAPP CA, 1987, IN VITRO CELL DEV B, V23, P686, DOI 10.1007/BF02620981; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Tanaka T, 2007, J MOL ENDOCRINOL, V39, P343, DOI 10.1677/JME-07-0076; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Theodoropoulou M, 2010, MOL CELL ENDOCRINOL, V326, P60, DOI 10.1016/j.mce.2010.01.033; Theodoropoulou M, 2009, INT J CANCER, V125, P2122, DOI 10.1002/ijc.24602; Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304; Tuominen I, 2015, ONCOGENE, V34, P1174, DOI 10.1038/onc.2014.50; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Zhou CQ, 2015, J CLIN INVEST, V125, P1692, DOI 10.1172/JCI78173	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164131	10.1371/journal.pone.0164131	http://dx.doi.org/10.1371/journal.pone.0164131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706259	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200088
J	Maher, IE; Higgins, DP				Maher, Iona E.; Higgins, Damien P.			Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; NEW-SOUTH-WALES; SAN-DIEGO-ZOO; HIV-1 INFECTION; CHLAMYDIA-TRACHOMATIS; IFN-GAMMA; ENDOGENOUS RETROVIRUSES; REHABILITATION FACILITY; FELINE RETROVIRUSES; LYMPHOID NEOPLASIA	Koala (Phascolarctos cinereus) populations are increasingly vulnerable and one of the main threats is chlamydial infection. Koala retrovirus (KoRV) has been proposed as an underlying cause of the koala's susceptibility to infection with Chlamydia and high rates of lymphoid neoplasia; however, the regionally ubiquitous, endogenous nature of this virus suggests that KoRV A infection is not sufficient for immune suppression to occur. A recently discovered exogenous variant of KoRV, KoRV B, has several structural elements that cause increased pathogenicity in related retroviruses and was associated with lymphoid neoplasia in one study. The present study assesses whether KoRV B infection is associated with alterations in immune function. Cytokine gene expression by mitogen stimulated lymphocytes of KoRV B positive (n = 5-6) and negative (n = 6-7) captive koalas was evaluated by qPCR four times (April 2014-February 2015) to control for seasonal variation. Key immune genes in the Th1 pathway (IFN gamma, TNF alpha), Th2 pathway (IL 10, IL4, IL6) and Th17 pathway (IL17A), along with CD4: CD8 ratio, were assessed. KoRV B positive koalas showed significantly increased up-regulation of IL17A and IL10 in three out of four sampling periods and IFN gamma, IL6, IL4 and TNF alpha in two out of four. IL17A is an immune marker for chlamydial pathogenesis in the koala; increased expression of IL17A in KoRV B positive koalas, and concurrent immune dysregulation, may explain the differences in susceptibility to chlamydial infection and severity of disease seen between individuals and populations. There was also marked seasonal variation in up-regulation for most of the cytokines and the CD4: CD8 ratio. The up-regulation in both Th1 and Th2 cytokines mirrors changes associated with immune dysregulation in humans and felids as a result of retroviral infections. This is the first report of altered immune expression in koalas infected by an exogenous variant of KoRV and also the first report of seasonal variation in cytokine up-regulation and CD4: CD8 ratio in marsupials.	[Maher, Iona E.; Higgins, Damien P.] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Sydney	Higgins, DP (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	damien.higgins@sydney.edu.au	Higgins, Damien P/A-9601-2011	Higgins, Damien/0000-0003-1215-6523	Australian Research Council [LP0989701]; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	DH received an Australian Research Council Grant (no: LP0989701) (http://www.arc.gov.au/). IM PhD is supported by an Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Blattner WA, 1999, P ASSOC AM PHYSICIAN, V111, P563, DOI 10.1046/j.1525-1381.1999.99210.x; Bolin LL, 2011, VIRUSES-BASEL, V3, P1681, DOI 10.3390/v3091681; Brown M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2701-7; CANFIELD PJ, 1987, AUST VET J, V64, P325, DOI 10.1111/j.1751-0813.1987.tb06059.x; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Connolly JH, 1998, AUST VET J, V76, P819, DOI 10.1111/j.1751-0813.1998.tb12337.x; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; Denner J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-108; Department of Sustainability E Water Population and Communities, 2013, KOAL POP QUEENSL NEW; Diehl LJ, 1996, J VIROL, V70, P2503, DOI 10.1128/JVI.70.4.2503-2507.1996; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Fiebig U, 2015, VIRUS RES, V198, P30, DOI 10.1016/j.virusres.2015.01.002; Fonfara S, 2007, J MAR BIOL ASSOC UK, V87, P305, DOI 10.1017/S0025315407055567; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gillett Amber K., 2014, Technical Reports of the Australian Museum Online, V24, P39, DOI 10.3853/j.1835-4211.24.2014.1612; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Graham EM, 2003, J IMMUNOL METHODS, V279, P69, DOI 10.1016/S0022-1759(03)00244-8; Griffith JE, 2012, AUST VET J, V90, P457, DOI 10.1111/j.1751-0813.2012.00963.x; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hartmann K, 2012, VIRUSES-BASEL, V4, P2684, DOI 10.3390/v4112684; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Ishida Y, 2015, VIROLOGY, V475, P28, DOI 10.1016/j.virol.2014.10.036; Ishida Y, 2015, MOL BIOL EVOL, V32, P109, DOI 10.1093/molbev/msu275; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Lau Q, 2012, VET IMMUNOL IMMUNOP, V147, P35, DOI 10.1016/j.vetimm.2012.04.010; Leal RO, 2015, RES VET SCI, V99, P87, DOI 10.1016/j.rvsc.2015.02.008; Linenberger ML, 1999, VET IMMUNOL IMMUNOP, V72, P343, DOI 10.1016/S0165-2427(99)00147-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney D., 2012, KOALAS CLIMATE CHANG, P150, DOI DOI 10.7882/FS.2012.0221016/J.VETMIC.2013.02.026; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; MAES M, 1994, EXPERIENTIA, V50, P821, DOI 10.1007/BF01956463; Maher IE, 2014, PEERJ, V2, DOI 10.7717/peerj.280; Mann DR, 2000, CELL IMMUNOL, V200, P105, DOI 10.1006/cimm.2000.1623; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; McKinnon LR, 2015, JAIDS-J ACQ IMM DEF, V68, P6, DOI 10.1097/QAI.0000000000000389; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Myrianthefs P, 2003, CYTOKINE, V24, P286, DOI 10.1016/j.cyto.2003.08.005; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Nelson RJ, 1995, J PINEAL RES, V19, P149, DOI 10.1111/j.1600-079X.1995.tb00184.x; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; OBENDORF DL, 1983, J WILDLIFE DIS, V19, P123, DOI 10.7589/0090-3558-19.2.123; Oliveira NM, 2007, P NATL ACAD SCI USA, V104, P17506, DOI 10.1073/pnas.0704313104; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Perry LL, 1997, J IMMUNOL, V158, P3344; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Pye GW, 2008, J ZOO WILDLIFE MED, V39, P61, DOI 10.1638/2007-0106.1; Pye GW, 2009, J ZOO WILDLIFE MED, V40, P453, DOI 10.1638/2008-0107.1; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimode S, 2014, FEBS LETT, V588, P41, DOI 10.1016/j.febslet.2013.10.046; Shojima T, 2013, J VIROL, V87, P9943, DOI 10.1128/JVI.01385-13; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Spencer AJ, 1996, J ZOO WILDLIFE MED, V27, P303; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Termorshuizen F, 2002, INT J HYG ENVIR HEAL, V205, P379, DOI 10.1078/1438-4639-00172; Tompkins MB, 2008, VET IMMUNOL IMMUNOP, V123, P45, DOI 10.1016/j.vetimm.2008.01.011; Turner AK, 2013, PARASITE IMMUNOL, V35, P386, DOI 10.1111/pim.12036; Waugh C, 2016, BIOL CONSERV, V197, P247, DOI 10.1016/j.biocon.2016.03.018; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wilson DP, 2015, J WILDLIFE DIS, V51, P833, DOI 10.7589/2014-12-278; Xu WQ, 2015, VIRUSES-BASEL, V7, P1258, DOI 10.3390/v7031258; Xu WQ, 2013, P NATL ACAD SCI USA, V110, P11547, DOI 10.1073/pnas.1304704110	76	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163780	10.1371/journal.pone.0163780	http://dx.doi.org/10.1371/journal.pone.0163780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706211	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200059
J	Hobara, H; Hashizume, S; Kobayashi, Y; Mochmaru, M				Hobara, Hiroaki; Hashizume, Satoru; Kobayashi, Yoshiyuki; Mochmaru, Masaaki			Spatiotemporal Parameters of 100-m Sprint in Different Levels of Sprinters with Unilateral Transtibial Amputation	PLOS ONE			English	Article							AMPUTEE SPRINTERS; STEP LENGTH; VARIABLES; STIFFNESS	The aim of this study was to investigate differences of the spatiotemporal parameters in a 100m sprint among elite, sub-elite, and non-elite sprinters with a unilateral transtibial amputation. Using publicly available Internet broadcasts, we analyzed 125, 19, and 33 records from 30 elite, 12 sub-elite, and 22 non-elite sprinters, respectively. For each sprinter's run, the average velocity, step frequency, and step length were calculated using the number of steps in conjunction with the official race time. Average velocity was greatest in elite sprinters (8.71 +/- 0.32 m/s), followed by the sub-elite (8.09 +/- 0.06 m/s) and non-elite groups (7.72 +/- 0.27 m/s). Although there was a significant difference in average step frequency between the three groups, the effect size was small and the relative difference among the three groups was 3.1%. Statistical analysis also revealed that the average step length was longest in elite sprinters, followed by the sub-elite and non-elite groups. These results suggest that the differences in sprint performance between the three groups is mainly due to the average step length rather than step frequency.	[Hobara, Hiroaki; Hashizume, Satoru; Kobayashi, Yoshiyuki; Mochmaru, Masaaki] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hobara, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tokyo, Japan.	hobara-hiroaki@aist.go.jp	Hobara, Hiroaki/Q-5333-2016; Kobayashi, Yoshiyuki/Q-5314-2016	Hobara, Hiroaki/0000-0003-4710-9962; Kobayashi, Yoshiyuki/0000-0001-7941-6575				Baum BS, 2013, ARCH PHYS MED REHAB, V94, P1776, DOI 10.1016/j.apmr.2013.03.010; Bezodis I., 2008, P 26 INT C BIOM SPOR, P537; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; Fortier S, 2005, J SPORT SCI MED, V4, P134; Gajer B., 1999, NEW STUD ATHL, V14, P43; Hobara H, 2016, INT J SPORTS MED, V37, P165, DOI 10.1055/s-0035-1564171; Hobara H, 2015, INT J SPORTS MED, V36, P494, DOI 10.1055/s-0034-1387794; Hobara H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1983-1; Hobara H, 2016, J APPL BIOMECH, V32, P93, DOI 10.1123/jab.2014-0297; Hobara H, 2015, PROSTHET ORTHOT INT, V39, P519, DOI 10.1177/0309364614564026; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; Nagahara R, 2014, INT J SPORTS MED, V35, P755, DOI 10.1055/s-0033-1363252; Nolan Lee, 2008, Foot Ankle Surg, V14, P125, DOI 10.1016/j.fas.2008.05.007; Noroozi S, 2014, P I MECH ENG P-J SPO, V228, P24, DOI 10.1177/1754337113501491; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Slawinski J, 2010, J STRENGTH COND RES, V24, P896, DOI 10.1519/JSC.0b013e3181ad3448; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991	21	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163712	10.1371/journal.pone.0163712	http://dx.doi.org/10.1371/journal.pone.0163712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701443	gold, Green Submitted, Green Published			2022-12-26	WOS:000385696900018
J	Jana, S; Chatterjee, K; Ray, AK; DasMahapatra, P; Swarnakar, S				Jana, Sayantan; Chatterjee, Kasturi; Ray, Amlan K.; DasMahapatra, Pramathes; Swarnakar, Snehasikta			Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TISSUE INHIBITORS; PERITONEAL-FLUID; VEGF; MATRIX-METALLOPROTEINASE-9; MACROPHAGES; ACTIVATION; EXPRESSION; MELATONIN; CURCUMIN	Endometriosis is characterized by the ectopic development of the endometrium which relies on angiogenesis. Although studies have identified the involvement of different matrix metalloproteinases (MMPs) in endometriosis, no study has yet investigated the role of MMP-2 in endometriosis-associated angiogenesis. The present study aims to understand the regulation of MMP-2 activity in endothelial cells and on angiogenesis during progression of ovarian endometriosis. Histological and biochemical data showed increased expressions of vascular endothelial growth factor (VEGF), VEGF receptor-2, cycloxygenase (COX)-2, von Willebrand factor along with angiogenesis during endometriosis progression. Women with endometriosis showed decreased MMP-2 activity in eutopic endometrium as compared to women without endometriosis. However, ectopic ovarian endometrioma showed significantly elevated MMP-2 activity with disease severity. In addition, increased MT1MMP and decreased tissue inhibitors of metalloproteinases (TIMP)-2 expressions were found in the late stages of endometriosis indicating more MMP-2 activation with disease progression. In vitro study using human endothelial cells showed that prostaglandin E2 (PGE2) significantly increased MMP-2 activity as well as tube formation. Inhibition of COX-2 and/or phosphorylated AKT suppressed MMP-2 activity and endothelial tube formation suggesting involvement of PGE2 in regulation of MMP-2 activity during angiogenesis. Moreover, specific inhibition of MMP-2 by chemical inhibitor significantly reduced cellular migration, invasion and tube formation. In ovo assay showed decreased angiogenic branching upon MMP-2 inhibition. Furthermore, a significant reduction of lesion numbers was observed upon inhibition of MMP-2 and COX-2 in mouse model of endometriosis. In conclusion, our study establishes the involvement of MMP-2 activity via COX-2-PGE2pAKT axis in promoting angiogenesis during endometriosis progression.	[Jana, Sayantan; Chatterjee, Kasturi; Swarnakar, Snehasikta] CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Ray, Amlan K.; DasMahapatra, Pramathes] Spectrum Clin & Endoscopy Res Inst, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Swarnakar, S (corresponding author), CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India.	snehasiktas@hotmail.com		Ray, Amlan/0000-0001-9428-1699; Swarnakar, Snehasikta/0000-0002-7139-9683; JANA, SAYANTAN/0000-0003-2855-1560	Council of Scientific and Industrial Research, India [BSC0111-INDEPTH, BSC0119-HUM]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by the Council of Scientific and Industrial Research, India [grant number BSC0111-INDEPTH & BSC0119-HUM]. The funders were not involved in the study design, data collection, data analysis, manuscript preparation and/or publication decisions.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brosens I, 2012, REPROD BIOMED ONLINE, V24, P496, DOI 10.1016/j.rbmo.2012.01.022; Bruner KL, 1997, J CLIN INVEST, V99, P2851, DOI 10.1172/JCI119478; Bulun SE, 1999, ENDOCR-RELAT CANCER, V6, P293, DOI 10.1677/erc.0.0060293; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Fagotti A, 2004, HUM REPROD, V19, P393, DOI 10.1093/humrep/deh054; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Huang HF, 2004, FERTIL STERIL, V81, P1235, DOI 10.1016/j.fertnstert.2003.10.027; Jana S, 2012, INDIAN J BIOCHEM BIO, V49, P342; Jana S, 2012, BIOCHEM PHARMACOL, V83, P797, DOI 10.1016/j.bcp.2011.12.030; Karck U, 1996, PROSTAG OTH LIPID M, V51, P49, DOI 10.1016/0090-6980(95)00159-X; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Li Zhi-gang, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P598; Lurlaro M, 1999, EUR J CLIN INVEST, V29, P793; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Nap AW, 2004, HUM REPROD, V19, P2180, DOI 10.1093/humrep/deh408; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osteen KG, 2003, SEMIN REPROD MED, V21, P155; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Paul S, 2010, J PINEAL RES, V49, P156, DOI 10.1111/j.1600-079X.2010.00780.x; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rocha AL, 2013, OBSTET GYNECOL INT, V2013, P26; Rocha ALL, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/859619; Sacco K, 2012, GYNECOL ENDOCRINOL, V28, P134, DOI 10.3109/09513590.2011.588753; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	38	62	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163540	10.1371/journal.pone.0163540	http://dx.doi.org/10.1371/journal.pone.0163540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695098	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100043
J	Kim, H; Choi, KI				Kim, HyunJin; Choi, Kang-Il			A Pipelined Non-Deterministic Finite Automaton-BasedString Matching Scheme Using Merged State Transitions in an FPGA	PLOS ONE			English	Article							PATTERN; ALGORITHM	This paper proposes a pipelined non-deterministic finite automaton (NFA)-based string matching scheme using field programmable gate array (FPGA) implementation. The characteristics of the NFA such as shared common prefixes and no failure transitions are considered in the proposed scheme. In the implementation of the automaton-based string matching using an FPGA, each state transition is implemented with a look-up table (LUT) for the combinational logic circuit between registers. In addition, multiple state transitions between stages can be performed in a pipelined fashion. In this paper, it is proposed that multiple one-to-one state transitions, called merged state transitions, can be performed with an LUT. By cutting down the number of used LUTs for implementing state transitions, the hardware overhead of combinational logic circuits is greatly reduced in the proposed pipelined NFA-based string matching scheme.	[Kim, HyunJin] Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea; [Choi, Kang-Il] Elect & Telecommun Res Inst, Adv Commun Res Lab, Daejeon, South Korea	Dankook University; Electronics & Telecommunications Research Institute - Korea (ETRI)	Kim, H (corresponding author), Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea.	hyunjin2kim@gmail.com		Kim, HyunJin/0000-0001-5017-3995	ICT R&D program of Institute for Information & communications Technology Promotion (IITP); Ministry of Science, ICT & Future Planning (MSIP) [B0101-16-0233]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - MSIP [2012R1A1A1002993]	ICT R&D program of Institute for Information & communications Technology Promotion (IITP); Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - MSIP	This work was partly supported by the ICT R&D program of Institute for Information & communications Technology Promotion (IITP) and the Ministry of Science, ICT & Future Planning (MSIP) (B0101-16-0233, Smart Networking Core Technology Development) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by MSIP (2012R1A1A1002993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Altera Santa Clara CA USA, 2015, STRAT 5 DEV OV; [Anonymous], 2001, BOOST GRAPH LIB USER; Baker ZK, 2004, ANN IEEE SYM FIELD P, P135, DOI 10.1109/FCCM.2004.6; Bourgeault M, 2011, ALTERAS PARTIAL RECO; Chen CC, 2013, ACM T ARCHIT CODE OP, V10, DOI 10.1145/2541228.2541232; Clark CR, 2004, ANN IEEE SYM FIELD P, P249, DOI 10.1109/fccm.2004.50; Hartenstein RW, 1896, ROADM REC COMP 10 IN; Hutchings BL, 2002, ANN IEEE SYM FIELD P, P111, DOI 10.1109/FPGA.2002.1106666; HyunJin Kim, 2015, Information Science and Applications, P157, DOI 10.1007/978-3-662-46578-3_19; Jiang WR, 2013, 2013 ACM/IEEE SYMPOSIUM ON ARCHITECTURES FOR NETWORKING AND COMMUNICATIONS SYSTEMS (ANCS), P71, DOI 10.1109/ANCS.2013.6665177; Kao C., 2005, XCELL J, V55, P65; Kim HJ, 2011, IEEE T PARALL DISTR, V22, P1904, DOI 10.1109/TPDS.2011.85; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126517; Kim H, 2012, IEICE T COMMUN, VE95B, P3594, DOI 10.1587/transcom.E95.B.3594; Kim H, 2010, IEICE ELECTRON EXPR, V7, P377, DOI 10.1587/elex.7.377; Kim H, 2010, IEEE COMMUN LETT, V14, P878, DOI 10.1109/LCOMM.2010.080210.092347; Kim H, 2010, IEICE T COMMUN, VE93B, P1612, DOI 10.1587/transcom.E93.B.1612; Kouzinopoulos CS, 2009, 13TH PANHELLENIC CONFERENCE ON INFORMATICS, PROCEEDINGS, P14, DOI 10.1109/PCI.2009.47; Kuon I, 2007, FOUND TRENDS ELECTRO, V2, P135, DOI 10.1561/1000000005; Le H, 2013, IEEE T COMPUT, V62, P844, DOI 10.1109/TC.2012.38; Lee CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139301; Lin CH, 2013, IEEE T COMPUT, V62, P1906, DOI 10.1109/TC.2012.254; Lin Cheng-Hung, 2010, GLOB TEL C GLOBECOM, p[1, 6], DOI DOI 10.1109/GLOCOM.2010.5683320; Pao D., 2008, COMPUTER ARCHITECTUR, V7, P33, DOI DOI 10.1109/L-CA.2008.5; Pao D, 2011, IEEE T COMPUT, V60, P1596, DOI 10.1109/TC.2010.250; Pao D, 2010, ACM T ARCHIT CODE OP, V7, DOI 10.1145/1839667.1839672; Piyachon P, 2007, DES AUT CON, P493, DOI 10.1109/DAC.2007.375215; Roesch M, 1999, USENIX ASSOCIATION PROCEEDINGS OF THE THIRTEENTH SYSTEMS ADMINISTRATION CONFERENCE (LISA XIII), P229; Sidhu R., 2001, FIELD PROGR CUST COM, P227, DOI DOI 10.1109/FCCM.2001.22; Sourdis I, 2003, LECT NOTES COMPUT SC, V2778, P880; Tan L., 2006, ACM T ARCHIT CODE OP, V3, P3, DOI DOI 10.1145/1132462.1132464; Vasiliadis G, 2008, LECT NOTES COMPUT SC, V5230, P116, DOI 10.1007/978-3-540-87403-4_7; Xilinx, 2014, 7 SER FPGAS CONF LOG 7 SER FPGAS CONF LOG; Xilinx, 2012, ISE DES SUIT	35	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163535	10.1371/journal.pone.0163535	http://dx.doi.org/10.1371/journal.pone.0163535			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695114	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100042
J	Lee, Y; Shin, H; Bae, E; Lim, H				Lee, Yoonsun; Shin, Hyunsoo; Bae, Eunjoo; Lim, Hyunjung			Aspects of Health-Related Factors and Nutritional Care Needs by Survival Stage among Female Cancer Patients in South Korea	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM SURVIVORS; BREAST-CANCER; POSTTRAUMATIC GROWTH; DIETARY CHANGE; BEHAVIORS; WOMEN	Purpose This study examined diet-related problems and needs associated with nutritional care according to survival stage in Korean female cancer survivors. Methods 186 outpatients (breast or gynecologic cancer survivors) recruited. Subjects were classified as (1) extended stage (ES, 2-5 years from diagnosis) and (2) long-term stage (LS, >= 5 years from diagnosis). Eating habits, changes in health related factors, nutritional needs, and quality of life were investigated. Results 43% of ES survivors had diet-related problems (p = .031); ES group reported dyspepsia and LS group reported anorexia/nausea as the major problem. Half of ES survivors had taste change, decreasing amount of intake, and reduced quality of life (p < .05). The LS group had a greater preference for sweet tastes than the ES group. According to their diagnosis, ES survivors with breast cancer gained weight (27.1%), whereas ES survivors with gynecologic cancer lost their body weight (34.5%) significantly. LS breast cancer patients showed great food preference for vegetables, whereas those with gynecologic cancer showed an increased preference for fish, meat and grain. Approximately 90% of survivors demanded nutritional care regarding restricted foods, preventing recurrence, particularly in ES survivors (p < .01). Moreover, main factors for nutritional care needs were body weight control for breast cancer and food environment for gynecologic cancer. Conclusion Survivors have different aspects of diet-related problems by survival stage as dyspepsia in ES and anorexia in LS. ES stage had changes in dietary patterns and their food consumption have decreased. Most of survivors have demanded nutritional care regardless of survival stage. These features of each stage should be considered to improve their health.	[Lee, Yoonsun; Lim, Hyunjung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea; [Lee, Yoonsun; Lim, Hyunjung] Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea; [Shin, Hyunsoo] CHA Univ, Dept Radiat Oncol, CHA Bundang Med Ctr, Bundang 13496, Gyenggi Do, South Korea; [Bae, Eunjoo] CHA Univ, CHA Bundang Med Ctr, Dept Food & Nutr Serv, Bundang 13496, Gyenggi Do, South Korea	Kyung Hee University; Kyung Hee University; Pochon Cha University; Pochon Cha University	Lim, H (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea.; Lim, H (corresponding author), Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea.	hjlim@khu.ac.kr	Lim, Hyunjung/AAJ-4089-2020	Lim, Hyunjung/0000-0001-7632-7315				Alfano CM, 2009, PSYCHO-ONCOL, V18, P128, DOI 10.1002/pon.1378; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Bussell VA, 2010, J PSYCHOSOC ONCOL, V28, P61, DOI 10.1080/07347330903438958; Choe MA, 2001, INT J NURS STUD, V38, P557, DOI 10.1016/S0020-7489(00)00102-4; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Demark-Wahnefried W, 2003, SEMIN ONCOL, V30, P789, DOI 10.1053/j.seminoncol.2003.08.023; Demark-Wahnefried W, 1997, J AM DIET ASSOC, V97, P159, DOI [10.1016/s0002-8223(97), DOI 10.1016/S0002-8223(97)]; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; 임정원, 2008, [Korean Journal of Social Welfare, 한국사회복지학], V60, P5; Health Insurance Review and Assessment Service, POL HOSP PALL CAR TE; Hong SJ, 2013, J NATUROPATHY, V2, P154; Kroenke CH, 2005, J CLIN ONCOL, V23, P9295, DOI 10.1200/JCO.2005.02.0198; Lee ES, 2013, KOREAN J ADULT NURS, V25, P312, DOI [10.7475/kjan.2013.25.3.312, DOI 10.7475/KJAN.2013.25.3.312, 10.7475/KJAN.2013.25.3.312]; Maunsell E, 2002, J CLIN ONCOL, V20, P1017, DOI 10.1200/JCO.20.4.1017; Miaskowski C, 1995, Oncol Nurs Forum, V22, P791; Min HS, 2008, J KOREAN ACAD NURS, V38, P187, DOI 10.4040/jkan.2008.38.2.187; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; National Cancer Center, 2015, POL HOSP PALL CAR TE; National Cancer Information Center;, 1993, 5 YEARS SURV RAT CAN; Park JS., 2002, KOREAN J ADULTS NURS, V14, P233; 김은경, 2010, [The Korean Journal of Rehabilitation Nursing, 재활간호학회지], V13, P114; Patterson RE, 2003, J AM DIET ASSOC, V103, P323, DOI 10.1053/jada.2003.50045; Pedro LW, 2001, CANCER NURS, V24, P1, DOI 10.1097/00002820-200102000-00001; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Song SiHan, 2015, Korean Journal of Community Nutrition, V20, P129, DOI 10.5720/kjcn.2015.20.2.129; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weiss T, 2002, J PSYCHOSOC ONCOL, V20, P65, DOI 10.1300/J077v20n02_04; 이인정, 2012, [Health and Social Welfare Review, 보건사회연구], V32, P522	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163281	10.1371/journal.pone.0163281	http://dx.doi.org/10.1371/journal.pone.0163281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695041	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100028
J	Losilevskii, G				Losilevskii, Gil			Hydrodynamics of a Flexible Soft-Rayed Caudal Fin	PLOS ONE			English	Article							MUSCLE RECRUITMENT; FISH; TEMPERATURE; PERFORMANCE; AMPLITUDE; VELOCITY; SPEED	The paper addresses hydrodynamic performance of a slender swimmer furnished with a flexible small-aspect-ratio soft-rayed caudal fin. The recoil of the fin is found by solving the coupled hydro-elastic problem, in which the structure of the fin is modeled by a cantilever of variable cross section and the hydrodynamic forces acting on it are modeled using the elongated body theory. It is shown that the recoil has practically no effect on the propulsion efficiency of anguilliform swimmers, but has a profound effect on the efficiency of carangiform swimmers, which can increase almost four-fold between low-speed (low-thrust) cruise and high-speed (high-thrust) burst. Whilst the magnitude of this effect furnishes a plausible argument in favor of burst-and-coast locomotion strategies, it also infers that carangiform swimmers cannot rely on elastic recoil of the caudal fin to be efficient throughout the usable speed range, and must actively flex it at low speeds.	[Losilevskii, Gil] Technion, Fac Aerosp Engn, Haifa, Israel	Technion Israel Institute of Technology	Losilevskii, G (corresponding author), Technion, Fac Aerosp Engn, Haifa, Israel.	igil@technion.ac.il		Iosilevskii, Gil/0000-0002-4114-3214				BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Bisplinghoff R, 1996, AEROELASTICITY, p[68, 69, 157]; BREDER C. M., 1926, ZOOLOGICA, V4, P159; Esposito CJ, 2012, J EXP BIOL, V215, P56, DOI 10.1242/jeb.062711; Fish FE, 2006, BIOINSPIR BIOMIM, V1, pS42, DOI 10.1088/1748-3182/1/4/S06; Flammang BE, 2008, J EXP BIOL, V211, P587, DOI 10.1242/jeb.012096; GEERLINK PJ, 1987, NETH J ZOOL, V37, P59; Iosilevskii G, 2016, J THEOR BIOL, V399, P159, DOI 10.1016/j.jtbi.2016.04.001; Iosilevskii G, 2012, J THEOR BIOL, V294, P172, DOI 10.1016/j.jtbi.2011.11.008; KATZ J, 1979, J FLUID MECH, V90, P713, DOI 10.1017/S0022112079002494; LIGHTHILL MJ, 1970, J FLUID MECH, V44, P265, DOI 10.1017/S0022112070001830; LIGHTHILL MJ, 1960, J FLUID MECH, V9, P305, DOI 10.1017/S0022112060001110; Newman JN, 1973, J FLUID MECH, V57, P673, DOI 10.1017/S0022112073001953; ROME LC, 1990, J EXP BIOL, V154, P163; ROME LC, 1992, J EXP BIOL, V163, P259; VIDELER J J, 1975, Netherlands Journal of Zoology, V25, P143; Videler JJ, 1993, FISH SWIMMING, p[48, 56]; WU TYT, 1971, J FLUID MECH, V46, P545, DOI 10.1017/S0022112071000697; Yates GT, 1983, FISH BIOMECHANICS, P207	19	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163517	10.1371/journal.pone.0163517	http://dx.doi.org/10.1371/journal.pone.0163517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695043	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100040
J	Mason, LMK; Wagemakers, A; van 't Veer, C; Oei, A; van der Pot, WJ; Ahmed, K; van der Poll, T; Geijtenbeek, TBH; Hovius, JWR				Mason, Lauren M. K.; Wagemakers, Alex; van 't Veer, Cornelis; Oei, Anneke; van der Pot, Wouter J.; Ahmed, Kalam; van der Poll, Tom; Geijtenbeek, Teunis B. H.; Hovius, Joppe W. R.			Borrelia burgdorferi Induces TLR2-Mediated Migration of Activated Dendritic Cells in an Ex Vivo Human Skin Model	PLOS ONE			English	Article							LANGERHANS CELLS; IMMUNE-RESPONSES; CUTTING EDGE; LIPOPROTEINS; FIBROBLASTS; EXPRESSION; INDUCTION; RESIDENT; DISTINCT; DISEASE	Borrelia burgdorferi is transmitted into the skin of the host where it encounters and interacts with two dendritic cell (DC) subsets; Langerhans cells (LCs) and dermal DCs (DDCs). These cells recognize pathogens via pattern recognition receptors, mature and migrate out of the skin into draining lymph nodes, where they orchestrate adaptive immune responses. In order to investigate the response of skin DCs during the early immunopathogenesis of Lyme borreliosis, we injected B. burgdorferi intradermally into full-thickness human skin and studied the migration of DCs out of the skin, the activation profile and phenotype of migrated cells. We found a significant increase in the migration of LCs and DDCs in response to B. burgdorferi. Notably, migration was prevented by blocking TLR2. DCs migrated from skin inoculated with higher numbers of spirochetes expressed significantly higher levels of CD83 and produced pro-inflammatory cytokines. No difference was observed in the expression of HLA-DR, CD86, CD38, or CCR7. To conclude, we have established an ex vivo human skin model to study DC-B. burgdorferi interactions. Using this model, we have demonstrated that B. burgdorferi-induced DC migration is mediated by TLR2. Our findings underscore the utility of this model as a valuable tool to study immunity to spirochetal infections.	[Mason, Lauren M. K.; Wagemakers, Alex; van 't Veer, Cornelis; van der Poll, Tom; Hovius, Joppe W. R.] Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Oei, Anneke] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van der Pot, Wouter J.; Ahmed, Kalam] Kennemer Gasthuis, Dept Plast Surg, Haarlem, Netherlands; [van der Poll, Tom; Hovius, Joppe W. R.] Acad Med Ctr, Div Infect Dis, Amsterdam, Netherlands; [Geijtenbeek, Teunis B. H.] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Mason, LMK (corresponding author), Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands.	l.m.mason@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437	"Veni" grant from The Netherlands Organisation for health research and development (ZonMw) [91611065]	"Veni" grant from The Netherlands Organisation for health research and development (ZonMw)	This work was supported by a "Veni" grant (91611065) from JWH received from The Netherlands Organisation for health research and development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Dai XJ, 2011, J ALLERGY CLIN IMMUN, V127, P806, DOI 10.1016/j.jaci.2010.12.006; Filgueira L, 1996, J IMMUNOL, V157, P2998; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Haniffa M, 2015, J DERMATOL SCI, V77, P85, DOI 10.1016/j.jdermsci.2014.08.012; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hartiala P, 2010, J IMMUNOL, V184, P5732, DOI 10.4049/jimmunol.0803944; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; HULINSKA D, 1994, ZBL BAKT-INT J MED M, V280, P348, DOI 10.1016/S0934-8840(11)80597-9; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Mason LMK, 2015, IMMUNOBIOLOGY, V220, P1141, DOI 10.1016/j.imbio.2015.06.006; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Saalbach A, 2010, J INVEST DERMATOL, V130, P444, DOI 10.1038/jid.2009.253; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Wagemakers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-418; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613	39	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164040	10.1371/journal.pone.0164040	http://dx.doi.org/10.1371/journal.pone.0164040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695100	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100079
J	Seino, H; Arai, Y; Nagao, N; Ozawa, N; Hamada, K				Seino, Haruyoshi; Arai, Yukari; Nagao, Norio; Ozawa, Noriyasu; Hamada, Kazuhiko			Efficient Percutaneous Delivery of the Antimelanogenic Agent Glabridin Using Cationic Amphiphilic Chitosan Micelles	PLOS ONE			English	Article							TYROSINASE ACTIVITY; DRUG-DELIVERY; HAIR CYCLE; HUMAN-SKIN; IN-VITRO; MELANOGENESIS; DERIVATIVES; CELLS; PIGMENTATION; PENETRATION	Partially myristoylated chitosan pyrrolidone carboxylate (PMCP) is a cationic amphiphilic chitosan derivative. Glabridin (Glab) from licorice root extracts is a hydrophobic antimelanogenic agent. Here we assessed the effects of cationic Glab-containing polymeric micelles derived from PMCP (Glab/PMCP-PM) on the ability of Glab to penetrate the skin and inhibit melanogenesis using a human skin model. The amount of Glab absorbed 24 h after the application of Glab/PMCP-PM was approximately four times higher than that of conventional oil-in-water micelles (control) prepared using Tween 60. Further, the release of IL-1 alpha, a mediator of inflammation, was not detected. Treatment with Glab/PMCP-PM significantly increased the inhibition of melanogenesis compared with control. The inhibition of melanogenesis depends upon the enhanced ability of Glab to penetrate the skin, particularly the epidermis. Moreover, the inhibition of melanogenesis and the cationic potential of the Glab/PMCP-PM levels were increased by the cationic phospholipid copolymer. Therefore, Glab/PMCP-PM shows potential as an effective transdermal delivery system for treating skin hyperpigmentation.	[Seino, Haruyoshi; Arai, Yukari; Ozawa, Noriyasu; Hamada, Kazuhiko] Pias Corp, Cent Res Lab, Nishi Ku, 1-3-1 Murotani, Kobe, Hyogo, Japan; [Nagao, Norio] Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Japan		Seino, H (corresponding author), Pias Corp, Cent Res Lab, Nishi Ku, 1-3-1 Murotani, Kobe, Hyogo, Japan.; Nagao, N (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Japan.	hseino@pias.co.jp; nagao@pu-hiroshima.ac.jp		Seino, Haruyoshi/0000-0001-9293-5409	 [Pias Corporation]		The funder (Pias Corporation) provided support in the form of salaries for authors Haruyoshi Seino, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Norio Nagao conducted joint research to instruct about this study. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta N, 2003, MACROMOL BIOSCI, V3, P546, DOI 10.1002/mabi.200300009; Bajaj G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030899; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; BURNETTE RR, 1987, J PHARM SCI, V76, P765, DOI 10.1002/jps.2600761003; CABANES J, 1994, J PHARM PHARMACOL, V46, P982, DOI 10.1111/j.2042-7158.1994.tb03253.x; Chen R. H., 2000, INT J COSMETIC SCI, V22, P349, DOI [DOI 10.1111/J.1467-2494.2000.00036.X, 10.1111/j.1467-2494.2000.00036.x]; Fujimori H, 2010, BIOSCI BIOTECH BIOCH, V74, P918, DOI 10.1271/bbb.90700; Goh MJ, 2012, PHYTOTHER RES, V26, P1107, DOI 10.1002/ptr.3682; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; HIRANO S, 1987, CARBOHYD RES, V165, P120, DOI 10.1016/0008-6215(87)80085-X; Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012; Hsieh MJ, 2014, BRIT J PHARMACOL, V171, P3037, DOI 10.1111/bph.12626; Jiang GB, 2006, MOL PHARMACEUT, V3, P152, DOI 10.1021/mp050010c; Jin YH, 1999, ARCH PHARM RES, V22, P232, DOI 10.1007/BF02976355; Joly-Tonetti N, 2016, EXP DERMATOL, V25, P501, DOI 10.1111/exd.13016; Kameyama K, 1996, J AM ACAD DERMATOL, V34, P29, DOI 10.1016/S0190-9622(96)90830-0; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Michalczyk D, 2009, ACTA BIOCHIM POL, V56, P343; Michalczyk-Wetula D, 2013, ACTA BIOCHIM POL, V60, P313; Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995; Nakajima M, 1998, PIGM CELL RES, V11, P12, DOI 10.1111/j.1600-0749.1998.tb00705.x; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Ni-Komatsu L, 2008, MOL PHARMACOL, V74, P1576, DOI 10.1124/mol.108.050633; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Nokhodchi A, 2003, INT J PHARM, V250, P359, DOI 10.1016/S0378-5173(02)00554-9; Nonaka K, 2001, J OLEO SCI, V50, P773, DOI [DOI 10.5650/JOS.50.773, 10.5650/jos.50.773]; Perez-Bernal A, 2000, Am J Clin Dermatol, V1, P261; SEINO H, 1991, AGR BIOL CHEM TOKYO, V55, P2421, DOI 10.1271/bbb1961.55.2421; Seino H, 2002, J JPN COSMETIC SCI S, V26, P71; Silva SS, 2013, ACTA BIOMATER, V9, P6790, DOI 10.1016/j.actbio.2013.02.027; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Som I, 2012, J PHARM BIOALLIED SC, V4, P2, DOI 10.4103/0975-7406.92724; Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Yokota T, 1998, PIGM CELL RES, V11, P355, DOI 10.1111/j.1600-0749.1998.tb00494.x; YOSHIOKA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1901, DOI 10.1271/bbb.59.1901; Zhang C, 2007, COLLOID SURFACE B, V55, P192, DOI 10.1016/j.colsurfb.2006.11.031; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314	41	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164061	10.1371/journal.pone.0164061	http://dx.doi.org/10.1371/journal.pone.0164061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695112	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100083
J	Yu, SB; Verges-Armstrong, LM; Chu, YX; Zmuda, JM; Zhang, YZ				Yu, Shibing; Verges-Armstrong, Laura M.; Chu, Yanxia; Zmuda, Joseph M.; Zhang, Yingze			Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1	PLOS ONE			English	Article							BINDING-SITE POLYMORPHISM; BONE-DENSITY; OSTEOPOROTIC FRACTURES; GENE-EXPRESSION; MITHRAMYCIN; DIFFERENTIATION; INHIBITION; PROMOTER; SAOS-2; GROWTH	The wingless pathway has a powerful influence on bone metabolism and is a therapeutic target in skeletal disorders. Wingless signaling is mediated in part through the Frizzled (FZD) receptor family. FZD transcriptional regulation is poorly understood. Herein we tested the hypothesis that Sp1 plays an important role in the transcriptional regulation of FZD1 expression in osteoblasts and osteoblast mineralization. To test this hypothesis, we conducted FZD1 promoter assays in Saos2 cells with and without Sp1 overexpression. We found that Sp1 significantly up-regulates FZD1 promoter activity in Saos2 cells. Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift (EMSA) assays identified a novel and functional Sp1 binding site at -44 to -40 from the translation start site in the FZD1 promoter. The Sp1-dependent activation of the FZD1 promoter was abolished by mithramycin A (MMA), an antibiotic affecting both Sp1 binding and Sp1 protein levels in Saos2 cells. Similarly, down-regulation of Sp1 in hFOB cells resulted in less FZD1 expression and lower alkaline phosphatase activity. Moreover, over-expression of Sp1 increased FZD1 expression and Saos2 cell mineralization while MMA decreased Sp1 and FZD1 expression and Saos2 cell mineralization. Knockdown of FZD1 prior to Sp1 overexpression partially abolished Sp1 stimulation of osteoblast differentiation markers. Taken together, our results suggest that Sp1 plays a role in human osteoblast differentiation and mineralization, which is at least partially mediated by Sp1-dependent transactivation of FZD1.	[Yu, Shibing; Chu, Yanxia; Zhang, Yingze] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Verges-Armstrong, Laura M.; Zmuda, Joseph M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Zmuda, Joseph M.; Zhang, Yingze] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Verges-Armstrong, Laura M.] Univ Maryland, Sch Med, Program Personalized & Genom Med, College Pk, MD 20742 USA; [Verges-Armstrong, Laura M.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Zhang, YZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.	zhangy@upmc.edu		Zhang, YIngze/0000-0001-8042-6105	National Institute on Aging [R01-AG033618, T32-AG00181]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR049747]; National Osteoporosis Foundation; Western Pennsylvania Arthritis Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Osteoporosis Foundation; Western Pennsylvania Arthritis Foundation	This study was supported by grants R01-AG033618 from the National Institute on Aging, R01-AR049747 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and funding from the National Osteoporosis Foundation and Western Pennsylvania Arthritis Foundation. Laura M. Yerges-Armstrong was supported by National Institute on Aging grant T32-AG00181. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Choi ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep07162; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Chupreta S, 2000, AM J PHYSIOL-CELL PH, V278, pC697, DOI 10.1152/ajpcell.2000.278.4.C697; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Feng X, 2000, J BIOL CHEM, V275, P8331, DOI 10.1074/jbc.275.12.8331; Garnero P, 1998, J BONE MINER RES, V13, P813, DOI 10.1359/jbmr.1998.13.5.813; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Haidweger E, 2001, J MOL BIOL, V306, P201, DOI 10.1006/jmbi.2000.4406; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Hirose T, 2013, NATURE, V500, P354, DOI 10.1038/nature12329; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Jia ZL, 2010, CANCER RES, V70, P1111, DOI 10.1158/0008-5472.CAN-09-3282; Langdahl BL, 1998, J BONE MINER RES, V13, P1384, DOI 10.1359/jbmr.1998.13.9.1384; Liu JZ, 2005, J CELL BIOCHEM, V96, P716, DOI 10.1002/jcb.20569; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Maneix L, 2014, J MOL MED, V92, P1179, DOI 10.1007/s00109-014-1195-5; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McGuigan FEA, 2000, OSTEOPOROSIS INT, V11, P338, DOI 10.1007/s001980070123; MCQUILLAN DJ, 1995, BONE, V16, P415; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otjacques E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062818; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; RODAN SB, 1987, CANCER RES, V47, P4961; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Suuriniemi M, 2006, BONE, V39, P591, DOI 10.1016/j.bone.2006.02.053; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Wang LW, 2008, INT J ONCOL, V33, P161; Williams LJS, 2000, J MOL ENDOCRINOL, V25, P309, DOI 10.1677/jme.0.0250309; YARBRO JW, 1966, CANCER RES, V26, P36; Yerges LM, 2009, J BONE MINER RES, V24, P87, DOI [10.1359/jbmr.080816, 10.1359/JBMR.080816]; Yu SB, 2015, BIOCHEM J, V465, P395, DOI 10.1042/BJ20140668; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhang YZ, 2010, BONE, V46, P1131, DOI 10.1016/j.bone.2009.12.026	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163277	10.1371/journal.pone.0163277	http://dx.doi.org/10.1371/journal.pone.0163277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695039	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100027
J	Zhang, MM; Fu, HR; Lai, XY; Tan, YM; Zheng, WY; Shi, JM; Zhao, YM; Lin, MF; He, JS; Cai, Z; Luo, Y; Huang, H				Zhang, Mingming; Fu, Huarui; Lai, Xiaoyu; Tan, Yamin; Zheng, Weiyan; Shi, Jimin; Zhao, Yanmin; Lin, Maofang; He, Jingsong; Cai, Zhen; Luo, Yi; Huang, He			Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; STANDARD; MRD	We evaluated the prognostic effect of minimal residual disease at first achievement of complete remission (MRD at CR1) in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). A total of 97 patients received treatment in our center between 2007 and 2012 were retrospectively reviewed in this study. Patients were divided into two arms according to the post-remission therapy (chemotherapy alone or allogeneic hematopoietic stem cell transplantation (allo-HSCT)) they received. MRD was detected by four-color flow cytometry. We chose 0.02% and 0.2% as the cut-off points of MRD at CR1 for risk stratification using receiver operating characteristic analysis. The 3-year overall survival (OS) and leukemia free survival (LFS) rates for the whole cohort were 46.2% and 40.5%. MRD at CR1 had a significantly negative correlation with survival in both arms. Three-year OS rates in the chemotherapy arm were 70.0%, 25.2%, 0% (P = 0.003) for low, intermediate, and high levels of MRD at CR1, respectively. Three-year OS rates in the transplant arm were 81.8%, 64.3%, 27.3% (P = 0.005) for low, intermediate, and high levels of MRD at CR1, respectively. Multivariate analysis confirmed that higher level of MRD at CR1 was a significant adverse factor for OS and LFS. Compared with chemotherapy alone, allo-HSCT significantly improved LFS rates in patients with intermediate (P = 0.005) and high (P = 0.022) levels of MRD at CR1, but not patients with low level of MRD at CR1 (P = 0.851). These results suggested that MRD at CR1 could strongly predict the outcome of adult ALL. Patients with intermediate and high levels of MRD at CR1 would benefit from allo-HSCT.	[Zhang, Mingming; Fu, Huarui; Lai, Xiaoyu; Tan, Yamin; Zheng, Weiyan; Shi, Jimin; Zhao, Yanmin; Lin, Maofang; He, Jingsong; Cai, Zhen; Luo, Yi; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Luo, Y; Huang, H (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China.	luoyijr@163.com; huanghe@zju.edu.co	zhao, yan/GWC-9174-2022	huang, he/0000-0002-2723-1621	Key Project of the National Natural Science Foundation of China [81230014]; National Natural Science Foundation of China [81370644, 81470307]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part by the Key Project of the National Natural Science Foundation of China (81230014, HH), and the National Natural Science Foundation of China (81370644, YL; 81470307 YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassan R, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.48; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bassan R, 2009, BLOOD, V113, P4153, DOI 10.1182/blood-2008-11-185132; Beldjord K, 2014, BLOOD, V123, P3739, DOI 10.1182/blood-2014-01-547695; Bruggemann M, 2006, BLOOD, V107, P1116, DOI 10.1182/blood-2005-07-2708; Dhedin N, 2015, BLOOD, V125, P2486, DOI 10.1182/blood-2014-09-599894; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gokbuget N, 2012, BLOOD, V120, P1868, DOI 10.1182/blood-2011-09-377713; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Holowiecki J, 2008, BRIT J HAEMATOL, V142, P227, DOI 10.1111/j.1365-2141.2008.07185.x; Luo Y, 2014, BLOOD, V124, P2735, DOI 10.1182/blood-2014-04-571570; Patel B, 2010, BRIT J HAEMATOL, V148, P80, DOI 10.1111/j.1365-2141.2009.07941.x; Ribera JM, 2014, J CLIN ONCOL, V32, P1595, DOI 10.1200/JCO.2013.52.2425; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; van Dongen JJM, 2015, BLOOD, V125, P3996, DOI 10.1182/blood-2015-03-580027	16	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163599	10.1371/journal.pone.0163599	http://dx.doi.org/10.1371/journal.pone.0163599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695097	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100046
J	Chisholm, JM; Pang, DSJ				Chisholm, Jessica M.; Pang, Daniel S. J.			Assessment of Carbon Dioxide, Carbon Dioxide/Oxygen, Isoflurane and Pentobarbital Killing Methods in Adult Female Sprague-Dawley Rats	PLOS ONE			English	Article							NOXIOUS CHEMICAL-STIMULATION; INTRAPERITONEAL INJECTIONS; NASAL STIMULATION; FLOW-RATE; EUTHANASIA; CO2; BRAIN; ANESTHESIA; RESPONSES; AVERSION	Background Exposure to carbon dioxide (CO2) gas as a killing method is aversive and exposure to high concentrations is likely to be painful. Bradycardia during exposure to CO2 is associated with nociception and pain. However, it is unclear if bradycardia occurs before loss of consciousness as definitions of loss of consciousness vary in the literature. The objectives of this study were to explore the relationship between recumbency, loss of righting reflex (LORR) and a quiescent electromyograph as measures of loss of consciousness, and identify the onset of bradycardia in relation to these measures. Our primary hypothesis was that CO2 exposure would result in bradycardia, which would precede LORR. Methods Thirty-two adult, female Sprague-Dawley rats were instrumented with a telemetry device and randomly assigned to one of four killing methods (concentrations of 100% CO2, CO2 (70%)/O-2 (30%), isoflurane (5%) and intraperitoneal pentobarbital (200 mg/kg). Time to achieve recumbency, LORR, quiescent electromyograph, isoelectric electrocorticograph, heart rate and apnea were recorded. Results The general order of progression was recumbency, LORR, quiescent electromyograph, isoelectric electrocorticograph and apnea. Recumbency preceded LORR in the majority of animals (CO2; 7/8, CO2/O-2; 8/8, isoflurane; 5/8, pentobarbital; 4/8). Bradycardia occurred before recumbency in the CO2 (p = 0.0002) and CO2/O2 (p = 0.005) groups, with a 50% reduction in heart rate compared to baseline. The slowest (time to apnea) and least consistent killing methods were CO2/O-2 (1180 +/- 658.1s) and pentobarbital (875 [239 to 4680] s). Conclusion Bradycardia, and consequently nociception and pain, occurs before loss of consciousness during CO2 exposure. Pentobarbital displayed an unexpected lack of consistency, questioning its classification as an acceptable euthanasia method in rats.	[Chisholm, Jessica M.; Pang, Daniel S. J.] Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB T2N 1N4, Canada; [Pang, Daniel S. J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Chisholm, Jessica M.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE, Canada; [Pang, Daniel S. J.] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ, Canada	University of Calgary; University of Calgary; University of Prince Edward Island; Universite de Montreal	Pang, DSJ (corresponding author), Univ Calgary, Dept Vet Clin & Diagnost Sci, Calgary, AB T2N 1N4, Canada.; Pang, DSJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada.; Pang, DSJ (corresponding author), Univ Montreal, Fac Med Vet, St Hyacinthe, PQ, Canada.	daniel.pang@umontreal.ca		Chisholm, Jessica/0000-0002-4410-4843; Pang, Daniel/0000-0002-6420-477X	Natural Sciences and Engineering Research Council of Canada Discovery Grant [424022-2013]; Margaret Gunn Endowment for Animal Research (University of Calgary)	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Margaret Gunn Endowment for Animal Research (University of Calgary)	Natural Sciences and Engineering Research Council of Canada Discovery Grant (424022-2013), awarded to DP. Margaret Gunn Endowment for Animal Research (University of Calgary), awarded to DP.	ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Antognini JF, 2005, COMPARATIVE MED, V55, P413; Antognini JF, 2002, ANESTHESIOLOGY, V96, P980, DOI 10.1097/00000542-200204000-00028; ANTON F, 1992, PAIN, V49, P53, DOI 10.1016/0304-3959(92)90187-G; ANTON F, 1991, NEUROSCI LETT, V123, P208, DOI 10.1016/0304-3940(91)90932-J; Association AVM, 2013, AVMA GUIDELINES EUTH; Azabou E, 2016, CLIN EEG NEUROSCI, V47, P75, DOI 10.1177/1550059415612375; Ballard T., 2009, Animal Technology and Welfare, V8, P17; Boivin GP, 2016, J AM ASSOC LAB ANIM, V55, P451; Charbonneau R., 2010, CCAC GUIDELINES EUTH; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Citerio G, 2014, NEUROCRIT CARE, V21, P376, DOI 10.1007/s12028-014-9983-x; COENEN AML, 1995, LAB ANIM, V29, P262, DOI 10.1258/002367795781088289; Coria-Avila GA, 2007, LAB ANIMAL, V36, P25, DOI 10.1038/laban0707-25; Correia R, 2015, IEEE 4PORT BIOENGINE; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; DRIPPS RD, 1947, AM J PHYSIOL, V149, P43, DOI 10.1152/ajplegacy.1947.149.1.43; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Feng YW, 2003, INVEST OPHTH VIS SCI, V44, P529, DOI 10.1167/iovs.02-0003; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; GREGORY GA, 1974, ANESTHESIOLOGY, V40, P301, DOI 10.1097/00000542-197403000-00022; Hawkins P., 2006, NEWCASTLE CONSENSUS; HEWETT TA, 1993, LAB ANIM SCI, V43, P579; Iwarsson K., 1993, Scandinavian Journal of Laboratory Animal Science, V20, P191; KIMURA J, 1968, ARCH INTERN MED, V121, P511, DOI 10.1001/archinte.121.6.511; Kirkden RD, 2008, ANIM WELFARE, V17, P79; Kobayashi M, 2004, BRAIN RES, V1009, P137, DOI 10.1016/j.brainres.2004.02.056; Kobayashi M, 1999, AM J PHYSIOL-HEART C, V276, pH176, DOI 10.1152/ajpheart.1999.276.1.H176; Leach MC, 2002, COMPARATIVE MED, V52, P249; LEWIS RE, 1966, LAB ANIM CARE, V16, P505; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Makowska IJ, 2009, APPL ANIM BEHAV SCI, V119, P229, DOI 10.1016/j.applanim.2009.04.003; MCARDLE L, 1959, BRIT J ANAESTH, V31, P142, DOI 10.1093/bja/31.4.142; Moody CM, 2015, APPL ANIM BEHAV SCI, V163, P183, DOI 10.1016/j.applanim.2014.11.010; Niel L, 2008, APPL ANIM BEHAV SCI, V109, P77, DOI 10.1016/j.applanim.2007.02.004; Niel L, 2007, APPL ANIM BEHAV SCI, V107, P100, DOI 10.1016/j.applanim.2006.08.002; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; PEPPEL P, 1993, J NEUROPHYSIOL, V70, P2260, DOI 10.1152/jn.1993.70.6.2260; POWNER DJ, 1976, JAMA-J AM MED ASSOC, V236, P1123, DOI 10.1001/jama.236.10.1123; Shemie SD, 2014, INTENS CARE MED, V40, P788, DOI 10.1007/s00134-014-3242-7; Shusterman D, 2003, CHEM SENSES, V28, P595, DOI 10.1093/chemse/bjg050; Smith W, 1997, LAB ANIM-UK, V31, P337, DOI 10.1258/002367797780596130; STOELTING RK, 1970, ANESTHESIOLOGY, V33, P5, DOI 10.1097/00000542-197007000-00004; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Thurauf N, 2002, BRAIN RES, V942, P79, DOI 10.1016/S0006-8993(02)02697-5; Valentine H, 2012, J AM ASSOC LAB ANIM, V51, P50; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; Yavari P, 1996, J AUTONOM NERV SYST, V61, P195, DOI 10.1016/S0165-1838(96)00072-0	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162639	10.1371/journal.pone.0162639	http://dx.doi.org/10.1371/journal.pone.0162639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648836	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100026
J	Mohr, A; Ripoli, FL; Hammer, SC; Willenbrock, S; Hewicker-Trautwein, M; Kielbowicz, Z; Escobar, HM; Nolte, I				Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Willenbrock, Saskia; Hewicker-Trautwein, Marion; Kielbowicz, Zdzislaw; Escobar, Hugo Murua; Nolte, Ingo			Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; BREAST-CANCER; TUMOR CHARACTERISTICS; CARCINOMAS; PROLACTIN; DOGS; IMMUNOHISTOCHEMISTRY; SERUM	Immunohistochemistry (IHC) is currently considered the method of choice for steroid hormone receptor status evaluation in human breast cancer and, therefore, it is commonly utilized for assessing canine mammary tumors. In case of low hormone receptor expression, IHC is limited and thus is complemented by molecular analyses. In the present study, a multiplex bDNA assay was evaluated as a method for hormone receptor gene expression detection in canine mammary tissues. Estrogen receptor (ESR1), progesterone receptor (PGR), prolactin receptor (PRLR) and growth hormone receptor (GHR) gene expressions were evaluated in neoplastic and non-neoplastic canine mammary tissues. A set of 119 fresh frozen and 180 formalin-fixed, paraffin-embedded (FFPE) was comparatively analyzed and used for assay evaluation. Furthermore, a possible association between the hormone receptor expression in different histological subtypes of canine malignant mammary tumors and the castration status, breed and invasive growth of the tumor were analyzed. Themultiplex bDNA assay proved to be more sensitive for fresh frozen specimens. Hormone receptor expression found was significantly decreased in malignant mammary tumors in comparison to non-neoplastic tissue and benign mammary tumors. Among the histological subtypes the lowest gene expression levels of ESR1, PGR and PRLR were found in solid, anaplastic and ductal carcinomas. In summary, the evaluation showed that the measurement of hormone receptors with the multiplex bDNA assay represents a practicable method for obtaining detailed quantitative information about gene expression in canine mammary tissue for future studies. Still, comparison with IHC or quantitative real-time PCR is needed for further validation of the present method.	[Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Willenbrock, Saskia; Escobar, Hugo Murua; Nolte, Ingo] Univ Vet Med Hannover, Fdn, Small Anim Clin, Hannover, Germany; [Mohr, Annika; Ripoli, Florenza Luder; Hammer, Susanne Conradine; Escobar, Hugo Murua] Univ Rostock, Div Med Clin Hematol Oncol & Palliat Med 3, Rostock, Germany; [Hewicker-Trautwein, Marion] Univ Vet Med Hannover, Inst Pathol, Fdn, Hannover, Germany; [Kielbowicz, Zdzislaw] Wroclaw Univ Environm & Life Sci, Dept & Clin Vet Surg, Fac Vet Med, Wroclaw, Poland	University of Veterinary Medicine Hannover, Foundation; University of Rostock; University of Veterinary Medicine Hannover, Foundation; Wroclaw University of Environmental & Life Sciences	Nolte, I (corresponding author), Univ Vet Med Hannover, Fdn, Small Anim Clin, Hannover, Germany.	ingo.nolte@tiho-hannover.de	Kiełbowicz, Zdzisław/D-1056-2017	Kiełbowicz, Zdzisław/0000-0003-4946-0449				Azizun-Nisa, 2008, ASIAN PAC J CANCER P, V9, P553; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Beck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075485; BOSTOCK DE, 1986, BRIT VET J, V142, P506, DOI 10.1016/0007-1935(86)90107-7; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Faupel-Badger JM, 2014, HORM CANCER-US, V5, P42, DOI 10.1007/s12672-013-0165-7; Flagella M, 2006, ANAL BIOCHEM, V352, P50, DOI 10.1016/j.ab.2006.02.013; Gebre-Medhin M, 2001, AM J PATHOL, V158, P1217, DOI 10.1016/S0002-9440(10)64071-0; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Guil-Luna S, 2011, J VET INTERN MED, V25, P518, DOI 10.1111/j.1939-1676.2011.0723.x; Hachim IY, 2015, PROLACTIN RECEPTOR E; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hennecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131280; Kim MS, 2010, METHODMOL BIOL CLI, V949, P349; Kim NH, 2014, J COMP PATHOL, V151, P42, DOI 10.1016/j.jcpa.2014.04.001; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Kraus JA, 2012, MODERN PATHOL, V25, P869, DOI 10.1038/modpathol.2011.219; Mainenti M, 2014, VET J, V202, P62, DOI 10.1016/j.tvjl.2014.06.003; Millanta F, 2005, RES VET SCI, V79, P225, DOI 10.1016/j.rvsc.2005.02.002; Nieto A, 2000, VET PATHOL, V37, P239, DOI 10.1354/vp.37-3-239; Pena L, 2014, VET PATHOL, V51, P127, DOI 10.1177/0300985813509388; Queiroga FL, 2014, VET REC, V175, P403, DOI 10.1136/vr.102263; Rasotto R, 2012, VET PATHOL, V49, P330, DOI 10.1177/0300985811409253; Ressel L, 2013, RES VET SCI, V94, P299, DOI 10.1016/j.rvsc.2012.09.016; Rivera P, 2009, CANCER RES, V69, P8770, DOI 10.1158/0008-5472.CAN-09-1725; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Sleeckx N, 2011, REPROD DOMEST ANIM, V46, P1112, DOI 10.1111/j.1439-0531.2011.01816.x; Sorenmo KU, 2000, J VET INTERN MED, V14, P266, DOI 10.1892/0891-6640(2000)014&lt;0266:EOSATO&gt;2.3.CO;2; Spoerri M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0546-y; URDEA MS, 1994, BIO-TECHNOL, V12, P926, DOI 10.1038/nbt0994-926; Yang W, 2006, BIOTECHNIQUES, V40, P481, DOI 10.2144/000112133; Yim HW, 2010, J BREAST CANCER, V13, P267, DOI 10.4048/jbc.2010.13.3.267	34	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163311	10.1371/journal.pone.0163311	http://dx.doi.org/10.1371/journal.pone.0163311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649560	gold, Green Submitted, Green Published			2022-12-26	WOS:000383892100078
J	Rincon, B; Kenchington, EL				Rincon, Beatriz; Kenchington, Ellen L.			Influence of Benthic Macrofauna as a Spatial Structuring Agent for Juvenile Haddock (Melanogrammus aeglefinus) on the Eastern Scotian Shelf, Atlantic Canada	PLOS ONE			English	Article							DEMERSAL FISH ASSEMBLAGES; NORTHWEST ATLANTIC; WESTERN BANK; ST-LAWRENCE; HABITAT; COD; COMMUNITIES; DYNAMICS; GULF; DISTRIBUTIONS	We examined the habitat of juvenile haddock on the eastern Scotian Shelf (off Nova Scotia, Canada) in relation to grab-sampled benthic macrofaunal invertebrate species assemblages in order to determine whether there were significant differences in benthic macrofauna between areas of historically persistent high and low juvenile haddock abundance. Our analyses were conducted over two spatial scales in each of two years: among banks (Emerald, Western and Sable Island), approximately 60 km distant from each other, and between areas of high and low juvenile haddock abundance at distances of 10 to 30 km-all in an area that had not experienced groundfishing in the decade prior to sampling. We also examined fine-scale (10s of metres) within-site variability in the macrofauna and used surficial sediment characteristics, along with hydrographic variables, to identify environmental correlates. PERMANOVA identified statistically significant differences in biomass, density and composition of the benthos associated with juvenile haddock abundance; however it was difficult to determine whether the results had biological relevance. Post hoc tests showed that these differences occurred only on Sable Island Bank where both fish and benthos may have been independently responding to sediment type which was most different there (100% sand in the area of low haddock abundance vs. 22% gravel in the area of high haddock abundance). In total, 383 benthic taxa representing 13 phyla were identified. Annelida was the most specious phylum (36.29% of taxa, representing 33 families), followed by Arthropoda (with Crustaceans, mostly Amphipoda, accounting for 25.07% of the total number of taxa). The strongest pattern in the macrofauna was expressed at the largest scale, between banks, accounting for approximately 25% of the variation in the data. Emerald Bank, deeper, warmer and saltier than the Western and Sable Island Banks, had a distinctive fauna.	[Rincon, Beatriz; Kenchington, Ellen L.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Kenchington, EL (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	Ellen.Kenchington@dfo-mpo.gc.ca			Science Branch of Fisheries and Oceans Canada	Science Branch of Fisheries and Oceans Canada	This project was funded by the Science Branch of Fisheries and Oceans Canada.	Anderson JT, 2005, AM FISH S S, V41, P251; Anderson JT, 2007, 2770 CAN TECH REP FI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Auster P.J., 2005, DIVING SCI 2005 P AM, P89; Auster PJ, 1997, ENVIRON BIOL FISH, V50, P195, DOI 10.1023/A:1007305628035; Auster PJ, 2003, ENVIRON BIOL FISH, V68, P381, DOI 10.1023/B:EBFI.0000005751.30906.d5; Auster PJ, 2001, ENVIRON BIOL FISH, V60, P331, DOI 10.1023/A:1011022320818; Auster PJ, 1998, AM FISH S S, V22, P150; Bowman RE, 1984, NMFSFNEC28 NOAA US D; Bowman RE, 1979, 7943 US DEP COMM NAT; Breeze H, 2002, CAN TECH REP FISH AQ; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Cargnelli L., 1999, NMFSNE128 NOAA; Cargnelli LM, 1999, NMESNF148 NOAA; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Courtney R. C., 2005, P INT C UND AC MEAS; Cuff A, 2015, CONT SHELF RES, V110, P149, DOI 10.1016/j.csr.2015.10.004; Dalley E. L., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P18; Davis SD, 1973, 10 NOV SCOT MUS; Davis SD, 1973, BENTHIC ANIMALS CRUI; Davis SD, 1974, BENTHIC ANIMALS CRUI; Desrosiers G, 2000, DEEP-SEA RES PT II, V47, P663, DOI 10.1016/S0967-0645(99)00122-8; Diaz RJ, 2003, ESTUARIES, V26, P12, DOI 10.1007/BF02691689; FADER GBJ, 2007, CAN TECH REP FISH AQ, V2770, P29; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frojan CRSB, 2012, ICES J MAR SCI, V69, P213, DOI 10.1093/icesjms/fss004; Gilkinson K., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P46; Gilkinson KD, 2005, ICES J MAR SCI, V62, P925, DOI 10.1016/j.icesjms.2005.03.009; Gilkinson KD, 2012, DFO CAN SCI ADVIS SE; Gordon D. C. Jr., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P1; Gordon Jr DC, 2000, ICES 2000 ANN C 2000; Gorley C.K., 2006, GETTING STARTED PRIM; GOTCEITAS V, 1993, OECOLOGIA, V93, P31, DOI 10.1007/BF00321187; Gregory R., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P10; Hargrave BT, 2004, MAR ECOL PROG SER, V270, P55, DOI 10.3354/meps270055; Henry LA, 2006, MAR ECOL PROG SER, V306, P63, DOI 10.3354/meps306063; Homans RES, 1944, P NOVA SCOTIA I SCI, V21, P1; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Murillo FJ, 2016, DEEP-SEA RES PT I, V109, P99, DOI 10.1016/j.dsr.2015.08.006; Kaiser MJ, 2004, ESTUAR COAST SHELF S, V60, P445, DOI 10.1016/j.ecss.2004.02.005; Kenchington E, 2013, MAR ECOL PROG SER, V477, P217, DOI 10.3354/meps10127; Kenchington E., 2004, AM FISHERIES SOC S, V41, P391; Kenchington EL, 2005, AM FISH S S, V41, P391; Kenchington ELR, 2006, J SEA RES, V56, P249, DOI 10.1016/j.seares.2006.03.010; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Kilada RW, 2009, MAR BIOL, V156, P1029, DOI 10.1007/s00227-009-1146-9; KOELLER PA, 1986, J CONSEIL, V43, P59; KOHLER AC, 1969, J FISH RES BOARD CAN, V26, P1273, DOI 10.1139/f69-113; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Kutti T, 2015, MAR ECOL PROG SER, V520, P175, DOI 10.3354/meps11047; Langton Richard W., 1995, Reviews in Fisheries Science, V3, P201; Langton RW, 1980, SSRF740 NOAA NMFS US; Legendre P., 2012, NUMERICAL ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lindholm JB, 1999, MAR ECOL PROG SER, V180, P247, DOI 10.3354/meps180247; Linehan J, 2004, 2526 CAN TECH REP FI; LOUGH RG, 1989, MAR ECOL PROG SER, V56, P1, DOI 10.3354/meps056001; Maciolek-Blake N, 1984, 141200129192 US MIN; MAHON R, 1989, CAN J FISH AQUAT SCI, V46, P134, DOI 10.1139/f89-285; MAHON R, 1987, MAR ECOL PROG SER, V37, P123, DOI 10.3354/meps037123; MATTSON S, 1992, SARSIA, V77, P33, DOI 10.1080/00364827.1992.10413490; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; McKeown DL, 1997, 2159 CAN TECH REP FI; Methven DA, 1999, 2267 CAN TECH REP FI; MILLER DAVID, 1963, JOUR CONS, V28, P37; MILLS EL, 1979, MAR BIOL, V54, P101, DOI 10.1007/BF00386589; Nesis KNN, 1970, FISHERIES RES BOARD, V1375; O'Boyle R, 2001, 2948 CAN TECH REP FI; Ollerhead L. M. N., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2770, P49; Rowell TW, 1997, 2190 CAN TECH REP FI; Scharf FS, 2006, J EXP MAR BIOL ECOL, V335, P167, DOI 10.1016/j.jembe.2006.03.018; SCHNEIDER DC, 1987, MAR ECOL PROG SER, V39, P1, DOI 10.3354/meps039001; Schuckel S, 2010, J FISH BIOL, V77, P98, DOI 10.1111/j.1095-8649.2010.02657.x; Sell AF, 2013, J SEA RES, V80, P12, DOI 10.1016/j.seares.2013.01.007; Shaw J, 2014, GEOL SOC MEM, V41, P7, DOI 10.1144/M41.2; Sissenwine M.P., 1984, Life Sciences Research Report, P59; Stanley DJ, 1971, SMITHSONIAN CONTRIBU, V6; Theroux Roger B, 1988, 140 NOAA NMES US DEP; Thorson G., 1957, TREATISE MARINE ECOL, V67, P461, DOI DOI 10.1130/MEM67V1-P461; Uiblein F, 2003, MAR ECOL PROG SER, V257, P223, DOI 10.3354/meps257223; Young EF, 2015, EVOL APPL, V8, P486, DOI 10.1111/eva.12259	84	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163374	10.1371/journal.pone.0163374	http://dx.doi.org/10.1371/journal.pone.0163374			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649419	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100084
J	Schenk-Jager, KM; Egli, S; Hanimann, D; Senn-Irlet, B; Kupferschmidt, H; Buntgen, U				Schenk-Jaeger, Katharina M.; Egli, Simon; Hanimann, David; Senn-Irlet, Beatrice; Kupferschmidt, Hugo; Buntgen, Ulf			Introducing Mushroom Fruiting Patterns from the Swiss National Poisons Information Centre	PLOS ONE			English	Article							CITIZEN SCIENCE; CLIMATE-CHANGE; LONG-TERM; GROWTH; BIODIVERSITY; RESPONSES; FUTURE; FUNGI; CO2	Changes in the ecology of macrofungi are poorly understood, not only because much of their life cycle is hidden belowground, but also because experiments often miss real-world complexity and most fruitbody inventories are limited in space and time. The National Poisons Information Centre 'Tox Info Suisse' provides countrywide 24hours/7days medical advice in case of poisonings since 1966. Here, we introduce a total of 12,126-mushroom-related phone calls that were received by Tox Info Suisse between 1966 and 2014. This indirect source of mycological information is dominated by the families of Boletaceae (11%), Agaricaceae (10%) and Amanitaceae (8%), which account for similar to 30% of all cases. Mushroom fruiting patterns revealed by the Poisons Centre inventory statistically resemble changes in fungal phenology, productivity and diversity as reflected by the Swiss National Data Centre 'SwissFungi'. Although the newly developed Tox Info Suisse dataset provides an innovative basis for timely environmental research, caution is advised when interpreting some of the observed long-term changes and autumnal extremes. Uncertainty of the new record relates to possible data incompleteness, imprecise species description and/or identification, as well as the inclusion of cultivated and non-indigenous mushrooms. Nevertheless, we hope that the Tox Info Suisse inventory will stimulate and enable a variety of ecological-oriented follow-up studies.	[Schenk-Jaeger, Katharina M.; Kupferschmidt, Hugo] Univ Zurich, Associated Inst, Tox Info Suisse, Natl Poisons Informat Ctr, Zurich, Switzerland; [Egli, Simon; Hanimann, David; Buntgen, Ulf] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Buntgen, Ulf] Oeschger Ctr Climate Change Res, Bern, Switzerland; [Buntgen, Ulf] Global Change Res Ctr AS CR, Brno, Czech Republic	University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Buntgen, U (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.; Buntgen, U (corresponding author), Oeschger Ctr Climate Change Res, Bern, Switzerland.; Buntgen, U (corresponding author), Global Change Res Ctr AS CR, Brno, Czech Republic.	buentgen@wsl.ch	buentgen, ulf/J-6952-2013; Senn-Irlet, Beatrice/AFQ-5299-2022		WSL-internal DITREC project; Ernst Gohner Foundation; Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0248]	WSL-internal DITREC project; Ernst Gohner Foundation; Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic	Funding was received from the WSL-internal DITREC project, the Ernst Gohner Foundation, as well as the Operational Programme of Education for Competitiveness of the Ministry of Education, Youth, and Sports of the Czech Republic (No. CZ.1.07/2.3.00/20.0248).	Andrew C, 2014, MYCORRHIZA, V24, P581, DOI 10.1007/s00572-014-0577-4; Andrew C, 2009, ECOL LETT, V12, P813, DOI 10.1111/j.1461-0248.2009.01334.x; [Anonymous], CLIN TOXICOL; Bedry R, 2001, NEW ENG J MED, V345; Boddy L, 2014, FUNGAL ECOL, V10, P20, DOI 10.1016/j.funeco.2013.10.006; Borsa AA, 2014, SCIENCE, V345, P1587, DOI 10.1126/science.1260279; Buntgen U, 2015, AGR ECOSYST ENVIRON, V202, P148, DOI 10.1016/j.agee.2014.12.016; Buntgen U, 2014, TRENDS PLANT SCI, V19, P613, DOI 10.1016/j.tplants.2014.07.001; Buntgen U, 2014, ECOL LETT, V17, P303, DOI 10.1111/ele.12231; Buntgen U, 2013, GLOBAL PLANET CHANGE, V107, P177, DOI 10.1016/j.gloplacha.2013.05.013; Buntgen U, 2013, GLOBAL CHANGE BIOL, V19, P2785, DOI 10.1111/gcb.12263; Buntgen U, 2012, NAT CLIM CHANGE, V2, P827, DOI 10.1038/nclimate1733; Buntgen U, 2012, FRONT ECOL ENVIRON, V10, P14, DOI 10.1890/110064; Davies S, 2008, CLIN TOXICOL, V46, P596; Diez JM, 2013, GLOBAL CHANGE BIOL, V19, P3145, DOI 10.1111/gcb.12278; Eggenberg S, 2013, HOTSPOT, V28, P10; Egli S, 2006, BIOL CONSERV, V129, P271, DOI 10.1016/j.biocon.2005.10.042; Flammer R, 2002, SWISS MED FORUM, V132, P5; Gange AC, 2007, SCIENCE, V316, P71, DOI 10.1126/science.1137489; Gange AC, 2013, P NATL ACAD SCI USA, V110, pE333, DOI 10.1073/pnas.1219640110; Gange AC, 2011, FUNGAL ECOL, V4, P184, DOI 10.1016/j.funeco.2010.09.004; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Halme P, 2012, FUNGAL ECOL, V5, P750, DOI 10.1016/j.funeco.2012.05.005; Heilmann-Clausen J, 2015, CONSERV BIOL, V29, P61, DOI 10.1111/cobi.12388; Henderson S, 2012, FRONT ECOL ENVIRON, V10, P283, DOI 10.1890/1540-9295-10.6.283; Henneken R, 2012, ENVIRON ENTOMOL, V41, P1462, DOI 10.1603/EN12139; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Kauserud H, 2008, P NATL ACAD SCI USA, V105, P3811, DOI 10.1073/pnas.0709037105; Kauserud H, 2012, P NATL ACAD SCI USA, V109, P14488, DOI 10.1073/pnas.1200789109; Kauserud H, 2011, BIOL LETTERS, V7, P273, DOI 10.1098/rsbl.2010.0820; Kauserud H, 2010, P ROY SOC B-BIOL SCI, V277, P1169, DOI 10.1098/rspb.2009.1537; Kirk PM., 2008, DICT FUNGI, V10th ed; Kupferschmidt H., 2003, Journal of Toxicology Clinical Toxicology, V41, P665; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Mills JA, 2015, TRENDS ECOL EVOL, V30, P581, DOI 10.1016/j.tree.2015.07.006; Moore D, 2008, BR MYCOL SY, V28, P79; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049777; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Senn-Irlet B, 2010, MYCOL BALCANICA, V7, P59; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Straatsma G, 2001, MYCOL RES, V105, P515, DOI 10.1017/S0953756201004154; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yang XF, 2012, FUNGAL DIVERS, V56, P189, DOI 10.1007/s13225-012-0163-z; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076	48	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162314	10.1371/journal.pone.0162314	http://dx.doi.org/10.1371/journal.pone.0162314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648562	gold, Green Published			2022-12-26	WOS:000383892100016
J	Teraguchi, M; Samartzis, D; Hashizume, H; Yamada, H; Muraki, S; Oka, H; Cheung, JPY; Kagotani, R; Iwahashi, H; Tanaka, S; Kawaguchi, H; Nakamura, K; Akune, T; Cheung, KMC; Yoshimura, N; Yoshida, M				Teraguchi, Masatoshi; Samartzis, Dino; Hashizume, Hiroshi; Yamada, Hiroshi; Muraki, Shigeyuki; Oka, Hiroyuki; Cheung, Jason Pui Yin; Kagotani, Ryohei; Iwahashi, Hiroki; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Akune, Toru; Cheung, Kenneth Man-Chee; Yoshimura, Noriko; Yoshida, Munehito			Classification of High Intensity Zones of the Lumbar Spine and Their Association with Other Spinal MRI Phenotypes: The Wakayama Spine Study	PLOS ONE			English	Article							LOW-BACK-PAIN; POPULATION-BASED COHORT; INTERVERTEBRAL DISC DEGENERATION; ISSLS PRIZE WINNER; MODIC CHANGES; PHYSICAL PERFORMANCE; ANNULAR TEARS; RISK-FACTORS; PREVALENCE; DISCOGRAPHY	Introduction High intensity zones (HIZ) of the lumbar spine are a phenotype of the intervertebral disc noted on MRI whose clinical relevance has been debated. Traditionally, T2-weighted (T2W) magnetic resonance imaging (MRI) has been utilized to identify HIZ of lumbar discs. However, controversy exists with regards to HIZ morphology, topography, and association with other MRI spinal phenotypes. Moreover, classification of HIZ has not been thoroughly defined in the past and the use of additional imaging parameters (e.g. T1W MRI) to assist in defining this phenotype has not been addressed. Materials and Methods A cross-sectional study of 814 (69.8% females) subjects with mean age of 63.6 years from a homogenous Japanese population was performed. T2W and T1W sagittal 1.5T MRI was obtained on all subjects to assess HIZ from L1-S1. We created a morphological and topographical HIZ classification based on disc level, shape type (round, fissure, vertical, rim, and enlarged), location within the disc (posterior, anterior), and signal type on T1W MRI (low, high and iso intensity) in comparison to the typical high intensity on T2W MRI. Results HIZ was noted in 38.0% of subjects. Of these, the prevalence of posterior, anterior, and both posterior/anterior HIZ in the overall lumbar spine were 47.3%, 42.4%, and 10.4%, respectively. Posterior HIZ was most common, occurring at L4/5 (32.5%) and L5/S1 (47.0%), whereas anterior HIZ was most common at L3/4 (41.8%). T1W iso-intensity type of HIZ was most prevalent (71.8%), followed by T1W high-intensity (21.4%) and T1W low-intensity (6.8%). Of all discs, round types were most prevalent (anterior: 3.6%, posterior: 3.7%) followed by vertical type (posterior: 1.6%). At all affected levels, there was a significant association between HIZ and disc degeneration, disc bulge/protrusion and Modic type II (p<0.01). Posterior HIZ and T1W high-intensity type of HIZ were significantly associated with disc bulge/protrusion and disc degeneration (p< 0.01). In addition, posterior HIZ was significantly associated with Modic type II and III. T1W low-intensity type of HIZ was significantly associated with Modic type II. Conclusions This is the first large-scale study reporting a novel classification scheme of HIZ of the lumbar spine. This study is the first that has utilized T2W and T1W MRIs in differentiating HIZ sub-phenotypes. Specific HIZ sub-phenotypes were found to be more associated with specific MRI degenerative changes. With a more detailed description of the HIZ phenotype, this scheme can be standardized for future clinical and research initiatives.	[Teraguchi, Masatoshi; Hashizume, Hiroshi; Yamada, Hiroshi; Kagotani, Ryohei; Iwahashi, Hiroki; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan; [Samartzis, Dino; Cheung, Jason Pui Yin; Cheung, Kenneth Man-Chee] Univ Hong Kong, Dept Orthopaed & Traumatol, Professorial Block,5th Floor,102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China; [Muraki, Shigeyuki] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Joint Dis Res,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Oka, Hiroyuki] Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Japan Community Healthcare Org, Tokyo Shinjuku Med Ctr, Shinjuku Ku, 5-1 Tsukudo Chome, Tokyo 1628543, Japan; [Nakamura, Kozo; Akune, Toru] Rehabil Serv Bur, Natl Rehabil Ctr Persons Disabil, 1 Namiki 4 Chome, Tokorozawa, Saitama 3598555, Japan	Wakayama Medical University; University of Hong Kong; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama 6418509, Japan.; Samartzis, D (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Professorial Block,5th Floor,102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.	dsamartzis@msn.com; hashizum@wakayama-med.ac.jp	Cheung, Jason Pui Yin/AAJ-2016-2020; Hashizume, Hiroshi/V-6888-2019; Tanaka, Sakae/Y-3061-2019; Cheung, Jason Pui Yin/J-2214-2012	Cheung, Jason Pui Yin/0000-0002-7052-0875; Hashizume, Hiroshi/0000-0002-9064-0284; Tanaka, Sakae/0000-0001-9210-9414; Cheung, Kenneth/0000-0001-8304-0419; Samartzis, Dino/0000-0002-7473-1311	Grants-in-Aid for Scientific Research [26462249] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Bogduk N, 2008, SPINE, V33, P1298, DOI 10.1097/BRS.0b013e3181732a0d; Carragee EJ, 2000, SPINE, V25, P2987, DOI 10.1097/00007632-200012010-00005; Carragee EJ, 2004, SPINE, V29, P1112, DOI 10.1097/00007632-200405150-00012; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Chen JY, 2011, CLIN J PAIN, V27, P125, DOI 10.1097/AJP.0b013e3181fb2203; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Dudli S, 2016, EUR SPINE J IN PRESS; Hayashi T, 2015, J NEUROSURG-SPINE, V22, P511, DOI 10.3171/2014.10.SPINE14496; HIRSCH C., 1953, ACTA ORTHOPAED SCAND, V22, P184; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Lam KS, 2000, EUR SPINE J, V9, P36, DOI 10.1007/s005860050006; Li Y, SPINE J IN PRESS; Luk KDK, 2015, SPINE J, V15, P1915, DOI 10.1016/j.spinee.2014.07.020; Maatta JH, MEDICINE IN PRESS; Maatta JH, 2015, SPINE J, V15, P1933, DOI 10.1016/j.spinee.2015.06.056; Maatta JH, 2015, SPINE, V40, P1187, DOI 10.1097/BRS.0000000000000937; Maatta JH, 2014, EUR SPINE J, V23, P1856, DOI 10.1007/s00586-014-3333-8; Martinez-Quinones JV, 2014, J SPINAL DI IN PRESS; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Mok FPS, 2010, SPINE, V35, P1944, DOI 10.1097/BRS.0b013e3181d534f3; Muraki S, 2012, OSTEOARTHR CARTILAGE, V20, P712, DOI 10.1016/j.joca.2012.03.009; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; OSTI OL, 1992, J BONE JOINT SURG BR, V74, P678, DOI 10.1302/0301-620X.74B5.1388173; Park KW, 2007, ASIAN SPINE J, V1, P38, DOI 10.4184/asj.2007.1.1.38; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rankine JJ, 1999, SPINE, V24, P1913, DOI 10.1097/00007632-199909150-00009; Ricketson R, 1996, SPINE, V21, P2758, DOI 10.1097/00007632-199612010-00010; Samartzis D, OSTEOARTHRI IN PRESS; Samartzis D, 2015, SPINE J, V15, P1919, DOI 10.1016/j.spinee.2014.09.010; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; Schellhas KP, 1996, SPINE, V21, P79, DOI 10.1097/00007632-199601010-00018; Schmidt TA, 1998, SPINE, V23, P2167, DOI 10.1097/00007632-199810150-00005; Sharma A, 2009, AM J NEURORADIOL, V30, P500, DOI 10.3174/ajnr.A1411; Takatalo J, 2012, SPINE, V37, P1231, DOI 10.1097/BRS.0b013e3182443855; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Teraguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147565; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Vangeneugden T, 2005, BIOMETRICS, V61, P295, DOI 10.1111/j.0006-341X.2005.031040.x; Vavken P, 2015, GLOB SPINE J, V5, P156, DOI 10.1055/s-0035-1547525; Wang HQ, 2014, INT J CLIN EXP PATHO, V7, P1293; Wang Y, 2012, SPINE J, V12, P411, DOI 10.1016/j.spinee.2012.03.026; Williams R, 2016, GLOB SPINE J, V6, P35, DOI 10.1055/s-0035-1555655; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; YU SW, 1989, AM J NEURORADIOL, V10, P1077	50	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0160111	10.1371/journal.pone.0160111	http://dx.doi.org/10.1371/journal.pone.0160111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649071	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100001
J	Sochalska, M; Schuler, F; Weiss, JG; Prchal-Murphy, M; Sexl, V; Villunger, A				Sochalska, M.; Schuler, F.; Weiss, J. G.; Prchal-Murphy, M.; Sexl, V.; Villunger, A.			MYC selects against reduced BCL2A1/A1 protein expression during B cell lymphomagenesis	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-X-L; LEUKOCYTE DEVELOPMENT; MYELOID-LEUKEMIA; IN-VIVO; FAMILY; A1/BFL-1; MICE; RESISTANCE; APOPTOSIS	Rearrangements of MYC or ABL proto-oncogenes lead to deregulated expression of key-regulators of cell cycle and cell survival, thereby constituting important drivers of blood cancer. Members of the BCL-2 family of apoptosis regulators contribute to oncogenic transformation downstream of these oncogenes, but the role of anti-apoptotic BCL2A1/A1 in transformation and drug resistance caused by deregulation of these oncogenes remains enigmatic. Here we analyzed the role of A1 in MYC as well as ABL kinase-driven blood cancer in mice, employing in vivo RNAi. We report that overexpression of either oncogene leads to a significant increase in A1 protein levels in otherwise A1-negative B cell progenitors, indicating a key role downstream of these oncogenes to secure survival during transformation. Knockdown of A1 by RNAi, however, did not impact on tumor latency in v-Abl-driven pre-B-ALL. In contrast, A1 knockdown in premalignant E mu-MYC mice caused a significant reduction of transgenic pre-B cells without impacting on tumor latency as the emerging lymphomas escaped silencing of A1 expression. These findings identify A1 as a MYC target that can be induced prematurely during B cell development to aid expansion of otherwise cell-death-prone MYC transgenic pre-B cells. Hence, A1 should be considered as a putative drug target in MYC-driven blood cancer.	[Sochalska, M.; Schuler, F.; Weiss, J. G.; Villunger, A.] Med Univ Innsbruck, Div Dev Immunol, Bioctr, Innrain 80, A-6020 Innsbruck, Austria; [Prchal-Murphy, M.; Sexl, V.] Univ Vet Med, Inst Pharmacol & Toxicol, Dept Biomed Sci, Vienna, Austria; [Villunger, A.] Tyrolean Canc Res Inst, Innsbruck, Austria	Medical University of Innsbruck; University of Veterinary Medicine Vienna	Villunger, A (corresponding author), Med Univ Innsbruck, Div Dev Immunol, Bioctr, Innrain 80, A-6020 Innsbruck, Austria.	andreas.villunger@i-med.ac.at	Sexl, Veronika/B-8657-2016	Sexl, Veronika/0000-0001-9363-0412; Sochalska, Maja/0000-0002-6665-3309	Austrian Science Fund (FWF) [I1298 (FOR-2036)]; MCBO Doctoral College 'Molecular Cell Biology and Oncology' [W1101]; 'Osterreichische Krebshilfe Tirol'; Doc-fellowship from the Austrian Academy of Science (OAW);  [SFB-F47]; Austrian Science Fund (FWF) [I 1298] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MCBO Doctoral College 'Molecular Cell Biology and Oncology'; 'Osterreichische Krebshilfe Tirol'; Doc-fellowship from the Austrian Academy of Science (OAW); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to K Rossi, C Soratroi and I Gaggl for excellent technical assistance and animal care as well as to S Tuzlak for western analysis of Vav-BFL-1 mice and S Herzog for MYC expression constructs and discussion. We also thank J Borst (NKI) and M Herold (WEHI) for anti-BFL-1 antiserum and anti-A1 antibodies, respectively, and M Hartl for MYC inhibitors. This work was supported by grants from the Austrian Science Fund (FWF), grant I1298 (FOR-2036) and the MCBO Doctoral College 'Molecular Cell Biology and Oncology' (W1101) and the 'Osterreichische Krebshilfe Tirol' to AV and the SFB-F47 to VS. FS is supported by a Doc-fellowship from the Austrian Academy of Science (OAW).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anderson MA, 2014, SEMIN HEMATOL, V51, P219, DOI 10.1053/j.seminhematol.2014.05.008; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Carter MJ, 2016, CELL DEATH DIFFER, V23, P303, DOI 10.1038/cdd.2015.97; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hatakeyama S, 1998, INT IMMUNOL, V10, P631, DOI 10.1093/intimm/10.5.631; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Kelly PN, 2007, BLOOD, V109, P4907, DOI 10.1182/blood-2006-10-051847; Kelly PN, 2011, BLOOD, V118, P6380, DOI 10.1182/blood-2011-07-367672; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lang MJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.519; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Muthalagu N, 2014, CELL REP, V8, P1347, DOI 10.1016/j.celrep.2014.07.057; Ogilvy S, 1999, BLOOD, V94, P1855; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ottina E, 2015, J IMMUNOL, V194, P1316, DOI 10.4049/jimmunol.1400637; Ottina E, 2012, BLOOD, V119, P6032, DOI 10.1182/blood-2011-12-399089; Ottina E, 2012, EXP CELL RES, V318, P1291, DOI 10.1016/j.yexcr.2012.01.021; Pegman PM, 2006, J VIROL, V80, P8133, DOI 10.1128/JVI.00278-06; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Sochalska M, 2016, CELL DEATH DIFFER, V23, P628, DOI 10.1038/cdd.2015.130; Sochalska M, 2015, FEBS J, V282, P834, DOI 10.1111/febs.13188; Vier J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.23; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	33	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 13	2017	36	15					2066	2073		10.1038/onc.2016.362	http://dx.doi.org/10.1038/onc.2016.362			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ES8DK	27694901	Green Published, hybrid			2022-12-26	WOS:000399782500003
J	Zhakupova, A; Debeuf, N; Krols, M; Toussaint, W; Vanhoutte, L; Alecu, I; Kutalik, Z; Vollenweider, P; Ernst, D; von Eckardstein, A; Lambrecht, BN; Janssens, S; Hornemann, T				Zhakupova, Assem; Debeuf, Nincy; Krols, Michiel; Toussaint, Wendy; Vanhoutte, Leen; Alecu, Irina; Kutalik, Zoltan; Vollenweider, Peter; Ernst, Daniela; von Eckardstein, Arnold; Lambrecht, Bart N.; Janssens, Sophie; Hornemann, Thorsten			ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase	FASEB JOURNAL			English	Article						asthma; ceramide; sphingolipid; metabolism; sphinganine	GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM MEMBRANE; SPHINGOLIPID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; SUSCEPTIBILITY LOCI; CHILDHOOD ASTHMA; PROTEINS MEDIATE; POPULATION; HOMEOSTASIS; COMPLEX	ORMDL proteins are believed to be negative regulators of serine palmitoyltransferase (SPT), which catalyzes the first and rate limiting step in sphingolipid (SL) de novo synthesis. Several single-nucleotide polymorphisms ( SNPs) that are close to the ORMDL3 locus have been reported to increase ORMDL3 expression and to be associated with an elevated risk for early childhood asthma; however, the direct effect of ORMDL3 expression on SPT activity and its link to asthma remains elusive. In this study, we investigated whether ORMDL3 expression is associated with changes in SPT activity and total SL levels. Ormdl3-knockout (Ormdl3(-/-)) and transgenic (Ormdl3(Tg/wt)) mice were generated to study the effect of ORMDL3 on total SL levels in plasma and tissues. Cellular SPT activity was measured in mouse embryonic fibroblasts from Ormdl3(-/-) mice, as well as in HEK293 cells in which ORMDL3 was overexpressed and silenced. Furthermore, we analyzed the association of the reported ORMDL3 asthma SNPs with plasma sphingoid bases in a population-based cohort of 971 individuals. Total C-18-long chain bases were not significantly altered in the plasma and tissues of Ormdl3(-/-) mice, whereas C-18-sphinganine showed a small and significant increase in plasma, lung, and liver tissues. Mouse embryonic fibroblast cells from Ormdl3(-/-) mice did not show an altered SPT activity compared with Ormdl3(+/-) and Ormdl3(+/+) mice. Overexpression or knockdown of ORMDL3 in HEK293 cells did not alter SPT activity; however, parallel knockdown of all 3 ORMDL isoforms increased enzyme activity significantly. A significant association of the annotated ORMDL3 asthma SNPs with plasma long-chain sphingoid base levels could not be confirmed. ORMDL3 expression levels seem not to be directly associated with changes in SPT activity. ORMDL3 might influence de novo sphingolipid metabolism downstream of SPT.	[Zhakupova, Assem; Alecu, Irina; Ernst, Daniela; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Zurich, Univ Zurich Hosp, Inst Clin Chem, Zurich, Switzerland; [Debeuf, Nincy; Toussaint, Wendy; Vanhoutte, Leen; Lambrecht, Bart N.; Janssens, Sophie] Vlaams Inst Biotechnol, Inflammat Res Ctr, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Debeuf, Nincy; Lambrecht, Bart N.; Janssens, Sophie] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Krols, Michiel] Univ Antwerp VIB, Dept Mol Genet, Antwerp, Belgium; [Kutalik, Zoltan] Univ Lausanne, CHU Vaudois, Inst Social & Prevent Med, Lausanne, Switzerland; [Vollenweider, Peter] Univ Lausanne, CHU Vaudois, Dept Med, Internal Med, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	University of Zurich; University Zurich Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Erasmus University Rotterdam; Erasmus MC	Hornemann, T (corresponding author), Univ Zurich, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.; Hornemann, T (corresponding author), Univ Zurich Hosp, Raemistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch	Lambrecht, Bart N/K-2484-2014; Kutalik, Zoltan/HHZ-5697-2022; Janssens, Sophie/HHN-1756-2022; Colaus, PsyColaus/K-6607-2013	Lambrecht, Bart N/0000-0003-4376-6834; Kutalik, Zoltan/0000-0001-8285-7523; Alecu, Irina/0000-0002-7659-9190	Seventh Framework Program of the European Commission (RESOLVE) [305707]; Gebert Ruf Foundation [GRS-047/09]; Center of Integrated Human Physiology (ZIHP); Swiss National Foundation SNF [31003A_153390/1]; Hurka Foundation; Novartis Foundation; Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich); Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants; Ghent University MRP grant (Group-ID); GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 33CS30-139468, 33CS30-148401]	Seventh Framework Program of the European Commission (RESOLVE); Gebert Ruf Foundation; Center of Integrated Human Physiology (ZIHP); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Hurka Foundation; Novartis Foundation(Novartis); Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich); Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants(FWO); Ghent University MRP grant (Group-ID); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Seventh Framework Program of the European Commission (RESOLVE, project number 305707), the Gebert Ruf Foundation (GRS-047/09), the Center of Integrated Human Physiology (ZIHP), the Swiss National Foundation SNF; Project 31003A_153390/1), the Hurka Foundation, the Novartis Foundation, and the Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich (to A.Z., I.A., D.E., A.V.E., and T.H.). N.D., B.N.L., and S.J. hold several Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants. B.N.L. and S.J. are recipients of a Ghent University MRP grant (Group-ID). The Cohorte Lausannoise study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (Grants 33CSCO-122661, 33CS30-139468, and 33CS30-148401). S.J. and T.H. are shared senior authors.	Antiochos P, 2015, NUTR METAB CARDIOVAS, V25, P1007, DOI 10.1016/j.numecd.2015.07.011; Antiochos P, 2016, ATHEROSCLEROSIS, V244, P59, DOI 10.1016/j.atherosclerosis.2015.10.104; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Drake KA, 2008, PHARMACOGENOMICS, V9, P453, DOI 10.2217/14622416.9.4.453; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hrdlickova B, 2011, HUM IMMUNOL, V72, P921, DOI 10.1016/j.humimm.2011.07.309; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Karunas A S, 2011, Mol Biol (Mosk), V45, P992; Kihara A, 2004, J BIOL CHEM, V279, P49243, DOI 10.1074/jbc.M405915200; Leung TF, 2009, ALLERGY, V64, P621, DOI 10.1111/j.1398-9995.2008.01873.x; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marques-Vidal P., 2016, EUR J NUTR; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow D, 2015, J LIPID RES, V56, P898, DOI 10.1194/jlr.M057539; Siow Deanna, 2015, Adv Biol Regul, V57, P42, DOI 10.1016/j.jbior.2014.09.002; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tafesse FG, 2010, NATURE, V463, P1028, DOI 10.1038/4631028a; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Walther TC, 2010, P NATL ACAD SCI USA, V107, P5701, DOI 10.1073/pnas.1001503107; WANG E, 1991, J BIOL CHEM, V266, P14486; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; Yang FF, 2012, GENET MOL RES, V11, P4646, DOI 10.4238/2012.October.19.1; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Ziv C, 2016, P NATL ACAD SCI USA, V113, pE1907, DOI 10.1073/pnas.1523168113	54	22	22	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4289	4300		10.1096/fj.201600639R	http://dx.doi.org/10.1096/fj.201600639R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27645259				2022-12-26	WOS:000388201500033
J	Sellmann, C; Doerner, A; Knuehl, C; Rasche, N; Sood, V; Krah, S; Rhiel, L; Messemer, A; Wesolowski, J; Schuette, M; Becker, S; Toleikis, L; Kolmar, H; Hock, B				Sellmann, Carolin; Doerner, Achim; Knuehl, Christine; Rasche, Nicolas; Sood, Vanita; Krah, Simon; Rhiel, Laura; Messemer, Annika; Wesolowski, John; Schuette, Mark; Becker, Stefan; Toleikis, Lars; Kolmar, Harald; Hock, Bjoern			Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) X c-MET Antibodies and Antibody-Drug Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; ACQUIRED-RESISTANCE; ANTITUMOR-ACTIVITY; ANTIGEN-EXPRESSION; LUNG-CANCER; INHIBITION; CETUXIMAB; DESIGN; TARGET; PROTEINS	Bispecific antibodies (bsAbs) and antibody-drug conjugates (ADCs) have already demonstrated benefits for the treatment of cancer in several clinical studies, showing improved drug selectivity and efficacy. In particular, simultaneous targeting of prominent cancer antigens, such as EGF receptor (EGFR) and c-MET, by bsAbs has raised increasing interest for potentially circumventing receptor cross-talk and c-MET-mediated acquired resistance during anti-EGFR monotherapy. In this study, we combined the selectivity of EGFR x c-MET bsAbs with the potency of cytotoxic agents via bispecific antibody-toxin conjugation. Affinity-attenuated bispecific EGFR x c-MET antibody-drug conjugates demonstrated high in vitro selectivity toward tumor cells overexpressing both antigens and potent anti-tumor efficacy. Due to basal EGFR expression in the skin, ADCs targeting EGFR in general warrant early safety assessments. Reduction in EGFR affinity led to decreased toxicity in keratinocytes. Thus, the combination of bsAb affinity engineering with the concept of toxin conjugation may be a viable route to improve the safety profile of ADCs targeting ubiquitously expressed antigens.	[Sellmann, Carolin; Krah, Simon; Messemer, Annika; Kolmar, Harald] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany; [Sellmann, Carolin; Doerner, Achim; Rasche, Nicolas; Krah, Simon; Rhiel, Laura; Schuette, Mark; Becker, Stefan; Toleikis, Lars; Hock, Bjoern] Merck KGaA, Prot Engn & Antibody Technol, Frankfurter Str 250, D-64293 Darmstadt, Germany; [Knuehl, Christine] Merck KGaA, Merck Res & Dev, Frankfurter Str 250, D-64293 Darmstadt, Germany; [Sood, Vanita; Wesolowski, John] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA	Technical University of Darmstadt; Merck KGaA; Merck KGaA	Kolmar, H (corresponding author), Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany.; Hock, B (corresponding author), Merck KGaA, Prot Engn & Antibody Technol, Frankfurter Str 250, D-64293 Darmstadt, Germany.	Kolmar@Biochemie-TUD.de; Bjoern.Hock@merckgroup.com	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993; Sood, Vanita/0000-0001-6714-3725; Doerner, Achim/0000-0002-4741-8039				BALINT RF, 1993, GENE, V137, P109, DOI 10.1016/0378-1119(93)90258-5; Basilico C, 2014, J CLIN INVEST, V124, P3172, DOI 10.1172/JCI72316; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; BIRD RE, 1991, TRENDS BIOTECHNOL, V9, P132, DOI 10.1016/0167-7799(91)90044-I; Castoldi R, 2013, ONCOGENE, V32, P5593, DOI 10.1038/onc.2013.245; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; Davies J., 2013, U.S. Patent, Patent No. [8,398,974B2, 8398974]; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Diamantis N, 2016, BRIT J CANCER, V114, P362, DOI 10.1038/bjc.2015.435; Dickgiesser S, 2015, ACS CHEM BIOL, V10, P2158, DOI 10.1021/acschembio.5b00315; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garber K, 2014, NAT REV DRUG DISCOV, V13, P799, DOI 10.1038/nrd4478; Goetsch L., 2012, U.S. Patent, Patent No. [8,329,173B2, 8329173]; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P798, DOI 10.1038/nrd3581; Hust Michael, 2007, V408, P243, DOI 10.1007/978-1-59745-547-3_14; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hyatt DC, 2008, EXP CELL RES, V314, P3415, DOI 10.1016/j.yexcr.2008.08.020; Jarantow SW, 2015, J BIOL CHEM, V290, P24689, DOI 10.1074/jbc.M115.651653; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Kim YJ, 2014, INT J CANCER, V134, P2424, DOI 10.1002/ijc.28566; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leal M, 2014, ANN NY ACAD SCI, V1321, P41, DOI 10.1111/nyas.12499; Lee BS, 2016, ANN SURG ONCOL, V23, P2046, DOI 10.1245/s10434-015-5084-0; Lee JM, 2016, ONCOGENE, V35, P4437, DOI 10.1038/onc.2015.514; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Liu L, 2014, CLIN CANCER RES, V20, P6059, DOI 10.1158/1078-0432.CCR-14-0543; Martin P, 2016, CLIN LUNG CANCER, V17, P375, DOI 10.1016/j.cllc.2016.01.002; Mazor Y, 2015, MABS-AUSTIN, V7, P461, DOI 10.1080/19420862.2015.1022695; Mazor Y, 2015, MABS-AUSTIN, V7, P377, DOI 10.1080/19420862.2015.1007816; Melosky B, 2009, CURR ONCOL, V16, P16; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Muda M, 2011, PROTEIN ENG DES SEL, V24, P447, DOI 10.1093/protein/gzq123; Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009; Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oh YM, 2012, MOL CELLS, V34, P523, DOI 10.1007/s10059-012-0194-z; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peng Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092924, 10.1371/journal.pone.0084502, 10.1371/journal.pone.0085663]; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; Phillips AC, 2016, MOL CANCER THER, V15, P661, DOI 10.1158/1535-7163.MCT-15-0901; Prat M, 2014, BIOMEDICINES, V2, P359, DOI 10.3390/biomedicines2040359; Rakestraw JA, 2009, BIOTECHNOL BIOENG, V103, P1192, DOI 10.1002/bit.22338; Reilly EB, 2015, MOL CANCER THER, V14, P1141, DOI 10.1158/1535-7163.MCT-14-0820; Rhoden JJ, 2016, J BIOL CHEM, V291, P11337, DOI 10.1074/jbc.M116.714287; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schwall R. H., 2001, U.S. Patent, Patent No. [6,214,344B1, 6214344]; Sengers BG, 2016, MABS-AUSTIN, V8, P905, DOI 10.1080/19420862.2016.1178437; Sharma Neelesh, 2011, Ther Adv Med Oncol, V3, pS37, DOI 10.1177/1758834011423403; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Wang JY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2138-z; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Yewale C, 2013, BIOMATERIALS, V34, P8690, DOI 10.1016/j.biomaterials.2013.07.100; Zheng SM, 2016, MABS-AUSTIN, V8, P551, DOI 10.1080/19420862.2015.1136762	74	37	39	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25106	25119		10.1074/jbc.M116.753491	http://dx.doi.org/10.1074/jbc.M116.753491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694443	Green Published, hybrid			2022-12-26	WOS:000388880100026
J	Davis, MI; Pragani, R; Fox, JT; Shen, M; Parmar, K; Gaudiano, EF; Liu, L; Tanega, C; Mcgee, L; Hall, MD; McKnight, C; Shinn, P; Nelson, H; Chattopadhyay, D; D'Andrea, AD; Auld, DS; DeLucas, LJ; Li, ZY; Boxer, MB; Sinneonov, A				Davis, Mindy I.; Pragani, Rajan; Fox, Jennifer T.; Shen, Min; Parmar, Kalindi; Gaudiano, Emily F.; Liu, Li; Tanega, Cordelle; McGee, Lauren; Hall, Matthew D.; McKnight, Crystal; Shinn, Paul; Nelson, Henrike; Chattopadhyay, Debasish; D'Andrea, Alan D.; Auld, Douglas S.; DeLucas, Larry J.; Li, Zhuyin; Boxer, Matthew B.; Sinneonov, Anton			Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PROSTATE-CANCER; DNA-DAMAGE; STABILITY; REPAIR; TARGET	Deubiquitinases are important components of the protein degradation regulatory network. We report the discovery of ML364, a small molecule inhibitor of the deubiquitinase USP2 and its use to interrogate the biology of USP2 and its putative substrate cyclin DL ML364 has an IC50 of 1.1 mu M in a biochemical assay using an internally quenched fluorescent di-ubiquitin substrate. Direct binding of ML364 to USP2 was demonstrated using microscale thermophoresis. ML364 induced an increase in cellular cyclin D1 degradation and caused cell cycle arrest as shown in Western blottings and flow cytometry assays utilizing both Mino and HCT116 cancer cell lines. ML364, and not the inactive analog 2, was antiproliferative in cancer cell lines. Consistent with the role of cyclin D1 in DNA damage response, ML364 also caused a decrease in homologous recombination mediated DNA repair. These effects by a small molecule inhibitor support a key role for USP2 as a regulator of cell cycle, DNA repair, and tumor cell growth.	[Davis, Mindy I.; Pragani, Rajan; Fox, Jennifer T.; Shen, Min; Liu, Li; Tanega, Cordelle; McGee, Lauren; Hall, Matthew D.; McKnight, Crystal; Shinn, Paul; Nelson, Henrike; Auld, Douglas S.; Li, Zhuyin; Boxer, Matthew B.; Sinneonov, Anton] NIH, Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Parmar, Kalindi; Gaudiano, Emily F.; D'Andrea, Alan D.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Chattopadhyay, Debasish; DeLucas, Larry J.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL 35294 USA; [Auld, Douglas S.] Novartis Inst Biomed Res, Ctr Proteorn Chem, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Novartis	Boxer, MB; Sinneonov, A (corresponding author), NIH, NCATS, 9800 Med Ctr Dr, Rockville, MD 20850 USA.	boxerrn@mail.nih.gov; asimeono@mail.nih.gov		McGee, Lauren/0000-0003-0166-7256	NCATS Intramural Research Program; Molecular Libraries Initiative of the National Institutes of Health Common Fund; National Institutes of Health [U54 MH 084681]; Alabama Drug Discovery Alliance; National Institutes of Health/NCI Grant [5P30CA13148-37]; Translational Research Grant from the Leukemia & Lymphoma Society [6237-13]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER	NCATS Intramural Research Program; Molecular Libraries Initiative of the National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance; National Institutes of Health/NCI Grant; Translational Research Grant from the Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCATS Intramural Research Program, Molecular Libraries Initiative of the National Institutes of Health Common Fund, National Institutes of Health Grant U54 MH 084681, Alabama Drug Discovery Alliance, National Institutes of Health/NCI Grant 5P30CA13148-37, and Translational Research Grant from the Leukemia & Lymphoma Society Grant 6237-13. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Avdeef A, 2001, PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH, P305, DOI 10.1002/9783906390437.ch18; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bozza WP, 2012, BIOCHEMISTRY-US, V51, P10075, DOI 10.1021/bi3009104; Byun S, 2013, CLIN CANCER RES, V19, P3894, DOI 10.1158/1078-0432.CCR-12-3696; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Copeland R.A, 2005, EVALUATION ENZYME IN, P48; Di L, 2006, INT J PHARMACEUT, V317, P54, DOI 10.1016/j.ijpharm.2006.03.007; Fernadez V, 2005, J CLIN ONCOL, V23, P6364, DOI 10.1200/JCO.2005.05.019; Flohr S., 2007, U. S. Patent, Patent No. [WO2007009715, 2007009715]; Gansler TS, 1997, HUM PATHOL, V28, P686, DOI 10.1016/S0046-8177(97)90177-5; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Halford B, 2012, CHEM ENG NEWS, V90, P34; Hunt DA, 2007, ANTICANCER RES, V27, P27; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Issaenko OA, 2012, CELL CYCLE, V11, P1804, DOI 10.4161/cc.20174; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lai R, 2002, LEUKEMIA RES, V26, P849, DOI 10.1016/S0145-2126(02)00013-9; Li JY, 1999, AM J PATHOL, V154, P1449, DOI 10.1016/S0002-9440(10)65399-0; Marampon F, 2016, ONCOTARGET, V7, P5383, DOI 10.18632/oncotarget.6579; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Nicholson B, 2008, PROTEIN SCI, V17, P1035, DOI 10.1110/ps.083450408; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhou RF, 2013, J BIOL CHEM, V288, P5389, DOI 10.1074/jbc.M112.425272	36	81	83	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24628	24640		10.1074/jbc.M116.738567	http://dx.doi.org/10.1074/jbc.M116.738567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27681596	Green Published, hybrid			2022-12-26	WOS:000388875500024
J	Kimura, A; Hata, S; Suzuki, T				Kimura, Ayano; Hata, Saori; Suzuki, Toshiharu			Alternative Selection of beta-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid beta-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the A beta Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (A); -secretase 1 (BACE1); secretase	ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; CYTOPLASMIC DOMAIN; CULTURED-CELLS; FAMILY-MEMBERS; PEPTIDE; BRAIN; NEURONS; IDENTIFICATION	beta-Site APP-cleaving enzyme 1 (BACE1) cleaves amyloid -protein precursor (APP) at the bond between Met(671) and Asp(672) (-site) to generate the carboxyl-terminal fragment (CTF/C99). BACE1 also cleaves APP at another bond between Thr(681) and Gln(682) (-site), yielding CTF/C89. Cleavage of CTF/C99 by -secretase generates A(1-XX), whereas cleavage of CTF/C89 generates A(11-XX). Thus, -site cleavage by BACE1 is amyloidolytic rather than amyloidogenic. cleavage of mouse APP is more common than the corresponding cleavage of human APP. We found that the H684R substitution within human A, which replaces the histidine in the human protein with the arginine found at the corresponding position in mouse, facilitated cleavage irrespective of the species origin of BACE1, thereby significantly increasing the level of A(11-XX) and decreasing the level of A(1-XX). Thus, amino acid substitutions within the A sequence influenced the selectivity of alternative - or -site cleavage of APP by BACE1. In familial Alzheimer's disease (FAD), the APP gene harbors pathogenic variations such as the Swedish (K670N/M671L), Leuven (E682K), and A673V mutations, all of which decrease A(11-40) generation, whereas the protective Icelandic mutation (A673T) increases generation of A(11-40). Thus, A673T promotes cleavage of APP and protects subjects against AD. In addition, CTF/C99 was cleaved by excess BACE1 activity to generate CTF/C89, followed by A(11-40), even if APP harbored pathogenic mutations. The resultant A(11-40) was more metabolically labile in vivo than A(1-40). Our analysis suggests that some FAD mutations in APP are amyloidogenic and/or amyloidolytic via selection of alternative BACE1 cleavage sites.	[Kimura, Ayano; Hata, Saori; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Suzuki, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Neurosci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	tsuzuki@pharm.hokudai.ac.jp	Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020	Hata, Saori/0000-0003-4723-5993	Ministry of Education, Culture, Sports, Science, and Technology of Japan [262930110, 16K14690, 15K18854]; Bilateral Joint Research Project of the Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bilateral Joint Research Project of the Japan Society for the Promotion of Science	This work was supported in part by Grants-in-aid for Scientific Research 262930110 and 16K14690 (to T. S.) and 15K18854 (to S. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Bilateral Joint Research Project of the Japan Society for the Promotion of Science (to S. H.). The authors declare that they have no conflict of interest with the contents of this article.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Caillava C, 2014, NEUROBIOL AGING, V35, P1570, DOI 10.1016/j.neurobiolaging.2014.01.011; Chiba K, 2014, MOL BIOL CELL, V25, P3569, DOI 10.1091/mbc.E14-06-1111; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iijima K, 1998, BIOCHEM J, V330, P29, DOI 10.1042/bj3300029; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; Jonson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133272; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Meral D, 2013, J MOL BIOL, V425, P2260, DOI 10.1016/j.jmb.2013.03.010; Messa M, 2014, J BIOL CHEM, V289, P24143, DOI 10.1074/jbc.M114.576256; Moore BD, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt121; Motodate R, 2016, BRAIN RES, V1646, P227, DOI 10.1016/j.brainres.2016.05.054; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; PEACOCK ML, 1993, NEUROLOGY, V43, P1254, DOI 10.1212/WNL.43.6.1254; Piao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062431; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Takami M., 2012, INT J ALZHEIMERS DIS, DOI [10.1055/2012/591392, DOI 10.1055/2012/591392]; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P19304, DOI 10.1074/jbc.273.30.19304; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Vanderstichele H, 2005, CLIN CHEM, V51, P1650, DOI 10.1373/clinchem.2005.051201; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 2016, NEUROSCI BIOBEHAV R, V65, P326, DOI 10.1016/j.neubiorev.2016.03.025; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhou L, 2011, EMBO MOL MED, V3, P291, DOI 10.1002/emmm.201100138	55	53	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24041	24053		10.1074/jbc.M116.744722	http://dx.doi.org/10.1074/jbc.M116.744722			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687728	hybrid, Green Published			2022-12-26	WOS:000388498100021
J	Ramakrishnan, SK; Russo, L; Ghanem, SS; Patel, PR; Oyarce, AM; Heinrich, G; Najjar, SM				Ramakrishnan, Sadeesh K.; Russo, Lucia; Ghanem, Simona S.; Patel, Payal R.; Oyarce, Ana Maria; Heinrich, Garrett; Najjar, Sonia M.			Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; fatty acid synthase (FAS); insulin resistance; insulin secretion; peroxisome proliferator-activated receptor (PPAR); fenofibrate; insulin clearance; insulin metabolism	ACTIVATED-RECEPTOR-ALPHA; FATTY-ACID OXIDATION; PPAR-ALPHA; PROTEIN EXPRESSION; LIPID-METABOLISM; GENE-EXPRESSION; LONG-CHAIN; NULL MICE; BETA-CELL; IN-VIVO	High fat diet reduces the expression of CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), a transmembrane glycoprotein that promotes insulin clearance and down-regulates fatty acid synthase activity in the liver upon its phosphorylation by the insulin receptor. Because peroxisome proliferator-activated receptor (PPAR) transcriptionally suppresses CEACAM1 expression, we herein examined whether high fat down-regulates CEACAM1 expression in a PPAR-dependent mechanism. By activating PPAR, the lipid-lowering drug fenofibrate reverses dyslipidemia and improves insulin sensitivity in type 2 diabetes in part by promoting fatty acid oxidation. Despite reducing glucose-stimulated insulin secretion, fenofibrate treatment does not result in insulin insufficiency. To examine whether this is mediated by a parallel decrease in CEACAM1-dependent hepatic insulin clearance pathways, we fed wild-type and Ppar(-/-) null mice a high fat diet supplemented with either fenofibrate or Wy14643, a selective PPAR agonist, and examined their effect on insulin metabolism and action. We demonstrated that the decrease in insulin secretion by fenofibrate and Wy14643 is accompanied by reduction in insulin clearance in wild-type but not Ppar(-/-) mice, thereby maintaining normoinsulinemia and insulin sensitivity despite continuous high fat intake. Intact insulin secretion in L-CC1 mice with protected hepatic insulin clearance and CEACAM1 levels provides in vivo evidence that insulin secretion responds to changes in insulin clearance to maintain physiologic insulin and glucose homeostasis. These results also emphasize the relevant role of hepatic insulin extraction in regulating insulin sensitivity.	[Ramakrishnan, Sadeesh K.; Russo, Lucia; Ghanem, Simona S.; Patel, Payal R.; Oyarce, Ana Maria; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Oyarce, Ana Maria; Heinrich, Garrett] Univ Toledo, Dept Pharmacol & Expt Therapeut, Coll Pharm & Pharmaceut Sci, Toledo, OH 43614 USA; [Najjar, Sonia M.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; Ohio University	Najjar, SM (corresponding author), 1 Ohio Univ, Heritage Coll Osteopath Med, Off Grants & Res, Irvine Hall,Rm 220B, Athens, OH 45701 USA.	najjar@ohio.edu	Najjar, Sonia M/GXW-2217-2022		National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248]; American Heart Association; Middle-East Diabetes Research Center; Heritage College of Osteopathic Medicine at Ohio University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R01DK083850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Middle-East Diabetes Research Center; Heritage College of Osteopathic Medicine at Ohio University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S. M. N.), a postdoctoral fellowship from the American Heart Association (to L. R.), the Middle-East Diabetes Research Center (to S. S. G.), and an intramural start-up fund from the Heritage College of Osteopathic Medicine at Ohio University (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Bernal-Mizrachi C, 2003, NAT MED, V9, P1069, DOI 10.1038/nm898; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; FERRARI C, 1977, METABOLISM, V26, P129, DOI 10.1016/0026-0495(77)90048-8; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMISANO P, 1995, J BIOL CHEM, V270, P24073, DOI 10.1074/jbc.270.41.24073; Gremlich S, 2005, ENDOCRINOLOGY, V146, P375, DOI 10.1210/en.2004-0667; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim SH, 2016, J INVEST MED, V64, P1162, DOI 10.1136/jim-2016-000149; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kulkarni RN, 2004, INT J BIOCHEM CELL B, V36, P365, DOI 10.1016/j.biocel.2003.08.010; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu SN, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-176; Montagner A, 2016, GUT, V65, P1202, DOI 10.1136/gutjnl-2015-310798; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pereira S, 2014, AM J PHYSIOL-ENDOC M, V307, pE34, DOI 10.1152/ajpendo.00436.2013; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Ramakrishnan SK, 2016, J BIOL CHEM, V291, P8121, DOI 10.1074/jbc.M116.714014; Rubi B, 2002, BIOCHEM J, V364, P219, DOI 10.1042/bj3640219; Rudovich NN, 2004, DIABETES, V53, P2359, DOI 10.2337/diabetes.53.9.2359; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Shipman KE, 2016, WORLD J DIABETES, V7, P74, DOI 10.4239/wjd.v7.i5.74; Sozio MS, 2010, SEMIN LIVER DIS, V30, P378, DOI 10.1055/s-0030-1267538; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Vu-Dac N, 1998, J BIOL CHEM, V273, P25713, DOI 10.1074/jbc.273.40.25713; Wiesenthal SR, 1999, DIABETES, V48, P766, DOI 10.2337/diabetes.48.4.766; Xiao C, 2006, DIABETOLOGIA, V49, P1371, DOI 10.1007/s00125-006-0211-x; Yoshii H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1089, DOI 10.1152/ajpendo.00306.2005; Zhou YT, 1998, P NATL ACAD SCI USA, V95, P8898, DOI 10.1073/pnas.95.15.8898	40	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23915	23924		10.1074/jbc.M116.745778	http://dx.doi.org/10.1074/jbc.M116.745778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27662905	Green Published, hybrid			2022-12-26	WOS:000388498100007
J	Ramani, K; Mavila, N; Ko, KS; Mato, JM; Lu, SC				Ramani, Komal; Mavila, Nirmala; Ko, Kwang Suk; Mato, Jose M.; Lu, Shelly C.			Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell growth; cell proliferation; hepatocellular carcinoma; hepatocyte; RNA; CCCTC-binding transcription factor; H19; Prohibitin 1; imprinting control region; insulin-like growth factor 2	HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; LIVER-INJURY; H19; ENHANCER; IGF2; STABILIZATION; METHYLATION; ACTIVATION; EXPRESSION	Prohibitin 1 (PHB1) is a mitochondrial chaperone that regulates cell growth. Phb1 knock-out mice exhibit liver injury and hepatocellular carcinoma (HCC). Phb1 knock-out livers show induction of tumor growth-associated genes, H19 and insulin-like growth factor 2 (Igf2). These genes are controlled by the imprinting control region (ICR) containing CCCTC-binding transcription factor (CTCF)-binding sites. Because Phb1 knock-out mice exhibited induction of H19 and Igf2, we hypothesized that PHB1-mediated regulation of the H19-Igf2 axis might control cell proliferation in normal hepatocytes. H19 and Igf2 were induced (8-20-fold) in 3-week-old Phb1 knock-out livers, in Phb1 siRNA-treated AML12 hepatocytes (2-fold), and HCC cell lines when compared with control. Phb1 knockdown lowered CTCF protein in AML12 by approximate to 30% when compared with control. CTCF overexpression lowered basal H19 and Igf2 expression by 30% and suppressed Phb1 knockdown-mediated induction of these genes. CTCF and PHB1 co-immunoprecipitated and co-localized on the ICR element, and Phb1 knockdown lowered CTCF ICR binding activity. The results suggest that PHB1 and CTCF cooperation may control the H19-Igf2 axis. Human HCC tissues with high levels of H19 and IGF2 exhibited a 40-50% reduction in PHB1 and CTCF expression and their ICR binding activity. Silencing Phb1 or overexpressing H19 in the mouse HCC cell line, SAMe-D, induced cell growth. Blocking H19 induction prevented Phb1 knockdown-mediated growth, whereas H19 overexpression had the reverse effect. Interestingly H19 silencing induced PHB1 expression. Taken together, our results demonstrate that the H19-Igf2 axis is negatively regulated by CTCF-PHB1 cooperation and that H19 is involved in modulating the growth-suppressive effect of PHB1 in the liver.	[Ramani, Komal; Mavila, Nirmala; Lu, Shelly C.] Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA; [Ko, Kwang Suk] Ewha Womans Univ, Coll Hlth Sci, Dept Nutr Sci & Food Management, Seoul 03760, South Korea; [Mato, Jose M.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, CIC bioGUNE, Technol Pk Bizkaia, Derio 48160, Bizkaia, Spain	Cedars Sinai Medical Center; Ewha Womans University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Lu, SC (corresponding author), Cedars Sinai Med Ctr, Div Gastroenterol & Hepatol, Los Angeles, CA 90048 USA.	shelly.lu@cshs.org	Lu, Shelly/AAH-5937-2021; Mavila, Nirmala/AAH-6140-2021; Ramani, Komal/AAH-5913-2021; MATO, JOSE/A-5187-2011	Lu, Shelly/0000-0003-2128-5407; MATO, JOSE/0000-0003-1264-3153	National Institutes of Health [R01CA172086]; Plan Nacional of I+D SAF [2014-52097R]; Departamento de Educacion del Gobierno Vasco; National Research Foundation of Korea [NRF-2012R1A1A1012261]; NATIONAL CANCER INSTITUTE [R01CA172086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plan Nacional of I+D SAF; Departamento de Educacion del Gobierno Vasco; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01CA172086 (to S. C. L., H. P. Yang, and J. M. M.), Plan Nacional of I+D SAF 2014-52097R, and Departamento de Educacion del Gobierno Vasco (to J. M. M.), and National Research Foundation of Korea NRF-2012R1A1A1012261 (to K. S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayoumi AS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030356; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; Ko KS, 2010, HEPATOLOGY, V52, P2096, DOI 10.1002/hep.23919; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Martinez-Lopez N, 2010, HEPATOLOGY, V52, P1621, DOI 10.1002/hep.23860; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Ramani K, 2015, J CELL PHYSIOL, V230, P1075, DOI 10.1002/jcp.24839; Sanchez-Quiles V, 2012, J PROTEOMICS, V75, P5783, DOI 10.1016/j.jprot.2012.08.009; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Thorvaldsen JL, 2002, MOL CELL BIOL, V22, P2450, DOI 10.1128/MCB.22.8.2450-2462.2002; Toretsky JA, 1996, J ENDOCRINOL, V149, P367, DOI 10.1677/joe.0.1490367; Vernucci M, 2000, ONCOGENE, V19, P6376, DOI 10.1038/sj.onc.1204024; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Yamamoto Y, 2004, J HEPATOL, V40, P808, DOI 10.1016/j.jhep.2004.01.022; Zhou TB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03123	26	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24148	24159		10.1074/jbc.M116.744045	http://dx.doi.org/10.1074/jbc.M116.744045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27687727	Green Published, hybrid			2022-12-26	WOS:000388498100030
J	Ibo, M; Srivastava, V; Robinson, DN; Gagnon, ZR				Ibo, Markela; Srivastava, Vasudha; Robinson, Douglas N.; Gagnon, Zachary R.			Cell Blebbing in Confined Microfluidic Environments	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; QUANTITATIVE-ANALYSIS; GRADIENT GENERATOR; MYOSIN-II; CHEMOTAXIS; MIGRATION; MOTILITY; MODES; INVASION; CHAMBER	Migrating cells can extend their leading edge by forming myosin-driven blebs and F-actin-driven pseudopods. When coerced to migrate in resistive environments, Dictyostelium cells switch from using predominately pseudopods to blebs. Bleb formation has been shown to be chemotactic and can be influenced by the direction of the chemotactic gradient. In this study, we determine the blebbing responses of developed cells of Dictyostelium discoideum to cAMP gradients of varying steepness produced in microfluidic channels with different confining heights, ranging between 1.7 mu m and 3.8 mu m. We show that microfluidic confinement height, gradient steepness, buffer osmolarity and Myosin II activity are important factors in determining whether cells migrate with blebs or with pseudopods. Dictyostelium cells were observed migrating within the confines of microfluidic gradient channels. When the cAMP gradient steepness is increased from 0.7 nM/mu m to 20 nM/mu m, cells switch from moving with a mixture of blebs and pseudopods to moving only using blebs when chemotaxing in channels with confinement heights less than 2.4 mu m. Furthermore, the size of the blebs increases with gradient steepness and correlates with increases in myosin-II localization at the cell cortex. Reduction of intracellular pressure by high osmolarity buffer or inhibition of myosin-II by blebbistatin leads to a decrease in bleb formation and bleb size. Together, our data reveal that the protrusion type formed by migrating cells can be influenced by the channel height and the steepness of the cAMP gradient, and suggests that a combination of confinement-induced myosin-II localization and cAMP-regulated cortical contraction leads to increased intracellular fluid pressure and bleb formation.	[Ibo, Markela; Gagnon, Zachary R.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Srivastava, Vasudha; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Gagnon, ZR (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	zgagnon1@jhmi.edu		Robinson, Douglas/0000-0003-1236-4891	National Institutes of Health [GM66817]; National Science Foundation (US) [CBET 1351253, 1605553]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066817] Funding Source: NIH RePORTER; Directorate For Engineering [1605553] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (US)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by DNR: National Institutes of Health (http://www.nih.gov US); GM66817; ZG: National Science Foundation (US); http://www.nsf.gov; CBET 1351253, 1605553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2012, LAB CHIP, V12, P309, DOI 10.1039/c1lc20829b; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bozzaro Salvatore, 2013, Methods Mol Biol, V983, P17, DOI 10.1007/978-1-62703-302-2_2; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Heuze ML, 2011, METHODS MOL BIOL, V769, P415, DOI 10.1007/978-1-61779-207-6_28; Huang Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3555195; Hung WC, 2016, CELL REP, V15, P1430, DOI 10.1016/j.celrep.2016.04.035; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jowhar D, 2010, INTEGR BIOL-UK, V2, P648, DOI 10.1039/c0ib00110d; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Long T, 2009, ENVIRON SCI TECHNOL, V43, P1546, DOI 10.1021/es802558j; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Mavrogiannis N, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4950753; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Skoge M, 2010, INTEGR BIOL-UK, V2, P659, DOI 10.1039/c0ib00033g; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Srivastava V, 2016, SEMIN CELL DEV BIOL, V53, P39, DOI 10.1016/j.semcdb.2015.10.023; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; vanHaastert PJM, 1997, FEBS LETT, V410, P25, DOI 10.1016/S0014-5793(97)00416-X; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147	53	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163866	10.1371/journal.pone.0163866	http://dx.doi.org/10.1371/journal.pone.0163866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706201	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200066
J	Kaspersen, KA; Dinh, KM; Erikstrup, LT; Burgdorf, KS; Pedersen, OB; Sorensen, E; Petersen, MS; Hjalgrim, H; Rostgaard, K; Nielsen, KR; Ullum, H; Erikstrup, C				Kaspersen, Kathrine Agergard; Dinh, Khoa Manh; Erikstrup, Lise Tornvig; Burgdorf, Kristoffer Solvsten; Pedersen, Ole Birger; Sorensen, Erik; Petersen, Mikkel Steen; Hjalgrim, Henrik; Rostgaard, Klaus; Nielsen, Kaspar Rene; Ullum, Henrik; Erikstrup, Christian			Low-Grade Inflammation Is Associated with Susceptibility to Infection in Healthy Men: Results from the Danish Blood Donor Study (DBDS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; INCREASED RISK; WOMEN; LIFE; DISTRIBUTIONS; PREDICTORS; QUALITY; MARKERS; OBESITY	Introduction The aim of this study was to examine whether low-grade inflammation (LGI) is associated with a subsequently increased risk of infection. Methods We included 15,754 healthy participants from the Danish Blood Donor Study, who completed a questionnaire on health-related items. LGI was defined as a C-reactive protein level between 3 and 10 mg/L. Infections were identified by ICD-10 codes in the Danish National Patient Register and ATC-codes in the Danish Prescription Register. Multivariable Cox proportional hazard analysis was used as the statistical model. Results During 53,302 person-years of observation, 571 participants were hospitalized for infection. Similarly, during 26,125 person-years of observation, 7,276 participants filled a prescription of antimicrobials. LGI was associated with increased risk of hospital-based treatment for infection only among men (hazard ratio = 1.60, 95% confidence interval (CI): 1.10-2.34) and specifically infections were abscesses and infections of the skin and subcutaneous tissue. Similarly, LGI was associated with the overall use of antimicrobials among men, and particularly with phenoxymethylpenicillin and broad-spectrum antimicrobials for treatment of urinary tract infections. The difference between men and women was not statistically significant. Conclusions In a large cohort of healthy individuals, LGI was associated with an increased risk of infection among healthy male blood donors.	[Kaspersen, Kathrine Agergard; Dinh, Khoa Manh; Petersen, Mikkel Steen; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Pedersen, Ole Birger] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Hjalgrim, Henrik; Rostgaard, Klaus] Statens Serum Inst, Dept Epidemiol Res, Copenhagen S, Denmark; [Erikstrup, Lise Tornvig] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark; [Burgdorf, Kristoffer Solvsten; Sorensen, Erik; Ullum, Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen S, Denmark; [Nielsen, Kaspar Rene] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark	Aarhus University; Naestved Hospital; Statens Serum Institut; Aarhus University; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Kaspersen, KA (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.	kathrinekaspersen@gmail.com	Pedersen, Ole Birger/W-8679-2019; Hjalgrim, Henrik/AAG-4973-2021	Pedersen, Ole Birger/0000-0003-2312-5976; Kaspersen, Kathrine Agergard/0000-0002-7973-3623; Rostgaard, Klaus/0000-0001-6220-9414; Burgdorf, Kristoffer/0000-0001-5814-6844; Erikstrup, Christian/0000-0001-6551-6647; Ullum, Henrik/0000-0001-7306-9058; Dinh, Khoa Manh/0000-0003-1881-5673	Lundbeckfonden; The Danish Council for Independent Research; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laegevidenskabens Fremme	Lundbeckfonden(Lundbeckfonden); The Danish Council for Independent Research; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laegevidenskabens Fremme	This study is funded by Lundbeckfonden, The Danish Council for Independent Research, The Danish Administrative Regions, Bloddonorernes Forskningsfond, and Fonden til Laegevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; Dinh KM, 2015, ATHEROSCLEROSIS, V242, P222, DOI 10.1016/j.atherosclerosis.2015.07.031; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Imhof A, 2003, CLIN CHEM, V49, P669, DOI 10.1373/49.4.669; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Kotze SR, 2016, VOX SANG, V111, P144, DOI 10.1111/vox.12396; Kotze SR, 2015, TRANSFUSION, V55, P1303, DOI 10.1111/trf.13011; Kuikka LK, 2009, J AM MED DIR ASSOC, V10, P348, DOI 10.1016/j.jamda.2009.02.007; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Legouffe E, 1998, LEUKEMIA LYMPHOMA, V31, P351, DOI 10.3109/10428199809059228; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Ording AG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005082; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pfitzner T, 2008, ORTHOPADE, V37, P1116, DOI 10.1007/s00132-008-1342-1; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Rigas AS, 2015, TRANSFUSION, V55, P1752, DOI 10.1111/trf.13085; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P223, DOI 10.1016/j.numecd.2010.07.007; World Health Organization, INT CLASS DIS; Zacho J, 2016, CLIN CHEM, V62, P335, DOI 10.1373/clinchem.2015.249680	40	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164220	10.1371/journal.pone.0164220	http://dx.doi.org/10.1371/journal.pone.0164220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701463	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900051
J	Bokharaeian, B; Diaz, A; Chitsaz, H				Bokharaeian, Behrouz; Diaz, Alberto; Chitsaz, Hamidreza			Enhancing Extraction of Drug-Drug Interaction from Literature Using Neutral Candidates, Negation, and Clause Dependency	PLOS ONE			English	Article								Motivation Supervised biomedical relation extraction plays an important role in biomedical natural language processing, endeavoring to obtain the relations between biomedical entities. Drug-drug interactions, which are investigated in the present paper, are notably among the critical biomedical relations. Thus far many methods have been developed with the aim of extracting DDI relations. However, unfortunately there has been a scarcity of comprehensive studies on the effects of negation, complex sentences, clause dependency, and neutral candidates in the course of DDI extraction from biomedical articles. Results Our study proposes clause dependency features and a number of features for identifying neutral candidates as well as negation cues and scopes. Furthermore, our experiments indicate that the proposed features significantly improve the performance of the relation extraction task combined with other kernel methods. We characterize the contribution of each category of features and finally conclude that neutral candidate features have the most prominent role among all of the three categories.	[Bokharaeian, Behrouz; Diaz, Alberto] Univ Complutense Madrid, NIL Grp, Ciudad Univ,Calle Prof Jose Garcia Santesmases, E-28040 Madrid, Spain; [Chitsaz, Hamidreza] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA	Complutense University of Madrid; Colorado State University	Bokharaeian, B (corresponding author), Univ Complutense Madrid, NIL Grp, Ciudad Univ,Calle Prof Jose Garcia Santesmases, E-28040 Madrid, Spain.	behroubo@ucm.es	Bokharaeian, Behrouz/AAA-5978-2022	Bokharaeian, Behrouz/0000-0002-3687-5568; DIAZ ESTEBAN, ALBERTO/0000-0003-1966-3421				Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; [Anonymous], 2006, EACL; [Anonymous], 2015, PATTERN JAVA PLATFOR; Bokharaeian B., 2015, 4 JOINT IR C FUZZ IN; Bokharaeian B., 2014, P 4 WORKSH BUILD EV; Chowdhury M.F.M., 2013, FBK IRST MULTIPHASE, V351, P53; Faisal M., 2013, HLTNAACL13; Frunza O., 2010, P 2010 WORKSH BIOM N; He LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065814; JOACHIMS T, 1999, MAKING LARGE SCALE S; Kim S, 2015, J BIOMED INFORM, V55, P23, DOI 10.1016/j.jbi.2015.03.002; Konstantinova N., 2012, P 8 INT C LANG RES E; Krallinger M., 2010, NESP NLP 10 P WORKSH; Lappin S., 1994, Computational Linguistics, V20, P535; Loos Eugene E., 2004, GLOSSARY LINGUISTIC; McClosky D., 2011, P BIONLP SHAR TASK 2; McDonald R, 2005, EXTRACTING RELATIONS; Miwa M., 2010, P 23 INT C COMP LING; Mooney Raymond, 2005, ADV NEURAL INFORM PR; Morante R., 2012, SEM 2012 1 JOINT C L; Morante R., 2012, SEM 2012 1 JOINT C L, V2; Peng Y., 2012, BIOINF BIOM BIBM 201; Rowan M, 1989, J BASIC WRITING, P21; Schmid H., 1995, INSTITUT F UR MASCHI, V43, P28; Segura-Bedmar I, 2013, 2 JOINT C LEX COMP S, V2; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Siddharthan A., 2014, INT J APPL LINGUISTI, P259, DOI [10.1075/itl.165.2.06sid, DOI 10.1075/ITL.165.2.06SID]; Szarvas Gyorgy, 2008, P WORKSH CURR TRENDS; Thomas P., 2013, 2 JOINT C LEX COMP S; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Velldal E, 2012, COMPUT LINGUIST, V38, P369, DOI 10.1162/COLI_a_00126; Vincze Veronika, 2011, J Biomed Semantics, V2 Suppl 5, pS8, DOI 10.1186/2041-1480-2-S5-S8; VISHWANATHAN SVN, 2003, ADV NEURAL INFORM PR, V15; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163480	10.1371/journal.pone.0163480	http://dx.doi.org/10.1371/journal.pone.0163480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695078	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100036
J	Groot-Kormelink, PJ; Ferrand, S; Kelley, N; Bill, A; Freuler, F; Imbert, PE; Marelli, A; Gerwin, N; Sivilotti, LG; Miraglia, L; Orth, AP; Oakeley, EJ; Schopfer, U; Siehler, S				Groot-Kormelink, Paul J.; Ferrand, Sandrine; Kelley, Nicholas; Bill, Anke; Freuler, Felix; Imbert, Pierre-Eloi; Marelli, Anthony; Gerwin, Nicole; Sivilotti, Lucia G.; Miraglia, Loren; Orth, Anthony P.; Oakeley, Edward J.; Schopfer, Ulrich; Siehler, Sandra			High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							ALPHA-SUBUNIT; BINDING-SITE; SELECTIVITY; DISEASE; IDENTIFICATION; PHARMACOLOGY; TRAFFICKING; RESOLUTION; MECHANISM; RESIDUES	High throughput random mutagenesis is a powerful tool to identify which residues are important for the function of a protein, and gain insight into its structure-function relation. The human muscle nicotinic acetylcholine receptor was used to test whether this technique previously used for monomeric receptors can be applied to a pentameric ligand-gated ion channel. A mutant library for the alpha 1 subunit of the channel was generated by error-prone PCR, and full length sequences of all 2816 mutants were retrieved using single molecule real time sequencing. Each a1 mutant was co-transfected with wildtype beta 1, delta, and epsilon subunits, and the channel function characterized by an ion flux assay. To test whether the strategy could map the structure-function relation of this receptor, we attempted to identify mutations that conferred resistance to competitive antagonists. Mutant hits were defined as receptors that responded to the nicotinic agonist epibatidine, but were not inhibited by either a-bungarotoxin or tubocurarine. Eight a1 subunit mutant hits were identified, six of which contained mutations at position Y233 or V275 in the transmembrane domain. Three single point mutations (Y233N, Y233H, and V275M) were studied further, and found to enhance the potencies of five channel agonists tested. This suggests that the mutations made the channel resistant to the antagonists, not by impairing antagonist binding, but rather by producing a gain-of-function phenotype, e.g. increased agonist sensitivity. Our data show that random high throughput mutagenesis is applicable to multimeric proteins to discover novel functional mutants, and outlines the benefits of using single molecule real time sequencing with regards to quality control of the mutant library as well as downstream mutant data interpretation.	[Groot-Kormelink, Paul J.; Gerwin, Nicole] Novartis Inst BioMed Res, Musculoskeletal Dis Area, Basel, Switzerland; [Ferrand, Sandrine; Freuler, Felix; Imbert, Pierre-Eloi; Schopfer, Ulrich; Siehler, Sandra] Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland; [Kelley, Nicholas; Oakeley, Edward J.] Novartis Inst BioMed Res, Analyt Sci & Imaging, Basel, Switzerland; [Bill, Anke] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Marelli, Anthony; Miraglia, Loren; Orth, Anthony P.] Novartis Res Fdn, Novartis Inst BioMed Res, Genom Inst, San Diego, CA USA; [Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Novartis; Novartis; Novartis; Novartis; Novartis; University of London; University College London	Siehler, S (corresponding author), Novartis Inst BioMed Res, Ctr Prote Chem, Basel, Switzerland.	sandra.siehler@novartis.com		Bill, Anke/0000-0003-1244-7574; Sivilotti, Lucia/0000-0003-2510-8424	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	The work was funded by the Novartis Institutes for BioMedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BEESON D, 1990, EMBO J, V9, P2101, DOI 10.1002/j.1460-2075.1990.tb07378.x; Bill A, 2015, J BIOL CHEM, V290, P889, DOI 10.1074/jbc.M114.618140; Bill A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097973; Brams M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001034; Briggs CA, 1999, EUR J PHARMACOL, V366, P301, DOI 10.1016/S0014-2999(98)00909-1; Buschmann T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-264; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; Engel AG, 1999, ARCH NEUROL-CHICAGO, V56, P163, DOI 10.1001/archneur.56.2.163; Guo XG, 2015, G3-GENES GENOM GENET, V5, P2801, DOI 10.1534/g3.115.023317; KOPTA C, 1994, J NEUROSCI, V14, P3922; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; Michelmore S, 2002, N-S ARCH PHARMACOL, V366, P235, DOI 10.1007/s00210-002-0589-z; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; Prince RJ, 1998, J BIOL CHEM, V273, P7843, DOI 10.1074/jbc.273.14.7843; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Shen XM, 2016, HUM MUTAT, DOI [10.2002/humu.23043, DOI 10.2002/HUMU.23043]; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Wan HS, 2012, ANAL BIOCHEM, V420, P163, DOI 10.1016/j.ab.2011.09.019; Wang HL, 2003, J BIOL CHEM, V278, P32284, DOI 10.1074/jbc.M304366200; Wenningmann I, 2001, MOL PHARMACOL, V60, P790	32	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163129	10.1371/journal.pone.0163129	http://dx.doi.org/10.1371/journal.pone.0163129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649498	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100058
J	Ogasawara, S; Chiba, T; Motoyama, T; Kanogawa, N; Saito, T; Shinozaki, Y; Suzuki, E; Ooka, Y; Tawada, A; Kato, H; Okabe, S; Kanai, F; Yoshikawa, M; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Motoyama, Tenyu; Kanogawa, Naoya; Saito, Tomoko; Shinozaki, Yusuke; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Kato, Hideyuki; Okabe, Shinichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu			Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							ENHANCED MRI; ADENOMATOUS HYPERPLASIA; CT; HYPOINTENSE; DEVELOP	Background Hypovascular nodules often occur together with hypervascular hepatocellular carcinoma (HCC). However, it remains controversial whether hypovascular nodules associated with hypervascular HCC have any prognostic value. This study evaluated the prognostic impact of hypovascular nodules co-existing with hypervascular HCC as diagnosed by computed tomography during arterial portography (CTAP) and computed tomography during hepatic arteriography (CTHA), which can sensitively capture the dynamic changes in blood flow through the portal vein and hepatic artery in patients with early stage HCC. Methods A total of 152 patients with hypervascular HCC (<= 30 mm, <= 3 nodules), who underwent initial local ablation, were analyzed retrospectively. All patients received CTAP and CTHA prior to treatment. Overall survival (OS) was compared among group A (hypervascular HCC only, 107 patients) and group B (hypovascular nodules and hypervascular HCC, 45 patients). Results Among all hypovascular nodules, 81% (46 of 57) developed hypervascularization within the follow-up period. The 1-and 2-year hypervascularization rates were 17% and 51%, respectively. OS was significantly longer for group A than for group B (P < 0.001). A Cox proportional-hazards model identified the presence of hypovascular nodules concurrent with hypervascular HCC as an independent poor prognostic factor. Conclusion The prognosis of hypervascular HCC patients with hypovascular nodules detected during CTAP and CTHA is poor. Clinical HCC categories seem to be dissimilar between patients with and without hypovascular nodules.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Motoyama, Tenyu; Kanogawa, Naoya; Saito, Tomoko; Shinozaki, Yusuke; Suzuki, Eiichiro; Ooka, Yoshihiko; Tawada, Akinobu; Okabe, Shinichiro; Kanai, Fumihiko; Yoshikawa, Masaharu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Kato, Hideyuki] Chiba Univ Hosp, Dept Radiol, Chiba, Japan	Chiba University; Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064				Bruix J, 2011, HEPATOLOGY, V54, P2238, DOI 10.1002/hep.24670; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Inoue T, 2013, DIGEST DIS, V31, P472, DOI 10.1159/000355248; Kobayashi M, 2006, CANCER-AM CANCER SOC, V106, P636, DOI 10.1002/cncr.21607; Komatsu N, 2014, HEPATOL RES, V44, P1339, DOI 10.1111/hepr.12309; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kudo M, 2010, HEPATOL RES, V40, P686, DOI 10.1111/j.1872-034X.2010.00674.x; MATSUI O, 1991, RADIOLOGY, V178, P493, DOI 10.1148/radiology.178.2.1846240; Midorikawa Y, 2013, J HEPATOL, V58, P306, DOI 10.1016/j.jhep.2012.09.026; Ogasawara S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125244; Ooka Y, 2013, MAGN RESON IMAGING, V31, P748, DOI 10.1016/j.mri.2012.10.028; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; TAKAYASU K, 1995, RADIOLOGY, V194, P101, DOI 10.1148/radiology.194.1.7997534; Toyoda H, 2013, J HEPATOL, V58, P1174, DOI 10.1016/j.jhep.2013.01.030; UNOURA M, 1993, HEPATO-GASTROENTEROL, V40, P305; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163119	10.1371/journal.pone.0163119	http://dx.doi.org/10.1371/journal.pone.0163119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649084	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100055
J	Fields, JB; Nemeth-Cahalan, KL; Freites, JA; Vorontsova, I; Hall, JE; Tobias, DJ				Fields, James B.; Nemeth-Cahalan, Karin L.; Freites, J. Alfredo; Vorontsova, Irene; Hall, James E.; Tobias, Douglas J.			Calmodulin Gates Aquaporin 0 Permeability through a Positively Charged Cytoplasmic Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWNIAN DYNAMICS SIMULATIONS; PROTEIN-PROTEIN ASSOCIATION; MOLECULAR-DYNAMICS; WATER-CHANNEL; HYDRODYNAMIC INTERACTIONS; ELECTRON-TRANSFER; STRUCTURAL BASIS; HUMAN LENS; MEMBRANE; PHOSPHORYLATION	Aquaporin 0 (AQP0), the major intrinsic protein of the eye lens, plays a vital role in maintaining lens clarity by facilitating the transport of water across lens fiber cell membranes. AQP0 reduces its osmotic water permeability constant (P-f) in response to increases in the external calcium concentration, an effect that is mediated by an interaction with the calcium-binding messenger protein, calmodulin (CaM), and phosphorylation of the CaM-binding site abolishes calcium sensitivity. Despite recent structural characterization of the AQP0-CaM complex, the mechanism by which CaM modulates AQP0 remains poorly understood. By combining atomistic molecular dynamics simulations and oocyte permeability assays, we conclude that serine phosphorylation of AQP0 does not inhibit CaM binding to the whole AQP0 protein. Instead, AQP0 phosphorylation alters calcium sensitivity by modifying the AQP0-CaM interaction interface, particularly at an arginine-rich loop that connects the fourth and fifth transmembrane helices. This previously unexplored loop, which sits outside of the canonical CaM-binding site on the AQP0 cytosolic face, mechanically couples CaM to the pore-gating residues of the second constriction site. We show that this allosteric loop is vital for CaM regulation of the channels, facilitating cooperativity between adjacent subunits and regulating factors such as serine phosphorylation. Similar allosteric interactions may also mediate CaM modulation of the properties of other CaM-regulated proteins.	[Fields, James B.; Freites, J. Alfredo; Tobias, Douglas J.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Nemeth-Cahalan, Karin L.; Vorontsova, Irene; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Tobias, DJ (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA.; Hall, JE (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	jhall@uci.edu; dtobias@uci.edu	Freites, J. Alfredo/S-8027-2017; Tobias, Douglas J/B-6799-2015	Freites, J. Alfredo/0000-0001-5842-7443; Vorontsova, Irene/0000-0002-3793-9201; Tobias, Douglas/0000-0002-6971-9828	National Science Foundation [ACI-1053575]; NATIONAL EYE INSTITUTE [R01EY005661] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We acknowledge all of the members of the Hall and Tobias laboratories that participated in many thoughtful discussions throughout this collaboration, in particular Matthias Heyden and Eric K. Wong, who helped to facilitate the computational portion of this research. We also thank Nathan Crawford and Joseph Farran for outstanding computational support. This work used computing resources through the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1053575.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Benson NC, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012500084; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; BLOEMENDAL H, 1972, Cell Differentiation, V1, P91, DOI 10.1016/0045-6039(72)90032-2; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chepelinsky AB, 2003, J EXP ZOOL PART A, V300A, P41, DOI 10.1002/jez.a.10307; Cormen T. H., 2009, INTRO ALGORITHMS, P693; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fields JB, 2015, BIOCHEMISTRY-US, V54, P7272, DOI 10.1021/acs.biochem.5b00569; Flock D, 2004, BIOPHYS J, V87, P65, DOI 10.1529/biophysj.103.035261; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Frembgen-Kesner T, 2010, BIOPHYS J, V99, pL75, DOI 10.1016/j.bpj.2010.09.006; Frick A, 2014, P NATL ACAD SCI USA, V111, P6305, DOI 10.1073/pnas.1321406111; Gabdoulline RR, 2009, J AM CHEM SOC, V131, P9230, DOI 10.1021/ja809567k; Gabdoulline RR, 2001, J MOL BIOL, V306, P1139, DOI 10.1006/jmbi.2000.4404; Gabdoulline RR, 1996, J PHYS CHEM-US, V100, P3868, DOI 10.1021/jp953109f; Gabdoulline RR, 1998, METHODS, V14, P329, DOI 10.1006/meth.1998.0588; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Golestaneh N, 2008, MOL VIS, V14, P1006; Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Gorba C, 2004, J CHEM PHYS, V121, P457, DOI 10.1063/1.1755668; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Kalman K, 2008, J BIOL CHEM, V283, P21278, DOI 10.1074/jbc.M801740200; Kitchen P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143027; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lin H, 2007, MOL VIS, V13, P1822; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez M, 2015, J COMPUT CHEM, V36, P1631, DOI 10.1002/jcc.23971; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Novotny J, 1997, J MOL BIOL, V268, P401, DOI 10.1006/jmbi.1997.0961; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rabaud NE, 2009, BIOCHEM BIOPH RES CO, V383, P54, DOI 10.1016/j.bbrc.2009.03.128; Rankin W. T., 1995, Proceedings of the Fourth IEEE International Symposium on High Performance Distributed Computing (Cat. No.95TB8075), P17, DOI 10.1109/HPDC.1995.518690; Reichow SL, 2008, STRUCTURE, V16, P1389, DOI 10.1016/j.str.2008.06.011; Reichow SL, 2013, NAT STRUCT MOL BIOL, V20, P1085, DOI 10.1038/nsmb.2630; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schilder J, 2013, CURR OPIN STRUC BIOL, V23, P911, DOI 10.1016/j.sbi.2013.07.009; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Team R. D. C., 2008, R LANG ENV STAT COMP; Wolfram Research, 2015, MATHEMATICA; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yu YB, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-6; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	59	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					185	195		10.1074/jbc.M116.743724	http://dx.doi.org/10.1074/jbc.M116.743724			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27660387	Green Published, hybrid			2022-12-26	WOS:000391578000016
J	Khariv, V; Ni, L; Ratnayake, A; Sampath, S; Lutz, BM; Tao, XX; Heary, RF; Elkabes, S				Khariv, Veronika; Ni, Li; Ratnayake, Ayomi; Sampath, Sujitha; Lutz, Brianna M.; Tao, Xuan-Xiang; Heary, Robert F.; Elkabes, Stella			Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception	FASEB JOURNAL			English	Article						ATP2b2; sensory function; spinal cord; glutamate; GABA	SPINAL GLUTAMATE TRANSPORTERS; NEUROPATHIC PAIN; DORSAL-HORN; NERVE INJURY; GENE-EXPRESSION; AMPA RECEPTORS; THERMAL HYPERALGESIA; GENDER-DIFFERENCES; INFLAMMATORY PAIN; GABA(B) RECEPTORS	Plasma membrane calcium ATPase 2 (PMCA2) is a calcium pump that plays important roles in neuronal function. Although it is expressed in pain-associated regions of the CNS, including in the dorsal horn (DH), its contribution to pain remains undefined. The present study assessed the role of PMCA2 in pain responsiveness and the link between PMCA2 and glutamate receptors, GABA receptors (GABARs), and glutamate transporters that have been implicated in pain processing in the DH of adult female and male PMCA2(+/+) and PMCA2(+/-) 2 mice. Behavioral assays evaluated mechanical and thermal pain responsiveness. Mechanical sensitivity was significantly increased by 52% and heat sensitivity was reduced by 29% in female, but not male, PMCA2(+/-) 2 mice compared with PMCA2(+/+) controls. There were female-specific changes in metabotropic glutamate receptor 1, NMDA receptor 2A, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluR1, GABA(B)R1, and GABA(B)R2 levels, whereas metabotropic glutamate receptor 5, NMDA receptor 2B, GluR2, and GABA(A)R alpha 2 levels were not altered. Glutamate aspartate transporter levels were higher and glial glutamate transporter 1 levels were lower in the DH of female, but not male, PMCA2(+/-) 2 mice. These findings indicate a novel role for PMCA2 in modality- and sex-dependent pain responsiveness. Female-specific molecular changes potentially account for the altered pain responses.-Khariv, V., Ni, L., Ratnayake, A., Sampath, S., Lutz, B. M., Tao, X.-X., Heary, R. F., Elkabes, S. Impaired sensitivity to pain stimuli inplasmamembrane calciumATPase 2 (PMCA2) heterozygous mice: a possible modality and sex-specific role for PMCA2 in nociception.	[Khariv, Veronika; Ni, Li; Ratnayake, Ayomi; Sampath, Sujitha; Heary, Robert F.; Elkabes, Stella] State Univ New Jersey, New Jersey Med Sch Rutgers, Dept Neurol Surg, Reynolds Family Spine Lab, Newark, NJ USA; [Lutz, Brianna M.; Tao, Xuan-Xiang] State Univ New Jersey, New Jersey Med Sch Rutgers, Dept Anesthesiol, Newark, NJ USA; [Khariv, Veronika; Lutz, Brianna M.] State Univ New Jersey, New Jersey Med Sch Rutgers, Grad Sch Biomed Sci, Newark, NJ USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Elkabes, S (corresponding author), State Univ New Jersey, New Jersey Med Sch Rutgers, 205 South Orange Ave,Canc Ctr F-1204, Newark, NJ 07103 USA.	elkabest@njms.rutgers.edu	Elkabes, Stella/AAR-8212-2020; Elkabes, Stella/H-7823-2019	Elkabes, Stella/0000-0003-3513-8088	Reynolds Family Spine Laboratory Funds; U.S. National Institutes of Health [DA033390, NS094664, NS094224, HL117684]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094664, F31NS092310, R01NS094224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033390] Funding Source: NIH RePORTER	Reynolds Family Spine Laboratory Funds; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Reynolds Family Spine Laboratory Funds and by U.S. National Institutes of Health Grants DA033390 (National Institute on Drug Abuse), NS094664 and NS094224 (National Institute of Neurological Disorders and Stroke), and HL117684 (National Heart, Lung, and Blood Institute). G. Shull, Ph.D. (University of Cincinnati, College of Medicine, Cincinnati, OH, USA), first established PMCA2<SUP>+/-</SUP> and PMCA2<SUP>+/+</SUP> mice. The authors declare no conflicts of interest.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P473, DOI 10.1017/S0140525X97591497; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Binns BC, 2005, BRAIN RES, V1041, P38, DOI 10.1016/j.brainres.2005.01.088; BONANNO G, 1992, J PHARMACOL EXP THER, V262, P114; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRANDT P, 1992, J BIOL CHEM, V267, P4376; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; CAGGIULA AR, 1995, PSYCHOPHARMACOLOGY, V122, P301, DOI 10.1007/BF02246552; Cavaliere C, 2007, NEURON GLIA BIOL, V3, P141, DOI 10.1017/S1740925X07000695; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; COYLE DE, 1995, NEUROSCI LETT, V186, P135, DOI 10.1016/0304-3940(95)11304-F; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeLeo JA, 2006, J BONE JOINT SURG AM, V88A, P58, DOI 10.2106/JBJS.E.01286; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Eljaja L, 2011, SCAND J PAIN, V2, P132, DOI 10.1016/j.sjpain.2011.03.003; Engelman HS, 1999, J NEUROSCI, V19, P2081; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Falnikar A, 2016, GLIA, V64, P396, DOI 10.1002/glia.22936; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Fisher K, 1998, NEUROREPORT, V9, P1169, DOI 10.1097/00001756-199804200-00038; Fisher K, 1996, PAIN, V68, P255, DOI 10.1016/S0304-3959(96)03212-5; Fritschy JM, 2014, EUR J NEUROSCI, V39, P1845, DOI 10.1111/ejn.12534; Fundytus ME, 2001, CNS DRUGS, V15, P29, DOI 10.2165/00023210-200115010-00004; Fundytus ME, 2001, BRIT J PHARMACOL, V132, P354, DOI 10.1038/sj.bjp.0703810; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Garcia Michael L., 1999, Frontiers in Bioscience, V4, pd869, DOI 10.2741/Garcia; Garry EA, 2004, PAIN, V109, P210, DOI 10.1016/j.pain.2004.04.002; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; HALEY JE, 1990, BRAIN RES, V518, P218, DOI 10.1016/0006-8993(90)90975-H; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heidinger V, 2002, J NEUROSCI, V22, P5452; Hobo S, 2011, NEUROSCI LETT, V502, P52, DOI 10.1016/j.neulet.2011.07.023; Hu YY, 2010, PAIN, V148, P284, DOI 10.1016/j.pain.2009.11.014; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; JAKOWEC MW, 1995, NEUROSCIENCE, V67, P909, DOI 10.1016/0306-4522(95)00094-Y; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kayser V, 1996, BRAIN RES, V742, P352, DOI 10.1016/S0006-8993(96)01108-0; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kroner-Herwig Birgit, 2012, Psychosoc Med, V9, pDoc01, DOI 10.3205/psm000079; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Kurnellas MP, 2010, CELL DEATH DIFFER, V17, P1501, DOI 10.1038/cdd.2010.54; Kurnellas MP, 2007, MOL CELL NEUROSCI, V34, P178, DOI 10.1016/j.mcn.2006.10.010; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Liaw WJ, 2005, PAIN, V115, P60, DOI 10.1016/j.pain.2005.02.006; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; MAO J, 1992, BRAIN RES, V598, P271, DOI 10.1016/0006-8993(92)90193-D; McCarson KE, 1999, NEUROPHARMACOLOGY, V38, P1767, DOI 10.1016/S0028-3908(99)00121-5; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; MOGIL JS, 1993, PAIN, V53, P17, DOI 10.1016/0304-3959(93)90050-Y; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Nicot A, 2003, BRAIN, V126, P398, DOI 10.1093/brain/awg041; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; POTASHNER SJ, 1984, J NEUROCHEM, V42, P1135, DOI 10.1111/j.1471-4159.1984.tb12722.x; Putatunda R, 2014, BRAIN RES, V1581, P64, DOI 10.1016/j.brainres.2014.05.003; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sevostianova N, 2006, NEUROPHARMACOLOGY, V51, P623, DOI 10.1016/j.neuropharm.2006.05.004; Sorkin LS, 2001, ANESTHESIOLOGY, V95, P965, DOI 10.1097/00000542-200110000-00028; Sorkin LS, 1999, NEUROREPORT, V10, P3523, DOI 10.1097/00001756-199911260-00011; Souayah N, 2008, EXP NEUROL, V214, P341, DOI 10.1016/j.expneurol.2008.09.002; Spike RC, 1998, EUR J NEUROSCI, V10, P324, DOI 10.1046/j.1460-9568.1998.00048.x; Sung BK, 2003, J NEUROSCI, V23, P2899; Swanson RA, 1997, J NEUROSCI, V17, P932; Tabatadze N, 2015, J NEUROSCI, V35, P11252, DOI 10.1523/JNEUROSCI.1067-15.2015; Tao YX, 2010, ANESTHESIOLOGY, V112, P1259, DOI 10.1097/ALN.0b013e3181d3e1ed; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011; Wu JZ, 2011, NEUROIMMUNOMODULAT, V18, P150, DOI 10.1159/000323141; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Young MR, 1998, J NEUROSCI, V18, P10180; Yowtak J, 2013, PAIN, V154, P2469, DOI 10.1016/j.pain.2013.07.024; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	92	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					224	237		10.1096/fj.201600541R	http://dx.doi.org/10.1096/fj.201600541R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27702770	Green Published			2022-12-26	WOS:000392177600023
J	Bahng, S; Hayama, R; Marians, KJ				Bahng, Soon; Hayama, Ryo; Marians, Kenneth J.			MukB-mediated Catenation of DNA Is ATP and MukEF Independent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA; DNA binding protein; DNA structure; DNA topology; nucleic acid enzymology; DNA enzymes	BACTERIAL CONDENSIN MUKB; ESCHERICHIA-COLI; TOPOISOMERASE-IV; IN-VITRO; MAGNESIUM CONTENT; CHROMOSOME; COMPLEX; PROTEINS; IDENTIFICATION; LOCALIZATION	Properly condensed chromosomes are necessary for accurate segregation of the sisters after DNA replication. The Escherichia coli condesin is MukB, a structural maintenance of chromosomes (SMC)-like protein, which forms a complex with MukE and the kleisin MukF. MukB is known to be able to mediate knotting of a DNA ring, an intramolecular reaction. In our investigations of how MukB condenses DNA we discovered that it can also mediate catenation of two DNA rings, an intermolecular reaction. This activity of MukB requires DNA binding by the head domains of the protein but does not require either ATP or its partner proteins MukE or MukF. The ability of MukB to mediate DNA catenation underscores its potential for bringing distal regions of a chromosome together.	[Bahng, Soon; Hayama, Ryo; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Hayama, Ryo] Rockefeller Univ, Lab Cellular & Struct Biol, 1230 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Marians, KJ (corresponding author), 1275 York Ave, New York, NY 10065 USA.	mariansk@mskcc.org		Hayama, Ryo/0000-0001-8706-213X	National Institutes of Health [GM34558]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K.J.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Chen N, 2008, J BACTERIOL, V190, P3731, DOI 10.1128/JB.01863-07; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; Elbatsh AMO, 2016, MOL CELL, V61, P575, DOI 10.1016/j.molcel.2016.01.025; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hayama R, 2013, J BIOL CHEM, V288, P7653, DOI 10.1074/jbc.M112.418087; Hayama Ryo, 2010, Proc Natl Acad Sci U S A, V107, P18826, DOI 10.1073/pnas.1008140107; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; HIRAGA S, 1991, RES MICROBIOL, V142, P189, DOI 10.1016/0923-2508(91)90029-A; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KRASNOW MA, 1982, J BIOL CHEM, V257, P2687; Li YY, 2010, P NATL ACAD SCI USA, V107, P18832, DOI 10.1073/pnas.1008678107; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Mascarenhas J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-28; MONCANY MLJ, 1981, EXPERIENTIA, V37, P846, DOI 10.1007/BF01985672; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; Niki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29469; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Petrushenko ZM, 2006, J BIOL CHEM, V281, P34208, DOI 10.1074/jbc.M606723200; Petrushenko ZM, 2010, EMBO J, V29, P1126, DOI 10.1038/emboj.2009.414; Pong H, 1999, METH MOL B, V94, P163; She WF, 2007, J BACTERIOL, V189, P7062, DOI 10.1128/JB.00770-07; Shin HC, 2009, FEBS J, V276, P5101, DOI 10.1111/j.1742-4658.2009.07206.x; Sun MX, 2013, NUCLEIC ACIDS RES, V41, P6149, DOI 10.1093/nar/gkt303; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Ullsperger C, 1996, J BIOL CHEM, V271, P31549, DOI 10.1074/jbc.271.49.31549; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamazoe M, 1999, EMBO J, V18, P5873, DOI 10.1093/emboj/18.21.5873	36	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23999	24008		10.1074/jbc.M116.749994	http://dx.doi.org/10.1074/jbc.M116.749994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697840	hybrid, Green Published			2022-12-26	WOS:000388498100016
J	AbdelKhalek, A; Ashby, CR; Patel, BA; Talele, TT; Seleem, MN				AbdelKhalek, Ahmed; Ashby, Charles R., Jr.; Patel, Bhargav A.; Talele, Tanaji T.; Seleem, Mohamed N.			In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; (Z)-5-ARYLMETHYLIDENE RHODANINES; STAPHYLOCOCCAL INFECTIONS; DAPTOMYCIN; DRUGS	Bacterial infections present a serious challenge to healthcare practitioners due to the emergence of resistance to numerous conventional antibacterial drugs. Therefore, new bacterial targets and new antimicrobials are unmet medical needs. Rhodanine derivatives have been shown to possess potent antimicrobial activity via a novel mechanism. However, their potential use as antibacterials has not been fully examined. In this study, we determined the spectrum of activity of seven rhodanine derivatives (compounds Rh 1-7) against clinical isolates of Gram-positive and Gram-negative bacterial strains and Candida albicans. We also synthesized and tested three additional compounds, ethyl ester and amide of rhodanine 2 (Rh 8 and Rh 10, respectively) and ethyl ester of rhodanine 3 (Rh 9) to determine the significance of the carboxyl group modification towards antibacterial activity and human serum albumin binding. A broth microdilution assay confirmed Rh 1-7 exhibit bactericidal activity against Gram-positive pathogens. Rh 2 had significant activity against various vancomycin-resistant (MIC90 = 4 mu M) and methicillin-resistant (MIC90 = 4 mu M) Staphylococcus aureus (VRSA and MRSA), Staphylococcus epidermidis (MIC = 4 mu M) and vancomycin-resistant Enterococcus (VRE) strains (MIC90 = 8 mu M). The rhodanine compounds exhibited potent activity against Bacillus spp., including Bacillus anthracis, with MIC range of 2-8 mu M. In addition, they had potent activity against Clostridium difficile. The most potent compound, Rh 2, at 4 and 8 times its MIC, significantly decreased S. epidermidis biofilm mass by more than 35% and 45%, respectively. None of the rhodanine compounds showed antimicrobial activity (MIC > 128 mu M) against various 1) Gram-negative pathogens (Acinetobacter baumannii, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Salmonella Typhimurium) or 2) strains of Candida albicans (MIC > 64 mu M). The MTS assay confirmed that rhodanines were not toxic to mouse murine macrophage (J774.1A) up to 64 mu M, human keratinocytes (HaCat) up to 32 mu M, and human ileocecal colorectal cell (HRT-18) up to 128 mu M. Overall, these data suggest that certain rhodanine compounds may have potential use for the treatment of several multidrug-resistant Gram-positive bacterial infections.	[AbdelKhalek, Ahmed; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathol, 625 Harrison St, W Lafayette, IN 47907 USA; [Ashby, Charles R., Jr.; Patel, Bhargav A.; Talele, Tanaji T.] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Seleem, Mohamed N.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Saint John's University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathol, 625 Harrison St, W Lafayette, IN 47907 USA.; Talele, TT (corresponding author), St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.; Seleem, MN (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	talelet@stjohns.edu; mseleem@purdue.edu	Patel, Bhargav/H-5563-2018; Seleem, Mohamed/H-2774-2018	Patel, Bhargav/0000-0002-0859-3803; Seleem, Mohamed/0000-0003-0939-0458	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R56AI114861]; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH [HHSN272200700055C]	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R56AI114861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract # HHSN272200700055C and BEI resources for providing S. aureus strains used in this study. We thank Dr. Alex O'Neill, University of Leeds, for providing the Escherichia coli SM1411 Delta acrAB strain.	Aldeghi M, 2014, CHEM BIOL DRUG DES, V83, P450, DOI 10.1111/cbdd.12260; [Anonymous], 2011, ADMET MED CHEM PRACT; CHRISTENSEN GD, 1982, ANN INTERN MED, V96, P1, DOI 10.7326/0003-4819-96-1-1; Clinical and Laboratory Standards Institute, 2012, M7A9 NCCLS CLSI; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Dolezel J, 2009, MOLECULES, V14, P4197, DOI 10.3390/molecules14104197; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Kamboj M, 2011, CLIN INFECT DIS, V53, P1003, DOI 10.1093/cid/cir643; Mohammad H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130385; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Patel BA, 2013, BIOORG MED CHEM LETT, V23, P5523, DOI 10.1016/j.bmcl.2013.08.059; Patel BA, 2013, BIOORGAN MED CHEM, V21, P3262, DOI 10.1016/j.bmc.2013.03.041; Randall CP, 2013, ANTIMICROB AGENTS CH, V57, P637, DOI 10.1128/AAC.02005-12; Singh SR, 2009, ANTIMICROB AGENTS CH, V53, P4495, DOI 10.1128/AAC.00237-09; Thangamani S, 2016, INT J ANTIMICROB AG, V47, P195, DOI 10.1016/j.ijantimicag.2015.12.016; Thangamani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22571; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; VILJANEN P, 1984, ANTIMICROB AGENTS CH, V25, P701, DOI 10.1128/AAC.25.6.701; Werner MM, 2015, BIOORGAN MED CHEM, V23, P6125, DOI 10.1016/j.bmc.2015.08.004	21	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164227	10.1371/journal.pone.0164227	http://dx.doi.org/10.1371/journal.pone.0164227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711156	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600100
J	Figueroa-Bonaparte, S; Segovia, S; Llauger, J; Belmonte, I; Pedrosa, I; Alejaldre, A; Mayos, M; Suarez-Cuartin, G; Gallardo, E; Illa, I; Diaz-Manera, J				Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Llauger, Jaume; Belmonte, Izaskun; Pedrosa, Irene; Alejaldre, Aida; Mayos, Merce; Suarez-Cuartin, Guillermo; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi		Spanish Pompe Study Grp	Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ENZYME REPLACEMENT THERAPY; ALGLUCOSIDASE ALPHA; INVOLVEMENT; PROGRESSION; MYOPATHIES; GUIDELINES; PATTERNS; DIXON; BOYS	Objectives Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD). The discovery of biomarkers useful for monitoring disease progression is one of the priority research topics in Pompe disease. Muscle MRI could be one possible test but the correlation between muscle MRI and muscle strength and function has been only partially addressed so far. Methods We studied 34 AOPD patients using functional scales (Manual Research Council scale, hand held myometry, 6 minutes walking test, timed to up and go test, time to climb up and down 4 steps, time to walk 10 meters and Motor Function Measure 20 Scale), respiratory tests (Forced Vital Capacity seated and lying, Maximun Inspiratory Pressure and Maximum Expiratory Pressure), daily live activities scales (Activlim) and quality of life scales (Short Form-36 and Individualized Neuromuscular Quality of Life questionnaire). We performed a whole body muscle MRI using T1w and 3-point Dixon imaging centered on thighs and lower trunk region. Results T1w whole body muscle MRI showed a homogeneous pattern of muscle involvement that could also be found in pre-symptomatic individuals. We found a strong correlation between muscle strength, muscle functional scales and the degree of muscle fatty replacement in muscle MRI analyzed using T1w and 3-point Dixon imaging studies. Moreover, muscle MRI detected mild degree of fatty replacement in paraspinal muscles in pre-symptomatic patients. Conclusion Based on our findings, we consider that muscle MRI correlates with muscle function in patients with AOPD and could be useful for diagnosis and follow-up in pre-symptomatic and symptomatic patients under treatment. Take home message Muscle MRI correlates with muscle function in patients with AOPD and could be useful to follow-up patients in daily clinic.	[Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Alejaldre, Aida; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi] Univ Autonoma Barcelona, Neuromuscular Disorders Unit, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Alejaldre, Aida; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi] Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain; [Llauger, Jaume] Univ Autonoma Barcelona, Dept Radiol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Belmonte, Izaskun; Pedrosa, Irene] Univ Autonoma Barcelona, Rehabil & Physiotherapy Dept, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Mayos, Merce; Suarez-Cuartin, Guillermo] Univ Autonoma Barcelona, Dept Resp Dis, Hosp Santa Creu & St Pau Barcelona, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Diaz-Manera, J (corresponding author), Univ Autonoma Barcelona, Neuromuscular Disorders Unit, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain.; Diaz-Manera, J (corresponding author), Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain.	jdiazm@santpau.cat	ILLA, Isabel/AAD-1816-2019; Coll-Canti, Jaume/N-5591-2019; Coll-Canti, Jaume/N-6693-2015; IBIS, NEUROCIENCIAS/C-2262-2016; Moris, German/AAT-8916-2021; Suarez-Cuartin, Guillermo/AAA-8105-2019	Coll-Canti, Jaume/0000-0001-7128-1186; Coll-Canti, Jaume/0000-0001-7128-1186; Moris, German/0000-0001-7608-2194; Suarez-Cuartin, Guillermo/0000-0003-2320-6047; Barcena Llona, Jose Eulalio/0000-0002-7156-5960; Diaz-Manera, Jordi/0000-0003-2941-7988; Gallardo, Eduard/0000-0002-3942-3436	Genzyme; Spanish Ministry of Health [FISS PI15/01822]; Spanish Association of Patients with Glycogenosis	Genzyme(Sanofi-AventisGenzyme Corporation); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Association of Patients with Glycogenosis	This work was supported by a grant from Genzyme to JDM (https://clinicaltrials.gov/ct2/show/NCT914536?term=pompe+disease&rank=13) and a grant from the Spanish Ministry of Health, FISS PI15/01822 to JDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Spanish Association of Patients with Glycogenosis (www.glucogenosis.org) for their support to our investigation. We thank Carolyn Newey for editorial support and Ignasi Gich for support with statistics. We thank Javier Sanchez Gonzalez and Paula Montesinos Suarez de la Vega from Philips HealthCare Iberia and Dr. Antoni Capdevila for the technical support with the MRI. We thank the MRI whole technician team Esther Alemany, Nieves Campillos, Elisenda Mestres, Eugenia Torres, Ricard Cullell, Alberto Fernandez and Mario Gonzalez for their patience and support with the study. We thank Lidia Gonzalez Quereda, from the Genetic department of Sant Pau Hospital, for reviewing genetic studies of all patients. We also thank Mrs. Concepcion Escold for her assistance during the visits of the study. This study was supported with a grant by GENZYME and a Grant from the Spanish Ministry of Health, FISS PI15/01822 to Dr. Jordi Diaz Manera.	Alejaldre A, 2012, NEUROMUSCULAR DISORD, V22, pS148, DOI 10.1016/j.nmd.2012.05.011; Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Barba-Romero MA, 2012, REV NEUROLOGIA, V54, P497, DOI 10.33588/rn.5408.2012088; Bembi B, 2008, NEUROLOGY, V71, pS4, DOI 10.1212/WNL.0b013e31818da91e; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Carlier PG, 2015, J INHERIT METAB DIS, V38, P565, DOI 10.1007/s10545-015-9825-9; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Cupler EJ, 2012, MUSCLE NERVE, V45, P319, DOI 10.1002/mus.22329; Diaz-Manera Jordi, 2015, Acta Myol, V34, P95; Diaz-Manera J, 2016, NEUROMUSCULAR DISORD, V26, P33, DOI 10.1016/j.nmd.2015.10.001; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Gruhn KM, 2015, MOLEC GENET METAB RE, V3, P58, DOI 10.1016/j.ymgmr.2015.03.010; Gungor D, 2016, J INHERIT METAB DIS, V39, P253, DOI 10.1007/s10545-015-9889-6; Gutieerrez-Rivas E, 2015, REV NEUROLOGIA, V60, P321, DOI 10.33588/rn.6007.2015029; Hollingsworth KG, 2014, NEUROLOGY, V83, P956, DOI 10.1212/WNL.0000000000000785; Horvath JJ, 2015, MUSCLE NERVE, V51, P722, DOI 10.1002/mus.24437; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Paradas C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0b013e3181ea1564; Pichiecchio A, 2009, MUSCLE NERVE, V40, P122, DOI 10.1002/mus.21304; Ravaglia S, 2010, J INHERIT METAB DIS, V33, P737, DOI 10.1007/s10545-010-9204-5; Straub Volker, 2012, Neuromuscul Disord, V22 Suppl 2, pS42, DOI 10.1016/j.nmd.2012.08.002; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Toscano A, 2013, J NEUROL, V260, P951, DOI 10.1007/s00415-012-6636-x; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2012, MOL GENET METAB, V107, P456, DOI 10.1016/j.ymgme.2012.09.015; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998; Wyatt K, 2012, HEALTH TECHNOL ASSES, V16, pV	32	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163493	10.1371/journal.pone.0163493	http://dx.doi.org/10.1371/journal.pone.0163493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711114	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600028
J	Rouxel, RN; Merour, E; Biacchesi, S; Bremont, M				Rouxel, Ronan N.; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel			Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines	PLOS ONE			English	Article							LIVE; GLYCOPROTEIN; STRATEGIES	Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20 degrees C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.	[Rouxel, Ronan N.; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel] Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bremont, M (corresponding author), Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France.	michel.bremont@jouy.inra.fr	Biacchesi, Stephane/A-6924-2010	Biacchesi, Stephane/0000-0002-7020-2391; Rouxel, Ronan/0000-0003-1664-5615	ABIVAX France	ABIVAX France	Dr RN Rouxel has been financially supported by ABIVAX France.	Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; Arkush KD, 2006, DIS AQUAT ORGAN, V69, P145, DOI 10.3354/dao069145; Biacchesi S, 2002, J VIROL, V76, P2881, DOI 10.1128/JVI.76.6.2881-2889.2002; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fields B. N., 2007, FIELDS VIROLOGY; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Ghedin E., 2006, INFLUENZA A VIRUS A; Halder N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-266; Jagt HJM, 2010, BIOLOGICALS, V38, P128, DOI 10.1016/j.biologicals.2009.07.006; Kiseleva I, 2012, VACCINE, V30, P7395, DOI 10.1016/j.vaccine.2012.09.076; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; Nunnally, 2015, VACCINE ANAL STRATEG, DOI 10.1007/978-3-662-45024-6; Nzonza A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091766; Orenstein V. P., 2012, VACCINES; Pliaka V, 2012, EXPERT REV VACCINES, V11, P609, DOI [10.1586/ERV.12.28, 10.1586/erv.12.28]; Ryder AB, 2016, J VIROL, V90, P2544, DOI 10.1128/JVI.02598-15; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Sridhar S, 2015, VACCINES, V3, P373, DOI 10.3390/vaccines3020373; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a; Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026; Tetsutani K, 2012, VACCINE, V30, P7658, DOI 10.1016/j.vaccine.2012.10.007; Treanor JJ, 2015, AM J PREV MED, V49, pS355, DOI 10.1016/j.amepre.2015.09.012; Vo NTK, 2015, J FISH DIS, V38, P121, DOI 10.1111/jfd.12208; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; World Health Organization, 2013, GUID QUAL SAF EFF BI; Yewdell JW, 2010, MOL IMMUNOL, V47, P1132, DOI 10.1016/j.molimm.2009.10.023	32	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164245	10.1371/journal.pone.0164245	http://dx.doi.org/10.1371/journal.pone.0164245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711176	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600105
J	Chen, F; Su, WQ; Becker, SH; Payne, M; Sweet, CMC; Peters, AL; Dall, TM				Chen, Fang; Su, Wenqing; Becker, Shawn H.; Payne, Mike; Sweet, Cynthia M. Castro; Peters, Anne L.; Dall, Timothy M.			Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIFE-STYLE INTERVENTION; PREVENTION PROGRAM; WEIGHT-LOSS; VALIDATION; PREDICTION; OUTCOMES; ADULTS	Background Type 2 diabetes and cardiovascular disease impose substantial clinical and economic burdens for seniors (age 65 and above) and the Medicare program. Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset. This paper estimated the potential health implications and medical savings of a digital version of IBC modeled after the NDPP. Methods and Findings Participants in this digital IBC intervention, the Omada program, include 1,121 overweight or obese seniors with additional risk factors for diabetes or heart disease. Weight changes were objectively measured via participant use of a networked weight scale. Participants averaged 6.8% reduction in body weight within 26 weeks, and 89% of participants completed 9 or more of the 16 core phase lessons. We used a Markov-based microsimulation model to simulate the impact of weight loss on future health states and medical expenditures over 10 years. Cumulative per capita medical expenditure savings over 3, 5 and 10 years ranged from $1,720 to 1,770 (3 years), $3,840 to $4,240 (5 years) and $11,550 to $14,200 (10 years). The range reflects assumptions of weight re-gain similar to that seen in the DPP clinical trial (lower bound) or minimal weight re-gain aligned with age-adjusted national averages (upper bound). The estimated net economic benefit after IBC costs is $10,250 to $12,840 cumulative over 10 years. Simulation outcomes suggest reduced incidence of diabetes by 27-41% for participants with prediabetes, and stroke by approximately 15% over 5 years. Conclusions A digital, remotely-delivered IBC program can help seniors at risk for diabetes and cardiovascular disease achieve significant weight loss, reduces risk for diabetes and cardiovascular disease, and achieve meaningful medical cost savings. These findings affirm recommendations for IBC coverage by the U.S. Preventive Services Task Force.	[Chen, Fang; Su, Wenqing; Dall, Timothy M.] IHS Life Sci, Washington, DC 98133 USA; [Becker, Shawn H.] Silvercat Advisors LLC, Burlingame, CA USA; [Payne, Mike; Sweet, Cynthia M. Castro] Omada Hlth Inc, San Francisco, CA USA; [Peters, Anne L.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Chen, F (corresponding author), IHS Life Sci, Washington, DC 98133 USA.	frank.chen@ihs.com		Castro Sweet, Cynthia/0000-0001-6860-4095; Peters, Anne/0000-0003-0520-0776	Omada Health, Inc	Omada Health, Inc	Funding for this study was provided by Omada Health, Inc, who provided raw data for analysis and participated in preparation of this manuscript. M.P. and C.M.C.S. are employees of the study sponsor. F.C., W.S., T.M.D., and S.H.B. provide paid consulting services to the study sponsor for this and other research. A.L.P. reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article. The study sponsor approved the study design developed by T.M.D., F. C., and W.S. Data provided by study sponsor was analyzed solely by F.C. All authors of this manuscript, with the exception of Dr. Anne L. Peters, contributed to interpretation of study findings and draft of the manuscript. A.L.P. provided critical comments to the intellectual content of manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention, 2015, CTR DIS CONTR PREV D; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Congressional Budget Office, 2015, MARCH 2015 MED BAS; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dall TM, 2015, AM J PREV MED, V48, P271, DOI 10.1016/j.amepre.2014.10.003; Faes C, 2011, J ANTIMICROB CHEMOTH, V66, P89, DOI 10.1093/jac/dkr461; Felix HC, 2013, AM J HEALTH PROMOT, V27, P191, DOI 10.4278/ajhp.110617-LIT-259; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Heianza Y, 2012, DIABETES CARE, V35, P1050, DOI 10.2337/dc11-1793; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Kaiser Family Foundation, 2014, MUCH IS EN OUT OF SP; Kannel W.B., 1987, FRAMINGHAM STUDY EPI; KANNEL WB, 1998, AM J CARDIOL, V0082; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; McGill HC, 1998, AM J CARDIOL, V82, p30T; Moin T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4332; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; National Cancer Institute, 2011, ANN MEAN NET COSTS C; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Semilla AP, 2015, AM J MANAG CARE, V21, pS165; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; Sepah SC, 2014, DIABETES EDUCATOR, V40, P435, DOI 10.1177/0145721714531339; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Su W, 2015, J MED ECON, V18, P886, DOI 10.3111/13696998.2015.1058805; Su WQ, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150357; Sumamo E, 2014, LIFESTYLE INTERVENTI; Thorpe KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-7; Wilson PWF, 2008, CIRCULATION, V118, P124, DOI 10.1161/CIRCULATIONAHA.108.772962; WILSON PWF, 1994, J GERONTOL, V49, pM252, DOI 10.1093/geronj/49.6.M252; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	39	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163627	10.1371/journal.pone.0163627	http://dx.doi.org/10.1371/journal.pone.0163627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706216	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200051
J	Diaz, AH; Kovacs, I; Lindermayr, C				Diaz, Areli Herrera; Kovacs, Izabella; Lindermayr, Christian			Inducible Expression of the De-Novo Designed Antimicrobial Peptide SP1-1 in Tomato Confers Resistance to Xanthomonas campestris pv. vesicatoria	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; PATHOGEN-INDUCED EXPRESSION; DNA-BINDING; STAPHYLOCOCCUS-AUREUS; DISEASE RESISTANCE; CECROPIN-B; GENE; ARABIDOPSIS; PLANTS; SYSTEM	Antimicrobial peptides (AMPs) are small peptides with less than 50 amino acids and are part of the innate immune response in almost all organisms, including bacteria, vertebrates, invertebrates and plants. AMPs are active against a broad-spectrum of pathogens. The inducible expression of AMPs in plants is a promising approach to combat plant pathogens with minimal negative side effects, such as phytotoxicity or infertility. In this study, inducible expression of the de-novo designed AMP SP1-1 in Micro Tom tomato protected tomato fruits against bacterial spot disease caused by Xanthomonas campestris pv. vesicatoria. The peptide SP1-1 was targeted to the apoplast which is the primary infection site for plant pathogens, by fusing SP1-1 peptide to the signal peptide RsAFP1 of radish (Raphanus sativus). The pathogen inducibility of the expression was enabled by using an optimized inducible 4XW2/4XS promoter. As a result, the tomato fruits of independently generated SP1-1 transgenic lines were significantly more resistant to X. campestris pv. vesicatoria than WT tomato fruits. In transgenic lines, bacterial infection was reduced up to 65% in comparison to the infection of WT plants. Our study demonstrates that the combination of the 4XW2/4XS cis-element from parsley with the synthetic antimicrobial peptide SP1-1 is a good alternative to protect tomato fruits against infections with X. campestris pv. vesicatoria.	[Diaz, Areli Herrera; Kovacs, Izabella; Lindermayr, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, D-85764 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindermayr, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, D-85764 Munich, Germany.	lindermayr@helmholtz-muenchen.de			Bundesministerium fur Bildung and Forschung	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by Bundesministerium fur Bildung and Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Salazar-Gonzalez JA, 2014, MOL BIOTECHNOL, V56, P1133, DOI 10.1007/s12033-014-9793-6; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Brouwer CPJM, 2006, PEPTIDES, V27, P2585, DOI 10.1016/j.peptides.2006.05.022; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Company N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109990; Cortina C, 2004, PLANT CELL TISS ORG, V76, P269, DOI 10.1023/B:TICU.0000009249.14051.77; Dan YH, 2006, PLANT CELL REP, V25, P432, DOI 10.1007/s00299-005-0084-3; Dangel A, 2013, FASEB J, V27, P4476, DOI 10.1096/fj.13-234575; Datta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11951; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hahn Matthias, 2014, Journal of Chemical Biology, V7, P133, DOI 10.1007/s12154-014-0113-1; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HIGHTOWER R, 1994, PLANT CELL REP, V13, P295, DOI 10.1007/BF00233324; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; Jindal HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128532; Kirsch C, 2000, MOL PLANT PATHOL, V1, P243, DOI 10.1046/j.1364-3703.2000.00029.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Lacerda ALM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136820; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lucca P, 2001, MOL BREEDING, V7, P43, DOI 10.1023/A:1009661014167; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Marti E, 2006, J EXP BOT, V57, P2037, DOI 10.1093/jxb/erj154; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Nan YH, 2009, FEMS MICROBIOL LETT, V292, P134, DOI 10.1111/j.1574-6968.2008.01484.x; Oard SV, 2006, PLANT CELL REP, V25, P561, DOI 10.1007/s00299-005-0102-5; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Piquerez SJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00671; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shokouhifar F, 2011, IRAN J BIOTECHNOL, V9, P1; Soria-Guerra RE, 2007, PLANT CELL REP, V26, P961, DOI 10.1007/s00299-007-0306-y; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang GS, 2015, PHARMACEUTICALS-BASE, V8, P123, DOI 10.3390/ph8010123; Wang GS, 2015, METHODS MOL BIOL, V1268, P43, DOI 10.1007/978-1-4939-2285-7_3; Wu TQ, 2013, GENE, V527, P235, DOI 10.1016/j.gene.2013.06.037; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang LT, 2005, J AGR FOOD CHEM, V53, P183, DOI 10.1021/jf0493730; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yevtushenko DP, 2007, PLANT BIOTECHNOL J, V5, P720, DOI 10.1111/j.1467-7652.2007.00277.x; Yevtushenko DP, 2005, J EXP BOT, V56, P1685, DOI 10.1093/jxb/eri165; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeitler B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071687; Zeitler B, 2013, PLANT MOL BIOL, V81, P259, DOI 10.1007/s11103-012-9996-9	54	4	4	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164097	10.1371/journal.pone.0164097	http://dx.doi.org/10.1371/journal.pone.0164097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706237	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200083
J	Hadjipanayis, A; Efstathiou, E; Alexandrou, M; Panayiotou, L; Zachariadou, C; Petrou, P; Papaevangelou, V				Hadjipanayis, Adamos; Efstathiou, Elisavet; Alexandrou, Maria; Panayiotou, Loukia; Zachariadou, Chrystalla; Petrou, Panayiotis; Papaevangelou, Vasiliki			Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE CARRIAGE; RESPIRATORY-TRACT INFECTIONS; CONJUGATE VACCINE; SEROGROUP 15; DAY-CARE; IMPACT; COLONIZATION; SEROTYPES; DISEASE; 19A	The objective of the study was to describe the incidence of pneumococcal nasopharyngeal carriage, serotype distribution and antibiotic resistance profile of pneumococcal nasopharyngeal isolates in healthy children aged 6 to 36 months following the implementation of conjugate vaccines. A nasopharyngeal swab was collected from 1105 healthy children following a stratified random sampling between September 2013 and April 2014. Demographics, vaccination status and data on possible risk factors were recorded. Isolates were serotyped and tested for antibiotic susceptibility. The nasopharyngeal carriage rate was 25.3%. Among 1105 children enrolled, 393 had received PCV13 and 685 PCV10. The prevailing isolated serotypes were: 23A (14.3%), 15A (8.9%), 6C (8.6%), 23B (7.5%), 19A (5.4%) and 15B (5%). The proportion of non-vaccine serotypes, PCV10 serotypes, PCV13 additional serotypes (3, 6A, 19A) was 76.8%, 2.1% and 10.4% respectively. Although children, who were fully or partially vaccinated with PCV13, were 63% less likely to be colonized with additional PCV13 serotypes compared to those vaccinated with PCV10, the difference is not significant (95%CI = 0.14-1.02, p = 0.053). The highest antibiotic non-susceptible rates were found for erythromycin (28.2%) and penicillin (27.9%). The overall multidrug resistance rate was 13.2%, with serotypes 24F (4/6), 15A (14/25) and 19A (6/15) being the main contributors. Carriage rate was similar between children vaccinated with PCV10 or PCV13. The high incidence of 15A serotype which is also multidrug resistant should be underlined. Ongoing surveillance is needed to monitor the dynamics on nasopharyngeal carriage.	[Hadjipanayis, Adamos; Efstathiou, Elisavet] Larnaca Gen Hosp, Dept Paediat, Larnax, Cyprus; [Hadjipanayis, Adamos] European Univ, Sch Med, 6 Diogenis St, CY-1516 Nicosia, Cyprus; [Alexandrou, Maria; Panayiotou, Loukia; Zachariadou, Chrystalla; Petrou, Panayiotis] Larnaca Gen Hosp, Microbiol Lab, Larnax, Cyprus; [Papaevangelou, Vasiliki] Natl & Kapodistrian Univ Athens, Gen Univ Hosp ATTIKON, Dept Paediat 3, Athens, Greece	Lefke Avrupa University; National & Kapodistrian University of Athens; University Hospital Attikon	Hadjipanayis, A (corresponding author), Larnaca Gen Hosp, Dept Paediat, Larnax, Cyprus.; Hadjipanayis, A (corresponding author), European Univ, Sch Med, 6 Diogenis St, CY-1516 Nicosia, Cyprus.	adamos@paidiatros.com	Hadjipanayis, Adamos/M-6102-2016	Hadjipanayis, Adamos/0000-0003-4337-3176	GSK, Cyprus	GSK, Cyprus	Part of serotype antisera was granted by GSK, Cyprus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abat C, 2015, EUR J CLIN MICROBIOL, V34, P2081, DOI 10.1007/s10096-015-2455-1; Abramson JS, 2000, PEDIATRICS, V106, P362; Ahn JG, 2015, INFECT DIS-NOR, V47, P385, DOI 10.3109/00365548.2014.1001997; Ben-Shimol S, 2015, CLIN INFECT DIS, V60, P1384, DOI 10.1093/cid/civ023; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Clinical and Laboratory Standards Institute (CLSI), 2021, M100ED31 CLSI; Cohen R, 2012, ARCH PEDIATRIE, V19, P1132, DOI 10.1016/j.arcped.2012.07.013; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cyprus Paediatric Society, 2011, VACC SCHED CHILDR; Dunais B, 2011, EUR J CLIN MICROBIOL, V30, P837, DOI 10.1007/s10096-011-1154-9; Dunais B, 2015, PEDIATR INFECT DIS J, V34, P286, DOI 10.1097/INF.0000000000000559; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Garcia-Vera C, 2011, MED CLIN-BARCELONA, V137, P1, DOI 10.1016/j.medcli.2010.09.051; Gounder PP, 2014, J INFECT DIS, V209, P1251, DOI 10.1093/infdis/jit642; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Ho PL, 2015, DIAGN MICR INFEC DIS, V81, P145, DOI 10.1016/j.diagmicrobio.2014.11.006; Hsieh YC, 2012, PEDIATR INFECT DIS J, V31, pE163, DOI 10.1097/INF.0b013e31825cb9f9; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lee GM, 2014, J PEDIATR INFECT DIS, V3, P23, DOI 10.1093/jpids/pit057; Lehmann D, 1997, PEDIATR INFECT DIS J, V16, P297, DOI 10.1097/00006454-199703000-00009; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Maraki S, 2010, EUR J CLIN MICROBIOL, V29, P1449, DOI 10.1007/s10096-010-1005-0; Martinelli Domenico, 2014, Hum Vaccin Immunother, V10, P33, DOI 10.4161/hv.26650; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Ozawa D, 2015, PEDIATR INFECT DIS J, V34, pE217, DOI 10.1097/INF.0000000000000776; Park SY, 2008, PEDIATR INFECT DIS J, V27, P335, DOI 10.1097/INF.0b013e318161434d; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Richter SS, 2013, EMERG INFECT DIS, V19, P1074, DOI 10.3201/eid1907.121830; Ricketson LJ, 2014, PEDIATR INFECT DIS J, V33, P724, DOI 10.1097/INF.0000000000000267; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Schutze GE, 2004, PEDIATR INFECT DIS J, V23, P1125, DOI 10.1097/01.inf.0000145478.36236.1e; Torres A, 2015, EUR J CLIN MICROBIOL, V34, P19, DOI 10.1007/s10096-014-2208-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Zuccotti G, 2014, VACCINE, V32, P527, DOI 10.1016/j.vaccine.2013.12.003	45	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163269	10.1371/journal.pone.0163269	http://dx.doi.org/10.1371/journal.pone.0163269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706247	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200036
J	Feng, QM; Liu, SL; Yang, L; Xie, MX; Zhang, Q				Feng, Qingmin; Liu, Shenglin; Yang, Lei; Xie, Mingxing; Zhang, Qiang			The Prevalence of and Risk Factors Associated with Musculoskeletal Disorders among Sonographers in Central China: A Cross-Sectional Study	PLOS ONE			English	Article							CUMULATIVE TRAUMA DISORDERS; REPETITIVE STRAIN INJURIES; CARPAL-TUNNEL-SYNDROME; OFFICE WORKERS; SYMPTOMS; HAND; PAIN; PREVENTION; COMPLAINTS; VALUES	Objective Studies from industrialized countries show that musculoskeletal disorders (MSD) occur commonly in sonographers. However, little is known about sonographers in China, where the awareness of ergonomics and MSD, workload, and available equipment/facilities may differ. We aimed to investigate the prevalence of MSD and associated risk factors in sonographers in central China. Methods A cross-sectional survey was conducted with 381 sonographers from 14 randomly selected tertiary hospitals in Hubei province, central China. Musculoskeletal symptoms (using the Nordic Questionnaire) and risk factors (mostly derived from the Health Benefit Trust survey instrument and the Dutch Musculoskeletal Questionnaire) were recorded. Multivariate logistic regression was used to quantify associations between risk factors and MSD. Results The 12-month period prevalence of MSD was 98.3%, being highest in the neck (93.5%) and shoulder (92.2%), followed by the lower back (83.2%), wrist/hand, upper back, and elbow. Factors contributing to neck pain were psychological fatigue, shoulder abduction and trunk bend-and-twist posture. Height-adjustable tables and chairs were protective factors. Shoulder pain was associated with female sex, health status, mental stress, shoulder abduction, and trunk bend-and-twist posture. Height-adjustable chairs and the awareness of adjusting the workstation before scanning were protective factors. Elbow pain was associated with health status and height-adjustable tables. Wrist/hand pain was associated with female sex, bending the wrist, and working with obese patients. Upper back pain was associated with shoulder abduction, height-adjustable chairs, and device location. Lower back pain was associated with the number of scans performed per day, awkward postures, bending the trunk, twisting or bending the neck forward, and using a footrest. Conclusions This study suggests a high prevalence of MSD in sonographers in central China. Hence, it is necessary to improve the awareness of MSD by training, and the ergonomics of their current work environment by addressing physical workload, and psychological and equipment/facility-related factors.	[Feng, Qingmin; Liu, Shenglin; Zhang, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Dept Med Engn, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China; [Feng, Qingmin; Liu, Shenglin; Zhang, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Healthcare Ergon Lab, 1277 JieFang Ave, Wuhan 430022, Peoples R China; [Yang, Lei] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, 13 HangKong Rd, Wuhan 430030, Peoples R China; [Xie, Mingxing] Huazhong Univ Sci & Technol, Union Hosp, Dept Med Ultrasound, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, Q (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Med Engn, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China.; Zhang, Q (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Healthcare Ergon Lab, 1277 JieFang Ave, Wuhan 430022, Peoples R China.	whuhcce@163.com		Xie, Mingxing/0000-0003-4984-1567				[Anonymous], 2011, JOINT BONE SPINE, DOI DOI 10.1016/j.jbspin.2011.01.014; ARMSTRONG TJ, 1987, J HAND SURG-AM, V12A, P830, DOI 10.1016/S0363-5023(87)80244-7; ASHBURY FD, 1995, J OCCUP ENVIRON MED, V37, P479, DOI 10.1097/00043764-199504000-00021; Baker JP, 2013, J ULTRAS MED, V32, P1363, DOI 10.7863/ultra.32.8.1363; Bastian EJ, 2009, J DIAGN MED SONOG, V25, P25, DOI 10.1177/8756479308327060; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bolton GC, 2015, J CLIN ULTRASOUND, V43, P145, DOI 10.1002/jcu.22216; Bureau Of Labour Protection Ministry Of Labour, 1988, 1000088 GB BUR LAB P, P17; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; Caillard J, 2000, P HUM FACT ERG SOC A, V44, DOI [10.1177/154193120004403144, DOI 10.1177/154193120004403144]; Carson R, 1994, AAOHN J, V42, P270; Cattell G, 2002, SYNERGY, P7; Cho CY, 2012, J MANIP PHYSIOL THER, V35, P534, DOI 10.1016/j.jmpt.2012.07.004; Claes F, 2015, HUM FACTORS, V57, P238, DOI 10.1177/0018720814547872; Coffin C.T., 2014, REP MED IMAG, V7, P15, DOI [10.2147/rmi.s34724, DOI 10.2147/RMI.S34724, 10.2147/RMI.S34724]; Danuser B, 2014, CONT ERGONOMICS, P69; Du Wei-wei, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P335; Eatough EM, 2012, APPL ERGON, V43, P554, DOI 10.1016/j.apergo.2011.08.009; European Agency of Safety andHealthatWork., 2008, WORK RELATED MUSCULO; Evans K, 2009, J DIAGN MED SONOG, V25, P287, DOI 10.1177/8756479309351748; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Feather C, 2001, SYNERGY; Feng BB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006451; Gobba Fabriziomaria, 2010, G Ital Med Lav Ergon, V32, P223; Hallman DM, 2015, INT ARCH OCC ENV HEA, V88, P1031, DOI 10.1007/s00420-015-1031-4; Hildebrandt VH, 2001, ERGONOMICS, V44, P1038, DOI 10.1080/00140130110087437; Hill JJ, 2009, WORK, V33, P181, DOI 10.3233/WOR-2009-0865; Hoe VCW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008570.pub2; Janga D, 2012, ARCH GYNECOL OBSTET, V286, P353, DOI 10.1007/s00404-012-2306-6; Kim T, 2014, J PHYS THER SCI, V26, P1423, DOI 10.1589/jpts.26.1423; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Li JY, 2012, BIOMED ENVIRON SCI, V25, P421, DOI 10.3967/0895-3988.2012.04.007; Liang BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070423; McDiarmid M, 2000, ENVIRON RES, V83, P23, DOI 10.1006/enrs.2000.4042; McGregor R, 2009, RADIOGRAPHY, V15, P313, DOI 10.1016/j.radi.2009.07.006; Morton B, 2008, RADIOGRAPHY, V14, P195, DOI 10.1016/j.radi.2007.02.004; National Health and Family Commission, 2015, 2014 REP CHIN RES CH; National Health and Family Commission, 2013, CHINA HLTH FAM PLANN; National Health and Family Commission, 2015, CHIN STAT YB 2015; National Institute for Occupational Safety and Health, 2006, PREV WORK REL MUSC O; Oldervoll LM, 2001, J REHABIL MED, V33, P156, DOI 10.1080/165019701750300618; Pike I., 1997, J DIAGN MED SONOGR, V13, P219, DOI DOI 10.1177/875647939701300501; REMPEL DM, 1992, JAMA-J AM MED ASSOC, V267, P838, DOI 10.1001/jama.267.6.838; Roll SC, 2012, ANAL OCCUPATIONAL FA, P355; Rousseau T, 2013, J ULTRAS MED, V32, P157; Russo A, 2002, APPL ERGON, V33, P385, DOI 10.1016/S0003-6870(02)00038-8; Schoenfeld A, 1999, Eur J Ultrasound, V10, P41, DOI 10.1016/S0929-8266(99)00031-2; Seto E, 2008, J DIAGN MED SONOG, V24, P127, DOI 10.1177/8756479308315230; Sikorski J M, 1988, Aust Fam Physician, V17, P81; SILVERSTEIN BA, 1986, BRIT J IND MED, V43, P779; Smith AC, 1997, J AM SOC ECHOCARDIOG, V10, P357, DOI 10.1016/S0894-7317(97)70073-7; Smith DR, 2006, INT J IND ERGONOM, V36, P599, DOI 10.1016/j.ergon.2006.01.014; Smith DR, 2004, OCCUP MED-OXFORD, V54, P579, DOI 10.1093/occmed/kqh117; Smith DR, 2004, J PROF NURS, V20, P390, DOI 10.1016/j.profnurs.2004.08.002; Suzuki H, 2013, J MED ULTRASON, V40, P189, DOI 10.1007/s10396-012-0415-2; Szeto GPY, 2009, J OCCUP REHABIL, V19, P175, DOI 10.1007/s10926-009-9176-1; Tzschatzsch H, 2015, ULTRASOUND MED BIOL, V41, P724, DOI 10.1016/j.ultrasmedbio.2014.11.009; VANDERPOOL HE, 1993, J OCCUP ENVIRON MED, V35, P604, DOI 10.1097/00043764-199306000-00018; Wihlidal LM, 1997, INT J IND ERGONOM, V19, P205, DOI 10.1016/S0169-8141(95)00107-7; Xu Lei, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P180; Yang L, 2009, IND HLTH OCCUPATIONA, P25; Yu SF, 2012, AM J IND MED, V55, P281, DOI 10.1002/ajim.21037; Yuan Y, 2014, CHINESE MED EQUIPMEN; Yue P, 2014, OCCUP MED-OXFORD, V64, P211, DOI 10.1093/occmed/kqu008; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	65	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163903	10.1371/journal.pone.0163903	http://dx.doi.org/10.1371/journal.pone.0163903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695095	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100063
J	Jernas, L; Wencel, J; Wiak, A; Bieniek, M; Bartosik-Psujek, H				Jernas, Lukasz; Wencel, Jacek; Wiak, Andrzej; Bieniek, Marek; Bartosik-Psujek, Halina			Risk Factors for Poor Adherence to Betaferon (R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome	PLOS ONE			English	Article							PLACEBO-CONTROLLED PHASE-3; INTERFERON-BETA THERAPY; BRAIN ATROPHY; ORAL BG-12; GLATIRAMER; EFFICACY; MS; TERIFLUNOMIDE; CONVERSION; DEFINITE	Introduction Adherence to treatment, including early treatment discontinuation, in patients with multiple sclerosis or clinically isolated syndrome can be affected by: treatment tolerability, route of drug administration, patient age, disease duration, comorbidities, medical care, and support from their caregivers. Aim This study aimed to identify the risk factors for poor adherence to Betaferon 1 treatment, including early discontinuation and omitting doses. Materials and Methods 852 adult patients treated with Betaferon participated in this 24-month study. All patients were interviewed using the Risk of Drop-out Questionnaire, the Center for Epidemiologic Studies Depression Scale and the Kurtzke Expanded Disability Status Scale. Results Patients who stopped therapy were younger (p = 0.003) had a higher mean EDSS score (p = 0.022), higher mean number of relapses (p = 0.017), and reported more often fear of injection (p = 0.027) and adverse events (p = 0.007) than those who did not stop treatment. Comparing patients who stopped therapy in the first and the second year, patients who stopped therapy in the first year of treatment more frequently reported flu-like symptoms and fever, and those who stopped therapy in the second year reported-ineffectiveness of treatment and disease progression. Multivariable logistic regression models confirmed that young age, short disease duration, advanced and progressing disease, and poor Betaferon tolerability were related to premature treatment discontinuation. The risk of omitting a dose during therapy was increased in patients who were working or studying, who had more advanced disease or more adverse events, and in patients who received less support from their caregivers. Conclusions Several reasons may lead to problems with adherence to Betaferon treatment. Patients at higher risk of discontinuing treatment need to be identified early to make caregivers' support available to them.	[Jernas, Lukasz] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Wencel, Jacek] L Bierkowski Minist Internal Affairs, Dept Neurolofy, Poznan, Poland; [Wencel, Jacek] Adm Hlth Care Ctr Poznan, Poznan, Poland; [Wiak, Andrzej] 4th Mil Clin Hosp Wroclaw, Dept Neurol, Wroclaw, Poland; [Bieniek, Marek] Bayer Sp Zoo, Pharmaceut, Dept Med, Warsaw, Poland; [Bartosik-Psujek, Halina] Univ Rzeszow, Fac Med, Rzeszow, Poland	Poznan University of Medical Sciences; Bayer AG; University of Rzeszow	Bieniek, M (corresponding author), Bayer Sp Zoo, Pharmaceut, Dept Med, Warsaw, Poland.	marek.bieniek@bayer.com		Bartosik-Psujek, Halina/0000-0002-2860-6456	Bayer sp. z o. o., Warsaw, Poland	Bayer sp. z o. o., Warsaw, Poland	This study was funded by Bayer sp. z o. o., Warsaw, Poland. The funder participated in study design, data analysis, decision to publish and preparation of the manuscript.	Alroughani Raed, 2012, Int J MS Care, V14, P17, DOI 10.7224/1537-2073-14.1.17; Bains SN, 2010, ANN ALLERG ASTHMA IM, V104, P321, DOI 10.1016/j.anai.2009.11.040; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; CLERICO M, 2008, COCHRANE DB SYST REV, V16; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Cox Darcy, 2006, J Neurosci Nurs, V38, P167; Cunningham A, 2010, ACTA NEUROL SCAND, V121, P154, DOI 10.1111/j.1600-0404.2009.01285.x; Daugherty KK, 2005, J AM PHARM ASSOC, V45, P371, DOI 10.1331/1544345054003804; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Dhib-Jalbut Suhayl, 2012, Int J MS Care, V14, P198, DOI 10.7224/1537-2073-14.4.198; Dubois BD, 2003, J NEUROL NEUROSUR PS, V74, P946, DOI 10.1136/jnnp.74.7.946; Eaton W. W., 2004, USE PSYCHOL TESTING, V3, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Francis GS, 2003, DRUG SAFETY, V26, P815, DOI 10.2165/00002018-200326110-00006; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Hansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133279; Hardmeier M, 2005, NEUROLOGY, V64, P236, DOI 10.1212/01.WNL.0000149516.30155.B8; He DA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009882.pub2; Hutchinson Michael, 2005, Int MS J, V12, P73; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Koch-Henriksen N, 2006, NEUROLOGY, V66, P1056, DOI 10.1212/01.wnl.0000204018.52311.ec; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Milo R, 2014, AUTOIMMUN REV, V13, P518, DOI 10.1016/j.autrev.2014.01.012; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Mohr DC, 1998, MULT SCLER, V4, P487, DOI 10.1191/135245898678845160; Nezu AM, 2002, HANDBOOK OF DEPRESSION, P61; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Rio J, 2004, NEUROLOGY, V63, P525, DOI 10.1212/01.WNL.0000133206.44931.25; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett H, 2008, PHARMACOEPIDEM DR S, V17, P565, DOI 10.1002/pds.1593; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0157950	10.1371/journal.pone.0157950	http://dx.doi.org/10.1371/journal.pone.0157950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695075	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100004
J	Park, Y; Hwang, HB; Kim, HS				Park, Yuli; Hwang, Hyung Bin; Kim, Hyun Seung			Observation of Influence of Cataract Surgery on the Ocular Surface	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; DRY-EYE DISEASE; LIPID LAYER THICKNESS; SJOGRENS-SYNDROME; TEAR FILM; KERATOCONJUNCTIVITIS SICCA; LOTEPREDNOL ETABONATE; GENE-EXPRESSION; MEIBOGRAPHY; CYTOKINE	Introduction To evaluate meibomian gland function, changes of lacrimal tears and ocular surface parameters and tear inflammatory mediators following cataract surgery. Methods 48 eyes of 34 patients who underwent uncomplicated phacoemulsification were involved and divided into 2 groups with those who had preexisting dry-eye before cataract surgery and those who did not. Ocular symptom score, Schirmer I test, tear film break-up time (TBUT), corneal sensitivity threshold, corneal staining, inflammatory cytokine activities, lid margin abnormalities, meibum expressibility, meibum quality and meibomian gland imaging were evaluated preoperatively, at 1 day, 1 and 2 months postoperatively. Results Ocular symptom scores were worse at 1 and 2 months postoperatively but, TBUT, corneal staining score and corneal sensitivity threshold showed gradual improvements at 1 month and 2 months postoperatively (p<0.05, respectively). Interestingly there were statistically significant improvements in TBUT, corneal staining score and corneal sensitivity threshold at 1 month postoperatively when topical eye drops were used compared to the period without topical therapy which is the months 2 postoperatively. There were statistically significant decreases in IL-1 beta, IL-6, IL-8, MCP-1, TNF-alpha and IFN-gamma concentrations at 1 and 2 months postoperatively. Lid margin abnormalities, meibum quality and expressibility scores increased significantly (p<0.05, respectively) at postoperative period. Compared with the no dry eye group, dry eye group revealed significantly higher ocular symptom scores, lower TBUT, higher lid margin abnormalities, meibum quality and expressibility scores after cataract surgery. There were significant correlations between IL-6 and parameters of dry eye, and between MGD parameters and ocular symptom scores. Conclusions Our study revealed that meibomian gland function is influenced after cataract surgery accompanying structural changes and these were correlated with increased ocular symptom scores. Therefore, it could elucidate the development of dry eye related to cataract surgery.	[Park, Yuli; Kim, Hyun Seung] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Hwang, Hyung Bin] Incheon St Marys Hosp, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea	Kim, HS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea.	sara514@catholic.ac.kr		Kim, Hyun Seung/0000-0001-6825-8612				Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; BRON A J, 1991, Eye (London), V5, P395; CHEW CKS, 1993, CURR EYE RES, V12, P247, DOI 10.3109/02713689308999470; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Goto E, 2003, INVEST OPHTH VIS SCI, V44, P533, DOI 10.1167/iovs.02-0170; Han KE, 2014, AM J OPHTHALMOL, V157, P1144, DOI 10.1016/j.ajo.2014.02.036; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Hwang HB, 2014, CORNEA, V33, P82, DOI 10.1097/ICO.0000000000000001; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; JONES DT, 1994, INVEST OPHTH VIS SCI, V35, P3493; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; Kasetsuwan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078657; Kim JR, 2011, JPN J OPHTHALMOL, V55, P283, DOI 10.1007/s10384-011-0008-4; Kissner A, 2007, KLIN MONATSBL AUGENH, V224, P95, DOI 10.1055/s-2006-927390; KORB DR, 1994, ADV EXP MED BIOL, V350, P293; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee H, 2014, AM J OPHTHALMOL, V158, P1172, DOI 10.1016/j.ajo.2014.08.015; Lemp Michael A., 1995, CLAO Journal, V21, P221; Li XM, 2007, CORNEA, V26, pS16, DOI 10.1097/ICO.0b013e31812f67ca; Liu Zuguo, 2002, Zhonghua Yan Ke Za Zhi, V38, P274; MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008; MATHERS WD, 1993, CORNEA, V12, P335, DOI 10.1097/00003226-199307000-00010; Moon H, 2014, CORNEA, V33, P373, DOI 10.1097/ICO.0000000000000072; Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59; Oh T, 2012, JPN J OPHTHALMOL, V56, P113, DOI 10.1007/s10384-012-0117-8; Pflugfelder SC, 2004, AM J OPHTHALMOL, V138, P444, DOI 10.1016/j.ajo.2004.04.052; Pflugfelder SC, 2004, AM J OPHTHALMOL, V137, P337, DOI 10.1016/j.ajo.2003.10.036; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Qiao J, 2013, CLIN OPHTHALMOL, V7, P1797, DOI 10.2147/OPTH.S33182; Ram J, 2002, J CATARACT REFR SURG, V28, P1386, DOI 10.1016/S0886-3350(02)01387-1; ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Simone JN, 2001, CURR OPIN OPHTHALMOL, V12, P63, DOI 10.1097/00055735-200102000-00011; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; TAPIE R, 1977, ANN OCUL, V210, P637; Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723; Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y	45	51	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0152460	10.1371/journal.pone.0152460	http://dx.doi.org/10.1371/journal.pone.0152460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695117	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100002
J	Sendra, L; Miguel, A; Perez-Enguix, D; Herrero, MJ; Montalva, E; Garcia-Gimeno, MA; Noguera, I; Diaz, A; Perez, J; Sanz, P; Lopez-Andujar, R; Marti-Bonmati, L; Alino, SF				Sendra, Luis; Miguel, Antonio; Perez-Enguix, Daniel; Jose Herrero, Maria; Montalva, Eva; Adelaida Garcia-Gimeno, Maria; Noguera, Inmaculada; Diaz, Ana; Perez, Judith; Sanz, Pascual; Lopez-Andujar, Rafael; Marti-Bonmati, Luis; Alino, Salvador F.			Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans	PLOS ONE			English	Article							NAKED PLASMID DNA; VEIN INJECTION; NONVIRAL DNA; SWINE LIVER; RAT-LIVER; DELIVERY; HEPATOCYTES; EXPRESSION; MECHANISM; VOLUME	Introduction Expressing exogenous genes after naked DNA delivery into hepatocytes might achieve sustained and high expression of human proteins. Tail vein DNA injection is an efficient procedure for gene transfer in murine liver. Hydrodynamic procedures in large animals require organ targeting, and improve with liver vascular exclusion. In the present study, two closed liver hydrofection models employing the human alpha-1-antitrypsin (hAAT) gene are compared to reference standards in order to evaluate their potential clinical interest. Material and Methods A solution of naked DNA bearing the hAAT gene was retrogradely injected in 7 pig livers using two different closed perfusion procedures: an endovascular catheterization-mediated procedure (n = 3) with infrahepatic inferior vena cava and portal vein blockage; and a surgery-mediated procedure (n = 4) with completely sealed liver. Gene transfer was performed through the suprahepatic inferior cava vein in the endovascular procedure and through the infrahepatic inferior vena cava in the surgical procedure. The efficiency of the procedures was evaluated 14 days after hydrofection by quantifying the hAAT protein copies per cell in tissue and in plasma. For comparison, samples from mice (n = 7) successfully hydrofected with hAAT and healthy human liver segments (n = 4) were evaluated. Results Gene decoding occurs efficiently using both procedures, with liver vascular arrest improving its efficiency. The surgically closed procedure (sealed organ) reached higher tissue protein levels (4x10<^>5- copies/cell) than the endovascular procedure, though the levels were lower than in human liver (5x10<^>6- copies/cell) and hydrofected mouse liver (10<^>6- copies/cell). However, protein levels in plasma were lower (p<0.001) than the reference standards in all cases. Conclusion Hydrofection of hAAT DNA to "in vivo" isolated pig liver mediates highly efficient gene delivery and protein expression in tissue. Both endovascular and surgically closed models mediate high tissue protein expression. Impairment of protein secretion to plasma is observed and might be species-related. This study reinforces the potential application of closed liver hydrofection for therapeutic purposes, provided protein secretion improves.	[Sendra, Luis; Miguel, Antonio; Jose Herrero, Maria; Alino, Salvador F.] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] IIS La Fey, Serv Radiol, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] IIS La Fe, Grp Invest Biorned Imagen GIBI239, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] Hosp Univ & Politecn La Fe, Valencia, Spain; [Jose Herrero, Maria; Alino, Salvador F.] Hosp Univ & Politecn La Fe, IIS La Fe, Unidad Farmacogenet, Valencia, Spain; [Jose Herrero, Maria; Alino, Salvador F.] Hosp Univ & Politecn La Fe, Area Clin Medicamento, Valencia, Spain; [Montalva, Eva; Lopez-Andujar, Rafael] Hosp Univ & Politecn La Fe, Unidad Cirugia Hepatobiliopancreat & Trasplante, Valencia, Spain; [Adelaida Garcia-Gimeno, Maria; Sanz, Pascual] CSIC, GIBER, Valencia, Spain; [Adelaida Garcia-Gimeno, Maria; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Noguera, Inmaculada; Diaz, Ana] Univ Valencia, SCSIE, Valencia, Spain; [Perez, Judith] Hosp Univ & Politecn La Fe, Serv Anat Patol, Valencia, Spain; [Alino, Salvador F.] Hosp Univ & Politecn La Fe, Area Clin Medicamento, Unidad Farmacol Clin, Valencia, Spain	University of Valencia; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Valencia; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Herrero, MJ (corresponding author), Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain.; Herrero, MJ (corresponding author), Hosp Univ & Politecn La Fe, IIS La Fe, Unidad Farmacogenet, Valencia, Spain.	maria.jose.herrero@uv.es	Montalva, Eva/ABH-7902-2020; Herrero, Maria Jose/M-1649-2014; Marti-Bonmati, Luis/AAF-7107-2020; Lopéz-Andujar, Rafael/ABH-7793-2020; García-Gimeno, María Adelaida/K-9855-2014; Sanz, Pascual/K-2751-2014	Montalva, Eva/0000-0002-8563-1340; Herrero, Maria Jose/0000-0002-6042-4185; Lopéz-Andujar, Rafael/0000-0001-8946-4343; García-Gimeno, María Adelaida/0000-0002-6483-3912; Sanz, Pascual/0000-0002-2399-4103; Diaz Cuevas, Ana/0000-0002-5396-4466; Alino Pellicer, Salvador Francisco/0000-0002-7830-8713; Sendra Gisbert, Luis/0000-0003-3176-9763	Ministerio Espanol de Economia y Competitividad [SAF2011-27002]	Ministerio Espanol de Economia y Competitividad(Spanish Government)	This work has been funded with a Grant from Ministerio Espanol de Economia y Competitividad (ref: SAF2011-27002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL; Alino SF, 2007, GENE THER, V14, P334, DOI 10.1038/sj.gt.3302873; Alino SF, 2003, GENE THER, V10, P1672, DOI 10.1038/sj.gt.3302065; Brown TA, 2002, GENOMES; Budker V, 1996, GENE THER, V3, P593; Carreno O, 2013, EUR SURG RES, V51, P47, DOI 10.1159/000351339; Crespo A, 2005, GENE THER, V12, P927, DOI 10.1038/sj.gt.3302469; Eastman SJ, 2002, HUM GENE THER, V13, P2065, DOI 10.1089/10430340260395910; Fabre JW, 2008, GENE THER, V15, P452, DOI 10.1038/sj.gt.3303079; Fabre JW, 2011, HUM GENE THER, V22, P879, DOI 10.1089/hum.2010.144; Herrero MJ, 2012, GENE THER, V19, P504, DOI 10.1038/gt.2011.144; Herrero MJ, 2005, GENE THER MOL BIOL, V9, P169; Kamimura K, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.52; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Karimi MH, 2015, INT J TRANSPLANT MED, V6, P45; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lodish H, 2000, MOL CELL BIOL; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Sawyer GJ, 2007, GENE THER, V14, P1208, DOI 10.1038/sj.gt.3302976; Sawyer GJ, 2010, GENE THER, V17, P560, DOI 10.1038/gt.2009.167; Sawyer GJ, 2009, CURR GENE THER, V9, P128, DOI 10.2174/156652309787909535; Sendra L, 2016, EUR RADIOL, V26, P95, DOI 10.1007/s00330-015-3792-2; Sendra L, 2014, J GENE MED, V16, P179, DOI 10.1002/jgm.2777; Suda T, 2007, GENE THER, V14, P129, DOI 10.1038/sj.gt.3302865; Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029; Yoshino H, 2006, GENE THER, V13, P1696, DOI 10.1038/sj.gt.3302833; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang GF, 1997, HUM GENE THER, V8, P1763, DOI 10.1089/hum.1997.8.15-1763; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang XH, 2001, HUM GENE THER, V12, P2179, DOI 10.1089/10430340152710522; Zhou TA, 2010, AAPS J, V12, P692, DOI 10.1208/s12248-010-9231-z	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163898	10.1371/journal.pone.0163898	http://dx.doi.org/10.1371/journal.pone.0163898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695064	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100062
J	Bradford, JR; Cox, A; Bernard, P; Camp, NJ				Bradford, James R.; Cox, Angela; Bernard, Philip; Camp, Nicola J.			Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment	PLOS ONE			English	Article							EXPRESSION; HOTAIR; METASTASIS; ANNOTATION; ACTIVATION; PROGNOSIS; ESTROGEN; GENCODE; LNCRNAS; CELLS	Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of cellular processes and diseases such as cancer; however, their functions remain poorly characterised. Several studies have demonstrated that lncRNAs are typically disease and tumour subtype specific, particularly in breast cancer where lncRNA expression alone is sufficient to discriminate samples based on hormone status and molecular intrinsic subtype. However, little attempt has been made to assess the reproducibility of lncRNA signatures across more than one dataset. In this work, we derive consensus lncRNA signatures indicative of breast cancer subtype based on two clinical RNA-Seq datasets: the Utah Breast Cancer Study and The Cancer Genome Atlas, through integration of differential expression and hypothesis-free clustering analyses. The most consistent signature is associated with breast cancers of the basal-like subtype, leading us to generate a putative set of six lncRNA basal-like breast cancer markers, at least two of which may have a role in cis-regulation of known poor prognosis markers. Through in silico functional characterization of individual signatures and integration of expression data from pre-clinical cancer models, we discover that discordance between signatures derived from different clinical cohorts can arise from the strong influence of non-cancerous cells in tumour samples. As a consequence, we identify nine lncRNAs putatively associated with breast cancer associated fibroblasts, or the immune response. Overall, our study establishes the confounding effects of tumour purity on lncRNA signature derivation, and generates several novel hypotheses on the role of lncRNAs in basal-like breast cancers and the tumour microenvironment.	[Bradford, James R.; Cox, Angela] Univ Sheffield, Sheffield Inst Nucle Acids SInFoNiA, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Bernard, Philip] Univ Utah, Dept Pathol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Camp, Nicola J.] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	University of Sheffield; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Bradford, JR (corresponding author), Univ Sheffield, Sheffield Inst Nucle Acids SInFoNiA, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	J.R.Bradford@sheffield.ac.uk		Cox, Angela/0000-0002-5138-1099; Bradford, James/0000-0002-7771-914X	Yorkshire Cancer Research (YCR) [SHEND01/02]; National Cancer Institute [R01 CA163353]; Avon Foundation [02-2009-080]; Komen Foundation [BCTR0706911]; Women's Cancer Disease-Oriented Research Team at Huntsman Cancer Institute; Biospecimen and Pathology Core - Comprehensive Cancer Centre grant [P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA163353] Funding Source: NIH RePORTER	Yorkshire Cancer Research (YCR); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Avon Foundation; Komen Foundation(Susan G. Komen Breast Cancer Foundation); Women's Cancer Disease-Oriented Research Team at Huntsman Cancer Institute; Biospecimen and Pathology Core - Comprehensive Cancer Centre grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JRB is funded by Yorkshire Cancer Research (YCR SHEND01/02). The UBCS data was funded by the National Cancer Institute (R01 CA163353), the Avon Foundation (02-2009-080), and the Komen Foundation (BCTR0706911), and supported by the Women's Cancer Disease-Oriented Research Team at Huntsman Cancer Institute and the Biospecimen and Pathology Core that is partially funded by P30 CA42014 Comprehensive Cancer Centre grant.; JRB is funded by Yorkshire Cancer Research (YCR SHEND01/02). The UBCS data was funded by the National Cancer Institute (R01 CA163353), the Avon Foundation (02-2009-080), and the Komen Foundation (BCTR0706911), and supported by the Women's Cancer Disease-Oriented Research Team at Huntsman Cancer Institute and the Biospecimen and Pathology Core that is partially funded by P30 CA42014 Comprehensive Cancer Centre grant. Thanks are extended to Guoying Wang for technical help, and Brian Dalley of the High Throughput Genomics Core for RNA sequencing. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas managed by the NCI and NHGRI. Information about TCGA can be found at http://cancergenome.nih.gov.	Adriaenssens E, 1998, AM J PATHOL, V153, P1597, DOI 10.1016/S0002-9440(10)65748-3; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beltran AS, 2014, ONCOGENE, V33, P4767, DOI 10.1038/onc.2013.422; Bradford JR, 2016, ONCOTARGET, V7, P20773, DOI 10.18632/oncotarget.8014; Bradford JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066003; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Herrmann P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1022-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; Leek RD, 1996, CANCER RES, V56, P4625; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li KG, 2010, BLOOD, V115, P133, DOI 10.1182/blood-2009-09-242180; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7; Su XP, 2014, ONCOTARGET, V5, P9864, DOI 10.18632/oncotarget.2454; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sun M, 2015, MOL CELL, V59, P698, DOI 10.1016/j.molcel.2015.06.023; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xia HJ, 2013, J BIOL CHEM, V288, P26731, DOI 10.1074/jbc.M113.483958; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang ZW, 2016, J CLIN PATHOL, V69, P76, DOI 10.1136/jclinpath-2015-203275; Zhao WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06591	47	16	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163238	10.1371/journal.pone.0163238	http://dx.doi.org/10.1371/journal.pone.0163238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CV	27685983	Green Published, gold, Green Accepted			2022-12-26	WOS:000384328500031
J	Huovinen, V; Buccil, M; Lipponenl, H; Kiviranta, R; Sandboge, S; Raikol, J; Koskinenl, S; Koskensalol, K; Eriksson, JG; Parkkola, R; Iozzo, P; Nuutila, P				Huovinen, Ville; Buccil, Marco; Lipponenl, Heta; Kiviranta, Riku; Sandboge, Samuel; Raikol, Juho; Koskinenl, Suvi; Koskensalol, Kalle; Eriksson, Johan G.; Parkkola, Riitta; Iozzo, Patricia; Nuutila, Pirjo			Femoral Bone Marrow Insulin Sensitivity Is Increased by Resistance Training in Elderly Female Offspring of Overweight and Obese Mothers	PLOS ONE			English	Article							ADIPOSE-TISSUE; SKELETAL-MUSCLE; GLUCOSE-UPTAKE; MATERNAL OBESITY; MINERAL DENSITY; MR SPECTROSCOPY; FAT-CONTENT; SECRETION; BIOMARKER; STRENGTH	Bone marrow insulin sensitivity may be an important factor for bone health in addition to bone mineral density especially in insulin resistant conditions. First we aimed to study if prenatal maternal obesity plays a role in determining bone marrow insulin sensitivity in elderly female offspring. Secondly we studied if a four-month individualized resistance training intervention increases bone marrow insulin sensitivity in elderly female offspring and whether this possible positive outcome is regulated by the offspring's mother's obesity status. 37 frail elderly females (mean age 71.9 +/- 3.1 years) of which 20 were offspring of lean/normal-weight mothers (OLM, maternal BMI <= 26.3 kg/m(2)) and 17 were offspring of obese/overweight mothers (OOM, maternal BMI >= 28.1 kg/m(2)) were studied before and after a four-month individualized resistance training intervention. Nine age-and sex-matched non-frail controls (maternal BMI <= 26.3 kg/m(2)) were studied at baseline. Femoral bone marrow (FBM) and vertebral bone marrow (VBM) insulin sensitivity were measured using [F-18] fluoro-2-deoxy-D-glucose positron emission tomography with computer tomography under hyperinsulinemic euglycemic clamp. We found that bone marrow insulin sensitivity was not related to maternal obesity status but FBM insulin sensitivity correlated with whole body insulin sensitivity (R = 0.487, p = 0.001). A four-month resistance training intervention increased FBM insulin sensitivity by 47% (p = 0.006) only in OOM, while VBM insulin sensitivity remained unchanged regardless of the maternal obesity status. In conclusion, FBM and VBM glucose metabolism reacts differently to a four-month resistance training intervention in elderly women according to their maternal obesity status.	[Huovinen, Ville; Buccil, Marco; Lipponenl, Heta; Raikol, Juho; Koskinenl, Suvi; Koskensalol, Kalle; Parkkola, Riitta; Iozzo, Patricia; Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland; [Huovinen, Ville; Parkkola, Riitta] Univ Turku, Dept Radiol, Turku, Finland; [Huovinen, Ville; Parkkola, Riitta] Turku Univ Hosp, Turku, Finland; [Kiviranta, Riku; Nuutila, Pirjo] Turku Univ Hosp, Dept Endocrinol, Turku, Finland; [Kiviranta, Riku] Univ Turku, Dept Med, Turku, Finland; [Kiviranta, Riku] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Sandboge, Samuel] Folkhalsan Res Ctr, Helsinki, Finland; [Sandboge, Samuel; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp Finland, Helsinki, Finland; [Iozzo, Patricia] CNR, Inst Clin Physiol, Pisa, Italy	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Folkhalsan Research Center; Finland National Institute for Health & Welfare; University of Helsinki; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Nuutila, P (corresponding author), Univ Turku, Turku PET Ctr, Turku, Finland.; Nuutila, P (corresponding author), Turku Univ Hosp, Dept Endocrinol, Turku, Finland.	pirnuu@utu.fi	Bucci, Marco/C-5130-2009; Parkkola, Riitta/AAZ-1341-2020	Bucci, Marco/0000-0002-5206-8651; Nuutila, Pirjo/0000-0001-9597-338X; Koskensalo, Kalle/0000-0001-8026-1099; Eriksson, Johan/0000-0002-2516-2060; Sandboge, Samuel/0000-0003-1354-4026	DORIAN EU FP7 (DORIAN: Developmental ORIgins of healthy and unhealthy AgeiNg: The role of maternal obesity) [278603]; Turku University Foundation; Medical Imaging Centre of Southwest Finland; Turku University Hospital; Emil Aaltonen foundation; Radiological society of Finland; Foundation of Uulo Arhio	DORIAN EU FP7 (DORIAN: Developmental ORIgins of healthy and unhealthy AgeiNg: The role of maternal obesity); Turku University Foundation; Medical Imaging Centre of Southwest Finland; Turku University Hospital; Emil Aaltonen foundation; Radiological society of Finland; Foundation of Uulo Arhio	This study was supported by funding from the DORIAN EU FP7, project number 278603 (DORIAN: Developmental ORIgins of healthy and unhealthy AgeiNg: The role of maternal obesity). The analysis and writing work were supported by Turku University Foundation, Medical Imaging Centre of Southwest Finland and Turku University Hospital, Emil Aaltonen foundation, Radiological society of Finland and Foundation of Uulo Arhio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2008, CURR PHARM DESIGN, V14, P405; Armamento-Villareal R, 2014, OSTEOPOROSIS INT, V25, P551, DOI 10.1007/s00198-013-2450-2; Baum T, 2012, J MAGN RESON IMAGING, V35, P117, DOI 10.1002/jmri.22757; Bucci M, 2016, DIABETOLOGIA, V59, P77, DOI 10.1007/s00125-015-3780-8; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chilibeck PD, 2014, MED SCI SPORTS EXERC; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Devlin MJ, 2015, LANCET DIABETES ENDO, V3, P141, DOI 10.1016/S2213-8587(14)70007-5; Epley B, 1985, B EPLEY WORKOUT; Eriksson JG, 2014, ANN MED, V46, P434, DOI 10.3109/07853890.2014.919728; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Guillerman RP, 2013, PEDIATR RADIOL, V43, pS181, DOI 10.1007/s00247-012-2582-0; Hamacher K, J NUCL MED; Huovinen V, 2014, BONE, V61, P33, DOI 10.1016/j.bone.2013.12.022; Iozzo P, 2014, OBESITY FACTS, V7, P130, DOI 10.1159/000362656; Krentz AJ, 2013, DIABETIC MED, V30, P535, DOI 10.1111/dme.12063; Kugel H, 2001, J MAGN RESON IMAGING, V13, P263, DOI 10.1002/1522-2586(200102)13:2<263::AID-JMRI1038>3.3.CO;2-D; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Ma HT, 2014, OSTEOPOROSIS INT, V25, P999, DOI 10.1007/s00198-013-2482-7; Machann J, 2008, EUR J RADIOL, V67, P275, DOI 10.1016/j.ejrad.2008.02.032; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; MOORE SG, 1990, RADIOLOGY, V175, P219, DOI 10.1148/radiology.175.1.2315484; NUUTILA P, 1992, J CLIN INVEST, V89, P1767, DOI 10.1172/JCI115780; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Patsch JM, 2013, J BONE MINER RES, V28, P1721, DOI 10.1002/jbmr.1950; Peltoniemi P, 2000, AM J PHYSIOL-ENDOC M, V279, pE1122, DOI 10.1152/ajpendo.2000.279.5.E1122; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Reichkendler MH, 2013, AM J PHYSIOL-ENDOC M, V305, pE496, DOI 10.1152/ajpendo.00128.2013; Roldan-Valadez E, 2013, EUR J RADIOL, V82, pE697, DOI 10.1016/j.ejrad.2013.07.012; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schwartz AV, 2013, J CLIN ENDOCR METAB, V98, P2294, DOI 10.1210/jc.2012-3949; Sundell J, 2011, ADV PREV MED, V2011, DOI DOI 10.4061/2011/984683; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Vaag A, 2014, ACTA OBSTET GYN SCAN, V93, P1099, DOI 10.1111/aogs.12494; Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Zhang YJ, 2012, BIOCHEM CELL BIOL, V90, P613, DOI [10.1139/O2012-022, 10.1139/o2012-022]	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2016	11	9							e0163723	10.1371/journal.pone.0163723	http://dx.doi.org/10.1371/journal.pone.0163723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX1ZV	27669153	Green Published, gold, Green Submitted			2022-12-26	WOS:000384167300066
J	Richards, KE; Zeleniak, AE; Fishel, ML; Wu, J; Littlepage, LE; Hill, R				Richards, K. E.; Zeleniak, A. E.; Fishel, M. L.; Wu, J.; Littlepage, L. E.; Hill, R.			Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; ANTITUMOR-ACTIVITY; KAPPA-B; GEMCITABINE; RESISTANCE; CHEMOTHERAPY; METASTASIS; MICROENVIRONMENT; INHIBITION; TARGET	Cancer-associated fibroblasts (CAFs) comprise the majority of the tumor bulk of pancreatic ductal adenocarcinomas (PDACs). Current efforts to eradicate these tumors focus predominantly on targeting the proliferation of rapidly growing cancer epithelial cells. We know that this is largely ineffective with resistance arising in most tumors following exposure to chemotherapy. Despite the long-standing recognition of the prominence of CAFs in PDAC, the effect of chemotherapy on CAFs and how they may contribute to drug resistance in neighboring cancer cells is not well characterized. Here, we show that CAFs exposed to chemotherapy have an active role in regulating the survival and proliferation of cancer cells. We found that CAFs are intrinsically resistant to gemcitabine, the chemotherapeutic standard of care for PDAC. Further, CAFs exposed to gemcitabine significantly increase the release of extracellular vesicles called exosomes. These exosomes increased chemoresistance-inducing factor, Snail, in recipient epithelial cells and promote proliferation and drug resistance. Finally, treatment of gemcitabine-exposed CAFs with an inhibitor of exosome release, GW4869, significantly reduces survival in co-cultured epithelial cells, signifying an important role of CAF exosomes in chemotherapeutic drug resistance. Collectively, these findings show the potential for exosome inhibitors as treatment options alongside chemotherapy for overcoming PDAC chemoresistance.	[Richards, K. E.; Zeleniak, A. E.; Hill, R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Richards, K. E.; Zeleniak, A. E.; Wu, J.; Littlepage, L. E.; Hill, R.] Univ Notre Dame, Harper Canc Res Inst, Dept Biol Sci, South Bend, IN USA; [Zeleniak, A. E.; Littlepage, L. E.; Hill, R.] Univ Notre Dame, Integrated Biomed Sci Program, South Bend, IN USA; [Fishel, M. L.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Fishel, M. L.] Indiana Univ, Dept Pharmacol, Indianapolis, IN 46204 USA; [Fishel, M. L.; Littlepage, L. E.; Hill, R.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Fishel, M. L.] Indiana Univ, Dept Toxicol, Indianapolis, IN 46204 USA; [Wu, J.; Littlepage, L. E.] Univ Notre Dame, Dept Chem, Notre Dame, IN 46556 USA; [Wu, J.; Littlepage, L. E.] Univ Notre Dame, Dept Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Notre Dame; University of Notre Dame	Hill, R (corresponding author), Harper Canc Res Inst, Dept Biol Sci, A126 Harper Hall,1234 North Notre Dame Ave, South Bend, IN 46617 USA.	rhill3@nd.edu	Hill, Reginald/D-2270-2016; Fishel, Melissa L./AAH-6608-2020	Fishel, Melissa L./0000-0002-9436-6382; Zeleniak, Ann/0000-0002-7974-9617	Indiana CTSI; Harper Cancer Research Institute of Notre Dame; Walther Cancer Foundation; Joseph D Boyle Memorial Fund; National Institutes of Health, NCI [CA167291]; Biomedical Research Grant; Jeff Gordon Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA167291] Funding Source: NIH RePORTER	Indiana CTSI; Harper Cancer Research Institute of Notre Dame; Walther Cancer Foundation; Joseph D Boyle Memorial Fund; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomedical Research Grant; Jeff Gordon Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Robert Stahelin of the Indiana University School of Medicine for generously allowing us to use his particle analyzer and ultracentrifuge, Dr Niranjan Awasthi of the Indiana University School of Medicine-South Bend for helpful discussions and Dr Steven Ruggiero of the University of Notre Dame for allowing us to perform light transmission spectroscopy in his lab. This research was funded by the Indiana CTSI and Harper Cancer Research Institute of Notre Dame.; Financial Information: R Hill was awarded financial support from the Walther Cancer Foundation and the Joseph D Boyle Memorial Fund. Work by ML Fishel was supported by grants from the National Institutes of Health, NCI CA167291, with additional support from the Biomedical Research Grant and in part by Jeff Gordon Children's Foundation.	Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arora S, 2013, J BIOL CHEM, V288, P21197, DOI 10.1074/jbc.M113.484576; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330; Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Chernyshev VS, 2015, ANAL BIOANAL CHEM, V407, P3285, DOI 10.1007/s00216-015-8535-3; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Gifford JB, 2016, MOL CANCER THER, V15, P1043, DOI 10.1158/1535-7163.MCT-15-0774; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125625; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Kadera BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071978; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lee TH, 2014, BIOCHEM BIOPH RES CO, V451, P295, DOI 10.1016/j.bbrc.2014.07.109; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mirjam C Boelens, CELL, V159, P499; Namba T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.172; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Quint K, 2012, INT J ONCOL, V41, P2093, DOI 10.3892/ijo.2012.1648; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ray Katrina, 2015, Nat Rev Gastroenterol Hepatol, V12, P371, DOI 10.1038/nrgastro.2015.93; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Sun N, 2015, ANAL BIOCHEM, V484, P58, DOI 10.1016/j.ab.2015.05.004; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	40	417	445	15	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1770	1778		10.1038/onc.2016.353	http://dx.doi.org/10.1038/onc.2016.353			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27669441	Green Submitted, Green Accepted			2022-12-26	WOS:000398128900003
J	Uo, T; Dvinge, H; Sprenger, CC; Bradley, RK; Nelson, PS; Plymate, SR				Uo, T.; Dvinge, H.; Sprenger, C. C.; Bradley, R. K.; Nelson, P. S.; Plymate, S. R.			Systematic and functional characterization of novel androgen receptor variants arising from alternative splicing in the ligand-binding domain	ONCOGENE			English	Article							HEAT-SHOCK PROTEIN; PROSTATE-CANCER; GLUCOCORTICOID-RECEPTOR; NUCLEAR-LOCALIZATION; INCREASED SURVIVAL; RESISTANCE; ENZALUTAMIDE; ABIRATERONE; ACTIVATION; EXPRESSION	The presence of intact ligand-binding domain (LBD) ensures the strict androgen-dependent regulation of androgen receptor (AR): binding of androgen induces structural reorganization of LBD resulting in release of AR from HSP90, suppression of nuclear export which otherwise dominates over import and nuclear translocation of AR as a transcription factor. Thus, loss or defects of the LBD abolish constraint from un-liganded LBD as exemplified by constitutively active AR variants (AR-Vs), which are associated with emerging resistance mechanism to anti-AR therapy in castration-resistant prostate cancer (mCRPC). Recent analysis of the AR splicing landscapes revealed mCRPC harboring multiple AR-Vs with diverse patterns of inclusion/exclusion of exons (exons 4-8) corresponding to LBD to produce namely exon-skipping variants. In silico construction for these AR-Vs revealed four novel AR-Vs having unique features: Exclusion of specified exons introduces a frameshift in variants v5es, v6es and v7es. ARv56es maintains the reading frame resulting in the inclusion of the C-terminal half of the LBD. We systematically characterized these AR-Vs regarding their subcellular localization, affinity for HSP90 and transactivation capability. Notably, ARv5es was free from HSP90, exclusively nuclear, and constitutively active similarly as previously reported for v567es. In contrast, v6es and v7es were similar in that they are cytoplasmic, transcriptionally inactive and bind HSP90, ARv56es was present in both nucleus and cytoplasm, does not bind HSP90 and is transcriptionally inactive. Converting these transcriptionally inactive AR-Vs into active forms, we identified the two separate elements that allosterically suppress otherwise constitutively active AR-Vs; one in exon 5 for v6es and v7es and the other in exon 8 for v56es. Our findings identify a novel constitutively active AR-V, ARv5es and establish a method to predict potential activities of AR-Vs carrying impaired LBD.	[Uo, T.; Dvinge, H.; Plymate, S. R.] Univ Washington, Dept Med, Harborview Res & Training Bldg,Box 359625,325 9th, Seattle, WA 98195 USA; [Dvinge, H.; Bradley, R. K.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA; [Dvinge, H.; Bradley, R. K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Nelson, P. S.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Plymate, SR (corresponding author), Univ Washington, Dept Med, Harborview Res & Training Bldg,Box 359625,325 9th, Seattle, WA 98195 USA.	splymate@u.washington.edu		Bradley, Robert/0000-0002-8046-1063; Dvinge, Heidi/0000-0003-1741-0738	Department of Defense [W81XWH-12-PCRP-TIA]; Veterans Affairs Research Program; National Cancer of Institute [P01CA163227, P50 CA 097186]; NATIONAL CANCER INSTITUTE [P50CA097186, P01CA163227] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003324] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Veterans Affairs Research Program; National Cancer of Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Defense (W81XWH-12-PCRP-TIA), Veterans Affairs Research Program (to SRP) and National Cancer of Institute (P01CA163227, P50 CA 097186) (to SRP and PSN).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; An J, 2014, CELL REP, V6, P657, DOI 10.1016/j.celrep.2014.01.013; Antonarakis ES, 2015, JAMA ONCOL, V1, P582, DOI 10.1001/jamaoncol.2015.1341; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Cao B, 2014, ONCOTARGET, V5, P1646, DOI 10.18632/oncotarget.1802; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; DALMAN FC, 1991, J BIOL CHEM, V266, P3482; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; Dehm SM, 2011, ENDOCR-RELAT CANCER, V18, pR183, DOI 10.1530/ERC-11-0141; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Gillis JL, 2013, ONCOTARGET, V4, P691, DOI 10.18632/oncotarget.975; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Liu LL, 2014, ONCOGENE, V33, P3140, DOI 10.1038/onc.2013.284; Lu CX, 2013, TRANSL ANDROL UROL, V2, P178, DOI 10.3978/j.issn.2223-4683.2013.09.08; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MARIVOET S, 1992, MOL CELL ENDOCRINOL, V88, P165, DOI 10.1016/0303-7207(92)90021-W; Mostaghel EA, 2014, CLIN CANCER RES, V20, P791, DOI 10.1158/1078-0432.CCR-12-3601; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sprenger CCT, 2014, HORM CANCER-US, V5, P207, DOI 10.1007/s12672-014-0177-y; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; TAKAHASHI H, 1995, CANCER RES, V55, P1621; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Thadani-Mulero M, 2014, CANCER RES, V74, P2270, DOI 10.1158/0008-5472.CAN-13-2876; van Soest RJ, 2013, EUR J CANCER, V49, P3821, DOI 10.1016/j.ejca.2013.09.026; Wang D, 2015, MOL ENDOCRINOL, V29, P1731, DOI 10.1210/me.2015-1112; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; WEN W, 1994, J BIOL CHEM, V269, P32214; Xu D, 2015, CANCER RES, V75, P3663, DOI 10.1158/0008-5472.CAN-15-0381; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Zhang GY, 2015, ONCOTARGET, V6, P23358, DOI 10.18632/oncotarget.4396; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	58	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1440	1450		10.1038/onc.2016.313	http://dx.doi.org/10.1038/onc.2016.313			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27694897	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000395862500012
J	Al-Mohaissen, MA; Carere, RG; Mancini, GBJ; Humphries, KH; Whalen, BA; Lee, T; Scheuermeyer, FX; Ignaszewski, AP				Al-Mohaissen, Maha A.; Carere, Ronald G.; Mancini, G. B. John; Humphries, Karin H.; Whalen, Beth A.; Lee, Terry; Scheuermeyer, Frank X.; Ignaszewski, Andrew P.			A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; PLASMA-PROTEIN; INFLAMMATORY MARKERS; UNSTABLE ANGINA; EARLY-DIAGNOSIS; ARTERY-DISEASE; PREGNANCY; INTERLEUKIN-6; ASSAY	Background Markers of plaque destabilization and disruption may have a role in identifying non-STE-type 1 Myocardial Infarction in patients presenting with troponin elevation. We hypothesized that a plaque disruption index (PDI) derived from multiple biomarkers and measured within 24 hours from the first detectable troponin in patients with acute non-STE-type 1 MI (NSTEMI-A) will confirm the diagnosis and identify these patients with higher specificity when compared to individual markers and coronary angiography. Methods We examined 4 biomarkers of plaque destabilization and disruption: myeloperoxidase (MPO), high-sensitivity interleukin-6, myeloid-related protein 8/14 (MRP8/14) and pregnancy-associated plasma protein-A (PAPP-A) in 83 consecutive patients in 4 groups: stable non-obstructive coronary artery disease (CAD), stable obstructive CAD, NSTEMI-A (enrolled within 24 hours of troponin positivity), and NSTEMI-L (Late presentation NSTEMI, enrolled beyond the 24 hour limit). The PDI was calculated and the patients' coronary angiograms were reviewed for evidence of plaque disruption. The diagnostic performance of the PDI and angiography were compared. Results Compared to other biomarkers, MPO had the highest specificity (83%) for NSTEMI-A diagnosis (P<0.05). The PDI computed from PAPP-A, MRP8/14 and MPO was higher in NSTEMI-A patients compared to the other three groups (p<0.001) and had the highest diagnostic specificity (87%) with 79% sensitivity and 86% accuracy, which were higher compared to those obtained with MPO, but did not reach statistical significance (P>0.05 for all comparisons). The PDI had higher specificity and accuracy for NSTEMI-A diagnosis compared to coronary angiography (P<0.05). Conclusions A PDI measured within 24 hour of troponin positivity has potential to identify subjects with acute Non-ST-elevation type 1 MI. Additional evidence using other marker combinations and investigation in a sufficiently large non-selected cohort is warranted to establish the diagnostic accuracy of the PDI and its potential role in differentiating type 1 and type 2 MI in patients presenting with troponin elevation of uncertain etiology.	[Al-Mohaissen, Maha A.] Princess Nourah Bint Abdul Rahman Univ, Dept Clin Sci, Riyadh, Saudi Arabia; [Carere, Ronald G.; Humphries, Karin H.; Ignaszewski, Andrew P.] St Pauls Hosp, Dept Med, Div Cardiol, Vancouver, BC, Canada; [Carere, Ronald G.; Humphries, Karin H.; Whalen, Beth A.; Lee, Terry; Scheuermeyer, Frank X.; Ignaszewski, Andrew P.] Univ British Columbia, Vancouver, BC, Canada; [Mancini, G. B. John] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Whalen, Beth A.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Lee, Terry] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Scheuermeyer, Frank X.] St Pauls Hosp, Dept Emergency Med, Vancouver, BC, Canada	Princess Nourah bint Abdulrahman University; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan	Al-Mohaissen, MA (corresponding author), Princess Nourah Bint Abdul Rahman Univ, Dept Clin Sci, Riyadh, Saudi Arabia.	mahaabdulrahman@hotmail.com	Al-Mohaissen, Maha/GQO-9962-2022					Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Blich M, 2008, AM J CARDIOL, V101, P1384, DOI 10.1016/j.amjcard.2008.01.011; Chan CPY, 2013, ADV CLIN CHEM, V59, P23, DOI 10.1016/B978-0-12-405211-6.00002-4; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; Ferrante G, 2010, CIRCULATION, V122, P2505, DOI 10.1161/CIRCULATIONAHA.110.955302; Fredericks S, 2006, CLIN CHEM, V52, P1619, DOI 10.1373/clinchem.2006.074138; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hayashida K, 2005, CIRCULATION, V112, P812, DOI 10.1161/CIRCULATIONAHA.104.468397; Ikonomidis I, 2012, BIOFACTORS, V38, P320, DOI 10.1002/biof.1024; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Lodh M, 2012, CARDIOVASC J AFR, V23, P330, DOI 10.5830/CVJA-2012-008; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Mancini GBJ, 2009, CIRC-CARDIOVASC QUAL, V2, P320, DOI 10.1161/CIRCOUTCOMES.108.830091; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Reichlin T, 2015, CAN MED ASSOC J, V187, pE243, DOI 10.1503/cmaj.141349; Rudolph V, 2012, CIRC-CARDIOVASC GENE, V5, P561, DOI 10.1161/CIRCGENETICS.111.962290; Rudolph V, 2011, INT J CARDIOL, V153, P267, DOI 10.1016/j.ijcard.2010.08.015; Schoos M, 2009, SCAND J CLIN LAB INV, V69, P121, DOI 10.1080/00365510802439080; SU JQ, 1993, J AM STAT ASSOC, V88, P1350; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Twerenbold R, 2015, CIRCULATION, V131, P2041, DOI 10.1161/CIRCULATIONAHA.114.014245; Waxman S, 2003, AM J CARDIOL, V92, P16, DOI 10.1016/S0002-9149(03)00457-0; Wittfooth S, 2011, CLIN CHIM ACTA, V412, P376, DOI 10.1016/j.cca.2010.11.024; Wlazel RN, 2013, ARCH MED SCI, V9, P14, DOI 10.5114/aoms.2013.33343; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Zhelev Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h15	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164315	10.1371/journal.pone.0164315	http://dx.doi.org/10.1371/journal.pone.0164315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711184	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600117
J	Perera, BPU; Kim, J				Perera, Bambarendage P. U.; Kim, Joomyeong			Sex and Tissue Specificity of Peg3 Promoters	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; CANCER-CELL-LINES; IMPRINTED DOMAIN; METHYLATION; EXPRESSION; BEHAVIOR; GROWTH	The expression of mouse Peg3 (Paternally expressed gene 3) is driven by 4 promoters, including its main and three alternative promoters. The sexual, temporal and spatial specificity of these promoters was characterized in the current study. According to the results, the main promoter displays ubiquitous expression patterns throughout different stages and tissues. In contrast, the expression of Peg3 driven by the alternative promoter U2 was detected mainly in muscle and skin, but not in brain, starting from the late embryonic stage, revealing its tissue and stage specificity. The expression levels of both the main and U2 promoters are also sexually biased: the levels in females start higher but become lower than those in males during early postnatal stages. As an imprinted locus, the paternal alleles of these promoters are active whereas the maternal alleles are silent. Interestingly, deletion of the repressed maternal allele of the main promoter has an unusual effect on the opposite paternal allele, causing the up-regulation of both the main and U2 promoters. Overall, the promoters of Peg3 derive sexually biased and tissue-specific expression patterns.	[Perera, Bambarendage P. U.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Perera, Bambarendage/0000-0002-7774-0985	National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (JK R01-GM066225, R01-GM097074).	Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; Gore AC, 2014, ENDOCR REV, V35, P961, DOI 10.1210/er.2013-1122; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Janssen AB, 2016, PSYCHOL MED, V46, P2999, DOI 10.1017/S0033291716001598; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154216; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Mozhui K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00063; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Veselovska L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0769-z; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164158	10.1371/journal.pone.0164158	http://dx.doi.org/10.1371/journal.pone.0164158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711129	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600090
J	Masini, EO; Mansour, O; Speer, CE; Addona, V; Hanson, CL; Sitienei, JK; Kipruto, HK; Githiomi, MM; Mungai, BN				Masini, Enos O.; Mansour, Omar; Speer, Clare E.; Addona, Vittorio; Hanson, Christy L.; Sitienei, Joseph K.; Kipruto, Hillary K.; Githiomi, Martin Muhingo; Mungai, Brenda Nyambura			Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya	PLOS ONE			English	Article							TRIAL; HIV	Despite high tuberculosis (TB) treatment success rate, treatment adherence is one of the major obstacles to tuberculosis control in Kenya. Our objective was to identify patient-related factors that were associated with time to TB treatment interruption and the geographic distribution of the risk of treatment interruption by county. Data of new and retreatment patients registered in TIBU, a Kenyan national case-based electronic data recording system, between 2013 and 2014 was obtained. Kaplan-Meier curves and log rank tests were used to assess the adherence patterns. Mixed-effects Cox proportional hazards modeling was used for multivariate analysis. Records from 90,170 patients were included in the study. The cumulative incidence of treatment interruption was 4.5% for new patients, and 8.5% for retreatment patients. The risk of treatment interruption was highest during the intensive phase of treatment. Having previously been lost to follow-up was the greatest independent risk factor for treatment interruption (HR: 4.79 [3.99, 5.75]), followed by being HIV-positive not on ART (HR: 1.96 [1.70, 2.26]) and TB relapse (HR: 1.70 [1.44, 2.00]). Male and underweight patients had high risks of treatment interruption (HR: 1.46 [1.35, 1.58]; 1.11 [1.03, 1.20], respectively). High rates of treatment interruption were observed in counties in the central part of Kenya while counties in the northeast had the lowest risk of treatment interruption. A better understanding of treatment interruption risk factors is necessary to improve adherence to treatment. Interventions should focus on patients during the intensive phase, patients who have previously been lost to follow-up, and promotion of integrated TB and HIV services among public and private facilities.	[Masini, Enos O.; Sitienei, Joseph K.; Githiomi, Martin Muhingo] Minist Hlth, Nairobi, Kenya; [Mansour, Omar; Speer, Clare E.; Addona, Vittorio; Hanson, Christy L.] Macalester Coll, St Paul, MN 55105 USA; [Kipruto, Hillary K.] World Hlth Org, Nairobi, Kenya; [Mungai, Brenda Nyambura] Ctr Hlth Solut, Nairobi, Kenya	Macalester College; World Health Organization	Mansour, O (corresponding author), Macalester Coll, St Paul, MN 55105 USA.	omar.mansour19@gmail.com	Kipruto, Hillary/ABB-7126-2021; Addona, Vittorio/T-2114-2019		World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, SUSTAINABLE DEV GOAL, V19; Atkins S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-275; Beith A, 2007, PERFORMANCE BASED IN; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Finlay A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-56; Garden B, 2013, SCAND J CARING SCI, V27, P117, DOI 10.1111/j.1471-6712.2012.01009.x; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Lee ET, 1997, ANNU REV PUBL HEALTH, V18, P105, DOI 10.1146/annurev.publhealth.18.1.105; Martins N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4248; Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease., 2014, NTLD PROGR ANN REP 2; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease, 2010, NTLD PROGR ANN REP 2; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease, 2013, GUID MAN TUB LEPR KE; Ministry of Health: Division ofLeprosy Tuberculosis and Lung Disease., 2016, THE TIBU IN; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Piwoz E., 2008, NUTR TUBERCULOSIS RE, P1; R Core Team, 2013, R LANG ENV STAT COMP; Schon T, 2011, TUBERCULOSIS, V91, P370, DOI 10.1016/j.tube.2011.06.002; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Ullah ANZ, 2012, INT J TUBERC LUNG D, V16, P1637, DOI 10.5588/ijtld.12.0378; Vijay S, 2015, INDIAN J TUBERCULOSI, V50, P185; Vuluku G, 2013, ECONOMICS, V2, P7; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, TUB COUNTR PROF KEN	29	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164172	10.1371/journal.pone.0164172	http://dx.doi.org/10.1371/journal.pone.0164172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706230	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200094
J	Tahara, T; Shibata, T; Horiguchi, N; Kawamura, T; Okubo, M; Ishizuka, T; Nagasaka, M; Nakagawa, Y; Ohmiya, N				Tahara, Tomomitsu; Shibata, Tomoyuki; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki			A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication	PLOS ONE			English	Article							MONGOLIAN GERBILS; FOLLOW-UP; INFECTION; CARCINOGENESIS; CARCINOMA; ULCER; RISK	Background The effect of H. pylori eradication in gastric cancer prevention can be attributed to the improvement of atrophic gastritis, which is a known risk of gastric cancer. However, gastric cancer has also been diagnosed after long-term H. pylori eradication. This study aimed to clarify the association between gastric atrophy and gastric cancer after H. pylori eradication, including its clinicopathological features. Methods A total of 55 consecutive patients with 64 early gastric cancers (EGCs) diagnosed after H. pylori eradication were enrolled. The degree of endoscopic atrophy and the histological degrees of mononuclear cell infiltration, atrophy, and metaplasia in the corpus and adjacent mucosa of the EGCs were determined and scored. Results The majority of EGCs (63/64) were located within the endoscopically assessed atrophic mucosa or along the atrophic border. The adjacent mucosa of the EGCs presented significantly higher degrees of all histological parameters than in the corpus (mononuclear cell infiltration, 0.86+/-0.09 vs. 0.51+/-0.11, P = 0.016; atrophy, 1.77+/-0.13 vs. 0.65+/-0.14, P<0.0001; metaplasia, 1.68+/-0.13 vs. 0.48+/-0.1, P<0.0001). The degree of endoscopic atrophy improved in the patients with longer post-H. pylori eradication periods; however, this trend was not observed for the histological parameters, and high degrees of atrophy and metaplasia were observed in the adjacent mucosa of the EGCs compared with the corpus during all periods (all P<0.05). The histological degrees of atrophy and metaplasia in the adjacent mucosa were particularly higher in the patients who underwent eradication due to gastric ulcers. Conclusions Severe gastric atrophy remained in the adjacent mucosa of the EGCs after H. pylori eradication, which may be linked to gastric carcinogenesis.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan	Fujita Health University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan.	tomomiccyu@yahoo.co.jp						CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Hanaoka N, 2010, J GASTROEN HEPATOL, V25, P1844, DOI 10.1111/j.1440-1746.2010.06442.x; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ito M, 2005, ALIMENT PHARM THER, V21, P559, DOI 10.1111/j.1365-2036.2005.02360.x; Kamada T, 2005, ALIMENT PHARM THER, V21, P1121, DOI 10.1111/j.1365-2036.2005.02459.x; Kimura K, 1973, ENDOSCOPY, V5, P21, DOI DOI 10.1055/S-0028-1098086; Kobayashi M, 2013, J GASTROENTEROL, V48, P1332, DOI 10.1007/s00535-013-0764-7; LEE S, 1990, SCAND J GASTROENTERO, V25, P1223, DOI 10.3109/00365529008998557; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Saka A, 2015, GASTRIC CANCER, DOI [10.1016/j.gie.2015.03.1860, DOI 10.1016/J.GIE.2015.03.1860]; Shimizu N, 2000, CANCER RES, V60, P1512; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamamoto K, 2011, HELICOBACTER, V16, P210, DOI 10.1111/j.1523-5378.2011.00833.x	18	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163700	10.1371/journal.pone.0163700	http://dx.doi.org/10.1371/journal.pone.0163700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706195	gold, Green Submitted, Green Published			2022-12-26	WOS:000385697200055
J	Flowerika; Alok, A; Kumar, J; Thakur, N; Pandey, A; Pandey, AK; Upadhyay, SK; Tiwari, S				Flowerika; Alok, Anshu; Kumar, Jitesh; Thakur, Neha; Pandey, Ashutosh; Pandey, Ajay Kumar; Upadhyay, Santosh Kumar; Tiwari, Siddharth			Characterization and Expression Analysis of Phytoene Synthase from Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CAROTENOID BIOSYNTHETIC-PATHWAY; LIGHT-DEPENDENT REGULATION; GENE FAMILY; CDNA CLONING; ARABIDOPSIS; LYCOPENE; ENZYMES; CAROTENOGENESIS; PROVITAMIN; EVOLUTION	Phytoene synthase (PSY) regulates the first committed step of the carotenoid biosynthetic pathway in plants. The present work reports identification and characterization of the three PSY genes (TaPSY1, TaPSY2 and TaPSY3) in wheat (Triticum aestivum L.). The TaPSY1, TaPSY2, and TaPSY3 genes consisted of three homoeologs on the long arm of group 7 chromosome (7L), short arm of group 5 chromosome (5S), and long arm of group 5 chromosome (5L), respectively in each subgenomes (A, B, and D) with a similarity range from 89% to 97%. The protein sequence analysis demonstrated that TaPSY1 and TaPSY3 retain most of conserved motifs for enzyme activity. Phylogenetic analysis of all TaPSY revealed an evolutionary relationship among PSY proteins of various monocot species. TaPSY derived from A and D subgenomes shared proximity to the PSY of Triticum urartu and Aegilops tauschii, respectively. The differential expression of TaPSY1, TaPSY2, and TaPSY3 in the various tissues, seed development stages, and stress treatments suggested their role in plant development, and stress condition. TaPSY3 showed higher expression in all tissues, followed by TaPSY1. The presence of multiple stress responsive cis-regulatory elements in promoter region of TaPSY3 correlated with the higher expression during drought and heat stresses has suggested their role in these conditions. The expression pattern of TaPSY3 was correlated with the accumulation of a-carotene in the seed developmental stages. Bacterial complementation assay has validated the functional activity of each TaPSY protein. Hence, TaPSY can be explored in developing genetically improved wheat crop.	[Flowerika; Alok, Anshu; Kumar, Jitesh; Thakur, Neha; Pandey, Ashutosh; Pandey, Ajay Kumar; Tiwari, Siddharth] Govt India, Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol, C-127,Ind Area,Phase 8, Mohali 160071, Punjab, India; [Upadhyay, Santosh Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Flowerika] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University; Panjab University	Tiwari, S (corresponding author), Govt India, Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol, C-127,Ind Area,Phase 8, Mohali 160071, Punjab, India.; Upadhyay, SK (corresponding author), Panjab Univ, Dept Bot, Chandigarh 160014, India.	santoshpandit16@gmail.com; siddharthdna20@yahoo.com	Upadhyay, Santosh/ABD-2302-2020; Alok, Anshu/AAA-2100-2020; Kumar, Jitesh/ABB-5150-2021; Tiwari, Siddharth/AAC-5135-2020; Tiwari, Siddharth/V-3054-2017	Upadhyay, Santosh/0000-0001-6991-0502; Kumar, Jitesh/0000-0003-1606-3420; Tiwari, Siddharth/0000-0003-3958-8465; Tiwari, Siddharth/0000-0003-3958-8465; Pandey, Ashutosh/0000-0002-5018-9628; Alok, Dr. Anshu/0000-0002-0733-9117; Pandey, Ajay Kumar/0000-0003-1064-139X	NABI CORE Research Grant; SERB, DST (Government of India) for Young Scientist Start up Research Grant [SB/YS/LS-214/2013]; DST (Government of India)	NABI CORE Research Grant; SERB, DST (Government of India) for Young Scientist Start up Research Grant; DST (Government of India)(Department of Science & Technology (India))	This study was funded by NABI CORE Research Grant and partially from SERB, DST (Government of India) for Young Scientist Start up Research Grant (SB/YS/LS-214/2013) to ST. SKU is thankful to DST (Government of India), for DST Inspire faculty fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Alok A, 2015, PLANT GENE, V4, P10, DOI DOI 10.1016/J.PLGENE.2015.09.004; Ampomah-Dwamena C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0573-7; Annpomah-Dwamena C, 2012, J EXP BOT, V63, P4497, DOI 10.1093/jxb/ers134; Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; Badakhshan H., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P57; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; Crawford AC, 2013, MOL GENET GENOMICS, V288, P483, DOI 10.1007/s00438-013-0767-3; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Dibari B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-221; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; GIULIANO G, 1993, PLANT CELL, V5, P379, DOI 10.1105/tpc.5.4.379; Han YJ, 2013, BIOLOGIA, V68, P258, DOI 10.2478/s11756-013-0002-z; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Lopez-Emparan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114878; Matsumoto H, 2007, J AGR FOOD CHEM, V55, P2356, DOI 10.1021/jf062629c; Mlalazi B, 2012, PLANTA, V236, P1585, DOI 10.1007/s00425-012-1717-8; Pizarro L, 2009, CIENC INVESTIG AGRAR, V36, P143; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shumayla, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153925; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Singh P, 2008, COMPR REV FOOD SCI F, V7, P255, DOI 10.1111/j.1541-4337.2008.00044.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang C, 2014, J EXP BOT, V65, P2545, DOI 10.1093/jxb/eru138; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zeng J, 2015, J AGR FOOD CHEM, V63, P9083, DOI 10.1021/acs.jafc.5b04279; Zhou XJ, 2015, P NATL ACAD SCI USA, V112, P3558, DOI 10.1073/pnas.1420831112	41	19	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162443	10.1371/journal.pone.0162443	http://dx.doi.org/10.1371/journal.pone.0162443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695116	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100013
J	Chen, R; Schwander, M; Barbe, MF; Chan, MM				Chen, Rensa; Schwander, Martin; Barbe, Mary F.; Chan, Marion M.			Ossicular Bone Damage and Hearing Loss in Rheumatoid Arthritis: A Correlated Functional and High Resolution Morphometric Study in Collagen-Induced Arthritic Mice	PLOS ONE			English	Article							MIDDLE-EAR FUNCTION; INVOLVEMENT; MODEL; CHOLESTEATOMA; DEAFNESS; DISEASE	Globally, a body of comparative case-control studies suggests that rheumatoid arthritis (RA) patients are more prone to developing hearing loss (HL). However, experimental evidence that supports this hypothesis is still lacking because the human auditory organ is not readily accessible. The aim of this study was to determine the association between bone damage to the ossicles of the middle ear and HL, using a widely accepted murine model of collagen-induced arthritis (RA mice). Diarthrodial joints in the middle ear were examined with microcomputer tomography (microCT), and hearing function was assessed by auditory brainstem response (ABR). RA mice exhibited significantly decreased hearing sensitivity compared to age-matched controls. Additionally, a significant narrowing of the incudostapedial joint space and an increase in the porosity of the stapes were observed. The absolute latencies of all ABR waves were prolonged, but mean interpeak latencies were not statistically different. The observed bone defects in the middle ear that were accompanied by changes in ABR responses were consistent with conductive HL. This combination suggests that conductive impairment is at least part of the etiology of RA-induced HL in a murine model. Whether the inner ear sustains bone erosion or other pathology, and whether the cochlear nerve sustains pathology await subsequent studies. Considering the fact that certain anti-inflammatories are ototoxic in high doses, monitoring RA patients' auditory function is advisable as part of the effort to ensure their well-being.	[Chen, Rensa; Chan, Marion M.] Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Schwander, Martin] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Barbe, Mary F.] Temple Univ, Lewis Katz Sch Med, Dept Anat, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Chan, MM (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	marion.chan@temple.edu		Chan, Marion/0000-0003-1706-2964	National Institutes of Health [R21R21AR051761, 1R03AR063290, R01DC013331, 1S10RR026727]; Aresty Research Center at Rutgers University; Temple University College of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Research Center at Rutgers University; Temple University College of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MC was funded by National Institutes of Health grants R21R21AR051761 and 1R03AR063290. MS was funded by National Institutes of Health grant R01DC013331, and MB was funded by National Institutes of Health grant 1S10RR026727.; The authors thank Dr. Kenny H Chan for sharing his clinical knowledge and reading the manuscript, Dr. Dunne Fong and Dr. Pamela Roehm for reading and commenting on the manuscript and Ms. Manta Amin for valuable technical assistance in the microCT study. RC was supported by a research fellowship from the Aresty Research Center at Rutgers University. The authors also thank Temple University College of Science and Technology undergraduate research program for financial and undergraduate student support. We thank Ms. Jessica Walsh for her work on the graphics and refining of the manuscript. Finally, we are grateful to Dr. Rosowski for his inspiring insights and suggestions on the manuscript.	Alonso L, 2011, Hindawi.Com. ISRN Rheumatol, DOI [10.5402/2011/208627, DOI 10.5402/2011/208627]; Bayazit YA, 2007, ORL-J OTO-RHIN-LARYN, V69, P233, DOI 10.1159/000101544; Biasi D, 1996, CLIN EXP RHEUMATOL, V14, P243; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chan MM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0565-x; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Colletti V, 1997, AUDIOLOGY, V36, P136; Decraemer WF, 2002, JARO-J ASSOC RES OTO, V4, P250; Dikici O, 2009, EUR ARCH OTO-RHINO-L, V266, P1719, DOI 10.1007/s00405-009-0975-y; ELWANY S, 1986, J RHEUMATOL, V13, P878; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Callejo FJG, 2007, ACTA OTORRINOLAR ESP, V58, P232, DOI 10.1016/S0001-6519(07)74919-1; Halligan CS, 2006, LARYNGOSCOPE, V116, P2044, DOI 10.1097/01.mlg.0000241365.54017.32; HOLMDAHL R, 1989, APMIS, V97, P575, DOI 10.1111/j.1699-0463.1989.tb00446.x; Ikiz AO, 2007, INT J PEDIATR OTORHI, V71, P1079, DOI 10.1016/j.ijporl.2007.03.017; Jahn AF, 2001, PHYSL EAR, P689; JUNG TTK, 1995, ACTA OTO-LARYNGOL, V115, P251, DOI 10.3109/00016489509139302; KAKANI RS, 1990, J OTOLARYNGOL, V19, P100; KASTANIOUDAKIS I, 1995, J LARYNGOL OTOL, V109, P713, DOI 10.1017/S0022215100131135; KITANO H, 1988, AM J OTOL, V9, P465; Lee JH, 2009, ANAT HISTOL EMBRYOL, V38, P311, DOI 10.1111/j.1439-0264.2009.00946.x; Lorenzi MC, 2003, LARYNGOSCOPE, V113, P312, DOI 10.1097/00005537-200302000-00021; MAGARO M, 1990, CLIN EXP RHEUMATOL, V8, P487; MAGARO M, 1984, ANN RHEUM DIS, V43, P658, DOI 10.1136/ard.43.4.658; Massicotte VS, 2015, EXP GERONTOL, V72, P204, DOI 10.1016/j.exger.2015.10.014; Mileshina N. A., 2015, Vestnik Otorinolaringologii, P25, DOI 10.17116/otorino201580125-27; Morita Y, 2014, AURIS NASUS LARYNX, V41, P417, DOI 10.1016/j.anl.2014.05.002; Murdin L, 2008, CLIN RHEUMATOL, V27, P637, DOI 10.1007/s10067-007-0802-z; Muszynski Piotr, 2007, Otolaryngol Pol, V61, P972, DOI 10.1016/S0030-6657(07)70563-2; Nakajima HH, 2005, LARYNGOSCOPE, V115, P147, DOI 10.1097/01.mlg.0000150692.23506.b7; Ozcan M, 2002, RHEUMATOL INT, V22, P16, DOI 10.1007/s00296-002-0185-z; Ozturk A, 2004, AM J OTOLARYNG, V25, P411, DOI 10.1016/j.amjoto.2004.06.001; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Raut VV, 2001, J OTOLARYNGOL, V30, P289, DOI 10.2310/7070.2001.19580; ROSENBERG JN, 1978, ANN RHEUM DIS, V37, P522, DOI 10.1136/ard.37.6.522; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Salomonsen RL, 2010, OTOL NEUROTOL, V31, P1109, DOI 10.1097/MAO.0b013e3181e9becb; Salvinelli F, 2004, CLIN OTOLARYNGOL, V29, P75, DOI 10.1111/j.1365-2273.2004.00783.x; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Sharma K, 2013, INDIAN J OTOLARYNGOL, V65, pS493, DOI 10.1007/s12070-011-0372-x; SIAMOPOULOUMAVRIDOU A, 1990, ANN RHEUM DIS, V49, P620, DOI 10.1136/ard.49.8.620; Takatsu M, 2005, OTOL NEUROTOL, V26, P755, DOI 10.1097/01.mao.0000178138.19848.bd; Takeda T, 1996, AM J OTOL, V17, P69; Tavernier L, 2011, OTOL NEUROTOL, V32, pE5, DOI 10.1097/MAO.0b013e3181d2f039; WALEK H, 1980, Z RHEUMATOL, V39, P91; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Yilmaz S, 2007, AURIS NASUS LARYNX, V34, P307, DOI 10.1016/j.anl.2006.11.003; YOO TJ, 1985, AM J OTOLARYNG, V6, P209, DOI 10.1016/S0196-0709(85)80087-9; YOO TJ, 1984, ANN OTO RHINOL LARYN, V93, P3, DOI 10.1177/00034894840930S502; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhu TY, 2013, J BONE MINER RES, V28, P794, DOI 10.1002/jbmr.1793	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0164078	10.1371/journal.pone.0164078	http://dx.doi.org/10.1371/journal.pone.0164078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690307	Green Published, Green Submitted, gold			2022-12-26	WOS:000384329200040
J	Conway, ML; Evans, BJW; Evans, JC; Suttle, CM				Conway, Miriam L.; Evans, Bruce J. W.; Evans, Josephine C.; Suttle, Catherine M.			Does Gender Influence Colour Choice in the Treatment of Visual Stress?	PLOS ONE			English	Article							CONTROLLED TRIAL; SEX-DIFFERENCES; PREFERENCES; OVERLAYS; CHILDREN; DYSLEXIA; FILTERS; DIFFICULTIES; MIGRAINE; LENSES	Purpose Visual Stress (VS) is a condition in which words appear blurred, in motion, or otherwise distorted when reading. Some people diagnosed with VS find that viewing black text on white paper through coloured overlays or precision tinted lenses (PTLs) reduces symptoms attributed to VS. The aim of the present study is to determine whether the choice of colour of overlays or PTLs is influenced by a patient's gender. Methods Records of all patients attending a VS assessment in two optometry practices between 2009 and 2014 were reviewed retrospectively. Patients who reported a significant and consistent reduction in symptoms with either overlay and or PTL were included in the analysis. Overlays and PTLs were categorized as stereotypical male, female or neutral colours based on gender preferences as described in the literature. Chi-square analysis was carried out to determine whether gender (across all ages or within age groups) was associated with overlay or PTL colour choice. Results 279 patients (133 males and 146 females, mean age 17 years) consistently showed a reduction in symptoms with an overlay and were included. Chi-square analysis revealed no significant association between the colour of overlay chosen and male or female gender (Chi-square 0.788, p = 0.674). 244 patients (120 males and 124 females, mean age 24.5 years) consistently showed a reduction in symptoms with PTLs and were included. Chi-square analysis revealed a significant association between stereotypical male/female/neutral colours of PTLs chosen and male/female gender (Chi-square 6.46, p = 0.040). More males preferred stereotypical male colour PTLs including blue and green while more females preferred stereotypical female colour PTLs including pink and purple. Conclusions For some VS patients, the choice of PTL colour is influenced not only by the alleviation of symptoms but also by other non-visual factors such as gender.	[Conway, Miriam L.; Evans, Bruce J. W.; Evans, Josephine C.; Suttle, Catherine M.] City Univ London, Div Optometry & Visual Sci, Sch Hlth Sci, London, England; [Evans, Bruce J. W.] Inst Optometry, Neville Chappell Res Clin, London, England	City University London; University of London; University College London	Suttle, CM (corresponding author), City Univ London, Div Optometry & Visual Sci, Sch Hlth Sci, London, England.	Catherine.suttle.1@city.ac.uk		Suttle, Catherine/0000-0001-8694-195X	Research Sustainability Fund, City University London [90000HS]	Research Sustainability Fund, City University London	Grant number 90000HS Funding received by MC from the Research Sustainability Fund, City University London. The funder had no role in any aspect of the study or preparation of the manuscript.	Akcay O, 2012, IJBSS, V3; Al-Rasheed AS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00030; Albon E., 2008, EFFECTIVENESS COST E; Allen PM, 2008, INVEST OPHTH VIS SCI, V49, P4210, DOI 10.1167/iovs.07-1587; Allen PM, 2010, INVEST OPHTH VIS SCI, V51, P6843, DOI 10.1167/iovs.09-5086; Allen PM, 2010, TEN ALPS CREATIVE; Auty S, 2004, PSYCHOL MARKET, V21, P697, DOI 10.1002/mar.20025; Bjerstedt A., 1960, PERCEPT MOTOR SKILL, V10, P31; Bouldoukian J, 2002, OPHTHAL PHYSL OPT, V22, P55, DOI 10.1046/j.1475-1313.2002.00002.x; Chiu SW, 2006, SEX ROLES, V55, P385, DOI 10.1007/s11199-006-9089-9; Chouinard BD, 2012, BRAIN TOPOGR, V25, P293, DOI 10.1007/s10548-011-0212-z; Coutts LV, 2012, CEPHALALGIA, V32, P621, DOI 10.1177/0333102412444474; Ellis L, 2001, PERS INDIV DIFFER, V31, P1375, DOI 10.1016/S0191-8869(00)00231-2; Evans BJ, 2016, J OPTOM IN PRESS; Funk D., 2006, MANAGE RES NEWS, V29, P41, DOI DOI 10.1108/01409170610645439; Griffiths PG, 2015, SCAND J OCCUP THER, V22, P328, DOI 10.3109/11038128.2015.1033456; Hollis J, 2006, OPHTHAL PHYSL OPT, V26, P566, DOI 10.1111/j.1475-1313.2006.00401.x; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Hurlbert AC, 2007, CURR BIOL, V17, pR623, DOI 10.1016/j.cub.2007.06.022; Jeanes R, 1997, BRIT J PSYCHOL, V88, P531; Kim Ji Hyun, 2015, Korean J Ophthalmol, V29, P121, DOI 10.3341/kjo.2015.29.2.121; Kriss I, 2005, J RES READ, V28, P350, DOI 10.1111/j.1467-9817.2005.00274.x; LIGHTSTONE A, 1995, OPHTHAL PHYSL OPT, V15, P507, DOI 10.1016/0275-5408(95)00060-Q; Lightstone A, 1999, OPHTHAL PHYSL OPT, V19, P279, DOI 10.1046/j.1475-1313.1999.00442.x; LoBue V, 2011, BRIT J DEV PSYCHOL, V29, P656, DOI 10.1111/j.2044-835X.2011.02027.x; MATHER J, 1971, GERONTOLOGIST, V11, P311, DOI 10.1093/geront/11.4_Part_1.311; Nandakumar K, 2008, CLIN EXP OPTOM, V91, P333, DOI 10.1111/j.1444-0938.2008.00277.x; Northway N, 2003, OPHTHAL PHYSL OPT, V23, P457, DOI 10.1046/j.1475-1313.2003.00144.x; Riddell PM, 2006, OPTOMETRY VISION SCI, V83, P299, DOI 10.1097/01.opx.0000216125.83236.af; Robinson GL, 1999, PERCEPT MOTOR SKILL, V89, P83, DOI 10.2466/PMS.89.5.83-113; Scott L, 2002, OPHTHAL PHYSL OPT, V22, P156, DOI 10.1046/j.1475-1313.2002.00009.x; SILVER NC, 1988, PERCEPT MOTOR SKILL, V66, P295, DOI 10.2466/pms.1988.66.1.295; Simmers AJ, 2001, INVEST OPHTH VIS SCI, V42, P879; Singleton C, 2007, DYSLEXIA, V13, P130, DOI 10.1002/dys.329; Sorokowski P, 2014, PSYCHON B REV, V21, P1195, DOI 10.3758/s13423-014-0591-8; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Taylor C, 2013, J EXP PSYCHOL GEN, V142, P1015, DOI 10.1037/a0030273; Tweedie W., 2001, J RES READ, V24, P41, DOI [10.1111/1467-9817.00132, DOI 10.1111/1467-9817.00132]; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wijk H, 1999, AGING CLIN EXP RES, V11, P176, DOI 10.1007/BF03399660; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins A, 1993, MANUAL INTUITIVE COL; WILKINS AJ, 1994, OPHTHAL PHYSL OPT, V14, P365, DOI 10.1111/j.1475-1313.1994.tb00126.x; Wilkins AJ, 1996, OPHTHAL PHYSL OPT, V16, P491, DOI 10.1016/0275-5408(96)00028-2; Wong WI, 2015, ARCH SEX BEHAV, V44, P1243, DOI 10.1007/s10508-015-0489-1	45	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163326	10.1371/journal.pone.0163326	http://dx.doi.org/10.1371/journal.pone.0163326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27648842	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000383892100080
J	Mehiriz, K; Gosselin, P				Mehiriz, Kaddour; Gosselin, Pierre			Municipalities' Preparedness for Weather Hazards and Response to Weather Warnings	PLOS ONE			English	Article							EMERGENCY MANAGEMENT; DISASTER MANAGEMENT; NATURAL DISASTERS; PERCEIVED RISK; CLIMATE-CHANGE; HEALTH; FRAMEWORK; CAPACITY; SERVICES; IMPACTS	The study of the management of weather-related disaster risks by municipalities has attracted little attention even though these organizations play a key role in protecting the population from extreme meteorological conditions. This article contributes to filling this gap with new evidence on the level and determinants of Quebec municipalities' preparedness for weather hazards and response to related weather warnings. Using survey data from municipal emergency management coordinators and secondary data on the financial and demographic characteristics of municipalities, the study shows that most Quebec municipalities are sufficiently prepared for weather hazards and undertake measures to protect the population when informed of imminent extreme weather events. Significant differences between municipalities were noted though. Specifically, the level of preparedness was positively correlated with the municipalities' capacity and population support for weather-related disaster management policies. In addition, the risk of weather-related disasters increases the preparedness level through its effect on population support. We also found that the response to weather warnings depended on the risk of weather-related disasters, the preparedness level and the quality of weather warnings. These results highlight areas for improvement in the context of increasing frequency and/or severity of such events with current climate change.	[Mehiriz, Kaddour] Inst Natl Rech Sci, Ctr Eau Terre & Environm, Quebec City, PQ, Canada; [Gosselin, Pierre] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Gosselin, Pierre] OURANOS, Montreal, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); Institut national de sante publique du Quebec (INSPQ); Ouranos Consortium	Mehiriz, K (corresponding author), Inst Natl Rech Sci, Ctr Eau Terre & Environm, Quebec City, PQ, Canada.	kaddour.mehiriz@inrs.ca			Natural Sciences and Engineering Research Council of Canada; Institut national de sante publique du Quebec; Environment Canada's Meteorological Service (Quebec Region); IRIACC-FACE program of the International Development Research Centre; Canadian Institutes for Health Research in Canada; Ministere de la Securite Publique du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Institut national de sante publique du Quebec; Environment Canada's Meteorological Service (Quebec Region); IRIACC-FACE program of the International Development Research Centre; Canadian Institutes for Health Research in Canada(Canadian Institutes of Health Research (CIHR)); Ministere de la Securite Publique du Quebec	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the reviewers of this article for their helpful comments and the Institut national de sante publique du Quebec, the Ministere de la Securite Publique du Quebec, Environment Canada's Meteorological Service (Quebec Region), the IRIACC-FACE program of the International Development Research Centre and the Canadian Institutes for Health Research in Canada for their support.	Abrahamson V, 2009, J PUBLIC HEALTH-UK, V31, P478, DOI 10.1093/pubmed/fdp059; [Anonymous], 2005, WORLD C DIS RED KOB; Basher R, 2006, PHILOS T R SOC A, V364, P2167, DOI 10.1098/rsta.2006.1819; Berkhout F, 2006, CLIMATIC CHANGE, V78, P135, DOI 10.1007/s10584-006-9089-3; BORCHERDING TE, 1972, AM ECON REV, V62, P891; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Daupras F, 2015, NAT HAZARDS, V75, P215, DOI 10.1007/s11069-014-1318-x; Donahue AK, 2014, AM REV PUBLIC ADM, V44, p89S, DOI 10.1177/0275074013506517; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Escaleras M, 2012, PUBLIC CHOICE, V151, P165, DOI 10.1007/s11127-010-9740-4; Fisher R.C., 2015, STATE LOCAL GOVT FIN, V4th ed., DOI https://doi.org/10.4324/9781315718729; Gall M., 2014, IRDR AIRDR PUBLICATI; Gasper JT, 2011, AM J POLIT SCI, V55, P340, DOI 10.1111/j.1540-5907.2010.00503.x; George D, 2003, SPSS WINDOWS STEP ST; Gerber BJ, 2005, POLICY STUD J, V33, P395, DOI 10.1111/j.1541-0072.2005.00122.x; Gouvernement du Quebec, APPR PRINC SEC CIV; Gouvernement du Quebec, 2016, FIN FISC ORG MUN QUE; Gouvernement du Quebec, 2008, PLAN REP SIN GUID IN; Gouvernement du Quebec, 2010, COMM ORG SEC CIV QUE; Government of Canada, 2011, EM MAN FRAM CAN; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Hansjurgens B., 2014, MEGACITIES, P9, DOI [10.1007/978-90-481-3417-5_2, DOI 10.1007/978-90-481-3417-5_2]; Healy A, 2009, AM POLIT SCI REV, V103, P387, DOI 10.1017/S0003055409990104; Henstra D, 2005, CAN PUBLIC POL, V31, P303, DOI 10.2307/3552443; Henstra D, 2010, PUBLIC ADMIN REV, V70, P236, DOI 10.1111/j.1540-6210.2010.02130.x; Huang, 2011, AM J PREV MED, V40, P183, DOI [10.1016/j.amepre.2010.10.025, DOI 10.1016/J.AMEPRE.2010.10.025]; Hwacha V., 2005, MITIG ADAPT STRATEG, V10, P507, DOI DOI 10.1007/S11027-005-0058-3; Ivey, 2004, ENVIRON MANAGE, V33, P36; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kalkstein AJ, 2007, INT J BIOMETEOROL, V52, P43, DOI 10.1007/s00484-006-0073-4; Kapucu N., 2008, DISASTERS J DISASTER, V32, P239, DOI DOI 10.1111/J.1467-7717.2008.01037.X; Leskens JG, 2014, ENVIRON MODELL SOFTW, V53, P53, DOI 10.1016/j.envsoft.2013.11.003; Maibach, 2008, CLIMATE CHANGE PUBLI, V3, P1; McGuire M, 2010, PUBLIC ADMIN REV, V70, P279, DOI 10.1111/j.1540-6210.2010.02134.x; Mehiriz K, 2014, PUBLIC BUDG FINANC, V34, P85, DOI 10.1111/pbaf.12026; Mendes CC, 2006, APPL ECON, V38, P239, DOI 10.1080/00036840500215378; Neumayer E, 2014, GLOBAL ENVIRON CHANG, V24, P8, DOI 10.1016/j.gloenvcha.2013.03.011; Parker DJ, 2012, WATER RESOUR MANAG, V26, P2927, DOI 10.1007/s11269-012-0057-6; Paton D, 2003, J DISASTER PREV MANA, V12, P210, DOI DOI 10.1108/09653560310480686; Polivka BJ, 2012, ENVIRON HEALTH PERSP, V120, P321, DOI 10.1289/ehp.1104025; Prater C.S., 2000, NAT HAZARDS REV, V1, P73, DOI [10.1061/(ASCE)1527-6988(2000)1:2(73), DOI 10.1061/(ASCE)1527-6988(2000)1:2(73), DOI 10.1061/(ASCE)1527-6988(2000)1]; Rahm D, 2011, J CONTING CRISIS MAN, V19, P136, DOI 10.1111/j.1468-5973.2011.00647.x; Reeves A, 2011, J POLIT, V73, P1142, DOI 10.1017/S0022381611000843; Robledo C., 2005, ADAPTATION FOREST EC; Rumbach A, 2016, HABITAT INT, V52, P35, DOI 10.1016/j.habitatint.2015.08.026; Sattele M, 2015, RELIAB ENG SYST SAFE, V142, P192, DOI 10.1016/j.ress.2015.05.003; Scott Z., 2011, GLOB ASS REP DIS RIS; Skidmore M, 2013, LAND ECON, V89, P101, DOI 10.3368/le.89.1.101; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Somers S, 2009, PUBLIC ADMIN REV, V69, P181, DOI 10.1111/j.1540-6210.2008.01963.x; Ullman S., 2001, USING MULTIVARIATE S, P653; UNDRR, 2015, AUST J EMERG MANAG; United Nations, 1997, REP EARL WARN HYDR H; Wildasin DE, 2008, PUBLIC FINANC REV, V36, P497, DOI 10.1177/1091142107306286; Wolensky R. P., 1990, POLICY STUDIES REV, V9, P703, DOI [10.1080/03003939108433570, DOI 10.1080/03003939108433570]; Yzer M, 2012, THEOR PRACT, P21; Zhang Q, 2015, NAT HAZARDS, V77, P1915, DOI 10.1007/s11069-015-1683-0	58	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163390	10.1371/journal.pone.0163390	http://dx.doi.org/10.1371/journal.pone.0163390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649547	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100086
J	Cui, XW; You, LH; Li, Y; Zhu, LJ; Zhang, F; Xie, KP; Cao, Y; Ji, CB; Guo, XR				Cui, Xianwei; You, Lianghui; Li, Yun; Zhu, Lijun; Zhang, Fan; Xie, Kaipeng; Cao, Yan; Ji, Chenbo; Guo, Xirong			A transcribed ultraconserved noncoding RNA, uc.417, serves as a negative regulator of brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						lncRNA; uc.417; brown adipocytes; energy expenditure	FAT; ADIPOCYTES; REVEALS; WHITE; BEIGE; CODE	Brown adipose tissue (BAT) oxidizes fatty acids for thermogenesis and could therefore be considered as part of a new strategy in combating obesity and associated metabolic diseases. It is well established that aging is accompanied by a decline of brown adipocyte regenerative capacity. How aging contributes to this loss is poorly understood. Here, we identify a long noncoding RNA, uc.417, which is transcribed from an ultraconserved region in rodents. Expression of uc.417 increases with age. Ectopic expression of uc.417 impairs adipogenesis and the thermogenic program in brown adipocytes. However, uc.417 is not required for brown fat function. In vivo, uc.417 attenuates the cold-induced thermogenic program in mouse BAT. Moreover, we find that uc.417 moderately inhibits phosphorylation of p38MAPK without affecting the total protein level of p38MAPK. The p38MAPK pathway is essential for activating BAT to stimulate uncoupling protein 1 gene expression. The data point to uc.417 as being an important factor in an age-dependent loss of function of brown adipose tissue.	[Cui, Xianwei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Cui, Xianwei; You, Lianghui; Li, Yun; Zhu, Lijun; Xie, Kaipeng; Cao, Yan; Ji, Chenbo; Guo, Xirong] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing, Jiangsu, Peoples R China; [Zhang, Fan] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University; Nanjing Medical University	Ji, CB; Guo, XR (corresponding author), Nanjing Med Univ, Nanjing Maternal & Child Hlth Med Inst, Affiliated Nanjing Maternal & Child Hlth Hosp, Nanjing 210004, Jiangsu, Peoples R China.	chenboji@njmu.edu.cn; xrguo@njmu.edu.cn			National Key Basic Research Program of China [2013CB530604]; Key project of the National Natural Science Foundation of China [81330067]; National Natural Science Foundation of China [81300683, 81200642]; Natural Science Foundation of Jiangsu Province, China [BK20140086]; Nanjing Medical Science and Technique Development Foundation [JQX13012]	National Key Basic Research Program of China(National Basic Research Program of China); Key project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Nanjing Medical Science and Technique Development Foundation	This work was funded by the National Key Basic Research Program of China (Grant 2013CB530604), the Key project of the National Natural Science Foundation of China (Grant 81330067), the National Natural Science Foundation of China (Grants 81300683 and 81200642), the Natural Science Foundation of Jiangsu Province, China (Grant BK20140086), and the Nanjing Medical Science and Technique Development Foundation (Grant JQX13012). The authors declare no conflicts of interest.	Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Emont MP, 2015, J ENDOCRINOL, V225, pR35, DOI 10.1530/JOE-15-0026; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Jeanson Y, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00158; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Kooijman S, 2015, TRENDS ENDOCRIN MET, V26, P657, DOI 10.1016/j.tem.2015.09.008; Peng JC, 2013, RNA BIOL, V10, P1771, DOI 10.4161/rna.26995; Pfeifer A, 2015, ANNU REV PHARMACOL, V55, P207, DOI 10.1146/annurev-pharmtox-010814-124346; Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Svensson KJ, 2016, CELL METAB, V23, P454, DOI 10.1016/j.cmet.2016.01.008; Tan CY, 2015, CELL REP, V13, P2039, DOI 10.1016/j.celrep.2015.11.004; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; You LH, 2015, MOL GENET GENOMICS, V290, P1659, DOI 10.1007/s00438-015-1026-6; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004	26	36	41	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4301	4312		10.1096/fj.201600694R	http://dx.doi.org/10.1096/fj.201600694R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27655899				2022-12-26	WOS:000388201500034
J	Liu, X; Shu, S; Billington, N; Williamson, CD; Yu, S; Brzeska, H; Donaldson, JG; Sellers, JR; Korn, ED				Liu, Xiong; Shu, Shi; Billington, Neil; Williamson, Chad D.; Yu, Shuhua; Brzeska, Hanna; Donaldson, Julie G.; Sellers, James R.; Korn, Edward D.			Mammalian Nonmuscle Myosin II Binds to Anionic Phospholipids with Concomitant Dissociation of the Regulatory Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE MYOSIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TRANSPORT VESICLES; PLASMA-MEMBRANE; GOLGI MEMBRANES; ATPASE ACTIVITY; IN-VITRO; PHOSPHORYLATION; ACTIN	Mammalian cells express three Class II nonmuscle myosins (NM): NM2A, NM2B, and NM2C. The three NM2s have well established essential roles in cell motility, adhesion, and cytokinesis and less well defined roles in vesicle transport and other processes that would require association of NM2s with cell membranes. Previous evidence for the mechanism of NM2-membrane association includes direct interaction of NM2s with membrane lipids and indirect interaction by association of NM2s with membrane-bound F-actin or peripheral membrane proteins. Direct binding of NM2s to phosphatidylserine-liposomes, but not to phosphatidylcholine-liposomes, has been reported, but the molecular basis of the interaction between NM2s and acidic phospholipids has not been previously investigated. We now show that filamentous, full-length NM2A, NM2B, and NM2C and monomeric, non-filamentous heavy meromyosin bind to liposomes containing one or more acidic phospholipids (phosphatidylserine, phosphatidylinositol 4,5-diphosphate, and phosphatidylinositol 3,4,5-triphosphate) but do not bind to 100% phosphatidylcholine-liposomes. Binding of NM2s to acidic liposomes occurs predominantly through interaction of the liposomes with the regulatory light chain (RLC) binding site in the myosin heavy chain with concomitant dissociation of the RLC. Phosphorylation of myosin-bound RLC by myosin light chain kinase substantially inhibits binding to liposomes of both filamentous NM2 and non-filamentous heavy meromyosin; the addition of excess unbound RLC, but not excess unbound essential light chain, competes with liposome binding. Consistent with the in vitro data, we show that endogenous and expressed NM2A associates with the plasma membrane of HeLa cells and fibrosarcoma cells independently of F-actin.	[Liu, Xiong; Shu, Shi; Williamson, Chad D.; Yu, Shuhua; Brzeska, Hanna; Donaldson, Julie G.; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA; [Billington, Neil; Sellers, James R.] NHLBI, Labs Mol Physiol, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov		Korn, Edward/0000-0003-3867-6295; Billington, Neil/0000-0003-2306-0228	Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001786, ZIAHL006130] Funding Source: NIH RePORTER	Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the support of the Electron and Light Microscopy Cores of the NHLBI, National Institutes of Health. We thank Dr. John Hammer 3rd (NHLBI) for NM2A-mTomato and Dr. Fang Zhang (NHLBI) for purified myosin light chain kinase.	ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Barylko B, 2005, ACTA BIOCHIM POL, V52, P373; Billington N, 2013, J BIOL CHEM, V288, P33398, DOI 10.1074/jbc.M113.499848; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2012, J BIOL CHEM, V287, P14923, DOI 10.1074/jbc.M111.318667; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; CRAIG R, 1983, NATURE, V302, P436, DOI 10.1038/302436a0; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; DeGiorgis JA, 2002, MOL BIOL CELL, V13, P1046, DOI 10.1091/mbc.01-06-0315; DePina AS, 2007, CELL MOTIL CYTOSKEL, V64, P739, DOI 10.1002/cm.20219; Dulyaninova Natalya G, 2013, Bioarchitecture, V3, P77; Duran JM, 2003, MOL BIOL CELL, V14, P445, DOI 10.1091/mbc.E02-04-0214; Ecay TW, 1997, BIOCHEM BIOPH RES CO, V231, P369, DOI 10.1006/bbrc.1997.6093; Fath KR, 2005, CELL MOTIL CYTOSKEL, V60, P222, DOI 10.1002/cm.20060; FECHHEIMER M, 1982, J CELL BIOL, V93, P261, DOI 10.1083/jcb.93.2.261; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Ikonen E, 1997, J CELL SCI, V110, P2155; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; LEBOWITZ EA, 1978, J BIOL CHEM, V253, P5443; LI DQ, 1994, P NATL ACAD SCI USA, V91, P853, DOI 10.1073/pnas.91.3.853; Linz-McGillem LA, 2003, EXP EYE RES, V76, P543, DOI 10.1016/S0014-4835(03)00031-9; Liu X, 2013, P NATL ACAD SCI USA, V110, pE33, DOI 10.1073/pnas.1219727110; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; MURAKAMI N, 1994, J BIOL CHEM, V269, P16082; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sanborn KB, 2011, BLOOD, V118, P5862, DOI 10.1182/blood-2011-03-344846; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stow JL, 1998, BBA-MOL CELL RES, V1404, P161, DOI 10.1016/S0167-4889(98)00055-X; SUZUKI H, 1982, J BIOCHEM-TOKYO, V91, P1699, DOI 10.1093/oxfordjournals.jbchem.a133861; SWANLJUNGCOLLINS H, 1992, J BIOL CHEM, V267, P3445; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; TROTTER JA, 1979, J BIOL CHEM, V254, P8781; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786	44	18	19	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24828	24837		10.1074/jbc.M116.739185	http://dx.doi.org/10.1074/jbc.M116.739185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27697842	hybrid, Green Published			2022-12-26	WOS:000388880100003
J	Li, MM; Yang, SY; Xu, D				Li, Miaomiao; Yang, Shuying; Xu, Ding			Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; dimerization; heparan sulfate; osteoblast; small-angle X-ray scattering (SAXS); RANKL; osteoclastogenesis; osteoprotegerin; ternary complex	KAPPA-B LIGAND; RECEPTOR ACTIVATOR; INHIBITORY FACTOR; DECOY RECEPTOR; BONE-DENSITY; PROTEIN; RANKL; GLYCOSAMINOGLYCANS; DIFFERENTIATION; CYTOKINE	Osteoprotegerin (OPG), a decoy receptor secreted by osteoblasts, is a major negative regulator of bone resorption. It functions by neutralizing the receptor activator of nuclear factor B ligand (RANKL), which plays a central role in promoting osteoclastogenesis. OPG is known to be a high-affinity heparan sulfate (HS)-binding protein. Presumably, HS could regulate the function of OPG and affect how it inhibits RANKL. However, the molecular detail of HS-OPG interaction remains poorly understood, which hinders our understanding of how HS functions in osteoclastogenesis. Here we report mapping of the HS-binding site of OPG. The HS-binding site, identified by mutagenesis study, consists of eight basic residues that are located mostly at the junction of the second death domain and the C-terminal domain. We further show that heparin-derived dodecasaccharide is able to induce dimerization of OPG monomers with a stoichiometry of 1:1. Small-angle X-ray scattering analysis revealed that upon binding of HS, OPG undergoes a dramatic conformational change, resulting in a more compact and less flexible structure. Importantly, we present here three lines of evidence that HS, OPG, and RANKL form a stable ternary complex. Using a HS binding-deficient OPG mutant, we further show that in an osteoblast/bone marrow macrophage co-culture system, immobilization of OPG by HS at the osteoblast cell surface substantially lowers the inhibitory threshold of OPG toward RANKL. These discoveries strongly suggest that HS plays an active role in regulating OPG-RANKL interaction and osteoclastogenesis.	[Li, Miaomiao; Yang, Shuying; Xu, Ding] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Xu, D (corresponding author), SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA.	dingxu@buffalo.edu	Xu, ding/B-2493-2009	Xu, ding/0000-0001-9380-2712; Li, Miaomiao/0000-0003-4508-196X	DOE Office of Biological and Environmental Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048388] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Xue Yuan for help with osteoblasts isolation and setting up co-culture osteoclastogenesis assay. We also thank Dr. Lars Pedersen for reviewing the manuscript. SAXS data collection was conducted at the Advanced Light Source (ALS), a national user facility operated by the Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research.	Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Ganesh VK, 2004, P NATL ACAD SCI USA, V101, P8924, DOI 10.1073/pnas.0400744101; Irie A, 2007, BONE, V41, P165, DOI 10.1016/j.bone.2007.04.190; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jono S, 2002, CIRCULATION, V106, P1192, DOI 10.1161/01.CIR.0000031524.49139.29; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Standal T, 2002, BLOOD, V100, P3002, DOI 10.1182/blood-2002-04-1190; Theoleyre S, 2006, BIOCHEM BIOPH RES CO, V347, P460, DOI 10.1016/j.bbrc.2006.06.120; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Udagawa N, 2000, ENDOCRINOLOGY, V141, P3478, DOI 10.1210/en.141.9.3478; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Yamaguchi K, 1998, J BIOL CHEM, V273, P5117, DOI 10.1074/jbc.273.9.5117; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuan X, 2015, CELL DEATH DIFFER, V22, P2046, DOI 10.1038/cdd.2015.45; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	26	21	22	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24160	24171		10.1074/jbc.M116.751974	http://dx.doi.org/10.1074/jbc.M116.751974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27697839	Green Published, hybrid			2022-12-26	WOS:000388498100031
J	Mathieu, C; Duval, R; Cocaign, A; Petit, E; Bui, LC; Haddad, I; Vinh, J; Etchebest, C; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; Duval, Romain; Cocaign, Angelique; Petit, Emile; Bui, Linh-Chi; Haddad, Iman; Vinh, Joelle; Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			An Isozyme-specific Redox Switch in Human Brain Glycogen Phosphorylase Modulates Its Allosteric Activation by AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; carbohydrate metabolism; disulfide; glycogen; glycogen storage disease; redox regulation	HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; OXIDATIVE STRESS; DISULFIDE BOND; METABOLISM; THIOREDOXIN; CHEMISTRY; DISEASE; SITE; NEURODEGENERATION	Brain glycogen and its metabolism are increasingly recognized as major players in brain functions. Moreover, alteration of glycogen metabolism in the brain contributes to neurodegenerative processes. In the brain, both muscle and brain glycogen phosphorylase isozymes regulate glycogen mobilization. However, given their distinct regulatory features, these two isozymes could confer distinct metabolic functions of glycogen in brain. Interestingly, recent proteomics studies have identified isozyme-specific reactive cysteine residues in brain glycogen phosphorylase (bGP). In this study, we show that the activity of human bGP is redox-regulated through the formation of a disulfide bond involving a highly reactive cysteine unique to the bGP isozyme. We found that this disulfide bond acts as a redox switch that precludes the allosteric activation of the enzyme by AMP without affecting its activation by phosphorylation. This unique regulatory feature of bGP sheds new light on the isoform-specific regulation of glycogen phosphorylase and glycogen metabolism.	[Mathieu, Cecile; Duval, Romain; Cocaign, Angelique; Petit, Emile; Bui, Linh-Chi; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, CNRS UMR 8251, Sorbonne Paris Cite, Unite BFA, F-75013 Paris, France; [Haddad, Iman; Vinh, Joelle] PSL Res Univ, ESPCI Paris, CNRS USR 3149, Spectromet Masse Biol & Proteom SMPB, 10 Rue Vauquelin, F-75231 Paris 05, France; [Etchebest, Catherine] Univ Paris Diderot, INSERM, UMR S1134, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Etchebest, Catherine] INTS, F-75015 Paris, France; [Etchebest, Catherine] GR Ex, Lab Dexcellence, F-75015 Paris, France; [Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, CNRS UMR 8251, Sorbonne Paris Cite, Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	etchebest, catherine/O-2485-2019; Duval, Romain/D-7764-2015; Vinh, Joelle/K-1347-2015	etchebest, catherine/0000-0002-5871-2372; Vinh, Joelle/0000-0001-7184-2668; Duval, Romain/0000-0002-5785-0685	University Paris Diderot; CNRS; University Paris Diderot (Ecole Doctorale BioSPC); Region Ile de France	University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot (Ecole Doctorale BioSPC); Region Ile de France(Region Ile-de-France)	This work was supported by the University Paris Diderot and CNRS. This work was also supported by Ph.D. fellowships from the University Paris Diderot (Ecole Doctorale BioSPC) (to C. M.), Region Ile de France (to R. D.), and University Paris Diderot (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Atmane N, 2003, J BIOL CHEM, V278, P35086, DOI 10.1074/jbc.M303813200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bhattacharya S, 2008, BIOORG MED CHEM LETT, V18, P5856, DOI 10.1016/j.bmcl.2008.06.029; Bogumil R, 2000, EUR J BIOCHEM, V267, P1407, DOI 10.1046/j.1432-1327.2000.01133.x; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; CATALDO AM, 1986, J NEUROCYTOL, V15, P511, DOI 10.1007/BF01611733; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dairou J, 2007, J MOL BIOL, V372, P1009, DOI 10.1016/j.jmb.2007.07.011; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; GERTZ HJ, 1985, MECH AGEING DEV, V31, P25, DOI 10.1016/0047-6374(85)90024-7; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gibbs ME, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00070; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; Gould NS, 2015, CHEM BIOL, V22, P965, DOI 10.1016/j.chembiol.2015.06.010; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Hampton MB, 2002, FEBS LETT, V517, P229, DOI 10.1016/S0014-5793(02)02629-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hossain MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097570; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jamsen J, 2010, BIOCHEMISTRY-US, V49, P1005, DOI 10.1021/bi9019737; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lindahl E, 2015, METHODS MOL BIOL, V1215, P3, DOI 10.1007/978-1-4939-1465-4_1; Lo Conte M, 2015, ACS CHEM BIOL, V10, P1825, DOI 10.1021/acschembio.5b00124; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; MARTIN JL, 1990, BIOCHEMISTRY-US, V29, P10745, DOI 10.1021/bi00500a005; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mathieu C, 2016, J BIOL CHEM, V291, P18072, DOI 10.1074/jbc.M116.738898; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Nishii W, 2015, NAT CHEM BIOL, V11, P46, DOI 10.1038/nchembio.1688; PARK EM, 1989, ARCH BIOCHEM BIOPHYS, V272, P25, DOI 10.1016/0003-9861(89)90190-2; de la Cruz VP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/494316; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato N, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3339/fnagi.2015,00199, 10.3389/fnagi.2015.00199]; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Seiwert B, 2008, J AM SOC MASS SPECTR, V19, P1, DOI 10.1016/j.jasms.2007.10.001; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swanson R A, 1989, Neurol Res, V11, P24; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang C, 2014, NAT METHODS, V11, P79, DOI [10.1038/NMETH.2759, 10.1038/nmeth.2759]; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Yang J, 2015, NAT PROTOC, V10, P1022, DOI 10.1038/nprot.2015.062; Zhang TF, 2012, CELL METAB, V15, P75, DOI 10.1016/j.cmet.2011.12.005	64	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23842	23853		10.1074/jbc.M116.757062	http://dx.doi.org/10.1074/jbc.M116.757062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27660393	Green Published, hybrid			2022-12-26	WOS:000388498100001
J	Cadavid, S; Beato, MS				Cadavid, Sara; Soledad Beato, Maria			Memory Distortion and Its Avoidance: An Event-Related Potentials Study on False Recognition and Correct Rejection	PLOS ONE			English	Article							BACKWARD ASSOCIATIVE STRENGTH; 3 CRITICAL WORDS; BRAIN POTENTIALS; ILLUSORY MEMORIES; ELECTROPHYSIOLOGICAL EVIDENCE; PHANTOM RECOLLECTION; ENCODING CONTEXT; DISTINGUISH TRUE; RETRIEVAL; FAMILIARITY	Memory researchers have long been captivated by the nature of memory distortions and have made efforts to identify the neural correlates of true and false memories. However, the underlying mechanisms of avoiding false memories by correctly rejecting related lures remains underexplored. In this study, we employed a variant of the Deese/Roediger-McDermott paradigm to explore neural signatures of committing and avoiding false memories. ERP were obtained for True recognition, False recognition, Correct rejection of new items, and, more importantly, Correct rejection of related lures. With these ERP data, early-frontal, left-parietal, and late right-frontal old/new effects (associated with familiarity, recollection, and monitoring processes, respectively) were analysed. Results indicated that there were similar patterns for True and False recognition in all three old/new effects analysed in our study. Also, False recognition and Correct rejection of related lures activities seemed to share common underlying familiarity-based processes. The ERP similarities between False recognition and Correct rejection of related lures disappeared when recollection processes were examined because only False recognition presented a parietal old/new effect. This finding supported the view that actual false recollections underlie false memories, providing evidence consistent with previous behavioural research and with most ERP and neuroimaging studies. Later, with the onset of monitoring processes, False recognition and Correct rejection of related lures waveforms presented, again, clearly dissociated patterns. Specifically, False recognition and True recognition showed more positive going patterns than Correct rejection of related lures signal and Correct rejection of new items signature. Since False recognition and Correct rejection of related lures triggered familiarity-recognition processes, our results suggest that deciding which items are studied is based more on recollection processes, which are later supported by monitoring processes. Results are discussed in terms of Activation-Monitoring Framework and Fuzzy Trace-Theory, the most prominent explanatory theories of false memory raised with the Deese/Roediger-McDermott paradigm.	[Cadavid, Sara] Univ Minho, Sch Psychol, Dept Basic Psychol, Human Cognit Lab,Res Ctr Psychol CIPsi, Braga, Portugal; [Soledad Beato, Maria] Univ Salamanca, Fac Psychol, Dept Basic Psychol Psychobiol & Methodol Behav Sc, Salamanca, Spain	Universidade do Minho; University of Salamanca	Cadavid, S (corresponding author), Univ Minho, Sch Psychol, Dept Basic Psychol, Human Cognit Lab,Res Ctr Psychol CIPsi, Braga, Portugal.	s.cadavid@psi.uminho.pt	Beato, Maria Soledad/A-5867-2017; Cadavid, Sara/D-8091-2018	Beato, Maria Soledad/0000-0001-6735-8398; Cadavid, Sara/0000-0002-2606-3742	Portuguese Foundation for Science and Technology [UID/PSI/01662/2013]; Portuguese Ministry of Science, Technology and Higher Education; FEDER through COMPETE [POCI-01-0145-FEDER-007653]; Universidade do Minho Portugal [CIPSI-BI-CH-02]; Universidad de Salamanca (Spain) [FPI-USAL-10]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science, Technology and Higher Education; FEDER through COMPETE; Universidade do Minho Portugal; Universidad de Salamanca (Spain)	This research was supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Science, Technology and Higher Education through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007653). Portuguese Foundation for Science and Technology also funded the Psychology Research Centre at Universidade do Minho, Portugal (UID/PSI/01662/2013) (http://www.fct.pt). This study was funded in part by the Portuguese Foundation for Science and Technology and Universidade do Minho Portugal (CIPSI-BI-CH-02 to SC) and in part by the Universidad de Salamanca (Spain) (FPI-USAL-10 to SC) (http://campus.usal.es/similar to agencia/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Achim AM, 2005, NEUROIMAGE, V24, P1113, DOI 10.1016/j.neuroimage.2004.10.036; Albuquerque P., 2011, LAB PSICOLOGIA, V9, P23, DOI [https://doi.org/10.14417/lp.634, DOI 10.14417/LP.634]; Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; AMDT J, 2012, PSYCHOL LEARN MOTIV, P81, DOI DOI 10.1016/B978-0-12-394393-4.00003-0; Arndt J, 2006, MEMORY, V14, P814, DOI 10.1080/09658210600680749; Arndt J, 2015, MEMORY, V23, P1093, DOI 10.1080/09658211.2014.959527; Arndt J, 2010, J EXP PSYCHOL LEARN, V36, P66, DOI 10.1037/a0017394; Baioui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030416; Boldini A, 2013, NEUROREPORT, V24, P108, DOI 10.1097/WNR.0b013e32835c93e3; Bowman CR, 2015, EXP BRAIN RES, V233, P1963, DOI 10.1007/s00221-015-4268-y; Brainerd CJ, 2005, J EXP PSYCHOL LEARN, V31, P554, DOI 10.1037/0278-7393.31.3.554; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Brainerd CJ, 2001, J EXP PSYCHOL LEARN, V27, P307, DOI 10.1037//0278-7393.27.2.307; Brainerd CJ., 2005, SCI FALSE MEMORY, DOI [10.1093/acprof:oso/9780195154054.001.0001, DOI 10.1093/ACPROF:OSO/9780195154054.001.0001]; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Cadavid S, 2012, PSICOLOGICA, V33, P39; Cheng SK, 2010, INT J PSYCHOPHYSIOL, V77, P95, DOI 10.1016/j.ijpsycho.2010.04.010; Coane JH, 2006, MEM COGNITION, V34, P1026, DOI 10.3758/BF03193249; Cruse D, 2009, NEUROPSYCHOLOGIA, V47, P2779, DOI 10.1016/j.neuropsychologia.2009.06.003; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; Curran T, 2003, COGNITIVE BRAIN RES, V15, P191, DOI 10.1016/S0926-6410(02)00192-1; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T., 2006, BINDING HUMAN MEMORY, P467, DOI DOI 10.1093/ACPROF:OSO/9780198529675.003.0018; Danker JF, 2008, PSYCHOPHYSIOLOGY, V45, P784, DOI 10.1111/j.1469-8986.2008.00672.x; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Dennis NA, 2014, BRAIN COGNITION, V88, P65, DOI 10.1016/j.bandc.2014.04.009; Dennis NA, 2014, NEUROBIOL AGING, V35, P395, DOI 10.1016/j.neurobiolaging.2013.08.019; Dennis NA, 2012, NEUROIMAGE, V59, P2982, DOI 10.1016/j.neuroimage.2011.09.079; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Fernandez A., 2011, MATERIALES NORMATIVO; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Gallo DA, 2004, J EXP PSYCHOL LEARN, V30, P120, DOI 10.1037/0278-7393.30.1.120; Gallo DA, 2002, J MEM LANG, V47, P469, DOI 10.1016/S0749-596X(02)00013-X; Gallo David, 2006, ASSOCIATIVE ILLUSION; Gallo DA, 2010, MEM COGNITION, V38, P833, DOI 10.3758/MC.38.7.833; Garoff-Eaton RJ, 2007, LEARN MEMORY, V14, P684, DOI 10.1101/lm.695707; Garoff-Eaton RJ, 2006, CEREB CORTEX, V16, P1645, DOI 10.1093/cercor/bhj101; Geng HY, 2007, BRAIN RES, V1136, P154, DOI 10.1016/j.brainres.2006.12.027; Giovanello KS, 2010, J COGNITIVE NEUROSCI, V22, P1348, DOI 10.1162/jocn.2009.21274; Goldmann RE, 2003, NEUROREPORT, V14, P1717, DOI 10.1097/00001756-200309150-00012; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greve A, 2007, NEUROIMAGE, V34, P801, DOI 10.1016/j.neuroimage.2006.07.043; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Hicks JL, 2002, PSYCHON B REV, V9, P807, DOI 10.3758/BF03196339; Hoppstadter M, 2015, NEUROIMAGE, V116, P112, DOI 10.1016/j.neuroimage.2015.05.026; Israel L, 1997, PSYCHON B REV, V4, P577, DOI 10.3758/BF03214352; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Jou J, 2013, PSYCHOL RES-PSYCH FO, V77, P671, DOI 10.1007/s00426-012-0472-6; Kim H, 2007, CEREB CORTEX, V17, P2143, DOI 10.1093/cercor/bhl122; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Kubota Y, 2006, NEUROIMAGE, V31, P1783, DOI 10.1016/j.neuroimage.2006.02.003; Kuo TY, 2008, NEUROPSYCHOLOGIA, V46, P2243, DOI 10.1016/j.neuropsychologia.2008.02.018; Kuo TY, 2006, J COGNITIVE NEUROSCI, V18, P1133, DOI 10.1162/jocn.2006.18.7.1133; Luck S, 2005, AN INTRODUCTION TO T; McDermott KB, 2001, J MEM LANG, V45, P160, DOI 10.1006/jmla.2000.2771; McDermott KB, 1998, J MEM LANG, V39, P508, DOI 10.1006/jmla.1998.2582; McDonough IM, 2015, ACTA PSYCHOL, V161, P7, DOI 10.1016/j.actpsy.2015.07.017; Meek SW, 2013, INT J PSYCHOPHYSIOL, V87, P81, DOI 10.1016/j.ijpsycho.2012.11.004; Miller AR, 2001, J EXP PSYCHOL LEARN, V27, P354, DOI 10.1037/0278-7393.27.2.354; Morcom AM, 2015, BRAIN RES, V1624, P336, DOI 10.1016/j.brainres.2015.07.049; Neath I, 2003, HUMAN MEMORY AN INTR; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nessler D, 2001, COGNITIVE BRAIN RES, V10, P283, DOI 10.1016/S0926-6410(00)00049-5; Oates JM, 2015, PSYCHOL PR FESTSCHR, P145; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paller KA, 2012, TRENDS COGN SCI, V16, P313, DOI 10.1016/j.tics.2012.04.010; Prohaska V, 2016, MEMORY, V24, P865, DOI 10.1080/09658211.2015.1059455; Ranganath C, 2000, COGNITIVE BRAIN RES, V9, P209, DOI 10.1016/S0926-6410(99)00048-8; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Roediger HL, THE NATURE OF REMEMB, P95, DOI [10.1037/10394-000, DOI 10.1037/10394-000]; Rugg MD, 1998, J MEM LANG, V39, P47, DOI 10.1006/jmla.1997.2555; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schloerscheidt AM, 2004, NEUROPSYCHOLOGIA, V42, P451, DOI 10.1016/j.neuropsychologia.2003.08.010; Schneider W., 2002, E PRIME VERSION 20 C; Senkfor AJ, 1998, J EXP PSYCHOL LEARN, V24, P1005, DOI 10.1037/0278-7393.24.4.1005; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Beato MS, 2014, PSICOTHEMA, V26, P457, DOI 10.7334/psicothema2014.79; Beato MS, 2012, NEUROREPORT, V23, P804, DOI 10.1097/WNR.0b013e32835734de; Beato MS, 2011, BEHAV RES METHODS, V43, P499, DOI 10.3758/s13428-010-0045-9; von Zerssen GC, 2001, EUR J NEUROSCI, V13, P2148, DOI 10.1046/j.0953-816x.2001.01589.x; Warren DE, 2014, J NEUROSCI, V34, P7677, DOI 10.1523/JNEUROSCI.0119-14.2014; Wiese H, 2006, BRAIN RES, V1075, P183, DOI 10.1016/j.brainres.2005.12.117; Wilding E. L., 2012, OXFORD HDB EVENT REL, P373; Wilding E. L., 2003, COGNITIVE ELECTROPHY, P169, DOI DOI 10.1016/B978-012775421-5/50009-1; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P119, DOI 10.1016/S0028-3932(96)00076-0; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P1185, DOI 10.1016/S0028-3932(97)00048-1; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Wilding EL, 2000, INT J PSYCHOPHYSIOL, V35, P81, DOI 10.1016/S0167-8760(99)00095-1; Wolk DA, 2009, BRAIN RES, V1250, P218, DOI 10.1016/j.brainres.2008.11.014; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415; Yu SS, 2010, BRAIN RES, V1320, P74, DOI 10.1016/j.brainres.2009.12.071	100	12	12	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164024	10.1371/journal.pone.0164024	http://dx.doi.org/10.1371/journal.pone.0164024			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711125	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600065
J	Chen, XL; Song, W; Gao, C; Qin, W; Luo, QL; Liu, J; Liu, LM				Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming			Fumarate Production by Torulopsis glabrata: Engineering Heterologous Fumarase Expression and Improving Acid Tolerance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RHIZOPUS-ORYZAE; ESCHERICHIA-COLI; PYRUVATE PRODUCTION; CANDIDA-GLABRATA; HYPEROSMOTIC STRESS; DIRECTED EVOLUTION; INTRACELLULAR PH; PATHWAY; GLUCOSE	Fumarate is a well-known biomass building block compound. However, the poor catalytic efficiency of fumarase is one of the major factors preventing its widespread production. To address this issue, we selected residues (HPND162)-H-159 of fumarase from Rhizopus oryzae as targets for site-directed mutagenesis based on molecular docking analysis. Twelve mutants were generated and characterized in detail. Kinetic studies showed that the K-m values of the P160A, P160T, P160H, N161E, and D162W mutants were decreased, whereas K-m values of H159Y, H159V, H159S, N161R, N161F, D162K, and D162M mutants were increased. In addition, all mutants displayed decreased catalytic efficiency except for the P160A mutant, whose k(cat)/K-m was increased by 33.2%. Moreover, by overexpressing the P160A mutant, the engineered strain T.G-PMS-P160A was able to produce 5.2 g/L fumarate. To further enhance fumarate production, the acid tolerance of T.G-PMS-P160A was improved by deleting ade12, a component of the purine nucleotide cycle, and the resulting strain T. G(Delta ade12)-PMS-P160A produced 9.2 g/L fumarate. The strategy generated in this study opens up new avenues for pathway optimization and efficient production of natural products.	[Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Liu, LM (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.; Liu, LM (corresponding author), Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Peoples R China.	mingll@jiangnan.edu.cn	Song, Wei/Q-3289-2019; Liu, Liming/B-1972-2009; Gao, Cong/AAB-4849-2022; Gao, Cong/N-2035-2018; song, wei/U-6787-2018; Chen, Xiulai/AAB-8395-2020	Song, Wei/0000-0002-2278-2205; Liu, Liming/0000-0003-3022-936X; Gao, Cong/0000-0001-8505-2026; Gao, Cong/0000-0001-8505-2026; song, wei/0000-0002-2278-2205; Chen, Xiulai/0000-0002-5154-3860	National High Technology Research and Development Program of China [2012AA022108, 2014AA021501, 2014AA021701]; National Natural Science Foundation of China [21422602]; Provincial Natural Science Foundation of Jiangsu Province [BK20160163]; Fundamental Research Funds for the Central Universities [JUSRP51611A, JUSRP116022]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National High Technology Research and Development Program of China (2012AA022108, 2014AA021501, 2014AA021701); the National Natural Science Foundation of China (21422602); the Provincial Natural Science Foundation of Jiangsu Province (BK20160163); the Fundamental Research Funds for the Central Universities (JUSRP51611A); and the Fundamental Research Funds for the Central Universities (JUSRP116022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Amara AA, 2002, APPL MICROBIOL BIOT, V59, P477, DOI 10.1007/s00253-002-1035-3; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Carta FS, 1999, BIORESOURCE TECHNOL, V68, P23, DOI 10.1016/S0960-8524(98)00074-1; Chen XL, 2015, METAB ENG, V31, P62, DOI 10.1016/j.ymben.2015.02.002; Chen XL, 2015, BIOTECHNOL BIOENG, V112, P156, DOI 10.1002/bit.25334; Chen XL, 2014, TRENDS BIOTECHNOL, V32, P337, DOI 10.1016/j.tibtech.2014.04.003; Chen XL, 2013, METAB ENG, V19, P10, DOI 10.1016/j.ymben.2013.05.002; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Engel CAR, 2008, APPL MICROBIOL BIOT, V78, P379, DOI 10.1007/s00253-007-1341-x; Foo JL, 2012, BIOTECHNOL ADV, V30, P541, DOI 10.1016/j.biotechadv.2011.09.008; FRIEDBERG D, 1995, GENE, V163, P139, DOI 10.1016/0378-1119(95)00367-F; Fu YQ, 2010, KOREAN J CHEM ENG, V27, P183, DOI 10.1007/s11814-009-0323-3; FUHRMANN GF, 1993, BIOCHIM BIOPHYS ACTA, V1145, P180, DOI 10.1016/0005-2736(93)90396-H; Hua Q, 2001, BIOTECHNOL PROGR, V17, P62, DOI 10.1021/bp000138l; Huang D, 2015, BIORESOURCE TECHNOL, V196, P263, DOI 10.1016/j.biortech.2015.07.104; Huang L, 2010, ANN MICROBIOL, V60, P287, DOI 10.1007/s13213-010-0039-y; Jin Congcong, 2016, Weishengwu Xuebao, V56, P1113, DOI 10.13343/j.cnki.wsxb.20150438; Li Y, 2001, APPL MICROBIOL BIOT, V55, P680, DOI 10.1007/s002530100598; Li Y., 2012, ARCH ANIM NUTR, V1, P1, DOI DOI 10.1099/VIR.0.039289-0; Liu LM, 2007, BIOTECHNOL BIOENG, V97, P825, DOI 10.1002/bit.21290; Liu LM, 2007, METAB ENG, V9, P21, DOI 10.1016/j.ymben.2006.07.007; Liu LM, 2004, LETT APPL MICROBIOL, V39, P199, DOI 10.1111/j.1472-765X.2004.01563.x; Liu YF, 2014, METAB ENG, V23, P42, DOI 10.1016/j.ymben.2014.02.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Reynolds TB, 2008, EUKARYOT CELL, V7, P122, DOI 10.1128/EC.00310-06; Riscaldati E, 2000, BIOTECHNOL LETT, V22, P1043, DOI 10.1023/A:1005621311898; Rose IA, 2004, P NATL ACAD SCI USA, V101, P3393, DOI 10.1073/pnas.0307524101; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Seo SW, 2012, BIOTECHNOL BIOPROC E, V17, P1, DOI 10.1007/s12257-011-0563-z; Song CW, 2013, BIOTECHNOL BIOENG, V110, P2025, DOI 10.1002/bit.24868; Torres LL, 2013, APPL ENVIRON MICROB, V79, P1555, DOI 10.1128/AEM.03215-12; Valli M, 2006, APPL ENVIRON MICROB, V72, P5492, DOI 10.1128/AEM.00683-06; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Vazquez-Figueroa E, 2007, CHEMBIOCHEM, V8, P2295, DOI 10.1002/cbic.200700500; Wang GY, 2013, BIORESOURCE TECHNOL, V137, P1, DOI 10.1016/j.biortech.2013.03.041; Weaver T, 1996, BIOCHEMISTRY-US, V35, P13955, DOI 10.1021/bi9614702; WEAVER TM, 1995, NAT STRUCT BIOL, V2, P654, DOI 10.1038/nsb0895-654; WEAVER TM, 1993, J MOL BIOL, V231, P141, DOI 10.1006/jmbi.1993.1264; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859; Xiao YT, 2008, INT J BIOCHEM CELL B, V40, P2002, DOI 10.1016/j.biocel.2007.08.006; Xu GQ, 2013, BIORESOURCE TECHNOL, V148, P91, DOI 10.1016/j.biortech.2013.08.115; Xu GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052086; Xu GQ, 2012, YEAST, V29, P209, DOI 10.1002/yea.2902; Xu GQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-24; Xu Q, 2012, BIOTECHNOL ADV, V30, P1685, DOI 10.1016/j.biotechadv.2012.08.007; Xu S, 2010, BIOTECHNOL BIOPROC E, V15, P285, DOI 10.1007/s12257-009-0131-y; Yu SZ, 2012, BIORESOURCE TECHNOL, V114, P610, DOI 10.1016/j.biortech.2012.03.087; Yu XX, 2014, APPL MICROBIOL BIOT, V98, P3099, DOI 10.1007/s00253-014-5589-7; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zhang BH, 2012, METAB ENG, V14, P512, DOI 10.1016/j.ymben.2012.07.001; Zhou JW, 2011, J APPL MICROBIOL, V110, P44, DOI 10.1111/j.1365-2672.2010.04865.x; Zhou JW, 2009, J MICROBIOL METH, V76, P70, DOI 10.1016/j.mimet.2008.09.011	59	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164141	10.1371/journal.pone.0164141	http://dx.doi.org/10.1371/journal.pone.0164141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711153	gold, Green Submitted, Green Published			2022-12-26	WOS:000385697600086
J	Braster, Q; Roig, CS; Hartwig, H; Beckers, L; den Toom, M; Doring, Y; Deemen, MJ; Lutgens, E; Soehnlein, O				Braster, Quinte; Roig, Carlos Silvestre; Hartwig, Helene; Beckers, Linda; den Toom, Myrthe; Doering, Yvonne; Deemen, Mat J.; Lutgens, Esther; Soehnlein, Oliver			Inhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in Mice	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE INHIBITION; NEUTROPHIL EXTRACELLULAR TRAPS; INSULIN-RESISTANCE; IMMUNE CELLS; MYELOPEROXIDASE; NETOSIS; ATHEROSCLEROSIS; ELASTASE; OBESITY	Obesity-associated diseases such as Type 2 diabetes, liver disease and cardiovascular diseases are profoundly mediated by low-grade chronic inflammation of the adipose tissue. Recently, the importance of neutrophils and neutrophil-derived myeloperoxidase and neutrophil elastase on the induction of insulin resistance has been established. Since neutrophil elastase and myeloperoxidase are critically involved in the release of neutrophil extracellular traps (NETs), we here hypothesized that NETs may be relevant to early adipose tissue inflammation. Thus, we tested the effect of the Peptidyl Arginine Deiminase 4 inhibitor Cl-amidine, a compound preventing histone citrullination and subsequent NET release, in a mouse model of adipose tissue inflammation. C57BL6 mice received a 60% high fat diet for 10 weeks and were treated with either Cl-amidine or vehicle. Flow cytometry of adipose tissue and liver, immunohistological analysis and glucose and insulin tolerance tests were performed to determine the effect of the treatment and diet. Although high fat diet feeding induced insulin resistance no significant effect was observed between the treatment groups. In addition no effect was found in leukocyte infiltration and activation in the adipose tissue and liver. Therefore we concluded that inhibition of neutrophil extracellular trap formation may have no clinical relevance for early obesity-mediated pathogenesis of the adipose tissue and liver.	[Braster, Quinte; Roig, Carlos Silvestre; Hartwig, Helene; Deemen, Mat J.; Soehnlein, Oliver] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Beckers, Linda; den Toom, Myrthe; Lutgens, Esther] Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Braster, Quinte; Roig, Carlos Silvestre; Doering, Yvonne; Lutgens, Esther; Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Soehnlein, Oliver] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Soehnlein, O (corresponding author), Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands.; Soehnlein, O (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany.; Soehnlein, O (corresponding author), Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany.	oliver.soehnlein@gmail.com	Silvestre-Roig, Carlos/ABF-9769-2020; Doring, Yvonne/E-1796-2013; Döring, Yvonne/E-9414-2017; Döring, Yvonne/AAA-3018-2022	Silvestre-Roig, Carlos/0000-0003-1169-7475; Döring, Yvonne/0000-0001-9307-3396; Daemen, Mat/0000-0003-1076-199X				Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chmelar J, 2013, THROMB HAEMOSTASIS, V109, P399, DOI 10.1160/TH12-09-0703; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	19	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163922	10.1371/journal.pone.0163922	http://dx.doi.org/10.1371/journal.pone.0163922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701440	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900033
J	Morikawa, M; Tsujibe, S; Kiyoshima-Shibata, J; Watanabe, Y; Kato-Nagaoka, N; Shida, K; Matsumoto, S				Morikawa, Masatoshi; Tsujibe, Satoshi; Kiyoshima-Shibata, Junko; Watanabe, Yohei; Kato-Nagaoka, Noriko; Shida, Kan; Matsumoto, Satoshi			Microbiota of the Small Intestine Is Selectively Engulfed by Phagocytes of the Lamina Propria and Peyer's Patches	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; DENDRITIC CELLS; HUMAN FECES; DIVERSITY; SEQUENCES; RESPONSES; SAMPLE; TH17; DIFFERENTIATION; TAXONOMY	Phagocytes such as dendritic cells and macrophages, which are distributed in the small intestinal mucosa, play a crucial role in maintaining mucosal homeostasis by sampling the luminal gut microbiota. However, there is limited information regarding microbial uptake in a steady state. We investigated the composition of murine gut microbiota that is engulfed by phagocytes of specific subsets in the small intestinal lamina propria (SILP) and Peyer's patches (PP). Analysis of bacterial 16S rRNA gene amplicon sequences revealed that: 1) all the phagocyte subsets in the SILP primarily engulfed Lactobacillus (the most abundant microbe in the small intestine), whereas CD11b(hi) and CD11b(hi) CD11c(hi) cell subsets in PP mostly engulfed segmented filamentous bacteria (indigenous bacteria in rodents that are reported to adhere to intestinal epithelial cells); and 2) among the Lactobacillus species engulfed by the SILP cell subsets, L. murinus was engulfed more frequently than L. taiwanensis, although both these Lactobacillus species were abundant in the small intestine under physiological conditions. These results suggest that small intestinal microbiota is selectively engulfed by phagocytes that localize in the adjacent intestinal mucosa in a steady state. These observations may provide insight into the crucial role of phagocytes in immune surveillance of the small intestinal mucosa.	[Morikawa, Masatoshi; Tsujibe, Satoshi; Kiyoshima-Shibata, Junko; Watanabe, Yohei; Kato-Nagaoka, Noriko; Shida, Kan; Matsumoto, Satoshi] Yakult Cent Inst, Tokyo, Japan	Yakult Honsha Company, Limited	Morikawa, M (corresponding author), Yakult Cent Inst, Tokyo, Japan.	masatoshi-morikawa@yakult.co.jp		Watanabe, Yohei/0000-0001-7740-1361				Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen H, 2015, IEEE-ASME T MECH, V21, P1, DOI DOI 10.1371/J0URNAL.P0NE.0142881; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hatano S, 2015, INT IMMUNOPHARMACOL, V25, P321, DOI 10.1016/j.intimp.2015.02.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	35	37	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163607	10.1371/journal.pone.0163607	http://dx.doi.org/10.1371/journal.pone.0163607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701454	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900014
J	Saito, S; Ohno, K; Okuyama, T; Sakuraba, H				Saito, Seiji; Ohno, Kazuki; Okuyama, Torayuki; Sakuraba, Hitoshi			Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; HUNTER-SYNDROME; DISEASE; IDURONATE-2-SULFATASE; MUTATIONS; IDENTIFICATION; GALACTOSIDASE; PHENOTYPES; ALGORITHMS; EXPRESSION	Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked genetic disorder caused by a deficiency of iduronate 2-sulfatase (IDS), and missense mutations comprising about 30% of the mutations responsible for MPS II result in heterogeneous phenotypes ranging from the severe to the attenuated form. To elucidate the basis of MPS II from the structural viewpoint, we built structural models of the wild type and mutant IDS proteins resulting from 131 missense mutations (phenotypes: 67 severe and 64 attenuated), and analyzed the influence of each amino acid substitution on the IDS structure by calculating the accessible surface area, the number of atoms affected and the root-mean-square distance. The results revealed that the amino acid substitutions causing MPS II were widely spread over the enzyme molecule and that the structural changes of the enzyme protein were generally larger in the severe group than in the attenuated one. Coloring of the atoms influenced by different amino acid substitutions at the same residue showed that the structural changes influenced the disease progression. Based on these data, we constructed a database of IDS mutations as to the structures of mutant IDS proteins.	[Saito, Seiji] Hokkaido Informat Univ, Dept Med Management & Informat, 59-2 Nishinopporo, Ebetsu, Hokkaido 0698585, Japan; [Ohno, Kazuki] Catalyst Inc, Chiyoda Ku, 1-5-6 Kudan Minami, Tokyo 1020074, Japan; [Ohno, Kazuki] Tokyo Inst Technol, Educ Acad Computat Life Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan; [Okuyama, Torayuki] Natl Ctr Child Hlth & Dev, Dept Clin Lab Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, 2-522-1 Noshio, Tokyo 2048588, Japan	Tokyo Institute of Technology; National Center for Child Health & Development - Japan; Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, 2-522-1 Noshio, Tokyo 2048588, Japan.	sakuraba@my-pharm.ac.jp			Japan Society for Promotion of Science [15K090]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (ID: 15K090, HS).	Chang JH, 2005, HUM GENET, V116, P160, DOI 10.1007/s00439-004-1234-3; Charoenwattanasatien R, 2012, BIOCHEM GENET, V50, P990, DOI 10.1007/s10528-012-9538-9; FLOMEN RH, 1993, HUM MOL GENET, V2, P5, DOI 10.1093/hmg/2.1.5; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Guffon N, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0259-0; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kato T, 2005, J HUM GENET, V50, P395, DOI 10.1007/s10038-005-0266-4; Kim CH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9128; KUNDROT CE, 1991, J COMPUT CHEM, V12, P402, DOI 10.1002/jcc.540120314; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; Millat G, 1998, BBA-MOL BASIS DIS, V1406, P214, DOI 10.1016/S0925-4439(97)00096-3; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Parini R, 2015, MOLEC GENET METAB RE, V3, P65, DOI 10.1016/j.ymgmr.2015.03.011; Parkinson-Lawrence E, 2005, BIOCHEM J, V386, P395, DOI 10.1042/BJ20040739; Saito S, 2011, J HUM GENET, V56, P467, DOI 10.1038/jhg.2011.31; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Sohn YB, 2015, MOL GENET METAB, V114, P156, DOI 10.1016/j.ymgme.2014.08.009; SUKEGAWA K, 1995, HUM MUTAT, V6, P136, DOI 10.1002/humu.1380060206; Sukegawa-Hayasaka K, 2006, J INHERIT METAB DIS, V29, P755, DOI 10.1007/s10545-006-0440-7; Tajima G, 2013, MOL GENET METAB, V108, P172, DOI 10.1016/j.ymgme.2012.12.010; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WILSON PJ, 1993, GENOMICS, V17, P773, DOI 10.1006/geno.1993.1406; WILSON PJ, 1991, HUM GENET, V86, P505; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163964	10.1371/journal.pone.0163964	http://dx.doi.org/10.1371/journal.pone.0163964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695081	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100069
J	Wang, YN; Qiu, XL; Lv, LS; Wang, CX; Ye, ZC; Li, SM; Liu, Q; Lou, TQ; Liu, X				Wang, Yanni; Qiu, Xilian; Lv, Linsheng; Wang, Caixia; Ye, Zengchun; Li, Shaomin; Liu, Qiong; Lou, Tanqi; Liu, Xun			Correlation between Serum Lipid Levels and Measured Glomerular Filtration Rate in Chinese Patients with Chronic Kidney Disease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN; PREVALENCE; DYSLIPIDEMIA; CHOLESTEROL; METABOLISM; MECHANISMS; ESRD	Introduction Dyslipidemia is often detected in patients with chronic kidney disease (CKD). Previous studies of the relationship between lipid profiles and kidney function have yielded variable results. We aimed to investigate the correlation between serum lipid levels and kidney function evaluated by measured glomerular filtration rate (mGFR) in Chinese patients with CKD. Methods A cross-sectional study was conducted on 2036 Chinese CKD patients who had mGFR. Linear regression analysis was performed to evaluate the correlation between different serum lipid levels and mGFR, while logistic regression analysis was used to investigate the association between CKD stages and the risk of different types of dyslipidemia. Results The mean age was 55 years and the mean mGFR was 63 mL/min/1.73m(2). After adjusting for some confounders (age, gender, body mass index, a history of diabetes, fasting glucose, a history of hypertension, systolic blood pressure, diastolic blood pressure, smoking status, hemoglobin, serum potassium, serum albumin, and serum uric acid), serum triglyceride level showed a negative correlation with mGFR (beta = -0.006, P = 0.006) in linear regression analysis, and CKD stages were positively related to the risk of hypertriglyceridemia (odds ratios were 1.329, 1.868, 2.514 and P were 0.046, < 0.001, < 0.001 for CKD stage 2, 3, 4/5, respectively) in logistic regression anlysis. Conclusions Serum triglyceride level is independently association with mGFR. Patients with reduced kidney function are more likely to have higher serum triglyceride levels. Further longitudinal, multicenter and well-conducted studies are needed to provide more evidence.	[Wang, Yanni; Wang, Caixia; Ye, Zengchun; Li, Shaomin; Lou, Tanqi; Liu, Xun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Wang, Yanni] Hainan Gen Hosp, Dept Nephrol, Haikou, Peoples R China; [Qiu, Xilian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Operat Room, Guangzhou, Guangdong, Peoples R China; [Liu, Qiong] South China Univ Tecchonol, Sch Software Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lou, TQ; Liu, X (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	lou.tq@163.com; naturestyle@163.com			National Natural Science Foundation of China [81370866, 81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [20116031800084, 20136021800190]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [201113A1101300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This study was funded by 1. the National Natural Science Foundation of China (No. 81370866 and 81070612), http://www.nsfc.gov.cn/, Ministry of Finance of China, XL; 2. the China Postdoctoral Science Foundation (No. 201104335), http://jj.chinapostdoctor.org.cn, Ministry of Finance of China, XL; 3. Guangdong Science and Technology Plan (No. 20116031800084 and 20136021800190), http://pro.gdstc.gov.cn, Finance Department of Guangdong Province, XL; 4. the Fundamental Research Funds for the Central Universities (No. 11ykpy38), Ministry of Finance of China, http://research.sysu.edu.cn/, XL; 5. the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (No. 201113A1101300), Ministry of Science & Technology of China, http://www.most.gov.cn, Ministry of Science & Technology of China, XL.	Alaupovic P, 2006, KIDNEY INT, V69, P1865, DOI 10.1038/sj.ki.5000327; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; ATTMAN PO, 1993, AM J KIDNEY DIS, V21, P573, DOI 10.1016/S0272-6386(12)80030-8; Baragetti A, 2013, J INTERN MED, V274, P252, DOI 10.1111/joim.12081; Bobik A, 2008, CIRCULATION, V118, P702, DOI 10.1161/CIRCULATIONAHA.108.794081; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hou X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106778, 10.1371/journal.pone.0108314]; Ikewaki K, 2005, ARTERIOSCL THROM VAS, V25, P2615, DOI 10.1161/01.ATV.0000188555.60475.c2; Liu X, 2010, ARCH GERONTOL GERIAT, V51, P13, DOI 10.1016/j.archger.2009.06.005; Mesquita Joana, 2010, Endocrinol Nutr, V57, P440, DOI 10.1016/j.endonu.2010.06.003; Odden MC, 2013, ANN EPIDEMIOL, V23, P106, DOI 10.1016/j.annepidem.2012.12.004; Prinsen BHCMT, 2004, KIDNEY INT, V65, P1064, DOI 10.1111/j.1523-1755.2004.00466.x; Scheffer PG, 2008, CLIN CHEM, V54, P1325, DOI 10.1373/clinchem.2008.103234; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stevens LA, 2008, J NEPHROL, V21, P797; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	25	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163767	10.1371/journal.pone.0163767	http://dx.doi.org/10.1371/journal.pone.0163767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695128	Green Submitted, Green Published, gold			2022-12-26	WOS:000385553100051
J	Wu, P; Xiong, XF; Xu, ZZ; Lu, CQ; Cheng, H; Lyu, XL; Zhang, JH; He, W; Deng, W; Lyu, YH; Lou, QS; Hong, YG; Fang, HD				Wu, Peng; Xiong, Xiaofei; Xu, Zhanzhou; Lu, Chuqian; Cheng, Hao; Lyu, Xiangli; Zhang, Jinghuai; He, Wei; Deng, Wei; Lyu, Yihua; Lou, Quansheng; Hong, Yiguo; Fang, Hongda			Bacterial Communities in the Rhizospheres of Three Mangrove Tree Species from Beilun Estuary, China	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ENVIRONMENTAL VARIABLES; MICROBIAL DIVERSITY; SEDIMENTS; SOIL; SEQUENCES	The bacterial communities played important roles in the high productivity mangrove ecosystem. In this study, we investigated the vertical distributions of rhizosphere bacteria from three mangrove species (Bruguiera gymnorrhiza, Kandelia candel and Aegiceras corniculatum) in Beilun Estuary, China using high throughput DNA pyrosequencing of the 16S rRNA gene. Phylogenetic analysis showed that bacterial communities from mangrove rhizosphere sediments were dominated by Proteobacteria (mostly Deltaproteobacteria and Gammaproteobacteria), followed by Chloroflexi, Bacteroidetes, Planctomycetes and Acid-obacteria. However, the ANOVA analysis on Shannon and Chao1 indices indicated that bacterial communities among sediments of the three mangrove species varied more strongly than the sampling depths. In addition, the PCA result demonstrated that the bacterial communities could be separated into three groups according to the mangrove species. Moreover, the dominated orders Rhodospirillales, GCA004 and envOPS12 were significantly different among sediments of the three mangrove species. The results of this study provided valuable information about the distribution feature of rhizosphere bacteria from Chinese mangrove plants and shed insights into biogeochemical transformations driven by bacteria in rhizosphere sediments.	[Wu, Peng; Xiong, Xiaofei; Xu, Zhanzhou; Lu, Chuqian; Lyu, Xiangli; Zhang, Jinghuai; He, Wei; Deng, Wei; Lyu, Yihua; Lou, Quansheng; Fang, Hongda] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China; [Cheng, Hao; Hong, Yiguo] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China	State Oceanic Administration; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Fang, HD (corresponding author), State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China.; Hong, YG (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China.	yghong@scsio.ac.cn; Fanghongda1@21cn.com	wu, peng/AAI-1749-2021; 张, 敬怀/GXH-6967-2022		Guangdong Natural Science Foundation [2014A030310495, 2014A030313783]; National Natural Science Foundation of China [41406179]; Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration [201508, 201608]; Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration [1516, 1511]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration; Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration	This work was supported by Guangdong Natural Science Foundation (2014A030310495, 2014A030313783), and National Natural Science Foundation of China (41406179), as well as the Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration (201508, 201608), and sponsored by the Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration (1516,1511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alvarenga DO, 2015, BIODIVERS CONSERV, V24, P799, DOI 10.1007/s10531-015-0871-2; Alzubaidy H, 2016, GENE, V576, P626, DOI 10.1016/j.gene.2015.10.032; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Basak P, 2015, MICROB ECOL, V69, P500, DOI 10.1007/s00248-014-0498-y; Bashan Y, 2002, TREES-STRUCT FUNCT, V16, P159, DOI 10.1007/s00468-001-0152-4; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blazejak A, 2010, FEMS MICROBIOL ECOL, V72, P198, DOI 10.1111/j.1574-6941.2010.00838.x; Cabezas A, 2015, ENV MICROBIOL REP, V7, P489, DOI 10.1111/1758-2229.12277; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cleary DFR, 2016, PLANT BIOLOGY, V18, P824, DOI 10.1111/plb.12459; Colares GB, 2013, APPL SOIL ECOL, V64, P171, DOI 10.1016/j.apsoil.2012.12.004; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Gomes NCM, 2014, ESTUAR COAST SHELF S, V139, P40, DOI 10.1016/j.ecss.2013.12.022; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Isobe K, 2014, MICROBES ENVIRON, V29, P4, DOI 10.1264/jsme2.ME13159; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Kaster AK, 2014, ISME J, V8, P1831, DOI 10.1038/ismej.2014.24; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Lee HJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00639; Loganathachetti DS, 2016, CURR MICROBIOL, V72, P68, DOI 10.1007/s00284-015-0920-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Rigonato J, 2013, ENVIRON MICROBIOL, V15, P1103, DOI 10.1111/j.1462-2920.2012.02830.x; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherman RE, 1998, OECOLOGIA, V115, P553, DOI 10.1007/s004420050553; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Thatoi H, 2013, ANN MICROBIOL, V63, P1, DOI 10.1007/s13213-012-0442-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yu J, 2011, MICROB ECOL, V62, P218, DOI 10.1007/s00248-011-9846-3; Zhang YY, 2009, SCI MAR, V73, P487, DOI 10.3989/scimar.2009.73n3487	42	36	43	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164082	10.1371/journal.pone.0164082	http://dx.doi.org/10.1371/journal.pone.0164082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695084	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100086
J	Chand, S; Atkinson, D; Collins, C; Briggs, D; Ball, S; Sharif, A; Skordilis, K; Vydianath, B; Neil, D; Borrows, R				Chand, Sourabh; Atkinson, David; Collins, Clare; Briggs, David; Ball, Simon; Sharif, Adnan; Skordilis, Kassiani; Vydianath, Bindu; Neil, Desley; Borrows, Richard			The Spectrum of Renal Allograft Failure	PLOS ONE			English	Article							KIDNEY-TRANSPLANT FAILURE; ANTIBODY-MEDIATED REJECTION; SURVIVAL; DISEASE; INFLAMMATION; METAANALYSIS; FIBROSIS; THERAPY; LESIONS; INJURY	Background Causes of "true" late kidney allograft failure remain unclear as study selection bias and limited follow-up risk incomplete representation of the spectrum. Methods We evaluated all unselected graft failures from 2008-2014 (n = 171; 0-36 years post-transplantation) by contemporary classification of indication biopsies "proximate" to failure, DSA assessment, clinical and biochemical data. Results The spectrum of graft failure changed markedly depending on the timing of allograft failure. Failures within the first year were most commonly attributed to technical failure, acute rejection (with T-cell mediated rejection [TCMR] dominating antibody-mediated rejection [ABMR]). Failures beyond a year were increasingly dominated by ABMR and 'interstitial fibrosis with tubular atrophy' without rejection, infection or recurrent disease ("IFTA"). Cases of IFTA associated with inflammation in non-scarred areas (compared with no inflammation or inflammation solely within scarred regions) were more commonly associated with episodes of prior rejection, late rejection and nonadherence, pointing to an alloimmune aetiology. Nonadherence and late rejection were common in ABMR and TCMR, particularly Acute Active ABMR. Acute Active ABMR and nonadherence were associated with younger age, faster functional decline, and less hyalinosis on biopsy. Chronic and Chronic Active ABMR were more commonly associated with Class II DSA. C1q-binding DSA, detected in 33% of ABMR episodes, were associated with shorter time to graft failure. Most non-biopsied patients were DSA-negative (16/21; 76.1%). Finally, twelve losses to recurrent disease were seen (16%). Conclusion This data from an unselected population identifies IFTA alongside ABMR as a very important cause of true late graft failure, with nonadherence-associated TCMR as a phenomenon in some patients. It highlights clinical and immunological characteristics of ABMR subgroups, and should informclinical practice and individualised patient care.	[Chand, Sourabh; Ball, Simon; Sharif, Adnan; Borrows, Richard] Queen Elizabeth Hosp, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England; [Chand, Sourabh; Ball, Simon; Sharif, Adnan; Borrows, Richard] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England; [Chand, Sourabh] Royal Shrewsbury Hosp, Renal Dept, Shrewsbury, Shrops, England; [Atkinson, David; Collins, Clare; Briggs, David] NHSBT Birmingham Ctr, Histocompatibil & Immunogenet Lab, Vincent Dr, Birmingham, W Midlands, England; [Skordilis, Kassiani; Vydianath, Bindu; Neil, Desley] Queen Elizabeth Hosp, Dept Renal Histopathol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham	Chand, S (corresponding author), Queen Elizabeth Hosp, Dept Nephrol & Kidney Transplantat, Birmingham, W Midlands, England.; Chand, S (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England.; Chand, S (corresponding author), Royal Shrewsbury Hosp, Renal Dept, Shrewsbury, Shrops, England.	sourabh.chand@nhs.net		Ball, Simon/0000-0001-7410-5268; Sharif, Adnan/0000-0002-7586-9136; Chand, Sourabh/0000-0002-6126-3678				Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; Del Bello A, 2012, CLIN J AM SOC NEPHRO, V7, P1310, DOI 10.2215/CJN.00260112; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Gaston RS, 2010, TRANSPLANTATION, V90, P68, DOI 10.1097/TP.0b013e3181e065de; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Halloran PF, 2013, AM J TRANSPLANT, V13, P1931, DOI 10.1111/ajt.12317; Halloran P.F., 2014, J AM SOC NEPHROL; HALLORAN PF, 1990, TRANSPLANTATION, V49, P85, DOI 10.1097/00007890-199001000-00019; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Kawakami T, 2014, KIDNEY INT SUPPL, V4, P107, DOI 10.1038/kisup.2014.20; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Loupy A, 2013, NEW ENGL J MED, V369, P1215, DOI 10.1056/NEJMoa1302506; McDonald S, 2011, 33 ANZDATA, V3. 2; McGettrick HM, 2012, J LEUKOCYTE BIOL, V91, P385, DOI 10.1189/jlb.0911458; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Naesens M, 2013, AM J TRANSPLANT, V13, P1933, DOI 10.1111/ajt.12316; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Prommool S, 2000, J AM SOC NEPHROL, V11, P565, DOI 10.1681/ASN.V113565; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Sellares J, 2011, AM J TRANSPLANT, V11, P489, DOI 10.1111/j.1600-6143.2010.03415.x; Sharif A, 2011, J AM SOC NEPHROL, V22, P2107, DOI 10.1681/ASN.2010111160; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Vitalone MJ, 2014, AM J TRANSPLANT, V14, P1912, DOI 10.1111/ajt.12746; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	26	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162278	10.1371/journal.pone.0162278	http://dx.doi.org/10.1371/journal.pone.0162278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649571	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100015
J	Mittal, A; Tandon, S; Singla, SK; Tandon, C				Mittal, Amisha; Tandon, Simran; Singla, Surender Kumar; Tandon, Chanderdeep			Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in Urolithiasis	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTAL; RENAL EPITHELIAL-CELLS; LLC-PK1 CELLS; IN-VITRO; MONOHYDRATE CRYSTALS; OXIDATIVE STRESS; APOPTOTIC CHANGES; LIGAND-BINDING; STONE DISEASE; TUBULAR CELLS	Kidney stone formation during hyperoxaluric condition is inherently dependent on the interaction between renal epithelial cells and calcium oxalate (CaOx) crystals. Although modern medicine has progressed in termsof removal of these stones, recurrence and persistent side effects restricts their use. Strategies involving plant based agents which could be used as adjunct therapy is an area which needs to be explored. Plant proteins having antilithiatic activity is a hitherto unexplored area and therefore, we conducted a detailed identification and characterization of antilithiatic proteins from Terminalia arjuna (T. arjuna). Proteins were isolated from the dried bark of T. arjuna and those having molecular weights > 3 kDa were subjected to anion exchange chromatography followed by gel filtration chromatography. Four proteins were identified exhibiting inhibitory activity against CaOx crystallization and crystal growth kinetics The cytoprotective and anti-apoptotic efficacy of these purified proteins was further investigated on oxalate injured renal epithelial cells (MDCK and NRK-52E) wherein, injury due to oxalate was significantly attenuated and led to a dose dependent increase in viability of these cells. These proteins also prevented the interaction of the CaOx crystals to the cell surface and reduced the number of apoptotic cells. Identification of these 4 anionic proteins from the bark of T. arjuna was carried out by Matrix-assisted laser desorption/ionization-time of flight Mass spectrometry (MALDI-TOF MS). This was followed by database search with the MASCOT server and sequence similaritywas found with Nuclear pore anchor, DEAD Box ATP-dependent RNA helicase 45, Lon protease homolog 1 and Heat shock protein 90-3. These novel proteins isolated from T. arjuna have the potential to inhibit CaOx crystallization and promote cell survival and therefore, offer novel avenues which need to be explored further for the medical management of urolithiasis.	[Mittal, Amisha] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Tandon, Simran] Amity Univ Uttar Pradesh, AIMMSCR, Noida, Uttar Pradesh, India; [Singla, Surender Kumar] Panjab Univ, Dept Biochem, Chandigarh, India; [Tandon, Chanderdeep] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Noida, Uttar Pradesh, India	Jaypee University of Information Technology; Amity University Noida; Panjab University; Amity University Noida	Tandon, C (corresponding author), Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Noida, Uttar Pradesh, India.	ctandon@amity.edu	TANDON, simran/AAF-1158-2020; Tandon, Chanderdeep/AAF-1124-2020	Tandon, Chanderdeep/0000-0003-3720-0455; Tandon, Simran/0000-0002-6937-0216	Department of Science and Technology, Govt. of India, New Delhi [SR/SO/HS/132/2010]	Department of Science and Technology, Govt. of India, New Delhi(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, Govt. of India, New Delhi, Grant Number-SR/SO/HS/132/2010.	Aggarwal A, 2014, INDIAN J EXP BIOL, V52, P103; Aggarwal A, 2010, INT BRAZ J UROL, V36, P480, DOI 10.1590/S1677-55382010000400011; Aggarwal KP, 2013, CLIN CHIM ACTA, V415, P181, DOI 10.1016/j.cca.2012.10.040; Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ankur C., 2010, INT J DRUG DEV RES, V2, P431; Bijarnia RK, 2009, PROTEIN J, V28, P161, DOI 10.1007/s10930-009-9179-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhary A, 2010, INDIAN J PHARM SCI, V72, P340, DOI 10.4103/0250-474X.70480; Chitme HR, 2010, INT J PHARM SCI RES, V1, P24, DOI 10.13040/IJPSR.0975-8232.1(2).24-31; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; DEGANELLO S, 1991, CALCIFIED TISSUE INT, V48, P421, DOI 10.1007/BF02556456; Dublin CH, 2009, DRUG DELIV TECHNOL, V9, P29; Dwivedi S, 2007, J ETHNOPHARMACOL, V114, P114, DOI 10.1016/j.jep.2007.08.003; HACKETT RL, 1995, SCANNING MICROSCOPY, V9, P587; HAMMES MS, 1995, KIDNEY INT, V48, P501, DOI 10.1038/ki.1995.320; Han HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC1058, DOI 10.1152/ajpcell.00063.2004; HESS B, 1995, UROL RES, V23, P231, DOI 10.1007/BF00393304; Jeong BC, 2005, UROL RES, V33, P87, DOI 10.1007/s00240-004-0451-5; Johri N, 2010, NEPHRON CLIN PRACT, V116, pC159, DOI 10.1159/000317196; Jonassen JA, 1999, J AM SOC NEPHROL, V10, pS446; Jonassen JA, 2003, CRIT REV EUKAR GENE, V13, P55, DOI 10.1615/CritRevEukaryotGeneExpr.v13.i1.50; Khan SR, 2004, NEPHRON EXP NEPHROL, V98, pE55, DOI 10.1159/000080257; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; Khan SR, 1999, J AM SOC NEPHROL, V10, pS457; Khaskhali MH, 2009, UROL RES, V37, P1, DOI 10.1007/s00240-008-0160-6; KNIGHT TF, 1979, KIDNEY INT, V16, P572, DOI 10.1038/ki.1979.167; Kohjimoto Y, 1999, KIDNEY INT, V56, P1432, DOI 10.1046/j.1523-1755.1999.00683.x; KOUL H, 1994, AM J PHYSIOL, V266, pF266, DOI 10.1152/ajprenal.1994.266.2.F266; Koul H, 1996, KIDNEY INT, V50, P1525, DOI 10.1038/ki.1996.467; KOUL H, 1994, BIOCHEM BIOPH RES CO, V205, P1632, DOI 10.1006/bbrc.1994.2854; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; LIESKE JC, 1995, AM J PHYSIOL-RENAL, V268, pF604, DOI 10.1152/ajprenal.1995.268.4.F604; LIESKE JC, 1993, AM J PHYSIOL, V264, pF800, DOI 10.1152/ajprenal.1993.264.5.F800; Maroni PD, 2004, ANN NY ACAD SCI, V1030, P144, DOI 10.1196/annals.1329.018; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; MENON M, 1992, J CLIN ENDOCR METAB, V74, P703, DOI 10.1210/jc.74.4.703; Mittal A, 2016, UROLITHIASIS, V44, P117, DOI 10.1007/s00240-015-0822-0; Mittal A, 2015, INT BRAZ J UROL, V41, P935, DOI 10.1590/S1677-5538.IBJU.2014.0547; Nagiah S, 2016, CHEM-BIOL INTERACT, V252, P82, DOI 10.1016/j.cbi.2016.03.021; NAKAGAWA Y, 1987, J CLIN INVEST, V79, P1782, DOI 10.1172/JCI113019; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Patnaik BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050900; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Pinti M, 2015, CELL MOL LIFE SCI, V72, P4807, DOI 10.1007/s00018-015-2039-3; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Prezioso D, 2014, ARCH ITAL UROL ANDRO, V86, P99, DOI 10.4081/aiua.2014.2.99; Rizvi SAH, 2002, BJU INT, V89, P62, DOI 10.1046/j.1465-5101.2001.134.x; Sarica K, 2001, UROL RES, V29, P34, DOI 10.1007/s002400000150; Scheid CR, 1995, SCANNING MICROSCOPY, V9, P1097; Scheid CR, 2004, FRONT BIOSCI-LANDMRK, V9, P797, DOI 10.2741/1265; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Selvam R, 2003, UROL RES, V31, P242, DOI 10.1007/s00240-003-0316-3; Semangoen T, 2008, J PROTEOME RES, V7, P2889, DOI 10.1021/pr800113k; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; STAPLETON AMF, 1994, MINER ELECTROL METAB, V20, P399; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tiwari A, 2012, ASIAN J PHARM CLIN R, V5, P7; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Umekawa T, 2005, NEPHROL DIAL TRANSPL, V20, P870, DOI 10.1093/ndt/gfh750; Vijaya R, 1999, BIOCHEM BIOPH RES CO, V266, P72, DOI 10.1006/bbrc.1999.1772; WORCESTER EM, 1994, J AM SOC NEPHROL, V5, pS46; WORCESTER EM, 1995, ANN NY ACAD SCI, V760, P375, DOI 10.1111/j.1749-6632.1995.tb44661.x; Xu J, 2015, GENE, V555, P318, DOI 10.1016/j.gene.2014.11.025; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Yamate T, 1999, UROL INT, V62, P81, DOI 10.1159/000030363; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang L, 2013, INT J MOL SCI, V14, P24742, DOI 10.3390/ijms141224742	71	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162600	10.1371/journal.pone.0162600	http://dx.doi.org/10.1371/journal.pone.0162600			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649531	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100023
J	Letts, JA; Degliesposti, G; Fiedorczuk, K; Skehel, M; Sazanov, LA				Letts, James A.; Degliesposti, Gianluca; Fiedorczuk, Karol; Skehel, Mark; Sazanov, Leonid A.			Purification of Ovine Respiratory Complex I Results in a Highly Active and Stable Preparation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C-OXIDASE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; INACTIVE TRANSITION; ACCESSORY SUBUNITS; DOMESTIC SHEEP; ATP SYNTHASE; DNA SEQUENCE	NADH-ubiquinone oxidoreductase (complex I) is the largest (similar to 1 MDa) and the least characterized complex of the mitochondrial electron transport chain, Because of the ease of sample availability, previous work has focused almost exclusively on bovine complex I. However, only medium resolution structural analyses of this complex have been reported. Working with other mammalian complex I homologues is a potential approach for overcoming these limitations. Due to the inherent difficulty of expressing large membrane protein complexes, screening of complex I homologues is limited to large mammals reared for human consumption. The high sequence identity among these available sources may preclude the benefits of screening. Here, we report the characterization of complex I purified from Ovis aries (ovine) heart mitochondria. All 44 unique subunits of the intact complex were identified by mass spectrometry. We identified differences in the subunit composition of subcomplexes of ovine complex I as compared with bovine, suggesting differential stability of inter-subunit interactions within the complex. Furthermore, the 42-kDa subunit, which is easily lost from the bovine enzyme, remains tightly bound to ovine complex I. Additionally, we developed a novel purification protocol for highly active and stable mitochondrial complex I using the branched-chain detergent lauryl maltose neopentyl glycol. Our data demonstrate that, although closely related, significant differences exist between the biochemical properties of complex I prepared from ovine and bovine mitochondria and that ovine complex I represents a suitable alternative target for further structural studies.	[Letts, James A.; Fiedorczuk, Karol; Sazanov, Leonid A.] IST Austria, A-3400 Klosterneuburg, Austria; [Degliesposti, Gianluca; Skehel, Mark] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Institute of Science & Technology - Austria; MRC Laboratory Molecular Biology	Sazanov, LA (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	sazanov@ist.ac.at	Fiedorczuk, Karol/ABC-1161-2021; Sazanov, Leonid A/ABF-2125-2021; Letts, James Anthony/AAN-6632-2020; Degliesposti, Gianluca/AAR-3501-2020	Sazanov, Leonid A/0000-0002-0977-7989; Letts, James Anthony/0000-0002-9864-3586; Degliesposti, Gianluca/0000-0001-6387-2533	European Union [701309]; FEBS long-term fellowship; Medical Research Council UK; MRC [MC_U105178788, MC_U105674180] Funding Source: UKRI; Medical Research Council [1373852, 1601061, MC_U105178788, MC_U105674180] Funding Source: researchfish	European Union(European Commission); FEBS long-term fellowship; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by European Union's 2020 Research and Innovation Program under Grant 701309. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a FEBS long-term fellowship.; Supported in part by a Medical Research Council UK Ph.D. fellowship.	Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; Angerer H, 2011, BIOCHEM J, V437, P279, DOI 10.1042/BJ20110359; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Birrell JA, 2011, FEBS LETT, V585, P2318, DOI 10.1016/j.febslet.2011.05.065; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chae PS, 2012, CHEM-EUR J, V18, P9485, DOI 10.1002/chem.201200069; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; deCoo RFM, 1997, GENOMICS, V45, P434, DOI 10.1006/geno.1997.4930; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; ESPOSTI MD, 1994, BIOCHEM J, V301, P161, DOI 10.1042/bj3010161; ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Hatefi Y, 1978, Methods Enzymol, V53, P5; Hatefi Y., 1978, BIOMEMBRANE, V53, P11; Hauer F, 2015, STRUCTURE, V23, P1769, DOI 10.1016/j.str.2015.06.029; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 1998, ANIM GENET, V29, P116, DOI 10.1046/j.1365-2052.1998.00295.x; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kmita K, 2013, BIOCHEM SOC T, V41, P1272, DOI 10.1042/BST20130091; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Letts JA, 2015, CURR OPIN STRUC BIOL, V33, P135, DOI 10.1016/j.sbi.2015.08.008; Lewinson O, 2008, J MOL BIOL, V377, P62, DOI 10.1016/j.jmb.2007.12.059; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Mariotti M, 2013, MITOCHONDR DNA, V24, P577, DOI 10.3109/19401736.2013.770493; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Okun JG, 2000, BBA-BIOENERGETICS, V1459, P77, DOI 10.1016/S0005-2728(00)00115-8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Rich PR, 2010, ESSAYS BIOCHEM, V47, P1, DOI [10.1042/bse0470001, 10.1042/BSE0470001]; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Sazanov LA, 2000, J MOL BIOL, V302, P455, DOI 10.1006/jmbi.2000.4079; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shinkarev VP, 1997, BIOPHYS J, V72, P2304, DOI 10.1016/S0006-3495(97)78875-1; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; SKEHEL JM, 1991, FEBS LETT, V282, P135, DOI 10.1016/0014-5793(91)80462-C; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Stevens TJ, 2001, PROTEIN SCI, V10, P2507, DOI 10.1110/ps.ps.10501; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Uenishi H, 2004, NUCLEIC ACIDS RES, V32, pD484, DOI 10.1093/nar/gkh037; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2016, BBA-BIOENERGETICS, V1857, P863, DOI 10.1016/j.bbabio.2015.11.004; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094; Yang CT, 2017, MITOCHONDRIAL DNA A, V28, P315, DOI 10.3109/19401736.2015.1122761; Ye RS, 2012, MOL BIOL REP, V39, P5767, DOI 10.1007/s11033-011-1387-9; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	79	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24657	24675		10.1074/jbc.M116.735142	http://dx.doi.org/10.1074/jbc.M116.735142			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27672209	Green Published, hybrid			2022-12-26	WOS:000388875500026
J	Schmidt, A; Lohrer, D; Alsop, RJ; Lenzig, P; Oslender-Bujotzek, A; Wirtz, M; Rheinstadter, MC; Grunder, S; Wiemuth, D				Schmidt, Axel; Lohrer, Daniel; Alsop, Richard J.; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Wirtz, Monika; Rheinstadter, Maikel C.; Grunder, Stefan; Wiemuth, Dominik			A Cytosolic Amphiphilic alpha-Helix Controls the Activity of the Bile Acid-sensitive Ion Channel (BASIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; ANIONIC LIPID-MEMBRANES; NA+ CHANNEL; LIDDLES SYNDROME; ACTIVATION; ASIC3; PAIN; ENAC; MECHANOTRANSDUCTION; CHOLESTEROL	The bile acid-sensitive ion channel (BASIC) is a member of the degenerin/epithelial Na+ channel (Deg/ENaC) family of ion channels. It is mainly found in bile duct epithelial cells, the intestinal tract, and the cerebellum and is activated by alterations of its membrane environment. Bile acids, one class of putative physiological activators, exert their effect by changing membrane properties, leading to an opening of the channel. The physiological function of BASIC, however, is unknown. Deg/ENaC channels are characterized by a trimeric subunit composition. Each subunit is composed of two transmembrane segments, which are linked by a large extracellular domain. The termini of the channels protrude into the cytosol. Many Deg/ENaC channels contain regulatory domains and sequence motifs within their cytosolic domains. In this study, we show that BASIC contains an amphiphilic alpha-helical structure within its N-terminal domain. This alpha-helix binds to the cytosolic face of the plasma membrane and stabilizes a closed state. Truncation of this domain renders the channel hyperactive. Collectively, we identify a cytoplasmic domain, unique to BASIC, that controls channel activity via membrane interaction.	[Schmidt, Axel; Lohrer, Daniel; Lenzig, Pia; Oslender-Bujotzek, Adrienne; Wirtz, Monika; Grunder, Stefan; Wiemuth, Dominik] Rhein Westfal TH Aachen, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Alsop, Richard J.; Rheinstadter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	RWTH Aachen University; McMaster University	Wiemuth, D (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.	dwiernuth@ukaachen.de	Rheinstadter, Maikel C/D-5322-2009; Schmidt, Axel/GLR-2893-2022; Gründer, Stefan/I-2495-2019	Rheinstadter, Maikel C/0000-0002-0558-7475; Schmidt, Axel/0000-0002-9780-7243; Gründer, Stefan/0000-0002-7635-9883	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (to D. W.). Part of this work was presented in abstract form in Abstracts of the 95th Meeting of the German Physiological Society, March 3-5, 2016, Lubeck, Germany (Wiemuth D., Lenzig P., and Grunder S. (2016) Acta Physiol 216, OS10-8 (Suppl. 707)). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi T, 2000, CHEM PHYS LIPIDS, V107, P93, DOI 10.1016/S0009-3084(00)00154-7; Alsop RJ, 2016, SOFT MATTER, V12, P6737, DOI 10.1039/c6sm00695g; Alsop RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22425; Alsop RJ, 2015, SOFT MATTER, V11, P4756, DOI 10.1039/c5sm00597c; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Barrett MA, 2015, MEMBRANES, V5, P824, DOI 10.3390/membranes5040824; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Boiko N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091326; Chen CC, 2013, J CELL MOL MED, V17, P337, DOI 10.1111/jcmm.12025; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Coryell MW, 2008, J NEUROSCI, V28, P13738, DOI 10.1523/JNEUROSCI.3907-08.2008; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dies H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099124; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ilyaskin AV, 2016, J BIOL CHEM, V291, P19835, DOI 10.1074/jbc.M116.726471; Jalalvand E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10002; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Lefevre CMT, 2014, PFLUG ARCH EUR J PHY, V466, P253, DOI 10.1007/s00424-013-1310-4; Lin SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11460; Madeja M, 1995, J NEUROSCI METH, V63, P211, DOI 10.1016/0165-0270(95)00094-1; Palmer LG, 2012, CLIN EXP NEPHROL, V16, P35, DOI 10.1007/s10157-011-0496-z; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Schmidt A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111549; Schwartz V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18242; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Tang J, 2016, SOFT MATTER, V12, P3165, DOI 10.1039/c5sm02619a; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2014, CHANNELS, V8, P29, DOI 10.4161/chan.27493; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064	48	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24551	24565		10.1074/jbc.M116.756437	http://dx.doi.org/10.1074/jbc.M116.756437			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27679529	Green Published, hybrid			2022-12-26	WOS:000388875500018
J	Huang, GC; Zhang, YF; Shan, YL; Yang, SZ; Chelliah, Y; Wang, H; Takahashi, JS				Huang, Guocun; Zhang, Yunfeng; Shan, Yongli; Yang, Shuzhang; Chelliah, Yogarany; Wang, Han; Takahashi, Joseph S.			Circadian Oscillations of NADH Redox State Using a Heterologous Metabolic Sensor in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosensor; cell metabolism; circadian; nicotinamide adenine dinucleotide (NADH); oxidation-reduction (redox); Rex; oscillation	DNA-BINDING; CLOCK; SIRT1; NAD(+); REX; TRANSCRIPTION; FLUORESCENCE; DEACETYLASE; EXPRESSION; BIOSENSOR	It is known that there are mechanistic links between circadian clocks and metabolic cycles. Reduced nicotinamide adenine dinucleotide (NADH) is a key metabolic cofactor in all living cells; however, it is not known whether levels of NADH oscillate or not. Here we employed REX, a bacterial NADH-binding protein, fused to the VP16 activator to convert intracellular endogenous redox balance into transcriptional readouts by a reporter gene in mammalian cells. EMSA results show that the DNA binding activity of both T- and S-REX::VP16 fusions is decreased with a reduced-to-oxidized cofactor ratio increase. Transient and stabilized cell lines bearing the REX::VP16 and the REX binding operator (ROP) exhibit two circadian luminescence cycles. Consistent with these results, NADH oscillations are observed in host cells, indicating REX can act as a NADH sensor to report intracellular dynamic redox homeostasis in mammalian cells in real time. NADH oscillations provide another metabolic signal for coupling the circadian clock and cellular metabolic states.	[Huang, Guocun; Shan, Yongli; Takahashi, Joseph S.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yang, Shuzhang; Chelliah, Yogarany; Takahashi, Joseph S.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Huang, Guocun; Zhang, Yunfeng; Wang, Han] Soochow Univ, Ctr Circadian Clocks, Suzhou 215123, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Soochow University - China	Huang, GC; Takahashi, JS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	guocun.huang@utsouthwestern.edu; joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Wang, Han/A-9774-2008	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Wang, Han/0000-0003-2420-3147; Shan, Yongli/0000-0002-5870-2107	National Natural Science Foundation of China [31571206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 31571206 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Blacker TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4936; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Du XH, 1999, NUCLEIC ACIDS RES, V27, P1690, DOI 10.1093/nar/27.7.1690; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Itoh TQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063113; Kumar V, 2010, CELL, V142, P841, DOI 10.1016/j.cell.2010.08.037; McLaughlin KJ, 2010, MOL CELL, V38, P563, DOI 10.1016/j.molcel.2010.05.006; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sickmier EA, 2005, STRUCTURE, V13, P43, DOI 10.1016/j.str.2004.10.012; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Stringari C, 2015, CELL REP, V10, P1, DOI 10.1016/j.celrep.2014.12.007; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhao YZ, 2011, CELL METAB, V14, P555, DOI 10.1016/j.cmet.2011.09.004	32	8	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23906	23914		10.1074/jbc.M116.728774	http://dx.doi.org/10.1074/jbc.M116.728774			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27645993	Green Published, hybrid			2022-12-26	WOS:000388498100006
J	Long, T; Li, J; Li, H; Zhou, M; Zhou, XL; Liu, RJ; Wang, ED				Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Zhou, Xiao-Long; Liu, Ru-Juan; Wang, En-Duo			Sequence-specific and Shape-selective RNA Recognition by the Human RNA 5-Methylcytosine Methyltransferase NSun6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-methylcytosine; RNA methylation; RNA methyltransferase; S-adenosylmethionine (SAM); transfer RNA (tRNA); NSun family; methyltransferase; substrate recognition; tRNA modification	RECESSIVE INTELLECTUAL DISABILITY; CODON-BIASED TRANSLATION; ENZYMATIC FORMATION; CELLULAR STRESS; NONCODING RNA; METHYLATION; IDENTIFICATION; DNMT2; ANTICODON; PROLIFERATION	Human NSun6 is an RNA methyltransferase that catalyzes the transfer of the methyl group from S-adenosyl-l-methionine (SAM) to C72 of tRNA(Thr) and tRNA(Cys). In the current study, we used mass spectrometry to demonstrate that human NSun6 indeed introduces 5-methylcytosine (m(5)C) into tRNA, as expected. To further reveal the tRNA recognition mechanism of human NSun6, we measured the methylation activity of human NSun6 and its kinetic parameters for different tRNA substrates and their mutants. We showed that human NSun6 requires a well folded, full-length tRNA as its substrate. In the acceptor region, the CCA terminus, the target site C72, the discriminator base U73, and the second and third base pairs (2:71 and 3:70) of the acceptor stem are all important RNA recognition elements for human NSun6. In addition, two specific base pairs (11:24 and 12:23) in the D-stem of the tRNA substrate are involved in interacting with human NSun6. Together, our findings suggest that human NSun6 relies on a delicate network for RNA recognition, which involves both the primary sequence and tertiary structure of tRNA substrates.	[Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Zhou, Xiao-Long; Liu, Ru-Juan; Wang, En-Duo] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Long, Tao; Li, Jing; Li, Hao; Zhou, Mi; Wang, En-Duo] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Liu, RJ; Wang, ED (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	liurj@sibcb.ac.cn; edwang@sibcb.ac.cn	Li, Hao/GPS-9834-2022	Liu, Ru-Juan/0000-0001-7459-3126	National Natural Science Foundation of China [91440204, 31270775, 81471113]; National Key Basic Research Foundation of China [2012CB911000]; Youth Innovation Promotion Association (Chinese Academy of Sciences)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Youth Innovation Promotion Association (Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 91440204, 31270775, and 81471113 and National Key Basic Research Foundation of China Grant 2012CB911000. This work was also supported by the Youth Innovation Promotion Association (Chinese Academy of Sciences) (to R.-J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Cerrudo CS, 2014, FEBS J, V281, P74, DOI 10.1111/febs.12602; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gillis D, 2014, J MED GENET, V51, P581, DOI 10.1136/jmedgenet-2014-102282; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Goto-Ito S, 2009, NAT STRUCT MOL BIOL, V16, P1109, DOI 10.1038/nsmb.1653; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Grosjean H., 2009, DNA RNA MODIFICATION; Guy MP, 2015, HUM MUTAT, V36, P1176, DOI 10.1002/humu.22897; Haag S, 2015, RNA, V21, P1532, DOI 10.1261/rna.051524.115; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Hazlewood J, 1989, Cancer Commun, V1, P29; Helm M, 1999, BIOCHEMISTRY-US, V38, P13338, DOI 10.1021/bi991061g; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Khosronezhad N, 2015, REPROD FERT DEVELOP, V27, P471, DOI 10.1071/RD13371; Kosi N, 2015, BRAIN RES, V1597, P65, DOI 10.1016/j.brainres.2014.11.040; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lipman RSA, 1998, P NATL ACAD SCI USA, V95, P13495, DOI 10.1073/pnas.95.23.13495; Liu RJ, 2015, NUCLEIC ACIDS RES, V43, P7489, DOI 10.1093/nar/gkv745; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Merla G, 2002, HUM GENET, V110, P429, DOI 10.1007/s00439-002-0710-x; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; PUTZ J, 1994, NAT STRUCT BIOL, V1, P580, DOI 10.1038/nsb0994-580; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Roundtree IA, 2016, CURR OPIN CHEM BIOL, V30, P46, DOI 10.1016/j.cbpa.2015.10.024; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaefer M, 2009, CANCER RES, V69, P8127, DOI 10.1158/0008-5472.CAN-09-0458; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Yuan S, 2014, MOL CELL BIOL, V34, P3630, DOI 10.1128/MCB.00243-14; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692; Zhou M, 2015, RNA BIOL, V12, P900, DOI 10.1080/15476286.2015.1050576	60	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24293	24303		10.1074/jbc.M116.742569	http://dx.doi.org/10.1074/jbc.M116.742569			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703015	hybrid, Green Published			2022-12-26	WOS:000388498100040
J	Delfiner, MS; Martinez, LR; Pavia, CS				Delfiner, Matthew S.; Martinez, Luis R.; Pavia, Charles S.			A Gram Stain Hands-On Workshop Enhances First Year Medical Students' Technique Competency in Comprehension and Memorization	PLOS ONE			English	Article							LABORATORY MEDICINE; SCHOOLS; PERFORMANCE; EDUCATION; RESIDENCY; PEER	Background Laboratory diagnostic tests have an essential role in patient care, and the increasing number of medical and health professions schools focusing on teaching laboratory medicine to pre-clinical students reflects this importance. However, data validating the pedagogical methods that best influence students' comprehension and interpretation of diagnostic tests have not been well described. The Gram stain is a simple yet significant and frequently used diagnostic test in the clinical setting that helps classify bacteria into two major groups, Gram positive and negative, based on their cell wall structure. Methods and Findings We used this technique to assess which educational strategies may improve students' learning and competency in medical diagnostic techniques. Hence, in this randomized controlled study, we compared the effectiveness of several educational strategies (e.g. workshop, discussion, or lecture) in first year medical students' competency in comprehension and interpretation of the Gram stain procedure. We demonstrated that a hands-on practical workshop significantly enhances students' competency in memorization and overall comprehension of the technique. Interestingly, most students irrespective of their cohort showed difficulty in answering Gram stain-related analytical questions, suggesting that more emphasis should be allocated by the instructors to clearly explain the interpretation of the diagnostic test results to students in medical and health professional schools. Conclusion This proof of principle study highlights the need of practical experiences on laboratory medical techniques during pre-clinical training to facilitate future medical doctors' and healthcare professionals' basic understanding and competency in diagnostic testing for better patient care.	[Delfiner, Matthew S.; Martinez, Luis R.; Pavia, Charles S.] New York Inst Technol, Dept Biomed Sci, NYIT Coll Osteopath Med, Old Westbury, NY 11568 USA	New York Institute Technology	Martinez, LR; Pavia, CS (corresponding author), New York Inst Technol, Dept Biomed Sci, NYIT Coll Osteopath Med, Old Westbury, NY 11568 USA.	lmarti13@nyit.edu; cpavia@nyit.edu			NYITCOM; National Institute of General Medical Sciences of the US NIH [R15GM117501]	NYITCOM; National Institute of General Medical Sciences of the US NIH	M.S.D., L.R.M., and C.S.P. were supported by NYITCOM intramural funds. L.R.M. was supported by the National Institute of General Medical Sciences of the US NIH under award number R15GM117501.	Armbruster P, 2009, CBE-LIFE SCI EDUC, V8, P203, DOI 10.1187/cbe.09-03-0025; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Iwashyna TJ, 2011, ACAD MED, V86, P139, DOI 10.1097/ACM.0b013e3181fd85c3; Langdale LA, 2003, ACAD MED, V78, P39, DOI 10.1097/00001888-200301000-00009; LEBOFFE MJ, 2002, MICROBIOLOGY LAB THE; Lyss-Lerman P, 2009, ACAD MED, V84, P823, DOI 10.1097/ACM.0b013e3181a82426; Magid MS, 2012, HUM PATHOL, V43, P567, DOI 10.1016/j.humpath.2011.06.006; Mamede S, 2012, MED EDUC, V46, P464, DOI 10.1111/j.1365-2923.2012.04217.x; Melber DJ, 2016, CLIN INFECT DIS, V63, P164, DOI 10.1093/cid/ciw262; Riskowski JL, 2009, INT J ENG EDUC, V25, P181; Simpson E.J., 1966, ILLINOIS TEACHER HOM, V10, P110; Smith BR, 2016, ACAD MED, V91, P107, DOI 10.1097/ACM.0000000000000817; Smith BR, 2010, AM J CLIN PATHOL, V133, P533, DOI 10.1309/AJCPQCT94SFERLNI; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919	15	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163658	10.1371/journal.pone.0163658	http://dx.doi.org/10.1371/journal.pone.0163658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711118	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697600033
J	Habbib, H; Verzeaux, J; Nivelle, E; Roger, D; Lacoux, J; Catterou, M; Hirel, B; Dubois, F; Tetu, T				Habbib, Hazzar; Verzeaux, Julien; Nivelle, Elodie; Roger, David; Lacoux, Jerome; Catterou, Manuella; Hirel, Bertrand; Dubois, Frederic; Tetu, Thierry			Conversion to No-Till Improves Maize Nitrogen Use Efficiency in a Continuous Cover Cropping System	PLOS ONE			English	Article							POSTANTHESIS WATER-DEFICIT; GRAIN-YIELD; WINTER-WHEAT; DRY-MATTER; MEDITERRANEAN CONDITIONS; CARBON SEQUESTRATION; RESIDUE MANAGEMENT; GENETIC-VARIATION; FERTILIZER RATE; ORGANIC-MATTER	A two-year experiment was conducted in the field to measure the combined impact of tilling and N fertilization on various agronomic traits related to nitrogen (N) use efficiency and to grain yield in maize cultivated in the presence of a cover crop. Four years after conversion to no-till, a significant increase in N use efficiency N harvest index, N remobilization and N remobilization efficiency was observed both under no and high N fertilization conditions. Moreover, we observed that grain yield and grain N content were higher under no-till conditions only when N fertilizers were applied. Thus, agronomic practices based on continuous no-till appear to be a promising for increasing N use efficiency in maize.	[Habbib, Hazzar; Verzeaux, Julien; Nivelle, Elodie; Roger, David; Lacoux, Jerome; Catterou, Manuella; Dubois, Frederic; Tetu, Thierry] Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, Ecol & Dynam Syst Anthropises EDYSAN, FRE 3498,CNRS, 33 Rue St Leu, F-80039 Amiens, France; [Hirel, Bertrand] Ctr Versailles Grignon, Inst Natl Rech Agron, Adaptat Plantes Environm, Inst Jean Pierre Bourgin,UMR 1318, RD 10, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Habbib, H (corresponding author), Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, Ecol & Dynam Syst Anthropises EDYSAN, FRE 3498,CNRS, 33 Rue St Leu, F-80039 Amiens, France.	hazzar.habbib@u-picardie.fr	Dubois, Frederic/AAG-9062-2020; Hirel, Bertrand/AAG-5662-2020	Dubois, Frederic/0000-0001-6972-9869; Hirel, Bertrand/0000-0002-5518-3671	University of Picardy Jules Verne in the context of the collaborative project VEGESOL; Bonduelle; Syngenta	University of Picardy Jules Verne in the context of the collaborative project VEGESOL; Bonduelle; Syngenta(Syngenta)	The study was funded by Bonduelle and Syngenta and the University of Picardy Jules Verne in the context of the collaborative project VEGESOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin MA, 2005, NITROGEN NUTR PLANT, P1; Al-Kaisi M, 2007, AGRON J, V99, P1548, DOI 10.2134/agronj2007.0012; Alvear M, 2005, SOIL TILL RES, V82, P195, DOI 10.1016/j.still.2004.06.002; Arshad MA, 1999, SOIL TILL RES, V53, P41, DOI 10.1016/S0167-1987(99)00075-6; Auguie B, 2017, GRIDEXTRA MISCELLANE; Aulakh MS, 2012, SOIL TILL RES, V120, P50, DOI 10.1016/j.still.2011.11.001; Awale R, 2013, SOIL TILL RES, V134, P213, DOI 10.1016/j.still.2013.08.006; Bahrani A, 2011, AFR J BIOTECHNOL, V10, P10585; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Beheshti AR, 2010, AUST J CROP SCI, V4, P185; Bertin P, 2000, MAYDICA, V45, P53; Birkas M, 2004, SOIL TILL RES, V78, P185, DOI 10.1016/j.still.2004.02.006; Botta GF, 2006, SOIL TILL RES, V91, P164, DOI 10.1016/j.still.2005.12.011; Brennan J, 2014, EUR J AGRON, V54, P61, DOI 10.1016/j.eja.2013.11.009; Burgess MS, 2002, CAN J SOIL SCI, V82, P127, DOI 10.4141/S01-013; Caviglia OP, 2014, FIELD CROP RES, V168, P27, DOI 10.1016/j.fcr.2014.08.005; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; DAC, 2015, PLIEG PET; Dalal RC, 2011, SOIL SCI SOC AM J, V75, P2251, DOI 10.2136/sssaj2010.0398; Dimassi B, 2013, AGR ECOSYST ENVIRON, V169, P12, DOI 10.1016/j.agee.2013.01.012; Dray S, 2015, ADE4 ANAL ECOLOGICAL; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Edmonds DE, 2013, J PLANT NUTR, V36, P1013, DOI 10.1080/01904167.2011.585198; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Erisman JW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0116; Fageria, 2014, NITROGEN MANAGEMENT, P436; Filipovic D, 2006, J TERRAMECHANICS, V43, P177, DOI 10.1016/j.jterra.2005.04.002; Galloway JN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0120; Giller K.E., 2001, NITROGEN FIXATION TR, P423; Green VS, 2007, SOIL TILL RES, V92, P114, DOI 10.1016/j.still.2006.01.004; Gselman A, 2008, AUST J AGR RES, V59, P1156, DOI 10.1071/AR08015; Gursoy S, 2010, FIELD CROP RES, V119, P260, DOI 10.1016/j.fcr.2010.07.016; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Hirel B., 2005, Journal of Crop Improvement, V15, P213, DOI 10.1300/J411v15n02_07; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; International Grains Council, 2013, REP FISC YEAR 2011 1; Josa R, 2010, INT AGROPHYS, V24, P139; Kahlon MS, 2013, SOIL TILL RES, V126, P151, DOI 10.1016/j.still.2012.08.001; Kankanen H, 2011, EUR J AGRON, V34, P35, DOI 10.1016/j.eja.2010.10.002; KARLEN DL, 1991, COMMUN SOIL SCI PLAN, V22, P1985, DOI 10.1080/00103629109368552; Kristensen HL, 2003, SOIL BIOL BIOCHEM, V35, P979, DOI 10.1016/S0038-0717(03)00159-7; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; Leveau V, 2011, ADV MAIZE, P509; Lopez-Bellido L, 2005, FIELD CROP RES, V94, P86, DOI 10.1016/j.fcr.2004.11.004; Lopez-Bellido RJ, 2001, FIELD CROP RES, V71, P31, DOI 10.1016/S0378-4290(01)00146-0; Lu P, 2012, PLANT SOIL ENVIRON, V58, P211, DOI 10.17221/531/2011-PSE; Lv Peng, 2011, Plant Nutrition and Fertilizer Science, V17, P852; Machado S, 2007, SOIL TILL RES, V94, P473, DOI 10.1016/j.still.2006.09.007; MACHET JM, 1990, P 1 C EUR SOC AGR PA, P21; Mallarino AP, 1999, AGRON J, V91, P37, DOI 10.2134/agronj1999.00021962009100010007x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Masoni A, 2007, EUR J AGRON, V26, P179, DOI 10.1016/j.eja.2006.09.006; Meijer AD, 2013, SOIL TILL RES, V126, P1, DOI 10.1016/j.still.2012.07.002; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Moser SB, 2006, AGR WATER MANAGE, V81, P41, DOI 10.1016/j.agwat.2005.04.005; Njarui DMG, 2010, ANIM PROD SCI, V50, P193, DOI 10.1071/AN09137; Nyakudya IW, 2015, SOIL TILL RES, V145, P184, DOI 10.1016/j.still.2014.09.003; Nyambati EM, 2006, J SUSTAIN AGR, V28, P97, DOI 10.1300/J064v28n01_09; Pampana S, 2007, ITAL J AGRON, V3, P3; Pandey D, 2014, SOIL TILL RES, V136, P51, DOI 10.1016/j.still.2013.09.013; Paponov I, 1996, EUR J AGRON, V5, P115, DOI 10.1016/S1161-0301(96)02015-1; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Reicosky DC, 2007, SOIL TILL RES, V94, P109, DOI 10.1016/j.still.2006.07.004; Robertson MJ, 2005, FIELD CROP RES, V91, P91, DOI 10.1016/j.fcr.2004.06.009; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Saiz-Fernandez I, 2015, J PLANT PHYSIOL, V173, P120, DOI 10.1016/j.jplph.2014.06.018; Salem HM, 2015, GEODERMA, V237, P60, DOI 10.1016/j.geoderma.2014.08.014; Setiyono TD, 2011, AGRON J, V103, P1276, DOI 10.2134/agronj2011.0053; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; Sip V, 2009, FIELD CROP RES, V113, P131, DOI 10.1016/j.fcr.2009.04.013; Soon YK, 2008, NUTR CYCL AGROECOSYS, V82, P149, DOI 10.1007/s10705-008-9176-0; Staggenborg SA, 2003, AGRON J, V95, P253, DOI 10.2134/agronj2003.0253; Tahmasebi Sarvestani Z., 2003, Journal of Agricultural Science and Technology, V5, P21; Thomas GA, 2007, SOIL TILL RES, V94, P295, DOI 10.1016/j.still.2006.08.005; Thorup-Kristensen K, 2001, PLANT SOIL, V230, P185, DOI 10.1023/A:1010306425468; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Torbert HA, 2001, AGRON J, V93, P1119, DOI 10.2134/agronj2001.9351119x; Torresen KS, 2003, CROP PROT, V22, P185, DOI 10.1016/S0261-2194(02)00145-X; Verachtert E, 2009, PLANT SOIL, V320, P281, DOI 10.1007/s11104-009-9893-4; Vos J, 2004, NUTR CYCL AGROECOSYS, V70, P23, DOI 10.1023/B:FRES.0000049358.24431.0d; Wang Y, 2015, SOIL TILL RES, V151, P82, DOI 10.1016/j.still.2015.03.003; Zhou JB, 2011, FIELD CROP RES, V122, P157, DOI 10.1016/j.fcr.2011.03.009	86	14	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164234	10.1371/journal.pone.0164234	http://dx.doi.org/10.1371/journal.pone.0164234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711154	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600102
J	Stanifer, JW; Cleland, CR; Makuka, GJ; Egger, JR; Maro, V; Maro, H; Karia, F; Patel, UD; Burton, MJ; Philippin, H				Stanifer, John W.; Cleland, Charles R.; Makuka, Gerald Jamberi; Egger, Joseph R.; Maro, Venance; Maro, Honest; Karia, Francis; Patel, Uptal D.; Burton, Matthew J.; Philippin, Heiko			Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTRACLASS CORRELATION-COEFFICIENT; MELLITUS; PREVENTION; DISEASE; EPIDEMIOLOGY; MANAGEMENT; COMMUNITY; OBESITY; BURDEN	Background In sub-Saharan Africa, diabetes is a growing burden, yet little is known about its prevalence, risk factors, and complications. To address these gaps and help inform public health efforts aimed at prevention and treatment, we conducted a community-based study assessing diabetes epidemiology. Methods and Findings We conducted a stratified, cluster-designed, serial cross-sectional household study from 2014-2015 in the Kilimanjaro Region, Tanzania. We used a three-stage cluster probability sampling method to randomly select individuals. To estimate prevalence, we screened individuals for glucose impairment, including diabetes, using hemoglobin A1C. We also screened for hypertension and obesity, and to assess for potential complications, individuals with diabetes were assessed for retinopathy, neuropathy, and nephropathy. We enrolled 481 adults from 346 urban and rural households. The prevalence of glucose impairment was 21.7% (95% CI 15.2-29.8), which included diabetes (5.7%; 95% CI 3.37 - 9.47) and glucose impairment with increased risk for diabetes (16.0%; 95% CI 10.2-24.0). Overweight or obesity status had an independent prevalence risk ratio for glucose impairment (2.16; 95% CI 1.39-3.36). Diabetes awareness was low (35.6%), and few individuals with diabetes were receiving biomedical treatment (33.3%). Diabetes-associated complications were common (50.2%; 95% CI 33.7-66.7), including renal (12.0%; 95% CI 4.7-27.3), ophthalmic (49.6%; 95% CI 28.6-70.7), and neurological (28.8%; 95% CI8.0-65.1) abnormalities. Conclusions In a northern region of Tanzania, diabetes is an under-recognized health condition, despite the fact that many people either have diabetes or are at increased risk for developing diabetes. Most individuals were undiagnosed or untreated, and the prevalence of diabetes-associated complications was high. Public health efforts in this region will need to focus on reducing modifiable risk factors, which appear to include obesity, as well as early detection that includes increasing awareness. These findings highlight a growing urgency of diabetes prevention in this region as well as the need for treatment, including management of complications.	[Stanifer, John W.; Patel, Uptal D.] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27708 USA; [Stanifer, John W.; Egger, Joseph R.; Patel, Uptal D.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Stanifer, John W.; Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA; [Cleland, Charles R.; Maro, Venance; Philippin, Heiko] Kilimanjaro Christian Med Ctr, Eye Dept, Moshi, Tanzania; [Makuka, Gerald Jamberi; Maro, Venance; Karia, Francis] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Burton, Matthew J.; Philippin, Heiko] London Sch Hyg &Trop Med, Int Ctr Eye Hlth, London, England; [Burton, Matthew J.] Moorfields Eye Hosp, London, England	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Div Nephrol, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA.	john.stanifer@duke.edu	Philippin, Heiko/AAN-4038-2020	Philippin, Heiko/0000-0002-5380-6994; Burton, Matthew/0000-0003-1872-9169	NIH Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; AusAID through Christian Blind Mission (CBM); FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; AusAID through Christian Blind Mission (CBM); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. Retinopathy screening for individuals with diabetes was done under the Kilimanjaro Diabetic Programme (KDP) supported by AusAID through Christian Blind Mission (CBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; AHREN B, 1984, DIABETOLOGIA, V26, P333, DOI 10.1007/BF00266032; Alikor C A, 2015, Niger J Med, V24, P114; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2013, UNITED REPUBLIC OF T; [Anonymous], 2011, UN REP TANZ ED SECT; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Atun R, 2015, LANCET DIABETES ENDO, V3, P675, DOI 10.1016/S2213-8587(15)00236-3; Cleland CR, 2015, TROPICAL MED INT HLT; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Elmadhoun WM, 2016, J DIABETES, V8, P839, DOI 10.1111/1753-0407.12364; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Harding S, 2003, DIABETIC MED, V20, P965, DOI 10.1111/j.1464-5491.2003.01077.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kengne AP, 2013, HEART, V99, P1072, DOI 10.1136/heartjnl-2013-303773; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Levitt NS, 1999, DIABETIC MED, V16, P946, DOI 10.1046/j.1464-5491.1999.00185.x; Mayega RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072554; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MCLARTY DG, 1989, LANCET, V1, P871; McLarty DG, 1996, DIABETIC MED, V13, P990; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Miller B.A., 2013, THESIS; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Narayan KMV, 2012, HEALTH AFFAIR, V31, P84, DOI 10.1377/hlthaff.2011.1040; nternational Diabetes Federation, 2015, DIABETES ATLAS; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Renzaho AMN, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27600; Ruhembe Carolyne C, 2014, Tanzan J Health Res, V16, P89; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; SWAI AB, 1992, BRIT MED J, V305, P1057, DOI 10.1136/bmj.305.6861.1057; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Werfalli M, 2016, LANCET DIABETES ENDO, V4, P72, DOI 10.1016/S2213-8587(15)00363-0; World Health Organization, 2016, OB OV; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Zou GY, 2004, BIOMETRICS, V60, P807, DOI 10.1111/j.0006-341X.2004.00232.x	44	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164428	10.1371/journal.pone.0164428	http://dx.doi.org/10.1371/journal.pone.0164428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711179	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000385697600127
J	Abdelwahab, H; Del Campo, JSM; Dai, YM; Adly, C; El-Sohaimy, S; Sobrado, P				Abdelwahab, Heba; Del Campo, Julia S. Martin; Dai, Yumin; Adly, Camelia; El-Sohaimy, Sohby; Sobrado, Pablo			Mechanism of Rifampicin Inactivation in Nocardia farcinica	PLOS ONE			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; STEADY-STATE; ACTIVE-SITE; RESISTANCE; GENE; OXIDATION; OXYGEN; CONFORMATION; RIBOSYLATION; RHODOCOCCUS	A novel mechanism of rifampicin (Rif) resistance has recently been reported in Nocardia farcinica. This new mechanism involves the activity of rifampicin monooxygenase (RifMO), a flavin-dependent monooxygenase that catalyzes the hydroxylation of Rif, which is the first step in the degradation pathway. Recombinant RifMO was overexpressed and purified for biochemical analysis. Kinetic characterization revealed that Rif binding is necessary for effective FAD reduction. RifMO exhibits only a 3-fold coenzyme preference for NADPH over NADH. RifMO catalyzes the incorporation of a single oxygen atom forming an unstable intermediate that eventually is converted to 2'-N-hydroxy-4-oxo-Rif. Stable C4a-hydroperoxyflavin was not detected by rapid kinetics methods, which is consistent with only 30% of the activated oxygen leading to product formation. These findings represent the first reported detailed biochemical characterization of a flavin-monooxygenase involved in antibiotic resistance.	[Abdelwahab, Heba; Del Campo, Julia S. Martin; Dai, Yumin; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Abdelwahab, Heba; Adly, Camelia] Damietta Univ, Dept Chem, Fac Sci, Dumyat 34517, Egypt; [Del Campo, Julia S. Martin; Sobrado, Pablo] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [El-Sohaimy, Sohby] City Sci Res & Technol Applicat, Arid Lands Cultivat Res Inst, Dept Food Technol, Alexandria 21934, Egypt; [Sobrado, Pablo] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Damietta University; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City); Virginia Polytechnic Institute & State University	Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Sobrado, P (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.; Sobrado, P (corresponding author), Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA.	psobrado@vt.edu	El Sohaimy, Sobhy/Q-3040-2016	El Sohaimy, Sobhy/0000-0002-1657-5162; abdelwahab, heba/0000-0002-4005-464X; S. Martin del Campo, Julia/0000-0001-8914-2504	National Science Foundation [CHE-1506206, MCB 1021384]; Joint Supervision Fellowship - Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Joint Supervision Fellowship - Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grants CHE-1506206 and MCB 1021384. This work was also supported by a Joint Supervision Fellowship to H. Abdelwahab funded by the Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SJ, 1997, ANTIMICROB AGENTS CH, V41, P218, DOI 10.1128/AAC.41.1.218; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; ATLAS E, 1968, AM J MED SCI, V256, P247, DOI 10.1097/00000441-196810000-00006; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Binda C, 2015, J BIOL CHEM, V290, P12676, DOI 10.1074/jbc.M114.629485; Budavari S., 1976, MERCK INDEX ENCY CHE, P12688, DOI [10.1074/jbc.M114.629485, DOI 10.1074/JBC.M114.629485]; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CASEY ML, 1975, J AM CHEM SOC, V97, P6231, DOI 10.1021/ja00854a048; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007, DOI 10.1128/AAC.39.4.1007; DABBS ER, 1987, FEMS MICROBIOL LETT, V44, P395, DOI 10.1016/0378-1097(87)90354-5; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; Fink MJ, 2015, CHEM COMMUN, V51, P2874, DOI 10.1039/c4cc08734h; Forsberg KJ, 2015, CHEM BIOL, V22, P888, DOI 10.1016/j.chembiol.2015.05.017; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; HARTMANN G, 1967, BIOCHIM BIOPHYS ACTA, V145, P843, DOI 10.1016/0005-2787(67)90147-5; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hoshino Y, 2011, J BACTERIOL, V193, P441, DOI 10.1128/JB.00897-10; Hoshino Y, 2010, J ANTIBIOT, V63, P23, DOI 10.1038/ja.2009.116; HOWELL LG, 1972, J BIOL CHEM, V247, P4340; Howes BD, 2007, J RAMAN SPECTROSC, V38, P859, DOI 10.1002/jrs.1727; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Ishikawa J, 2006, ANTIMICROB AGENTS CH, V50, P1342, DOI 10.1128/AAC.50.4.1342-1346.2006; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Kim TK, 2006, APPL ENVIRON MICROB, V72, P2118, DOI 10.1128/AEM.72.3.2118-2125.2006; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; MAGGI N, 1966, CHEMOTHERAPY, V11, P285, DOI 10.1159/000220462; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McDonald CA, 2013, BIOCHEMISTRY-US, V52, P6076, DOI 10.1021/bi4008462; McMurray DN, 1996, MED MICROBIOLOGY, VFourth; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; MORISAKI N, 1993, J ANTIBIOT, V46, P1605, DOI 10.7164/antibiotics.46.1605; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; PALFEY BA, 1994, BIOCHEMISTRY-US, V33, P1545, DOI 10.1021/bi00172a035; Quan S, 1999, ANTIMICROB AGENTS CH, V43, P181, DOI 10.1128/AAC.43.1.181; SCHNEIDER H, 1972, BRIT J VENER DIS, V48, P500; SENSI P., 1959, ANTIBIOT ANN, V7, P262; SENSI P, 1983, REV INFECT DIS, V5, pS402; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Shimizu M, 2015, DRUG METAB PHARMACOK, V30, P70, DOI 10.1016/j.dmpk.2014.09.008; Shirey C, 2013, J BIOL CHEM, V288, P32440, DOI 10.1074/jbc.M113.487181; Spanogiannopoulos P, 2012, ANTIMICROB AGENTS CH, V56, P5061, DOI 10.1128/AAC.01166-12; SPECTOR T, 1972, J BIOL CHEM, V247, P4679; Staudinger T, 2014, BBA-PROTEINS PROTEOM, V1844, P750, DOI 10.1016/j.bbapap.2014.02.001; Stogios PJ, 2016, NATURE COMMUNICATION, V7; Tanaka Y, 1996, MICROBIOL IMMUNOL, V40, P1, DOI 10.1111/j.1348-0421.1996.tb03303.x; Tao Y, 2004, APPL ENVIRON MICROB, V70, P3814, DOI 10.1128/AEM.70.7.3814-3820.2004; Tupin A, 2010, INT J ANTIMICROB AG, V35, P519, DOI 10.1016/j.ijantimicag.2009.12.017; Ventola C Lee, 2015, P T, V40, P277; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; YAZAWA K, 1994, J ANTIMICROB CHEMOTH, V33, P1127, DOI 10.1093/jac/33.6.1127; Zucchini D, 2011, ARCH BIOCHEM BIOPHYS, V515, P1, DOI 10.1016/j.abb.2011.08.004	62	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162578	10.1371/journal.pone.0162578	http://dx.doi.org/10.1371/journal.pone.0162578			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706151	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200013
J	Snowden, MC; Cope, KR; Bugbee, B				Snowden, M. Chase; Cope, Kevin R.; Bugbee, Bruce			Sensitivity of Seven Diverse Species to Blue and Green Light: Interactions with Photon Flux	PLOS ONE			English	Article							EMITTING-DIODES LEDS; RED-LIGHT; PLANT-GROWTH; LEAF PHOTOSYNTHESIS; SUPPLEMENTAL BLUE; QUANTUM YIELD; LETTUCE; RADIATION; PHOTOMORPHOGENESIS; SPECTRUM	Despite decades of research, the effects of spectral quality on plant growth, and development are not well understood. Much of our current understanding comes from studies with daily integrated light levels that are less than 10% of summer sunlight thus making it difficult to characterize interactions between light quality and quantity. Several studies have reported that growth is increased under fluorescent lamps compared to mixtures of wavelengths from LEDs. Conclusions regarding the effect of green light fraction range from detrimental to beneficial. Here we report the effects of eight blue and green light fractions at two photosynthetic photon fluxes (PPF; 200 and 500 mu mol m(-2) s(-1); with a daily light integral of 11.5 and 29 mol m(-2) d(-1)) on growth (dry mass), leaf expansion, stem and petiole elongation, and whole-plant net assimilation of seven diverse plant species. The treatments included cool, neutral, and warm white LEDs, and combinations of blue, green and/or red LEDs. At the higher PPF (500), increasing blue light in increments from 11 to 28% reduced growth in tomato, cucumber, and pepper by 22, 26, and 14% respectively, but there was no statistically significant effect on radish, soybean, lettuce or wheat. At the lower PPF (200), increasing blue light reduced growth only in tomato (41%). The effects of blue light on growth were mediated by changes in leaf area and radiation capture, with minimal effects on whole-plant net-assimilation. In contrast to the significant effects of blue light, increasing green light in increments from 0 to 30% had a relatively small effect on growth, leaf area and net assimilation at either low or high PPF. Surprisingly, growth of three of the seven species was not reduced by a treatment with 93% green light compared to the broad spectrum treatments. Collectively, these results are consistent with a shade avoidance response associated with either low blue or high green light fractions.	[Snowden, M. Chase; Cope, Kevin R.; Bugbee, Bruce] Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, 4820 Old Main Hill, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Snowden, MC (corresponding author), Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, 4820 Old Main Hill, Logan, UT 84322 USA.	chase.snowden@gmail.com	Cope, Kevin R./AAB-9174-2020	Cope, Kevin R./0000-0003-0173-2871	Utah Agriculture Experiment Station	Utah Agriculture Experiment Station	This research was supported by the Utah Agriculture Experiment Station. We thank Ty Weaver, Alec Hay, Saundra Rhoades and Boston Swan for conscientious technical support. We also thank the four anonymous reviewers whose comments improved the manuscript. All three authors directly contributed to the design and execution of the experiments and the writing of the manuscript. This work was part of a graduate thesis for M. Chase Snowden and part of an undergraduate research project for Kevin Cope, who is now a PhD candidate at the University of Wisconsin. The work was done in the Crop Physiology Laboratory at USU under the direction of Bruce Bugbee. Mention of trade names is for information only and does not constitute an endorsement by the authors.	[Anonymous], 1957, ENV CONTROL PLANT GR; BROWN CS, 1995, J AM SOC HORTIC SCI, V120, P808, DOI 10.21273/JASHS.120.5.808; BULA RJ, 1991, HORTSCIENCE, V26, P203, DOI 10.21273/HORTSCI.26.2.203; BULLOCK DG, 1988, CROP SCI, V28, P254, DOI 10.2135/cropsci1988.0011183X002800020015x; Chen XL, 2014, SCI HORTIC-AMSTERDAM, V172, P168, DOI 10.1016/j.scienta.2014.04.009; Cope KR, 2014, PHOTOCHEM PHOTOBIOL, V90, P574, DOI 10.1111/php.12233; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Dougher TAO, 2004, J AM SOC HORTIC SCI, V129, P467, DOI 10.21273/JASHS.129.4.0467; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; Fan X, 2013, ASIA PACIFIC J TOURI, P1; Folta KM, 2007, J EXP BOT, V58, P3099, DOI 10.1093/jxb/erm130; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Goins G.D, 2001, SAE TECHNICAL PAPER, DOI DOI 10.4271/2001-01-2422; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Hernandez R, 2016, ENVIRON EXP BOT, V121, P66, DOI 10.1016/j.envexpbot.2015.04.001; Hernandez R, 2014, SCI HORTIC-AMSTERDAM, V173, P92, DOI 10.1016/j.scienta.2014.04.035; HOENECKE ME, 1992, HORTSCIENCE, V27, P427, DOI 10.21273/HORTSCI.27.5.427; Hogewoning SW, 2010, J EXP BOT, V61, P3107, DOI 10.1093/jxb/erq132; Hogewoning SW, 2010, J EXP BOT, V61, P1267, DOI 10.1093/jxb/erq005; Hoover W.H., 1937, SMITHSONIAN MISC COL, V95, P1; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Hunt R., 1982, PLANT GROWTH ANAL, V4; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Kim HH, 2004, ANN BOT-LONDON, V94, P691, DOI 10.1093/aob/mch192; Kim Hyeon-Hye, 2005, Habitation (Elmsford), V10, P71, DOI 10.3727/154296605774791232; Klassen S. P., 2003, Digital imaging and spectral techniques: applications to precision agriculture and crop physiology. Proceedings of a symposium sponsored by Division C-2 of the Crop Science Society of America, the USDA-ARS, and the Rockefeller Foundation in Minneapolis, MN, November 2001, P3; Lambers H., 2008, PLANT PHYSL ECOLOGY, V2nd ed., P321; LEOPOLD AC, 1975, PLANT GROWTH DEV; Li T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00416; Lin KH, 2013, SCI HORTIC, V150; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; Nelson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138930; Nishio JN, 2000, PLANT CELL ENVIRON, V23, P539, DOI 10.1046/j.1365-3040.2000.00563.x; Ouzounis T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00019; Ouzounis T, 2014, J PLANT PHYSIOL, V171, P1491, DOI 10.1016/j.jplph.2014.06.012; Paradiso R, 2011, SCI HORTIC-AMSTERDAM, V127, P548, DOI 10.1016/j.scienta.2010.11.017; Parry C, 2014, PLANT CELL ENVIRON; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Sepulveda-Ugarte J, 2011, J PHOTOCH PHOTOBIO A, V219, P211, DOI 10.1016/j.jphotochem.2011.02.012; SINCLAIR TR, 1992, CROP SCI, V32, P1281, DOI 10.2135/cropsci1992.0011183X003200050043x; Smith K, 2013, SCI PHOTOBIOLOGY; Son KH, 2013, HORTSCIENCE, V48, P988; Sun JD, 1998, PLANT CELL PHYSIOL, V39, P1020, DOI 10.1093/oxfordjournals.pcp.a029298; Taiz L., 2015, PLANT PHYSL DEV; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Terfa MT, 2013, PHYSIOL PLANTARUM, V148, P146, DOI 10.1111/j.1399-3054.2012.01698.x; Tubiello F, 1996, LIFE SUPPORT BIOSPH, V4, P77; von Sachs J, 1864, WIRKUNGEN FARBIGEN L; Wang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00250; Wang X, 2014, COMP MATH MATH PHYS, V2014, P1, DOI DOI 10.1111/CAS.12531; Wang YH, 2013, AM J BOT, V100, P70, DOI 10.3732/ajb.1200354; Wargent JJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P279, DOI 10.1111/j.1751-1097.2008.00433.x; WASSINK EC, 1956, ANNU REV PLANT PHYS, V7, P373, DOI 10.1146/annurev.pp.07.060156.002105; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380	56	107	108	8	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163121	10.1371/journal.pone.0163121	http://dx.doi.org/10.1371/journal.pone.0163121			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706176	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200034
J	Fava, F; Ponti, M; Abbiati, M				Fava, Federica; Ponti, Massimo; Abbiati, Marco			Role of Recruitment Processes in Structuring Coralligenous Benthic Assemblages in the Northern Adriatic Continental Shelf	PLOS ONE			English	Article							MARINE HARD SUBSTRATA; EPIBENTHIC COLONIZATION; POMATOCEROS-TRIQUETER; ARTIFICIAL SUBSTRATA; EPIFAUNAL COMMUNITY; TEMPORAL VARIATIONS; PERMUTATION TESTS; SPATIAL VARIATION; ROCELLARIA-DUBIA; LIGURIAN SEA	Coralligenous biogenic reefs are among the most diverse marine habitats in the Mediterranean Sea. The northern Adriatic mesophotic coralligenous outcrops host very rich and diverse epibenthic assemblages. Several studies quantified the low temporal variability and high spatial heterogeneity of these habitats, while processes driving structuring and differentiation are still poorly understood. To shed light on these processes, temporal and spatial patterns of colonisation were investigated using travertine tiles deployed on three coralligenous outcrops, corresponding to the main typologies of benthic assemblages described in previous studies. Three years after deployment, assemblages colonising travertine tiles resembled the differentiation among sites revealed by the natural assemblages in terms of major ecological groups. Processes structuring and maintaining species diversity have been explored. Pioneer species with high reproduction rate, long distance larval dispersal and fast growth (e.g. the serpulid polychaete Spirobranchus triqueter and the bivalve Anomia ephippium), were the most abundant in the early stages of recruitment on the two outcrops further away from the coast and with lower sedimentation. Their success may vary according to larval availability and environmental conditions (e.g., sedimentation rates). At these sites early-stage lasted 10-12 months, during which even species from natural substrates began colonising tiles by settlement of planktonic propagules (e.g., encrusting calcareous Rhodophyta) and lateral encroachment (e.g., sponges and ascidians). On coastal outcrop, exposed to a higher sedimentation rates, tiles were colonised by fast-growing algal turfs. Resilience of northern Adriatic coralligenous assemblages, and maintenance of their diversity, appeared largely entrusted to asexual reproduction. Exploring the mechanisms that underlie the formation and maintenance of the species diversity is crucial to improve our understanding of ecological processes and to implement appropriate conservation strategies of the Adriatic coralligenous reefs.	[Fava, Federica; Ponti, Massimo; Abbiati, Marco] Univ Bologna, CoNISMa, Dipartimento Sci Biol Geol & Ambientali BiGeA, Ravenna, Italy; [Fava, Federica; Ponti, Massimo; Abbiati, Marco] Univ Bologna, CoNISMa, CIRSA, Ravenna, Italy; [Abbiati, Marco] CNR, Ist Sci Marine, Bologna, Italy	CoNISMa; University of Bologna; CoNISMa; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Ponti, M (corresponding author), Univ Bologna, CoNISMa, Dipartimento Sci Biol Geol & Ambientali BiGeA, Ravenna, Italy.; Ponti, M (corresponding author), Univ Bologna, CoNISMa, CIRSA, Ravenna, Italy.	massimo.ponti@unibo.it	Ponti, Massimo/R-3093-2016	Ponti, Massimo/0000-0002-6521-1330; Abbiati, Marco/0000-0002-2426-4524				Abbiati M., 2009, P 1 MED S CONS COR O, P34; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2000, ECOLOGY, V81, P798, DOI 10.2307/177378; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 1997, OECOLOGIA, V109, P442, DOI 10.1007/s004420050104; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Andersson MH, 2009, HELGOLAND MAR RES, V63, P249, DOI 10.1007/s10152-009-0156-9; Antoniadou C, 2010, J EXP MAR BIOL ECOL, V382, P145, DOI 10.1016/j.jembe.2009.11.004; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Balata D, 2008, BOT MAR, V51, P464, DOI 10.1515/BOT.2008.068; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; BOURGET E, 1994, J EXP MAR BIOL ECOL, V181, P31, DOI 10.1016/0022-0981(94)90102-3; Bramanti L, 2003, ITAL J ZOOL, V70, P175, DOI 10.1080/11250000309356512; BRUNETTI R, 1994, B ZOOL, V61, P89, DOI 10.1080/11250009409355864; Cabanellas-Reboredo Miguel, 2009, Marine Biodiversity Records, V2, pe126, DOI 10.1017/S1755267209001274; Calcinai B, 2015, MEDITERR MAR SCI, V16, P413, DOI 10.12681/mms.900; Casas-Guell E, 2015, MAR BIOL, V162, P901, DOI 10.1007/s00227-015-2635-7; Casellato S, 2008, MAR ECOL-EVOL PERSP, V29, P321, DOI 10.1111/j.1439-0485.2008.00236.x; Casoli E, 2016, INT BIODETER BIODEGR, V108, P9, DOI 10.1016/j.ibiod.2015.11.026; Casoli E, 2015, MAR ECOL-EVOL PERSP, V36, P1060, DOI 10.1111/maec.12201; Cerrano C, 2007, ITAL J ZOOL, V74, P13, DOI 10.1080/11250000600929370; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocito S, 2002, SCI MAR, V66, P175, DOI 10.3989/scimar.2002.66n2175; Cotter E, 2003, MAR BIOL, V142, P905, DOI 10.1007/s00227-002-0987-2; Curiel D, 2012, BOT MAR, V55, P625, DOI 10.1515/bot-2012-0166; DEGOBBIS D, 1995, SCI TOTAL ENVIRON, V165, P43, DOI 10.1016/0048-9697(95)04542-9; DEGOBBIS D, 1989, MAR POLLUT BULL, V20, P452, DOI 10.1016/0025-326X(89)90066-0; Denitto F, 2007, MAR ECOL-EVOL PERSP, V28, P35, DOI 10.1111/j.1439-0485.2007.00172.x; Di Camillo CG, 2012, HYDROBIOLOGIA, V687, P299, DOI 10.1007/s10750-011-0877-z; Downes BJ, 1998, AUST J ECOL, V23, P8, DOI 10.1111/j.1442-9993.1998.tb00702.x; EDGAR GJ, 1991, HYDROBIOLOGIA, V226, P111, DOI 10.1007/BF00006812; EDYVEAN RGJ, 1984, BIOL J LINN SOC, V23, P353, DOI 10.1111/j.1095-8312.1984.tb00151.x; EDYVEAN RGJ, 1986, BRIT PHYCOL J, V21, P255, DOI 10.1080/00071618600650291; European Commission DG Environment, 2013, EUR28 EUR COMM DG EN; Falace A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140931; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Gabriele M, 1999, CAH BIOL MAR, V40, P65; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1998, MAR FRESHWATER RES, V49, P429, DOI 10.1071/MF98008; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KLOCKNER K, 1976, HELGOLAND WISS MEER, V28, P352, DOI 10.1007/BF01610588; Krohling W, 2008, BRAZ ARCH BIOL TECHN, V51, P213, DOI 10.1590/S1516-89132008000100025; Lambeck K, 2004, QUATERNARY SCI REV, V23, P1567, DOI 10.1016/j.quascirev.2004.02.009; Lopez-Legentil S, 2013, INVERTEBR BIOL, V132, P69, DOI 10.1111/ivb.12013; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Molin Emiliano, 2003, Bollettino del Museo Civico di Storia Naturale di Venezia, V54, P19; Molin Emiliano, 2011, Bollettino del Museo di Storia Naturale di Venezia, V62, P5; Morton B, 2011, BIOL J LINN SOC, V104, P786, DOI 10.1111/j.1095-8312.2011.01763.x; MYERS AA, 1980, J MAR BIOL ASSOC UK, V60, P963, DOI 10.1017/S0025315400042028; Norderhaug KM, 2002, MAR BIOL, V141, P965, DOI 10.1007/s00227-002-0893-7; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Osman RW, 1998, HYDROBIOLOGIA, V375-76, P113, DOI 10.1023/A:1017000820646; Pech D, 2002, ESTUAR COAST SHELF S, V55, P743, DOI 10.1006/ecss.2001.0933; Piazzi L, 2004, BOT MAR, V47, P105, DOI 10.1515/BOT.2004.010; Piazzi L, 2002, BOT MAR, V45, P243, DOI 10.1515/BOT.2002.023; Piazzi L, 2010, J NAT HIST, V44, P1, DOI 10.1080/00222930903377547; Piazzi L, 2011, SCI MAR, V75, P399, DOI 10.3989/scimar.2011.75n2399; Ponti M, 2002, ICES J MAR SCI, V59, pS316, DOI 10.1006/jmsc.2002.1225; Ponti M, 2014, P 2 MED S CONS COR O, P147; Ponti M, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2897-8; Ponti M, 2015, MAR ENVIRON RES, V104, P10, DOI 10.1016/j.marenvres.2014.12.004; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Ponti M, 2011, MAR BIOL, V158, P1447, DOI 10.1007/s00227-011-1661-3; Ramos Espla AA, 1991, ASCIDIAS LITORALES M; Relini G, 1973, ATT 5 C SOC IT BIOL, P226; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Rule MJ, 2005, MAR ECOL PROG SER, V290, P67, DOI 10.3354/meps290067; Sara M, 1969, MAR ECOL, V37, P124; Schiaparelli S., 2003, ATTI ASS ITALIANA OC, V16, P29; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Stefanon A, 1980, OXYGEN CRISIS NO ADR, P167; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; TRINCARDI F, 1994, GEO-MAR LETT, V14, P41, DOI 10.1007/BF01204470; TURNER SJ, 1993, J EXP MAR BIOL ECOL, V166, P251, DOI 10.1016/0022-0981(93)90223-B; Tursi A., 1985, Oebalia, V11, P401; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT; Virgilio M, 2006, CORAL REEFS, V25, P265, DOI 10.1007/s00338-006-0100-2; Watson DI, 2004, MAR BIOL, V145, P201, DOI 10.1007/s00227-003-1291-5	87	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163494	10.1371/journal.pone.0163494	http://dx.doi.org/10.1371/journal.pone.0163494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701418	Green Published, gold, Green Submitted			2022-12-26	WOS:000385696900009
J	Park, H; Li, XY; Song, YE; He, KRY; Zhu, XF				Park, Haeil; Li, Xiaoyin; Song, Yeunjoo E.; He, Karen Y.; Zhu, Xiaofeng			Multivariate Analysis of Anthropometric Traits Using Summary Statistics of Genome-Wide Association Studies from GIANT Consortium	PLOS ONE			English	Article							METAANALYSIS; LOCI; INSIGHTS; COHORTS; POWER; TWIN	Meta-analysis of single trait for multiple cohorts has been used for increasing statistical power in genome-wide association studies (GWASs). Although hundreds of variants have been identified by GWAS, these variants only explain a small fraction of phenotypic variation. Cross-phenotype association analysis (CPASSOC) can further improve statistical power by searching for variants that contribute to multiple traits, which is often relevant to pleiotropy. In this study, we performed CPASSOC analysis on the summary statistics from the Genetic Investigation of ANthropometric Traits (GIANT) consortium using a novel method recently developed by our group. Sex-specific meta-analysis data for height, body mass index (BMI), and waist-to-hip ratio adjusted for BMI (WHRadjBMI) from discovery phase of the GIANT consortium study were combined using CPASSOC for each trait as well as 3 traits together. The conventional meta-analysis results from the discovery phase data of GIANT consortium studies were used to compare with that from CPASSOC analysis. The CPASSOC analysis was able to identify 17 loci associated with anthropometric traits that were missed by conventional meta-analysis. Among these loci, 16 have been reported in literature by including additional samples and 1 is novel. We also demonstrated that CPASSOC is able to detect pleiotropic effects when analyzing multiple traits.	[Park, Haeil; Li, Xiaoyin; Song, Yeunjoo E.; He, Karen Y.; Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Park, Haeil] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Lab Med, Seoul, South Korea	Case Western Reserve University; Catholic University of Korea	Zhu, XF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	Xiaofeng.Zhu@case.edu	Li, Xiaoyin/AAU-3662-2021; Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X; Song, Yeunjoo/0000-0002-7452-3731; Park, Hae-il/0000-0002-1092-0607; He, Karen/0000-0002-8686-7697	NHGRI NIH HHS [R01 HG003054] Funding Source: Medline; NHLBI NIH HHS [T32 HL007567] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Panagiotou OA, 2013, ANNU REV GENOM HUM G, V14, P441, DOI 10.1146/annurev-genom-091212-153520; Province Michael A, 2013, Pac Symp Biocomput, P236; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Wei FJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11900; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163912	10.1371/journal.pone.0163912	http://dx.doi.org/10.1371/journal.pone.0163912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701450	gold, Green Published, Green Submitted			2022-12-26	WOS:000385696900030
J	Peng, DH; Ungewiss, C; Tong, P; Byers, LA; Wang, J; Canales, JR; Villalobos, PA; Uraoka, N; Mino, B; Behrens, C; Wistuba, II; Han, RI; Wanna, CA; Fahrenholtz, M; Grande-Allen, KJ; Creighton, CJ; Gibbons, DL				Peng, D. H.; Ungewiss, C.; Tong, P.; Byers, L. A.; Wang, J.; Canales, J. R.; Villalobos, P. A.; Uraoka, N.; Mino, B.; Behrens, C.; Wistuba, I. I.; Han, R. I.; Wanna, C. A.; Fahrenholtz, M.; Grande-Allen, K. J.; Creighton, C. J.; Gibbons, D. L.			ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYSYL OXIDASE; THERAPEUTIC TARGET; MIR-200 FAMILY; SECRETED LOXL2; EXPRESSION; EMT; ADENOCARCINOMA; ENZYME; CELLS	Lung cancer is the leading cause of cancer-related deaths, primarily due to distant metastatic disease. Metastatic lung cancer cells can undergo an epithelial-to-mesenchymal transition (EMT) regulated by various transcription factors, including a double-negative feedback loop between the microRNA-200 (miR-200) family and ZEB1, but the precise mechanisms by which ZEB1-dependent EMT promotes malignancy remain largely undefined. Although the cell-intrinsic effects of EMT are important for tumor progression, the reciprocal dynamic crosstalk between mesenchymal cancer cells and the extracellular matrix (ECM) is equally critical in regulating invasion and metastasis. Investigating the collaborative effect of EMT and ECM in the metastatic process reveals increased collagen deposition in metastatic tumor tissues as a direct consequence of amplified collagen gene expression in ZEB1-activated mesenchymal lung cancer cells. In addition, collagen fibers in metastatic lung tumors exhibit greater linearity and organization as a result of collagen crosslinking by the lysyl oxidase (LOX) family of enzymes. Expression of the LOX and LOXL2 isoforms is directly regulated by miR-200 and ZEB1, respectively, and their upregulation in metastatic tumors and mesenchymal cell lines is coordinated to that of collagen. Functionally, LOXL2, as opposed to LOX, is the principal isoform that crosslinks and stabilizes insoluble collagen deposition in tumor tissues. In turn, focal adhesion formation and FAK/SRC signaling is activated in mesenchymal tumor cells by crosslinked collagen in the ECM. Our study is the first to validate direct regulation of LOX and LOXL2 by the miR-200/ZEB1 axis, defines a novel mechanism driving tumor metastasis, delineates collagen as a prognostic marker, and identifies LOXL2 as a potential therapeutic target against tumor progression.	[Peng, D. H.; Ungewiss, C.; Byers, L. A.; Behrens, C.; Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, 1515 Holcombe Blvd,Unit 432, Houston, TX 77030 USA; [Peng, D. H.; Ungewiss, C.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Tong, P.; Wang, J.; Creighton, C. J.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Canales, J. R.; Villalobos, P. A.; Uraoka, N.; Mino, B.; Wistuba, I. I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Han, R. I.; Wanna, C. A.; Fahrenholtz, M.; Grande-Allen, K. J.] Rice Univ, Dept Bioengn, Houston, TX USA; [Creighton, C. J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Creighton, C. J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Gibbons, D. L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, 1515 Holcombe Blvd,Unit 432, Houston, TX 77030 USA.	dlgibbon@mdanderson.org	Villalobos, Pamela/AAM-2677-2021	Fahrenholtz, Monica/0000-0003-4112-8230; Han, Richard I/0000-0002-8332-622X; Peng, David/0000-0003-0511-1888	NCI [K08 CA151661, RP120713 C2 and NCI grant CA125123]; MD Anderson Cancer Center Physician Scientist Award; Rexanna's Foundation for Fighting Lung Cancer [RP120713 P2]; CPRIT [RP120713 P2, RP120713 C2]; CPRIT Graduate Scholar Training Grant [RP140106]; Lung SPORE [P50 CA070907]; Cancer Center Support Grant [CCSG CA016672]; Mary K Chapman Foundation; Jeane F Shelby Scholarship Fund; NATIONAL CANCER INSTITUTE [K08CA151651, P50CA070907, P30CA016672] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Physician Scientist Award; Rexanna's Foundation for Fighting Lung Cancer; CPRIT; CPRIT Graduate Scholar Training Grant; Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Mary K Chapman Foundation; Jeane F Shelby Scholarship Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr G Goodall (University of Adelaide, Australia) for the kind gift of the pTRIPz-miR-200 expression constructs. We thank Dr M Dickinson (Baylor College of Medicine, Houston, TX, USA) for providing access to the multiphoton microscope for SHG analysis. We would like to thank members of the Gibbons lab for their assistance and critical reading of the manuscript. This work was supported by NCI K08 CA151661 (DLG), an MD Anderson Cancer Center Physician Scientist Award (DLG), Rexanna's Foundation for Fighting Lung Cancer (DLG) and CPRIT grant RP120713 P2 (DLG and JG-A). DP was supported by a CPRIT Graduate Scholar Training Grant (RP140106). JW and PT are supported by Lung SPORE (P50 CA070907), Cancer Center Support Grant (CCSG CA016672) and Mary K Chapman Foundation. CJC was supported by CPRIT grant RP120713 C2 and NCI grant CA125123. LAB and DLG are R Lee Clark Fellows of the University of Texas MD Anderson Cancer Center, supported by the Jeane F Shelby Scholarship Fund.	Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Barker HE, 2013, MOL CANCER RES, V11, P1425, DOI 10.1158/1541-7786.MCR-13-0033-T; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Canesin G, 2015, ONCOGENE, V34, P951, DOI 10.1038/onc.2014.23; CHAUDHURI BB, 1993, PATTERN RECOGN LETT, V14, P147, DOI 10.1016/0167-8655(93)90088-U; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Hong HH, 2004, J CELL PHYSIOL, V200, P53, DOI 10.1002/jcp.10476; Jung HY, 2015, CLIN CANCER RES, V21, P962, DOI 10.1158/1078-0432.CCR-13-3173; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kundu ST, 2016, ONCOGENE, V35, P173, DOI 10.1038/onc.2015.71; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Pickup MW, 2013, CANCER RES, V73, P5336, DOI 10.1158/0008-5472.CAN-13-0012; Rossi MA, 1998, CIRCULATION, V97, P934, DOI 10.1161/01.CIR.97.9.934; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; Ungewiss C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18652; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiao Dakai, 2010, J Thorac Dis, V2, P154, DOI 10.3978/j.issn.2072-1439.2010.02.03.7; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YA, 2014, J CLIN INVEST, V124, P2696, DOI 10.1172/JCI72171; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Zhan P, 2012, MED ONCOL, V29, P648, DOI 10.1007/s12032-011-9959-z	58	115	119	0	25	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1925	1938		10.1038/onc.2016.358	http://dx.doi.org/10.1038/onc.2016.358			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27694892	Green Accepted			2022-12-26	WOS:000398898500004
J	Seviour, EG; Sehgal, V; Mishra, D; Rupaimoole, R; Rodriguez-Aguayo, C; Lopez-Berestein, G; Lee, JS; Sood, AK; Kim, MP; Mills, GB; Ram, PT				Seviour, E. G.; Sehgal, V.; Mishra, D.; Rupaimoole, R.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Lee, J-S; Sood, A. K.; Kim, M. P.; Mills, G. B.; Ram, P. T.			Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p	ONCOGENE			English	Article							LUNG-CANCER; DNA METHYLATION; K-RAS; EXPRESSION; PATHWAYS; YAP	KRas is mutated in a significant number of human cancers and so there is an urgent therapeutic need to target KRas signalling. To target KRas in lung cancers we used a systems approach of integrating a genome-wide miRNA screen with patient-derived phospho-proteomic signatures of the KRas downstream pathway, and identified miR-193a-3p, which directly targets KRas. Unique aspects of miR-193a-3p biology include two functionally independent target sites in the KRas 3' UTR and clinically significant correlation between miR-193a-3p and KRas expression in patients. Rescue experiments with mutated KRas 3' UTR showed very significantly that the anti-tumour effect of miR-193a-3p is via specific direct targeting of KRas and not due to other targets. Ex vivo and in vivo studies utilizing nanoliposome packaged miR-193a-3p demonstrated significant inhibition of tumour growth, circulating tumour cell viability and decreased metastasis. These studies show the broader applicability of using miR-193a-3p as a therapeutic agent to target KRas-mutant cancer.	[Seviour, E. G.; Sehgal, V.; Lee, J-S; Mills, G. B.; Ram, P. T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Mishra, D.; Kim, M. P.] Methodist Hosp, Res Inst, 6535 Fannin, Houston, TX 77030 USA; [Rupaimoole, R.; Sood, A. K.] UTMDACC, Dept Gynecol Oncol, Houston, TX USA; [Rodriguez-Aguayo, C.; Lopez-Berestein, G.] UTMDACC, Dept Expt Therapeut, Houston, TX USA; [Lopez-Berestein, G.; Lee, J-S; Sood, A. K.; Ram, P. T.] UTMDACC, Ctr RNA Interference & Noncoding RNA, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ram, PT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	pram@mdanderson.org	Sood, Anoop Kumar/A-7344-2013	Sood, Anoop Kumar/0000-0001-5702-4108; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Mishra, Dhruva/0000-0001-8651-005X; Ram, Prahlad/0000-0003-4739-3166; Mills, Gordon/0000-0002-0144-9614	NIH/NCI ICBP [U54-CA112970]; CCBTP training grant from the CPRIT; NIH [UH2 TR000943]; RGK Foundation; CPRIT [RP110595]; NATIONAL CANCER INSTITUTE [U54CA112970, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000943] Funding Source: NIH RePORTER	NIH/NCI ICBP; CCBTP training grant from the CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RGK Foundation; CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	All the data reported in the paper are presented. The microarray data are available from GEO under the accession number GSE73194. The work presented here was funded by NIH/NCI ICBP grant U54-CA112970 (Project 2 PI-JWG, Project 4 Co-PI's PTR and GBM), VS was funded by the CCBTP training grant from the CPRIT, and grants from the NIH (UH2 TR000943), the RGK Foundation, and CPRIT RP110595 (AKS).	Agarwal A, 2008, LEUKEMIA, V22, P2269, DOI 10.1038/leu.2008.124; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BOS JL, 1989, CANCER RES, V49, P4682; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; DER CJ, 1983, CELL, V32, P201, DOI 10.1016/0092-8674(83)90510-X; Grana TM, 2002, CANCER RES, V62, P4142; Grechukhina O, 2012, EMBO MOL MED, V4, P206, DOI 10.1002/emmm.201100200; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Jancik S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/150960; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; Kalinichenko VV, 2015, EXPERT OPIN THER TAR, V19, P865, DOI 10.1517/14728222.2015.1042366; Katzel JA, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Li CX, 2006, CELL CYCLE, V5, P2103, DOI 10.4161/cc.5.18.3192; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lv L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.367; Mishra DK, 2015, ANN THORAC SURG, V99, P1149, DOI 10.1016/j.athoracsur.2014.08.085; Mishra DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045308; Mishra DK, 2012, ANN THORAC SURG, V93, P1075, DOI 10.1016/j.athoracsur.2012.01.011; Moss TJ, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.1; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Rosell R, 1995, SEMIN ONCOL, V22, P12; Seviour EG, 2016, ONCOGENE, V35, P801, DOI 10.1038/onc.2015.177; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Uberall I, 2008, EXP MOL PATHOL, V84, P79, DOI 10.1016/j.yexmp.2007.12.002; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	36	34	34	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1339	1350		10.1038/onc.2016.308	http://dx.doi.org/10.1038/onc.2016.308			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27669434	Green Accepted			2022-12-26	WOS:000395862500003
J	Cisternas, P; Salazar, P; Silva-Alvarez, C; Barros, LF; Inestrosa, NC				Cisternas, Pedro; Salazar, Paulina; Silva-Alvarez, Carmen; Felipe Barros, L.; Inestrosa, Nibaldo C.			Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT/BETA-CATENIN PATHWAY; BRAIN ENERGY-METABOLISM; ALZHEIMERS-DISEASE; PROTEIN-KINASE; COMPETITIVE-INHIBITION; COGNITIVE FUNCTION; GLYCOGEN-SYNTHESIS; CEREBRAL GLUCOSE; SKELETAL-MUSCLE; HEXOKINASE	The Wnt signaling pathway is critical for a number of functions in the central nervous system, including regulation of the synaptic cleft structure and neuroprotection against injury. Deregulation of Wnt signaling has been associated with several brain pathologies, including Alzheimer's disease. In recent years, it has been suggested that the Wnt pathway might act as a central integrator of metabolic signals from peripheral organs to the brain, which would represent a new role for Wnt signaling in cell metabolism. Energy metabolism is critical for normal neuronal function, which mainly depends on glucose utilization. Brain energy metabolism is important in almost all neurological disorders, to which a decrease in the capacity of the brain to utilize glucose has been linked. However, little is known about the relationship between Wnt signaling and neuronal glucose metabolism in the cellular context. In the present study, we found that acute treatment with the Wnt3a ligand induced a large increase in glucose uptake, without changes in the expression or localization of glucose transporter type 3. In addition, we observed that Wnt3a treatment increased the activation of the metabolic sensor Akt. Moreover, we observed an increase in the activity of hexokinase and in the glycolytic rate, and both processes were dependent on activation of the Akt pathway. Furthermore, we did not observe changes in the activity of glucose-6-phosphate dehydrogenase or in the pentose phosphate pathway. The effect of Wnt3a was independent of both the transcription of Wnt target genes and synaptic effects of Wnt3a. Together, our results suggest that Wnt signaling stimulates glucose utilization in cortical neurons through glycolysis to satisfy the high energy demand of these cells.	[Cisternas, Pedro; Salazar, Paulina; Silva-Alvarez, Carmen; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Envejecimiento & Regenerac CARE UC, Santiago 8330025, Chile; [Cisternas, Pedro] Univ Atacama, Fac Ciencias Nat, Dept Quim & Biol, Copayapu 485, Copiapo, Chile; [Felipe Barros, L.] Ctr Estudios Cient, Casilla 1469, Valdivia, Chile; [Inestrosa, Nibaldo C.] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW 1235, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes CEBIMA, Punta Arenas 6200732, Chile	Pontificia Universidad Catolica de Chile; Universidad de Atacama; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, CARE UC Biomed Res Ctr, A Bernardo OHiggins 340,POB 114-D, Santiago, Chile.	ninestrosa@bio.puc.cl			Sociedad Quimica y Minera de Chile (SQM); Basal Centers of Excellence Program (CONICYT-PFB)	Sociedad Quimica y Minera de Chile (SQM); Basal Centers of Excellence Program (CONICYT-PFB)	We thank the Sociedad Quimica y Minera de Chile (SQM) for the special grants "The role of K<SUP>+</SUP> on Hypertension and Cognition" and "The role of Lithium in Human Health and Disease." The Centro de Estudios Cientificos (CECs) is funded by the Basal Centers of Excellence Program (CONICYT-PFB).	Amado NG, 2012, CURR TOP MED CHEM, V12, P2103; Amato S, 2011, CELL CYCLE, V10, P3452, DOI 10.4161/cc.10.20.17953; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Avila ME, 2010, J BIOL CHEM, V285, P18939, DOI 10.1074/jbc.M110.103028; Babkin P, 2015, FEBS OPEN BIO, V5, P335, DOI 10.1016/j.fob.2015.04.006; Barros LF, 2009, J NEUROCHEM, V109, P94, DOI 10.1111/j.1471-4159.2009.05885.x; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benzler J, 2013, ENDOCRINOLOGY, V154, P4737, DOI 10.1210/en.2013-1746; Benzler J, 2012, BIOCHEM J, V447, P175, DOI 10.1042/BJ20120834; BERTONI JM, 1981, J NEUROCHEM, V37, P1523, DOI 10.1111/j.1471-4159.1981.tb06322.x; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Ciani L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9302; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cisternas P, 2014, CURR MOL MED, V14, P510, DOI 10.2174/1566524014666140414210346; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Craft S, 2005, NEUROBIOL AGING, V26, pS65, DOI 10.1016/j.neurobiolaging.2005.08.021; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Dienel GA, 2017, NEUROSCI LETT, V637, P18, DOI 10.1016/j.neulet.2015.02.052; Euser SM, 2010, DIABETES, V59, P1601, DOI 10.2337/db09-0568; Falkowska A, 2015, INT J MOL SCI, V16, P25959, DOI 10.3390/ijms161125939; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P484, DOI 10.1021/cn5000315; Codocedo JF, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0071-x; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Godoy JA, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-23; Helfer G, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12368; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Inestrosa NC, 2014, J MOL CELL BIOL, V6, P64, DOI 10.1093/jmcb/mjt051; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; JUNG CY, 1977, J BIOL CHEM, V252, P5456; Kadir A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.015; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Komiya Yuko, 2008, Organogenesis, V4, P68; Konagaya M, 1990, Rinsho Shinkeigaku, V30, P1078; LARRABEE MG, 1990, BIOCHEM J, V272, P127, DOI 10.1042/bj2720127; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liu S, 2015, PAIN, V156, P2572, DOI 10.1097/j.pain.0000000000000366; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Ma T, 2011, J NEUROSCI, V31, P17537, DOI 10.1523/JNEUROSCI.4761-11.2011; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; McNay EC, 1998, J NEUROSCI, V18, P3853; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Moon JS, 2011, BIOCHEM J, V433, P225, DOI 10.1042/BJ20101104; Morris SAL, 2016, GENES DIS, V3, P41, DOI 10.1016/j.gendis.2015.12.003; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Murphy GG, 1999, J NEUROSCI, V19, P10595; Naujok Ortwin, 2014, BMC Res Notes, V7, P273, DOI 10.1186/1756-0500-7-273; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Niccoli T, 2016, CURR BIOL, V26, P2291, DOI [10.1016/j.cub.2016.07.017, 10.1016/j.cub.2016.09.018]; Nobrega MA, 2013, DIABETES, V62, P706, DOI 10.2337/db12-1418; Novellasdemunt L, 2013, J BIOL CHEM, V288, P10640, DOI 10.1074/jbc.M113.455998; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oliva CA, 2015, EXP NEUROL, V269, P43, DOI 10.1016/j.expneurol.2015.03.027; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Ramirez VT, 2016, J BIOL CHEM, V291, P19092, DOI 10.1074/jbc.M116.722132; Ramirez VT, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4258171; Rios JA, 2014, PROG NEUROBIOL, V121, P125, DOI 10.1016/j.pneurobio.2014.07.004; Rosa J. C., 2016, CURR MOL PH IN PRESS; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Shao WJ, 2013, DIABETES, V62, P789, DOI 10.2337/db12-0365; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Tapia-Rojas C, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0057-0; Tapia-Rojas C, 2015, BIOCHEM J, V466, P415, DOI 10.1042/BJ20140207; Tian J, 2015, J HUAZHONG U SCI-MED, V35, P212, DOI 10.1007/s11596-015-1413-6; Tsai CS, 1998, BIOCHEM CELL BIOL, V76, P107, DOI 10.1139/bcb-76-1-107; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Varela-Nallar L., 2014, CELL NEUROSCI, V8, P17; Varela-Nallar L, 2012, NEURODEGENER DIS, V10, P23, DOI 10.1159/000333360; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Vargas JY, 2015, EXP NEUROL, V264, P14, DOI 10.1016/j.expneurol.2014.11.005; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; Verdile G, 2015, NEUROBIOL DIS, V84, P22, DOI 10.1016/j.nbd.2015.04.008; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Zeve D, 2012, CELL METAB, V15, P492, DOI 10.1016/j.cmet.2012.03.010	100	37	37	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2016	291	50					25950	25964		10.1074/jbc.M116.735373	http://dx.doi.org/10.1074/jbc.M116.735373			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF5BH	27703002	Green Published, hybrid			2022-12-26	WOS:000390345200017
J	Kehrli, K; Phelps, M; Lazarchuk, P; Chen, E; Monnat, R; Sidorova, JM				Kehrli, Keffy; Phelps, Michael; Lazarchuk, Pavlo; Chen, Eleanor; Monnat, Ray; Sidorova, Julia M.			Class I Histone Deacetylase HDAC1 and WRN RECQ Helicase Contribute Additively to Protect Replication Forks upon Hydroxyurea-induced Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; BLOOMS-SYNDROME; NASCENT DNA; HUMAN-CELLS; DEFICIENT CELLS; SYNDROME GENE; STRESS; PROGRESSION; RESTART; DAMAGE	The WRN helicase/exonuclease is mutated in Werner syndrome of genomic instability and premature aging. WRN-depleted fibroblasts, although remaining largely viable, have a reduced capacity to maintain replication forks active during a transient hydroxyurea-induced arrest. A strand exchange protein, RAD51, is also required for replication fork maintenance, and here we show that recruitment of RAD51 to stalled forks is reduced in the absence of WRN. We performed a siRNA screen for genes that are required for viability of WRN-depleted cells after hydroxyurea treatment, and identified HDAC1, a member of the class I histone deacetylase family. One of the functions of HDAC1, which it performs together with a close homolog HDAC2, is deacetylation of new histone H4 deposited at replication forks. We show that HDAC1 depletion exacerbates defects in fork reactivation and progression after hydroxyurea treatment observed in WRN- or RAD51-deficient cells. The additive WRN, HDAC1 loss-of-function phenotype is also observed with a catalytic mutant of HDAC1; however, it does not correlate with changes in histone H4 deacetylation at replication forks. On the other hand, inhibition of histone deacetylation by an inhibitor specific to HDACs 1-3, CI-994, correlates with increased processing of newly synthesized DNA strands in hydroxyurea-stalled forks. WRN co-precipitates with HDAC1 and HDAC2. Taken together, our findings indicate that WRN interacts with HDACs 1 and 2 to facilitate activity of stalled replication forks under conditions of replication stress.	[Kehrli, Keffy; Phelps, Michael; Lazarchuk, Pavlo; Chen, Eleanor; Monnat, Ray; Sidorova, Julia M.] Univ Washington, Dept Pathol, K-065,Box 357705,1959 NE Pacific St, Seattle, WA 98195 USA; [Monnat, Ray] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kehrli, Keffy] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Lazarchuk, Pavlo] Adapt Biotechnol, Seattle, WA 98102 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sidorova, JM (corresponding author), Univ Washington, Dept Pathol, K-065,Box 357705,1959 NE Pacific St, Seattle, WA 98195 USA.	julias@uw.edu	Phelps, Michael/O-6686-2018; Kehrli, Keffy/ABA-3390-2020	Phelps, Michael/0000-0001-8246-0710; Kehrli, Keffy/0000-0002-6573-2216; Sidorova, Julia/0000-0001-5502-4323	National Institutes of Health [R01GM115482, P01CA77852, K08 AR063165-03, R01CA196882]; St. Baldrick's Scholar Award; Sarcoma Foundation; Rally Foundation; University of Washington Royalty Research Fund; Seattle Cancer Consortium Breast NCI SPORE; NATIONAL CANCER INSTITUTE [P01CA077852, R01CA196882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR063165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Scholar Award; Sarcoma Foundation; Rally Foundation; University of Washington Royalty Research Fund(University of Washington); Seattle Cancer Consortium Breast NCI SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM115482 (to J. M. S.), P01CA77852 (to R. M., Jr.), and K08 AR063165-03 and R01CA196882 (to E C.). This work was also supported by St. Baldrick's Scholar Award, Sarcoma Foundation and Rally Foundation grants (to E. C.), and by the University of Washington Royalty Research Fund and Seattle Cancer Consortium Breast NCI SPORE (to J. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Aranda S, 2014, NUCLEIC ACIDS RES, V42, P6972, DOI 10.1093/nar/gku374; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Croteau DL, 2014, ANNU REV BIOCHEM, V83, P519, DOI 10.1146/annurev-biochem-060713-035428; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Fukuda T, 2015, CANCER SCI, V106, P1050, DOI 10.1111/cas.12717; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Iannascoli C, 2015, NUCLEIC ACIDS RES, V43, P9788, DOI 10.1093/nar/gkv836; Kehrli Keffy R M, 2014, Oncoscience, V1, P540; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Lauper JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059709; Leman AR, 2013, GENES-BASEL, V4, P1, DOI 10.3390/genes4010001; Leung KHT, 2013, BIOTECHNIQUES, V55, P204, DOI 10.2144/000114089; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Mao FJ, 2010, CANCER RES, V70, P6548, DOI 10.1158/0008-5472.CAN-10-0475; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Pathania S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6496; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Rodriguez-Lopez AM, 2002, AGING CELL, V1, P30, DOI 10.1046/j.1474-9728.2002.00002.x; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidorova J. M., 2015, Advances in Genomics and Genetics, V5, P19; Sidorova JM, 2008, DNA REPAIR, V7, P1776, DOI 10.1016/j.dnarep.2008.07.017; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Sidorova JM, 2013, DNA REPAIR, V12, P128, DOI 10.1016/j.dnarep.2012.11.005; Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54; Sirbu BM, 2013, J BIOL CHEM, V288, P31458, DOI 10.1074/jbc.M113.511337; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Su FT, 2014, CELL REP, V9, P1387, DOI 10.1016/j.celrep.2014.10.025; Swanson C, 2004, DNA REPAIR, V3, P475, DOI 10.1016/j.dnarep.2004.01.002; Thangavel S, 2015, J CELL BIOL, V208, P545, DOI 10.1083/jcb.201406100; Yu CE, 1997, AM J HUM GENET, V60, P330; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	54	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24487	24503		10.1074/jbc.M115.708594	http://dx.doi.org/10.1074/jbc.M115.708594			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27672210	Green Published, hybrid			2022-12-26	WOS:000388875500013
J	Maphisa, DH; Smit-Robinson, H; Underhill, LG; Altwegg, R				Maphisa, David H.; Smit-Robinson, Hanneline; Underhill, Les G.; Altwegg, Res			Drivers of Bird Species Richness within Moist High-Altitude Grasslands in Eastern South Africa	PLOS ONE			English	Article							MPUMALANGA PROVINCE; HABITAT USE; FIRE; CONSERVATION; WILDLIFE; IMPACT; NEST; HETEROGENEITY; VEGETATION; DIVERSITY	Moist high-altitude grasslands in South Africa are renowned for high avifaunal diversity and are priority areas for conservation. Conservation management of these areas conflicts with management for other uses, such as intensive livestock agriculture, which requires annual burning and leads to heavy grazing. Recently the area has become target for water storage schemes and renewable electricity energy projects. There is therefore an urgent need to investigate environmental factors and habitat factors that affect bird species richness in order to optimise management of those areas set aside for conservation. A particularly good opportunity to study these issues arose at Ingula in the eastern South African high-altitude grasslands. An area that had been subject to intense grazing was bought by the national power utility that constructed a pumped storage scheme on part of the land and set aside the rest for bird conservation. Since the new management took over in 2005 the area has been mostly annually burned with relatively little grazing. The new management seeks scientific advice on how to maintain avian species richness of the study area. We collected bird occurrence and vegetation data along random transects between 2006 and 2010 to monitor the impact of the new management, and to study the effect of the habitat changes on bird species richness. To achieve these, we convert bird transect data to presence only data to investigate how bird species richness were related to key transect vegetation attributes under this new grassland management. First we used generalised linear mixed models, to examine changes in vegetation grass height and cover and between burned and unburned habitats. Secondly, we examined how total bird species richness varied across seasons and years. And finally we investigated which habitat vegetation attributes were correlated with species richness of a group of grassland depended bird species only. Transects that were burned showed a larger decrease in vegetation cover compared to transects that were not burned. Grass height increased over time. Bird species richness was highest in summer compared to other seasons and increased over time. Overall bird species richness increased over the three summer surveys but species richness of birds that prefer heavily grazed habitat showed little change over the three years. Changes in bird species richness were best explained by the model with grass height for combined species richness of grassland depended birds but also for birds that prefer heavy grazing when treated alone. On one hand birds that prefer moderate grazing were best explained by a null model. However, overall bird species richness was better positively correlated to grass height than grass cover or dead grass. We conclude that frequent burning alone with relatively reduced grazing led to higher but less dense grass, which benefited some species and disadvantaged others. We suggest that management of this grassland use combination of fire and grazing and leave some areas unburned to accommodates birds of various habitat needs.	[Maphisa, David H.] South African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa; [Maphisa, David H.; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Rondebosch, South Africa; [Maphisa, David H.; Underhill, Les G.] Univ Cape Town, Anim Demog Unit, Dept Biol Sci, ZA-7701 Rondebosch, South Africa; [Smit-Robinson, Hanneline] BirdLife South Africa, Private Bag X5000, ZA-2121 Parklands, South Africa; [Smit-Robinson, Hanneline] UNISA, ABEERU, Private Bag X6, ZA-1717 Florida, South Africa; [Altwegg, Res] Univ Cape Town, African Climate & Dev Initiat, ZA-7701 Rondebosch, South Africa	South African National Biodiversity Institute; University of Cape Town; University of Cape Town; University of South Africa; University of Cape Town	Maphisa, DH (corresponding author), South African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa.; Maphisa, DH (corresponding author), Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Rondebosch, South Africa.; Maphisa, DH (corresponding author), Univ Cape Town, Anim Demog Unit, Dept Biol Sci, ZA-7701 Rondebosch, South Africa.	Maphisad@gmail.com		Underhill, Les/0000-0002-8758-1527	Eskom through The Ingula Partnership; Mazda Wildlife Fund; South African National Biodiversity Institute; National Research Foundation of South Africa [85802]	Eskom through The Ingula Partnership; Mazda Wildlife Fund; South African National Biodiversity Institute; National Research Foundation of South Africa(National Research Foundation - South Africa)	The first author was supported in the position of BirdLife South Africa Ingula Project Manager with funding by Eskom through The Ingula Partnership. The Mazda Wildlife Fund supported the first author with a vehicle for the duration of the project, while employed by BirdLife South Africa. South African National Biodiversity Institute provided funding during the data analysis and writing up of this paper. RA was supported by the National Research Foundation of South Africa (Grant 85802). The NRF accepts no liability for opinions, findings and conclusions or recommendations expressed in this publication. I confirm that the funders (Ingula Partnership/Mazda Wildlife) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DG, 1997, BIOL CONSERV, V79, P173, DOI 10.1016/S0006-3207(96)00098-5; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Barnes K. N., 1998, IMPORTANT BIRD AREAS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; BERRUTI A, 1994, OSTRICH, V65, P54, DOI 10.1080/00306525.1994.9639666; Blank PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109989; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cao J, 2009, BIOMETRICS, V65, P1052, DOI 10.1111/j.1541-0420.2009.01204.x; Carrascal L, 2009, ANIMAL BIODIVERSITY, V2, P45; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Coppedge BR, 2008, BIOL CONSERV, V141, P1196, DOI 10.1016/j.biocon.2008.02.015; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; DAVIES B. R., 1998, VANISHING WATERS; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Fairbanks DHK, 2000, S AFR J SCI, V96, P69; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Frankow-Lindberg BE, 2009, ANN BOT-LONDON, V103, P913, DOI 10.1093/aob/mcp008; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griebel Randall L., 1998, Great Plains Research, V8, P255; Hardman CJ, 2016, J APPL ECOL, V53, P171, DOI 10.1111/1365-2664.12557; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hofmeyr SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096772; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00340.1; Howland B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105966; Jansen R, 1999, BIODIVERS CONSERV, V8, P587, DOI 10.1023/A:1008817415103; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; Johnson RR, 2010, J FISH WILDL MANAG, V1, P38, DOI 10.3996/JFWM-022; Kery M, 2006, J APPL ECOL, V43, P101, DOI 10.1111/j.1365-2664.2005.01111.x; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Klug PE, 2010, OECOLOGIA, V162, P803, DOI 10.1007/s00442-009-1549-9; Kruger SC, 2014, BIRD CONSERV INT, V24, P162, DOI 10.1017/S0959270913000440; Little IT, 2013, BIOL CONSERV, V158, P258, DOI 10.1016/j.biocon.2012.09.017; Maphisa DH, 2009, OSTRICH, V80, P19, DOI 10.2989/OSTRICH.2009.80.1.3.761; Maphisa DH, 2015, THESIS; Maphisa DH, 1997, VULTURES 21 CENTURY, P90; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; McGrann MC, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00695-090208; Mentis MT., 2006, BRAAMHOEK PUMPED STO; Muchai M, 2005, J AVIAN BIOL, V36, P110, DOI 10.1111/j.0908-8857.2005.03312.x; Mucina L., 2006, VEGETATION S AFRICA; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nichols JD, 1998, ECOL APPL, V8, P1213, DOI 10.2307/2640974; O'Connor TG, 2009, J ENVIRON MANAGE, V90, P384, DOI 10.1016/j.jenvman.2007.10.012; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; Pearce-Higgins JW, 2009, J APPL ECOL, V46, P1323, DOI 10.1111/j.1365-2664.2009.01715.x; Pillsbury FC, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00154.1; Prince K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117850; R Development Core Team, R LANG ENV STAT COMP; Renner SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112347; Reyers B., 2001, Diversity and Distributions, V7, P79, DOI 10.1046/j.1472-4642.2001.00098.x; Reynolds C, 2013, AFR ZOOL, V48, P228, DOI 10.3377/004.048.0217; Simmons RE, 2005, GABAR, V16, P25; Spurr E.B., 2012, NZ J ECOLOGY, V36, P1; Svensson M, 2013, PLOS ONE, V8, P1; Taylor M. R., 2015, RED DATA BOOK TAJIKI; Thiele J., 2012, CAB Reviews, V7, P1, DOI [10.1079/PAVSNNR20127017, 10.1079/PAVSNNR20127020, 10.1079/PAVSNNR20127016, 10.1079/PAVSNNR20127018, 10.1079/PAVSNNR20127019]; Trollope WSW, 2011, FIRE ECOL, V7, P57, DOI 10.4996/fireecology.0701057; Valko O, 2014, AGR ECOSYST ENVIRON, V182, P80, DOI 10.1016/j.agee.2013.06.012; Valko O, 2014, BASIC APPL ECOL, V15, P26, DOI 10.1016/j.baae.2013.11.002; White CS, 2010, J RANGE MANAGE, V53, P52; Whittingham MJ, 2008, BASIC APPL ECOL, V9, P779, DOI 10.1016/j.baae.2007.08.002	68	7	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162609	10.1371/journal.pone.0162609	http://dx.doi.org/10.1371/journal.pone.0162609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706186	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200015
J	Umu, OCO; Bauerl, C; Oostindjer, M; Pope, PB; Hernandez, PE; Perez-Martinez, G; Diep, DB				Umu, Ozgun C. O.; Bauerl, Christine; Oostindjer, Marije; Pope, Phillip B.; Hernandez, Pablo E.; Perez-Martinez, Gaspar; Diep, Dzung B.			The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOCOCCUS-GARVIEAE DCC43; ENTEROCOCCUS-FAECIUM L50; CLOSTRIDIUM-DIFFICILE; DIET; DIVERSITY; SEQUENCES; OBESITY; STRAIN; MECHANISMS	Production of bacteriocins is a potential probiotic feature of many lactic acid bacteria (LAB) as it can help prevent the growth of pathogens in gut environments. However, knowledge on bacteriocin producers in situ and their function in the gut of healthy animals is still limited. In this study, we investigated five bacteriocin-producing strains of LAB and their isogenic non-producing mutants for probiotic values. The LAB bacteriocins, sakacin A (SakA), pediocin PA-1 (PedPA-1), enterocins P, Q and L50 (enterocins), plantaricins EF and JK (plantaricins) and garvicin ML (GarML), are all class II bacteriocins, but they differ greatly from each other in terms of inhibition spectrum and physicochemical properties. The strains were supplemented to mice through drinking water and changes on the gut microbiota composition were interpreted using 16S rRNA gene analysis. In general, we observed that overall structure of the gut microbiota remained largely unaffected by the treatments. However, at lower taxonomic levels, some transient but advantageous changes were observed. Some potentially problematic bacteria were inhibited (e.g., Staphylococcus by enterocins, Enterococcaceae by GarML, and Clostridium by plantaricins) and the proportion of LAB was increased in the presence of SakA-, plantaricins- and GarML-producing bacteria. Moreover, the treatment with GarML-producing bacteria co-occurred with decreased triglyceride levels in the host mice. Taken together, our results indicate that several of these bacteriocin producers have potential probiotic properties at diverse levels as they promote favorable changes in the host without major disturbance in gut microbiota, which is important for normal gut functioning.	[Umu, Ozgun C. O.; Oostindjer, Marije; Pope, Phillip B.; Diep, Dzung B.] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway; [Bauerl, Christine; Perez-Martinez, Gaspar] CSIC, IATA, Dept Biotecnol, Valencia, Spain; [Hernandez, Pablo E.] Univ Complutense Madrid, Fac Vet, Dept Nutr Bromatol & Tecnol Alimentos, Madrid, Spain	Norwegian University of Life Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Complutense University of Madrid	Diep, DB (corresponding author), Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway.	dzung.diep@nmbu.no	Martinez, Gaspar Perez/H-4167-2012; Pope, Phillip/AAQ-2251-2021; Diệp, Dzũng/ABG-9262-2020; Bäuerl, Christine/A-4334-2017; Hernandez, Pablo E./P-8701-2014; Diep, Dzung B./AAK-1419-2021	Martinez, Gaspar Perez/0000-0003-3501-1626; Pope, Phillip/0000-0002-2067-4059; Bäuerl, Christine/0000-0002-5226-9920; Hernandez, Pablo E./0000-0001-6259-8456; Diep, Dzung/0000-0001-7661-5501; Onarman Umu, Ozgun Candan/0000-0003-4060-7766	Norwegian University of Life Sciences (NMBU) [1205051025]; Spanish Ministerio de Economia y Competitividad [AGL2013-47420-R]; European Research Council [336355-MicroDE]; EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project [017-CM-01-2013]	Norwegian University of Life Sciences (NMBU); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project	OCOU was supported by a strategic scholarship program to food science research, from Norwegian University of Life Sciences (NMBU) (project 1205051025). CB and part of this work was supported by a contract financed by the Spanish Ministerio de Economia y Competitividad (AGL2013-47420-R). PBP is supported by a grant from the European Research Council (336355-MicroDE). Travels and stays in Spain and Norway for this study were supported by EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project 017-CM-01-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bhardwaj A, 2010, INT J FOOD MICROBIOL, V141, P156, DOI 10.1016/j.ijfoodmicro.2010.05.001; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Borrero J, 2011, APPL ENVIRON MICROB, V77, P369, DOI 10.1128/AEM.01173-10; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Chang YH, 2001, ANTON LEEUW INT J G, V80, P193, DOI 10.1023/A:1012213728917; Cintas LM, 1998, J BACTERIOL, V180, P1988, DOI 10.1128/JB.180.8.1988-1994.1998; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Criado R, 2006, APPL ENVIRON MICROB, V72, P6653, DOI 10.1128/AEM.00859-06; Dabour N, 2009, INT J FOOD MICROBIOL, V133, P225, DOI 10.1016/j.ijfoodmicro.2009.05.005; DAESCHEL M A, 1990, Food Microbiology (London), V7, P91, DOI 10.1016/0740-0020(90)90014-9; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Diep DB, 2000, MICROBIOL-SGM, V146, P2155, DOI 10.1099/00221287-146-9-2155; Diep DB, 2009, PEPTIDES, V30, P1562, DOI 10.1016/j.peptides.2009.05.014; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eijsink VGH, 2002, ANTON LEEUW INT J G, V81, P639, DOI 10.1023/A:1020582211262; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gabrielsen C, 2014, J BACTERIOL, V196, P911, DOI 10.1128/JB.01115-13; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; HOLZAPFEL WH, 1995, INT J FOOD MICROBIOL, V24, P343, DOI 10.1016/0168-1605(94)00036-6; Illumina, 16S MET SEQ LIB PREP, P1; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jeffery IB, 2013, NUTRIENTS, V5, P234, DOI 10.3390/nu5010234; Kjos M, 2011, MICROBIOL-SGM, V157, P3256, DOI 10.1099/mic.0.052571-0; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Kwok LY, 2015, BENEF MICROBES, V6, P405, DOI 10.3920/BM2014.0063; La Rosa SL, 2013, APPL ENVIRON MICROB, V79, P3986, DOI 10.1128/AEM.00831-13; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luoto R, 2013, ANN NUTR METAB, V63, P17, DOI 10.1159/000354896; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Malys MK, 2015, MEDICINA-LITHUANIA, V51, P69, DOI 10.1016/j.medici.2015.03.001; MARUGG JD, 1992, APPL ENVIRON MICROB, V58, P2360, DOI 10.1128/AEM.58.8.2360-2367.1992; Millette M, 2008, APPL ENVIRON MICROB, V74, P1997, DOI 10.1128/AEM.02150-07; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Mota-Meira M, 2005, J ANTIMICROB CHEMOTH, V56, P869, DOI 10.1093/jac/dki295; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rea MC, 2013, J MED MICROBIOL, V62, P1369, DOI 10.1099/jmm.0.058933-0; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Umu OCO, 2013, ANTON LEEUW INT J G, V104, P609, DOI 10.1007/s10482-013-0008-0; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	72	68	71	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164036	10.1371/journal.pone.0164036	http://dx.doi.org/10.1371/journal.pone.0164036			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695121	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000385553100078
J	Clark, JL; Perez-Brumer, AG; Segura, ER; Salvatierra, HJ; Sanchez, J; Lama, JR				Clark, Jesse L.; Perez-Brumer, Amaya G.; Segura, Eddy R.; Salvatierra, Hector J.; Sanchez, Jorge; Lama, Javier R.			Anticipated Notification of Sexual Partners following STD Diagnosis among Men Who Have Sex with Men and Transgender Women in Lima, Peru: A Mixed Methods Analysis	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; PREGNANT-WOMEN; HIV; SYPHILIS; MSM; EXPERIENCES; DISEASES; BOLIVIA; TRANSMISSION; ORIENTATION	Background New strategies to support partner notification (PN) are critical for STD control and require detailed understanding of how specific individual and partnership characteristics guide notification decisions. Methods From 2011 to 2012, 397 MSM and TW recently diagnosed with HIV, syphilis, or another STD completed a survey on anticipated notification of recent sexual partners and associated factors. Qualitative interviews were conducted with a subset of participants to provide further depth to quantitative findings. Prevalence ratios and generalized estimating equation (GEE) models were used to analyze participant-and partner-level factors associated with anticipated PN. Results Among all partners reported, 52.5% were described as "Very Likely" or "Somewhat Likely" to be notified. Anticipated notification was more likely for main partners than casual (adjusted Prevalence Ratio [aPR], 95% CI: 0.63, 0.54-0.75) or commercial (aPR, 95% CI: 0.44, 0.31-0.62) partners. Other factors associated with likely notification included perception of the partner as an STD source (aPR, 95% CI: 1.27, 1.10-1.48) and anticipated future sexual contact with the partner (aPR, 95% CI: 1.30, 1.11-1.52). An HIV diagnosis was associated with a lower likelihood of notification than non-HIV STDs (aPR: 0.68, 0.55-0.86). Qualitative discussion of the barriers and incentives to PN reflected a similar differentiation of anticipated notification according to partnership type and type of HIV/STD diagnosis. Discussion Detailed attention to how partnership characteristics guide notification outcomes is essential to the development of new PN strategies. By accurately and thoroughly assessing the diversity of partnership interactions among individuals with HIV/STD, new notification techniques can be tailored to partner-specific circumstances.	[Clark, Jesse L.; Segura, Eddy R.] UCLA Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Perez-Brumer, Amaya G.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Salvatierra, Hector J.; Sanchez, Jorge; Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University	Clark, JL (corresponding author), UCLA Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	jlclark@mednet.ucla.edu	Perez-Brumer, Amaya/AAF-6336-2021	Clark, Jesse/0000-0001-5862-6530; Segura, Eddy R/0000-0003-3580-7712; Perez-Brumer, Amaya/0000-0003-2441-4358	National Institutes of Health [T32 HD049339, K23 MH084611]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH084611, R21MH092232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding support was provided by the National Institutes of Health (T32 HD049339 to APB and K23 MH084611 to JLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2011, AIDS BEHAV, V15, P1359, DOI 10.1007/s10461-010-9811-z; Alam N, 2010, SOC SCI MED, V71, P1921, DOI 10.1016/j.socscimed.2010.09.009; Alam N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-19; Althaus CL, 2014, HEALTH TECHNOL ASSES, V18, pXIX, DOI 10.3310/hta18020; Apoola A, 2007, INT J STD AIDS, V18, P493, DOI 10.1258/095646207781147238; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bilardi JE, 2010, SEX TRANSM DIS, V37, P563, DOI 10.1097/OLQ.0b013e3181d707f1; Bilardi JE, 2010, SEX TRANSM DIS, V37, P253, DOI 10.1097/OLQ.0b013e3181d012e0; Blair CS, 2016, AIDS BEHAV, V20, P2178, DOI 10.1007/s10461-015-1276-7; Cambou MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102894; Clark JL, 2007, SEX TRANSM DIS, V34, P309, DOI 10.1097/01.olq.0000240289.84094.93; Clark JL, 2015, AIDS BEHAV, V19, P2245, DOI 10.1007/s10461-015-1049-3; Coleman C, 2007, J ADV NURS, V58, P35, DOI 10.1111/j.1365-2648.2007.04193.x; Olavarrieta CD, 2011, SEX TRANSM INFECT, V87, P415, DOI 10.1136/sti.2010.047985; Diaz-Olavarrieta C, 2007, SEX TRANSM DIS, V34, pS42, DOI [10.1097/olq.0000261725.79965.af, 10.1097/01.olq.0000261725.79965.af]; Faxelid EA, 1997, SOC SCI MED, V44, P1239, DOI 10.1016/S0277-9536(96)00312-7; Fortenberry JD, 2002, ARCH PEDIAT ADOL MED, V156, P1133, DOI 10.1001/archpedi.156.11.1133; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Garcia PJ, 2015, SEX TRANSM DIS, V42, P457, DOI 10.1097/OLQ.0000000000000314; Golden MR, 2005, INFECT DIS CLIN N AM, V19, P513, DOI 10.1016/j.idc.2005.03.004; Golden MR, 2002, SEX TRANSM DIS, V29, P472, DOI 10.1097/00007435-200208000-00007; Gorbach PM, 2004, SEX TRANSM INFECT, V80, P512, DOI 10.1136/sti.2004.010918; Gorbach PM, 2003, J URBAN HEALTH, V80, P15; Gorbach PM, 2000, SEX TRANSM DIS, V27, P193, DOI 10.1097/00007435-200004000-00003; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harrison A, 1997, Health Transit Rev, V7 Suppl 3, P103; Hawkes S, 2003, BRIT MED J, V327, P633, DOI 10.1136/bmj.327.7416.633; Hogben M, 2007, CLIN INFECT DIS, V44, pS160, DOI 10.1086/511429; Jones Heidi E, 2006, Gac Med Mex, V142 Suppl 2, P69; Klisch SA, 2007, SOC SCI MED, V65, P1124, DOI 10.1016/j.socscimed.2007.04.025; Lawrence JSS, 2004, SOC SCI MED, V59, P1011, DOI [10.1016/j.socscimed.2003.12.018, 10.1016/j.socicmed.2003.12.018]; Lichtenstein B, 2005, MED ANTHROPOL Q, V19, P383, DOI 10.1525/maq.2005.19.4.383; Lohan M, 2009, CRIT PUBLIC HEALTH, V19, P325, DOI DOI 10.1080/; Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8; Mathews C, 2007, BMJ-BRIT MED J, V334, P323, DOI 10.1136/bmj.39114.635405.80; Menza TW, 2008, SEX TRANSM DIS, V35, P84, DOI 10.1097/OLQ.0b013e31814fb125; Mimiaga MJ, 2008, SEX TRANSM DIS, V35, P111, DOI 10.1097/OLQ.0b013e3181573d84; Mimiaga MJ, 2009, AIDS BEHAV, V13, P738, DOI 10.1007/s10461-008-9424-y; Mimiaga MJ, 2009, PUBLIC HEALTH REP, V124, P111, DOI 10.1177/003335490912400114; Nuwaha F, 2001, SOC SCI MED, V53, P1287, DOI 10.1016/S0277-9536(00)00410-X; Perez-Brumer AG, 2016, SEX TRANSM INFECT, V92, P554, DOI 10.1136/sextrans-2015-052310; Pines HA, 2015, SEX TRANSM INFECT, V91, P207, DOI 10.1136/sextrans-2014-051663; Rosenfeld EA, 2016, INT J STD AIDS, V27, P656, DOI 10.1177/0956462415591938; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; Valles X, 2011, GAC SANIT, V25, P224, DOI 10.1016/j.gaceta.2010.12.003; van Aar F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-114; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68	48	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163905	10.1371/journal.pone.0163905	http://dx.doi.org/10.1371/journal.pone.0163905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CV	27685158	Green Published, Green Submitted, gold			2022-12-26	WOS:000384328500137
J	Lajoie, I; Tancredi, FB; Hoge, RD				Lajoie, Isabelle; Tancredi, Felipe B.; Hoge, Richard D.			Regional Reproducibility of BOLD Calibration Parameter M, OEF and Resting-State CMRO2 Measurements with QUO2 MRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SPIN-LABELING MRI; POSITRON-EMISSION-TOMOGRAPHY; OXYGEN EXTRACTION FRACTION; LEVEL-DEPENDENT RESPONSES; TEST-RETEST RELIABILITY; QUANTITATIVE MEASUREMENT; ALZHEIMERS-DISEASE; METABOLIC-RATE; NORMAL VALUES	The current generation of calibrated MRI methods goes beyond simple localization of task-related responses to allow the mapping of resting-state cerebral metabolic rate of oxygen (CMRO2) in micromolar units and estimation of oxygen extraction fraction (OEF). Prior to the adoption of such techniques in neuroscience research applications, knowledge about the precision and accuracy of absolute estimates of CMRO2 and OEF is crucial and remains unexplored to this day. In this study, we addressed the question of methodological precision by assessing the regional inter-subject variance and intra-subject reproducibility of the BOLD calibration parameter M, OEF, O-2 delivery and absolute CMRO2 estimates derived from a state-of-the-art calibrated BOLD technique, the QUantitative O-2 (QUO2) approach. We acquired simultaneous measurements of CBF and R2* at rest and during periods of hypercapnia (HC) and hyperoxia (HO) on two separate scan sessions within 24 hours using a clinical 3 T MRI scanner. Maps of M, OEF, oxygen delivery and CMRO2, were estimated from the measured end-tidal O-2, CBF0, CBFHC/HO and R2(HC/HO)*. Variability was assessed by computing the between-subject coefficients of variation (bwCV) and within-subject CV (wsCV) in seven ROIs. All tests GM-averaged values of CBF0, M, OEF, O-2 delivery and CMRO2 were: 49.5 +/- 6.4 mL/100 g/min, 4.69 +/- 0.91%, 0.37 +/- 0.06, 377 +/- 51 mu mol/100 g/min and 143 +/- 34 mu mol/100 g/min respectively. The variability of parameter estimates was found to be the lowest when averaged throughout all GM, with general trends toward higher CVs when averaged over smaller regions. Among the MRI measurements, the most reproducible across scans was R2(0)* (wsCV(GM) = 0.33%) along with CBF0 (wsCV(GM) = 3.88%) and R2(HC)* (wsCV(GM) = 6.7%). CBFHC and R2(HO)* were found to have a higher intra-subject variability (wsCV(GM) = 22.4% and wsCV(GM) = 16% respectively), which is likely due to propagation of random measurement errors, especially for CBFHC due to the low contrast-to-noise ratio intrinsic to ASL. Reproducibility of the QUO2 derived estimates were computed, yielding a GM intra-subject reproducibility of 3.87% for O-2 delivery, 16.8% for the M value, 13.6% for OEF and 15.2% for CMRO2. Although these results focus on the precision of the QUO2 method, rather than the accuracy, the information will be useful for calculation of statistical power in future validation studies and ultimately for research applications of the method. The higher test-retest variability for the more extensively modeled parameters (M, OEF, and CMRO2) highlights the need for further improvement of acquisition methods to reduce noise levels.	[Lajoie, Isabelle] Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada; [Lajoie, Isabelle; Hoge, Richard D.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Tancredi, Felipe B.] Hosp Israelita Albert Einstein, Ctr Pesquisa Imagem, Dept Radiol, Sao Paulo, SP, Brazil	Universite de Montreal; McGill University; Hospital Israelita Albert Einstein	Lajoie, I (corresponding author), Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada.; Lajoie, I (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	isabelle.lajoie@mail.mcgill.ca			Canadian Institutes of Health Research [MOP 123492]; Canada Foundation for Innovation [17380]; Natural Sciences and Engineering Research Council of Canada [R0018142]; Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM)	This study was supported by the Canadian Institutes of Health Research MOP 123492 to RDH, Canada Foundation for Innovation 17380 to RDH, Natural Sciences and Engineering Research Council of Canada R0018142 to RDH, Fonds Quebecois de la Recherche sur la Nature et les Technologies (CA) Mrs. Isabelle Lajoie Le Consortium quebecois sur la decouverte du medicament (CQDM) to RDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.0.CO;2-8; Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Asllani I, 2008, J CEREBR BLOOD F MET, V28, P725, DOI 10.1038/sj.jcbfm.9600570; Asllani I, 2008, MAGN RESON MED, V60, P1362, DOI 10.1002/mrm.21670; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bolar DS, 2011, MAGN RESON MED, V66, P1550, DOI 10.1002/mrm.22946; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Bremmer JP, 2011, MOL IMAGING BIOL, V13, P759, DOI 10.1007/s11307-010-0382-1; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte DP, 2009, MAGN RESON MED, V61, P391, DOI 10.1002/mrm.21862; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen JJ, 2010, NEUROIMAGE, V53, P383, DOI 10.1016/j.neuroimage.2010.07.003; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Donahue MJ, 2014, J CEREBR BLOOD F MET, V34, P1243, DOI 10.1038/jcbfm.2014.81; Du AT, 2006, NEUROLOGY, V67, P1215, DOI 10.1212/01.wnl.0000238163.71349.78; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Gallichan D, 2009, MAGN RESON MED, V61, P686, DOI 10.1002/mrm.21886; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Gauthier CJ, 2011, NEUROIMAGE, V54, P1001, DOI 10.1016/j.neuroimage.2010.09.059; Gauthier CJ, 2013, HUM BRAIN MAPP, V34, P1053, DOI 10.1002/hbm.21495; Ghariq E, 2014, NEUROIMAGE, V103, P316, DOI 10.1016/j.neuroimage.2014.09.051; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Gustard S, 2003, MAGN RESON IMAGING, V21, P599, DOI 10.1016/S0730-725X(03)00083-3; Hino JK, 2000, CRIT CARE MED, V28, P3505, DOI 10.1097/00003246-200010000-00026; HORVATH I, 1994, J CEREBR BLOOD F MET, V14, P503, DOI 10.1038/jcbfm.1994.62; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Jahanian H, 2011, NMR BIOMED, V24, P1202, DOI 10.1002/nbm.1675; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jain V, 2010, J CEREBR BLOOD F MET, V30, P1598, DOI 10.1038/jcbfm.2010.49; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson NA, 2005, RADIOLOGY, V234, P851, DOI 10.1148/radiol.2343040197; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Krieger SN, 2014, NEUROIMAGE, V101, P8, DOI 10.1016/j.neuroimage.2014.06.072; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Lin AL, 2008, MAGN RESON MED, V60, P380, DOI 10.1002/mrm.21655; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; MCPHERSON RW, 1991, J NEUROSURG ANESTH, V3, P12, DOI 10.1097/00008506-199103000-00003; Merola A, 2016, NEUROIMAGE, V129, P159, DOI 10.1016/j.neuroimage.2016.01.021; Padhani AR, 2002, NMR BIOMED, V15, P143, DOI 10.1002/nbm.732; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Pilkinton DT, 2012, MAGN RESON MED, V67, P1556, DOI 10.1002/mrm.23137; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; SEVERINGHAUS JW, 1989, ANESTHESIOLOGY, V70, P996, DOI 10.1097/00000542-198906000-00019; Sherif T, 2014, FRONT NEUROINFORM, V8, DOI [10.3389/fninf.2014.00054, 10.3389/fninf.2014.00089]; Siero JCW, 2015, NMR BIOMED, V28, P1518, DOI 10.1002/nbm.3411; Tancredi FB, 2013, J CEREB BLOOD FLOW M, P1; Tancredi FB, 2015, J MAGN RESON IMAGING, V42, P1144, DOI 10.1002/jmri.24878; Tancredi Felipe B, 2014, BMC Res Notes, V7, P235, DOI 10.1186/1756-0500-7-235; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Tohgi H, 1998, NEURORADIOLOGY, V40, P131, DOI 10.1007/s002340050553; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Wu WC, 2009, IEEE T MED IMAGING, V28, P703, DOI 10.1109/TMI.2008.2012020; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zaharchuk G, 2008, AM J NEURORADIOL, V29, P663, DOI 10.3174/ajnr.A0896; Zappe AC, 2008, MAGN RESON IMAGING, V26, P961, DOI 10.1016/j.mri.2008.02.005; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310	87	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163071	10.1371/journal.pone.0163071	http://dx.doi.org/10.1371/journal.pone.0163071			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649493	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100049
J	Liu, H; Qiu, H; Song, Y; Liu, Y; Wang, H; Lu, M; Deng, M; Gu, Y; Yin, J; Luo, K; Zhang, Z; Jia, X; Zheng, G; He, Z				Liu, H.; Qiu, H.; Song, Y.; Liu, Y.; Wang, H.; Lu, M.; Deng, M.; Gu, Y.; Yin, J.; Luo, K.; Zhang, Z.; Jia, X.; Zheng, G.; He, Z.			Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; EPITHELIAL-MESENCHYMAL TRANSITION; KINASE INHIBITOR P27; C-MYC; CLINICAL-IMPLICATIONS; PHOSPHORYLATES P27; CYTOPLASMIC P27; PARP INHIBITION; POOR-PROGNOSIS; LUNG-CANCER	Triple-negative breast cancer (TNBC) is very aggressive and currently has no specific therapeutic targets; as a consequence, TNBC exhibits poor clinical outcome. In this study, we showed that cancerous inhibitor of protein phosphatase 2A (Cip2a) represents a promising target in TNBC because Cip2a was highly expressed in TNBC cells and tumor tissues, and its expression showed an inverse correlation with overall survival in patients with TNBC. We found that inhibition of Cip2a in TNBC cells induced cell cycle arrest at the G2/M phase, inhibited cell proliferation and delayed tumor growth in the xenograft model. Moreover, Cip2a markedly decreased the expression and nuclear localization of p27Kip1 and this is critical for the ability of Cip2a to promote TNBC progression. Mechanistically, our studies showed that Cip2a promoted p27Kip1 phosphoration at Ser10 via inhibiting Akt-associated PP2A activity, which seems to relocalize p27Kip1 to the cytoplasm in TNBC cells. On the other hand, Cip2a also recruited c-myc to mediate the transcriptional inhibition of p27Kip1. Notably, we observed negative correlation between Cip2a and p27Kip1 expression in TNBC specimens. In addition, our data showed that Cip2a depletion could sensitize TNBC to PARP inhibition. Collectively, these data suggested that Cip2a effectively promotes TNBC cell cycle progression and tumor growth via regulation of PP2A/c-myc/p27Kip1 signaling, which could serve as a potential therapeutic target for TNBC patients.	[Liu, H.; Qiu, H.; Song, Y.; Lu, M.; Deng, M.; Gu, Y.; Yin, J.; Luo, K.; Zhang, Z.; Jia, X.; Zheng, G.; He, Z.] Guangzhou Med Univ, Canc Hosp, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China; [Liu, H.; Qiu, H.; Song, Y.; Lu, M.; Deng, M.; Gu, Y.; Yin, J.; Luo, K.; Zhang, Z.; Jia, X.; Zheng, G.; He, Z.] Guangzhou Med Univ, Canc Res Inst, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China; [Liu, Y.] Guangdong Inst Microbiol, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Guangdong, Peoples R China; [Wang, H.] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; Sun Yat Sen University	He, Z (corresponding author), Guangzhou Med Univ, Canc Hosp, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China.; He, Z (corresponding author), Guangzhou Med Univ, Canc Res Inst, 78 Hengzhigang Rd, Guangzhou 510095, Guangdong, Peoples R China.	hezhimin2005@yahoo.com		Liu, Hao/0000-0001-6338-4003	National Natural Science Foundation of China [81472184, 81402497]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 81472184, No. 81402497).	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Baldacchino S, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-3; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chibazakura T, 2004, P NATL ACAD SCI USA, V101, P4465, DOI 10.1073/pnas.0400655101; Choi YA, 2011, FEBS LETT, V585, P755, DOI 10.1016/j.febslet.2011.01.018; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; De P, 2015, AM J CANCER RES, V5, P2872; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hnit SST, 2015, INT J BIOCHEM CELL B, V68, P9, DOI 10.1016/j.biocel.2015.08.005; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Iwase H, 2010, BREAST CANCER-TOKYO, V17, P118, DOI 10.1007/s12282-009-0113-0; Janghorban M, 2014, P NATL ACAD SCI USA, V111, P9157, DOI 10.1073/pnas.1317630111; Johnson N, 2011, NAT MED, V17, P875, DOI 10.1038/nm.2377; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2015, ONCOTARGET, V6, P19661, DOI 10.18632/oncotarget.3875; Khanna A, 2013, CANCER RES, V73, P6548, DOI 10.1158/0008-5472.CAN-13-1994; Kim JS, 2013, CANCER RES, V73, P6667, DOI 10.1158/0008-5472.CAN-13-0888; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu H, 2015, ONCOTARGET, V6, P14913, DOI 10.18632/oncotarget.3818; Lucas CM, 2011, BLOOD, V117, P6660, DOI 10.1182/blood-2010-08-304477; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pagano M, 2004, MOL CELL, V14, P414, DOI 10.1016/S1097-2765(04)00268-0; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Puustinen P, 2014, J CELL BIOL, V204, P713, DOI 10.1083/jcb.201304012; Qu W, 2012, MED ONCOL, V29, P113, DOI 10.1007/s12032-010-9768-9; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tseng LM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3175; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wu Y, 2015, CANCER LETT, V356, P646, DOI 10.1016/j.canlet.2014.10.013; Yanagi T, 2014, CANCER RES, V74, P5795, DOI 10.1158/0008-5472.CAN-14-0872; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yu GZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0524-9; Zhao D, 2015, ONCOGENE, V34, P5447, DOI 10.1038/onc.2014.473	58	14	15	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1952	1964		10.1038/onc.2016.355	http://dx.doi.org/10.1038/onc.2016.355			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27694903				2022-12-26	WOS:000398898500006
J	McNair, C; Urbanucci, A; Comstock, CES; Augello, MA; Goodwin, JF; Launchbury, R; Zhao, SG; Schiewer, MJ; Ertel, A; Karnes, J; Davicioni, E; Wang, L; Wang, Q; Mills, IG; Feng, FY; Li, W; Carroll, JS; Knudsen, KE				McNair, C.; Urbanucci, A.; Comstock, C. E. S.; Augello, M. A.; Goodwin, J. F.; Launchbury, R.; Zhao, S. G.; Schiewer, M. J.; Ertel, A.; Karnes, J.; Davicioni, E.; Wang, L.; Wang, Q.; Mills, I. G.; Feng, F. Y.; Li, W.; Carroll, J. S.; Knudsen, K. E.			Cell cycle-coupled expansion of AR activity promotes cancer progression	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; RESISTANT PROSTATE-CANCER; ANDROGEN RECEPTOR; TRANSCRIPTIONAL REGULATION; CERAMIDE 1-PHOSPHATE; SIGNALING PATHWAYS; DNA-REPAIR; IN-VITRO; C-JUN; GROWTH	The androgen receptor (AR) is required for prostate cancer (PCa) survival and progression, and ablation of AR activity is the first line of therapeutic intervention for disseminated disease. While initially effective, recurrent tumors ultimately arise for which there is no durable cure. Despite the dependence of PCa on AR activity throughout the course of disease, delineation of the AR-dependent transcriptional network that governs disease progression remains elusive, and the function of AR in mitotically active cells is not well understood. Analyzing AR activity as a function of cell cycle revealed an unexpected and highly expanded repertoire of AR-regulated gene networks in actively cycling cells. New AR functions segregated into two major clusters: those that are specific to cycling cells and retained throughout the mitotic cell cycle ('Cell Cycle Common'), versus those that were specifically enriched in a subset of cell cycle phases ('Phase Restricted'). Further analyses identified previously unrecognized AR functions in major pathways associated with clinical PCa progression. Illustrating the impact of these unmasked AR-driven pathways, dihydroceramide desaturase 1 was identified as an AR-regulated gene in mitotically active cells that promoted pro-metastatic phenotypes, and in advanced PCa proved to be highly associated with development of metastases, recurrence after therapeutic intervention and reduced overall survival. Taken together, these findings delineate AR function in mitotically active tumor cells, thus providing critical insight into the molecular basis by which AR promotes development of lethal PCa and nominate new avenues for therapeutic intervention.	[McNair, C.; Comstock, C. E. S.; Augello, M. A.; Goodwin, J. F.; Schiewer, M. J.; Ertel, A.; Knudsen, K. E.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, BLSB Room 1008,233 South 10th St, Philadelphia, PA 19107 USA; [Urbanucci, A.; Mills, I. G.] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway NCMM, Prostate Canc Res Grp, Oslo, Norway; [Urbanucci, A.; Mills, I. G.] Oslo Univ Hosp, Oslo, Norway; [Urbanucci, A.; Mills, I. G.] Oslo Univ Hosp, Inst Canc Res, Dept Mol Oncol, Oslo, Norway; [Launchbury, R.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge Res Inst, Cambridge, England; [Zhao, S. G.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Karnes, J.; Wang, L.] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Davicioni, E.] GenomeDx Biosci, San Diego, CA USA; [Wang, Q.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Mills, I. G.] Queens Univ, Ctr Canc Res & Cell Biol, Prostate Canc UK Movember Ctr Excellence Prostat, Belfast, Antrim, North Ireland; [Feng, F. Y.] Univ Calif San Francisco, Dept Radiat Oncol Urol & Med, San Francisco, CA 94143 USA; [Feng, F. Y.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Li, W.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Li, W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Jefferson University; University of Oslo; University of Oslo; University of Oslo; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Michigan System; University of Michigan; Mayo Clinic; GenomeDx Biosciences; University System of Ohio; Ohio State University; Queens University Belfast; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Knudsen, KE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, BLSB Room 1008,233 South 10th St, Philadelphia, PA 19107 USA.; Knudsen, KE (corresponding author), Thomas Jefferson Univ, Dept Urol, BLSB Room 1008,233 South 10th St, Philadelphia, PA 19107 USA.; Knudsen, KE (corresponding author), Thomas Jefferson Univ, Dept Radiat Oncol, BLSB Room 1008,233 South 10th St, Philadelphia, PA 19107 USA.	karen.knudsen@jefferson.edu	Mills, Ian/AAK-9292-2020; zhao, shuangling/HCI-6255-2022; Urbanucci, Alfonso/S-4450-2019	Mills, Ian/0000-0001-5347-5083; Urbanucci, Alfonso/0000-0003-2931-3652; Wang, Liguo/0000-0003-2072-4826; Knudsen, Karen/0000-0002-1301-890X; Schiewer, Matthew/0000-0002-2325-4228; McNair, Christopher/0000-0003-3204-8482; Carroll, Jason/0000-0003-3643-0080	PCF; NCI [CA159945, CA176401]; Pennsylvania Department of Health;  [R01HG007538];  [R01CA193466];  [P30-CA056036]; Cancer Research UK [20411] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA159945, R01CA176401, P30CA056036, R01CA193466] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER	PCF; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pennsylvania Department of Health; ; ; ; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We gratefully thank Mandeep Takhar for her assistance in providing microarray data analysis, K Knudsen lab members for their input, Bin Fang for assistance in creation of motif diagrams and E Schade for graphical support and expertise. This work was supported by grants to WL (R01HG007538 and R01CA193466), SGZ by the PCF, and to KEK by grants from the NCI (CA159945, CA176401), P30-CA056036, and in part by a grant to KEK with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions.	Augello MA, 2015, EMBO MOL MED, V7, P628, DOI 10.15252/emmm.201404242; Augello MA, 2014, CANCER METAST REV, V33, P399, DOI 10.1007/s10555-013-9471-3; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Barfeld SJ, 2015, ONCOTARGET, V6, P12587, DOI 10.18632/oncotarget.3494; Barfeld SJ, 2014, ENDOCR-RELAT CANCER, V21, pT57, DOI 10.1530/ERC-13-0515; Beekman KW, 2008, UROL ONCOL-SEMIN ORI, V26, P415, DOI 10.1016/j.urolonc.2007.11.003; Bubulya A, 1996, J BIOL CHEM, V271, P24583, DOI 10.1074/jbc.271.40.24583; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Chalfant CE, 2005, J CELL SCI, V118, P4605, DOI 10.1242/jcs.02637; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chua SS, 2004, VITAM HORM, V68, P231; Comstock CES, 2013, ONCOGENE, V32, P5481, DOI 10.1038/onc.2013.83; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fan L, 2016, ONCOGENE, V35, P2441, DOI 10.1038/onc.2015.309; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Goodwin JF, 2015, CANCER CELL, V28, P97, DOI 10.1016/j.ccell.2015.06.004; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Grabowska MM, 2014, MOL ENDOCRINOL, V28, P949, DOI 10.1210/me.2013-1213; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; He B, 2014, P NATL ACAD SCI USA, V111, P18261, DOI 10.1073/pnas.1421415111; Jian H, 2015, CELL SIGNAL, V27, P1208, DOI 10.1016/j.cellsig.2015.02.027; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Knudsen KE, 2011, EXPERT REV ENDOCRINO, V6, P483, DOI 10.1586/EEM.11.33; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Knudsen KE, 1999, CANCER RES, V59, P2297; Koryakina Y, 2015, ENDOCR-RELAT CANCER, V22, P249, DOI 10.1530/ERC-14-0549; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Mallik I, 2008, BBA-MOL CELL RES, V1783, P1737, DOI 10.1016/j.bbamcr.2008.05.006; Martinez ED, 2002, J BIOL CHEM, V277, P29719, DOI 10.1074/jbc.M112134200; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Prensner JR, 2014, LANCET ONCOL, V15, P1469, DOI 10.1016/S1470-2045(14)71113-1; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schrecengost RS, 2014, CANCER RES, V74, P272, DOI 10.1158/0008-5472.CAN-13-1954; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Venant H, 2015, MOL CANCER THER, V14, P2744, DOI 10.1158/1535-7163.MCT-15-0279; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Williams K, 2012, CANCER RES, V72, P5407, DOI 10.1158/0008-5472.CAN-12-1158; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yamamoto A, 2000, J CELL BIOL, V150, P873, DOI 10.1083/jcb.150.4.873; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Yun EJ, 2015, ONCOGENE, V34, P2741, DOI 10.1038/onc.2014.215; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhou W, 2009, MOL CARCINOGEN, V48, P886, DOI 10.1002/mc.20533	65	24	24	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1655	1668		10.1038/onc.2016.334	http://dx.doi.org/10.1038/onc.2016.334			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27669432	Green Accepted, Green Submitted			2022-12-26	WOS:000397460600005
J	Lee, JH; Hsieh, CF; Liu, HW; Chen, CY; Wu, SC; Chen, TW; Hsu, CS; Liao, YH; Yang, CY; Shyu, JF; Fischer, WB; Lin, CH				Lee, Jui-Hao; Hsieh, Chia-Fen; Liu, Hong-Wen; Chen, Chin-Yau; Wu, Shao-Chin; Chen, Tung-Wei; Hsu, Chih-Sin; Liao, Yu-Hsiu; Yang, Chih-Yung; Shyu, Jia-Fwu; Fischer, Wolfgang B.; Lin, Chi-Hung			Lipid raft-associated stomatin enhances cell fusion	FASEB JOURNAL			English	Article						exosome; membrane permeability; osteoclastogenesis	INFLUENZA HEMAGGLUTININ; ELECTRON-MICROSCOPY; MEMBRANE-PROTEIN; DC-STAMP; OSTEOCLASTOGENESIS; DOMAIN; STOMATOCYTOSIS; IDENTIFICATION; MICRODOMAINS; CYTOKINESIS	Membrane fusions that occur during vesicle transport, virus infection, and tissue development, involve receptors that mediate membrane contact and initiate fusion and effectors that execute membrane reorganization and fusion pore formation. Some of these fusogenic receptors/effectors are preferentially recruited to lipid raft membrane microdomains. Therefore, major constituents of lipid rafts, such as stomatin, may be involved in the regulation of cell-cell fusion. Stomatin produced in cells can be released to the extracellular environment, either through protein refolding to pass across lipid bilayer or through exosome trafficking. We report that cells expressing more stomatin or exposed to exogenous stomatin are more prone to undergoing cell fusion. During osteoclastogenesis, depletion of stomatin inhibited cell fusion but had little effect on tartrate-resistant acid phosphatase production. Moreover, in stomatin transgenic mice, increased cell fusion leading to enhanced bone resorption and subsequent osteoporosis were observed. With its unique molecular topology, stomatin forms molecular assembly within lipid rafts or on the appositional plasma membranes, and promotes membrane fusion by modulating fusogenic protein engagement.-Lee, J.-H., Hsieh, C.-F., Liu, H.-W., Chen, C.-Y., Wu, S.-C., Chen, T.-W., Hsu, C.-S., Liao, Y.-H., Yang, C.-Y., Shyu, J.-F., Fischer, W. B., Lin, C.-H. Lipid raft-associated stomatin enhances cell fusion.	[Lee, Jui-Hao; Lin, Chi-Hung] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan; [Lee, Jui-Hao; Lin, Chi-Hung] Acad Sinica, Taipei, Taiwan; [Lee, Jui-Hao; Hsieh, Chia-Fen; Liu, Hong-Wen; Chen, Chin-Yau; Hsu, Chih-Sin; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sec 2, Taipei 112, Taiwan; [Lee, Jui-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Liu, Hong-Wen] Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan; [Wu, Shao-Chin; Chen, Tung-Wei; Liao, Yu-Hsiu; Fischer, Wolfgang B.; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Chen, Chin-Yau] Dept Surg, Ilan, Taiwan; [Yang, Chih-Yung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Shyu, Jia-Fwu] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Defense Medical Center	Lin, CH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.	linch@ym.edu.tw			Ministry of Education, Aim for the Top University Plan [MOST 104-2319-B-010-001]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The authors thank Dr. Li-Li Li (Institute of Microbiology and Immunology, National Yang-Ming University) for her helpful proofreading of the manuscript; Dr. Chien-Yi Tung (Institute of Microbiology and Immunology, National Yang-Ming University) for the statistical analysis; Chia-Wen Wang (Institute of Biophotonics, National Yang-Ming University) for the operation of planar lipid bilayer system; the Molecular and Genetic Imaging Core from the National Research Program for Genomic Medicine (NRPGM); and the Taiwan Mouse Clinic (TMC) from the National Research Program for Biopharmaceutics (NRPB) Resource Center for technical support. This work was supported by the Ministry of Education, Aim for the Top University Plan: MOST 104-2319-B-010-001. The authors declare no conflicts of interest.	BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; Brand J, 2012, EMBO J, V31, P3635, DOI 10.1038/emboj.2012.203; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Desneves J, 1996, BIOCHEM BIOPH RES CO, V224, P108, DOI 10.1006/bbrc.1996.0992; Feuk-Lagerstedt E, 2002, J LEUKOCYTE BIOL, V72, P970; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	45	14	17	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					47	59		10.1096/fj.201600643R	http://dx.doi.org/10.1096/fj.201600643R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27663861				2022-12-26	WOS:000392177600008
J	Kurth, JM; Brito, JA; Reuter, J; Flegler, A; Koch, T; Franke, T; Klein, EM; Rowe, SF; Butt, JN; Denkmann, K; Pereira, IAC; Archer, M; Dahl, C				Kurth, Julia M.; Brito, Jose A.; Reuter, Jula; Flegler, Alexander; Koch, Tobias; Franke, Thomas; Klein, Eva-Maria; Rowe, Sam F.; Butt, Julea N.; Denkmann, Kevin; Pereira, Ines A. C.; Archer, Margarida; Dahl, Christiane			Electron Accepting Units of the Diheme Cytochrome c TsdA, a Bifunctional Thiosulfate Dehydrogenase/Tetrathionate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN HIPIP; STRUCTURE VALIDATION; MAXIMUM-LIKELIHOOD; IRON PROTEIN; OXIDATION; REDOX; BACTERIUM; COMPLEX; DEHYDROGENASE; REFINEMENT	The enzymes of the thiosulfate dehydrogenase (TsdA) family are wide-spread diheme c-type cytochromes. Here, redox carriers were studied mediating the flow of electrons arising from thiosulfate oxidation into respiratory or photosynthetic electron chains. In a number of organisms, including Thiomonas intermedia and Sideroxydans lithotrophicus, the tsdA gene is immediately preceded by tsdB encoding for another diheme cytochrome. Spectrophotometric experiments in combination with enzymatic assays in solution showed that TsdB acts as an effective electron acceptor of TsdA in vitro when TsdA and TsdB originate from the same source organism. Although TsdA covers a range from -300 to +150 mV, TsdB is redox active between -100 and +300 mV, thus enabling electron transfer between these hemoproteins. The three-dimensional structure of the TsdB-TsdA fusion protein from the purple sulfur bacterium Marichromatium purpuratum was solved by X-ray crystallography to 2.75 angstrom resolution providing insights into internal electron transfer. In the oxidized state, this tetraheme cytochrome c contains three hemes with axial His/Met ligation, whereas heme 3 exhibits the His/Cys coordination typical for TsdA active sites. Interestingly, thiosulfate is covalently bound to Cys(330) on heme 3. In several bacteria, including Allochromatium vinosum, TsdB is not present, precluding a general and essential role for electron flow. Both AvTsdA and theMpTsdBA fusion react efficiently in vitro with high potential iron-sulfur protein from A. vinosum (E-m + 350 mV). High potential ironsulfur protein not only acts as direct electron donor to the reaction center in anoxygenic phototrophs but can also be involved in aerobic respiratory chains.	[Kurth, Julia M.; Reuter, Jula; Flegler, Alexander; Koch, Tobias; Franke, Thomas; Klein, Eva-Maria; Denkmann, Kevin; Dahl, Christiane] Rheinische Friedrich Wilhelms Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; [Brito, Jose A.; Pereira, Ines A. C.; Archer, Margarida] Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Rowe, Sam F.; Butt, Julea N.] Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Rowe, Sam F.; Butt, Julea N.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Reuter, Jula] Rheinische Friedrich Wilhelms Univ Bonn, Inst Pharmazeut Mikrobiol, Meckenheimer Allee 168, D-53115 Bonn, Germany; [Klein, Eva-Maria] Rheinische Friedrich Wilhelms Univ Bonn, Inst Virol, Siegmund Freud Str 25, D-53127 Bonn, Germany; [Denkmann, Kevin] Dunn Labortech GmbH, Thelenberg 6, D-53567 Asbach, Germany	University of Bonn; Universidade Nova de Lisboa; University of East Anglia; University of East Anglia; University of Bonn; University of Bonn	Dahl, C (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany.; Archer, M (corresponding author), Univ Nova Lisboa ITQB UNL, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal.	archer@itqb.unl.pt; chdahl@uni-bonn.de	Dahl, Christiane/H-4786-2019; Kurth, Julia/AAE-7008-2021; Butt, Julea/E-2133-2011; Brito, Jose A./A-5605-2011; Pereira, Ines A. C./C-2748-2009	Dahl, Christiane/0000-0001-8288-7546; Butt, Julea/0000-0002-9624-5226; Brito, Jose A./0000-0002-8307-2282; Kurth, Julia/0000-0002-1221-1230; Pereira, Ines A. C./0000-0003-3283-4520; Archer, Margarida/0000-0001-8419-5420; Flegler, Alexander/0000-0002-3019-9597	Deutsche Forschungsgemeinschaft [Da 351/7-2]; Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit - Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES) [LISBOA-01-0145-FEDER-007344]; Fonds Europeen de Developpement Economique et Regional (FEDER) [UID/Multi/04551/2013]; MostMicro Unit - FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI) [LISBOA-01-0145-FEDER-007660]; National Funds through FCT; Aventis Foundation [700051]; Fonds der Chemischen Industrie; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/79224/2011]; Biotechnology and Biological Sciences Research Council, United Kingdom; Royal Society Leverhulme Trust Senior Research Fellowship;  [1493]; Biotechnology and Biological Sciences Research Council [1369608] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit - Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES); Fonds Europeen de Developpement Economique et Regional (FEDER); MostMicro Unit - FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI); National Funds through FCT(Portuguese Foundation for Science and Technology); Aventis Foundation; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Leverhulme Trust Senior Research Fellowship; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grant Da 351/7-2; Fundacao para a Ciencia e Tecnologia through iNOVA4Health Research Unit, LISBOA-01-0145-FEDER-007344, co-funded by Fundacao para a Ciencia e a Tecnologia do Ministerio para a Ciencia e Ensino Superior (FCT/MCES) and Fonds Europeen de Developpement Economique et Regional (FEDER) under the PT2020 Partnership Agreement through the Research and Development Unit; UID/Multi/04551/2013 (GreenIT); Bio-Struct-X Proposal 1493; MostMicro Unit by Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI), and by National Funds through FCT.r Recipient of Scholarship 700051 funded by the Aventis Foundation and awarded by the Fonds der Chemischen Industrie.r Recipient of Fundacao para a Ciencia e a Tecnologia Fellowship SFRH/BPD/79224/2011.r Supported by a studentship from the Biotechnology and Biological Sciences Research Council, United Kingdom.r Supported by a Royal Society Leverhulme Trust Senior Research Fellowship.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Barco RA, 2015, APPL ENVIRON MICROB, V81, P5927, DOI 10.1128/AEM.01374-15; Bartsch R G, 1978, Methods Enzymol, V53, P329; BARTSCH RG, 1991, BIOCHIM BIOPHYS ACTA, V1058, P28, DOI 10.1016/S0005-2728(05)80262-2; Beckwith CR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00332; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bonora P, 1999, BBA-BIOENERGETICS, V1410, P51, DOI 10.1016/S0005-2728(98)00173-X; Bradley JM, 2012, J BIOL CHEM, V287, P40350, DOI 10.1074/jbc.M112.396192; Branca RMM, 2007, ARCH BIOCHEM BIOPHYS, V467, P174, DOI 10.1016/j.abb.2007.07.031; Brito JA, 2015, J BIOL CHEM, V290, P9222, DOI 10.1074/jbc.M114.623397; Bruser T, 1997, BBA-GENE STRUCT EXPR, V1352, P18, DOI 10.1016/S0167-4781(97)00033-X; Chang HY, 2010, BIOCHEMISTRY-US, V49, P7494, DOI 10.1021/bi1004574; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CUSANOVI.MA, 1969, BIOCHIM BIOPHYS ACTA, V189, P245, DOI 10.1016/0005-2728(69)90051-6; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Du J, 2011, COORDIN CHEM REV, V255, P700, DOI 10.1016/j.ccr.2011.01.029; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FUKUMORI Y, 1979, CURR MICROBIOL, V3, P117, DOI 10.1007/BF02602443; Grabarczyk DB, 2015, J BIOL CHEM, V290, P9209, DOI 10.1074/jbc.M114.618025; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOCHKOEPPLER A, 1995, J BACTERIOL, V177, P608, DOI 10.1128/jb.177.3.608-613.1995; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igarashi N, 1997, NAT STRUCT BIOL, V4, P276, DOI 10.1038/nsb0497-276; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMPF C, 1980, ARCH MICROBIOL, V127, P125, DOI 10.1007/BF00428016; Kappler U, 2008, J BIOL CHEM, V283, P22206, DOI 10.1074/jbc.M800315200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KENNEL SJ, 1972, BIOPHYS J, V12, P882, DOI 10.1016/S0006-3495(72)86131-9; Kilmartin JR, 2011, J BIOL CHEM, V286, P24872, DOI 10.1074/jbc.M110.212183; Kurth JM, 2015, J AM CHEM SOC, V137, P13232, DOI 10.1021/jacs.5b08291; Lieutaud C, 2003, BBA-BIOENERGETICS, V1557, P83, DOI 10.1016/S0005-2728(02)00397-3; Liu YW, 2013, MOL MICROBIOL, V88, P173, DOI 10.1111/mmi.12176; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marritt SJ, 2008, J AM CHEM SOC, V130, P8588, DOI 10.1021/ja802641a; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MILES CS, 1993, BIOCHIM BIOPHYS ACTA, V1202, P82, DOI 10.1016/0167-4838(93)90066-Z; Nagashima KVP, 2002, BIOCHEMISTRY-US, V41, P14028, DOI 10.1021/bi026511a; Nissum M, 1997, J BIOL INORG CHEM, V2, P302, DOI 10.1007/s007750050136; Ohmine M, 2009, BIOCHEMISTRY-US, V48, P9132, DOI 10.1021/bi901202m; Pires RH, 2006, BIOCHEMISTRY-US, V45, P249, DOI 10.1021/bi0515265; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; Segel IH., 1993, ENZYME KINETICS BEHA; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Vermeglio A, 2002, BIOCHEMISTRY-US, V41, P8868, DOI 10.1021/bi012037h; Visser JM, 1996, ARCH MICROBIOL, V166, P372, DOI 10.1007/BF01682982; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	56	21	24	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					24804	24818		10.1074/jbc.M116.753863	http://dx.doi.org/10.1074/jbc.M116.753863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27694441	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000388880100001
J	Aydemir, TB; Troche, C; Kim, MH; Cousins, RJ				Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.			Hepatic ZIP14-mediated Zinc Transport Contributes to Endosomal Insulin Receptor Trafficking and Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; glycogen; glycolysis; insulin; mitochondria; Insulin degrading enzyme	RAT HEPATOCYTES; HORMONAL-REGULATION; CATHEPSIN-D; BETA-CELL; LIVER; MICE; ASSOCIATION; RESISTANCE; INHIBITION; OBESITY	Zinc influences signaling pathways through controlled targeted zinc transport. Zinc transporter Zip14 KO mice display a phenotype that includes impaired intestinal barrier function with low grade chronic inflammation, hyperinsulinemia, and increased body fat, which are signatures of diet-induced diabetes (type 2 diabetes) and obesity in humans. Hyperglycemia in type 2 diabetes and obesity is caused by insulin resistance. Insulin resistance results in inhibition of glucose uptake by liver and other peripheral tissues, principally adipose and muscle and with concurrently higher hepatic glucose production. Therefore, modulation of hepatic glucose metabolism is an important target for antidiabetic treatment approaches. We demonstrate that during glucose uptake, cell surface abundance of zinc transporter ZIP14 and mediated zinc transport increases. Zinc is distributed to multiple sites in hepatocytes through sequential translocation of ZIP14 from plasma membrane to early and late endosomes. Endosomes from Zip14 KO mice were zinc-deficient because activities of the zinc-dependent insulin-degrading proteases insulin-degrading enzyme and cathepsin D were impaired; hence insulin receptor activity increased. Transient increases in cytosolic zinc levels are concurrent with glucose uptake and suppression of glycogen synthesis. In contrast, Zip14 KO mice exhibited greater hepatic glycogen synthesis and impaired gluconeogenesis and glycolysis related to low cytosolic zinc levels. We can conclude that ZIP14-mediated zinc transport contributes to regulation of endosomal insulin receptor activity and glucose homeostasis in hepatocytes. Therefore, modulation of ZIP14 transport activity presents a new target for management of diabetes and other glucose-related disorders.	[Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.] Univ Florida, Coll Med, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Aydemir, Tolunay Beker; Troche, Catalina; Kim, Min-Hyun; Cousins, Robert J.] Univ Florida, Coll Med, Ctr Nutrit Sci, Coll Agr & Life Sci, Gainesville, FL 32611 USA; [Cousins, Robert J.] Univ Florida, Dept Biochem & Mol Biol, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cousins, RJ (corresponding author), Univ Florida, 572 Newell Dr,POB 110370, Gainesville, FL 32611 USA.	cousins@ufl.edu	Aydemir, Tolunay Beker/I-5385-2019	Kim, Min-Hyun/0000-0001-5108-9816	National Institutes of Health [R01-DK-94244]; Boston Family Endowment of the University of Florida Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094244] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Family Endowment of the University of Florida Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01-DK-94244 and the Boston Family Endowment of the University of Florida Foundation (to R.J.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARAKI N, 1995, EXP CELL RES, V217, P469, DOI 10.1006/excr.1995.1111; Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Aydemir TB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048679; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Brand IA, 1996, J BIOL CHEM, V271, P1941, DOI 10.1074/jbc.271.4.1941; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Capdor J, 2013, J TRACE ELEM MED BIO, V27, P137, DOI 10.1016/j.jtemb.2012.08.001; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Clayton D. A., 2014, COLD SPRING HARBOR P, V2014; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; COWEN LA, 1986, BIOCHEM BIOPH RES CO, V134, P944, DOI 10.1016/S0006-291X(86)80511-3; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Eisenberg ML, 2005, CELL PHYSIOL BIOCHEM, V15, P51, DOI 10.1159/000083638; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Elia Giuliano, 2012, Methods Mol Biol, V869, P361, DOI 10.1007/978-1-61779-821-4_29; ETZEL KR, 1983, J NUTR, V113, P1657, DOI 10.1093/jn/113.8.1657; Fagerholm S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005985; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Huang LP, 2012, J BIOL CHEM, V287, P33883, DOI 10.1074/jbc.M111.309666; Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; KING JC, 1994, J NUTR, V124, P508, DOI 10.1093/jn/124.4.508; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Mannucci E, 2012, ACTA DIABETOL, V49, P307, DOI 10.1007/s00592-011-0355-0; Mitchell RK, 2016, MOL ENDOCRINOL, V30, P77, DOI 10.1210/me.2015-1227; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Murphy R. F., 1988, ADV MOL CELL BIOL, P159; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PEDROSA FO, 1977, P NATL ACAD SCI USA, V74, P2742, DOI 10.1073/pnas.74.7.2742; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; ROGNSTAD R, 1984, BIOCHEM BIOPH RES CO, V122, P726, DOI 10.1016/S0006-291X(84)80094-7; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SIPE DM, 1991, J BIOL CHEM, V266, P3469; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song YP, 2006, PROTEOMICS, V6, P5269, DOI 10.1002/pmic.200500893; Stasyk T, 2007, MOL CELL PROTEOMICS, V6, P908, DOI 10.1074/mcp.M600463-MCP200; Suski JM, 2014, NAT PROTOC, V9, P312, DOI 10.1038/nprot.2014.016; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Troche C, 2016, AM J PHYSIOL-ENDOC M, V310, pE258, DOI 10.1152/ajpendo.00421.2015; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0	54	26	27	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23939	23951		10.1074/jbc.M116.748632	http://dx.doi.org/10.1074/jbc.M116.748632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703010	hybrid, Green Published			2022-12-26	WOS:000388498100011
J	Dietl, A; Stark, K; Zimmermann, ME; Meisinger, C; Schunkert, H; Birner, C; Maier, LS; Peters, A; Heid, IM; Luchner, A				Dietl, Alexander; Stark, Klaus; Zimmermann, Martina E.; Meisinger, Christa; Schunkert, Heribert; Birner, Christoph; Maier, Lars S.; Peters, Annette; Heid, Iris M.; Luchner, Andreas			NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; CHAMBER QUANTIFICATION; DYSFUNCTION; MORTALITY; EVENTS; RISK; ECHOCARDIOGRAPHY	Aims B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) predict cardiovascular endpoints in patients and all-cause death in the general population. This was assigned to their association with clinical cardiac remodelling defined as changes in size, shape and function of the heart. The aim of this study was to evaluate whether NT-proBNP and BNP were associated with cardiovascular and overall death independent of clinical cardiac remodelling measured by echocardiography as left ventricular hypertrophy (LVH), diastolic dysfunction and left ventricular ejection fraction (EF). Methods and Results In a general population-based cohort study from Germany (KORA-S3) with subjects' baseline age ranging from 25 to 74 years, cardiac morphology and function were assessed as left ventricular mass (LVM), diastolic dysfunction and EF by echocardiography and circulating NT-proBNP and BNP were measured at baseline. In 1,223 subjects with mortality follow-up information, we examined the association of baseline NT-proBNP and BNP with cardiovascular mortality (number of deaths = 52, median follow-up time = 12.9years) using Cox regression without and with adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF. The risk of cardiovascular mortality increased with higher NT-proBNP levels measured at baseline (hazard ratio HR = 1.67 per unit increment in logNT-proBNP, p = 2.78*10(-4), adjusted for age and sex). This increased risk persisted after adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF (HR = 1.73; p = 0.047). When excluding subjects with relevant LVH (LVM to body surface area > 149g/m(2) in men / 122g/m(2) in women), the NT-proBNP association with mortality was still significant (n = 1,138; number of deaths = 35; HR = 1.48; p = 0.04). We found similar results for BNP. Conclusion Our data confirms NT-proBNP and BNP as predictor of cardiovascular mortality in a large general population-based study with long-term follow-up. Our study extends previously published population-based studies to younger and potentially healthier individuals without relevant LVH, diastolic dysfunction or LVD.	[Dietl, Alexander; Stark, Klaus; Zimmermann, Martina E.; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Dietl, Alexander; Birner, Christoph; Maier, Lars S.; Luchner, Andreas] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Meisinger, Christa; Peters, Annette] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Schunkert, Heribert] Tech Univ Muenchen, Deutsch Herzzentrum Muenchen, Munich, Germany; [Schunkert, Heribert] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Luchner, Andreas] Klinikum Amberg, Amberg, Germany	University of Regensburg; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.	iris.heid@ukr.de	Meisinger, Christine/B-5358-2014; Stark, Klaus/L-7367-2013; Zimmermann, Martina/AAL-2990-2021; Maier, Lars/AAQ-8313-2021; Peters, Annette/A-6117-2011	Stark, Klaus/0000-0002-7832-1942; Zimmermann, Martina/0000-0002-6916-4404; Maier, Lars/0000-0001-9915-4429; Peters, Annette/0000-0001-6645-0985	Helmholtz Zentrum Muenchen; German Research Centre for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria (Germany); Deutsche Forschungsgemeinschaft (Germany) [LU 562/3-1]; Competence Network of Heart Failure (Germany) [BMBF-01GI0205]	Helmholtz Zentrum Muenchen; German Research Centre for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria (Germany); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); Competence Network of Heart Failure (Germany)	The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Muenchen, German Research Centre for Environmental Health which is funded by the German Federal Ministry of Science and Research (Berlin, Germany) and by the State of Bavaria (Germany). The study was further supported by the Deutsche Forschungsgemeinschaft (LU 562/3-1, Germany) and the Competence Network of Heart Failure (BMBF-01GI0205, Germany). Roche Diagnostics has provided kits for assessment of NT-proBNP free of charge, but it did not play a role in the study design, in the collection, analysis, and interpretation of data, in the writing of the manuscript or in the decision to submit the manuscript for publication.	Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; American Diabetes A, 2010, DIABETES CARE S1, V33, pS62, DOI [10.2337/dc10-S062, DOI 10.2337/DC10-S062]; Authors/Task Force M Document R, 2016, EUR J HEART FAIL; Birner C, 2012, J CARD FAIL, V18, P660, DOI 10.1016/j.cardfail.2012.06.418; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bower JK, 2015, AM J HYPERTENS; Burton RF, 2008, ANN HUM BIOL, V35, P170, DOI 10.1080/03014460801908439; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Dietl A, 2014, EUR J HEART FAIL, V16, P835, DOI 10.1002/ejhf.122; Eckel R. H., 2013, CIRCULATION; Folsom AR, 2015, CIRCULATION; Gjesdal O, 2011, NAT REV CARDIOL, V8, P673, DOI 10.1038/nrcardio.2011.154; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Kara K, 2015, INT J CARDIOL, V183, P155, DOI 10.1016/j.ijcard.2015.01.082; Kathiresan S, 2006, CIRCULATION, V113, P938, DOI 10.1161/CIRCULATIONAHA.105.580233; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kuch B, 2000, CIRCULATION, V102, P405; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Laukkanen JA, 2006, EUR HEART J, V27, P1230, DOI 10.1093/eurheartj/ehi878; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Luchner A, 2013, EUR J HEART FAIL, V15, P859, DOI 10.1093/eurjhf/hft048; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Maragiannis D, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-014-0561-9; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Park S H, 1996, J Am Soc Echocardiogr, V9, P119, DOI 10.1016/S0894-7317(96)90019-X; Pastormerlo LE, 2016, EUR J PREV CARDIOL, V23, P366, DOI 10.1177/2047487315569675; Patterson CC, 2015, INT J CARDIOL, V201, P113, DOI 10.1016/j.ijcard.2015.07.106; Ponikowski P, 2016, EUR J HEART FAIL; Portegies MLP, 2015, EUR J NEUROL, V22, P695, DOI 10.1111/ene.12633; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schunkert H, 2000, J HYPERTENS, V18, P1483, DOI 10.1097/00004872-200018100-00017; Stritzke J, 2009, J AM COLL CARDIOL, V54, P1982, DOI 10.1016/j.jacc.2009.07.034; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	44	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164060	10.1371/journal.pone.0164060	http://dx.doi.org/10.1371/journal.pone.0164060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711172	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600072
J	Wu, CM; Gong, YH; Wu, J; Zhang, SC; Yin, XX; Dong, XX; Li, WZ; Cao, SY; Mkandawire, N; Lu, ZX				Wu, Chunmei; Gong, Yanhong; Wu, Jiang; Zhang, Shengchao; Yin, Xiaoxv; Dong, Xiaoxin; Li, Wenzhen; Cao, Shiyi; Mkandawire, Naomie; Lu, Zuxun			Chinese Version of the EQ-5D Preference Weights: Applicability in a Chinese General Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; UTILITY MEASURES; NORMATIVE DATA; STATES; SAMPLE; US; MULTIATTRIBUTE; QUESTIONNAIRE; VALIDATION	Objectives This study aimed to test the reliability, validity and sensitivity of Chinese version of the EQ-5D preference weights in Chinese general people, examine the differences between the China value set and the UK, Japan and Korea value sets, and provide methods for evaluating and comparing the EQ-5D value sets of different countries. Methods A random sample of 2984 community residents (15 years or older) were interviewed using a questionnaire including the EQ-5D scale. Level of agreement, convergent validity, known-groups validity and sensitivity of the EQ-5D China, United Kingdom (UK), Japan and Korea value sets were determined. Results The mean EQ-5D index scores were significantly (P<0.05) different among the UK (0.964), Japan (0.981), Korea (0.987), and China (0.985) weights. High level of agreement (intraclass correlations coefficients >0.75) and convergent validity (Pearson's correlation coefficients P>0.95) were found between each paired schemes. The EQ-5D index scores discriminated equally well for the four versions between levels of 10 known-groups (P<0.05). The effect size and the relative efficiency statistics showed that the China weights had better sensitivity. Conclusions The China EQ-5D preference weights show equivalent psychometric properties with those from the UK, Japan and Korea weights while slightly more sensitive to known group differences than those from the Japan and Korea weights. Considering both psychometric and sociocultural issues, the China scheme should be a priority as an EQ-5D based measure of the health related quality of life in Chinese general population.	[Wu, Chunmei; Gong, Yanhong; Yin, Xiaoxv; Li, Wenzhen; Cao, Shiyi; Mkandawire, Naomie; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China; [Wu, Chunmei] Gannan Med Univ, Sch Basic Med, Ganzhou, Jiangxi, Peoples R China; [Wu, Jiang; Zhang, Shengchao] Xixiang Management Ctr Community Hlth Serv, Shenzhen, Guangdong, Peoples R China; [Dong, Xiaoxin] Ningbo Coll Hlth Sci, Ningbo, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Gannan Medical University	Lu, ZX (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China.	zuxunlu@yahoo.com						Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Busschbach J, 2003, MEASUREMENT AND VALUATION OF HEALTH STATUS USING EQ-5D: A EUROPEAN PERSPECTIVE, P143; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colton T., 1974, STAT MED, P307; Cruz LN, 2013, CIENC SAUDE COLETIVA, V18, P1911, DOI 10.1590/S1413-81232013000700006; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Fukuhara S., 2004, MANUAL SF 36V2 JAPAN; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; HAYS RD, 1993, QUAL LIFE RES, V2, P441, DOI 10.1007/BF00422218; Huang IC, 2007, QUAL LIFE RES, V16, P1065, DOI 10.1007/s11136-007-9206-4; Ikeda S, 1999, IRYO SHAKAI, V9, P83, DOI DOI 10.4091/IKEN1991.9.3_; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041550; Jo MW, 2008, VALUE HEALTH, V11, P1186, DOI 10.1111/j.1524-4733.2008.00348.x; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Kim J, 2010, JPN J OPHTHALMOL, V54, P325, DOI 10.1007/s10384-010-0825-x; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kind P., 2009, REVISED PROTOCOL VAL; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Pickard AS, 2012, VALUE HEALTH, V15, P305, DOI 10.1016/j.jval.2011.11.029; Prieto Luis, 2004, BMC Med Res Methodol, V4, P10, DOI 10.1186/1471-2288-4-10; Rosner B., 2000, FUNDAMENTAL BIOSTATI; Sakthong P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-71; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0156-6; Wu Yi-qun, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P397; 2002, J HLTH EC, V21, P271, DOI DOI 10.1016/S0167-6296(01)00130-8	42	45	45	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164334	10.1371/journal.pone.0164334	http://dx.doi.org/10.1371/journal.pone.0164334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711169	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697600120
J	Bakrania, K; Yates, T; Rowlands, AV; Esliger, DW; Bunnewell, S; Sanders, J; Davies, M; Khunti, K; Edwardson, CL				Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Esliger, Dale W.; Bunnewell, Sarah; Sanders, James; Davies, Melanie; Khunti, Kamlesh; Edwardson, Charlotte L.			Intensity Thresholds on Raw Acceleration Data: Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) Approaches	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY TIME; TRIAXIAL ACCELEROMETER; WEARABLE MONITORS; HUMAN MOVEMENT; ADULTS; WRIST; CLASSIFICATION; COMPARABILITY; METAANALYSIS	Objectives (1) To develop and internally-validate Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) thresholds for separating sedentary behaviours from common light-intensity physical activities using raw acceleration data collected from both hip-and wrist-worn tri-axial accelerometers; and (2) to compare and evaluate the performances between the ENMO and MAD metrics. Methods Thirty-three adults [mean age (standard deviation (SD)) = 27.4 (5.9) years; mean BMI (SD) = 23.9 (3.7) kg/m(2); 20 females (60.6%)] wore four accelerometers; an ActiGraph GT3X+ and a GENEActiv on the right hip; and an ActiGraph GT3X+ and a GENEActiv on the non-dominant wrist. Under laboratory-conditions, participants performed 16 different activities (11 sedentary behaviours and 5 light-intensity physical activities) for 5 minutes each. ENMO and MAD were computed from the raw acceleration data, and logistic regression and receiver-operating-characteristic (ROC) analyses were implemented to derive thresholds for activity discrimination. Areas under ROC curves (AUROC) were calculated to summarise performances and thresholds were assessed via executing leave-one-out-cross-validations. Results For both hip and wrist monitor placements, in comparison to the ActiGraph GT3X+ monitors, the ENMO and MAD values derived from the GENEActiv devices were observed to be slightly higher, particularly for the lower-intensity activities. Monitor-specific hip and wrist ENMO and MAD thresholds showed excellent ability for separating sedentary behaviours from motion-based light-intensity physical activities (in general, AUROCs >0.95), with validation indicating robustness. However, poor classification was experienced when attempting to isolate standing still from sedentary behaviours (in general, AUROCs <0.65). The ENMO and MAD metrics tended to perform similarly across activities and accelerometer brands. Conclusions Researchers can utilise these robust monitor-specific hip and wrist ENMO and MAD thresholds, in order to accurately separate sedentary behaviours from common motion-based light-intensity physical activities. However, caution should be taken if isolating sedentary behaviours from standing is of particular interest.	[Bakrania, Kishan] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester, Leics, England; [Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Bunnewell, Sarah; Davies, Melanie; Khunti, Kamlesh; Edwardson, Charlotte L.] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England; [Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Esliger, Dale W.; Sanders, James; Davies, Melanie; Edwardson, Charlotte L.] Leicester Gen Hosp, Diabet Res Ctr, Lifestyle & Phys Act Biomed Res Unit BRU, Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England; [Rowlands, Alex V.] Univ South Australia, Div Hlth Sci, Sansom Inst Hlth Res, ARENA, Adelaide, SA, Australia; [Esliger, Dale W.; Sanders, James] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Khunti, Kamlesh] Leicester Gen Hosp, Diabet Res Ctr, CLAHRC EM, NIHR, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of South Australia; Loughborough University; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Bakrania, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester, Leics, England.; Bakrania, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England.; Bakrania, K (corresponding author), Leicester Gen Hosp, Diabet Res Ctr, Lifestyle & Phys Act Biomed Res Unit BRU, Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England.	kb318@le.ac.uk	Rowlands, Alex V/J-8878-2019; /ABC-9527-2021	Rowlands, Alex V/0000-0002-1463-697X; Davies, Melanie/0000-0002-9987-9371; Yates, Thomas/0000-0002-5724-5178; Edwardson, Charlotte/0000-0001-6485-9330; Bunnewell, Sarah/0000-0001-6590-5415	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM); Leicester Clinical Trials Unit	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM); Leicester Clinical Trials Unit	The research was supported by the National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM) and the Leicester Clinical Trials Unit. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Aittasalo M, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0010-0; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brond JC, 2016, J APPL PHYSIOL, V120, P362, DOI 10.1152/japplphysiol.00628.2015; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chung WY, 2008, C P IEEE ENG MED BIO; Colley RC, 2011, HLTH REP, V22, P7; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Efron B, 1994, INTRO BOOTSTRAP, P240; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Figo D, 2010, PERS UBIQUIT COMPUT, V14, P645, DOI 10.1007/s00779-010-0293-9; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Grentved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI [10.1001/jama.2011.812, DOI 10.1001/JAMA.2011.812]; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Husu P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3591-y; John D, 2013, SENSORS-BASEL, V13, P14754, DOI 10.3390/s131114754; Joint Health Surveys Unit, HLTH SURV ENGL 2008; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Khusainov R, 2013, SENSORS-BASEL, V13, P12852, DOI 10.3390/s131012852; Loprinzi PD, 2013, J DIABETES COMPLICAT, V27, P134, DOI 10.1016/j.jdiacomp.2012.09.004; Marschollek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063522; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Rowlands AV, 2015, MED SCI SPORT EXER, V47, P201, DOI 10.1249/MSS.0000000000000394; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224; Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Vaha-Ypya H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134813; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zhang SY, 2012, MED SCI SPORT EXER, V44, P742, DOI 10.1249/MSS.0b013e31823bf95c	41	52	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164045	10.1371/journal.pone.0164045	http://dx.doi.org/10.1371/journal.pone.0164045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706241	Green Published, gold, Green Accepted			2022-12-26	WOS:000385697200078
J	Dankai, W; Pongpom, M; Youngchim, S; Cooper, CR; Vanittanakom, N				Dankai, Wiyada; Pongpom, Monsicha; Youngchim, Sirida; Cooper, Chester R., Jr.; Vanittanakom, Nongnuch			The yapA Encodes bZIP Transcription Factor Involved in Stress Tolerance in Pathogenic Fungus Talaromyces marneffei	PLOS ONE			English	Article							PENICILLIUM-MARNEFFEI; OXIDATIVE STRESS; CANDIDA-ALBICANS; GENE; INFECTION; YEAST; HOMOLOG; RESISTANCE; PATHWAYS; PATIENT	Talaromyces marneffei, formerly Penicillium marneffei, is a thermally dimorphic fungus. It causes a fatal disseminated disease in patients infected with the human immunodeficiency virus (HIV). Studies on the stress defense mechanism of T. marneffei can lead to a better understanding of the pathogenicity and the progression of the disease due to this fungus. The basic leucine-zipper (bZip) transcription factor gene in Saccharomyces cerevisiae, named yap1 (yeast activating protein-1), is known as a crucial central regulator of stress responses including those caused by oxidative agents, cadmium, and drugs. An ortholog of yap1, designated yapA, was identified in T. marneffei. We found that the yapA gene was involved in growth and fungal cell development. The yapA deletion mutant exhibited delays in the rate of growth, germination, and conidiation. Surprisingly, the yapA gene was also involved in the pigmentation of T. marneffei. Moreover, the mutant was sensitive to oxidative stressors such as H2O2 and menadione, similar to S. cerevisiae yap1 mutant, as well as the nitrosative stressor NaNO2. In addition, the yapA mutant demonstrated significantly decreased survival in human macrophage THP-1 compared to wild-type and complemented strains. This study reveals the role of yapA in fungal growth, cell development, stress response, and potential virulence in T. marneffei.	[Dankai, Wiyada; Pongpom, Monsicha; Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Cooper, Chester R., Jr.] Youngstown State Univ, Ctr Appl Chem Biol, One Univ Plaza, Youngstown, OH USA; [Cooper, Chester R., Jr.] Youngstown State Univ, Dept Biol Sci, One Univ Plaza, Youngstown, OH USA	Chiang Mai University; University System of Ohio; Youngstown State University; University System of Ohio; Youngstown State University	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand.	drnongnuch@gmail.com	Pongpom, Monsicha/AAH-9133-2019	Pongpom, Monsicha/0000-0003-4822-5850	"National Research University" Project under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	"National Research University" Project under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	This work was supported by the "National Research University" Project under Thailand's Office of the Higher Education Commission, and the Faculty of Medicine, Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Borneman AR, 2001, GENETICS, V157, P1003; Bugeja HE, 2012, FUNGAL GENET BIOL, V49, P772, DOI 10.1016/j.fgb.2012.08.003; Campos EG, 2005, GENET MOL RES, V4, P409; Cao CW, 2009, MYCOPATHOLOGIA, V168, P23, DOI 10.1007/s11046-009-9192-x; Cartwright GM, 2013, EUKARYOT CELL, V12, P1335, DOI 10.1128/EC.00129-13; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Lee PPW, 2014, J ALLERGY CLIN IMMUN, V133, P894, DOI 10.1016/j.jaci.2013.08.051; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Lo Y, 2000, T ROY SOC TROP MED H, V94, P187, DOI 10.1016/S0035-9203(00)90271-2; Luo DQ, 2011, MYCOPATHOLOGIA, V171, P191, DOI 10.1007/s11046-010-9363-9; Ma Bosco H M, 2009, Can Respir J, V16, pe50; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Moye-Rowley WS, 2008, BRIT MYCOL SOC, V27, P275; Nimmanee P, 2015, INT J MED MICROBIOL, V305, P65, DOI 10.1016/j.ijmm.2014.11.003; Nimmanee P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111200; Patassi Akouda Akessiwe, 2013, BMC Res Notes, V6, P506, DOI 10.1186/1756-0500-6-506; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Sripa C, 2010, J MED ASS THAI S3, V93, P69; Thirach S, 2007, MED MYCOL, V45, P409, DOI 10.1080/13693780701381271; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom Nongnuch, 1997, Current Topics in Medical Mycology, V8, P35; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Woo PCY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06728; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832	31	11	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163778	10.1371/journal.pone.0163778	http://dx.doi.org/10.1371/journal.pone.0163778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706212	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200058
J	Othman, SA; Majawit, LP; Hassan, WNW; Wey, MC; Razi, RM				Othman, Siti Adibah; Majawit, Lynnora Patrick; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd			Anthropometric Study of Three-Dimensional Facial Morphology in Malay Adults	PLOS ONE			English	Article							SOFT-TISSUE LANDMARKS; WHITE-POPULATIONS; SEXUAL-DIMORPHISM; REPRODUCIBILITY; CHINESE; HEAD; AGE	Objectives To establish the three-dimensional (3D) facial soft tissue morphology of adult Malaysian subjects of the Malay ethnic group; and to determine the morphological differences between the genders, using a non-invasive stereo-photogrammetry 3D camera. Material and Methods One hundred and nine subjects participated in this research, 54 Malay men and 55 Malay women, aged 20-30 years old with healthy BMI and with no adverse skeletal deviation. Twenty-three facial landmarks were identified on 3D facial images captured using a VECTRA M5-360 Head System (Canfield Scientific Inc, USA). Two angular, 3 ratio and 17 linear measurements were identified using Canfield Mirror imaging software. Intra-and inter-examiner reliability tests were carried out using 10 randomly selected images, analyzed using the intra-class correlation coefficient (ICC). Multivariate analysis of variance (MANOVA) was carried out to investigate morphologic differences between genders. Results ICC scores were generally good for both intra-examiner (range 0.827-0.987) and inter-examiner reliability (range 0.700-0.983) tests. Generally, all facial measurements were larger in men than women, except the facial profile angle which was larger in women. Clinically significant gender dimorphisms existed in biocular width, nose height, nasal bridge length, face height and lower face height values (mean difference > 3mm). Clinical significance was set at 3mm. Conclusion Facial soft tissue morphological values can be gathered efficiently and measured effectively from images captured by a non-invasive stereo-photogrammetry 3D camera. Adult men in Malaysia when compared to women had a wider distance between the eyes, a longer and more prominent nose and a longer face.	[Othman, Siti Adibah; Majawit, Lynnora Patrick; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd] Univ Malaya, Dept Paediat Dent & Orthodont, Kuala Lumpur, Malaysia; [Othman, Siti Adibah; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd] Univ Malaya, Clin Craniofacial Dent Res Grp, Fac Dent, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Othman, SA (corresponding author), Univ Malaya, Dept Paediat Dent & Orthodont, Kuala Lumpur, Malaysia.; Othman, SA (corresponding author), Univ Malaya, Clin Craniofacial Dent Res Grp, Fac Dent, Kuala Lumpur, Malaysia.	sitiadibah@um.edu.my	WEY, MANG CHEK/C-1039-2010; Hassan, Wan Wan/R-2690-2019; Hassan, Wan N Wan/F-8889-2010; razi, roziana mohd/G-4994-2011; Othman, Siti Adibah/B-9784-2010	WEY, MANG CHEK/0000-0003-0188-0727; Hassan, Wan Wan/0000-0003-1627-3671; Hassan, Wan N Wan/0000-0003-1627-3671; razi, roziana mohd/0000-0003-3398-2672; Othman, Siti Adibah/0000-0002-3846-7701	University Malaya High Impact Research Grant - SAO [UM.C/625/1/HIR/MOHE/DENT/13]; University Malaya Postgraduate Research Fund [PPPC/C1-2013/DKGC/04]	University Malaya High Impact Research Grant - SAO; University Malaya Postgraduate Research Fund	UM.C/625/1/HIR/MOHE/DENT/13 http://hir.um.edu.my/ University Malaya High Impact Research Grant - SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PPPC/C1-2013/DKGC/04 http://umresearch.um.edu.my/index.php University Malaya Postgraduate Research Fund - LPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib AR, 2012, CLEFT PALATE-CRAN J, V49, P463, DOI 10.1597/11-151; Al-Khatib AR, 2010, ARCH OROFAC SCI, V5, P1; [Anonymous], 2010, MAL DIET GUID, P20; [Anonymous], 2005, EUR J ORTHODONT, V27, P562, DOI [10.1093/ejo/cji052, DOI 10.1093/EJO/CJI052]; Baik Hyoung-Seon, 2006, World J Orthod, V7, P7; Baik HS, 2007, AM J ORTHOD DENTOFAC, V131, P759, DOI 10.1016/j.ajodo.2005.08.038; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bastir M, 2011, AM J PHYS ANTHROPOL, V146, P414, DOI 10.1002/ajpa.21596; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898; Buretic-Tomljanovic A, 2007, ANN HUM BIOL, V34, P296, DOI 10.1080/03014460701211017; Dong Y, 2011, J ORAL MAXIL SURG, V69, P1195, DOI 10.1016/j.joms.2010.05.023; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fang JJ, 2011, LECT NOTES COMPUT SC, V6777, P12, DOI 10.1007/978-3-642-21799-9_2; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; Farkas LG, 1996, AM J MED GENET, V65, P1, DOI 10.1002/ajmg.1320650102; Gor T, 2010, AM J ORTHOD DENTOFAC, V137, P424, DOI 10.1016/j.ajodo.2008.12.022; Gwilliam JR, 2006, EUR J ORTHODONT, V28, P408, DOI 10.1093/ejo/cjl024; Hajnis Karle, 1994, P201; Holton NE, 2014, AM J PHYS ANTHROPOL, V153, P52, DOI 10.1002/ajpa.22402; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Jayaratne YSN, 2014, CRANIOMAX TRAUM REC, V7, P101, DOI 10.1055/s-0034-1371540; Kau C H, 2006, Orthod Craniofac Res, V9, P10, DOI 10.1111/j.1601-6343.2006.00359.x; Kau CH, 2010, AM J DENTOFACIAL ORT, V137, pe51, DOI DOI 10.1016/J.AJ0D0.2009.04.022; Kau CH, 2010, 3 DIEMENSIONAL IMAGI, DOI [10.1002/9781118786642, DOI 10.1002/9781118786642]; Lin CS, 2013, BANGLADESH J MED SCI, V12, P209, DOI 10.3329/bjms.v12i2.14951; Little BB, 2006, AM J PHYS ANTHROPOL, V131, P127, DOI 10.1002/ajpa.20406; MOORREES CFA, 1958, AM J PHYS ANTHROPOL, V16, P213, DOI 10.1002/ajpa.1330160206; Ngeow WC, 2009, SINGAP MED J, V50, P525; Othman SA, 2014, BRIT J ORAL MAX SURG, V52, P208, DOI 10.1016/j.bjoms.2013.11.008; Othman SA, 2013, AUST ORTHOD J, V29, P58; Ozdemir ST, 2009, AESTHET PLAST SURG, V33, P175, DOI 10.1007/s00266-008-9274-z; Plooij JM, 2011, INT J ORAL MAX SURG, V40, P341, DOI 10.1016/j.ijom.2010.10.013; Reksodiputro MH, 2009, ARCH FACIAL PLAST S, V11, P347, DOI 10.1001/archfacial.2009.59; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Savoye I, 1998, ANGLE ORTHOD, V68, P467; Seager DC, 2009, ANGLE ORTHOD, V79, P991, DOI 10.2319/111408-579.1; Smith R, 2009, ARCH ORAL BIOL, V54, pS118, DOI 10.1016/j.archoralbio.2008.05.018; Torlakovic L, 2011, ANGLE ORTHOD, V81, P50, DOI 10.2319/042110-215.1; Wen YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134525; Wirthlin J, 2013, INT J ORAL MAX SURG, V42, P1100, DOI 10.1016/j.ijom.2013.03.008; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175	43	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164180	10.1371/journal.pone.0164180	http://dx.doi.org/10.1371/journal.pone.0164180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706220	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697200096
J	Payne, L; Heard, PJ; Scott, TB				Payne, Liam; Heard, Peter J.; Scott, Thomas B.			Examination of Surface Deposits on Oldbury Reactor Core Graphite to Determine the Concentration and Distribution of C-14	PLOS ONE			English	Article							RAMAN-SPECTROSCOPIC CHARACTERIZATION; IRRADIATED GRAPHITE; NUCLEAR GRAPHITE	Pile Grade A graphite was used as a moderator and reflector material in the first generation of UK Magnox nuclear power reactors. As all of these reactors are now shut down there is a need to examine the concentration and distribution of long lived radioisotopes, such as C-14, to aid in understanding their behaviour in a geological disposal facility. A selection of irradiated graphite samples from Oldbury reactor one were examined where it was observed that Raman spectroscopy can distinguish between underlying graphite and a surface deposit found on exposed channel wall surfaces. The concentration of C-14 in this deposit was examined by sequentially oxidising the graphite samples in air at low temperatures (450 degrees C and 600 degrees C) to remove the deposit and then the underlying graphite. The gases produced were captured in a series of bubbler solutions that were analysed using liquid scintillation counting. It was observed that the surface deposit was relatively enriched with C-14, with samples originating lower in the reactor exhibiting a higher concentration of C-14. Oxidation at 600 degrees C showed that the remaining graphite material consisted of two fractions of C-14, a surface associated fraction and a graphite lattice associated fraction. The results presented correlate well with previous studies on irradiated graphite that suggest there are up to three fractions of C-14; a readily releasable fraction (corresponding to that removed by oxidation at 450 degrees C in this study), a slowly releasable fraction (removed early at 600 degrees C in this study), and an unreleasable fraction (removed later at 600 degrees C in this study).	[Payne, Liam; Heard, Peter J.; Scott, Thomas B.] Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England	University of Bristol	Payne, L (corresponding author), Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England.	Liam.Payne@bristol.ac.uk	Heard, Peter J/C-2155-2008	Heard, Peter J/0000-0002-8926-4680	Engineering and Physical Sciences Research Council (EPSRC); Radioactive Waste Management (RWM) [EP/I036354/1]; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; EPSRC [EP/I036354/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management (RWM); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (EPSRC) and Radioactive Waste Management (RWM) under the contract GeoWaste (EP/I036354/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baston GMN, 2012, MINERAL MAG, V76, P3293, DOI 10.1180/minmag.2012.076.8.42; Baston GMN, 2014, CARBON 14 RELEASE OL; Black G, 2013, MODELLING MEASURING; Brown T, 2013, WAST MAN S 2013 P PH; Cleaver J, 2012, WAST MAN S 2012 P PH; Cleaver J, 2014, WAST MAN S 2014 P PH; Dunzik-Gougar ML, 2014, J NUCL MATER, V451, P328, DOI 10.1016/j.jnucmat.2014.03.018; Dunzik-Gougar ML, 2013, WAST MAN S 2013 P PH; El-Genk MS, 2011, J NUCL MATER, V411, P193, DOI 10.1016/j.jnucmat.2011.01.129; Fachinger J, 2008, NUCL ENG DES, V238, P3086, DOI 10.1016/j.nucengdes.2008.02.010; Fuller L, 1997, J NUCL MATER, V240, P241, DOI 10.1016/S0022-3115(96)00462-X; GULBRANSEN EA, 1963, J ELECTROCHEM SOC, V110, P476, DOI 10.1149/1.2425797; Handy BJ, 2006, 11996TR001 NNC; Heard PJ, 2014, J NUCL MATER, V445, P91, DOI 10.1016/j.jnucmat.2013.10.058; JAWHARI T, 1995, CARBON, V33, P1561, DOI 10.1016/0008-6223(95)00117-V; Jones AN, 2008, J NUCL MATER, V381, P152, DOI 10.1016/j.jnucmat.2008.07.038; Kim HR, 2011, PROGR NUCL SCI TECHN, V1, P412, DOI [10.15669/pnst.1.412, DOI 10.15669/PNST.1.412]; KNIGHT DS, 1989, J MATER RES, V4, P385, DOI 10.1557/JMR.1989.0385; Krishna R, 2015, RADIAT PHYS CHEM, V107, P121, DOI 10.1016/j.radphyschem.2014.10.005; LaBrier D, 2014, J NUCL MATER, V448, P113, DOI 10.1016/j.jnucmat.2014.01.041; Marshall TA, 2011, LONGER TERM RELEASE; Metcalfe MP, 2015, ANN NUCL ENERGY, V75, P665, DOI 10.1016/j.anucene.2014.08.071; Metcalfe MP, 2016, ANNEX IAEA TECDOC 17; Mironov BE, 2012, J PHYS CONF SER, V371, DOI 10.1088/1742-6596/371/1/012017; Moskovic R, 2013, NUCL ENG DES, V263, P431, DOI 10.1016/j.nucengdes.2013.05.011; NIKIEL L, 1993, CARBON, V31, P1313, DOI 10.1016/0008-6223(93)90091-N; Nuclear Decommissioning Authority, 2013, HIGH ACT WAST LONG T; Nuclear Decommissioning Authority, 2012, GEOL DISP CARB 14 PR; Payne L, 2015, WAST MAN S 2015 P PH; Payne L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143041; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; von Lensa W, 2011, ATW-INT J NUCL POWER, V56, P263; Vulpius D, 2013, NUCL ENG DES, V265, P294, DOI 10.1016/j.nucengdes.2013.09.007; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; White I. F, 1984, ASSESSMENT GRAPHITE; Wickham AJ, 2010, GRAPHITE DUST EXPLOS; Wickham AJ, 1998, GRAPHITE CORE STABIL; Yim MS, 2006, PROG NUCL ENERG, V48, P2, DOI 10.1016/j.pnucene.2005.04.002	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164159	10.1371/journal.pone.0164159	http://dx.doi.org/10.1371/journal.pone.0164159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706228	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200091
J	Lin, YS; Wang, HY; Huang, DF; Hsieh, PF; Lin, MY; Chou, CH; Wu, IJ; Huang, GJ; Gau, SSF; Huang, HS				Lin, Yi-Sian; Wang, Han-Ying; Huang, De-Fong; Hsieh, Pei-Fen; Lin, Meng-Ying; Chou, Chih-Hsuan; Wu, I-Ju; Huang, Guo-Jen; Gau, Susan Shur-Fen; Huang, Hsien-Sung			Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis	PLOS ONE			English	Article							MOUSE CEREBRAL NEOCORTEX; LONG-TERM DEPRESSION; KINASE-C INHIBITOR; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CEREBELLAR DEVELOPMENT; MICE; BALANCE; LEARN; MOTOR	Dysfunction of RBFOX3 has been identified in neurodevelopmental disorders such as autism spectrum disorder, cognitive impairments and epilepsy and a causal relationship with these diseases has been previously demonstrated with Rbfox3 homozygous knockout mice. Despite the importance of RBFOX3 during neurodevelopment, the function of RBFOX3 regarding neurogenesis and synaptogenesis remains unclear. To address this critical question, we profiled the developmental expression pattern of Rbfox3 in the brain of wild-type mice and analyzed brain volume, disease-relevant behaviors, neurogenesis, synaptic plasticity, and synaptogenesis in Rbfox3 homozygous knockout mice and their corresponding wild-type counterparts. Here we report that expression of Rbfox3 differs developmentally for distinct brain regions. Moreover, Rbfox3 homozygous knockout mice exhibited cold hyperalgesia and impaired cognitive abilities. Focusing on hippocampal phenotypes, we found Rbfox3 homozygous knockout mice displayed deficits in neurogenesis, which was correlated with cognitive impairments. Furthermore, RBFOX3 regulates the exons of genes with synapse-related function. Synaptic plasticity and density, which are related to cognitive behaviors, were altered in the hippocampal dentate gyrus of Rbfox3 homozygous knockout mice; synaptic plasticity decreased and the density of synapses increased. Taken together, our results demonstrate the important role of RBFOX3 during neural development and maturation. In addition, abnormalities in synaptic structure and function occur in Rbfox3 homozygous knockout mice. Our findings may offer mechanistic explanations for human brain diseases associated with dysfunctional RBFOX3.	[Lin, Yi-Sian; Wang, Han-Ying; Huang, De-Fong; Hsieh, Pei-Fen; Lin, Meng-Ying; Chou, Chih-Hsuan; Wu, I-Ju; Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Huang, Guo-Jen] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan; [Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan; [Huang, Hsien-Sung] Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan; [Huang, Hsien-Sung] Acad Sinica, Taipei, Taiwan; [Huang, Hsien-Sung] Neurodev Club Taiwan, Taipei, Taiwan	National Taiwan University; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan.; Huang, HS (corresponding author), Acad Sinica, Taipei, Taiwan.; Huang, HS (corresponding author), Neurodev Club Taiwan, Taipei, Taiwan.	huang.hsiensung@gmail.com	Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; Huang, De-Fong/0000-0003-0289-3650; Huang, Guo-Jen/0000-0002-6392-2155; Huang, Hsien-Sung/0000-0003-2657-3635	Ministry of Science and Technology, Taiwan [NSC 102-2320-B-002-001, MOST 103-2320-B-002-057, MOST 104-2314-B-002-078-MY3]; National Taiwan University (AIM for Top University Excellent Research Project) [102C101-42, 103R4000]; National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2325-B-001-011]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University (AIM for Top University Excellent Research Project); National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan	This work was funded by the Ministry of Science and Technology, Taiwan (NSC 102-2320-B-002-001, MOST 103-2320-B-002-057 and MOST 104-2314-B-002-078-MY3 to H-S.H.), and National Taiwan University (AIM for Top University Excellent Research Project, 102C101-42 and 103R4000 to H-S.H. and S.S.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Welgene Company conducted RNA-Seq and its data analysis. We thank the Behavior Core Lab of the Neurobiology and Cognitive Science Center, National Taiwan University for technical and facility support. We also thank the staff of the imaging core at the First Core Labs, National Taiwan University College of Medicine, for technical assistance. We thank the Taiwan Mouse Clinic (MOST 104-2325-B-001-011) which is funded by the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan for technical support in Biospec 4.7T 40-cm bore horizontal MRI system experiment.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BERGER TW, 1984, SCIENCE, V224, P627, DOI 10.1126/science.6324350; Bosch D, 2015, J PHYSIOL-LONDON, V593, P4387, DOI 10.1113/JP270645; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eto R, 2010, INT J DEV NEUROSCI, V28, P359, DOI 10.1016/j.ijdevneu.2010.04.004; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Keays DA, 2010, DEV NEUROSCI-BASEL, V32, P268, DOI 10.1159/000319663; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lee E, 2017, BIOL PSYCHIAT, V81, P838, DOI 10.1016/j.biopsych.2016.05.011; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; LEUBA G, 1978, J HIRNFORSCH, V19, P301; LEUBA G, 1977, J HIRNFORSCH, V18, P461; Lim CR, 2004, GENE, V333, P3, DOI 10.1016/j.gene.2004.02.026; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lucas CH, 2014, NEUROSCI LETT, V558, P97, DOI 10.1016/j.neulet.2013.10.037; Mahmmoud RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139739; Matoba R, 2000, PHYSIOL GENOMICS, V4, P155, DOI 10.1152/physiolgenomics.2000.4.2.155; Maxeiner S, 2014, HISTOCHEM CELL BIOL, V141, P43, DOI 10.1007/s00418-013-1159-9; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monteiro BMM, 2014, HIPPOCAMPUS, V24, P239, DOI 10.1002/hipo.22218; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Tsai CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9373; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yau SY, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/717958; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164164	10.1371/journal.pone.0164164	http://dx.doi.org/10.1371/journal.pone.0164164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701470	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900048
J	Goertler, PAL; Scheuerell, MD; Simenstad, CA; Bottom, DL				Goertler, Pascale A. L.; Scheuerell, Mark D.; Simenstad, Charles A.; Bottom, Daniel L.			EstimatingCommon Growth Patterns in Juvenile Chinook Salmon (Oncorhynchus tshawytscha) from Diverse Genetic Stocks and a Large Spatial Extent	PLOS ONE			English	Article							RIVER ESTUARY; HABITAT QUALITY; LIFE-HISTORY; COLUMBIA; MICROSTRUCTURE; IDENTIFICATION; POPULATION; SURVIVAL; RATES; FISH	Life history variation in Pacific salmon (Oncorhynchus spp.) supports species resilience to natural disturbances and fishery exploitation. Within salmon species, life-history variation often manifests during freshwater and estuarine rearing, as variation in growth. To date, however, characterizing variability in growth patterns within and among individuals has been difficult via conventional sampling methods because of the inability to obtain repeated size measurements. In this study we related otolith microstructures to growth rates of individual juvenile Chinook salmon (O. tshawytscha) from the Columbia River estuary over a two-year period (2010-2012). We used dynamic factor analysis to determine whether there were common patterns in growth rates within juveniles based on their natal region, capture location habitat type, and whether they were wild or of hatchery origin. We identified up to five large-scale trends in juvenile growth rates depending on month and year of capture. We also found that hatchery fish had a narrower range of trend loadings for some capture groups, suggesting that hatchery fish do not express the same breadth of growth variability as wild fish. However, we were unable to resolve a relationship between specific growth patterns and habitat transitions. Our study exemplifies how a relatively new statistical analysis can be applied to dating or aging techniques to summarize individual variation, and characterize aspects of life history diversity.	[Goertler, Pascale A. L.; Simenstad, Charles A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Scheuerell, Mark D.; Bottom, Daniel L.] NOAA, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Goertler, PAL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	pascale.goertler@water.ca.gov	Scheuerell, Mark/N-6683-2016	Scheuerell, Mark/0000-0002-8284-1254	National Oceanic and Atmospheric Administration [EST-O10-1, W66QKZ20272260]; University of Washington School of Aquatic and Fishery Sciences [65-4094]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Washington School of Aquatic and Fishery Sciences(University of Washington)	This study was funded by the National Oceanic and Atmospheric Administration (Administrative Code EST-O10-1, MIPR number W66QKZ20272260) and University of Washington School of Aquatic and Fishery Sciences (fellowship account number 65-4094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 1999, MAR ECOL PROG SER, V187, P227, DOI 10.3354/meps187227; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson G. A., 2006, THESIS; Anderson SC, 2015, ECOL APPL, V25, P559, DOI 10.1890/14-0266.1; [Anonymous], THESIS; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bottom D, 2012, CONTRIBUTION TIDAL F; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Bottom DL, 2005, NMFSNWFSC70 NOAA US; Bradford MJ, 1997, CAN J FISH AQUAT SCI, V54, P1585, DOI 10.1139/cjfas-54-7-1585; Burke JL, 2004, THESIS; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Campbell L. A., 2010, THESIS OREGON STATE; CARL LM, 1984, CAN J FISH AQUAT SCI, V41, P1070, DOI 10.1139/f84-125; Dawley E.M., 1986, MIGRATIONAL CHARACTE; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Fraser EDG, 2007, CLIMATIC CHANGE, V83, P495, DOI 10.1007/s10584-007-9240-9; Goertler PAL, 2016, ESTUAR COAST, V39, P542, DOI 10.1007/s12237-015-0002-z; GUNDERSON DR, 1990, ESTUARIES, V13, P59, DOI 10.2307/1351433; Hanson P. C., 1997, WISCUT97001 U WISC S; HEALEY MC, 1983, CAN FIELD NAT, V97, P427; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Holmes E, 2014, MULTIVARIATE AUTOREG; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson GE, 2015, CAN J FISH AQUAT SCI, V72, P684, DOI 10.1139/cjfas-2014-0085; Johnson GE, 2010, ECOLOGY JUVENILE SAL, P312; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Kitchell J.F., 1977, J FISH RES BOARD CAN, V34, P1910, DOI [DOI 10.1139/F77-258, 10.1139/f77-258]; Kjelson M, 1981, ESTUARINE COMP, P393; Kukulka T, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001382; LEVINGS CD, 1986, CAN J FISH AQUAT SCI, V43, P1386, DOI 10.1139/f86-172; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Marcoe K, 2013, HABITAT CHANGE LOWER; MARSHALL SL, 1982, CAN J FISH AQUAT SCI, V39, P542, DOI 10.1139/f82-077; McElhany P., 2000, NMFSNWFSC42 NOAA US; Meng L, 2000, MAR ECOL PROG SER, V201, P287, DOI 10.3354/meps201287; Miller JA, 2013, CAN J FISH AQUAT SCI, V70, P617, DOI 10.1139/cjfas-2012-0354; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; Necaise AMD, 2005, MAR ECOL PROG SER, V285, P157, DOI 10.3354/meps285157; NEILSON JD, 1985, CAN J FISH AQUAT SCI, V42, P899, DOI 10.1139/f85-114; Ohlberger J, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1333; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; REIMERS P E, 1973, Research Reports of the Fish Commission of Oregon, V4, P3; Reimers P.E., 1971, THESIS; Roegner C, 2015, SALMON HABITAT USE T; Roegner GC, 2014, T AM FISH SOC, V143, P1161, DOI 10.1080/00028487.2014.918055; Roegner GC, 2012, MAR COAST FISH, V4, P450, DOI 10.1080/19425120.2012.675982; Ruckelshaus MH, 2002, ANNU REV ECOL SYST, V33, P665, DOI 10.1146/annurev.ecolsys.33.010802.150504; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; SHERWOOD CR, 1990, PROG OCEANOGR, V25, P299, DOI 10.1016/0079-6611(90)90011-P; Simenstad C.A., 1982, ESTUARINE COMP, P343; Simenstad CA, 2011, 20111228 US GEOL SUR; Simenstad CA, 1992, WATERSHED MANAGEMENT, P266; SOGARD SM, 1992, MAR ECOL PROG SER, V85, P35, DOI 10.3354/meps085035; Stachura MM, 2014, CAN J FISH AQUAT SCI, V71, P226, DOI 10.1139/cjfas-2013-0367; Sturrock AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122380; Teel DJ, 2014, N AM J FISH MANAGE, V34, P621, DOI 10.1080/02755947.2014.901258; Teel DJ, 2009, T AM FISH SOC, V138, P211, DOI 10.1577/T08-084.1; Thorson JT, 2014, J ANIM ECOL, V83, P157, DOI 10.1111/1365-2656.12117; Titus RG, 2004, AM FISH S S, V39, P181; Volk EC, 2010, T AM FISH SOC, V139, P535, DOI 10.1577/T08-163.1; Weitkamp LA, 2012, FISH B-NOAA, V110, P426; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	70	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162121	10.1371/journal.pone.0162121	http://dx.doi.org/10.1371/journal.pone.0162121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695094	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100011
J	Peng, YP; Zhu, Y; Yin, LD; Zhang, JJ; Guo, S; Fu, Y; Miao, Y; Wei, JS				Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu			The Expression and Prognostic Roles of MCMs in Pancreatic Cancer	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; DOUBLE-HEXAMERIC MCM2-7; CLINICAL-SIGNIFICANCE; DNA-REPLICATION; COMPLEX; INTERACT; CDT1; PROLIFERATION; TRANSCRIPTION; ASSOCIATION	Objectives Minichromosome maintenance (MCM) proteins play important roles in DNA replication by interacting with other factors which participate in the regulation of DNA synthesis. Abnormal over-expression of MCMs was observed in numerous malignancies, such as colorectal cancer. However, the expression of MCMs in pancreatic cancer (PC) was less investigated so far. This study was designed to analyze the expression and prognostic roles of MCM1-10 in PC based on the data provided by The Cancer Genome Atlas (TCGA). Methods Pearson chi(2) test was applied to evaluate the association of MCMs expression with clinicopathologic indicators, and biomarkers for tumor biological behaviors. Kaplan-Meier plots and log-rank tests were used to assess survival analysis, and univariate and multivariate Cox proportional hazard regression models were used to recognize independent prognostic factors. Results MCM1-10 were generally expressed in PC samples. The levels of some molecules were markedly correlated with that of biomarkers for S phase, proliferation, gemcitabine resistance. And part of these molecules over-expression was significantly associated with indicators of disease progression, such as depth of tumor invasion and lymph node metastasis. Furthermore, MCM2, 4, 6, 8, and 10 over-expression was remarkably associated with shorter disease free survival time, and MCM2, 4,8, and 10 over-expression was associated with shorter overall survival time. Further multivariate analysis suggested that MCM8 was an independent prognostic factor for PC. Conclusion MCMs abnormal over-expression was significantly associated with PC progression and prognosis. These molecules could be regarded as prognostic and therapeutic biomarkers for PC. The roles of MCMs may be vitally important and the underlying mechanisms need to be furtherinvestigated.	[Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Pancreas Inst, Nanjing 210029, Jiangsu, Peoples R China; [Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Pancreas Inst, Nanjing 210029, Jiangsu, Peoples R China.; Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing 210029, Jiangsu, Peoples R China.; Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China.	miaoyi@njmu.edu.cn; weijishu@njmu.edu.cn			National Natural Science Foundation of China [81170336, 81272239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by grant numbers: 81170336 and 81272239, website: http://www.nsfc.gov.cn/, full name of the funding institutions: National Natural Science Foundation of China, authors who received the funding: Yi Miao. Dr. Yi Miao designed this study.	Abraham DS, 2005, EUKARYOT CELL, V4, P1808, DOI 10.1128/EC.4.11.1808-1819.2005; Bryant VL, 2015, MOL CANCER RES, V13, P1296, DOI 10.1158/1541-7786.MCR-14-0464; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069607; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Giaginis C, 2011, DIGEST DIS SCI, V56, P777, DOI 10.1007/s10620-010-1348-5; Giaginis C, 2009, DIGEST DIS SCI, V54, P282, DOI 10.1007/s10620-008-0305-z; Homesley L, 2000, GENE DEV, V14, P913; Hua C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-526; Hussain SP, 2016, INT J BIOL SCI, V12, P270, DOI 10.7150/ijbs.14950; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Kwok HF, 2015, AM J CANCER RES, V5, P52; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Qin Y, 2014, CANCER LETT, V347, P225, DOI 10.1016/j.canlet.2014.02.013; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Traver S, 2015, MOL CELL, V59, P831, DOI 10.1016/j.molcel.2015.07.010; Tuveson DA, 2012, CELL, V148, P21, DOI 10.1016/j.cell.2011.12.021; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Zhu Y, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0309-8; Zienert E, 2015, CANCER LETT, V364, P17, DOI 10.1016/j.canlet.2015.04.019	37	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164150	10.1371/journal.pone.0164150	http://dx.doi.org/10.1371/journal.pone.0164150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695057	gold, Green Submitted, Green Published			2022-12-26	WOS:000385553100093
J	Samy, AM; Elaagip, AH; Kenawy, MA; Ayres, CFJ; Peterson, AT; Soliman, DE				Samy, Abdallah M.; Elaagip, Arwa H.; Kenawy, Mohamed A.; Ayres, Constancia F. J.; Peterson, A. Townsend; Soliman, Doaa E.			Climate Change Influences on the Global Potential Distribution of the Mosquito Culex quinquefasciatus, Vector of West Nile Virus and Lymphatic Filariasis	PLOS ONE			English	Article							PIPIENS COMPLEX; DIPTERA; CULICIDAE; TRANSMISSION; TEMPERATURE; BORNE; IDENTIFICATION; EPIDEMIOLOGY; NIGRIPALPUS; DRIVERS	Rapid emergence of most vector-borne diseases (VBDs) may be associated with range expansion of vector populations. Culex quinquefasciatus Say 1823 is a potential vector of West Nile virus, Saint Louis encephalitis virus, and lymphatic filariasis. We estimated the potential distribution of Cx. quinquefasciatus under both current and future climate conditions. The present potential distribution of Cx. quinquefasciatus showed high suitability across low-latitude parts of the world, reflecting the current distribution of the species. Suitable conditions were identified also in narrow zones of North Africa and Western Europe. Model transfers to future conditions showed a potential distribution similar to that under present-day conditions, although with higher suitability in southern Australia. Highest stability with changing climate was between 30 degrees S and 30 degrees N. The areas present high agreement among diverse climate models as regards distributional potential in the future, but differed in anticipating potential for distribution in North and Central Africa, southern Asia, central USA, and southeastern Europe. Highest disparity in model predictions across representative concentration pathways (RCPs) was in Saudi Arabia and Europe. The model predictions allow anticipation of changing distributional potential of the species in coming decades.	[Samy, Abdallah M.; Kenawy, Mohamed A.; Soliman, Doaa E.] Ain Shams Univ, Dept Entomol, Fac Sci, Cairo 11566, Egypt; [Samy, Abdallah M.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Elaagip, Arwa H.] Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Ayres, Constancia F. J.] Fundacao Oswaldo Cruz, Dept Entomol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Egyptian Knowledge Bank (EKB); Ain Shams University; University of Kansas; University of Khartoum; Fundacao Oswaldo Cruz	Samy, AM (corresponding author), Ain Shams Univ, Dept Entomol, Fac Sci, Cairo 11566, Egypt.; Samy, AM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	samy@sci.asu.edu.eg	Ayres, Constancia/AAQ-3448-2020; Samy, Abdallah/B-4375-2010; Soliman, Doaa/GRT-0145-2022; Peterson, A. Townsend/I-5697-2013	Samy, Abdallah/0000-0003-3978-1134; Kenawy, Mohamed/0000-0003-0855-5855; Peterson, A. Townsend/0000-0003-0243-2379; Soliman, Doaa/0000-0002-1646-9140	Graduate Fulbright Egyptian Mission Program (EFMP)	Graduate Fulbright Egyptian Mission Program (EFMP)	AMS was supported by the Graduate Fulbright Egyptian Mission Program (EFMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137; [Anonymous], 2011, ECOLOGICAL NICHES GE; Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6; Barve N., 2013, ENMGADGETS TOOLS PRE; Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003; Conley AK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-289; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Day JF, 2000, J MED ENTOMOL, V37, P626, DOI 10.1603/0022-2585-37.4.626; de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fontes G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-272; Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760; Gunay F, 2015, ACTA TROP, V143, P112, DOI 10.1016/j.actatropica.2014.10.013; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hribar LJ, 2003, J MED ENTOMOL, V40, P361, DOI 10.1603/0022-2585-40.3.361; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Humeres SG, 1998, MEM I OSWALDO CRUZ, V93, P57, DOI 10.1590/S0074-02761998000100011; Kading RC, 2012, J AM MOSQUITO CONTR, V28, P100, DOI 10.2987/8756-971X-28.4.100; Khan AM, 2015, J VECTOR DIS, V52, P314; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manimegalai K, INT J CURR MICROBIOL, V3, P718; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Development Core Team, 2015, LANG ENV STAT COMP; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Roth D, 2010, EMERG INFECT DIS, V16, P1251, DOI 10.3201/eid1608.100483; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Rutledge CR, 2003, J MED ENTOMOL, V40, P253, DOI 10.1603/0022-2585-40.3.253; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150489; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Sunish IP, 2007, B WORLD HEALTH ORGAN, V85, P138, DOI 10.2471/BLT.06.029389; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123; URBANELLI S, 1995, J MED ENTOMOL, V32, P778, DOI 10.1093/jmedent/32.6.778; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; World Health Organization, 2016, ZIK VIR MICR GUILL B	50	104	107	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163863	10.1371/journal.pone.0163863	http://dx.doi.org/10.1371/journal.pone.0163863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695107	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100058
J	van Tok, MN; Yeremenko, NG; Teitsma, CA; Kream, BE; Knaup, VL; Lories, RJ; Baeten, DL; van Duivenvoorde, LM				van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Kream, Barbara E.; Knaup, Veronique L.; Lories, Rik J.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.			Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; IGF-I; DISEASE; CELLS; MICE; SPONDYLOARTHRITIS; SPONDYLARTHRITIS; PROGRESSION	Introduction Insulin like growth factor (IGF)-I can act on a variety of cells involved in cartilage and bone repair, yet IGF-I has not been studied extensively in the context of inflammatory arthritis. The objective of this study was to investigate whether IGF-I overexpression in the osteoblast lineage could lead to increased reparative or pathological bone formation in rheumatoid arthritis and/or spondyloarthritis respectively. Methods Mice overexpressing IGF-I in the osteoblast lineage (Ob-IGF-I+/-) line 324-7 were studied during collagen induced arthritis and in the DBA/1 aging model for ankylosing enthesitis. Mice were scored clinically and peripheral joints were analysed histologically for the presence of hypertrophic chondrocytes and osteocalcin positive osteoblasts. Results 90-100% of the mice developed CIA with no differences between the Ob-IGF-I+/- and non-transgenic littermates. Histological analysis revealed similar levels of hypertrophic chondrocytes and osteocalcin positive osteoblasts in the ankle joints. In the DBA/1 aging model for ankylosing enthesitis 60% of the mice in both groups had a clinical score 1<. Severity was similar between both groups. Histological analysis revealed the presence of hypertrophic chondrocytes and osteocalcin positive osteoblasts in the toes in equal levels. Conclusion Overexpression of IGF-I in the osteoblast lineage does not contribute to an increase in repair of erosions or syndesmophyte formation in mouse models for destructive and remodeling arthritis.	[van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Knaup, Veronique L.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands; [van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Knaup, Veronique L.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Kream, Barbara E.] Uconn Hlth, Dept Med, Farmington, CT USA; [Lories, Rik J.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Lab Tissue Homeostasis & Dis, Leuven, Belgium; [Lories, Rik J.] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; KU Leuven; University Hospital Leuven	van Duivenvoorde, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands.; van Duivenvoorde, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.	l.m.vamduivenvoorde@amc.uva.nl	/AAF-6018-2020; Lories, Rik/Q-8328-2019; Lories, Rik/T-2196-2017; Yeremenko, Nataliya/AAR-2962-2020	Lories, Rik/0000-0002-5986-3092; Lories, Rik/0000-0002-5986-3092; 	VICI grant from the Netherlands Scientific Organization (NWO); Consolidator grant from the European Research Council (ERC); Dutch Arthritis Association; ReumaFonds [13-3-305, LLP-2] Funding Source: researchfish	VICI grant from the Netherlands Scientific Organization (NWO); Consolidator grant from the European Research Council (ERC); Dutch Arthritis Association; ReumaFonds	DB is supported by a VICI grant from the Netherlands Scientific Organization (NWO) and a Consolidator grant from the European Research Council (ERC). MT is supported by a grant from the Dutch Arthritis Association.	Braem K, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-10; Corthay A, 2000, ARTHRITIS RHEUM-US, V43, P844, DOI 10.1002/1529-0131(200004)43:4<844::AID-ANR15>3.0.CO;2-B; Dhaunsi GS, 2012, SCAND J RHEUMATOL, V41, P421, DOI 10.3109/03009742.2012.691177; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; Lories RJ, 2009, CLIN EXP RHEUMATOL, V27, pS10; Lories RJU, 2006, ARTHRITIS RHEUM, V54, P1736, DOI 10.1002/art.21897; MCCARTHY TL, 1989, CONNECT TISSUE RES, V20, P277, DOI 10.3109/03008208909023897; Nakasaki M, 2008, BONE, V43, P869, DOI 10.1016/j.bone.2008.07.241; Niemann I, 2013, BONE, V56, P184, DOI 10.1016/j.bone.2013.06.013; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Schett G, 2008, AUTOIMMUNITY, V41, P224, DOI 10.1080/08916930701694717; Schett G, 2007, ANN RHEUM DIS, V66, P42, DOI 10.1136/ard.2007.078972; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Turina MC, 2014, ANN RHEUM DIS, V73, P1746, DOI 10.1136/annrheumdis-2014-205506; van Duivenvoorde LM, 2012, ARTHRITIS RHEUM-US, V64, P3210, DOI 10.1002/art.34600; van Duivenvoorde LM, 2004, ARTHRITIS RHEUM-US, V50, P3354, DOI 10.1002/art.20513; Vandooren B, 2009, ANN RHEUM DIS, V68, P1044, DOI 10.1136/ard.2007.085837; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163632	10.1371/journal.pone.0163632	http://dx.doi.org/10.1371/journal.pone.0163632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695067	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100047
J	Lopez-Duarte, PC; Fodrie, FJ; Jensen, OP; Whitehead, A; Galvez, F; Dubansky, B; Able, KW				Lopez-Duarte, Paola C.; Fodrie, F. Joel; Jensen, Olaf P.; Whitehead, Andrew; Galvez, Fernando; Dubansky, Benjamin; Able, Kenneth W.			Is Exposure to Macondo Oil Reflected in the Otolith Chemistry of Marsh-Resident Fish?	PLOS ONE			English	Article							GULF-OF-MEXICO; MUMMICHOG FUNDULUS-HETEROCLITUS; CRUDE-OIL; SALT MARSHES; CALIFORNIA HALIBUT; COASTAL LOUISIANA; MISSISSIPPI RIVER; ATLANTIC CROAKER; ESTUARINE FISH; FRESH-WATER	Genomic and physiological responses in Gulf killifish (Fundulus grandis) in the northern Gulf of Mexico have confirmed oil exposure of resident marsh fish following the Macondo blowout in 2010. Using these same fish, we evaluated otolith microchemistry as a method for assessing oil exposure history. Laser-ablation inductively-coupled-plasma mass spectrometry was used to analyze the chemical composition of sagittal otoliths to assess whether a trace metal signature could be detected in the otoliths of F. grandis collected from a Macondo-oil impacted site in 2010, post-spill relative to pre-spill, as well as versus fish from areas not impacted by the spill. We found no evidence of increased concentrations of two elements associated with oil contamination (nickel and vanadium) in F. grandis otoliths regardless of Macondo oil exposure history. One potential explanation for this is that Macondo oil is relatively depleted of those metals compared to other crude oils globally. During and after the spill, however, elevated levels of barium, lead, and to a lesser degree, copper were detected in killifish otoliths at the oil-impacted collection site in coastal Louisiana. This may reflect oil contact or other environmental perturbations that occurred concomitant with oiling. For example, increases in barium in otoliths from oil-exposed fish followed (temporally) freshwater diversions in Louisiana in 2010. This implicates (but does not conclusively demonstrate) freshwater diversions from the Mississippi River (with previously recorded higher concentrations of lead and copper), designed to halt the ingress of oil, as a mechanism for elevated elemental uptake in otoliths of Louisiana marsh fishes. These results highlight the potentially complex and indirect effects of the Macondo oil spill and human responses to it on Gulf of Mexico ecosystems, and emphasize the need to consider the multiple stressors acting simultaneously on inshore fish communities.	[Lopez-Duarte, Paola C.; Able, Kenneth W.] Rutgers State Univ, Dept Marine & Coastal Sci, Rutgers Univ Marine Field Stn, Tuckerton, NJ 08087 USA; [Fodrie, F. Joel] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Fodrie, F. Joel] Univ North Carolina Chapel Hill, Dept Marine Sci, Morehead City, NC USA; [Jensen, Olaf P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ USA; [Whitehead, Andrew] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Galvez, Fernando] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Dubansky, Benjamin] Univ North Texas, Dept Biol Sci, Denton, TX USA	Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Rutgers State University New Brunswick; University of California System; University of California Davis; Louisiana State University System; Louisiana State University; University of North Texas System; University of North Texas Denton	Lopez-Duarte, PC (corresponding author), Rutgers State Univ, Dept Marine & Coastal Sci, Rutgers Univ Marine Field Stn, Tuckerton, NJ 08087 USA.	lopez-duarte@rutgers.edu		Dubansky, Benjamin/0000-0003-4584-1690; Lopez-Duarte, Paola/0000-0003-1332-4859	Gulf of Mexico Research Initiative program through the Coastal Waters Consortium (CWC); National Science Foundation [DEB-1048206, DEB-1120512, EF-0723771]; Gulf of Mexico Research Initiative; Gulf Research Program Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021934] Funding Source: NIH RePORTER; Directorate For Geosciences [1314454] Funding Source: National Science Foundation	Gulf of Mexico Research Initiative program through the Coastal Waters Consortium (CWC); National Science Foundation(National Science Foundation (NSF)); Gulf of Mexico Research Initiative; Gulf Research Program Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for otolith microchemistry was provided by The Gulf of Mexico Research Initiative program through the Coastal Waters Consortium (CWC). The fish used in this study were collected as part of a study supported by the National Science Foundation (Grants DEB-1048206 and DEB-1120512 to AW, Grant EF-0723771 to AW and FG) and the Gulf of Mexico Research Initiative (award to AW and FG). FJF was supported by a Gulf Research Program Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the staff of the Mass Spectrometry Facility at the University of North Carolina at Chapel Hill and Christopher Filosa for assistance with otolith preparation. We also thank the editorial team at PLoS ONE and two anonymous reviewers for suggestions that strengthen the manuscript. This research was made possible by a grant from The Gulf of Mexico Research Initiative. Data are publicly available through the Gulf of Mexico Research Initiative Information & Data Cooperative (GRIIDC) at https://data.gulfresearchinitiative.org (doi:10.7266/N7NP22CQ).	Able KW, 2015, ESTUAR COAST, V38, P1385, DOI 10.1007/s12237-014-9890-6; Able KW, 2012, ESTUAR COAST, V35, P743, DOI 10.1007/s12237-011-9471-x; Adams CM, 2004, OCEAN COAST MANAGE, V47, P565, DOI 10.1016/j.ocecoaman.2004.12.002; Amiard JC, 2004, AQUAT LIVING RESOUR, V17, P281, DOI 10.1051/alr:2004037; [Anonymous], 2003, ENERG SOURCE, DOI DOI 10.1080/00908310390195589; Baguley JG, 2015, MAR ECOL PROG SER, V528, P127, DOI 10.3354/meps11290; Ball J. S., 1960, J CHEM ENG DATA, V5, P553, DOI DOI 10.1021/JE60008A038; BARWISE AJG, 1990, ENERG FUEL, V4, P647, DOI 10.1021/ef00024a005; Bianchi TS, 2011, MAR ENVIRON RES, V72, P248, DOI 10.1016/j.marenvres.2011.09.007; Blanchard J, 2005, ENVIRON TOXICOL CHEM, V24, P1403, DOI 10.1897/04-373R.1; BOESCH DF, 1984, ESTUARIES, V7, P460, DOI 10.2307/1351627; BRITSCH LD, 1993, J COASTAL RES, V9, P324; Brock JC, 2013, J COASTAL RES, P1, DOI 10.2112/SI63-001.1; Brzorad JN, 1994, BEFORE AFTER OIL SPI, P178; BURTON JD, 1968, NATURE, V217, P834, DOI 10.1038/217834a0; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Carmichael RH, 2012, ENVIRON SCI TECHNOL, V46, P12787, DOI 10.1021/es302369h; Chesney EJ, 2000, ECOL APPL, V10, P350; Chiffoleau JF, 2004, AQUAT LIVING RESOUR, V17, P273, DOI 10.1051/alr:2004032; Couvillion BR, 2013, J COASTAL RES, P58, DOI 10.2112/SI63-006.1; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Crowe KM, 2014, ENVIRON TOXICOL CHEM, V33, P370, DOI 10.1002/etc.2427; DIEHL DS, 1971, J WATER POLLUT CON F, V43, P2254; dos Anjos NA, 2011, AQUAT TOXICOL, V103, P46, DOI 10.1016/j.aquatox.2011.02.004; Dubansky B, 2013, ENVIRON SCI TECHNOL, V47, P5074, DOI 10.1021/es400458p; Ellis J, 2011, J ANAL ATOM SPECTROM, V26, P1674, DOI 10.1039/c1ja10058k; Elsdon TS, 2005, CAN J FISH AQUAT SCI, V62, P1143, DOI 10.1139/F05-029; Elsdon TS, 2003, REV FISH BIOL FISHER, V13, P219; Elsdon TS, 2004, J EXP MAR BIOL ECOL, V313, P269, DOI 10.1016/j.jembe.2004.08.010; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; ENGELHARDT FR, 1981, AQUAT TOXICOL, V1, P175, DOI 10.1016/0166-445X(81)90013-8; Fisher CR, 2014, BIOSCIENCE, V64, P796, DOI 10.1093/biosci/biu129; Fodrie FJ, 2008, LIMNOL OCEANOGR, V53, P799, DOI 10.4319/lo.2008.53.2.0799; Fodrie FJ, 2014, BIOSCIENCE, V64, P778, DOI 10.1093/biosci/biu123; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Forrester GE, 2002, MAR ECOL PROG SER, V241, P201, DOI 10.3354/meps241201; Garbarino JR, 1995, CONTAMINANTS MISSISS; Garcia TI, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-474; Gittman RK, 2015, FRONT ECOL ENVIRON, V13, P301, DOI 10.1890/150065; Grosser ZA, 2012, AGRO FOOD IND HI TEC, V23, P24; Hagan SM, 2007, WETLANDS, V27, P54, DOI 10.1672/0277-5212(2007)27[54:POMFHR]2.0.CO;2; Hanson PJ, 1999, J FISH BIOL, V54, P656; Hanson PJ, 1997, ESTUARIES, V20, P659, DOI 10.2307/1352242; Holth TF, 2014, AQUAT TOXICOL, V154, P240, DOI 10.1016/j.aquatox.2014.05.013; Hurlbert SH, 2009, ANN ZOOL FENN, V46, P311, DOI 10.5735/086.046.0501; Jackman G, 2016, ENVIRON BIOL FISH, V99, P27, DOI 10.1007/s10641-015-0451-z; Joung D, 2014, GEOCHIM COSMOCHIM AC, V141, P303, DOI 10.1016/j.gca.2014.06.021; Joung D, 2013, ENVIRON SCI TECHNOL, V47, P2161, DOI 10.1021/es303167p; Kearney MS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047847; Kerambrun E, 2012, CHEMOSPHERE, V87, P692, DOI 10.1016/j.chemosphere.2011.12.059; Kuhl AJ, 2013, ENVIRON TOXICOL CHEM, V32, P2611, DOI 10.1002/etc.2346; LELLISDIBBLE KA, 2008, NMFSFSPO90 NOAA; LIPCIUS RN, 1986, ESTUAR COAST SHELF S, V22, P101, DOI 10.1016/0272-7714(86)90026-0; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; Loughery JR, 2014, ARCH ENVIRON CON TOX, V66, P19, DOI 10.1007/s00244-013-9954-9; Marcantonio F, 1999, ENVIRON GEOL, V39, P1070; Marohn L, 2011, ANAL BIOANAL CHEM, V399, P2175, DOI 10.1007/s00216-010-4412-2; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Middleton BA, 2015, ECOHYDROLOGY, V8, P838, DOI 10.1002/eco.1625; Moody RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058376; Morales-Nin B, 2007, MAR POLLUT BULL, V54, P1732, DOI 10.1016/j.marpolbul.2007.07.007; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Moreno R, 2011, ENVIRON POLLUT, V159, P2454, DOI 10.1016/j.envpol.2011.06.033; Murtaugh PA, 2014, ECOLOGY, V95, P611, DOI 10.1890/13-0590.1; Nelson TR, 2015, ESTUAR COAST, V38, P2044, DOI 10.1007/s12237-014-9934-y; Nelson TR, 2014, ESTUAR COAST, V37, P1295, DOI 10.1007/s12237-013-9762-5; Palaseanu-Lovejoy M, 2013, J COASTAL RES, P97, DOI [10.2112/SI63-009.1, 10.2112/S163-009.1]; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Pennings SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032735, DOI 10.1371/J0UMAL.P0NE.0032735]; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; PETERSON GW, 1994, ESTUARIES, V17, P235, DOI 10.2307/1352573; Pilcher W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106351; ROZAS LP, 1990, ESTUARIES, V13, P332, DOI 10.2307/1351924; Sasaki T, 1998, ENVIRON SCI TECHNOL, V32, P3618, DOI 10.1021/es980287o; Secor DH, 2001, MAR ECOL PROG SER, V211, P245, DOI 10.3354/meps211245; Shukla P, 2007, B ENVIRON CONTAM TOX, V79, P601, DOI 10.1007/s00128-007-9272-x; Thorrold SR, 1997, LIMNOL OCEANOGR, V42, P102, DOI 10.4319/lo.1997.42.1.0102; TREFRY JH, 1985, SCIENCE, V230, P439, DOI 10.1126/science.230.4724.439; Trefry JH, 2013, MAR ENVIRON RES, V86, P35, DOI 10.1016/j.marenvres.2013.02.008; Turner RE, 2004, MAR POLLUT BULL, V49, P548, DOI 10.1016/j.marpolbul.2004.03.013; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Van Veld Peter A., 2008, P597, DOI 10.1201/9780203647295.ch13; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Wang ZD, 2003, MAR POLLUT BULL, V47, P423, DOI 10.1016/S0025-326X(03)00215-7; Webb SD, 2012, MAR ECOL PROG SER, V453, P189, DOI 10.3354/meps09653; WEIS JS, 1991, T AM FISH SOC, V120, P127, DOI 10.1577/1548-8659(1991)120<0127:NRIPCA>2.3.CO;2; Whitehead A, 2013, INTEGR COMP BIOL, V53, P635, DOI 10.1093/icb/ict080; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108; Whitehead A, 2011, J HERED, V102, P499, DOI 10.1093/jhered/esq077; Woodin BR, 1997, ENVIRON SCI TECHNOL, V31, P1198, DOI 10.1021/es9607190; Yuill B, 2009, J COASTAL RES, P23, DOI 10.2112/SI54-012.1	92	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2016	11	9							e0162699	10.1371/journal.pone.0162699	http://dx.doi.org/10.1371/journal.pone.0162699			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX2BH	27682216	gold, Green Published, Green Submitted			2022-12-26	WOS:000384171400019
J	Qiao, T; King, B; Long, JA; Ahlberg, PE; Zhu, M				Qiao, Tuo; King, Benedict; Long, John A.; Ahlberg, Per E.; Zhu, Min			Early Gnathostome Phylogeny Revisited: Multiple Method Consensus	PLOS ONE			English	Article							LOPHOSTEUS-SUPERBUS PANDER; NEW-SOUTH-WALES; BAYESIAN-INFERENCE; MAXIMUM-LIKELIHOOD; COMMON ANCESTOR; DEVONIAN FISH; SHEDS LIGHT; ORIGIN; PLACODERM; PARSIMONY	A series of recent studies recovered consistent phylogenetic scenarios of jawed vertebrates, such as the paraphyly of placoderms with respect to crown gnathostomes, and antiarchs as the sister group of all other jawed vertebrates. However, some of the phylogenetic relationships within the group have remained controversial, such as the positions of Entelognathus, ptyctodontids, and the Guiyu-lineage that comprises Guiyu, Psarolepis and Achoania. The revision of the dataset in a recent study reveals a modified phylogenetic hypothesis, which shows that some of these phylogenetic conflicts were sourced from a few inadvertent miscodings. The interrelationships of early gnathostomes are addressed based on a combined new dataset with 103 taxa and 335 characters, which is the most comprehensive morphological dataset constructed to date. This dataset is investigated in a phylogenetic context using maximum parsimony (MP), Bayesian inference (BI) and maximum likelihood (ML) approaches in an attempt to explore the consensus and incongruence between the hypotheses of early gnathostome interrelationships recovered from different methods. Our findings consistently corroborate the paraphyly of placoderms, all 'acanthodians' as a paraphyletic stem group of chondrichthyans, Entelognathus as a stem gnathostome, and the Guiyu-lineage as stem sarcopterygians. The incongruence using different methods is less significant than the consensus, and mainly relates to the positions of the placoderm Wuttagoonaspis, the stem chondrichthyan Ramirosuarezia, and the stem osteichthyan Lophosteus D the taxa that are either poorly known or highly specialized in character complement. Given that the different performances of each phylogenetic approach, our study provides an empirical case that the multiple phylogenetic analyses of morphological data are mutually complementary rather than redundant.	[Qiao, Tuo; Zhu, Min] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [King, Benedict; Long, John A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Ahlberg, Per E.] Uppsala Univ, Dept Organismal Biol, Evolutionary Biol Ctr, Uppsala, Sweden	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Flinders University South Australia; Uppsala University	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	zhumin@ivpp.ac.cn	Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Qiao, Tuo/AAJ-6317-2021	Zhu, Min/0000-0002-4786-0898; Qiao, Tuo/0000-0002-0488-7265; Long, John/0000-0001-8012-0114; Ahlberg, Per/0000-0001-9054-2900	MST of China [2012CB821902]; National Natural Science Foundation of China [41202016, 41472016, 41530102]; National Science Fund for Talent Training in Basic Science [J1210008]; State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [133109]; Australian Research Council [DP14014161]	MST of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Talent Training in Basic Science; State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS); Australian Research Council(Australian Research Council)	This work was supported by Major State Basic Research Projects (2012CB821902) of MST of China, National Natural Science Foundation of China (41202016, 41472016, and 41530102), the National Science Fund for Talent Training in Basic Science (J1210008), and the State Key Laboratory of Palaeobiology and Straigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (133109) and Australian Research Council Grant DP14014161.	AHLBERG PE, 1989, ZOOL J LINN SOC-LOND, V96, P119, DOI 10.1111/j.1096-3642.1989.tb01824.x; ANDERSON ME, 1994, S AFR J SCI, V90, P397; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; Asher RJ, 2008, SYST BIOL, V57, P311, DOI 10.1080/10635150802033022; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2015, NATURE, V520, P490, DOI 10.1038/nature14438; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Burrow Carole J., 1995, Geobios Memoire Special (Villeurbanne), V19, P327; Chang M., 1981, SCI SINICA, V24, P89; Chang M-M, 1993, MEM ASS AUSTRALAS PA, V15, P16; Chang M-M, 1982, BRAINCASE YOUNGOLEPI; Chang M-M, 2004, RECENT ADV ORIGIN EA, P665; Chang MM, 1992, J VERTEBR PALEONTOL, V12, P294, DOI 10.1080/02724634.1992.10011461; Chang Mee-mann, 1991, P355; Clement Gael, 2010, P363; Clement Gael, 2004, Fossils and Strata, V50, P92; Cloutier Richard, 1996, P227; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Coates MI, 2010, J VERT PALEO S, V30, p74A; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; de Villemereuil P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-102; Denison, 1979, ACANTHODII; Denison RH, 1978, HDB PALEOICHTHYOLOGY, V2, P128; Duchene S, 2015, J EXP ZOOL PART B, V324, P517, DOI 10.1002/jez.b.22638; Dupret V, 2008, GEOL MAG, V145, P257, DOI 10.1017/S0016756807004207; Dupret V, 2014, NATURE, V507, P500, DOI 10.1038/nature12980; Dupret V, 2010, GEODIVERSITAS, V32, P5, DOI 10.5252/g2010n1a1; Forey P.L., 1998, HIST COELACANTH FISH; Forey PL, 2000, J VERTEBR PALEONTOL, V20, P243, DOI 10.1671/0272-4634(2000)020[0243:ANCFTM]2.0.CO;2; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Garcia-Comas Carmen, 2016, P ROY SOC B-BIOL SCI, V283, P20152129, DOI [10.1098/rspb.2015.2129, DOI 10.1098/RSPB.2015.2129, DOI 10.HTTP://DX.D0I.0RG/10.1098/RSPB.2015.2210.D0I:10.1098/RSPB.2015.2210]; GARDINER BG, 1994, ZOOL J LINN SOC-LOND, V112, P443, DOI 10.1006/zjls.1994.1053; Giles S, 2015, NATURE, V520, P82, DOI 10.1038/nature14065; Giles S, 2013, J MORPHOL, V274, P627, DOI 10.1002/jmor.20119; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goujet D., 1973, Palaeontographica Abt A, V143, P73; Goujet D, 1984, POISSONS PLACODERMES; Goujet D, 2004, RECENT ADV ORIGIN EA, P109; Goujet Daniel, 1995, Geobios Memoire Special (Villeurbanne), V19, P89; Goujet DF, 1975, PROBLEMES ACTUELS PA, V218, P81; Greenwood P.H., 1973, Zoological J Linn Soc, V53, P1; GROSS W, 1971, LETHAIA, V4, P131, DOI 10.1111/j.1502-3931.1971.tb01285.x; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; Gross W., 1963, Notizblatt des Hessischen Landesamtes fuer Bodenforschung zu Wiesbaden, V91, P36; HALSTEAD LB, 1979, NATURE, V282, P833, DOI 10.1038/282833a0; Hemmings S.K., 1978, Palaeontographical Society Monographs (London), V131, P1; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JANVIER P, 1981, Journal of Vertebrate Paleontology, V1, P121; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P773, DOI 10.1671/0272-4634(2004)024[0773:CCITPF]2.0.CO;2; Janvier P, 1985, CAHIERS PALEONTOLOGI; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1977, PROBLEMS VERTEBRATE, P199; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JARVIK ERIK, 1948, ARKIV ZOOL, V41 A, P1; JESSEN H L, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V167, P180; Jessen HL, 1975, C INT CTR NATIONAL R, V218, P213; Johanson Z, 1997, GEOL MAG, V134, P813, DOI 10.1017/S0016756897007838; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lee M, 2011, BEHAV COGN PSYCHOTH, V39, P413, DOI 10.1017/S1352465810000925; Lewis PO, 2001, TRENDS ECOL EVOL, V16, P30, DOI 10.1016/S0169-5347(00)02025-5; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liu T-S, 1958, PALAEONTOL SINICA, V141, P1; LIU Y-H, 1973, Vertebrata Palasiatica, V11, P132; Liu Yu-hai, 1991, P139; Long J.A., 1984, Proceedings of the Linnean Society of New South Wales, V107, P263; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Lu J, 2016, CURR BIOL, V26, P1602, DOI 10.1016/j.cub.2016.04.045; Maddison W.P., 2008, MESQUITE MODULAR SYS; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Miles R. S., 1968, P109; Miles R. S, 1977, Linnean Soc Symp Ser, VNo. 4, P123; Miles R.S., 1973, Zoological J Linn Soc, V53, P63; Miles R. S., 1971, PALAEOZOIC FISHES; MILES RS, 1971, PHILOS T R SOC B, V263, P101, DOI 10.1098/rstb.1971.0111; Miles RS., 1973, B BR MUS NAT HIS G, V24, P111; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Moy-Thomas J.A., 1936, GEOL MAG, V73, P488, DOI [10.1017/S0016756800095212, DOI 10.1017/S0016756800095212]; Muller J, 2006, SYSTEMATIC BIOL, V55, P503, DOI 10.1080/10635150600755396; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; Nixon K.C., 2002, WINCLADA VER 1 00 08; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; O'Reilly JE, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0081; OTTO M, 1991, Palaeontologische Zeitschrift, V65, P345; PAN J, 1980, ACTA GEOL SIN-ENGL, V54, P176; Pan J, 1992, NEW GALEASPIDS AGNAT; Pan J., 1987, CONTINENTAL DEVONIAN; Pan K., 1978, P298; Pander CH., 1856, MONOGRAPHIE FOSSILEN; Pickett KM, 2005, MOL PHYLOGENET EVOL, V34, P203, DOI 10.1016/j.ympev.2004.09.001; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Pradel A, 2009, ACTA ZOOL-STOCKHOLM, V90, P123, DOI 10.1111/j.1463-6395.2008.00350.x; Qiao T, 2010, SCI CHINA EARTH SCI, V53, P1836, DOI 10.1007/s11430-010-4089-6; Qu QM, 2015, NATURE, V526, P108, DOI 10.1038/nature15259; RADE J, 1964, J PALEONTOL, V38, P929; Rambaut A., TRACER V 1 5; Rayner DH, 1951, T ROY SOC EDINBURGH, V62, P53; Rindal E, 2011, CLADISTICS, V27, P331, DOI 10.1111/j.1096-0031.2010.00342.x; Ritchie A., 1992, Records of the Australian Museum, V44, P319; RITCHIE A, 1975, NATURE, V254, P569, DOI 10.1038/254569a0; Ritchie A., 1973, Palaeontographica Abt A, V143, P58; Rohon JV, 1893, MEMOIRES ACAD IMPERI, V41, P1; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ronquist F, 2011, MRBAYES VER IN PRESS, P172; SCHULTZE H-P, 1982, Palaeontologische Zeitschrift, V56, P95; Schultze H-P, 2004, ACTA U LATV, V679, P57; Schultze HP, 2016, CR PALEVOL, V15, P83, DOI 10.1016/j.crpv.2015.04.001; Shultze H. P., 1973, Palaeontographica Abt A, V143, P188; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stensi/ E.A., 1969, TRAITE PALEONTOL, V4, P71; Taverne L., 1997, SCI TERRE, V67, P57; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Traquair RH, 1888, GEOLOGICAL MAGAZINE, V5, P507; Trinajstic K, 2015, BIOL REV, V90, P467, DOI 10.1111/brv.12118; Tuffley C, 1997, B MATH BIOL, V59, P581, DOI 10.1016/S0092-8240(97)00001-3; Turner S, 2005, PALAEONTOLOGY, V48, P963, DOI 10.1111/j.1475-4983.2005.00479.x; Wang Nian-zhong, 1991, P41; Warren A, 2000, J VERTEBR PALEONTOL, V20, P225, DOI 10.1671/0272-4634(2000)020[0225:ARAROG]2.0.CO;2; WHITE E I, 1978, Transactions of the Zoological Society of London, V34, P149; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210; Xu X, 2013, J SYST PALAEONTOL, V2013, P1, DOI [DOI 10.1080/14772019.2013, 10.1080/14772019.2013]; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Young G.C., 2003, Records of the Western Australian Museum Supplement, V65, P1; YOUNG GC, 1986, ZOOL J LINN SOC-LOND, V88, P1, DOI 10.1111/j.1096-3642.1986.tb00876.x; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; ZHANG MM, 1980, VERTEBRAT PALASIATIC, V18, P179; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M., 2004, RECENT ADV ORIGIN EA, P271; Zhu Min, 1991, P179; Zhu M, 2014, NATL SCI REV, V1, P490, DOI 10.1093/nsr/nwu062; Zhu M, 2013, NATURE, V502, P188, DOI 10.1038/nature12617; Zhu Min, 2010, P199; Zhu Min, 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P233; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	148	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163157	10.1371/journal.pone.0163157	http://dx.doi.org/10.1371/journal.pone.0163157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649538	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100059
J	Savill, SA; Leitch, HF; Harvey, JN; Thomas, TH				Savill, Stuart A.; Leitch, Helen F.; Harvey, John N.; Thomas, Trevor H.			Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients	PLOS ONE			English	Article							INSULIN; ATHEROSCLEROSIS	Cardiovascular disease and cancer are increased in Type 2 diabetes. TPM1 and TPM4 genes encode proteins associated with cardiovascular and neoplastic disease. High (HMW) and low (LMW) molecular weight isoforms from TPM1 and TPM4 are altered in several cancer cells and the 3'UTR of TPM1 mRNA is tumour suppressive. Leukocytes influence cardiovascular and neoplastic disease by immunosurveillance for cancer and by chronic inflammation in Type 2 diabetes and cardiovascular disease. The aim was to determine changes in expression of isoforms from TPM1 and TPM4 genes in leukocytes from Type 2 diabetic patients and to use the leukocyte cell line THP1 to identify possible mediators of changes in the patients. Gene expression was determined by RT-qPCR. In diabetes, expression of HMW isoforms from TPM1 were markedly decreased (0.55 v 1.00; p = 0.019) but HMW isoforms from TPM4 were not significantly different (0.76 v 1.00; p = 0.205). Within individual variance in expression of HMW isoforms was very high. The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNF alpha (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1 alpha (0.17 and 0.14 v 1.00 respectively). Increased insulin or glucose concentrations had no substantial effects on TPM1 or TPM4 expression. Decreased TPM1 mRNA resulted in decreases in HMW protein levels. Expression of HMW isoforms from TPM1 is decreased in Type 2 diabetes. This is probably due to increased levels of inflammatory cytokines TNF alpha and IL-1 alpha in Type 2 diabetes. Lower levels of TPM1 mRNA reduce tumour suppression and could contribute to increased cancer risk in Type 2 diabetes. Decreased HMW tropomyosin isoforms are associated with cancer. Decreased HMW isoforms give rise to cells that are more plastic, motile, invasive and prone to dedifferentiation resulting in leukocytes that are more invasive but less functionally effective.	[Savill, Stuart A.; Leitch, Helen F.; Harvey, John N.; Thomas, Trevor H.] Betsi Cadwaladr Univ Hlth Board, Croesnewydd Rd, Wrexham, Wales; [Harvey, John N.] Bangor Univ, Wrexham Acad Unit, Sch Med Sci, Bangor, Gwynedd, Wales	Bangor University	Savill, SA (corresponding author), Betsi Cadwaladr Univ Hlth Board, Croesnewydd Rd, Wrexham, Wales.	stuart.savill@wales.nhs.uk			North Wales Research Grants Committee	North Wales Research Grants Committee	This work was supported by SAS: North Wales Research Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouhamed M, 2003, EUR J CELL BIOL, V82, P473, DOI 10.1078/0171-9335-00333; Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Barua B, 2014, BIOCHEMISTRY-US, V53, P4015, DOI 10.1021/bi500162z; Bigornia SJ, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chow MT, 2012, SEMIN CANCER BIOL, V22, P23, DOI 10.1016/j.semcancer.2011.12.004; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Helfman DM, 2008, ADV EXP MED BIOL, V644, P124; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jin SY, 2014, BBA-MOL BASIS DIS, V1842, P1539, DOI 10.1016/j.bbadis.2014.06.003; Kee AJ, 2015, TRAFFIC, V16, P691, DOI 10.1111/tra.12282; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lomnytska MI, 2011, BRIT J CANCER, V104, P110, DOI 10.1038/sj.bjc.6605992; Milioli HH, 2015, CANCER GENOM PROTEOM, V12, P89; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Strissel KJ, 2014, CURR OPIN ENDOCRINOL, V21, P330, DOI 10.1097/MED.0000000000000085; Tang HY, 2013, J PROTEOMICS, V89, P165, DOI 10.1016/j.jprot.2013.06.016; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162908	10.1371/journal.pone.0162908	http://dx.doi.org/10.1371/journal.pone.0162908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649540	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100041
J	Ihara, T; Hosokawa, Y; Kumazawa, K; Ishikawa, K; Fujimoto, J; Yamamoto, M; Muramkami, T; Goshima, N; Ito, E; Watanabe, S; Semba, K				Ihara, T.; Hosokawa, Y.; Kumazawa, K.; Ishikawa, K.; Fujimoto, J.; Yamamoto, M.; Muramkami, T.; Goshima, N.; Ito, E.; Watanabe, S.; Semba, K.			An in vivo screening system to identify tumorigenic genes	ONCOGENE			English	Article							PROTEIN-KINASE-A; CARNEY COMPLEX; LYSOPHOSPHATIDIC ACID; COUPLED RECEPTORS; TUMOR-GROWTH; CANCER; EXPRESSION; ADENOSINE; CELL	Screening for oncogenes has mostly been performed by in vitro transformation assays. However, some oncogenes might not exhibit their transforming activities in vitro unless putative essential factors from in vivo microenvironments are adequately supplied. Here, we have developed an in vivo screening system that evaluates the tumorigenicity of target genes. This system uses a retroviral high-efficiency gene transfer technique, a large collection of human cDNA clones corresponding to similar to 70% of human genes and a luciferase-expressing immortalized mouse mammary epithelial cell line (NMuMG-luc). From 845 genes that were highly expressed in human breast cancer cell lines, we focused on 205 genes encoding membrane proteins and/or kinases as that had the greater possibility of being oncogenes or drug targets. The 205 genes were divided into five subgroups, each containing 34-43 genes, and then introduced them into NMuMG-luc cells. These cells were subcutaneously injected into nude mice and monitored for tumor development by in vivo imaging. Tumors were observed in three subgroups. Using DNA microarray analyses and individual tumorigenic assays, we found that three genes, ADORA2B, PRKACB and LPAR3, were tumorigenic. ADORA2B and LPAR3 encode G-protein-coupled receptors and PRKACB encodes a protein kinase A catalytic subunit. Cells overexpressing ADORA2B, LPAR3 or PRKACB did not show transforming phenotypes in vitro, suggesting that transformation by these genes requires in vivo microenvironments. In addition, several clinical data sets, including one for breast cancer, showed that the expression of these genes correlated with lower overall survival rate.	[Ihara, T.; Hosokawa, Y.; Kumazawa, K.; Yamamoto, M.; Semba, K.] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Ishikawa, K.; Fujimoto, J.] Japan Biol Informat Consortium, Tokyo, Japan; [Muramkami, T.] Takasaki Univ Hlth & Welf, Lab Tumor Biol, Fac Pharm, Takasaki, Gunma, Japan; [Goshima, N.] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Quantitat Prote Team, Tokyo, Japan; [Goshima, N.] Div Transcriptome Anal, Fukushima, Japan; [Ito, E.; Watanabe, S.] Div Gene Express Anal, Fukushima, Japan; [Semba, K.] Fukushima Med Univ, Div Gene Funct Anal, Translat Res Ctr, Fukushima, Japan	Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); Fukushima Medical University	Semba, K (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	ksemba@waseda.jp	直樹, 五島/M-8363-2018; Yamamoto, Mizuki/AAW-1688-2020	Yamamoto, Mizuki/0000-0003-3731-1702	JSPS KAKENHI Grant [23241064]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank our laboratory members, especially Kumiko Semba for secretarial assistance and Sakura Azuma-Tamamura for technical assistance. This work was conducted as part of the Fukushima Translational Research Project and supported, in part, by JSPS KAKENHI Grant Number 23241064, and a Grant-in-Aid for Scientific Research (A).	Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Correa R, 2015, EUR J ENDOCRINOL, V173, pM85, DOI 10.1530/EJE-15-0209; Desmet CJ, 2013, P NATL ACAD SCI USA, V110, P5139, DOI 10.1073/pnas.1222085110; Doi A, 2015, MOL ONCOL, V9, P355, DOI 10.1016/j.molonc.2014.09.005; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; Feigin ME, 2013, FEBS J, V280, P4729, DOI 10.1111/febs.12473; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Griffin KJ, 2004, J MED GENET, V41, P923, DOI 10.1136/jmg.2004.028043; HYNES NE, 1985, MOL CELL BIOL, V5, P268, DOI 10.1128/MCB.5.1.268; Ito E, 2007, FEBS LETT, V581, P3909, DOI 10.1016/j.febslet.2007.07.016; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Matsui Atsuka, 2013, Biomol Concepts, V4, P567, DOI 10.1515/bmc-2013-0026; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Padmanabhan A, 2013, J BIOL CHEM, V288, P14158, DOI 10.1074/jbc.M112.432377; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Saito M, 2012, FEBS LETT, V586, P1708, DOI 10.1016/j.febslet.2012.05.003; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	30	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					2023	2029		10.1038/onc.2016.351	http://dx.doi.org/10.1038/onc.2016.351			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27694896				2022-12-26	WOS:000398898500012
J	Famenini, S; Rigali, EA; Olivera-Perez, HM; Dang, J; Chang, MT; Halder, R; Rao, RV; Pellegrini, M; Porter, V; Bredesen, D; Fiala, M				Famenini, Sam; Rigali, Elizabeth A.; Olivera-Perez, Henry M.; Dang, Johnny; Chang, Michael To; Halder, Ramesh; Rao, Rammohan V.; Pellegrini, Matteo; Porter, Verna; Bredesen, Dale; Fiala, Milan			Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on omega-3 supplementation	FASEB JOURNAL			English	Article						omega-3 fatty acids; resolvin D1; amyloid-beta phagocytosis; inflammation; ApoE genotype	AMYLOID-BETA PHAGOCYTOSIS; ALZHEIMERS-DISEASE PATIENTS; RESOLVING LIPID MEDIATORS; APOLIPOPROTEIN-E; APOE EPSILON-4; DOUBLE-BLIND; INFLAMMATION; ACTIVATION; RESOLUTION; BRAIN	Monocyte/macrophages of patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) are defective in phagocytosis and degradation amyloid beta(1-42) (A beta(1-42)), but are improved by omega-3 fatty acids (omega-3s). The hypothesis of this study was that active A beta(1-42) phagocytosis by macrophages prevents brain amyloidosis and thus maintains cognition. We studied the effects of self-supplementation with a drink withv-3s, antioxidants, and resveratrol on Mini-Mental State Examination (MMSE) scores, macrophage M1M2 phenotype [the ratio of inflammatory cluster of differentiation (CD) 54+CD80 and proresolution markers CD163+CD206], and A beta(1-42) phagocytosis in patients initially diagnosed as having MCI or subjective cognitive impairment (SCI). At baseline, the median MMSE score in patients in both the apolipoprotein E (ApoE) epsilon 3/epsilon 3 and ApoE epsilon 3/epsilon 4 groups was 26.0 and macrophage Ab1-42 phagocytosis was defective. The MMSE rate of change increased in the ApoE epsilon 3/epsilon 3 group a median 2.2 points per year (P=0.015 compared to 0) but did not change in the ApoE epsilon 3/epsilon 4 group(P = 0.014 between groups). In the ApoE epsilon 3/epsilon 3 group, all patients remained cognitively stable or improved; in the ApoE epsilon 3/epsilon 4 group, 1 recovered from dementia, but 3 lapsed into dementia. The macrophage phenotype polarized in patients bearing ApoE epsilon 3/epsilon 3 to an intermediate (green zone) M1-M2 type at the rate of 0.226 U/yr, whereas in patients bearing ApoE epsilon 3/epsilon 4, polarization was negative (P=0.08 between groups). The baseline M1M2 type in the extreme M1(red zone) or M2 (white zone) was unfavorable for cognitive outcome. A beta(1-42) phagocytosis increased in both ApoE groups (P= 0.03 in each groups). In vitro, the lipidic mediator resolv in D1(RvD1) down regulated the M1 type in patients with ApoE epsilon 3/epsilon 3 but in some patients with epsilon 3/epsilon 4, paradoxically up-regulated the M1 type. Antioxidant/omega-3/resveratrol supplementation was associated with favorable immune and cognitive responses in ApoE epsilon 3/epsilon 3 and individual patients bearing ApoE epsilon 3/epsilon 4, and brings into personalized clinical practice the immune benefits expected from omega-3 mediators called resolvins. The validity of this study is limited by its small size and uncontrolled design.-Famenini, S., Rigali, E. A., Olivera-Perez, H. M., Dang, J., Chang, M T., Halder, R., Rao, R. V., Pellegrini, M., Porter, V., Bredesen, D., Fiala, M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on v-3 supplementation.	[Famenini, Sam; Rigali, Elizabeth A.; Olivera-Perez, Henry M.; Dang, Johnny; Chang, Michael To; Halder, Ramesh; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Rao, Rammohan V.; Bredesen, Dale] Buck Inst Res Aging, Novato, CA USA; [Porter, Verna; Bredesen, Dale] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Porter, Verna; Bredesen, Dale] Univ Calif Los Angeles, Sch Med, Easton Labs Neurodegenerat Dis, Los Angeles, CA USA	University of California System; University of California Los Angeles; Buck Institute for Research on Aging; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fiala, M (corresponding author), 100 UCLA Med Plaza,Suite 220, Los Angeles, CA 90095 USA.	mfiala@ucla.edu		Pellegrini, Matteo/0000-0001-9355-9564; Fiala, Milan/0000-0001-8023-6053	U.S. National Institutes of Health Institute of General Medical Sciences [5P01GM099134-03]; Alzheimer's Association; Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	U.S. National Institutes of Health Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alzheimer's Association(Alzheimer's Association); Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Jeffrey Gornbein for statistical analysis of the data and Sarah Weitzman and Leonard Haller (all from the University of California, Los Angeles) for data collection and assistance with statistical analysis. The studies were supported by U.S. National Institutes of Health Institute of General Medical Sciences Grant 5P01GM099134-03 (to M.P.), a grant from the Alzheimer's Association, and a donation from Smartfish AS (to M.F.). Smartfish AS supplied the drink to the patients who requested it. Smartfish was not involved in the design of the study, analysis or interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria from Smartfish. The remaining authors declare no conflicts of interest.	Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cederholm T, 2013, ADV NUTR, V4, P672, DOI 10.3945/an.113.004556; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; Duara R, 2011, AM J GERIAT PSYCHIAT, V19, P951, DOI 10.1097/JGP.0b013e3182107c69; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2015, J ALZHEIMERS DIS, V48, P293, DOI 10.3233/JAD-150367; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Girodet PO, 2016, AM J RESP CELL MOL B; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; McGeer PL, 2015, EXPERT OPIN THER TAR, V19, P497, DOI 10.1517/14728222.2014.988707; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Mizwicki MT, 2012, J ALZHEIMERS DIS, V29, P51, DOI 10.3233/JAD-2012-110560; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Raine A, 2015, J CHILD PSYCHOL PSYC, V56, P509, DOI 10.1111/jcpp.12314; ROGERS J, 1992, RES IMMUNOL, V143, P624, DOI 10.1016/0923-2494(92)80046-N; Salem N, 2015, PROSTAG LEUKOTR ESS, V92, P15, DOI 10.1016/j.plefa.2014.10.003; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Theendakara V, 2016, J NEUROSCI, V36, P685, DOI 10.1523/JNEUROSCI.3562-15.2016; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	42	54	54	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					148	160		10.1096/fj.201600677RR	http://dx.doi.org/10.1096/fj.201600677RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27677546	hybrid, Green Published			2022-12-26	WOS:000392177600016
J	Ng, T; Hor, CHH; Chew, B; Zhao, J; Zhong, Z; Ryu, JR; Goh, ELK				Ng, Teclise; Hor, Catherine H. H.; Chew, Benjamin; Zhao, Jing; Zhong, Zhong; Ryu, Jae Ryun; Goh, Eyleen L. K.			Neuropilin 2 Signaling Is Involved in Cell Positioning of Adult-born Neurons through Glycogen Synthase Kinase-3 beta (GSK3 beta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY GENERATED NEURONS; SYNAPTIC INTEGRATION; REGULATES MIGRATION; NEUROGENESIS; HIPPOCAMPUS; GSK-3; PATHWAY; SEMA3A; BRAIN	Proper positioning of neurons is fundamental for brain functions. However, little is known on how adult-born neurons generated in the hilar side of hippocampal dentate gyrus migrate into the granular cell layer. Because class 3 Semaphorins (Sema3) are involved in dendritic growth of these newborn neurons, we examined whether they are essential for cell positioning. We disrupted Sema3 signaling by silencing neuropilin 1 (NRP1) or 2 (NRP2), the main receptors for Sema3A and Sema3F, in neural progenitors of adult mouse dentate gyrus. Silencing of NRP2, but not NRP1, affected cell positioning of adult newborn neurons. Glycogen synthase kinase-3 beta (GSK3 beta) knockdown phenocopied this NRP2 silencing-mediated cell positioning defect, but did not affect dendritic growth. Furthermore, GSK3 beta is activated upon stimulation with Sema3F, and GSK3 beta overexpression rescued the cell positioning phenotypes seen in NRP2-deficient neurons. These results point to a new role for NRP2 in the positioning of neurons during adult hippocampal neurogenesis, acting via the GSK3 beta signaling pathway.	[Ng, Teclise; Chew, Benjamin; Ryu, Jae Ryun; Goh, Eyleen L. K.] Duke NUS Med Sch, Programme Neurosci & Behav Disorder, Singapore 169857, Singapore; [Hor, Catherine H. H.; Goh, Eyleen L. K.] Duke NUS Med Sch, Neurosci Acad Clin Programme, 8 Coll Rd, Singapore 169857, Singapore; [Hor, Catherine H. H.; Goh, Eyleen L. K.] Natl Neurosci Inst, Dept Res, Singapore 308433, Singapore; [Zhao, Jing; Zhong, Zhong] GlaxoSmithKline China R&D Co Ltd, Shanghai 201203, Peoples R China; [Goh, Eyleen L. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Goh, Eyleen L. K.] KK Womens & Childrens Hosp, KK Res Ctr, Singapore 229899, Singapore	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); GlaxoSmithKline; National University of Singapore; KK Women's & Children's Hospital	Ryu, JR; Goh, ELK (corresponding author), Duke NUS Med Sch, Neurosci Acad Clin Programme, 8 Coll Rd, Singapore 169857, Singapore.	jaeryunryu@gmail.com; eyleen.goh@duke-nus.edu.sg		Goh, Eyleen/0000-0002-8244-6959; Hor, Catherine/0000-0002-7467-2243	Abbott Nutrition; Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK); National Research Foundation Singapore under its Competitive Research Program [NRF 2008 NRF-CRP 002-082]	Abbott Nutrition(Abbott Laboratories); Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK); National Research Foundation Singapore under its Competitive Research Program(National Research Foundation, Singapore)	This work was supported by Abbott Nutrition, the Academic Center of Excellence (ACE) research award from GlaxoSmithKline (GSK), and the National Research Foundation Singapore under its Competitive Research Program (Grant NRF 2008 NRF-CRP 002-082) (to E. L. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bagri A, 2002, DEVELOPMENT, V129, P4249; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chew B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00158; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Duveau V, 2011, EUR J NEUROSCI, V34, P362, DOI 10.1111/j.1460-9568.2011.07782.x; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fitzsimons CP, 2013, MOL PSYCHIATR, V18, P993, DOI 10.1038/mp.2012.123; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ito K, 2008, J NEUROSCI, V28, P4414, DOI 10.1523/JNEUROSCI.0372-08.2008; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Koga T, 2015, J BIOL CHEM, V290, P30366, DOI 10.1074/jbc.M115.664169; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Larimer P, 2010, NAT NEUROSCI, V13, P213, DOI 10.1038/nn.2458; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Manning EE, 2012, HIPPOCAMPUS, V22, P309, DOI 10.1002/hipo.20900; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; Namba T, 2011, J NEUROCHEM, V118, P34, DOI 10.1111/j.1471-4159.2011.07282.x; Ng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065572; Shelly M, 2011, NEURON, V71, P433, DOI 10.1016/j.neuron.2011.06.041; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Su CTE, 2015, JOVE-J VIS EXP, DOI 10.3791/52408; Tamamaki N, 2003, J COMP NEUROL, V455, P238, DOI 10.1002/cne.10476; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Whissell PD, 2013, ANN NEUROL, V74, P611, DOI 10.1002/ana.23941; Zhao N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00158; Zhou MO, 2013, NEURON, V77, P647, DOI 10.1016/j.neuron.2012.12.033	40	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25088	25095		10.1074/jbc.M116.755215	http://dx.doi.org/10.1074/jbc.M116.755215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27687730	Green Published, hybrid			2022-12-26	WOS:000388880100024
J	Chanda-Kapata, P; Kapata, N; Masiye, F; Maboshe, M; Klinkenberg, E; Cobelens, F; Grobusch, MP				Chanda-Kapata, Pascalina; Kapata, Nathan; Masiye, Felix; Maboshe, Mwendaweli; Klinkenberg, Eveline; Cobelens, Frank; Grobusch, Martin P.			Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SOUTH-AFRICA; DIAGNOSTIC DELAY; VIETNAM; GENDER; DETERMINANTS; ETHIOPIA; PATIENT	Background Tuberculosis (TB) prevalence surveys offer a unique opportunity to study health seeking behaviour at the population level because they identify individuals with symptoms that should ideally prompt a health consultation. Objective To assess the health-seeking behaviour among individuals who were presumptive TB cases in a national population based TB prevalence survey. Methods A cross sectional survey was conducted between 2013 and 2014 among 66 survey clusters in Zambia. Clusters were census supervisory areas (CSAs). Participants (presumptive TB cases) were individuals aged 15 years and above; having either cough, fever or chest pain for 2 weeks or more; and/or having an abnormal or inconclusive chest x-ray image. All survey participants were interviewed about symptoms and had a chest X-ray taken. An in-depth interview was conducted to collect information on health seeking behaviour and previous TB treatment. Results Of the 6,708 participants, the majority reported at least a history of chest pain (3,426; 51.1%) followed by cough (2,405; 35.9%), and fever (1,030; 15.4%) for two weeks or more. Only 34.9% (2,340) had sought care for their symptoms, mainly (92%) at government health facilities. Of those who sought care, 13.9% (326) and 12.1% (283) had chest x-ray and sputum examinations, respectively. Those ever treated for TB were 9.6% (644); while 1.7% (114) was currently on treatment. The average time (in weeks) from onset of symptoms to first care-seeking was 3 for the presumptive TB cases. Males, urban dwellers and individuals in the highest wealth quintile were less likely to seek care for their symptoms. The likelihood of having ever been treated for TB was highest among males, urban dwellers; respondents aged 35-64 years, individuals in the highest wealth quintile, or HIV positive. Conclusion Some presumptive TB patients delay care-seeking for their symptoms. The health system misses opportunities to diagnose TB among those who seek care. Improving health-seeking behaviour among males, urban dwellers and those with a higher social economic status; and addressing health care lapses in TB case detection is required if TB is to be effectively controlled in Zambia.	[Chanda-Kapata, Pascalina] Minist Hlth, Dept Dis Surveillance Control & Res, Lusaka, Zambia; [Chanda-Kapata, Pascalina; Kapata, Nathan; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Kapata, Nathan] Minist Hlth, Dept Dis Surveillance Control & Res, Natl TB Leprosy Control Program, Lusaka, Zambia; [Masiye, Felix] Univ Zambia, Dept Econ, Lusaka, Zambia; [Maboshe, Mwendaweli] World Hlth Org Country Off, Lusaka, Zambia; [Klinkenberg, Eveline; Cobelens, Frank] KNCV TB Fdn, Epidemiol, The Hague, Netherlands; [Cobelens, Frank] Acad Med Ctr, Dept Global Hlth & Dev, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Zambia; World Health Organization; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Chanda-Kapata, P (corresponding author), Minist Hlth, Dept Dis Surveillance Control & Res, Lusaka, Zambia.; Chanda-Kapata, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands.	pascykapata@gmail.com	Kapata, Nathan/AAW-2469-2020		Government of The Republic of Zambia through the Ministry of Health; United States Government through USAID/CDC/TBCARE I	Government of The Republic of Zambia through the Ministry of Health; United States Government through USAID/CDC/TBCARE I(United States Agency for International Development (USAID))	This work was funded by the Government of The Republic of Zambia through the Ministry of Health and The United States Government through USAID/CDC/TBCARE I.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuo P O, 2008, East Afr Med J, V85, P263; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Cheng SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067516; Chongwe G, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.692; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Huong NT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-110; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Ministry of Health, NAT TB LEPR REP 2014; Ministry of Health, TECHNICAL REPORT; Mulenga C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-756; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Ouedraogo M, 2006, INT J TUBERC LUNG D, V10, P184; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Skordis-Worrall J, 2010, INT J TUBERC LUNG D, V14, P171; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Waako J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-349	25	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163975	10.1371/journal.pone.0163975	http://dx.doi.org/10.1371/journal.pone.0163975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711170	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600057
J	Karl, S; White, MT; Milne, GJ; Gurarie, D; Hay, SI; Barry, AE; Felger, I; Mueller, I				Karl, Stephan; White, Michael T.; Milne, George J.; Gurarie, David; Hay, Simon I.; Barry, Alyssa E.; Felger, Ingrid; Mueller, Ivo			Spatial Effects on the Multiplicity of Plasmodium falciparum Infections	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; VECTOR CONTROL; HOST-SEEKING; POPULATION; DIPTERA; DISEASE; VIVAX; CULICIDAE	As malaria is being pushed back on many frontiers and global case numbers are declining, accurate measurement and prediction of transmission becomes increasingly difficult. Low transmission settings are characterised by high levels of spatial heterogeneity, which stands in stark contrast to the widely used assumption of spatially homogeneous transmission used in mathematical transmission models for malaria. In the present study an individual-based mathematical malaria transmission model that incorporates multiple parasite clones, variable human exposure and duration of infection, limited mosquito flight distance and most importantly geographically heterogeneous human and mosquito population densities was used to illustrate the differences between homogeneous and heterogeneous transmission assumptions when aiming to predict surrogate indicators of transmission intensity such as population parasite prevalence or multiplicity of infection (MOI). In traditionally highly malaria endemic regions where most of the population harbours malaria parasites, humans are often infected with multiple parasite clones. However, studies have shown also in areas with low overall parasite prevalence, infection with multiple parasite clones is a common occurrence. Mathematical models assuming homogeneous transmission between humans and mosquitoes cannot explain these observations. Heterogeneity of transmission can arise from many factors including acquired immunity, body size and occupational exposure. In this study, we show that spatial heterogeneity has a profound effect on predictions of MOI and parasite prevalence. We illustrate, that models assuming homogeneous transmission underestimate average MOI in low transmission settings when compared to field data and that spatially heterogeneous models predict stable transmission at much lower overall parasite prevalence. Therefore it is very important that models used to guide malaria surveillance and control strategies in low transmission and elimination settings take into account the spatial features of the specific target area, including human and mosquito vector distribution.	[Karl, Stephan; White, Michael T.; Barry, Alyssa E.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Based Biol Div, Parkville, Vic, Australia; [Karl, Stephan; Barry, Alyssa E.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Karl, Stephan] Papua New Guinea Insititute Med Res, Vectorborne Dis Unit, Madang, Madang Province, Papua N Guinea; [White, Michael T.] Imperial Coll, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA, Australia; [Gurarie, David] Case Western Reserve Univ, Dept Math Appl Math & Stat, Cleveland, OH 44106 USA; [Hay, Simon I.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Hay, Simon I.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Felger, Ingrid] Univ Basel, Basel, Switzerland; [Mueller, Ivo] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasites & Hosts Unit, Paris, France	Walter & Eliza Hall Institute; University of Melbourne; PNG Institute Of Medical Research; Imperial College London; University of Western Australia; Case Western Reserve University; Institute for Health Metrics & Evaluation; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Karl, S (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Based Biol Div, Parkville, Vic, Australia.; Karl, S (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Karl, S (corresponding author), Papua New Guinea Insititute Med Res, Vectorborne Dis Unit, Madang, Madang Province, Papua N Guinea.	karl@wehi.edu.au	Karl, Stephan/A-2365-2012; Hay, Simon Iain/F-8967-2015; Gurarie, David/AAA-2096-2021	Hay, Simon Iain/0000-0002-0611-7272; Barry, Alyssa/0000-0002-1189-2310; Milne, George/0000-0002-9796-0600; White, Michael/0000-0002-7472-4138; Felger, Ingrid/0000-0003-1255-2606; Gurarie, David/0000-0002-5314-7888	Victorian State Government Operational Infrastructure Support; NHMRC (Australia) [GNT 1052760]; MRC (UK); Australian Government NHMRC IRIISS	Victorian State Government Operational Infrastructure Support; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	SK, AB and IM acknowledge support from the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. SK was supported by an NHMRC (Australia) Early Career Fellowship (GNT 1052760). MTW was supported by an MRC (UK) Research Fellowship. The authors thank all researchers and study participants involved in the PNG studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMALEK AA, 1966, B WORLD HEALTH ORGAN, V35, P968; Achee NL, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:AMSTDT]2.0.CO;2; Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; ANDERSON R M, 1991; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Arifin SMN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-424; Bailey S F, 1967, Proc Pap Annu Conf Calif Mosq Control Assoc, V35, P55; Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Betuela I, 2012, J INFECT DIS, V206, P1771, DOI 10.1093/infdis/jis580; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bomblies A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-308; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; CHARLWOOD JD, 1987, MED VET ENTOMOL, V1, P319, DOI 10.1111/j.1365-2915.1987.tb00361.x; CHARLWOOD JD, 1988, MED VET ENTOMOL, V2, P101, DOI 10.1111/j.1365-2915.1988.tb00059.x; CHARLWOOD JD, 1985, B ENTOMOL RES, V75, P463, DOI 10.1017/S0007485300014577; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; EJERCTTO A, 1951, Bull World Health Organ, V3, P663; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Gurarie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034040; Hetzel MW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-242; Hii JLK, 1997, J MED ENTOMOL, V34, P193, DOI 10.1093/jmedent/34.2.193; Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Kaufmann C, 2004, J VECTOR ECOL, V29, P140; Keating J, 2005, J MED ENTOMOL, V42, P241, DOI 10.1603/0022-2585(2005)042[0241:AGSAAF]2.0.CO;2; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101601; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Koinari M, 2013, J HELMINTHOL, V87, P409, DOI 10.1017/S0022149X12000594; Koram KA, 2003, TROP MED INT HEALTH, V8, P793, DOI 10.1046/j.1365-3156.2003.01092.x; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Liebman KA, 2012, PLOS NEGLECT TROP D, V6, pe1472, DOI [10.1371/journal.pntd.0001472, DOI 10.1371/JOURNAL.PNTD.0001472]; Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Maude RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-191; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Milne GJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002518; MUIRHEADTHOMSON RC, 1951, BRIT MED J, V1, P1114, DOI 10.1136/bmj.1.4715.1114; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; National Statistical Office of Papua New Guinea, 2013, PREM FIG PAP NEW GUI; Parthasarathy PR, 1997, IMA J MATH APPL MED, V14, P113; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; REUBEN R, 1993, SOC SCI MED, V37, P473, DOI 10.1016/0277-9536(93)90282-9; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; SMITH D, 2010, NEW RESPONSE YOUTH C, P1, DOI DOI 10.1038/NC0MMS1107; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Wernsdorfer Walther H., 1988, MALARIA PRINCIPLES P; Wesolowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05678; White MT, 2014, ELIFE, V3, DOI 10.7554/eLife.04692; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153	79	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164054	10.1371/journal.pone.0164054	http://dx.doi.org/10.1371/journal.pone.0164054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711149	gold, Green Published, Green Accepted			2022-12-26	WOS:000385697600070
J	Wang, WY; Liu, SH; Lin, MY; Lin, CC; Wang, IJ				Wang, Wen-Yi; Liu, Sing-Huh; Lin, Meng-Yin; Lin, Che-Chen; Wang, I-Jong			Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; VARICELLA-ZOSTER; POSTHERPETIC NEURALGIA; NATURAL-HISTORY; PAIN; TAIWAN; VIRUS; EPIDEMIOLOGY; OPHTHALMICUS; RESPONSES	Herpes zoster (HZ) is associated with complications such as postherpetic neuralgia (PHN) and HZ ophthalmicus (HZO). However, few studies have focused on identifying patients having a high risk of PHN and HZO according to the initial presentation sites. The current study investigated these factors in a nationwide population-based cohort derived from Taiwan's Longitudinal Health Insurance Database. The results indicate that the initial presentation sites can predict the complication site of HZ. In this study, elderly patients were found to be more susceptible to HZ and were the first to present with neurological signs (HZN). Furthermore, compared with patients with HZO and other signs (HZT), those with HZN had a higher comorbidity risk. Patients with HZN showed a significantly higher visceral complication risk than did those with HZO (adjusted hazard ratio [HR] = 1.47, 95% confidence interval [CI] = 1.27-1.71). In addition, patients with HZT showed lower risks of ocular and neurological complications than did those with HZN after stratification by age and sex (adjusted HR = 0.46, 95% CI = 0.31-0.68 and HR = 0.73, 95% CI = 0.59-0.91, respectively).	[Wang, Wen-Yi; Liu, Sing-Huh; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Lin, Meng-Yin] Taipei Med Univ, Taipei Med Sch Med, Shuang Ho Hosp, Dept Ophthalmol, Taipei, Taipei County, Taiwan; [Lin, Meng-Yin] Natl Taiwan Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Lin, Che-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] China Med Univ, Sch Med, Taichung, Taiwan; [Wang, I-Jong] China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan.	ijong@ms8.hinet.net		Wang, I-Jong/0000-0002-3045-0614	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105- TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105- TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Atherton S S, 2001, Herpes, V8, P69; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; Chao DY, 2012, EPIDEMIOL INFECT, V140, P1131, DOI 10.1017/S0950268811001786; Cheng TM, 2010, SIX COUNTRIES SIX RE, P171; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; COHEN PR, 1989, CLIN EXP DERMATOL, V14, P273, DOI 10.1111/j.1365-2230.1989.tb01978.x; Decroix J, 2000, J EUR ACAD DERMATOL, V14, P23, DOI 10.1046/j.1468-3083.2000.00020.x; Furuta Y, 2000, J MED VIROL, V62, P42, DOI 10.1002/1096-9071(200009)62:1&lt;42::AID-JMV7&gt;3.0.CO;2-C; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Harpaz-Rotem I, 2008, PSYCHIAT SERV, V59, P1184, DOI 10.1176/appi.ps.59.10.1184; HAYWARD AR, 1987, J CLIN IMMUNOL, V7, P174, DOI 10.1007/BF00916011; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Katz J, 2005, J PAIN, V6, P782, DOI 10.1016/j.jpain.2005.07.006; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; 정성규, 2012, [Korean Journal of Dermatology, 대한피부과학회지], V50, P287; Kurokawa I, 2002, J INT MED RES, V30, P56, DOI 10.1177/147323000203000109; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Margolis T, 1996, OCULAR INFECT IMMUNI, P1155; Nagasako EM, 2002, J AM ACAD DERMATOL, V46, P834, DOI 10.1067/mjd.2002.120924; Parruti G, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-58; SCHMADER K, 1990, J AM GERIATR SOC, V38, P1188, DOI 10.1111/j.1532-5415.1990.tb01497.x; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Thomas SL, 2004, BRIT MED J, V328, P439, DOI 10.1136/bmj.37991.511829.F7; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tran TN, 2014, SCAND J INFECT DIS, V46, P528, DOI 10.3109/00365548.2014.901554; Tsai TF, 2015, INT J DERMATOL, V54, P529, DOI 10.1111/ijd.12484; Vandercam T, 2008, NEUROLOGY, V71, P1268, DOI 10.1212/01.wnl.0000327615.99124.99; Weinberg JM, 2007, J AM ACAD DERMATOL, V57, pS130, DOI 10.1016/j.jaad.2007.08.046; Whitley RJ, 1998, J INFECT DIS, V178, pS71, DOI 10.1086/514274; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Yawn BP, 2013, MAYO CLIN PROC, V88, P562, DOI 10.1016/j.mayocp.2013.03.014; Yawn BP, 2011, MAYO CLIN PROC, V86, P88, DOI 10.4065/mcp.2010.0618	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164019	10.1371/journal.pone.0164019	http://dx.doi.org/10.1371/journal.pone.0164019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711168	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697600063
J	Pageaux, B; Lepers, R; Marcora, SM				Pageaux, Benjamin; Lepers, Romuald; Marcora, Samuele M.			Reliability of a Novel High Intensity One Leg Dynamic Exercise Protocol to Measure Muscle Endurance	PLOS ONE			English	Article							PERIPHERAL FATIGUE; NEUROMUSCULAR FUNCTION; CYCLING EXERCISE; SPORTS-MEDICINE; GROUP-III; HUMANS; PERFORMANCE; FEEDBACK; MASS; AFFERENTS	We recently developed a high intensity one leg dynamic exercise (OLDE) protocol to measure muscle endurance and investigate the central and peripheral mechanisms of muscle fatigue. The aims of the present study were to establish the reliability of this novel protocol and describe the isokinetic muscle fatigue induced by high intensity OLDE and its recovery. Eight subjects performed the OLDE protocol (time to exhaustion test of the right leg at 85% of peak power output) three times over a week period. Isokinetic maximal voluntary contraction torque at 60 (MVC60), 100 (MVC100) and 140 (MVC140) deg/s was measured pre-exercise, shortly after exhaustion (13 +/- 4 s), 20 s (P20) and 40 s (P40) post-exercise. Electromyographic (EMG) signal was analyzed via the root mean square (RMS) for all three superficial knee extensors. Mean time to exhaustion was 5.96 +/- 1.40 min, coefficient of variation was 8.42 +/- 6.24%, typical error of measurement was 0.30 min and intraclass correlation was 0.795. MVC torque decreased shortly after exhaustion for all angular velocities (all P < 0.001). MVC60 and MVC100 recovered between P20 (P < 0.05) and exhaustion and then plateaued. MVC140 recovered only at P40 (P < 0.05). High intensity OLDE did not alter maximal EMG RMS of the three superficial knee extensors during MVC. The results of this study demonstrate that this novel high intensity OLDE protocol could be reliably used to measure muscle endurance, and that muscle fatigue induced by high intensity OLDE should be examined within similar to 30 s following exhaustion.	[Pageaux, Benjamin; Marcora, Samuele M.] Univ Kent Medway, Sch Sport & Exercise Sci, Endurance Res Grp, Chatham, Kent, England; [Pageaux, Benjamin; Lepers, Romuald] Univ Bourgogne Franche Comte, INSERM, CAPS UMR1093, Dijon, France	University of Kent; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Pageaux, B (corresponding author), Univ Kent Medway, Sch Sport & Exercise Sci, Endurance Res Grp, Chatham, Kent, England.; Pageaux, B (corresponding author), Univ Bourgogne Franche Comte, INSERM, CAPS UMR1093, Dijon, France.	benjaminpageaux@gmail.com	Lepers, Romuald/T-8782-2019; Marcora, Samuele/W-4284-2019	Marcora, Samuele/0000-0002-1570-7936; Lepers, Romuald/0000-0002-3870-4017; Pageaux, Benjamin/0000-0001-9302-5183	Region de Bourgogne [9201AA0049S03018]; Fonds Europeen de Developpement Regional (FEDER)	Region de Bourgogne(Region Bourgogne-Franche-Comte); Fonds Europeen de Developpement Regional (FEDER)(European Commission)	The manuscript was written during the postdoctoral position of BP that was funded by the Region de Bourgogne (contract 9201AA0049S03018) and the Fonds Europeen de Developpement Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Amann M, 2011, J PHYSIOL-LONDON, V589, P3855, DOI 10.1113/jphysiol.2011.209353; ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Dempsey JA, 2014, J PHYSIOL-LONDON, V592, P463, DOI 10.1113/jphysiol.2013.261925; Deschenes M, 2013, ACSMS GUIDELINES EXE, P162; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Garten RS, 2014, J APPL PHYSIOL, V116, P1204, DOI 10.1152/japplphysiol.00103.2014; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Impellizzeri FM, 2008, INT J SPORTS MED, V29, P899, DOI 10.1055/s-2008-1038491; Impellizzeri FM, 2009, INT J SPORT PHYSIOL, V4, P269, DOI 10.1123/ijspp.4.2.269; Marcora SM, 2008, AM J PHYSIOL-REG I, V294, pR874, DOI 10.1152/ajpregu.00678.2007; Marcora SM., ENCY PERCEPTION, V2010, P380, DOI DOI 10.4135/9781412972000.N119; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; MORROW JR, 1993, RES Q EXERCISE SPORT, V64, P352, DOI 10.1080/02701367.1993.10608821; O'Connor PJ, 2001, MED SCI SPORT EXER, V33, P1046, DOI 10.1097/00005768-200106000-00026; Pageaux B, 2016, EUR J SPORT SCI, V16, P885, DOI 10.1080/17461391.2016.1188992; Pageaux B, 2015, AM J PHYSIOL-REG I, V308, pR1008, DOI 10.1152/ajpregu.00280.2014; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; Pageaux B, 2013, MED SCI SPORT EXER, V45, P2254, DOI 10.1249/MSS.0b013e31829b504a; Rossman MJ, 2012, ACTA PHYSIOL, V206, P242, DOI 10.1111/j.1748-1716.2012.02471.x; Rossman MJ, 2014, AM J PHYSIOL-REG I, V306, pR934, DOI 10.1152/ajpregu.00043.2014; Rossman MJ, 2013, AM J PHYSIOL-REG I, V305, pR1163, DOI 10.1152/ajpregu.00360.2013; Rossman MJ, 2013, MED SCI SPORT EXER, V45, P1235, DOI 10.1249/MSS.0b013e3182846d7e; Sidhu SK, 2013, SPORTS MED, V43, P437, DOI 10.1007/s40279-013-0020-6; Strange S, 1999, J PHYSIOL-LONDON, V514, P283, DOI 10.1111/j.1469-7793.1999.283af.x; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163979	10.1371/journal.pone.0163979	http://dx.doi.org/10.1371/journal.pone.0163979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706196	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000385697200072
J	Ssali, T; Anazodo, UC; Bureau, Y; MacIntosh, BJ; Gunther, M; St Lawrence, K				Ssali, Tracy; Anazodo, Udunna C.; Bureau, Yves; MacIntosh, Bradley J.; Guenther, Matthias; St Lawrence, Keith			Mapping Long-Term Functional Changes in Cerebral Blood Flow by Arterial Spin Labeling	PLOS ONE			English	Article							PERFUSION MRI; FMRI DATA; REPRODUCIBILITY; RELIABILITY; BRAIN; ACTIVATION; TASK; TIME; 3T; NORMALIZATION	Although arterial spin labeling (ASL) is appealing for mapping long-term changes in functional activity, inter-sessional variations in basal blood flow, arterial transit times (ATTs), and alignment errors, can result in significant false activation when comparing images from separate sessions. By taking steps to reduce these sources of noise, this study assessed the ability of ASL to detect functional CBF changes between sessions. ASL data were collected in three sessions to image ATT, resting CBF and CBF changes associated with motor activation (7 participants). Activation maps were generated using rest and task images acquired in the same session and from sessions separated by up to a month. Good agreement was found when comparing between-session activation maps to within-session activation maps with only a 16% decrease in precision (within-session: 90 +/- 7%) and a 13% decrease in the Dice similarity (within-session: 0.75 +/- 0.07) coefficient after a month. In addition, voxel-wise reproducibility (within-session: 4.7 +/- 4.5%) and reliability (within-session: 0.89 +/- 0.20) of resting grey-matter CBF decreased by less than 18% for the between-session analysis relative to within-session values. ATT variability between sessions (5.0 +/- 2.7%) was roughly half the between-subject variability, indicating that its effects on longitudinal CBF were minimal. These results demonstrate that conducting voxel-wise analysis on CBF images acquired on different days is feasible with only modest loss in precision, highlighting the potential of ASL for longitudinal studies.	[Ssali, Tracy; Anazodo, Udunna C.; Bureau, Yves; St Lawrence, Keith] Lawson Hlth Res Inst, London, ON, Canada; [Ssali, Tracy; Anazodo, Udunna C.; St Lawrence, Keith] Western Univ, Dept Med Biophys, London, ON, Canada; [MacIntosh, Bradley J.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Guenther, Matthias] Fraunhofer Inst Med Image Comp MEVIS, Bremen, Germany; [Guenther, Matthias] Mediri GmbH, Heidelberg, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fraunhofer Gesellschaft	Ssali, T (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Ssali, T (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	tssali@uwo.ca		MacIntosh, Bradley/0000-0001-7300-2355; Anazodo, Udunna/0000-0001-8864-035X; St Lawrence, Keith/0000-0001-8022-8205	Canadian Institutes of Health Research [MOP-119453]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research (MOP-119453). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Borghammer P, 2008, NEUROIMAGE, V40, P529, DOI 10.1016/j.neuroimage.2007.12.057; Borogovac A, 2010, J CEREBR BLOOD F MET, V30, P1721, DOI 10.1038/jcbfm.2010.89; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Diamant M, 2002, ACTA PHYSIOL SCAND, V175, P1, DOI 10.1046/j.1365-201X.2002.00953.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fernandez-Seara MA, 2008, MAGN RESON MED, V59, P1467, DOI 10.1002/mrm.21633; Fischmeister FPS, 2013, NEUROIMAGE-CLIN, V3, P369, DOI 10.1016/j.nicl.2013.09.007; Fleiss J.L., 2013, STAT METHODS RATES P; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Howard MA, 2012, ARTHRITIS RHEUM-US, V64, P3936, DOI 10.1002/art.37685; Howard MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017096; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maclntosh BJ, 2010, AM J NEURORADIOL, V31, P1892, DOI 10.3174/ajnr.A2008; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MATHEW RJ, 1991, AM J PSYCHIAT, V148, P292; Mezue M, 2014, J CEREBR BLOOD F MET, V34, P1919, DOI 10.1038/jcbfm.2014.163; Mutsaerts HJMM, 2015, NEUROIMAGE, V113, P143, DOI 10.1016/j.neuroimage.2015.03.043; Owen DG, 2010, PAIN, V148, P375, DOI 10.1016/j.pain.2009.10.003; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; RAMSAY SC, 1993, J PHYSIOL-LONDON, V471, P521, DOI 10.1113/jphysiol.1993.sp019913; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skup M, 2010, STAT INTERFACE, V3, P235; Sousa I, 2014, J MAGN RESON IMAGING, V40, P1453, DOI 10.1002/jmri.24493; Tan H, 2011, MAGN RESON MED, V66, P168, DOI 10.1002/mrm.22768; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ushida Takahiro, 2010, Open Neuroimag J, V4, P182, DOI 10.2174/1874440001004010182; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164112	10.1371/journal.pone.0164112	http://dx.doi.org/10.1371/journal.pone.0164112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706218	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200084
J	Taye, M; Afework, M; Fantaye, W; Diro, E; Worku, A				Taye, Molla; Afework, Mekbeb; Fantaye, Wondwossen; Diro, Ermias; Worku, Alemayehu			Magnitude of Birth Defects in Central and Northwest Ethiopia from 2010-2014: A Descriptive Retrospective Study	PLOS ONE			English	Article							CONGENITAL-ANOMALIES; MALFORMATIONS; PREVALENCE; INFANTS	Background Birth defects are defined as structural and functional defects that develop during the organogenesis period and present at birth or detected later in life. They are one of the leading causes of infant and child mortality, morbidity, and long term disability. The magnitude of birth defects varies from country to country and from race/ethnicity to race/ethnicity, and about 40-60% of their causes are unknown. The known causes of birth defects are genetic and environmental factors which may be prevented. For various reasons, there is lack of data and research on birth defects in Ethiopia. Objective The major objective of this study is to estimate the magnitude of birth defects in Ethiopia. Subject and Methods A hospital based, retrospective, cross sectional, descriptive study was conducted. The subjects were babies/children aged 0-17years who visited selected hospitals between 2010 and 2014. Fourteen hospitals (8 in Addis Ababa, 6 in Amhara Region) were selected purposively based on case load. A data retrieving form was developed to extract relevant information from record books. Results In the hospitals mentioned, 319,776 various medical records of children aged 0-17years were found. Of these, 6,076 (1.9% with 95% CI: 1.85%-1.95%) children were diagnosed as having birth defects. The majority (58.5%) of the children were male and 41.5% female. A slightly more than half (51.1%) of the children were urban dwellers, while 48.9% were from rural areas. Among the participants of the study the proportion of birth defects ranged as follows: orofacial (34.2%), neural tube (30.8%), upper and lower limb (12.8%), cardiovascular system (10.3%), digestive system and abdominal wall (4.8%), unspecified congenital malformations (2.5%), Down syndrome (2%), genitourinary system (2%), head, face, and neck defects (0.4%), and others (0.3%). The trend of birth defects increased linearly over time [Extended Mantel-Haenszel chi square for linear trend = 356.7 (P<0.0001)]. About 275 (4.5%) of the cases had multiple (associated) birth defects and 5,801 (95.5%) isolated (single) birth defects. Out of the total birth defects, 6,018 (99%) were major and 58 (1%) minor. Conclusion The magnitude of birth defects increased from 2010-2014. Orofacial and neural tube defects contributed about two thirds of the birth defects. There is an urgent need for registry and surveillance system strategies for intervention and control of birth defects in Ethiopia.	[Taye, Molla; Afework, Mekbeb] Univ Addis Ababa, Coll Hlth Sci, Dept Anat, Addis Ababa, Ethiopia; [Fantaye, Wondwossen] Univ Addis Ababa, Sch Dent, Coll Hlth Sci, Addis Ababa, Ethiopia; [Diro, Ermias] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Internal Med, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; University of Gondar; Addis Ababa University	Taye, M (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Dept Anat, Addis Ababa, Ethiopia.	mollataye2@gmail.com			Addis Ababa University; University of Gondar	Addis Ababa University; University of Gondar	This study obtained fund from Addis Ababa University and the University of Gondar for data collection only. The authors declare that they have no fund for the publication of this manuscript. The funders have no role in the study design, data analysis and decision to publish for preparation of the manuscript.	Ahmed A. M., 2011, The Journal of American Science, V7, P899; Anyanwu LC, 2015, U J PUBLIC HLTH, V3, P89; Bakare T I B, 2009, Afr J Paediatr Surg, V6, P28, DOI 10.4103/0189-6725.48572; Barisic I, 2009, ZDRAV VESTN S1, V78; Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Central Statistical Agency [Ethiopia], 2008, STAT ABSTR POP PROJ; Christianson A, 2006, HIDDEN TOLL DYING DI; Costa Cláudia Maria da Silva, 2006, Cad. Saúde Pública, V22, P2423, DOI 10.1590/S0102-311X2006001100016; Dastgiri S, 2002, ARCH DIS CHILD, V86, P257, DOI 10.1136/adc.86.4.257; Ekwere OE., 2011, INT J PHARM SCI INVE, V3, P24; Eluwa MA., 2013, INT J PHARM SCI INVE, V2, P27; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Gonzalez-Andrade F, 2010, APPL CLIN GENET, V3, P29; Kishimba RS, 2015, PAN AFRICAN MED J, V20, DOI 10.11604/pamj.2015.20.153.4492; Kucik JE, 2012, PUBLIC HEALTH REP, V127, P52, DOI 10.1177/003335491212700106; Mashuda Florentina, 2014, BMC Res Notes, V7, P195, DOI 10.1186/1756-0500-7-195; Mazer P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-102; Muga R, 2009, AFRICAN J FOOD AGR N, V9, DOI [10.4314/ajfand.v9i3.43008, DOI 10.4314/AJFAND.V9I3.43008]; Ndibazza J, 2011, BIRTH DEFECTS RES A, V91, P857, DOI 10.1002/bdra.20838; Nordenskjold A, 2015, EUR UROL SUPPL, V14, P2, DOI 10.1016/j.eursup.2015.01.003; Obu Herbert A, 2012, BMC Res Notes, V5, P177, DOI 10.1186/1756-0500-5-177; Oliveira Camila Ive Ferreira, 2011, BMC Res Notes, V4, P343, DOI 10.1186/1756-0500-4-343; Postoev VA, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-3; Radu R., 2009, Applied Medical Informatics, V25, P37; Riley M, 2005, HIM J, V34, P94; Rizk F., 2014, U J PUBLIC HLTH, V2, P58; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Sadler T., 2010, LANGMANS MED EMBRYOL; Serra-Juhe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045530; Shawky RM., 2011, EJMHG, V12, P69, DOI [10.1016/j.ejmhg.2011.02.016, DOI 10.1016/J.EJMHG.2011.02.016]; Tomatir AG, 2009, GENET MOL RES, V8, P19, DOI 10.4238/vol8-1gmr506; van Gelder MMHJ, 2014, HUM REPROD, V29, P161, DOI 10.1093/humrep/det369; World Health Organization, 2014, BIRTH DEF SURV MAN P; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125; Zhu MT, 2006, BIRTH DEFECTS RES A, V76, P467, DOI 10.1002/bdra.20270; Zwink N, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-25	36	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161998	10.1371/journal.pone.0161998	http://dx.doi.org/10.1371/journal.pone.0161998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706169	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200005
J	Wang, QQ; Zhang, LL; Yuan, XD; Ou, Y; Zhu, XH; Cheng, ZZ; Zhang, PS; Wu, XY; Meng, Y; Zhang, LP				Wang, Quanquan; Zhang, Lili; Yuan, Xiaodong; Ou, Ya; Zhu, Xuhong; Cheng, Zanzan; Zhang, Pingshu; Wu, Xiaoying; Meng, Yan; Zhang, Liping			The Relationship between the Bcl-2/Bax Proteins and the Mitochondria-Mediated Apoptosis Pathway in the Differentiation of Adipose-Derived Stromal Cells into Neurons	PLOS ONE			English	Article							TISSUE; ULTRASTRUCTURE; DEATH	Our objective is to study the relationship between the regulatory proteins Bcl-2/Bax and mitochondria-mediated apoptosis during the differentiation of adipose-derived stromal cells (ADSCs) into neurons. Immunocytochemistry and western blotting showed that the cells weakly expressed neuron-specific enolase (NSE) in the non-induced group and expressed NSE more strongly in the groups induced for 1 h, 3 h, 5 h and 8 h. NSE expression peaked at 5 h (P < 0.05), although there was no significant difference between 5 and 8 h (P > 0.05). Bcl-2 expression gradually decreased over time in the non-induced group (P < 0.05). However, Bax, caspase-9, Cyt-c and caspase-3 expression gradually increased and peaked at 8 h (P < 0.05). Transmission electron microscopy revealed karyopyknosis, chromatin edge setting, mitochondria swelling and cavitation in cells at 5 h, and the mitochondrial membrane potential decreased over time, as demonstrated by laser scanning confocal microscopy. After a 5 h induction, cells differentiated into typical neurons and expressed Bcl-2, which inhibited apoptosis. Bax showed a strong apoptosis-promoting capacity, leading to changes in the mitochondrial membrane potential and structure, and then triggered the caspase-independent apoptotic response through the mitochondrial pathway. At the same time, Cyt-c was directly or indirectly released from the mitochondria to the cytoplasm to trigger the caspase-dependent apoptotic response through the mitochondrial pathway. Therefore, Bcl-2/Bax play an important role in regulating caspase-dependent and caspase-independent apoptosis mediated by the mitochondrial pathway during the differentiation of ADSCs into neurons.	[Wang, Quanquan; Zhang, Lili; Yuan, Xiaodong; Ou, Ya; Zhu, Xuhong; Cheng, Zanzan; Meng, Yan; Zhang, Liping] Univ Sci & Technol, Affiliated Kailuan Gen Hosp North China, Dept Neurol, Tangshan 063000, Hebei Province, Peoples R China; [Zhang, Pingshu] Key Lab Neurol & Biol Funct Hebei Prov, Tangshan 063000, Hebei Province, Peoples R China; [Wu, Xiaoying] Key Lab Neurol Tangshan, Tangshan 063000, Hebei Province, Peoples R China		Yuan, XD (corresponding author), Univ Sci & Technol, Affiliated Kailuan Gen Hosp North China, Dept Neurol, Tangshan 063000, Hebei Province, Peoples R China.	yxd68@sohu.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cai YN, 2011, NEURAL REGEN RES, V6, P750, DOI 10.3969/j.issn.1673-5374.2011.10.005; Cai YN, 2011, ZHONGHUA XINGWEI YIX, V20, P302; Dhar S, 2007, TISSUE ENG, V13, P2625, DOI 10.1089/ten.2007.0017; Faccenda D, 2013, CELL CYCLE, V12, P2530, DOI 10.4161/cc.25840; He JL, 2000, J PHARMACOL EXP THER, V295, P896; Inayat-Hussain SH, 2010, TOXICOL LETT, V193, P108, DOI 10.1016/j.toxlet.2009.12.010; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Keswani T, 2015, ENVIRON TOXICOL, V30, P411, DOI 10.1002/tox.21916; [刘斌 Liu Bin], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P15; Lu YH, 2012, NEURAL REGEN RES, V7, P1205, DOI 10.3969/j.issn.1673-5374.2012.16.001; Ou Y, 2011, ZHONGGUO BINGLI SHEN, V27, p[1414, 1212], DOI [10.3969/j.issn.1673-5374.2012.16.001, DOI 10.3969/J.ISSN.1673-5374.2012.16.001]; Ou Y, 2011, CHINESE MED J-PEKING, V124, P2656, DOI 10.3760/cma.j.issn.0366-6999.2011.17.016; Ou Y, 2011, NEURAL REGEN RES, V6, P738, DOI 10.3969/j.issn.1673-5374.2011.10.003; Vitagliano O, 2013, EXPERT REV HEMATOL, V6, P587, DOI 10.1586/17474086.2013.827415; Ye CQ, 2010, NEURAL REGEN RES, V5, P1456, DOI 10.3969/j.issn.1673-5374.2010.19.003; Yuan XD, 2011, NEURAL REGEN RES, V6, P2681, DOI 10.3969/j.issn.1673-5374.2011.34.006; Zhang LL, 2014, NEUROSCI LETT, V575, P19, DOI 10.1016/j.neulet.2014.05.025; Zhang Q., 2007, ENV OCCUP MED, V24, P102; Zhang XL, 2015, MOL MED REP, V11, P3317, DOI 10.3892/mmr.2015.3155; [周向阳 Zhou Xiangyang], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P3024; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	24	68	89	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163327	10.1371/journal.pone.0163327	http://dx.doi.org/10.1371/journal.pone.0163327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706181	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200038
J	Berman, R; Jiang, D; Wu, Q; Stevenson, CR; Schaefer, NR; Chu, HW				Berman, Reena; Jiang, Di; Wu, Qun; Stevenson, Connor R.; Schaefer, Niccolette R.; Chu, Hong Wei			MUC18 Regulates Lung Rhinovirus Infection and Inflammation	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; HUMAN-MELANOMA; KINASE M; INTERFERON; RESPONSES	Background MUC18 is upregulated in the lungs of asthma and COPD patients. It has been shown to have pro-inflammatory functions in cultured human airway epithelial cells during viral infections and in mice during lung bacterial infections. However, the in vivo role of MUC18 in the context of viral infections remains poorly understood. The goal of this study is to define the in vivo function of MUC18 during respiratory rhinovirus infection. Methods Muc18 wild-type (WT) and knockout (KO) mice were infected with human rhinovirus 1B (HRV-1B) and sacrificed after 1 day to determine the inflammatory and antiviral responses. To examine the direct effects of Muc18 on viral infection, tracheal epithelial cells isolated from WT and KO mice were grown under air-liquid interface and infected with HRV-1B. Finally, siRNA mediated knockdown of MUC18 was performed in human airway epithelial cells (AECs) to define the impact of MUC18 on human airway response to HRV-1B. Results Both viral load and neutrophilic inflammation were significantly decreased in Muc18 KO mice compared to WT mice. In the in vitro setting, viral load was significantly lower and antiviral gene expression was higher in airway epithelial cells of Muc18 KO mice than the WT mice. Furthermore, in MUC18 knockdown human AECs, viral load was decreased and antiviral gene expression was increased compared to controls. Conclusions Our study is the first to demonstrate MUC18's pro-inflammatory and pro-viral function in an in vivo mouse model of rhinovirus infection.	[Berman, Reena; Jiang, Di; Wu, Qun; Stevenson, Connor R.; Schaefer, Niccolette R.; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA	National Jewish Health	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	chuhw@njhealth.org			NHLBI NIH HHS [R01 HL125128, R01 HL122321] Funding Source: Medline; NIAID NIH HHS [R01 AI106287] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125128, R01HL122321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berman R, 2014, J CLIN CELLULAR IMMU, V5, DOI [10.4172/2155-9899.1000257, DOI 10.4172/2155-9899.1000257]; Berman R, 2016, INT J CHRONIC OBSTR, V11, P1279, DOI 10.2147/COPD.S105717; Bosco A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2405-z; Dauletbaev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143129; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Gulraiz F, 2015, FASEB J, V29, P849, DOI 10.1096/fj.14-254359; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hatchwell L, 2015, THORAX, V70, P854, DOI 10.1136/thoraxjnl-2014-205465; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Simon GC, 2011, AM J RESP CELL MOL, V44, P606, DOI 10.1165/rcmb.2010-0384OC; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; Suzuki T, 2001, AM J PHYSIOL-LUNG C, V280, pL1115, DOI 10.1152/ajplung.2001.280.6.L1115; Thitithanyanont A, 2010, BIOCHEM BIOPH RES CO, V398, P752, DOI 10.1016/j.bbrc.2010.07.017; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2013, AM J PATHOL, V182, P819, DOI 10.1016/j.ajpath.2012.11.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043	23	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163927	10.1371/journal.pone.0163927	http://dx.doi.org/10.1371/journal.pone.0163927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701461	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900034
J	Bossard, M; Kreuzmann, R; Hochgruber, T; Krisai, P; Zimmermann, AJ; Aeschbacher, S; Pumpol, K; Kessel-Schaefer, A; Stephan, FP; Handschin, N; Sticherling, C; Osswald, S; Kaufmann, BA; Pare, G; Kuhne, M; Conen, D				Bossard, Matthias; Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Handschin, Nadja; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Pare, Guillaume; Kuhne, Michael; Conen, David			Determinants of Left Atrial Volume in Patients with Atrial Fibrillation	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; CHRONIC KIDNEY-DISEASE; NATRIURETIC PEPTIDE; DIABETES-MELLITUS; RISK; SIZE; STROKE; DEATH; QUANTIFICATION; PREVALENCE	Introduction Left atrial (LA) enlargement is an important risk factor for incident stroke and a key determinant for the success of rhythm control strategies in patients with atrial fibrillation (AF). However, factors associated with LA volume in AF patients remain poorly understood. Methods Patients with paroxysmal or persistent AF were enrolled in this study. Real time 3-D echocardiography was performed in all participants and analyzed offline in a standardized manner. We performed stepwise backward linear regression analyses using a broad set of clinical parameters to determine independent correlates for 3-D LA volume. Results We included 210 patients (70.9% male, mean age 61 +/- 11years). Paroxysmal and persistent AF were present in 95 (45%) and 115 (55%) patients, respectively. Overall, 115 (55%) had hypertension, 11 (5%) had diabetes, and 18 (9%) had ischemic heart disease. Mean indexed LA volume was 36 +/- 12ml/m(2). In multivariable models, significant associations were found for female sex (beta coefficient -10.51 (95% confidence interval (CI) -17.85;-3.16), p = 0.0053), undergoing cardioversion (beta 11.95 (CI 5.15; 18.74), p = 0.0006), diabetes (beta 14.23 (CI 2.36; 26.10), p = 0.019), body surface area (BSA) (beta 34.21 (CI 19.30; 49.12), p< 0.0001), glomerular filtration rate (beta -0.21 (CI -0.36; -0.06), p = 0.0064) and plasma levels of NT-pro brain natriuretic peptide (NT-proBNP) (beta 6.79 (CI 4.05; 9.52), p<0.0001), but not age (p = 0.59) or hypertension (p = 0.42). Our final model explained 52% of the LA volume variability. Conclusions In patients with AF, the most important correlates with LA volume are sex, BSA, diabetes, renal function and NT-proBNP, but not age or hypertension. These results may help to refine rhythm control strategies in AF patients.	[Bossard, Matthias] McMaster Univ, Div Cardiol, Hamilton Gen Hosp, Hamilton Hlth Sci, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Bossard, Matthias; Pare, Guillaume] McMaster Univ, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Bossard, Matthias; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Kuhne, Michael; Conen, David] Univ Basel Hosp, Div Cardiol, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Bossard, Matthias; Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Handschin, Nadja; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Kuhne, Michael; Conen, David] Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland; [Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Conen, David] Univ Basel Hosp, Dept Med, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Michael G DeGroote Sch Med, 1280 Main St West, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University; Population Health Research Institute; University of Basel; University of Basel; University of Basel; McMaster University	Conen, D (corresponding author), Univ Basel Hosp, Div Cardiol, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.; Conen, D (corresponding author), Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland.; Conen, D (corresponding author), Univ Basel Hosp, Dept Med, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland.	david.conen@usb.ch	Kaufmann, Beat/AAB-7805-2022; Aeschbacher, Stefanie/E-4935-2017; Osswald, Stefan/A-6904-2018; Sticherling, Christian/AAY-4435-2021; Pare, Guillaume/T-9631-2018; Kühne, Michael/AAB-5202-2022	Osswald, Stefan/0000-0002-9240-6731; Sticherling, Christian/0000-0001-8428-7050; Pare, Guillaume/0000-0002-6795-4760; Kühne, Michael/0000-0002-2937-3711; Kaufmann, Beat/0000-0001-6295-3630	Mach Gaensslen Foundation; University Hospital Basel; Freie Akademische Gesellschaft (FAG) Basel; Swiss National Science Foundation [PP00P3_133681, PP00P3_159322, 3232B0_141603, 310030_149718]	Mach Gaensslen Foundation; University Hospital Basel; Freie Akademische Gesellschaft (FAG) Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a grant of the Mach Gaensslen Foundation and the University Hospital Basel. Matthias Bossard was supported by a grant of the University of Basel and the Freie Akademische Gesellschaft (FAG) Basel. David Conen and Beat Kaufmann were supported by grants of the Swiss National Science Foundation (PP00P3_133681 and PP00P3_159322 to David Conen, 3232B0_141603 and 310030_149718 to Beat Kaufmann).	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bansal N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001303; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; Buechel RR, 2013, INT J CARDIOVAS IMAG, V29, P601, DOI 10.1007/s10554-012-0127-0; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cappato R, 2009, J AM COLL CARDIOL, V53, P1798, DOI 10.1016/j.jacc.2009.02.022; Conen D, 2013, INT J CARDIOL, V168, P1894, DOI 10.1016/j.ijcard.2012.12.060; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; D'Andrea A, 2013, ECHOCARDIOGR-J CARD, V30, P1001, DOI 10.1111/echo.12217; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Gupta S, 2013, EUR HEART J, V34, P278, DOI 10.1093/eurheartj/ehs188; Heo R, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0032-5; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hwang HJ, 2009, CLIN RES CARDIOL, V98, P213, DOI 10.1007/s00392-009-0744-3; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kadappu KK, 2014, ECHOCARDIOGR-J CARD, V31, P956, DOI 10.1111/echo.12503; Kadappu KK, 2012, EUR HEART J-CARD IMG, V13, P1016, DOI 10.1093/ehjci/jes084; Kou S, 2014, EUR HEART J-CARD IMG, V15, P680, DOI 10.1093/ehjci/jet284; Llombart V, 2015, STROKE, V46, P1187, DOI 10.1161/STROKEAHA.114.008311; Mor-Avi V, 2012, JACC-CARDIOVASC IMAG, V5, P769, DOI 10.1016/j.jcmg.2012.05.011; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Parkash R, 2004, AM HEART J, V148, P649, DOI 10.1016/j.ahj.2004.04.029; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Rohner A, 2011, EUR J ECHOCARDIOGR, V12, P497, DOI 10.1093/ejechocard/jer066; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Solheim E, 2012, J INTERV CARD ELECTR, V34, P129, DOI 10.1007/s10840-011-9629-2; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Zimmermann AJ, 2015, CAN J CARDIOL, V31, P36, DOI 10.1016/j.cjca.2014.10.032	38	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164145	10.1371/journal.pone.0164145	http://dx.doi.org/10.1371/journal.pone.0164145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701468	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900045
J	Esmail, H; Oni, T; Thienemann, F; Omar-Davies, N; Wilkinson, RJ; Ntsekhe, M				Esmail, Hanif; Oni, Tolu; Thienemann, Friedrich; Omar-Davies, Nashreen; Wilkinson, Robert J.; Ntsekhe, Mpiko			Cardio-Thoracic Ratio Is Stable, Reproducible and Has Potential as a Screening Tool for HIV-1 Related Cardiac Disorders in Resource Poor Settings	PLOS ONE			English	Article							HEART-DISEASE; DILATED CARDIOMYOPATHY; CHEST ROENTGENOGRAM; FAILURE; ADULTS; ECHOCARDIOGRAPHY; ENLARGEMENT; MARKER; SIZE	Background Cardiovascular disorders are common in HIV-1 infected persons in Africa and presentation is often insidious. Development of screening algorithms for cardiovascular disorders appropriate to a resource-constrained setting could facilitate timely referral. Cardiothoracic ratio (CTR) on chest radiograph (CXR) has been suggested as a potential screening tool but little is known about its reproducibility and stability. Our primary aim was to evaluate the stability and the inter-observer variability of CTR in HIV-1 infected outpatients. We further evaluated the prevalence of cardiomegaly (CTR >= 0.5) and its relationship with other risk factors in this population. Methodology HIV-1 infected participants were identified during screening for a tuberculosis vaccine trial in Khayelitsha, South Africa between August 2011 and April 2012. Participants had a digital posterior-anterior CXR performed as well as history, examination and baseline observations. CXRs were viewed using OsiriX software and CTR calculated using digital callipers. Results 450 HIV-1-infected adults were evaluated, median age 34 years (IQR 30-40) with a CD4 count 566/mm(3) (IQR 443-724), 70% on antiretroviral therapy (ART). The prevalence of cardiomegaly was 12.7% (95% C. I. 9.6%-15.8%). CTR was calculated by a 2 nd reader for 113 participants, measurements were highly correlated r = 0.95 (95% C. I. 0.93-0.97) and agreement of cardiomegaly substantial k = 0.78 (95% C. I 0.61-0.95). CXR were repeated in 51 participants at 4-12 weeks, CTR measurements between the 2 time points were highly correlated r = 0.77 (95% C. I 0.68-0.88) and agreement of cardiomegaly excellent. = 0.92 (95% C. I. 0.77-1). Participants with cardiomegaly had a higher median BMI (31.3; IQR 27.4-37.4) versus 26.9; IQR 23.2-32.4); p<0.0001) and median systolic blood pressure (130; IQR 121-141 versus 125; IQR 117-135; p = 0.01). Conclusion CTR is a robust measurement, stable over time with substantial inter-observer agreement. A prospective study evaluating utility of CXR to identify cardiovascular disorder in this population is warranted.	[Esmail, Hanif; Oni, Tolu; Thienemann, Friedrich; Omar-Davies, Nashreen; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa; [Esmail, Hanif; Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Esmail, Hanif] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Oni, Tolu] Univ Cape Town, Div Publ Hlth Med, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Thienemann, Friedrich; Wilkinson, Robert J.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Wilkinson, Robert J.] Francis Crick Inst, Mill Hill Lab, London, England; [Ntsekhe, Mpiko] Univ Cape Town, Div Cardiol, Dept Med, Cape Town, South Africa	University of Cape Town; Imperial College London; University of Oxford; University of Cape Town; University of Cape Town; Francis Crick Institute; University of Cape Town	Esmail, H (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa.; Esmail, H (corresponding author), Imperial Coll London, Dept Med, London, England.; Esmail, H (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.	hanif.esmail@ndols.ox.ac.uk	ntsekhe, mpiko/AAI-8001-2021; Thienemann, Friedrich/AAX-1197-2020	ntsekhe, mpiko/0000-0002-0851-7675; Thienemann, Friedrich/0000-0002-4801-2030; Esmail, Hanif/0000-0002-4278-9316; Wilkinson, Robert/0000-0002-2753-1800; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10218] Funding Source: researchfish; Wellcome Trust [090170] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; Wellcome Trust(Wellcome TrustEuropean Commission)		Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6; Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; Danzer CS, 1919, AM J MED SCI, V157, P513, DOI 10.1097/00000441-191904000-00007; DAVIS JL, 1986, AM J CARDIOL, V58, P658, DOI 10.1016/0002-9149(86)90300-0; Dimopoulos K, 2013, INT J CARDIOL, V166, P453, DOI 10.1016/j.ijcard.2011.10.125; Fukuta H, 2007, AM J CARDIOL, V99, P62, DOI 10.1016/j.amjcard.2006.07.067; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; General Assembly of the United Nations, 2011, POL DECL HIGH LEV M; Hemingway H, 1998, EUR HEART J, V19, P859, DOI 10.1053/euhj.1997.0862; Herman CR, 2002, AM J ROENTGENOL, V179, P825, DOI 10.2214/ajr.179.4.1790825; KONO T, 1992, JPN CIRC J, V56, P359, DOI 10.1253/jcj.56.359; Loomba RS, 2015, FUTUR CARDIOL, V11, P171, DOI [10.2217/fca.15.5, 10.2217/FCA.15.5]; Morales MA, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.96540; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; OBERMAN A, 1967, CIRCULATION, V35, P724, DOI 10.1161/01.CIR.35.4.724; Petrie MC, 2003, EUR J HEART FAIL, V5, P117, DOI 10.1016/S1388-9842(02)00239-8; Remick J, 2014, CIRCULATION, V129, P1781, DOI 10.1161/CIRCULATIONAHA.113.004574; Reuter H, 2005, Cardiovasc J S Afr, V16, P108; Schwartz T, 2012, INT HEALTH, V4, P30, DOI 10.1016/j.inhe.2011.12.003; Sigurdsson E, 1996, AM J CARDIOL, V78, P1355, DOI 10.1016/S0002-9149(96)00650-9; Sliwa K, 2012, EUR HEART J, V33, P866, DOI 10.1093/eurheartj/ehr398; Thienemann F, 2013, EUR HEART J, V34, P3538, DOI 10.1093/eurheartj/eht388; WALKER ARP, 1972, POSTGRAD MED J, V48, P584, DOI 10.1136/pgmj.48.564.584	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163490	10.1371/journal.pone.0163490	http://dx.doi.org/10.1371/journal.pone.0163490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701421	Green Submitted, Green Published, gold			2022-12-26	WOS:000385696900008
J	Lee, DW; Hsu, HL; Bacon, KB; Daniel, S				Lee, Donald W.; Hsu, Hung-Lun; Bacon, Kaitlyn B.; Daniel, Susan			Image Restoration and Analysis of Influenza Virions Binding to Membrane Receptors Reveal Adhesion-Strengthening Kinetics	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; SUPPORTED LIPID-BILAYERS; A VIRUS HEMAGGLUTININ; SIALIC-ACID; SUPERRESOLUTION MICROSCOPY; REOVIRUS ATTACHMENT; ELECTRON-MICROSCOPY; MOLECULE TRACKING; FUSION; PLANAR	With the development of single-particle tracking (SPT) microscopy and host membrane mimics called supported lipid bilayers (SLBs), stochastic virus-membrane binding interactions can be studied in depth while maintaining control over host receptor type and concentration. However, several experimental design challenges and quantitative image analysis limitations prevent the widespread use of this approach. One main challenge of SPT studies is the low signal-to-noise ratio of SPT videos, which is sometimes inevitable due to small particle sizes, low quantum yield of fluorescent dyes, and photobleaching. These situations could render current particle tracking software to yield biased binding kinetic data caused by intermittent tracking error. Hence, we developed an effective image restoration algorithm for SPT applications called STAWASP that reveals particles with a signal-to-noise ratio of 2.2 while preserving particle features. We tested our improvements to the SPT binding assay experiment and imaging procedures by monitoring X31 influenza virus binding to alpha 2,3 sialic acid glycolipids. Our interests lie in how slight changes to the peripheral oligosaccharide structures can affect the binding rate and residence times of viruses. We were able to detect viruses binding weakly to a glycolipid called G(M3), which was undetected via assays such as surface plasmon resonance. The binding rate was around 28 folds higher when the virus bound to a different glycolipid called G(D1a), which has a sialic acid group extending further away from the bilayer surface than G(M3). The improved imaging allowed us to obtain binding residence time distributions that reflect an adhesion-strengthening mechanism via multivalent bonds. We empirically fitted these distributions using a time-dependent unbinding rate parameter, k(off), which diverges from standard treatment of k(off) as a constant. We further explain how to convert these models to fit ensemble-averaged binding data obtained by assays such as surface plasmon resonance.	[Lee, Donald W.; Hsu, Hung-Lun; Bacon, Kaitlyn B.; Daniel, Susan] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA	Cornell University	Lee, DW; Daniel, S (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.	dwl57@cornell.edu; sd386@cornell.edu			National Science Foundation (NSF) [DGE-1045513, DGE-0841291]; Engineering Learning Initiative fund; NSF [CBET-1263701, ECCS-0335765]	National Science Foundation (NSF)(National Science Foundation (NSF)); Engineering Learning Initiative fund; NSF(National Science Foundation (NSF))	DWL acknowledges financial support from the National Science Foundation (NSF) GK12 programs, award number DGE-1045513 to Cornell's Grass Roots program and award number DGE-0841291 to Cornell's Learning Initiative for Medicine and Bioengineering (CLIMB) program. KBB acknowledges support from the Engineering Learning Initiative fund, with donations from Genentech and Proctor & Gamble. We thank the NSF (grant CBET-1263701) for financial support for this project. This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network supported by the NSF (grant ECCS-0335765). The funding agencies did not influence the study design, data collection and analysis, or manuscript submission.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Balasubramanian S., 2009, INT C CONTR AUT COMM; Bally M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026011; Bally M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188103; Bally M, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-4; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; Chao L, 2011, J AM CHEM SOC, V133, P15635, DOI 10.1021/ja205274g; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Costello DA, 2015, J VIROL, V89, P350, DOI 10.1128/JVI.01927-14; Costello DA, 2013, LANGMUIR, V29, P6409, DOI 10.1021/la400861u; Costello DA, 2012, ANAL CHEM, V84, P8480, DOI 10.1021/ac3006473; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Cureton DK, 2012, J VIROL, V86, P5330, DOI 10.1128/JVI.07194-11; Dupont A, 2013, BIOPHYS J, V104, P2373, DOI 10.1016/j.bpj.2013.04.005; Endesfelder U, 2014, NAT METHODS, V11, P235, DOI 10.1038/nmeth.2852; Enoki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049208; Esakkirajan S, 2011, IEEE SIGNAL PROC LET, V18, P287, DOI 10.1109/LSP.2011.2122333; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Greenwood R, 1999, J EUR CERAM SOC, V19, P479, DOI 10.1016/S0955-2219(98)00208-8; GREIFF D, 1954, J EXP MED, V100, P89, DOI 10.1084/jem.100.1.89; Hayden O, 2003, SENSOR ACTUAT B-CHEM, V91, P316, DOI 10.1016/S0925-4005(03)00093-5; HAYWOOD AM, 1994, J VIROL, V68, P1; Hidari KIPJ, 2007, GLYCOCONJUGATE J, V24, P583, DOI 10.1007/s10719-007-9055-y; Hu JL, 2013, P NATL ACAD SCI USA, V110, P15283, DOI 10.1073/pnas.1305766110; HUERTAS A, 1986, IEEE T PATTERN ANAL, V8, P651, DOI 10.1109/TPAMI.1986.4767838; Ivanovic T, 2013, ELIFE, V2, DOI 10.7554/eLife.00333; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jaqaman Khuloud, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.top65; JERRI AJ, 1977, P IEEE, V65, P1565, DOI 10.1109/PROC.1977.10771; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; Karatekin E, 2012, NAT PROTOC, V7, P903, DOI 10.1038/nprot.2012.019; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee DW, 2016, J VIROL, V90, P4849, DOI 10.1128/JVI.03204-15; Lee DW, 2014, BIOPHYS J, V106, P843, DOI 10.1016/j.bpj.2013.12.048; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Otterstrom J, 2013, BIOCHEMISTRY-US, V52, P1654, DOI 10.1021/bi301573w; Richards MJ, 2016, LANGMUIR, V32, P2963, DOI 10.1021/acs.langmuir.5b03415; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rowland DJ, 2014, CHEMPHYSCHEM, V15, P712, DOI 10.1002/cphc.201300774; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; RUIGROK RWH, 1984, J GEN VIROL, V65, P799, DOI 10.1099/0022-1317-65-4-799; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Saint-Michel E, 2009, BIOPHYS J, V97, P480, DOI 10.1016/j.bpj.2009.04.044; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Seu KJ, 2007, BIOPHYS J, V92, P2445, DOI 10.1529/biophysj.106.099721; Small A, 2014, NAT METHODS, V11, P267, DOI [10.1038/NMETH.2844, 10.1038/nmeth.2844]; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Stettner E, 2015, J VIROL, V89, P6136, DOI 10.1128/JVI.00433-15; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; SUZUKI Y, 1992, VIROLOGY, V189, P121, DOI 10.1016/0042-6822(92)90687-K; Szklarczyk OM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003310; Takahashi T, 2013, GLYCOCONJUGATE J, V30, P709, DOI 10.1007/s10719-013-9477-7; Takemoto DK, 1996, VIROLOGY, V217, P452, DOI 10.1006/viro.1996.0139; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wessels L, 2007, BIOPHYS J, V93, P526, DOI 10.1529/biophysj.106.097485; Witt H, 2016, BIOPHYS J, V110, P1582, DOI 10.1016/j.bpj.2016.03.006; Woll D, 2013, PHYS CHEM CHEM PHYS, V15, P6196, DOI 10.1039/c3cp44693j; XU YS, 1994, IEEE T IMAGE PROCESS, V3, P747, DOI 10.1109/83.336245	74	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163437	10.1371/journal.pone.0163437	http://dx.doi.org/10.1371/journal.pone.0163437			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695072	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100033
J	Martin, AJM; Dominguez, C; Contreras-Riquelme, S; Holmes, DS; Perez-Acle, T				Martin, Alberto J. M.; Dominguez, Calixto; Contreras-Riquelme, Sebastian; Holmes, David S.; Perez-Acle, Tomas			Graphlet Based Metrics for the Comparison of Gene Regulatory Networks	PLOS ONE			English	Article							EVOLUTIONARY CONSERVATION; TRANSCRIPTION FACTORS; EXPRESSION; MOTIFS	Understanding the control of gene expression remains one of the main challenges in the post-genomic era. Accordingly, a plethora of methods exists to identify variations in gene expression levels. These variations underlay almost all relevant biological phenomena, including disease and adaptation to environmental conditions. However, computational tools to identify how regulation changes are scarce. Regulation of gene expression is usually depicted in the form of a gene regulatory network (GRN). Structural changes in a GRN over time and conditions represent variations in the regulation of gene expression. Like other biological networks, GRNs are composed of basic building blocks called graphlets. As a consequence, two new metrics based on graphlets are proposed in this work: REConstruction Rate (REC) and REC Graphlet Degree (RGD). REC determines the rate of graphlet similarity between different states of a network and RGD identifies the subset of nodes with the highest topological variation. In other words, RGD discerns how th GRN was rewired. REC and RGD were used to compare the local structure of nodes in condition-specific GRNs obtained from gene expression data of Escherichia coli, forming biofilms and cultured in suspension. According to our results, most of the network local structure remains unaltered in the two compared conditions. Nevertheless, changes reported by RGD necessarily imply that a different cohort of regulators (i.e. transcription factors (TFs)) appear on the scene, shedding light on how the regulation of gene expression occurs when E. coli transits from suspension to biofilm. Consequently, we propose that both metrics REC and RGD should be adopted as a quantitative approach to conduct differential analyses of GRNs. A tool that implements both metrics is available as an on-line web server (http://dlab.cl/loto).	[Martin, Alberto J. M.; Dominguez, Calixto; Contreras-Riquelme, Sebastian; Perez-Acle, Tomas] Fdn Ciencia & Vida, Computat Biol Lab, Santiago, Chile; [Martin, Alberto J. M.; Perez-Acle, Tomas] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Dominguez, Calixto; Holmes, David S.] Univ Andres Bello, Ctr Bioinformat & Genome Biol, Fdn Ciencia & Vida, Santiago, Chile; [Dominguez, Calixto; Holmes, David S.] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile	Universidad de Valparaiso; Universidad Andres Bello; Universidad Andres Bello	Martin, AJM; Perez-Acle, T (corresponding author), Fdn Ciencia & Vida, Computat Biol Lab, Santiago, Chile.; Martin, AJM; Perez-Acle, T (corresponding author), Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	ajmm@dlab.cl; tomas@dlab.cl	Perez-Acle, Tomas/F-7176-2012	Perez-Acle, Tomas/0000-0002-3769-390X; Holmes, David/0000-0001-9555-138X; Martin, Alberto J/0000-0002-6147-3325	Proyecto Basal from Fundacion Ciencia & Vida (FCV) Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA) [PFB16]; Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia] [P09-022-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [11140342, 1130683, 3140007]; Universidad Andres Bello; Chilean National Laboratory for High Performance Computing (NLHPC) [ECM-02]	Proyecto Basal from Fundacion Ciencia & Vida (FCV) Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA); Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia]; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello; Chilean National Laboratory for High Performance Computing (NLHPC)	The authors acknowledge partial economical support from Proyecto Basal from Fundacion Ciencia & Vida (FCV) [PFB16] Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA http://www.conicyt.cl/pia/) and Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia P09-022-F] (http://www.iniciativamilenio.cl/). AJMM and SCR acknowledge economical support from Fondo Nacional de Desarrollo Cientifico y Tecnologico project [11140342] (FONDECYT http://www.conicyt.cl/fondecyt/). SCR acknowledges economical support from Beca asistencia academica from Universidad Andres Bello (http://www.unab.cl/). CD acknowledges economical support from Fondo Nacional de Desarrollo Cientifico y Tecnologico postdoctoral project [3140007] (FONDECYT http//www.concyt.cl/fondecyt/). DSH acknowledges economical support to Fondo Nacional de Desarrollo Cientifico y Tecnologico project [1130683] (FONDECYT http://www.conicyt.cl/fondecyt/). Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the Chilean National Laboratory for High Performance Computing (NLHPC) [ECM-02] (Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA http://www.conicyt.cl/pia/).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artzy-Randrup Yael, 2004, Science, V305, P1107; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Ben Hassen H, 2008, J THEOR BIOL, V253, P717, DOI 10.1016/j.jtbi.2008.04.030; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Cheng XR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0574; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Faisal FE, 2014, BIOINFORMATICS, V30, P1721, DOI 10.1093/bioinformatics/btu089; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Guo YC, 2011, EXP BIOL MED, V236, P628, DOI 10.1258/ebm.2011.010324; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hulovatyy Y, 2015, BIOINFORMATICS, V31, P171, DOI 10.1093/bioinformatics/btv227; Jin RM, 2007, IEEE DATA MINING, P541, DOI 10.1109/ICDM.2007.92; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Knabe JF, 2008, BIOSYSTEMS, V94, P68, DOI 10.1016/j.biosystems.2008.05.012; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114503; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Narang V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004504; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Palumbo MC, 2005, FEBS LETT, V579, P4642, DOI 10.1016/j.febslet.2005.07.033; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Caso C, 2009, MOL BIOSYST, V5, P1617, DOI [10.1039/b904960f, 10.1039/B904960f]; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Ruan D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0735-5; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Silva F, 2015, ARXIV151101964; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wong SWH, 2015, PROTEOMICS, V15, P608, DOI 10.1002/pmic.201400233; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yang TH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-102; Yaveroglu ON, 2015, BIOINFORMATICS, V31, P2697, DOI 10.1093/bioinformatics/btv170; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zickenrott S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.393	48	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163497	10.1371/journal.pone.0163497	http://dx.doi.org/10.1371/journal.pone.0163497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695050	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100037
J	Sedegah, M; Peters, B; Hollingdale, MR; Ganeshan, HD; Huang, J; Farooq, F; Belmonte, MN; Belmonte, AD; Limbach, KJ; Diggs, C; Soisson, L; Chuang, I; Villasante, ED				Sedegah, Martha; Peters, Bjoern; Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.; Diggs, Carter; Soisson, Lorraine; Chuang, Ilin; Villasante, Eileen D.			Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes	PLOS ONE			English	Article							ALTERED PEPTIDE LIGANDS; CLASS-I SUPERTYPES; T-CELL RECEPTOR; MALARIA; BINDING; PROTEIN; IMMUNIZATION; ORIENTATION; PREDICTIONS; AFFINITIES	A DNA prime/adenovirus boost malaria vaccine encoding Plasmodium falciparum strain 3D7 CSP and AMA1 elicited sterile clinical protection associated with CD8+ T cell interferon-gamma (IFN-gamma) cells responses directed to HLA class 1-restricted AMA1 epitopes of the vaccine strain 3D7. Since a highly effective malaria vaccine must be broadly protective against multiple P. falciparum strains, we compared these AMA1 epitopes of two P. falciparum strains (7G8 and 3D7), which differ by single amino acid substitutions, in their ability to recall CD8+ T cell activities using ELISpot and flow cytometry/intracellular staining assays. The 7G8 variant peptides did not recall 3D7 vaccine-induced CD8+ T IFN-gamma cell responses in these assays, suggesting that protection may be limited to the vaccine strain. The predicted MHC binding affinities of the 7G8 variant epitopes were similar to the 3D7 epitopes, suggesting that the amino acid substitutions of the 7G8 variants may have interfered with TCR recognition of the MHC: peptide complex or that the 7G8 variant may have acted as an altered peptide ligand. These results stress the importance of functional assays in defining protective epitopes.	[Sedegah, Martha; Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.; Chuang, Ilin; Villasante, Eileen D.] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD 20910 USA; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD 20817 USA; [Diggs, Carter; Soisson, Lorraine] USAID, Washington, DC 20523 USA	Naval Medical Research Center (NMRC); La Jolla Institute for Immunology; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Agency for International Development (USAID)	Hollingdale, MR (corresponding author), Naval Med Res Ctr, Malaria Dept, Silver Spring, MD 20910 USA.; Hollingdale, MR (corresponding author), Henry M Jackson Fdn Adv Mil Med, Rockville, MD 20817 USA.	Michael.r.hollingdale.ctr@mail.mil		Farooq, Fouzia/0000-0001-6491-6323	United States Agency for International Development [GHA-P-00-03-00006-01, 936-3118]; Congressionally Directed Medical Research Program [W81XWH-05-2-0041]; Military Infectious Research Program [62787A 870 F 1432]	United States Agency for International Development(United States Agency for International Development (USAID)); Congressionally Directed Medical Research Program(United States Department of Defense); Military Infectious Research Program	This study was supported by the United States Agency for International Development "Development of Adenovirus-Vectored Malaria Vaccines" interagency agreement # GHA-P-00-03-00006-01, project number 936-3118, www.usaid.gov, recipient EV; Congressionally Directed Medical Research Program (https//cdmrp.org) "Development of Recombinant Adenoviral-based Vaccines against Malaria", grant # W81XWH-05-2-0041, recipient EV; Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-naive adults", work unit number 62787A 870 F 1432, https://midrp.amedd.army.mil, recipient EV. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Bermudez A, 2014, VACCINE, V32, P2117, DOI 10.1016/j.vaccine.2014.02.003; Bronke C, 2013, AIDS, V27, P899, DOI 10.1097/QAD.0b013e32835e1616; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Elias SC, 2013, J IMMUNOL, V190, P1135, DOI 10.4049/jimmunol.1201455; Patarroyo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123249; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Flanagan KL, 2016, EXPERT REV VACCINES, V15, P389, DOI 10.1586/14760584.2016.1125785; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Hawse WF, 2014, J IMMUNOL, V192, P2885, DOI 10.4049/jimmunol.1302953; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hodgson SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00686; Kirkman LA, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0022-2014; Lee EAM, 2006, EUR J IMMUNOL, V36, P1168, DOI 10.1002/eji.200526010; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mantzourani ED, 2007, J MOL GRAPH MODEL, V26, P471, DOI 10.1016/j.jmgm.2007.02.004; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Plebanski M, 1999, NAT MED, V5, P565, DOI 10.1038/8444; Plebanski M, 1997, PARASITOLOGY, V115, pS55, DOI 10.1017/S0031182097002035; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Tamminga C, 2013, HUM VACC IMMUNOTHER, V9, P2165, DOI 10.4161/hv.24941; Terheggen U, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0183-5; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Valkenburg SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3663; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wilson KL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00303	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163026	10.1371/journal.pone.0163026	http://dx.doi.org/10.1371/journal.pone.0163026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695088	gold, Green Published			2022-12-26	WOS:000385553100020
J	Kapila, N; Sharma, A; Kishore, A; Sodhi, M; Tripathi, PK; Mohanty, AK; Mukesh, M				Kapila, Neha; Sharma, Ankita; Kishore, Amit; Sodhi, Monika; Tripathi, Pawan K.; Mohanty, Ashok K.; Mukesh, Manishi			Impact of Heat Stress on Cellular and Transcriptional Adaptation of Mammary Epithelial Cells in Riverine Buffalo (Bubalus Bubalis)	PLOS ONE			English	Article							GENE-EXPRESSION; DAIRY-CATTLE; IN-VITRO; GRANULOSA-CELLS; DRY PERIOD; PCR DATA; PROTEIN; SHOCK; APOPTOSIS; MODEL	The present study aims to identify the heat responsive genes and biological pathways in heat stressed buffalo mammary epithelial cells (MECs). The primary mammary epithelial cells of riverine buffalo were exposed to thermal stress at 42 degrees C for one hour. The cells were subsequently allowed to recover at 37 degrees C and harvested at different time intervals (30 min to 48 h) along with control samples (un-stressed). In order to assess the impact of heat stress in buffalo MECs, several in-vitro cellular parameters (lactate dehydrogenase activity, cell proliferation assay, cellular viability, cell death and apoptosis) and transcriptional studies were conducted. The heat stress resulted in overall decrease in cell viability and cell proliferation of MECs while induction of cellular apoptosis and necrosis. The transcriptomic profile of heat stressed MECs was generated using Agilent 44 K bovine oligonucleotide array and at cutoff criteria of >= 3-or <= 3 fold change, a total of 153 genes were observed to be upregulated while 8 genes were down regulated across all time points post heat stress. The genes that were specifically up-regulated or down-regulated were identified as heat responsive genes. The upregulated genes in heat stressed MECs belonged to heat shock family viz., HSPA6, HSPB8, DNAJB2, HSPA1A. Along with HSPs, genes like BOLA, MRPL55, PFKFB3, PSMC2, ENDODD1, ARID5A, and SENP3 were also upregulated. Microarray data revealed that the heat responsive genes belonged to different functional classes viz., chaperons; immune responsive; cell proliferation and metabolism related. Gene ontology analysis revealed enrichment of several biological processes like; cellular process, metabolic process, response to stimulus, biological regulation, immune system processes and signaling. The transcriptome analysis data was further validated by RT-qPCR studies. Several HSP (HSP40, HSP60, HSP70, HSP90, and HSPB1), apoptotic (Bax and Bcl2), immune (IL6, TNF alpha and NF-kappa beta) and oxidative stress (GPX1 and DUSP1) related genes showed differential expression profile at different time points post heat stress. The transcriptional data strongly indicated the induction of survival/apoptotic mechanism in heat stressed buffalo MECs. The overrepresented pathways across all time points were; electron transport chain, cytochrome P450, apoptosis, MAPK, FAS and stress induction of HSP regulation, delta Notch signaling, apoptosis modulation by HSP70, EGFR1 signaling, cytokines and inflammatory response, oxidative stress, TNF-alpha and NF-kappa B signaling pathway. The study thus identified several genes from different functional classes and biological pathways that could be termed as heat responsive in buffalo MEC. The responsiveness of buffalo MECs to heat stress in the present study clearly suggested its suitability as a model to understand the modulation of buffalo mammary gland expression signature in response to environmental heat load.	[Kapila, Neha; Sharma, Ankita; Kishore, Amit; Sodhi, Monika; Mukesh, Manishi] ICAR Natl Bur Anim Genet Resources, Karnal 132001, Haryana, India; [Kapila, Neha; Tripathi, Pawan K.] Singhania Univ, Jhunjhunu, Rajasthan, India; [Mohanty, Ashok K.] ICAR Natl Dairy Res Inst, Karnal 132001, Haryana, India; [Kishore, Amit] Palacky Univ, Fac Med & Dent, Lab Immunogen, Dept Pathol Physiol, Olomouc, Czech Republic	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Palacky University Olomouc	Mukesh, M (corresponding author), ICAR Natl Bur Anim Genet Resources, Karnal 132001, Haryana, India.	mmukesh_26@hotmail.com	Kishore, Amit/G-1785-2015	Kishore, Amit/0000-0002-8051-1593	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi [27(3)/2010-HRD]; ICAR; National Fellow project of Indian Council of Agricultural Research, New Delhi	National Fellow Scheme of Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); ICAR(Indian Council of Agricultural Research (ICAR)); National Fellow project of Indian Council of Agricultural Research, New Delhi	This work was supported under National Fellow Scheme of Indian Council of Agricultural Research, New Delhi. Grant number: 27(3)/2010-HRD, http://www.icar.org.in/files/edu/Award-of-National-Fellow.pdf. MM-Principal Scientist and National fellow received the funding from ICAR.; The authors duly acknowledge the financial support received for this study under National Fellow project of Indian Council of Agricultural Research, New Delhi. The authors also acknowledge Director, ICAR-NBAGR, Karnal for providing research facilities during the course of this study.	Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Adnan M, 2011, MOL CELL BIOCHEM, V357, P275, DOI 10.1007/s11010-011-0898-y; Agnew LL, 2008, VET IMMUNOL IMMUNOP, V123, P197, DOI 10.1016/j.vetimm.2008.01.038; Albers R, 1996, TOXICOL APPL PHARM, V140, P70, DOI 10.1006/taap.1996.0198; Amaral MEJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-631; Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basu, 1985, GENETIC IMPROVEMENT; BECK SC, 1995, AM J PHYSIOL-REG I, V269, pR608, DOI 10.1152/ajpregu.1995.269.3.R608; Bonnet A, 2008, REPRODUCTION, V136, P211, DOI 10.1530/REP-07-0312; Cabello CM, 2009, FREE RADICAL BIO MED, V46, P220, DOI 10.1016/j.freeradbiomed.2008.10.025; Calderon-Villalobos LIA, 2007, GENE, V392, P106, DOI 10.1016/j.gene.2006.11.016; Chase LE, 2006, CLIMATE CHANGE AGR P, P8; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Collier RJ, 2006, J DAIRY SCI, V89, P1244, DOI 10.3168/jds.S0022-0302(06)72193-2; Dangi SS, 2012, TROP ANIM HEALTH PRO, V44, P1905, DOI 10.1007/s11250-012-0155-8; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; Dehbi M, 2010, CELL STRESS CHAPERON, V15, P593, DOI 10.1007/s12192-010-0172-3; Del Vesco AP, 2013, J ANIM SCI, V91, P582, DOI 10.2527/jas.2012-5498; Desarnaud F, 2008, CELL ADHES MIGR, V2, P38, DOI 10.4161/cam.2.1.6013; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du Juan, 2006, Acta Zoologica Sinica, V52, P959; Du J, 2008, J THERM BIOL, V33, P37, DOI 10.1016/j.jtherbio.2007.06.002; Du Juan, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P471; Ehmann UK, 2003, CELL PROLIFERAT, V36, P177, DOI 10.1046/j.1365-2184.2003.00265.x; FAO, 2000, WAT BUFF ASS UND; Fehrenbach E, 2000, MED SCI SPORT EXER, V32, P592, DOI 10.1097/00005768-200003000-00007; Ferencz A, 2012, ACTA BIOL HUNG, V63, P15, DOI 10.1556/ABiol.63.2012.1.2; Fernando WGD, 2005, SOIL BIOL BIOCHEM, V37, P955, DOI 10.1016/j.soilbio.2004.10.021; Gaughan JB, 1999, J ANIM SCI, V77, P2398; Givisiez PEN, 1999, BRIT POULTRY SCI, V40, P292, DOI 10.1080/00071669987728; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Grune T, 2011, FREE RADICAL BIO MED, V51, P1355, DOI 10.1016/j.freeradbiomed.2011.06.015; GUERRIERO V, 1990, J ANIM SCI, V68, P2779; Gurzov EN, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-184; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Hansen PJ, 1999, J ANIM SCI, V77, P36; Hass R, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-127; Hayashi Y, 1991, RADIAT RES, V125, P1, DOI DOI 10.2307/3577985; Hernandes R, 2002, REV BRAS ZOOTECN, V31, P1442, DOI 10.1590/S1516-35982002000600016; Hildebrat U, 2002, APPL ENVIRON MICROB, V69, P2848; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hu Han, 2011, Journal of Agricultural Biotechnology, V19, P287; Hu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007636; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulst M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-18; Imao M, 2006, LAB INVEST, V86, P959, DOI 10.1038/labinvest.3700451; Jensen K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-36; Kadzere CT, 2002, LIVEST PROD SCI, V77, P59, DOI 10.1016/S0301-6226(01)00330-X; Kapila N, 2012, ISRN BIOTECH; Kim D, 2001, J TOXICOL ENV HEAL A, V63, P475, DOI 10.1080/15287390152410129; KLINEDINST PL, 1993, CLIMATIC CHANGE, V23, P21, DOI 10.1007/BF01092679; Kumura H, 2001, BIOSCI BIOTECH BIOCH, V65, P2098, DOI 10.1271/bbb.65.2098; Lewis S, 1999, ECOTOXICOLOGY, V8, P351, DOI 10.1023/A:1008982421299; Li P, 1999, HISTOCHEM J, V31, P379, DOI 10.1023/A:1003700224900; Liang TB, 2003, P NATL ACAD SCI USA, V100, P4690, DOI 10.1073/pnas.0737182100; Liu HY, 2007, J ANIM FEED SCI, V16, P330, DOI 10.22358/jafs/74520/2007; Liu HY, 2010, J THERM BIOL, V35, P250, DOI 10.1016/j.jtherbio.2010.05.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALAYER JR, 1988, J REPROD FERTIL, V84, P567, DOI 10.1530/jrf.0.0840567; Marai IFM, 2010, LIVEST SCI, V127, P89, DOI 10.1016/j.livsci.2009.08.001; Masuda K, 2011, INT IMMUNOL, V23, P637, DOI 10.1093/intimm/dxr072; Meza-Herrera CA, 2006, J APPL ANIM RES, V29, P9, DOI 10.1080/09712119.2006.9706560; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Minchenko OH, 2005, MOL CELL BIOCHEM, V280, P227, DOI 10.1007/s11010-005-8009-6; Mishra A, 2011, J ANIM PHYSIOL AN N, V95, P540, DOI 10.1111/j.1439-0396.2010.01082.x; Moya A, 2012, MOL ECOL, V21, P1158, DOI 10.1111/j.1365-294X.2012.05458.x; Norgaard JV, 2008, J DAIRY SCI, V91, P2319, DOI 10.3168/jds.2007-0767; Pantschenko AG, 2000, IN VITRO CELL DEV-AN, V36, P351, DOI 10.1290/1071-2690(2000)036<0351:EACOAC>2.0.CO;2; Pantschenko AG, 2000, IN VITRO CELL DEV-AN, V36, P26, DOI 10.1290/1071-2690(2000)036<0026:EACOAC>2.0.CO;2; Park CM, 2005, VET IMMUNOL IMMUNOP, V105, P221; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PUTNEY DJ, 1988, BIOL REPROD, V39, P717, DOI 10.1095/biolreprod39.3.717; Rispoli LA, 2013, REPRODUCTION, V146, P193, DOI 10.1530/REP-12-0487; Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x; SCHMID E, 1983, J CELL BIOL, V96, P37, DOI 10.1083/jcb.96.1.37; Sese M, 2006, J CELL SCI, V119, P5047, DOI 10.1242/jcs.03294; SHARMA AK, 1988, J DAIRY SCI, V71, P819, DOI 10.3168/jds.S0022-0302(88)79622-8; SHEIL JM, 1992, J EXP MED, V175, P545, DOI 10.1084/jem.175.2.545; Shimizu T, 2005, REPRODUCTION, V129, P463, DOI 10.1530/rep.1.00502; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Tao S, 2013, J DAIRY SCI, V96, P378, DOI 10.3168/jds.2012-5811; Taylor P, 2010, BR POULT SCI, V43; Taylor P, 1989, J CELL SCI, V94, P403; Thanida S, 2013, J REPROD DEV, V59; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2000, CLIN SCI, V99, P489, DOI 10.1042/CS20000059; WANG SY, 1993, COMP BIOCHEM PHYS B, V106, P621, DOI 10.1016/0305-0491(93)90139-V; Wang ZQ, 2008, J BIOL CHEM, V283, P21011, DOI 10.1074/jbc.M802229200; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Yadav A, 2013, REPROD DOMEST ANIM, V48, P858, DOI 10.1111/rda.12175; Yu J, 2010, COMP BIOCHEM PHYS A, V156, P119, DOI 10.1016/j.cbpa.2010.01.008; Zanello G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018573; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0; Zhao K, 2010, CELL BIOL INT, V34, P717, DOI 10.1042/CBI20100023; Zulkifli I, 2003, ANIM WELFARE, P1	98	39	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2016	11	9							e0157237	10.1371/journal.pone.0157237	http://dx.doi.org/10.1371/journal.pone.0157237			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX2BH	27682256	Green Submitted, Green Published, gold			2022-12-26	WOS:000384171400001
J	Li, J; Chen, XL; Yi, J; Liu, YC; Li, DM; Wang, JF; Hou, DX; Jiang, XH; Zhang, JF; Wang, J; Zen, K; Yang, FQ; Zhang, CY; Zhang, YJ				Li, Jing; Chen, Xiulan; Yi, Jiao; Liu, Yuchen; Li, Dameng; Wang, Jifeng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Wang, Jin; Zen, Ke; Yang, Fuquan; Zhang, Chen-Yu; Zhang, Yujing			Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components	PLOS ONE			English	Article							DRUG-DELIVERY VEHICLES; HUMAN URINARY EXOSOME; MEMBRANE-VESICLES; MICROVESICLES; BIOGENESIS; MOLECULES; MECHANISM; GRANULES; PLATFORM; RELEASE	Cell-derived exosomes are leading candidates for in vivo drug delivery carriers. In particular, exosomes derived from 293T cells are used most frequently, although exosome dosing has varied greatly among studies. Considering their biological origin, it is crucial to characterize the molecular composition of exosomes if large doses are to be administered in clinical settings. In this study, we present the first comprehensive analysis of the protein, messenger RNA and microRNA profiles of 293T cell-derived exosomes; then, we characterized these data using Gene Ontology annotation and Kyoto Encyclopedia for Genes and Genomes pathway analysis. Our study will provide the basis for the selection of 293T cell-derived exosome drug delivery systems. Profiling the exosomal signatures of 293T cells will lead to a better understanding of 293T exosome biology and will aid in the identification of any harmful factors in exosomes that could cause adverse clinical effects.	[Li, Jing; Yi, Jiao; Liu, Yuchen; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Wang, Jin; Zen, Ke; Zhang, Chen-Yu; Zhang, Yujing] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, NJU Adv Inst Life Sci,Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Xiulan; Wang, Jifeng; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China; [Chen, Xiulan; Wang, Jifeng; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing, Peoples R China	Nanjing University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, CY; Zhang, YJ (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, NJU Adv Inst Life Sci,Sch Life Sci, Nanjing, Jiangsu, Peoples R China.; Yang, FQ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing, Peoples R China.; Yang, FQ (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing, Peoples R China.	fqyang@sun5.ibp.ac.cn; cyzhang@nju.edu.cn; yjzhang@nju.edu.cn		Liu, Yuchen/0000-0001-8922-9976	National Basic Research Program of China (973 Program) [2011CB504803]; Natural Science Foundation of Jiangsu Province, China [BK20130890, BK2011013, BK2012014]; National Natural Science Foundation of China [31200969, 31200874, 81101330, 31271378, 81250044]; National Science Fund for Distinguished Young Scholars [81025019]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); program for New Century Excellent Talents in University from the Ministry of Education, China	National Basic Research Program of China (973 Program) (No. 2011CB504803), Natural Science Foundation of Jiangsu Province, China (BK20130890, BK2011013 and BK2012014), the National Natural Science Foundation of China (31200969, 31200874, 81101330, 31271378 and 81250044), the National Science Fund for Distinguished Young Scholars (81025019) and the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Aryani A, 2016, MOL NEUROBIOL, V53, P818, DOI 10.1007/s12035-014-9054-5; Bruschi M, 2016, J PROTEOMICS, V136, P25, DOI 10.1016/j.jprot.2016.02.001; Bruschi M, 2015, EXPERT REV PROTEOMIC, V12, P425, DOI 10.1586/14789450.2015.1055324; Chen XL, 2014, THERANOSTICS, V4, P1164, DOI 10.7150/thno.8502; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Khalyfa A, 2001, J BIOL CHEM, V276, P22915, DOI 10.1074/jbc.M101011200; Lee C, 2015, NANOSCALE, V7, P9290, DOI 10.1039/c5nr01333j; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Panfoli I, 2016, FASEB J, V30, P1416, DOI 10.1096/fj.15-279679; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Romana R, 2011, PLOS ONE, V6, P965; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tan A, 2013, ADV DRUG DELIVER REV, V65, P357, DOI 10.1016/j.addr.2012.06.014; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van den Boorn JG, 2011, NAT BIOTECHNOL, V29, P325, DOI 10.1038/nbt.1830; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	38	66	69	8	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163043	10.1371/journal.pone.0163043	http://dx.doi.org/10.1371/journal.pone.0163043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649079	gold, Green Submitted, Green Published			2022-12-26	WOS:000383892100046
J	Ma, DY; Ding, HN; Wang, CY; Qin, HX; Han, QX; Hou, JF; Lu, HF; Xie, YX; Guo, TC				Ma, Dongyun; Ding, Huina; Wang, Chenyang; Qin, Haixia; Han, Qiaoxia; Hou, Junfeng; Lu, Hongfang; Xie, Yingxin; Guo, Tiancai			Alleviation of Drought Stress by Hydrogen Sulfide Is Partially Related to the Abscisic Acid Signaling Pathway in Wheat	PLOS ONE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; TOLERANCE; BIOSYNTHESIS; ENZYME; RESPONSES; SALINITY	Little information is available describing the effects of exogenous H2S on the ABA pathway in the acquisition of drought tolerance in wheat. In this study, we investigated the physiological parameters, the transcription levels of several genes involved in the abscisic acid (ABA) metabolism pathway, and the ABA and H2S contents in wheat leaves and roots under drought stress in response to exogenous NaHS treatment. The results showed that pretreatment with NaHS significantly increased plant height and the leaf relative water content of seedlings under drought stress. Compared with drought stress treatment alone, H2S application increased antioxidant enzyme activities and reduced MDA and H2O2 contents in both leaves and roots. NaHS pretreatment increased the expression levels of ABA biosynthesis and ABA reactivation genes in leaves; whereas the expression levels of ABA biosynthesis and ABA catabolism genes were up-regulated in roots. These results indicated that ABA participates in drought tolerance induced by exogenous H2S, and that the responses in leaves and roots are different. The transcription levels of genes encoding ABA receptors were up-regulated in response to NaHS pretreatment under drought conditions in both leaves and roots. Correspondingly, the H2S contents in leaves and roots were increased by NaHS pretreatment, while the ABA contents of leaves and roots decreased. This implied that there is complex crosstalk between these two signal molecules, and that the alleviation of drought stress by H2S, at least in part, involves the ABA signaling pathway.	[Ma, Dongyun; Ding, Huina; Wang, Chenyang; Qin, Haixia; Han, Qiaoxia; Hou, Junfeng; Lu, Hongfang; Xie, Yingxin; Guo, Tiancai] Henan Agr Univ, Agron, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China; [Ma, Dongyun; Wang, Chenyang] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Peoples R China; [Lu, Hongfang; Xie, Yingxin; Guo, Tiancai] Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 45002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Guo, TC (corresponding author), Henan Agr Univ, Agron, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China.; Guo, TC (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 45002, Peoples R China.	tcguo88@163.com			Science and Technology Support Program [2015BAD26B00]; Key Scientific Research Project of Higher Education Insitution [15A210004]	Science and Technology Support Program; Key Scientific Research Project of Higher Education Insitution	This project was funded by the Science and Technology Support Program (2015BAD26B00), and the Key Scientific Research Project of Higher Education Insitution (15A210004).	Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; Christou A, 2013, J EXP BOT, V64, P1953, DOI 10.1093/jxb/ert055; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Dawood M, 2012, J HAZARD MATER, V209, P121, DOI 10.1016/j.jhazmat.2011.12.076; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Garcia-Mata C, 2010, NEW PHYTOL, V188, P977, DOI 10.1111/j.1469-8137.2010.03465.x; Guo HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-015-2038-x; Guoth A, 2009, J PLANT GROWTH REGUL, V28, P167, DOI 10.1007/s00344-009-9085-8; Hernandez I, 2004, TREE PHYSIOL, V24, P1303, DOI 10.1093/treephys/24.11.1303; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Kettlewell P., 2011, INT J AGR MANAGEMENT, V1, P43; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Li ZG, 2015, PLANT CELL TISSUE OR; Lisjak M, 2011, PLANT SIGNAL BEHAV, V6, P1444, DOI 10.4161/psb.6.10.17104; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Scuffi D, 2014, PLANT PHYSIOL, V166, P2065, DOI 10.1104/pp.114.245373; Shi HT, 2013, PLANT PHYSIOL BIOCH, V71, P226, DOI 10.1016/j.plaphy.2013.07.021; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Wang YS, 2004, ACTA BOT SIN, V46, P819; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhang H, 2009, PLANT GROWTH REGUL, V58, P243, DOI 10.1007/s10725-009-9372-1	34	62	67	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163082	10.1371/journal.pone.0163082	http://dx.doi.org/10.1371/journal.pone.0163082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649534	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100050
J	Pereira-Gomez, M; Bou, JV; Andreu, I; Sanjuan, R				Pereira-Gomez, Marianoel; Bou, Juan-Vicente; Andreu, Ivaan; Sanjuan, Rafael			Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients	PLOS ONE			English	Article							EVOLUTIONARY RATE; ERROR CATASTROPHE; POLYMERASE; RIBAVIRIN; FIDELITY; REPLICATION; MANAGEMENT; INFECTION; VARIANTS; GENOTYPE	The high levels of genetic diversity shown by hepatitis B virus (HBV) are commonly attributed to the low fidelity of its polymerase. However, the rate of spontaneous mutation of human HBV in vivo is currently unknown. Here, based on the evolutionary principle that the population frequency of lethal mutations equals the rate at which they are produced, we have estimated the mutation rate of HBV in vivo by scoring premature stop codons in 621 publicly available, full-length, molecular clone sequences derived from patients. This yielded an estimate of 8.7 x 10(-5) spontaneous mutations per nucleotide per cell infection in untreated patients, which should be taken as an upper limit estimate because PCR errors and/or lack of effective lethality may inflate observed mutation frequencies. We found that, in patients undergoing lamivudine/adefovir treatment, the HBV mutation rate was elevated by more than sixfold, revealing a mutagenic effect of this treatment. Genome-wide analysis of single-nucleotide polymorphisms indicated that lamivudine/adefovir treatment increases the fraction of A/T-to-G/C base substitutions, consistent with recent work showing similar effects of lamivudine in cellular DNA. Based on these data, the rate at which HBV produces new genetic variants in treated patients is similar to or even higher than in RNA viruses.	[Pereira-Gomez, Marianoel; Bou, Juan-Vicente; Andreu, Ivaan; Sanjuan, Rafael] Univ Valencia, Inst Integrat Syst Biol I2SysBio, Valencia, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain	University of Valencia; University of Valencia	Sanjuan, R (corresponding author), Univ Valencia, Inst Integrat Syst Biol I2SysBio, Valencia, Spain.; Sanjuan, R (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	rafael.sanjuan@uv.es	Pereira-Gómez, Marianoel/AAG-8725-2021	Pereira-Gómez, Marianoel/0000-0003-3665-392X; Bou-Prados, Juan-Vicente/0000-0002-9572-0822; Sanjuan, Rafael/0000-0002-1844-545X; Andreu-Moreno, Ivan/0000-0002-0146-7839	Spanish Ministerio de Economia y Competitividad [BFU2011-25271]; European Research Council [ERC-2011-StG-281191-VIRMUT]; Spanish Ministerio de Educacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Spanish Ministerio de Educacion(Spanish Government)	This work was supported by grants from the Spanish Ministerio de Economia y Competitividad (BFU2011-25271) and the European Research Council (ERC-2011-StG-281191-VIRMUT) to R.S., and by a Ph.D. fellowship from the Spanish Ministerio de Educacion to M.P.-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; Caligiuri P, 2016, WORLD J GASTROENTERO, V22, P145, DOI 10.3748/wjg.v22.i1.145; Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08; Cheung PPH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5794; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002251; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dapp MJ, 2013, J MOL BIOL, V425, P41, DOI 10.1016/j.jmb.2012.10.009; Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gao S, 2015, WORLD J HEPATOL, V7, P1086, DOI 10.4254/wjh.v7.i8.1086; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Guimaraes NN, 2010, EXPERT OPIN DRUG SAF, V9, P771, DOI 10.1517/14740331003702384; Gunther S, 1997, VIROLOGY, V235, P104, DOI 10.1006/viro.1997.8676; Hao R, 2015, INFECT GENET EVOL, V33, P261, DOI 10.1016/j.meegid.2015.05.013; Harrison A, 2011, VIRUSES-BASEL, V3, P83, DOI 10.3390/v3020083; Hong YB, 2004, J BIOCHEM MOL BIOL, V37, P167; Huang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089753; Jammeh S, 2008, J GEN VIROL, V89, P901, DOI 10.1099/vir.0.83468-0; Kanda T, 2015, WORLD J HEPATOL, V7, P1913, DOI [10.4254/wjh.v7.i15.1913, 10.4254/wjh.v7.i11.1541]; Lai MW, 2008, ANTIVIR THER, V13, P875; Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163; Li ZX, 2014, J CLIN VIROL, V61, P47, DOI 10.1016/j.jcv.2014.06.010; Lin Xu, 2001, Journal of Medical Virology, V64, P299, DOI 10.1002/jmv.1050; Lin YY, 2015, J VIROL, V89, P3512, DOI 10.1128/JVI.03131-14; Mansky LM, 2002, J VIROL, V76, P9253, DOI 10.1128/JVI.76.18.9253-9259.2002; Marzio DHD, 2014, WORLD J GASTROENTERO, V20, P401, DOI 10.3748/wjg.v20.i2.401; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Menendez-Arias L, 2009, VIRUSES-BASEL, V1, P1137, DOI 10.3390/v1031137; Meng T, 2014, J VIROL, V88, P5803, DOI 10.1128/JVI.00289-14; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Osiowy C, 2006, J VIROL, V80, P10307, DOI 10.1128/JVI.00996-06; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pult I, 2001, J VIROL, V75, P9623, DOI 10.1128/JVI.75.20.9623-9632.2001; Ribeiro RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002881; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeger C, 2015, VIROLOGY, V479, P672, DOI 10.1016/j.virol.2015.02.031; Severson WE, 2003, J VIROL, V77, P481, DOI 10.1128/JVI.77.1.481-488.2003; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Shen Tao, 2011, Hepat Res Treat, V2011, P939148, DOI 10.1155/2011/939148; Su HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021125; Suppiah J, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22565; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Zhang YL, 2015, J NEUROVIROL, V21, P500, DOI 10.1007/s13365-015-0347-x; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163363	10.1371/journal.pone.0163363	http://dx.doi.org/10.1371/journal.pone.0163363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649318	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100083
J	Stacey, AF; Gill, TK; Price, K; Warmington, R; Taylor, AW				Stacey, Anne F.; Gill, Tiffany K.; Price, Kay; Warmington, Rosemary; Taylor, Anne W.			Unpaid Informal Caregivers in South Australia: Population Characteristics, Prevalence and Age-Period-Cohort Effects 1994-2014	PLOS ONE			English	Article							CARE; HEALTH	Background The ongoing need for an availability of informal carers is taking on greater relevance as the global burden of disease transitions from acute fatal diseases to long termmorbidity. Growing evidence suggests that extra burden on family carers may further impact on their health and ability to provide care. Importantas it is to monitor the prevalence of those conditions which influence the burden of disease, it is also important to monitor the prevalence and health profiles of those who provide the informal care. The aim of this study was to demonstrate the prevalence and demographics of adult carers aged 15 and over in the state of South Australia over 20 years between 1994 and 2014. Methods Data from nine representative, cross-sectional population surveys, conducted in South Australia, Australia were used, (total N = 26,788 and n = 1,504 carers). The adjusted prevalence estimate of carers and their demographic characteristics were determined. So as to examine whether there were any generational effects on the prevalence of carers, an Age-Period Cohort (APC) analysis was undertaken. Results The prevalence estimates of carers increased during the two decades from 3.7% in 1994 to 6.7% by 2014. Large increases in the proportion of retired carers, those aged 70 years and over, those carers employed, and those with higher educational qualifications were observed. There were also larger proportions of respondents with a country of birth other than Australia, UK, Ireland and European counties. The APC analysis illustrated an increasing prevalence rate over each decade for carers aged 20-80 years, especially for those over the age of 60 years. Conclusions The results illustrate changing carer characteristics and carer prevalence estimates in South Australia as new generations of carers take on the caring role. There is a need to include questions regarding informal carers within ongoing mainstream population surveys, particularly at state levels, so as to plan for their future health care and home support.	[Stacey, Anne F.; Gill, Tiffany K.; Taylor, Anne W.] Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Price, Kay] Univ South Australia, Sch Nursing & Midwifery, Adelaide, SA, Australia; [Warmington, Rosemary] Carers SA, Adelaide, SA, Australia	University of Adelaide; Flinders University South Australia; University of South Australia	Stacey, AF (corresponding author), Univ Adelaide, Discipline Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	anne.stacey@adelaide.edu.au	Gill, Tiffany/F-9042-2010; Taylor, Anne w/F-5708-2010	Gill, Tiffany/0000-0002-2822-2436; Taylor, Anne w/0000-0002-4422-7974	Carers SA	Carers SA	Funding was received from Carers SA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2000, DIS AG AUSTR POP PAT; [Anonymous], 2015, EC VAL INF CAR AUSTR; Australian Bureau of Statistics, 2018, DISABILITY AGEING CA; Australian Bureau of Statistics, 2011, SOCIO EC INDEXES ARE; Australian Bureau of Statistics (ABS), 2012, DIS AG CAR AUSTR SUM; Australian Bureau of Statistics (ABS), 2015, AUSTR DEM STAT COUNT; Australian Institute of Health and Welfare, 2018, CDK16 AUSTR I HLTH W; Australian Institute of Health and Welfare, 2015, AUSTR BURD DIS STUD, V1; Australian Institute of Health and Welfare (AIHW), 2015, AUSTR WELF 2015 BRIE; Australian Institute of Health and Welfare (AIHW). Australia's Health, 2014, LEAD TYP ILL HLTH; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Bloch B. S, 1998, INT TECHNICAL C ENHA; Borowski A, 1997, AGEING SOCIAL POLICY, P37; Brehaut JC, 2009, AM J PUBLIC HEALTH, V99, P1254, DOI 10.2105/AJPH.2007.129817; Bruhn JG, 2014, CLIN SOCIOL RES PRAC, P1, DOI 10.1007/978-94-017-8857-1; Bryant L, 2013, AGEING SOC, V33, P1401, DOI 10.1017/S0144686X12000657; Carers V, 2015, RISING VALUE CARERS; Colombo F, 2011, OECD HLTH POLICY STU, DOI [10.1787/9789264097759-en+-, DOI 10.1757/9789264097759-44+-]; Day C, 2015, J YOUTH STUD, V18, P855, DOI 10.1080/13676261.2014.1001826; Farfan-Portet MI, 2010, EUR J PUBLIC HEALTH, V20, P52, DOI 10.1093/eurpub/ckp045; Grady PA, 2014, NURS OUTLOOK, V62, P362, DOI 10.1016/j.outlook.2014.05.007; Hastrup LH, 2011, SCAND J PUBLIC HEALT, V39, P598, DOI 10.1177/1403494811414247; Hirst M, 2005, SOC SCI MED, V61, P697, DOI 10.1016/j.socscimed.2005.01.001; Hirst M, 2002, J EPIDEMIOL COMMUN H, V56, P579, DOI 10.1136/jech.56.8.579; Hosseinpoor AR, 2013, AGE AGEING, V42, P330, DOI 10.1093/ageing/afs196; Hsu HC, 2001, GERONTOLOGIST, V41, P742, DOI 10.1093/geront/41.6.742; Hugo G., 2014, DEMOGRAPHIC FACTS AG; Hugo G, 2009, OLDER CARERS CARERS, P233; Jenkins A., 2003, FUTURE SUPPLY INFORM; Jowsey T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-374; Kaambwa B, 2015, SOC SCI MED, V140, P81, DOI 10.1016/j.socscimed.2015.06.034; Knight BG, 2010, J GERONTOL B-PSYCHOL, V65, P5, DOI 10.1093/geronb/gbp096; Levine C, 2005, AM J PUBLIC HEALTH, V95, P2071, DOI 10.2105/AJPH.2005.067702; Lin SF, 2012, AM J PUBLIC HEALTH, V102, P2157, DOI 10.2105/AJPH.2011.300602; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Park HJ, 2015, J AGING SOC POLICY, V27, P280, DOI 10.1080/08959420.2015.1024536; Prince M, 2007, AM J PUBLIC HEALTH, V97, P224; Public Policy Institute, 2015, RES REPORT; Reinhard S., 2012, HOME ALONE FAMILY CA; Reither EN, 2009, SOC SCI MED, V69, P1439, DOI 10.1016/j.socscimed.2009.08.040; Rutherford MJ, 2010, STATA J, V10, P606, DOI 10.1177/1536867X1101000405; SA Health Health Omnibus Survey, 2002, METH BRIEF REP S AUS; Schofield D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-561; Sinha M, 2012, SPOTLIGHT CANADIANS; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P393, DOI 10.2105/AJPH.2004.059337; Taylor AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125233; Trivedi R, 2014, CHRONIC ILLN, V10, P167, DOI 10.1177/1742395313506947; Turcotte M, FAMILY CAREGIVING WH; Twigg Julia, 1996, CARERS PERCEIVED POL; van den Berg B, 2014, J HEALTH ECON, V35, P123, DOI 10.1016/j.jhealeco.2014.01.008; Viana MC, 2013, REV BRAS PSIQUIATR, V35, P115, DOI 10.1590/1516-4446-2012-0919; Yeandle S, 2007, 2 CES CAR UK	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0161994	10.1371/journal.pone.0161994	http://dx.doi.org/10.1371/journal.pone.0161994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GE	27649074	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000383892100010
J	Frank, SR; Kollmann, CP; de Jeude, JFV; Thiagarajah, JR; Engelholm, LH; Frodin, M; Hansen, SH				Frank, S. R.; Kollmann, C. P.; de Jeude, J. F. van Lidth; Thiagarajah, J. R.; Engelholm, L. H.; Frodin, M.; Hansen, S. H.			The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion	ONCOGENE			English	Article							PAXILLIN-KINASE-LINKER; TYROSINE PHOSPHORYLATION; CELL; SRC; ACTIVATION; FAMILY; FAK; COMPLEX; LOCALIZATION; RECRUITMENT	DOCK proteins are guanine nucleotide exchange factors for Rac and Cdc42 GTPases. DOCK1 is the founding member of the family and acts downstream of integrins via the canonical Crk-p130Cas complex to activate Rac GTPases in numerous contexts. In contrast, DOCK5, which possesses the greatest similarity to DOCK1, remains sparingly studied. Here we establish that DOCK5 has a non-redundant role in regulating motile and invasive capacities of epithelial cells. DOCK1 is constitutively associated with sites of integrin attachment termed focal adhesions (FAs). In contrast, we demonstrate that DOCK5 recruitment to FAs in Hela cells is restricted by GIT2, an established regulator of FA signaling. We determine that GIT2 is targeted to FAs in response to Rho-ROCK signaling and actomyosin contractility. Accordingly, inhibition of ROCK activity or MLC function promotes enrichment of DOCK5 in membrane protrusions and nascent cell-substratum adhesions. We further demonstrate that GIT2 inhibits the interaction of DOCK5 with Crk. Moreover, we show that depletion of GIT2 promotes DOCK5-dependent activation of the Crk-p130Cas signaling cascade to promote Rac1-mediated lamellipodial protrusion and FA turnover. The antagonism between GIT2 and DOCK5 extends to non-transformed MCF10A mammary epithelial cells, with DOCK5 'dialing-up' and GIT2 'dialing-down' invasiveness. Finally, we determine that DOCK5 inhibition attenuates invasion and metastasis of MDA-MB-231 cells and prolongs life span of mice injected with these cells. Collectively, our work identifies DOCK5 as a key regulator of epithelial invasion and metastasis, and demonstrates that suppression of DOCK5 by GIT2 represents a previously unappreciated mechanism for coordination of Rho and Rac GTPases.	[Frank, S. R.; Kollmann, C. P.; de Jeude, J. F. van Lidth; Thiagarajah, J. R.; Hansen, S. H.] Childrens Hosp Boston, GI Cell Biol Res Lab, Boston, MA USA; [Frank, S. R.; Kollmann, C. P.; de Jeude, J. F. van Lidth; Thiagarajah, J. R.; Hansen, S. H.] Harvard Med Sch, Enders Bldg,Room 605,300 Longwood Ave, Boston, MA 02115 USA; [Engelholm, L. H.] Rigshosp, Finsen Lab, Copenhagen Bioctr, Copenhagen, Denmark; [Frodin, M.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hansen, SH (corresponding author), Harvard Med Sch, Enders Bldg,Room 605,300 Longwood Ave, Boston, MA 02115 USA.; Hansen, SH (corresponding author), Childrens Hosp Boston, GI Cell Biol, Enders Bldg,Room 605,300 Longwood Ave, Boston, MA 02115 USA.	steen.hansen@childrens.harvard.edu		Hansen, Steen/0000-0002-9408-4676; Engelholm, Lars/0000-0002-6616-1232; Frodin, Morten/0000-0003-3691-9820	NIH [R01 CA142647]; Danish Cancer Society [R40-A1936-11-S2, R2-A132-02-S2]; Roy and Lynne Frank Foundation; NATIONAL CANCER INSTITUTE [R01CA142647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, T32DK007477] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); Roy and Lynne Frank Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH R01 CA142647 to SHH, as well as grants from the Danish Cancer Society R40-A1936-11-S2 to SHH and R2-A132-02-S2 to MF. SHH is a recipient of an Endowed Investigatorship from the Roy and Lynne Frank Foundation.	Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Feng HZ, 2012, P NATL ACAD SCI USA, V109, P3018, DOI 10.1073/pnas.1121457109; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Frank SR, 2012, CURR BIOL, V22, P1747, DOI 10.1016/j.cub.2012.07.011; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Nishikimi A, 2013, EXP CELL RES, V319, P2343, DOI 10.1016/j.yexcr.2013.07.024; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Ogawa K, 2014, J EXP MED, V211, P1401, DOI 10.1084/jem.20131926; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Patel Manishha, 2011, Small GTPases, V2, P268; Phee H, 2010, NAT IMMUNOL, V11, P503, DOI 10.1038/ni.1868; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Sanders MA, 2009, J BIOL CHEM, V284, P27, DOI 10.1074/jbc.M808010200; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Terasawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046277; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Watanabe M, 2014, J IMMUNOL, V193, P5660, DOI 10.4049/jimmunol.1400885; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Yu JXA, 2009, MOL BIOL CELL, V20, P4706, DOI 10.1091/mbc.E09-07-0548	38	19	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1816	1828		10.1038/onc.2016.345	http://dx.doi.org/10.1038/onc.2016.345			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27669437	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-26	WOS:000398128900007
J	Lefort, S; Thuleau, A; Kieffer, Y; Sirven, P; Bieche, I; Marangoni, E; Vincent-Salomon, A; Mechta-Grigoriou, F				Lefort, S.; Thuleau, A.; Kieffer, Y.; Sirven, P.; Bieche, I.; Marangoni, E.; Vincent-Salomon, A.; Mechta-Grigoriou, F.			CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CXCR4; GROWTH-STIMULATING FACTOR; WEAK PARTIAL AGONISTS; TUMOR-GROWTH; FUNCTIONAL EXPRESSION; DUCTAL CARCINOMA; PROGENITOR CELLS; METASTASIS; STEM; MICROENVIRONMENT	The CXCR4 receptor and its ligand CXCL12 (also named stromal cell-derived factor 1, SDF1) have a critical role in chemotaxis and homing, key steps in cancer metastasis. Although myofibroblasts expressing CXCL12 are associated with the presence of axillary metastases in HER2 breast cancers (BC), the therapeutic interest of targeting CXCR4/CXCL12 axis in the different BC subtypes remains unclear. Here, we investigate this question by testing antitumor activity of CXCR4 inhibitors in patient-derived xenografts (PDX), which faithfully reproduce human tumor properties. We observed that two CXCR4 inhibitors, AMD3100 and TN14003, efficiently impair tumor growth and metastasis dissemination in both Herceptin-sensitive and Herceptin-resistant HER2 BC. Conversely, blocking CXCR4/CXCL12 pathway in triple-negative (TN) BC does not reduce tumor growth, and can even increase metastatic spread. Moreover, although CXCR4 inhibitors significantly reduce myofibroblast content in all BC subtypes, they decrease angiogenesis only in HER2 BC. Thus, our findings suggest that targeting CXCR4 could provide some therapeutic interest for HER2 BC patients, whereas it has no impact or could even be detrimental for TN BC patients.	[Lefort, S.; Kieffer, Y.; Sirven, P.; Mechta-Grigoriou, F.] Inst Curie Res Dept, Stress & Canc Lab, LNCC Labelized Team, 26 Rue Ulm, F-75248 Paris 05, France; [Lefort, S.; Kieffer, Y.; Sirven, P.; Mechta-Grigoriou, F.] INSERM, U830, Genet & Biol Canc, F-75248 Paris, France; [Thuleau, A.; Marangoni, E.] Inst Curie Res Dept, Translat Res Dept, Lab Pre Clin Invest, Paris, France; [Bieche, I.] Inst Curie Hosp Grp, Serv Genet, Unite Pharmacognet, Paris, France; [Vincent-Salomon, A.] Hosp Grp Paris, Inst Curie, Dept Pathol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Mechta-Grigoriou, F (corresponding author), PSL Res Univ, Inst Curie Res Dept, Stress & Canc Lab, LNCC Labelized Team, 26 Rue Ulm, Paris, France.	fatima.mechta-grigoriou@curie.fr	MECHTA-GRIGORIOU, Fatima/C-5253-2017; Bièche, Ivan/O-7399-2017; Marangoni, Elisabetta/GSO-3945-2022	MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; Bièche, Ivan/0000-0002-2430-5429; Marangoni, Elisabetta/0000-0002-3337-6448; Lefort, Sylvain/0000-0001-7320-4256; KIEFFER, Yann/0000-0003-2722-3071	Fondation ARC; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Curie	Fondation ARC; Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie	We are grateful to M Cardon from the 'Stress and Cancer' lab, at the Institut Curie, as well as R Leclere, E Martel, M Richardson and A Nicolas from the experimental pathology platform for help and advice. We acknowledge O Mariani from CRB Institut Curie for her help in preparing RNA samples from patient tumors. We are grateful to all members of the animal facilities of Institute Curie for their helpful expertize. SL was supported by funding from the Fondation ARC. The experimental work was also supported by grants from the Institut National de la Sante et de la Recherche Medicale (Inserm) and the Institut Curie. FMG's laboratory is labelized by the Ligue Nationale Contre le Cancer (LNCC). We are very grateful to the LNCC, Institut Curie and Inserm for providing their support these last years. We also thank the Institut National du Cancer (INCa), the FRM and the Fondation ARC (Association pour la Recherche contre le Cancer).	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Carion A, 2003, BRIT J HAEMATOL, V122, P918, DOI 10.1046/j.1365-2141.2003.04545.x; Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Falco V, 2007, CANCER RES, V67, P11821, DOI 10.1158/0008-5472.CAN-07-0899; Dommange F, 2006, FASEB J, V20, P1913, DOI 10.1096/fj.05-5667fje; Gruosso T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9583; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Hori T, 1998, J IMMUNOL, V160, P180; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Lefort S, 2014, AUTOPHAGY, V10, P2122, DOI 10.4161/15548627.2014.981788; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang SX, 2015, ONCOTARGET, V6, P1020, DOI 10.18632/oncotarget.2741; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Liang ZX, 2005, CANCER RES, V65, P967; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Ling XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058426; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Marty M, 2005, J CLIN ONCOL, V23, P4265, DOI 10.1200/JCO.2005.04.173; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 1999, IMMUNOLOGY, V98, P36; Nafi SNM, 2014, ONCOTARGET, V5, P5934; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reyal F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3095; Rhodes LV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-295; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Salvucci O, 2006, BREAST CANCER RES TR, V97, P275, DOI 10.1007/s10549-005-9121-8; Schmid BC, 2004, BREAST CANCER RES TR, V84, P247, DOI 10.1023/B:BREA.0000019962.18922.87; Sharma M, 2014, CELL ADHES MIGR, V8, P384, DOI 10.4161/cam.29285; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Trent JO, 2003, J BIOL CHEM, V278, P47136, DOI 10.1074/jbc.M307850200; Xu TP, 2013, CANCER EPIDEMIOL, V37, P725, DOI 10.1016/j.canep.2013.04.017; Yazhou C, 2004, TUMOR BIOL, V25, P290, DOI 10.1159/000081394; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhang ZG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-49; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	48	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1211	1222		10.1038/onc.2016.284	http://dx.doi.org/10.1038/onc.2016.284			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27669438	hybrid, Green Published			2022-12-26	WOS:000395861300005
J	Ramadoss, S; Sen, S; Ramachandran, I; Roy, S; Chaudhuri, G; Farias-Eisner, R				Ramadoss, S.; Sen, S.; Ramachandran, I.; Roy, S.; Chaudhuri, G.; Farias-Eisner, R.			Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance	ONCOGENE			English	Article							GENE-EXPRESSION; HISTONE; P53; CELLS; INHIBITION; RESISTANCE; CHROMATIN; MARKERS; JHDM2A	Ovarian cancer is the leading cause of death among all gynecological malignancies due to the development of acquired chemoresistance and disease relapse. Although the role of cancer stem cells (CSCs), a subset of tumor cells with the self-renewal and differentiation capabilities, in therapeutic resistance is beginning to be better understood, the significance of epigenetic regulatory mechanisms responsible for integrating the stemness with drug resistance remain poorly understood. Here we identified that lysine demethylase KDM3A as a critical regulator of ovarian cancer stemness and cisplatin resistance by inducing the expressions of pluripotent molecules Sox2 and Nanog and anti-apoptotic B-cell lymphoma 2 (Bcl-2), respectively. In addition, KDM3A induces ovarian cancer growth while antagonizing cellular senescence by repressing the expression of cyclin-dependent kinase inhibitor, p21(Waf1/Cip1). The underlying mechanism of the noted biological processes include KDM3A-mediatedstimulation of Sox2 expression, and demethylating p53 protein and consequently, modulating its target genes such as Bcl-2 and p(21Waf1/Cip1) expression. Consistently, KDM3A depletion inhibited the growth of subcutaneously implanted cisplatin-resistant human ovarian cancer cells in athymic nude mice. Moreover, KDM3A is abundantly expressed and positively correlated with Sox2 expression in human ovarian cancer tissues. In brief, our findings reveal a novel mechanism by which KDM3A promotes ovarian CSCs, proliferation and chemoresistance and thus, highlights the significance of KDM3A as a novel therapeutic target for resistant ovarian cancer.	[Ramadoss, S.; Sen, S.; Roy, S.; Chaudhuri, G.; Farias-Eisner, R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Ramachandran, I.] Univ Madras, Dr ALM PG Inst Basic Med Sci, Dept Endocrinol, Taramani Campus, Madras 600113, Tamil Nadu, India; [Chaudhuri, G.] Univ Calif Los Angeles, David Geffen Sch Med, Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Madras; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ramadoss, S; Farias-Eisner, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.	ramasiva@ucla.edu; rfeisner@mednet.ucla.edu			The Roberta Deutsch Foundation	The Roberta Deutsch Foundation	We acknowledge The Roberta Deutsch Foundation and Kelly Day for their financial support. We thank Professor Oliver Dorigo, Stanford University Medical Center, for the generous gift of cisplatin-resistant ovarian cancer cell lines. We thank Dr Xiangming Ding, UCLA Clinical Microarray Core for the statistical assistance.	Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cioffi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10357; Cohen Joshua G, 2014, World J Biol Chem, V5, P286, DOI 10.4331/wjbc.v5.i3.286; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kong Yahui, 2011, J Aging Res, V2011, P963172, DOI 10.4061/2011/963172; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Liu T, 2015, TUMOR BIOL, V36, P1881, DOI 10.1007/s13277-014-2790-3; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; McEvoy LM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1539-8; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Nair SS, 2012, MOL ONCOL, V6, P611, DOI 10.1016/j.molonc.2012.09.005; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Ramadoss S, 2017, ONCOGENE, V36, P47, DOI 10.1038/onc.2016.174; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Rasheed ZA, 2011, STEM CELLS, V29, P883, DOI 10.1002/stem.648; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tapia N, 2010, J EXP MED, V207, P2045, DOI 10.1084/jem.20101866; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zhang XM, 2013, CELL REP, V5, P445, DOI 10.1016/j.celrep.2013.09.018	36	30	32	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1537	1545		10.1038/onc.2016.320	http://dx.doi.org/10.1038/onc.2016.320			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27694900	Green Published, hybrid			2022-12-26	WOS:000397458100008
J	Yu, PF; Huang, Y; Xu, CL; Lin, LY; Han, YY; Sun, WH; Hu, GH; Rabson, AB; Wang, Y; Shi, YF				Yu, P. F.; Huang, Y.; Xu, C. L.; Lin, L. Y.; Han, Y. Y.; Sun, W. H.; Hu, G. H.; Rabson, A. B.; Wang, Y.; Shi, Y. F.			Downregulation of CXCL12 in mesenchymal stromal cells by TGF beta promotes breast cancer metastasis	ONCOGENE			English	Article							STEM-CELLS; CHEMOKINE RECEPTOR; TUMOR-DEVELOPMENT; IN-VIVO; MIGRATION; GROWTH; RECRUITMENT; INTERLEUKIN-6; PROGRESSION; SECRETION	Mesenchymal stromal cells (MSCs) are one of major components of the tumour microenvironment. Recent studies have shown that MSC tumour residence and their close interactions with inflammatory factors are important factors that affect tumour progression. Among tumour-associated inflammatory factors, transforming growth factor beta (TGF beta) is regarded as a key determinant of malignancy. By employing a lung metastasis model of a murine breast cancer, we show here that the prometastatic effect of MSCs was dependent on their response to TGF beta. Interestingly, we found that MSC-produced CXCL12, an important chemokine in tumour metastasis, was markedly inhibited by TGF beta. Furthermore, silencing of CXCL12 in TGF beta-unresponsive MSCs restored their ability to promote tumour metastasis. We found that 4T1 breast cancer cells expressed high levels of CXCR7, but not of CXCR4, both of which are CXCL12 receptors. In presence of CXCL12, CXCR7 expression on tumour cells was decreased. Indeed, when CXCR7 was silenced in breast cancer cells, their metastatic ability was inhibited. Therefore, our data demonstrated that sustained expression of CXCL12 by MSCs in the primary tumour site inhibits metastasis through reduction of CXCR7, while, in the presence of TGF beta, this CXCL12 effect of MSCs on tumour cells is relieved. Importantly, elevated CXCR7 and depressed CXCL12 expression levels were prominent features of clinical breast cancer lesions and were related significantly with poor survival. Our findings reveal a novel mechanism of MSC effects on malignant cells through which crosstalk between MSCs and TGF beta regulates tumour metastasis.	[Yu, P. F.; Huang, Y.; Xu, C. L.; Lin, L. Y.; Han, Y. Y.; Sun, W. H.; Hu, G. H.; Wang, Y.; Shi, Y. F.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yu, P. F.; Huang, Y.; Xu, C. L.; Lin, L. Y.; Han, Y. Y.; Sun, W. H.; Hu, G. H.; Wang, Y.; Shi, Y. F.] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Rabson, A. B.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ USA; [Shi, Y. F.] Soochow Univ, Inst Translat Med, Affiliated Hosp 1, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Rutgers State University New Brunswick; Rutgers State University Medical Center; Soochow University - China	Wang, Y; Shi, YF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	HUANG, YIN/AAH-6871-2020; Shi, Yufang/AAE-4431-2020; Xu, Chunliang/R-7065-2018; Yu, Pengfei/AHC-3497-2022	HUANG, YIN/0000-0001-5602-9871; Shi, Yufang/0000-0001-8964-319X; Yu, Pengfei/0000-0002-3894-5697; Sun, Weihong/0000-0002-6292-903X; wang, ying/0000-0002-2571-9367; Hu, Guohong/0000-0002-2980-5166	Programs of National Natural Science of China [81330046, 81273316, 81571612, 81530043]; Scientific Innovation Project of the Chinese Academy of Science [XDA 01040100]; Ministry of Science and Technology of China [2015CB964400]; External Cooperation Program of BIC, Chinese Academy of Sciences [GJHZ201307]; Shanghai Rising-Star Program [14QA1404200]; Youth Innovation Promotion Association, Chinese Academy of Sciences	Programs of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Scientific Innovation Project of the Chinese Academy of Science; Ministry of Science and Technology of China(Ministry of Science and Technology, China); External Cooperation Program of BIC, Chinese Academy of Sciences; Shanghai Rising-Star Program; Youth Innovation Promotion Association, Chinese Academy of Sciences	This study was supported by grants from the Programs of National Natural Science of China (81330046, 81273316, 81571612, 81530043), the Scientific Innovation Project of the Chinese Academy of Science (XDA 01040100), the Ministry of Science and Technology of China (2015CB964400), the External Cooperation Program of BIC, Chinese Academy of Sciences (GJHZ201307), Shanghai Rising-Star Program (14QA1404200) and the Youth Innovation Promotion Association, Chinese Academy of Sciences.	Arabanian LS, 2014, HAEMATOLOGICA, V99, P997, DOI 10.3324/haematol.2013.097675; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boimel PJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3108; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; De Luca A, 2012, J CELL BIOCHEM, V113, P3363, DOI 10.1002/jcb.24212; Duvall-Noelle N, 2016, ONCOGENE, V35, P1122, DOI 10.1038/onc.2015.166; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Ganju RK, 2012, SIGNALING PATHWAYS M, P221; Giacobbe A, 2016, ONCOGENE, V35, P1602, DOI 10.1038/onc.2015.230; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Meijer J, 2008, BRIT J CANCER, V99, P1493, DOI 10.1038/sj.bjc.6604727; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ohnuki H, 2014, CANCER RES, V74, P2038, DOI 10.1158/0008-5472.CAN-13-3118; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; Ray P, 2015, ONCOGENE, V34, P2043, DOI 10.1038/onc.2014.157; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Stacer AC, 2016, ONCOGENE, V35, P1716, DOI 10.1038/onc.2015.236; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; Xu CL, 2014, J IMMUNOL, V192, P103, DOI 10.4049/jimmunol.1302164; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	37	60	61	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					840	849		10.1038/onc.2016.252	http://dx.doi.org/10.1038/onc.2016.252			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27669436	Green Published, hybrid			2022-12-26	WOS:000394168200011
J	Kanemura, S; Okumura, M; Yutani, K; Ramming, T; Hikima, T; Appenzeller-Herzog, C; Akiyama, S; Inaba, K				Kanemura, Shingo; Okumura, Masaki; Yutani, Katsuhide; Ramming, Thomas; Hikima, Takaaki; Appenzeller-Herzog, Christian; Akiyama, Shuji; Inaba, Kenji			Human ER Oxidoreductin-1 alpha (Ero1 alpha) Undergoes Dual Regulation through Complementary Redox Interactions with Protein-Disulfide Isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; endoplasmic reticulum (ER); hydrogen peroxide; protein-disulfide isomerase; redox regulation	X-RAY-SCATTERING; ENDOPLASMIC-RETICULUM; BOND FORMATION; PDI FAMILY; HYDROGEN-PEROXIDE; OXIDATION; PEROXIREDOXIN; PATHWAY; MECHANISMS; REDUCTION	In the mammalian endoplasmic reticulum, oxidoreductin-1 (Ero1) generates protein disulfide bonds and transfers them specifically to canonical protein-disulfide isomerase (PDI) to sustain oxidative protein folding. This oxidative process is coupled to the reduction of O-2 to H2O2 on the bound flavin adenine dinucleotide cofactor. Because excessive thiol oxidation and H2O2 generation cause cell death, Ero1 activity must be properly regulated. In addition to the four catalytic cysteines (Cys(94), Cys(99), Cys(104), and Cys(131)) that are located in the flexible active site region, the Cys(208)-Cys(241) pair located at the base of another flexible loop is necessary for Ero1 regulation, although the mechanistic basis is not fully understood. The present study revealed that the Cys(208)-Cys(241) disulfide was reduced by PDI and other PDI family members during PDI oxidation. Differential scanning calorimetry and small angle X-ray scattering showed that mutation of Cys(208) and Cys(241) did not grossly affect the thermal stability or overall shape of Ero1, suggesting that redox regulation of this cysteine pair serves a functional role. Moreover, the flexible loop flanked by Cys(208) and Cys(241) provides a platform for functional interaction with PDI, which in turn enhances the oxidative activity of Ero1 through reduction of the Cys(208)-Cys(241) disulfide. We propose a mechanism of dual Ero1 regulation by dynamic redox interactions between PDI and the two Ero1 flexible loops that harbor the regulatory cysteines.	[Kanemura, Shingo; Okumura, Masaki; Inaba, Kenji] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan; [Okumura, Masaki; Yutani, Katsuhide; Hikima, Takaaki; Akiyama, Shuji] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Ramming, Thomas; Appenzeller-Herzog, Christian] Univ Basel, Div Mol & Syst Toxicol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland; [Appenzeller-Herzog, Christian] Berufsfachschule Gesundheit Baselland, CH-4142 Munchenstein, Switzerland; [Akiyama, Shuji] Res Ctr Integrat Mol Syst CIMoS, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Akiyama, Shuji] Grad Univ Adv Studies, SOKENDAI, Dept Funct Mol Sci, Kanagawa 2400193, Japan; [Inaba, Kenji] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020076, Japan	Tohoku University; RIKEN; University of Basel; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Inaba, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	kinaba@tagen.tohoku.ac.jp	okumura, masaki/AAO-3454-2020; Appenzeller-Herzog, Christian/A-2894-2014	okumura, masaki/0000-0001-8130-2470; Appenzeller-Herzog, Christian/0000-0001-7430-294X; AKIYAMA, Shuji/0000-0002-7184-189X; Kanemura, Shingo/0000-0002-7012-8179; Inaba, Kenji/0000-0001-8229-0467	Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan [26116005, 15641922]; Takeda Science Foundation; Japan Society for the Promotion of Science [15J06349, 13J04030]; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [15J06349] Funding Source: KAKEN	Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Core Research for Evolutional Science and Technology program of Japan Science and Technology Agency (to K. I.), a Grant-in-Aid for Scientific Research B (to K. I.), Grants-in-Aid 26116005 (to K. I.) and 15641922 (to M. O.) for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from the Takeda Science Foundation (to K. I.), Fellowships 15J06349 (to S. K.) and 13J04030 (to M. O.) from the Japan Society for the Promotion of Science, funds from the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. A. and M. O.), and funds from the Uehara Memorial Foundation (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; KUROKI R, 1992, BIOCHEMISTRY-US, V31, P8323, DOI 10.1021/bi00150a028; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Okumura M., 2014, CURR PROTOC PROTEIN, V76; Okumura M, 2015, FREE RADICAL BIO MED, V83, P314, DOI 10.1016/j.freeradbiomed.2015.02.010; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Okumura M, 2011, FEBS J, V278, P1137, DOI 10.1111/j.1742-4658.2011.08039.x; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Ramming T, 2016, REDOX BIOL, V7, P14, DOI 10.1016/j.redox.2015.11.004; Ramming T, 2015, FREE RADICAL BIO MED, V83, P361, DOI 10.1016/j.freeradbiomed.2015.02.011; Ramming T, 2014, FREE RADICAL BIO MED, V70, P106, DOI 10.1016/j.freeradbiomed.2014.01.018; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	42	11	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23952	23964		10.1074/jbc.M116.735662	http://dx.doi.org/10.1074/jbc.M116.735662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27703014	Green Published, hybrid			2022-12-26	WOS:000388498100012
J	Oliva, CR; Markert, T; Ross, LJ; White, EL; Rasmussen, L; Zhang, W; Everts, M; Moellering, DR; Bailey, SM; Suto, MJ; Griguer, CE				Oliva, Claudia R.; Markert, Tahireh; Ross, Larry J.; White, E. Lucile; Rasmussen, Lynn; Zhang, Wei; Everts, Maaike; Moellering, Douglas R.; Bailey, Shannon M.; Suto, Mark J.; Griguer, Corinne E.			Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemoresistance; cytochrome c oxidase (complex IV); glioblastoma; inhibitor; metabolism; mitochondria; small molecule; stem cells	MITOCHONDRIAL ELECTRON-TRANSPORT; CULTURED-CELLS; CAPACITY; GLUTATHIONE; CYANIDE; GLIOBLASTOMA; TEMOZOLOMIDE; METABOLISM; TISSUES; CHAIN	The enzyme cytochrome c oxidase (CcO) or complex IV (EC 1.9.3.1) is a large transmembrane protein complex that serves as the last enzyme in the respiratory electron transport chain of eukaryotic mitochondria. CcO promotes the switch from glycolytic to oxidative phosphorylation (OXPHOS) metabolism and has been associated with increased self-renewal characteristics in gliomas. Increased CcO activity in tumors has been associated with tumor progression after chemotherapy failure, and patients with primary glioblastoma multiforme and high tumor CcO activity have worse clinical outcomes than those with low tumor CcO activity. Therefore, CcO is an attractive target for cancer therapy. We report here the characterization of a CcO inhibitor (ADDA 5) that was identified using a high throughput screening paradigm. ADDA 5 demonstrated specificity for CcO, with no inhibition of other mitochondrial complexes or other relevant enzymes, and biochemical characterization showed that this compound is a non-competitive inhibitor of cytochrome c. When tested in cellular assays, ADDA 5 dose-dependently inhibited the proliferation of chemosensitive and chemoresistant glioma cells but did not display toxicity against non-cancer cells. Furthermore, treatment with ADDA 5 led to significant inhibition of tumor growth in flank xenograft mouse models. Importantly, ADDA 5 inhibited CcO activity and blocked cell proliferation and neurosphere formation in cultures of glioma stem cells, the cells implicated in tumor recurrence and resistance to therapy in patients with glioblastoma. In summary, we have identified ADDA 5 as a lead CcO inhibitor for further optimization as a novel approach for the treatment of glioblastoma and related cancers.	[Oliva, Claudia R.; Markert, Tahireh; Griguer, Corinne E.] Univ Alabama Birmingham, Div Infect Dis, Dept Neurosurg, Birmingham, AL 35294 USA; [Griguer, Corinne E.] Univ Alabama Birmingham, Div Infect Dis, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Everts, Maaike] Univ Alabama Birmingham, Div Infect Dis, Dept Pediat, Birmingham, AL 35294 USA; [Ross, Larry J.; White, E. Lucile; Rasmussen, Lynn; Zhang, Wei; Suto, Mark J.] Southern Res, Drug Discovery Div, Birmingham, AL 35205 USA; [Bailey, Shannon M.] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA; [Moellering, Douglas R.] Univ Alabama Birmingham, Diabet Res Ctr BARB Core, UAB Nutr Sci Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Griguer, CE (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Dept Neurosurg, Birmingham, AL 35294 USA.	cegriguer@uabmc.edu		, Corinne/0000-0003-3877-5031; Bailey, Shannon/0000-0003-0002-3424; Oliva, Claudia/0000-0003-0624-5490; Moellering, Douglas/0000-0003-2040-4187; Everts, Maaike/0000-0001-7421-4691	National Institutes of Health [R01CA160821, P30 DK079626]; Alabama Drug Discovery Alliance (ADDA); University of Alabama at Birmingham; Southern Research Institute; National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health) [UL1TR00165]; NATIONAL CANCER INSTITUTE [R01CA160821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000165, UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance (ADDA); University of Alabama at Birmingham; Southern Research Institute; National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01CA160821 and P30 DK079626. Work reported in this publication was supported by the Alabama Drug Discovery Alliance (ADDA) and collaboration between the University of Alabama at Birmingham and Southern Research Institute as well as the National Center for Advancing Translational Sciences of the National Institutes of Health (National Institutes of Health) under award UL1TR00165. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; Darley-Usmar V. M., 1987, MITOCHONDRIA PRACTIC; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Eng J, 2013, ACAD RADIOL, V20, P795, DOI 10.1016/j.acra.2013.05.001; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061035; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Gunasekar PG, 1998, J PHARMACOL EXP THER, V285, P236; HARRIS SI, 1981, J BIOL CHEM, V256, P319; JONES MG, 1984, BIOCHEM J, V220, P57, DOI 10.1042/bj2200057; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010; Oliva CR, 2015, ONCOTARGET, V6, P4330, DOI 10.18632/oncotarget.3015; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Partridge MA, 2007, CANCER RES, V67, P5239, DOI 10.1158/0008-5472.CAN-07-0074; Ragan C, 1987, MITOCHONDRIA PRACTIC; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152; Sansbury BE, 2011, CHEM-BIOL INTERACT, V191, P288, DOI 10.1016/j.cbi.2010.12.002; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; SUN AS, 1980, CANCER RES, V40, P4677; SUN AS, 1981, LAB INVEST, V44, P13; Sun Wenqing G, 2010, Cancers (Basel), V2, P68, DOI 10.3390/cancers2010068; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; WAY JL, 1984, ANNU REV PHARMACOL, V24, P451, DOI 10.1146/annurev.pa.24.040184.002315; WAY JL, 1988, CIBA F SYMP, V140, P232; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; WILLIAMS JN, 1964, ARCH BIOCHEM BIOPHYS, V107, P537, DOI 10.1016/0003-9861(64)90313-3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24188	24199		10.1074/jbc.M116.749978	http://dx.doi.org/10.1074/jbc.M116.749978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679486	Green Published, hybrid			2022-12-26	WOS:000388498100033
J	Woo, MS; Yang, J; Beltran, C; Cho, S				Woo, Moon-Sook; Yang, Jiwon; Beltran, Cesar; Cho, Sunghee			Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; macrophage; monocyte; phagocytosis; stroke; CD36; ischemic stroke; resolution	SCAVENGER RECEPTOR CD36; BRAIN-INJURY; PPAR-GAMMA; ACID TRANSLOCASE; OXIDIZED LDL; IDENTIFICATION; ACTIVATION; EXPRESSION; MICROGLIA; DIFFERENTIATION	Infiltrating monocyte-derived macrophages (M-M-phi) influence stroke-induced brain injury. Although the inflammatory nature of M-M-phi in acute stroke has been well documented, their role during the resolution phase of stroke is less clear. With emerging evidence for the involvement of scavenger receptors in innate immunity, this study addresses an M-M-phi CD36 role in mediating phagocytosis during the recovery phase of stroke. Stroke increases CD36 and TSP-1/2 mRNA levels in the ipsilateral hemisphere at acute (3-day (d)) and recovery (7d) periods. Quantification of total, intracellular, and cell surface CD36 protein levels showed relatively unchanged expression at 3d post-ischemia. At 7d, there was a significant increase in cell surface CD36 (p < 0.05) with a concurrent reduction of intracellular CD36 (p < 0.05) in the ipsilateral hemisphere. Both cell surface and intracellular CD36 were found in whole brain lysates, whereas cell surface CD36 was predominantly detected in isolated brain mononuclear cells, blood monocytes, and peritoneal macrophages, suggesting that cell surface CD36 expressed in the post-ischemic brain originates from the periphery. The stroke-induced CD36 mRNA level correlated with increased expression of lysosomal acid lipase, an M2 macrophage marker. Functionally, higher CD36 expression in M-M-phi is correlated with higher phagocytic indices in post-ischemic brain immune cells. Moreover, pharmacological inhibition of CD36 attenuated phagocytosis in peritoneal macrophages and brain M-M-phi. These findings demonstrate that cell surface CD36 on M-M-phi mediates phagocytosis during the recovery phase in post-stroke brains and suggests that CD36 plays a reparative role during the resolution of inflammation in ischemic stroke.	[Cho, Sunghee] Burke Cornell Med Res Inst, White Plains, NY 10605 USA; Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Cho, S (corresponding author), Burke Med Res Inst, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	suc2002@med.cornell.edu			National Institutes of Health [R01HL82511, R01NS077897, R01NS095359]; Burke Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095359, R01NS077897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01HL82511, R01NS077897, and R01NS095359 (to S. C.) and the Burke Foundation (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JC, 2004, INT J BIOCHEM CELL B, V36, P1102, DOI 10.1016/j.biocel.2004.01.022; Alessio M, 1996, J BIOL CHEM, V271, P1770, DOI 10.1074/jbc.271.3.1770; Ballesteros I, 2014, J LEUKOCYTE BIOL, V95, P587, DOI 10.1189/jlb.0613326; Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Bohlson SS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00402; BORDESSOULE D, 1993, BRIT J HAEMATOL, V83, P370, DOI 10.1111/j.1365-2141.1993.tb04659.x; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Cho S, 2009, J NEUROCHEM, V109, P126, DOI 10.1111/j.1471-4159.2009.05801.x; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; De Haas AH, 2007, GLIA, V55, P1374, DOI 10.1002/glia.20554; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Garcia-Bonilla L, 2015, J NEUROSCI, V35, P14783, DOI 10.1523/JNEUROSCI.2980-15.2015; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; KIEFFER N, 1988, BIOCHIM BIOPHYS ACTA, V967, P408, DOI 10.1016/0304-4165(88)90104-3; Kim E, 2008, J NEUROSCI, V28, P4661, DOI 10.1523/JNEUROSCI.0982-08.2008; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Kim E, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-83; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; TALLE MA, 1983, CELL IMMUNOL, V78, P83, DOI 10.1016/0008-8749(83)90262-9; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; VANNIEUWENHOVEN FA, 1995, BIOCHEM BIOPH RES CO, V207, P747, DOI 10.1006/bbrc.1995.1250; Woo MS, 2012, ANN NEUROL, V72, P961, DOI 10.1002/ana.23727; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974	37	70	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23654	23661		10.1074/jbc.M116.750018	http://dx.doi.org/10.1074/jbc.M116.750018			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27646002	Green Published, hybrid			2022-12-26	WOS:000387884400025
J	Hoover, AR; Dozmorov, I; MacLeod, J; Du, QM; de la Morena, MT; Forbess, J; Guleserian, K; Cleaver, OB; van Oers, NSC				Hoover, Ashley R.; Dozmorov, Igor; MacLeod, Jessica; Du, Qiumei; de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine; Cleaver, Ondine B.; van Oers, Nicolai S. C.			MicroRNA-205 Maintains T Cell Development following Stress by Regulating Forkhead Box N1 and Selected Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; AGED THYMUS; EXPRESSION; GENE; TOLERANCE; MIGRATION; FOXN1; MICROENVIRONMENTS; DIFFERENTIATION; REGENERATION	The thymus, an organ responsible for T cell development, is one of the more stress-sensitive tissues in the body. Stress, in the form of infections, radiation exposure, and steroids, impairs thymic epithelial cell (TEC) functions and induces the programmed cell death of immature thymocytes. MicroRNAs are small noncoding RNAs involved in tissue repair and homeostasis, with several supporting T cell development. We report that miR-205, an epithelial-specific miR, maintains thymopoiesis following inflammatory perturbations. Thus, the activation of diverse pattern recognition receptors in mice causes a more severe thymic hypoplasia and delayed T cell recovery when miR-205 is conditionally ablated in TECs. Gene expression comparisons in the TECs with/without miR-205 revealed a significant differential regulation of chemokine/chemokine receptor pathways, antigen processing components, and changes in the Wnt signaling system. This was partly a consequence of reduced expression of the transcriptional regulator of epithelial cell function, Forkhead Box N1 (Foxn1), and its two regulated targets, stem cell factor and ccl25, following stress. miR-205 mimics supplemented into miR-205-deficient fetal thymic organ cultures restored Foxn1 expression along with ccl25 and stem cell factor. A number of putative targets of miR-205 were up-regulated in TECs lacking miR-205, consistent with an important role for this miR in supporting T cell development in response to stress.	[Hoover, Ashley R.; Dozmorov, Igor; MacLeod, Jessica; Du, Qiumei; van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, NA2-200,6000 Harry Hines Blvd, Dallas, TX 75390 USA; [de la Morena, M. Teresa; van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cleaver, Ondine B.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [de la Morena, M. Teresa; Forbess, Joseph; Guleserian, Kristine] Childrens Hlth, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	van Oers, NSC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, NA2-200,6000 Harry Hines Blvd, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021	van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health [R01 AI114523, F31 AI110140]; Children's Medical Center Research Foundation; University of Texas Southwestern Medical Center; Jeffery Model Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114523, F31AI110140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Center Research Foundation; University of Texas Southwestern Medical Center; Jeffery Model Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI114523 (to N. v. O.) and F31 AI110140 (to A. H.), and grants from the Children's Medical Center Research Foundation (to N. v. O., and M. d. l. M.), the Beecherl Grant from the University of Texas Southwestern Medical Center (to N. v. O.), and the Jeffery Model Foundation (to M. d. l. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Belkaya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085274; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Berki T, 2002, INT IMMUNOL, V14, P463, DOI 10.1093/intimm/14.5.463; Billard MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017940; Birling MC, 2012, GENESIS, V50, P482, DOI 10.1002/dvg.20826; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Bunting MD, 2014, IMMUNOL CELL BIOL, V92, P489, DOI 10.1038/icb.2014.14; Bunting MD, 2011, IMMUNOL CELL BIOL, V89, P185, DOI 10.1038/icb.2010.142; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dixit VD, 2010, CURR OPIN IMMUNOL, V22, P521, DOI 10.1016/j.coi.2010.06.010; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Dozmorov I, 2009, NUCLEIC ACIDS RES, V37, P6323, DOI 10.1093/nar/gkp706; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Farmer DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076634; Gennery AR, 2012, CELL MOL LIFE SCI, V69, P17, DOI 10.1007/s00018-011-0842-z; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hagman Z, 2013, BRIT J CANCER, V108, P1668, DOI 10.1038/bjc.2013.131; Halkias J, 2014, CELL MOL LIFE SCI, V71, P3101, DOI 10.1007/s00018-014-1607-2; Halkias J, 2013, J CLIN INVEST, V123, P2131, DOI 10.1172/JCI67175; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Khan IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135440; Khan IS, 2014, EUR J IMMUNOL, V44, P1313, DOI 10.1002/eji.201344079; Li B, 2011, CLIN IMMUNOL, V140, P244, DOI 10.1016/j.clim.2011.04.004; Liang CC, 2013, IMMUNOL CELL BIOL, V91, P511, DOI 10.1038/icb.2013.34; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Otero DC, 2013, J IMMUNOL, V190, P3289, DOI 10.4049/jimmunol.1203086; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Park CY, 2012, CELL REP, V1, P385, DOI 10.1016/j.celrep.2012.02.008; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Seach N, 2012, J IMMUNOL METHODS, V385, P23, DOI 10.1016/j.jim.2012.07.023; Takaba H, 2015, CELL, V163, P975, DOI 10.1016/j.cell.2015.10.013; Varecza Z, 2011, MECH AGEING DEV, V132, P249, DOI 10.1016/j.mad.2011.04.007; Vidalain PO, 2002, J VIROL, V76, P6415, DOI 10.1128/JVI.76.13.6415-6424.2002; Wallin J, 1996, DEVELOPMENT, V122, P23; Williams KM, 2009, CTS-CLIN TRANSL SCI, V2, P279, DOI 10.1111/j.1752-8062.2009.00128.x; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zuklys S, 2012, J IMMUNOL, V189, P3894, DOI 10.4049/jimmunol.1200783	47	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23237	23247		10.1074/jbc.M116.744508	http://dx.doi.org/10.1074/jbc.M116.744508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27646003	Green Published, hybrid			2022-12-26	WOS:000387224800032
J	Poder, TG; Pruneau, D; Dorval, J; Thibault, L; Fisette, JF; Bedard, SK; Jacques, A; Beauregard, P				Poder, Thomas G.; Pruneau, Denise; Dorval, Josee; Thibault, Louis; Fisette, Jean-Francois; Bedard, Suzanne K.; Jacques, Annie; Beauregard, Patrice			Pressure Infusion Cuff and Blood Warmer during Massive Transfusion: An Experimental Study About Hemolysis and Hypothermia	PLOS ONE			English	Article							MANAGEMENT; TEMPERATURE; HEMORRHAGE	Background Blood warmers were developed to reduce the risk of hypothermia associated with the infusion of cold blood products. During massive transfusion, these devices are used with compression sleeve, which induce a major stress to red blood cells. In this setting, the combination of blood warmer and compression sleeve could generate hemolysis and harm the patient. We conducted this study to compare the impact of different pressure rates on the hemolysis of packed red blood cells and on the outlet temperature when a blood warmer set at 41.5 degrees C is used. Methods Pressure rates tested were 150 and 300 mmHg. Ten packed red blood cells units were provided by He A ma-Que A bec and each unit was sequentially tested. Results We found no increase in hemolysis either at 150 or 300 mmHg. By cons, we found that the blood warmer was not effective at warming the red blood cells at the specified temperature. At 150 mmHg, the outlet temperature reached 37.1 degrees C and at 300 mmHg, the temperature was 33.7 degrees C. Conclusion To use a blood warmer set at 41.5 degrees C in conjunction with a compression sleeve at 150 or 300 mmHg does not generate hemolysis. At 300 mmHg a blood warmer set at 41.5 degrees C does not totally avoid a risk of hypothermia.	[Poder, Thomas G.; Fisette, Jean-Francois; Bedard, Suzanne K.] CIUSSS Estrie CHUS, UETMIS, Sherbrooke, PQ J1G 2E8, Canada; [Poder, Thomas G.] CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ J1H 5N4, Canada; [Pruneau, Denise; Dorval, Josee; Beauregard, Patrice] CIUSSS Estrie CHUS, Blood Bank, Sherbrooke, PQ J1H 5N4, Canada; [Thibault, Louis; Jacques, Annie] Hema Quebec, Div Res & Dev, Quebec City, PQ G1V 5C3, Canada; [Beauregard, Patrice] CIUSSS Estrie CHUS, Div Hematol Oncol, Sherbrooke, PQ J1H 5N4, Canada	Hema-Quebec	Poder, TG (corresponding author), CIUSSS Estrie CHUS, UETMIS, Sherbrooke, PQ J1G 2E8, Canada.; Poder, TG (corresponding author), CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ J1H 5N4, Canada.	tpoder.chus@sss.gouv.qc.ca		Poder, Thomas/0000-0001-7017-096X	operating budgets of the health technology assessment unit of the CHUS; Blood Bank of the CHUS; Hema-Quebec; FRQS	operating budgets of the health technology assessment unit of the CHUS; Blood Bank of the CHUS; Hema-Quebec; FRQS	This project was funded from the operating budgets of the health technology assessment unit of the CHUS, the Blood Bank of the CHUS and Hema-Quebec.; We acknowledge Flavien Nicolas Andrianary, Christian Bellemare, Sylvie Bergeron, Valerie Bertelle, Line Bilodeau, Lise L. Blais, Martine Comtois, Stephanie Dion, Renee Lafreniere, Helene Levesque, Genevieve Paquette, Monique Robillard, Daniel Sale Menard and Sylvie Thibault for their support and advice. We also acknowledge the personnel of the Blood Bank of the CHUS for their cooperation during the study. TGP is a member of the FRQS-funded Centre de recherche du CHUS (CRCHUS).	AABB, 2002, GUID US BLOOD WARM D; AABB, 2014, STANDARDS BLOOD BANK, p[215, 111], DOI [10.1016/s0887-7963(88)70036-x, DOI 10.1016/S0887-7963(88)70036-X]; Aslam AF, 2006, AM J MED, V119, P297, DOI 10.1016/j.amjmed.2005.09.062; BEAUREGARD P, 1994, TRANSFUS MED REV, V8, P184, DOI 10.1016/S0887-7963(94)70110-3; Ciavarella D, 1988, Transfus Med Rev, V2, P95, DOI 10.1016/S0887-7963(88)70036-X; Du Plessis J M, 1966, S Afr Med J, V40, P479; Hardy JF, 2004, CAN J ANAESTH, V51, P293, DOI 10.1007/BF03018233; Hayter MA, 2012, CAN J ANESTH, V59, P1130, DOI 10.1007/s12630-012-9795-4; Hess JR, 2009, TRANSFUSION, V49, P2599, DOI 10.1111/j.1537-2995.2009.02275.x; Kim HJ, 2016, CLIN HEMORHEOL MICRO, V62, P13, DOI 10.3233/CH-151926; Kim P, 2004, CAN J SURG, V47, P295; Lacroix J, 2011, TRANSFUS CLIN BIOL, V18, P97, DOI 10.1016/j.tracli.2011.02.020; LINKO K, 1979, ACTA ANAESTH SCAND, V23, P46, DOI 10.1111/j.1399-6576.1979.tb01420.x; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; MATEER JR, 1985, ANN EMERG MED, V14, P966, DOI 10.1016/S0196-0644(85)80238-9; Miller TE, 2013, PERIOPER MED, V2, DOI 10.1186/2047-0525-2-13; PAPPAS CG, 1995, CRIT CARE MED, V23, P1243, DOI 10.1097/00003246-199507000-00015; Perlman R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1271-z; Pisciotto PT., 2004, HDB PEDIAT TRANSFUSI, pP. 121, DOI [10.1016/B978-012348776-6/50014-5, DOI 10.1016/B978-012348776-6/50014-5]; Poder TG, 2015, TRANSFUS MED REV, V29, P172, DOI 10.1016/j.tmrv.2015.03.002; Ramakrishnan VT, 2014, INDIAN J ANAESTH, V58, P609, DOI 10.4103/0019-5049.144668; Refaai MA, 2013, BEST PRACT RES-CLIN, V27, P17, DOI 10.1016/j.bpa.2012.12.006; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Smith CE, 2008, INT TRAUMACARE, V18, P71; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Unite d'evaluation des technologies et des modes d'intervention en sante du Centre hospitalier universitaire de Sherbrooke (UETMIS-CHUS), 2013, UN EV TECHN MOD INT, VXIV; VANDERWALT JH, 1978, BRIT J ANAESTH, V50, P815, DOI 10.1093/bja/50.8.815; WILLIAMSON JR, 1975, BLOOD, V46, P611	29	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163429	10.1371/journal.pone.0163429	http://dx.doi.org/10.1371/journal.pone.0163429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711116	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600024
J	Vila, A; Abal, M; Muinelo-Romay, L; Rodriguez-Abreu, C; Rivas, J; Lopez-Lopez, R; Costa, C				Vila, Ana; Abal, Miguel; Muinelo-Romay, Laura; Rodriguez-Abreu, Carlos; Rivas, Jose; Lopez-Lopez, Rafael; Costa, Clotilde			EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; EXPRESSION; CARCINOMA; LINES; EMT; DIFFERENTIATION; DISSEMINATION; ESTABLISHMENT	Circulating tumour cells (CTCs) play a key role in the metastasis process, as they are responsible for micrometastasis and are a valuable tool for monitoring patients in real-time. Moreover, efforts to develop new strategies for CTCs isolation and characterisation, and the translation of CTCs into clinical practice needs to overcome the limitation associated with the sole use of Epithelial Cell Adhesion Molecule (EpCAM) expression to purify this tumour cell subpopulation. CTCs are rare events in the blood of patients and are believed to represent the epithelial population from a primary tumour of epithelial origin, thus EpCAM immunoisolation is considered an appropriate strategy. The controversy stems from the impact that the more aggressive mesenchymal tumour phenotypes might have on the whole CTC population. In this work, we first characterised a panel of cell lines representative of tumour heterogeneity, confirming the existence of tumour cell subpopulations with restricted epithelial features and supporting the limitations of EpCAM-based technologies. We next developed customised polystyrene magnetic beads coated with antibodies to efficiently isolate the phenotypically different subpopulations of CTCs from the peripheral blood mononuclear cells (PBMCs) of patients with metastatic cancer. Besides EpCAM, we propose Epidermal Growth Factor Receptor (EGFR) as an additional isolation marker for efficient CTCs detection.	[Vila, Ana; Rodriguez-Abreu, Carlos; Rivas, Jose] INL Int Iberian Nanotechnol Lab, AvdaMestre Jose Veiga, P-4715330 Braga, Portugal; [Abal, Miguel; Lopez-Lopez, Rafael; Costa, Clotilde] ComplexoHosp Univ Santiago de Compostela SERGAS, Translat Med Oncol, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain; [Muinelo-Romay, Laura; Lopez-Lopez, Rafael] ComplexoHosp Univ Santiago de Compostela SERGAS, Liquid Biopsy Anal Unit, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain; [Rivas, Jose] Univ Santiago de Compostela, Dept Appl Phys, Technol Res Inst, Nanotechnol & Magnetism Lab NANOMAG, Santiago De Compostela 15782, Spain	International Iberian Nanotechnology Laboratory; Universidade de Santiago de Compostela	Vila, A (corresponding author), INL Int Iberian Nanotechnol Lab, AvdaMestre Jose Veiga, P-4715330 Braga, Portugal.; Costa, C (corresponding author), ComplexoHosp Univ Santiago de Compostela SERGAS, Translat Med Oncol, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain.	ana.vila@inl.int; clotilde.costa.nogueira@sergas.es	Rodriguez-Abreu, Carlos/B-8690-2014	Rodriguez-Abreu, Carlos/0000-0002-5917-6508; Lopez Lopez, Rafael/0000-0003-1315-655X; Abal Posada, Miguel/0000-0003-3533-7781; Costa, Clotilde/0000-0001-7327-2259; Rivas, Jose/0000-0002-5059-3196	Axencia Galega de Innovacion (Xunta de Galicia); InveNNta (Innovation in Nanomedicine); European Union (EU) through Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP); European Regional Development Fund (ERDF)	Axencia Galega de Innovacion (Xunta de Galicia)(Xunta de Galicia); InveNNta (Innovation in Nanomedicine); European Union (EU) through Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP); European Regional Development Fund (ERDF)(European Commission)	This work was supported by Axencia Galega de Innovacion (Xunta de Galicia) and InveNNta (Innovation in Nanomedicine), co-financed by the European Union (EU) through the Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP 2007-2013), and European Regional Development Fund (ERDF).	Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Barriere G, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.10.04; Bedussi F, 2014, EXPERT OPIN THER TAR, V18, P665, DOI 10.1517/14728222.2014.898064; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carnio S, 2014, EXPERT REV ANTICANC, V14, P1495, DOI 10.1586/14737140.2014.949245; Chen CJ, 2015, ONCOL LETT, V9, P1128, DOI 10.3892/ol.2015.2873; Cheng TH, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/130438; Colas E, 2012, ONCOGENE, V31, P4778, DOI 10.1038/onc.2011.632; Costa C, 2014, SENSORS-BASEL, V14, P4856, DOI 10.3390/s140304856; Curtis C, 2015, CURR OPIN OBSTET GYN, V27, P34, DOI 10.1097/GCO.0000000000000145; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Feng SC, 2015, HISTOL HISTOPATHOL, V30, P13, DOI 10.14670/HH-30.13; Fernandez SV, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0445-3; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fons P, 2015, J CELL PHYSIOL, V230, P43, DOI 10.1002/jcp.24656; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gazzaniga P, 2014, INT J CANCER, V135, P1978, DOI 10.1002/ijc.28830; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; Hewitt RE, 2000, J PATHOL, V192, P446; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Joosse SA, 2015, EMBO MOL MED, V7, P1, DOI 10.15252/emmm.201303698; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Lustberg MB, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3622; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Mikolajczyk SD, 2011, J ONCOL, V2011, DOI 10.1155/2011/252361; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Monge M, 2007, CANCER RES, V67, P6753, DOI 10.1158/0008-5472.CAN-06-4487; Muinelo-Romay L, 2014, CANCERS, V6, P153, DOI 10.3390/cancers6010153; Pestrin M, 2015, MOL ONCOL, V9, P749, DOI 10.1016/j.molonc.2014.12.001; Polioudaki H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1386-7; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Raimondi C, 2014, ONCOTARGETS THER, V7, P619, DOI 10.2147/OTT.S46200; Ramirez LP, 2003, MACROMOL CHEM PHYSIC, V204, P22, DOI 10.1002/macp.200290052; Ranieri D, 2015, INT J CANCER, V137, P61, DOI 10.1002/ijc.29373; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Serrano MJ, 2014, ONCOTARGET, V5, P7486, DOI 10.18632/oncotarget.2217; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Terry S, 2015, ONCOTARGET, V6, P11994, DOI 10.18632/oncotarget.2740; Toge M, 2015, INT J ONCOL, V46, P1844, DOI 10.3892/ijo.2015.2861; Tomlinson GE, 1998, CANCER RES, V58, P3237; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vila A, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2324411; Woelfle U, 2004, CLIN CANCER RES, V10, P2670, DOI 10.1158/1078-0432.CCR-03-0114; Yanamoto S, 2007, ORAL ONCOL, V43, P869, DOI 10.1016/j.oraloncology.2006.10.010; Yin KB., 2011, BREAST CANC FOCUSING, P386, DOI [10.3892/ol.2015.2873, DOI 10.3892/OL.2015.2873]; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhu DY, 2014, WORLD J GASTROENTERO, V20, P18306, DOI 10.3748/wjg.v20.i48.18306	59	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163705	10.1371/journal.pone.0163705	http://dx.doi.org/10.1371/journal.pone.0163705			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711186	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697600034
J	Potocar, U; Hudoklin, S; Kreft, ME; Zavrsnik, J; Bozikov, K; Frohlich, M				Potocar, Urska; Hudoklin, Samo; Kreft, Mateja Erdani; Zavrsnik, Janja; Bozikov, Kresimir; Frohlich, Mirjam			Adipose-Derived Stem Cells Respond to Increased Osmolarities	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; INFRAPATELLAR FAT PAD; CHONDROGENIC DIFFERENTIATION; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; CHEMICAL MICROENVIRONMENT; CARTILAGE DEFECTS; NUCLEAR FACTOR; BONE-MARROW; TISSUE	Cell therapies present a feasible option for the treatment of degenerated cartilaginous and intervertebral disc (IVD) tissues. Microenvironments of these tissues are specific and often differ from the microenvironment of cells that, could be potentially used for therapy, e.g. human adipose-derived stem cells (hASC). To ensure safe and efficient implantation of hASC, it is important to evaluate how microenvironmental conditions at the site of implantation affect the implanted cells. This study has demonstrated that cartilaginous tissue-specific osmolarities ranging from 400-600 mOsm/L affected hASC in a dose-and time-dependent fashion in comparison to 300 mOsm/L. Increased osmolarities resulted in transient (nuclear DNA and actin reorganisation) and non-transient, long-term morphological changes (vesicle formation, increase in cell area, and culture morphology), as well as reduced proliferation in monolayer cultures. Increased osmolarities diminished acid proteoglycan production and compactness of chondrogenically induced pellet cultures, indicating decreased chondrogenic potential. Viability of hASC was strongly dependent on the type of culture, with hASC in monolayer culture being more tolerant to increased osmolarity compared to hASC in suspension, alginate-agarose hydrogel, and pellet cultures, thus emphasizing the importance of choosing relevant in vitro conditions according to the specifics of clinical application.	[Potocar, Urska; Frohlich, Mirjam] Educell Ltd, Trzin, Slovenia; [Hudoklin, Samo; Kreft, Mateja Erdani; Frohlich, Mirjam] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Zavrsnik, Janja; Frohlich, Mirjam] Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana, Slovenia; [Bozikov, Kresimir] Univ Med Ctr Ljubljana, Div Surg, Dept Plast Surg & Burns, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University Medical Centre Ljubljana	Frohlich, M (corresponding author), Educell Ltd, Trzin, Slovenia.; Frohlich, M (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.; Frohlich, M (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana, Slovenia.	mirjam.frohlich@mf.uni-lj.si		Kreft, Mateja Erdani/0000-0001-6486-165X	European Commission (GENODISC) [HEALTH-F2-2008-201626]; SPIRIT Slovenia Grant [P-MR-10/45]; Slovenian Research Agency [Z4-4063]; Educell Ltd	European Commission (GENODISC); SPIRIT Slovenia Grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Educell Ltd	The work was supported in part by European Commission's Seventh Framework Programme FP7 (project GENODISC, Grant Agreement no.: HEALTH-F2-2008-201626; http://www.physiol.ox.ac.uk/genodisc/), SPIRIT Slovenia (Grant to UP: P-MR-10/45; http://www.spiritslovenia.si/), and Slovenian Research Agency (Grant to MF: Z4-4063; https://www.arrs.gov.si/sl/). The funder (Educell Ltd) had a role in study design, data collection and analysis, decision to publish, and preparation of manuscript.	Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Bajuk-Studen K., 2009, ZDR VESTN, V78, P129; Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559; Barone AAL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/383685; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Bush PG, 2001, J ORTHOP RES, V19, P768, DOI 10.1016/S0736-0266(01)00013-4; Caron MMJ, 2013, BONE, V53, P94, DOI 10.1016/j.bone.2012.11.032; Chan S, 2015, GLOBAL SPINE J, pP008, DOI [10.1055/s-0035-1554503, DOI 10.1055/S-0035-1554503]; Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005; Cherubino M, 2009, REGEN MED, V4, P109, DOI 10.2217/17460751.4.1.109; DALLASTA V, 1994, J BIOL CHEM, V269, P10485; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Hopewell B, 2003, BIORHEOLOGY, V40, P73; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jin XB, 2007, BIOMATERIALS, V28, P2994, DOI 10.1016/j.biomaterials.2007.03.002; Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034; Jurgens WJFM, 2012, J TISSUE ENG REGEN M, V6, P570, DOI 10.1002/term.464; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Bui KHT, 2014, BIOMED RES THER, V1, P2, DOI 10.15419/bmrat.v1i01.11; Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4; Koh YG, 2015, KNEE SURG SPORT TR A, V23, P1308, DOI 10.1007/s00167-013-2807-2; Koh YG, 2013, ARTHROSCOPY, V29, P748, DOI 10.1016/j.arthro.2012.11.017; LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3; Lee WCC, 2009, INT J CARDIOL, V133, P399, DOI 10.1016/j.ijcard.2007.11.068; Li XD, 2005, CONNECT TISSUE RES, V46, P75, DOI 10.1080/03008200590954104; Liang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-49; Lim MH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.8; Luh EH, 1996, J SURG RES, V60, P122, DOI 10.1006/jsre.1996.0020; Maidhof R, 2012, DISCOV MED, V14, P401; MAROUDAS A, 1972, Connective Tissue Research, V1, P69, DOI 10.3109/03008207209152058; Martincic D, 2014, KNEE SURG SPORT TR A, V22, P1277, DOI 10.1007/s00167-013-2778-3; Masilamani S, 2000, KIDNEY, P595; Mavrogonatou E, 2012, J CELL PHYSIOL, V227, P1179, DOI 10.1002/jcp.22840; Mavrogonatou E, 2009, DNA REPAIR, V8, P930, DOI 10.1016/j.dnarep.2009.05.005; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Neidlinger-Wilke C, 2012, J ORTHOP RES, V30, P112, DOI 10.1002/jor.21481; Orth P, 2014, STEM CELLS CLONING, V7, P1, DOI 10.2147/SCCAA.S42880; Pak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436029; Perdisa F, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/597652; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saadat E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2040; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Takeno K, 2007, J NEUROSURG-SPINE, V7, P637, DOI 10.3171/SPI-07/12/637; Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; URBAN JPG, 1993, J CELL PHYSIOL, V154, P262, DOI 10.1002/jcp.1041540208; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; Vilaboa SD- A, 2013, PLASTIC RECONSTRUCTI, V132, P10; Vrhovec S, 2011, LAB CHIP, V11, P4200, DOI 10.1039/c1lc20531e; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Willerth S.M., 2008, STEMBOOK; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436; Wuertz K, 2008, SPINE, V33, P1843, DOI 10.1097/BRS.0b013e31817b8f53; Xu X, 2010, OSTEOARTHR CARTILAGE, V18, P433, DOI 10.1016/j.joca.2009.10.003; Yang L, 2008, J BIOL CHEM, V283, P11823, DOI 10.1074/jbc.M800308200; Zhao SY, 2014, FEBS OPEN BIO, V4, P190, DOI 10.1016/j.fob.2014.02.003; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	70	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163870	10.1371/journal.pone.0163870	http://dx.doi.org/10.1371/journal.pone.0163870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706209	Green Published, Green Submitted, gold			2022-12-26	WOS:000385697200067
J	Xu, LQ; Hiller, S; Simington, S; Nickeleit, V; Maeda, N; James, LR; Yi, XW				Xu, Longquan; Hiller, Sylvia; Simington, Stephen; Nickeleit, Volker; Maeda, Nobuyo; James, Leighton R.; Yi, Xianwen			Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; OXIDATIVE STRESS; MESANGIAL CELLS; NADPH OXIDASES; VITAMIN-C; MICE; PATHOGENESIS; KIDNEY; INFLAMMATION; COMPLICATIONS	Oxidative stress is implicated in the pathogenesis of diabetic nephropathy (DN) but outcomes of many clinical trials are controversial. To define the role of antioxidants in kidney protection during the development of diabetic nephropathy, we have generated a novel genetic antioxidant mouse model with over-or under-expression of lipoic acid synthase gene (Lias). These models have been mated with Ins2(Akita/+) mice, a type I diabetic mouse model. We compare the major pathologic changes and oxidative stress status in two new strains of the mice with controls. Our results show that Ins2(Akita/+) mice with under-expressed Lias gene, exhibit higher oxidative stress and more severe DN features (albuminuria, glomerular basement membrane thickening and mesangial matrix expansion). In contrast, Ins2(Akita/+) mice with highly-expressed Lias gene display lower oxidative stress and less DN pathologic changes. Our study demonstrates that strengthening endogenous antioxidant capacity could be an effective strategy for prevention and treatment of DN.	[Xu, Longquan; Hiller, Sylvia; Simington, Stephen; Nickeleit, Volker; Maeda, Nobuyo; Yi, Xianwen] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [James, Leighton R.] Univ Florida, Dept Med, Div Nephrol & Hypertens, Jacksonville, FL 32611 USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Yi, XW (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.; James, LR (corresponding author), Univ Florida, Dept Med, Div Nephrol & Hypertens, Jacksonville, FL 32611 USA.	Leighton.James@jax.ufl.edu; xyi2000@med.unc.edu	James, Leighton/AAJ-1455-2021	, Xianwen/0000-0001-9320-2020; James, Leighton/0000-0002-7613-705X	Juvenile Diabetes Research Foundation [5-2011-471]; Diabetic Complications Consortium DCC [3U24DK076169-0452]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, U01HL087946] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetic Complications Consortium DCC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study design, data collection and analysis, decision to publish, or preparation of the manuscript are supported by Juvenile Diabetes Research Foundation (5-2011-471) and Diabetic Complications Consortium DCC)3U24DK076169-0452 grants.	Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biewenga GP, 1997, DRUG METAB REV, V29, P1025, DOI 10.3109/03602539709002242; Blum S, 2010, ATHEROSCLEROSIS, V211, P25, DOI 10.1016/j.atherosclerosis.2010.02.018; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Carlson DA, 2007, ALTERN MED REV, V12, P343; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Darko D, 2002, CLIN SCI, V103, P339, DOI 10.1042/cs1030339; Doherty HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012909; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gaede P, 2001, DIABETIC MED, V18, P756, DOI 10.1046/j.0742-3071.2001.00574.x; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; hi Y, 2013, AM J PHYSIOL-RENAL, V304, pF1335, DOI [10.1152/aiprenal.00405.2012PMID:23552883, DOI 10.1152/AIPRENAL.00405.2012]; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Mitchell T, 2013, AM J PHYSIOL-ENDOC M, V305, pE585, DOI 10.1152/ajpendo.00093.2013; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473; Park IS, 1997, DIABETES, V46, P473, DOI 10.2337/diabetes.46.3.473; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Reed LJ, 1998, PROTEIN SCI, V7, P220, DOI 10.1002/pro.5560070125; ROVIN BH, 1992, J IMMUNOL, V148, P2148; Sancar-Bas S, 2015, GROWTH FACTORS, V33, P419, DOI 10.3109/08977194.2015.1125349; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Valero E, 1996, ANAL BIOCHEM, V239, P47, DOI 10.1006/abio.1996.0289; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yi XW, 2012, J AM SOC NEPHROL, V23, P103, DOI 10.1681/ASN.2011010003; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163208	10.1371/journal.pone.0163208	http://dx.doi.org/10.1371/journal.pone.0163208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706190	gold, Green Published, Green Submitted			2022-12-26	WOS:000385697200035
J	Floryszak-Wieczorek, J; Arasimowicz-Jelonek, M				Floryszak-Wieczorek, Jolanta; Arasimowicz-Jelonek, Magdalena			Contrasting Regulation of NO and ROS in Potato Defense-Associated Metabolism in Response to Pathogens of Different Lifestyles	PLOS ONE			English	Article							NITRIC-OXIDE; CELL-DEATH; BOTRYTIS-CINEREA; OXALATE OXIDASE; SCLEROTINIA-SCLEROTIORUM; HYPERSENSITIVE RESPONSE; NITROSATIVE STRESS; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA	Our research provides new insights into how the low and steady-state levels of nitric oxide (NO) and reactive oxygen species (ROS) in potato leaves are altered after the challenge with the hemibiotroph Phytophthora infestans or the necrotroph Botrytis cinerea, with the subsequent rapid and invader-dependent modification of defense responses with opposite effects. Mainly in the avirulent (avr) P. infestans-potato system, NO well balanced with the superoxide level was tuned with a battery of SA-dependent defense genes, leading to the establishment of the hypersensitive response (HR) successfully arresting the pathogen. Relatively high levels of S-nitrosoglutathione and S-nitrosothiols concentrated in the main vein of potato leaves indicated the mobile function of these compounds as a reservoir of NO bioactivity. In contrast, low-level production of NO and ROS during virulent (vr) P. infestans-potato interactions might be crucial in the delayed up-regulation of PR-1 and PR-3 genes and compromised resistance to the hemibiotrophic pathogen. In turn, B. cinerea triggered huge NO overproduction and governed inhibition of superoxide production by blunting NADPH oxidase. Nevertheless, a relatively high level of H2O2 was found owing to the germin-like activity in cooperation with NO-mediated HR-like cell death in potato genotypes favorable to the necrotrophic pathogen. Moreover, B. cinerea not only provoked cell death, but also modulated the host redox milieu by boosting protein nitration, which attenuated SA production but not SA-dependent defense gene expression. Finally, based on obtained data the organismal cost of having machinery for HR in plant resistance to biotrophs is also discussed, while emphasizing new efforts to identify other components of the NO/ROS cell death pathway and improve plant protection against pathogens of different lifestyles.	[Floryszak-Wieczorek, Jolanta] Poznan Univ Life Sci, Dept Plant Physiol, Wolynska 35, PL-60637 Poznan, Poland; [Arasimowicz-Jelonek, Magdalena] Adam Mickiewicz Univ, Dept Plant Ecophysiol, Fac Biol, Umultowska 89, PL-61614 Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University	Arasimowicz-Jelonek, M (corresponding author), Adam Mickiewicz Univ, Dept Plant Ecophysiol, Fac Biol, Umultowska 89, PL-61614 Poznan, Poland.	arasim@amu.edu.pl	Floryszak-Wieczorek, Jolanta/AAO-9997-2021	Floryszak-Wieczorek, Jolanta/0000-0003-2281-223X; Arasimowicz-Jelonek, Magdalena/0000-0002-3109-5933	National Science Centre [NCN 2011/01/B/NZ9/00243]	National Science Centre(National Science Centre, Poland)	This work was supported by the grant of the National Science Centre - project no. NCN 2011/01/B/NZ9/00243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Abramowski D, 2015, EUR J PLANT PATHOL, V143, P237, DOI 10.1007/s10658-015-0677-9; Arasimowicz-Jelonek M, 2011, PHYTOCHEMISTRY, V72, P681, DOI 10.1016/j.phytochem.2011.02.025; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; Bolwell GP, 2009, SIGNAL COMMUN PLANTS, P113, DOI 10.1007/978-3-642-00390-5_7; Campos-Soriano L, 2011, PLANT SIGNAL BEHAV, V6, P553, DOI 10.4161/psb.6.4.14914; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Chaki M, 2011, PLANT CELL ENVIRON, V34, P1803, DOI 10.1111/j.1365-3040.2011.02376.x; Chaouch S, 2012, PLANT J, V69, P613, DOI 10.1111/j.1365-313X.2011.04816.x; Chen YC, 2014, INT J PUBLIC ADM DIG, V1, P1, DOI 10.4018/ijpada.2014010101; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI [10.1094/mpmi.2004.17.1.109, DOI 10.1094/MPMI.2004.17.1.109]; Colmenares AJ, 2002, J CHEM ECOL, V28, P997, DOI 10.1023/A:1015209817830; Corpas FJ, 2008, PLANT CELL PHYSIOL, V49, P1711, DOI 10.1093/pcp/pcn144; De Vleesschauwer D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-9; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; ELAD Y, 1992, PLANT PATHOL, V41, P417, DOI 10.1111/j.1365-3059.1992.tb02436.x; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2006, PHYTOPATHOLOGY, V96, P299, DOI 10.1094/PHYTO-96-0299; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Halim VA, 2009, PLANT J, V57, P230, DOI 10.1111/j.1365-313X.2008.03688.x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Huang JC, 2007, TALANTA, V72, P1283, DOI 10.1016/j.talanta.2007.01.033; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; James W. C, 1971, CAN PLANT DIS SURV, V51, P39; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Kliebenstein DJ, 2008, PLANT SCI, V174, P551, DOI 10.1016/j.plantsci.2008.03.005; Kovacs I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00137; Kumar R, 2011, INDIAN J BIOCHEM BIO, V48, P42; Livingstone DM, 2005, PLANT PHYSIOL, V137, P1354, DOI 10.1104/pp.104.057232; Lopez-Cruz J, 2017, MOL PLANT PATHOL, V18, P16, DOI 10.1111/mpp.12370; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; MEUWLY P, 1993, ANAL BIOCHEM, V214, P500, DOI 10.1006/abio.1993.1529; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Mur LAJ, 2005, PLANT CELL ENVIRON, V28, P548, DOI 10.1111/j.1365-3040.2005.01301.x; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Neill S. J., 2009, Signal crosstalk in plant stress responses, P136, DOI 10.1002/9780813805931.ch7; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plich J, 2015, AM J POTATO RES, V92, P350, DOI 10.1007/s12230-015-9437-9; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Schaller A, 2000, PLANTA, V210, P599, DOI 10.1007/s004250050049; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Siegmund U, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055879, 10.1371/annotation/84c258cf-4f98-43d8-a4f0-7032cba36f22]; Sivakumaran A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00709; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2004, MOL PLANT MICROBE IN, V17, P245, DOI 10.1094/MPMI.2004.17.3.245; Trapet P, 2015, PHYTOCHEMISTRY, V112, P72, DOI 10.1016/j.phytochem.2014.03.015; Valderrama R, 2007, FEBS LETT, V581, P453, DOI 10.1016/j.febslet.2007.01.006; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; VANKAN JAL, 1995, PLANT MOL BIOL, V27, P1205, DOI 10.1007/BF00020894; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739; Yun BW, 2016, NEW PHYTOL, V211, P516, DOI 10.1111/nph.13903; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	81	12	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163546	10.1371/journal.pone.0163546	http://dx.doi.org/10.1371/journal.pone.0163546			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695047	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100044
J	Sadeghi, K; Wisgrill, L; Wessely, I; Diesner, SC; Schuller, S; Durr, C; Heinle, A; Sachet, M; Pollak, A; Forster-Waldl, E; Spittler, A				Sadeghi, Kambis; Wisgrill, Lukas; Wessely, Isabelle; Diesner, Susanne C.; Schueller, Simone; Duerr, Celia; Heinle, Armando; Sachet, Monika; Pollak, Arnold; Foerster-Waldl, Elisabeth; Spittler, Andreas			GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INNATE; PRETERM; SEPSIS; TRIAL	Toll-like receptors (TLR) are crucial sensors of microbial agents such as bacterial or viral compounds. These receptors constitute key players in the induction of inflammation, e.g. in septic or chronic inflammatory diseases. Colony-stimulating factors (CSFs) such as granulocyte-macrophage-CSF (GM-CSF) or granulocyte-CSF (G-CSF) have been extensively investigated in their capacity to promote myelopoiesis in febrile neutropenia or to overcome immunosuppression in patients suffering from sepsis-associated neutropenia or from monocytic immunoincompetence. We report here that GM-CSF, downregulates TLR1, TLR2 and TLR4 in a time-and dose-dependent fashion in human monocytes. Diminished pathogen recognition receptor expression was accompanied by reduced downstream p38 and extracellular-signal-regulated kinase (ERK) signaling upon lipoteichoic acid (LTA) and lipopolysaccharide (LPS) binding D and accordingly led to impaired proinflammatory cytokine production. Knockdown experiments of the transcription factors PU.1 and VentX showed that GM-CSF driven effects on TLR regulation is entirely PU.1 but not VentX dependent. We further analysed monocyte TLR and CD14 expression upon exposure to the IMID (R) immunomodulatory drug Pomalidomide (CC-4047), a Thalidomide analogue known to downregulate PU.1. Indeed, Pomalidomide in part reversed the GM-CSF-mediated effects. Our data indicate a critical role of PU.1 in the regulation of TLR1, 2, 4 and of CD14, thus targeting PU.1 ultimately results in TLR modulation. The PU.1 mediated immunomodulatory properties of GM-CSF should be taken into consideration upon usage of GM-CSF in inflammatory or infection-related conditions.	[Sadeghi, Kambis; Wisgrill, Lukas; Wessely, Isabelle; Diesner, Susanne C.; Schueller, Simone; Duerr, Celia; Pollak, Arnold; Foerster-Waldl, Elisabeth] Med Univ Vienna, Dept Paediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediatr, Vienna, Austria; [Heinle, Armando; Sachet, Monika] Med Univ Vienna, Dept Surg, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil Flow Cytometry, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Forster-Waldl, E (corresponding author), Med Univ Vienna, Dept Paediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediatr, Vienna, Austria.	elisabeth.foerster-waldl@meduniwien.ac.at	Wisgrill, Lukas/V-3682-2019; Schüller, Simone/ADA-8472-2022	Schüller, Simone/0000-0003-0344-8786; Spittler, Andreas/0000-0003-2657-6836; Wisgrill, Lukas/0000-0001-9833-9499; Sadeghi, Kambis/0000-0002-1039-3958; Diesner-Treiber, Susanne/0000-0001-8955-4752; Forster-Waldl, Elisabeth/0000-0002-8484-9890	Austrian National Bank "Jubilaumsfond" [13071]; "Hygiene Fonds" of the Medical University of Vienna	Austrian National Bank "Jubilaumsfond"; "Hygiene Fonds" of the Medical University of Vienna	This work was supported in part by the Austrian National Bank "Jubilaumsfond" (grant Number 13071 to KS and EFW) and in part by the "Hygiene Fonds" of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge Celgene Corporation (www.celgene.com) for kindly providing the substance pomalidomide. The authors have no conflicting financial interests.	Ahmad A, 2002, PEDIATR INFECT DIS J, V21, P1061, DOI 10.1097/00006454-200211000-00017; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Anderson G, 2006, BLOOD, V107, P3098, DOI 10.1182/blood-2005-08-3450; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Carr R, 2009, LANCET, V373, P226, DOI 10.1016/S0140-6736(09)60071-4; Cashen Amanda F, 2004, Curr Hematol Rep, V3, P406; CHATTA GS, 1994, BLOOD, V84, P2923; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Erridge C, 2008, TRENDS CARDIOVAS MED, V18, P52, DOI 10.1016/j.tcm.2007.12.003; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kuritzkes DR, 2000, CLIN INFECT DIS, V30, P256, DOI 10.1086/313642; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; Lonial S, 2004, BIOL BLOOD MARROW TR, V10, P848, DOI 10.1016/j.bbmt.2004.07.008; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Pal R, 2010, BLOOD, V115, P605, DOI 10.1182/blood-2009-05-221077; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556	32	13	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162667	10.1371/journal.pone.0162667	http://dx.doi.org/10.1371/journal.pone.0162667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695085	Green Submitted, gold, Green Published			2022-12-26	WOS:000385553100016
J	Boulin, M; Diaby, V; Tannenbaum, C				Boulin, Mathieu; Diaby, Vakaramoko; Tannenbaum, Cara			Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada	PLOS ONE			English	Article							MELLITUS; EVENTS; RISK; US; THIAZOLIDINEDIONES; INSULIN; PEOPLE	Background The costs of drug-induced hypoglycemia are a critical but often neglected component of value-based arguments to reduce tight glycemic control in older adults with type 2 diabetes. Methods An economic (decision-tree) analysis compared rates, costs, quality-adjusted life-years, and incremental costs per quality-adjusted life-year gained associated with mild, moderate and severe hypoglycemic events for 6 glucose-lowering medication classes in type 2 diabetic adults aged 65-79 versus those 80 years and older. The national U.S. (Center for Medicare Services) and Canadian public health payer perspectives were adopted. Findings Incidence rates of drug-induced hypoglycemia were the highest for basal insulin and sulfonylureas: 8.64 and 4.32 events per person-year in 65-79 year olds, and 12.06 and 6.03 events per person-year for 80 years and older. In both the U.S. and Canada, metformin dominated sulfonylureas, basal insulin and glucagon-like peptide1 receptor agonists. Relative to sulfonylureas, thiazolidinediones had the lowest incremental cost-effectiveness ratios in the U.S. and dominated sulfonylureas in Canada for adults 80 years and older. Relative to sulfonylureas, dipeptidyl peptidase4 inhibitors were cost-effective for adults 80 years and older in both countries, and for 65-79 year olds in Canada. Annual costs of hypoglycemia for older adults attaining very tight glycemic control with the use of insulin or sulfonylureas were estimated at U.S.$509,214,473 in the U.S. and CAN$65,497,849 in Canada. Conclusions Optimizing drug therapy for older type 2 diabetic adults through the avoidance of drug-induced hypoglycemia will dramatically improve patient health while also generating millions of dollars by saving unnecessary medical costs.	[Boulin, Mathieu; Tannenbaum, Cara] Inst Univ Geriatriede Montreal, Montreal, PQ, Canada; [Diaby, Vakaramoko] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA; [Tannenbaum, Cara] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Tannenbaum, Cara] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	State University System of Florida; Florida A&M University; Universite de Montreal; Universite de Montreal	Tannenbaum, C (corresponding author), Inst Univ Geriatriede Montreal, Montreal, PQ, Canada.; Tannenbaum, C (corresponding author), Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada.; Tannenbaum, C (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	cara.tannenbaum@umontreal.ca	Diaby, Vakaramoko/AAH-4029-2020		Canadian MITACS Accelerate program [IT04775]; National Institute on Minority Health and Health Disparities [P20MD006738, G12MD007582] Funding Source: NIH RePORTER	Canadian MITACS Accelerate program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	MB was supported by the Canadian MITACS Accelerate program (postdoctoral fellowship bursary IT04775) for this study (https://www.mitacs.ca/en/programs/accelerate). MITACS had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.	American Diabetes Association, STAT DIAB; American Diabetes Association, 2014, STAT DIAB; American Geriatrics Society, 2015, CHOOS WISELY; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; [Anonymous], 2008, GUID METH TECHN APPR; [Anonymous], 2013, FDA DRUG SAF COMM FD; [Anonymous], 2015, SING CIT AG GROUP ET; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bordier L, 2015, DIABETES METAB, V41, P301, DOI 10.1016/j.diabet.2015.03.001; Boye KS, 2011, EUR J HEALTH ECON, V12, P219, DOI 10.1007/s10198-010-0224-8; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Bullano MF, 2006, AM J HEALTH-SYST PH, V63, P2473, DOI 10.2146/ajhp050552; Caverly TJ, 2015, JAMA INTERN MED, V175, P1994, DOI 10.1001/jamainternmed.2015.5950; Clemens KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137596; Evans M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-90; Farmer AJ, 2012, DIABETIC MED, V29, P1447, DOI 10.1111/j.1464-5491.2012.03657.x; Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777; Fu HD, 2014, CURR MED RES OPIN, V30, P1787, DOI 10.1185/03007995.2014.922944; Gangji AS, 2007, DIABETES CARE, V30, P389, DOI 10.2337/dc06-1789; GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697; Gomes T, 2010, CAN MED ASSOC J, V182, P35, DOI 10.1503/cmaj.091017; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Leiter LA., 2005, CAN J DIABETES, V29, P186; Lipska KJ, 2015, JAMA INTERN MED, V175, P356, DOI 10.1001/jamainternmed.2014.7345; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Meneilly GS, 2013, CAN J DIABETES, V37, pS184, DOI [10.1016/j.jcjd.2013.01.045, 10.1007/s12170-010-0117-5]; Nicolucci A, 2015, ACTA DIABETOL, V52, P677, DOI 10.1007/s00592-015-0717-0; Ontario Ministry of Health and Long-term Care, 2015, EXC ACC PROGR 2015; Ozieh M. N., 2015, DIABETES CARE; Public Health Agency of Canada, DIAB CAN FACTS FIG P; Rowe BH, 2015, CAN J DIABETES, V39, P55, DOI [10.1016/j.jcjd.2014.04.001, 10.1016/j.jcjd.2015.09.084]; Samuel S, 2015, CURR MED RES OPIN, V31, P633, DOI 10.1185/03007995.2015.1020363; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; Slabaugh SL, 2015, DRUG AGING, V32, P169, DOI 10.1007/s40266-014-0235-8; The World Bank, 2015, GROSS DOM PROD PER C; Thompson Angela, 2013, Consult Pharm, V28, P296, DOI 10.4140/TCP.n.2013.296; U.S. Census Bureau Population Division, 2014, ANN EST RES POP SEL; U.S. Departmentof Health and Human Services Office of Disease Prevention and Health Promotion, 2014, NAT ACT PLAN ADV DRU; World Health Organization, 2015, CHOOS INT AR COST EF	46	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162951	10.1371/journal.pone.0162951	http://dx.doi.org/10.1371/journal.pone.0162951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648831	Green Submitted, Green Published, gold			2022-12-26	WOS:000383892100044
J	Ma, HM; Song, T; Wang, TH; Wang, S				Ma, Huimin; Song, Teng; Wang, Tianhua; Wang, Shui			Influence of Human p53 on Plant Development	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; CELL-CYCLE; HUMAN RAD51; GENE-TRANSCRIPTION; HUMAN FIBROBLASTS; ARABIDOPSIS SNI1; BRC REPEATS	Mammalian p53 is a super tumor suppressor and plays a key role in guarding genome from DNA damage. However, p53 has not been found in plants which do not bear cancer although they constantly expose to ionizing radiation of ultraviolet light. Here we introduced p53 into the model plant Arabidopsis and examined p53-conferred phenotype in plant. Most strikingly, p53 caused early senescence and fasciation. In plants, fasciation has been shown as a result of the elevated homologous DNA recombination. Consistently, a reporter with overlapping segments of the GUS gene (1445) showed that the frequency of homologous recombination was highly induced in p53-transgenic plants. In contrast to p53, SUPPRESSOR OF NPR1-1 INDUCIBLE 1 (SNI1), as a negative regulator of homologous recombination in plants, is not present in mammals. Comet assay and clonogenic survival assay demonstrated that SNI1 inhibited DNA damage repair caused by either ionizing radiation or hydroxyurea in human osteosarcoma U2OS cancer cells. RAD51D is a recombinase in homologous recombination and functions downstream of SNI1 in plants. Interestingly, p53 rendered the sni1 mutants madly branching of inflorescence, a phenotype of fasciation, whereas rad51d mutant fully suppressed the p53-induced phenotype, indicating that human p53 action in plant is mediated by the SNI1-RAD51D signaling pathway. The reciprocal species-swap tests of p53 and SNI1 in human and Arabidopsis manifest that these species-specific proteins play a common role in homologous recombination across kingdoms of animals and plants.	[Ma, Huimin; Song, Teng; Wang, Tianhua; Wang, Shui] Shanghai Normal Univ, Dev Ctr Plant Germplasm Resources, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	Shanghai Normal University	Wang, S (corresponding author), Shanghai Normal Univ, Dev Ctr Plant Germplasm Resources, Coll Life & Environm Sci, Shanghai 200234, Peoples R China.	shuiwang@shnu.edu.cn	Wang, Shui/GLU-0896-2022		National Natural Science Foundation of China [31571254]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 31571254 from National Natural Science Foundation of China (http://www.nsfc.gov.cn).	Amor IYH, 2008, FEMS YEAST RES, V8, P1254, DOI 10.1111/j.1567-1364.2008.00445.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baumann C, 2006, NUCLEIC ACIDS RES, V34, P1036, DOI 10.1093/nar/gkj509; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BISCHOFF JR, 1992, MOL CELL BIOL, V12, P1405, DOI 10.1128/MCB.12.4.1405; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Buchhop S, 1997, NUCLEIC ACIDS RES, V25, P3868, DOI 10.1093/nar/25.19.3868; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Carreira A, 2011, P NATL ACAD SCI USA, V108, P10448, DOI 10.1073/pnas.1106971108; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; CLARK SE, 1993, DEVELOPMENT, V119, P397; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Doonan J, 1996, NATURE, V380, P481, DOI 10.1038/380481a0; Doonan JH, 2010, NAT REV CANCER, V10, P793, DOI 10.1038/nrc2942; Dudenhoffer C, 1999, ONCOGENE, V18, P5773, DOI 10.1038/sj.onc.1202964; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Endo M, 2006, EMBO J, V25, P5579, DOI 10.1038/sj.emboj.7601434; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hartung F., 2004, Current Genomics, V5, P109, DOI 10.2174/1389202043489917; Heitzeberg F, 2004, PLANT J, V38, P954, DOI 10.1111/j.1365-313X.2004.02097.x; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hisanaga T, 2013, PLANT PHYSIOL, V162, P831, DOI 10.1104/pp.113.216796; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jensen RB, 2013, DNA REPAIR, V12, P306, DOI 10.1016/j.dnarep.2012.12.007; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kirik A, 2006, PLANT CELL, V18, P2431, DOI 10.1105/tpc.106.045088; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Linke SP, 2003, CANCER RES, V63, P2596; Liu DP, 2010, NAT CELL BIOL, V12, P993, DOI 10.1038/ncb2100; Lucht JM, 2002, NAT GENET, V30, P311, DOI 10.1038/ng846; Manova V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00885; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Missirian Victor, 2014, Front Plant Sci, V5, P364, DOI 10.3389/fpls.2014.00364; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ridgway P, 2000, J CELL SCI, V113, P2647; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Rutkowski R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001131; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Song JQ, 2011, CELL HOST MICROBE, V9, P115, DOI 10.1016/j.chom.2011.01.011; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Sturzbecher HW, 1996, EMBO J, V15, P1992, DOI 10.1002/j.1460-2075.1996.tb00550.x; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang S, 2014, CELL HOST MICROBE, V16, P787, DOI 10.1016/j.chom.2014.10.005; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Willers H, 2000, ONCOGENE, V19, P632, DOI 10.1038/sj.onc.1203142; Yan SP, 2013, MOL CELL, V52, P602, DOI 10.1016/j.molcel.2013.09.019; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Yoon D, 2004, J MOL BIOL, V336, P639, DOI 10.1016/j.jmb.2003.12.050; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	78	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162840	10.1371/journal.pone.0162840	http://dx.doi.org/10.1371/journal.pone.0162840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648563	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100034
J	Kwak, T; Drews-Elger, K; Ergonul, A; Miller, PC; Braley, A; Hwang, GH; Zhao, D; Besser, A; Yamamoto, Y; Yamamoto, H; El-Ashry, D; Slingerland, JM; Lippman, ME; Hudson, BI				Kwak, T.; Drews-Elger, K.; Ergonul, A.; Miller, P. C.; Braley, A.; Hwang, G. H.; Zhao, D.; Besser, A.; Yamamoto, Y.; Yamamoto, H.; El-Ashry, D.; Slingerland, J. M.; Lippman, M. E.; Hudson, B. I.			Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis	ONCOGENE			English	Article							GLYCATION END-PRODUCTS; TUMOR MICROENVIRONMENT; CYTOPLASMIC DOMAIN; NEURITE OUTGROWTH; DIABETES-MELLITUS; MOUSE MODEL; RECEPTOR; EXPRESSION; ACTIVATION; PROMOTES	The receptor for advanced glycation end products (RAGE) is highly expressed in various cancers and is correlated with poorer outcome in breast and other cancers. Here we tested the role of targeting RAGE by multiple approaches in the tumor and tumor microenvironment, to inhibit the metastatic process. We first tested how RAGE impacts tumor cell-intrinsic mechanisms using either RAGE overexpression or knockdown with short hairpin RNAs (shRNAs). RAGE ectopic overexpression in breast cancer cells increased MEK-EMT (MEK-epithelial-to-mesenchymal transition) signaling, transwell invasion and soft agar colony formation, and in vivo promoted lung metastasis independent of tumor growth. RAGE knockdown with multiple independent shRNAs in breast cancer cells led to decreased transwell invasion and soft agar colony formation, without affecting proliferation. In vivo, targeting RAGE shRNA knockdown in human and mouse breast cancer cells, decreased orthotopic tumor growth, reduced tumor angiogenesis and recruitment of inflammatory cells, and markedly decreased metastasis to the lung and liver in multiple xenograft and syngeneic mouse models. To test the non-tumor cell microenvironment role of RAGE, we performed syngeneic studies with orthotopically injected breast cancer cells in wild-type and RAGE-knockout C57BL6 mice. RAGE-knockout mice displayed striking impairment of tumor cell growth compared with wild-type mice, along with decreased mitogen-activated protein kinase signaling, tumor angiogenesis and inflammatory cell recruitment. To test the combined inhibition of RAGE in both tumor cell-intrinsic and nontumor cells of the microenvironment, we performed in vivo treatment of xenografted tumors with FPS-ZM1 (1 mg/kg, two times per week). Compared with vehicle, FPS-ZM1 inhibited primary tumor growth, inhibited tumor angiogenesis and inflammatory cell recruitment and, most importantly, prevented metastasis to the lung and liver. These data demonstrate that RAGE drives tumor progression and metastasis through distinct tumor cell-intrinsic and -extrinsic mechanisms, and may represent a novel and therapeutically viable approach for treating metastatic cancers.	[Kwak, T.; Hudson, B. I.] Univ Miami, Leonard M Miller Sch Med, Dept Cell Biol, 1550 NW 10th Ave,PAP Bldg,Room 528, Miami, FL 33136 USA; [Drews-Elger, K.; Ergonul, A.; Miller, P. C.; El-Ashry, D.; Lippman, M. E.; Hudson, B. I.] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL USA; [Braley, A.; Slingerland, J. M.] Univ Miami, Leonard M Miller Sch Med, Dept Biochem, Miami, FL USA; [Hwang, G. H.; Zhao, D.; Besser, A.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Yamamoto, Y.; Yamamoto, H.] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa, Japan; [El-Ashry, D.; Slingerland, J. M.; Lippman, M. E.; Hudson, B. I.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; Kanazawa University; University of Miami	Hudson, BI (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Cell Biol, 1550 NW 10th Ave,PAP Bldg,Room 528, Miami, FL 33136 USA.	bhudson@med.miami.edu	Hudson, Barry/B-3122-2009; Ergonul, Ayse Burcu/AFJ-8120-2022; Ergonul, Ayse Burcu/AAF-4987-2022	Hudson, Barry/0000-0001-7647-8121; Drews-Elger, Katherine/0000-0001-9540-0610; Braley, Alexander/0000-0002-1443-1472	Susan G Komen for the Cure [CCR15331076]; American Cancer Society Institutional Research [98-277-10]	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); American Cancer Society Institutional Research(American Cancer Society)	This research was supported by a Career Catalyst Research from Susan G Komen for the Cure Grant No. CCR15331076 and by the American Cancer Society Institutional Research Grant No. 98-277-10.	Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Allmen EU, 2008, PROSTATE, V68, P748, DOI 10.1002/pros.20736; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bjork P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063012; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Drews-Elger K, 2014, BREAST CANCER RES TR, V148, P41, DOI 10.1007/s10549-014-3122-4; Drews-Elger K, 2014, BREAST CANCER RES TR, V144, P503, DOI 10.1007/s10549-014-2887-9; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Huang JS, 2001, J CELL BIOCHEM, V81, P102, DOI 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jackel A, 1999, HAUTARZT, V50, P250, DOI 10.1007/s001050050897; Jules J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078267; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2012, P NATL ACAD SCI USA, V109, P7031, DOI 10.1073/pnas.1113865109; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Nasser MW, 2015, CANCER RES, V75, P974, DOI 10.1158/0008-5472.CAN-14-2161; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Pietzsch J, 2009, AMINO ACIDS, V36, P381, DOI 10.1007/s00726-008-0097-7; Radia AM, 2013, INT J MOL SCI, V14, P7959, DOI 10.3390/ijms14047959; Sharaf H, 2015, BBA-MOL BASIS DIS, V1852, P429, DOI 10.1016/j.bbadis.2014.12.009; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SIROTNAK FM, 1984, CANCER CHEMOTH PHARM, V12, P26; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Vernon PJ, 2013, J IMMUNOL, V190, P1372, DOI 10.4049/jimmunol.1201151; Xiong F, 2011, J BIOL CHEM, V286, P35061, DOI 10.1074/jbc.M111.261073; Yamagishi S, 2006, METABOLISM, V55, P1227, DOI 10.1016/j.metabol.2006.05.007; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1; Zen K, 2007, J IMMUNOL, V178, P2483, DOI 10.4049/jimmunol.178.4.2483; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	56	75	81	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1559	1572		10.1038/onc.2016.324	http://dx.doi.org/10.1038/onc.2016.324			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27669433				2022-12-26	WOS:000397458100010
J	Alvarado, R; To, J; Lund, ME; Pinar, A; Mansell, A; Robinson, MW; O'Brien, BA; Dalton, JP; Donnelly, S				Alvarado, Raquel; To, Joyce; Lund, Maria E.; Pinar, Anita; Mansell, Ashley; Robinson, Mark W.; O'Brien, Bronwyn A.; Dalton, John P.; Donnelly, Sheila			The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages	FASEB JOURNAL			English	Article						trematode; liver fluke; IL-1 beta; lysosome	NALP3 INFLAMMASOME; LYSOSOMAL DAMAGE; RAT HEPATOCYTES; MECHANISM; DISEASE; CELLS; CYTOKINES; RESPONSES; CRYSTALS; VACCINE	The NLRP3 inflammasome is a multimeric protein complex that controls the production of IL-1 beta, a cytokine that influences the development of both innate and adaptive immune responses. Helminth parasites secrete molecules that interact with innate immune cells, modulating their activity to ultimately determine the phenotype of differentiated T cells, thus creating an immune environment that is conducive to sustaining chronic infection. We show that one of these molecules, FhHDM-1, a cathelicidin-like peptide secreted by the helminth parasite, Fasciola hepatica, inhibits the activation of the NLRP3 inflammasome resulting in reduced secretion of IL-1 beta by macrophages. FhHDM-1 had no effect on the synthesis of pro-IL-1 beta. Rather, the inhibitory effect was associatedwith the capacity of the peptide to prevent acidification of the endolysosome. The activation of cathepsin B protease by lysosomal destabilization was prevented in FhHDM-1-treated macrophages. By contrast, peptide derivatives of FhHDM-1 that did not alter the lysosomal pH did not inhibit secretion of IL-1 beta. Wepropose a novel immunemodulatory strategy usedby F. hepatica, whereby secretion of the FhHDM-1 peptide impairs the activation of NLRP3 by lysosomal cathepsin B protease, which prevents the downstream production of IL-1 beta and the development of protective T helper 1 type immune responses that are detrimental to parasite survival.-Alvarado, R., To, J., Lund, M. E., Pinar, A., Mansell, A., Robinson, M. W., O'Brien, B. A., Dalton, J. P., Donnelly, S. The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages.	[Alvarado, Raquel; To, Joyce; Lund, Maria E.; O'Brien, Bronwyn A.; Donnelly, Sheila] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Pinar, Anita; Mansell, Ashley] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Robinson, Mark W.; Dalton, John P.] Queens Univ, Sch Biol Sci, Belfast, Antrim, North Ireland	University of Technology Sydney; Monash University; Queens University Belfast	Donnelly, S (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, POB 123, Broadway, NSW 2007, Australia.	sheila.donnelly@uts.edu.au	Mansell, Ashley/B-9553-2008; Alvarado, Raquel/J-5073-2019	Mansell, Ashley/0000-0002-6540-1281; Alvarado, Raquel/0000-0001-7250-2200; Lund, Maria/0000-0001-7360-5041; Robinson, Mark/0000-0001-7191-0034; Pinar, Anita/0000-0001-7779-4986; Donnelly, Sheila/0000-0003-2005-3698; To, Joyce/0000-0003-3482-4369	Diabetes Australia Research Trust (DART) project grant; National Health and Medical Research Council (NHMRC) [1087341]; European Research Council Advanced Grant HELIVAC [322725]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L019612/1]; Horizon; Biotechnology and Biological Sciences Research Council [BB/L019612/1] Funding Source: researchfish; BBSRC [BB/L019612/1] Funding Source: UKRI	Diabetes Australia Research Trust (DART) project grant; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Research Council Advanced Grant HELIVAC; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horizon; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dr. Suat Dervish (Centenary Institute, Sydney, NSW, Australia) for technical support with flow cytometry analysis and the technical staff at the UTS i3 Microbial Imaging Facility for advice and provision of instrumentation. This work was funded in part by a Diabetes Australia Research Trust (DART) project grant; in part by National Health and Medical Research Council (NHMRC) Project Grant 1087341; European Research Council Advanced Grant HELIVAC, 322725 (to J.P.D.); and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L019612/1. J.P.D. is a member of the Horizon 2020-funded Consortium Paragone. The authors declare no conflicts of interest.	Alvarado R, 2015, IMMUNOBIOLOGY, V220, P262, DOI 10.1016/j.imbio.2014.11.008; Andrews SJ, 1999, FASCIOLOSIS, P1; Baska P, 2013, ACTA PARASITOL, V58, P215, DOI 10.2478/s11686-013-0126-x; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Berbudi A, 2016, DIABETES-METAB RES, V32, P238, DOI 10.1002/dmrr.2673; Chen Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11596; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Correale J, 2011, J NEUROIMMUNOL, V233, P6, DOI 10.1016/j.jneuroim.2011.01.002; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dolman N. J., 2013, CURR PROTOC CYTOM; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gaide O, 2008, EXPERT REV CLIN IMMU, V4, P61, DOI 10.1586/1744666X.4.1.61; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Molina-Hernandez V, 2015, VET PARASITOL, V208, P101, DOI 10.1016/j.vetpar.2015.01.004; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Rojas-Caraballo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134910; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schmitz ML, 2011, BBA-MOL CELL RES, V1813, P2165, DOI 10.1016/j.bbamcr.2011.06.019; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Siemieniuk E, 2008, TOXICOL MECH METHOD, V18, P519, DOI 10.1080/15376510701624001; Thibodeau MS, 2004, TOXICOL SCI, V80, P34, DOI 10.1093/toxsci/kfh121; THILO L, 1995, J CELL SCI, V108, P1791; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Wesolowska A, 2012, PARASITOL RES, V110, P395, DOI 10.1007/s00436-011-2504-3; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	53	41	41	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					85	+		10.1096/fj.201500093R	http://dx.doi.org/10.1096/fj.201500093R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27682204				2022-12-26	WOS:000392177600011
J	Das, DK; Mallis, RJ; Duke-Cohan, JS; Hussey, RE; Tetteh, PW; Hilton, M; Wagner, G; Lang, MJ; Reinherz, EL				Das, Dibyendu Kumar; Mallis, Robert J.; Duke-Cohan, Jonathan S.; Hussey, Rebecca E.; Tetteh, Paul W.; Hilton, Mark; Wagner, Gerhard; Lang, Matthew J.; Reinherz, Ellis L.			Pre-T Cell Receptors (Pre-TCRs) Leverage V Complementarity Determining Regions (CDRs) and Hydrophobic Patch in Mechanosensing Thymic Self-ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell differentiation; cell surface receptor; crystallography; major histocompatibility complex (MHC); nuclear magnetic resonance (NMR); optical tweezers; mechanobiology; pre-T cell receptor; structural transition	BETA FG LOOP; THYMOCYTE DEVELOPMENT; MECHANICAL FORCE; STRUCTURAL BASIS; ANTIGEN RECEPTOR; FAB FRAGMENT; PEPTIDE-MHC; IN-VITRO; COMPLEX; SELECTION	The pre-T cell receptor (pre-TCR) is a pT- heterodimer functioning in early T cell development. Although once thought to be ligand-autonomous, recent studies show that pre-TCRs participate in thymic repertoire formation through recognition of peptides bound to major histocompatibility molecules (pMHC). Using optical tweezers, we probe pre-TCR bonding with pMHC at the single molecule level. Like the TCR, the pre-TCR is a mechanosensor undergoing force-based structural transitions that dynamically enhance bond lifetimes and exploiting allosteric control regulated via the C FG loop region. The pre-TCR structural transitions exhibit greater reversibility than TCR and ordered force-bond lifetime curves. Higher piconewton force requires binding through both complementarity determining region loops and hydrophobic V patch apposition. This patch functions in the pre-TCR as a surrogate V domain, fostering ligand promiscuity to favor development of chains with self-reactivity but is occluded by subunit replacement of pT upon TCR formation. At the double negative 3 thymocyte stage where the pre-TCR is first expressed, pre-TCR interaction with self-pMHC ligands imparts growth and survival advantages as revealed in thymic stromal cultures, imprinting fundamental self-reactivity in the T cell repertoire. Collectively, our data imply the existence of sequential mechanosensor TCR repertoire tuning via the pre-TCR.	[Das, Dibyendu Kumar; Hilton, Mark; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Mallis, Robert J.; Wagner, Gerhard] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Duke-Cohan, Jonathan S.; Tetteh, Paul W.; Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Duke-Cohan, Jonathan S.; Hussey, Rebecca E.; Tetteh, Paul W.; Reinherz, Ellis L.] Dana Farber Canc Inst, Immunobiol Lab, Dept Med Oncol, Boston, MA 02115 USA; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University	Lang, MJ (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.; Reinherz, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Dept Med Oncol, Boston, MA 02115 USA.; Lang, MJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA.	matt.lang@vanderbilt.edu; ellis_reinherz@dfci.harvard.edu	Duke-Cohan, Jonathan/A-5812-2010	Duke-Cohan, Jonathan/0000-0002-9478-9609; Das, Dibyendu Kumar/0000-0002-8450-9298	National Institutes of Health [R01AI100643, R01AI37581, P01GM047467]; National Science Foundation [MCB-1330792]; Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; American Association for Cancer Research [SU2C-AACR-DT-13-14]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100643, R01AI037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; Direct For Biological Sciences [1330792] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; American Association for Cancer Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grants R01AI100643, R01AI37581, and P01GM047467; National Science Foundation Grant MCB-1330792; the Singapore-Massachusetts Institute of Technology Alliance for Research and Technology (SMART) Program; and American Association for Cancer Research Grant SU2C-AACR-DT-13-14. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Castro CE, 2011, BIOPHYS J, V101, P439, DOI 10.1016/j.bpj.2011.06.016; Cheng AM, 1997, P NATL ACAD SCI USA, V94, P9797, DOI 10.1073/pnas.94.18.9797; Choi YI, 2014, P NATL ACAD SCI USA, V111, P379, DOI 10.1073/pnas.1314209111; Choi YI, 2008, IMMUNITY, V29, P888, DOI 10.1016/j.immuni.2008.10.008; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Dai BB, 2009, STEM CELLS DEV, V18, P235, DOI 10.1089/scd.2008.0021; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Hoerter JAH, 2013, J EXP MED, V210, P1807, DOI 10.1084/jem.20122528; Hu KH, 2016, J CELL BIOL, V213, P535, DOI 10.1083/jcb.201511053; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kim ST, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00076; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kuhns MS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00159; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Ma ZY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00217; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Pyzocha NK, 2014, METHODS MOL BIOL, V1114, P269, DOI 10.1007/978-1-62703-761-7_17; R Core Team, 2015, LANG ENV STAT COMP V; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sasada T, 2002, J EXP MED, V195, P1419, DOI 10.1084/jem.20020119; Smelty P, 2010, P NATL ACAD SCI USA, V107, P19991, DOI 10.1073/pnas.1010166107; STALLCUP KC, 1981, J IMMUNOL, V127, P923; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; von Boehmer H, 2014, CANCER IMMUNOL RES, V2, P592, DOI 10.1158/2326-6066.CIR-14-0070; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	57	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2016	291	49					25292	25305		10.1074/jbc.M116.752865	http://dx.doi.org/10.1074/jbc.M116.752865			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF1OV	27707880	Green Published, hybrid			2022-12-26	WOS:000390095300002
J	Speen, AM; Kim, HYH; Bauer, RN; Meyer, M; Gowdy, KM; Fessler, MB; Duncan, KE; Liu, W; Porter, NA; Jaspers, I				Speen, Adam M.; Kim, Hye-Young H.; Bauer, Rebecca N.; Meyer, Megan; Gowdy, Kymberly M.; Fessler, Michael B.; Duncan, Kelly E.; Liu, Wei; Porter, Ned A.; Jaspers, Ilona			Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; BIOLOGICALLY-ACTIVE OXYSTEROLS; BRONCHOALVEOLAR LAVAGE FLUID; LEMLI-OPITZ SYNDROME; NF-KAPPA-B; OZONATION PRODUCTS; LUNG SURFACTANT; INNATE IMMUNITY; INFLAMMATORY MEDIATORS; OXIDIZED PHOSPHOLIPIDS	When inhaled, ozone (O-3) interacts with cholesterols of airway epithelial cell membranes or the lung-lining fluid, generating chemically reactive oxysterols. The mechanism by which O-3-derived oxysterols affect molecular function is unknown. Our data show that in vitro exposure of human bronchial epithelial cells to O-3 results in the formation of oxysterols, epoxy-cholesterol-alpha and -beta and secosterol A and B (Seco A and Seco B), in cell lysates and apical washes. Similarly, bronchoalveolar lavage fluid obtained from human volunteers exposed to O-3 contained elevated levels of these oxysterol species. As expected, O-3-derived oxysterols have a pro-inflammatory effect and increase NF-kappa B activity. Interestingly, expression of the cholesterol efflux pump ATP-binding cassette transporter 1 (ABCA1), which is regulated by activation of the liver X receptor (LXR), was suppressed in epithelial cells exposed to O-3. Additionally, exposure of LXR knock-out mice to O-3 enhanced pro-inflammatory cytokine production in the lung, suggesting LXR inhibits O-3-induced inflammation. Using alkynyl surrogates of O-3-derived oxysterols, our data demonstrate adduction of LXR with Seco A. Similarly, supplementation of epithelial cells with alkynyl-tagged cholesterol followed by O-3 exposure causes observable lipid-LXR adduct formation. Experiments using Seco A and the LXR agonist T0901317 (T09) showed reduced expression of ABCA1 as compared with stimulation with T0901317 alone, indicating that Seco A-LXR protein adduct formation inhibits LXR activation by traditional agonists. Overall, these data demonstrate that O-3-derived oxysterols have pro-inflammatory functions and form lipid-protein adducts with LXR, thus leading to suppressed cholesterol regulatory gene expression and providing a biochemical mechanism mediating O-3-derived formation of oxidized lipids in the airways and subsequent adverse health effects.	[Speen, Adam M.; Bauer, Rebecca N.; Meyer, Megan; Duncan, Kelly E.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Dept Pediat, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Speen, Adam M.; Bauer, Rebecca N.; Meyer, Megan; Duncan, Kelly E.; Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Dept Microbiol & Immunol, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Kim, Hye-Young H.; Liu, Wei; Porter, Ned A.] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA; [Kim, Hye-Young H.; Liu, Wei; Porter, Ned A.] Vanderbilt Univ, Ctr Mol Toxicol, Nashville, TN 37235 USA; [Gowdy, Kymberly M.] East Carolina Univ, Brody Sch Med, Dept Pharmacol & Toxicol, Greenville, NC 27834 USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Vanderbilt University; University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jaspers, I (corresponding author), Univ North Carolina Chapel Hill, Dept Pediat Microbiol & Immunol, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Jaspers, I (corresponding author), Univ North Carolina Chapel Hill, Environm Sci & Engn, 104 Mason Farm Rd, Chapel Hill, NC 27599 USA.	ilona_jaspers@med.unc.edu	Jaspers, Ilona/AAZ-5035-2020; Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Jaspers, Ilona/0000-0001-8728-0305; Gowdy, Kymberly/0000-0002-7227-0697	United States Environmental Protection Agency [CR83346301]; Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill; National Institutes of Health [T32ES007126, R21ES024666]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211, R01HD064727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024666, ZIAES102005, T32ES007126] Funding Source: NIH RePORTER	United States Environmental Protection Agency(United States Environmental Protection Agency); Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the United States Environmental Protection Agency through cooperative agreement CR83346301 with the Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina at Chapel Hill (to I. J. and K. E. D.) and National Institutes of Health Grants T32ES007126 (to A. M. S. and R. N. B.) and R21ES024666 (to H. Y. K., N. A. P., and I. J.). The authors declare that they have no conflicts of interest with the contents of this article. This article has not been formally reviewed by EPA. The views expressed in this document are solely those of the authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexis NE, 2010, INHAL TOXICOL, V22, P593, DOI 10.3109/08958371003596587; Almstrand AC, 2015, ANAL BIOCHEM, V474, P50, DOI 10.1016/j.ab.2014.12.018; Azzam KM, 2012, TRENDS ENDOCRIN MET, V23, P169, DOI 10.1016/j.tem.2012.02.001; Bauer RN, 2015, AM J RESP CELL MOL, V52, P285, DOI 10.1165/rcmb.2014-0035OC; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2013, BIOCHIMIE, V95, P448, DOI 10.1016/j.biochi.2012.02.029; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bochem AE, 2015, ARTERIOSCL THROM VAS, V35, P1663, DOI 10.1161/ATVBAHA.114.304959; Connor RE, 2011, CHEM RES TOXICOL, V24, P1275, DOI 10.1021/tx200157t; Crisafulli C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-19; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; Devlin RB, 1996, TOXICOL APPL PHARM, V138, P176, DOI 10.1006/taap.1996.0111; Draper DW, 2012, J IMMUNOL, V188, P5327, DOI 10.4049/jimmunol.1101605; Fessler MB, 2008, CURR SIGNAL TRANSD T, V3, P75, DOI 10.2174/157436208784223170; Fessler MB, 2009, AM J RESP CRIT CARE, V180, P1031, DOI 10.1164/ajrccm.180.10.1031; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gong HBA, 2009, J BIOL CHEM, V284, P30113, DOI 10.1074/jbc.M109.047753; Gowdy KM, 2013, PULM PHARMACOL THER, V26, P430, DOI 10.1016/j.pupt.2012.06.002; Hemming JM, 2015, BIOCHEMISTRY-US, V54, P5185, DOI 10.1021/acs.biochem.5b00308; Hollingsworth John W, 2007, Proc Am Thorac Soc, V4, P240, DOI 10.1513/pats.200701-023AW; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jaspers I, 2005, TOXICOL SCI, V85, P990, DOI 10.1093/toxsci/kfi141; Jaspers I, 1997, AM J PHYSIOL-LUNG C, V272, pL504, DOI 10.1152/ajplung.1997.272.3.L504; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Jorres RA, 2000, AM J RESP CRIT CARE, V161, P1855; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kafoury RM, 2007, ENVIRON TOXICOL, V22, P159, DOI 10.1002/tox.20246; Kafoury RM, 1999, AM J RESP CRIT CARE, V160, P1934, DOI 10.1164/ajrccm.160.6.9902025; Kafoury RM, 1998, TOXICOL APPL PHARM, V150, P338, DOI 10.1006/taap.1998.8418; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; Kim CS, 2011, AM J RESP CRIT CARE, V183, P1215, DOI 10.1164/rccm.201011-1813OC; Kim HYH, 2009, MOL CELL PROTEOMICS, V8, P2080, DOI 10.1074/mcp.M900121-MCP200; Kim HJ, 2013, J LEUKOCYTE BIOL, V94, P99, DOI 10.1189/jlb.1112601; Kirichenko A, 1996, TOXICOL APPL PHARM, V141, P416, DOI 10.1006/taap.1996.0307; Liu W, 2013, J LIPID RES, V54, P244, DOI 10.1194/jlr.M031732; Lopez-Souza N, 2003, IN VITRO CELL DEV-AN, V39, P266; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Miyata R, 2013, CHEST, V143, P452, DOI 10.1378/chest.12-1237; Muller L, 2013, AM J PHYSIOL-LUNG C, V304, pL332, DOI 10.1152/ajplung.00256.2012; Murphy RC, 2008, J BIOL CHEM, V283, P15521, DOI 10.1074/jbc.R700049200; Nieva J, 2008, BIOCHEMISTRY-US, V47, P7695, DOI 10.1021/bi800333s; O'Neill MS, 2007, OCCUP ENVIRON MED, V64, P373, DOI 10.1136/oem.2006.030023; OOSTING RS, 1991, AM J PHYSIOL, V261, pL77, DOI 10.1152/ajplung.1991.261.2.L77; Ostro B, 2014, ENVIRON RES, V132, P168, DOI 10.1016/j.envres.2014.03.042; PRYOR WA, 1992, BIOCHEM BIOPH RES CO, V188, P618, DOI 10.1016/0006-291X(92)91101-U; Pulfer MK, 2005, J PHARMACOL EXP THER, V312, P256, DOI 10.1124/jpet.104.073437; Pulfer MK, 2004, J BIOL CHEM, V279, P26331, DOI 10.1074/jbc.M403581200; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; SMITH LL, 1989, FREE RADICAL BIO MED, V7, P285, DOI 10.1016/0891-5849(89)90136-6; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Solan PD, 2011, SHOCK, V35, P367, DOI 10.1097/SHK.0b013e3181f7d742; Stewart CR, 2007, BIOCHEMISTRY-US, V46, P5552, DOI 10.1021/bi602554z; Tal TL, 2010, TOXICOL APPL PHARM, V243, P46, DOI 10.1016/j.taap.2009.11.011; Tang CR, 2016, J LIPID RES, V57, P848, DOI 10.1194/jlr.M065797; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Uchida K, 1999, J BIOL CHEM, V274, P2234, DOI 10.1074/jbc.274.4.2234; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; United States Environmental Protection Agency, 2014, NAT AMB AIR QUAL STA; UPPU RM, 1995, ARCH BIOCHEM BIOPHYS, V319, P257, DOI 10.1006/abbi.1995.1290; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Wentworth AD, 2009, CHEM COMMUN, P3098, DOI 10.1039/b821584g; Windsor K, 2014, CHEM RES TOXICOL, V27, P1757, DOI 10.1021/tx500229h; Windsor K, 2013, J LIPID RES, V54, P2842, DOI 10.1194/jlr.M041061; Wu CH, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0524-8; Zanobetti A, 2004, EPIDEMIOLOGY, V15, pS22, DOI 10.1097/00001648-200407000-00042; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	76	19	19	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2016	291	48					25192	25206		10.1074/jbc.M116.732362	http://dx.doi.org/10.1074/jbc.M116.732362			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5GR	27703007	hybrid, Green Published			2022-12-26	WOS:000388880100033
J	Mitra, S; Ghosh, B; Gayen, N; Roy, J; Mandal, AK				Mitra, Shahana; Ghosh, Baijayanti; Gayen, Nilanjan; Roy, Joydeep; Mandal, Atin K.			Bipartite Role of Heat Shock Protein 90 (Hsp90) Keeps CRAF Kinase Poised for Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; MOLECULAR CHAPERONE; IN-VIVO; CO-CHAPERONE; RAF KINASE; STEROID-RECEPTOR; TYROSINE KINASE; QUALITY-CONTROL; ATPASE ACTIVITY; SRC-KINASE	GRAF kinase maintains cell viability, growth, and proliferation by participating in the MAPK pathway. Unlike BRAF, CRAF requires continuous chaperoning by Hsp90 to retain MAPK signaling. However, the reason behind the continuous association of Hsp90 with CRAF is still elusive. In this study, we have identified the bipartite role of Hsp90 in chaperoning CRAF kinase. Hsp90 facilitates Ser-621 phosphorylation of CRAF and prevents the kinase from degradation. Co-chaperone Cdc37 assists in this phosphorylation event. However, after folding, the stability of the kinase becomes insensitive to Hsp90 inhibition, although the physical association between Hsp90 and CRAF remains intact. We observed that overexpression of Hsp90 stimulates MAPK signaling by activating CRAF. The interaction between Hsp90 and CRAF is substantially increased under an elevated level of cellular Hsp90 and in the presence of either active Ras (Ras(V12)) or EGF. Surprisingly, enhanced binding of Hsp90 to CRAF occurs prior to the Ras-CRAF association and facilitates actin recruitment to CRAF for efficient Ras-CRAF interaction, which is independent of the ATPase activity of Hsp90. However, monomeric CRAF (CRAF(R401H)) shows abrogated interaction with both Hsp90 and actin, thereby affecting Hsp90-dependent CRAF activation. This finding suggests that stringent assemblage of Hsp90 keeps CRAF kinase equipped for participating in the MAPK pathway. Thus, the role of Hsp90 in GRAF maturation and activation acts as a limiting factor to maintain the function of a strong client like CRAF kinase.	[Mitra, Shahana; Ghosh, Baijayanti; Gayen, Nilanjan; Roy, Joydeep; Mandal, Atin K.] Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, India	Department of Science & Technology (India); Bose Institute	Mandal, AK (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata 700054, India.	mandalak@jcbose.ac.in		Mitra, Sahana/0000-0001-8339-1307	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR6544/BRB/10/1151/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by Department of Biotechnology, Ministry of Science and Technology, Government of India Grant BT/PR6544/BRB/10/1151/2012 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; Baljuls A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194167; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dasgupta G, 1997, EXP CELL RES, V237, P29, DOI 10.1006/excr.1997.3766; Dey B, 1996, MOL BIOL CELL, V7, P1405, DOI 10.1091/mbc.7.9.1405; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Dhillon AS, 2003, MOL CELL BIOL, V23, P1983, DOI 10.1128/MCB.23.6.1983-1993.2003; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; FABIAN JR, 1993, J CELL BIOL, V122, P645, DOI 10.1083/jcb.122.3.645; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Luo ZJ, 1997, MOL CELL BIOL, V17, P46, DOI 10.1128/MCB.17.1.46; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Mandal AK, 2007, J CELL BIOL, V176, P319, DOI 10.1083/jcb.200604106; Marais R, 1996, CANCER SURV, V27, P101; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Miao RQ, 2008, ARTERIOSCL THROM VAS, V28, P105, DOI 10.1161/ATVBAHA.107.155499; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Muller P, 2005, J BIOL CHEM, V280, P6682, DOI 10.1074/jbc.M412767200; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prince T, 2005, BIOCHEM BIOPH RES CO, V338, P1447, DOI 10.1016/j.bbrc.2005.10.100; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Pullen L, 2011, J BIOL CHEM, V286, P11091, DOI 10.1074/jbc.M111.223131; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roering Michael, 2012, Critical Reviews in Oncogenesis, V17, P97; Roy J, 2015, MOL BIOL CELL, V26, P1583, DOI 10.1091/mbc.E14-08-1262; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2015, ONCOGENE, V34, P15, DOI 10.1038/onc.2013.519; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Weber CK, 2001, CANCER RES, V61, P3595; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	115	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24579	24593		10.1074/jbc.M116.746420	http://dx.doi.org/10.1074/jbc.M116.746420			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27703006	Green Published, hybrid			2022-12-26	WOS:000388875500020
J	Maruyama, K; Kawasaki, T; Hamaguchi, M; Hashimoto, M; Furu, M; Ito, H; Fujii, T; Takemura, N; Karuppuchamy, T; Kondo, T; Kawasaki, T; Fukasaka, M; Misawa, T; Saitoh, T; Suzuki, Y; Martino, MM; Kumagai, Y; Akira, S				Maruyama, Kenta; Kawasaki, Takahiko; Hamaguchi, Masahide; Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Takemura, Naoki; Karuppuchamy, Thangaraj; Kondo, Takeshi; Kawasaki, Takumi; Fukasaka, Masahiro; Misawa, Takuma; Saitoh, Tatsuya; Suzuki, Yutaka; Martino, Mikael M.; Kumagai, Yutaro; Akira, Shizuo			Bone-protective Functions of Netrin 1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arthritis; interleukin 17A (IL-17 or IL-17A); osteoblast; osteoclast; osteoporosis; netrin 1; cell fusion; rheumatoid arthritis	NF-KAPPA-B; OSTEOCLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; RHEUMATOID-ARTHRITIS; AXON GUIDANCE; CELL-FUSION; IN-VITRO; DC-STAMP; ACTIVATION	Netrin 1 was initially identified as an axon guidance factor, and recent studies indicate that it inhibits chemokine-directed monocyte migration. Despite its importance as a neuroimmune guidance cue, the role of netrin 1 in osteoclasts is largely unknown. Here we detected high netrin 1 levels in the synovial fluid of rheumatoid arthritis patients. Netrin 1 is potently expressed in osteoblasts and synovial fibroblasts, and IL-17 robustly enhances netrin 1 expression in these cells. The binding of netrin 1 to its receptor UNC5b on osteoclasts resulted in activation of SHP1, which inhibited VAV3 phosphorylation and RAC1 activation. This significantly impaired the actin polymerization and fusion, but not the differentiation of osteoclast. Strikingly, netrin 1 treatment prevented bone erosion in an autoimmune arthritis model and age-related bone destruction. Therefore, the netrin 1-UNC5b axis is a novel therapeutic target for bone-destructive diseases.	[Maruyama, Kenta; Karuppuchamy, Thangaraj; Kondo, Takeshi; Kawasaki, Takumi; Fukasaka, Masahiro; Misawa, Takuma; Saitoh, Tatsuya; Martino, Mikael M.; Kumagai, Yutaro; Akira, Shizuo] Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Hamaguchi, Masahide] Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Expt Immunol, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Osaka 5650871, Japan; [Kawasaki, Takahiko] Natl Inst Genet, Div Brain Funct, 1111 Yata, Mishima, Shizuoka 4118540, Japan; [Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto 6068507, Japan; [Takemura, Naoki] Univ Tokyo, Div Innate Immune Regulat, Int Res & Dev Ctr Mucosal Vaccine, Inst Med Sci,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Saitoh, Tatsuya] Univ Tokushima, Dept Inflammat Biol, Inst Enzyme Res, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708503, Japan; [Suzuki, Yutaka] Univ Tokyo, Dept Funct Genom & Med Genome Sci, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan; [Martino, Mikael M.] Monash Univ, European Mol Biol Lab, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia	Osaka University; Osaka University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; University of Tokyo; Tokushima University; University of Tokyo; Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University	Maruyama, K; Akira, S (corresponding author), Osaka Univ, WPI, Immunol Frontier Res Ctr IFReC, Lab Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	maruyama@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Martino, Mikaël M/N-9345-2013; Karuppuchamy, Thangaraj/O-2123-2017; Kumagai, Yutaro/L-7732-2018; KONDO, Takeshi/AGV-4963-2022; Akira, Shizuo/C-3134-2009	Martino, Mikaël M/0000-0002-5012-4605; Karuppuchamy, Thangaraj/0000-0002-7537-1530; Kumagai, Yutaro/0000-0002-5039-3979; Hamaguchi, Masahide/0000-0002-8651-4445; Kawasaki, Takahiko/0000-0001-9939-8407	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); JSPS for the Promotion of Science for Young Scientists; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation Natural Science; Takeda Science Foundation; Japan Intractable Diseases Research Foundation; SENSHIN Medical Research Foundation; Senri Life Science Foundation Kishimoto; Nouchi Shitagau; Japan Prize Foundation; Mochida Memorial; Japan Rheumatism Foundation	Cabinet Office, Government of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS for the Promotion of Science for Young Scientists; Osaka University MEET project; Astellas Foundation for Research on Metabolic Disorders; Naito Foundation Natural Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Intractable Diseases Research Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Senri Life Science Foundation Kishimoto; Nouchi Shitagau; Japan Prize Foundation(Japan Prize Foundation); Mochida Memorial; Japan Rheumatism Foundation(Japan Rheumatism Foundation)	This research was supported by the Cabinet Office, Government of Japan, and the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), a research fellowship from the JSPS for the Promotion of Science for Young Scientists, a grant from the Osaka University MEET project, a grant from the Astellas Foundation for Research on Metabolic Disorders, a scholarship from the Naito Foundation Natural Science, a visionary research grant from Takeda Science Foundation, a KAKENHI grant-in-aid for Challenging Exploratory Research, a KAKENHI grant-in-aid for Young Scientists A, grants from the Japan Intractable Diseases Research Foundation and the SENSHIN Medical Research Foundation, a Senri Life Science Foundation Kishimoto grant, and grants from Nouchi Shitagau, Japan Prize Foundation, Mochida Memorial, and Japan Rheumatism Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki K, 1999, BONE, V25, P261, DOI 10.1016/S8756-3282(99)00174-X; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Enoki Y, 2014, FEBS LETT, V588, P2262, DOI 10.1016/j.febslet.2014.05.009; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo XK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/462152; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Maruyama K, 2006, J IMMUNOL, V177, P3799, DOI 10.4049/jimmunol.177.6.3799; Maruyama K, 2013, J EXP MED, V210, P1947, DOI 10.1084/jem.20130512; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mori Y, 2008, J IMMUNOL, V181, P4742, DOI 10.4049/jimmunol.181.7.4742; Okamoto K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3323; Paradisi A, 2013, EMBO MOL MED, V5, P1821, DOI 10.1002/emmm.201302654; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V304, pF1187, DOI 10.1152/ajprenal.00702.2012; Reginster JY, 2013, EXPERT OPIN DRUG SAF, V12, P507, DOI 10.1517/14740338.2013.793669; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Zhang RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020780; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	53	19	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23854	23868		10.1074/jbc.M116.738518	http://dx.doi.org/10.1074/jbc.M116.738518			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27681594	hybrid, Green Published			2022-12-26	WOS:000388498100002
J	Prajapati, RK; Sur, R; Mukhopadhyay, J				Prajapati, Ranjit Kumar; Sur, Runa; Mukhopadhyay, Jayanta			A Novel Function of Factor from Bacillus subtilis as a Transcriptional Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial transcription; gene regulation; repressor protein; sporulation	RNA-POLYMERASE; DELTA-SUBUNIT; STREPTOCOCCUS-MUTANS; PROMOTER SELECTIVITY; GENE; EXPRESSION; INITIATION; SIGMA; SPORULATION; PURIFICATION	delta , a small protein found in most Gram-positive bacteria was, for a long time, thought to be a subunit of RNA polymerase (RNAP) and was shown to be involved in recycling of RNAP at the end of each round of transcription. However, how participates in both up-regulation and down-regulation of genes in vivo remains unclear. We have recently shown, in addition to the recycling of RNAP, functions as a transcriptional activator by binding to an A-rich sequence located immediately upstream of the -35 element, consequently facilitating the open complex formation. The result had explained the mechanism of up-regulation of the genes by . Here, we show that Bacillus subtilis could also function as a transcriptional repressor. Our results demonstrate that binds to an A-rich sequence located near the -35 element of the spo0B promoter, the gene involved in the regulatory cascade of bacterial sporulation and inhibits the open complex formation due to steric clash with sigma region 4.2. We observed a significant increase in the mRNA level of the spo0B gene in a -knock-out strain of B. subtilis compared with the wild-type. Thus, the results report a novel function of , and suggest the mechanism of down-regulation of genes in vivo by the protein.	[Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta] Univ Calcutta, Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India; [Sur, Runa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, 93-1 APC Rd, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute; University of Calcutta; University of Calcutta	Mukhopadhyay, J (corresponding author), Univ Calcutta, Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	jayanta@jcbose.ac.in		Prajapati, Ranjit/0000-0002-9294-3537	Department of Biotechnology, India Research Grants [BT/PR 5345/MED/29/648/2012, BT/PR 5270/BRB/10/1066/2012]	Department of Biotechnology, India Research Grants	This work was supported in part by Department of Biotechnology, India Research Grants BT/PR 5345/MED/29/648/2012 and BT/PR 5270/BRB/10/1066/2012. The authors declare no conflicts of interest with the contents of this article.	ACHBERGER EC, 1981, J BIOL CHEM, V256, P7424; Banerjee R, 2015, J BACTERIOL, V197, P646, DOI 10.1128/JB.02445-14; BOUVIER J, 1984, P NATL ACAD SCI-BIOL, V81, P7012, DOI 10.1073/pnas.81.22.7012; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; DESARO FJL, 1995, J MOL BIOL, V252, P189, DOI 10.1006/jmbi.1995.0487; DICKEL CD, 1980, BIOCHEM BIOPH RES CO, V95, P1789, DOI 10.1016/S0006-291X(80)80106-9; DOBINSON KF, 1987, BIOCHEMISTRY-US, V26, P8206, DOI 10.1021/bi00399a028; Gao HC, 2004, CURR MICROBIOL, V48, P401, DOI 10.1007/s00284-003-4229-8; Garcia-Vallve S, 1999, MOL BIOL EVOL, V16, P1125, DOI 10.1093/oxfordjournals.molbev.a026203; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; HOLMBERG C, 1991, MOL MICROBIOL, V5, P2891, DOI 10.1111/j.1365-2958.1991.tb01849.x; HYDE EI, 1986, J BIOL CHEM, V261, P6565; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; LAMPE M, 1988, GENE, V67, P13, DOI 10.1016/0378-1119(88)90003-0; Prajapati RK, 2016, J BIOL CHEM, V291, P1064, DOI 10.1074/jbc.M115.686170; Rabatinova A, 2013, J BACTERIOL, V195, P2603, DOI 10.1128/JB.00188-13; Sambrook J., 2001, MOL CLONING LAB MANU; SAXILD HH, 1995, MICROBIOL-SGM, V141, P2211, DOI 10.1099/13500872-141-9-2211; Seepersaud R, 2006, J BACTERIOL, V188, P2096, DOI 10.1128/JB.188.6.2096-2105.2006; Shafikhani SH, 2002, J BACTERIOL, V184, P564, DOI 10.1128/JB.184.2.564-571.2002; Sonenshein AL, 2000, CURR OPIN MICROBIOL, V3, P561, DOI 10.1016/S1369-5274(00)00141-7; TJIAN R, 1977, EUR J BIOCHEM, V74, P149, DOI 10.1111/j.1432-1033.1977.tb11376.x; Weiss A, 2014, INFECT IMMUN, V82, P1424, DOI 10.1128/IAI.01508-14; WILLIAMSON VM, 1979, MOL GEN GENET, V174, P47, DOI 10.1007/BF00433304; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Xue XL, 2012, MICROBIOL-SGM, V158, P191, DOI 10.1099/mic.0.047936-0; Xue XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020075; Xue XL, 2010, J BACTERIOL, V192, P5081, DOI 10.1128/JB.00653-10; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	30	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24029	24035		10.1074/jbc.M116.746065	http://dx.doi.org/10.1074/jbc.M116.746065			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27679485	hybrid, Green Published			2022-12-26	WOS:000388498100019
J	Webb, BA; White, KA; Grillo-Hill, BK; Schonichen, A; Choi, C; Barber, DL				Webb, Bradley A.; White, Katharine A.; Grillo-Hill, Bree K.; Schoenichen, Andre; Choi, Changhoon; Barber, Diane L.			A Histidine Cluster in the Cytoplasmic Domain of the Na-H Exchanger NHE1 Confers pH-sensitive Phospholipid Binding and Regulates Transporter Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; focal adhesions; pH regulation; phospholipid; sodium-proton exchange	NA+/H+ EXCHANGER; ALZHEIMERS-DISEASE; INTRACELLULAR PH; FYVE DOMAIN; ACTIVATION; PHOSPHORYLATION; GROWTH; ISOFORM-1; KINASE; CANCER	The Na-H exchanger NHE1 contributes to intracellular pH (pH(i)) homeostasis in normal cells and the constitutively increased pH(i) in cancer. NHE1 activity is allosterically regulated by intracellular protons, with greater activity at lower pH(i). However, the molecular mechanism for pH-dependent NHE1 activity remains incompletely resolved. We report that an evolutionarily conserved cluster of histidine residues located in the C-terminal cytoplasmic domain between two phosphatidylinositol 4,5-bisphosphate binding sites (PI(4,5)P-2) of NHE1 confers pH-dependent PI(4,5)P-2 binding and regulates NHE1 activity. A GST fusion of the wild type C-terminal cytoplasmic domain of NHE1 showed increased maximum PI(4,5)P-2 binding at pH 7.0 compared with pH 7.5. However, pH-sensitive binding is abolished by substitutions of the His-rich cluster to arginine (RXXR3) or alanine (AXXA3), mimicking protonated and neutral histidine residues, respectively, and the RXXR3 mutant had significantly greater PI(4,5)P-2 binding than AXXA3. When expressed in cells, NHE1 activity and pH(i) were significantly increased with NHE1-RXXR3 and decreased with NHE1-AXXA3 compared with wild type NHE1. Additionally, fibroblasts expressing NHE1-RXXR3 had significantly more contractile actin filaments and focal adhesions compared with fibroblasts expressing wild type NHE1, consistent with increased pH(i) enabling cytoskeletal remodeling. These data identify a molecular mechanism for pH-sensitive PI(4,5)P-2 binding regulating NHE1 activity and suggest that the evolutionarily conserved cluster of four histidines in the proximal cytoplasmic domain of NHE1 may constitute a proton modifier site. Moreover, a constitutively activated NHE1-RXXR3 mutant is a new tool that will be useful for studying how increased pH(i) contributes to cell behaviors, most notably the biology of cancer cells.	[Webb, Bradley A.; White, Katharine A.; Grillo-Hill, Bree K.; Schoenichen, Andre; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave,HSW618,Box 0512, San Francisco, CA 94143 USA; [Choi, Changhoon] Samsung Med Ctr, Dept Radiat Oncol, Seoul 06351, South Korea	University of California System; University of California San Francisco; Sungkyunkwan University (SKKU); Samsung Medical Center	Barber, DL (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave,HSW618,Box 0512, San Francisco, CA 94143 USA.	diane.barber@ucsf.edu	Webb, Bradley/F-6946-2013; Webb, Bradley/HDO-7820-2022; White, Katharine A./X-9101-2019	Webb, Bradley/0000-0002-5299-2852; White, Katharine A./0000-0002-5831-1886; Grillo-Hill, Bree/0000-0001-6471-7025; Choi, Changhoon/0000-0002-2847-1168	National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship [CA177085, R01 GM116384]; Canadian Institutes of Health research postdoctoral fellowship; Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO [1410/1-1]; NATIONAL CANCER INSTITUTE [F32CA177085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116384] Funding Source: NIH RePORTER	National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health F32 NRSA (National Research Service Award) Postdoctoral Fellowship CA177085 (to K.A.W.) and Grant R01 GM116384 (to D.L.B.). This work was also supported in whole or part by Canadian Institutes of Health research postdoctoral fellowship (to B.A.W.) and Deutsche Forschungsgemeinschaft (DFG) Postdoctoral Fellowship SCHO 1410/1-1 (to A.S.).The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Abu Jawdeh BG, 2011, J BIOL CHEM, V286, P42435, DOI 10.1074/jbc.M110.212845; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cha B, 2003, J MEMBRANE BIOL, V191, P49, DOI 10.1007/s00232-002-1044-2; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; Clement DL, 2013, J CELL SCI, V126, P953, DOI 10.1242/jcs.116426; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Dibrov P, 2000, BIOSCIENCE REP, V20, P185, DOI 10.1023/A:1005567519792; Fang BY, 2010, INT J NEUROSCI, V120, P591, DOI 10.3109/00207454.2010.505353; Frantz C, 2007, J CELL BIOL, V179, P403, DOI 10.1083/jcb.200704169; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Grillo-Hill BK, 2015, ELIFE, V4, DOI 10.7554/eLife.03270; Harguindey S, 2007, CURR ALZHEIMER RES, V4, P53, DOI 10.2174/156720507779939841; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; KAPUS A, 1994, J BIOL CHEM, V269, P23544; Khan S, 2014, J CLIN INVEST, V124, P1057, DOI 10.1172/JCI71863; Krump E, 1997, J BIOL CHEM, V272, P17303, DOI 10.1074/jbc.272.28.17303; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Schonichen A, 2013, ANNU REV BIOPHYS, V42, P289, DOI 10.1146/annurev-biophys-050511-102349; Shimada-Shimizu N, 2014, MOL PHARMACOL, V85, P18, DOI 10.1124/mol.113.089268; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	41	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24096	24104		10.1074/jbc.M116.736215	http://dx.doi.org/10.1074/jbc.M116.736215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27650500	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000388498100026
J	Li, J; Wang, RP; Gannon, OJ; Rezey, AC; Jiang, SX; Gerlach, BD; Liao, GN; Tang, DD				Li, Jia; Wang, Ruping; Gannon, Olivia J.; Rezey, Alyssa C.; Jiang, Sixin; Gerlach, Brennan D.; Liao, Guoning; Tang, Dale D.			Polo-like Kinase 1 Regulates Vimentin Phosphorylation at Ser-56 and Contraction in Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; excitation-contraction coupling (E-C coupling); intermediate filament; phosphorylation; signal transduction; smooth muscle	CRK-ASSOCIATED SUBSTRATE; P21-ACTIVATED KINASE; AIRWAY HYPERRESPONSIVENESS; ACTIN POLYMERIZATION; STRUCTURAL BASIS; TYROSINE KINASE; ACTIVATION; CELLS; ABL; CYTOSKELETON	Polo-like kinase 1 (Plk1) is a serine/threonine-protein kinase that has been implicated in mitosis, cytokinesis, and smooth muscle cell proliferation. The role of Plk1 in smooth muscle contraction has not been investigated. Here, stimulation with acetylcholine induced Plk1 phosphorylation at Thr-210 (an indication of Plk1 activation) in smooth muscle. Contractile stimulation also activated Plk1 in live smooth muscle cells as evidenced by changes in fluorescence resonance energy transfer signal of a Plk1 sensor. Moreover, knockdown of Plk1 in smooth muscle attenuated force development. Smooth muscle conditional knock-out of Plk1 also diminished contraction of mouse tracheal rings. Plk1 knockdown inhibited acetylcholine-induced vimentin phosphorylation at Ser-56 without affecting myosin light chain phosphorylation. Expression of T210A Plk1 inhibited the agonist-induced vimentin phosphorylation at Ser-56 and contraction in smooth muscle. However, myosin light chain phosphorylation was not affected by T210A Plk1. Ste20-like kinase (SLK) is a serine/threonine-protein kinase that has been implicated in spindle orientation and microtubule organization during mitosis. In this study knockdown of SLK inhibited Plk1 phosphorylation at Thr-210 and activation. Finally, asthma is characterized by airway hyperresponsiveness, which largely stems from airway smooth muscle hyperreactivity. Here, smooth muscle conditional knock-out of Plk1 attenuated airway resistance and airway smooth muscle hyperreactivity in a murine model of asthma. Taken together, these findings suggest that Plk1 regulates smooth muscle contraction by modulating vimentin phosphorylation at Ser-56. Plk1 activation is regulated by SLK during contractile activation. Plk1 contributes to the pathogenesis of asthma.	[Li, Jia; Wang, Ruping; Gannon, Olivia J.; Rezey, Alyssa C.; Jiang, Sixin; Gerlach, Brennan D.; Liao, Guoning; Tang, Dale D.] Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave,MC-8, Albany, NY 12208 USA.	tangd@mail.amc.edu	T, Dale/AAE-9643-2020	T, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	National Institutes of Health [HL-110951, HL-113208, HL-130304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130304, R01HL110951, R01HL113208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-110951, HL-113208, and HL-130304 (NHLBI; to D. D. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amrani Y, 2004, CURR OPIN PHARMACOL, V4, P230, DOI 10.1016/j.coph.2004.02.004; Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cleary RA, 2014, AM J PHYSIOL-CELL PH, V306, pC753, DOI 10.1152/ajpcell.00327.2013; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Garrod DR, 2002, MOL MEMBR BIOL, V19, P81, DOI 10.1080/09687680210132476; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; Jiang SX, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0257-8; Johnson TM, 2008, BIOCHEMISTRY-US, V47, P3688, DOI 10.1021/bi702134c; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Lee KY, 2012, J CELL PHYSIOL, V227, P739, DOI 10.1002/jcp.22782; Li J, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0415-7; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Liu TG, 2014, J CELL PHYSIOL, V229, P1484, DOI 10.1002/jcp.24590; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2008, AM J PHYSIOL-CELL PH, V294, pC869, DOI 10.1152/ajpcell.00154.2007; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Tang DD, 2009, J CARDIOVASC PHARM T, V14, P89, DOI 10.1177/1074248409333490; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; VANDERLOOP FTL, 1995, EUR J CELL BIOL, V68, P62; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2014, J BIOL CHEM, V289, P14157, DOI 10.1074/jbc.M114.548099; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Wang T, 2015, J BIOL CHEM, V290, P8913, DOI 10.1074/jbc.M114.621003; Wang T, 2014, AM J RESP CELL MOL, V51, P652, DOI 10.1165/rcmb.2014-0125OC; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wu YD, 2015, J BIOL CHEM, V290, P11403, DOI 10.1074/jbc.M115.645788; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Zhapparova ON, 2013, MOL BIOL CELL, V24, P3205, DOI 10.1091/mbc.E13-03-0137	47	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23693	23703		10.1074/jbc.M116.749341	http://dx.doi.org/10.1074/jbc.M116.749341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27662907	Green Published, hybrid			2022-12-26	WOS:000387884400029
J	Carchman, EH; Matkowskyj, KA; Meske, L; Lambert, PF				Carchman, Evie H.; Matkowskyj, Kristina A.; Meske, Louise; Lambert, Paul F.			Dysregulation of Autophagy Contributes to Anal Carcinogenesis	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; E7 ONCOGENE; CARCINOMA; CANCER; MICE; ONCOPROTEINS; SENESCENCE; INFECTION; REVEALS; CELLS	Introduction Autophagy is an intracellular catabolic process that removes and recycles unnecessary/dysfunctional cellular components, contributing to cellular health and survival. Autophagy is a highly regulated cellular process that responds to several intracellular signals, many of which are deregulated by human papillomavirus (HPV) infection through the expression of HPV-encoded oncoproteins. This adaptive inhibitory response helps prevent viral clearance. A strong correlation remains between HPV infection and the development of squamous cell carcinoma (SCC) of the anus, particularly in HIV positive and other immunosuppressed patients. We hypothesize that autophagy is inhibited by HPV-encoded oncoproteins thereby promoting anal carcinogenesis (Fig 1). Materials and Methods HPV16 transgenic mice (K14E6/E7) and non-transgenic mice (FVB/N), both of which do not spontaneously develop anal tumors, were treated topically with the chemical carcinogen, 7,12-Dimethylbenz[a]anthracene (DMBA), to induce anal cancer. The anuses at different time points of treatment (5, 10, 15 and 20 weeks) were analyzed using immunofluorescence (IF) for two key autophagy marker proteins (LC3 beta and p62) in addition to histological grading. The anuses from the K14E6/E7 mice were also analyzed for visual evidence of autophagic activity by electron microscopy (EM). To see if there was a correlation to humans, archival anal specimens were assessed histologically for grade of dysplasia and then analyzed for LC3 beta and p62 protein content. To more directly examine the effect of autophagic inhibition on anal carcinogenesis, nontransgenic mice that do not develop anal cancer with DMBA treatment were treated with a known pharmacologic inhibitor of autophagy, chloroquine, and examined for tumor development and analyzed by IF for autophagic proteins. Results Histologically, we observed the progression of normal anoderm to invasive SCC with DMBA treatment in K14E6/E7 mice but not in nontransgenic, syngeneic FVB/N background control mice. With the development of low-grade dysplasia in the K14E6/E7 mice, there was an increase in both punctate LC3 beta and p62 expression while EM revealed increased autophagosomes without evidence of autophagolysosomes. These observations are consistent with autophagy being inhibited at a later stage in the autophagic process. In contrast, in high-grade dysplasia and SCC in the DMBA-treated K14E6/E7 mice, there were decreased levels of p62 with a continued increase in punctate LC3 beta expression by IF, while autophagolysosomes were seen on EM, consistent with the process of autophagy proceeded to completion. Similar findings, including histological grade dependent changes in LC3 beta and p62 expression, were noted with human samples upon analysis of IF. Finally, with pharmacologic inhibition of autophagy in DMBA-treated, nontrangenic FVB/N mice, there was a significant increase in anal cancer development similar to that observed in DMBA-treated K14E6/E7 mice. Conclusion Autophagic dysregulation is noted early on in HPV-associated anal carcinogenesis (low-grade dysplasia), with normalization of the autophagic process arising in late stages of HPV-associated anal carcinogenesis (high-grade dysplasia and invasive carcinoma).	[Carchman, Evie H.; Meske, Louise] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab, Madison, WI USA; [Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carchman, EH (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI 53792 USA.	carchman@surgery.wisc.edu			Society for Surgery of the Alimentary Tract [PRJ96MZ]; Department of General Surgery [PRJ91NA]; Central Surgical Association [AAA1353]; NIH [CM 71873]; NATIONAL CANCER INSTITUTE [R01CA171873] Funding Source: NIH RePORTER	Society for Surgery of the Alimentary Tract; Department of General Surgery; Central Surgical Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Society for Surgery of the Alimentary Tract: PRJ96MZ (EC) Department of General Surgery: PRJ91NA (EC) Central Surgical Association: AAA1353 (EC) NIH CM 71873 (PFL).	[Anonymous], 2015, SEER CANC STAT FACTS; Baricevic I, 2015, EUR J CANCER, V51, P776, DOI 10.1016/j.ejca.2015.01.058; Chung JH, 2016, ANN ONCOL, V27, P1336, DOI 10.1093/annonc/mdw152; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Jabbar SF, 2009, CANCER RES, V69, P4407, DOI 10.1158/0008-5472.CAN-09-0023; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li XL, 2015, INT J CLIN EXP MED, V8, P10304; Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200; Mack Hildegard I D, 2012, Cells, V1, P204, DOI 10.3390/cells1030204; Mileo AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007254; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stelzer MK, 2010, CANCER PREV RES, V3, P1534, DOI 10.1158/1940-6207.CAPR-10-0086; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yan MM, 2015, ONCOL LETT, V10, P1959, DOI 10.3892/ol.2015.3508	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164273	10.1371/journal.pone.0164273	http://dx.doi.org/10.1371/journal.pone.0164273			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706233	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200101
J	Loach, JC; Wang, JZ				Loach, James C.; Wang, Jinzhao			Optimizing the Learning Order of Chinese Characters Using a Novel Topological Sort Algorithm	PLOS ONE			English	Article							RADICALS	We present a novel algorithm for optimizing the order in which Chinese characters are learned, one that incorporates the benefits of learning them in order of usage frequency and in order of their hierarchal structural relationships. We show that our work outperforms previously published orders and algorithms. Our algorithm is applicable to any scheduling task where nodes have intrinsic differences in importance and must be visited in topological order.	[Loach, James C.] Shanghai Jiao Tong Univ, INPAC, Shanghai 200240, Peoples R China; Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Loach, JC (corresponding author), Shanghai Jiao Tong Univ, INPAC, Shanghai 200240, Peoples R China.	james.loach@sjtu.edu.cn	Loach, James/O-1604-2015	Loach, James/0000-0002-9273-1286	Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC) [15DZ2272100]	Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC)	This work was supported by the Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC), Grant No. 15DZ2272100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JR, 2008, FOREIGN LANG ANN, V41, P237, DOI 10.1111/j.1944-9720.2008.tb03291.x; Burnett FH, 2015, SECRET GARDEN MANDAR; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Chiang T., 2016, NEW YORKER; DeFrancis John., 1989, VISIBLE SPEECH DIVER; Dickens C, 2016, GREAT EXP 1; Feldman LB, 1999, J MEM LANG, V40, P559, DOI 10.1006/jmla.1998.2629; Heisig JW, 2012, REMEMBERING SIMPLIFI; Heisig JW, 2008, REMEMBERING SIMPLIFI; Henson A, 2015, OUTLIER DICT; Ho CY, 2014, APPL ECON, V46, P3828, DOI 10.1080/00036846.2014.943884; Ho CSH, 1999, J CHILD PSYCHOL PSYC, V40, P393; Kane Daniel, 2006, CHINESE LANGUAGE ITS; Ke C., 2001, J CHINESE LANGUAGE T, V36, P25; Lam HC., 2011, ELECT J FOREIGN LANG, V8, P57; Lam HC, 2010, LEARNING CHINESE, P53; Lam HC, 2013, INSTR SCI, V41, P955, DOI 10.1007/s11251-013-9264-7; Li JY, 2007, PHYSICA A, V380, P629, DOI 10.1016/j.physa.2007.02.059; Light T., 1975, J CHINESE LANGUAGE T, V10, P70; Ling LM, 2012, INT J LESSON LEARN S, V1, P7, DOI [10.1108/20468251211179678, 10.1108/ijlls.2012.57901baa.002]; Marton F, 2006, J LEARN SCI, V15, P193, DOI 10.1207/s15327809jls1502_2; Marton F., 1997, LEARNING AWARENESS; Reigeluth CharlesW., 2007, ORDER LEARN SEQUENCE, P19; Richardson TW, 2007, COGNITION LEARNING T; Shen H., 2005, SYSTEM, V33, P49, DOI DOI 10.1016/J.SYSTEM.2004.11.001; *Shen H.H., 2004, LANG EDUC-UK, V18, P167, DOI [DOI 10.1080/, 10.1080/09500780408666873, DOI 10.1080/09500780408666873]; Shen HH, 2007, MOD LANG J, V91, P97, DOI 10.1111/j.1540-4781.2007.00511.x; Shu H, 1997, READ RES QUART, V32, P78, DOI 10.1598/RRQ.32.1.5; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Taft M, 1999, PSYCHOLOGIA, V42, P243; Tse SK, 2010, LEARNING CHINESE, P75; Tse SK, 2010, LEARNING CHINESE, P1; Walker Galal, 1989, J CHINESE LANGUAGE T, V24, P43; WANG AY, 1992, LANG LEARN, V42, P359, DOI 10.1111/j.1467-1770.1992.tb01340.x; Wang M, 2003, SCI STUD READ, V7, P183, DOI 10.1207/S1532799XSSR0702_4; Xu Y, 2014, MOD LANG J, V98, P773, DOI 10.1111/j.1540-4781.2014.12122.x; Yan XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069745	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163623	10.1371/journal.pone.0163623	http://dx.doi.org/10.1371/journal.pone.0163623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706234	Green Submitted, Green Published, gold			2022-12-26	WOS:000385697200050
J	Stewart, MJ; Wang, TF; Harding, BI; Bose, U; Wyeth, RC; Storey, KB; Cummins, SF				Stewart, Michael J.; Wang, Tianfang; Harding, Bradley I.; Bose, U.; Wyeth, Russell C.; Storey, Kenneth B.; Cummins, Scott F.			Characterisation of Reproduction-Associated Genes and Peptides in the Pest Land Snail, Theba pisana	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; EGG-LAYING HORMONE; GNRH-LIKE PEPTIDE; APGWAMIDE-RELATED PEPTIDES; CENTRAL-NERVOUS-SYSTEM; LOVE-DART; MOLECULAR-CLONING; NEUROPEPTIDES; APLYSIA; LOCALIZATION	Increased understanding of the molecular components involved in reproductionmay assist in understanding the evolutionary adaptations used by animals, including hermaphrodites, to produce offspring and retain a continuation of their lineage. In this study, we focus on the Mediterranean snail, Theba pisana, a hermaphroditic land snail that has become a highly invasive pest species within agricultural areas throughout the world. Our analysis of T. pisana CNS tissue has revealed gene transcripts encoding molluscan reproduction-associated proteins including APGWamide, gonadotropin-releasing hormone (GnRH) and an egg-laying hormone (ELH). ELH isoform 1 (ELH1) is known to be a potent reproductive peptide hormone involved in ovulation and egg-laying in some aquatic molluscs. Two other non-CNS ELH isoforms were also present in T. pisana (Tpi-ELH2 and Tpi-ELH3) within the snail dart sac and mucous glands. Bioactivity of a synthetic ELH1 on sexually mature T. pisana was confirmed through bioassay, with snails showing ELH1-induced egg-laying behaviours, including soil burrowing and oviposition. In summary, this study presents a detailed molecular analysis of reproductive neuropeptide genes in a land snail and provides a foundation for understanding ELH function.	[Stewart, Michael J.; Wang, Tianfang; Harding, Bradley I.; Bose, U.; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Wyeth, Russell C.] St Francis Xavier Univ, Antigonish, NS 5000, Canada; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada; [Storey, Kenneth B.] Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada	University of the Sunshine Coast; Saint Francis Xavier University - Canada; Carleton University; Carleton University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	Wang, Tianfang/L-5192-2016; Wyeth, Russell/ABE-1310-2021; Wang, Tianfang/GRO-0844-2022; Bose, Utpal/A-1785-2019; Bose, Utpal/AAU-5241-2020; Wang, Tianfang/AAG-4290-2020; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Bose, Utpal/0000-0003-1156-6504; Bose, Utpal/0000-0003-1156-6504; Wang, Tianfang/0000-0002-4876-7767; Harding, Bradley/0000-0002-4165-2457; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [DP120104360]	Australian Research Council(Australian Research Council)	Funded by Australian Research Council: DP120104360.	ADAMO SA, 1990, J EXP ZOOL, V255, P80, DOI 10.1002/jez.1402550111; ADAMO SA, 1988, CAN J ZOOL, V66, P1446, DOI 10.1139/z88-211; Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; Akalal DBG, 2003, PEPTIDES, V24, P1117, DOI 10.1016/j.peptides.2003.06.001; Amano M, 2008, GEN COMP ENDOCR, V156, P277, DOI 10.1016/j.ygcen.2008.01.008; Amano M, 2010, ZOOL SCI, V27, P656, DOI 10.2108/zsj.27.656; BAKER GH, 1990, J APPL ECOL, V27, P16, DOI 10.2307/2403565; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bernard A, 1930, CR SOC BIOL, V103, P1119; BRANTON WD, 1978, P NATL ACAD SCI USA, V75, P5732, DOI 10.1073/pnas.75.11.5732; Casadio A, 2004, J NEUROSCI RES, V75, P32, DOI 10.1002/jnr.10841; Chansela P, 2008, AQUACULTURE, V279, P142, DOI 10.1016/j.aquaculture.2008.03.058; Chase R., 2002, BEHAV ITS NEURAL CON; Chase R, 2007, AM MALACOL BULL, V23, P183, DOI 10.4003/0740-2783-23.1.183; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; CHIU AY, 1979, P NATL ACAD SCI USA, V76, P6656, DOI 10.1073/pnas.76.12.6656; Cummins SF, 2010, PEPTIDES, V31, P394, DOI 10.1016/j.peptides.2009.10.010; Cummins SF, 2009, INT J DEV BIOL, V53, P1081, DOI 10.1387/ijdb.082791sc; De Boer PACM, 1997, J NEUROPHYSIOL, V78, P2823; de Lange RPJ, 1998, GEN COMP ENDOCR, V109, P166, DOI 10.1006/gcen.1997.7001; DeLange RPJ, 1997, NEUROSCIENCE, V78, P289, DOI 10.1016/S0306-4522(96)00576-3; Di Cristo C, 2009, PEPTIDES, V30, P531, DOI 10.1016/j.peptides.2008.07.008; DUDEK FE, 1978, GEN COMP ENDOCR, V36, P618, DOI 10.1016/0016-6480(78)90103-X; EBBERINK RHM, 1985, P NATL ACAD SCI USA, V82, P7767, DOI 10.1073/pnas.82.22.7767; Favrel P, 1996, NEUROSCI LETT, V205, P210, DOI 10.1016/0304-3940(96)12390-9; Gess F., 2007, VELD FLORA, V93, P216; Ghabooli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059328; GOLDBERG JI, 1993, J COMP NEUROL, V336, P571, DOI 10.1002/cne.903360409; Gorbman A, 2003, GEN COMP ENDOCR, V131, P62, DOI 10.1016/S0016-6480(02)00647-0; Heifetz Y, 2005, P NATL ACAD SCI USA, V102, P743, DOI 10.1073/pnas.0407692102; HELLER E, 1980, P NATL ACAD SCI-BIOL, V77, P2328, DOI 10.1073/pnas.77.4.2328; Henry J, 1997, PEPTIDES, V18, P1469, DOI 10.1016/S0196-9781(97)00241-6; Henry J, 2000, BRAIN RES, V862, P162, DOI 10.1016/S0006-8993(00)02108-9; Henry J, 2002, PEPTIDES, V23, P1031, DOI 10.1016/S0196-9781(02)00033-5; Hermann PM, 1997, J NEUROPHYSIOL, V78, P2859, DOI 10.1152/jn.1997.78.6.2859; Iwakoshi E, 2002, BIOCHEM BIOPH RES CO, V291, P1187, DOI 10.1006/bbrc.2002.6594; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069968; Koene JM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00167; Koene JM, 2009, EVOL ECOL, V23, P533, DOI 10.1007/s10682-008-9253-5; KUROKI Y, 1990, BIOCHEM BIOPH RES CO, V167, P273, DOI 10.1016/0006-291X(90)91761-G; Kurosky Alexander, 1997, Invertebrate Neuroscience, V2, P261, DOI 10.1007/BF02211939; Landolfa MA, 2001, BEHAV ECOL, V12, P773, DOI 10.1093/beheco/12.6.773; Leonard E., 2003, BASHEM BURNEM BAITEM; Li LJ, 1999, J EXP BIOL, V202, P2961; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Morishita F, 2010, CAN J ZOOL, V88, P825, DOI 10.1139/Z10-041; Nakamura S, 2007, MOL REPROD DEV, V74, P108, DOI 10.1002/mrd.20544; NAMBU JR, 1986, J NEUROSCI, V6, P2026; Nuurai P, 2010, ACTA HISTOCHEM, V112, P557, DOI 10.1016/j.acthis.2009.06.002; Osada M, 2013, GEN COMP ENDOCR, V181, P254, DOI 10.1016/j.ygcen.2012.09.002; PAINTER SD, 1991, BIOL BULL, V181, P81, DOI 10.2307/1542491; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Rogers DW, 2001, BEHAV ECOL SOCIOBIOL, V50, P122, DOI 10.1007/s002650100345; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzet M, 1997, MOL BRAIN RES, V49, P211, DOI 10.1016/S0169-328X(97)00145-9; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Stewart MJ, 2016, J BIOL CHEM, V291, P7938, DOI 10.1074/jbc.M115.704395; Stewart MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-840; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai PS, 2003, GEN COMP ENDOCR, V130, P20, DOI 10.1016/S0016-6480(02)00519-1; VANGOLEN FA, 1995, NEUROSCIENCE, V69, P1275, DOI 10.1016/0306-4522(95)00311-6; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watt S., 2012, GROUND COVER, V97, P37; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Young KG, 1999, J COMP NEUROL, V404, P427, DOI 10.1002/(SICI)1096-9861(19990222)404:4<427::AID-CNE1>3.0.CO;2-R; Zhang LH, 2008, GEN COMP ENDOCR, V156, P201, DOI 10.1016/j.ygcen.2007.11.015	72	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162355	10.1371/journal.pone.0162355	http://dx.doi.org/10.1371/journal.pone.0162355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706146	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200010
J	Falgreen, S; Bilgrau, AE; Brondum, RF; Jakobsen, LH; Have, J; Nielsen, KL; El-Galaly, TC; Bodker, JS; Schmitz, A; Young, KH; Johnsen, HE; Dybkaer, K; Bogsted, M				Falgreen, Steffen; Bilgrau, Anders Ellern; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Bodker, Julie Stove; Schmitz, Alexander; Young, Ken H.; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin			hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine	PLOS ONE			English	Article							AFFYMETRIX-GENECHIP DATA; CELL LYMPHOMA; EXPRESSION; CHEMOTHERAPY; REGULARIZATION; PREDICTION; REGRESSION; SUMMARIES; SELECTION; SURVIVAL	Background Dozens of omics based cancer classification systems have been introduced with prognostic, diagnostic, and predictive capabilities. However, they often employ complex algorithms and are only applicable on whole cohorts of patients, making them difficult to apply in a personalized clinical setting. Results This prompted us to create hemaClass.org, an online web application providing an easy interface to one-by-one RMA normalization of microarrays and subsequent risk classifications of diffuse large B-cell lymphoma (DLBCL) into cell-of-origin and chemotherapeutic sensitivity classes. Classification results for one-by-one array pre-processing with and without a laboratory specific RMA reference dataset were compared to cohort based classifiers in 4 publicly available datasets. Classifications showed high agreement between one-by-one and whole cohort pre-processsed data when a laboratory specific reference set was supplied. The website is essentially the R-package hemaClass accompanied by a Shiny web application. The well-documented package can be used to run the website locally or to use the developed methods programmatically. Conclusions The website and R-package is relevant for biological and clinical lymphoma researchers using affymetrix U-133 Plus 2 arrays, as it provides reliable and swift methods for calculation of disease subclasses. The proposed one-by-one pre-processing method is relevant for all researchers using microarrays.	[Falgreen, Steffen; Bilgrau, Anders Ellern; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Bodker, Julie Stove; Schmitz, Alexander; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Bilgrau, Anders Ellern; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Young, Ken H.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Aalborg University; Aalborg University Hospital; Aalborg University; University of Texas System; UTMD Anderson Cancer Center	Bogsted, M (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.; Bogsted, M (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	mbaegsted@dcm.aau.dk		Johnsen, Hans Erik/0000-0001-8253-2913; Dybkaer, Karen/0000-0003-2488-435X; Bogsted, Martin/0000-0001-9192-1814; Brondum, Rasmus/0000-0001-5537-6767; El-Galaly, Tarec Christoffer/0000-0002-4406-380X				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2014, EXPT HEMATOLOGY, V42, P927, DOI [10.1016/j.exphem.2014.07.263, DOI 10.1016/J.EXPHEM.2014.07.263]; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bilgrau AE, 2015, DLBCLDATA AUTOMATED; Boegsted M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019322; Bogsted M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083252; Bolstad B. M., 2004, LOW LEVEL ANAL HIGH; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Care MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055895; Chang W, 2015, SHINY WEB APPL FRAME; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; Chen XM, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-15; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coutinho R, 2013, DOVE PRESS, V3, P17, DOI DOI 10.2147/CBF.S29208; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Eddelbuettel D, 2014, COMPUT STAT DATA AN, V71, P1054, DOI 10.1016/j.csda.2013.02.005; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Falgreen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1237-6; Friedberg JW, 2011, CLIN CANCER RES, V17, P6112, DOI 10.1158/1078-0432.CCR-11-1073; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Lausen MB, 2015, STUDIES ANTI C UNPUB; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Malumbres R, 2008, BLOOD, V111, P5509, DOI 10.1182/blood-2008-02-136374; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Poulsen CB, 2005, EUR J HAEMATOL, V74, P453, DOI 10.1111/j.1600-0609.2005.00429.x; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanderson C., 2010, ARMADILLO OPEN SOURC; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sehn LH, 2015, BLOOD, V125, P22, DOI 10.1182/blood-2014-05-577189; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163711	10.1371/journal.pone.0163711	http://dx.doi.org/10.1371/journal.pone.0163711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701436	Green Published, Green Submitted, gold			2022-12-26	WOS:000385696900017
J	Harrison, D; Wilding, J; Bowman, A; Fuller, A; Nicholls, SG; Pound, CM; Reszel, J; Sampson, M				Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret			Using YouTube to Disseminate Effective Vaccination Pain Treatment for Babies	PLOS ONE			English	Article							ROUTINE CHILDHOOD IMMUNIZATIONS; INFORMATION; MANAGEMENT; VIDEOS; HEALTH; ONLINE	Background Infant vaccinations are necessary for public health, but are painful, causing distress to the infant and caregivers. Breastfeeding and sucrose effectively reduce infants' pain during vaccinations, and these strategies are recommended in health care provider (HCP)-targeted education and vaccination pain guidelines. However studies show these strategies are infrequently used. YouTube is a popular medium to publicly share and watch videos, and many consumer posted YouTube videos show distressed infants being vaccinated with no pain treatment. The aims of this study were to evaluate the reach and impact of a consumer-targeted YouTube video demonstrating use of effective pain reduction strategies during infant vaccinations. Methods A brief consumer-targeted video showing two infants being vaccinated was posted onto YouTube on October 2013. One infant was breastfed and another infant received sucrose by mouth before and during the injection. A link to a viewer survey was visible on a banner near the end of the video. An intensive strategically planned knowledge dissemination strategy using the media, social media and messages to professional organizations took place to promote the video. Data analysis of the viewer survey, YouTube analytics of the reach of the video in terms of number of views, country of viewers, and comments relating to the video took place 12 months after the video was posted. Results Twelve months after posting, the video had 65,478views, 68 comments, 245 likes, 17 dislikes, and 90 shares. Average duration of viewer time was 65% of the video. The viewer survey was completed by 156 (0.24%) viewers; 90 (58%) answered as HCPs and 66 (42%) as parents. Survey results showed that the video was persuasive; intent to use or support breastfeeding or sucrose was high in both parents and HCPs after viewing the video. Comments posted were often emotional in nature, and were related to anti-vaccination (n = 26, 38%); effectiveness or positive personal experiences (n = 21, 32%); research team comments or promotion (n = 12, 18%); pro-vaccination (n = 6, 8%) and barriers to using breastfeeding or sucrose during vaccinations (n = 3, 4%). Conclusion The video posted onto YouTube demonstrating effective pain treatment during infant vaccinations was viewed by large numbers of people around the world, however the response rate to the linked survey was extremely low. Using YouTube videos for knowledge dissemination has an extensive reach, however it is difficult to evaluate impact on behaviours and practices.	[Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret] CHEO Res Inst, Ottawa, ON, Canada; [Harrison, Denise; Bowman, Amanda] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	Harrison, D (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON, Canada.; Harrison, D (corresponding author), CHEO Res Inst, Ottawa, ON, Canada.; Harrison, D (corresponding author), Univ Ottawa, Sch Nursing, Ottawa, ON, Canada.	dharrison@cheo.on.ca	Nicholls, Stuart G./I-9160-2019; Harrison, Denise/N-6684-2017	Nicholls, Stuart G./0000-0003-0485-9069; Harrison, Denise/0000-0001-7549-7742	Canadian Pain Society Nursing Research and Education Award	Canadian Pain Society Nursing Research and Education Award	This work was partly funded by the Canadian Pain Society (http://www.canadianpainsociety.ca/) Nursing Research and Education Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge The Canadian Pain Society Nursing Research and Education Award 2013 for funding support and Kalina Charnock for her support in data collection.	[Anonymous], 2014, INTERNET IS ZOO IDEA; [Anonymous], 1993, NEONATAL INFANT PAIN, V12, P1993; Brna PM, 2013, EPILEPSY BEHAV, V29, P305, DOI 10.1016/j.yebeh.2013.08.003; Butler DP, 2013, BURNS, V39, P856, DOI 10.1016/j.burns.2012.10.017; Clauser SB, 2011, AM J PREV MED, V40, pS198, DOI 10.1016/j.amepre.2011.01.014; Farkas C, 2015, CLIN J PAIN, V31, P591, DOI [10.1097/AJP.0000000000000263, 10.1097/AJP.0000000000000197]; Gao XL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2290; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison D., 2014, INT ASS STUDY D  DEC; Harrison D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-134; Harrison D, 2013, J PAEDIATR CHILD H, V49, P313, DOI 10.1111/jpc.12161; Harrison D, 2010, ARCH DIS CHILD, V95, P406, DOI 10.1136/adc.2009.174227; Hordern A, 2011, HEALTH INF MANAG J, V40, P6, DOI 10.1177/183335831104000202; Kassab M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008411.pub2; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Keller B, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2982; Lee GY, 2014, PEDIATRICS, V133, P500, DOI 10.1542/peds.2013-2744; Lisi D, 2013, PAIN, V154, P1245, DOI 10.1016/j.pain.2013.03.036; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Nanji A, 2015, TOP 10 ONLINE VIDEO; Nikbakht Nasrabadi Alireza, 2015, Int J Community Based Nurs Midwifery, V3, P105; Public Health Agency of Canada, 2014, PUBL FUND IMM PROGR; Riddell RP, 2013, PAIN, V154, P714, DOI 10.1016/j.pain.2013.01.015; Robichaud P, 2012, VACCINE, V30, P3763, DOI 10.1016/j.vaccine.2012.03.074; Russell Kathryn, 2015, Nurs N Z, V21, P22; Schechter NL, 2007, PEDIATRICS, V119, pE1184, DOI 10.1542/peds.2006-1107; Shah PS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004950.pub3; Shah V, 2009, CLIN THER, V31, pS104, DOI 10.1016/j.clinthera.2009.08.001; Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237; Taddio A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-23; Taddio A, 2010, CAN MED ASSOC J, V182, pE843, DOI 10.1503/cmaj.101720; Taddio A, 2009, CLIN THER, V31, pS152, DOI 10.1016/j.clinthera.2009.07.022; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853	35	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164123	10.1371/journal.pone.0164123	http://dx.doi.org/10.1371/journal.pone.0164123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695054	Green Published, Green Submitted, gold			2022-12-26	WOS:000385553100091
J	Suenaga, G; Ikeda, T; Komohara, Y; Takamatsu, K; Kakuma, T; Tasaki, M; Misumi, Y; Ueda, M; Ito, T; Senju, S; Ando, Y				Suenaga, Genki; Ikeda, Tokunori; Komohara, Yoshihiro; Takamatsu, Koutaro; Kakuma, Tatsuyuki; Tasaki, Masayoshi; Misumi, Yohei; Ueda, Mitsuharu; Ito, Takaaki; Senju, Satoru; Ando, Yukio			Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment	PLOS ONE			English	Article							HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; SCAVENGER RECEPTOR; PIGMENT-EPITHELIUM; DENDRITIC CELLS; HUMAN PLASMA; MONOCYTES; CD163; REGENERATION	We hypothesized that tissue-resident macrophages in familial amyloid polyneuropathy (FAP) patients will exhibit qualitative or quantitative abnormalities, that may accelerate transthyretin (TTR)-derived amyloid deposition. To evaluate this, we examined the number and subset of tissue-resident macrophages in heart tissue from amyloid-deposited FAP and control patients. In both FAP and control patients, tissue-resident macrophages in heart tissue were all Iba(+)/CD163(+)/CD206(+) macrophages. However, the number of macrophages was significantly decreased in FAP patients compared with control patients. Furthermore, the proportion of intracellular TTR in CD14(+) monocytes was reduced in peripheral blood compared with healthy donors. Based on these results, we next examined degradation and endocytosis of TTR in human induced pluripotent stem (iPS) cell-derived myeloid lineage cells (MLs), which function like macrophages. iPS-MLs express CD163 and CD206, and belong to the inhibitory macrophage category. In addition, iPS-MLs degrade both native and aggregated TTR in a cell-dependent manner in vitro. Further, iPS-MLs endocytose aggregated, and especially polymerized, TTR. These results suggest that decreased tissue-localized macrophages disrupt clearance of TTR-derived amyloid deposits, leading to progression of a pathological condition in FAP patients. To improve this situation, clinical application of pluripotent stem cell-derived MLs may be useful as an approach for FAP therapy.	[Suenaga, Genki; Ikeda, Tokunori; Takamatsu, Koutaro; Tasaki, Masayoshi; Misumi, Yohei; Ueda, Mitsuharu; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Ikeda, Tokunori] Kumamoto Univ, Grad Sch Med Sci, Dept Clin Res Support Ctr, Kumamoto, Japan; [Komohara, Yoshihiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Sch Med, Dept Biostat Ctr, Kurume, Fukuoka, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kurume University; Kumamoto University; Kumamoto University	Ikeda, T; Ando, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan.; Ikeda, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Clin Res Support Ctr, Kumamoto, Japan.	ryousei@kumamoto-u.ac.jp; andoy709@kumamoto-u.ac.jp	Ueda, Mitsuharu/Q-8595-2019; Ikeda, Tokunori/S-6043-2019	Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15K19493, 26860673, 24249036, 15H04841]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was all supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (URL; http://www.mext.go.jp/english/), grant numbers 15K19493 (to T. Ikeda), 26860673 (to K. Takamatsu), 24249036 and 15H04841 (to Y. Ando). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki Y, 2015, ARTHRITIS RHEUMATOL, V67, P2097, DOI 10.1002/art.39178; Ando Y, 2012, CURR MED CHEM, V19, P2312, DOI 10.2174/092986712800269317; Araki S, 2010, P JPN ACAD B-PHYS, V86, P694, DOI 10.2183/pjab.86.694; Batra AS, 2001, CURR OPIN PEDIATR, V13, P234, DOI 10.1097/00008480-200106000-00004; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Benson MD, 2013, MUSCLE NERVE, V47, P157, DOI 10.1002/mus.23521; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; COELHO T, 1994, J MED GENET, V31, P293, DOI 10.1136/jmg.31.4.293; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dey A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00683; DICKSON PW, 1986, NEUROSCI LETT, V66, P311, DOI 10.1016/0304-3940(86)90037-6; Ericzon BG, 2015, TRANSPLANTATION, V99, P1847, DOI 10.1097/TP.0000000000000574; Goncalves NP, 2014, AMYLOID, V21, P175, DOI 10.3109/13506129.2014.927759; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Hawkins PN, 2015, ANN MED, V47, P625, DOI 10.3109/07853890.2015.1068949; Hemming AW, 1998, LIVER TRANSPLANT SUR, V4, P236, DOI 10.1002/lt.500040303; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; HOLNESS CL, 1993, BLOOD, V81, P1607; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; INGBAR SH, 1958, ENDOCRINOLOGY, V63, P256; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kawaji T, 2005, EXP EYE RES, V81, P306, DOI 10.1016/j.exer.2005.02.003; Koba C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067567; Komohara Y, 2012, CANCER SCI, V103, P2165, DOI 10.1111/cas.12015; Kowal K, 2011, FOLIA HISTOCHEM CYTO, V49, P365, DOI 10.5603/FHC.2011.0052; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Mills CD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00620; Misumi Y, 2013, LAB INVEST, V93, P911, DOI 10.1038/labinvest.2013.83; MITA S, 1986, J BIOCHEM-TOKYO, V100, P1215, DOI 10.1093/oxfordjournals.jbchem.a121826; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Obayashi Konen, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006593; Okumura K, 2016, AMYLOID, V13, P1; ONG DE, 1994, BIOCHEMISTRY-US, V33, P1835, DOI 10.1021/bi00173a029; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Su Y, 2012, PANCREAS, V41, P971, DOI 10.1097/MPA.0b013e318249926a; Suhr OB, 2003, J INTERN MED, V254, P225, DOI 10.1046/j.1365-2796.2003.01173.x; TAKAHASHI K, 1991, HUM PATHOL, V22, P519, DOI 10.1016/0046-8177(91)90227-G; Takamatsu K, 2014, STEM CELL RES, V13, P442, DOI 10.1016/j.scr.2014.10.001; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tsuchiya A, 2008, LIVER TRANSPLANT, V14, P563, DOI 10.1002/lt.21395; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	52	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163944	10.1371/journal.pone.0163944	http://dx.doi.org/10.1371/journal.pone.0163944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695122	gold, Green Published, Green Submitted			2022-12-26	WOS:000385553100067
J	Arruda, MB; Campagnari, F; de Almeida, TB; Couto-Fernandez, JC; Tanuri, A; Cardoso, CC				Arruda, Monica Barcellos; Campagnari, Francine; de Almeida, Tailah Bernardo; Couto-Fernandez, Jose Carlos; Tanuri, Amilcar; Cardoso, Cynthia Chester			Single Nucleotide Polymorphisms in Cellular Drug Transporters Are Associated with Intolerance to Antiretroviral Therapy in Brazilian HIV-1 Positive Individuals	PLOS ONE			English	Article							RIO-DE-JANEIRO; INFECTED PATIENTS; PLASMA-CONCENTRATIONS; PROTEASE INHIBITORS; HAART REGIMEN; OATP-B; P-GP; AIDS; PHARMACOGENETICS; EFAVIRENZ	Adverse reactions are the main cause of treatment discontinuation among HIV+ individuals. Genes related to drug absorption, distribution, metabolism and excretion (ADME) influence drug bioavailability and treatment response. We have investigated the association between single nucleotide polymorphisms (SNPs) in 29 ADME genes and intolerance to therapy in a case-control study including 764 individuals. Results showed that 15 SNPs were associated with intolerance to nucleoside and 11 to non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs), and 8 to protease inhibitors (PIs) containing regimens under alpha = 0.05. After Bonferroni adjustment, two associations remained statistically significant. SNP rs2712816, at SLCO2B1 was associated to intolerance to NRTIs (ORGA/AA = 2.37; p = 0.0001), while rs4148396, at ABCC2, conferred risk of intolerance to PIs containing regimens (ORCT/TT = 2.64; p = 0.00009). Accordingly, haplotypes carrying rs2712816A and rs4148396T alleles were also associated to risk of intolerance to NRTIs and PIs, respectively. Our data reinforce the role of drug transporters in response to HIV therapy and may contribute to a future development of personalized therapies.	[Arruda, Monica Barcellos; de Almeida, Tailah Bernardo; Tanuri, Amilcar; Cardoso, Cynthia Chester] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Mol Virol Lab, Rio De Janeiro, Brazil; [Campagnari, Francine] Deoxi Biotecnol, Aracatuba, SP, Brazil; [Couto-Fernandez, Jose Carlos] Fiocruz MS, Inst Oswaldo Cruz, Lab Aids & Imunol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Cardoso, CC (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Mol Virol Lab, Rio De Janeiro, Brazil.	cynthiac@biologia.ufrj.br	Tanuri, Amilcar/AAM-8601-2021; Cardoso, Cynthia/K-5824-2012	Cardoso, Cynthia/0000-0003-0565-7047; Couto-Fernandez, Jose Carlos/0000-0001-7091-9774	Brazilian Ministry of Science and Technology [03.12.0057.00, FINEP 01/2010]; Deoxi Biotecnologia	Brazilian Ministry of Science and Technology; Deoxi Biotecnologia	This work was supported by the "Brazilian Ministry of Science and Technology" [FINEP 01/2010 - contact number 03.12.0057.00]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Deoxi Biotecnologia provided support in the form of salaries for authors [FC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Agarwal S, 2007, INT J PHARMACEUT, V339, P139, DOI 10.1016/j.ijpharm.2007.02.036; Ammassari A, 2001, J ACQ IMMUN DEF SYND, P445; Bonolo PD, 2005, AIDS, V19, pS5; Brasil, 2015, B EPIDEMIOLOGICO HIV, P1; Cardoso SW, 2010, AIDS RES HUM RETROV, V26, P865, DOI 10.1089/aid.2009.0274; Cecchin E, 2013, PHARMACOGENOMICS J, V13, P403, DOI 10.1038/tpj.2012.31; Coelho AVC, 2013, J CLIN PHARMACOL, V53, P1286, DOI 10.1002/jcph.165; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; Guimaraes MDC, 2008, CLINICS, V63, P165, DOI 10.1590/S1807-59322008000200003; Estrela RC, 2009, PHARMACOGENOMICS, V10, P311, DOI 10.2217/14622416.10.2.311; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2004, AIDS, V18, P2391; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Hulgan T, 2008, J INFECT DIS, V197, P858, DOI 10.1086/528697; Izzedine H, 2006, J INFECT DIS, V194, P1481, DOI 10.1086/508546; Janneh O, 2005, AIDS, V19, P2097, DOI 10.1097/01.aids.0000194793.36175.40; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2015, JC25711E UNAIDS, P1; Kis O, 2010, J PHARMACOL EXP THER, V334, P1009, DOI 10.1124/jpet.110.166314; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kohlrausch FB, 2010, BRIT J CLIN PHARMACO, V69, P95, DOI 10.1111/j.1365-2125.2009.03551.x; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lazzaretti RK, 2013, SCI WORLD J, DOI 10.1155/2013/608415; Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976; Lubomirov R, 2010, PHARMACOGENET GENOM, V20, P217, DOI 10.1097/FPC.0b013e328336eee4; de Padua CA, 2007, BRAZ J INFECT DIS, V11, P20, DOI 10.1590/S1413-86702007000100007; Michaud V, 2012, PHARMACOL REV, V64, P803, DOI 10.1124/pr.111.005553; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2001, AIDS, V15, P185, DOI 10.1097/00002030-200101260-00007; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Ribeiro FA, 2012, BRAZ J INFECT DIS, V16, P27, DOI 10.1590/S1413-86702012000100005; Rodriguez-Novoa S, 2007, AIDS, V21, P41, DOI 10.1097/QAD.0b013e328011d7c1; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Rotger M, 2009, CIRC-CARDIOVASC GENE, V2, P621, DOI 10.1161/CIRCGENETICS.109.874412; Saves M, 2002, CLIN INFECT DIS, V34, P1396, DOI 10.1086/339866; Tarr PE, 2005, J INFECT DIS, V191, P1419, DOI 10.1086/429295; Tsamandouras N, 2014, CLIN PHARMACOL THER, V96, P90, DOI 10.1038/clpt.2014.55; Turatti L, 2012, AIDS RES HUM RETROV, V28, P815, DOI [10.1089/aid.2011.0261, 10.1089/AID.2011.0261]; Weiss J, 2009, J PHARMACOL SCI, V109, P242, DOI 10.1254/jphs.08209FP; Williams GC, 2002, ANTIMICROB AGENTS CH, V46, P3456, DOI 10.1128/AAC.46.11.3456-3462.2002; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							0163170	10.1371/journal.pone.0163170	http://dx.doi.org/10.1371/journal.pone.0163170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648838	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100062
J	Kim, D; Kim, HE; Kim, CH				Kim, Doory; Kim, Han-Eol; Kim, Chang-Hong			Development of a Blue Emitting Calcium-Aluminate Phosphor	PLOS ONE			English	Article							PERSISTENT LUMINESCENCE; DY3+; MECHANISM; EU2+; SRAL2O4-EU2+; SR; BA	We report methodological advances that enhance the phosphorescence efficiency of a blue-emitting calcium aluminate phosphor (CaAl2O4: Eu2+, Nd3+). The investigation of long-persistence blue-emitting phosphors is highly desirable due to their promising applications, such as white LEDs; however, the development of highly efficient blue-emitting phosphors is still challenging. Here, we have quantitatively characterized the phosphorescence properties of the blue-emitting phosphor CaAl2O4: Eu2+, Nd3+ with various compositions and directly related these properties to the quality of its luminescence. We optimized the composition of the activator Eu2+ and the co-activator Nd3+, the doping conditions with alkaline earth metals, alkali metals, and Si to create crystallographic distortions and, finally, the flux conditions to find the best parameters for bright and persistent blue-emitting phosphors. Our research has identified several doping compositions with good to excellent performance, with which we have demonstrated bright and persistent phosphors with afterglow characteristics superior to those of conventional phosphors.	[Kim, Doory] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kim, Han-Eol] Gwangju Inst Sci & Technol, Gwangju, South Korea; [Kim, Chang-Hong] Korea Inst Sci & Technol, Seoul, South Korea	University of California System; University of California Berkeley; Gwangju Institute of Science & Technology (GIST); Korea Institute of Science & Technology (KIST)	Kim, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	kim33@berkeley.edu		Kim, Doory/0000-0002-2675-106X				ABBRUSCATO V, 1971, J ELECTROCHEM SOC, V118, P930, DOI 10.1149/1.2408226; Aitasalo T, 2003, J SOLID STATE CHEM, V171, P114, DOI 10.1016/S0022-4596(02)00194-9; Aitasalo T, 2002, J ALLOY COMPD, V341, P76, DOI 10.1016/S0925-8388(02)00068-3; Clabau F, 2005, CHEM MATER, V17, P3904, DOI 10.1021/cm050763r; Clabau F, 2007, SOLID STATE SCI, V9, P608, DOI 10.1016/j.solidstatesciences.2007.03.020; Garlick GFJ, 1949, LUMINESCENT MAT, DOI [10.1039/c4dt03999h, DOI 10.1039/C4DT03999H]; Goldberg P., 1966, LUMINESCENCE INORGAN, Vfirst; Holsa J, 2001, J ALLOY COMPD, V323, P326, DOI 10.1016/S0925-8388(01)01084-2; Jia D, 2002, APPL PHYS LETT, V80, P1535, DOI 10.1063/1.1456955; Jia DD, 2007, J ELECTROCHEM SOC, V154, pJ1, DOI 10.1149/1.2372589; Katsumata T, 1997, J ELECTROCHEMICAL SO; Kim D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145434; Kinoshita T, 1999, J APPL PHYS, V86, P3729, DOI 10.1063/1.371243; Li K, 2016, J MATER CHEM C, V4, P5507, DOI 10.1039/c6tc00436a; Li YQ, 2005, CHEM MATER, V17, P3242, DOI 10.1021/cm050175d; Liang C, 2015, DALTON T, V44, P8100, DOI 10.1039/c4dt03999h; Lima NBD, 2013, SCI REPORTS, P3; Lin YH, 2003, J ALLOY COMPD, V348, P76, DOI 10.1016/S0925-8388(02)00796-X; Liu ZF, 2004, MICROELECTRON J, V35, P375, DOI 10.1016/s0026-2692(03)00249-0; Matsuzawa T, 1996, J ELECTROCHEM SOC, V143, P2670, DOI 10.1149/1.1837067; Palilla FC, 1968, J ELECTROCHEMICAL SO, V115; Shi YF, 2012, CELL STEM CELL, V10, P6, DOI 10.1016/j.stem.2011.12.010; Tanner PA, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/21/216213; Vishwakarma AK, 2015, DALTON T, V44, P17166, DOI 10.1039/c5dt02436f; Wang D, 2002, J LUMIN, V97, P1, DOI 10.1016/S0022-2313(01)00413-6; Yamamoto H, 1997, J LUMIN, V72-4, P287, DOI 10.1016/S0022-2313(97)00012-4; Zhang SY, 2011, INORG CHEM, V50, P2897, DOI 10.1021/ic102504x	27	3	3	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162920	10.1371/journal.pone.0162920	http://dx.doi.org/10.1371/journal.pone.0162920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648560	Green Published, gold, Green Submitted			2022-12-26	WOS:000383892100043
J	Portis, E; Portis, F; Valente, L; Moglia, A; Barchi, L; Lanteri, S; Acquadro, A				Portis, Ezio; Portis, Flavio; Valente, Luisa; Moglia, Andrea; Barchi, Lorenzo; Lanteri, Sergio; Acquadro, Alberto			A Genome-Wide Survey of the Microsatellite Content of the Globe Artichoke Genome and the Development of a Web-Based Database	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; NEUROLOGICAL DISEASE; MEDICAGO-TRUNCATULA; GENETIC DIVERSITY; VAR. SCOLYMUS; M-AFLP; MARKERS; L.; IDENTIFICATION; INSTABILITY	The recently acquired genome sequence of globe artichoke (Cynara cardunculus var. scolymus) has been used to catalog the genome's content of simple sequence repeat (SSR) markers. More than 177,000 perfect SSRs were revealed, equivalent to an overall density across the genome of 244.5 SSRs/Mbp, but some 224,000 imperfect SSRs were also identified. About 21% of these SSRs were complex (two stretches of repeats separated by <100 nt). Some 73% of the SSRs were composed of dinucleotide motifs. The SSRs were categorized for the numbers of repeats present, their overall length and were allocated to their linkage group. A total of 4,761 perfect and 6,583 imperfect SSRs were present in 3,781 genes (14.11% of the total), corresponding to an overall density across the gene space of 32,5 and 44,9 SSRs/Mbp for perfect and imperfect motifs, respectively. A putative function has been assigned, using the gene ontology approach, to the set of genes harboring at least one SSR. The same search parameters were applied to reveal the SSR content of 14 other plant species for which genome sequence is available. Certain species-specific SSR motifs were identified, along with a hexa-nucleotide motif shared only with the other two Compositae species (sunflower (Helianthus annuus) and horseweed (Conyza canadensis)) included in the study. Finally, a database, called "Cynara cardunculus MicroSatellite DataBase" (CyMSatDB) was developed to provide a searchable interface to the SSR data. CyMSatDB facilitates the retrieval of SSR markers, as well as suggested forward and reverse primers, on the basis of genomic location, genomic vs genic context, perfect vs imperfect repeat, motif type, motif sequence and repeat number. The SSR markers were validated via an in silico based PCR analysis adopting two available assembled transcriptomes, derived from contrasting globe artichoke accessions, as templates.	[Portis, Ezio; Moglia, Andrea; Barchi, Lorenzo; Lanteri, Sergio; Acquadro, Alberto] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, Plant Genet & Breeding, I-10095 Turin, Italy; [Portis, Flavio; Valente, Luisa] Yebokey User Experience Design & Web Dev, I-10134 Turin, Italy	University of Turin	Acquadro, A (corresponding author), Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, Plant Genet & Breeding, I-10095 Turin, Italy.	alberto.acquadro@unito.it	BARCHI, Lorenzo/ABC-4206-2020	BARCHI, Lorenzo/0000-0001-6414-4239; MOGLIA, Andrea/0000-0001-7431-844X; ACQUADRO, Alberto/0000-0002-5322-9701; PORTIS, Ezio/0000-0002-1548-6096	Yebokey	Yebokey	The authors received no specific funding for this work. Yebokey provided support in the form of salary for the author Luisa Valente. Flavio Portis is a consultant of Yebokey who took part in the research for free to gain professional exposure. Yebokey provided logistic support and shared professional knowledge to Flavio Portis. Yebokey played a role in the study design, data collection and analysis, web development and decision to publish the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acquadro A, 2003, MOL ECOL NOTES, V3, P37, DOI 10.1046/j.1471-8286.2003.00343.x; Acquadro A, 2005, MOL ECOL NOTES, V5, P272, DOI 10.1111/j.1471-8286.2005.00897.x; Acquadro A, 2005, GENOME, V48, P217, DOI [10.1139/G04-111, 10.1139/g04-111]; Acquadro A, 2009, THEOR APPL GENET, V118, P1573, DOI 10.1007/s00122-009-1005-6; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen M, 2010, MOL BIOL EVOL, V27, P2227, DOI 10.1093/molbev/msq100; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18919; Golubov A, 2010, PLANT PHYSIOL, V154, P1415, DOI 10.1104/pp.110.162933; Iquebal MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-197; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Kujur A, 2013, DNA RES, V20, P355, DOI 10.1093/dnares/dst015; Lanteri S, 2006, THEOR APPL GENET, V112, P1532, DOI 10.1007/s00122-006-0256-8; Liu WX, 2015, MOLECULES, V20, P8759, DOI 10.3390/molecules20058759; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Mauro R, 2009, CONSERV GENET, V10, P431, DOI 10.1007/s10592-008-9621-2; Mondal TK, 2014, GENE, V535, P204, DOI 10.1016/j.gene.2013.11.033; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; Portis E, 2005, PLANT SCI, V168, P1591, DOI 10.1016/j.plantsci.2005.02.009; Portis E, 2005, PLANT BREEDING, V124, P299, DOI 10.1111/j.1439-0523.2005.01098.x; Portis E, 2015, EUPHYTICA, V206, P523, DOI 10.1007/s10681-015-1521-1; Portis E, 2014, MOL BREEDING, V34, P615, DOI 10.1007/s11032-014-0061-z; Portis Ezio, 2012, BMC Res Notes, V5, P252, DOI 10.1186/1756-0500-5-252; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Whittaker JC, 2003, GENETICS, V164, P781; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yu JK, 2010, PLANT MOL BIOL REP, V28, P352, DOI 10.1007/s11105-009-0154-8; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]	37	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162841	10.1371/journal.pone.0162841	http://dx.doi.org/10.1371/journal.pone.0162841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27648830	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100035
J	Kondo, S; Wakae, K; Wakisaka, N; Nakanishi, Y; Ishikawa, K; Komori, T; Moriyama-Kita, M; Endo, K; Murono, S; Wang, Z; Kitamura, K; Nishiyama, T; Yamaguchi, K; Shigenobu, S; Muramatsu, M; Yoshizaki, T				Kondo, S.; Wakae, K.; Wakisaka, N.; Nakanishi, Y.; Ishikawa, K.; Komori, T.; Moriyama-Kita, M.; Endo, K.; Murono, S.; Wang, Z.; Kitamura, K.; Nishiyama, T.; Yamaguchi, K.; Shigenobu, S.; Muramatsu, M.; Yoshizaki, T.			APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers	ONCOGENE			English	Article							SIMPLEX-VIRUS 1; MUTATIONAL PROCESSES; CYTIDINE DEAMINASES; DNA; HYPERMUTATION; EXPRESSION; PATTERNS; TYPE-16; HEAD; RESTRICTION	The prevalence of human papillomavirus (HPV)-related oropharyngeal cancers has been increasing in developed countries. We recently demonstrated that members of the apolipoprotein B mRNA-editing catalytic polypeptide 3 (APOBEC3, A3) family, which are antiviral factors, can induce hypermutation of HPV DNA in vitro. In the present study, we found numerous C-to-T and G-to-A hypermutations in the HPV16 genome in oropharyngeal cancer (OPC) biopsy samples using differential DNA denaturation PCR and next-generation sequencing. A3s were more abundantly expressed in HPV16-positive OPCs than in HPV-negative, as assessed using immunohistochemistry and reverse transcription quantitative PCR. In addition, interferons upregulated A3s in an HPV16-positive OPC cell line. Furthermore, quantitative PCR analysis of HPV DNA suggests that APOBEC3A (A3A) expression is strongly correlated with the integration of HPV DNA. These results suggest that HPV16 infection may upregulate A3A expression, thereby increasing the chance of viral DNA integration. The role of A3A in HPV-induced carcinogenesis is discussed.	[Kondo, S.; Wakisaka, N.; Nakanishi, Y.; Ishikawa, K.; Komori, T.; Moriyama-Kita, M.; Endo, K.; Murono, S.; Yoshizaki, T.] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan; [Wakae, K.; Wang, Z.; Kitamura, K.; Muramatsu, M.] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa, Japan; [Wang, Z.] Dalian Univ, Affiliated Zhongshan Hosp, Div Med Oncol, Dalian, Peoples R China; [Nishiyama, T.] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Yamaguchi, K.; Shigenobu, S.] Natl Inst Basic Biol, Funct Genom Facil, Okazaki, Aichi, Japan	Kanazawa University; Kanazawa University; Dalian University; Kanazawa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Kondo, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol Head & Neck Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	tomoy@med.kanazawa-u.ac.jp	Kitamura, Kouichi/L-3654-2015; Shigenobu, Shuji/B-6239-2011	Kitamura, Kouichi/0000-0001-9692-8724; Yamaguchi, Katsushi/0000-0001-6871-7882; Shigenobu, Shuji/0000-0003-4640-2323	Ministry of Education, Science, Sports, Culture and Technology of Japan [A24689064, B23390396]; Grants-in-Aid for Scientific Research [26460993] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr H Joenje for providing the VU147T cell line. We thank Dr P Howley for providing p1203 PML2d HPV16 and p1321-HPV16 E6/E7. The authors would like to thank Ms A Akita and Ms M Koura for technical assistance. This study was supported by research grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan (A24689064 for SK and B23390396 for TY).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2007, HUMAN PAPILLOMAVIRUS; Argyris EG, 2007, VIROLOGY, V367, P440, DOI 10.1016/j.virol.2007.06.010; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Edge SB, 2009, CANC STAGING MANUAL; Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Hoopes JI, 2016, CELL REP, V14, P1273, DOI 10.1016/j.celrep.2016.01.021; Kim SH, 2007, INT J CANCER, V120, P1418, DOI 10.1002/ijc.22464; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Krokan HE, 2014, DNA REPAIR, V19, P38, DOI 10.1016/j.dnarep.2014.03.028; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liang GX, 2013, P NATL ACAD SCI USA, V110, P2246, DOI 10.1073/pnas.1221921110; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nagao S, 2002, J CLIN MICROBIOL, V40, P863, DOI 10.1128/JCM.40.3.863-867.2002; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062066; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; Ohba K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097787; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Roberts I, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-57; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; STEENBERGEN RDM, 1995, CANCER RES, V55, P5465; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wang Z, 2014, J VIROL, V88, P1308, DOI 10.1128/JVI.03091-13; Warren CJ, 2015, J VIROL, V89, P688, DOI 10.1128/JVI.02383-14; Wilczynski SP, 1998, AM J PATHOL, V152, P145; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	53	34	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1687	1697		10.1038/onc.2016.335	http://dx.doi.org/10.1038/onc.2016.335			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27694899				2022-12-26	WOS:000397460600008
J	Kumar, B; Arora, S; Ahmed, S; Banerjea, AC				Kumar, Binod; Arora, Sakshi; Ahmed, Shaista; Banerjea, Akhil C.			Hyperactivation of mammalian target of rapamycin complex 1 by HIV-1 is necessary for virion production and latent viral reactivation	FASEB JOURNAL			English	Article						protein synthesis; 4E-BP1; nucleotide biogenesis; CAD; Tat	PENTOSE-PHOSPHATE PATHWAY; T-CELL-ACTIVATION; TAT PROTEIN; MTOR; EXPRESSION; GROWTH; METABOLISM; INDUCTION; PHOSPHORYLATION; REPLICATION	Generation of new HIV-1 virions requires the constant supply of proteins, nucleotides, and energy; however, it is not known which cellular pathways are perturbed and what molecular mechanisms are employed. We hypothesized that HIV-1 may regulate pathways that control synthesis of biomolecules in the cell. In this study, we provide evidence that HIV-1 hyperactivates mammalian target of rapamycin complex 1 (mTORC1), the central regulator of biosynthesis. Mechanistically, we identify the viral regulatory gene tat (transactivator) as being responsible for increasing mTORC1 activity in a PI3K-dependent manner. Furthermore, we show that hyperactivation of mTORC1 leads to activation of the enzyme, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, dihydroorotase, and repression of initiation factor 4E-binding protein 1 activity. These are regulators of nucleotide biogenesis and protein translation, respectively. Moreover, we are able to replicate these results in HIV-1 latent cell line models. Finally, we show that inhibition of mTORC1 or PI3K inhibits viral replication and viral reactivation as a result of a decrease in biosynthesis. Overall, our study identifies a new avenue in HIV-1 biology that can lead to development of novel therapeutic targets.-Kumar, B., Arora, S., Ahmed, S., Banerjea, A. C. Hyperactivation of mammalian target of rapamycin complex 1 byHIV-1 is necessary for virion production and latent viral reactivation.	[Kumar, Binod; Arora, Sakshi; Ahmed, Shaista; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi, India; [Arora, Sakshi] Univ Heidelberg Hosp, Heidelberg, Germany	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Ruprecht Karls University Heidelberg	Kumar, B; Banerjea, AC (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	binod@nii.ac.in; akhil@nii.res.in	arora, sakshi/AAU-5305-2021	arora, sakshi/0000-0002-4347-480X; Ahmed, Shaista/0000-0003-4695-4718	Department of Biotechnology [BT/PR8322/Med/14/1245/2006]; Department of Science and Technology; Indian Council of Medical Research [HIV/50/142/9/2011-ECD-II]; National Institute of Immunology (New Delhi, India)	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute of Immunology (New Delhi, India)	This work was supported by grants from the Department of Biotechnology (Grant BT/PR8322/Med/14/1245/2006), Department of Science and Technology, the Indian Council of Medical Research (Grant HIV/50/142/9/2011-ECD-II), and National Institute of Immunology (New Delhi, India). The authors thank all members of the A.C.B. laboratory for helpful insights, in particular, Richa Kapoor for critical reading of the manuscript and Sanket Singh Ponia for ideas and advice. The authors also thank Utpreksha Vaish and Alaknanda Mishra for helping with PBL cultures and given a special thanks to Amanda Chase for critically editing the revised manuscript.	Abbas Wasim, 2013, Open Virol J, V7, P57, DOI 10.2174/1874357920130621001; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Barillari G, 1999, BLOOD, V94, P663; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Bond P, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0118-y; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Buel GR, 2013, CELL METAB, V17, P633, DOI 10.1016/j.cmet.2013.04.018; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Ciobanasu C, 2010, BIOPHYS J, V99, P153, DOI 10.1016/j.bpj.2010.03.065; Cornall A, 2010, J VIROL METHODS, V165, P90, DOI 10.1016/j.jviromet.2010.01.010; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gangwani MR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-136; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Heredia A, 2015, P NATL ACAD SCI USA, V112, P9412, DOI 10.1073/pnas.1511144112; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Janoo A, 2005, J CELL BIOCHEM, V94, P816, DOI 10.1002/jcb.20347; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; MICHAEL NL, 1991, J VIROL, V65, P1291, DOI 10.1128/JVI.65.3.1291-1303.1991; Mitchell NC, 2015, CELL SIGNAL, V27, P2045, DOI 10.1016/j.cellsig.2015.07.018; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tsouko E, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.18; Vatakis DN, 2010, IMMUNOL RES, V48, P110, DOI 10.1007/s12026-010-8171-0; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	59	12	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					180	191		10.1096/fj.201600813R	http://dx.doi.org/10.1096/fj.201600813R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27702769				2022-12-26	WOS:000392177600019
J	Bao, L; Chen, SJ; Conrad, K; Keefer, K; Abraham, T; Lee, JP; Wang, J; Zhang, XQ; Hirschler-Laszkiewicz, I; Wang, HG; Dovat, S; Gans, B; Madesh, M; Cheung, JY; Miller, BA				Bao, Lei; Chen, Shu-Jen; Conrad, Kathleen; Keefer, Kerry; Abraham, Thomas; Lee, John P.; Wang, JuFang; Zhang, Xue-Qian; Hirschler-Laszkiewicz, Iwona; Wang, Hong-Gang; Dovat, Sinisa; Gans, Brian; Madesh, Muniswamy; Cheung, Joseph Y.; Miller, Barbara A.			Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Modulation of Mitochondrial Reactive Oxygen Species and Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-SUPEROXIDE-DISMUTASE; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; ADP-RIBOSE; CATION CHANNEL; CANCER-CELLS; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; INDUCIBLE FACTOR-1; GENE-EXPRESSION	Transient receptor potential melastatin 2 (TRPM2) ion channel has an essential function in modulating cell survival following oxidant injury and is highly expressed in many cancers including neuroblastoma. Here, in xenografts generated from neuroblastoma cells in which TRPM2 was depleted with CRISPR/Cas9 technology and in in vitro experiments, tumor growth was significantly inhibited and doxorubicin sensitivity increased. The hypoxia-inducible transcription factor 1/2 alpha (HIF-1/2 alpha) signaling cascade including proteins involved in oxidant stress, glycolysis, and mitochondrial function was suppressed by TRPM2 depletion. TRPM2-depleted SH-SYSY neuroblastoma cells demonstrated reduced oxygen consumption and ATP production after doxorubicin, confirming impaired cellular bioenergetics. In cells in which TRPM2 was depleted, mitochondrial superoxide production was significantly increased, particularly following doxorubicin. Ectopic expression of superoxide dismutase 2 (SOD2) reduced ROS and preserved viability of TRPM2-depleted cells, however, failed to restore ATP levels. Mitochondrial reactive oxygen species (ROS) were also significantly increased in cells in which TRPM2 function was inhibited by TRPM2-S, and pretreatment of these cells with the antioxidant MitoTEMPO significantly reduced ROS levels in response to doxorubicin and protected cell viability. Expression of the TRPM2 pore mutant E960D, in which calcium entry through TRPM2 is abolished, also resulted in significantly increased mitochondrial ROS following doxorubicin treatment, showing the critical role of TRPM2-mediated calcium entry. These findings demonstrate the important function of TRPM2 in modulation of cell survival through mitochondrial ROS, and the potential of targeted inhibition of TRPM2 as a therapeutic approach to reduce cellular bioenergetics, tumor growth, and enhance susceptibility to chemotherapeutic agents.	[Bao, Lei; Chen, Shu-Jen; Conrad, Kathleen; Keefer, Kerry; Lee, John P.; Hirschler-Laszkiewicz, Iwona; Wang, Hong-Gang; Dovat, Sinisa; Gans, Brian; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Microscopy Imaging Facil, Hershey, PA 17033 USA; [Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Dovat, Sinisa; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Wang, JuFang; Zhang, Xue-Qian; Cheung, Joseph Y.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; [Madesh, Muniswamy] Temple Univ, Sch Med, Dept Mol Genet & Med Biochem, Philadelphia, PA 19140 USA; [Zhang, Xue-Qian; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, BA (corresponding author), Milton S Hershey Med Ctr, Dept Pediat, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu	Abraham, Thomas/AAJ-7950-2020; Wang, Hong-Gang/A-3018-2015; Abraham, Thomas/J-7080-2014	Wang, Hong-Gang/0000-0003-0551-0571; Dovat, Sinisa/0000-0003-3906-6165; Abraham, Thomas/0000-0003-0750-8774	National Institutes of Health [RO1-GM117014, RO1-DK46778, RO1-HL-58672, RO1-HL74854, RO1-HL123093, R01GM109882, R01HL086699, R01HL119306, 1S10RR027327]; Hyundai Hope on Wheels; Four Diamonds Fund of the Pennsylvania State University; American Heart Association [15GRNT25680042]; PA CURE Grant [4100062220]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123093, R01HL058672, R01HL119306, R01HL086699, R01HL074854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117014, R01GM109882] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010756, S10OD018124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope on Wheels; Four Diamonds Fund of the Pennsylvania State University; American Heart Association(American Heart Association); PA CURE Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants RO1-GM117014 and RO1-DK46778 (to B. A. M.), RO1-HL-58672, RO1-HL74854, and RO1-HL123093 (to J. Y. C.), R01GM109882, R01HL086699, R01HL119306, and 1S10RR027327 (to M. M.), grants from the Hyundai Hope on Wheels, the Four Diamonds Fund of the Pennsylvania State University, American Heart Association (Great Rivers Affiliate) Grant-in-aid 15GRNT25680042, and PA CURE Grant (Project 5) SAP#4100062220. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen SJ, 2014, J BIOL CHEM, V289, P36284, DOI 10.1074/jbc.M114.620922; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Csanady L, 2010, J PHYSIOL-LONDON, V588, P1661, DOI 10.1113/jphysiol.2010.190223; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Duncan LM, 1998, CANCER RES, V58, P1515; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hoffman NE, 2015, AM J PHYSIOL-HEART C, V308, pH637, DOI 10.1152/ajpheart.00720.2014; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Klumpp D, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8026702; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; O-Uchi J, 2014, ANTIOXID REDOX SIGN, V21, P863, DOI 10.1089/ars.2013.5394; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Park JH, 2016, CELL REP, V14, P2154, DOI 10.1016/j.celrep.2016.02.004; Park YR, 2016, CANCER GENOM PROTEOM, V13, P83; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Toth B, 2015, J GEN PHYSIOL, V145, P419, DOI 10.1085/jgp.201511377; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsavaler L, 2001, CANCER RES, V61, P3760; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	84	42	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24449	24464		10.1074/jbc.M116.747147	http://dx.doi.org/10.1074/jbc.M116.747147			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27694440	hybrid, Green Published			2022-12-26	WOS:000388875500010
J	Farache, D; Jauneau, A; Chemin, C; Chartrain, M; Remy, MH; Merdes, A; Haren, L				Farache, Dorian; Jauneau, Alain; Chemin, Cecile; Chartrain, Marine; Remy, Marie-Helene; Merdes, Andreas; Haren, Laurence			Functional Analysis of gamma-Tubulin Complex Proteins Indicates Specific Lateral Association via Their N-terminal Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE NUCLEATION; RING COMPLEX; CENTRIOLE DUPLICATION; CENTROSOME; TURC; RECRUITMENT; COMPONENTS; GCP6; ORGANIZATION; SUBUNIT	Microtubules are nucleated from multiprotein complexes containing gamma-tubulin and associated gamma-tubulin complex proteins (GCPs). Small complexes (gamma TuSCs) comprise two molecules of gamma-tubulin bound to the C-terminal domains of GCP2 and GCP3. gamma TuSCs associate laterally into helical structures, providing a structural template for microtubule nucleation. In most eukaryotes gamma TuSCs associate with additional GCPs (4, 5, and 6) to form the core of the so-called gamma-tubulin ring complex (gamma TuRC). GCPs2-6 constitute a family of homologous proteins. Previous structural analysis and modeling of GCPs suggest that all family members can potentially integrate into the helical structure. Here we provide experimental evidence for this model. Using chimeric proteins in which the N- and C-terminal domains of different GCPs are swapped, we show that the N-terminal domains define the functional identity of GCPs, whereas the C-terminal domains are exchangeable. FLIM-FRET experiments indicate that GCP4 and GCP5 associate laterally within the complex, and their interaction is mediated by their N-terminal domains as previously shown for gamma TuSCs. Our results suggest that all GCPs are incorporated into the helix via lateral interactions between their N-terminal domains, whereas the C-terminal domains mediate longitudinal interactions with gamma-tubulin. Moreover, we show that binding to gamma-tubulin is not essential for integrating into the helical complex.	[Farache, Dorian; Chemin, Cecile; Chartrain, Marine; Remy, Marie-Helene; Merdes, Andreas; Haren, Laurence] Univ Toulouse III, CNRS, Ctr Biol Dev, 118 Route Narbonne, F-31062 Toulouse, France; [Jauneau, Alain] FR 3450 Pole Biotechnol Vegetale, Plateforme Imagerie Microscopie, F-31326 Castanet Tolosan, France; [Chartrain, Marine] Oncopole, Syntivia, F-31106 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Merdes, A; Haren, L (corresponding author), Univ Toulouse III, CNRS, Ctr Biol Dev, 118 Route Narbonne, F-31062 Toulouse, France.	andreas.merdes@univ-tlse3.fr; laurence.haren@univ-tlse3.fr		CHEMIN, Cecile/0000-0002-5483-8103; farache, dorian/0000-0003-3715-9739	Agence Nationale de la Recherche (ANR, France) [08-BLAN-0281, 13-BSV8-0007-01]; Fondation ARC pour la Recherche sur le Cancer [SFI20121205511]	Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by Agence Nationale de la Recherche (ANR, France) Grants 08-BLAN-0281 and 13-BSV8-0007-01 and Fondation ARC pour la Recherche sur le Cancer Grant SFI20121205511. The authors declare that they have no conflicts of interest with the contents of this article.	Anders A, 2006, MOL BIOL CELL, V17, P5075, DOI 10.1091/mbc.E05-11-1009; Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Cala O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063908; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chinen T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9722; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Choy RM, 2009, J STRUCT BIOL, V168, P571, DOI 10.1016/j.jsb.2009.08.012; Dhani DK, 2013, MOL BIOL CELL, V24, P3337, DOI 10.1091/mbc.E13-05-0253; Erlemann S, 2012, J CELL BIOL, V197, P59, DOI 10.1083/jcb.201111123; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Greenberg CH, 2016, J STRUCT BIOL, V194, P303, DOI 10.1016/j.jsb.2016.03.006; Guillet V, 2011, NAT STRUCT MOL BIOL, V18, P915, DOI 10.1038/nsmb.2083; Gunawardane RN, 2003, MOL BIOL CELL, V14, P1017, DOI 10.1091/mbc.E02-01-0034; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Izumi N, 2008, J BIOL CHEM, V283, P12981, DOI 10.1074/jbc.M710282200; Janski N, 2012, PLANT CELL, V24, P1171, DOI 10.1105/tpc.111.094904; JULIAN M, 1993, J CELL SCI, V105, P145; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Kollman JM, 2015, NAT STRUCT MOL BIOL, V22, P132, DOI 10.1038/nsmb.2953; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lin TC, 2014, ELIFE, V3, DOI 10.7554/eLife.02208; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Lyon AS, 2016, MOL BIOL CELL, V27, P2245, DOI 10.1091/mbc.E16-02-0072; Masuda H, 2016, MOL BIOL CELL, V27, P1753, DOI 10.1091/mbc.E15-08-0577; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, NATURE, V378, P638, DOI 10.1038/378638a0; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Oriolo AS, 2007, MOL BIOL CELL, V18, P781, DOI 10.1091/mbc.E06-03-0201; Remy MH, 2013, PROG MOL BIOL TRANSL, V117, P511, DOI 10.1016/B978-0-12-386931-9.00019-2; Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011; Suri C, 2015, PROTEINS, V83, P827, DOI 10.1002/prot.24773; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Teixido-Travesa N, 2010, MOL BIOL CELL, V21, P3963, DOI 10.1091/mbc.E10-05-0408; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Xiong Y, 2009, J CELL SCI, V122, P4218, DOI 10.1242/jcs.059196; Zhang LJ, 2000, J CELL BIOL, V151, P1525, DOI 10.1083/jcb.151.7.1525; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	41	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23112	23125		10.1074/jbc.M116.744862	http://dx.doi.org/10.1074/jbc.M116.744862			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27660388	Green Published, hybrid			2022-12-26	WOS:000387224800022
J	Hicks, MJ; Chiuchiolo, MJ; Ballon, D; Dyke, JP; Aronowitz, E; Funato, K; Tabar, V; Havlicek, D; Fan, F; Sondhi, D; Kaminsky, SM; Crystal, RG				Hicks, Martin J.; Chiuchiolo, Maria J.; Ballon, Douglas; Dyke, Jonathan P.; Aronowitz, Eric; Funato, Kosuke; Tabar, Viviane; Havlicek, David; Fan, Fan; Sondhi, Dolan; Kaminsky, Stephen M.; Crystal, Ronald G.			Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADENOASSOCIATED VIRAL VECTORS; BLOOD-BRAIN-BARRIER; HIGH-GRADE GLIOMA; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; IMMUNE-RESPONSE; IN-VIVO; VIRUS; RADIOTHERAPY	Glioblastoma multiforme (GBM) is the most common and aggressive primary intracranial brain tumor in adults with a mean survival of 14 to 15 months. Aberrant activation of the epidermal growth factor receptor (EGFR) plays a significant role in GBM progression, with amplification or overexpression of EGFR in 60% of GBM tumors. To target EGFR expressed by GBM, we have developed a strategy to deliver the coding sequence for cetuximab, an anti-EGFR antibody, directly to the CNS using an adeno-associated virus serotype rh.10 gene transfer vector. The data demonstrates that single, local delivery of an anti-EGFR antibody by an AAVrh.10 vector coding for cetuximab (AAVrh. 10Cetmab) reduces GBM tumor growth and increases survival in xenograft mouse models of a human GBM EGFR-expressing cell line and patient-derived GBM. AAVrh10.CetMab-treated mice displayed a reduction in cachexia, a significant decrease in tumor volume and a prolonged survival following therapy. Adeno-associated-directed delivery of a gene encoding a therapeutic anti-EGFR monoclonal antibody may be an effective strategy to treat GBM.	[Hicks, Martin J.; Chiuchiolo, Maria J.; Havlicek, David; Fan, Fan; Sondhi, Dolan; Kaminsky, Stephen M.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Ballon, Douglas; Dyke, Jonathan P.; Aronowitz, Eric] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Funato, Kosuke; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY USA; [Hicks, Martin J.] Monmouth Univ, Dept Biol Sci, West Long Branch, NJ USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Monmouth University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Dyke, Jonathan/AAX-4362-2020; Kaminsky, Stephen/J-5141-2016	Dyke, Jonathan/0000-0001-7170-488X; Funato, Kosuke/0000-0003-2437-1116; Kaminsky, Stephen/0000-0003-1869-834X; Hicks, Martin J/0000-0001-8787-981X	Starr Cancer Consortium [I5-A537]; National Foundation for Cancer Research; Malcolm Hewitt Wiener Foundation; NIH [T32HL094284]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094284] Funding Source: NIH RePORTER	Starr Cancer Consortium; National Foundation for Cancer Research; Malcolm Hewitt Wiener Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by the Starr Cancer Consortium I5-A537, the National Foundation for Cancer Research and the Malcolm Hewitt Wiener Foundation. MJH was supported, in part, by NIH T32HL094284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Aghi M, 2005, CURR OPIN MOL THER, V7, P419; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Allen C, 2013, GENE THER, V20, P444, DOI 10.1038/gt.2012.62; Amano S, 2011, CANCER GENOM PROTEOM, V8, P245; Ayoub D, 2013, MABS-AUSTIN, V5, P699, DOI 10.4161/mabs.25423; Azuaje F, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0098-6; Bourdenx M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00050; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bronisz A, 2016, CELL MOL NEUROBIOL, V36, P361, DOI 10.1007/s10571-015-0293-4; Brown MC, 2015, CURR OPIN VIROL, V13, P81, DOI 10.1016/j.coviro.2015.05.007; Buning H, 2015, CURR OPIN PHARMACOL, V24, P94, DOI 10.1016/j.coph.2015.08.002; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Castle MJ, 2016, METHODS MOL BIOL, V1382, P133, DOI 10.1007/978-1-4939-3271-9_10; Castro MG, 2014, EXPERT OPIN BIOL TH, V14, P1241, DOI 10.1517/14712598.2014.915307; Clement N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.2; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fine HA, 2015, CLIN CANCER RES, V21, P1984, DOI 10.1158/1078-0432.CCR-14-1328; Freskgard PO, 2017, NEUROPHARMACOLOGY, V120, P38, DOI 10.1016/j.neuropharm.2016.03.014; Fu P, 2016, MOL CLIN ONCOL, V4, P833, DOI 10.3892/mco.2016.816; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Graham J, 2004, NAT REV DRUG DISCOV, V3, P549, DOI 10.1038/nrd1445; Hernandez-Pedro NY, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/716813; Hicks MJ, 2015, CANCER GENE THER, V22, P1, DOI 10.1038/cgt.2014.58; Jacobs Andreas, 1999, Neoplasia (New York), V1, P402, DOI 10.1038/sj.neo.7900056; Jordan JT, 2015, CANCER TREAT RES, V163, P117, DOI 10.1007/978-3-319-12048-5_8; Kane JR, 2015, NEURO-ONCOLOGY, V17, pII24, DOI 10.1093/neuonc/nou355; Khasraw M, 2014, EXPERT OPIN BIOL TH, V14, P729, DOI 10.1517/14712598.2014.898060; Kober C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0586-x; Kwiatkowska Aneta, 2013, Cancers (Basel), V5, P1271, DOI 10.3390/cancers5041271; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maguire CA, 2010, J NEURO-ONCOL, V96, P337, DOI 10.1007/s11060-009-9972-7; Murlidharan G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00076; Murphy AM, 2013, TRANSL RES, V161, P339, DOI 10.1016/j.trsl.2012.11.003; Natsume A, 2008, CELL ADHES MIGR, V2, P186, DOI 10.4161/cam.2.3.6278; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Niyazi M, 2016, ONCOTARGET, V7, P2313, DOI 10.18632/oncotarget.6320; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Okura Hidehiro, 2014, Mol Cell Ther, V2, P21, DOI 10.1186/2052-8426-2-21; Omuro A, 2014, CLIN CANCER RES, V20, P5023, DOI 10.1158/1078-0432.CCR-14-0822; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357; Rainov NG, 2000, GENE THER, V7, P1853, DOI 10.1038/sj.gt.3301311; Rashnonejad A, 2016, MOL BIOTECHNOL, V58, P30, DOI 10.1007/s12033-015-9899-5; Rosen S T, 2015, CURRENT UNDERSTANDIN; Rosenberg JB, 2014, HUM GENE THER CL DEV, V25, P164, DOI 10.1089/humc.2013.239; Rosso L, 2009, CANCER RES, V69, P120, DOI 10.1158/0008-5472.CAN-08-2356; Santiago-Ortiz JL, 2016, J CONTROL RELEASE, V240, P287, DOI 10.1016/j.jconrel.2016.01.001; Shah K, 2011, METHODS MOL BIOL, V680, P153, DOI 10.1007/978-1-60761-901-7_11; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sondhi D, 2007, MOL THER, V15, P481, DOI 10.1038/sj.mt.6300049; St-Amour I, 2013, J CEREBR BLOOD F MET, V33, P1983, DOI 10.1038/jcbfm.2013.160; Staedtke V, 2016, EXPERT OPIN INV DRUG, V25, P937, DOI 10.1080/13543784.2016.1182497; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tobias A, 2013, J NEUROL NEUROSUR PS, V84, P213, DOI 10.1136/jnnp-2012-302946; Van den Eynde M, 2011, ACTA CLIN BELG, V66, P10, DOI 10.1179/ACB.66.1.2062508; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Watanabe M, 2010, GENE THER, V17, P1042, DOI 10.1038/gt.2010.87; Wehrenberg-Klee E, 2015, AM J NUCL MED MOLEC, V5, P379; Weidle UH, 2015, CANCER GENOM PROTEOM, V12, P167; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Zerah M, 2015, HUM GENE THER CL DEV, V26, P113, DOI 10.1089/humc.2014.139; Zinn KR, 2015, MOL IMAGING BIOL, V17, P49, DOI 10.1007/s11307-014-0773-9	69	15	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162978	10.1371/journal.pone.0162978	http://dx.doi.org/10.1371/journal.pone.0162978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711187	Green Submitted, gold, Green Published			2022-12-26	WOS:000385697600011
J	Rinne, P; Mace, M; Nakornchai, T; Zimmerman, K; Fayer, S; Sharma, P; Liardon, JL; Burdet, E; Bentley, P				Rinne, Paul; Mace, Michael; Nakornchai, Tagore; Zimmerman, Karl; Fayer, Susannah; Sharma, Pankaj; Liardon, Jean-Luc; Burdet, Etienne; Bentley, Paul			Democratizing Neurorehabilitation: How Accessible are Low-Cost Mobile-Gaming Technologies for Self-Rehabilitation of Arm Disability in Stroke?	PLOS ONE			English	Article							ROBOT-ASSISTED THERAPY; PROOF-OF-CONCEPT; FORCE CONTROL	Motor-training software on tablets or smartphones (Apps) offer a low-cost, widely-available solution to supplement arm physiotherapy after stroke. We assessed the proportions of hemiplegic stroke patients who, with their plegic hand, could meaningfully engage with mobile-gaming devices using a range of standard control-methods, as well as by using a novel wireless grip-controller, adapted for neurodisability. We screened all newly-diagnosed hemiplegic stroke patients presenting to a stroke centre over 6 months. Subjects were compared on their ability to control a tablet or smartphone cursor using: finger-swipe, tap, joystick, screen-tilt, and an adapted handgrip. Cursor control was graded as: no movement (0); less than full-range movement (1); full-range movement (2); directed movement (3). In total, we screened 345 patients, of which 87 satisfied recruitment criteria and completed testing. The commonest reason for exclusion was cognitive impairment. Using conventional controls, the proportion of patients able to direct cursor movement was 38-48%; and to move it full-range was 55-67% (controller comparison: p>0.1). By comparison, handgrip enabled directed control in 75%, and full-range movement in 93% (controller comparison: p<0.001). This difference between controllers was most apparent amongst severely-disabled subjects, with 0% achieving directed or full-range control with conventional controls, compared to 58% and 83% achieving these two levels of movement, respectively, with handgrip. In conclusion, hand, or arm, training Apps played on conventional mobile devices are likely to be accessible only to mildly-disabled stroke patients. Technological adaptations such as grip-control can enable more severely affected subjects to engage with self-training software.	[Rinne, Paul; Nakornchai, Tagore; Zimmerman, Karl; Fayer, Susannah; Liardon, Jean-Luc; Bentley, Paul] Imperial Coll, Div Brain Sci, London, England; [Mace, Michael; Burdet, Etienne] Imperial Coll, Dept Bioengn, Human Robot Grp, London, England; [Sharma, Pankaj] Royal Holloway Univ London, Inst Cardiovasc Res, London, England	Imperial College London; Imperial College London; University of London; Royal Holloway University London	Bentley, P (corresponding author), Imperial Coll, Div Brain Sci, London, England.	p.bentley@ic.ac.uk	Zimmerman, Karl/AAL-4988-2020; sharma, pankaj/HGE-4423-2022; Zimmerman, Karl/S-3406-2016	Zimmerman, Karl/0000-0003-1239-3414; Zimmerman, Karl/0000-0003-1239-3414; Bentley, Paul/0000-0001-8036-7010; Burdet, Etienne/0000-0002-2123-0185; Nakornchai, Tagore/0000-0003-1573-9812	Imperial College Confidence in Concept Award; NHS England Innovation Challenge; EU [PEOPLE-ITN-317488-CONTEST, ICT-601003 BALANCE, ICT-2013-10 SYMBITRON, EU-H2020 ICT-644727 COGIMON]; MRC [MC_PC_14100] Funding Source: UKRI; Medical Research Council [MC_PC_14100] Funding Source: researchfish	Imperial College Confidence in Concept Award; NHS England Innovation Challenge; EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by an Imperial College Confidence in Concept Award, NHS England Innovation Challenge Prize, and in part by EU-FP7 grants PEOPLE-ITN-317488-CONTEST, ICT-601003 BALANCE, ICT-2013-10 SYMBITRON, and EU-H2020 ICT-644727 COGIMON.	Balasubramanian S, 2010, CURR OPIN NEUROL, V23, P661, DOI 10.1097/WCO.0b013e32833e99a4; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; Bernhardt J, 2007, J REHABIL MED, V39, P43, DOI 10.2340/16501977-0013; Dipietro L, 2012, IEEE T NEUR SYS REH, V20, P48, DOI 10.1109/TNSRE.2011.2175008; Friedman N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-76; Jarrasse Nathanael, 2013, IEEE Int Conf Rehabil Robot, V2013, P6650379, DOI 10.1109/ICORR.2013.6650379; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Krebs HI, 2007, IEEE T NEUR SYS REH, V15, P327, DOI 10.1109/TNSRE.2007.903899; Lambercy O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-63; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Mace M, 2015, REH ROB ICORR 2015 I; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; NICE, 2013, NAT I CLIN EXC CG 16; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Noskin O, 2008, J NEUROL NEUROSUR PS, V79, P401, DOI 10.1136/jnnp.2007.118463; Raghavan Preeti, 2007, Curr Treat Options Cardiovasc Med, V9, P221; Rand D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0796-9; Rinne P, 2013, NEUROLOGY, V81, P812, DOI 10.1212/WNL.0b013e3182a2ca34; Saposnik G, 2014, INT J STROKE, V9, P956, DOI 10.1111/ijs.12328; Susanto EA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0033-5; Thomson K, 2016, DISABIL REHABIL-ASSI, V11, P454, DOI 10.3109/17483107.2015.1005031; Thomson K, 2014, INT J STROKE, V9, P479, DOI 10.1111/ijs.12263; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442	24	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163413	10.1371/journal.pone.0163413	http://dx.doi.org/10.1371/journal.pone.0163413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706248	Green Published, gold, Green Submitted			2022-12-26	WOS:000385697200044
J	Adler, PH; Takaoka, H; Sofian-Azirun, M; Low, V; Ya'cob, Z; Chen, CD; Lau, KW; Pham, XD				Adler, Peter H.; Takaoka, Hiroyuki; Sofian-Azirun, Mohd; Low, Van Lun; Ya'cob, Zubaidah; Chen, Chee Dhang; Lau, Koon Weng; Xuan Da Pham			Vietnam, a Hotspot for Chromosomal Diversity and Cryptic Species in Black Flies (Diptera: Simuliidae)	PLOS ONE			English	Article							SALIVARY-GLAND CHROMOSOME; COMPLEX DIPTERA; CYTOLOGICAL DESCRIPTION; POPULATION-GENETICS; TUBEROSUM; THAILAND; SPECIATION; CYTOGENETICS; POLYMORPHISM; DROSOPHILA	The increasing attention on Vietnam as a biodiversity hotspot prompted an investigation of the potential for cryptic diversity in black flies, a group well known elsewhere for its high frequency of isomorphic species. We analyzed the banding structure of the larval polytene chromosomes in the Simulium tuberosum species group to probe for diversity beyond the morphological level. Among 272 larvae, 88 different chromosomal rearrangements, primarily paracentric inversions, were discovered in addition to 25 already known in the basic sequences of the group in Asia. Chromosomal diversity in Vietnam far exceeds that known for the group in Thailand, with only about 5% of the rearrangements shared between the two countries. Fifteen cytoforms and nine morphoforms were revealed among six nominal species in Vietnam. Chromosomal evidence, combined with available molecular and morphological evidence, conservatively suggests that at least five of the cytoforms are valid species, two of which require formal names. The total chromosomal rearrangements and species (15) now known from the group in Vietnam far exceed those of any other area of comparable size in the world, supporting the country's status as a biodiversity hotspot. Phylogenetic inference based on uniquely shared, derived chromosomal rearrangements supports the clustering of cytoforms into two primary lineages, the Simulium tani complex and the Southeast Asian Simulium tuberosum subgroup. Some of these taxa could be threatened by habitat destruction, given their restricted geographical distributions and the expanding human population of Vietnam.	[Adler, Peter H.] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC 29634 USA; [Takaoka, Hiroyuki; Sofian-Azirun, Mohd; Ya'cob, Zubaidah; Chen, Chee Dhang; Lau, Koon Weng] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Low, Van Lun] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia; [Xuan Da Pham] Natl Agcy Southern Reg, Minist Sci & Technol, Ho Chi Minh City 700000, Vietnam	Clemson University; Universiti Malaya; Universiti Malaya	Adler, PH (corresponding author), Clemson Univ, Dept Agr & Environm Sci, Clemson, SC 29634 USA.	padler@clemson.edu	AZIRUN, MOHD SOFIAN/B-9127-2010; Lau, Koon Weng/ABD-9347-2021; Ya'cob, Zubaidah/R-4012-2019; Low, Van Lun/C-8045-2013; Chen, Chee Dhang/ABD-9353-2021; Chen, Chee Dhang/C-6482-2011; Ya'cob, Zubaidah/L-7021-2017	Low, Van Lun/0000-0002-4299-5339; Ya'cob, Zubaidah/0000-0002-7178-6122	National Institute of Food and Agriculture of the US Department of Agriculture; University of Malaya [RP021A-16SUS]	National Institute of Food and Agriculture of the US Department of Agriculture; University of Malaya(Universiti Malaya)	National Institute of Food and Agriculture of the US Department of Agriculture (https://nifa.usda.gov) partly supported the work of PHA. University of Malaya (http://www.um.edu.my/) research grant RP021A-16SUS to HT supported the research of HT, MSA, VLL, ZY, CDC, and KWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PH, 2015, MED VET ENTOMOL, V29, P276, DOI 10.1111/mve.12115; Adler P. H., 2016, WORLD BLACKFLIES DIP; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147673; Adler PH, 2015, ZOOTAXA, V3975, P1, DOI 10.11646/zootaxa.3975.1.1; Adler PH, 2015, BIOL J LINN SOC, V114, P163, DOI 10.1111/bij.12403; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; ADLER PH, 1994, ENTOMOL SCAND, V25, P439; Adler PH, 2001, CAN J ZOOL, V79, P1972, DOI 10.1139/cjz-79-11-1972; Adler PH, 2004, BLACK FLIES SIMULIID; Bain RH, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)417<0001:CSOACF>2.0.CO;2; BEDO DG, 1979, EVOLUTION, V33, P296, DOI [10.2307/2407620, 10.1111/j.1558-5646.1979.tb04683.x]; Besansky NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P97; CARSON HL, 1967, P NATL ACAD SCI USA, V57, P1280, DOI 10.1073/pnas.57.5.1280; Chubareva L.A., 2008, TSITOLOGICHESKIE KAR; Conflitti IM, 2014, MOL PHYLOGENET EVOL, V78, P43, DOI 10.1016/j.ympev.2014.05.001; CONN J, 1989, CAN J ZOOL, V67, P1217, DOI 10.1139/z89-176; Gaffigan TV, 2016, SYSTEMATIC CATALOG C; Giao PM, 1998, ANIM CONSERV, V1, P61, DOI 10.1111/j.1469-1795.1998.tb00227.x; HENDERSON CAP, 1986, CAN J ZOOL, V64, P859, DOI 10.1139/z86-129; Huang Yao-Te, 2011, Medical Entomology and Zoology, V62, P23; LANDAU R, 1962, CAN J ZOOLOG, V40, P921, DOI 10.1139/z62-082; MASON GF, 1984, CAN J ZOOL, V62, P647, DOI 10.1139/z84-096; MAURAND J, 1975, Annales de Parasitologie Humaine et Comparee, V50, P371; Monastyrskii A.L., 2013, CURRENT PROGR BIOL R, P95, DOI [10.5772/55490, DOI 10.5772/55490]; NEWMAN LJ, 1983, CAN J ZOOL, V61, P2816, DOI 10.1139/z83-369; O'Grady PM, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-6; PASTERNAK J, 1964, CAN J ZOOLOG, V42, P135, DOI 10.1139/z64-013; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pramual P, 2013, ENTOMOL SCI, V16, P298, DOI 10.1111/ens.12008; Pramual P, 2012, GENOME, V55, P447, DOI [10.1139/G2012-031, 10.1139/g2012-031]; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1983, CAN J ZOOL, V61, P1220, DOI 10.1139/z83-166; Rowley JJL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128382; SHIELDS GF, 1982, POLAR BIOL, V1, P181, DOI 10.1007/BF00287005; Sriphirom P, 2014, GENOME, V57, P45, DOI 10.1139/gen-2013-0145; Sterling E. J., 2007, VIETNAM NATURAL HIST; Sterling Eleanor J., 2005, Proceedings of the California Academy of Sciences, V56, P98; Takano KT, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-41; Takaoka H, 2014, TROP BIOMED, V31, P742; Takaoka H., 1984, Japanese Journal of Sanitary Zoology, V35, P7; Takaoka H, 2016, BLACK FLIES; Takaoka H, 2015, ZOOTAXA, V3961, P1, DOI 10.11646/zootaxa.3961.1.1; Takaoka H, 2014, ZOOTAXA, V3866, P555, DOI 10.11646/zootaxa.3866.4.6; Takaoka H, 2014, ZOOTAXA, V3838, P347, DOI 10.11646/zootaxa.3838.3.6; Tangkawanit U, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2048.1.2; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Low VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20346; Wikramanayake E., 2002, TERRESTRIAL ECOREGIO	57	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163881	10.1371/journal.pone.0163881	http://dx.doi.org/10.1371/journal.pone.0163881			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695048	Green Published, gold			2022-12-26	WOS:000385553100061
J	Ganguly, S; Kumar, GT; Mantha, S; Panda, K				Ganguly, Souradipta; Kumar, Taposh G.; Mantha, Sudarshan; Panda, Koustubh			Simultaneous Determination of Black Tea-Derived Catechins and Theaflavins in Tissues of Tea Consuming Animals Using Ultra-Performance Liquid-Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							GREEN TEA; HEART-DISEASE; POLYPHENOLS; PLASMA; CANCER; RAT; GLUCURONIDATION; PHARMACOKINETICS; METHYLATION; METABOLITES	The bioavailability, tissue distribution and metabolic fate of the major tea polyphenols, catechins and theaflavins as well as their gallated derivatives are yet to be precisely elucidated on a single identification platform for assessment of their relative bioefficacy in vivo. This is primarily due to the lack of suitable analytical tools for their simultaneous determination especially in an in vivo setting, which continues to constrain the evaluation of their relative health beneficiary potential and therefore prospective therapeutic application. Herein, we report a rapid and sensitive Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-MS/MS) based method for the simultaneous determination of the major catechins and theaflavins in black tea infusions as well as in different vital tissues and body fluids of tea-consuming guinea pigs. This method allowed efficient separation of all polyphenols within seven minutes of chromatographic run and had a lower limit of quantification (LLOQ) of similar to 5 ng/ml. Using this method, almost all bioactive catechins and theaflavins could be simultaneously detected in the plasma of guinea pigs orally administered 5% black tea for 14 days. Our method could further detect the majority of these polyphenols in the lung and kidney as well as identify the major catechin metabolites in the urine of the tea-consuming animals. Overall, our study presents a novel tool for simultaneous detection and quantitation of both catechins and theaflavins in a single detection platform that could potentially enable precise elucidation of their relative bioavailability and bioefficacy as well as true health beneficiary potential in vivo. Such information would ultimately facilitate the accurate designing of therapeutic strategies utilizing high efficacy formulations of tea polyphenols for effective mitigation of oxidative damage and inflammation in humans as well as prevention of associated diseases.	[Ganguly, Souradipta; Panda, Koustubh] Univ Calcutta, Dept Biotechnol, Kolkata, India; [Ganguly, Souradipta; Panda, Koustubh] Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Kumar, Taposh G.; Mantha, Sudarshan] Waters India Private Ltd, Waters Applicat Lab, Bangalore, Karnataka, India	University of Calcutta; University of Calcutta	Panda, K (corresponding author), Univ Calcutta, Dept Biotechnol, Kolkata, India.; Panda, K (corresponding author), Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata, India.	kpbcg@caluniv.ac.in	Panda, Koustubh/E-5273-2017	Panda, Koustubh/0000-0002-4783-2221	Tea Board of India, Govt. of India [RL 21 (20) /2007/Part-I/4103]	Tea Board of India, Govt. of India	Financial support for this work was received from Tea Board of India, Govt. of India to KP (Sanction No. RL 21 (20) /2007/Part-I/4103). The funder (Tea Board of India, Govt. of India) provided support in the form of salary (research fellowship) for SG (first author) and funds for procurement of chemicals, equipment and other research materials to KP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SG and KP in the study are clearly described in the 'author contributions' section. Neither Waters India Pvt. Ltd. nor its Application Scientists TG and SM, serving as co-authors in this manuscript, were involved in any form in the funding or designing of the study but providing assistance in operating of the instruments, acquisition and processing of data (TG & SM) as well as preparation of manuscript (SM).	AITIO A, 1973, XENOBIOTICA, V3, P13, DOI 10.3109/00498257309151496; Banerjee Shuvojit, 2007, J Inflamm (Lond), V4, P3, DOI 10.1186/1476-9255-4-3; BORGHOFF SJ, 1985, DRUG METAB DISPOS, V13, P62; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Chhabra SK, 2001, EPIDEMIOL REV, V23, P106, DOI 10.1093/oxfordjournals.epirev.a000774; Chu KO, 2004, J CHROMATOGR B, V810, P187, DOI 10.1016/j.jchromb.2004.07.031; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Fu T, 2008, J CHROMATOGR B, V875, P363, DOI 10.1016/j.jchromb.2008.09.027; Henning SM, 2004, AM J CLIN NUTR, V80, P1558; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489; HJELLE JT, 1986, J PHARMACOL EXP THER, V236, P150; Kadian N, 2016, J PHARMACEUT BIOMED, V126, P83, DOI 10.1016/j.jpba.2016.03.052; Kida K, 2000, J AGR FOOD CHEM, V48, P4151, DOI 10.1021/jf000386x; Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5; Kohri T, 2001, J AGR FOOD CHEM, V49, P1042, DOI 10.1021/jf0011236; Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S; Lee BL, 2000, J CHROMATOGR A, V881, P439, DOI 10.1016/S0021-9673(00)00215-6; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Masukawa Y, 2006, J CHROMATOGR B, V834, P26, DOI 10.1016/j.jchromb.2006.02.008; Mata-Bilbao MDL, 2007, J AGR FOOD CHEM, V55, P8857, DOI [10.1021/jf0713962, 10.1021/if0713962]; Misaka S, 2013, BIOMED CHROMATOGR, V27, P1, DOI 10.1002/bmc.2740; Misra A, 2003, J NUTR, V133, P2622, DOI 10.1093/jn/133.8.2622; Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7; MUNROE DG, 1987, AM J HUM GENET, V40, P102; Nakagawa K, 1997, ANAL BIOCHEM, V248, P41, DOI 10.1006/abio.1997.2098; Peterson J, 2004, J FOOD COMPOS ANAL, V17, P397, DOI 10.1016/j.jfca.2004.03.022; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Rietveld A, 2003, J NUTR, V133, p3285S, DOI 10.1093/jn/133.10.3285S; Rimm EB, 1996, ANN INTERN MED, V125, P384, DOI 10.7326/0003-4819-125-5-199609010-00005; Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194; Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118; Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118; Vaidyanathan JB, 2002, DRUG METAB DISPOS, V30, P897, DOI 10.1124/dmd.30.8.897; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wang PW, 2012, FOOD FUNCT, V3, P635, DOI 10.1039/c2fo10254d; Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 2006, MOL CARCINOGEN, V45, P431, DOI 10.1002/mc.20228; Yang CS, 1999, CANCER EPIDEM BIOMAR, V8, P83; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu M, 2001, XENOBIOTICA, V31, P51, DOI 10.1080/00498250010024988; Zimmermann BF, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P387, DOI 10.1016/B978-0-12-384937-3.00032-X	49	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163498	10.1371/journal.pone.0163498	http://dx.doi.org/10.1371/journal.pone.0163498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695123	Green Published, gold, Green Submitted			2022-12-26	WOS:000385553100038
J	Uyeda, JC; Harmon, LJ; Blank, CE				Uyeda, Josef C.; Harmon, Luke J.; Blank, Carrine E.			A Comprehensive Study of Cyanobacterial Morphological and Ecological Evolutionary Dynamics through Deep Geologic Time	PLOS ONE			English	Article							MESOPROTEROZOIC GAOYUZHUANG FORMATION; PRECAMBRIAN ORGANIC WORLD; RIBOSOMAL-RNA GENE; BIOGEOCHEMICAL PROCESSES; MOLECULAR EVOLUTION; SEQUENCE-ANALYSIS; DIVERGENCE TIMES; PRINCIPAL STAGES; ABSOLUTE RATES; DIVERSIFICATION	Cyanobacteria have exerted a profound influence on the progressive oxygenation of Earth. As a complementary approach to examining the geologic record D phylogenomic and trait evolutionary analyses of extant species can lead to new insights. We constructed new phylogenomic trees and analyzed phenotypic trait data using novel phylogenetic comparative methods. We elucidated the dynamics of trait evolution in Cyanobacteria over billion-year timescales, and provide evidence that major geologic events in early Earth's history have shaped D and been shaped by D evolution in Cyanobacteria. We identify a robust core cyanobacterial phylogeny and a smaller set of taxa that exhibit long-branch attraction artifacts. We estimated the age of nodes and reconstruct the ancestral character states of 43 phenotypic characters. We find high levels of phylogenetic signal for nearly all traits, indicating the phylogeny carries substantial predictive power. The earliest cyanobacterial lineages likely lived in freshwater habitats, had small cell diameters, were benthic or sessile, and possibly epilithic/ endolithic with a sheath. We jointly analyzed a subset of 25 binary traits to determine whether rates of trait evolution have shifted over time in conjunction with major geologic events. Phylogenetic comparative analysis reveal an overriding signal of decreasing rates of trait evolution through time. Furthermore, the data suggest two major rate shifts in trait evolution associated with bursts of evolutionary innovation. The first rate shift occurs in the aftermath of the Great Oxidation Event and broken vertical bar Snowball Earth - glaciations and is associated with decrease in the evolutionary rates around 1.8 +/- 1.6 Ga. This rate shift seems to indicate the end of a major diversification of cyanobacterial phenotypes - particularly related to traits associated with filamentous morphology, heterocysts and motility in freshwater ecosystems. Another burst appears around the time of the Neoproterozoic Oxidation Event in the Neoproterozoic, and is associated with the acquisition of traits involved in planktonic growth in marine habitats. Our results demonstrate how uniting genomic and phenotypic datasets in extant bacterial species can shed light on billion-year old events in Earth's history.	[Uyeda, Josef C.; Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Blank, Carrine E.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA	Idaho; University of Idaho; University of Montana System; University of Montana	Uyeda, JC (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	josef.uyeda@gmail.com		Uyeda, Josef/0000-0003-4624-9680; Harmon, Luke/0000-0002-4985-5750	National Science Foundation [DEB-1208912, DEB-1208534]	National Science Foundation(National Science Foundation (NSF))	DEB-1208912 (https://www.risf.govi awardsearch/showAward?AWD_ID=12085348&HistoricalAwards=false) supported the work of LJH and postdoctoral funding for JCU. DEB-1208534 (https://www.nst.gov/ awardsearch/showAward?AWD_ID=1208534&HistoricalAwards=false) supported CEB.; This work was funded by grants from the National Science Foundation (award DEB-1208534 to C.E.B. and DEB-1208912 to L.J.H.). We would like to thank Matt Pennell, Lisa Moore, Daniel Caetano, and several anonymous reviewers for helpful feedback on earlier versions of this manuscript.	Altermann W, 2001, J AFR EARTH SCI, V33, P427, DOI 10.1016/S0899-5362(01)00089-6; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; [Anonymous], 2001, BERGEYS MANUAL SYSTE; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bielejec F, 2014, SYST BIOL, V63, P493, DOI 10.1093/sysbio/syu015; Blank CE, 2010, GEOBIOLOGY, V8, P1, DOI 10.1111/j.1472-4669.2009.00220.x; Blank CE, 2013, J PHYCOL, V49, P1040, DOI 10.1111/jpy.12111; Blank CE, 2012, ARCHAEA, V2012, DOI 10.1155/2012/843539; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; Blank CE, 2002, THESIS; Boyer SL, 2002, J PHYCOL, V38, P1222, DOI 10.1046/j.1529-8817.2002.01168.x; Bressan A, 2012, MICROB ECOL, V63, P628, DOI 10.1007/s00248-011-9933-5; Bryant WA, 2013, J COMPUT BIOL, V20, P755, DOI 10.1089/cmb.2013.0079; Butterfield NJ, 2015, PALAEONTOLOGY, V58, P953, DOI 10.1111/pala.12211; Castenholz R. W., 2001, BERGEYS MANUAL SYSTE, P539; Castenholz RW, 2001, BERGEYS MANUAL SYSTE; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Criscuolo A, 2011, MOL BIOL EVOL, V28, P3019, DOI 10.1093/molbev/msr108; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dvorak P, 2015, BIODIVERS CONSERV, V24, P739, DOI 10.1007/s10531-015-0888-6; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FitzJohn RG, 2012, METHODS ECOL EVOL, V3, P1084, DOI 10.1111/j.2041-210X.2012.00234.x; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Golubic S, 1995, LETHAIA, V28, P285, DOI 10.1111/j.1502-3931.1995.tb01817.x; Goode M, 2008, GENOME INFORM SER, V21, P150; Gubry-Rangin C, 2015, P NATL ACAD SCI USA, V112, P9370, DOI 10.1073/pnas.1419329112; Gugger MF, 2004, INT J SYST EVOL MICR, V54, P349, DOI 10.1099/ijs.0.02744-0; Guilbaud R, 2015, NAT GEOSCI, V8, P466, DOI 10.1038/NGEO2434; Hardisty DS, 2014, GEOLOGY, V42, P619, DOI 10.1130/G35439.1; Harmon LJ, 2013, PLOS CURRENTS, P5, DOI [10.1371/currents.tol, DOI 10.1371/CURRENTS.TOL]; Herdman M, 2001, BERGEYS MANUAL SYSTE; Hoffmann L., 2005, ALGOL STUD, V117, P95, DOI DOI 10.1127/1864-1318/2005/0117-0095; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; Hofmann HJ, 1994, MEMOIR PALEONTOLOGIC, P1; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Howard-Azzeh M, 2014, PHOTOSYNTH RES, V122, P171, DOI 10.1007/s11120-014-0020-x; Kah LC, 2001, PRECAMBRIAN RES, V111, P203, DOI 10.1016/S0301-9268(01)00161-9; Kaplan-Levy RN, 2010, TOP CURR GENET, V21, P5, DOI 10.1007/978-3-642-12422-8_2; Katz LA, 2015, SYST BIOL, V64, P406, DOI 10.1093/sysbio/syu126; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Leigh JW, 2011, MOL BIOL EVOL; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li HK, 2013, J ASIAN EARTH SCI, V72, P216, DOI 10.1016/j.jseaes.2013.02.020; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Maddison WP., 2021, MESQUITE MODULAR SYS; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Mishler BD, 2000, SPECIES CONCEPTS AND PHYLOGENETIC THEORY: A DEBATE, P119; MITRA AK, 1950, ANN BOT-LONDON, V14, P457, DOI 10.1093/oxfordjournals.aob.a083258; Muhlsteinova R, 2014, PHYTOTAXA, V163, P216; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petitjean C, 2015, MOL BIOL EVOL, V32, P1242, DOI 10.1093/molbev/msv015; Pietrasiak N, 2014, PHYCOLOGIA, V53, P529, DOI 10.2216/14-029.1; Ramulu HG, 2014, MOL PHYLOGENET EVOL, V75, P103, DOI 10.1016/j.ympev.2014.02.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosen MJ, 2015, SCIENCE, V348, P1019, DOI 10.1126/science.aaa4456; Sachs JL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2146; Sanchez-Baracaldo P, 2005, GEOBIOLOGY, V3, P145, DOI 10.1111/j.1472-4669.2005.00050.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Schopf J.W., 1992, PROTEROZOIC BIOSPHER, P195, DOI DOI 10.1017/CBO9780511601064; Schopf JW, 2011, PHOTOSYNTH RES, V107, P87, DOI 10.1007/s11120-010-9577-1; Seong-Joo L, 1999, PRECAMBRIAN RES, V96, P183, DOI 10.1016/S0301-9268(99)00004-2; Seong-Joo L, 1998, LETHAIA, V31, P169; Sergeev VN, 2007, STRATIGR GEO CORREL+, V15, P141, DOI 10.1134/S0869593807020025; Sergeev VN, 2010, STRATIGR GEO CORREL+, V18, P561, DOI 10.1134/S0869593810060018; Sergeev VN, 2009, PRECAMBRIAN RES, V173, P212, DOI 10.1016/j.precamres.2009.04.002; Sergeev VN, 1997, PRECAMBRIAN RES, V85, P201, DOI 10.1016/S0301-9268(97)00035-1; Sharma M, 2004, PRECAMBRIAN RES, V134, P317, DOI 10.1016/j.precamres.2004.07.001; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Siegesmund MA, 2008, J PHYCOL, V44, P1572, DOI 10.1111/j.1529-8817.2008.00604.x; SINGH S, 1988, NEW PHYTOL, V110, P97, DOI 10.1111/j.1469-8137.1988.tb00241.x; Staley JT, 2009, J IND MICROBIOL BIOT, V36, P1331, DOI 10.1007/s10295-009-0642-8; Swithers KS, 2012, GENOME BIOL EVOL, V4, P842, DOI 10.1093/gbe/evs057; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Wagner A, 2008, MOL GENET GENOMICS, V280, P397, DOI 10.1007/s00438-008-0373-y; Waldbauer JR, 2011, P NATL ACAD SCI USA, V108, P13409, DOI 10.1073/pnas.1104160108; WILDON DC, 1963, ARCH MIKROBIOL, V47, P19, DOI 10.1007/BF00408286; Wilmotte A, 2001, BERGEYS MAN SYST BAC, P487; Xu Zl, ACTA BOT SINICA, V26, P216; Young GM, 2013, GEOSCI FRONT, V4, P247, DOI 10.1016/j.gsf.2012.07.003; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972	94	42	42	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0162539	10.1371/journal.pone.0162539	http://dx.doi.org/10.1371/journal.pone.0162539			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649395	gold, Green Published, Green Submitted			2022-12-26	WOS:000383892100021
J	Wei, XD; Liu, Z; Li, M; Yang, CH; Wang, WM; Li, XL; Zhang, SP; Li, XR; Tian, G; Bergquist, J; Wang, B; Mi, J				Wei, Xiaodan; Liu, Zhuang; Li, Min; Yang, Chunhua; Wang, Wenming; Li, Xianglin; Zhang, Shuping; Li, Xuri; Tian, Geng; Bergquist, Jonas; Wang, Bin; Mi, Jia			The Number of Stenotic Intracranial Arteries Is Independently Associated with Ischemic Stroke Severity	PLOS ONE			English	Article							CAROTID-ENDARTERECTOMY; CIRCULATION; OCCLUSION; STENOSIS; DENSITY; IMPACT; SCORE; FLOW	Background The severity of ischemic stroke symptoms varies among patients and is a critical determinant of patient outcome. To date, the association between the number of stenotic intracranial arteries and stroke severity remains unclear. Aims We aimed to investigate the association between the number of stenotic major intracranial arteries (NSMIA) and ischemic stroke severity, as well as the degree of stenosis and common stroke risk factors. Methods We performed a retrospective analysis of patients with digital subtraction angiography (DSA)-confirmed ischemic stroke. Clinical stroke severity was measured using the National Institutes of Health Stroke Scale (NIHSS). The number of stenotic vessels was counted from the internal carotid arteries and vertebral arteries, bilaterally. Results Eighty three patients were recruited from a single center and included in the study. NSMIA was significantly correlated with stroke severity (Pearson Correlation Coefficient = 0.485, P < 0.001), but not with the degree of stenosis (Pearson Correlation Coefficient = 0.01, P = 0.90). Multivariate regression analysis revealed that NSMIA was significantly associated with the NIHSS score after adjusting for stroke risk factors. The adjusted odds ratio (per lateral) was 2.092 (95% CI, 0.865 to 3.308, P = 0.001). The degree of stenosis was also significantly associated with the NIHSS score after adjusting for common risk factors. The odds ratio (per 10%) was 0.712 (95% CI, 0.202 to 1.223, P = 0.007). Conclusions The number of stenotic intracranial major arteries is associated with the severity of ischemic stroke independent of the degree of stenosis and other stroke risk factors. To the best of our knowledge, this has not been previosuly studied in great detail using DSA. Our data highlight the importance of examining all major arteries in stroke patients.	[Wei, Xiaodan; Li, Min; Yang, Chunhua; Li, Xianglin; Zhang, Shuping; Li, Xuri; Tian, Geng; Wang, Bin; Mi, Jia] Binzhou Med Univ, Med & Pharmaceut Res Ctr, Yantai, Shandong, Peoples R China; [Liu, Zhuang; Wang, Wenming] Binzhou Med Univ, Affiliated Hosp, Dept Clin Imaging, Binzhou, Shandong, Peoples R China; [Bergquist, Jonas; Mi, Jia] Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden; [Bergquist, Jonas; Mi, Jia] Uppsala Univ, SciLifeLab, Analyt Chem, Uppsala, Sweden	Binzhou Medical University; Binzhou Medical University; Uppsala University; SciLifeLab; Uppsala University	Yang, CH; Wang, B; Mi, J (corresponding author), Binzhou Med Univ, Med & Pharmaceut Res Ctr, Yantai, Shandong, Peoples R China.; Mi, J (corresponding author), Uppsala Univ, Dept Chem, BMC, Uppsala, Sweden.; Mi, J (corresponding author), Uppsala Univ, SciLifeLab, Analyt Chem, Uppsala, Sweden.	yangchunhua08@126.com; wangbinbzmc@163.com; Jiajiami@gmail.com		Bergquist, Jonas/0000-0002-4597-041X	National Natural Science Foundation of China [81171303, 81400771, 31170321]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China 81400771 (GT, http://www.nsfc.gov.cn/, study design), National Natural Science Foundation of China 81171303 (BW, http://www.nsfc.gov.cn/, decision to publish), and National Natural Science Foundation of China 31170321 (SZ, http://www.nsfc.gov.cn/, study design).	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Adla T, 2015, INT J ANGIOL, V24, P179, DOI 10.1055/s-0035-1556056; Albright K, 2014, STROKE S1, V45; [Anonymous], 1991, STROKE, V22, P816; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Cloud GC, 2003, QJM-INT J MED, V96, P27, DOI 10.1093/qjmed/hcg003; Cuadrado-Godia E, 2013, J NEUROL NEUROSUR PS, V84, P305, DOI 10.1136/jnnp-2012-303638; FABRIS F, 1994, STROKE, V25, P1133, DOI 10.1161/01.STR.25.6.1133; Fischer U, 2005, STROKE, V36, P2121, DOI 10.1161/01.STR.0000182099.04994.fc; Kawano H, 2016, STROKE, V47, P742, DOI 10.1161/STROKEAHA.115.011320; Kim A, 2015, ANN SURG TREAT RES, V89, P261, DOI 10.4174/astr.2015.89.5.261; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Marquardt L, BRAIN; Melnikova E A, 2015, Vopr Kurortol Fizioter Lech Fiz Kult, V92, P4, DOI 10.17116/kurort201554-11; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; Nicolau C, 2001, J ULTRAS MED, V20, P105; Putaala J, 2013, ACTA NEUROL SCAND, V127, P61, DOI 10.1111/j.1600-0404.2012.01683.x; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Romero JR, 2009, CURR CARDIOL REV, V5, P279, DOI 10.2174/157340309789317887; Sachar R, 2004, J AM COLL CARDIOL, V43, P1358, DOI 10.1016/j.jacc.2003.11.049; Shin HK, 1999, ARCH NEUROL-CHICAGO, V56, P1353, DOI 10.1001/archneur.56.11.1353; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Soderholm M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124957; van Dijk AC, 2014, STROKE, V45, P728, DOI 10.1161/STROKEAHA.113.003197; Yeh PS, 2013, ATHEROSCLEROSIS, V228, P472, DOI 10.1016/j.atherosclerosis.2013.03.015	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2016	11	9							e0163356	10.1371/journal.pone.0163356	http://dx.doi.org/10.1371/journal.pone.0163356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GE	27649086	Green Published, Green Submitted, gold			2022-12-26	WOS:000383892100082
J	Lee, YT; Chiang, MC; Kuo, SC; Wang, YC; Lee, IH; Chen, TL; Yang, YS				Lee, Yi-Tzu; Chiang, Mei-Chun; Kuo, Shu-Chen; Wang, Yung-Chih; Lee, I-Hsin; Chen, Te-Li; Yang, Ya-Sung			Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia	PLOS ONE			English	Article							BORNE BLA(OXA-58) GENE; SUSCEPTIBILITY BREAKPOINTS; IDENTIFICATION; RESISTANCE; EMERGENCE; INFECTION; COMPLEX; TAIWAN; SPACER; LEVEL	The carbapenem breakpoints set by different organizations for Acinetobacter are discordant, but supporting clinical data are lacking. This study aimed to provide the first clinical outcome data to support the carbapenem breakpoints for Acinetobacter baumannii (Ab) group in patients with bacteremia. This study included 117 adults who received carbapenems for treatment of Ab group bacteremia in Taipei Veterans General Hospital over an 8-year period. We analyzed 30-day mortality rates among patient groups acquiring isolates with different carbapenem minimal inhibitory concentrations (MICs). The carbapenem MIC breakpoint derived from classification and regression tree (CART) analysis to delineate the risk of 30-day mortality was between MICs of <= 4 mg/L and >= 8 mg/L. Mortality rate was higher in patients acquiring isolates with carbapenem MIC >= 8 mg/L than <= 4 mg/L, by bivariate (54.9% [28/51] vs 25.8% [17/66]; P = 0.003) and survival analysis (P = 0.001 by log-rank test). Multivariate analysis using logistic regression and Cox regression models including severity of illness indices demonstrated that treating patients with Ab group bacteremia caused by isolates with a carbapenem MIC >= 8 mg/L with carbapenem was an independent predictor of 30-day mortality (odds ratio, 5.125; 95% confidence interval [CI], 1.946-13.498; P = 0.001, and hazard ratio, 2.630; 95% CI, 1.431-4.834; P = 0.002, respectively). The clinical outcome data confirmed that isolates with MIC <= 4 mg/L were susceptible to carbapenem, and those with MIC >= 8 mg/L were resistant in patients with Ab group bacteremia.	[Lee, Yi-Tzu; Lee, I-Hsin] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Lee, Yi-Tzu; Lee, I-Hsin] Taipei Vet Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chiang, Mei-Chun] Natl Yang Ming Univ, Inst Publ Hlth, Sch Med, Div Prevent Med, Taipei, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan Township, Maoli County, Taiwan; [Wang, Yung-Chih; Yang, Ya-Sung] Triserv Gen Hosp, Div Infect Dis & Trop Med, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Wang, Yung-Chih] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Lee, I-Hsin] Natl Yang Ming Univ, Inst Biomed Informat, Sch Med, Taipei, Taiwan; [Chen, Te-Li] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Te-Li] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Defense Medical Center; Taipei Veterans General Hospital	Yang, YS (corresponding author), Triserv Gen Hosp, Div Infect Dis & Trop Med, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.	ysyoung4097@gmail.com	Kuo, Shu-Chen/U-6115-2019; Wang, Yung-Chih/ABE-9069-2020	Kuo, Shu-Chen/0000-0002-6940-6450; Wang, Yung-Chih/0000-0002-8491-8972	Tri-Service General Hospital, National Defense Medical Center [TSGH-C104-119, TSGH-105-113, TSGH-C106-096, DV104-09]; Taipei Veterans General Hospital [V104B-017, V105B-005]; Ministry of Science and Technology [MOST 104-2314-B-016-051, MOST 104-2314-B-075-043-MY3, MOST 105-2628-B-016-003-MY2]	Tri-Service General Hospital, National Defense Medical Center; Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from Tri-Service General Hospital, National Defense Medical Center (TSGH-C104-119, TSGH-105-113, TSGH-C106-096, and DV104-09), Taipei Veterans General Hospital (V104B-017 and V105B-005), and the Ministry of Science and Technology (MOST 104-2314-B-016-051, MOST 104-2314-B-075-043-MY3, and MOST 105-2628-B-016-003-MY2).	[Anonymous], 2015, M100S25 CLSI; Aronoff GR, 2007, DRUG PRESCRIBING REN, V5th; Bhat SV, 2007, ANTIMICROB AGENTS CH, V51, P4390, DOI 10.1128/AAC.01487-06; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chen LY, 2011, J MICROBIOL IMMUNOL, V44, P358, DOI 10.1016/j.jmii.2011.01.032; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P4575, DOI 10.1128/AAC.00764-10; Chen TL, 2010, ANTIMICROB AGENTS CH, V54, P3107, DOI 10.1128/AAC.00128-10; Chiang MC, 2012, INFECTION, V40, P19, DOI 10.1007/s15010-011-0187-4; Dalhoff A, 2009, INFECTION, V37, P296, DOI 10.1007/s15010-009-7108-9; DeRyke CA, 2007, DIAGN MICR INFEC DIS, V58, P337, DOI 10.1016/j.diagmicrobio.2007.01.004; Frei CR, 2008, J ANTIMICROB CHEMOTH, V61, P621, DOI 10.1093/jac/dkm536; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Huang LY, 2008, CLIN MICROBIOL INFEC, V14, P1010, DOI 10.1111/j.1469-0691.2008.02077.x; Jean SS, 2013, INT J ANTIMICROB AG, V41, P457, DOI 10.1016/j.ijantimicag.2013.02.001; Koomanachai P, 2010, CLIN THER, V32, P766, DOI 10.1016/j.clinthera.2010.04.003; Lee NY, 2010, J INFECTION, V61, P219, DOI 10.1016/j.jinf.2010.07.002; Lee YT, 2012, CLIN INFECT DIS, V55, P209, DOI 10.1093/cid/cis385; Lee YT, 2009, J CHEMOTHERAPY, V21, P514, DOI 10.1179/joc.2009.21.5.514; Lee YT, 2009, INT J ANTIMICROB AG, V34, P580, DOI 10.1016/j.ijantimicag.2009.06.027; MacVane SH, 2014, ANTIMICROB AGENTS CH, V58, P599, DOI 10.1128/AAC.02029-13; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Turnidge J, 2007, CLIN MICROBIOL REV, V20, P391, DOI 10.1128/CMR.00047-06	27	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163271	10.1371/journal.pone.0163271	http://dx.doi.org/10.1371/journal.pone.0163271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644087	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900040
